"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,A1,US 2016/0002844 A1,072-322-837-250-751,2016-01-07,2016,US 201514747811 A,2015-06-23,US 201514747811 A;;US 201462021015 P,2014-07-04,Hygienic Laundry Basket,"A sanitary laundry basket that prevents cross-contamination between dirty laundry and clean laundry by having a flexible partition shaped like half of the interior of the laundry basket, attached to the midpoint of the interior of the laundry basket, where the flexible partition can be “flipped” inside out to cover the other half of the interior of the laundry basket, so that the clean laundry never touches the same surface as the dirty laundry.",FLEMING HEATHER;;FLEMING MARK,FLEMING HEATHER;;FLEMING MARK,,https://lens.org/072-322-837-250-751,Patent Application,yes,0,4,1,1,0,B65D21/086;;B65D25/06;;B65D25/30;;B65D81/24;;D06F95/002;;D06F95/002,D06F95/00;;B65D21/08;;B65D25/06;;B65D25/30;;B65D81/24,,0,0,,,,DISCONTINUED
2,US,A1,US 2015/0297941 A1,139-471-675-034-930,2015-10-22,2015,US 201414575940 A,2014-12-18,US 201414575940 A;;US 201414512278 A;;US 201361890183 P,2013-10-12,Fold and Roll Exercise Mat,"A yoga mat comprising a folding hinge, said yoga mat designed to be folded and then rolled up while it is folded.",FLEMING HEATHER;;FLEMING MARK,FLEMING HEATHER;;FLEMING MARK,,https://lens.org/139-471-675-034-930,Patent Application,yes,16,4,2,3,0,A63B21/4037;;A63B21/4037;;A63B2210/50;;A63B2210/50,A63B21/00,,0,0,,,,ACTIVE
3,US,B2,US 9669253 B2,135-338-589-804-515,2017-06-06,2017,US 201414575940 A,2014-12-18,US 201414575940 A;;US 201414512278 A;;US 201361890183 P,2013-10-12,Fold and roll exercise mat,"A yoga mat comprising a folding hinge, said yoga mat designed to be folded and then rolled up while it is folded.",FLEMING HEATHER;;FLEMING MARK,FLEMING HEATHER;;FLEMING MARK,,https://lens.org/135-338-589-804-515,Granted Patent,yes,19,2,2,3,0,A63B21/4037;;A63B21/4037;;A63B2210/50;;A63B2210/50,A63B26/00;;A63B21/00,,0,0,,,,ACTIVE
4,US,A1,US 2015/0143631 A1,184-563-229-499-754,2015-05-28,2015,US 201414512278 A,2014-10-10,US 201414512278 A;;US 201361890183 P,2013-10-12,Fold and Roll Exercise Mat,"A yoga mat comprising a folding hinge, said yoga mat designed to be folded in the middle and then rolled up in such a way that the edges of the mat line up when it is folded and then rolled.",FLEMING HEATHER;;FLEMING MARK,FLEMING HEATHER;;FLEMING MARK,,https://lens.org/184-563-229-499-754,Patent Application,yes,13,4,1,3,0,A63B21/4037;;A63B21/4037;;A63B2209/10;;A63B2209/10;;A63B2210/50;;A63B2210/50,A63B21/00;;A63B6/00,5/417,0,0,,,,DISCONTINUED
5,US,A1,US 2018/0056338 A1,049-053-915-989-388,2018-03-01,2018,US 201615252780 A,2016-08-31,US 201615252780 A,2016-08-31,Automated Grill Cleaning System,An automated grill cleaning system for automatically cleaning a grill in a cooker includes a cooking unit that may be used to cook. The cooking unit has a housing and a grill is positioned in the housing. The housing has an outer wall. A cleaning unit is coupled to the cooking unit and the cleaning unit is positioned on the outer wall. The cleaning unit selectively engages the grill. The cleaning unit urges itself to travel along the grill to abrade debris from the grill.,FLEMING MARK,FLEMING MARK,,https://lens.org/049-053-915-989-388,Patent Application,yes,3,4,2,2,0,A47L13/34;;A47J37/0786;;B08B1/165;;B08B1/30;;A47J37/0786;;A47J37/0704;;A47L13/34;;B08B1/30;;B08B1/165;;B08B1/12,B08B1/00;;A47J37/07,,0,0,,,,INACTIVE
6,US,B2,US 10244895 B2,037-399-809-757-121,2019-04-02,2019,US 201615252780 A,2016-08-31,US 201615252780 A,2016-08-31,Automated grill cleaning system,An automated grill cleaning system for automatically cleaning a grill in a cooker includes a cooking unit that may be used to cook. The cooking unit has a housing and a grill is positioned in the housing. The housing has an outer wall. A cleaning unit is coupled to the cooking unit and the cleaning unit is positioned on the outer wall. The cleaning unit selectively engages the grill. The cleaning unit urges itself to travel along the grill to abrade debris from the grill.,FLEMING MARK,FLEMING MARK,,https://lens.org/037-399-809-757-121,Granted Patent,yes,11,0,2,2,0,A47L13/34;;A47J37/0786;;B08B1/165;;B08B1/30;;A47J37/0786;;A47J37/0704;;A47L13/34;;B08B1/30;;B08B1/165;;B08B1/12,A47J37/07;;A47L13/34;;B08B1/00,,0,0,,,,INACTIVE
7,EP,A1,EP 3119251 A1,075-931-316-503-533,2017-01-25,2017,EP 15765838 A,2015-03-20,US 201461968150 P;;US 2015/0021663 W,2014-03-20,CONTAINER/LID/BLENDER INTERLOCK,,VITA-MIX MAN CORP,FLEMING MARK FREDERICK,,https://lens.org/075-931-316-503-533,Patent Application,yes,0,0,9,9,0,F16P3/08;;F16P3/10;;A47J43/0772;;B01F35/6052;;B01F35/2131;;B01F35/2209;;F16P3/08;;F16P3/10;;A47J43/0772;;B01F35/6052;;B01F35/2131;;B01F35/2209,A47J43/046;;A47J43/07;;B01F35/60,,0,0,,,,DISCONTINUED
8,US,A1,US 2019/0001287 A1,045-996-979-455-009,2019-01-03,2019,US 201815991393 A,2018-05-29,US 201815991393 A;;US 201514663627 A;;US 201461968150 P,2014-03-20,Container/Lid/Blender Interlock,"An interlocking method and blending apparatus is provided which includes a base, container, and lid. The apparatus comprises light emitters, light sensors, and light reflectors. Light is emitted by the light emitters from the base, through the container, and toward the lid. Light reflectors in the lid reflect the light back through the container and toward the base. The light sensors detect the reflected light and can be used to control operation of the blender and illumination of the container. Light may be in the visible spectrum, or sub-visible spectrum. The light emitters and light sensors may be at the base and/or the bottom of the container.",VITA MIX MAN CORP,FLEMING MARK FREDERICK,VITA-MIX MANAGEMENT CORPORATION (2016-07-28),https://lens.org/045-996-979-455-009,Patent Application,yes,0,0,9,9,0,F16P3/08;;F16P3/10;;A47J43/0772;;B01F35/6052;;B01F35/2131;;B01F35/2209;;F16P3/08;;F16P3/10;;A47J43/0772;;B01F35/6052;;B01F35/2131;;B01F35/2209,B01F35/60;;A47J43/07;;F16P3/08;;F16P3/10,,0,0,,,,ACTIVE
9,US,A,US 4441203 A,199-238-945-203-702,1984-04-03,1984,US 26000782 A,1982-03-04,US 26000782 A,1982-03-04,Music speech filter,"A music/speech filter is provided for automatically determining whether an audio signal is music or speech by obtaining a relative measure of the energy in a selective frequency range and, from this determination, controlling the passage or path of the audio signal. The filter can be attached to a radio receiver to selectively pass either music or speech at the option of the user.",FLEMING MARK C,FLEMING MARK C,,https://lens.org/199-238-945-203-702,Granted Patent,yes,5,14,1,1,0,G10L25/78;;G10L25/78;;G10H1/12;;G10H1/12;;G10H2210/046;;G10H2210/046,G10H1/12;;G10L11/02,381/110;;381/46,3,0,,,"Gannett, E. K., Radio Attachment Eliminates Commercials; Institute of Radio Engineers, N.Y., 3/22/51, presented at Radio Engineers Convention.;;Radio Electronics; vol. 27, No. 9, Sept. 1956, pp. 62 64; Speech Music Discriminator, by Edward Predmore.;;Electronics, Apr. 1957, pp. 183 185; Music Pulse Analyzer Rejects Voice Signals, by Ronald L. Ives.",EXPIRED
10,EP,A4,EP 3119251 A4,128-122-931-945-262,2017-11-29,2017,EP 15765838 A,2015-03-20,US 201461968150 P;;US 2015/0021663 W,2014-03-20,CONTAINER/LID/BLENDER INTERLOCK,,VITA-MIX MAN CORP,FLEMING MARK FREDERICK,,https://lens.org/128-122-931-945-262,Search Report,no,4,0,9,9,0,F16P3/08;;F16P3/10;;A47J43/0772;;B01F35/6052;;B01F35/2131;;B01F35/2209;;F16P3/08;;F16P3/10;;A47J43/0772;;B01F35/6052;;B01F35/2131;;B01F35/2209,A47J43/07;;A47J43/046;;B01F35/60,,0,0,,,,DISCONTINUED
11,US,A1,US 2013/0282596 A1,171-372-666-462-171,2013-10-24,2013,US 201213454942 A,2012-04-24,US 201213454942 A,2012-04-24,SYSTEMS AND METHODS FOR EVALUATING PROPERTY VALUATIONS,"Systems and methods are disclosed for evaluating a property valuation. In some implementations, market information and transactional information for a group of properties is accessed. The market information can include property-specific factors, locational factors, and market sales factors. The transactional information can include exogenous factors that can influence a property evaluator. Statistical information relating to the market values of the properties and the property valuations can be calculated. An estimate of the degree of certainty for a property valuation can be determined based at least partly on the calculated statistical information.",FLEMING MARK M;;CORELOGIC SOLUTIONS LLC,FLEMING MARK M,CORELOGIC SOLUTIONS LLC (2012-04-23),https://lens.org/171-372-666-462-171,Patent Application,yes,19,18,2,2,0,G06Q50/16;;G06Q30/0206;;G06Q50/16;;G06Q30/0206,G06Q50/16,705/306,1,1,045-439-447-316-583,10.1007/s11146-010-9290-z,"Zhu, ""Distressed Properties : Valuation Bias and Accuracy,"" J. Real Estate Finan. Econ. (2012) 44:153-166. Published Online: November 16, 2010. http://link.springer.com/article/10.1007%2Fs11146-010-9290-z",DISCONTINUED
12,US,A,US 5277828 A,007-019-837-431-203,1994-01-11,1994,US 87209692 A,1992-04-21,US 87209692 A,1992-04-21,Steam regenerable filter and method,"A filter assembly for fluids such as air and water employs a cleanable filter. The filter is located within a housing having a reservoir, and a steam generator which can be selectively operated to clean the filter.",FLEMING MARK A,FLEMING MARK A,,https://lens.org/007-019-837-431-203,Granted Patent,yes,14,15,1,1,0,B01D24/08;;B01D35/04;;B01D46/24;;B01D24/4631;;B01D46/84;;B01D46/24;;B01D24/08;;B01D35/04;;B01D46/84,B01D24/08;;B01D35/04;;B01D46/00;;B01D46/24;;B01D46/42,210/792;;210/791;;210/134;;210/89;;210/175;;210/149;;210/295;;210/264;;210/261,0,0,,,,EXPIRED
13,US,S,US D0766383 S,020-825-809-597-051,2016-09-13,2016,US 201529526940 F,2015-05-14,US 201529526940 F,2015-05-14,Forearm stretcher,,FLEMING MARK E,FLEMING MARK E,,https://lens.org/020-825-809-597-051,Design Right,no,0,3,1,1,0,,,2102;;D21/684,0,0,,,,ACTIVE
14,AU,A,AU 1989/040662 A,041-216-730-706-014,1990-03-05,1990,AU 1989/040662 A,1989-08-15,AU 986088 A;;AU 1989/040662 A,1988-08-15,EVAPORATOR PLATE,,SIDDONS RAMSET LTD,FLEMING MARK GEORGE,,https://lens.org/041-216-730-706-014,Patent Application,no,0,0,1,1,0,,F25B39/02,,0,0,,,,DISCONTINUED
15,US,B2,US 10357749 B2,067-607-918-983-349,2019-07-23,2019,US 201815991393 A,2018-05-29,US 201815991393 A;;US 201514663627 A;;US 201461968150 P,2014-03-20,Container/lid/blender interlock,"An interlocking method and blending apparatus is provided which includes a base, container, and lid. The apparatus comprises light emitters, light sensors, and light reflectors. Light is emitted by the light emitters from the base, through the container, and toward the lid. Light reflectors in the lid reflect the light back through the container and toward the base. The light sensors detect the reflected light and can be used to control operation of the blender and illumination of the container. Light may be in the visible spectrum, or sub-visible spectrum. The light emitters and light sensors may be at the base and/or the bottom of the container.",VITA MIX MAN CORP,FLEMING MARK FREDERICK,VITA-MIX MANAGEMENT CORPORATION (2016-07-28),https://lens.org/067-607-918-983-349,Granted Patent,yes,94,5,9,9,0,F16P3/08;;F16P3/10;;A47J43/0772;;B01F35/6052;;B01F35/2131;;B01F35/2209;;F16P3/08;;F16P3/10;;A47J43/0772;;B01F35/6052;;B01F35/2131;;B01F35/2209,B01F35/60;;A47J43/07;;F16P3/08;;F16P3/10,,1,0,,,"European Patent Office Communication pursuant to Article 94(3) EPC for Application No. 15765838.6, dated Mar. 26, 2019; 5 pages.",ACTIVE
16,WO,A1,WO 2015/143268 A1,080-924-012-140-855,2015-09-24,2015,US 2015/0021663 W,2015-03-20,US 201461968150 P,2014-03-20,CONTAINER/LID/BLENDER INTERLOCK,"An interlocking method and blending apparatus is provided which includes a base, container, and lid. The apparatus comprises light emitters, light sensors, and light reflectors. Light is emitted by the light emitters from the base, through the container, and toward the lid. Light reflectors in the lid reflect the light back through the container and toward the base. The light sensors detect the reflected light and can be used to control operation of the blender and illumination of the container. Light may be in the visible spectrum, or sub-visible spectrum. The light emitters and light sensors may be at the base and/or the bottom of the container.",VITA MIX CORP,FLEMING MARK FREDERICK,,https://lens.org/080-924-012-140-855,Patent Application,yes,12,3,9,9,0,F16P3/08;;F16P3/10;;A47J43/0772;;B01F35/6052;;B01F35/2131;;B01F35/2209;;F16P3/08;;F16P3/10;;A47J43/0772;;B01F35/6052;;B01F35/2131;;B01F35/2209,A47J43/07;;A47J43/046;;B01F35/60,,0,0,,,,PENDING
17,WO,A1,WO 2009/135297 A1,168-970-392-684-86X,2009-11-12,2009,CA 2009000609 W,2009-05-07,US 5146508 P,2008-05-08,MULTIPLE MODE REFRIGERATION,"A refrigeration system has a primary refrigeration circuit with an evaporator, a network driver, a condenser, and an expansion valve. These components are connected in series by a primary refrigerant line. The system also has a secondary refrigeration circuit which includes the evaporator, the condenser, and a bypass valve conncted in series by a secondary refrigerant line. The secondary refrigerant line is in fluid communication with the primary refrigerant line and has a network driver bypass line bridging an inlet and an outlet of the network driver. The network driver bypass line incorporates the bypass valve. A controller selectively de-activates the primary refrigeration circuit by de-activating the network driver and activates the secondary refrigeration circuit by opening the bypass valve.",UNIFIED CORP;;FLEMING MARK A,FLEMING MARK A,,https://lens.org/168-970-392-684-86X,Patent Application,yes,3,14,1,1,0,F25B41/00;;F25B2400/0401;;F25B2400/0411;;F25B2500/01;;F25B2700/2106,F25B6/04;;F25B49/02,,0,0,,,,PENDING
18,US,A1,US 2016/0275791 A1,117-936-621-986-548,2016-09-22,2016,US 201514658467 A,2015-03-16,US 201514658467 A,2015-03-16,SYNCRONIZED TRAFFIC WARNING SIGNAL SYSTEM,"A traffic warning signal system includes a substrate, and at least one light-emitting device embedded into the substrate and placed in proximity to a traffic signal such as to be visible upon approach to the traffic signal, such as the at least one light-emitting device is synchronized in at least one of a timing, a color, or a frequency with the traffic signal.",IBM,FLEMING MARK S,INTERNATIONAL BUSINESS MACHINES CORPORATION (2015-03-13),https://lens.org/117-936-621-986-548,Patent Application,yes,9,3,2,2,0,E01F9/529;;E01F9/529;;E01F9/559;;E01F9/559;;G08G1/095;;G08G1/095,G08G1/095,,0,0,,,,ACTIVE
19,CN,A,CN 106163353 A,133-924-837-876-155,2016-11-23,2016,CN 201580014817 A,2015-03-20,US 201461968150 P;;US 2015/0021663 W,2014-03-20,Container/lid/blender interlock,"An interlocking method and blending apparatus is provided which includes a base, container, and lid. The apparatus comprises light emitters, light sensors, and light reflectors. Light is emitted by the light emitters from the base, through the container, and toward the lid. Light reflectors in the lid reflect the light back through the container and toward the base. The light sensors detect the reflected light and can be used to control operation of the blender and illumination of the container. Light may be in the visible spectrum, or sub-visible spectrum. The light emitters and light sensors may be at the base and/or the bottom of the container.",VITA-MIX CORP,FLEMING MARK FREDERICK,,https://lens.org/133-924-837-876-155,Patent Application,no,7,2,9,9,0,F16P3/08;;F16P3/10;;A47J43/0772;;B01F35/6052;;B01F35/2131;;B01F35/2209;;F16P3/08;;F16P3/10;;A47J43/0772;;B01F35/6052;;B01F35/2131;;B01F35/2209,A47J43/046;;B01F35/60;;A47J43/07,,0,0,,,,INACTIVE
20,US,A1,US 2015/0265983 A1,166-545-525-683-116,2015-09-24,2015,US 201514663627 A,2015-03-20,US 201514663627 A;;US 201461968150 P,2014-03-20,Container/Lid/Blender Interlock,"An interlocking method and blending apparatus is provided which includes a base, container, and lid. The apparatus comprises light emitters, light sensors, and light reflectors. Light is emitted by the light emitters from the base, through the container, and toward the lid. Light reflectors in the lid reflect the light back through the container and toward the base. The light sensors detect the reflected light and can be used to control operation of the blender and illumination of the container. Light may be in the visible spectrum, or sub-visible spectrum. The light emitters and light sensors may be at the base and/or the bottom of the container.",VITA MIX CORP,FLEMING MARK FREDERICK,VITA-MIX MANAGEMENT CORPORATION (2015-04-30);;VITA-MIX HOLDINGS COMPANY (2014-12-29),https://lens.org/166-545-525-683-116,Patent Application,yes,4,19,9,9,0,F16P3/08;;F16P3/10;;A47J43/0772;;B01F35/6052;;B01F35/2131;;B01F35/2209;;F16P3/08;;F16P3/10;;A47J43/0772;;B01F35/6052;;B01F35/2131;;B01F35/2209,B01F35/60,,0,0,,,,ACTIVE
21,AU,A1,AU 2013/205293 A1,171-268-353-726-789,2013-11-07,2013,AU 2013/205293 A,2013-04-18,US 201213454942 A,2012-04-24,Systems and Methods for Evaluating Property Valuations,"SYSTEMS AND METHODS FOR EVALUATING PROPERTY VALUATIONS Systems and methods are disclosed for evaluating a property valuation. In some implementations, market information and transactional information for a group of properties is accessed. The market information can include property-specific factors, locational factors, and market sales factors. The transactional information can include exogenous factors that can influence a property evaluator. Statistical information relating to the market values of the properties and the property valuations can be calculated. An estimate of the degree of certainty for a property valuation can be determined based at least partly on the calculated statistical information. -30- ACCESS MARKET INFORMATION 405 FOR PROPERTIES CALCULATE STATISTICAL g/0 INFORMATION FOR THE MARKET VALUES OF THE PROPERTIES PREDICT MARKET VALUES FOR THE PROPERTIES ACCESS TRANSACTIONAL 420 INFORMATION FOR THE PROPERTIES CALCULATE STATISTICAL 425 INFORMATION FOR EVALUATIONS OF THE PROPERTIES PROVIDE ESTIMATE FOR DEGREE OF 430 CERTAINTY OF A PROPERTY",CORELOGIC SOLUTIONS LLC,FLEMING MARK M,,https://lens.org/171-268-353-726-789,Patent Application,no,0,1,2,2,0,G06Q50/16;;G06Q30/0206;;G06Q50/16;;G06Q30/0206,G06Q50/16,,0,0,,,,DISCONTINUED
22,WO,A1,WO 1990/001659 A1,089-517-752-377-195,1990-02-22,1990,AU 1945/089003 W,1989-08-15,AU PI986088 A,1988-08-15,EVAPORATOR PLATE,"An evaporator plate (2, 3, 4) suitable for use in a heat pump system, comprising a metallic plate in a substantially vertical orientation and having a refrigerant carrying passage (8) formed therein, said passage (8) including a refrigerant inlet passage (9) opening into a distribution chamber or manifold (11) from which a multiplicity of refrigerant flow passages (13-17) extend and branch into substantially parallel refrigerant flow passages (13a-17b) extending longitudinally of said plate, and a refrigerant outlet passage (10) connected to the ends of said parallel passages (13a-17b) for connection to a compressor, said inlet passage (9) being connected to said manifold (11) at a position (12) which is lower than the refrigerant flow carrying passages (13-17), said manifold (11) being constructed to define a surface down which liquid that separates from the refrigerant may flow back towards the inlet (12) to said manifold (11).",SIDDONS RAMSET LTD,FLEMING MARK GEORGE,,https://lens.org/089-517-752-377-195,Patent Application,yes,3,21,1,1,0,F28F9/0275;;F25B39/024;;F28F3/14;;F28F2210/02,F25B39/02,,0,0,,,,PENDING
23,US,B2,US 9666068 B2,067-193-799-587-994,2017-05-30,2017,US 201514658467 A,2015-03-16,US 201514658467 A,2015-03-16,Synchronized traffic warning signal system,"A traffic warning signal system includes a substrate, and at least one light-emitting device embedded into the substrate and placed in proximity to a traffic signal such as to be visible upon approach to the traffic signal, such as the at least one light-emitting device is synchronized in at least one of a timing, a color, or a frequency with the traffic signal.",IBM,FLEMING MARK S,INTERNATIONAL BUSINESS MACHINES CORPORATION (2015-03-13),https://lens.org/067-193-799-587-994,Granted Patent,yes,54,4,2,2,0,E01F9/529;;E01F9/529;;E01F9/559;;E01F9/559;;G08G1/095;;G08G1/095,G08G1/095;;E01F9/529;;E01F9/559,,1,0,,,"Moore, A.F., “Evaluation of Experimental Rumble Strips”, 26 pages, National Technical Information Service, 1987.",ACTIVE
24,US,B2,US 9981234 B2,059-946-294-905-153,2018-05-29,2018,US 201514663627 A,2015-03-20,US 201514663627 A;;US 201461968150 P,2014-03-20,Container/lid/blender interlock,"An interlocking method and blending apparatus is provided which includes a base, container, and lid. The apparatus comprises light emitters, light sensors, and light reflectors. Light is emitted by the light emitters from the base, through the container, and toward the lid. Light reflectors in the lid reflect the light back through the container and toward the base. The light sensors detect the reflected light and can be used to control operation of the blender and illumination of the container. Light may be in the visible spectrum, or sub-visible spectrum. The light emitters and light sensors may be at the base and/or the bottom of the container.",VITA MIX MAN CORP,FLEMING MARK FREDERICK,VITA-MIX MANAGEMENT CORPORATION (2015-04-30);;VITA-MIX HOLDINGS COMPANY (2014-12-29),https://lens.org/059-946-294-905-153,Granted Patent,yes,14,0,9,9,0,F16P3/08;;F16P3/10;;A47J43/0772;;B01F35/6052;;B01F35/2131;;B01F35/2209;;F16P3/08;;F16P3/10;;A47J43/0772;;B01F35/6052;;B01F35/2131;;B01F35/2209,B01F35/60;;A47J43/07;;F16P3/08;;F16P3/10,,1,0,,,"International Search Report for PCT/US2015/021663 dated Jun. 25, 2015.",ACTIVE
25,US,S,US D0320649 S,056-274-085-969-89X,1991-10-08,1991,US 30771689 F,1989-02-08,AU 198802669 F,1988-08-09,Evaporator panel to be wrapped around a solar and other atmospheric,,SIDDONS RAMSET LTD,FLEMING MARK G,QUANTUM ENERGY SYSTEMS (INTERNATIONAL) PTY LIMITED (1998-08-17);;SIDDONS RAMSET LIMITED A CORP. OF VICTORIA AUSTRALIA (1989-02-28);;SIDDONS INVESTMENT CO. PTY LTD (1990-07-01),https://lens.org/056-274-085-969-89X,Design Right,yes,8,9,2,2,0,,,D23/386,0,0,,,,EXPIRED
26,US,A1,US 2019/0295196 A1,096-318-295-135-300,2019-09-26,2019,US 201815927960 A,2018-03-21,US 201815927960 A,2018-03-21,COMPARABILITY SCORE USING MULTI-CHARACTERISTIC DIMENSION REDUCTION METHOD,"The disclosure describes systems and methods for measuring the multi-characteristic degree of comparability of a subject property and each of a set of potential comparable properties searched in one or more databases based on geographical proximity to the subject property and most recent sale date. A multi-characteristic dimension reduction method may be used that includes derived importance weights of property characteristics to create an objective measure of comparability distance, between a subject property and a compared property. The measure may be applied to calculate the comparability distances for all potential comparable properties. The distance measure may be applied to calculate the distances for all comparable properties selected on an appraisal. The distances of the appraisal selected comparable properties may be compared to the distances for all searched potential comparable properties to score or otherwise assess the appropriateness of an appraiser selected dataset.",FIRST AMERICAN FINANCIAL CORP,FLEMING MARK M,FIRST AMERICAN FINANCIAL CORPORATION (2018-03-20),https://lens.org/096-318-295-135-300,Patent Application,yes,0,3,1,1,0,G06Q10/067;;G06Q30/0206;;G06Q50/16;;G06Q50/16;;G06Q30/0206;;G06Q10/067,G06Q50/16;;G06Q10/06;;G06Q30/02,,0,0,,,,DISCONTINUED
27,US,B1,US 7201307 B1,116-037-112-126-288,2007-04-10,2007,US 38812506 A,2006-03-23,US 38812506 A,2006-03-23,High security mail box,"A high security mail box which comprises an elongated housing having a front wall, a rear opening and a chamber therein to receive and store incoming mail items. A facility in the elongated housing, is for depositing the incoming mail items within the chamber by a mail person. An access door is hinged to the rear opening of the elongated housing, wherein the access door will move between an open position and a closed position. A mechanism operatively associated with the access door, is for locking the access door in the closed position. An authorized person can disengage the locking mechanism to move the access door from the closed position to the open position, so that the authorized person can remove the incoming mail items from the chamber of the elongated housing.",FLEMING MARK J,FLEMING MARK J,,https://lens.org/116-037-112-126-288,Granted Patent,yes,13,1,1,1,0,A47G29/12095;;A47G29/12095,A47G29/12,232/17;;232/20;;232/27;;232/45,0,0,,,,INACTIVE
28,WO,A1,WO 2018/165186 A1,081-309-968-142-734,2018-09-13,2018,US 2018/0021189 W,2018-03-06,US 201762468281 P;;US 201762550102 P,2017-03-07,ASSESSMENT OF CHRONIC IRON DEFICIENCY,"The present application relates to methods of using humanized antibodies that specifically bind to hepcidin to quantify hepcidin in a fluid sample. Another aspect relates to discriminating, using quantified plasma hepcidin levels, between a subject with a condition due to biallelic TMPRSS6 mutation and other chronic iron deficiency/iron deficiency anemia. Another aspect relates to methods of treatment of a disease or condition related to hepcidin comprising use of humanized antibodies which bind hepcidin to determine hepcidin levels in the subject.",INTRINSIC LIFESCIENCES LLC;;CHILDRENS MEDICAL CENTER,FLEMING MARK D;;WESTERMAN MARK,,https://lens.org/081-309-968-142-734,Patent Application,yes,5,2,1,1,92,A61P3/00;;A61K33/26;;A61K38/00;;C07K16/26;;G01N33/84;;G01N33/90;;G01N2800/02;;G01N2800/52,A61K33/26;;A61K38/17;;A61K39/395;;A61P3/00;;G01N33/53;;G01N33/68,,0,0,,,,PENDING
29,US,B1,US 6876955 B1,128-066-266-252-410,2005-04-05,2005,US 32407502 A,2002-12-20,US 32407502 A;;US 34284201 P,2001-12-28,Method and apparatus for predicting and reporting a real estate value based on a weighted average of predicted values,"A system and method of accurately predicting and reporting a value of a property based on a weighted average of values predicted by at least two prediction models. The system and method include the steps of accessing predicted values, determined by the prediction models, for the property; determining property-specific proportional prediction error distribution information for each predicted value determined by each prediction model; assigning a weight to the predicted value determined by each prediction model by using the property-specific proportional prediction error distribution information; and generating a property-specific weighted average value based on combination of the weight and the predicted value determined by each prediction model and reporting the property-specific weighted average value to minimize prediction error during prediction of the property value.",FANNIE MAE,FLEMING MARK;;KUO CHIONGLONG,FANNIE MAE (2003-04-03),https://lens.org/128-066-266-252-410,Granted Patent,yes,9,92,2,2,0,G06Q30/06;;G06Q40/00;;G06Q30/06;;G06Q40/00,G06Q30/00,702/194;;702/181;;702/182;;705/35,48,34,139-232-872-790-403;;053-531-736-667-138;;024-681-428-102-719;;017-838-373-191-572;;091-196-859-345-414;;047-783-794-966-981;;156-841-227-062-788;;029-314-637-602-266;;176-313-955-257-790;;055-491-811-770-67X;;059-202-234-923-964;;021-227-928-455-407;;027-061-523-810-192;;151-686-998-874-806;;031-850-186-778-107;;078-520-971-322-07X;;047-242-373-480-957;;122-422-034-003-108;;026-331-317-043-288;;077-602-547-841-682;;120-511-592-758-849;;067-552-071-776-663;;097-546-228-909-848;;031-476-894-305-346;;078-286-392-156-246;;036-666-163-778-990;;104-052-315-789-84X;;139-960-748-422-588;;103-395-354-907-093;;029-034-462-638-382;;022-696-541-901-781;;064-426-828-876-441;;063-820-040-910-914;;093-549-473-153-464,10.1002/for.3980080306;;10.1016/0169-2070(89)90013-7;;10.1057/jors.1969.103;;10.1002/for.3980080312;;10.1002/for.3980080302;;10.1016/0169-2070(89)90012-5;;10.1016/0169-2070(89)90014-9;;10.1111/1540-6229.00574;;10.1007/bf00153706;;10.1002/for.3980080315;;10.1006/jhec.1995.1001;;10.1002/for.3980080309;;10.1002/for.3980080316;;10.1002/for.3980080311;;10.1016/0169-2070(89)90018-6;;10.2307/3145298;;10.2307/3146179;;10.1002/for.3980080303;;10.1002/for.3980030207;;10.1002/for.3980080308;;10.1002/for.3980080307;;10.1002/for.3980080310;;10.1002/for.3980080305;;10.1162/003465397556818;;10.1016/0169-2070(89)90015-0;;10.1002/for.3980080304;;10.1111/1540-6229.00590;;10.1111/1540-6229.00690;;10.1016/0169-2070(89)90016-2;;10.1016/0169-2070(89)90017-4;;10.2307/3146178;;10.1006/juec.1996.0036;;10.3386/w2393;;10.1111/1540-6229.00550,"Anandalingam, G. & Chen, L., ""Linear Combination of Forecasts; a General Bayesian Model"", J. of Forecasting, Jul./Sep. 1989, 8(3), pp. 199-214.;;Andrews, R.L. & Ferguson, J.T., ""Integrating Judgment with Regression Appraisal"", Real Estate Appraiser and Analyst, Spring 1986, pp. 71-74.;;Armstrong, J.S., ""Combining Forecasts: The End of the Beginning or the Beginning of the End?"", Int'l J. of Forecasting, 1989, 5, pp. 585-588.;;Bates, J.M. & Granger, C.W.J., ""The Combination of Forecasts"", OR Quarterly, Operational Research Society, Dec. 1969, 20(4), pp. 451-468.;;Bischoff, C.W., ""The Combination of Macroeconomic Forecasts"", J. of Forecasting, Jul./Sep. 1989, 8(3), pp. 293-314.;;Bunn, D., ""Forecasting With More than One Model"", J. of Forecasting, Jul./Sep. 1989, 8(3), pp. 161-166.;;Case, B. & Quigley, J.M., ""The Dynamics of Real Estate Prices"", Rev. of Econ. & Stats., Feb. 1991, 73(1), pp. 50-58.;;Clemen, R.T., ""Combining Forecasts; A Review and Annotated Bibliography"", Int'l J. of Forecasting, 1989, 5, pp. 559-583.;;Diebold, F.X., ""Forecast Combination and Encompassing: Reconciling Two Divergent Literatures"", Int'l J. Forecasting, 1989, 5, pp. 589-592.;;Flores, B.E. & White, E.M., ""Subjective Versus Objective Combining of Forecasts: an Experiment"", J. of Forecasting, Jul./Sep. 1989, 8(3), pp. 331-341.;;Gau, G.W. et al., ""Optimal Comparable Selection and Weighting in Real Property Valuation: an Extension"", J. of the AREUEA, 1992, 20(1), pp. 107-123.;;Gilley, O.W. & Pace, R.K., ""A Hybrid Cost and Market-Based Estimator for Appraisal"", J. of Real Estate Research, 1990, 5(1), pp. 75-88.;;Granger, C.W.J., ""Forecasting in Business and Economics"", 2<nd >Edition, Academic Press, USA, 1989, pp. 153-165.;;Granger, C.W.J. & Newbold, P., ""Forecasting Economic Time Series"", 2<nd >Edition, Academic Press, USA, 1986, pp. 265-276.;;Pace, R.K. & Gilley, O.W., ""Estimation Employing A Priori Information Within Mass Appraisal and Hedonic Pricing Models"", J. of Real Estate Finance & Economics, 1990, 3, pp. 55-72.;;Pace, R.K. & Gilley, O.W., ""Appraisal Across Jurisdictions Using Bayesian Estimation with Bootstrapped Priors for Secondary Mortgage Market Applications"", Prop. Tax J, Mar. 1989, 8(1), pp. 27-42.;;Pereira, B. et al., ""Experience in Combining Subjective & Quantitative Forecasts of Open Market Rates"", J. of Forecasting, 1989, 8(3), pp. 343-348.;;Quigley, J.M., ""A Simple Hybrid Model for Estimating Real Estate Price Indexes"", J. Housing Econ., Mar. 1995, 4(1), pp. 1-12.;;Raferty, A. et al., ""Model Selection and Accounting for Model Uncertainty in Linear Regression Models"", Nov. 19, 1993, U of Washington, pp. 1-24.;;Sessions, D.N. & Chatterjee, S., ""The Combining of Forecasts Using Recursive Techniques With Non-Stationary Weights"", J. of Forecasting, 1989, 8(3), pp. 239-251.;;Smith, D.G.C., ""Combination of Forecasts in Electricity Demand Prediction"", J. of Forecasting, 1989, 8(3), pp. 349-356.;;Wall, K.D. & Correia, C., ""A Preference-Based Method of Forecast Combination"", J. of Forecasting, 1989, 8(3), pp. 269-292.;;Winkler, R.L., ""Combining Forecasts: A Philosophical Basis & Some Current Issues"", Int'l J. of Forecasting, 1989, 5, pp. 605-609.;;Wong, S.K. et al., ""Estimating Age Effects in Repeat-Sales Price Indices"", Proc. Of 2<nd >Postgraduate Res. Conf. in the Built & Human Environ., Apr. 2002, U of Salford, England, pp. 290-300.;;Wood, S., ""Combining Forecasts to Predict Property Values for Single-Family Residences"", Land Economics, May 1976, 52(2), pp. 221-229.;;Wood, S., ""Combining Forecasts to Predict Property Values for Single-Family Residences: Reply"", Land Economics, Nov. 1978, 54(4), pp. 528-530.;;Granger, C.W.J., ""Invited Review: Combining Forecasts-Twenty Years Later"", J. of Forecasting, Jul./Sep. 1989, 8(3), pp. 167-173.;;Granger, C.W.J. & Ramanathan, R., ""Improved Methods of Combining Forecasts"", J. of Forecasting, Apr./Jun. 1984, 3(2), pp. 197-204.;;Guerarde, J.B. Jr., ""Composite Model Building for Foreign Exchange Rates"", J. of Forecasting, Jul./Sep. 1989, 8(3), pp. 315-329.;;Guerard, J.B. Jr. & Clemen, R.T., ""Collinearity and the Use of Latent Root Regression for Combining GNP Forecasts"", J. of Forecasting, Jul./Sep. 1989, 8(3), pp. 231-238.;;Guerrero, V.M., ""Optimal Conditional ARIMA Forecasts"", J. of Forecasting, Jul./Sep. 1989, 8(3), pp. 215-229.;;Gunter, S.I. & Aksu, C., ""N-Step Combinations of Forecasts"", J. of Forecasting, Jul./Sep. 1989, 8(3), pp. 253-267.;;Hallman, J. & Kamstra, M., ""Combining Algorithms Based on Robust Estimation Techniques and Co-Integrating Restrictions"", J. of Forecasting, Jul./Sep. 1989, 8(3), pp. 189-198.;;Hill, R.C. et al., ""Estimating Capital Asset Price Indexes"",Rev. of Econ. and Stats., May 1997, 79(2), pp. 226-233.;;Hogarth, R. M., ""On Combining Diagnostic 'Forecasts': Thoughts and Some Evidence"", Int'l J. of Forecasting, 1989, 5, pp. 593-597.;;Holden, K. & Peel, D.A., ""Unbiasedness, Efficiency and the Combination of Economic Forecasts"", J. of Forecasting, Jul./Sep. 1989, 8(3), pp. 175-188.;;Holden, K. et al., ""Economic Forecasting: An Introduction"", 1989, Cambidge University Press, pp. 85-107.;;Knight, J.R. et al., ""Biased Prediction of Housing Values"", J. of the AREUEA, 1992, 20(3), pp. 427-456.;;Lockwood, L.J. & Rutherford, R.C., ""Determinants of Industrial Property Value"", Real Estate Economics, Summer 1996, 24(2), pp. 257-273.;;Maddala, G.S., ""Econometrics"", 1977, McGraw-Hill, USA, pp. 314-317.;;Mahmoud, E., ""Combining Forecasts; Some Managerial Issues"", Int'l J. of Forecasting, 1989, 5, pp. 599-600.;;Makridakis, S., ""Why Combining Works?"", Int'l J. of Forecasting, 1989, 5, pp. 601-603.;;Oliveira, R.A., ""Combining Forecasts to Predict Property Values for Single-Family Residences: Comment"", Land Economics, Nov. 1978, 54(4), pp. 524-527.;;Archer, W.R. et al., ""Measuring the Importance of Location in House Price Appreciation"", J. of Urban Economics, vol. 40, 1996, pp. 334-353.;;Case, K.E. & Shiller, R.J., ""Prices of Single-Family Homes Since 1970: New Indexes for Four Cities"", New England Economic Review, Sep./Oct. 1987, pp. 45-56.;;Case, K.E. & Shiller, R.J., ""The Efficiency of the Market for Single-Family Homes"", The American Economic Review, vol. 79(1), Mar. 1989, pp. 125-137.;;Stephens, W. et al., ""Conventional Mortgage Home Price Index"", J. of Housing Research, vol. 6(3), pp. 389-418.;;Vandell, K.D., ""Optimal Comparable Selection and Weighting in Real Property Valuation"", AREUEA Journal, vol. 19(2), 1991, pp. 213-239.",EXPIRED
30,DE,T5,DE 112011103626 T5,036-547-710-548-421,2013-09-12,2013,DE 112011103626 T,2011-10-21,US 91357510 A;;US 2011/0057381 W,2010-10-27,"Verfahren, System und Vorrichtung zur Hochfrequenz- und Gleichstromschaltung",Es werden hierin im Allgemeinen Ausführungsformen zur Hochfrequenz- und Gleichstromschaltung beschrieben. Andere Ausführungsformen können beschrieben und beansprucht werden.,PEREGRINE SEMICONDUCTOR CORP,BURGENER MARK;;LAM FLEMING,"PSEMI CORPORATION, SAN DIEGO, US (2022-03-21)",https://lens.org/036-547-710-548-421,Patent Application,no,0,1,5,5,0,H03C1/36;;H03C1/36,H03C1/36,,1,0,,,Artikel 37 C.F.R. §1.72(b),ACTIVE
31,US,B1,US 11790680 B1,083-368-277-453-691,2023-10-17,2023,US 202117231953 A,2021-04-15,US 202117231953 A;;US 201816226370 A,2018-12-19,System and method for automated selection of best description from descriptions extracted from a plurality of data sources using numeric comparison and textual centrality measure,"Techniques are described for collecting descriptions of an entity from different data sources and using a numeric comparison and textual centrality measure to automatically select a best description. In one implementation, a method includes: retrieving a real property description dataset, the real property description dataset including descriptions from multiple data sources that describe the real property; extracting, from each of the descriptions, numbers that identify the property; performing a numerical comparison of the numbers extracted from each of the descriptions to determine if any descriptions needs to be discarded from further consideration; applying a text cleaning process to normalize the descriptions; and performing a textual centrality measure of remaining descriptions to determine a level agreement of each of the remaining descriptions with each of the other remaining descriptions; and using at least the textual centrality measure to select a description. The selected description may be used to populate a document.",FIRST AMERICAN FINANCIAL CORP,FLEMING MARK;;QIU YAN,FIRST AMERICAN FINANCIAL CORPORATION (2018-12-17),https://lens.org/083-368-277-453-691,Granted Patent,yes,42,0,2,4,0,G06F40/284;;G06F40/186;;G06F40/216;;G06Q40/08;;G06Q50/16;;G06Q50/18;;G06Q40/03;;G06F18/285;;G06F18/217;;G06F17/18;;G06F40/205;;G06F40/289;;G06V30/413;;G06F18/22;;G06F40/284,G06V30/413;;G06F17/18;;G06F18/22;;G06F40/205;;G06F40/289,,0,0,,,,ACTIVE
32,CA,A1,CA 3110561 A1,113-168-272-172-479,2022-08-26,2022,CA 3110561 A,2021-02-26,CA 3110561 A,2021-02-26,BITUMEN PROCESSING VIA SOLVENT DEASPHALTING AND SLURRY-PHASE HYDROCRACKING,"Process implementations for upgrading an asphaltenic feedstock, such as a bitumen feedstock: the asphaltenic feedstock is subjected to solvent deasphalting to produce a deasphalted oil and an asphaltene-rich component, and a feedstream including the asphaltene-rich component is subjected to slurry-phase hydrocracking to produce a gas-liquid mixture. The feedstream can have a resin-to-asphaltenes ratio of at least 1.4. The liquid component of the gas-liquid mixture includes a naphtha fraction, a middle distillates fraction and a gasoil fraction. The naphtha fraction can be hydrotreated to produce a hydrotreated naphtha fraction that is supplied as diluent to the deasphalted oil to form a partially upgraded product that is transportable via pipeline. The gasoil fraction can be recycled into the asphaltene-rich component to form part of the feedstream. The middle distillates fraction can be hydrotreated and recovered as a sweet fraction including diesel for valorisation thereof.",SUNCOR ENERGY INC,FLEMING MARK;;PUGSLEY TODD,,https://lens.org/113-168-272-172-479,Patent Application,no,0,0,1,1,0,C10G67/049;;C10G2400/04,C10G67/04;;C10C3/08;;F17D1/16,,0,0,,,,PENDING
33,US,S,US D0983700 S,191-121-878-823-951,2023-04-18,2023,US 35512599 F,2021-09-01,GB 6122083 F,2021-03-01,Planter,,PLANET BIOTECTURE LTD,SABIN RICHARD;;FLEMING MARK,,https://lens.org/191-121-878-823-951,Design Right,no,20,0,1,1,0,A01G27/02,,1102;;D11/156,0,0,,,,ACTIVE
34,WO,A1,WO 2020/081521 A1,043-075-283-700-855,2020-04-23,2020,US 2019/0056256 W,2019-10-15,US 201862745543 P;;US 201862779852 P,2018-10-15,IN-CONTAINER INDUCTIVE HEATING FOR A BLENDER,"[0074] A blending system includes a container or housing, a blade assembly, and an insert are described herein. The insert is disposed in or on the container or housing. The blade assembly includes a drive shaft. The drive shaft is rotatable. A magnet is attached to the drive shaft. Rotation of the magnet induces current in the insert. The current induces heat.",VITA MIX MAN CORP,FLEMING MARK;;TAREEN SAIFUR,,https://lens.org/043-075-283-700-855,Patent Application,yes,9,0,2,2,0,A47J43/0716;;A47J27/004;;A47J36/321;;A47J43/0465;;A47J43/085;;A47J2202/00;;H05B6/108;;H05B6/06;;H05B6/10;;H05B6/109;;H05B6/12,H05B6/12,,0,0,,,,PENDING
35,US,B1,US 10997403 B1,085-407-984-843-711,2021-05-04,2021,US 201816226370 A,2018-12-19,US 201816226370 A,2018-12-19,System and method for automated selection of best description from descriptions extracted from a plurality of data sources using numeric comparison and textual centrality measure,"Techniques are described for collecting descriptions of an entity from different data sources and using a numeric comparison and textual centrality measure to automatically select a best description. In one implementation, a method includes: retrieving a real property description dataset, the real property description dataset including descriptions from multiple data sources that describe the real property; extracting, from each of the descriptions, numbers that identify the property; performing a numerical comparison of the numbers extracted from each of the descriptions to determine if any descriptions needs to be discarded from further consideration; applying a text cleaning process to normalize the descriptions; and performing a textual centrality measure of remaining descriptions to determine a level agreement of each of the remaining descriptions with each of the other remaining descriptions; and using at least the textual centrality measure to select a description. The selected description may be used to populate a document.",FIRST AMERICAN FINANCIAL CORP,FLEMING MARK;;QIU YAN,FIRST AMERICAN FINANCIAL CORPORATION (2018-12-17),https://lens.org/085-407-984-843-711,Granted Patent,yes,31,2,2,4,0,G06F40/284;;G06F40/186;;G06F40/216;;G06Q40/08;;G06Q50/16;;G06Q50/18;;G06Q40/03;;G06F18/285;;G06F18/217;;G06F17/18;;G06F40/205;;G06F40/289;;G06V30/413;;G06F18/22;;G06F40/284,G06K9/00;;G06F17/18;;G06F40/205;;G06F40/289;;G06K9/62,,0,0,,,,ACTIVE
36,US,B1,US 7305328 B1,042-078-555-538-247,2007-12-04,2007,US 97533704 A,2004-10-29,US 97533704 A;;US 32407502 A;;US 34284201 P,2001-12-28,Method and apparatus for predicting and reporting a real estate value based on a weighted average of predicted values,"A system and method of accurately predicting and reporting a value of a property based on a weighted average of values predicted by at least two prediction models. The system and method include the steps of accessing predicted values, determined by the prediction models, for the property; determining property-specific proportional prediction error distribution information for each predicted value determined by each prediction model; assigning a weight to the predicted value determined by each prediction model by using the property-specific proportional prediction error distribution information; and generating a property-specific weighted average value based on combination of the weight and the predicted value determined by each prediction model and reporting the property-specific weighted average value to minimize prediction error during prediction of the property value.",FANNIE MAE,FLEMING MARK;;KUO CHIONGLONG,,https://lens.org/042-078-555-538-247,Granted Patent,yes,9,20,2,2,0,G06Q30/06;;G06Q40/00;;G06Q30/06;;G06Q40/00,G06Q30/00,702/194;;702/181;;702/182;;705/35,43,30,139-232-872-790-403;;053-531-736-667-138;;024-681-428-102-719;;017-838-373-191-572;;091-196-859-345-414;;047-783-794-966-981;;156-841-227-062-788;;029-314-637-602-266;;122-422-034-003-108;;026-331-317-043-288;;014-558-626-376-175;;077-602-547-841-682;;120-511-592-758-849;;067-552-071-776-663;;097-546-228-909-848;;078-286-392-156-246;;036-666-163-778-990;;139-960-748-422-588;;103-395-354-907-093;;029-034-462-638-382;;022-696-541-901-781;;176-313-955-257-790;;055-491-811-770-67X;;059-202-234-923-964;;021-227-928-455-407;;027-061-523-810-192;;151-686-998-874-806;;031-850-186-778-107;;078-520-971-322-07X;;047-242-373-480-957,10.1002/for.3980080306;;10.1016/0169-2070(89)90013-7;;10.1057/jors.1969.103;;10.1002/for.3980080312;;10.1002/for.3980080302;;10.1016/0169-2070(89)90012-5;;10.1016/0169-2070(89)90014-9;;10.1111/1540-6229.00574;;10.1002/for.3980080303;;10.1002/for.3980030207;;10.1002/for.3980080313;;10.1002/for.3980080308;;10.1002/for.3980080307;;10.1002/for.3980080310;;10.1002/for.3980080305;;10.1016/0169-2070(89)90015-0;;10.1002/for.3980080304;;10.1111/1540-6229.00690;;10.1016/0169-2070(89)90016-2;;10.1016/0169-2070(89)90017-4;;10.2307/3146178;;10.1007/bf00153706;;10.1002/for.3980080315;;10.1006/jhec.1995.1001;;10.1002/for.3980080309;;10.1002/for.3980080316;;10.1002/for.3980080311;;10.1016/0169-2070(89)90018-6;;10.2307/3145298;;10.2307/3146179,"Anandalingam, G. & Chen, L., ""Linear Combination of Forecasts: A General Bayesian Model"", J. of Forecasting, Jul./Sep. 1989, 8(3), pp. 199-214.;;Andrews, R.L. & Ferguson, J.T., ""Integrating Judgement with Regression Appraisal"", Real Estate Appraiser and Analyst, Spring 1986, pp. 71-74.;;Armstrong, J.S., ""Combining Forecasts: The End of the Beginning or the Beginning of the End?"", Int'l J. of Forecasting, 1989, 5, pp. 585-588.;;Bates, J.M. & Granger, C.W.J., ""The Combination of Forecasts"", OR Quarterly, Operational Research Society, Dec. 1969, 20(4), pp. 451-468.;;Bischoff, C.W., ""The Combination of Macroeconomic Forecasts"", J. of Forecasting, Jul./Sep. 1989, 8(3), pp. 293-314.;;Bunn, D., ""Forecasting With More than One Model"", J. of Forecasting, Jul./Sep. 1989, 8(3), pp. 161-166.;;Case, B. & Quigley, J.M., ""The Dynamics of Real Estate Prices"", Rev. of Econ. & Stats., Feb. 1991, 73(1), pp. 50-58.;;Clemen, R.T., ""Combining Forecasts: A Reveiw and Annotated Bibliography"", Int'l J. of Forecasting, 1989, 5, pp. 559-583.;;Diebold, F.X., ""Forecast Combination and Encompassing: Reconciling Two Divergent Literatures"", Int'l J. Forecasting, 1989, 5, pp. 589-592.;;Flore, B.E. & White, E.M., ""Subjective Versus Objective Combining of Forecasts: an Experiment"", J. of Forecasting, Jul./Sep. 1989, 8(3), pp. 331-341.;;Gau, G.W. et al., ""Optimal Comparable Selection and Weighting in Real Property Valuation: an Extension"", J. of the AREUEA, 1992, 20(1), pp. 107-123.;;Gilley, O.W. & Pace, R.K., ""A Hybrid Cost and Market-Based Estimator for Appraisal"", J. of Real Estate Research, 1990, 5(1), pp. 75-88.;;Granger, C.W.J., ""Forecasting in Business and Economics"", 2<SUP>nd </SUP>Edition, Academic Press, USA, 1989, pp. 153-165.;;Granger, C.W.J. & Newbold, P., ""Forecasting Economic Time Series"", 2<SUP>nd </SUP>Edition, Academic Press, USA, 1986, pp. 265-276.;;Granger, C.W.J., ""Invited Review: Combining Forecasts-Twenty Years Later"", J. of Forecasting, Jul./Sep. 1989, 8(3), pp. 167-173.;;Granger, C.W.J. & Ramanathan, R., ""Improved Methods of Combining Forecasts"", J. of Forecasting, Apr./Jun. 1984, 3(2), pp. 197-204.;;Guerard, J.B. Jr., ""Composite Model Building for Foreign Exchange Rates"", J. of Forecasting, Jul./Sep. 1989, 8(3) pp. 315-329.;;Guerard, J.B. Jr. & Clemen, R.T., ""Collinearity and the Use of Latent Root Regression for Combining GNP Forecasts"", J. of Forecasting, Jul./Sep. 1989, 8(3), pp. 231-238.;;Guerrero, V.M., ""Optimal Conditional ARIMA Forecasts"", J. of Forecasting, Jul./Sep. 1989, 8(3), pp. 215-229.;;Gunter, S.I. & Aksu, C., ""N-Step Combinations of Forecasts"", J. of Forecasting, Jul./Sep. 1989, 8(3), pp. 253-267.;;Hallman, J. & Kamstra, M., ""Combining Algorithms Based on Robust Estimation Techniques and Co-Intergrating Restrictions"", J. of Forecasting, Jul./Sep. 1989, 8(3), pp. 189-198.;;Hill, R.C. et al., ""Estimating Capital Assed Price Indexes"", Rev. of Econ. and Stats., May 1997, 79(2), pp. 226-233.;;Hogarth, R.M., ""On Combining Diagnostic 'Forecasts': Thoughts and Some Evidence"", Int'l J. of Forecasting, 1989, 5, pp. 593-597.;;Holden, K. & Peel, D.A., ""Unbiasedness, Efficiency and the Combination of Economic Forecasts"", J. of Forecasting, Jul./Sep. 1989, 8(3), pp. 175-188.;;Holden, K. et al., ""Economic Forecasting: An Introduction"", 1989, Cambridge University Press, pp. 85-107.;;Knight, J.R. et al., ""Biased Prediction of Housing Values"", J. of the AREUEA, 1992, 20(3), pp. 424-456.;;Lockwood, L.J. & Rutherford, R.C., ""Determinants of Industrial Property Value"", Real Estate Economics, Summer 1996, 24(2), pp. 257-373.;;Maddala, G.S., ""Econometrics"", 1977, McGraw-Hill, USA, pp. 314-317.;;Mahmoud, E., ""Combining Forecasts: Some Managerial Issues"", Int'l J. of Forecasting, 1989, 5, pp. 599-600.;;Makridakis, S., ""Why Combining Works?"", Int'l J. of Forecasting, 1989, 5, pp. 601-603.;;Oliveira, R.A., ""Combining Forecasts to Predict Property Values for Single-Family Residneces: Comment"", Land Economics, Nov. 1978, 54(4), pp. 524-527.;;Pace, R.K. & Gilley, O. W., ""Estimation Employing A Priori Information Within Mass Appraisal and Hedonic Pricing Models"", J. of Real Estate Finance & Economics , 1990, 3, pp. 55-72.;;Pace, R.K. & Gilley, O.W., ""Appraisal Across Jurisdictions using Bayesian Estimation with Bootstrapped Priors for Secondary Mortgage Market Applications"", Prop. Tax j, Mar. 1989, 8(1), pp. 27-42.;;Pereira, B. et al., ""Experience in Combining Subjective & Quantitative Forecasts of Open Market Rates"", J. of Forecasting, 1989, 8(3), pp. 343-348.;;Quigley, J.M., ""A Simple Hybrid Model for Estimating Real Estate Price Indexes"", J. Housing Econ., Mar. 1995, 4(1), pp. 1-12.;;Raftery, A. et al., ""Model Selection and Accounting for Model Uncertainty in Linear Regression Models"", Nov. 19, 1993, U of Washington, pp. 1-24.;;Sessions, D.N. & Chatterjee, S., ""The Combining of Forecasts Using Recursive Techniques With Non-Stationary Weights"", J. of Forecasting, 1989, 8(3), pp. 239-251.;;Smith, D.G.C., ""Combination of Forecasts in Electricity Demand Prediction"", J. of Forecasting, 1989, 8(3), pp. 349-356.;;Wall, K.D. & Correia, C., ""A Preference-Based Method of Forecast Combination"", J. of Forecasting, 1989, 8(3), pp. 269-292.;;Winkler, R.L., ""Combining Forecasts: A Philosophical Basis & Some Current Issues"", Int'l J. of Forecasting, 1989, 5, pp. 605-609.;;Wong, S.K. et al., ""Estimating Age Effects in Repeat-Sales Price Indices"", Proc. Of 2<SUP>nd </SUP>Int'l Postgraduate Res. Conf. in the Built & Human Environ., Apr. 2002, U of Salford, England, pp. 290-300.;;Wood, S., ""Combining Forecasts to Predict Property Values for Single-Family Residences"", Land Economics, May 1976, 52(2), pp. 221-229.;;Wood, S., ""Combining Forecasts to Predict Property Values for Single-Family Residences: Reply"", Land Economics, Nov. 1978, 54(4), pp. 528-530.",EXPIRED
37,US,A1,US 2021/0315421 A1,146-775-458-397-854,2021-10-14,2021,US 201917285668 A,2019-10-15,US 201917285668 A;;US 201862745543 P;;US 201862779852 P;;US 2019/0056256 W,2018-10-15,IN-CONTAINER INDUCTIVE HEATING FOR A BLENDER,"A blending system includes a container or housing, a blade assembly, and an insert are described herein. The insert is disposed in or on the container or housing. The blade assembly includes a drive shaft. The drive shaft is rotatable. A magnet is attached to the drive shaft. Rotation of the magnet induces current in the insert. The current induces heat.",VITA MIX MAN CORP,FLEMING MARK;;TAREEN SAIFUR,VITA-MIX MANAGEMENT CORPORATION (2023-03-15),https://lens.org/146-775-458-397-854,Patent Application,yes,0,1,2,2,0,A47J43/0716;;A47J27/004;;A47J36/321;;A47J43/0465;;A47J43/085;;A47J2202/00;;H05B6/108;;H05B6/06;;H05B6/10;;H05B6/109;;H05B6/12,A47J43/07;;A47J27/00;;A47J36/32;;A47J43/046;;A47J43/08;;H05B6/10,,0,0,,,,PENDING
38,US,B2,US 8373490 B2,147-581-332-001-050,2013-02-12,2013,US 91357510 A,2010-10-27,US 91357510 A,2010-10-27,"Method, system, and apparatus for RF and DC switching",Embodiments of RF and DC switching are described generally herein. Other embodiments may be described and claimed.,PEREGRINE SEMICONDUCTOR CORP;;BURGENER MARK L;;LAM FLEMING,BURGENER MARK L;;LAM FLEMING,PSEMI CORPORATION (2010-11-22),https://lens.org/147-581-332-001-050,Granted Patent,yes,28,27,5,5,0,H03C1/36;;H03C1/36,G06G7/14;;G06F7/42,327/361,6,0,,,"Nguyen, Khanh V., Office Action received from the USPTO dated Apr. 5, 2012 for related U.S. Appl. No. 12/807,365, 10 pgs.;;Ghilini, Marie, International Search Report and Written Opinion received from the EPO dated Apr. 16, 2012 for related appln. No. PCT/US2011/057381, 11 pgs.;;Nguyen, Khanh V., Office Action received from the USPTO dated Nov. 4, 2011 for related U.S. Appl. No. 12/807,365, 14 pgs.;;Peregrine Semiconductor Corporation, Demand filed in the EPO dated Aug. 24, 2012 for related appln. No. PCT/US2011/057381, 24 pgs.;;Nguyen, Khanh V., Notice of Allowance received from the USPTO dated Sep. 6, 2012 for related U.S. Appl. No. 12/807,365, 13 pgs.;;Ratajski, Andre, Written Opinion of the International Preliminary Examining Authority received from the EPO dated Oct. 18, 2012 for related appln. No. PCT/US2011/057381, 6 pgs.",ACTIVE
39,US,A1,US 2007/0218343 A1,067-049-576-895-248,2007-09-20,2007,US 37822406 A,2006-03-17,US 37822406 A,2006-03-17,Gas diffusion media and fuel cell,"Diffusion media for fuel cell is made by preparing an aqueous dispersion comprising a powder resin, a binder material, and a fiber material comprising carbon fibers, of these; forming a layer of the dispersion on a support; removing water from the layer to form a fiber layer; molding the fiber layer; and carbonizing or graphitizing the molded layer.",JI CHUNXIN;;FLEMING GERALD J;;FLEMING MARGARET;;MATHIAS MARK,JI CHUNXIN;;FLEMING GERALD J;;FLEMING MARGARET;;MATHIAS MARK,GM GLOBAL TECHNOLOGY OPERATIONS LLC (2006-02-28);;SPECTRACORP (2006-02-28),https://lens.org/067-049-576-895-248,Patent Application,yes,8,2,8,8,0,H01M8/0243;;H01M8/0243;;H01M8/0234;;H01M8/0234;;H01M8/0239;;H01M8/0239;;H01M8/1007;;H01M8/1007;;Y02E60/50;;Y02E60/50;;Y02P70/50;;Y02P70/50,H01M4/94;;C01D3/00;;H01M4/88;;H01M4/96,429/42;;502/101;;423/449.6;;429/44;;423/447.2,0,0,,,,INACTIVE
40,CN,A,CN 1898077 A,102-971-334-798-359,2007-01-17,2007,CN 200480039003 A,2004-12-13,US 2004/0041595 W;;US 74682903 A,2003-12-24,Energy efficient construction surfaces,,3M INNOVATIVE PROPERTIES CO,ANDERSON MARK T FLEMING PETER,,https://lens.org/102-971-334-798-359,Patent Application,no,0,6,15,15,0,E04D2001/005;;G02B5/0816;;Y10T428/24372;;Y02A30/254;;Y02B80/00;;E04D1/28;;G02B5/0816;;E04D2001/005;;E04D1/22;;Y10T428/24372;;E04D2001/005;;G02B5/0816;;Y02A30/254;;Y02B80/00;;E04D1/28,B32B1/00;;E04D1/22;;G02B5/08,,0,0,,,,INACTIVE
41,CN,A,CN 101047253 A,183-009-163-380-712,2007-10-03,2007,CN 200710105345 A,2007-03-20,US 38470606 A,2006-03-20,Acrylic fiber bonded carbon fiber paper as gas diffusion media for fuel cell,"A gas diffusion media for a fuel cell, such as a proton exchange membrane fuel cell, is provided. The gas diffusion media includes carbonizable acrylic pulp fibers instead of conventional phenolic resin as a binder material. The acrylic fibers are mixed with the carbon fiber dispersion during the papermaking step, thus eliminating the phenolic resin impregnation step typically associated with conventional gas diffusion media manufacturing processes. The mat is then cured and carbonized to produce gas diffusion media.",GM GLOBAL TECH OPERATIONS INC,MARK JI CHUNXIN FLEMING MARGAR,,https://lens.org/183-009-163-380-712,Patent Application,no,0,2,8,8,0,D21H13/50;;D21H13/50;;D21H13/18;;D21H13/18;;D21H17/36;;D21H17/36;;H01M8/0234;;H01M8/0234;;H01M8/0239;;H01M8/0239;;Y02E60/50;;Y02P70/50;;Y02P70/50;;Y10T428/30;;Y10T428/30,H01M8/02;;D21H27/00;;H01M4/86;;H01M4/88,,0,0,,,,INACTIVE
42,US,A1,US 2007/0218346 A1,060-757-952-650-416,2007-09-20,2007,US 38470606 A,2006-03-20,US 38470606 A,2006-03-20,Acrylic fiber bonded carbon fiber paper as gas diffusion media for fuel cell,"A gas diffusion media for a fuel cell, such as a proton exchange membrane fuel cell, is provided. The gas diffusion media includes carbonizable acrylic pulp fibers instead of conventional phenolic resin as a binder material. The acrylic fibers are mixed with the carbon fiber dispersion during the papermaking step, thus eliminating the phenolic resin impregnation step typically associated with conventional gas diffusion media manufacturing processes. The mat is then cured and carbonized to produce gas diffusion media.",JI CHUNXIN;;FLEMING GERALD J;;FLEMING MARGARET;;MATHIAS MARK,JI CHUNXIN;;FLEMING GERALD J;;FLEMING MARGARET;;MATHIAS MARK,GM GLOBAL TECHNOLOGY OPERATIONS LLC (2006-02-28);;SPECTRACORP (2006-02-28),https://lens.org/060-757-952-650-416,Patent Application,yes,31,15,8,8,0,D21H13/50;;D21H13/50;;D21H13/18;;D21H13/18;;D21H17/36;;D21H17/36;;H01M8/0234;;H01M8/0234;;H01M8/0239;;H01M8/0239;;Y02E60/50;;Y02P70/50;;Y02P70/50;;Y10T428/30;;Y10T428/30,H01M4/94;;B32B9/00;;D01F9/12;;H01M4/96,429/44;;428/408;;423/447.2,0,0,,,,INACTIVE
43,DE,B4,DE 112011103626 B4,026-815-212-469-363,2022-05-25,2022,DE 112011103626 T,2011-10-21,US 91357510 A;;US 2011/0057381 W,2010-10-27,"Verfahren, System und Vorrichtung zur Hochfrequenz- und Gleichstromschaltung","Schaltungs-Vorrichtung geeignet zum Erzeugen eines zweiten Signals (20C) aus einem ersten Signal (20B) basierend auf einem Steuersignal (20A), umfassend:ein erstes Summiermodul (12A) zum Summieren des Steuersignals (20A) mit dem ersten Signal (20B), um ein erstes summiertes Vorspannungssignal (13A) zu erzeugen;ein zweites Summiermodul (12B) zum Summieren des Steuersignals (20A) mit dem zweiten Signal (20C), um ein zweites summiertes Vorspannungssignal (13F) zu erzeugen; undeinen gestapelten FET-Schalter (40A-F), wobei der gestapelte FET-Schalter (40A-F) das erste Signal (20B), das erste summierte Vorspannungssignal (13A) und das zweite summierte Vorspannungssignal (13F) empfängt und das zweite Signal (20C) aus dem ersten Signal (20B) erzeugt, wobei das erste und zweite summierte Vorspannungssignal (13A, 13F) derart ausgebildet sind, dass sie den gestapelten FET-Schalter (40A-F) steuern, wobei das erste Signal (20B) ein Eingangssignal des gestapelten FET-Schalters (40A-F) ist und das zweite Signal (20C) ein Ausgangssignal des gestapelten FET-Schalters ist.",PSEMI CORP,BURGENER MARK L;;LAM FLEMING,"PSEMI CORPORATION, SAN DIEGO, US (2022-03-21)",https://lens.org/026-815-212-469-363,Granted Patent,no,3,0,5,5,0,H03C1/36;;H03C1/36,H03C1/36,,0,0,,,,ACTIVE
44,US,A1,US 2012/0105127 A1,095-063-757-806-108,2012-05-03,2012,US 91357510 A,2010-10-27,US 91357510 A,2010-10-27,"Method, System, and Apparatus for RF and DC Switching",Embodiments of RF and DC switching are described generally herein. Other embodiments may be described and claimed.,BURGENER MARK L;;LAM FLEMING,BURGENER MARK L;;LAM FLEMING,PSEMI CORPORATION (2010-11-22),https://lens.org/095-063-757-806-108,Patent Application,yes,16,4,5,5,0,H03C1/36;;H03C1/36,G06G7/14,327/361,0,0,,,,ACTIVE
45,US,A1,US 2015/0032598 A1,195-635-970-518-873,2015-01-29,2015,US 201414341160 A,2014-07-25,US 201414341160 A;;US 201361858788 P,2013-07-26,SYSTEM AND METHOD FOR GENERATING A NATURAL HAZARD CREDIT MODEL,"Embodiments include systems and methods of detecting and assessing multiple types of risks related to mortgage lending. One embodiment includes a system and method of detecting and assessing risks including early payment default risks, and natural hazards risks on loan applications. One embodiment includes a computerized method that includes creating a combined risk detection model based on a default and natural hazards risk detection models and using the combined risk detection model to evaluate loan application data and generate a combined risk score that takes into account the different types of risks individually and collectively detected by the plurality of risk detection models.",CORELOGIC SOLUTIONS LLC,FLEMING MARK M;;DOBBYN KATHRYN,CORELOGIC SOLUTIONS LLC (2014-08-18),https://lens.org/195-635-970-518-873,Patent Application,yes,2,27,1,1,0,G06Q40/03;;G06Q40/03,G06Q40/02,705/38,0,0,,,,DISCONTINUED
46,WO,A1,WO 2012/058122 A1,062-561-266-443-722,2012-05-03,2012,US 2011/0057381 W,2011-10-21,US 91357510 A,2010-10-27,"METHOD, SYSTEM, AND APPARATUS FOR RF AND DC SWITCHING",Embodiments of RF and DC switching are described generally herein. Other embodiments may be described and claimed.,PEREGRINE SEMICONDUCTOR CORP;;BURGENER MARK L;;LAM FLEMING,BURGENER MARK L;;LAM FLEMING,,https://lens.org/062-561-266-443-722,Patent Application,yes,4,7,5,5,0,H03C1/36;;H03C1/36,H03C1/36,,0,0,,,,PENDING
47,GB,A,GB 2602329 A,025-888-219-324-985,2022-06-29,2022,GB 202020500 A,2020-12-23,GB 202020500 A,2020-12-23,Modular surround,"A modular surround 2 for a plurality of vertically stackable planters (1, figure 1), the modular surround comprising: a base receptacle 3 for holding irrigation fluid: at least one pair our upstanding side panels 4 each positioned on opposite sides of the base receptacle; and fastening means 5 for fastening each side panel to the base receptacle and/or to another side panel in a vertical plane; whereby in use the base receptacle is located beneath the planters and is configured to hold any excess irrigation fluid flowing from the planters, and the side panels are configured to substantially surround and hold together an end of at least two vertically stacked planters. The base receptacle may be a drip tray 7 or tank (8, figure 4) and the side panels may incorporate sliding means for sliding the drip tray in and out of the surround. The modular surround may incorporate fireproofing means (28, figure 15). Further disclosed is a modular surround having a pair of struts for mounting beneath the lowermost planter in the stack, whereby, in use, the pair of struts is configured to support the stack of planters in a raised position within the tank such that a space is created for tank access and equipment storage. Also disclosed is a pair of side panels for a stack of vertically stackable planters, wherein the side panels are configured for mounting to the ends of the planters to secure the stack together in a vertical arrangement, such that, in use, lateral movement of one planter from another planter is prevented.",PLANET BIOTECTURE LTD,RICHARD ALEXANDER SABIN;;MARK FLEMING,,https://lens.org/025-888-219-324-985,Patent Application,no,9,0,2,2,0,A01G9/025;;A01G9/249;;A01G9/247;;A01G9/023;;A01G9/025;;A01G27/00,A01G9/02;;A01G27/00,,0,0,,,,PENDING
48,WO,A2,WO 2008/066617 A2,107-318-971-688-646,2008-06-05,2008,US 2007/0022257 W,2007-10-17,US 82983206 P,2006-10-17,LOW VOLTAGE OSCILLATOR FOR MEDICAL DEVICES,"Low voltage oscillators that provide a stable output frequency with varying supply voltage are provided. The subject oscillators find use in a variety of different types of devices, e.g., medical devices, including both implantable and ex-vivo devices.",PROTEUS BIOMEDICAL INC;;FLEMING ROBERT;;FLEMING CHERIE;;JANI NILAY;;WITHRINGTON JONATHAN;;ZDEBLICK MARK,FLEMING ROBERT;;FLEMING CHERIE;;JANI NILAY;;WITHRINGTON JONATHAN;;ZDEBLICK MARK,,https://lens.org/107-318-971-688-646,Patent Application,yes,0,59,9,9,0,H03K3/011;;H03K3/0322;;H03K5/133;;H03K2005/00208;;H03K2005/00234;;H03K3/0322;;H03K3/011;;H03K2005/00234;;H03K5/133;;H03K2005/00208,H03K3/03,,0,0,,,,PENDING
49,WO,A3,WO 2008/066617 A3,141-949-462-870-136,2008-07-24,2008,US 2007/0022257 W,2007-10-17,US 82983206 P,2006-10-17,LOW VOLTAGE OSCILLATOR FOR MEDICAL DEVICES,"Low voltage oscillators that provide a stable output frequency with varying supply voltage are provided. The subject oscillators find use in a variety of different types of devices, e.g., medical devices, including both implantable and ex-vivo devices.",PROTEUS BIOMEDICAL INC;;FLEMING ROBERT;;FLEMING CHERIE;;JANI NILAY;;WITHRINGTON JONATHAN;;ZDEBLICK MARK,FLEMING ROBERT;;FLEMING CHERIE;;JANI NILAY;;WITHRINGTON JONATHAN;;ZDEBLICK MARK,,https://lens.org/141-949-462-870-136,Search Report,yes,7,0,9,9,0,H03K3/011;;H03K3/0322;;H03K5/133;;H03K2005/00208;;H03K2005/00234;;H03K3/0322;;H03K3/011;;H03K2005/00234;;H03K5/133;;H03K2005/00208,H03K3/03,,0,0,,,,PENDING
50,CN,A,CN 1449504 A,009-228-195-850-302,2003-10-15,2003,CN 01814594 A,2001-07-20,AU PQ968800 A,2000-08-25,Polymer optical waveguide,"An optical waveguide in the form of an optical fibre ( 10 ) having at least one longitudinally extending light guiding core region ( 11 ) composed at least in part of a polymeric material, a longitudinally extending core-surrounding region ( 12 ) composed of a polymeric material, and a plurality of light confining elements ( 15 ), such as, for example, channel-like holes, located within the core surrounding region. The light confining elements extend in the longitudinal direction of the core region and are distributed about the core region, and at least a majority of the light confining elements having a refractive index less than that of the polymeric material from which the core-surrounding region is composed. A preform for use in manufacture of the optical waveguide is also disclosed.",UNIV SYDNEY,SIMON FLEMING;;IAN BASSETT;;MARK SCEATS,,https://lens.org/009-228-195-850-302,Patent Application,no,0,6,17,18,0,G02B6/02;;G02B6/02347;;G02B6/02357;;G02B6/02361;;G02B6/02371;;G02B6/00;;G02B6/02347;;G02B6/02;;G02B6/02357;;G02B6/02361;;G02B6/02371,G02B6/00;;G02B6/02;;G02B6/032,,0,0,,,,DISCONTINUED
51,AT,T1,AT E190313 T1,102-313-638-350-436,2000-03-15,2000,AT 96916892 T,1996-05-31,US 45589695 A;;US 9608235 W,1995-05-31,DNS-SEQUENZ UND KODIERTES BRUSTDRÜSENSPEZIFISISCHES BRUSTKREBSPROTEIN,,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/102-313-638-350-436,Granted Patent,no,0,0,41,41,0,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,C12N15/09;;A61K38/00;;C07H21/04;;C07K14/47;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,0,0,,,,PENDING
52,US,B1,US 6622244 B1,108-514-697-795-514,2003-09-16,2003,US 37200499 A,1999-08-11,US 37200499 A,1999-08-11,Booting from a reprogrammable memory on an unconfigured bus by modifying boot device address,"
    Boot up instructions may be stored on a memory coupled to the peripheral component interconnect (PCI) bus. These instructions may be accessed, despite the fact that peripheral component interconnect devices are normally not active during the boot up sequence. As a result, both the basic input/output system and other information may be stored on a reprogrammable memory coupled to the PCI bus. In some embodiments, this may reduce costs by avoiding the need for two semiconductor memories, one on the PCI bus and the other on a legacy bus. 
",INTEL CORP,EIDSON MARK E;;FLEMING BRUCE L,INTEL CORPORATION (1999-08-09),https://lens.org/108-514-697-795-514,Granted Patent,yes,9,10,3,3,0,G06F9/4403;;G06F9/4403,G06F9/445,713/2;;710/3;;710/313,2,0,,,"IBM Technical Disclosure Bulletin, ""Means for Generating a Pass A20 Signal from a Single Register"", vol. 35, No. 7, pp. 324-324, Dec. 1992.*;;""Flash Memory PCI Add-In Card for Embedded Systems,"" AP-758 Application Note, Intel Corporation, Sep. 1997 pp. 1-13.",EXPIRED
53,ES,T3,ES 2145451 T3,172-240-433-104-383,2000-07-01,2000,ES 96916892 T,1996-05-31,US 45589695 A,1995-05-31,SECUENCIA DE DNA Y PROTEINA DE CANCER DE MAMAS CODIFICADA ESPECIFICA PARA MAMAS.,"SE REVELAN UNA SECUENCIA AISLADA Y PURIFICADA DE ADN Y SU PROTEINA ESPECIFICA MAMARIA CODIFICADA, MAMAGLOBINA. TAMBIEN SE REVELAN METODOS PARA DETECTAR EL CANCER DE MAMA BASADOS EN LA SUPEREXPRESION Y SECRECION DE MAMAGLOBINA POR LAS CELULAS DEL CANCER DE MAMA. ESTOS METODOS DETECTAN Y/O CUANTIFICAN LA PRESENCIA DE LA MAMAGLOBINA O DEL ARNM QUE CODIFICA LA MAMAGLOBINA.",UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/172-240-433-104-383,Granted Patent,no,0,0,41,41,0,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,A61K38/00;;C07H21/04;;C07K14/47;;C12N15/09;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,0,0,,,,EXPIRED
54,HU,A2,HU P9900873 A2,027-029-425-663-512,1999-07-28,1999,HU P9900873 A,1996-05-31,US 45589695 A,1995-05-31,DNA SEQUENCE AND ENCODED MAMMARY-SPECIFIC BREAST CANCER PROTEIN,"A találmány tárgyát egy cDNS-szekvencia és az általa kódőltemlőspecifikűs emlőrák-prőtein (mammaglőbin) képezi, valaminteljárásők emlőrák kiműtatására a találmány szerinti szekvenciaalkalmazásával. A találmány szerinti megőldás alkalmas neőpláziásemlősejtek jelenlétének kőrai kiműtatására. A találmány szerintieljárással növelhető a mammőgráfiás vizsgálatők hatékőnysága és azőkprőgnősztizáló értéke. ŕ",UNIV WASHINGTON,FLEMING TIMOTHY P;;WATSON MARK A,,https://lens.org/027-029-425-663-512,Patent Application,no,0,0,41,41,0,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,A61K38/00;;C07H21/04;;C07K14/47;;C12N15/09;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,0,0,,,,PENDING
55,US,B1,US 6373960 B1,083-956-383-556-062,2002-04-16,2002,US 340898 A,1998-01-06,US 340898 A,1998-01-06,Embedding watermarks into compressed video data,"
    A for method watermarking a compressed video bitstream selects for modification numerous sites within an MPEG compressed video bitstream, each of which sites includes a DCT coefficient which is apt for modification. Watermarking sites are preferably located in MPEG B frames, and the DCT coefficient to be modified preferably has a run-length of zero (0). The method then embeds the watermark by modifying the DCT coefficient for at least some of the selected sites. A list specifying the watermarking sites may be transmitted together with the compressed video bitstream to permit further watermarking by subsequent bitstream receivers. A system for detecting an unauthorized copy of a watermarked video forms a synchronized, frame-by-frame difference between a possibly unauthorized copy of the watermarked compressed video and an un-watermarked copy of the video. Data in the watermarking site list permits readily locating watermarks within the possibly unauthorized copy. 
",PIXEL TOOLS CORP,CONOVER MARK D;;OLIVER FLEMING M,PIXEL TOOLS CORPORATION (1998-01-06),https://lens.org/083-956-383-556-062,Granted Patent,yes,10,236,1,1,0,G06T1/0035;;G06T1/0035;;G06T2201/0052;;G06T2201/0052;;G06T2201/0053;;G06T2201/0053;;G06T2201/0081;;G06T2201/0081,G06T1/00,382/100;;348/412.1;;382/232,8,2,037-303-043-585-741;;107-035-650-497-814,10.1109/southc.1996.535064;;10.1109/30.663749,"Cox et al., ""A Secure, Robust Watermark for Multimedia"", Information Hiding, NEC Research Institute, pp. 185-206, May 30, 1996.*;;Cox et al., ""A Secure, Imperceptable yet Perceptually Salient, Spread Spectrum Watermark for Multimedia"", NEC Research Institute, Southcon '96, Jun. 25, 1996, pp. 192-197.*;;Hsu et al. (""DCT-Based Watermarking for Video"", IEEE Transactions on Consumer Electronics, vol. 44, No. 1, Feb. 1998, pp. 206-216.*;;Multimedia Computing and Networking 1997, Feb. 10-11, 1997, Copyright 1997, The Society of Photo-Optical Instrumentation Engineers, pp. 264-273.;;Goffin, F., et al., ""A Low Cost Perceptive Digital Picture Watermarking Method,"" SPIE vol. 3022.;;Storage and Retrieval for Image and Video Database V, Feb. 13-14, 1997, Copyright 1997, The Society of Photo-Optical Instrumentation Engineers, pp. 264-277.;;Okon, C., ""Digital Watermarking: New Techniques for Image Ownership Branding,"" Advanced Imaging, Oct. 1996, pp. 93-94.;;Hartung, F., et al., ""Watermarking of MPEG-2 Encoded Video Without Decoding and Re-Encoding,"" SPIE vol. 3020.",EXPIRED
56,WO,A3,WO 2012/054870 A3,113-837-882-317-079,2013-01-10,2013,US 2011/0057347 W,2011-10-21,US 40561910 P,2010-10-21,BIOMARKERS FOR HCV INFECTED PATIENTS,The invention relates to biomarkers measurable in a human subject that have prognostic value with respect to efficacy of therapeutic treatments for Hepatitis C viral infection. The markers also are believed to have value for diagnosis liver health/liver damage.,VERTEX PHARMA;;FLEMING MARK ANDREW;;HARE BRIAN J,FLEMING MARK ANDREW;;HARE BRIAN J,,https://lens.org/113-837-882-317-079,Search Report,yes,12,0,5,5,0,G01N33/5767;;G16H50/30;;A61K38/08;;A61K38/21;;G01N33/5767;;G16H50/30;;A61K31/7056;;A61K38/08;;A61K38/21;;C12Q1/32;;C12Q1/48;;C12Q1/485;;G01N33/53;;G01N33/573,G01N33/576;;A61K38/08,,3,3,033-073-942-440-240;;017-562-541-938-387;;048-091-817-338-208,10.1002/hep.21520;;17256741;;10.1097/qai.0b013e3180559219;;17414926;;10.1046/j.1365-2893.2002.00341.x;;11876795,"MASAHIKO KODA ET AL: ""Fibroindex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C"", HEPATOLOGY, vol. 45, no. 2, 1 February 2007 (2007-02-01), pages 297 - 306, XP055020655, ISSN: 0270-9139, DOI: 10.1002/hep.21520;;ZEREMSKI MARIJA ET AL: ""Interferon gamma-inducible protein 10 - A predictive marker of successful treatment response in hepatitis C virus/HIV-coinfected patients"", JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, LIPPINCOTT WILLIAMS AND WILKINS,PHILADELPHIA, PA, US, vol. 45, no. 3, 1 July 2007 (2007-07-01), pages 262 - 268, XP009157012, ISSN: 1525-4135, DOI: 10.1097/QAI.0B013E3180559219;;T. POYNARD ET AL: ""Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial"", JOURNAL OF VIRAL HEPATITIS, vol. 9, no. 2, 1 March 2002 (2002-03-01), pages 128 - 133, XP055020656, ISSN: 1352-0504, DOI: 10.1046/j.1365-2893.2002.00341.x",PENDING
57,NO,L,NO 20011394 L,152-872-001-902-912,2001-05-22,2001,NO 20011394 A,2001-03-19,US 16262298 A;;US 9922616 W,1998-09-29,"Mammoglobin, et sekrert brystspesifikt brystkreftprotein","En renset og isolert DNA-sekvens og det kodede mamma-spesifikke utskilte proteinet, mammaglobin, er beskrevet. Det er også beskrevet fremgangsmåter for å påvise brystkreft basert på en overekspresjon og utskillelse av mammaglobin av brystkreftceller. Fremgangsmåten påviser og/eller kvantifiserer nærværet av mammaglobin eller det mRNA som koder mammaglobin. Det er også beskrevet immunoterapi-baserte metoder for å behandle en brystkreftpasient med en mammaglobin- uttrykkende tumor. Fremgangsmåten innbefatter bruk av mammaglobinantigener for å indusere en humoral og/eller celle-styrt immunreaksjon mot tumoren.",UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/152-872-001-902-912,Abstract,no,0,0,21,23,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;C12Q1/6886;;G01N33/57415;;G01N2800/52;;C12Q2600/158;;C12Q1/68;;A61K39/00;;C07K14/47;;A61K38/00;;C12Q1/6886;;C07K14/4721;;A61K39/00;;G01N33/57415;;C12Q2600/158;;G01N2800/52,A61K38/00;;G01N33/53;;A61K39/00;;C07K14/47;;C12N15/09;;C12Q1/68;;C12Q1/6886;;G01N33/566;;G01N33/574;;G01N33/577,,0,0,,,,DISCONTINUED
58,US,A,US 5855889 A,162-150-045-540-309,1999-01-05,1999,US 72230496 A,1996-09-30,US 72230496 A;;US 45589695 A,1995-05-31,"Mammaglobin, a mammary-specific breast cancer protein","A purified and isolated DNA sequence and the encoded mammary-specific protein, mammaglobin, are disclosed. Also disclosed are methods for the detecting breast cancer based upon the overexpression and secretion of mammaglobin by breast cancer cells. The methods detect and/or quantitate the presence of mammaglobin or the mRNA encoding mammaglobin.",UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/162-150-045-540-309,Granted Patent,yes,1,52,41,41,13,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,A61K38/00;;C07H21/04;;C07K14/47;;C12N15/09;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,424/185.1;;424/184.1;;530/350;;530/330,4,4,091-118-019-367-617;;027-521-885-095-522;;015-696-872-509-326;;060-981-882-240-003,pmc7131057;;10.1006/viro.1994.1376;;8030220;;10.1073/pnas.78.6.3824;;6167991;;pmc319665;;10.1111/j.1432-1033.1981.tb06206.x;;7014218;;10.1111/j.1432-1033.1981.tb06205.x;;8062249,"Daniel et al. Mapping of linear antigenic sites on the S glycoprotein of a neurotropic murine coronavirus with synthetic peptides: a combination of nine predictive algorithms fails to identify relevant epitopes and peptide immunogenicity is drastically i, 1994.;;Hopp et al. Prediction of protein antigenic determinants from amino acid sequences. Proceedings of the National Academy of Scinces, USA. vol. 78, No. 6, pp. 3824 3828, Jun. 1981.;;Peeters et al. Structural studies on rat prostatic binding protein. European Journal of Biochemistry. vol. 115, pp. 115 121, 1981.;;Watson et al. Isolation of differentially expressed sequence tags from human breast cancer. Cancer Research. vol. 54, pp. 4598 4602, Sep. 1, 1994 .",EXPIRED
59,TR,T2,TR 200001646 T2,187-171-804-952-786,2000-10-23,2000,TR 200001646 T,1998-09-18,US 93314997 A,1997-09-18,Bir salgılanmış meme kanseri proteini olan mamaglobin.,"Bir saflastirilmis ve izole edilmis DNA dizisi ve kodlanmis memeye özgü salgilanmis protein olan mamaglobin anlatilmistir.Ayni zamanda,gögüs kanseri hücreleri tarafindan mamaglobinin salgilamasi ve fazla sentezlenmesine dayali gögüs kanserinin bulgulanmasi için yöntemlerde anlatilmistir. Yöntemler mamaglobin ya da mamaglobini kodlayan mRNA'nin mevcudiyetini bulgulamakta ve/veya nicellestirmektedir. Bir mamaglobin sentezleyen tümöre sahip bir gögüs kanserli hastanin tedavi edilmesi için imünoterapi esasli yöntemler de anlatilmis. Yöntemler, tümöre karsi bir humoral ve/veya hücre-aracili bagisiklik karsiliginin uyarilmasi için mamaglobin antigenlerinin kullanimini kapsamaktadir.",UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/187-171-804-952-786,Patent Application,no,0,0,20,20,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;A61P35/00;;A61K39/00;;C07K14/47;;A61K39/00;;C07K14/4721;;A61K38/00,A61K35/26;;A61K38/00;;A61K39/00;;A61K39/395;;C12N15/09;;A61P35/00;;C07K14/47,,0,0,,,,PENDING
60,GB,A,GB 2529456 A,176-265-099-827-143,2016-02-24,2016,GB 201414846 A,2014-08-20,GB 201414846 A,2014-08-20,Intermittent fault simulation system,"A fault simulation system 1 for evaluating the performance of multiÂ­channel intermittent fault detection (IFD) test equipment 6 comprises a circuit 4 that creates defined resistance changes of varying characteristics to simulate real-world intermittent faults experienced by electrical/electronic equipment. The system is connected to the IFD tester under evaluation by an interface adapter 5 and to a computing device 2 which hosts intermittent fault simulation software. The software controls switches in the system to switch in or out different resistors, producing changes in resistance on an output channel. This simulates a continuity fault which is detected by the IFD tester if it is operating correctly. Pseudo-random variations of resistance with time or user-defined fault simulation sequences may be produced, saved, run and repeated by the system.",COPERNICUS TECHNOLOGY LTD,COCKRAM JAMES DAVID;;FLEMING MARK ANSELM,,https://lens.org/176-265-099-827-143,Patent Application,no,1,3,2,2,0,G01R31/2848;;G01R35/00;;G01R31/54;;G01R31/54,G01R35/00,,0,0,,,,DISCONTINUED
61,NO,L,NO 20001358 L,038-457-980-118-628,2000-05-12,2000,NO 20001358 A,2000-03-15,US 93314997 A;;US 9817991 W,1997-09-18,"Mammaglobin, et sekrert brystspesifikt brystkreftprotein","En renset og isolert DNA sekvens og det kodede brystspesifikke utskilte proteinet, mammaglobin, er angitt. Også angitt er metoder for å detektere brystkreft basert på overekspresjonen og sekresjonen av mammaglobin av brystkreftceller. Metodene detekterer og/eller kvantiteter nærværet av mammaglobin eller mRNAet som koder for mammaglobin. Immunoterapi- baserte metoder for å behandle en brystkreftpasient med en mammaglobinuttrykkende tumor er også beskrevet. Metodene involverer anvendelsen av mammaglobin- antigener for å indusere en humoral og/eller cellemediert immunrespons mot tumoren.",UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/038-457-980-118-628,Abstract,no,0,0,20,20,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;A61P35/00;;A61K39/00;;C07K14/47;;A61K39/00;;C07K14/4721;;A61K38/00,A61K35/26;;A61K38/00;;A61K39/00;;C12N15/09;;A61K39/395;;A61P35/00;;C07K14/47,,0,0,,,,DISCONTINUED
62,CZ,A3,CZ 378397 A3,039-764-131-225-118,1998-06-17,1998,CZ 378397 A,1996-05-31,US 45589695 A,1995-05-31,DNA SEQUENCE AND ENCODED PROTEIN SPECIFIC FOR MASTOCARCINOMA,,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/039-764-131-225-118,Patent Application,no,0,0,41,41,0,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,A61K38/00;;C07H21/04;;C07K14/47;;C12N15/09;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,0,0,,,,PENDING
63,WO,A1,WO 2007/000042 A1,047-474-089-713-875,2007-01-04,2007,CA 2006001042 W,2006-06-22,US 69413405 P,2005-06-27,REFRIGERATOR OR FREEZER WITH ENHANCED EFFICIENCY,A refrigerator (10) or a freezer comprises a primary refrigeration system (11) which is augmented with a passive secondary refrigeration loop (15) having a condenser (30) in thermal contact with a primary fluid line (12) at the location between a primary compressor (16) and a primary condenser (18) and preferably placed outside a building so that the passive secondary refrigeration loop (15) provides cooling to the primary refrigeration system (11) when the outside temperature is sufficiently low The condenser (30) of the passive secondary refrigeration loop (15) is positioned above the points where the primary fluid line (12) connects with mlet (32) and outlet (34) lines of the secondary loop condenser (30),FLEMING MARK A;;BRUNGER ALFRED P,FLEMING MARK A;;BRUNGER ALFRED P,,https://lens.org/047-474-089-713-875,Patent Application,yes,6,6,3,3,0,F25B6/04;;F25B6/04;;F25B40/04;;F25B40/04;;F25D23/003;;F25D23/003,F25D17/00;;F25D11/00;;F25D23/00,,0,0,,,,PENDING
64,NO,D0,NO 20001358 D0,061-908-051-987-005,2000-03-15,2000,NO 20001358 A,2000-03-15,US 93314997 A;;US 9817991 W,1997-09-18,"Mammaglobin, et sekrert brystspesifikt brystkreftprotein",,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/061-908-051-987-005,Patent Application,no,0,0,20,20,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;A61P35/00;;A61K39/00;;C07K14/47;;A61K39/00;;C07K14/4721;;A61K38/00,A61K35/26;;C12N15/09;;A61K38/00;;A61K39/00;;A61K39/395;;A61P35/00;;C07K14/47,,0,0,,,,DISCONTINUED
65,CA,A1,CA 2304167 A1,109-945-569-129-93X,1999-03-25,1999,CA 2304167 A,1998-09-18,US 93314997 A;;US 9817991 W,1997-09-18,"MAMMAGLOBIN, A SECRETED MAMMARY-SPECIFIC BREAST CANCER PROTEIN","A purified and isolated DNA sequence and the encoded mammary-specific secreted protein, mammaglobin, are disclosed. Also disclosed are methods for detecting breast cancer based upon the overexpression and secretion of mammaglobin by breast cancer cells. The methods detect and/or quantitate the presence of mammaglobin or the mRNA encoding mammaglobin. Immunotherapy-based methods for treating a breast cancer patient with a mammaglobin-expressing tumor are also disclosed. The methods involve using mammaglobin antigens to induce a humoral and/or cell-mediated immune response against the tumor.",UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/109-945-569-129-93X,Patent Application,no,0,0,20,20,14,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;A61P35/00;;A61K39/00;;C07K14/47;;A61K39/00;;C07K14/4721;;A61K38/00,C12N15/09;;A61K35/26;;A61K38/00;;A61K39/00;;A61K39/395;;A61P35/00;;C07K14/47,,0,0,,,,DISCONTINUED
66,CZ,A3,CZ 20011025 A3,132-716-795-056-251,2001-09-12,2001,CZ 20011025 A,1999-09-29,US 16262298 A,1998-09-29,Detection method presence of mastocarcinoma and uterus carcinoma cells and detection kit therefor,,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/132-716-795-056-251,Patent Application,no,0,0,21,23,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;C12Q1/6886;;G01N33/57415;;G01N2800/52;;C12Q2600/158;;C12Q1/68;;A61K39/00;;C07K14/47;;A61K38/00;;C12Q1/6886;;C07K14/4721;;A61K39/00;;G01N33/57415;;C12Q2600/158;;G01N2800/52,A61K38/00;;A61K39/00;;C07K14/47;;G01N33/53;;C12N15/09;;C12Q1/68;;C12Q1/6886;;G01N33/566;;G01N33/574;;G01N33/577,,0,0,,,,PENDING
67,CN,B,CN 101047253 B,082-963-500-330-281,2012-09-26,2012,CN 200710105345 A,2007-03-20,US 38470606 A,2006-03-20,Acrylic fiber bonded carbon fiber paper as gas diffusion media for fuel cell,"The invention provides an acrylic fiber bonded carbon fiber paper as the gas diffusion media for a fuel cell and discloses a gas diffusion media for a fuel cell, such as a proton exchange membrane fuel cell. The gas diffusion media includes carbonizable acrylic pulp fibers instead of conventional phenolic resin as a binder material. The acrylic fibers are mixed with the carbon fiber dispersion during the papermaking step, thus eliminating the phenolic resin impregnation step typically associated with conventional gas diffusion media manufacturing processes. The mat is then cured and carbonized to produce gas diffusion media.",GM GLOBAL TECH OPERATIONS INC;;SPECTRACORP,MARK MATHIAS;;MARGARET FLEMING;;CHUNXIN JI,,https://lens.org/082-963-500-330-281,Granted Patent,no,0,0,8,8,0,D21H13/50;;D21H13/50;;D21H13/18;;D21H13/18;;D21H17/36;;D21H17/36;;H01M8/0234;;H01M8/0234;;H01M8/0239;;H01M8/0239;;Y02E60/50;;Y02P70/50;;Y02P70/50;;Y10T428/30;;Y10T428/30,H01M8/02;;D21H27/00;;H01M4/86;;H01M4/88,,0,0,,,,INACTIVE
68,US,A1,US 2009/0210574 A1,081-666-960-047-105,2009-08-20,2009,US 3360608 A,2008-02-19,US 3360608 A,2008-02-19,OPEN HOST ISSUED STATESAVE TO ATTACHED STORAGE,"A method to issue a statesave command from a host system to attached storage is provided. The attached storage is monitored for a predetermined threshold time to identify an inaccessible device. Upon expiration of the predetermined threshold time, the statesave command is issued from a device driver of the host system to the attached storage.",IBM,FLEMING MARK SEAN;;MARTINEZ LISA R,INTERNATIONAL BUSINESS MACHINES CORPORATION (2008-02-13),https://lens.org/081-666-960-047-105,Patent Application,yes,14,15,2,2,0,G06F11/0757;;G06F11/0757;;G06F11/0778;;G06F11/0778;;G06F11/201;;G06F11/201,G06F3/00,710/19,0,0,,,,INACTIVE
69,NO,D0,NO 975508 D0,191-818-820-273-811,1997-11-28,1997,NO 975508 A,1997-11-28,US 45589695 A;;US 9608235 W,1995-05-31,DNA-sekvens og kodet bryst- spesifikk brystkreftprotein,,UNIV WASHINGTON,WATSON MARK A;;FLEMING THIMOTHY P,,https://lens.org/191-818-820-273-811,Patent Application,no,0,0,41,41,0,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,A61K38/00;;C12N15/09;;C07H21/04;;C07K14/47;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,0,0,,,,DISCONTINUED
70,PL,A1,PL 323632 A1,188-175-097-383-530,1998-04-14,1998,PL 32363296 A,1996-05-31,US 45589695 A,1995-05-31,DNA SEQUENCE AND ECODED BREAST CARCINOMA PROTEIN SPECIFIC FOR MAMMARY GLANDS,,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/188-175-097-383-530,Patent Application,no,0,0,41,41,0,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,A61K38/00;;C07H21/04;;C07K14/47;;C12N15/09;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,0,0,,,,PENDING
71,US,B2,US 7249253 B2,137-748-626-538-952,2007-07-24,2007,US 60910903 A,2003-06-27,US 60910903 A;;US 37200499 A,1999-08-11,Booting from a re-programmable memory on an unconfigured bus,"Boot up instructions may be stored on a memory coupled to the peripheral component interconnect (PCI) bus. These instructions may be accessed, despite the fact that peripheral component interconnect devices are normally not active during the boot up sequence. As a result, both the basic input/output system and other information may be stored on a reprogrammable memory coupled to the PCI bus. In some embodiments, this may reduce costs by avoiding the need for two semiconductor memories, one on the PCI bus and the other on a legacy bus.",INTEL CORP,EIDSON MARK E;;FLEMING BRUCE L,,https://lens.org/137-748-626-538-952,Granted Patent,yes,3,4,3,3,0,G06F9/4403;;G06F9/4403,G06F9/24;;G06F9/445,713/2;;710/3;;710/313,0,0,,,,EXPIRED
72,EP,A1,EP 1117673 A1,160-299-255-209-625,2001-07-25,2001,EP 99950003 A,1999-09-29,US 9922616 W;;US 16262298 A,1998-09-29,"MAMMAGLOBIN, A SECRETED MAMMARY-SPECIFIC BREAST CANCER PROTEIN",,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/160-299-255-209-625,Patent Application,yes,0,0,21,23,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;C12Q1/6886;;G01N33/57415;;G01N2800/52;;C12Q2600/158;;C12Q1/68;;A61K39/00;;C07K14/47;;A61K38/00;;C12Q1/6886;;C07K14/4721;;A61K39/00;;G01N33/57415;;C12Q2600/158;;G01N2800/52,A61K38/00;;A61K39/00;;G01N33/53;;C07K14/47;;C12N15/09;;C12Q1/68;;C12Q1/6886;;G01N33/566;;G01N33/574;;G01N33/577,,0,0,,,,DISCONTINUED
73,BR,A,BR 9812472 A,147-891-647-980-779,2000-09-19,2000,BR 9812472 A,1998-09-18,US 93314997 A;;US 9817991 W,1997-09-18,"Vacina especìfica de mamaglobina, processo para tratar um paciente com um tumor que expressa mamaglobina, e, polipeptìdeo isolado e purificado","""VACINA ESPECìFICA DE MAMAGLOBINA, PROCESSO PARA TRATAR UM PACIENTE COM UM TUMOR QUE EXPRESSA MAMAGLOBINA, E, POLIPEPTìDEO ISOLADO E PURIFICADO"" São apresentadas uma seq³ência de DNA purificada e isolada e a proteína codificada secretada especificamente pelas mamas, a mamaglobina. Também são apresentados métodos para detectar o câncer de mama com base na superexpressão e na secreção da mamaglobina pelas células do câncer de mama. Os métodos detectam e/ou quantificam a presença de mamaglobina ou o mRNA que codifica a mamaglobina. Os métodos com base na imunoterapia para tratar de uma paciente com câncer de mama com um tumor expressando a mamaglobina também são apresentados. Os métodos envolvem o uso de antígenos de mamaglobina para induzir uma resposta imune humoral e/ou mediada por células contra o tumor.",UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/147-891-647-980-779,Patent Application,no,0,0,20,20,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;A61P35/00;;A61K39/00;;C07K14/47;;A61K39/00;;C07K14/4721;;A61K38/00,C12N15/09;;A61K35/26;;A61K38/00;;A61K39/00;;A61K39/395;;A61P35/00;;C07K14/47,,0,0,,,,DISCONTINUED
74,US,A,US 5922836 A,006-753-262-975-815,1999-07-13,1999,US 93314997 A,1997-09-18,US 93314997 A;;US 45589695 A;;US 9608235 W,1995-05-31,Mammaglobin antigens,"A purified and isolated DNA sequence and the encoded mammary-specific secreted protein, mammaglobin, are disclosed. Also disclosed are methods for detecting breast cancer based upon the overexpression and secretion of mammaglobin by breast cancer cells. The methods detect and/or quantitate the presence of mammaglobin or the mRNA encoding mammaglobin. Immunotherapy-based methods for treating a breast cancer patient with a mammaglobin-expressing tumor are also disclosed. The methods involve using mammaglobin antigens to induce a humoral and/or cell-mediated immune response against the tumor.",UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,WASHINGTON UNIVERSITY (1997-08-29),https://lens.org/006-753-262-975-815,Granted Patent,yes,5,56,20,20,14,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;A61P35/00;;A61K39/00;;C07K14/47;;A61K39/00;;C07K14/4721;;A61K38/00,A61K35/26;;A61K38/00;;A61K39/00;;C12N15/09;;A61K39/395;;A61P35/00;;C07K14/47,530/300;;530/324;;530/327;;530/328;;530/329;;530/350,33,33,003-849-961-384-35X;;007-822-064-014-928;;057-945-343-734-358;;015-696-872-509-326;;060-981-882-240-003;;039-229-624-803-022;;047-850-427-018-32X;;049-477-935-103-029;;093-298-749-737-02X;;053-457-015-539-969;;119-356-842-486-362;;001-465-886-657-534;;011-052-065-868-454;;069-204-673-706-269;;166-392-684-735-433;;016-273-221-621-842;;094-881-140-637-816;;115-916-545-155-724;;104-304-928-520-85X;;083-308-152-083-020;;014-017-617-421-956;;011-964-364-173-232;;022-264-904-824-000;;050-904-893-659-406;;082-770-528-105-755;;084-368-082-646-975;;028-076-553-910-600;;040-713-726-205-55X;;041-446-829-885-810;;091-739-663-074-980;;002-882-127-467-426;;100-874-429-486-692;;025-173-207-852-618,1699952;;pmc2116333;;10.1083/jcb.111.5.2129;;10.1128/mcb.8.3.1247-1252.1988;;10.1128/mcb.8.3.1247;;pmc363269;;3285178;;2507634;;10.4049/jimmunol.143.8.2595;;10.1111/j.1432-1033.1981.tb06206.x;;7014218;;10.1111/j.1432-1033.1981.tb06205.x;;8062249;;10.1007/bf03349687;;7868811;;0007868811;;8227325;;pmc288387;;10.1172/jci116810;;7066904;;1888147;;3319534;;10.1210/edrv-8-4-474;;3994306;;6598318;;10.1111/j.1749-6632.1984.tb38280.x;;10.1016/0022-4731(84)90190-0;;6538620;;0008631025;;8631025;;10.1073/pnas.91.23.11236;;pmc45202;;7972041;;8084586;;8187086;;2470152;;10.1126/science.2470152;;10.1093/jnci/84.11.845;;1317462;;10.1093/jnci/85.3.200;;8423624;;10.1097/00000441-199209000-00011;;1476160;;10.1016/b978-0-444-82027-3.50022-5;;10.1016/s1054-3589(08)60935-7;;8504068;;10.1016/0304-3835(93)90224-w;;7689035;;10.1002/eji.1830170820;;2442000;;10.1126/science.2434994;;2434994;;1280333;;10.1038/360434a0;;1402647;;pmc2119397;;10.1084/jem.176.4.1007;;1709722;;10.1038/351290a0;;pmc42754;;7831305;;10.1073/pnas.92.2.432;;1546329;;10.1126/science.1546329;;8548758;;1736535;;10.1016/0042-6822(92)90321-f;;2481588;;10.1002/eji.1830191209,"Burgess et al. (J. Cell Bio, III:2129 2138), 1990.;;Lazar et al. (Mol & Cell Bio, 8: 1247 1252), 1988.;;Tao et al. (J. Immunol, 143:2595 2601, 1989.;;Peeters et al. (Eur. J. Biochem., 115:115 121), 1981.;;Watson et al., Isolation of Differentially Expressed Sequence Tags form Human Breast Cancer, Cancer Res 54 :4598 4602 (1994).;;Miele et al., Uteroglobin and Uterglobin like Proteins: the Uterglobin family of Proteins, J. Endocrinol Invest 17 :679 92 (1994).;;Peri et al., Tissue Specific expression of the Gene Coding for Human Clara Cell 10 kD Protein, a Phospholipase A 2 inhibitory Protein, J Clin Invest 92 :2099 2109 (1993).;;Bjork et al., Partial Characterization and Quantitiation of a Human Prostatic Estramustinebinding Protein, Cancer Res 42 :1935 42 (1982).;;Bjork et al., Expression and Partial Characterization of Estramustine Binding Protein (EMBP) in Human Brast Cancer and malignant Melanoma, Anticancer Res 11 :1173 82 (1991).;;Miele et al., Uteroglobin: Structure, Molecular Biology, and New perspectives on Its Function as a Phospholipase A 2 Inhibitor, Endocrine Rev 8 :474 90 (1987).;;Cato et al., The Hormonal Regulation of Uteroglobin Gene Expression, Anticancer Res 5 :65 72 (1985).;;Parker et al., Organization and Expression of Genes Encoding Prostatic Steroid Binding Protein Ann NY Acad Sci 438 :115 24 (1984).;;Parker et al., Organization and Expression of Prostatic Steroid Binding Protein Genes, J Steroid Biochem 20 :67 71 (1984).;;Watson et al., Cancer Res. 56:860 865, 1996.;;Maroulako et al., Proc Nat Acad Sci U.S. 91 :11236 11240, 1994.;;Sandmoller et al., Oncogene 9 :2805 2815, 1994.;;Schoenfeld et al., Cancer Res. 54 :2986 90.;;Slamon et al. Sci 244 :707 712, 1989.;;Thor et al., J Nat l Cancer Inst 84 :845 855, 1992.;;Allerd et al., J Nat l Cancer Inst 85 :200 206, 1993.;;LoBuglio and Saleh, Am. J Med Sci 304:214 224, 1992.;;Bagshawe, Adv Pharmacol 24 :99 121, 1993.;;Denton et al., Cancer Letters 70 :143 150 (1993).;;Borras Cuesta et al., Eur. J. Immunol. 17 , 1213 1215 (1987).;;Good et al., Science 235 :1059 1062 (1987).;;Hill et al., Nature 360 :434 (1992).;;Hammer et al., J. Exp. Med. 176 :1007 (1992).;;Falk et al., Nature 351 :290 296 (1991).;;Peoples et al., Proc. Natl. Acad. Sci. 92 :432 436 (1995).;;Henderson, et al., Science 255 :1264 1266 (1992).;;Toso et al., Cancer Research 56 :16 20 (1996).;;Taylor et al., Virology 187 :321 328 (1991).;;Panina Bordignon et al., Eur. J. Immunol. 19 :2237 (1989).",EXPIRED
75,CA,C,CA 2222747 C,011-346-133-992-080,2011-06-28,2011,CA 2222747 A,1996-05-31,US 45589695 A;;US 9608235 W,1995-05-31,DNA SEQUENCE AND ENCODED MAMMARY-SPECIFIC BREAST CANCER PROTEIN,"A purified and isolated DNA sequence and the encoded mammary-specific protein, mammaglobin, are disclosed. Also disclosed are methods for the detecting breast cancer based upon the overexpression and secretion of mammaglobin by breast cancer cells. The methods detect and/or quantitate the presence of mammaglobin or the mRNA encoding mammaglobin.",UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/011-346-133-992-080,Granted Patent,no,0,0,41,41,0,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,C12N15/09;;C12N15/12;;A61K38/00;;C07H21/00;;C07H21/04;;C07K14/47;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,0,0,,,,EXPIRED
76,US,A1,US 2004/0098516 A1,030-504-154-324-647,2004-05-20,2004,US 60910903 A,2003-06-27,US 60910903 A;;US 37200499 A,1999-08-11,Booting from a re-programmable memory on an unconfigured bus,"
   Boot up instructions may be stored on a memory coupled to the peripheral component interconnect (PCI) bus. These instructions may be accessed, despite the fact that peripheral component interconnect devices are normally not active during the boot up sequence. As a result, both the basic input/output system and other information may be stored on a reprogrammable memory coupled to the PCI bus. In some embodiments, this may reduce costs by avoiding the need for two semiconductor memories, one on the PCI bus and the other on a legacy bus. 
",EIDSON MARK E.;;FLEMING BRUCE L.,EIDSON MARK E;;FLEMING BRUCE L,,https://lens.org/030-504-154-324-647,Patent Application,yes,3,5,3,3,0,G06F9/4403;;G06F9/4403,G06F9/445,710/1,0,0,,,,EXPIRED
77,WO,A1,WO 1999/014230 A1,035-651-217-116-346,1999-03-25,1999,US 9817991 W,1998-09-18,US 93314997 A,1997-09-18,"MAMMAGLOBIN, A SECRETED MAMMARY-SPECIFIC BREAST CANCER PROTEIN","A purified and isolated DNA sequence and the encoded mammary-specific secreted protein, mammaglobin, are disclosed. Also disclosed are methods for detecting breast cancer based upon the overexpression and secretion of mammaglobin by breast cancer cells. The methods detect and/or quantitate the presence of mammaglobin or the mRNA encoding mammaglobin. Immunotherapy-based methods for treating a breast cancer patient with a mammaglobin-expressing tumor are also disclosed. The methods involve using mammaglobin antigens to induce a humoral and/or cell-mediated immune response against the tumor.",UNIV WASHINGTON;;WATSON MARK A;;FLEMING TIMOTHY P,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/035-651-217-116-346,Patent Application,yes,1,12,20,20,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;A61P35/00;;A61K39/00;;C07K14/47;;A61K39/00;;C07K14/4721;;A61K38/00,A61K35/26;;A61K38/00;;A61K39/00;;A61K39/395;;C12N15/09;;A61P35/00;;C07K14/47,,2,1,015-696-872-509-326,10.1111/j.1432-1033.1981.tb06206.x;;7014218;;10.1111/j.1432-1033.1981.tb06205.x,"PEETERS B., ET AL.: ""STRUCTURAL STUDIES ON RAT PROSTATIC BINDING PROTEIN. THE PRIMARY STRUCTURE OF ITS GLYCOSYLATED COMPONENT C3."", EUROPEAN JOURNAL OF BIOCHEMISTRY, WILEY-BLACKWELL PUBLISHING LTD., GB, vol. 115., 1 January 1981 (1981-01-01), GB, pages 115 - 121., XP002914730, ISSN: 0014-2956;;See also references of EP 1037901A4",PATENTED
78,AU,B2,AU 735338 B2,057-705-831-100-845,2001-07-05,2001,AU 1998/093737 A,1998-09-18,US 93314997 A;;US 9817991 W,1997-09-18,"Mammaglobin, a secreted mammary-specific breast cancer protein",,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/057-705-831-100-845,Granted Patent,no,0,0,20,20,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;A61P35/00;;A61K39/00;;C07K14/47;;A61K39/00;;C07K14/4721;;A61K38/00,C12N15/09;;A61K35/26;;A61K38/00;;A61K39/00;;A61K39/395;;A61P35/00;;C07K14/47,,0,0,,,,EXPIRED
79,CA,A1,CA 2222747 A1,104-128-429-522-455,1996-12-05,1996,CA 2222747 A,1996-05-31,US 45589695 A;;US 9608235 W,1995-05-31,DNA SEQUENCE AND ENCODED MAMMARY-SPECIFIC BREAST CANCER PROTEIN,"A purified and isolated DNA sequence and the encoded mammary-specific protein, mammaglobin, are disclosed. Also disclosed are methods for the detecting breast cancer based upon the overexpression and secretion of mammaglobin by breast cancer cells. The methods detect and/or quantitate the presence of mammaglobin or the mRNA encoding mammaglobin.",UNIV WASHINGTON,FLEMING TIMOTHY P;;WATSON MARK A,,https://lens.org/104-128-429-522-455,Patent Application,no,0,0,41,41,0,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,C12N15/09;;A61K38/00;;C07H21/04;;C07K14/47;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,0,0,,,,EXPIRED
80,US,A,US 5668267 A,165-806-930-506-208,1997-09-16,1997,US 45589695 A,1995-05-31,US 45589695 A,1995-05-31,"Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein","A purified and isolated DNA sequence and the encoded mammary-specific protein, mammaglobin, are disclosed. Also disclosed are methods for the detecting breast cancer based upon the overexpression and secretion of mammaglobin by breast cancer cells. The methods detect and/or quantitate the presence of mammaglobin or the mRNA encoding mammaglobin.",UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,WASHINGTON UNIVERSITY (1995-05-31),https://lens.org/165-806-930-506-208,Granted Patent,yes,0,58,41,41,13,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,A61K38/00;;C07H21/04;;C12N15/09;;C07K14/47;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,536/23.5;;536/24.31;;536/23.1,10,10,060-981-882-240-003;;039-229-624-803-022;;047-850-427-018-32X;;049-477-935-103-029;;093-298-749-737-02X;;053-457-015-539-969;;119-356-842-486-362;;001-465-886-657-534;;011-052-065-868-454;;036-740-421-551-776,8062249;;10.1007/bf03349687;;7868811;;0007868811;;8227325;;pmc288387;;10.1172/jci116810;;7066904;;1888147;;3319534;;10.1210/edrv-8-4-474;;3994306;;6598318;;10.1111/j.1749-6632.1984.tb38280.x;;10.1016/0022-4731(84)90190-0;;6538620;;0006294095;;6294095;;10.1016/s0021-9258(18)33208-3,"Watson et al., Isolation of Differentially Expressed Sequence Tags from Human Breast Cancer, Cancer Res 54:4598 4602 (1994).;;Miele et al., Uteroglobin and Uteroglobin like Proteins: The Uteroglobin Family of Proteins, J. Endocrinol Invest 17:679 92 (1994).;;Peri et al., Tissue Specific Expression of the Gene Coding for Human Clara Cell 10 kD Protein, a Phospholipase A 2 inhibitory Protein, J Clin Invest 92:2099 2109 (1993).;;Bjork et al., Partial Characterization and Quantitation of a Human Prostatic Estramustine binding Protein, Cancer Res 42:1935 42 (1992).;;Bjork et al., Expression and Partial Characterization of Estramustine Binding Protein (EMBP) in Human Breast Cancer and malignant Melanoma, Anticancer Res 11:1173 82 (1991).;;Miele et al., Uteroglobin: Structure, Molecular Biology, and New Perspectives on Its Function as a Phospholipase A 2 Inhibitor, Endocrine Rev 8:474 90 (1987).;;Cato et al., The Hormonal Regulation of Uteroglobin Gene Expression, Anticancer Res 5:65 72 (1985).;;Parker et al., Organization and Expression of Genes Encoding Prostatic Steroid Binding Protein, Ann N Y Acad Sci 438:115 24 (1984).;;Parker et al., Organization and Expression of Prostatic Steroid Binding Protein Genes, J. Steroid Biochem 20:67 71 (1984).;;Parker et al. (1983) J. Biol. Chem 258:12 15.",EXPIRED
81,GB,B,GB 2584812 B,061-585-885-673-498,2022-03-02,2022,GB 201901771 A,2019-02-08,GB 201901771 A,2019-02-08,Stackable modular planter,,RICHARD ALEXANDER SABIN;;MARK ANDREW FLEMING,RICHARD ALEXANDER SABIN;;MARK ANDREW FLEMING,,https://lens.org/061-585-885-673-498,Granted Patent,no,3,0,8,8,0,A01G9/023;;A01G27/02;;A01G27/06;;A01G27/008;;A01G9/023;;A01G27/06;;A01G9/023;;A01G9/027;;A01G27/008;;A01G27/06,A01G9/02;;A01G27/06,,0,0,,,,ACTIVE
82,WO,A9,WO 2000/018783 A9,070-348-557-812-994,2000-09-21,2000,US 9922616 W,1999-09-29,US 16262298 A,1998-09-29,"MAMMAGLOBIN, A SECRETED MAMMARY-SPECIFIC BREAST CANCER PROTEIN","A purified and isolated DNA sequence and the encoded mammary-specific secreted protein, mammaglobin, are disclosed. Also disclosed are methods for detecting breast cancer based upon the overexpression and secretion of mammaglobin by breast cancer cells. The methods detect and/or quantitate the presence of mammaglobin or the mRNA enconding mammaglobin. Immunotherapy-based methods for treating a breast cancer patient with a mammaglobin-expressing tumor are also disclosed. The methods involve using mammaglobin antigens to induce a humoral and/or cell-mediated immune response against the tumor.",UNIV WASHINGTON;;WATSON MARK A;;FLEMING TIMOTHY P,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/070-348-557-812-994,Patent Application,no,0,0,21,23,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;C12Q1/6886;;G01N33/57415;;G01N2800/52;;C12Q2600/158;;C12Q1/68;;A61K39/00;;C07K14/47;;A61K38/00;;C12Q1/6886;;C07K14/4721;;A61K39/00;;G01N33/57415;;C12Q2600/158;;G01N2800/52,A61K38/00;;A61K39/00;;G01N33/53;;C07K14/47;;C12N15/09;;C12Q1/68;;C12Q1/6886;;G01N33/566;;G01N33/574;;G01N33/577,,0,0,,,,PATENTED
83,US,A1,US 2004/0064672 A1,067-614-195-871-364,2004-04-01,2004,US 26205602 A,2002-09-30,US 26205602 A,2002-09-30,Method and apparatus for managing a dynamic alias page table,"
   A method and apparatus for managing a dynamic alias page table are provided. With the apparatus and method, alias page table entries are added to an alias page table dynamically by determining if the alias page table has space for the entry and, if so, the entry describing the virtual address to physical address mapping is added to the alias page table and a successful completion is returned to the virtual memory manager. If the alias page table does not have space for the entry, a new page is used to map the next virtual page of the alias page table. This page must be marked as a fixed page if it not so marked already. This page is pinned in the software page frame table, and the hardware page table entry for this page is also pinned. 
",IBM,FLEMING MATTHEW DAVID;;ROGERS MARK DOUGLASS,INTERNATIONAL BUSINESS MACHINES CORPORATION (2002-09-27),https://lens.org/067-614-195-871-364,Patent Application,yes,1,15,2,2,0,G06F12/1018;;G06F12/1018,G06F12/10,711/207;;711/206,0,0,,,,EXPIRED
84,TR,T1,TR 200003685 T1,090-876-956-589-51X,2001-04-20,2001,TR 200003685 T,1998-09-18,US 93314997 A,1997-09-18,Bir salgılanmış meme kanseri proteini olan mamaglobin,"Bir saflastirilmis ve izole edilmis DNA dizisi ve kodlanmis memeye özgü salgilanmis protein olan mamaglobin anlatilmistir. Ayni zamanda,gögüs kanseri hücreleri tarafindan mamaglobinin salgilanmasi ve fazla sentezlenmesine dayali gögüs kanserinin bulgulanmasi için yöntemler de anlatilmistir.Yöntemler mamaglobin yada mamaglobini kodlayan mRNA'nin mevcudiyetini bulgulamakta ve/veya nicellestirmektedir. Bir mamaglobin sentezleyen tümöre sahip bir gögüs kanserli hastanin tedavi edilmesi için imünoterapi esasli yöntemler de antatilmistir. Yöntemler, tümöre karsi bir humoral ve/veya hücre-aracili bagisiklik karsiliginin uyarilmasi için mamaglobin antigenlerinin kullanimini kapsamaktadir.",UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/090-876-956-589-51X,Patent Application,no,0,0,20,20,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;A61P35/00;;A61K39/00;;C07K14/47;;A61K39/00;;C07K14/4721;;A61K38/00,A61K35/26;;A61K38/00;;A61K39/00;;A61K39/395;;C12N15/09;;A61P35/00;;C07K14/47,,0,0,,,,PENDING
85,TR,T2,TR 200101702 T2,019-403-164-826-201,2001-12-21,2001,TR 200101702 T,1999-09-29,US 16262298 A,1998-09-29,"Mammaglobin, göğse özgü salgılanan bir göğüs kanseri proteini.","Saflastirilmis ve izole edilmis bir DNA dizisi ve salgilanan kodlanmis gögse özgü bir protein, mammaglobin, tarif edilmektedir. Ayrica, gögüs kanseri hücreleri tarafindan mammaglobinin asiri ifadesi ve salgilanmasina göre gögüs kanserinin tespit edilmesi için yöntemler tarif edilmektedir. Yöntemler, mammaglobinin veya mammaglobin kodlayan mRNA'nin mevcudiyetini tespit eder ve miktarini belirler. Ayrica, mammaglobin ifade eden bir tümörü olan bir gögüs kanseri hastasinin tedavi edilmesi için imünoterapiye dayali yöntemler de tarif edilmektedir. Yöntemler tümöre karsi bir humoral ve/veya hücre araciligiyla olan bagisiklik tepkisi indüklemek için mammaglobin antijenlerinin kullanilmasini içerir.",UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/019-403-164-826-201,Patent Application,no,0,0,21,23,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;C12Q1/6886;;G01N33/57415;;G01N2800/52;;C12Q2600/158;;C12Q1/68;;A61K39/00;;C07K14/47;;A61K38/00;;C12Q1/6886;;C07K14/4721;;A61K39/00;;G01N33/57415;;C12Q2600/158;;G01N2800/52,A61K38/00;;A61K39/00;;G01N33/53;;C07K14/47;;C12N15/09;;C12Q1/68;;C12Q1/6886;;G01N33/566;;G01N33/574;;G01N33/577,,0,0,,,,PENDING
86,PL,A1,PL 340689 A1,053-958-677-509-510,2001-02-26,2001,PL 34068998 A,1998-09-18,US 93314997 A,1997-09-18,MAMMOGLOBIN - A BREAST CARCINOMA SPECIFIC SECRETORY PROTEIN,,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/053-958-677-509-510,Patent Application,no,0,0,20,20,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;A61P35/00;;A61K39/00;;C07K14/47;;A61K39/00;;C07K14/4721;;A61K38/00,A61K35/26;;A61K38/00;;A61K39/00;;A61K39/395;;C12N15/09;;A61P35/00;;C07K14/47,,0,0,,,,DISCONTINUED
87,AU,A,AU 1999/062758 A,061-467-226-035-073,2000-04-17,2000,AU 1999/062758 A,1999-09-29,AU 1999/062758 A;;AU 1996/059616 A;;US 16262298 A;;US 9922616 W,1996-05-31,"Mammaglobin, a secreted mammary-specific breast cancer protein",,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/061-467-226-035-073,Patent Application,no,0,0,2,23,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;C12Q1/6886;;G01N33/57415;;C12Q2600/158;;G01N2800/52;;C07K14/47,G01N33/53;;A61K38/00;;A61K39/00;;C07H21/02;;C07H21/04;;C07K14/47;;C12N15/09;;C12Q1/68;;G01N33/566;;G01N33/574;;G01N33/577,,0,0,,,,EXPIRED
88,WO,B1,WO 2000/018783 B1,070-919-948-827-84X,2000-05-11,2000,US 9922616 W,1999-09-29,US 16262298 A,1998-09-29,"MAMMAGLOBIN, A SECRETED MAMMARY-SPECIFIC BREAST CANCER PROTEIN","A purified and isolated DNA sequence and the encoded mammary-specific secreted protein, mammaglobin, are disclosed. Also disclosed are methods for detecting breast cancer based upon the overexpression and secretion of mammaglobin by breast cancer cells. The methods detect and/or quantitate the presence of mammaglobin or the mRNA enconding mammaglobin. Immunotherapy-based methods for treating a breast cancer patient with a mammaglobin-expressing tumor are also disclosed. The methods involve using mammaglobin antigens to induce a humoral and/or cell-mediated immune response against the tumor.",UNIV WASHINGTON;;WATSON MARK A;;FLEMING TIMOTHY P,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/070-919-948-827-84X,Patent Application,no,0,0,21,23,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;C12Q1/6886;;G01N33/57415;;G01N2800/52;;C12Q2600/158;;C12Q1/68;;A61K39/00;;C07K14/47;;A61K38/00;;C12Q1/6886;;C07K14/4721;;A61K39/00;;G01N33/57415;;C12Q2600/158;;G01N2800/52,A61K38/00;;A61K39/00;;G01N33/53;;C07K14/47;;C12N15/09;;C12Q1/68;;C12Q1/6886;;G01N33/566;;G01N33/574;;G01N33/577,,0,0,,,,PATENTED
89,NZ,A,NZ 309445 A,111-564-367-867-013,1999-11-29,1999,NZ 30944596 A,1996-05-31,US 45589695 A;;US 9608235 W,1995-05-31,Dna sequence and encoded mammary specific breast cancer protein,"A purified and isolated DNA sequence and the encoded mammary-specific protein, mammaglobin, are disclosed. Also disclosed are methods for the detecting breast cancer based upon the overexpression and secretion of mammaglobin by breast cancer cells. The methods detect and/or quantitate the presence of mammaglobin or the mRNA encoding mammaglobin.",UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/111-564-367-867-013,Patent Application,no,0,0,41,41,0,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,A61K38/00;;C12N15/09;;C07H21/04;;C07K14/47;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,0,0,,,,DISCONTINUED
90,NZ,A,NZ 503729 A,112-708-777-374-082,2001-12-21,2001,NZ 50372998 A,1998-09-18,US 93314997 A;;US 9817991 W,1997-09-18,Secreted mammary-specific breast cancer protein (mammaglobin) and vaccines,"A purified and isolated DNA sequence and the encoded mammary-specific secreted protein, mammaglobin, are provided. Immunotherapy-based methods for treating a breast cancer patient with a mammaglobin-expressing tumour are also disclosed. Vaccines comprising mammaglobin antigens may be used for inducing a humoral and/or cell-mediated immune response against the tumour.",UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/112-708-777-374-082,Patent Application,no,0,0,20,20,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;A61P35/00;;A61K39/00;;C07K14/47;;A61K39/00;;C07K14/4721;;A61K38/00,A61K35/26;;A61K38/00;;C12N15/09;;A61K39/00;;A61K39/395;;A61P35/00;;C07K14/47,,0,0,,,,DISCONTINUED
91,WO,A1,WO 1996/038463 A1,136-718-990-678-78X,1996-12-05,1996,US 9608235 W,1996-05-31,US 45589695 A,1995-05-31,DNA SEQUENCE AND ENCODED MAMMARY-SPECIFIC BREAST CANCER PROTEIN,"A purified and isolated DNA sequence and the encoded mammary-specific protein, mammaglobin, are disclosed. Also disclosed are methods for the detecting breast cancer based upon the overexpression and secretion of mammaglobin by breast cancer cells. The methods detect and/or quantitate the presence of mammaglobin or the mRNA encoding mammaglobin.",UNIV WASHINGTON;;WATSON MARK A;;FLEMING TIMOTHY P,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/136-718-990-678-78X,Patent Application,yes,0,33,41,41,0,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,A61K38/00;;C07H21/04;;C07K14/47;;C12N15/09;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,1,1,069-204-673-706-269,0008631025;;8631025,"CANCER RESEARCH, Volume 56, No. 4, issued 15 February 1996, M.A. WATSON et al., ""Mammaglobin, a Mammary-Specific member of the Uteroglobin Gene Family, Is Overexpressed in Human Breast Cancer"", pages 860-865.",PATENTED
92,US,B2,US 6961840 B2,143-386-952-173-006,2005-11-01,2005,US 26205602 A,2002-09-30,US 26205602 A,2002-09-30,Method and apparatus for managing a dynamic alias page table,"A method and apparatus for managing a dynamic alias page table are provided. With the apparatus and method, alias page table entries are added to an alias page table dynamically by determining if the alias page table has space for the entry and, if so, the entry describing the virtual address to physical address mapping is added to the alias page table and a successful completion is returned to the virtual memory manager. If the alias page table does not have space for the entry, a new page is used to map the next virtual page of the alias page table. This page must be marked as a fixed page if it not so marked already. This page is pinned in the software page frame table, and the hardware page table entry for this page is also pinned.",IBM,FLEMING MATTHEW DAVID;;ROGERS MARK DOUGLASS,INTERNATIONAL BUSINESS MACHINES CORPORATION (2002-09-27),https://lens.org/143-386-952-173-006,Granted Patent,yes,1,21,2,2,0,G06F12/1018;;G06F12/1018,G06F12/10,711/207;;711/202;;711/203;;711/206;;711/208;;711/209;;711/216;;711/221,3,2,059-944-111-228-198;;056-029-275-930-946,10.1145/42404.42410;;10.1145/46157.330532,"Per-Ake Larson, Dynamic Hash Tables, Apr. 1988, Communications of ACM, vol. 31, pp 446-457.;;Enbody et al., Dynamic Hashing Schemes, Jun. 1988, ACM Computing Surveys, vol. 20, pp 85-113.;;Swanberg, Atomic Memory Migration Apparatus and Method.",EXPIRED
93,US,A1,US 2022/0046872 A1,186-805-670-312-016,2022-02-17,2022,US 202017428723 A,2020-02-07,GB 201901771 A;;GB 2020000011 W,2019-02-08,Stackable Modular Planter,"A stackable modular planter includes an open top plant box with a base and four side walls adapted to receive a growing medium and plants. The open top plant box has a first width. An irrigation box below the open top plant box base has a second width larger than the first width. The irrigation box can be filled with irrigation fluid. An open top hopper on one side of the open top plant box on top of the irrigation box can receive irrigation fluid which drains into the irrigation box. An overflow drain aperture in the irrigation box lets excess irrigation fluid flow. When a plurality of the stackable modular planters are stacked above another planter, excess irrigation can flow from the overflow aperture into the hopper of the planter below.",SABIN RICHARD ALEXANDER;;FLEMING MARK ANDREW,SABIN RICHARD ALEXANDER;;FLEMING MARK ANDREW,,https://lens.org/186-805-670-312-016,Patent Application,yes,13,0,8,8,0,A01G9/023;;A01G27/02;;A01G27/06;;A01G27/008;;A01G9/023;;A01G27/06;;A01G9/023;;A01G9/027;;A01G27/008;;A01G27/06,A01G27/06;;A01G9/02;;A01G27/00,,0,0,,,,PENDING
94,US,A1,US 2010/0043463 A1,071-195-438-400-593,2010-02-25,2010,US 99314706 A,2006-06-22,US 99314706 A;;US 69413405 P;;CA 2006001042 W,2005-06-27,REFRIGERATOR OR FREEZER WITH ENHANCED EFFICIENCY,A refrigerator or a freezer comprises a primary refrigeration system ( 11 ) which is augmented with a passive secondary refrigeration loop ( 15 ) having a condenser ( 30 ) in thermal contact with a primary fluid line ( 12 ) at the location between a primary compressor ( 16 ) and a primary condenser ( 18 ) and preferably placed outside a building so that the passive secondary refrigeration loop ( 15 ) provides cooling to the primary refrigeration system ( 11 ) when the outside temperature is sufficiently low The condenser ( 30 ) of the passive secondary refrigeration loop ( 15 ) is positioned above the points where the primary fluid line ( 12 ) connects with mlet ( 32 ) and outlet ( 34 ) lines of the secondary loop condenser ( 30 ),FLEMING MARK A;;BRUNGER ALFRED P,FLEMING MARK A;;BRUNGER ALFRED P,BODYCOTE MATERIALS TESTING CANADA INC (2006-12-29);;FLEMING MARK A (2007-01-15),https://lens.org/071-195-438-400-593,Patent Application,yes,10,3,3,3,0,F25B6/04;;F25B6/04;;F25B40/04;;F25B40/04;;F25D23/003;;F25D23/003,F25B41/00;;F25B1/00,62/113;;62/513;;62/498,0,0,,,,DISCONTINUED
95,WO,A1,WO 2000/018783 A1,080-043-361-101-504,2000-04-06,2000,US 9922616 W,1999-09-29,US 16262298 A,1998-09-29,"MAMMAGLOBIN, A SECRETED MAMMARY-SPECIFIC BREAST CANCER PROTEIN","A purified and isolated DNA sequence and the encoded mammary-specific secreted protein, mammaglobin, are disclosed. Also disclosed are methods for detecting breast cancer based upon the overexpression and secretion of mammaglobin by breast cancer cells. The methods detect and/or quantitate the presence of mammaglobin or the mRNA enconding mammaglobin. Immunotherapy-based methods for treating a breast cancer patient with a mammaglobin-expressing tumor are also disclosed. The methods involve using mammaglobin antigens to induce a humoral and/or cell-mediated immune response against the tumor.",UNIV WASHINGTON;;WATSON MARK A;;FLEMING TIMOTHY P,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/080-043-361-101-504,Patent Application,yes,1,1,21,23,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;C12Q1/6886;;G01N33/57415;;G01N2800/52;;C12Q2600/158;;C12Q1/68;;A61K39/00;;C07K14/47;;A61K38/00;;C12Q1/6886;;C07K14/4721;;A61K39/00;;G01N33/57415;;C12Q2600/158;;G01N2800/52,A61K38/00;;A61K39/00;;G01N33/53;;C07K14/47;;C12N15/09;;C12Q1/68;;C12Q1/6886;;G01N33/566;;G01N33/574;;G01N33/577,,0,0,,,,PATENTED
96,CA,A1,CA 2741641 A1,134-011-149-182-010,1996-12-05,1996,CA 2741641 A,1996-05-31,US 45589695 A;;CA 2222747 A,1995-05-31,DNA SEQUENCE AND ENCODED MAMMARY-SPECIFIC BREAST CANCER PROTEIN,A purified antibody that reacts with a mammaglobin polypeptide wherein the mammaglobin polypeptide comprises SEQ ID NO: 2.,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/134-011-149-182-010,Patent Application,no,0,0,41,41,14,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,C07K16/18;;C12N15/09;;A61K38/00;;C07H21/04;;C07K14/47;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,0,0,,,,EXPIRED
97,NO,L,NO 975508 L,037-082-267-327-526,1998-03-18,1998,NO 975508 A,1997-11-28,US 45589695 A;;US 9608235 W,1995-05-31,DNA-sekvens og kodet bryst- spesifikt brystkreftprotein,,UNIV WASHINGTON,WATSON MARK A;;FLEMING THIMOTHY P,,https://lens.org/037-082-267-327-526,Abstract,no,0,0,41,41,0,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,A61K38/00;;C12N15/09;;C07H21/04;;C07K14/47;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,0,0,,,,DISCONTINUED
98,US,A,US 6004756 A,062-595-829-293-779,1999-12-21,1999,US 8225398 A,1998-05-20,US 8225398 A;;US 72230496 A;;US 45589695 A,1995-05-31,Method for detecting the presence of breast cancer by detecting an increase in mammaglobin mRNA expression,"A purified and isolated DNA sequence and the encoded mammary-specific protein, mammaglobin, are disclosed. Also disclosed are methods for the detecting breast cancer based upon the overexpression and secretion of mammaglobin by breast cancer cells. The methods detect and/or quantitate the presence of mammaglobin or the mRNA encoding mammaglobin.",UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/062-595-829-293-779,Granted Patent,yes,2,44,41,41,13,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,A61K38/00;;C07H21/04;;C12N15/09;;C07K14/47;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,435/6;;435/91.21;;435/91.2,15,14,094-657-190-841-800;;086-019-826-094-569;;069-204-673-706-269;;049-477-935-103-029;;093-298-749-737-02X;;119-356-842-486-362;;053-457-015-539-969;;039-229-624-803-022;;036-740-421-551-776;;011-052-065-868-454;;001-465-886-657-534;;015-696-872-509-326;;047-850-427-018-32X;;060-981-882-240-003,10.1006/geno.1998.5539;;9806831;;9488047;;10.1038/sj.onc.1201597;;0008631025;;8631025;;7066904;;1888147;;3994306;;3319534;;10.1210/edrv-8-4-474;;10.1007/bf03349687;;7868811;;0007868811;;0006294095;;6294095;;10.1016/s0021-9258(18)33208-3;;10.1016/0022-4731(84)90190-0;;6538620;;6598318;;10.1111/j.1749-6632.1984.tb38280.x;;10.1111/j.1432-1033.1981.tb06206.x;;7014218;;10.1111/j.1432-1033.1981.tb06205.x;;8227325;;pmc288387;;10.1172/jci116810;;8062249,"Becker et al. Genomics (1988 Nov. 15) 54(1):70 8.;;Watson et al. Oncogene (1998 Feb. 12) 16(6):817 824.;;Watson et al. Cancer Res. (1996 Feb. 15) 56(4) 860 4.;;Leygue et al. Breast Cancer Res & Treatment (Oct. 1997) vol. 46, No. 1, p. 44.;;Bjork et al, Partial Characterization and Quantitation of a Human Prostatic Estramustine binding Protein, Cancer Res. 42:1935 1942 (1982).;;Bjork et al., Expression and Partial Characterization of Estramustine Binding Protein IEMBP) in Human Breast Cancer and Malignant Melanoma, Anticancer Res. 11:1173 1182 (1991).;;Cato et al., The Hormonal Regulation of Uteroglobin Gene Expression, Anticancer Res. 4:65:72 (1985).;;Miele et al., Uteroglobin: Structure, Molecular Biology, and New Perspectives on its Function as a Phospholipase A 2 Inhibitor, Endocrine Rev. *:474 490 (1987).;;Miele et al., Uteroglobin and uteroglobin like proteins: The uteroglobin family of proteins, J. Endocrinol. Invest. 17:679 692 (1994).;;Parker et al., Prostatic Steroid binding Protein, J. Biol. Chem. 258:12 15 (1983).;;Parker et al., Organization and Expression of Prostatic Steroid Binding Protein Genes, J. Steroid Biochem. 20:67 71 (1984).;;Parker et al., Organization and Expression of Genes Encoding Prostatic Steroid Binding Protein, Ann N.Y. Acad. Sci. 438:115 124 (1984).;;Peeters et al., Structural Studies on Rat Prostatic Binding Protein, Eur. J. Biochem. 115:115 121 (1981.;;Peri et al., Tissue specific Expression of the Gene Coding for Human Clara Cell 10 kD Protein, a Phospholipase A 2 inhibitory Protein, J. Clin. Invest. 92:2099 2109 (1991).;;Watson et al., Isolation of Differentially Expressed Sequence Tags from Human Breast Cancer, Cancer Res. 54:4598 4602 (1994).",EXPIRED
99,CA,A1,CA 2343980 A1,075-867-913-955-032,2000-04-06,2000,CA 2343980 A,1999-09-29,US 16262298 A;;US 9922616 W,1998-09-29,"MAMMAGLOBIN, A SECRETED MAMMARY-SPECIFIC BREAST CANCER PROTEIN","A purified and isolated DNA sequence and the encoded mammary-specific secret ed protein, mammaglobin, are disclosed. Also disclosed are methods for detectin g breast cancer based upon the overexpression and secretion of mammaglobin by breast cancer cells. The methods detect and/or quantitate the presence of mammaglobin or the mRNA enconding mammaglobin. Immunotherapy-based methods f or treating a breast cancer patient with a mammaglobin-expressing tumor are als o disclosed. The methods involve using mammaglobin antigens to induce a humora l and/or cell-mediated immune response against the tumor.",UNIV WASHINGTON,FLEMING TIMOTHY P;;WATSON MARK A,,https://lens.org/075-867-913-955-032,Patent Application,no,0,0,21,23,21,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;C12Q1/6886;;G01N33/57415;;G01N2800/52;;C12Q2600/158;;C12Q1/68;;A61K39/00;;C07K14/47;;A61K38/00;;C12Q1/6886;;C07K14/4721;;A61K39/00;;G01N33/57415;;C12Q2600/158;;G01N2800/52,G01N33/53;;A61K38/00;;A61K39/00;;C07K14/47;;C12N15/09;;C12Q1/68;;C12Q1/6886;;G01N33/566;;G01N33/574;;G01N33/577,,0,0,,,,EXPIRED
100,EP,A1,EP 1037901 A1,102-216-389-247-459,2000-09-27,2000,EP 98946799 A,1998-09-18,US 9817991 W;;US 93314997 A,1997-09-18,"MAMMAGLOBIN, A SECRETED MAMMARY-SPECIFIC BREAST CANCER PROTEIN",,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/102-216-389-247-459,Patent Application,yes,0,0,20,20,14,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;A61P35/00;;A61K39/00;;C07K14/47;;A61K39/00;;C07K14/4721;;A61K38/00,A61K35/26;;A61K38/00;;A61K39/00;;A61K39/395;;C12N15/09;;A61P35/00;;C07K14/47,,0,0,,,,DISCONTINUED
101,US,B1,US 6677428 B1,130-077-236-435-019,2004-01-13,2004,US 50901500 A,2000-05-30,US 50901500 A;;US 9608235 W;;US 45589695 A;;US 9917991 W,1995-05-31,"Mammaglobin, a secreted mammary-specific breast cancer protein","
    A purified and isolated DNA sequence and the encoded mammary-specific secreted protein, mammaglobin, are disclosed. Also disclosed are methods for detecting breast cancer based upon the overexpression and secretion of mammaglobin by breast cancer cells. The methods detect and/or quantitate the presence of mammaglobin or the mRNA encoding mammaglobin. Immunotherapy-based methods for treating a breast cancer patient with a mammaglobin-expressing tumor are also disclosed. The methods involve using mammaglobin antigens to induce a humoral and/or cell-mediated immune response against the tumor. 
",UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,WASHINGTON UNIVERSITY (2000-05-17);;UNIVERSITY WASHINGTON (2000-05-17),https://lens.org/130-077-236-435-019,Granted Patent,yes,8,10,41,41,14,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,A61K38/00;;C07H21/04;;C12N15/09;;C07K14/47;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,530/300;;424/184.1;;424/185.1;;424/198.1,36,35,029-220-161-772-595;;117-486-888-028-669;;083-308-152-083-020;;011-964-364-173-232;;093-298-749-737-02X;;049-477-935-103-029;;050-904-893-659-406;;003-849-961-384-35X;;119-356-842-486-362;;022-264-904-824-000;;040-713-726-205-55X;;082-770-528-105-755;;028-076-553-910-600;;091-739-663-074-980;;084-368-082-646-975;;007-822-064-014-928;;014-017-617-421-956;;166-392-684-735-433;;039-229-624-803-022;;053-457-015-539-969;;025-173-207-852-618;;001-465-886-657-534;;011-052-065-868-454;;015-696-872-509-326;;041-446-829-885-810;;047-850-427-018-32X;;016-273-221-621-842;;012-993-442-583-931;;115-916-545-155-724;;057-945-343-734-358;;100-874-429-486-692;;104-304-928-520-85X;;002-882-127-467-426;;060-981-882-240-003;;069-204-673-706-269,10.1517/13543784.10.3.511;;11227049;;10.2307/3415364;;10.1093/jnci/85.3.200;;8423624;;10.1016/b978-0-444-82027-3.50022-5;;10.1016/s1054-3589(08)60935-7;;8504068;;1888147;;7066904;;10.1002/eji.1830170820;;2442000;;1699952;;pmc2116333;;10.1083/jcb.111.5.2129;;3994306;;10.1016/0304-3835(93)90224-w;;7689035;;1709722;;10.1038/351290a0;;10.1126/science.2434994;;2434994;;1402647;;pmc2119397;;10.1084/jem.176.4.1007;;1546329;;10.1126/science.1546329;;1280333;;10.1038/360434a0;;10.1128/mcb.8.3.1247-1252.1988;;10.1128/mcb.8.3.1247;;pmc363269;;3285178;;10.1097/00000441-199209000-00011;;1476160;;10.1073/pnas.91.23.11236;;pmc45202;;7972041;;10.1007/bf03349687;;7868811;;0007868811;;3319534;;10.1210/edrv-8-4-474;;2481588;;10.1002/eji.1830191209;;6598318;;10.1111/j.1749-6632.1984.tb38280.x;;10.1016/0022-4731(84)90190-0;;6538620;;10.1111/j.1432-1033.1981.tb06206.x;;7014218;;10.1111/j.1432-1033.1981.tb06205.x;;pmc42754;;7831305;;10.1073/pnas.92.2.432;;8227325;;pmc288387;;10.1172/jci116810;;8084586;;10.1016/0960-9776(93)90144-5;;2470152;;10.1126/science.2470152;;2507634;;10.4049/jimmunol.143.8.2595;;1736535;;10.1016/0042-6822(92)90321-f;;10.1093/jnci/84.11.845;;1317462;;8548758;;8062249;;0008631025;;8631025,"Holmes (Exp. Opin. Invest. Drugs, 2001, 10(3):511-519).*;;Taber's Cyclopedic Medical Dictionary, F.A. Davis Co., Philadelphia, 1989,p 41.*;;Herbert et al (Dictionary of Immunology, 4th Ed., Academic Press, London, 1985, p. 11).*;;Allred et al., Journ. of the Nat'l Cancer Inst., vol. 85, Association of p53 Protein Expression with Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast Cancer, pp. 200-206, Feb. 3, 1993.;;Bagshawe, Adv. in Pharm., vol. 24, Antibody-Directed Exzyme Prodrug Therapy (ADEPT), pp. 99-121, 1993.;;Bjork et al., Anticancer Research 11, Expression and Partial Characterization of Estramustine-Binding protein (EMBP) in Human Breast Cancer and Malignant Melanoma, pp. 1173-1182, 1991.;;Bjork et al., Cancer Research vol. 42, Partial Characterization and ""Quantitation"" of Human Prostatic Estramustine-binding Protein, pp. 1935-1942, May 1982.;;Borras-Cuesta, Eur.J. Immunol., vol. 17, Engineering of immunogenic peptides by co-linear synthesis of determinants recognized by B and T cells, pp. 1213-1215, 1987.;;Burgess et al., Journ. of Cell Bio., vol. 111, Possible Dissociation of the Heparin-binding and Mitogenic Activities of Heparin-binding (Acidic Fibroblast)Growth Factor-1 from Its Receptor-binding Activities by Site-directed Mutagenesis of a Single Lysine Residue, pp. 2129-2138, 1990.;;Cato et al., Anticancer Research, vol. 5, The Hormonal Regulation of Uteroglobin Gene Expression, pp. 65-72, 1985.;;Denton et al., Cancer Letters, vol. 70, Inducation of antibody responses to breast carcinoma associated mucins using synthetic peptide constructs as immunogens, pp. 143-150, 1993.;;Falk et al., Nature vol. 351, Allele-specific motifs revealed by sequencing of self-peptides eluted form MHC molecules, pp. 290-296, May 23, 1991.;;Good et al., Science, vol. 235, Construction of Synthetic Immunogen: Use of New T-Helper Epitope on Malaria Circumsporozoite Protein, pp. 1059-1062, Feb. 27, 1987.;;Hammer et al., J. Exp. Med., Identification of a Motif for HLA-DR1 Binding Peptides Uising M13 Display Llbraries, pp. 1007-1013, 1992.;;Henderson et al., Science, vol. 255, HLA-A2. 1-Associated Peptides from a Mutant Cell Line: A Second Pathway of Antigen Presentation, pp. 1264-1266, 1992.;;Hill et al., Nature, vol. 360, Molecular analysis of the association of HLA-B53 and resistance to severe malaria, pp. 434-439, Dec. 3, 1992.;;Lazar et al., Molecular and Cellular Bio., Transforming Growth Factor : Mutation of Aspartic Acid 47 and Leucine 48 Results in Different BIological Activities, pp. 1247-1252, Mar., 1988.;;LoBuglio et al., Amer. Journ. of the Med. Sci., vol. 304, No. 3, Advances in Monoclonal Antibody Therapy of Cancer, pp. 214224, Sep., 1992.;;Maroulakou et al., Proc. Natl. Acad. Sci. USA, vol. 91, Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene, pp. 11236-11240, Nov. 1994.;;Miele et al., J. Endocrinol. Invest. vol. 17, Uteroglobin and Uteroglobin-like proteins; The uteroglobin family of proteins, pp. 679-692, 1994.;;Miele et al., Endocrine Rev., vol. 8, No. 4, Uteroglobin: Structure, Molecure Biology, and New Perspectives on Its Function as a Phospholipase A2 Inhibitor, pp. 474-490, 1987.;;Panina-Bordignon et al., Eur. J. Immunol. vol. 19, Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells, pp. 2237-2242, 1989.;;Parker et al., Annals N. Y. Acad. of Sci. vol. 438, Organization and Expression of Genes Encoding Prostatic Steroid Binding Protein, p. 115-124, 1984.;;Parker et al., J. Steroid Biochem., Vol 20, No. 1, Organization and Expression of Prostatic Steroid Binding Protein Genes, pp. 67-71, 1984.;;Peeters et al., Eur.J. Biochem. vol. 115, Structural Studies on Rat Prostatic Binding Protein, pp. 115-121, 1981.;;Peoples et al., Proc. Natl. Acad. Sci. USA, vol. 92, Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HEr2/neu-derived peptide, pp. 432-436, Jan. 1995.;;Peri et al., Journ. of Clin. Invest., vol. 92, Tissue-specific Expression of the Gene Coding for Human Clara Cell 10-kD Protein, a Phospholipase A2-inhibitority Protein, pp. 2099-2109, Nov., 1993.;;Sandmoeller et al., Oncogene vol. 9, The uteroglobin promoter targets expression of the SV40 T antigen to a variety of secretory epithelial cells in transgenic mice, pp. 2805-2815, 1994.;;Schoenfeld et al., Cancer Research 54, Detection of Breast Cancer Micrometastases in Axillary Lymph Nodes by Using Polymerase Chain Reaction, pp. 2986-2990, 1994.;;Slamon et al., Science, vol. 244, Studies of the HER-2/neu Proto-oncogene in Human Breast and Ovarian Cancer, pp. 707-712, May 12, 1989.;;Tao et al., Journ. of Immun., vol. 143, Studies of Aglycosylated Chimeric Mouse-Huma IgG, pp. 2595-2601, 1989.;;Taylor et al., Virology, vol. 187, Nonreplicating Viral Vectors as Potential Vaccines; Recombinant Canarypox Virus Expressing Measles Virus Fusion (F) and Hemagglutinin (HA) Glycoproteins, pp. 321-328, 1992.;;Thor et al., Journ. of the Nat'l Cancer Inst., vol. 84, No. 11, Accumulation of p53 Tumor Suppressor Gene Protein; An Independent Marker of Prognosis in Breast Cancer, Jun. 3, 1992.;;Toso et al., Cancer Research, vol. 56, MAGE-1-specific Precursor Cytotoxic T-Lymphocytes Present among tumor-infiltrating Lymphocytes from a Patient with Breast Cancer: Characterization and Antigen-specific Activation, pp. 16-20, Jan. 1, 1996.;;Watson et al., Cancer Research 54, Isolation of Differentially Expressed Sequence Tags from Human Breast Cancer, pp. 4598-4602, Sep. 1, 1994.;;Watson et al., Cancer Research, vol. 56, Mammaglobin, a Mammary-specific Member of the Uteroglobin Gene Family, Is Overexpressed in Human Breast Cancer<1>, pp. 860-865, 1996.",EXPIRED
102,HU,A2,HU P0004022 A2,035-256-863-534-809,2001-03-28,2001,HU P0004022 A,1998-09-18,US 93314997 A;;US 9817991 W,1997-09-18,"MAMMAGLOBIN, A SECRETED MAMMARY-SPECIFIC BREAST CANCER PROTEIN",,UNIV WASHINGTON,FLEMING TIMOTHY P;;WATSON MARK A,,https://lens.org/035-256-863-534-809,Patent Application,no,0,0,20,20,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;A61P35/00;;A61K39/00;;C07K14/47;;A61K39/00;;C07K14/4721;;A61K38/00,A61K35/26;;C12N15/09;;A61K38/00;;A61K39/00;;A61K39/395;;A61P35/00;;C07K14/47,,0,0,,,,PENDING
103,EP,A4,EP 1117673 A4,071-631-879-678-29X,2004-08-04,2004,EP 99950003 A,1999-09-29,US 9922616 W;;US 16262298 A,1998-09-29,"MAMMAGLOBIN, A SECRETED MAMMARY-SPECIFIC BREAST CANCER PROTEIN",,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/071-631-879-678-29X,Search Report,no,2,0,21,23,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;C12Q1/6886;;G01N33/57415;;G01N2800/52;;C12Q2600/158;;C12Q1/68;;A61K39/00;;C07K14/47;;A61K38/00;;C12Q1/6886;;C07K14/4721;;A61K39/00;;G01N33/57415;;C12Q2600/158;;G01N2800/52,A61K38/00;;A61K39/00;;G01N33/53;;C07K14/47;;C12N15/09;;C12Q1/68;;C12Q1/6886;;G01N33/566;;G01N33/574;;G01N33/577,,1,0,,,See also references of WO 0018783A1,DISCONTINUED
104,US,A1,US 2016/0180469 A1,083-539-048-012-837,2016-06-23,2016,US 201514970860 A,2015-12-16,US 201514970860 A;;US 201462095424 P,2014-12-22,WORKFLOW MANAGEMENT SYSTEM,"The present invention relates to a workflow management system that manages all aspects of a customer account, including account initiation, management and electronic document storage through one simple and clean user interface running on a server via a terminal. The system includes a server and a user terminal in network communication with the server, wherein the user terminal is a dummy terminal. The system further includes a software application installed on and operated by the server. The system comprises a unique folder structure for each account created by the system in response to execution of the instructions of the software application by the server, wherein the unique folder structure is created within an electronic document library stored on the hard drive of the server. The system further includes an automatic email save function, wherein emails are automatically saved in a folder of the folder structure of the electronic document library.",WHOLESOURCE LLC,KEATING JAMES;;MEURY MARK;;FLEMING DONALD,WHOLESOURCE LLC (2015-12-15),https://lens.org/083-539-048-012-837,Patent Application,yes,5,2,1,2,0,H04L51/02;;G06Q40/08;;H04L67/10;;G06Q40/08;;H04L67/10;;H04L51/02,G06Q40/08;;H04L12/58;;H04L29/08,,0,0,,,,DISCONTINUED
105,US,A1,US 2002/0177981 A1,101-054-228-380-149,2002-11-28,2002,US 6317302 A,2002-03-27,US 6317302 A;;US 27917901 P,2001-03-27,System and method for switchboard feeder design,"
   A method for configuring an individually mounted feeder section of a switchboard, the method comprising: initiating a utility for configuring a switchboard design; selecting a feeder device to be included in said switchboard design; entering a plurality of parameters for the feeder device in fields queried by the utility; checking existence of any individually mounted device; accessing a database for determining whether individually mounted feeder design is viable; retrieving a set of parameters for the individually mounted device, if any; and displaying output data corresponding to said selected feeder device and entered said plurality of parameters. 
",FLEMING MARK JOSEPH;;NESMITH CYRIL LATRELL,FLEMING MARK JOSEPH;;NESMITH CYRIL LATRELL,GENERAL ELECTRIC COMPANY (2002-07-03),https://lens.org/101-054-228-380-149,Patent Application,yes,6,3,1,1,0,G06F30/00;;G06F30/00;;G06F2111/02;;G06F2111/02,G06F17/50,703/1,0,0,,,,DISCONTINUED
106,US,A,US 5968754 A,104-607-224-480-819,1999-10-19,1999,US 8234398 A,1998-05-20,US 8234398 A;;US 72230496 A;;US 45589695 A,1995-05-31,"Mammaglobin, a mammary-specific breast cancer protein","A purified and isolated DNA sequence and the encoded mammary-specific protein, mammaglobin, are disclosed. Also disclosed are methods for the detecting breast cancer based upon the overexpression and secretion of mammaglobin by breast cancer cells. The methods detect and/or quantitate the presence of mammaglobin or the mRNA encoding mammaglobin.",UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/104-607-224-480-819,Granted Patent,yes,2,28,41,41,13,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,A61K38/00;;C07H21/04;;C07K14/47;;C12N15/09;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,435/7.23;;435/7.1;;435/7.2;;530/387.1,11,11,049-477-935-103-029;;093-298-749-737-02X;;119-356-842-486-362;;053-457-015-539-969;;039-229-624-803-022;;036-740-421-551-776;;011-052-065-868-454;;001-465-886-657-534;;015-696-872-509-326;;047-850-427-018-32X;;060-981-882-240-003,7066904;;1888147;;3994306;;3319534;;10.1210/edrv-8-4-474;;10.1007/bf03349687;;7868811;;0007868811;;0006294095;;6294095;;10.1016/s0021-9258(18)33208-3;;10.1016/0022-4731(84)90190-0;;6538620;;6598318;;10.1111/j.1749-6632.1984.tb38280.x;;10.1111/j.1432-1033.1981.tb06206.x;;7014218;;10.1111/j.1432-1033.1981.tb06205.x;;8227325;;pmc288387;;10.1172/jci116810;;8062249,"Bjork et al, Partial Characterization and Quantitation of a Human Prostatic Estramustine binding Protein, Cancer Res. 42:1935 1942 (1982).;;Bjork et al., Expression and Partial Characterization of Estramustine Binding Protein (EMBP) in Human Breast Cancer and Malignant Melanoma, Anticancer Res. 11:1173 1182 (1991).;;Cato et al., The Hormonal Regulation of Uteroglobin Gene Expression, Anticancer Res. 5:65 72 (1985).;;Miele et al., Uteroglobin: Structure, Molecular Biology, and New Perspectives on Its Function as a Phospholipase A 2 Inhibitor, Endocrine Rev 8:474 490 (1987).;;Miele et al., Uteroglobin and uteroglobin like proteins: The uteroglobin family of proteins, J. Endocrinol. Invest. 17:679 692 (1994).;;Parker et al., Prostatic Steroid binding Protein, J. Biol. Chem. 258:12 15 (1983).;;Parker et al., Organization and Expression of Prostatic Steroid Binding Protein Genes, J. Steroid Biochem. 20:67 71 (1984).;;Parker et al., Organization and Expression of Genes Encoding Prostatic Steroid Binding Protein, Ann N.Y. Acad., Sci. 438:115 124 (1984).;;Peeters et al., Structural Studies on Rat Prostatic Binding Protein, Eur. J. Biochem. 115:115 121 (1981).;;Peri et al., Tissue specific Expression of the Gene Coding for Human Clara Cell 10 kD Protein, a Phospholipase A 2 inhibitory Protein, J. Clin. Invest. 92:2099 2109 (1991).;;Watson et al., Isolation of Differentially Expressed Sequence Tags from Human Breast Cancer, Cancer Res. 54:4598 4602 (1994).",EXPIRED
107,HU,A2,HU P0104408 A2,157-503-673-142-352,2002-03-28,2002,HU P0104408 A,1999-09-29,US 16262298 A;;US 9922616 W,1998-09-29,"MAMMAGLOBIN, A SECRETED MAMMARY-SPECIFIC BREAST CANCER PROTEIN","A találmány tárgya általánosságban a mellrák patogenezisévelkapcsolatos. A találmány tárgya közelebbről egy, a mellrákkimutatásában és kezelésében alkalmazható cDNS-szekvencia és az általakódolt, mammaglobin elnevezésű emlőspecifikus fehérje, valamint atalálmány szerinti fehérje és kódolószekvencia alkalmazásamellráksejtek kimutatására. Ó",UNIV WASHINGTON,FLEMING TIMOTHY P;;WATSON MARK A,,https://lens.org/157-503-673-142-352,Patent Application,no,0,0,21,23,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;C12Q1/6886;;G01N33/57415;;G01N2800/52;;C12Q2600/158;;C12Q1/68;;A61K39/00;;C07K14/47;;A61K38/00;;C12Q1/6886;;C07K14/4721;;A61K39/00;;G01N33/57415;;C12Q2600/158;;G01N2800/52,A61K38/00;;G01N33/53;;A61K39/00;;C07K14/47;;C12N15/09;;C12Q1/68;;C12Q1/6886;;G01N33/566;;G01N33/574;;G01N33/577,,0,0,,,,DISCONTINUED
108,DK,T3,DK 0833834 T3,171-703-474-074-151,2000-07-31,2000,DK 96916892 T,1996-05-31,US 45589695 A;;US 9608235 W,1995-05-31,DNA-sekvens og kodet mamma-specifikt brystcancerprotein,,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/171-703-474-074-151,Granted Patent,no,0,0,41,41,0,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,A61K38/00;;C07H21/04;;C07K14/47;;C07K14/82;;C12N15/09;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,0,0,,,,EXPIRED
109,EP,A4,EP 0833834 A4,058-774-166-613-485,1998-06-03,1998,EP 96916892 A,1996-05-31,US 9608235 W;;US 45589695 A,1995-05-31,DNA SEQUENCE AND ENCODED MAMMARY-SPECIFIC BREAST CANCER PROTEIN,,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,WASHINGTON UNIVERSITY (2008-06-25),https://lens.org/058-774-166-613-485,Search Report,no,0,0,41,41,0,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,A61K38/00;;C07H21/04;;C07K14/47;;C12N15/09;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,3,2,036-740-421-551-776;;060-981-882-240-003,0006294095;;6294095;;10.1016/s0021-9258(18)33208-3;;8062249,"PARKER M G ET AL.: ""Prostatic steroid-binding protein"", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 258, no. 1, 10 January 1983 (1983-01-10), pages 12 - 15, XP002058665;;WATSON M A ET AL: ""ISOLATION OF DIFFERENTIALLY EXPRESSED SEQUENCE TAGS FROM HUMAN BREAST CANCER"", CANCER RESEARCH, vol. 54, 1 September 1994 (1994-09-01), pages 4598 - 4602, XP002019977;;See also references of WO 9638463A1",EXPIRED
110,WO,A1,WO 2020/161461 A1,079-220-282-896-395,2020-08-13,2020,GB 2020000011 W,2020-02-07,GB 201901771 A,2019-02-08,STACKABLE MODULAR PLANTER,"The invention relates to a stackable modular planter 1. Planter 1 has: a) an open top plant box (10) having a base and four side walls adapted to receive a growing medium and plants, said open top box having a first width, b) an irrigation box (20) below the open top box base having a second width larger than the top box first width, said irrigation box adapted to be filled with irrigation fluid, c) an open top hopper (30) on one side of the open top box on top of the irrigation box adapted to receive irrigation fluid which drains into the irrigation box, d) an overflow drain aperture (60) in the irrigation box through which excess irrigation fluid can flow, and e) means (50A,50B) to stack one planter above another planter. In use, when one planter is stacked above another planter, excess irrigation can flow from the overflow aperture into the hopper of the planter below.",SABIN RICHARD ALEXANDER;;FLEMING MARK ANDREW,SABIN RICHARD ALEXANDER;;FLEMING MARK ANDREW,,https://lens.org/079-220-282-896-395,Patent Application,yes,4,0,8,8,0,A01G9/023;;A01G27/02;;A01G27/06;;A01G27/008;;A01G9/023;;A01G27/06;;A01G9/023;;A01G9/027;;A01G27/008;;A01G27/06,A01G27/00;;A01G9/02;;A01G27/02;;A01G27/06,,0,0,,,,PENDING
111,US,A1,US 2017/0323390 A1,095-888-102-072-365,2017-11-09,2017,US 201715596358 A,2017-05-16,US 201715596358 A;;US 201514970860 A;;US 201462095424 P,2014-12-22,"INSURANCE WORKFLOW MANAGEMENT SERVER, SYSTEM AND METHOD","Some embodiments of the invention include a workflow management system including a server, a user terminal configurable as a geographically distributed computing network in network communication with the server. The server is configured to execute the software instructions to automatically direct a user through an insurance account binding process by communicating with the server using the user terminal. The system is configured to execute the software instructions to automatically generate a document library that includes a folder structure associated with a particular account. An automated email server can email the account to at least one insurance market or underwriter based at least in part on user preference. Further, the software application can provide for a drag and drop feature where a user selecting, dragging and dropping an icon representing an electronic file, and automatically saving the file in a named folder corresponding to the electronic file.",WHOLESOURCE LLC,KEATING JAMES;;MEURY MARK;;FLEMING DONALD,WHOLESOURCE LLC (2017-08-02),https://lens.org/095-888-102-072-365,Patent Application,yes,4,4,1,2,0,G06Q40/08;;G06Q40/08;;G06F3/04817;;G06F3/04842;;G06F3/0486;;G06Q10/00;;G06Q10/00;;H04L51/02;;H04L51/02,G06Q40/08;;G06F3/0481;;G06F3/0484;;G06F3/0486,,0,0,,,,DISCONTINUED
112,BR,A,BR 9914161 A,113-944-778-564-380,2001-06-26,2001,BR 9914161 A,1999-09-29,US 16262298 A;;US 9922616 W,1998-09-29,Métodos para detectar a presença de células de câncer de mama e de células de câncer endometrial e a presença de câncer de mama e de câncer endometrial em um paciente e kits para detectar a presença de células de neoplasia de mama e a presença de câncer de mama em uma amostra,"""MéTODOS PARA DETECTAR A PRESENçA DE CéLULAS DE CâNCER DE MAMA E DE CéLULAS DE CâNCER ENDOMETRIAL E A PRESENçA DE CâNCER DE MAMA E DE CâNCER ENDOMETRIAL EM UM PACIENTE E KITS PARA DETECTAR A PRESENçA DE CéLULAS DE NEOPLASIA DE MAMA E A PRESENçA DE CâNCER DE MAMA EM UMA AMOSTRA"". Descreve-se uma seq³ência de DNA purificada e isolada e a proteína secretada especificamente mamária codificada, mamaglobina. Também descreve-se métodos para detectar câncer de mama com base na superexpressão e secreção de mamaglobina pelas células do câncer de mama. Os métodos detectam e/ou quantificam a presença de mamaglobina ou do mRNA codificando mamaglobina. Descreve-se também métodos baseados em imunoterapia para o tratamento de um paciente de câncer de mama com um tumor expressando mamaglobina. Os métodos envolvem a utilização de antígenos de mamaglobina para induzir uma resposta imunilógica contra o tumor, sendo que esta resposta é humoral e/ou mediada por células.",UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/113-944-778-564-380,Patent Application,no,0,0,21,23,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;C12Q1/6886;;G01N33/57415;;G01N2800/52;;C12Q2600/158;;C12Q1/68;;A61K39/00;;C07K14/47;;A61K38/00;;C12Q1/6886;;C07K14/4721;;A61K39/00;;G01N33/57415;;C12Q2600/158;;G01N2800/52,G01N33/53;;A61K38/00;;A61K39/00;;C07K14/47;;C12N15/09;;C12Q1/68;;C12Q1/6886;;G01N33/566;;G01N33/574;;G01N33/577,,0,0,,,,DISCONTINUED
113,EP,A4,EP 1037901 A4,146-360-157-069-385,2003-07-16,2003,EP 98946799 A,1998-09-18,US 9817991 W;;US 93314997 A,1997-09-18,"MAMMAGLOBIN, A SECRETED MAMMARY-SPECIFIC BREAST CANCER PROTEIN",,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/146-360-157-069-385,Search Report,no,4,0,20,20,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;A61P35/00;;A61K39/00;;C07K14/47;;A61K39/00;;C07K14/4721;;A61K38/00,A61K35/26;;A61K38/00;;A61K39/00;;A61K39/395;;A61P35/00;;C07K14/47;;C12N15/09,,2,1,041-446-829-885-810,pmc42754;;7831305;;10.1073/pnas.92.2.432,"PEOPLES G E ET AL: ""BREAST AND OVARIAN CANCER-SPECIFIC CYTOTOXIC T LYMPHOCYTES RECOGNIZE THE SAME HER2/NEU-DERIVED PEPTIDE"", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 92, 1995, pages 432 - 436, XP002071201, ISSN: 0027-8424;;See also references of WO 9914230A1",DISCONTINUED
114,WO,A2,WO 2012/054870 A2,156-642-299-909-464,2012-04-26,2012,US 2011/0057347 W,2011-10-21,US 40561910 P,2010-10-21,BIOMARKERS FOR HCV INFECTED PATIENTS,The invention relates to biomarkers measurable in a human subject that have prognostic value with respect to efficacy of therapeutic treatments for Hepatitis C viral infection. The markers also are believed to have value for diagnosis liver health/liver damage.,VERTEX PHARMA;;FLEMING MARK ANDREW;;HARE BRIAN J,FLEMING MARK ANDREW;;HARE BRIAN J,,https://lens.org/156-642-299-909-464,Patent Application,yes,21,3,5,5,42,G01N33/5767;;G16H50/30;;A61K38/08;;A61K38/21;;G01N33/5767;;G16H50/30;;A61K31/7056;;A61K38/08;;A61K38/21;;C12Q1/32;;C12Q1/48;;C12Q1/485;;G01N33/53;;G01N33/573,G01N33/576;;A61K38/08,,56,43,071-927-443-606-319;;103-646-040-125-99X;;090-068-075-577-142;;006-255-774-333-726;;039-668-643-193-383;;024-751-383-662-691;;031-049-514-664-480;;013-997-361-311-947;;086-686-689-616-146;;071-931-952-211-261;;009-914-034-889-417;;031-479-116-009-093;;043-599-710-962-348;;073-200-013-951-425;;100-964-379-581-462;;194-029-211-108-156;;069-102-844-790-593;;077-532-829-551-519;;015-339-909-605-122;;019-941-060-457-50X;;111-624-689-261-964;;099-900-812-708-588;;103-621-044-191-088;;022-431-699-856-26X;;093-998-397-567-158;;020-449-071-784-742;;057-156-304-558-548;;031-912-631-962-342;;031-501-930-831-338;;179-750-649-462-942;;007-384-333-132-029;;062-967-721-247-716;;101-092-734-598-13X;;057-430-966-859-998;;038-020-569-130-529;;027-744-779-247-412;;015-322-496-399-787;;033-322-978-725-55X;;019-037-052-772-934;;070-265-761-998-411;;036-444-793-633-629;;073-302-114-702-046;;033-471-818-914-254,10.1016/s0168-8278(99)80369-9;;10622555;;10.1073/pnas.88.6.2451;;pmc51250;;1848704;;2175903;;pmc55204;;10.1073/pnas.87.24.9524;;10.1128/jvi.65.3.1105-1113.1991;;pmc239876;;1847440;;2523562;;10.1126/science.2523562;;1648221;;10.1073/pnas.88.13.5547;;pmc51914;;pmc236449;;7518529;;10.1128/jvi.68.8.5063-5073.1994;;8389908;;10.1128/jvi.67.7.3835-3844.1993;;pmc237748;;10.1128/jvi.71.11.8416-8428.1997;;pmc192304;;9343198;;9740782;;10.1006/viro.1998.9311;;10.1128/jvi.74.4.2046-2051.2000;;10644379;;pmc111684;;10.1056/nejm199811193392101;;0009819446;;9819446;;10.1056/nejm199811193392102;;9819447;;10.1053/jhep.2001.21747;;11172346;;11197053;;10.1046/j.1440-1746.2000.02371.x;;10418039;;10.1201/9781351071840;;10.1038/nbt1142;;16151406;;1696564;;10.1002/ijc.2910460228;;10.1016/s1046-2023(05)80210-5;;14427334;;10.1016/0003-9861(60)90049-7;;pmc1197021;;10.1042/bj0730119;;14434282;;10.1074/jbc.m209764200;;12473676;;10.1023/a:1026036521852;;14619983;;10.1093/clinchem/32.8.1563;;3731453;;10.1111/j.1365-2893.2009.01083.x;;19226329;;10.1159/000232486;;19729943;;10.1373/clinchem.2007.089144;;17702858;;10.1371/journal.pone.0010484;;pmc2864746;;20463963;;10.1515/cclm.2001.155;;11758611;;19432394;;10.1021/pr9002504;;10.1111/j.1742-4658.2010.07640.x;;20402763;;10.2174/092986709789909620;;19929783;;10.2210/pdb2nsm/pdb;;17157876;;10.1016/j.jmb.2006.11.025;;10.1016/j.jhep.2008.06.029;;18809223;;pmc2644636;;10905755;;10.1515/cclm.2000.029;;2814926;;10.1055/s-0038-1646905;;10.1016/s0165-2478(01)00288-7;;11600203;;19857204;;10.1042/bc20090125;;10.1373/49.3.450;;12600957;;10.1016/j.bbrc.2007.03.174;;17434454;;10.1007/s00428-006-0257-7;;16941151;;pmc2850332;;10.1186/1477-5956-8-12;;20222986,"ALBERTI ET AL., J. HEPATOLOGY, vol. 31, no. 1, 1999, pages 17 - 24;;CHOO ET AL., PROC. NATL. ACAD. SCI. USA, vol. 88, 1991, pages 2451 - 2455;;KATO ET AL., PROC. NATL. ACAD. SCI. USA, vol. 87, 1990, pages 9524 - 9528;;TAKAMIZAWA ET AL., J. VIROL., vol. 65, 1991, pages 1105 - 1113;;CHOO ET AL., SCIENCE, vol. 244, 1989, pages 359 - 362;;HIJIKATA ET AL., PROC. NATL. ACAD. SCI. USA, vol. 88, 1991, pages 5547 - 5551;;LIN ET AL., J. VIROL., vol. 68, 1994, pages 5063 - 5073;;BARTENSCHLAGER ET AL., J. VIROL., vol. 67, 1993, pages 3835 - 3844;;LOHMANN ET AL., VIROL., vol. 71, 1997, pages 8416 - 8428;;LOHMANN ET AL., VIROLOGY, vol. 249, 1998, pages 108 - 118;;KOLYKHALOV ET AL., J. VIROL., vol. 74, no. 4, 2000, pages 2046 - 2051;;""Management of Hepatitis C: 2002. National Institutes of Health Consensus Development Conference Update"", HEPATOLOGY, vol. 36, 10 June 2002 (2002-06-10);;MCHUTCHISON ET AL., N. ENGL. J. MED., vol. 339, 1998, pages 1485 - 1492;;DAVIS ET AL., N. ENGL. J. MED., vol. 339, 1998, pages 1493 - 1499;;MCHUTCHINSON ET AL., N. ENGL. J. MED., vol. 361, 2009, pages 580 - 539;;""American Hospital Formulary Service- Drug Information 2005"", 2005, AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS, INC., pages: 811;;REDDY, K.R. ET AL.: ""Efficacy and Safety of Pegylated (40-kd) Interferon alpha-2a Compared with Interferon alpha-2a in Noncirrhotic Patients with Chronic Hepatitis C"", HEPATOLOGY, vol. 33, 2001, pages 433 - 438;;KAO, J.H. ET AL.: ""Efficacy of Consensus Interferon in the Treatment of Chronic Hepatitis"", J. GASTROENTEROL. HEPATOL, vol. 15, 2000, pages 1418 - 1423;;CLAYETTE, P. ET AL.: ""IFN-tau, A New Interferon Type I with Antiretroviral activity"", PATHOL. BIOL. (PARIS, vol. 47, 1999, pages 553 - 559;;""Remington's Pharmaceutical Sciences"", MACK PUBLISHING CO.;;E. MAGGIO: ""Enzyme-Immunoassay"", 1980, CRC PRESS, INC.;;HOLLINGER, HUDSON, NATURE BIOTECHNOLOGY, vol. 23, no. 9, 2005, pages 1126 - 1136;;LOSMAN ET AL., INT. J. CANCER, vol. 46, 1990, pages 310;;COURTENAY-LUCK ET AL.: ""Monoclonal Antibodies: Production, Engineering and Clinical Application"", 1995, CAMBRIDGE UNIVERSITY PRESS, article ""Genetic Manipulation of Monoclonal Antibodies"", pages: 166;;WARD ET AL.: ""Monoclonal Antibodies: Principles and Applications"", 1995, WILEY-LISS, INC., article ""Genetic Manipulation and Expression of Antibodies"", pages: 137;;LARRICK ET AL., METHODS: A COMPANION TO METHODS IN ENZYMOLOGY, vol. 2, 1991, pages 106 - 110;;COLIGAN ET AL.: ""Current Protocols in Immunology"", 1991, JOHN WILEY & SONS, pages: 1.2.5 - 12.6.7;;KENNETT, MCKEARN, AND BECHTOL: ""Monoclonal Antibodies, Hybridomas: A New Dimension in Biological Analyses"", 1980, PLENUM PRESS;;HARLOW AND LANE: ""Antibodies: A Laboratory Manual"", 1988, COLD SPRING HARBOR LABORATORY PRESS;;PICKSLEY ET AL.: ""DNA Cloning 2: Expression Systems, 2nd Edition"", 1995, OXFORD UNIVERSITY PRESS, article ""Production of monoclonal antibodies against proteins expressed in E. coli"", pages: 93;;EDELMAN ET AL.: ""Methods in Enzymology"", vol. 1, 1967, ACADEMIC PRESS, pages: 422;;NISONOFF ET AL., ARCH. BIOCHEM. BIOPHYS., vol. 89, 1960, pages 230 - 244;;PORTER, BIOCHEM. J., vol. 73, 1959, pages 119 - 127;;ANDREWS, S.M., TITUS, J.A. ET AL.: ""Current Protocols in Immunology"", 2003, JOHN WILEY & SONS, pages: 2.8.1 - 2.8.10,2;;AUSUBEL ET AL.,: ""Current Protocols in Molecular Biology"", 2007, JOHN WILEY & SONS;;TEUFEL ET AL.: ""Sequence Identification and Characterization of Human Carnosinase and a Closely Related Non-specific Dipeptidase"", J. BIOL. CHEM., vol. 278, no. 8, 2003, pages 6521 - 31, XP002590950, DOI: doi:10.1074/jbc.m209764200;;ALIYA S, REDDANNA P, THYAGARAJU K.: ""Does glutathione S-transferase Pi (GST-Pi) a marker protein for cancer?"", MOL CELL BIOCHEM., vol. 253, no. 1-2, 2003, pages 319 - 27;;BANDO K, ICHIHARA K, TOYOSHIMA H, SHIMOTUJI T, KODA K, HAYASHI C, MIYAI K.: ""Decreased activity of carnosinase in serum of patients with chronic liver disorders"", CLIN CHEM., vol. 32, no. 8, 1986, pages 1563 - 5;;CHEUNG KJ, TILLEMAN K, DEFORCE D, COLLE I, VAN VLIERBERGHE H.: ""The HCV serum proteome: a search for fibrosis protein markers"", J VIRAL HEPAT., vol. 16, no. 6, 2009, pages 418 - 29;;DOMENE HM, HWA V, ARGENTE J, WIT JM, CAMACHO-H3BNER C, JASPER HG, POZO J, VAN DUYVENVOORDE HA, YAKAR S, FOFANOVA-GAMBETTI OV: ""International ALS Collaborative Group. Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences"", HORM RES., vol. 72, no. 3, 2009, pages 129 - 41;;GANGADHARAN B, ANTROBUS R, DWEK RA, ZITZMANN N.: ""Novel serum biomarker candidates for liver fibrosis in hepatitis C patients"", CLIN CHEM., vol. 53, no. 10, 2007, pages 1792 - 9, XP055018487, DOI: doi:10.1373/clinchem.2007.089144;;GANDHI KS, MCKAY FC, DIEFENBACH E, CROSSETT B, SCHIBECI SD, HEARD RN, STEWART GJ, BOOTH DR, ARTHUR JW.: ""Novel approaches to detect serum biomarkers for clinical response to interferon-beta treatment in multiple sclerosis"", PLOS ONE., vol. 5, no. 5, 2010, pages E10484;;LACOVAZZI PA, TRISOLINI A, BARLETTA D, ELBA S, MANGHISI OG, CORREALE M.: ""Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein"", CLIN CHEM LAB MED., vol. 39, no. 10, 2001, pages 961 - 5, XP003000888, DOI: doi:10.1515/CCLM.2001.155;;JOHANSSON ME, THOMSSON KA, HANSSON GC.: ""Proteomic analyses of the two mucus layers of the colon barrier reveal that their main component, the Muc2 mucin, is strongly bound to the Fcgbp protein"", J PROTEOME RES., vol. 8, no. 7, 2009, pages 3549 - 57;;KATAOKA H, KAWAGUCHI M.: ""Hepatocyte growth factor activator (HGFA): pathophysiological functions in vivo"", FEBS J., vol. 277, no. 10, 2010, pages 2230 - 7, XP002622115, DOI: doi:10.1111/J.1742-4658.2010.07640.X;;KAWAGUCHI T, YAMAGISHI S, SATA M.: ""Branched-chain amino acids and pigment epithelium- derived factor: novel therapeutic agents for hepatitis c virus-associated insulin resistance"", CURR MED CHEM., vol. 16, no. 36, 2009, pages 4843 - 57;;KEIL C, MASKOS K, THAN M, HOOPES JT, HUBER R, TAN F, DEDDISH PA, ERDOS EG, SKIDGEL RA, BODE W.: ""Crystal structure of the human carboxypeptidase N (kininase 1) catalytic domain"", J MOL BIOL., vol. 366, no. 2, 2007, pages 504 - 16, XP005854071, DOI: doi:10.1016/j.jmb.2006.11.025;;KIM E, LI K, LIEU C, TONG S, KAWAI S, FUKUTOMI T, ZHOU Y, WANDS J, LI J.: ""Expression of apolipoprotein C-IV is regulated by Ku antigen/peroxisome proliferator-activated receptor gamma complex and correlates with liver steatosis"", J HEPATOL., vol. 49, no. 5, 2008, pages 787 - 98, XP025587135, DOI: doi:10.1016/j.jhep.2008.06.029;;KITTL EM, HOFMANN J, HARTMANN G, SEBESTA C, BEER F, BAUER K, HUBER KR.: ""Serum protein 90K/Mac-2BP is an independent predictor of disease severity during hepatitis C virus infection"", CLIN CHEM LAB MED., vol. 38, no. 3, 2000, pages 205 - 8, XP008082982, DOI: doi:10.1515/CCLM.2000.029;;KLUFT C, LOS P, CLEMMENSEN I, BROMMER EJ, GEVERS LEUVEN JA, BOKS AL, VELLENGA E.: ""Quantitation of plasma levels of tetranectin--effects of oral contraceptives, pregnancy, treatment with L-asparaginase and liver cirrhosis"", THROMB HAEMOST., vol. 62, no. 2, 1989, pages 792 - 6;;KOBAYASHI K, YAGASAKI M, HARADA N, CHICHIBU K, HIBI T, YOSHIDA T, BROWN WR, MORIKAWA M.: ""Detection of Fcgamma binding protein antigen in human sera and its relation with autoimmune diseases"", IMMUNOL LETT., vol. 79, no. 3, 2001, pages 229 - 35;;POPESCU CL, DUBUISSON J.: ""Role of lipid metabolism in hepatitis C virus assembly and entry"", BIOL CELL, vol. 102, no. 1, 2009, pages 63 - 74;;ROSSI E, ADAMS L, PRINS A, BULSARA M, DE BOER B, GARAS G, MACQUILLAN G, SPEERS D, JEFFREY G.: ""Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients"", CLIN CHEM., vol. 49, no. 3, 2003, pages 450 - 4;;SAKAI M, MURAMATSU M.: ""Regulation of glutathione transferase P: a tumor marker of hepatocarcinogenesis"", BIOCHEM BIOPHYS RES COMMUN., vol. 357, no. 3, 2007, pages 575 - 8, XP022138277, DOI: doi:10.1016/j.bbrc.2007.03.174;;SASAKI M, IKEDA H, KATAOKA H, NAKANUMA Y.: ""Augmented expression of hepatocytes growth factor activator inhibitor type 1 (HAI-1) in intrahepatic small bile ducts in primary biliary cirrhosis"", VIRCHOWS ARCH., vol. 449, no. 4, 2006, pages 462 - 71, XP019443381, DOI: doi:10.1007/s00428-006-0257-7;;ZHANG L, JIA X, ZHANG X, SUN J, PENG X, QI T, MA F, YIN L, YAO Y, QIU C: ""Proteomic analysis of PBMCs: characterization of potential HIV-associated proteins"", PROTEOME SCI., vol. 8, 2010, pages 12 - 23",PENDING
115,AU,A1,AU 2020/217892 A1,195-149-689-531-060,2021-09-09,2021,AU 2020/217892 A,2020-02-07,GB 201901771 A;;GB 2020000011 W,2019-02-08,Stackable modular planter,"The invention relates to a stackable modular planter 1. Planter 1 has: a) an open top plant box (10) having a base and four side walls adapted to receive a growing medium and plants, said open top box having a first width, b) an irrigation box (20) below the open top box base having a second width larger than the top box first width, said irrigation box adapted to be filled with irrigation fluid, c) an open top hopper (30) on one side of the open top box on top of the irrigation box adapted to receive irrigation fluid which drains into the irrigation box, d) an overflow drain aperture (60) in the irrigation box through which excess irrigation fluid can flow, and e) means (50A,50B) to stack one planter above another planter. In use, when one planter is stacked above another planter, excess irrigation can flow from the overflow aperture into the hopper of the planter below.",FLEMING MARK ANDREW;;SABIN RICHARD ALEXANDER,SABIN RICHARD ALEXANDER;;FLEMING MARK ANDREW,,https://lens.org/195-149-689-531-060,Patent Application,no,0,0,8,8,0,A01G9/023;;A01G27/02;;A01G27/06;;A01G27/008;;A01G9/023;;A01G27/06;;A01G9/023;;A01G9/027;;A01G27/008;;A01G27/06,A01G9/02;;A01G27/00;;A01G27/02;;A01G27/06,,0,0,,,,PENDING
116,GB,A,GB 2584812 A,053-637-267-826-663,2020-12-23,2020,GB 201901771 A,2019-02-08,GB 201901771 A,2019-02-08,Stackable modular planter,"A stackable modular planter 1 has a vegetation receiving box 10 having a base 11 and four side walls 12, 13, 14, 15 to receive a growing medium and plants. The width of the irrigation bottom box 20 has a width larger than the top open box. The planter box has an open top hopper 30 on one side of the vegetation box on top of the irrigation box to receive irrigation fluid which drains into the irrigation box, an overflow drain aperture (60, figure 2) through which excess irrigation fluid can flow and means 50A, 50B to stack one planter above another planter. When a planter is stacked above another, excess irrigation fluid can flow from the overflow aperture into the hopper of the planter below. The width of the irrigation box may be equal to the combined width of the hopper and the vegetation box. The walls of the planter box may be tapered inwards. The stackable means 50A and 50B may be side frames.",RICHARD ALEXANDER SABIN;;MARK ANDREW FLEMING,RICHARD ALEXANDER SABIN;;MARK ANDREW FLEMING,,https://lens.org/053-637-267-826-663,Patent Application,no,2,1,8,8,0,A01G9/023;;A01G27/02;;A01G27/06;;A01G27/008;;A01G9/023;;A01G27/06;;A01G9/023;;A01G9/027;;A01G27/008;;A01G27/06,A01G9/02;;A01G27/06,,0,0,,,,ACTIVE
117,EP,B1,EP 0833834 B1,116-802-048-383-364,2000-03-08,2000,EP 96916892 A,1996-05-31,US 9608235 W;;US 45589695 A,1995-05-31,DNA SEQUENCE AND ENCODED MAMMARY-SPECIFIC BREAST CANCER PROTEIN,,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,WASHINGTON UNIVERSITY (2008-06-25),https://lens.org/116-802-048-383-364,Granted Patent,yes,0,0,41,41,0,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,A61K38/00;;C07H21/04;;C07K14/47;;C12N15/09;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,3,0,,,"PARKER M G ET AL.: ""Prostatic steroid-binding protein"" JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 258, no. 1, 10 January 1983, pages 12-15, XP002058665;;WATSON M A ET AL: ""ISOLATION OF DIFFERENTIALLY EXPRESSED SEQUENCE TAGS FROM HUMAN BREAST CANCER"" CANCER RESEARCH, vol. 54, 1 September 1994, pages 4598-4602, XP002019977;;CANCER RESEARCH, Volume 56, No. 4, issued 15 February 1996, M.A. WATSON et al., ""Mammaglobin, a Mammary-Specific member of the Uteroglobin Gene Family, Is Overexpressed in Human Breast Cancer"", pages 860-865.",EXPIRED
118,PT,E,PT 833834 E,113-981-217-811-161,2000-08-31,2000,PT 96916892 T,1996-05-31,US 45589695 A,1995-05-31,SEQUENCIA DE DNA E PROTEINA CODIFICADA DO CANCRO DA MAMA ESPECIFICA DA GLANDULA MAMARIA,,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/113-981-217-811-161,Granted Patent,no,0,0,41,41,0,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,A61K38/00;;C07H21/04;;C07K14/47;;C07K14/82;;C12N15/09;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,0,0,,,,EXPIRED
119,US,B2,US 8806081 B2,143-033-051-922-213,2014-08-12,2014,US 3360608 A,2008-02-19,US 3360608 A,2008-02-19,Open host issued statesave to attached storage,"A method to issue a statesave command from a host system to attached storage is provided. The attached storage is monitored for a predetermined threshold time to identify an inaccessible device. Upon expiration of the predetermined threshold time, the statesave command is issued from a device driver of the host system to the attached storage.",FLEMING MARK SEAN;;MARTINEZ LISA R;;IBM,FLEMING MARK SEAN;;MARTINEZ LISA R,INTERNATIONAL BUSINESS MACHINES CORPORATION (2008-02-13),https://lens.org/143-033-051-922-213,Granted Patent,yes,14,1,2,2,0,G06F11/0757;;G06F11/0757;;G06F11/0778;;G06F11/0778;;G06F11/201;;G06F11/201,G06F3/00;;G06F11/07;;G06F11/20,710/19;;710/17,0,0,,,,INACTIVE
120,JP,A,JP 2007145855 A,168-314-838-617-43X,2007-06-14,2007,JP 2007021666 A,2007-01-31,US 45589695 A,1995-05-31,DNA SEQUENCE AND ENCODED MAMMA-SPECIFIC BREAST CANCER PROTEIN,"<P>PROBLEM TO BE SOLVED: To provide a purified and isolated DNA sequence and an encoded mamma-specific protein, mammaglobin, and a method for detecting breast cancer based on the over expression and secretion of the mammaglobin caused by breast cancer cells. <P>SOLUTION: This isolated and purified protein consists of a mammaglobin epitope having a specific amino acid sequence. The method for detecting the breast cancer is provided by detecting/determining the existence of the mammaglobin or an mRNA encoding the mammaglobin. <P>COPYRIGHT: (C)2007,JPO&INPIT",UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/168-314-838-617-43X,Patent Application,no,0,0,41,41,0,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,C07K14/435;;A61K38/00;;C12N15/09;;C07H21/04;;C07K14/47;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,0,0,,,,INACTIVE
121,EP,A1,EP 0833834 A1,016-606-596-843-807,1998-04-08,1998,EP 96916892 A,1996-05-31,US 9608235 W;;US 45589695 A,1995-05-31,DNA SEQUENCE AND ENCODED MAMMARY-SPECIFIC BREAST CANCER PROTEIN,,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,WASHINGTON UNIVERSITY (2008-06-25),https://lens.org/016-606-596-843-807,Patent Application,yes,0,0,41,41,14,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,A61K38/00;;C07H21/04;;C07K14/47;;C07K14/82;;C12N15/09;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,0,0,,,,EXPIRED
122,MX,A,MX 9709364 A,043-376-981-130-043,1998-08-30,1998,MX 9709364 A,1997-12-01,US 45589695 A,1995-05-31,DNA SEQUENCE AND ENCODED MAMMARY-SPECIFIC BREAST CANCER PROTEIN.,"A purified and isolated DNA sequence and the encoded mammary-specific protein, mammaglobin, are disclosed. Also disclosed are methods for the detecting breast cancer based upon the overexpression and secretion of mammaglobin by breast cancer cells. The methods detect and/or quantitate the presence of mammaglobin or the mRNA encoding mammaglobin.",UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/043-376-981-130-043,Patent Application,no,0,0,41,41,0,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,A61K38/00;;C07H21/04;;C07K14/47;;C12N15/09;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,0,0,,,,PENDING
123,US,B1,US 6566072 B1,002-133-351-854-211,2003-05-20,2003,US 16262298 A,1998-09-29,US 16262298 A;;US 93314997 A;;US 9608235 W;;US 45589695 A,1995-05-31,"Mammaglobin, a secreted mammary-specific breast cancer protein","
    A purified and isolated DNA sequence and the encoded mammary-specific secreted protein, mammaglobin, are disclosed. Also disclosed are methods for detecting breast cancer based upon the overexpression and secretion of mammaglobin by breast cancer cells. The methods detect and/or quantitate the presence of mammaglobin or the mRNA encoding mammaglobin. Immunotherapy-based methods for treating a breast cancer patient with a mammaglobin-expressing tumor are also disclosed. The methods involve using mammaglobin antigens to induce a humoral and/or cell-mediated immune response against the tumor. 
",UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,WASHINGTON UNIVERSITY (1998-09-18),https://lens.org/002-133-351-854-211,Granted Patent,yes,6,18,21,23,21,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;C12Q1/6886;;G01N33/57415;;G01N2800/52;;C12Q2600/158;;C12Q1/68;;A61K39/00;;C07K14/47;;A61K38/00;;C12Q1/6886;;C07K14/4721;;A61K39/00;;G01N33/57415;;C12Q2600/158;;G01N2800/52,A61K38/00;;A61K39/00;;G01N33/53;;C07K14/47;;C12N15/09;;C12Q1/68;;C12Q1/6886;;G01N33/566;;G01N33/574;;G01N33/577,435/7.1;;435/4,42,37,051-004-962-394-986;;046-350-065-506-934;;034-134-907-055-024;;083-308-152-083-020;;011-964-364-173-232;;049-477-935-103-029;;093-298-749-737-02X;;050-904-893-659-406;;119-356-842-486-362;;022-264-904-824-000;;040-713-726-205-55X;;082-770-528-105-755;;028-076-553-910-600;;091-739-663-074-980;;084-368-082-646-975;;014-017-617-421-956;;166-392-684-735-433;;053-457-015-539-969;;039-229-624-803-022;;025-173-207-852-618;;011-052-065-868-454;;036-740-421-551-776;;001-465-886-657-534;;015-696-872-509-326;;041-446-829-885-810;;047-850-427-018-32X;;016-273-221-621-842;;094-881-140-637-816;;115-916-545-155-724;;100-874-429-486-692;;104-304-928-520-85X;;002-882-127-467-426;;069-204-673-706-269;;086-019-826-094-569;;060-981-882-240-003;;094-657-190-841-800;;047-850-427-018-32X,10216947;;10.1016/s1357-2725(98)00135-6;;10.1016/0959-8049(93)90215-2;;7906532;;1563002;;10.1093/jnci/85.3.200;;8423624;;10.1016/b978-0-444-82027-3.50022-5;;10.1016/s1054-3589(08)60935-7;;8504068;;7066904;;1888147;;10.1002/eji.1830170820;;2442000;;3994306;;10.1016/0304-3835(93)90224-w;;7689035;;1709722;;10.1038/351290a0;;10.1126/science.2434994;;2434994;;1402647;;pmc2119397;;10.1084/jem.176.4.1007;;1546329;;10.1126/science.1546329;;1280333;;10.1038/360434a0;;10.1097/00000441-199209000-00011;;1476160;;10.1073/pnas.91.23.11236;;pmc45202;;7972041;;3319534;;10.1210/edrv-8-4-474;;10.1007/bf03349687;;7868811;;0007868811;;2481588;;10.1002/eji.1830191209;;10.1016/0022-4731(84)90190-0;;6538620;;0006294095;;6294095;;10.1016/s0021-9258(18)33208-3;;6598318;;10.1111/j.1749-6632.1984.tb38280.x;;10.1111/j.1432-1033.1981.tb06206.x;;7014218;;10.1111/j.1432-1033.1981.tb06205.x;;pmc42754;;7831305;;10.1073/pnas.92.2.432;;8227325;;pmc288387;;10.1172/jci116810;;8084586;;8187086;;2470152;;10.1126/science.2470152;;1736535;;10.1016/0042-6822(92)90321-f;;10.1093/jnci/84.11.845;;1317462;;8548758;;0008631025;;8631025;;9488047;;10.1038/sj.onc.1201597;;8062249;;10.1006/geno.1998.5539;;9806831;;8227325;;pmc288387;;10.1172/jci116810,"Reiger et al (Glossary of Genetics and Cytogenetics, Classical and Molecular, 4th Ed., Springer-Verlag, Berlin), 1976.*;;Alberts et al (Molecular Biology of the Cell, 3rd Ed., 1994, p. 465).*;;Shantz and Pegg (Int. J. of Blochem and Cell Biol., 1999, 31:107-122).*;;McClean and Hill (Eur. J. Cancer, 1993, 29A:2243-2248).*;;Fu et al (EMBO J. 1996, 15:4329-4401).*;;Tockman et al (Cancer Res. 1998 (Suppl), 52:2711s-2718s).*;;Allerd et al., J. Nat'l Cancer Inst. 85:200-206 (1993).;;Bagshawa, Adv. Pharmacol. 24:99-121 (1993).;;Bjork et al., Partial Characterization and ""Quantitation"" of a Human Prostatic Estramustine-binding Protein, Cancer Res. 42:1935-1942 (1982).;;Bjork et al., Expression and Partial Characterization of Estramustine-Binding Protein (EMBP) in Human Breast Cancer and Malignant Melanoma, Anticancer Res. 11:1173-7792 (1991).;;Borras-Cuesta et al., Eur. J. Immunol. 17:1213-1215 (1987).;;Cato et al., The Hormonal Regulation of Uteroglobin Gene Expression, Anticancer Res. 5:65:72 (1985).;;Denton et al., Cancer Letters 70:143-150 (1993).;;Falk et al., Nature 351:290-296 (1991).;;Good et al., Science 235:1059-1062 (1987).;;Hammer et al., J. Exp. Med. 176:1007 (1992).;;Henderson et al., Science 255:1264-1266 (1992).;;Hill et al., Nature 360:434 (1992).;;LoBuglio and Saleh, Am. J. med. Sci. 304:214-224 (1992).;;Maroulako et al, Proc. Nat. Acad. Sci. USA 91:11236-11240 (1994).;;Miele et al., Uteroglobin: Structure, Molecular Biology, and New Perspectives on its Function as a Phospholipase A2 Inhibitor, Endocrine Rev. 8:474-490 (1987).;;Miele et al., Uteroglobin and Uteroglobin-like Proteins: the uteroglobin family of Proteins, J. Endocrinol. Invest. 17:679-92 (1994).;;Panina-Bordignon et al., Eur. J. Immunol. 19:2237 (1989).;;Parker et al., Organization and Expression of Prostatic Steroid Binding Protein Genes, J. Steroid Biochem 20:67-71 (1984).;;Parker et al., J. Biol. Chem. 258:12-15 (1983).;;Parker et al., Organization and Expression of Genes Encoding Prostatic Steroid Binding Protein, Ann. NY Acad. Sci. 438:115-124 (1984).;;Peeters et al, Eur. J. Biochem., 115:115-121.;;Peoples et al., Proc. Natl. Acad. Sci. 92:432-436 (1995).;;Peri et al., Tissue-Specific expression of the Gene Coding for Human Clara Cell 10-kD Protein, a Phospholipase A2-inhibitory Protein, J. Clin. Invest. 92:2099-2109 (1993).;;Sandmoller et al., Oncogene 9:2805-2815 (1994).;;Schoenfield et al., Cancer Res. 54:2986-2990 (1994).;;Slamon et al., Sci. 244:707-712 (1989).;;Taylor et al., Virology 187:321-328 (1991).;;Thor et al., J. Nat'l Cancer Inst. 84:845-855 (1992).;;Toso et al., Cancer Research 56:16-20 (1996).;;Watson et al., Cancer Res. 56:860-865 (1996).;;Watson et al., Structure and transcriptional regulation of the human mammaglobin gene, a breast cancer associated member of the uteroglobin gene family localized to Chromosome 11q13, Oncogene 16:817-824 (1998).;;Watson et al., Isolation of Differentially Expressed Sequence Tags from Human Breast Cancer, Cancer Res. 54:4598-4602 (1994).;;Becker et al.; ""Identification of Mammaglobin B, a Novel Member of the Uteroglobin Gene Family""; Genomics, vol. 54, 1998, pp. 70-78.;;Peri et al.; Tissue-specific Expression of the Gene Coding for Human Clara Cell 10-kD Protein, A Phospholipase A2-inhibitory Protein; The Journal of Clinical Investigation, Inc., vol. 92, Nov. 1993, pp. 2099-2109.;;Sambrook et al.; ""Purification of Antibodies""; Molecular Cloning, A Laboratory Manual, second edition, 1989, pp. 18. 11-18. 18.;;Stryer, Lubert; Biochemistry, third edition, 1988, pp. 28-29.",EXPIRED
124,TR,T1,TR 199701462 T1,012-599-955-601-319,1998-04-21,1998,TR 9701462 T,1996-05-31,US 45589695 A,1995-05-31,DNA Dizisi ve bununla kodlanmis meme'ye özel gögüs kanseri proteini.,"Saflastirilmis ve izole edilmis bir DNA dizisi ve bu diziyle kodlanmis memeye özel protein olan mamaglobin anlatilmistir. Ayni zamanda, meme kanseri hücreleri tarafindan memaglobinin fazla sentezlenmesi ve salgilanmasi üzerine meme kanserinin bulgulanmasi için yöntemler de anlatilmistir. Yöntemler, mamaglobinin ya da mamaglobini kodlayan mRNA'nin mevcudiyetini nicellestirmektedir.",UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/012-599-955-601-319,Patent Application,no,0,0,41,41,0,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,A61K38/00;;C07H21/04;;C07K14/47;;C12N15/09;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,0,0,,,,PENDING
125,AU,A,AU 1996/059616 A,086-478-904-412-896,1996-12-18,1996,AU 1996/059616 A,1996-05-31,US 45589695 A;;US 9608235 W,1995-05-31,Dna sequence and encoded mammary-specific breast cancer prot ein,,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/086-478-904-412-896,Patent Application,no,0,0,41,41,0,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,C12N15/09;;A61K38/00;;C07H21/04;;C07K14/47;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,0,0,,,,EXPIRED
126,CA,C,CA 2343980 C,090-868-360-223-920,2012-06-26,2012,CA 2343980 A,1999-09-29,US 16262298 A;;US 9922616 W,1998-09-29,"MAMMAGLOBIN, A SECRETED MAMMARY-SPECIFIC BREAST CANCER PROTEIN","A purified and isolated DNA sequence and the encoded mammary-specific secreted protein, mammaglobin, are disclosed. Also disclosed are methods for detecting breast cancer based upon the overexpression and secretion of mammaglobin by breast cancer cells. The methods detect and/or quantitate the presence of mammaglobin or the mRNA enconding mammaglobin. Immunotherapy-based methods for treating a breast cancer patient with a mammaglobin-expressing tumor are also disclosed. The methods involve using mammaglobin antigens to induce a humoral and/or cell-mediated immune response against the tumor.",UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/090-868-360-223-920,Granted Patent,no,0,0,21,23,21,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;C12Q1/6886;;G01N33/57415;;G01N2800/52;;C12Q2600/158;;C12Q1/68;;A61K39/00;;C07K14/47;;A61K38/00;;C12Q1/6886;;C07K14/4721;;A61K39/00;;G01N33/57415;;C12Q2600/158;;G01N2800/52,C07H21/02;;G01N33/53;;A61K38/00;;A61K39/00;;C07H21/04;;C07K14/47;;C12N15/09;;C12Q1/68;;C12Q1/6886;;G01N33/566;;G01N33/574;;G01N33/577,,0,0,,,,EXPIRED
127,ZA,B,ZA 988526 B,025-156-506-545-111,1999-08-16,1999,ZA 988526 A,1998-09-17,US 93314997 A,1997-09-18,"Mammaglobin, a secreted mammary-specific breast cancer protein.",,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/025-156-506-545-111,Granted Patent,no,0,0,20,20,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;A61P35/00;;A61K39/00;;C07K14/47;;A61K39/00;;C07K14/4721;;A61K38/00,A61K35/26;;A61K38/00;;C12N15/09;;A61K39/00;;A61K39/395;;A61P35/00;;C07K14/47,,0,0,,,,EXPIRED
128,CZ,A3,CZ 2000993 A3,028-536-497-551-491,2000-11-15,2000,CZ 2000993 A,1998-09-18,CZ 2000993 A,1998-09-18,"Mammaglobin, secreted protein specific for mastocarcinoma",,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/028-536-497-551-491,Patent Application,no,0,0,1,1,0,,A61K31/7084;;A61P35/00;;A61P37/04;;C07H21/00;;C07K1/00,,0,0,,,,PENDING
129,AU,B2,AU 698823 B2,039-293-343-263-206,1998-11-05,1998,AU 1996/059616 A,1996-05-31,US 45589695 A;;US 9608235 W,1995-05-31,DNA sequence and encoded mammary-specific breast cancer protein,,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/039-293-343-263-206,Granted Patent,no,0,0,41,41,0,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,C12N15/09;;A61K38/00;;C07H21/04;;C07K14/47;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,1,1,069-204-673-706-269,0008631025;;8631025,CANCER RESEARCH VOL. 56 NO. 4 1996 M.A. WATSON ET AL,EXPIRED
130,GB,A,GB 2460242 A,042-321-539-276-053,2009-11-25,2009,GB 0809160 A,2008-05-20,GB 0809160 A,2008-05-20,Morcellating laparoscopic instrument with bipolar electrodes and double skin wall.,"A device for morcellating tissue within a body cavity of a patient, such as during a laparoscopic hysterectomy procedure, comprises means to grasp tissue 24 and a double-skin walled stationary tube 8 having a bipolar electrosurgical electrode assembly 14, 15, 16 at the distal end of the tube. The assembly comprises a first electrode 14 mounted on the facing edge of an insulator 15, and a second return electrode 16 mounted behind the insulator with a extended portion 30 acting as a heatsink. The tube 8 has a twin-walled construction with inner 27 and outer 28 walls forming an air gap 23 therebetween. This twin-walled construction reduces the heat conduction from the electrodes along the tube 8. The outer wall may additionally have apertures (fig 4) to remove smoke from the instrument tip through the gap in the tube walls.",GYRUS MEDICAL LTD,FLEMING ALISTAIR I;;EBBUTT JULIAN MARK,,https://lens.org/042-321-539-276-053,Patent Application,no,5,6,10,10,0,A61B17/32002;;A61B17/32053;;A61B18/1445;;A61B18/16;;A61B2017/320024;;A61B2018/00005;;A61B2018/00083;;A61B2218/008;;A61B18/1445;;A61B17/32;;A61B17/42;;A61B18/14;;A61B2017/320024;;A61B2018/00339;;A61B2018/00005;;A61B2018/00083;;A61B2218/008;;A61B17/32053;;A61B18/1482;;A61B18/16;;A61B18/1485;;A61B18/1445;;A61B2018/00005;;A61B17/32002;;A61B2218/008;;A61B18/16;;A61B2018/00083;;A61B2017/320024;;A61B17/32053,A61B18/14,,0,0,,,,DISCONTINUED
131,CA,C,CA 2741641 C,056-097-144-334-399,2014-08-05,2014,CA 2741641 A,1996-05-31,US 45589695 A;;CA 2222747 A,1995-05-31,ANTIBODY SPECIFIC FOR A MAMMAGLOBIN POLYPEPTIDE,A purified antibody that reacts with a mammaglobin polypeptide wherein the mammaglobin polypeptide comprises SEQ ID NO: 2.,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/056-097-144-334-399,Granted Patent,no,0,0,41,41,14,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,C07K16/18;;C12N15/09;;A61K38/00;;C07H21/04;;C07K14/47;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,0,0,,,,EXPIRED
132,EP,A1,EP 3920683 A1,075-669-769-047-314,2021-12-15,2021,EP 20705447 A,2020-02-07,GB 201901771 A;;GB 2020000011 W,2019-02-08,STACKABLE MODULAR PLANTER,,SABIN RICHARD ALEXANDER;;FLEMING MARK ANDREW,SABIN RICHARD ALEXANDER;;FLEMING MARK ANDREW,,https://lens.org/075-669-769-047-314,Patent Application,yes,0,0,8,8,0,A01G9/023;;A01G27/02;;A01G27/06;;A01G27/008;;A01G9/023;;A01G27/06;;A01G9/023;;A01G9/027;;A01G27/008;;A01G27/06,A01G9/02;;A01G27/00;;A01G27/02;;A01G27/06,,0,0,,,,PENDING
133,AU,B2,AU 767962 B2,093-602-947-311-218,2003-11-27,2003,AU 1999/062758 A,1999-09-29,AU 1999/062758 A;;AU 1996/059616 A;;US 16262298 A;;US 9922616 W,1996-05-31,"Mammaglobin, a secreted mammary-specific breast cancer protein",,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/093-602-947-311-218,Granted Patent,no,0,0,2,23,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;C12Q1/6886;;G01N33/57415;;C12Q2600/158;;G01N2800/52;;C07K14/47,G01N33/53;;A61K38/00;;A61K39/00;;C07H21/02;;C07H21/04;;C07K14/47;;C12N15/09;;C12Q1/68;;G01N33/566;;G01N33/574;;G01N33/577,,0,0,,,,EXPIRED
134,PL,A1,PL 347021 A1,115-299-411-492-310,2002-03-11,2002,PL 34702199 A,1999-09-29,US 16262298 A,1998-09-29,"MAMMAGLOBIN, A SECRETED MAMMARY-SPECIFIC BREAST CANCER PROTEIN",,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/115-299-411-492-310,Patent Application,no,0,0,21,23,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;C12Q1/6886;;G01N33/57415;;G01N2800/52;;C12Q2600/158;;C12Q1/68;;A61K39/00;;C07K14/47;;A61K38/00;;C12Q1/6886;;C07K14/4721;;A61K39/00;;G01N33/57415;;C12Q2600/158;;G01N2800/52,A61K38/00;;A61K39/00;;C07K14/47;;G01N33/53;;C12N15/09;;C12Q1/68;;C12Q1/6886;;G01N33/566;;G01N33/574;;G01N33/577,,0,0,,,,DISCONTINUED
135,US,S,US D0324265 S,166-278-159-698-954,1992-02-25,1992,US 30771489 F,1989-02-08,AU 198802668 F,1988-08-09,Liquid heater which operates on solar energy or any other energy source,,SIDDONS RAMSET LTD,FLEMING MARK G;;COLLINS DAVID C,QUANTUM ENERGY SYSTEMS (INTERNATIONAL) PTY LIMITED (1998-08-17);;SIDDONS RAMSET LIMITED A CORP. OF VICTORIA AUSTRALIA (1989-02-28);;SIDDONS INVESTMENT CO. PTY LTD (1990-07-01),https://lens.org/166-278-159-698-954,Design Right,yes,4,4,2,2,0,,,D23/318,2,0,,,"Electrical Merchandising, Oct. 1947, p. 61, Viking Water Heater, lower left side of page.;;Grainger's Spring '86 Cat.; p. 1033, Solar Heat Water Storage Tank, top left side of page.",EXPIRED
136,NO,D0,NO 20011394 D0,154-329-013-999-561,2001-03-19,2001,NO 20011394 A,2001-03-19,US 16262298 A;;US 9922616 W,1998-09-29,"Mammoglobin, et sekrert brystspesifikt brystkreftprotein",,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/154-329-013-999-561,Patent Application,no,0,0,21,23,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;C12Q1/6886;;G01N33/57415;;G01N2800/52;;C12Q2600/158;;C12Q1/68;;A61K39/00;;C07K14/47;;A61K38/00;;C12Q1/6886;;C07K14/4721;;A61K39/00;;G01N33/57415;;C12Q2600/158;;G01N2800/52,A61K38/00;;G01N33/53;;A61K39/00;;C07K14/47;;C12N15/09;;C12Q1/68;;C12Q1/6886;;G01N33/566;;G01N33/574;;G01N33/577,,0,0,,,,DISCONTINUED
137,GR,T3,GR 3033636 T3,166-598-876-543-333,2000-10-31,2000,GR 20000401323 T,2000-06-08,US 45589695 A;;US 9608235 W,1995-05-31,DNA SEQUENCE AND ENCODED MAMMARY-SPECIFIC BREAST CANCER PROTEIN,,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/166-598-876-543-333,Granted Patent,no,0,0,41,41,0,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,A61K38/00;;C07H21/04;;C07K14/47;;C12N15/09;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,0,0,,,,EXPIRED
138,GB,A,GB 2531268 A,181-534-656-767-459,2016-04-20,2016,GB 201418088 A,2014-10-13,GB 201418088 A,2014-10-13,Health monitoring and indication system for intermittent Fault detection test equipment,"A health monitoring and indication (HMI) system 1 for intermittent fault detection (IFD) test equipment 2 monitors, records and displays the IFD circuit boards' voltage and environmental parameters, e.g. temperature and humidity, that are necessary for correct functioning of the IFD test equipment 2. The HMI system 1 compares the voltage and environment inputs with stored baseline values in a memory 11 to provide a continuous visual indication of the test equipment's serviceability. Each parameter can be displayed on the IFD test equipment's screen 13 or can be downloaded via an external USB connection 15. Different colours may be used to indicate that the monitored parameters are normal, abnormal or, whilst normal at present, have been abnormal during the monitoring. A digital heartbeat signal 8 may also be monitored to check that the IFD is operating during the monitoring.",COPERNICUS TECHNOLOGY LTD;;UNIVERSAL SYNAPTICS CORP,COCKRAM JAMES DAVID;;FLEMING MARK ANSELM,,https://lens.org/181-534-656-767-459,Patent Application,no,2,4,2,2,0,G01R31/2829;;G01R35/00;;G01R31/2803;;G01R35/00,G01R31/28;;G01R35/00,,0,0,,,,DISCONTINUED
139,BR,A,BR 9609270 A,192-431-402-298-338,1999-05-11,1999,BR 9609270 A,1996-05-31,US 45589695 A;;US 9608235 W,1995-05-31,Polinucleotídeo isolado e purificado peptídeo isolado e purificado processo para detectar a presença da câncer mamário em um paciente e kit para a detecção da presença de células neoplásticas mamárias em uma amostra,,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/192-431-402-298-338,Patent Application,no,0,0,41,41,0,A61K38/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;C12Q2600/112;;A61P35/00;;C07K14/47;;C12Q1/6886;;G01N33/57415;;A61K38/00;;C12Q2600/112,C12N15/09;;A61K38/00;;C07H21/04;;C07K14/47;;C07K14/82;;C07K16/32;;C12P21/08;;C12Q1/68;;G01N33/574,,0,0,,,,DISCONTINUED
140,AU,A,AU 1998/093737 A,199-611-906-314-402,1999-04-05,1999,AU 1998/093737 A,1998-09-18,US 93314997 A;;US 9817991 W,1997-09-18,"Mammaglobin, a secreted mammary-specific breast cancer protein",,UNIV WASHINGTON,WATSON MARK A;;FLEMING TIMOTHY P,,https://lens.org/199-611-906-314-402,Patent Application,no,0,0,20,20,0,A61K38/00;;A61K39/00;;C07K14/47;;C07K14/4721;;A61P35/00;;A61K39/00;;C07K14/47;;A61K39/00;;C07K14/4721;;A61K38/00,C12N15/09;;A61K35/26;;A61K38/00;;A61K39/00;;A61K39/395;;A61P35/00;;C07K14/47,,0,0,,,,EXPIRED
141,US,B2,US 8343452 B2,149-535-878-379-069,2013-01-01,2013,US 38470606 A,2006-03-20,US 38470606 A,2006-03-20,Acrylic fiber bonded carbon fiber paper as gas diffusion media for fuel cell,"A gas diffusion media for a fuel cell, such as a proton exchange membrane fuel cell, is provided. The gas diffusion media includes carbonizable acrylic pulp fibers instead of conventional phenolic resin as a binder material. The acrylic fibers are mixed with the carbon fiber dispersion during the papermaking step, thus eliminating the phenolic resin impregnation step typically associated with conventional gas diffusion media manufacturing processes. The mat is then cured and carbonized to produce gas diffusion media.",GM GLOBAL TECH OPERATIONS INC;;JI CHUNXIN;;FLEMING GERALD J;;FLEMING LEGAL REPRESENTATIVE MARGARET;;MATHIAS MARK,JI CHUNXIN;;FLEMING GERALD J;;FLEMING LEGAL REPRESENTATIVE MARGARET;;MATHIAS MARK,GM GLOBAL TECHNOLOGY OPERATIONS LLC (2006-02-28);;SPECTRACORP (2006-02-28),https://lens.org/149-535-878-379-069,Granted Patent,yes,34,3,8,8,0,D21H13/50;;D21H13/50;;D21H13/18;;D21H13/18;;D21H17/36;;D21H17/36;;H01M8/0234;;H01M8/0234;;H01M8/0239;;H01M8/0239;;Y02E60/50;;Y02P70/50;;Y02P70/50;;Y10T428/30;;Y10T428/30,H01M4/86;;H01M4/88;;H01M4/96;;H01M8/02;;H01M8/10,423/447.2;;429/521;;429/523;;429/535;;428/408,1,0,,,"Mathias, et al., Diffusion media for PEM fuel cells, Handbook of Fuel cells,-Fundamentals Technology and Applications, 2003.",INACTIVE
142,AU,A8,AU 2003/224847 A8,014-240-429-335-446,2003-10-27,2003,AU 2003/224847 A,2003-04-04,US 11626902 A;;US 0310484 W,2002-04-04,Non-invasive spectroscopic measurement of analytes using a matched reference analyte,,INLIGHT SOLUTIONS INC,ROBINSON MARK RIES;;FLEMING CLIONA;;ROHRSCHEIB MARK;;JONES HOWLAND,,https://lens.org/014-240-429-335-446,Patent Application,no,0,0,8,8,0,A61B5/1455;;A61B5/1455;;A61B5/14532;;A61B5/14532;;A61B5/1495;;A61B5/1495,A61B5/00,,0,0,,,,DISCONTINUED
143,US,B2,US 7027848 B2,057-873-118-751-434,2006-04-11,2006,US 11626902 A,2002-04-04,US 11626902 A,2002-04-04,Apparatus and method for non-invasive spectroscopic measurement of analytes in tissue using a matched reference analyte,"A method is provided for building improved calibration models or for improving modifications to these models or validation of the models used in the non-invasive spectroscopic measurement of an analyte or attribute of tissue. The method uses a matched reference sample and measurement of that sample to ensure that the correct relationship between the spectra and analyte is made during the model building, modification or calibration process. A matched reference sample is one in which the analyte of interest or attribute of interest in the reference sample is representative of the analyte or attribute at the site being non-invasively sampled or the agreement between the reference concentration and the non-invasively sampled concentration is clinically significant.",UNIV NEW MEXICO,ROBINSON MARK RIES;;FLEMING CLIONA;;JONES HOWLAND;;ROHRSCHEIB MARK,INLIGHT SOLUTIONS INC (2002-03-05);;NEW MEXICO UNIVERSITY OF (2002-03-12),https://lens.org/057-873-118-751-434,Granted Patent,yes,106,239,8,8,0,A61B5/1455;;A61B5/1455;;A61B5/14532;;A61B5/14532;;A61B5/1495;;A61B5/1495,A61B5/00,600/310;;600/316,86,63,092-771-153-385-988;;044-664-172-234-507;;124-765-584-741-866;;022-198-244-828-15X;;031-476-967-177-796;;041-019-677-910-047;;070-224-419-916-221;;002-001-025-906-958;;024-983-908-521-350;;034-306-664-915-533;;122-631-998-355-379;;063-417-839-541-566;;050-117-202-302-537;;032-536-190-956-413;;082-460-718-619-024;;074-132-137-516-059;;180-609-633-021-125;;006-379-722-203-14X;;046-322-430-003-406;;017-970-021-522-76X;;043-252-763-147-07X;;007-474-196-360-234;;001-286-294-696-309;;092-298-111-366-526;;044-887-587-437-419;;026-859-120-920-078;;024-672-258-988-769;;011-029-078-287-565;;010-835-829-873-259;;008-055-011-697-368;;064-576-175-601-048;;008-347-435-254-215;;049-026-789-807-681;;120-704-949-414-127;;006-908-371-140-239;;094-094-024-337-813;;067-344-060-266-59X;;107-231-158-714-635;;056-103-033-101-013;;152-936-152-957-152;;036-152-520-823-174;;099-142-983-444-96X;;072-230-138-586-696;;011-916-096-747-247;;006-051-452-576-851;;000-102-768-648-582;;080-806-236-291-970;;000-263-485-321-843;;041-566-733-967-631;;077-900-439-745-605;;064-454-960-562-165;;004-714-228-138-066;;102-360-264-494-76X;;045-818-405-987-346;;031-044-686-499-44X;;026-224-918-339-689;;095-059-891-142-961;;051-362-616-047-404;;044-681-414-499-167;;030-130-496-137-311;;023-395-153-667-898;;025-495-438-340-611;;070-235-870-002-591,9000704;;10.2337/diabetes.46.2.265;;10.2337/diab.46.2.265;;10751207;;10.1152/ajpendo.2000.278.4.e716;;10.1366/0003702991945515;;10.1021/ac60364a030;;10.1021/ac50035a023;;10.1117/12.7972819;;9358083;;10.1016/s0022-2143(97)90044-5;;21619367;;10.1021/ac960388+;;10.1364/ao.36.002206;;18253194;;10.1364/ao.35.002891;;21085438;;10.1007/bf00058655;;10.4271/950904;;10.1016/0169-7439(94)85037-2;;10.1021/ac980415r;;21662714;;10587837;;10.2337/diacare.22.12.2026;;10.1366/000370292789619232;;10.1016/b978-0-12-330050-8.50009-3;;10.1016/s0003-2670(98)00318-3;;12166611;;10.1515/cclm.2000.021;;10834401;;8934210;;10.1055/s-2007-979846;;10.1063/1.55781;;10.1111/j.1525-1594.1994.tb02230.x;;8060253;;10.1016/s0889-8529(05)70161-4;;11149159;;10.1524/zpch.1995.191.part_2.179;;10.1366/0003702971939073;;9931037;;10.1093/clinchem/45.2.165;;19855776;;10.1364/ol.19.002170;;10.1088/0031-9155/40/7/009;;7568382;;10.1366/0003702884428491;;18253204;;10.1364/ao.36.002286;;11369356;;10.1016/s0009-8981(01)00426-0;;10.1002/(sici)1099-128x(199605)10:3<215::aid-cem411>3.0.co;2-v;;10.1021/ac960862b;;1160662;;10.1007/bf01220982;;10.1366/0003702934415354;;20963158;;10.1364/ao.34.000610;;985402;;10.1152/jappl.1976.41.4.565;;18250650;;10.1364/ao.36.000093;;10.1117/12.7978742;;10.1255/jnirs.247;;10.1366/0003702981943932;;10.1366/0003702864509330;;10.1093/clinchem/38.9.1618;;1525990;;23014651;;10.1117/12.227698;;10.1016/s0169-7439(96)00052-4;;10.1366/0003702944029749;;10.1366/0003702963905295;;10.2337/diacare.20.9.1426;;9283791;;10647982;;10.1097/00004032-200002000-00005;;10.1088/0950-7671/41/4/308;;10.1016/s0169-7439(99)00016-7;;10.1366/0003702981944418;;10.1366/0003702981942528;;10.1016/s0169-7439(98)00055-0;;10.1016/s0169-7439(99)00028-3;;10.2307/1271449;;10.1366/0003702924124808;;10.1021/ac00029a021;;10.1021/ac00110a009;;10.1366/0003702924124493;;10.1007/bf00625070;;1612090;;18286001;;10.1364/ao.37.005227,"Anderson et al., ""Reduction of Postprandial Hyperglycemia and Frequency of Hypoglycemia in IDDM Patients on Insulin-Analog Treatment,"" Diabetes, Feb. 1997, vol. 46, No. 2, 14 pages.;;Aussedat et al., ""Interstitial Glucose Concentration and Glycemia: Implications for Continuous Subcutaneous Glucose Monitoring,"" Am J. Physiol. Endocrinol Metab., vol. 278, No. 4, Apr. 2000, 22 pages.;;Anderson, C.E. et al., ""Fundamentals of Calibration Transfer Through Procrustes Analysis,"" Appln. Spectros., vol. 53, No. 10 (1999) p. 1268.;;Anderson, Robert J. et al., ""Errors in Absorbance Measurements in Infrared Fourier Transform Spectrometry because of Limited Instrument Resolution,"" Analytical Chemistry, vol. 47, No. 14, Dec. 1975, pp. 2339-2347.;;Anderson, Robert J. et al., ""Resolution and Instrument Line Shape Effects on Spectral Compensation with Fourier Transform Infrared Spectrometers,"" Analytical Chemistry, vol. 50, No. 13, Nov. 1978, pp. 1804-1811.;;Ashbourn, Julian, Biometrics: Advanced Identity Verification, Springer, 2000, pp. 63-64.;;Atherton, P.D. et al., ""Tunable Fabry-Perot Filters,"" Optical Engineering, vol. 20, No. 6, Nov./Dec. 1981, pp. 806-814.;;Bantle, John P. et al., ""Glucose Measurement in Patients with Diabetes Mellitus with Dermal Interstitial Fluid,"" J. Lab Clin Med., vol. 130, No. 4, Oct. 1997, pp. 436-441.;;Beebe, Kenneth R. et al., ""Chapter 3: Preprocessing,"" Chemometrics: A Practical Guide, (C)John Wiley & Sons, Inc., date unknown, pp. 26-55.;;Blank, T.B. et al., ""Transfer of Near-Infrared Multivariate Calibrations Without Standards,"" Anal. Chem., vol. 68 (1996) p. 2987.;;Brasunas John C. et al., ""Uniform Time-Sampling Fourier Transform Spectroscopy,"" Applied Optics, vol. 36, No. 10, Apr. 1, 1997, pp. 2206-2210.;;Brault, James W., ""New Approach to High-Precision Fourier Transform Spectrometer Design,"" Applied Optics, Vo. 35, No. 16, Jun. 1, 1996, pp. 2891-2896.;;Breiman, Leo, ""Bagging Predictors,"" Machine Learning, vol. 24 (1996) pp. 123-140.;;Cassarly, W.J. et al., ""Distributed Lighting Systems: Uniform Light Delivery,"" Source Unknown, pp. 1698-1702.;;Chang, Chong-Min et al., ""An Uniform Rectangular Illuminating Optical System for Liquid Crystal Light Valve Projectors,"" Euro Display '96 (1996) pp. 257-260.;;Coyne, Lawrence J. et al., ""Distributive Fiber Optic couplers Using Rectangular Lightguides as Mixing Elements,"" (Information Gatekeepers, Inc. Brookline, MA, 1979) pp. 160-164.;;de Noord, Onno E., ""Multivariate Calibration Standardization,"" Chemometrics and Intelligent Laboratory Systems 25, (1994) pp. 85-97.;;Despain, Alvin M. et al., ""A Large-Aperture Field-Widened Interferometer-Spectrometer for Airglow Studies,"" Aspen International Conference on Fourier Spectroscopy, 1970, pp. 293-300.;;Faber, Nicolaas, ""Multivariate Sensitivity for the Interpretation of the Effect of Spectral Pretreatment Methods on Near-Infrared Calibration Model Predictions,"" Analytical Chemistry, vol. 71, No. 3, Feb. 1, 1999, pp. 557-565.;;Gabriely, Ilan MD et al., ""Transcutaneous Glucose Measurement Using Near-Infrared Spectroscopy During Hypoglycemia,"" Diabetes Care, vol. 22, No. 12, Dec. 1999, pp. 2026-2032.;;Geladi, Paul et al., ""A Multivariate NIR Study of Skin Alterations in Diabetic Patients as Compared to Control Subjects,"" J. Nera Infrared Spectrosc., vol. 8 (2000) pp. 217-227.;;Haaland, David M., ""Multivariate Calibration Methods Applied to the Quantitative Analysis of Infrared Spectra,"" Computer-Enhanced Analytical Spectroscopy, vol. 3 (1992), pp. 1-29.;;Haaland, David M. et al. ""Reagentless Near-Infrared Determination of Glucose in Whole Blood Using Multivariate Calibration,"" Applied Spectroscopy, vol. 46, No. 10 (1992) pp. 1575-1578.;;Harwit, M. et al., ""Chapter 5-Instrumental Considerations"" Hadamard Transform Optics, Academic Press (1979) pp. 109-145.;;Hazen, Kevin H. et al., ""Measurement of Glucose and Other Analytes in Undiluted Human Serum with Near-Infrared Transmission Spectroscopy, "" Analytica Chemica Acta, 371 (1998) 255-267.;;Heinemann, Lutz et al., ""Continuous Glucose Monitoring: An Overview of Today's Technologies and Their Clinical Applications,"" IJCP Supplement 129, Jul. 2002, pp. 75-79.;;Heise H. Michael et al., ""Near-Infrared Reflectance Spectroscopy for Noninvasive Monitoring of Metabolites,"" Clin. Chem. Lab. Med. 2000, 38(2) (2000) pp. 137-145.;;Heise, H.M. ""Non-Invasive Monitoring of Metabolites Using Near Infrared Spectroscopy: State of the Art,"" Horm. Metab. Res., vol. 28 (1996) pp. 527-534.;;Heise, H.M. et al., ""Near Infrared Spectrometric Investigation of Pulsatile Blood Flow for Non-Invasive Metabolite Monitoring,"" CP430, Fourier Tranform Spectroscopy: 11<SUP>th </SUP>International Conference, (1998) pp. 282-285.;;Heise, H.M. et al., ""Noninvasive Blood Glucose Sensors Based on Near-Intrared Spectroscopy,"" Artif Organs, vol. 18, No. 6 (1994) pp. 1-9.;;Herbel et al., ""Hypoglycemia Pathophysiology and Treatment,"" Endocrinology and Metabolism Clinics, vol. 29, No. 4, Dec. 2000, 16 pages.;;Hopkins, George W. et al., ""In-vivo NIR Diffuse-reflectance Tissue Spectroscopy of Human Subjects,"" SPIE, vol. 3597, Jan. 1999, pp. 632-641.;;Jagemann, Kay-Uwe et al. ""Application of Near-Infrared Spectroscopy for Non-Invasive Determination of Blood/Tissue Glucose Using Neural Networks,"" Zeitschrift for Physikalische Chemie, Bd.191, S. 179-190 (1995).;;Johansen, Ib-Rune et al., ""Calibration of an FT-IR Spectrometer for Ambient Air Monitoring Using PLS,"" Applied Spectroscopy, vol. 51, No. 10 (1997,) pp. 1540-1546.;;Khalil, Omar S., ""Spectroscopic and Clinical Aspects of Noninvasive Glucose Measurements,"" Clinical Chemistry, 45:2 (1999) pp. 165-177.;;Kohl, Matthias et al., ""Influence of Glucose concentration on Light Scattering in Tissue-Simulating Phantoms,"" Optics Letters, vol. 19, No. 24, Dec. 15, 1994, pp. 2170-2172.;;Kohl, Matthias et al., ""The Influence of Glucose Concentration Upon the Transport of Light in Tissue-simulating Phantoms,"" Phys. Med. Biol., vol. 40 (1995) pp. 1267-1287.;;Korte, E.H. et al., ""Infrared Diffuse Reflectance Accessory for Local Analysis on Bulky Samples,"" Applied Spectroscopy, vol. 42, No. 1, Jan. 1988, pp. 38-43.;;Kumar, G. et al., ""Optimal Probe Geometry for Near-Infrared Spectroscopy of Biological Tissue,"" Applied Spectroscopy, vol. 36 (1997) p. 2286.;;Kuwa, Katsuhiko et al. ""Relationships of Glucose Concentrations in Capillary Whole Blood, Venous Whole Blood and Venous Plasma,"" Clinica Chimica Acta, 307 (3001) pp. 187-192.;;Lorber, Avraham et al., ""Local Centering in Multivariate Calibration,"" Journal of Chemometrics, vol. 10 (1996) pp. 215-220.;;Lorber, Avraham et al., ""Net Analyte Signal Calculation in Multivariate Calibration,"" Analytical Chemistry, vol. 69, No. 8, Apr. 15, 1997, pp. 1620-1626.;;Malin, Stephen F., ""Non-Invasive Measurement of Glucose by Near Infrared Diffuse Reflectance Spectroscopy,"" 31<SUP>st </SUP>Annual Oak Ridge Conference, Sigma Diagnostics, Inc., Apr. 23, 1999, 1 sheet.;;Manasteriski, A. et al. ""Blanking and the Determination of Cholesterol,"" Mikrochimica Acta, (1975 II) pp. 1-16.;;Marbach, R. et al, ""Noninvasive Blood Glucose Assay by Near-Infrared Diffuse Reflectance Spectroscopy of the Human Inner Lip,"" Applied Spectroscopy, vol. 47, No. 7 (1993) pp. 875-881.;;Marbach, R. et al. ""Optical Diffuse Reflectance Accessory for Measurements of Skin Tissue by Near-Infrared Spectroscopy,"" Applied Optics, vol. 34, No. 4, Feb. 1, 1995, pp. 610-621.;;Marbach, Ralf, ""Measurement Techniques for IR Spectroscopic Blood Glucose Determination,"" (1994) pp. 1-158.;;Mardia, K.V. et al., Multivariate Analysis, Academic Press (1979) pp. 300-325.;;Martens, Harald et al., Updating Multivariate Calibrations of Process NIR Instruments, Adv. Instru. Control(1990) pp. 371-381.;;McGarraugh, Geoff et al., ""Glucose Measurements Using Blood Extracted from the Forearm and the Finger,""(C)TheraSense, Inc. (2001) pp. 1-7.;;McGuire E.A.H. et al., ""Effects of Arterial Versus Venous Sampling on Analysis of Glucose Kinetics in Man,"" Journal of Applied Physiology, vol. 41, No. 4, Oct. 1976, pp. 565-572.;;McIntosh, Bruce C. et al. ""Quantitative Reflectance Spectroscopy in the Mid-IR, 16<SUP>th </SUP>Annual FACSS Conference, Oct. 1989.;;Monfre, Stephen L. et al., ""Physiologic Differences Between Volar and Dorsal Capillary Forearm Glucose Concentrations and Finger Stick Glucose Concentrations in Diabetics,"" Abstracts from the ADA 62<SUP>nd </SUP>Scientific Sessions, date unknown, p. A125, No. 503-P. (abstract).;;Nichols, et al., Design and Testing of a White-Light, Steady-State Diffuse Reflectance Spectrometer for Determination of Optical Properties of Highly Scattering Systems, Applied Optics, Jan. 1, 1997, 36(1), pp. 93-104.;;Offner, A., ""New Concepts in Projection Mask Aligners,"" Optical Engineering, vol. 14, No. 2, Mar.-Apr. 1975, pp. 130-132.;;Osborne, B.G. et al., ""Optical Matching of Near Infrared Reflectance Monochromator Instruments for the Analysis of Ground and Whole Wheat,"" J. Near Infrared Spectrosc., vol. 7 (1999) p. 167.;;Ozdemir, d. et al., ""Hybrid Calibration Models: An Alternative to Calibration Transfer,""0 Appl. Spectros,, vol. 52, No. 4 (1998) p. 599.;;Powell, J.R. et al, ""An Algorithm for the Reproducible Spectral Subtraction of Water from the FT-IR Spectra of Proteins in Dilute Solutions and Adsorbed Monolayers,"" Applied Spectroscopy, vol. 40, No. 3 (1986) pp. 339-344.;;Ripley, B.D. Pattern Recognition and Neural Networks, Cambridge University Press (1996) pp. 91-120.;;Robinson, M. Ries et al., ""Noninvasive Glucose Monitoring in Diabetic Patients: A Preliminary Evaluation,"" Clinical Chemistry, vol. 38, No. 9 (1992) pp. 1618-1622.;;Royston, David D. et al., ""Optical Properties of Scattering and Absorbing Materials Used in the Development of Optical Phantoms at 1064 NM,"" Journal of Biomedical Optics, vol. 1, No. 1, Jan. 1996, pp. 110-116.;;Rutan, Sarah C. et al., ""Correction for Drift in Multivariate Systems Using the Kalman Filter,"" Chemometrics and Intelligent Laboratory Systems 35, (1996) pp. 199-211.;;Salit, M.L. et al., ""Heuristic and Statistical Algorithms for Automated Emission Spectral Background Intensity Estimation,"" Applied Spectroscopy, vol. 48, No. 8 (1994) pp. 915-925.;;Saptari, Vidi Alfandi, ""Analysis Design and Use of a Fourier-Transform Spectrometer for Near Infrared Glucose Absorption Measurement,""(Massachusetts Institute of Technology, 1999) pp. 1-76.;;Schmitt, J.M. et al., ""Spectral Distortions in Near-Infrared Spectroscopy of Turbid Materials,"" Applied Spectroscopy, No. 50 (1996) p. 1066.;;Service, F. John et al., Dermal Interstitial Glucose as an Indicator of Ambient Glycemia, Diabetes Care, vol. 20, No. 9, Sep. 1997, 9 pages.;;Shroder, Robert, (Internet Article) MicroPac Forum Presentation, Current performance results, May 11, 2000.;;Sjoblom, J. et al., ""An Evaluation of Orthogonal Signal correction Applied to Calibration Transfer of Near Infrared Spectra,"" Chemom & Intell Lab. Sys., vol. 44 (1998) p. 229.;;Spitz, Henry et al., ""A New Anthropometric Phantom for Calibrating In Vivo Measurements of Stable Lead in the Human Leg Using X-ray Fluorescence,"" Health Physics, vol. 78, No. 2, Feb. 2000, pp. 159-169.;;Steel, W.H., ""Interferometers for Fourier Spectroscopy,"" Aspen International Conference on Fourier Spectroscopy, (1970) pp. 43-53.;;Sternberg R.S. et al., ""A New Type of Michelson Interference Spectrometer,""Sci. Instrum., vol. 41 (1964) pp. 225-226.;;Stork, Chris L. et al., ""Weighting Schemes for Updating Regression Models-a Theoretical Approach,"" Chemometrics and Intelligent Laboratory Systems 48, (1999) pp. 151-166.;;Sum, Stephen T. et al., ""Standardization of Fiber-Optic Probes for Near-Infrared Multivariate Calibrations,"" Applied Spectroscopy, vol. 52, No. 6 (1998) pp. 869-877.;;Swierenga, H. et al., ""Comparison of Two Different Approaches Toward Model Transferability in NIR Spectroscopy,"" Applied Spectroscopy, vol. 52, No. 1 (1998) pp. 7-16.;;Swierenga, H. et al., ""Improvement of PLS Model Transferability by Robust Wavelength Selection,"" Chemometrics and Intelligent Laboratory Systems, vol. 41 (1998) pp. 237-248.;;Swierenga, H. et al., ""Strategy for Constructing Robust Multivariate Calibration Models,"" Chemometrics and Intelligent Laboratory Systems, vol. 49 (1999) pp. 1-17.;;Teijido, J.M. et al., ""Design of a Non-conventional Illumination System Using a Scattering Light Pipe,"" SPIE, vo. 2774 (1996) pp. 747-756.;;Teijido, J.M. et al., ""Illumination Light Pipe Using Micro-Optics as Diffuser,"" SPIE, vol. 2951 (1996) pp. 146-155.;;Thomas, Edward V. et al., ""Development of Robust Multivariate Calibration Models,"" Technometrics, vol. 42, No. 2, May 2000, pp. 168-177.;;Tipler, Paul A., Physics, Second Edition, Worth Publishers, Inc., Chapter 34, Section 34-2, Nov. 1983, pp. 901-908.;;Wang, Y-D. et al., ""Calibration Transfer and Measurement Stability of Near-Infrared Spectrometers,"" Appl. Spectros., vol. 46, No. 5 (1992) pp. 764-771.;;Wang, Y-D. et al., ""Improvement of Multivariate Calibration Through Instrument Standardization,"" Anal. Chem., vol. 64 (1992) pp. 562-564.;;Wang, Z., ""Additive Background Correction in Multivariate Instrument Standardization,"" Anal. Chem., vol. 67 (1995) pp. 2379-2385.;;Ward, Kenneth J. et al., ""Post-Prandial Blood Glucose Determination by Quantitative Mid-Infrared Spectroscopy,"" Applied Spectroscopy, vol. 46, No. 6 (1992) pp. 959-965.;;Webb, Paul, ""Temperatures of Skin, Subcutaneous Tissue, Muscle and Core in Resting Men in Cold, Comfortable and Hot Conditions,"" European Journal of Applied Physiology, vol. 64(1992) pp. 471-476.;;Whitehead, L.A. et al., ""High-efficiency Prism Light Guides with Confocal Parabolic Cross Sections,"" Applied Optics, vol. 37, No. 22 (1998) pp. 5227-5233.",EXPIRED
144,WO,A2,WO 2003/087759 A2,110-322-652-335-296,2003-10-23,2003,US 0310484 W,2003-04-04,US 11626902 A,2002-04-04,NON-INVASIVE SPECTROSCOPIC MEASUREMENT OF ANALYTES USING A MATCHED REFERENCE ANALYTE,"A method is provided for building improved calibration models or for improving modifications to these models or validation of the models used in the non-invasive spectroscopic measurement of an analyte or attribute of tissue. The method uses a matched reference sample and measurement of that sample to ensure that the correct relationship between the spectra and analyte is made during the model building, modification or calibration process. A matched reference sample is one in which the analyte of interest or attribute of interest in the reference sample is representative of the analyte or attribute at the site being non-invasively sampled or the agreement between the reference concentration and the non-invasively sampled concentration is clinically significant.",INLIGHT SOLUTIONS INC,ROBINSON MARK RIES;;FLEMING CLIONA;;JONES HOWLAND;;ROHRSCHEIB MARK,,https://lens.org/110-322-652-335-296,Patent Application,yes,8,0,8,8,0,A61B5/1455;;A61B5/1455;;A61B5/14532;;A61B5/14532;;A61B5/1495;;A61B5/1495,A61B5/00,,1,0,,,See also references of EP 1542581A4,PENDING
145,EP,A4,EP 1542581 A4,057-638-547-232-763,2009-03-11,2009,EP 03721541 A,2003-04-04,US 0310484 W;;US 11626902 A,2002-04-04,NON-INVASIVE SPECTROSCOPIC MEASUREMENT OF ANALYTES USING A MATCHED REFERENCE ANALYTE,,INLIGHT SOLUTIONS INC,ROBINSON MARK RIES;;FLEMING CLIONA;;JONES HOWLAND;;ROHRSCHEIB MARK,,https://lens.org/057-638-547-232-763,Search Report,no,0,0,8,8,0,A61B5/14532;;A61B5/1455;;A61B5/1495;;A61B5/1455;;A61B5/14532;;A61B5/1495,A61B5/00,,1,0,,,No Search,DISCONTINUED
146,AU,A1,AU 2003/224847 A1,104-621-146-903-484,2003-10-27,2003,AU 2003/224847 A,2003-04-04,US 11626902 A;;US 0310484 W,2002-04-04,NON-INVASIVE SPECTROSCOPIC MEASUREMENT OF ANALYTES USING A MATCHED REFERENCE ANALYTE,,INLIGHT SOLUTIONS INC,FLEMING CLIONA;;JONES HOWLAND;;ROHRSCHEIB MARK;;ROBINSON MARK RIES,,https://lens.org/104-621-146-903-484,Patent Application,no,0,0,8,8,0,A61B5/1455;;A61B5/1455;;A61B5/14532;;A61B5/14532;;A61B5/1495;;A61B5/1495,A61B5/00,,0,0,,,,DISCONTINUED
147,EP,A2,EP 1542581 A2,188-239-465-406-856,2005-06-22,2005,EP 03721541 A,2003-04-04,US 0310484 W;;US 11626902 A,2002-04-04,NON-INVASIVE SPECTROSCOPIC MEASUREMENT OF ANALYTES USING A MATCHED REFERENCE ANALYTE,,INLIGHT SOLUTIONS INC,ROBINSON MARK RIES;;FLEMING CLIONA;;JONES HOWLAND;;ROHRSCHEIB MARK,,https://lens.org/188-239-465-406-856,Patent Application,yes,0,0,8,8,0,A61B5/1455;;A61B5/1455;;A61B5/14532;;A61B5/14532;;A61B5/1495;;A61B5/1495,A61B5/00,,0,0,,,,DISCONTINUED
148,US,A1,US 2003/0191377 A1,192-432-944-394-353,2003-10-09,2003,US 11626902 A,2002-04-04,US 11626902 A,2002-04-04,Apparatus and method for non-invasive spectroscopic measurement of analytes in tissue using a matched reference analyte,"
   A method is provided for building improved calibration models or for improving modifications to these models or validation of the models used in the non-invasive spectroscopic measurement of an analyte or attribute of tissue. The method uses a matched reference sample and measurement of that sample to ensure that the correct relationship between the spectra and analyte is made during the model building, modification or calibration process. A matched reference sample is one in which the analyte of interest or attribute of interest in the reference sample is representative of the analyte or attribute at the site being non-invasively sampled or the agreement between the reference concentration and the non-invasively sampled concentration is clinically significant. 
",INLIGHT SOLUTIONS INC;;UNIV NEW MEXICO,ROBINSON MARK RIES;;FLEMING CLIONA;;JONES HOWLAND;;ROHRSCHEIB MARK,INLIGHT SOLUTIONS INC (2002-03-05);;NEW MEXICO UNIVERSITY OF (2002-03-12),https://lens.org/192-432-944-394-353,Patent Application,yes,7,214,8,8,0,A61B5/1455;;A61B5/1455;;A61B5/14532;;A61B5/14532;;A61B5/1495;;A61B5/1495,A61B5/00,60031,0,0,,,,EXPIRED
149,WO,A3,WO 2003/087759 A3,193-703-790-453-493,2004-04-01,2004,US 0310484 W,2003-04-04,US 11626902 A,2002-04-04,NON-INVASIVE SPECTROSCOPIC MEASUREMENT OF ANALYTES USING A MATCHED REFERENCE ANALYTE,"A method is provided for building improved calibration models or for improving modifications to these models or validation of the models used in the non-invasive spectroscopic measurement of an analyte or attribute of tissue. The method uses a matched reference sample and measurement of that sample to ensure that the correct relationship between the spectra and analyte is made during the model building, modification or calibration process. A matched reference sample is one in which the analyte of interest or attribute of interest in the reference sample is representative of the analyte or attribute at the site being non-invasively sampled or the agreement between the reference concentration and the non-invasively sampled concentration is clinically significant.",INLIGHT SOLUTIONS INC,ROBINSON MARK RIES;;FLEMING CLIONA;;JONES HOWLAND;;ROHRSCHEIB MARK,,https://lens.org/193-703-790-453-493,Search Report,yes,4,0,8,8,0,A61B5/1455;;A61B5/1455;;A61B5/14532;;A61B5/14532;;A61B5/1495;;A61B5/1495,A61B5/00,,1,0,,,See also references of EP 1542581A4,PENDING
150,JP,A,JP 2011192653 A,005-827-720-493-788,2011-09-29,2011,JP 2011107226 A,2011-05-12,US 37822406 A,2006-03-17,"GAS DIFFUSION MEDIA, AND FUEL CELL","<P>PROBLEM TO BE SOLVED: To provide a method of producing a gas diffusion media, by which method cost is reduced, a process is simplified or performances of media are improved. <P>SOLUTION: The gas diffusion media is made by: preparing an aqueous dispersion liquid composed by containing a powder resin, a binder material, and a fiber material composed by including carbon fibers, graphite fibers and those combinations; forming a layer of the dispersion product on a carrier; removing water from the layer to form a fiber layer; molding the fiber layer; and carbonizing or graphitizing the molded layer. <P>COPYRIGHT: (C)2011,JPO&INPIT",GM GLOBAL TECH OPERATIONS INC;;SPECTRACORP,JI CHUNXIN;;FLEMING GERALD J;;MATHIAS MARK,,https://lens.org/005-827-720-493-788,Patent Application,no,9,0,8,8,0,H01M8/0243;;H01M8/0243;;H01M8/0234;;H01M8/0234;;H01M8/0239;;H01M8/0239;;H01M8/1007;;H01M8/1007;;Y02E60/50;;Y02E60/50;;Y02P70/50;;Y02P70/50,H01M4/88;;D21H13/50;;D21H21/14;;H01M4/96;;H01M8/10,,0,0,,,,PENDING
151,DE,A1,DE 102007012495 A1,017-548-318-251-08X,2007-10-18,2007,DE 102007012495 A,2007-03-15,US 37822406 A,2006-03-17,Gasdiffusionsmedien und Brennstoffzelle,"Ein Diffusionsmedium für eine Brennstoffzelle wird dadurch hergestellt, dass eine wässrige Dispersion, die ein Pulverharz, ein Bindematerial und ein Fasermaterial umfasst, das Kohlefasern umfasst, aus diesen hergestellt wird; eine Schicht der Dispersion auf einem Träger ausgebildet wird; Wasser von der Schicht entfernt wird, um eine Faserschicht zu bilden; die Faserschicht geformt wird und die geformte Schicht karbonisiert oder graphitisiert wird.",GM GLOBAL TECH OPERATIONS INC;;SPECTRACORP,JI CHUNXIN;;FLEMING GERALD J;;MATHIAS MARK,"GM GLOBAL TECHNOLOGY OPERATIONS LLC (N. D. GES, US (2011-03-21);;SPECTRACORP, SHELTON, CONN., US (2011-05-26);;GM GLOBAL TECHNOLOGY OPERATIONS LLC , ( N. D. , US (2011-05-26);;SPECTRACORP, SHELTON, US (2011-03-21)",https://lens.org/017-548-318-251-08X,Patent Application,no,0,0,8,8,0,H01M8/0243;;H01M8/0243;;H01M8/0234;;H01M8/0234;;H01M8/0239;;H01M8/0239;;H01M8/1007;;H01M8/1007;;Y02E60/50;;Y02E60/50;;Y02P70/50;;Y02P70/50,H01M8/02;;H01M8/24,,0,0,,,,INACTIVE
152,DE,A1,DE 102007012718 A1,127-002-775-545-802,2007-10-25,2007,DE 102007012718 A,2007-03-16,US 38470606 A,2006-03-20,Acrylfasergebundenes Kohlefaserpapier als Gasdiffusionsmedium für eine Brennstoffzelle,"Es ist ein Gasdiffusionsmedium für eine Brennstoffzelle, wie eine Protonenaustauschmembran-Brennstoffzelle vorgesehen. Das Gasdiffusionsmedium umfasst karbonisierbare Acrylpulpefasern anstelle eines herkömmlichen Phenolharzes als ein Bindermaterial. Die Acrylfasern werden mit der Kohlefaserdispersion während des Papierherstellschrittes gemischt, wodurch der Phenolharzimpränierungsschritt, der den herkömmlichen Prozessen zum Herstellen von Gasdiffusionsmedien typischerweise zugeordnet ist, beseitigt wird. Die Matte wird dann gehärtet und karbonisiert, um ein Gasdiffusionsmedium herzustellen.",GM GLOBAL TECH OPERATIONS INC;;SPECTRACORP,JI CHUNXIN;;FLEMING GERALD J;;MATHIAS MARK,"GM GLOBAL TECHNOLOGY OPERATIONS LLC (N. D. GES, US (2011-03-21);;SPECTRACORP, SHELTON, CONN., US (2011-05-26);;GM GLOBAL TECHNOLOGY OPERATIONS LLC , ( N. D. , US (2011-05-26);;SPECTRACORP, SHELTON, US (2011-03-21)",https://lens.org/127-002-775-545-802,Patent Application,no,0,1,8,8,0,D21H13/50;;D21H13/50;;D21H13/18;;D21H13/18;;D21H17/36;;D21H17/36;;H01M8/0234;;H01M8/0234;;H01M8/0239;;H01M8/0239;;Y02E60/50;;Y02P70/50;;Y02P70/50;;Y10T428/30;;Y10T428/30,H01M8/02,,0,0,,,,INACTIVE
153,US,B1,US 9913429 B1,158-391-209-782-287,2018-03-13,2018,US 201615353500 A,2016-11-16,US 201615353500 A;;US 201514697375 A,2015-04-27,Tagging of fruit-producing flowers for robotic selective harvesting,"The locations of flowers on a plant, rather than the locations of agricultural products produced from such flowers, are used to facilitate the performance of harvesting and other agricultural operations in robotic agricultural applications. In some implementations, the identified location of a fruit-producing flower may be used by a robotic device to apply an indicator tag to a flowering plant proximate the flower for later identification when performing various types of directed and automated agricultural operations. In other implementations, the identified location of a fruit-producing flower may be used by a robotic device to anchor a stem of a flowering plant to a predetermined location such that the location of the flower, and of any fruit(s) later produced by such flower, are controlled and/or known when performing subsequent agricultural operations.",X DEV LLC,STUBBS MARK ADRIAN;;MCCLOSKEY KEVIN JAMES FLEMING,X DEVELOPMENT LLC (2016-09-01);;MINERAL EARTH SCIENCES LLC (2022-12-19);;GOOGLE INC (2015-04-24),https://lens.org/158-391-209-782-287,Granted Patent,yes,47,14,3,3,0,A01B79/005;;B25J19/021;;A01D46/30;;Y10S901/01;;Y10S901/31;;Y10S901/47;;B25J5/007;;A01G22/05;;G06V20/10;;G06V20/68;;A01G9/006;;G05B19/0425;;A01D46/30;;Y10S901/01;;Y10S901/31;;Y10S901/47;;A01B79/005;;B25J19/021;;A01G22/05;;G06V20/10;;G06V20/68;;G06T7/70;;A01D91/04;;B25J5/007;;B25J9/1697;;H04N7/183,B25J5/00;;A01D46/30;;A01D91/04;;B25J9/16;;G06K9/20;;G06K9/78;;G06T7/70;;H04N7/18,,5,2,114-618-344-853-583;;077-384-487-435-451,10.1007/s11370-010-0075-2;;10.1504/ijcvr.2012.046419,"Intelligent sensing and manipulation for sustainable production and harvesting of high value crops, http://www.crops-robots.eu/; Webpage accessed Apr. 29, 2015; 1 page.;;Cherry Harvester, https://www.youtube.com/watch?v=UX—t1hkqTVQ; Webpage accessed Apr. 29, 2015; 2 pages.;;Tomato harvesting machine in action, http://www.youtube.com/watch?v=R3EpFTyN26E; Webpage accessed Apr. 29, 2015; 2 pages.;;McCarthy, et al. “Applied machine vision of plants—a review with implications for field deployment in automated farming operations.” Intelligent Service Robotics 3.4 (2010): 209-217.;;Kapach, Keren, et al. “Computer vision for fruit harvesting robots-state of the art and challenges ahead.” International Journal of Computational Vision and Robotics 3.1 (2012): 4-34.",ACTIVE
154,US,B1,US 9532508 B1,178-405-661-910-660,2017-01-03,2017,US 201514697375 A,2015-04-27,US 201514697375 A,2015-04-27,Tagging of fruit-producing flowers for robotic selective harvesting,"The locations of flowers on a plant, rather than the locations of agricultural products produced from such flowers, are used to facilitate the performance of harvesting and other agricultural operations in robotic agricultural applications. In some implementations, the identified location of a fruit-producing flower may be used by a robotic device to apply an indicator tag to a flowering plant proximate the flower for later identification when performing various types of directed and automated agricultural operations. In other implementations, the identified location of a fruit-producing flower may be used by a robotic device to anchor a stem of a flowering plant to a predetermined location such that the location of the flower, and of any fruit(s) later produced by such flower, are controlled and/or known when performing subsequent agricultural operations.",X DEV LLC,STUBBS MARK ADRIAN;;MCCLOSKEY KEVIN JAMES FLEMING,X DEVELOPMENT LLC (2016-09-01);;MINERAL EARTH SCIENCES LLC (2022-12-19);;GOOGLE INC (2015-04-24),https://lens.org/178-405-661-910-660,Granted Patent,yes,39,30,3,3,0,A01B79/005;;B25J19/021;;A01D46/30;;Y10S901/01;;Y10S901/31;;Y10S901/47;;B25J5/007;;A01G22/05;;G06V20/10;;G06V20/68;;A01G9/006;;G05B19/0425;;A01D46/30;;Y10S901/01;;Y10S901/31;;Y10S901/47;;A01B79/005;;B25J19/021;;A01G22/05;;G06V20/10;;G06V20/68;;G06T7/70;;A01D91/04;;B25J5/007;;B25J9/1697;;H04N7/183,A01G17/00;;A01C21/00;;A01D46/30;;A01G1/00;;A01G7/00;;G05B19/042;;G06K9/20;;G06K9/78;;G06T7/00,,5,2,114-618-344-853-583;;077-384-487-435-451,10.1007/s11370-010-0075-2;;10.1504/ijcvr.2012.046419,"Intelligent sensing and manipulation for sustainable production and harvesting of high value crops, http://www.crops-robots.eu/; Webpage accessed Apr. 29, 2015; 1 page.;;Cherry Harvester, https://www.youtube.com/watch?v=UX-t1hkqTVQ; Webpage accessed Apr. 29, 2015; 2 pages.;;Tomato harvesting machine in action, http://www.youtube.com/watch?v=R3EpFTyN26E; Webpage accessed Apr. 29, 2015; 3 pages.;;McCarthy, et al. ""Applied machine vision of plants-a review with implications for field deployment in automated farming operations."" Intelligent Service Robotics 3.4 (2010): 209-217.;;Kapach, Keren, et al. ""Computer vision for fruit harvesting robots-state of the art and challenges ahead."" International Journal of Computational Vision and Robotics 3.1 (2012): 4-34.",ACTIVE
155,DE,B4,DE 102007012718 B4,197-497-161-304-883,2013-10-17,2013,DE 102007012718 A,2007-03-16,US 38470606 A,2006-03-20,Herstellung eines acrylfasergebundenen Kohlefaserpapiers als Gasdiffusionsmedium für eine Brennstoffzelle,"Verfahren zum Ausbilden einer Gasdiffusionsschicht zur Verwendung in Brennstoffzellen, umfassend, dass: eine Vielzahl von Kohlefasern bereitgestellt wird; eine Vielzahl von Acrylpulpefasern bereitgestellt wird; die Acrylpulpefasern und die Kohlefasern kombiniert werden, um eine Matte zu bilden; und die Acrylfasern nach dem Bilden der Matte gehärtet und karbonisiert werden, wobei die Kohlefasern in einem Bereich von 25 bis 50 Gewichtsprozent auf Grundlage des Gesamtgewichts der Matte vor dem Härten und Karbonisieren vorhanden sind.",GM GLOBAL TECH OPERATIONS INC;;SPECTRACORP,JI CHUNXIN;;FLEMING GERALD J;;MATHIAS MARK,"GM GLOBAL TECHNOLOGY OPERATIONS LLC (N. D. GES, US (2011-03-21);;SPECTRACORP, SHELTON, CONN., US (2011-05-26);;GM GLOBAL TECHNOLOGY OPERATIONS LLC , ( N. D. , US (2011-05-26);;SPECTRACORP, SHELTON, US (2011-03-21)",https://lens.org/197-497-161-304-883,Granted Patent,no,3,1,8,8,0,D21H13/50;;D21H13/50;;D21H13/18;;D21H13/18;;D21H17/36;;D21H17/36;;H01M8/0234;;H01M8/0234;;H01M8/0239;;H01M8/0239;;Y02E60/50;;Y02P70/50;;Y02P70/50;;Y10T428/30;;Y10T428/30,H01M8/02,,0,0,,,,INACTIVE
156,DE,B4,DE 102007012495 B4,113-126-735-155-232,2020-07-16,2020,DE 102007012495 A,2007-03-15,US 37822406 A,2006-03-17,VERFAHREN ZUM HERSTELLEN EINES DIFFUSIONSMEDIUMS,"Verfahren zum Herstellen eines Diffusionsmediums (34, 36, 38, 40), umfassend, dass:eine wässrige Dispersion, die ein Pulverharz, ein Bindermaterial und ein Fasermaterial umfasst, das Kohlefasern, Graphitfasern und Kombinationen daraus umfasst, hergestellt wird (110),eine Schicht der Dispersion auf einem Träger ausgebildet wird (120),Wasser von der Schicht entfernt wird, um eine Faserschicht zu bilden,die Faserschicht geformt wird, unddie geformte Schicht karbonisiert oder graphitisiert wird (140), wobei das Bindermaterial vollständig weggebrannt wird.",GM GLOBAL TECH OPERATIONS LLC;;SPECTRACORP,JI CHUNXIN;;FLEMING GERALD J;;MATHIAS MARK,"GM GLOBAL TECHNOLOGY OPERATIONS LLC (N. D. GES, US (2011-03-21);;SPECTRACORP, SHELTON, CONN., US (2011-05-26);;GM GLOBAL TECHNOLOGY OPERATIONS LLC , ( N. D. , US (2011-05-26);;SPECTRACORP, SHELTON, US (2011-03-21)",https://lens.org/113-126-735-155-232,Granted Patent,no,6,0,8,8,0,H01M8/0243;;H01M8/0243;;H01M8/0234;;H01M8/0234;;H01M8/0239;;H01M8/0239;;H01M8/1007;;H01M8/1007;;Y02E60/50;;Y02E60/50;;Y02P70/50;;Y02P70/50,H01M8/02,,0,0,,,,INACTIVE
157,US,B1,US 10602664 B1,070-688-903-671-938,2020-03-31,2020,US 201815885978 A,2018-02-01,US 201815885978 A;;US 201615353500 A;;US 201514697375 A,2015-04-27,Tagging of fruit-producing flowers for robotic selective harvesting,"The locations of flowers on a plant, rather than the locations of agricultural products produced from such flowers, are used to facilitate the performance of harvesting and other agricultural operations in robotic agricultural applications. In some implementations, the identified location of a fruit-producing flower may be used by a robotic device to apply an indicator tag to a flowering plant proximate the flower for later identification when performing various types of directed and automated agricultural operations. In other implementations, the identified location of a fruit-producing flower may be used by a robotic device to anchor a stem of a flowering plant to a predetermined location such that the location of the flower, and of any fruit(s) later produced by such flower, are controlled and/or known when performing subsequent agricultural operations.",X DEV LLC,STUBBS MARK ADRIAN;;MCCLOSKEY KEVIN JAMES FLEMING,X DEVELOPMENT LLC (2016-09-01);;MINERAL EARTH SCIENCES LLC (2022-12-19);;GOOGLE INC (2015-04-24),https://lens.org/070-688-903-671-938,Granted Patent,yes,51,2,3,3,0,A01B79/005;;B25J19/021;;A01D46/30;;Y10S901/01;;Y10S901/31;;Y10S901/47;;B25J5/007;;A01G22/05;;G06V20/10;;G06V20/68;;A01G9/006;;G05B19/0425;;A01D46/30;;Y10S901/01;;Y10S901/31;;Y10S901/47;;A01B79/005;;B25J19/021;;A01G22/05;;G06V20/10;;G06V20/68;;G06T7/70;;A01D91/04;;B25J5/007;;B25J9/1697;;H04N7/183,A01D46/00;;A01D46/30;;A01D91/04;;A01G22/00;;A01G22/05;;B25J5/00;;B25J9/16;;G06K9/20;;G06K9/78;;G06T7/70;;H04N7/18,,5,2,114-618-344-853-583;;077-384-487-435-451,10.1007/s11370-010-0075-2;;10.1504/ijcvr.2012.046419,"Intelligent sensing and manipulation for sustainable production and harvesting of high value crops, http://www.crops-robots.eu/; Webpage accessed Apr. 29, 2015; 1 page.;;Cherry Harvester, https://www.youtube.com/watch?v=UX_t1hkqTVQ; Webpage accessed Apr. 29, 2015; 2 pages.;;Tomato harvesting machine in action, http://www.youtube.com/watch?v=R3EpFTyN26E; Webpage accessed Apr. 29, 2015; 2 pages.;;McCarthy, et al. “Applied machine vision of plants—a review with implications for field deployment in automated farming operations.” Intelligent Service Robotics 3.4 (2010): 209-217.;;Kapach, Keren, et al. “Computer vision for fruit harvesting robots—state of the art and challenges ahead.” International Journal of Computational Vision and Robotics 3.1 (2012): 4-34.",ACTIVE
158,CN,A,CN 101602284 A,104-618-054-270-045,2009-12-16,2009,CN 200910139982 A,2006-01-05,US 2956205 A,2005-01-05,Viscosity control and colorant circulation for printing lens molds,"The invention discloses a method of using colorant circulation in printing system, includes providing a colorant cup that is adjacent to a platter, the cut contains colorant; controlling viscosity of the colorant in the colorant container; transfering the colorant from the colorant container to the cup; and transfering colorant remained in the cup to the container at a speed higher than the speed of transfering colorant from the colorant container to the cup. The disclosed methods are useful in the preparation of tinted contact lenses.",JOHNSON & JOHNSON VISION CARE,MARK POWELL PAUL;;AIDAN FLEMING;;JOSEPH RYAN,,https://lens.org/104-618-054-270-045,Patent Application,no,0,0,15,18,0,B29D11/00903;;B41F17/001;;B29D11/00903;;B29D11/00951;;B29D11/00951;;B41F17/001;;B41F31/005;;B41F31/005;;G01N11/00;;G01N11/00,B41F31/00;;B67D7/06;;B41F17/00;;B67D7/08;;B67D7/78;;G01N11/00,,0,0,,,,DISCONTINUED
159,CA,A1,CA 3191619 A1,131-447-734-412-460,2023-09-03,2023,CA 3191619 A,2023-03-02,US 202263316176 P,2022-03-03,COMPOSITION AND METHODS FOR PROCESSING HEAVY OIL FEEDSTOCKS,"Implementations of the present disclosure relate to catalytic compositions useful in hydroprocessing heavy oil feedstocks. The catalytic compositions may be used in methods and systems to facilitate hydroconversion of the heavy oil feedstocks. The catalytic compositions can comprise a combination of a first metal being a transition metal, a second metal and a non-metal, wherein the second metal is a Group 11 transition metal, a Group 12 transition metal, a Group 13 metal or a combination thereof, and wherein the first metal and the second metal are different.",SUNCOR ENERGY INC,PUGSLEY TODD;;FLEMING MARK;;SMITH KEVIN J,,https://lens.org/131-447-734-412-460,Patent Application,no,0,0,1,1,0,,B01J23/80;;B01J23/755;;C10G11/02;;C10G11/06,,0,0,,,,PENDING
160,US,B2,US 9023556 B2,000-295-528-596-908,2015-05-05,2015,US 37822406 A,2006-03-17,US 37822406 A,2006-03-17,Method of preparing gas diffusion media for a fuel cell,"Diffusion media for fuel cell is made by preparing an aqueous dispersion comprising a powder resin, a binder material, and a fiber material comprising carbon fibers, of these; forming a layer of the dispersion on a support; removing water from the layer to form a fiber layer; molding the fiber layer; and carbonizing or graphitizing the molded layer.",JI CHUNXIN;;MATHIAS MARK;;FLEMING MARGARET;;GM GLOBAL TECH OPERATIONS INC,JI CHUNXIN;;FLEMING GERALD J;;MATHIAS MARK,GM GLOBAL TECHNOLOGY OPERATIONS LLC (2006-02-28);;SPECTRACORP (2006-02-28),https://lens.org/000-295-528-596-908,Granted Patent,yes,15,0,8,8,0,H01M8/0243;;H01M8/0243;;H01M8/0234;;H01M8/0234;;H01M8/0239;;H01M8/0239;;H01M8/1007;;H01M8/1007;;Y02E60/50;;Y02E60/50;;Y02P70/50;;Y02P70/50,H01M8/00;;H01M8/02;;H01M8/10,429/535;;429/465;;429/483,1,0,,,"Mark Mathias et al., ""Chapter 46, Diffusion media materials and characterisation"", John Wiley & Sons, Ltd., 2003, pp. 1-21.",INACTIVE
161,JP,A,JP 2007273464 A,063-199-267-687-291,2007-10-18,2007,JP 2007068234 A,2007-03-16,US 37822406 A,2006-03-17,GAS DIFFUSION MEDIUM AND FUEL CELL,"<P>PROBLEM TO BE SOLVED: To provide the manufacturing method of a fuel cell gas diffusion medium omitting a resin impregnation process of a fiber mat; the diffusion medium manufactured by this method; and the manufacturing method of the fuel cell gas diffusion medium equipped with the diffusion medium. <P>SOLUTION: The diffusion medium for a fuel cell is made by preparing an aqueous dispersion comprising resin powder, a binder material, and carbon fibers, forming a layer of the dispersion on a support, removing water from the layer to form a fiber layer; molding the fiber layer; and carbonizing or graphitizing the molded layer. <P>COPYRIGHT: (C)2008,JPO&INPIT",GM GLOBAL TECH OPERATIONS INC;;SPECTRACORP,JI CHUNXIN;;FLEMING GERALD J;;MATHIAS MARK,,https://lens.org/063-199-267-687-291,Patent Application,no,4,1,8,8,0,H01M8/0243;;H01M8/0243;;H01M8/0234;;H01M8/0234;;H01M8/0239;;H01M8/0239;;H01M8/1007;;H01M8/1007;;Y02E60/50;;Y02E60/50;;Y02P70/50;;Y02P70/50,H01M4/88;;H01M4/96;;H01M8/10,,0,0,,,,PENDING
162,JP,A,JP 2007273466 A,000-281-585-042-285,2007-10-18,2007,JP 2007071896 A,2007-03-20,US 38470606 A,2006-03-20,ACRYLIC FIBER BONDING CARBON FIBER PAPER AS GAS DIFFUSION MEDIUM FOR FUEL CELL,"<P>PROBLEM TO BE SOLVED: To provide a new, improved gas diffusion medium for a fuel cell such as a proton exchange membrane type fuel cell. <P>SOLUTION: The gas diffusion medium contains carbonizable acrylic pulp fibers in place of conventional phenol resin as a binder material, and the acrylic fibers are mixed with carbon fiber dispersion in a paper making process. A mat is cured and carbonized to manufacture the gas diffusion medium. A phenol resin impregnation process usually accompanied by a customary gas diffusion medium manufacturing process can be omitted. <P>COPYRIGHT: (C)2008,JPO&INPIT",GM GLOBAL TECH OPERATIONS INC;;SPECTRACORP,JI CHUNXIN;;FLEMING GERALD J;;MATHIAS MARK,,https://lens.org/000-281-585-042-285,Patent Application,no,6,31,8,8,0,D21H13/50;;D21H13/50;;D21H13/18;;D21H13/18;;D21H17/36;;D21H17/36;;H01M8/0234;;H01M8/0234;;H01M8/0239;;H01M8/0239;;Y02E60/50;;Y02P70/50;;Y02P70/50;;Y10T428/30;;Y10T428/30,H01M4/88;;H01M4/96;;H01M8/10,,0,0,,,,INACTIVE
163,CN,A,CN 113613420 A,011-574-875-694-140,2021-11-05,2021,CN 202110499639 A,2021-05-06,US 202063019571 P;;US 202117243852 A,2020-05-04,DATA CENTER CABINET AND TOP CAPS FOR A DATA CENTER CABINET,"A data center cabinet has a base frame and a top cap attached to the base frame. The top cap has a main panel having a front edge, rear edge, first side edge, a second side edge, top surface, and bottom surface. An opening is formed through the main panel and is inset and spaced apart from the front, rear, first side, and second side edges. A removable door is positioned over the opening and is hinged to the main panel such that the door can rotate between an open position and a closed position and be removed from the main panel.",PANDUIT CORP,MARCUS RICHARD A;;FLEMING JAMES N;;SHURHAY MARK,,https://lens.org/011-574-875-694-140,Patent Application,no,0,0,4,4,0,H05K5/0217;;H05K5/03;;H05K7/1488;;E05C1/04;;E05D7/123;;E05Y2900/606;;H05K5/0221;;H05K7/1488,H05K5/02;;H05K5/03,,0,0,,,,PENDING
164,MX,A,MX 2009007402 A,042-686-062-762-32X,2009-10-28,2009,MX 2009007402 A,2008-01-15,US 65575707 A;;US 2008/0051082 W,2007-01-19,OVERHEAD CABLE TERMINATON ARRANGEMENT.,A system including an overhead cable pathway structure and an adapter panel or cable termination device that mounts overhead to the cable pathway structure. The cable termination device including a plurality of adapters and a cable pathway exit having a curved surface that guides cables exiting from the overhead cable pathway structure to the adapters.,ADC TELECOMMUNICATIONS INC,SMRHA MARK;;COBURN HUTCH;;FLEMING CRAIG;;SJODIN CHAD,,https://lens.org/042-686-062-762-32X,Patent Application,no,0,0,23,23,0,G02B6/4459;;G02B6/4459;;H02G3/0608;;H02G3/0608;;Y10T29/49826;;Y10T29/49826,H02G3/22,,0,0,,,,ACTIVE
165,US,B2,US 10169563 B2,172-821-191-823-38X,2019-01-01,2019,US 201715418203 A,2017-01-27,US 201715418203 A,2017-01-27,Encryption authorization dongle having volatile memory,"Embodiments of the present invention disclose a method, computer program product, and device for accessing encrypted data. A communication link may be established between an authorization dongle and a secure device having encrypted data stored thereon. A communication link may also be established between the authorization dongle and a secure server. An encryption key associated with the encrypted data may be received from the secure server. The encryption key may be stored in volatile memory on the authorization dongle. An indication that a user is attempting to access the encrypted data may be received. The encryption key may be transmitted from the authorization dongle to the secure device in response to the user attempting to access the encrypted data.",IBM,BIESECKER TIMOTHY;;DICKENS LOUIE A;;FLEMING MARK S,INTERNATIONAL BUSINESS MACHINES CORPORATION (2017-01-19),https://lens.org/172-821-191-823-38X,Granted Patent,yes,16,0,4,4,0,G06F21/602;;G06F21/34;;G06F21/602;;G06F21/575,G06F21/34;;G06F21/57;;G06F21/60,,7,0,,,"Anonymous, “USB Encryption Adapter,” An IP.com Prior Art Database Technical Disclosure, IP.com No. IPCOM000237994D, IP.com Electronic Publication Date: Jul. 24, 2014, 5 pgs.;;Keylock, “In the fight against piracy . . . choose your weapon wisely,” https://www.keylok.com/products, printed Nov. 3, 2016, 1 pg.;;Ragan, S. “USB ‘Ciphering Dongle’ Offers Instant Full Disk Encryption for USB Drives,” http://www.securityweek.com/usb-ciphering-dongle-offers-instant-full-disk-encryption-usb-drives, printed Nov. 3, 2016, 7 pgs.;;Unknown, “GoSafe: File Encryption using USB Dongle,” http://softwarefileprotection.com/gosafe-file-encryption, printed Nov. 3, 2016, 8 pgs.;;Unknown, “USB/IP Project,” http://usbip.sourceforge.net/, printed Nov. 3, 2016, 5 pgs.;;Biesecker et al., “Encryption Authorization Dongle Having Volatile Memory,” U.S. Appl. No. 15/694,188, filed Sep. 1, 2017.;;List of IBM Patents or Patent Applications Treated as Related, signed Sep. 1, 2017, 2 pages.",INACTIVE
166,US,B2,US 8099524 B2,183-941-265-436-362,2012-01-17,2012,US 24375408 A,2008-10-01,US 24375408 A,2008-10-01,Automated method to configure a data storage system,"An automated, computer-implemented method to configure a data storage system comprising a host computer, a storage controller in communication with said host computer, and a plurality of data storage media in communication with said storage controller, wherein the method provides a configuration algorithm encoded as computer readable program code, and executes that computer readable program code. The configuration algorithm creates a command procedure comprising a plurality of physical configuration commands to establish a physical configuration for the data storage system. The configuration algorithm further creates a command procedure comprising a plurality of logical configuration commands to establish a logical configuration for the data storage system.",FLEMING MARK SEAN;;MARTINEZ LISA R;;NGUYEN LU;;IBM,FLEMING MARK SEAN;;MARTINEZ LISA R;;NGUYEN LU,INTERNATIONAL BUSINESS MACHINES CORPORATION (2008-09-18),https://lens.org/183-941-265-436-362,Granted Patent,yes,9,0,2,2,0,G06F3/0605;;G06F3/0631;;G06F3/0689;;G06F3/0605;;G06F3/0689;;G06F3/0631,G06F9/00;;G06F3/00,710/8;;713/1;;713/2;;719/325;;719/326;;719/327,0,0,,,,INACTIVE
167,GB,A,GB 2607712 A,096-060-158-421-401,2022-12-14,2022,GB 202205924 A,2020-05-05,GB 202205924 A;;GB 202006661 A,2020-05-05,Safety helmet with modular enhancements,"A safety helmet 100 for an industrial worker, comprising a protective shell 104, a plurality of receiving portions 132 preferably within a rim 118, and at least two modular units 134 removably mounted in the receiving portions, wherein a first modular unit 134a comprises a power source 138 configured to power the receiving portions, and wherein a second modular unit 134b comprises an input device, such as a camara 146, a switch, a microphone and/or a sensor, an output device, such as a light-emitting device 144, a sound-emitting device and/or a haptic feedback device, and a communication module 148 configured to provide two-way remote communication with a central controller (250, fig.9). The input and/or output device may be controlled based on signals from the central controller and/or signals from the other modules. Alerts may be generated based on environmental and/or locational hazards, impacts, and/or improper wearing of the helmet. The power source may be wirelessly rechargeable. The protective shell may diffuse light emitted from elements, such as LEDs (108, fig.1), underneath.",GLO SAFE LTD,CHARLES KENWARD;;CHYNA KENWARD;;MARK LITTLE;;ALEX FLEMING,,https://lens.org/096-060-158-421-401,Patent Application,no,6,0,2,10,0,A42B3/04;;A42B3/04;;A42B3/042;;A42B3/0433;;A42B3/044;;A42B3/0446;;A42B3/0453;;A42B3/046;;A42B3/0466;;A42B3/30,A42B3/30;;A42B3/04,,0,0,,,,PENDING
168,WO,A1,WO 2018/115461 A1,129-002-135-683-679,2018-06-28,2018,EP 2017084424 W,2017-12-22,EP 16206492 A,2016-12-22,A DRESSING SYSTEM,"The invention provides a dressing system for a wound comprising an absorbent pad; at least one sensor for detecting wound or dressing data, wherein the at least one sensor is a moisture sensor; a flexible electronic circuit communicable with the sensor; a backing film adapted to cooperate with the absorbent pad, wherein the electronic circuit and the at least one sensor is printed directly on the backing film; and a communications module adapted to communicate the wound data from the electronic circuit to a user or clinician. The invention provides a simple to use disposable dressing wound system that is effective in providing dressing wound data that provides an indicator of the status of the wound as well as information that the dressing wound system needs to be replaced.",FLEMING MEDICAL LTD;;UNIV COLLEGE CORK NATIONAL UNIV OF IRELAND CORK,O'MAHONY CONOR;;O'FLYNN BRENDAN;;GALVIN PAUL;;FLEMING MARK,,https://lens.org/129-002-135-683-679,Patent Application,yes,5,62,3,3,0,A61F13/00051;;A61B2562/0214;;A61F13/00055;;A61B5/6833;;A61B5/01;;A61B5/445;;A61B5/7275;;A61B2562/0247;;A61B2562/029;;G16H40/63;;G16H40/63;;A61B5/01;;A61B5/445;;A61B5/6833;;A61B2562/0214;;A61B2562/0247;;A61B2562/029;;A61F13/00055;;A61F13/00085;;A61B5/7275;;A61B5/0002;;A61B5/14539;;A61B2562/166;;A61B5/0024;;A61B5/4875,A61F13/00;;A61B5/145,,0,0,,,,PENDING
169,US,B2,US 7899299 B2,138-194-526-204-394,2011-03-01,2011,US 29133208 A,2008-11-07,US 29133208 A;;US 65575707 A,2007-01-19,Overhead cable termination arrangement,A system including an overhead cable pathway structure and an adapter panel or cable termination device that mounts overhead to the cable pathway structure. The cable termination device including a plurality of adapters and a cable pathway exit having a curved surface that guides cables exiting from the overhead cable pathway structure to the adapters.,ADC TELECOMMUNICATIONS INC,COBURN HUTCH;;SMRHA MARK;;SJODIN CHAD;;FLEMING CRAIG,COMMSCOPE EMEA LIMITED (2015-08-28);;COMMSCOPE TECHNOLOGIES LLC (2015-08-28);;TYCO ELECTRONICS SERVICES GMBH (2011-09-30),https://lens.org/138-194-526-204-394,Granted Patent,yes,28,7,23,23,0,G02B6/4459;;G02B6/4459;;H02G3/0608;;H02G3/0608;;Y10T29/49826;;Y10T29/49826,G02B6/00,385/137;;385/136,0,0,,,,ACTIVE
170,EP,A2,EP 1846040 A2,054-544-979-774-156,2007-10-24,2007,EP 06734023 A,2006-01-27,US 2006/0003129 W;;US 64817205 P;;US 4660805 A;;US 12894705 A,2005-01-28,NON-IONIC NON-AQUEOUS VEHICLES FOR TOPICAL AND ORAL ADMINISTRATION OF CARRIER-COMPLEXED ACTIVE AGENTS,,COLLEGIUM PHARMACEUTICAL INC,HIRSH JANE;;RARIY ROMAN V;;TRUMBORE MARK;;FLEMING ALISON;;HIRSH MARK,,https://lens.org/054-544-979-774-156,Patent Application,yes,0,0,5,7,0,A61K31/4402;;A61K31/4402;;A61K9/006;;A61K9/006;;A61K9/5026;;A61K9/5026;;A61K31/137;;A61K31/137;;A61K47/585;;A61K47/585,A61K47/48,,1,0,,,See references of WO 2006081518A3,DISCONTINUED
171,CA,A,CA 1207630 A,008-816-996-502-265,1986-07-15,1986,CA 468196 A,1984-11-20,US 56429183 A,1983-12-22,CONTINUOUS PROCESS FOR NEUTRALIZATION OF ALUMINATE SOLUTION TO FORM GELS AND APPARATUS THEREFOR,"Alumina gel is produced on a continuous basis in a stirred reactor into which is bubbled carbon dioxide to neutralize an aluminate solution feeding into the reactor. Careful control of the process parameters, including pH, residence time, temperature and gas flow rate, as well as the geometry of the reactor and other apparatus parameters, can result in the formation of preselected types of gel. When pseudoboehmite is formed in accordance with the invention, alumina gels can be formed with surface areas as high as 300 to 700 square meters per gram.",ALUMINUM CO OF AMERICA,PEARSON ALAN;;FLEMING HUBERT L;;LARROUSSE MARK F,,https://lens.org/008-816-996-502-265,Granted Patent,no,0,0,5,5,0,B01J10/002;;B01J19/0066;;B01J19/0086;;B01J2219/00063;;B01J2219/0009;;B01J2219/00094;;B01J2219/00126;;B01J2219/00164;;B01J2219/00166;;B01J2219/00177;;C01F7/141;;C01F7/142;;C01P2002/60;;C01P2006/12,B01J10/00;;B01J19/00;;C01F7/141;;C01F7/142,134-51,0,0,,,,EXPIRED
172,US,A,US 4752547 A,078-452-520-225-279,1988-06-21,1988,US 87057286 A,1986-06-04,US 87057286 A,1986-06-04,Dye-forming electrothermographic material and process,"A dye-forming electrothermographic element comprises an electrically activatable recording layer comprising (a) a reducing agent or reducing agent precursor capable of being activated by a Lewis base; (b) a cobalt(III) Lewis base complex; and (c) at least one of (i) a reducible dye-forming compound that has an oxidation state above that of the conjugate dye, (ii) a dye capable of changing its wavelength of absorption by reaction with a Lewis base, and (iii) a dye-forming coupler capable of reacting with the oxidized form of the reducing agent in (a) to form a dye. A negative or positive dye image is formed in such a dye-forming electrothermographic element by applying an electrical potential imagewise to the element of a magnitude and for a time sufficient to produce in the image areas a charge density sufficient to produce a latent image; and, then, heating the element to a temperature and for a time sufficient to form a dye image in the element. The dye-forming electrothermographic element can be a multicolor, multilayer electrothermographic element.",EASTMAN KODAK CO,COWEN STANLEY W;;FLEMING JAMES C;;LELENTAL MARK,EASTMAN KODAK COMPANY A NEW JERSEY CORP (1986-05-29),https://lens.org/078-452-520-225-279,Granted Patent,yes,8,2,2,2,0,G03G5/00;;G03G5/00;;G03C1/67;;G03C1/67;;G03C7/46;;G03C7/46,B41M5/323;;B41M5/20;;G03C1/67;;G03C7/46;;G03G5/00,430/42;;430/45;;430/351;;430/353;;430/502;;430/618;;430/619,2,0,,,"Research Disclosure, Dec. 1978, Item No. 17643.;;Research Disclosure, Jul. 1986, Item No. 14719.",EXPIRED
173,CA,A1,CA 3047142 A1,182-370-826-301-423,2018-07-19,2018,CA 3047142 A,2018-01-08,US 201762445429 P;;US 2018/0012730 W,2017-01-12,INSECTICIDAL PROTEINS,"Compositions and methods for controlling plant pests are disclosed. In particular, novel insecticidal proteins having toxicity against Coleopteran and/or Lepidopteran insect pests are provided. Nucleic acid molecules encoding the novel insecticidal proteins are also provided. Methods of making the insecticidal proteins and methods of using the insecticidal proteins and nucleic acids encoding the insecticidal proteins of the invention, for example in transgenic plants to confer protection from insect damage, are also disclosed.",SYNGENTA PARTICIPATIONS AG,REYNOLDS CLARENCE MICHAEL;;FLEMING CHRISTOPHER;;MONTGOMERY MARK GREER,,https://lens.org/182-370-826-301-423,Patent Application,no,0,0,20,20,100,C07K14/195;;C12N15/8286;;A01N37/46;;Y02A40/146;;C12N15/82;;C12N15/113;;A01H5/00;;A01H6/4684;;C12N15/8286;;C07K14/195;;Y02A40/146,C12N15/31;;A01H1/00;;A01H5/00;;A01P7/04;;C07K14/195;;C12N1/21;;C12N5/10;;C12N15/63;;C12N15/82;;C12P21/02,,0,0,,,,PENDING
174,CL,A1,CL 2019001898 A1,082-673-989-944-688,2019-10-04,2019,CL 2019001898 A,2019-07-08,US 201762445429 P,2017-01-12,Proteinas para insecticidas.,"SE DIVULGAN COMPOSICIONES Y MÉTODOS PARA CONTROLAR PLAGAS DE PLANTAS. EN PARTICULAR, SE PROPORCIONAN PROTEÍNAS INSECTICIDAS NOVEDOSAS QUE TIENEN TOXICIDAD CONTRA PLAGAS DE INSECTOS COLEÓPTEROS Y/O LEPIDÓPTEROS. TAMBIÉN SE PROPORCIONAN MOLÉCULAS DE ÁCIDO NUCLEICO QUE CODIFICAN LAS PROTEÍNAS INSECTICIDAS NOVEDOSAS. TAMBIÉN SE DIVULGAN MÉTODOS DE PREPARACIÓN DE LAS PROTEÍNAS INSECTICIDAS Y MÉTODOS DE UTILIZACIÓN DE LAS PROTEÍNAS INSECTICIDAS Y ÁCIDOS NUCLEICOS QUE CODIFICAN LAS PROTEÍNAS INSECTICIDAS DE LA INVENCIÓN, POR EJEMPLO, EN PLANTAS TRANSGÉNICAS PARA CONFERIR PROTECCIÓN CONTRA EL DAÑO DEBIDO A INSECTOS.",SYNGENTA PARTICIPATIONS AG,REYNOLDS CLARENCE MICHAEL;;FLEMING CHRISTOPHER;;MONTGOMERY MARK GREER,,https://lens.org/082-673-989-944-688,Patent Application,no,0,0,20,20,0,C07K14/195;;C12N15/8286;;A01N37/46;;Y02A40/146;;C12N15/82;;C12N15/113;;A01H5/00;;A01H6/4684;;C12N15/8286;;C07K14/195;;Y02A40/146,A01N37/18;;A01P7/04;;C12N1/21;;C12N15/31;;C12N15/63;;C12N15/82,,0,0,,,,PENDING
175,US,A1,US 2012/0110385 A1,097-634-523-488-88X,2012-05-03,2012,US 91636610 A,2010-10-29,US 91636610 A,2010-10-29,MULTIPLE FUNCTIONALITY IN A VIRTUAL STORAGE AREA NETWORK DEVICE,"In one aspect of the present description, a connection between a predetermined input port and a predetermined output port is created in a partition of a VSAN switch, in which the connection is a destination address independent physical layer connection conforming to the physical layer of a communication protocol. Another connection between a plurality of input ports and a plurality of output ports may be created in another partition of the VSAN switch, in which the connection is a multi-layer connection which includes a network layer connection conforming to the network layer of the communication protocol. Other features and aspects may be realized, depending upon the particular application.",FLEMING MARK SEAN;;KALLURI HEMANTH;;LARSON JEFFRY LYNN;;IBM,FLEMING MARK SEAN;;KALLURI HEMANTH;;LARSON JEFFRY LYNN,INTERNATIONAL BUSINESS MACHINES CORPORATION (2010-10-25),https://lens.org/097-634-523-488-88X,Patent Application,yes,19,5,2,2,0,H04L41/0803;;H04L67/1097;;H04L67/1097;;H04L41/0803,G06F15/16;;G06F11/25,714/39;;709/230;;X714E11024,0,0,,,,INACTIVE
176,TW,A,TW 200844518 A,101-452-681-363-332,2008-11-16,2008,TW 97102087 A,2008-01-18,US 65575707 A,2007-01-19,Overhead cable termination arrangement,A system including an overhead cable pathway structure and an adapter panel or cable termination device that mounts overhead to the cable pathway structure. The cable termination device including a plurality of adapters and a cable pathway exit having a curved surface that guides cables exiting from the overhead cable pathway structure to the adapters.,ADC TELECOMMUNICATIONS INC,COBURN HUTCH;;SMRHA MARK;;SJODIN CHAD;;FLEMING CRAIG,,https://lens.org/101-452-681-363-332,Patent of Addition,no,0,0,23,23,0,G02B6/4459;;G02B6/4459;;H02G3/0608;;H02G3/0608;;Y10T29/49826;;Y10T29/49826,G02B6/00;;G02B6/44,,0,0,,,,INACTIVE
177,US,A1,US 2018/0218141 A1,192-876-182-754-435,2018-08-02,2018,US 201715694188 A,2017-09-01,US 201715694188 A;;US 201715418203 A,2017-01-27,ENCRYPTION AUTHORIZATION DONGLE HAVING VOLATILE MEMORY,"Embodiments of the present invention disclose a method, computer program product, and device for accessing encrypted data. A communication link may be established between an authorization dongle and a secure device having encrypted data stored thereon. A communication link may also be established between the authorization dongle and a secure server. An encryption key associated with the encrypted data may be received from the secure server. The encryption key may be stored in volatile memory on the authorization dongle. An indication that a user is attempting to access the encrypted data may be received. The encryption key may be transmitted from the authorization dongle to the secure device in response to the user attempting to access the encrypted data.",IBM,BIESECKER TIMOTHY;;DICKENS LOUIE A;;FLEMING MARK S,COMPUTER TASK GROUP INC (2017-01-27);;INTERNATIONAL BUSINESS MACHINES CORPORATION (2017-01-19),https://lens.org/192-876-182-754-435,Patent Application,yes,0,3,4,4,0,G06F21/602;;G06F21/34;;G06F21/602;;G06F21/575,G06F21/34;;G06F21/57;;G06F21/60,,0,0,,,,INACTIVE
178,CN,A,CN 110167351 A,084-881-953-192-831,2019-08-23,2019,CN 201880005721 A,2018-01-08,US 201762445429 P;;US 2018/0012730 W,2017-01-12,INSECTICIDAL PROTEINS,"Compositions and methods for controlling plant pests are disclosed. In particular, novel insecticidal proteins having toxicity against Coleopteran and/or Lepidopteran insect pests are provided. Nucleic acid molecules encoding the novel insecticidal proteins are also provided. Methods of making the insecticidal proteins and methods of using the insecticidal proteins and nucleic acids encoding the insecticidal proteins of the invention, for example in transgenic plants to confer protection from insect damage, are also disclosed.",SYNGENTA PARTICIPATIONS AG,REYNOLDS CLARENCE MICHAEL;;FLEMING CHRISTOPHER;;MONTGOMERY MARK GREER,,https://lens.org/084-881-953-192-831,Patent Application,no,5,0,20,20,0,C07K14/195;;C12N15/8286;;A01N37/46;;Y02A40/146;;C12N15/82;;C12N15/113;;A01H5/00;;A01H6/4684;;C12N15/8286;;C07K14/195;;Y02A40/146,A01P7/04;;A01N37/18;;C12N1/21;;C12N15/31;;C12N15/63;;C12N15/82,,2,0,,,"RASADO C,J等: ""A Common Fold Mediates Vertebrate Defense and Bacterial Attack"", 《SCIENCE》;;彭琦等: ""苏云金芽胞杆菌杀虫晶体蛋白研究进展"", 《中国生物防治学报》",ACTIVE
179,US,A1,US 2011/0116758 A1,120-679-775-058-203,2011-05-19,2011,US 93095111 A,2011-01-19,US 93095111 A;;US 29133208 A;;US 65575707 A,2007-01-19,Overhead cable termination arrangement,A system including an overhead cable pathway structure and an adapter panel or cable termination device that mounts overhead to the cable pathway structure. The cable termination device including a plurality of adapters and a cable pathway exit having a curved surface that guides cables exiting from the overhead cable pathway structure to the adapters.,ADC TELECOMMUNICATIONS INC,COBURN HUTCH;;SMRHA MARK;;SJODIN CHAD;;FLEMING CRAIG,COMMSCOPE EMEA LIMITED (2015-08-28);;COMMSCOPE TECHNOLOGIES LLC (2015-08-28);;TYCO ELECTRONICS SERVICES GMBH (2011-09-30),https://lens.org/120-679-775-058-203,Patent Application,yes,31,6,23,23,0,G02B6/4459;;G02B6/4459;;H02G3/0608;;H02G3/0608;;Y10T29/49826;;Y10T29/49826,G02B6/00;;B23P11/00,385/137;;29/428,0,0,,,,INACTIVE
180,AU,A,AU 1984/036060 A,185-410-717-718-329,1985-06-27,1985,AU 1984/036060 A,1984-11-30,US 56429183 A,1983-12-22,ALUMINA GEL FROM ALUMINATES,,ALUMINUM CO OF AMERICA,PEARSON ALAN;;FLEMING HUBERT L;;LARROUSSE MARK F,,https://lens.org/185-410-717-718-329,Patent Application,no,0,2,5,5,0,B01J10/002;;B01J19/0066;;B01J19/0086;;B01J2219/00063;;B01J2219/0009;;B01J2219/00094;;B01J2219/00126;;B01J2219/00164;;B01J2219/00166;;B01J2219/00177;;C01F7/141;;C01F7/142;;C01P2002/60;;C01P2006/12,B01J10/00;;B01J19/00;;C01F7/141;;C01F7/142,,0,0,,,,DISCONTINUED
181,WO,A1,WO 2008/089192 A1,199-515-098-297-543,2008-07-24,2008,US 2008/0051082 W,2008-01-15,US 65575707 A,2007-01-19,OVERHEAD CABLE TERMINATON ARRANGEMENT,A system including an overhead cable pathway structure and an adapter panel or cable termination device that mounts overhead to the cable pathway structure. The cable termination device including a plurality of adapters and a cable pathway exit having a curved surface that guides cables exiting from the overhead cable pathway structure to the adapters.,ADC TELECOMMUNICATIONS INC;;COBURN HUTCH;;SMRHA MARK;;SJODIN CHAD;;FLEMING CRAIG,COBURN HUTCH;;SMRHA MARK;;SJODIN CHAD;;FLEMING CRAIG,,https://lens.org/199-515-098-297-543,Patent Application,yes,4,20,23,23,0,Y10T29/49826;;G02B6/4459;;H02G3/0608;;Y10T29/49826;;G02B6/4459;;H02G3/0608,H02G3/22,,0,0,,,,PENDING
182,EP,A2,EP 2787364 A2,024-403-774-563-067,2014-10-08,2014,EP 14161753 A,2014-03-26,EP 13250039 A;;EP 14161753 A,2013-03-26,"Radiobeacon stations, user devices, location determination systems, methods for controlling a radiobeacon station, methods for controlling a user device, and location determination methods","A radiobeacon station is described comprising: a satellite receiver configured to receive satellite navigation data from a satellite; a timing circuit configured to determine a timing scheme based on the satellite navigation data; and a terrestrial transmitter configured to transmit a plurality of beacon signals based on the determined timing scheme.
",INTEL IP CORP,FLEMING PETER MARK;;WHITWORTH GERALD;;ANYAEGBU ESTHER OLULU,INTEL CORPORATION (2015-10-28),https://lens.org/024-403-774-563-067,Patent Application,yes,0,2,4,4,0,G01S5/0226;;G01S5/0226;;G01S1/042;;G01S5/0045;;G01S5/0045;;H04W56/00;;H04W56/00,G01S5/02;;G01S5/00;;H04B7/26;;H04W56/00,,0,0,,,,ACTIVE
183,US,A1,US 2016/0226697 A1,040-048-886-981-710,2016-08-04,2016,US 201314917834 A,2013-10-03,US 201314917834 A;;US 201361881555 P;;IB 2013059084 W,2013-09-24,METHOD AND APPARATUS FOR USE WITH RECEIVED ELECTROMAGNETIC SIGNAL AT A FREQUENCY NOT KNOWN EXACTLY IN ADVANCE,"In a software receiver, a received electromagnetic signal is sampled in “slices”, each having a duration of some multiple of a reference frequency. The samples of each slice are correlated with values in a pair of reference signals, such as sine and cosine, at the reference frequency. This yields a two-tuple for each slice, which two-tuples may be stored. The stored two-tuples can be simply added to arrive at a correlation value of narrower bandwidth than that of any slice taken alone. The stored two-tuples can be taken in sequence, each rotated by some predetermined angle relative to its predecessor in sequence, and the rotated two-tuples summed to arrive at a correlation value with respect to a frequency that is offset from the reference frequency to an extent that relates to the predetermined angle. In this way, the receiver is able to proceed despite the transmitted frequency not being known exactly in advance and does not require prodigious storage or computational resources.",PROTEUS DIGITAL HEALTH INC,KUSHNER CHERIE ELAINE;;FLEMING ROBERT ALAN;;ZDEBLICK MARK,PROTEUS DIGITAL HEALTH INC (2014-01-03),https://lens.org/040-048-886-981-710,Patent Application,yes,10,5,4,4,0,H04B1/0003;;G06F16/22;;G06F16/22;;H04B1/0003;;H04L27/3416;;H04L27/361,H04L27/34;;G06F17/30;;H04L27/36,,0,0,,,,ACTIVE
184,ES,T3,ES 2779005 T3,062-344-775-181-045,2020-08-13,2020,ES 08727684 T,2008-01-15,US 65575707 A;;US 2008/0051082 W,2007-01-19,Disposición de terminación de cables aéreos,"Un sistema (10) de instalación que comprende: a) un bastidor (54) de telecomunicaciones que tiene un equipo (64) montado en el mismo; b) una estructura (14) de trazado de cables aéreos ubicada sobre el bastidor (54) de telecomunicaciones; c) cables (58) que discurren a lo largo de la estructura (14) de trazado de cables aéreos; y d) un dispositivo (12) de terminación de cables montado en la estructura (14) de trazado de cables aéreos, incluyendo el dispositivo (12) de terminación de cables una pluralidad de adaptadores (24) montados fuera de una región portadora (60) de cables de la estructura (14) de trazado de cables aéreos; e) en el que los cables (58) que salen de la estructura (14) de trazado de cables aéreos terminan en los adaptadores (24) del dispositivo (12) de terminación de cables montado en la estructura (14) de trazado de cables aéreos.",COMMSCOPE TECHNOLOGIES LLC,COBURN HUTCH;;SMRHA MARK;;SJODIN CHAD;;FLEMING CRAIG,,https://lens.org/062-344-775-181-045,Granted Patent,no,0,0,23,23,0,G02B6/4459;;G02B6/4459;;H02G3/0608;;H02G3/0608;;Y10T29/49826;;Y10T29/49826,H02G3/22;;G02B6/44;;H02G3/06,,0,0,,,,ACTIVE
185,US,B1,US 10055568 B1,126-867-588-391-912,2018-08-21,2018,US 201715694188 A,2017-09-01,US 201715694188 A;;US 201715418203 A,2017-01-27,Encryption authorization dongle having volatile memory,"Embodiments of the present invention disclose a method, computer program product, and device for accessing encrypted data. A communication link may be established between an authorization dongle and a secure device having encrypted data stored thereon. A communication link may also be established between the authorization dongle and a secure server. An encryption key associated with the encrypted data may be received from the secure server. The encryption key may be stored in volatile memory on the authorization dongle. An indication that a user is attempting to access the encrypted data may be received. The encryption key may be transmitted from the authorization dongle to the secure device in response to the user attempting to access the encrypted data.",IBM,BIESECKER TIMOTHY;;DICKENS LOUIE A;;FLEMING MARK S,COMPUTER TASK GROUP INC (2017-01-27);;INTERNATIONAL BUSINESS MACHINES CORPORATION (2017-01-19),https://lens.org/126-867-588-391-912,Granted Patent,yes,14,0,4,4,0,G06F21/602;;G06F21/34;;G06F21/602;;G06F21/575,H04L29/06;;G06F21/34;;G06F21/57;;G06F21/60,,7,0,,,"Anonymous, “USB Encryption Adapter,” An IP.com Prior Art Database Technical Disclosure, IP.com No. IPCOM000237994D, IP.com Electronic Publication Date: Jul. 24, 2014, 5 pgs.;;Keylock, “In the fight against piracy . . . choose your weapon wisely,” https://www.keylok.com/products, printed Nov. 3, 2016, 1 pg.;;Ragan, S. “USB ‘Ciphering Dongle’ Offers Instant Full Disk Encryption for USB Drives,” http://www.securityweek.com/usb-ciphering-dongle-offers-instant-full-disk-encryption-usb-drives, printed Nov. 3, 2016, 7 pgs.;;Unknown, “GoSafe: File Encryption using USB Dongle,” http://softwarefileprotection.com/gosafe-file-encryption, printed Nov. 3, 2016, 8 pgs.;;Unknown, “USB/IP Project,” http://usbip.sourceforge.net/, printed Nov. 3, 2016, 5 pgs.;;Biesecker et al., “Encryption Authorization Dongle Having Volatile Memory,” U.S. Appl. No. 15/418,203, filed Jan. 27, 2017.;;List of IBM Patents or Patent Applications Treated as Related, signed Sep. 1, 2017, 2 pages.",INACTIVE
186,US,A1,US 2018/0218140 A1,144-379-792-938-540,2018-08-02,2018,US 201715418203 A,2017-01-27,US 201715418203 A,2017-01-27,ENCRYPTION AUTHORIZATION DONGLE HAVING VOLATILE MEMORY,"Embodiments of the present invention disclose a method, computer program product, and device for accessing encrypted data. A communication link may be established between an authorization dongle and a secure device having encrypted data stored thereon. A communication link may also be established between the authorization dongle and a secure server. An encryption key associated with the encrypted data may be received from the secure server. The encryption key may be stored in volatile memory on the authorization dongle. An indication that a user is attempting to access the encrypted data may be received. The encryption key may be transmitted from the authorization dongle to the secure device in response to the user attempting to access the encrypted data.",IBM,BIESECKER TIMOTHY;;DICKENS LOUIE A;;FLEMING MARK S,INTERNATIONAL BUSINESS MACHINES CORPORATION (2017-01-19),https://lens.org/144-379-792-938-540,Patent Application,yes,0,1,4,4,0,G06F21/602;;G06F21/34;;G06F21/602;;G06F21/575,G06F21/34;;G06F21/57;;G06F21/60,,0,0,,,,INACTIVE
187,EP,B1,EP 3568022 B1,082-588-901-193-618,2022-06-15,2022,EP 18739286 A,2018-01-08,US 201762445429 P;;US 2018/0012730 W,2017-01-12,INSECTICIDAL PROTEINS,,SYNGENTA PARTICIPATIONS AG,REYNOLDS CLARENCE MICHAEL;;FLEMING CHRISTOPHER;;MONTGOMERY MARK GREER,,https://lens.org/082-588-901-193-618,Granted Patent,yes,4,0,20,20,0,C07K14/195;;C12N15/8286;;A01N37/46;;Y02A40/146;;C12N15/82;;C12N15/113;;A01H5/00;;A01H6/4684;;C12N15/8286;;C07K14/195;;Y02A40/146,A01P7/04;;A01N37/18;;C12N1/21;;C12N15/31;;C12N15/63;;C12N15/82,,2,0,,,"ROSADO ET AL.: 'A common fold mediates vertebrate defense and bacterial attack' SCIENCE vol. 317, no. 5844, 14 September 2007, pages 1548 - 1551, XP055071606;;REBOUL ET AL.: 'Giant MACPF/CDC pore forming toxins: A class of their own' BIOCHIMICA ET BIOPHYSICA ACTA (BBA) vol. 1858, no. 3, March 2016, pages 475 - 486, XP029402251",ACTIVE
188,WO,A1,WO 2018/132325 A1,105-916-143-887-970,2018-07-19,2018,US 2018/0012730 W,2018-01-08,US 201762445429 P,2017-01-12,INSECTICIDAL PROTEINS,"Compositions and methods for controlling plant pests are disclosed. In particular, novel insecticidal proteins having toxicity against Coleopteran and/or Lepidopteran insect pests are provided. Nucleic acid molecules encoding the novel insecticidal proteins are also provided. Methods of making the insecticidal proteins and methods of using the insecticidal proteins and nucleic acids encoding the insecticidal proteins of the invention, for example in transgenic plants to confer protection from insect damage, are also disclosed.",SYNGENTA PARTICIPATIONS AG,REYNOLDS CLARENCE MICHAEL;;FLEMING CHRISTOPHER;;MONTGOMERY MARK GREER,,https://lens.org/105-916-143-887-970,Patent Application,yes,2,2,20,20,100,C07K14/195;;C12N15/8286;;A01N37/46;;Y02A40/146;;C12N15/82;;C12N15/113;;A01H5/00;;A01H6/4684;;C12N15/8286;;C07K14/195;;Y02A40/146,A01P7/04;;A01N37/18;;C12N1/21;;C12N15/31;;C12N15/63;;C12N15/82,,9,3,028-461-041-014-002;;037-573-090-292-941;;000-654-286-546-079,17717151;;10.1126/science.1144706;;10.1016/j.bbamem.2015.11.017;;26607011;;10.1038/nbt0290-135;;1366557,"ROSADO ET AL.: ""A common fold mediates vertebrate defense and bacterial attack"", SCIENCE, vol. 317, no. 5844, 14 September 2007 (2007-09-14), pages 1548 - 1551, XP055071606;;REBOUL ET AL.: ""Giant MACPF/CDC pore forming toxins: A class of their own"", BIOCHIMICA ET BIOPHYSICA ACTA (BBA), vol. 1858, no. 3, March 2016 (2016-03-01), pages 475 - 486, XP029402251;;SREEKRISHNA: ""Industrial microorganisms:basic and applied molecular genetics"", 1993, AMERICAN SOCIETY FOR MICROBIOLOGY, pages: 173 - 177;;DEQUINBARRE, BIOTECHNOLOGY, vol. L2, 1994;;VAN DEN BERG ET AL., BIOTECHNOLOGY, vol. 8, 1990, pages 135 - 139;;AUSUBEL, F.M. ET AL.: ""Current Protocols in Molecular Biology"", 1988, JOHN WILEY AND SONS INC.;;REITER ET AL.: ""Methods in Arabidopsis Research"", 1992, WORLD SCIENTIFIC PRESS;;SCHULTZ ET AL.: ""Plant Molecular Biology Manual"", 1998, KLUWER ACADEMIC PUBLISHERS;;See also references of EP 3568022A4",PENDING
189,US,B1,US 11232114 B1,124-322-853-489-417,2022-01-25,2022,US 202117328784 A,2021-05-24,US 202117328784 A;;US 201916459003 A;;US 201816226370 A,2018-12-19,System and method for automated classification of structured property description extracted from data source using numeric representation and keyword search,"Some implementations of the disclosure are directed to retrieving a property description describing a real property; generating a numeric representation of the property description; determining one or more keywords of a keyword list present or absent in the property description; generating one or more values corresponding to a presence or absence of the one or more keywords in the property description; combining the numeric representation of the property description with the one or more values to create a combination; and computing, based on the combination, a most likely classification of the property description from a plurality of classifications.",FIRST AMERICAN FINANCIAL CORP,FLEMING MARK M;;BLACKMAN DAVID H;;QIU YAN,FIRST AMERICAN FINANCIAL CORPORATION (2019-10-31),https://lens.org/124-322-853-489-417,Granted Patent,yes,37,0,2,4,0,G06F40/186;;G06F40/216;;G06F40/284;;G06Q40/08;;G06Q50/16;;G06Q50/18;;G06F40/30;;G06F16/285;;G06F16/2462;;G06N3/088;;G06N20/00;;G06N3/045;;G06Q40/03;;G06F16/2462;;G06F16/93;;G06N3/088;;G06F16/285;;G06F40/186,G06F16/2458;;G06F16/28;;G06F16/93;;G06N3/08,,1,0,,,"Non-final Office Action dated Sep. 14, 2020 for U.S. Appl. No. 16/226,370, filed Dec. 19, 2018.",ACTIVE
190,US,A1,US 2009/0067803 A1,170-887-761-021-67X,2009-03-12,2009,US 29133208 A,2008-11-07,US 29133208 A;;US 65575707 A,2007-01-19,Overhead cable termination arrangement,A system including an overhead cable pathway structure and an adapter panel or cable termination device that mounts overhead to the cable pathway structure. The cable termination device including a plurality of adapters and a cable pathway exit having a curved surface that guides cables exiting from the overhead cable pathway structure to the adapters.,ADC TELECOMMUNICATIONS INC,COBUM HUTCH;;SMRHA MARK;;SJODIN CHAD;;FLEMING CRAIG,COMMSCOPE EMEA LIMITED (2015-08-28);;COMMSCOPE TECHNOLOGIES LLC (2015-08-28);;TYCO ELECTRONICS SERVICES GMBH (2011-09-30),https://lens.org/170-887-761-021-67X,Patent Application,yes,24,9,23,23,0,G02B6/4459;;G02B6/4459;;H02G3/0608;;H02G3/0608;;Y10T29/49826;;Y10T29/49826,G02B6/48,385/136,0,0,,,,ACTIVE
191,EP,A2,EP 0147167 A2,199-500-901-708-849,1985-07-03,1985,EP 84308889 A,1984-12-19,US 56429183 A,1983-12-22,Continuous process for neutralization of aluminate solution to form gels and appartatus therefor.,"Alumina gel is produced on a continuous basis in a stirred reactor into which is bubbled carbon dioxide to neutralize an aluminate solution feeding into the reactor. Careful control of the process parameters, including pH, residence time, temperature and gas flow rate, as well as the geometry of the reactor and other apparatus parameters, can result in the formation of preselected types of gel. When pseudoboehmite is formed in accordance with the invention, alumina gels can be formed with surface areas as high as 300 to 700 square meters per gram.",ALUMINUM CO OF AMERICA,PEARSON ALAN;;FLEMING HUBERT L;;LARROUSSE MARK F,,https://lens.org/199-500-901-708-849,Patent Application,yes,0,28,5,5,0,B01J10/002;;B01J19/0066;;B01J19/0086;;B01J2219/00063;;B01J2219/0009;;B01J2219/00094;;B01J2219/00126;;B01J2219/00164;;B01J2219/00166;;B01J2219/00177;;C01F7/141;;C01F7/142;;C01P2002/60;;C01P2006/12,B01J10/00;;B01J19/00;;C01F7/141;;C01F7/142,,0,0,,,,DISCONTINUED
192,EP,A1,EP 3568022 A1,016-313-722-634-370,2019-11-20,2019,EP 18739286 A,2018-01-08,US 201762445429 P;;US 2018/0012730 W,2017-01-12,INSECTICIDAL PROTEINS,,SYNGENTA PARTICIPATIONS AG,REYNOLDS CLARENCE MICHAEL;;FLEMING CHRISTOPHER;;MONTGOMERY MARK GREER,,https://lens.org/016-313-722-634-370,Patent Application,yes,0,0,20,20,100,C07K14/195;;C12N15/8286;;A01N37/46;;Y02A40/146;;C12N15/82;;C12N15/113;;A01H5/00;;A01H6/4684;;C12N15/8286;;C07K14/195;;Y02A40/146,A01P7/04;;A01N37/18;;C12N1/21;;C12N15/31;;C12N15/63;;C12N15/82,,0,0,,,,ACTIVE
193,CN,B,CN 101584095 B,039-242-308-260-456,2013-10-30,2013,CN 200880002471 A,2008-01-15,US 2008/0051082 W;;US 65575707 A,2007-01-19,Overhead cable terminaton arrangement,,ADC TELECOMMUNICATIONS INC,COBURN HUTCH;;SMRHA MARK;;SJODIN CHAD;;FLEMING CRAIG,,https://lens.org/039-242-308-260-456,Granted Patent,no,0,0,23,23,0,G02B6/4459;;G02B6/4459;;H02G3/0608;;H02G3/0608;;Y10T29/49826;;Y10T29/49826,H02G3/22,,0,0,,,,INACTIVE
194,US,B2,US 11180774 B2,061-542-794-438-214,2021-11-23,2021,US 201816474127 A,2018-01-08,US 201816474127 A;;US 201762445429 P;;US 2018/0012730 W,2017-01-12,Insecticidal proteins,"Compositions and methods for controlling plant pests are disclosed. In particular, novel insecticidal proteins having toxicity against Coleopteran and/or Lepidopteran insect pests are provided. Nucleic acid molecules encoding the novel insecticidal proteins are also provided. Methods of making the insecticidal proteins and methods of using the insecticidal proteins and nucleic acids encoding the insecticidal proteins of the invention, for example in transgenic plants to confer protection from insect damage, are also disclosed.",SYNGENTA PARTICIPATIONS AG,REYNOLDS CLARENCE MICHAEL;;FLEMING CHRISTOPHER;;MONTGOMERY MARK GREER,SYNGENTA PARTICIPATIONS AG (2018-02-20),https://lens.org/061-542-794-438-214,Granted Patent,yes,2,5,20,20,100,C07K14/195;;C12N15/8286;;A01N37/46;;Y02A40/146;;C12N15/82;;C12N15/113;;A01H5/00;;A01H6/4684;;C12N15/8286;;C07K14/195;;Y02A40/146,C12N15/82;;A01H6/46;;C07K14/195,,8,2,028-461-041-014-002;;037-573-090-292-941,17717151;;10.1126/science.1144706;;10.1016/j.bbamem.2015.11.017;;26607011,"Rosado et al., A common fold mediates vertebrate defense and bacterial attack. Science 2007, 317 (5844): 1548-51; Abstract: Supplementary materials, p. 2.;;GenBank CP009678.1. Pectobacterium cartovorum subsp. odoriferum strain BC S7, complete genome. Oct. 28, 2014 [Retrieved from the Internet Apr. 4, 2018: <https://www.ncbi.nim.nih.gov/nuccore/CP009678>]; in entirety, nucleotides: 1936981-1934569, 16. 1% identity to SEQ ID No. 2.;;GenBank AM711867.1. Clavibacter michiganensis subsp. michiganensis NCPPB 382 complete genome. Feb. 27, 2015 [Retrieved from the Internet Apr. 4, 2018: <https://www.ncbi.nim.nih.gov/nuccore/AM711867>]; p. 897, gene 2685035. 2686447, 18.3% identify to SEQ ID No. 99.;;UniProtKB/TrEMBL A0A0F4QUD9_9GAMM. Dec. 9, 2015. [Retreived from the Internet: Mar. 27, 2018. <http://www.uniprot.org/uniprot/AoA0F-4QUD9.txt?version=4]; in entirety.;;GenBank NP_928713.1. hypothetical protein plu 1415 [Photorhabdus luminescens subsp. laumondi TT01] (2014) [Retrieved from the Internet Apr. 11, 2018: <https://www.ncbi.nim.nih.gov/protein/NP_928713.1?report=genpept>]; in entirety.;;Reboul et al.. Giant MACPF/CDC pore forming toxins: A class of their own. Biochim Biophys Acta 2016, 1858(3) 475-86; AbstractL p. 477, Fig. 2 and its legend.;;UniProtKB/TrEMBL A8GEE9_SERP5. Membrane attack complex component/perforin/complement C9 (Nov. 2, 2016) [Retreived from the Internet: Apr. 4, 2018. <http://www.uniprot.org/uniprot/A8GEE9.text?version=38>]; amino acids 312-486, 42.4% identity to SEQ ID No. 71.;;International Search Report dated Apr. 25, 2018 for International Application No. PCT/US2018/012730.",ACTIVE
195,EP,A3,EP 0147167 A3,076-144-658-294-915,1986-12-03,1986,EP 84308889 A,1984-12-19,US 56429183 A,1983-12-22,CONTINUOUS PROCESS FOR NEUTRALIZATION OF ALUMINATE SOLUTION TO FORM GELS AND APPARTATUS THEREFOR,"Alumina gel is produced on a continuous basis in a stirred reactor into which is bubbled carbon dioxide to neutralize an aluminate solution feeding into the reactor. Careful control of the process parameters, including pH, residence time, temperature and gas flow rate, as well as the geometry of the reactor and other apparatus parameters, can result in the formation of preselected types of gel. When pseudoboehmite is formed in accordance with the invention, alumina gels can be formed with surface areas as high as 300 to 700 square meters per gram.",ALUMINUM COMPANY OF AMERICA,"PEARSON, ALAN;;FLEMING, HUBERT L.;;LARROUSSE, MARK F.",,https://lens.org/076-144-658-294-915,Search Report,yes,4,0,5,5,0,B01J10/002;;B01J19/0066;;B01J19/0086;;B01J2219/00063;;B01J2219/0009;;B01J2219/00094;;B01J2219/00126;;B01J2219/00164;;B01J2219/00166;;B01J2219/00177;;C01F7/141;;C01F7/142;;C01P2002/60;;C01P2006/12,B01J10/00;;B01J19/00;;C01F7/141;;C01F7/142,,0,0,,,,DISCONTINUED
196,EP,B1,EP 2127049 B1,178-768-494-653-478,2019-12-25,2019,EP 08727684 A,2008-01-15,US 2008/0051082 W;;US 65575707 A,2007-01-19,OVERHEAD CABLE TERMINATON ARRANGEMENT,,ADC TELECOMMUNICATIONS INC,COBURN HUTCH;;SMRHA MARK;;SJODIN CHAD;;FLEMING CRAIG,"COMMSCOPE TECHNOLOGIES LLC (2020-05-13);;COMMSCOPE TECHNOLOGIES LLC, HICKORY, US (2020-05-04)",https://lens.org/178-768-494-653-478,Granted Patent,yes,4,0,23,23,0,Y10T29/49826;;G02B6/4459;;H02G3/0608;;Y10T29/49826;;G02B6/4459;;H02G3/0608,H02G3/22;;G02B6/44;;H02G3/06,,0,0,,,,ACTIVE
197,US,A1,US 2021/0345509 A1,023-898-684-636-251,2021-11-04,2021,US 202117243852 A,2021-04-29,US 202117243852 A;;US 202063019571 P,2020-05-04,DATA CENTER CABINET AND TOP CAPS FOR A DATA CENTER CABINET,"A data center cabinet has a base frame and a top cap attached to the base frame. The top cap has a main panel having a front edge, rear edge, first side edge, a second side edge, top surface, and bottom surface. An opening is formed through the main panel and is inset and spaced apart from the front, rear, first side, and second side edges. A removable door is positioned over the opening and is hinged to the main panel such that the door can rotate between an open position and a closed position and be removed from the main panel.",PANDUIT CORP,MARCUS RICHARD A;;FLEMING JAMES N;;SHURHAY MARK,PANDUIT CORP (2020-06-29),https://lens.org/023-898-684-636-251,Patent Application,yes,15,4,4,4,0,H05K5/0217;;H05K5/03;;H05K7/1488;;E05C1/04;;E05D7/123;;E05Y2900/606;;H05K5/0221;;H05K7/1488,H05K7/14;;E05C1/04;;E05D7/12;;H05K5/02,,0,0,,,,ACTIVE
198,RU,C2,RU 2761666 C2,031-251-225-463-34X,2021-12-13,2021,RU 2019124715 A,2018-01-08,US 201762445429 P;;US 2018/0012730 W,2017-01-12,INSECTICIDAL PROTEINS,"FIELD: biochemistry.SUBSTANCE: invention relates to the field of biochemistry, in particular to an expression cassette for the expression of polypeptide toxic to insects of the Diabrotica species. An expression vector and a transgenic maize plant containing the specified expression cassette, a host cell containing the specified vector are also disclosed. A method for controlling the pest population of the Diabrotica species using the specified polypeptide is disclosed.EFFECT: invention has the capability of effective controlling the pest population of the Diabrotica species.8 cl, 26 tbl, 12 ex",SYNGENTA PARTICIPATIONS AG,REYNOLDS CLARENCE MICHAEL;;FLEMING CHRISTOPHER;;MONTGOMERY MARK GREER,,https://lens.org/031-251-225-463-34X,Granted Patent,no,3,0,20,20,0,C07K14/195;;C12N15/8286;;A01N37/46;;Y02A40/146;;C12N15/82;;C12N15/113;;A01H5/00;;A01H6/4684;;C12N15/8286;;C07K14/195;;Y02A40/146,C12N15/82;;A01H5/00;;A01P7/04;;C12N15/113;;C12N15/31;;C12N15/63,,0,0,,,,ACTIVE
199,US,A1,US 2010/0082933 A1,061-239-950-987-273,2010-04-01,2010,US 24375408 A,2008-10-01,US 24375408 A,2008-10-01,AUTOMATED METHOD TO CONFIGURE A DATA STORAGE SYSTEM,"An automated, computer-implemented method to configure a data storage system comprising a host computer, a storage controller in communication with said host computer, and a plurality of data storage media in communication with said storage controller, wherein the method provides a configuration algorithm encoded as computer readable program code, and executes that computer readable program code. The configuration algorithm creates a command procedure comprising a plurality of physical configuration commands to establish a physical configuration for the data storage system. The configuration algorithm further creates a command procedure comprising a plurality of logical configuration commands to establish a logical configuration for the data storage system.",IBM,FLEMING MARK SEAN;;MARTINEZ LISA R;;NGUYEN LU,INTERNATIONAL BUSINESS MACHINES CORPORATION (2008-09-18),https://lens.org/061-239-950-987-273,Patent Application,yes,9,10,2,2,0,G06F3/0605;;G06F3/0631;;G06F3/0689;;G06F3/0605;;G06F3/0689;;G06F3/0631,G06F12/00,711/170;;X711E12002,0,0,,,,INACTIVE
200,US,A1,US 2017/0248766 A1,132-691-832-160-560,2017-08-31,2017,US 201715460903 A,2017-03-16,US 201715460903 A;;US 201414279926 A;;US 93095111 A;;US 29133208 A;;US 65575707 A,2007-01-19,Overhead Cable Termination Arrangement,A method of terminating a cable includes: a) providing an overhead cable pathway structure that defines a cable-carrying region; b) mounting adapters to the overhead cable pathway structure outside of the cable-carrying region; c) routing a cable from the cable-carrying region of the overhead cable pathway structure to the adapter mounted to the cable pathway structure; and d) terminating the cable to the adapter.,COMMSCOPE TECHNOLOGIES LLC,COBURN HUTCH;;SMRHA MARK;;SJODIN CHAD;;FLEMING CRAIG,,https://lens.org/132-691-832-160-560,Patent Application,yes,47,2,23,23,0,G02B6/4459;;G02B6/4459;;H02G3/0608;;H02G3/0608;;Y10T29/49826;;Y10T29/49826,G02B6/44;;H02G3/06,,1,0,,,"US RE38,311 E",ACTIVE
201,WO,A3,WO 2006/081518 A3,199-859-732-422-938,2006-11-23,2006,US 2006/0003129 W,2006-01-27,US 64817205 P;;US 4660805 A;;US 12894705 A,2005-01-28,NON-IONIC NON-AQUEOUS VEHICLES FOR TOPICAL AND ORAL ADMINISTRATION OF CARRIER-COMPLEXED ACTIVE AGENTS,"An improved controlled release composition for non-parenteral administration of active agents and other therapeutics, particularly for oral or topical administration, has been developed. The composition is made by dispersing a complex formed of an active agent bound to an ion-exchange resin or to another form of resin or carrier, in a non-ionic non-aqueous ('NINA') vehicle. The complexes are optionally coated with one or more layers of coating material to provide a controlled pattern of release of active agent from the carrier. The combination of multiple active agents is possible with this system, in which one or more active agents are bound to particles and one or more active agents are dissolved or dispersed in the NINA vehicle. This allows the combination of two or more active agents, which are otherwise incompatible, into a single dosage form.",COLLEGIUM PHARMACEUTICAL INC;;HIRSH JANE;;RARIY ROMAN V;;TRUMBORE MARK;;FLEMING ALISON;;HIRSH MARK,HIRSH JANE;;RARIY ROMAN V;;TRUMBORE MARK;;FLEMING ALISON;;HIRSH MARK,,https://lens.org/199-859-732-422-938,Search Report,yes,13,0,5,7,0,A61K31/4402;;A61K31/4402;;A61K9/006;;A61K9/006;;A61K9/5026;;A61K9/5026;;A61K31/137;;A61K31/137;;A61K47/585;;A61K47/585,A61K47/48;;A61K9/58,,3,3,031-568-254-992-094;;037-984-034-188-29X;;093-249-620-784-166,11853935;;10.1016/s0168-3659(01)00553-3;;10.1080/713840399;;12944135;;11343883;;10.1016/s0939-6411(01)00124-2,"CHENG Y-H ET AL: ""Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation"", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 79, no. 1-3, 19 February 2002 (2002-02-19), pages 243 - 254, XP004340929, ISSN: 0168-3659;;UMAMAHESHWARI R B ET AL: ""A new approach in gastroretentive drug delivery system using cholestyramine."", DRUG DELIVERY. 2003 JUL-SEP, vol. 10, no. 3, July 2003 (2003-07-01), pages 151 - 160, XP009069547, ISSN: 1071-7544;;CUNA M ET AL: ""Preparation and in vivo evaluation of mucoadhesive microparticles containing amoxycillin-resin complexes for drug delivery to the gastric mucosa"", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM, NL, vol. 51, no. 3, May 2001 (2001-05-01), pages 199 - 205, XP004239479, ISSN: 0939-6411",PENDING
202,US,A1,US 2023/0172301 A1,030-830-368-463-355,2023-06-08,2023,US 202117997946 A,2021-05-05,GB 202006661 A;;GB 2021051092 W,2020-05-05,SAFETY HELMET,A safety helmet ( 100 ) for an industrial worker is provided. The safety helmet ( 100 ) comprises an inner layer ( 102 ) and an outer layer ( 104 ) spaced from the inner layer ( 102 ) and defining a cavity ( 106 ) therebetween. The safety helmet ( 100 ) also comprises an array of light-emitting elements ( 108 ) arranged in the cavity ( 106 ) and distributed over the inner layer ( 102 ). The outer layer ( 104 ) includes a diffusing element for diffusing light emitted from the array of light-emitting elements 108 through the outer layer ( 104 ). One of the inner ( 102 ) and outer ( 104 ) layers forms a protective shell for protecting a user's head while wearing the helmet ( 100 ).,GLO SAFE LTD,KENWARD CHARLES;;KENWARD CHYNA;;LITTLE MARK;;FLEMING ALEX,GLO SAFE LIMITED (2022-10-31),https://lens.org/030-830-368-463-355,Patent Application,yes,0,0,5,10,0,A42B3/044;;A42B3/04;;A42B3/0406;;A42B3/0433;;A42B3/044;;A42B3/044,A42B3/04,,0,0,,,,PENDING
203,GB,A,GB 2608001 A,029-197-425-308-444,2022-12-21,2022,GB 202205927 A,2020-05-05,GB 202205927 A;;GB 202006661 A,2020-05-05,Safety helmet and centralised control system,"A safety helmet 100 for an industrial worker, comprising an array of light-emitting elements 108, a communication module (148, fig.6) configured to provide two-way remote communication with a remote central controller (250, fig.9), and a local controller configured to receive instructions from the central controller via the communication module and to operate the light-emitting elements in response. The colour, number and/or intensity of the light-emitting elements operating may be controlled. The helmet may include a sensor that receives instructions from, and sends data to, the central controller, where said data may be used to control the light-emitting elements. The helmet may include an output device operated via instructions from the central controller. The light-emitting elements may be located in a cavity 106 between inner and outer helmet layers 102, 104, where the outer layer may include a diffusing element.",GLO SAFE LTD,CHARLES KENWARD;;CHYNA KENWARD;;MARK LITTLE;;ALEX FLEMING,,https://lens.org/029-197-425-308-444,Patent Application,no,3,0,3,10,0,A42B3/30;;A42B3/0433;;A42B3/04;;A42B3/042;;A42B3/0433;;A42B3/044;;A42B3/0453;;A42B3/30,A42B3/30;;A42B3/04,,0,0,,,,ACTIVE
204,GB,B,GB 2608001 B,057-515-541-440-617,2023-10-04,2023,GB 202205927 A,2020-05-05,GB 202205927 A;;GB 202006661 A,2020-05-05,Safety helmet and centralised control system,,GLO SAFE LTD,CHARLES KENWARD;;CHYNA KENWARD;;MARK LITTLE;;ALEX FLEMING,,https://lens.org/057-515-541-440-617,Granted Patent,no,3,0,3,10,0,A42B3/30;;A42B3/0433;;A42B3/04;;A42B3/042;;A42B3/0433;;A42B3/044;;A42B3/0453;;A42B3/30,A42B3/30;;A42B3/04,,0,0,,,,ACTIVE
205,EP,B1,EP 2787364 B1,061-803-046-264-231,2020-11-11,2020,EP 14161753 A,2014-03-26,EP 13250039 A;;EP 14161753 A,2013-03-26,"Radiobeacon stations, user devices, location determination systems, methods for controlling a radiobeacon station, methods for controlling a user device, and location determination methods",,INTEL CORP,FLEMING PETER MARK;;WHITWORTH GERALD;;ANYAEGBU ESTHER OLULU,INTEL CORPORATION (2015-10-28),https://lens.org/061-803-046-264-231,Granted Patent,yes,2,0,4,4,0,G01S5/0226;;G01S5/0226;;G01S1/042;;G01S5/0045;;G01S5/0045;;H04W56/00;;H04W56/00,G01S5/02;;G01S1/04;;G01S5/00;;H04B7/26;;H04W56/00,,0,0,,,,ACTIVE
206,US,A1,US 2008/0175554 A1,086-576-474-520-924,2008-07-24,2008,US 65575707 A,2007-01-19,US 65575707 A,2007-01-19,Overhead cable termination arrangement,A system including an overhead cable pathway structure and an adapter panel or cable termination device that mounts overhead to the cable pathway structure. The cable termination device including a plurality of adapters and a cable pathway exit having a curved surface that guides cables exiting from the overhead cable pathway structure to the adapters.,COBURN HUTCH;;SMRHA MARK;;SJODIN CHAD;;FLEMING CRAIG,COBURN HUTCH;;SMRHA MARK;;SJODIN CHAD;;FLEMING CRAIG,ADC TELECOMMUNICATIONS INC (2007-04-10);;COMMSCOPE EMEA LIMITED (2015-08-28);;COMMSCOPE TECHNOLOGIES LLC (2015-08-28);;TYCO ELECTRONICS SERVICES GMBH (2011-09-30),https://lens.org/086-576-474-520-924,Patent Application,yes,15,15,23,23,0,G02B6/4459;;G02B6/4459;;H02G3/0608;;H02G3/0608;;Y10T29/49826;;Y10T29/49826,G02B6/48,385/136,0,0,,,,ACTIVE
207,PH,A1,PH 12016500537 A1,128-170-100-714-11X,2016-06-13,2016,PH 12016500537 A,2016-03-21,US 201361880786 P;;US 2014/0056576 W,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING A SIGNAL IN THE PRESENCE OF NOISE USING SLICES AND WARPING",A method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of a selected number of samples of the signal representing a correlation of the signal to reference functions in the receiver. The presence of the data packet may then be detected and the detected packet decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. The slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.,PROTEUS DIGITAL HEALTH INC,CHERIE KUSHNER;;ROBERT FLEMING;;WILLIAM MCALLISTER;;MARK ZDEBLICK,,https://lens.org/128-170-100-714-11X,Patent Application,no,0,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L25/03;;H04L47/43,,0,0,,,,ACTIVE
208,BR,A2,BR 112019014369 A2,173-008-393-308-065,2020-02-11,2020,BR 112019014369 A,2018-01-08,US 2018/0012730 W;;US 201762445429 P,2017-01-12,proteínas inseticidas,"são divulgadas composições e métodos para controlar pragas de plantas. em particular, são proporcionadas novas proteínas inseticidas que têm toxicidade contra pragas de insetos coleópteros e/ou lepidópteros. são também proporcionadas moléculas de ácido nucleico que codificam as novas proteínas inseticidas. métodos de produção das proteínas inseticidas e métodos de uso das proteínas inseticidas e ácidos nucleicos que codificam as proteínas inseticidas da presente invenção, por exemplo, em plantas transgênicas para conferir proteção contra danos causados por insetos, são também divulgados.",SYNGENTA PARTICIPATIONS AG,CHRISTOPHER FLEMING;;CLARENCE MICHAEL REYNOLDS;;MARK GREER MONTGOMERY,,https://lens.org/173-008-393-308-065,Patent Application,no,0,0,20,20,0,C07K14/195;;C12N15/8286;;A01N37/46;;Y02A40/146;;C12N15/82;;C12N15/113;;A01H5/00;;A01H6/4684;;C12N15/8286;;C07K14/195;;Y02A40/146,C12N1/21;;A01N37/18;;A01P7/04;;C12N15/31;;C12N15/63;;C12N15/82,,0,0,,,,ACTIVE
209,US,B1,US 11048711 B1,169-159-975-521-003,2021-06-29,2021,US 201916459003 A,2019-07-01,US 201916459003 A;;US 201816226370 A,2018-12-19,System and method for automated classification of structured property description extracted from data source using numeric representation and keyword search,Some implementations of the disclosure are directed to retrieving a structured description; using a model trained on a plurality of structured descriptions to generate a numeric representation of the retrieved description; searching the retrieved description for a plurality of keywords in a keyword list to generate one or more values corresponding to a presence of the plurality of searched keywords; combining the numeric representation of the structured description with the generated one or more values to create a combination; using the combination to compute a most likely classification of the description from a plurality of classifications; and returning the most likely classification.,FIRST AMERICAN FINANCIAL CORP,FLEMING MARK M;;BLACKMAN DAVID H;;QIU YAN,FIRST AMERICAN FINANCIAL CORPORATION (2019-10-31),https://lens.org/169-159-975-521-003,Granted Patent,yes,37,4,2,4,0,G06F40/186;;G06F40/216;;G06F40/284;;G06Q40/08;;G06Q50/16;;G06Q50/18;;G06F40/30;;G06F16/285;;G06F16/2462;;G06N3/088;;G06N20/00;;G06N3/045;;G06Q40/03;;G06F16/2462;;G06F16/93;;G06N3/088;;G06F16/285;;G06F40/186,G06F16/2458;;G06F16/28;;G06F16/93;;G06N3/08,,1,0,,,"Non-final Office Action dated Sep. 14, 2020 for U.S. Appl. No. 16/226,370, filed Dec. 19, 2018.",ACTIVE
210,GB,A,GB 2594729 A,174-905-496-552-796,2021-11-10,2021,GB 202006661 A,2020-05-05,GB 202006661 A,2020-05-05,Safety Helmet,"A safety helmet 100 comprises an inner layer 102, an outer layer 104 spaced from the inner layer and defining a cavity 106 therebetween. An array of light-emitting elements 108 arranged in the cavity and distributed over the inner layer. The outer layer includes a diffusing element. The diffusing element may be translucent. The inner layer may compromise a rim 118 at its base which will receive the outer layer to seal the cavity. A modular unit (134d, fig 7) may be attached. The helmet may have a communication module (148, fig 7) for two-way communication with a central controller at a remote location.",GLO SAFE LTD,MARK LITTLE;;CHARLES KENWARD;;CHYNA KENWARD;;ALEX FLEMING,,https://lens.org/174-905-496-552-796,Patent Application,no,8,0,5,10,0,A42B3/044;;A42B3/04;;A42B3/0406;;A42B3/0433;;A42B3/044;;A42B3/044,A42B3/04,,0,0,,,,ACTIVE
211,US,A1,US 2019/0365571 A1,015-683-586-447-782,2019-12-05,2019,US 201716472786 A,2017-12-22,EP 16206492 A;;EP 2017084424 W,2016-12-22,A DRESSING SYSTEM,"The invention provides a dressing system for a wound comprising an absorbent pad; at least one sensor for detecting wound or dressing data, wherein the at least one sensor is a moisture sensor; a flexible electronic circuit communicable with the sensor; a backing film adapted to cooperate with the absorbent pad, wherein the electronic circuit and the at least one sensor is printed directly on the backing film; and a communications module adapted to communicate the wound data from the electronic circuit to a user or clinician. The invention provides a simple to use disposable dressing wound system that is effective in providing dressing wound data that provides an indicator of the status of the wound as well as information that the dressing wound system needs to be replaced.",FLEMING MEDICAL LTD;;UNIV COLLEGE CORK NATIONAL UNIV OF IRELAND,O'MAHONY CONOR;;O'FLYNN BRENDAN;;GALVIN PAUL;;FLEMING MARK,,https://lens.org/015-683-586-447-782,Patent Application,yes,30,13,3,3,0,A61F13/00051;;A61B2562/0214;;A61F13/00055;;A61B5/6833;;A61B5/01;;A61B5/445;;A61B5/7275;;A61B2562/0247;;A61B2562/029;;G16H40/63;;G16H40/63;;A61B5/01;;A61B5/445;;A61B5/6833;;A61B2562/0214;;A61B2562/0247;;A61B2562/029;;A61F13/00055;;A61F13/00085;;A61B5/7275;;A61B5/0002;;A61B5/14539;;A61B2562/166;;A61B5/0024;;A61B5/4875,A61F13/00;;A61B5/00,,0,0,,,,DISCONTINUED
212,EP,A4,EP 3568022 A4,072-295-000-009-842,2020-07-22,2020,EP 18739286 A,2018-01-08,US 201762445429 P;;US 2018/0012730 W,2017-01-12,INSECTICIDAL PROTEINS,,SYNGENTA PARTICIPATIONS AG,REYNOLDS CLARENCE MICHAEL;;FLEMING CHRISTOPHER;;MONTGOMERY MARK GREER,,https://lens.org/072-295-000-009-842,Search Report,no,3,0,20,20,0,C07K14/195;;C12N15/8286;;A01N37/46;;Y02A40/146;;C12N15/82;;C12N15/113;;A01H5/00;;A01H6/4684;;C12N15/8286;;C07K14/195;;Y02A40/146,A01P7/04;;A01N37/18;;C12N1/21;;C12N15/31;;C12N15/63;;C12N15/82,,1,0,,,See also references of WO 2018132325A1,ACTIVE
213,TW,B,TW I561867 B,113-434-390-159-151,2016-12-11,2016,TW 97102087 A,2008-01-18,US 65575707 A,2007-01-19,"Overehead cable management system, overhead cable terminaltion device, method of terminating a cable, and facility arrangement",,ADC TELECOMMUNICATIONS INC,COBURN HUTCH;;SMRHA MARK;;SJODIN CHAD;;FLEMING CRAIG,,https://lens.org/113-434-390-159-151,Granted Patent,no,4,0,23,23,0,G02B6/4459;;G02B6/4459;;H02G3/0608;;H02G3/0608;;Y10T29/49826;;Y10T29/49826,,,0,0,,,,INACTIVE
214,EP,A3,EP 2787364 A3,166-118-749-016-025,2014-12-17,2014,EP 14161753 A,2014-03-26,EP 13250039 A;;EP 14161753 A,2013-03-26,"Radiobeacon stations, user devices, location determination systems, methods for controlling a radiobeacon station, methods for controlling a user device, and location determination methods","A radiobeacon station is described comprising: a satellite receiver configured to receive satellite navigation data from a satellite; a timing circuit configured to determine a timing scheme based on the satellite navigation data; and a terrestrial transmitter configured to transmit a plurality of beacon signals based on the determined timing scheme.
",INTEL IP CORP,FLEMING PETER MARK;;WHITWORTH GERALD;;ANYAEGBU ESTHER OLULU,INTEL CORPORATION (2015-10-28),https://lens.org/166-118-749-016-025,Search Report,yes,3,0,4,4,0,G01S5/0226;;G01S5/0226;;G01S1/042;;G01S5/0045;;G01S5/0045;;H04W56/00;;H04W56/00,G01S5/02;;G01S5/00;;H04B7/26;;H04W56/00,,0,0,,,,ACTIVE
215,US,B2,US 8750670 B2,033-113-548-185-206,2014-06-10,2014,US 93095111 A,2011-01-19,US 93095111 A;;US 29133208 A;;US 65575707 A,2007-01-19,Overhead cable termination arrangement,A system including an overhead cable pathway structure and an adapter panel or cable termination device that mounts overhead to the cable pathway structure. The cable termination device including a plurality of adapters and a cable pathway exit having a curved surface that guides cables exiting from the overhead cable pathway structure to the adapters.,COBURN HUTCH;;SMRHA MARK;;SJODIN CHAD;;FLEMING CRAIG;;ADC TELECOMMUNICATIONS INC,COBURN HUTCH;;SMRHA MARK;;SJODIN CHAD;;FLEMING CRAIG,COMMSCOPE EMEA LIMITED (2015-08-28);;COMMSCOPE TECHNOLOGIES LLC (2015-08-28);;TYCO ELECTRONICS SERVICES GMBH (2011-09-30),https://lens.org/033-113-548-185-206,Granted Patent,yes,34,2,23,23,0,G02B6/4459;;G02B6/4459;;H02G3/0608;;H02G3/0608;;Y10T29/49826;;Y10T29/49826,G02B6/00;;G02B6/44;;H02G3/06,385/137;;385/135,0,0,,,,INACTIVE
216,US,B2,US 11785734 B2,067-740-372-506-585,2023-10-10,2023,US 202117243852 A,2021-04-29,US 202117243852 A;;US 202063019571 P,2020-05-04,Data center cabinet and top caps for a data center cabinet,"A data center cabinet has a base frame and a top cap attached to the base frame. The top cap has a main panel having a front edge, rear edge, first side edge, a second side edge, top surface, and bottom surface. An opening is formed through the main panel and is inset and spaced apart from the front, rear, first side, and second side edges. A removable door is positioned over the opening and is hinged to the main panel such that the door can rotate between an open position and a closed position and be removed from the main panel.",PANDUIT CORP,MARCUS RICHARD A;;FLEMING JAMES N;;SHURHAY MARK,PANDUIT CORP (2020-06-29),https://lens.org/067-740-372-506-585,Granted Patent,yes,41,0,4,4,0,H05K5/0217;;H05K5/03;;H05K7/1488;;E05C1/04;;E05D7/123;;E05Y2900/606;;H05K5/0221;;H05K7/1488,H05K7/00;;E05C1/04;;E05D7/12;;H05K5/02;;H05K7/14,,1,0,,,"Chatsworth Products, Inc.'s Slimframe™ C-Series Cabinet System product brochure; 6 pgs., 2001.",ACTIVE
217,US,B2,US 7463812 B2,146-993-959-131-830,2008-12-09,2008,US 65575707 A,2007-01-19,US 65575707 A,2007-01-19,Overhead cable termination arrangement,A system including an overhead cable pathway structure and an adapter panel or cable termination device that mounts overhead to the cable pathway structure. The cable termination device including a plurality of adapters and a cable pathway exit having a curved surface that guides cables exiting from the overhead cable pathway structure to the adapters.,ADC TELECOMMUNICATIONS INC,COBURN HUTCH;;SMRHA MARK;;SJODIN CHAD;;FLEMING CRAIG,ADC TELECOMMUNICATIONS INC (2007-04-10);;COMMSCOPE EMEA LIMITED (2015-08-28);;COMMSCOPE TECHNOLOGIES LLC (2015-08-28);;TYCO ELECTRONICS SERVICES GMBH (2011-09-30),https://lens.org/146-993-959-131-830,Granted Patent,yes,19,17,23,23,0,G02B6/4459;;G02B6/4459;;H02G3/0608;;H02G3/0608;;Y10T29/49826;;Y10T29/49826,G02B6/00,385/137;;385/136,0,0,,,,ACTIVE
218,US,A1,US 2014/0245589 A1,192-867-508-257-259,2014-09-04,2014,US 201414279926 A,2014-05-16,US 201414279926 A;;US 93095111 A;;US 29133208 A;;US 65575707 A,2007-01-19,Overhead Cable Termination Arrangement,A method of terminating a cable includes: a) providing an overhead cable pathway structure that defines a cable-carrying region; b) mounting adapters to the overhead cable pathway structure outside of the cable-carrying region; c) routing a cable from the cable-carrying region of the overhead cable pathway structure to the adapter mounted to the cable pathway structure; and d) terminating the cable to the adapter.,ADC TELECOMMUNICATIONS INC,COBURN HUTCH;;SMRHA MARK;;SJODIN CHAD;;FLEMING CRAIG,COMMSCOPE EMEA LIMITED (2015-08-28);;COMMSCOPE TECHNOLOGIES LLC (2015-08-28);;TYCO ELECTRONICS SERVICES GMBH (2015-08-25),https://lens.org/192-867-508-257-259,Patent Application,yes,33,0,23,23,0,G02B6/4459;;G02B6/4459;;H02G3/0608;;H02G3/0608;;Y10T29/49826;;Y10T29/49826,G02B6/44,29/428,0,0,,,,ACTIVE
219,GB,B,GB 2594729 B,054-359-641-560-121,2022-06-08,2022,GB 202006661 A,2020-05-05,GB 202006661 A,2020-05-05,Safety Helmet,,GLO SAFE LTD,MARK LITTLE;;CHARLES KENWARD;;CHYNA KENWARD;;ALEX FLEMING,,https://lens.org/054-359-641-560-121,Granted Patent,no,8,0,5,10,0,A42B3/044;;A42B3/04;;A42B3/0406;;A42B3/0433;;A42B3/044;;A42B3/044,A42B3/04,,0,0,,,,ACTIVE
220,UA,C2,UA 125632 C2,101-350-885-217-858,2022-05-04,2022,UA A201908337 A,2018-01-08,US 201762445429 P;;US 2018/0012730 W,2017-01-12,INSECTICIDAL PROTEIN,"The invention relates to insecticidal proteins having toxicity against Coleopteran and/or Lepidopteran insect pests as well as nucleic acid molecules encoding the insecticidal proteins, and methods of using the insecticidal proteins and nucleic acids encoding the insecticidal proteins of the invention, in transgenic plants to confer protection from insect damage.",SYNGENTA PARTICIPATIONS AG,REYNOLDS CLARENCE MICHAEL;;FLEMING CHRISTOPHER;;MONTGOMERY MARK GREER,,https://lens.org/101-350-885-217-858,Limited Patent,no,0,0,20,20,0,C07K14/195;;C12N15/8286;;A01N37/46;;Y02A40/146;;C12N15/82;;C12N15/113;;A01H5/00;;A01H6/4684;;C12N15/8286;;C07K14/195;;Y02A40/146,,,0,0,,,,ACTIVE
221,US,B2,US 9632274 B2,191-353-774-285-282,2017-04-25,2017,US 201414279926 A,2014-05-16,US 201414279926 A;;US 93095111 A;;US 29133208 A;;US 65575707 A,2007-01-19,Overhead cable termination arrangement,A method of terminating a cable includes: a) providing an overhead cable pathway structure that defines a cable-carrying region; b) mounting adapters to the overhead cable pathway structure outside of the cable-carrying region; c) routing a cable from the cable-carrying region of the overhead cable pathway structure to the adapter mounted to the cable pathway structure; and d) terminating the cable to the adapter.,COMMSCOPE TECHNOLOGIES LLC,COBURN HUTCH;;SMRHA MARK;;SJODIN CHAD;;FLEMING CRAIG,COMMSCOPE EMEA LIMITED (2015-08-28);;COMMSCOPE TECHNOLOGIES LLC (2015-08-28);;TYCO ELECTRONICS SERVICES GMBH (2015-08-25),https://lens.org/191-353-774-285-282,Granted Patent,yes,95,0,23,23,0,G02B6/4459;;G02B6/4459;;H02G3/0608;;H02G3/0608;;Y10T29/49826;;Y10T29/49826,G02B6/44;;H02G3/06,,0,0,,,,ACTIVE
222,CA,A1,CA 2596035 A1,122-938-425-581-033,2006-08-03,2006,CA 2596035 A,2006-01-27,US 64817205 P;;US 4660805 A;;US 12894705 A;;US 2006/0003129 W,2005-01-28,NON-IONIC NON-AQUEOUS VEHICLES FOR TOPICAL AND ORAL ADMINISTRATION OF CARRIER-COMPLEXED ACTIVE AGENTS,"An improved controlled release composition for non-parenteral administration of active agents and other therapeutics, particularly for oral or topical administration, has been developed. The composition is made by dispersing a complex formed of an active agent bound to an ion-exchange resin or to anoth er form of resin or carrier, in a non-ionic non-aqueous (""NINA"") vehicle. The complexes are optionally coated with one or more layers of coating material to provide a controlled pattern of release of active agent from the carrier. Th e combination of multiple active agents is possible with this system, in which one or more active agents are bound to particles and one or more active agen ts are dissolved or dispersed in the NINA vehicle. This allows the combination of two or more active agents, which are otherwise incompatible, into a single dosage form.",COLLEGIUM PHARMACEUTICAL INC,TRUMBORE MARK;;HIRSH JANE;;RARIY ROMAN V;;HIRSH MARK;;FLEMING ALISON,,https://lens.org/122-938-425-581-033,Patent Application,no,0,0,5,7,0,A61K31/4402;;A61K31/4402;;A61K9/006;;A61K9/006;;A61K9/5026;;A61K9/5026;;A61K31/137;;A61K31/137;;A61K47/585;;A61K47/585,A61K47/48;;A61K9/58,,0,0,,,,DISCONTINUED
223,CN,A,CN 101584095 A,038-931-193-535-698,2009-11-18,2009,CN 200880002471 A,2008-01-15,US 2008/0051082 W;;US 65575707 A,2007-01-19,Overhead cable terminaton arrangement,A system including an overhead cable pathway structure and an adapter panel or cable termination device that mounts overhead to the cable pathway structure. The cable termination device including a plurality of adapters and a cable pathway exit having a curved surface that guides cables exiting from the overhead cable pathway structure to the adapters.,ADC TELECOMMUNICATIONS INC,HUTCH COBURN;;MARK SMRHA;;CHAD SJODIN;;CRAIG FLEMING,,https://lens.org/038-931-193-535-698,Patent Application,no,0,0,23,23,0,G02B6/4459;;G02B6/4459;;H02G3/0608;;H02G3/0608;;Y10T29/49826;;Y10T29/49826,H02G3/22,,0,0,,,,INACTIVE
224,EP,A1,EP 2127049 A1,091-403-940-377-754,2009-12-02,2009,EP 08727684 A,2008-01-15,US 2008/0051082 W;;US 65575707 A,2007-01-19,OVERHEAD CABLE TERMINATON ARRANGEMENT,,ADC TELECOMMUNICATIONS INC,COBURN HUTCH;;SMRHA MARK;;SJODIN CHAD;;FLEMING CRAIG,"COMMSCOPE TECHNOLOGIES LLC (2020-05-13);;COMMSCOPE TECHNOLOGIES LLC, HICKORY, US (2020-05-04)",https://lens.org/091-403-940-377-754,Patent Application,yes,0,0,23,23,0,G02B6/4459;;G02B6/4459;;H02G3/0608;;H02G3/0608;;Y10T29/49826;;Y10T29/49826,H02G3/22,,1,0,,,See references of WO 2008089192A1,ACTIVE
225,EP,A1,EP 3908091 A1,138-241-319-866-976,2021-11-10,2021,EP 21172164 A,2021-05-04,US 202063019571 P;;US 202117243852 A,2020-05-04,DATA CENTER CABINET AND TOP CAPS FOR A DATA CENTER CABINET,"A data center cabinet has a base frame and a top cap attached to the base frame. The top cap has a main panel having a front edge, rear edge, first side edge, a second side edge, top surface, and bottom surface. An opening is formed through the main panel and is inset and spaced apart from the front, rear, first side, and second side edges. A removable door is positioned over the opening and is hinged to the main panel such that the door can rotate between an open position and a closed position and be removed from the main panel.
",PANDUIT CORP,MARCUS RICARD A;;FLEMING JAMES N;;SHURHAY MARK,,https://lens.org/138-241-319-866-976,Patent Application,yes,3,0,4,4,0,H05K5/0217;;H05K5/03;;H05K7/1488;;E05C1/04;;E05D7/123;;E05Y2900/606;;H05K5/0221;;H05K7/1488,H05K7/14,,0,0,,,,PENDING
226,CL,A1,CL 2020002529 A1,015-536-202-013-978,2021-01-29,2021,CL 2020002529 A,2020-09-30,US 201762445429 P,2017-01-12,Proteínas insecticidas.(divisional de solicitud 1898-2019),"Se divulgan composiciones y métodos para controlar plagas de plantas. En particular, se proporcionan proteínas insecticidas novedosas que tienen toxicidad contra plagas de insectos coleópteros y/o lepidópteros. También se proporcionan moléculas de ácido nucleico que codifican las proteínas insecticidas novedosas. También se divulgan métodos de preparación de las proteínas insecticidas y métodos de utilización de las proteínas insecticidas y ácidos nucleicos que codifican las proteínasinsecticidas de la invención, por ejemplo, en plantastransgénicas para conferir protección contra el daño debido a insectos.",SYNGENTA PARTICIPATIONS AG,REYNOLDS CLARENCE MICHAEL;;FLEMING CHRISTOPHER;;MONTGOMERY MARK GREER,,https://lens.org/015-536-202-013-978,Patent Application,no,0,0,20,20,0,C07K14/195;;C12N15/8286;;A01N37/46;;Y02A40/146;;C12N15/82;;C12N15/113;;A01H5/00;;A01H6/4684;;C12N15/8286;;C07K14/195;;Y02A40/146,A01N37/18;;A01P7/04;;C12N1/21;;C12N15/31;;C12N15/63;;C12N15/82,,0,0,,,,PENDING
227,EP,A1,EP 3558184 A1,012-127-474-036-640,2019-10-30,2019,EP 17829655 A,2017-12-22,EP 16206492 A;;EP 2017084424 W,2016-12-22,A DRESSING SYSTEM,,FLEMING MEDICAL LTD;;UNIV COLLEGE CORK NATIONAL UNIV OF IRELAND CORK,O'MAHONY CONOR;;O'FLYNN BRENDAN;;GALVIN PAUL;;FLEMING MARK,,https://lens.org/012-127-474-036-640,Patent Application,yes,0,0,3,3,0,A61F13/00051;;A61B2562/0214;;A61F13/00055;;A61B5/6833;;A61B5/01;;A61B5/445;;A61B5/7275;;A61B2562/0247;;A61B2562/029;;G16H40/63;;G16H40/63;;A61B5/01;;A61B5/445;;A61B5/6833;;A61B2562/0214;;A61B2562/0247;;A61B2562/029;;A61F13/00055;;A61F13/00085;;A61B5/7275;;A61B5/0002;;A61B5/14539;;A61B2562/166;;A61B5/0024;;A61B5/4875,A61F13/00;;A61B5/145,,0,0,,,,DISCONTINUED
228,MX,A,MX 2019007962 A,161-294-639-401-767,2019-09-04,2019,MX 2019007962 A,2018-01-08,US 201762445429 P;;US 2018/0012730 W,2017-01-12,INSECTICIDAL PROTEINS.,"Compositions and methods for controlling plant pests are disclosed. In particular, novel insecticidal proteins having toxicity against Coleopteran and/or Lepidopteran insect pests are provided. Nucleic acid molecules encoding the novel insecticidal proteins are also provided. Methods of making the insecticidal proteins and methods of using the insecticidal proteins and nucleic acids encoding the insecticidal proteins of the invention, for example in transgenic plants to confer protection from insect damage, are also disclosed.",SYNGENTA PARTICIPATIONS AG,CLARENCE MICHAEL REYNOLDS;;CHRISTOPHER FLEMING;;MARK GREER MONTGOMERY,,https://lens.org/161-294-639-401-767,Patent Application,no,0,0,20,20,0,C07K14/195;;C12N15/8286;;A01N37/46;;Y02A40/146;;C12N15/82;;C12N15/113;;A01H5/00;;A01H6/4684;;C12N15/8286;;C07K14/195;;Y02A40/146,A01P7/04;;A01N37/18;;C12N1/21;;C12N15/31;;C12N15/63;;C12N15/82,,0,0,,,,PENDING
229,AR,A1,AR 110881 A1,195-831-185-939-224,2019-05-15,2019,AR P180100038 A,2018-01-08,US 201762445429 P,2017-01-12,"PROTEÍNAS INSECTICIDAS DERIVADAS DE UNA BACTERIA MARÍTIMA, WOODSHOLEA MARÍTIMA","Se divulgan composiciones y métodos para controlar plagas de plantas. En particular, se proporcionan proteínas insecticidas que tienen toxicidad contra plagas de insectos coleópteros y/o lepidópteros. También se proporcionan moléculas de ácido nucleico que codifican las proteínas insecticidas. También se divulgan métodos de preparación de las proteínas insecticidas y métodos de utilización de las proteínas insecticidas y ácidos nucleicos que codifican las proteínas insecticidas de la presente, por ejemplo, en plantas transgénicas para conferir protección contra el daño debido a insectos.",SYNGENTA PARTICIPATIONS AG,MONTGOMERY MARK GREER;;FLEMING CHRISTOPHER;;REYNOLDS CLARENCE MICHAEL,,https://lens.org/195-831-185-939-224,Patent Application,no,0,0,20,20,0,C07K14/195;;C12N15/8286;;A01N37/46;;Y02A40/146;;C12N15/82;;C12N15/113;;A01H5/00;;A01H6/4684;;C12N15/8286;;C07K14/195;;Y02A40/146,C12N15/31;;A01H5/00;;C12N1/21;;C12N15/63;;C12N15/82,,0,0,,,,PENDING
230,ES,T3,ES 2931105 T3,197-758-083-539-750,2022-12-27,2022,ES 18739286 T,2018-01-08,US 201762445429 P;;US 2018/0012730 W,2017-01-12,Proteínas insecticidas,"Se describen composiciones y métodos para controlar plagas de plantas. En particular, se proporcionan proteínas insecticidas novedosas que tienen toxicidad contra plagas de insectos coleópteros y/o lepidópteros. También se proporcionan moléculas de ácido nucleico que codifican las nuevas proteínas insecticidas. También se describen métodos para preparar las proteínas insecticidas y métodos para usar las proteínas insecticidas y los ácidos nucleicos que codifican las proteínas insecticidas de la invención, por ejemplo, en plantas transgénicas para conferir protección contra daños por insectos. (Traducción automática con Google Translate, sin valor legal)",SYNGENTA PARTICIPATIONS AG,REYNOLDS CLARENCE MICHAEL;;FLEMING CHRISTOPHER;;MONTGOMERY MARK GREER,,https://lens.org/197-758-083-539-750,Granted Patent,no,0,0,20,20,0,C07K14/195;;C12N15/8286;;A01N37/46;;Y02A40/146;;C12N15/82;;C12N15/113;;A01H5/00;;A01H6/4684;;C12N15/8286;;C07K14/195;;Y02A40/146,A01P7/04;;A01N37/18;;C12N1/21;;C12N15/31;;C12N15/63;;C12N15/82,,0,0,,,,ACTIVE
231,WO,A2,WO 2006/081518 A2,154-375-530-818-391,2006-08-03,2006,US 2006/0003129 W,2006-01-27,US 64817205 P;;US 4660805 A;;US 12894705 A,2005-01-28,NON-IONIC NON-AQUEOUS VEHICLES FOR TOPICAL AND ORAL ADMINISTRATION OF CARRIER-COMPLEXED ACTIVE AGENTS,"An improved controlled release composition for non-parenteral administration of active agents and other therapeutics, particularly for oral or topical administration, has been developed. The composition is made by dispersing a complex formed of an active agent bound to an ion-exchange resin or to another form of resin or carrier, in a non-ionic non-aqueous ('NINA') vehicle. The complexes are optionally coated with one or more layers of coating material to provide a controlled pattern of release of active agent from the carrier. The combination of multiple active agents is possible with this system, in which one or more active agents are bound to particles and one or more active agents are dissolved or dispersed in the NINA vehicle. This allows the combination of two or more active agents, which are otherwise incompatible, into a single dosage form.",COLLEGIUM PHARMACEUTICAL INC;;HIRSH JANE;;RARIY ROMAN V;;TRUMBORE MARK;;FLEMING ALISON;;HIRSH MARK,HIRSH JANE;;RARIY ROMAN V;;TRUMBORE MARK;;FLEMING ALISON;;HIRSH MARK,,https://lens.org/154-375-530-818-391,Patent Application,yes,0,16,5,7,0,A61K31/4402;;A61K31/4402;;A61K9/006;;A61K9/006;;A61K9/5026;;A61K9/5026;;A61K31/137;;A61K31/137;;A61K47/585;;A61K47/585,A61K47/48;;A61K9/58,,0,0,,,,PENDING
232,WO,A1,WO 2021/224623 A1,029-506-958-103-43X,2021-11-11,2021,GB 2021051092 W,2021-05-05,GB 202006661 A,2020-05-05,SAFETY HELMET,A safety helmet (100) for an industrial worker is provided. The safety helmet (100) comprises an inner layer (102) and an outer layer (104) spaced from the inner layer (102) and defining a cavity (106) therebetween. The safety helmet (100) also comprises an array of light-emitting elements (108) arranged in the cavity (106) and distributed over the inner layer (102). The outer layer (104) includes a diffusing element for diffusing light emitted from the array of light-emitting elements 108 through the outer layer (104). One of the inner (102) and outer (104) layers forms a protective shell for protecting a user's head while wearing the helmet (100).,GLO SAFE LTD,KENWARD CHARLES;;KENWARD CHYNA;;LITTLE MARK;;FLEMING ALEX,,https://lens.org/029-506-958-103-43X,Patent Application,yes,5,3,5,10,0,A42B3/044;;A42B3/04;;A42B3/0406;;A42B3/0433;;A42B3/044;;A42B3/044,A42B3/04,,0,0,,,,PENDING
233,US,A1,US 2019/0316148 A1,069-084-146-440-91X,2019-10-17,2019,US 201816474127 A,2018-01-08,US 201816474127 A;;US 201762445429 P;;US 2018/0012730 W,2017-01-12,Insecticidal Proteins,"Compositions and methods for controlling plant pests are disclosed. In particular, novel insecticidal proteins having toxicity against Coleopteran and/or Lepidopteran insect pests are provided. Nucleic acid molecules encoding the novel insecticidal proteins are also provided. Methods of making the insecticidal proteins and methods of using the insecticidal proteins and nucleic acids encoding the insecticidal proteins of the invention, for example in transgenic plants to confer protection from insect damage, are also disclosed.",SYNGENTA PARTICIPATIONS AG,REYNOLDS CLARENCE MICHAEL;;FLEMING CHRISTOPHER;;MONTGOMERY MARK GREER,SYNGENTA PARTICIPATIONS AG (2018-02-20),https://lens.org/069-084-146-440-91X,Patent Application,yes,0,1,20,20,100,C07K14/195;;C12N15/8286;;A01N37/46;;Y02A40/146;;C12N15/82;;C12N15/113;;A01H5/00;;A01H6/4684;;C12N15/8286;;C07K14/195;;Y02A40/146,C12N15/82;;C12N15/113,,0,0,,,,ACTIVE
234,US,B2,US 8594080 B2,088-953-524-420-539,2013-11-26,2013,US 91636610 A,2010-10-29,US 91636610 A,2010-10-29,Multiple functionality in a virtual storage area network device,"In one aspect of the present description, a connection between a predetermined input port and a predetermined output port is created in a partition of a VSAN switch, in which the connection is a destination address independent physical layer connection conforming to the physical layer of a communication protocol. Another connection between a plurality of input ports and a plurality of output ports may be created in another partition of the VSAN switch, in which the connection is a multi-layer connection which includes a network layer connection conforming to the network layer of the communication protocol. Other features and aspects may be realized, depending upon the particular application.",FLEMING MARK SEAN;;KALLURI HEMANTH;;LARSON JEFFRY LYNN;;IBM,FLEMING MARK SEAN;;KALLURI HEMANTH;;LARSON JEFFRY LYNN,INTERNATIONAL BUSINESS MACHINES CORPORATION (2010-10-25),https://lens.org/088-953-524-420-539,Granted Patent,yes,29,3,2,2,0,H04L41/0803;;H04L67/1097;;H04L67/1097;;H04L41/0803,H04L12/28;;G06F3/00;;G06F15/16;;G06F15/173;;H04L12/54,370/355;;370/392;;370/397;;370/409;;370/428;;370/469;;709/220;;709/223;;709/230;;709/250;;710/36;;711/203,6,0,,,"""VSAN"", Wikipedia, (online), Jul. 10, 2010., Retrieved from the Internet at URL://http://en.wikipedia.org/wiki/VSAN, 1 pg.;;""Fibre Channel"", Wikipedia, (online), Oct. 1, 2010. Retrieved from the internet at URL://http://en.wikipedia.orgiwiki/Fibre-Channel, 8 pgs.;;""Fibre Channel Switch"", Wikipedia, (online), Dec. 17, 2009., Retrieved from the Internet at URL://http:www.en.wikipedia.org/wiki/Fibre-Channel-switch, 1 pg.;;""Network Switch"", Wikipedia, (online), Oct. 27, 2010., Retrieved from the Internet at URL://http:www.en.wikipedia.org/wiki/Network-switch, 6 pgs.;;""OSI Model"", Wikipedia, (online), Aug. 16, 2010., Retrieved from the Internet at URL://http:www.en.wikipedia.org/wiki/OSI-Model, 9 pgs.;;""Storage Area Network"", Wikipedia, (online), Oct. 29, 2010., Retrieved from the Internet at URL://http:www.en.wikipedia.org/wiki/Storage-area-network, 5 pgs.",INACTIVE
235,US,B2,US 10585259 B2,175-203-940-441-970,2020-03-10,2020,US 201715460903 A,2017-03-16,US 201715460903 A;;US 201414279926 A;;US 93095111 A;;US 29133208 A;;US 65575707 A,2007-01-19,Overhead cable termination arrangement,A method of terminating a cable includes: a) providing an overhead cable pathway structure that defines a cable-carrying region; b) mounting adapters to the overhead cable pathway structure outside of the cable-carrying region; c) routing a cable from the cable-carrying region of the overhead cable pathway structure to the adapter mounted to the cable pathway structure; and d) terminating the cable to the adapter.,COMMSCOPE TECHNOLOGIES LLC,COBURN HUTCH;;SMRHA MARK;;SJODIN CHAD;;FLEMING CRAIG,,https://lens.org/175-203-940-441-970,Granted Patent,yes,71,0,23,23,0,G02B6/4459;;G02B6/4459;;H02G3/0608;;H02G3/0608;;Y10T29/49826;;Y10T29/49826,G02B6/44;;H02G3/06,,1,0,,,"International Search Report and Written Opinion in PCT/US2008/051082 dated Jun. 20, 2008, 13 pages.",ACTIVE
236,US,B2,US 11102038 B2,030-224-044-037-026,2021-08-24,2021,US 201916600174 A,2019-10-11,US 201916600174 A;;US 201816121736 A;;US 201715678349 A;;US 201614989409 A;;US 201414491447 A;;US 201361880786 P,2013-09-20,"Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping",A method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of a selected number of samples of the signal representing a correlation of the signal to reference functions in the receiver. The presence of the data packet may then be detected and the detected packet decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. The slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.,OTSUKA PHARMA CO LTD,FLEMING ROBERT;;KUSHNER CHERIE;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,PROTEUS DIGITAL HEALTH INC (2014-02-11);;OTSUKA AMERICA PHARMACEUTICAL INC (2020-12-10);;OTSUKA PHARMACEUTICAL CO. LTD (2020-12-21),https://lens.org/030-224-044-037-026,Granted Patent,yes,1101,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L27/148;;H04L47/43;;H04B1/00;;H04L7/04;;H04L25/08;;H04L27/00;;H04L27/144,,71,25,055-061-122-716-256;;078-928-935-877-210;;115-503-002-121-573;;021-105-698-172-720;;020-429-685-293-077;;010-850-715-067-828;;125-568-654-521-572;;006-779-079-382-873;;028-355-179-339-927;;034-889-687-992-512;;119-428-445-234-356;;083-089-269-400-619;;025-399-612-692-728;;070-806-113-494-855;;058-786-009-599-841;;058-427-408-233-519;;072-268-151-160-087;;016-284-130-373-090;;007-791-330-066-861;;060-836-788-950-075;;106-238-568-760-584;;013-389-953-231-546;;119-603-577-296-247;;022-564-808-245-652;;020-208-605-928-943,10.1016/b978-1-4377-2333-5.00018-3;;10.1109/lcn.2002.1181789;;10.1109/icassp.1997.599620;;10.1088/0967-3334/20/1/004;;10374826;;18790434;;10.1016/j.bpg.2008.06.003;;10.1109/wd.2008.4812855;;18075039;;10.1109/tbme.2007.908332;;10.1109/tcsi.2004.838240;;10.1109/tbme.2007.910678;;18232361;;10.1126/science.134.3486.1196;;17753692;;13440945;;10.1038/1791239a0;;10.1016/j.jtherbio.2004.08.020;;10.1016/0016-5085(85)90342-7;;3891497;;10.1109/mwsym.2002.1011677;;10941095;;10.1002/1521-3773(20000717)39:14<2396::aid-anie2396>3.3.co;2-l;;10.1002/1521-3773(20000717)39:14<2396::aid-anie2396>3.0.co;2-u;;10.1016/s1359-0286(02)00032-3;;10.2174/1874476110801010022;;10.1201/9781420018677.ch12;;10.1007/978-3-540-95948-9_3;;10.1149/1.2086853;;10.1089/tmj.2004.10.s-110;;23570221;;10.1109/4.871321;;17947184;;10.1109/iembs.2006.259862;;10.1147/sj.353.0609;;10.1038/179898a0,"Aade, “AADE 37th Annual Meeting San Antonio Aug. 4-7, 2010” American Association of Diabetes Educators (2010); http://www.diabeteseducator.org/annualmeeting/2010/index.html; 2 pp.;;Arshak et al., A Review and Adaptation of Methods of Object Tracking to Telemetry Capsules IC-Med (2007) vol. 1, No. 1, Issue 1, 12 pp.;;“ASGE Technology Status Evaluation Report: wireless capsule endoscopy” American Soc. for Gastrointestinal Endoscopy (2006) vol. 63, No. 4; 7 pp.;;Au-Yeung, K., et al., “A Networked System for Self-Management of Drug Therapy and Wellness”, Wireless Health '10, Oct. 5-7, 2010, San Diego, 9 pages.;;Aydin et al., “Design and implementation considerations for an advanced wireless interface in miniaturized integrated sensor Microsystems” Sch. of Eng. & Electron., Edinburgh Univ., UK; (2003); abstract.;;Barrie, Heidelberg pH capsule gastric analysis. Texbook of Natural Medicine, (1992), Pizzorno, Murray & Barrie.;;Baskiyar, S. “A Real-time Fault Tolerant Intra-body Network” Dept. of Comp. Sci & Soft Eng; Auburn University; Proceedings of the 27th Annual IEEE Conference; 0742-1303/02 (2002) IEEE; 6 pp.;;Bergogne C., et al., “A new frequency estimator applied to burst transmission”, IEEE International Conference on Acoustics, Speech and Signal Processing, Apr. 21, 1997, vol. 1, pp. 267-270.;;Brock, “Smart Medicine: The Application of Auto-ID Technology to Healthcare” Auto-ID Labs (2002) http://www.autoidlabs.org/uploads/media/MIT-AUTOID-WH-010.pdf.;;Carlson et al., “Evaluation of a non-invasive respiratory monitoring system for sleeping subjects” Physiological Measurement (1999) 20(1): 53.;;Delvaux et al., “Capsule endoscopy: Technique and indications” Clinical Gastoenterology (2008) vol. 22, Issue 5, pp. 813-837.;;Description of ePatch Technology Platform for ECG and EMG, located it http://www.madebydelta.com/imported/images/DELTA_Web/documents/ME/ePatch_ECG_EMG.pdf, Dated Sep. 2, 2010.;;Evanczuk, S., “PIC MCU software library uses human body for secure communications link” EDN Network; edn.com; Feb. 26 (2013) Retrieved from internet Jun. 19, 2013 at http://www.edn.com/electronics-products/other/4407842/PIC-MCU-software-library-uses-human-body-for-secure-communications-link; 5 pp.;;Fawaz et al., “Enhanced Telemetry System using CP-QPSK Band-Pass Modulation Technique Suitable for Smart Pill Medical Application” IFIP IEEE Dubai Conference (2008); http://www.asic.fh-offenburg.de/downloads/ePille/IFIP_IEEE_Dubai_Conference.pdf.;;Gilson, D.R. “Molecular dynamics simulation of dipole interactions”, Department of Physics, Hull University, Dec. 2002, p. 1-43.;;Given Imaging, “Agile Patency Brochure” (2006) http://www.inclino.no/documents/AgilePatencyBrochure_Global_GMB-0118-01.pdf; 4pp.;;Gonzalez-Guillaumin et al., “Ingestible capsule for impedance and pH monitoring in the esophagus” IEEE Trans Biomed Eng. (2007) 54(12: 2231-6; abstract.;;Greene, “Edible RFID microchip monitor can tell if you take your medicine” Bloomberg Businessweek (2010) 2 pp.; http://www.businessweek.com/idg/2010-03-31/edible-rfid-microchip-monitor-can-tell-if-you-take-your-medicine.html.;;Halthion Medical Technologies “Providing Ambulatory Medical Devices Which Monitor, Measure and Record” webpage. Online website: http://www.halthion.com/; downloaded May 30, 2012.;;Heydari et al., “Analysis of the PLL jitter due to power/ground and substrate noise”; IEEE Transactions on Circuits and Systems (2004) 51(12): 2404-16.;;Hoover et al., “Rx for health: Engineers design pill that signals it has been swallowed” University of Florida News (2010) 2pp.; http://news.ufl.edu/2010/03/31/antenna-pill-2/.;;Hotz “The Really Smart Phone” the Wall Street Journal, What They Know (2011); 6 pp.; http://online.wsj.com/article/SB10001424052748704547604576263261679848814.html?mod=djemTECH_t.;;Intromedic, MicroCam Innovative Capsule Endoscope Pamphlet. (2006) 8 pp (http://www.intromedic.com/en/product/productinfo.asp).;;ISFET—Ion Sensitive Field-Effect Transistor; Microsens S.A. pdf document. First in Office Action dated Jun. 13, 2011 for U.S. Appl. No. 12/238,345; 4pp.;;Jung, S. “Dissolvable ‘Transient Electronics’ Will be Good for Your Body and the Environment” MedGadget; Oct. 1, 2012; Onlne website: http://medgadget.com/2012/10/dissolvable-transient-electronics-will-be-good-for-your-body-and-the-environment.html; downloaded Oct. 24, 2012; 4 pp.;;Juvenile Diabetes Research Foundation International (JDRF), “Artificial Pancreas Project” (2010); http://www.artificialpancreasproject.com/; 3 pp.;;Kang et al., “Nonwoven Fabric Active Electrodes for Biopotential Measurement During Normal Daily Activity,” IEEE Trans Biomed Eng. Jan. 2008; vol. 55, No. 1, pp. 188-195.;;Li, P-Y, et al. “An electrochemical intraocular drug delivery device”, Sensors and Actuators A 143 (2008) p. 41-48.;;Lifescan, “OneTouch UltraLink™” http://www.lifescan.com/products/meters/ultralink (2010) 2 pp.;;MacKay et al., “Radio Telemetering from within the Body” Inside Information is Revealed by Tiny Transmitters that can be Swallowed or Implanted in Man or Animal Science (1991) 1196-1202; 134; American Association for the Advancement of Science, Washington D.C.;;MacKay et al., “Endoradiosonde” Nature, (1957) 1239-1240, 179 Nature Publishing Group.;;McKenzie et al., “Validation of a new telemetric core temperature monitor” J. Therm. Biol. (2004) 29(7-8):605-11.;;Medtronic, “CareLink Therapy Management Software for Diabetes” (2010); https://carelink.minimed.com/patient/entry.jsp?bhcp=1; 1 pp.;;Medtronic, “Carelink™ USB” (2008) http://www.medtronicdiabetes.com/pdf/carelink_usb_factsheet.pdf 2pp.;;Medtronic “The New MiniMed Paradigm® Real-Time Revel™ System” (2010) http://www.medtronicdiabetes.com/products/index.html; 2 pp.;;Medtronic, “Mini Med Paradigm ® Revel™ Insulin Pump” (2010) http://www.medtronicdiabetes.com/products/insulinpumps/index.html; 2 pp.;;Medtronic, Mini Med Paradigm™ Veo™ System: Factsheet (2010). http://www.medtronic-diabetes.com.au/downloads/Paradigm%20Veo%20Factsheet.pdf ; 4 pp.;;Melanson, “Walkers swallow RFID pills for science” Engadget (2008); http://www.engadget.com/2008/07/29/walkers-swallow-rfid-pills-for-science/.;;MiniMitter Co. Inc. “Actiheart” Traditional 510(k) Summary. Sep. 27, 2005.;;MiniMitter Co. Inc. Noninvasive technology to help your studies succeed. Mini Mitter.com Mar. 31, 2009.;;Mini Mitter Co, Inc. 510(k) Premarket Notification Mini-Logger for Diagnostic Spirometer. Sep. 21, 1999.;;Mini Mitter Co, Inc. 510(k) Premarket Notification for VitalSense. Apr. 22, 2004.;;MiniMitter Co. Inc. VitalSense Integrated Physiological Monitoring System. Product Description. (2005).;;MiniMitter Co. Inc. VitalSense Wireless Vital Signs Monitoring. Temperatures.com Mar. 31, 2009.;;Mojaverian et al., “Estimation of gastric residence time of the Heidelberg capsule in humans: effect of varying food composition” Gastroenterology (1985) 89:(2): 392-7.;;“New ‘smart pill’ to track adherence” E-Health-Insider (2010) http://www.e-health-insider.com/news/5910/new_‘smart_pill’_monitors_medicines.;;Owano, N., “Study proposes smart sutures with sensors for wounds” Phys.Org. Aug. 2012. http://phys.org/news/2012-08-smart-sutures-sensors-wounds.html.;;Park, “Medtronic to Buy MiniMed for $3.7 Billion” (2001) HomeCare; http://homecaremag.com/mag/medical_medtronic_buy_minimed/; 2 pp.;;Radio Antennae, http://www.erikdeman.de/html/sail018h.htm; (2008) 5 pages.;;“RFID “pill” monitors marchers” RFID News (2008) http://www.rfidnews.org/2008/07/23/rfid-pill-monitors-marchers/.;;Sanduleanu et al., “Octave tunable, highly linear, RC-ring oscillator with differential fine-coarse tuning, quadrature outputs and amplitude control for fiber optic transceivers” (2002) IEEE MTT-S International Microwave Symposium Digest 545-8.;;Santini, J.T. et al, “Microchips as controlled drug delivery-devices”, Agnew. Chem. Int. Ed. (2000), vol. 39, p. 2396-2407.;;“SensiVida minimally invasive clinical systems” Investor Presentation Oct. 2009 28pp; http://www.sensividamedtech.com/SensiVidaGeneralOctober09.pdf.;;Shawgo, R.S. et al. “BioMEMS from drug delivery”, Current Opinion in Solid State and Material Science 6 (2002), p. 329-334.;;Shrivas et al., “A New Platform for Bioelectronics-Electronic Pill”, Cummins College, (2010).; http://www.cumminscollege.org/downloads/electronics_and_telecommunication/Newsletters/Current%20Newsletters.pdf; First cited in third party client search conducted by Patent Eagle Search May 18, 2010 (2010).;;“Smartlife awarded patent for knitted transducer” Innovation in Textiles News: http://www.innovationintextiles.com/articles/208.php; 2pp. (2009).;;“The SmartPill Wireless Motility Capsule” SmartPill, the Measure of GI Health; (2010) http://www.smartpillcorp.com/index.cfm?pagepath=Products/The_SmartPill_Capsule&id=17814.;;Solanas et al., “RFID Technology for the Health Care Sector” Recent Patents on Electrical Engineering (2008) 1, 22-31.;;Soper, S.A. et al. “Bio-Mems Technologies and Applications”, Chapter 12, “MEMS for Drug Delivery”, p. 325-346 (2007).;;Swedberg, “University Team Sees Ingestible RFID Tag as a Boon to Clinical Trials” RFID Journal Apr. 27, 2010; http://www.rfidjournal.com/article/view/7560/1.;;Tajalli et al., “Improving the power-delay performance in subthreshold source-coupled logic circuits” Integrated Circuit and System Design. Power and Timing Modeling, Optimization and Simulation, Springer Berlin Heidelberg (2008) 21-30.;;Tatbul et al., “Confidence-based data management for personal area sensor networks” ACM International Conference Proceeding Series (2004) 72.;;Tierney, M.J. et al “Electroreleasing Composite Membranes for Delivery of Insulin and other Biomacromolecules”, J. Electrochem. Soc., vol. 137, No. 6, Jun. 1990, p. 2005-2006.;;Walkey, “Mosfet Structure and Processing”; 97.398* Physical Electronics Lecture 20, 24 pages, First in Office Action dated Jun. 13, 2011 for U.S. Appl. No. 12/238,345.;;Xiaoming et al., “A telemedicine system for wireless home healthcare based on bluetooth and the internet” Telemedicine Journal and e-health (2004) 10(S2): S110-6.;;Yang et al., “Fast-switching frequency synthesizer with a discriminator-aided phase detector” IEEE Journal of Solid-State Circuits (2000) 35(10): 1445-52.;;Yao et al., “Low Power Digital Communication in Implantable Devices Using Volume Conduction of Biological Tissues” Proceedings of the 28th IEEE, EMBS Annual International Conference, Aug. 30-Sep. 3, 2006.;;Zimmerman, “Personal Area Networks: Near-field intrabody communication” IBM Systems Journal (1996) 35 (3-4):609-17.;;Zworykin, “A Radio Pill” Nature, (1957) 898, 179 Nature Publishing Group.;;International Search Report and Written Opinion for International PCT Application No. PCT/2014/056576, dated Dec. 17, 2014.;;International Preliminary Report on Patentability for International PCT Application No. PCT/2014/056576, dated Mar. 22, 2016.",ACTIVE
237,US,A1,US 2018/0212808 A1,107-934-469-759-92X,2018-07-26,2018,US 201715678349 A,2017-08-16,US 201715678349 A;;US 201614989409 A;;US 201414491447 A;;US 201361880786 P,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING A SIGNAL IN THE PRESENCE OF NOISE USING SLICES AND WARPING",A method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of a selected number of samples of the signal representing a correlation of the signal to reference functions in the receiver. The presence of the data packet may then be detected and the detected packet decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. The slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.,PROTEUS DIGITAL HEALTH INC,FLEMING ROBERT;;KUSHNER CHERIE;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,PROTEUS DIGITAL HEALTH INC (2013-09-24),https://lens.org/107-934-469-759-92X,Patent Application,yes,0,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L27/148;;H04L47/43;;H04B1/00;;H04L7/04;;H04L25/08;;H04L27/00;;H04L27/144,,0,0,,,,ACTIVE
238,US,A1,US 2007/0036843 A1,024-162-655-656-717,2007-02-15,2007,US 34101606 A,2006-01-27,US 34101606 A;;US 4660805 A;;US 12894705 A;;US 64817205 P,2005-01-28,Non-ionic non-aqueous vehicles for topical and oral administration of carrier-complexed active agents,"An improved controlled release composition for non-parenteral administration of active agents and other therapeutics, particularly for oral or topical administration, has been developed. The composition is made by dispersing a complex formed of an active agent bound to an ion-exchange resin or to another form of resin or carrier, in a non-ionic non-aqueous (“NINA”) vehicle. The complexes are optionally coated with one or more layers of coating material to provide a controlled pattern of release of active agent from the carrier. Replacing the usual aqueous vehicle with a NINA vehicle, such as an oil or an ointment, allows the active agent-carrier complexes, with or without coatings, to be both orally and topically administered. The compositions can be formulated as powders, liquids, liquid suspensions, gels, capsules, soft gelatin capsules, tablets, chewable tablets, topical ointments, lotions, pourable or pumpable fluids, semisolid, crushable tablets, and unit-of-use sachets or capsules for reconstitution or direct application. The combination of multiple active agents is possible with this system, in which one or more active agents are bound to particles and one or more active agents are dissolved or dispersed in the NINA vehicle. This allows the combination of two or more active agents, which are otherwise incompatible, into a single dosage form.",COLLEGIUM PHARMACEUTICAL INC,HIRSH JANE;;RARIY ROMAN V;;TRUMBORE MARK W;;FLEMING ALISON;;HIRSH MARK,COLLEGIUM PHARMACEUTICAL INC (2006-02-08),https://lens.org/024-162-655-656-717,Patent Application,yes,57,77,5,7,0,A61K31/4402;;A61K31/4402;;A61K9/006;;A61K9/006;;A61K9/5026;;A61K9/5026;;A61K31/137;;A61K31/137;;A61K47/585;;A61K47/585,A61K9/70;;A61K9/22,424/443;;424/468,0,0,,,,DISCONTINUED
239,US,A1,US 2015/0036992 A1,000-384-167-105-062,2015-02-05,2015,US 201313957135 A,2013-08-01,US 201313957135 A,2013-08-01,APPARATUS FOR CABLE ORGANIZATION,"A cable management apparatus includes a flexible planar body and a plurality of channels aligned along a longitudinal axis on a surface of the flexible planar body. The flexible planar body has a plurality of fasteners aligned along a first edge and a second edge of the flexible planar body, the flexible planar body capable of forming a substantially circular bundle along the longitudinal axis. Each channel of the plurality of channels is configured to secure an individual cable to keep the cable from intersecting with another cable.",IBM,FLEMING MARK S;;MCNEAL STEVEN E;;NELSEN MICHAEL A,INTERNATIONAL BUSINESS MACHINES CORPORATION (2013-08-01),https://lens.org/000-384-167-105-062,Patent Application,yes,5,10,2,2,0,H05K7/1491;;H02G3/0481;;H02G3/30;;G02B6/4471;;G02B6/4454;;G02B6/4455;;G02B6/4453;;G02B6/4452;;H05K7/1491;;H02G3/0481;;H02G3/30;;H02G3/045;;G02B6/4471,H01B17/16;;G02B6/44,385/135;;174/174,0,0,,,,INACTIVE
240,US,B2,US 8909884 B2,031-071-183-707-044,2014-12-09,2014,US 201213457245 A,2012-04-26,CN 201110104772 A,2011-04-26,Migrating virtual machines across sites,"The invention relates to apparatus for managing data swap in a migration of virtual memory data of a virtual machine. In one embodiment, an apparatus comprises a receiving unit configured to receive a migration instruction and the second site information; a copying unit configured to copy memory data to a sub-logical unit in the first storage device; and a notifying unit configured to send a notification to instruct the second host to read the memory data from a mirror logical unit of a sub-logical unit in the second storage device. The apparatus modifies a mirror direction between the first and second storage devices and modifies a path table related to the first and second storage devices. Data of the virtual machine can be migrated and swapped in a metro mirror manner, thereby the virtual machine data can be migrated across sites without affecting system operation.",FLEMING MARK S;;PENG JIANG;;XIN ZHANG;;ZHANG RONG;;IBM,FLEMING MARK S;;PENG JIANG;;XIN ZHANG;;ZHANG RONG,INTERNATIONAL BUSINESS MACHINES CORPORATION (2012-04-28),https://lens.org/031-071-183-707-044,Granted Patent,yes,19,6,8,8,0,G06F2009/4557;;G06F9/45558;;G06F11/2076;;G06F2201/815;;G06F11/1469;;G06F2009/4557;;G06F9/45558;;G06F11/2076;;G06F2201/815;;H04L65/40;;G06F9/455;;G06F11/203;;G06F11/2058,G06F12/00;;G06F9/455;;G06F11/14;;H04L29/08,711/162;;711/165;;714/6.2;;714/6.23;;714/6.3,3,0,,,"VMware Corporation, ""VMware Vmotion, Live migration for virtual machines without service interruption,"" Product datasheet, 2009.;;Non-Final Office Action from U.S. Appl. No. 13/787,650 dated Apr. 8, 2014.;;Notice of Allowance and Fee(s) Due from U.S. Appl. No. 13/787,650 dated Jul. 25, 2014.",ACTIVE
241,US,B2,US 9787511 B2,039-976-483-383-851,2017-10-10,2017,US 201614989409 A,2016-01-06,US 201614989409 A;;US 201414491447 A;;US 201361880786 P,2013-09-20,"Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping",A method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of a selected number of samples of the signal representing a correlation of the signal to reference functions in the receiver. The presence of the data packet may then be detected and the detected packet decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. The slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.,PROTEUS DIGITAL HEALTH INC,FLEMING ROBERT;;KUSHNER CHERIE;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,PROTEUS DIGITAL HEALTH INC (2013-09-24),https://lens.org/039-976-483-383-851,Granted Patent,yes,1004,7,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L27/148;;H04L47/43;;H04B1/00;;H04L7/04;;H04L25/08;;H04L27/00;;H04L27/144,,68,24,055-061-122-716-256;;078-928-935-877-210;;021-105-698-172-720;;020-429-685-293-077;;010-850-715-067-828;;125-568-654-521-572;;006-779-079-382-873;;034-889-687-992-512;;119-428-445-234-356;;083-089-269-400-619;;025-399-612-692-728;;070-806-113-494-855;;058-786-009-599-841;;058-427-408-233-519;;072-268-151-160-087;;016-284-130-373-090;;007-791-330-066-861;;060-836-788-950-075;;106-238-568-760-584;;013-389-953-231-546;;119-603-577-296-247;;022-564-808-245-652;;020-208-605-928-943;;115-503-002-121-573,10.1016/b978-1-4377-2333-5.00018-3;;10.1109/lcn.2002.1181789;;10.1088/0967-3334/20/1/004;;10374826;;18790434;;10.1016/j.bpg.2008.06.003;;10.1109/wd.2008.4812855;;18075039;;10.1109/tbme.2007.908332;;10.1109/tcsi.2004.838240;;10.1126/science.134.3486.1196;;17753692;;13440945;;10.1038/1791239a0;;10.1016/j.jtherbio.2004.08.020;;10.1016/0016-5085(85)90342-7;;3891497;;10.1109/mwsym.2002.1011677;;10941095;;10.1002/1521-3773(20000717)39:14<2396::aid-anie2396>3.3.co;2-l;;10.1002/1521-3773(20000717)39:14<2396::aid-anie2396>3.0.co;2-u;;10.1016/s1359-0286(02)00032-3;;10.2174/1874476110801010022;;10.1201/9781420018677.ch12;;10.1007/978-3-540-95948-9_3;;10.1149/1.2086853;;10.1089/tmj.2004.10.s-110;;23570221;;10.1109/4.871321;;17947184;;10.1109/iembs.2006.259862;;10.1147/sj.353.0609;;10.1038/179898a0;;10.1109/icassp.1997.599620,"AADE, “AADE 37th Annual Meeting San Antonio Aug. 4-7, 2010” American Association of Diabetes Educators (2010); http://www.diabeteseducator.org/annualmeeting/2010/index.html; 2 pp.;;Arshak et al., A Review and Adaptation of Methods of Object Tracking to Telemetry Capsules IC-Med (2007) vol. 1, No. 1, Issue 1, 12 pp.;;“ASGE Technology Status Evaluation Report: wireless capsule endoscopy” American Soc. For Gastrointestinal Endoscopy (2006) vol. 63, No. 4; 7 pp.;;Au-Yeung, K., et al., “A Networked System for Self-Management of Drug Therapy and Wellness”, Wireless Health '10, Oct. 5-7, 2010, San Diego, 9 pages.;;Aydin et al., “Design and implementation considerations for an advanced wireless interface in miniaturized integrated sensor Microsystems” Sch. of Eng. & Electron., Edinburgh Univ., UK; (2003); abstract.;;Barrie, Heidelberg pH capsule gastric analysis. Texbook of Natural Medicine, (1992), Pizzorno, Murray & Barrie.;;Baskiyar, S. “A Real-time Fault Tolerant Intra-body Network” Dept. of Comp. Sci & Soft Eng; Auburn University; Proceedings of the 27th Annual IEEE Conference; 0742-1303/02 (2002) IEEE; 6 pp.;;Brock, “Smart Medicine: The Application of Auto-ID Technology to Healthcare” Auto-ID Labs (2002) http://www.autoidlabs.org/uploads/media/MIT-AUTOID-WH-010.pdf.;;Carlson et al., “Evaluation of a non-invasive respiratory monitoring system for sleeping subjects” Physiological Measurement (1999) 20(1): 53.;;Delvaux et al., “Capsule endoscopy: Technique and indications” Clinical Gastoenterology (2008) vol. 22, Issue 5, pp. 813-837.;;Description of ePatch Technology Platform for ECG and EMG, located it http://www.madebydelta.com/imported/images/DELTA—Web/documents/ME/ePatch—ECG—EMG.pdf, Dated Sep. 2, 2010.;;Evanczuk, S., “PIC MCU software library uses human body for secure communications link” EDN Network; edn.com; (Feb. 26, 2013) Retrieved from internet Jun. 19, 2013 at http://www.edn.com/electronics-products/other/4407842/PIC-MCU-software-library-uses-human-body-for-secure-communications-link; 5 pp.;;Fawaz et al., “Enhanced Telemetry System using CP-QPSK Band—Pass Modulation Technique Suitable for Smart Pill Medical Application” IFIP IEEE Dubai Conference (2008); http://www.asic.fh-offenburg.de/downloads/ePille/IFIP—IEEE—Dubai—Conference.pdf.;;Gilson, D.R. “Molecular dynamics simulation of dipole interactions”, Department of Physics, Hull University, (Dec. 2002), p. 1-43.;;Given Imaging, “Agile Patency Brochure” (2006) http://www.inclino.no/documents/AgilePatencyBrochure—Global—GMB-0118-01.pdf; 4pp.;;Gonzalez-Guillaumin et al., “Ingestible capsule for impedance and pH monitoring in the esophagus” IEEE Trans Biomed Eng. (2007) 54(12: 2231-6; abstract.;;Greene, “Edible RFID microchip monitor can tell if you take your medicine” Bloomberg Businessweek (2010) 2 pp.; http://www.businessweek.com/idg/2010-03-31/edible-rfid-microchip-monitor-can-tell-if-you-take-your-medicine.html.;;Halthion Medical Technologies “Providing Ambulatory Medical Devices Which Monitor, Measure and Record” webpage. Online website: http://www.halthion.com/; downloaded (May 30, 2012).;;Heydari et al., “Analysis of the PLL jitter due to power/ground and substrate noise”; IEEE Transactions on Circuits and Systems (2004) 51(12): 2404-16.;;Hoover et al., “Rx for health: Engineers design pill that signals it has been swallowed” University of Florida News (2010) 2pp.; http://news.ufl.edu/2010/03/31/antenna-pill-2/.;;Hotz “The Really Smart Phone” The Wall Street Journal, What They Know (2011); 6 pp.; http://online.wsj.com/article/SB10001424052748704547604576263261679848814.html?mod=djemTECH—t.;;Intromedic, MicroCam Innovative Capsule Endoscope Pamphlet. (2006) 8 pp (http://www.intromedic.com/en/product/productinfo.asp).;;ISFET—Ion Sensitive Field-Effect Transistor; Microsens S.A. pdf document. First in Office Action dated (Jun. 13, 2011) for U.S. Appl. No. 12/238,345; 4pp.;;Jung, S. “Dissolvable ‘Transient Electronics’ Will Be Good for Your Body and the Environment” MedGadget; (Oct. 1, 2012); Onlne website: http://medgadget.com/2012/10/dissolvable-transient-electronics-will-be-good-for-your-body-and-the-environment.html; downloaded Oct. 24, 2012; 4 pp.;;Juvenile Diabetes Research Foundation International (JDRF), “Artificial Pancreas Project” (2010); http://www.artificialpancreasproject.com/; 3 pp.;;Li, P-Y, et al. “An electrochemical intraocular drug delivery device”, Sensors and Actuators A 143 (2008) p. 41-48.;;Lifescan, “OneTouch UltraLink™” http://www.lifescan.com/products/meters/ultralink (2010) 2 pp.;;MacKay et al., “Radio Telemetering from within the Body” Inside Information is Revealed by Tiny Transmitters that can be Swallowed or Implanted in Man or Animal Science (1991) 1196-1202; 134; American Association for the Advancement of Science, Washington D.C.;;MacKay et al., “Endoradiosonde” Nature, (1957) 1239-1240, 179 Nature Publishing Group.;;McKenzie et al., “Validation of a new telemetric core temperature monitor” J. Therm. Biol. (2004) 29(7-8):605-11.;;Medtronic, “CareLink Therapy Management Software for Diabetes” (2010); https://carelink.minimed.com/patient/entry.jsp?bhcp=1; 1 pp.;;Medtronic, “Carelink™ USB” (2008) http://www.medtronicdiabetes.com/pdf/carelink—usb—factsheet.pdf 2pp.;;Medtronic “The New MiniMed Paradigm® REAL-Time Revel™ System” (2010) http://www.medtronicdiabetes.com/products/index.html; 2 pp.;;Medtronic, “Mini Med Paradigm® Revel™ Insulin Pump” (2010) http://www.medtronicdiabetes.com/products/insulinpumps/index.html; 2 pp.;;Medtronic, Mini Med Paradigm™ Veo™ System: Factsheet (2010). http://www.medtronic-diabetes.com.au/downloads/Paradigm%20Veo%20Factsheet.pdf ; 4 pp.;;Melanson, “Walkers swallow RFID pills for science” Engadget (2008); http://www.engadget.com/2008/07/29/walkers-swallow-rfid-pills-for-science/.;;MiniMitter Co. Inc. “Actiheart” Traditional 510(k) Summary. (Sep. 27, 2005).;;MiniMitter Co. Inc. Noninvasive technology to help your studies succeed. Mini Mitter.com (Mar. 31, 2009).;;Mini Mitter Co, Inc. 510(k) Premarket Notification Mini-Logger for Diagnostic Spirometer. (Sep. 21, 1999).;;Mini Mitter Co, Inc. 510(k) Premarket Notification for VitalSense. (Apr. 22, 2004).;;MiniMitter Co. Inc. VitalSense Integrated Physiological Monitoring System. Product Description. (2005).;;MiniMitter Co. Inc. VitalSense Wireless Vital Signs Monitoring. Temperatures.com (Mar. 31, 2009).;;Mojaverian et al., “Estimation of gastric residence time of the Heidelberg capsule in humans: effect of varying food composition” Gastroenterology (1985) 89:(2): 392-7.;;“New ‘smart pill’ to track adherence” E-Health-Insider (2010) http://www.e-health-insider.com/news/5910/new—‘smart—pill’—monitors—medicines.;;Owano, N., “Study proposes smart sutures with sensors for wounds” phys.org. (Aug. 2012). http://phys.org/news/2012-08-smart-sutures-sensors-wounds.html.;;Park, “Medtronic to Buy MiniMed for $3.7 Billion” (2001) HomeCare; http://homecaremag.com/mag/medical—medtronic—buy—minimed/; 2 pp.;;Radio Antennae, http://www.erikdeman.de/html/sail018h.htm; (2008) 5 pages.;;“RFID “pill” monitors marchers” RFID News (2008) http://www.rfidnews.org/2008/07/23/rfid-pill-monitors-marchers/.;;Sanduleanu et al., “Octave tunable, highly linear, RC-ring oscillator with differential fine-coarse tuning, quadrature outputs and amplitude control for fiber optic transceivers” (2002) IEEE MTT-S International Microwave Symposium Digest 545-8.;;Santini, J.T. et al, “Microchips as controlled drug delivery-devices”, Agnew. Chem. Int. Ed. (2000), vol. 39, p. 2396-2407.;;“SensiVida minimally invasive clinical systems” Investor Presentation (Oct. 2009) 28pp; http://www.sensividamedtech.com/SensiVidaGeneralOctober09.pdf.;;Shawgo, R.S. et al. “BioMEMS from drug delivery”, Current Opinion in Solid State and Material Science 6 (2002), p. 329-334.;;Shrivas et al., “A New Platform for Bioelectronics-Electronic Pill”, Cummins College, (2010).; http://www.cumminscollege.org/downloads/electronics—and—telecommunication/Newsletters/Current%20Newsletters.pdf; First in third party client search conducted by Patent Eagle Search May 18, 2010 (2010).;;“Smartlife awarded patent for knitted transducer” Innovation in Textiles News: http://www.innovationintextiles.com/articles/208.php; 2pp. (2009).;;“The SmartPill Wireless Motility Capsule” Smartpill, The Measure of GI Health; (2010) http://www.smartpillcorp.com/index.cfm?pagepath=Products/The—SmartPill—Capsule&id=17814.;;Solanas et al., “RFID Technology for the Health Care Sector” Recent Patents on Electrical Engineering (2008) 1, 22-31.;;Soper, S.A. et al. “Bio-Mems Technologies and Applications”, Chapter 12, “MEMS for Drug Delivery”, p. 325-346 (2007).;;Swedberg, “University Team Sees Ingestible RFID Tag as a Boon to Clinical Trials” RFID Journal (Apr. 27, 2010); http://www.rfidjournal.com/article/view/7560/1.;;Tajalli et al., “Improving the power-delay performance in subthreshold source-coupled logic circuits” Integrated Circuit and System Design. Power and Timing Modeling, Optimization and Simulation, Springer Berlin Heidelberg (2008) 21-30.;;Tatbul et al., “Confidence-based data management for personal area sensor networks” ACM International Conference Proceeding Series (2004) 72.;;Tierney, M.J. et al “Electroreleasing Composite Membranes for Delivery of Insulin and other Biomacromolecules”, J. Electrochem. Soc., vol. 137, No. 6, (Jun. 1990), p. 2005-2006.;;Walkey, “MOSFET Structure and Processing”; 97.398 Physical Electronics Lecture 20.;;Xiaoming et al., “A telemedicine system for wireless home healthcare based on bluetooth and the internet” Telemedicine Journal and e-health (2004) 10(S2): S110-6.;;Yang et al., “Fast-switching frequency synthesizer with a discriminator-aided phase detector” IEEE Journal of Solid-State Circuits (2000) 35(10): 1445-52.;;Yao et al., “Low Power Digital Communication in Implantable Devices Using Volume Conduction of Biological Tissues” Proceedings of the 28th IEEE, EMBS Annual International Conference, (Aug. 30-Sep. 3, 2006).;;Zimmerman, “Personal Area Networks: Near-field intrabody communication” IBM Systems Journal (1996) 35 (3-4):609-17.;;Zworkin, “A Radio Pill” Nature, (1957) 898, 179 Nature Publishing Group.;;Bergogne C., et al., “A new frequency estimator applied to burst transmission”, IEEE International Conference on Acoustics, Speech and Signal Processing, Apr. 21, 1997, vol. 1, pp. 267-270.",ACTIVE
242,US,A1,US 2019/0260618 A1,044-084-170-997-024,2019-08-22,2019,US 201816121736 A,2018-09-05,US 201816121736 A;;US 201715678349 A;;US 201614989409 A;;US 201414491447 A;;US 201361880786 P,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING A SIGNAL IN THE PRESENCE OF NOISE USING SLICES AND WARPING",A method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of a selected number of samples of the signal representing a correlation of the signal to reference functions in the receiver. The presence of the data packet may then be detected and the detected packet decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. The slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.,PROTEUS DIGITAL HEALTH INC,FLEMING ROBERT;;KUSHNER CHERIE;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,PROTEUS DIGITAL HEALTH INC (2013-09-24),https://lens.org/044-084-170-997-024,Patent Application,yes,0,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L27/148;;H04L47/43;;H04B1/00;;H04L7/04;;H04L25/08;;H04L27/00;;H04L27/144,,0,0,,,,ACTIVE
243,JP,A,JP 2018061293 A,086-163-749-637-887,2018-04-12,2018,JP 2018000593 A,2018-01-05,US 201361880786 P,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING SIGNAL IN PRESENCE OF NOISE USING SLICES AND WARPING","PROBLEM TO BE SOLVED: To provide preferable methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping.SOLUTION: The method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of the selected number of samples of the signal, the pair of values representing a correlation of the signal to reference functions in a receiver. The presence of the data packet may then be detected and the detected packet may be decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. A slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.SELECTED DRAWING: Figure 12",PROTEUS DIGITAL HEALTH INC,CHERIE KUSHNER;;ROBERT FLEMING;;WILLIAM H MCALLISTER;;ZDEBLICK MARK,,https://lens.org/086-163-749-637-887,Patent Application,no,5,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04B1/10;;H04L47/43;;H04L27/00,,0,0,,,,ACTIVE
244,JP,A,JP 2015057941 A,098-940-455-460-624,2015-03-26,2015,JP 2014221329 A,2014-10-30,US 65575707 A,2007-01-19,OVERHEAD CABLE TERMINATION ARRANGEMENT,"PROBLEM TO BE SOLVED: To improve methods and devices for managing and organizing systems, cabling and components in providing telecommunication services.SOLUTION: The present invention provides a system including an overhead cable pathway structure and an adapter panel or cable termination device that mounts overhead to the cable pathway structure, the cable termination device including a plurality of adapters and a cable pathway exit having a curved surface that guides cables exiting from the overhead cable pathway structure to the adapters.",ADC TELECOMMUNICATIONS INC,HUTCH COBURN;;MARK SMRHA;;CHAD J SJODIN;;CRAIG FLEMING,,https://lens.org/098-940-455-460-624,Patent Application,no,4,0,23,23,0,G02B6/4459;;G02B6/4459;;H02G3/0608;;H02G3/0608;;Y10T29/49826;;Y10T29/49826,H02G3/30;;G02B6/36;;G02B6/46;;H02G3/00;;H02G3/08,,0,0,,,,PENDING
245,US,A1,US 2015/0131764 A1,142-200-241-664-883,2015-05-14,2015,US 201414491447 A,2014-09-19,US 201414491447 A;;US 201361880786 P,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING A SIGNAL IN THE PRESENCE OF NOISE USING SLICES AND WARPING",A method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of a selected number of samples of the signal representing a correlation of the signal to reference functions in the receiver. The presence of the data packet may then be detected and the detected packet decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. The slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.,PROTEUS DIGITAL HEALTH INC,KUSHNER CHERIE;;FLEMING ROBERT;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,PROTEUS DIGITAL HEALTH INC (2013-09-24),https://lens.org/142-200-241-664-883,Patent Application,yes,4,6,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L25/08;;H04L47/43,375/343;;375/340,0,0,,,,ACTIVE
246,EP,A1,EP 1320774 A1,164-832-808-628-570,2003-06-25,2003,EP 01951247 A,2001-07-20,AU 1991/001008 W;;AU PQ968800 A,2000-08-25,Microstructured polymer optical waveguide,"An optical waveguide in the form of an optical fibre ( 10 ) having at least one longitudinally extending light guiding core region ( 11 ) composed at least in part of a polymeric material, a longitudinally extending core-surrounding region ( 12 ) composed of a polymeric material, and a plurality of light confining elements ( 15 ), such as, for example, channel-like holes, located within the core surrounding region. The light confining elements extend in the longitudinal direction of the core region and are distributed about the core region, and at least a majority of the light confining elements having a refractive index less than that of the polymeric material from which the core-surrounding region is composed. A preform for use in manufacture of the optical waveguide is also disclosed.",UNIV SYDNEY,FLEMING SIMON;;BASSETT IAN;;SCEATS MARK;;VAN EIJKELENBORG MARTIJN,,https://lens.org/164-832-808-628-570,Patent Application,yes,0,0,17,18,0,G02B6/02;;G02B6/02347;;G02B6/02357;;G02B6/02361;;G02B6/02371;;G02B6/00;;G02B6/02347;;G02B6/02;;G02B6/02357;;G02B6/02361;;G02B6/02371,G02B6/00;;G02B6/02;;G02B6/032,,0,0,,,,EXPIRED
247,US,B2,US 9270503 B2,070-563-646-638-889,2016-02-23,2016,US 201414491447 A,2014-09-19,US 201414491447 A;;US 201361880786 P,2013-09-20,"Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping",A method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of a selected number of samples of the signal representing a correlation of the signal to reference functions in the receiver. The presence of the data packet may then be detected and the detected packet decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. The slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.,PROTEUS DIGITAL HEALTH INC,FLEMING ROBERT;;KUSHNER CHERIE;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,PROTEUS DIGITAL HEALTH INC (2013-09-24),https://lens.org/070-563-646-638-889,Granted Patent,yes,103,9,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H03K9/00;;H04L47/43;;H04L7/04;;H04L25/08;;H04L27/00;;H04L27/144;;H04L27/148,,68,24,016-284-130-373-090;;007-791-330-066-861;;060-836-788-950-075;;119-428-445-234-356;;106-238-568-760-584;;013-389-953-231-546;;119-603-577-296-247;;022-564-808-245-652;;020-208-605-928-943;;055-061-122-716-256;;078-928-935-877-210;;021-105-698-172-720;;020-429-685-293-077;;010-850-715-067-828;;125-568-654-521-572;;006-779-079-382-873;;034-889-687-992-512;;119-428-445-234-356;;083-089-269-400-619;;025-399-612-692-728;;070-806-113-494-855;;058-786-009-599-841;;058-427-408-233-519;;072-268-151-160-087,10.1201/9781420018677.ch12;;10.1007/978-3-540-95948-9_3;;10.1149/1.2086853;;13440945;;10.1038/1791239a0;;10.1089/tmj.2004.10.s-110;;23570221;;10.1109/4.871321;;17947184;;10.1109/iembs.2006.259862;;10.1147/sj.353.0609;;10.1038/179898a0;;10.1016/b978-1-4377-2333-5.00018-3;;10.1109/lcn.2002.1181789;;10.1088/0967-3334/20/1/004;;10374826;;18790434;;10.1016/j.bpg.2008.06.003;;10.1109/wd.2008.4812855;;18075039;;10.1109/tbme.2007.908332;;10.1109/tcsi.2004.838240;;10.1126/science.134.3486.1196;;17753692;;13440945;;10.1038/1791239a0;;10.1016/j.jtherbio.2004.08.020;;10.1016/0016-5085(85)90342-7;;3891497;;10.1109/mwsym.2002.1011677;;10941095;;10.1002/1521-3773(20000717)39:14<2396::aid-anie2396>3.3.co;2-l;;10.1002/1521-3773(20000717)39:14<2396::aid-anie2396>3.0.co;2-u;;10.1016/s1359-0286(02)00032-3;;10.2174/1874476110801010022,"Soper, S.A. et al. ""Bio-Mems Technologies and Applications"", Chapter 12, ""MEMS for Drug Delivery"", p. 325-346 (2007).;;Swedberg, ""University Team Sees Ingestible RFID Tag as a Boon to Clinical Trials"" RFID Journal Apr. 27, (2010); http://www.rfidjournal.com/article/view/7560/1.;;Tajalli et al., ""Improving the power-delay performance in subthreshold source-coupled logic circuits"" Integrated Circuit and System Design. Power and Timing Modeling, Optimization and Simulation, Springer Berlin Heidelberg (2008) 21-30.;;Tatbul et al., ""Confidence-based data management for personal area sensor networks"" ACM International Conference Proceeding Series (2004) 72.;;Tierney, M.J. et al ""Electroreleasing Composite Membranes for Delivery of Insulin and other Biomacromolecules"", J. Electrochem. Soc., vol. 137, No. 6, Jun. (1990), p. 2005-2006.;;Walkey, ""MOSFET Structure and Processing""; 97.398* Physical Electronics Lecture 20.;;Whipple, Fred L.; ""Endoradiosonde,"" Nature, Jun. 1957, 1239-1240.;;Xiaoming et al., ""A telemedicine system for wireless home healthcare based on bluetooth and the internet"" Telemedicine Journal and e-health (2004) 10(S2): S110-6.;;Yang et al., ""Fast-switching frequency synthesizer with a discriminator-aided phase detector"" IEEE Journal of Solid-State Circuits (2000) 35(10): 1445-52.;;Yao et al., ""Low Power Digital Communication in Implantable Devices Using Volume Conduction of Biological Tissues"" Proceedings of the 28th IEEE, EMBS Annual International Conference, Aug. 30,-Sep. 3, (2006).;;Zimmerman, ""Personal Area Networks: Near-field intrabody communication"" IBM Systems Journal (1996) 35 (3-4):609-17.;;Zworkin, ""A Radio Pill"" Nature, (1957) 898, 179 Nature Publishing Group.;;Written Opinion and International Search Report for PCT/US2014/056576, dated Dec. 17, 2014 (13 pages).;;AADE, ""AADE 37th Annual Meeting San Antonio Aug. 4-7, 2010"" American Association of Diabetes Educators (2010); http://www.diabeteseducator.org/annualmeeting/2010/index.html; 2 pp.;;Arshak et al., A Review and Adaptation of Methods of Object Tracking to Telemetry Capsules IC-Med (2007) vol. 1, No. 1, Issue 1, 12 pp.;;""ASGE Technology Status Evaluation Report: wireless capsule endoscopy"" American Soc. For Gastrointestinal Endoscopy (2006) vol. 63, No. 4; 7 pp.;;Aydin et al., ""Design and implementation considerations for an advanced wireless interface in miniaturized integrated sensor Microsystems"" Sch. of Eng. & Electron., Edinburgh Univ., UK; (2003); abstract.;;Barrie, Heidelberg pH capsule gastric analysis. Texbook of Natural Medicine, (1992), Pizzorno, Murray & Barrie.;;Baskiyar, S. ""A Real-time Fault Tolerant Intra-body Network"" Dept. of Comp. Sci & Soft Eng; Auburn University; Proceedings of the 27th Annual IEEE Conference; 0742-1303/02 (2002) IEEE; 6 pp.;;Brock, ""Smart Medicine: The Application of Auto-ID Technology to Healthcare"" Auto-ID Labs (2002) http://www.autoidlabs.org/uploads/media/MIT-AUTOID-WH-010.pdf.;;Carlson et al., ""Evaluation of a non-invasive respiratory monitoring system for sleeping subjects"" Physiological Measurement (1999) 20(1): 53.;;Delvaux et al., ""Capsule endoscopy: Technique and indications"" Clinical Gastoenterology (2008) vol. 22, Issue 5, pp. 813-837.;;Description of ePatch Technology Platform for ECG and EMG, located it http://www.madebydelta.com/imported/images/DELTA-Web/documents/ME/ePatch-ECG-EMG.pdf, Dated Sep. 2, 2010.;;Evanczuk, S., ""PIC MCU software library uses human body for secure communications link"" EDN Network; edn.com; Feb. 26, (2013) Retrieved from internet Jun. 19, 2013 at http://www.edn.com/electronics-products/other/4407842/PIC-MCU-software-library-uses-human-body-for-secure-communications-link; 5 pp.;;Fawaz et al., ""Enhanced Telemetry System using CP-QPSK Band-Pass Modulation Technique Suitable for Smart Pill Medical Application"" IFIP IEEE Dubai Conference (2008); http://www.asic.fh-offenburg.de/downloads/ePille/IFIP-IEEE-Dubai-Conference.pdf.;;Gilson, D.R. ""Molecular dynamics simulation of dipole interactions"", Department of Physics, Hull University, Dec. (2002), p. 1-43.;;Given Imaging, ""Agile Patency Brochure"" (2006) http://www.inclino.no/documents/AgilePatencyBrochure-Global-GMB-0118-01.pdf; 4pp.;;Gonzalez-Guillaumin et al., ""Ingestible capsule for impedance and pH monitoring in the esophagus"" IEEE Trans Biomed Eng. (2007) 54(12: 2231-6; abstract.;;Greene, ""Edible RFID microchip monitor can tell if you take your medicine"" Bloomberg Businessweek (2010) 2 pp.; http://www.businessweek.com/idg/2010-03-31/edible-rfid-microchip-monitor-can-tell-if-you-take-your-medicine.html.;;Halthion Medical Technologies ""Providing Ambulatory Medical Devices Which Monitor, Measure and Record"" webpage. Online website: http://www.halthion.com/; downloaded May 30, (2012).;;Heydari et al., ""Analysis of the PLL jitter due to power/ground and substrate noise""; IEEE Transactions on Circuits and Systems (2004) 51(12): 2404-16.;;Hoover et al., ""Rx for health: Engineers design pill that signals it has been swallowed"" University of Florida News (2010) 2pp.; http://news.ufl.edu/2010/03/31/antenna-pill-2/.;;Hotz ""The Really Smart Phone"" The Wall Street Journal, What They Know (2011); 6 pp.; http://online.wsj.com/article/SB10001424052748704547604576263261679848814.html?mod=djemTECH-t.;;Intromedic, MicroCam Innovative Capsule Endoscope Pamphlet. (2006) 8 pp (http://www.intromedic.com/en/product/productinfo.asp).;;ISFET-Ion Sensitive Field-Effect Transistor; Microsens S.A. pdf document. First cited by Examiner in Office Action dated Jun. 13 (2011) for U.S. Appl. No. 12/238,345; 4pp.;;Jung, S. ""Dissolvable 'Transient Electronics' Will Be Good for Your Body and the Environment"" MedGadget; Oct. 1 (2012); Onlne website: http://medgadget.com/2012/10/dissolvable-transient-electronics-will-be-good-for-your-body-and-the-environment.html; downloaded Oct. 24, 2012; 4 pp.;;Juvenile Diabetes Research Foundation International (JDRF), ""Artificial Pancreas Project"" (2010); http://www.artificialpancreasproject.com/; 3 pp.;;Li, P-Y, et al. ""An electrochemical intraocular drug delivery device"", Sensors and Actuators A 143 (2008) p. 41-48.;;Lifescan, ""OneTouch UltraLink(TM)"" http://www.lifescan.com/products/meters/ultralink (2010) 2 pp.;;Mackay et al., ""Radio Telemetering from within the Body"" Inside Information is Revealed by Tiny Transmitters that can be Swallowed or Implanted in Man or Animal Science (1991) 1196-1202; 134; American Association for the Advancement of Science, Washington D.C.;;Mackay et al., ""Endoradiosonde"" Nature, (1957) 1239-1240, 179 Nature Publishing Group.;;McKenzie et al., ""Validation of a new telemetric core temperature monitor"" J. Therm. Biol. (2004) 29(7-8):605-11.;;Medtronic, ""CareLink Therapy Management Software for Diabetes"" (2010); https://carelink.minimed.com/patient/entry.jsp?bhcp=1; 1 pp.;;Medtronic, ""Carelink(TM) USB"" (2008) http://www.medtronicdiabetes.com/pdf/carelink-usb-factsheet.pdf 2pp.;;Medtronic ""The New MiniMed Paradigm� Real-Time Revel(TM) System"" (2010) http://www.medtronicdiabetes.com/products/index.html; 2 pp.;;Medtronic, ""MINI MED Paradigm� Revel(TM) Insulin Pump"" (2010) http://www.medtronicdiabetes.com/products/insulinpumps/index.html; 2 pp.;;Medtronic, Mini Med Paradigm(TM) Veo(TM) System: Factsheet (2010). http://www.medtronic-diabetes.com.au/downloads/Paradigm%20Veo%20Factsheet.pdf ; 4 pp.;;Melanson, ""Walkers swallow RFID pills for science"" Engadget (2008); http://www.engadget.com/2008/07/29/walkers-swallow-rfid-pills-for-science/.;;Minimitter Co. Inc. ""Actiheart"" Traditional 510(k) Summary. Sep. 27, (2005).;;Minimitter Co. Inc. Noninvasive technology to help your studies succeed. Mini Mitter.com Mar. 31, (2009).;;Mini Mitter Co, Inc. 510(k) Premarket Notification Mini-Logger for Diagnostic Spirometer. Sep. 21, (1999).;;Mini Mitter Co, Inc. 510(k) Premarket Notification for VitalSense. Apr. 22, (2004).;;Minimitter Co. Inc. VitalSense Integrated Physiological Monitoring System. Product Description. (2005).;;Minimitter Co. Inc. VitalSense Wireless Vital Signs Monitoring. Temperatures.com Mar. 31, (2009).;;Mojaverian et al., ""Estimation of gastric residence time of the Heidelberg capsule in humans: effect of varying food composition"" Gastroenterology (1985) 89:(2): 392-7.;;""New 'smart pill' to track adherence"" E-Health-Insider (2010) http://www.e-health-insider.com/news/5910/new-'smart-pill'-monitors-medicines.;;Owano, N., ""Study proposes smart sutures with sensors for wounds"" PHYS.ORG. Aug. (2012). http://phys.org/news/2012-08-smart-sutures-sensors-wounds.html.;;Park, ""Medtronic to Buy MiniMed for $3.7 Billion"" (2001) HomeCare; http://homecaremag.com/mag/medical-medtronic-buy-minimed/; 2 pp.;;Radio Antennae, http://www.erikdeman.de/html/sail018h.htm; (2008) 5 pages.;;""RFID ""pill"" monitors marchers"" RFID News (2008) http://www.rfidnews.org/2008/07/23/rfid-pill-monitors-marchers/.;;Sanduleanu et al., ""Octave tunable, highly linear, RC-ring oscillator with differential fine-coarse tuning, quadrature outputs and amplitude control for fiber optic transceivers"" (2002) IEEE MTT-S International Microwave Symposium Digest 545-8.;;Santini, J.T. et al, ""Microchips as controlled drug delivery-devices"", Agnew. Chem. Int. Ed. (2000), vol. 39, p. 2396-2407.;;""SensiVida minimally invasive clinical systems"" Investor Presentation Oct. (2009) 28pp; http://www.sensividamedtech.com/SensiVidaGeneralOctober09.pdf.;;Shawgo, R.S. et al. ""BioMEMS from drug delivery"", Current Opinion in Solid State and Material Science 6 (2002), p. 329-334.;;Shrivas et al., ""A New Platform for Bioelectronics-Electronic Pill"", Cummins College, (2010).; http://www.cumminscollege.org/downloads/electronics-and-telecommunication/Newsletters/Current%20Newsletters.pdf; First cited in third party client search conducted by Patent Eagle Search May 18, 2010 (2010).;;""Smartlife awarded patent for knitted transducer"" INNOVATION IN TEXTILES NEWS: http://www.innovationintextiles.com/articles/208.php; 2pp. (2009).;;""The SmartPill Wireless Motility Capsule"" SMARTPILL, The Measure of GI Health; (2010) http://www.smartpillcorp.com/index.cfm?pagepath=Products/The-SmartPill-Capsule&id=17814.;;Solanas et al., ""RFID Technology for the Health Care Sector"" Recent Patents on Electrical Engineering (2008) 1, 22-31.",ACTIVE
248,US,B2,US 7113681 B2,108-752-427-985-215,2006-09-26,2006,US 36257303 A,2003-06-11,AU PQ968800 A;;AU 1991/001008 W,2000-08-25,Polymer optical waveguide,"An optical waveguide in the form of an optical fibre ( 10 ) having at least one longitudinally extending light guiding core region ( 11 ) composed at least in part of a polymeric material, a longitudinally extending core-surrounding region ( 12 ) composed of a polymeric material, and a plurality of light confining elements ( 15 ), such as, for example, channel-like holes, located within the core surrounding region. The light confining elements extend in the longitudinal direction of the core region and are distributed about the core region, and at least a majority of the light confining elements having a refractive index less than that of the polymeric material from which the core-surrounding region is composed. A preform for use in manufacture of the optical waveguide is also disclosed.",UNIV SYDNEY,FLEMING SIMON;;BASSETT IAN;;SCEATS MARK;;VAN EIJKELENBORG MARTIJN,SYDNEY UNIVERSITY OF THE (2000-08-31),https://lens.org/108-752-427-985-215,Granted Patent,yes,9,1,17,18,0,G02B6/02;;G02B6/02347;;G02B6/02357;;G02B6/02361;;G02B6/02371;;G02B6/00;;G02B6/02347;;G02B6/02;;G02B6/02357;;G02B6/02361;;G02B6/02371,G02B6/00;;G02B6/032;;G02B6/02,385/125;;385/123;;385/124;;385/127,2,0,,,"Patent Abstracts of Japan, JP 2000-3035521 A, Nippon Telegraph & Ttelepyhone Corp., (Feb. 2, 2000).;;Patent Abstracts of Japan, JP 08-054520 A, Sumitomo Electric Ind. Ltd, (Feb. 27, 1996).",EXPIRED
249,AU,A,AU 1996/049913 A,115-250-097-429-083,1996-10-16,1996,AU 1996/049913 A,1996-02-21,US 41099395 A;;US 9602385 W,1995-03-27,Diaper registration control system,,PROCTER & GAMBLE,FLEMING JAMES MICHAEL;;STUEBE MYRON LEE;;WHALEY MARK DAVID,,https://lens.org/115-250-097-429-083,Patent Application,no,0,0,11,11,0,A61F13/15772;;A61F13/15772;;A61F13/15772;;A61F13/15723;;A61F13/15723;;A61F13/15723;;Y10T83/543;;Y10T83/543,A61F13/49;;A61F5/44;;A61F13/15;;A61F13/472,,0,0,,,,PENDING
250,US,A1,US 2016/0261441 A1,150-367-561-087-012,2016-09-08,2016,US 201614989409 A,2016-01-06,US 201614989409 A;;US 201414491447 A;;US 201361880786 P,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING A SIGNAL IN THE PRESENCE OF NOISE USING SLICES AND WARPING",A method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of a selected number of samples of the signal representing a correlation of the signal to reference functions in the receiver. The presence of the data packet may then be detected and the detected packet decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. The slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.,PROTEUS DIGITAL HEALTH INC,FLEMING ROBERT;;KUSHNER CHERIE;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,PROTEUS DIGITAL HEALTH INC (2013-09-24),https://lens.org/150-367-561-087-012,Patent Application,yes,2,3,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L27/148;;H04L47/43;;H04B1/00;;H04L25/08,,0,0,,,,ACTIVE
251,KR,A,KR 20160050018 A,161-824-013-223-36X,2016-05-10,2016,KR 20167003233 A,2014-09-19,US 201361880786 P;;US 2014/0056576 W,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING A SIGNAL IN THE PRESENCE OF NOISE USING SLICES AND WARPING","방법은 신호를 수신하고 샘플링하는 단계를 포함할 수 있다. 신호는 데이터 패킷을 인코딩할 수 있다. 신호와 수신기 내의 기준 함수의 상관을 나타내는 신호의 선택된 수의 샘플 각각에 대해 쌍의 값을 포함하는 슬라이스가 생성되고 저장될 수 있다. 데이터 패킷의 존재가 이후 검출될 수 있고, 검출된 패킷은 저장된 슬라이스로부터 디코딩된다. 슬라이스를 생성하고 저장하는 단계는 수신된 신호가 샘플링될 때 수행될 수 있다. 신호의 샘플 값은 슬라이스가 생성되고 저장될 때 폐기될 수 있다. 신호의 슬라이스 표현은 유연한 대역폭과 중심 주파수를 갖는 필터를 생성하기 위해 조절될 수 있다.",PROTEUS DIGITAL HEALTH INC,KUSHNER CHERIE;;FLEMING ROBERT;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,,https://lens.org/161-824-013-223-36X,Patent Application,no,1,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L47/43;;H04L7/04;;H04L27/00;;H04L27/144;;H04L27/148,,0,0,,,,ACTIVE
252,EP,A4,EP 1320774 A4,006-592-403-620-555,2005-04-06,2005,EP 01951247 A,2001-07-20,AU 1991/001008 W;;AU PQ968800 A,2000-08-25,POLYMER OPTICAL WAVEGUIDE,"An optical waveguide in the form of an optical fibre ( 10 ) having at least one longitudinally extending light guiding core region ( 11 ) composed at least in part of a polymeric material, a longitudinally extending core-surrounding region ( 12 ) composed of a polymeric material, and a plurality of light confining elements ( 15 ), such as, for example, channel-like holes, located within the core surrounding region. The light confining elements extend in the longitudinal direction of the core region and are distributed about the core region, and at least a majority of the light confining elements having a refractive index less than that of the polymeric material from which the core-surrounding region is composed. A preform for use in manufacture of the optical waveguide is also disclosed.",UNIV SYDNEY,FLEMING SIMON;;BASSETT IAN;;SCEATS MARK;;VAN EIJKELENBORG MARTIJN,,https://lens.org/006-592-403-620-555,Search Report,no,1,0,17,18,0,G02B6/02;;G02B6/02347;;G02B6/02357;;G02B6/02361;;G02B6/02371;;G02B6/00;;G02B6/02347;;G02B6/02;;G02B6/02357;;G02B6/02361;;G02B6/02371,G02B6/00;;G02B6/02;;G02B6/032,,2,1,056-764-269-381-590,10.1364/oe.9.000813;;19424319,"VAN EIJKELENBORG M A ET AL: ""Microstructured polymer optical fibre"", OPTICS EXPRESS OPT. SOC. AMERICA USA, vol. 9, no. 7, 20 January 9240 (9240-01-20), pages 319 - 327, XP002314921, ISSN: 1094-4087;;ARGYROS A ET AL: ""Ring structures in microstructured polymer optical fibres"", OPTICS EXPRESS OPT. SOC. AMERICA USA, vol. 9, no. 13, 20 January 1217 (1217-01-20), pages 813 - 820, XP002314922, ISSN: 1094-4087",EXPIRED
253,WO,A1,WO 2015/042411 A1,018-293-274-669-39X,2015-03-26,2015,US 2014/0056576 W,2014-09-19,US 201361880786 P,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING A SIGNAL IN THE PRESENCE OF NOISE USING SLICES AND WARPING",A method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of a selected number of samples of the signal representing a correlation of the signal to reference functions in the receiver. The presence of the data packet may then be detected and the detected packet decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. The slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.,PROTEUS DIGITAL HEALTH INC,KUSHNER CHERIE;;FLEMING ROBERT;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,,https://lens.org/018-293-274-669-39X,Patent Application,yes,5,14,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L25/03;;H04L47/43,,1,0,,,See also references of EP 3047618A4,PENDING
254,MX,A,MX 9707368 A,024-548-132-602-738,1997-11-29,1997,MX 9707368 A,1996-02-21,US 41099395 A;;US 9602385 W,1995-03-27,DIAPER REGISTRATION CONTROL SYSTEM.,"The automatic registration control system of the present invention is a closed loop system including a driving mechanism (10) for feeding a continuous web (12) of disposable absorbent articles, such as diaper pads, toward a cutter (14). The cutter (14) may separate completed pads from the web. A sensor (26) is positioned along the manufacturing line, and preferably preceding the cutter (14), for detecting at least one preselected feature of each diaper pad and producing a detection signal when the feature passes by the sensor (26). A position resolver (32) determines the angular position of the cutter (14) at the moment when the preselected diaper feature is detected, and the average angular position is calculated from a predetermined number of cutter (14) positions. The average cutter (14) position is compared to and subtracted from a target cutter (14) position to produce an error signal. The error signal is then converted into a control signal and supplied to a phase variator (44) which adjusts the position of the cutter (14) in response to the control signal.",PROCTER & GAMBLE,STUEBE MYRON LEE;;FLEMING JAMES MICHAEL;;WHALEY MARK DAVID,,https://lens.org/024-548-132-602-738,Patent Application,no,0,0,11,11,0,A61F13/15772;;A61F13/15772;;A61F13/15772;;A61F13/15723;;A61F13/15723;;A61F13/15723;;Y10T83/543;;Y10T83/543,A61F13/49;;A61F5/44;;A61F13/15;;A61F13/472,,0,0,,,,EXPIRED
255,US,A1,US 2013/0086340 A1,046-611-841-290-236,2013-04-04,2013,US 201213602051 A,2012-08-31,CN 201110305476 A,2011-09-30,MANAGING STORAGE DEVICES IN A CLOUD STORAGE ENVIRONMENT,"A method of managing storage devices including storage resources that are virtualized and integrated into corresponding intermediate volumes, wherein the intermediate volumes are virtualized and integrated into individual logical volumes. The method comprises acquiring storage resource requirements presented to the logical volumes where the requirements comprise redundancy, obtaining storage resources available from respective intermediate volumes, selecting intermediate volumes to satisfy the storage resource requirements based on the requirements and available storage resources, where a minimum number of the intermediate volumes is determined based on the required redundancy, and storing user data in selected intermediate volumes based on the required redundancy.",FLEMING MARK S;;JIANG PENG;;ZHANG RONG;;ZHANG XIN;;IBM,FLEMING MARK S;;JIANG PENG;;ZHANG RONG;;ZHANG XIN,INTERNATIONAL BUSINESS MACHINES CORPORATION (2012-08-21),https://lens.org/046-611-841-290-236,Patent Application,yes,1,39,4,4,0,H04L69/40;;G06F11/2094;;G06F3/0665;;G06F3/067;;G06F3/0605;;G06F3/0665;;G06F3/067;;H04L69/40;;G06F11/2094;;G06F3/0605,G06F12/02;;H04L69/40,711/161;;X711E12002,0,0,,,,INACTIVE
256,ES,T3,ES 2163007 T3,046-678-824-908-467,2002-01-16,2002,ES 96906574 T,1996-02-21,US 41099395 A,1995-03-27,SISTEMA DE CONTROL DE COINCIDENCIA PARA PAÑALES.,"EL SISTEMA AUTOMATICO DE CONTROL DE ALINEACION EN LA PRESENTE INVENCION, ES UN SISTEMA DE CICLO CERRADO QUE INCLUYE UN MECANISMO ACCIONADOR (10), PARA ALIMENTAR UNA TRAMA CONTINUA (12) DE ARTICULOS ABSORBENTES DESECHABLES, COMO GUATEADOS DE PAÑAL, HACIA UNA MAQUINA DE CORTAR (14). LA MAQUINA DE CORTAR (14) PUEDE SEPARAR GUATEADOS COMPLETOS DE LA TRAMA. SE COLOCA UN SENSOR (26) A LO LARGO DE LA LINEA DE FABRICACION, Y PREFERIBLEMENTE PRECEDIENDO A LA MAQUINA DE CORTAR (14), PARA DETECTAR AL MENOS UN RASGO PRESELECCIONADO DE CADA GUATEADO DE PAÑAL Y PRODUCIR UNA SEÑAL DE RECONOCIMIENTO CUANDO EL RASGO PASA POR EL SENSOR (26). UN REVOLVER DE POSICION (32) DETERMINA LA POSICION ANGULAR DE LA MAQUINA DE CORTAR (14), EN EL MOMENTO EN QUE SE DETECTA LA CARACTERISTICA PRESELECCIONADO DEL PAÑAL, Y SE CALCULA LA POSICION ANGULAR MEDIA A PARTIR DE VARIAS POSICIONES PREDETERMINADAS DE LA MAQUINA DE CORTAR (14). LA POSICION MEDIA DE LA MAQUINA DE CORTAR (14), SE COMPARA CON Y SE RESTA A UNA POSICION DEREFERENCIA DE LA MAQUINA DE CORTAR (14), PARA PRODUCIR UNA SEÑAL DE ERROR. SE CONVIERTE ENTONCES LA SEÑAL DE ERROR EN UNA SEÑAL DE CONTROL Y SE SUMINISTRA A UN VARIADOR DE FASE (44), QUE AJUSTA LA POSICION DE LA MAQUINA DE CORTAR (14) EN RESPUESTA A LA SEÑAL DE CONTROL.",PROCTER & GAMBLE,STUEBE MYRON LEE;;FLEMING JAMES MICHAEL;;WHALEY MARK DAVID,,https://lens.org/046-678-824-908-467,Granted Patent,no,0,0,11,11,0,A61F13/15772;;A61F13/15772;;A61F13/15772;;A61F13/15723;;A61F13/15723;;A61F13/15723;;Y10T83/543;;Y10T83/543,A61F13/49;;A61F5/44;;A61F13/15;;A61F13/472,,0,0,,,,EXPIRED
257,CA,A1,CA 2420075 A1,076-497-508-038-725,2002-02-28,2002,CA 2420075 A,2001-07-20,AU PQ968800 A;;AU 1991/001008 W,2000-08-25,POLYMER OPTICAL WAVEGUIDE,"An optical waveguide in the form of an optical fibre (10) having at least on e longitudinally extending light guiding core region (11) composed at least in part of a polymeric material, a longitudinally extending core-surrounding region (12) composed of a polymeric material, and a plurality of light confining elements (15), such as, for example, channel-like holes, located within the core surrounding region. The light confining elements extend in t he longitudinal direction of the core region and are distributed about the core region, and at least a majority of the light confining elements having a refractive index less than that of the polymeric material from which the cor e- surrounding region is composed. A preform for use in manufacture of the optical waveguide is also disclosed.",UNIV SYDNEY,VAN EIJKELENBORG MARTIJN;;SCEATS MARK;;FLEMING SIMON;;BASSETT IAN,,https://lens.org/076-497-508-038-725,Patent Application,no,0,0,17,18,0,G02B6/02;;G02B6/02347;;G02B6/02357;;G02B6/02361;;G02B6/02371;;G02B6/00;;G02B6/02347;;G02B6/02;;G02B6/02357;;G02B6/02361;;G02B6/02371,G02B6/00;;G02B6/02;;G02B6/032,,0,0,,,,EXPIRED
258,US,A1,US 2004/0101262 A1,150-545-551-230-216,2004-05-27,2004,US 36257303 A,2003-06-11,AU PQ968800 A;;AU 1991/001008 W,2000-08-25,Polymer optical waveguide,"
    An optical waveguide in the form of an optical fibre ( 10 ) having at least one longitudinally extending light guiding core region ( 11 ) composed at least in part of a polymeric material, a longitudinally extending core-surrounding region ( 12 ) composed of a polymeric material, and a plurality of light confining elements ( 15 ), such as, for example, channel-like holes, located within the core surrounding region. The light confining elements extend in the longitudinal direction of the core region and are distributed about the core region, and at least a majority of the light confining elements having a refractive index less than that of the polymeric material from which the core-surrounding region is composed. A preform for use in manufacture of the optical waveguide is also disclosed. 
",FLEMING SIMON;;BASSETT IAN;;SCEATS MARK;;EIJKELENBORG MARTIJN VAN,FLEMING SIMON;;BASSETT IAN;;SCEATS MARK;;EIJKELENBORG MARTIJN VAN,SYDNEY UNIVERSITY OF THE (2000-08-31),https://lens.org/150-545-551-230-216,Patent Application,yes,5,11,17,18,0,G02B6/02;;G02B6/02347;;G02B6/02357;;G02B6/02361;;G02B6/02371;;G02B6/00;;G02B6/02347;;G02B6/02;;G02B6/02357;;G02B6/02361;;G02B6/02371,G02B6/02;;G02B6/00;;G02B6/032,385/125,0,0,,,,EXPIRED
259,EP,A1,EP 3047618 A1,148-391-202-802-422,2016-07-27,2016,EP 14845438 A,2014-09-19,US 201361880786 P;;US 2014/0056576 W,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING A SIGNAL IN THE PRESENCE OF NOISE USING SLICES AND WARPING",,PROTEUS DIGITAL HEALTH INC,KUSHNER CHERIE;;FLEMING ROBERT;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,"OTSUKA PHARMACEUTICAL CO., LTD. (2021-05-26)",https://lens.org/148-391-202-802-422,Patent Application,yes,0,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L27/00;;H04L47/43;;H04B1/00;;H04L7/04;;H04L25/03;;H04L27/144;;H04L27/148,,0,0,,,,ACTIVE
260,US,B2,US 10498572 B2,167-429-005-547-83X,2019-12-03,2019,US 201816121736 A,2018-09-05,US 201816121736 A;;US 201715678349 A;;US 201614989409 A;;US 201414491447 A;;US 201361880786 P,2013-09-20,"Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping",A method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of a selected number of samples of the signal representing a correlation of the signal to reference functions in the receiver. The presence of the data packet may then be detected and the detected packet decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. The slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.,PROTEUS DIGITAL HEALTH INC,FLEMING ROBERT;;KUSHNER CHERIE;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,PROTEUS DIGITAL HEALTH INC (2013-09-24),https://lens.org/167-429-005-547-83X,Granted Patent,yes,1079,5,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L27/14;;H04L47/43;;H04B1/00;;H04L7/04;;H04L25/08;;H04L27/00;;H04L27/144;;H04L27/148,,69,25,055-061-122-716-256;;078-928-935-877-210;;115-503-002-121-573;;021-105-698-172-720;;020-429-685-293-077;;010-850-715-067-828;;125-568-654-521-572;;006-779-079-382-873;;028-355-179-339-927;;034-889-687-992-512;;119-428-445-234-356;;083-089-269-400-619;;025-399-612-692-728;;070-806-113-494-855;;058-786-009-599-841;;058-427-408-233-519;;072-268-151-160-087;;016-284-130-373-090;;007-791-330-066-861;;060-836-788-950-075;;106-238-568-760-584;;013-389-953-231-546;;119-603-577-296-247;;022-564-808-245-652;;020-208-605-928-943,10.1016/b978-1-4377-2333-5.00018-3;;10.1109/lcn.2002.1181789;;10.1109/icassp.1997.599620;;10.1088/0967-3334/20/1/004;;10374826;;18790434;;10.1016/j.bpg.2008.06.003;;10.1109/wd.2008.4812855;;18075039;;10.1109/tbme.2007.908332;;10.1109/tcsi.2004.838240;;10.1109/tbme.2007.910678;;18232361;;10.1126/science.134.3486.1196;;17753692;;13440945;;10.1038/1791239a0;;10.1016/j.jtherbio.2004.08.020;;10.1016/0016-5085(85)90342-7;;3891497;;10.1109/mwsym.2002.1011677;;10941095;;10.1002/1521-3773(20000717)39:14<2396::aid-anie2396>3.3.co;2-l;;10.1002/1521-3773(20000717)39:14<2396::aid-anie2396>3.0.co;2-u;;10.1016/s1359-0286(02)00032-3;;10.2174/1874476110801010022;;10.1201/9781420018677.ch12;;10.1007/978-3-540-95948-9_3;;10.1149/1.2086853;;10.1089/tmj.2004.10.s-110;;23570221;;10.1109/4.871321;;17947184;;10.1109/iembs.2006.259862;;10.1147/sj.353.0609;;10.1038/179898a0,"AADE, “AADE 37th Annual Meeting San Antonio Aug. 4-7, 2010” American Association of Diabetes Educators (2010); http://www.diabeteseducator.org/annualmeeting/2010/index.html; 2 pp.;;Arshak et al., A Review and Adaptation of Methods of Object Tracking to Telemetry Capsules IC-Med (2007) vol. 1, No. 1, Issue 1, 12 pp.;;“ASGE Technology Status Evaluation Report: wireless capsule endoscopy” American Soc. for Gastrointestinal Endoscopy (2006) vol. 63, No. 4; 7 pp.;;Au-Yeung, K., et al., “A Networked System for Self-Management of Drug Therapy and Wellness”, Wireless Health '10, Oct. 5-7, 2010, San Diego, 9 pp.;;Aydin et al., “Design and implementation considerations for an advanced wireless interface in miniaturized integrated sensor Microsystems” Sch. of Eng. & Electron., Edinburgh Univ., UK; (2003); abstract.;;Barrie, Heidelberg pH capsule gastric analysis. Texbook of Natural Medicine, (1992), Pizzorno, Murray & Barrie.;;Baskiyar, S. “A Real-time Fault Tolerant Intra-body Network” Dept. of Comp. Sci & Soft Eng; Auburn University; Proceedings of the 27th Annual IEEE Conference; 0742-1303/02 (2002) IEEE; 6 pp.;;Bergogne C., et al., “A new frequency estimator applied to burst transmission”, IEEE International Conference on Acoustics, Speech and Signal Processing, Apr. 21, 1997, vol. 1, pp. 267-270.;;Brock, “Smart Medicine: The Application of Auto-ID Technology to Healthcare” Auto-ID Labs (2002) http://www.autoidlabs.org/uploads/media/MIT-AUTOID-WH-010.pdf.;;Carlson et al., “Evaluation of a non-invasive respiratory monitoring system for sleeping subjects” Physiological Measurement (1999) 20(1): 53.;;Delvaux et al., “Capsule endoscopy: Technique and indications” Clinical Gastoenterology (2008) vol. 22, Issue 5, pp. 813-837.;;Description of ePatch Technology Platform for ECG and EMG, located it http://www.madebydelta.com/imported/images/DELTA_Web/documents/ME/ePatch_ECG_EMG.pdf, Dated Sep. 2, 2010.;;Evanczuk, S., “PIC MCU software library uses human body for secure communications link” EDN Network; edn.com; Feb. 26, 2013 Retrieved from internet Jun. 19, 2013 at http://www.edn.com/electronics-products/other/4407842/PIC-MCU-software-library-uses-human-body-for-secure-communications-link; 5 pp.;;Fawaz et al., “Enhanced Telemetry System using CP-QPSK Band-Pass Modulation Technique Suitable for Smart Pill Medical Application” IFIP IEEE Dubai Conference (2008); http://www.asic.fh-offenburg.de/downloads/ePille/IFIP_IEEE_Dubai_Conference.pdf.;;Gilson, D.R. “Molecular dynamics simulation of dipole interactions”, Department of Physics, Hull University, Dec. 2002, p. 1-43.;;Given Imaging, “Agile Patency Brochure” (2006) http://www.inclino.no/documents/AgilePatencyBrochure_Global_GMB-0118-01.pdf; 4pp.;;Gonzalez-Guillaumin et al., “Ingestible capsule for impedance and pH monitoring in the esophagus” IEEE Trans Biomed Eng. (2007) 54(12: 2231-6; abstract.;;Greene, “Edible RFID microchip monitor can tell if you take your medicine” Bloomberg Businessweek (2010) 2 pp.; http://www.businessweek.com/idg/2010-03-31/edible-rfid-microchip-monitor-can-tell-if-you-take-your-medicine.html.;;Halthion Medical Technologies “Providing Ambulatory Medical Devices Which Monitor, Measure and Record” webpage. Online website: http://www.halthion.com/; downloaded May 30, 2012.;;Heydari et al., “Analysis of the PLL jitter due to power/ground and substrate noise”; IEEE Transactions on Circuits and Systems (2004) 51(12): 2404-16.;;Hoover et al., “Rx for health: Engineers design pill that signals it has been swallowed” University of Florida News (2010) 2pp.; http://news.ufl.edu/2010/03/31/antenna-pill-2/.;;Hotz “The Really Smart Phone” The Wall Street Journal, What They Know (2011); 6 pp.; http://online.wsj.com/article/SB10001424052748704547604576263261679848814.html?mod=djemTECH_t.;;Intromedic, MicroCam Innovative Capsule Endoscope Pamphlet. (2006) 8 pp (http://www.intromedic.com/en/product/productinfo.asp).;;ISFET—Ion Sensitive Field-Effect Transistor; MICROSENS S.A. pdf document. First cited by Examiner in Office Action dated Jun. 13, 2011 for U.S. Appl. No. 12/238,345; 4pp.;;Jung, S. “Dissolvable ‘Transient Electronics’ Will Be Good for Your Body and the Environment” MedGadget; Oct. 1, 2012; Onlne website: http://medgadget.com/2012/10/dissolvable-transient-electronics-will-be-good-for-your-body-and-the-environment.html; downloaded Oct. 24, 2012; 4 pp.;;Juvenile Diabetes Research Foundation International (JDRF), “Artificial Pancreas Project” (2010); http://www.artificialpancreasproject.com/; 3 pp.;;Kang et al., “Nonwoven Fabric Active Electrodes for Biopotential Measurement During Normal Daily Activity,” IEEE Trans Biomed Eng. Jan. 2008; vol. 55, No. 1, pp. 188-195.;;Li, P-Y, et al. “An electrochemical intraocular drug delivery device”, Sensors and Actuators A 143 (2008) p. 41-48.;;Lifescan, “OneTouch UltraLink™”http://www.lifescan.com/products/meters/ultralink (2010) 2 pp.;;Mackay et al., “Radio Telemetering from within the Body Inside Information is Revealed by Tiny Transmitters that can be Swallowed or Implanted in Man or Animal Science” (1991) 1196-1202; 134; American Association for the Advancement of Science, Washington D.C.;;Mackay et al., “Endoradiosonde” Nature, (1957) 1239-1240, 179 Nature Publishing Group.;;McKenzie et al., “Validation of a new telemetric core temperature monitor” J. Therm. Biol. (2004) 29(7-8):605-11.;;Medtronic, “CareLink Therapy Management Software for Diabetes” (2010); https://carelink.minimed.com/patient/entry.jsp?bhcp=1; 1 pp.;;Medtronic, “Carelink198 USB” (2008) http://www.medtronicdiabetes.com/pdf/carelink_usb_factsheet.pdf 2pp.;;Medtronic “The New MiniMed Paradigm® Real-Time Revel™ System” (2010) http://www.medtronicdiabetes.com/products/index.html; 2 pp.;;Medtronic, “Mini Med Paradigm® Revel™ Insulin Pump” (2010) http://www.medtronicdiabetes.com/products/insulinpumps/index.html; 2 pp.;;Medtronic, Mini Med Paradigm™ Veo™ System: Factsheet (2010). http://www.medtronic-diabetes.com.au/downloads/Paradigm%20Veo%20Factsheet.pdf ; 4 pp.;;Melanson, “Walkers swallow RFID pills for science” Engadget (2008); http://www.engadget.com/2008/07/29/walkers-swallow-rfid-pills-for-science/.;;Minimitter Co. Inc. “Actiheart” Traditional 510(k) Summary. Sep. 27, 2005.;;Minimitter Co. Inc. Noninvasive technology to help your studies succeed. Mini Mitter.com Mar. 31, 2009.;;Mini Mitter Co, Inc. 510(k) Premarket Notification Mini-Logger for Diagnostic Spirometer. 9-21 (1999).;;Mini Mitter Co, Inc. 510(k) Premarket Notification for VitalSense. Apr. 22, 2004.;;Minimitter Co. Inc. VitalSense Integrated Physiological Monitoring System. Product Description. (2005).;;Minimitter Co. Inc. VitalSense Wireless Vital Signs Monitoring. Temperatures.com Mar. 31, 2009.;;Mojaverian et al., “Estimation of gastric residence time of the Heidelberg capsule in humans: effect of varying food composition” Gastroenterology (1985) 89:(2): 392-7.;;“New ‘smart pill’ to track adherence” E-Health-Insider (2010) http://www.e-health-insider.com/news/5910/new_‘smart_pill’_monitors_medicines.;;Owano, N., “Study proposes smart sutures with sensors for wounds” phys.org. Aug. 2012. http://phys.org/news/2012-08-smart-sutures-sensors-wounds.html.;;Park, “Medtronic to Buy MiniMed for $3.7 Billion” (2001) HomeCare; http://homecaremag.com/mag/medical_medtronic_buy_minimed/; 2 pp.;;Radio Antennae, http://www.erikdeman.de/html/sail018h.htm; (2008) 5 pages.;;“RFID “pill” monitors marchers” RFID News (2008) http://www.rfidnews.org/2008/07/23/rfid-pill-monitors-marchers/.;;Sanduleanu et al., “Octave tunable, highly linear, RC-ring oscillator with differential fine-coarse tuning, quadrature outputs and amplitude control for fiber optic transceivers” (2002) IEEE MTT-S International Microwave Symposium Digest 545-8.;;Santini, J.T. et al, “Microchips as controlled drug delivery-devices”, Agnew. Chem. Int. Ed. (2000), vol. 39, p. 2396-2407.;;“SensiVida minimally invasive clinical systems” Investor Presentation Oct. 2009 28pp; http://www.sensividamedtech.com/SensiVidaGeneralOctober09.pdf.;;Shawgo, R.S. et al. “BioMEMS from drug delivery”, Current Opinion in Solid State and Material Science 6 (2002), p. 329-334.;;Shrivas et al., “A New Platform for Bioelectronics-Electronic Pill”, Cummins College, (2010).; http://www.cumminscollege.org/downloads/electronics_and_telecommunication/Newsletters/Current%20Newsletters.pdf; First cited in third party client search conducted by Patent Eagle Search May 18, 2010 (2010).;;“Smartlife awarded patent for knitted transducer” Innovation in Textiles News: http://www.innovationintextiles.com/articles/208.php; 2pp. (2009).;;“The SmartPill Wireless Motility Capsule” SmartPill, The Measure of GI Health; (2010) http://www.smartpillcorp.com/index.cfm?pagepath=Products/The_SmartPill_Capsule&id=17814.;;Solanas et al., “RFID Technology for the Health Care Sector” Recent Patents on Electrical Engineering (2008) 1, 22-31.;;Soper, S.A. et al. “Bio-Mems Technologies and Applications”, Chapter 12, “MEMS for Drug Delivery”, p. 325-346 (2007).;;Swedberg, “University Team Sees Ingestible RFID Tag as a Boon to Clinical Trials” RFID Journal Apr. 27, 2010; http://www.rfidjournal.com/article/view/7560/1.;;Tajalli et al., “Improving the power-delay performance in subthreshold source-coupled logic circuits” Integrated Circuit and System Design. Power and Timing Modeling, Optimization and Simulation, Springer Berlin Heidelberg (2008) 21-30.;;Tatbul et al., “Confidence-based data management for personal area sensor networks” ACM International Conference Proceeding Series (2004) 72.;;Tierney, M.J. et al “Electroreleasing Composite Membranes for Delivery of Insulin and other Biomacromolecules”, J. Electrochem. Soc., vol. 137, No. 6, Jun. 1990, p. 2005-2006.;;Walkey, “MOSFET Structure and Processing”; 97.398* Physical Electronics Lecture 20, 24 pages, First cited by Examiner in Office Action dated Jun. 13, 2011 for U.S. Appl. No. 12/238,345.;;Xiaoming et al., “A telemedicine system for wireless home healthcare based on bluetooth and the internet” Telemedicine Journal and e-health (2004) 10(S2): S110-6.;;Yang et al., “Fast-switching frequency synthesizer with a discriminator-aided phase detector” IEEE Journal of Solid-State Circuits (2000) 35(10): 1445-52.;;Yao et al., “Low Power Digital Communication in Implantable Devices Using Volume Conduction of Biological Tissues” Proceedings of the 28th IEEE, EMBS Annual International Conference, Aug. 30-Sep. 3, 2006.;;Zimmerman, “Personal Area Networks: Near-field intrabody communication” IBM Systems Journal (1996) 35 (3-4):609-17.;;Zworykin, “A Radio Pill” Nature, (1957) 898, 179 Nature Publishing Group.",ACTIVE
261,AU,B2,AU 2014/321320 B2,161-659-658-508-585,2019-03-14,2019,AU 2014/321320 A,2014-09-19,US 201361880786 P;;US 2014/0056576 W,2013-09-20,"Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping",A method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of a selected number of samples of the signal representing a correlation of the signal to reference functions in the receiver. The presence of the data packet may then be detected and the detected packet decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. The slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.,OTSUKA PHARMA CO LTD,KUSHNER CHERIE;;FLEMING ROBERT;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,"OTSUKA PHARMACEUTICAL CO., LTD. (2021-05-13)",https://lens.org/161-659-658-508-585,Granted Patent,no,1,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L25/03;;H04L47/43,,0,0,,,,ACTIVE
262,CA,A1,CA 2213640 A1,012-205-507-040-859,1996-10-03,1996,CA 2213640 A,1996-02-21,US 41099395 A,1995-03-27,DIAPER REGISTRATION CONTROL SYSTEM,"The automatic registration control system of the present invention is a closed loop system including a driving mechanism (10) for feeding a continuous web (12) of disposable absorbent articles, such as diaper pads, toward a cutter (14). The cutter (14) may separate completed pads from the web. A sensor (26) is positioned along the manufacturing line, and preferably preceding the cutter (14), for detecting at least one preselected feature of each diaper pad and producing a detection signal when the feature passes by the sensor (26). A position resolver (32) determines the angular position of the cutter (14) at the moment when the preselected diaper feature is detected, and the average angular position is calculated from a predetermined number of cutter (14) positions. The average cutter (14) position is compared to and subtracted from a target cutter (14) position to produce an error signal. The error signal is then converted into a control signal and supplied to a phase variator (44) which adjusts the position of the cutter (14) in response to the control signal.",PROCTER & GAMBLE,WHALEY MARK DAVID;;STUEBE MYRON LEE;;FLEMING JAMES MICHAEL,,https://lens.org/012-205-507-040-859,Patent Application,no,0,0,11,11,0,A61F13/15772;;A61F13/15772;;A61F13/15772;;A61F13/15723;;A61F13/15723;;A61F13/15723;;Y10T83/543;;Y10T83/543,A61F13/49;;A61F5/44;;A61F13/15;;A61F13/472,,0,0,,,,DISCONTINUED
263,RU,C2,RU 2736776 C2,069-883-174-910-123,2020-11-20,2020,RU 2017127771 A,2014-09-19,US 201361880786 P,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING SIGNALS IN THE PRESENCE OF NOISE USING SECTIONS AND DEFORMATION","FIELD: wireless communication.SUBSTANCE: invention can be used in ""communication systems with the body"". Data packet may be encoded in the signal. Slice may be generated and stored containing a pair of values for each of a given number of signal samples representing correlation of the signal with reference functions in the receiver. Presence of a data packet can then be detected, and the detected packet can be decoded from the stored slices. Generation and storage of cuts can be carried out as the received signal is sampled. Discrete signal values can be discarded as slices are generated and stored. Representation of the signal in the form of cuts can be manipulated in order to generate filters with a flexible pass band and average frequency.EFFECT: technical result is reduction of power consumption and memory capacity.18 cl, 13 dwg",PROTEUS DIDZHITAL KHELS INK,KUSHNER CHERIE;;FLEMING ROBERT;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,,https://lens.org/069-883-174-910-123,Granted Patent,no,0,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L27/148;;H04L47/43,,0,0,,,,ACTIVE
264,EP,A4,EP 3047618 A4,184-609-922-591-146,2017-05-10,2017,EP 14845438 A,2014-09-19,US 201361880786 P;;US 2014/0056576 W,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING A SIGNAL IN THE PRESENCE OF NOISE USING SLICES AND WARPING",,PROTEUS DIGITAL HEALTH INC,KUSHNER CHERIE;;FLEMING ROBERT;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,"OTSUKA PHARMACEUTICAL CO., LTD. (2021-05-26)",https://lens.org/184-609-922-591-146,Search Report,no,1,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L27/00;;H04L47/43;;H04B1/00;;H04L7/04;;H04L25/03;;H04L27/144;;H04L27/148,,2,1,115-503-002-121-573,10.1109/icassp.1997.599620,"BERGOGNE C ET AL: ""A new frequency estimator applied to burst transmission"", IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, 1997. ICASSP-97, MUNICH, GERMANY 21-24 APRIL 1997, LOS ALAMITOS, CA, USA,IEEE COMPUT. SOC; US, US, 21 April 1997 (1997-04-21), pages 267 - 270vol.1, XP032392671, ISBN: 978-0-8186-7919-3, DOI: 10.1109/ICASSP.1997.599620;;See also references of WO 2015042411A1",ACTIVE
265,AU,A,AU 2001/072229 A,187-310-063-008-217,2002-03-04,2002,AU 2001/072229 A,2001-07-20,AU PQ968900 A;;AU 1990/001008 W;;AU 2001/072229 A,2000-08-25,Optical waveguide fibre,,UNIV SYDNEY,BASSETT IAN;;FLEMING SIMON;;SCEATS MARK;;EIJKELENBORG MARTIJN VAN,,https://lens.org/187-310-063-008-217,Patent Application,no,0,0,1,4,0,,,,0,0,,,,PENDING
266,US,B2,US 9122653 B2,094-411-703-324-447,2015-09-01,2015,US 201414539963 A,2014-11-12,US 201414539963 A;;CN 201110104772 A;;US 201313787650 A;;US 201213457245 A,2011-04-26,Migrating virtual machines across sites,"A method for managing data swapping in a migration of virtual memory data in a virtual machine, where the data swapping is from a first host associated with a first storage device to a second host associated with a second storage device, is provided in another embodiment. The method includes receiving a migration instruction indicating the virtual machine to be migrated, and instructing the first host to copy data of the virtual machine to a sub-logical unit in the first storage device, the sub-logical unit having a mirror logical unit in the second storage device. A notification is sent, the notification being usable to instruct the second host to read data from the mirror logical unit.",IBM,FLEMING MARK S;;PENG JIANG;;XIN ZHANG;;ZHANG RONG,INTERNATIONAL BUSINESS MACHINES CORPORATION (2013-03-05),https://lens.org/094-411-703-324-447,Granted Patent,yes,22,3,8,8,0,G06F2009/4557;;G06F9/45558;;G06F11/2076;;G06F2201/815;;G06F11/1469;;G06F2009/4557;;G06F9/45558;;G06F11/2076;;G06F2201/815;;H04L65/40;;G06F9/455;;G06F11/203;;G06F11/2058,G06F12/00;;G06F9/455;;G06F11/14;;G06F11/20;;H04L29/08,,9,0,,,"VMware Corporation, ""VMware VMotion; Live Migration for Virtual Machines Without Service Interruption,"" Product datasheet, 2009.;;""Live Partition Mobility With Oracle e-Business Suite on AIX Proof of Concept,"" May 2008, abstract only.;;Pegler et al., ""VMAX and VPLEX Building the virtual data center,"" 2011 EMC Corporation, pp. 1-46.;;Notice of Allowance from U.S. Appl. No. 13/457,245, dated Jul. 25, 2014.;;Non-Final Office Action from U.S. Appl. No. 13/457,245, dated Apr. 7, 2014.;;Notice of Allowance from U.S. Appl. No. 13/787,650, dated Jul. 25, 2014.;;Non-Final Office Action from U.S. Appl. No. 13/787,650, dated Apr. 8, 2014.;;Fleming et al., U.S. Appl. No. 13/457,245, filed Apr. 26, 2012.;;Fleming et al., U.S. Appl. No. 13/787,650, filed Mar. 6, 2013.",INACTIVE
267,EP,B1,EP 0817602 B1,170-599-898-360-836,2001-10-31,2001,EP 96906574 A,1996-02-21,US 9602385 W;;US 41099395 A,1995-03-27,DIAPER REGISTRATION CONTROL SYSTEM,,PROCTER & GAMBLE,STUEBE MYRON LEE;;FLEMING JAMES MICHAEL;;WHALEY MARK DAVID,,https://lens.org/170-599-898-360-836,Granted Patent,yes,5,0,11,11,0,A61F13/15772;;A61F13/15772;;A61F13/15772;;A61F13/15723;;A61F13/15723;;A61F13/15723;;Y10T83/543;;Y10T83/543,A61F13/49;;A61F5/44;;A61F13/15;;A61F13/472,,0,0,,,,EXPIRED
268,US,A,US 4918659 A,173-460-088-599-442,1990-04-17,1990,US 40373989 A,1989-09-06,US 40373989 A;;US 20008588 A,1988-05-27,Apparatus and method for adding a selected additive into a mixture,"A complete additive transport and mixing system is carried on a single vehicle. A collection of liquid additive containers, a collection of metering devices, and a mixing system are all mounted on the vehicle, as is a dry additive metering device. A selected liquid additive container can be selectively and changeably connected to a selected liquid additive metering device, and a selected liquid additive metering device can be selectably and changeably connected to a selected input into the mixing system. The metering of the liquid additives is monitored and a concentration display given so that the metering devices can be manually controlled to obtain an actual concentration equal to a desired concentration. A display indicating a desired setting for the dry additive metering device is also given so that the dry additive metering device can be manually controlled to allow a suitable amount of the dry additive to be added into the mixing system to obtain a desired concentration of the dry additive.",HALLIBURTON CO,BRAGG DALE E;;CLARK MARK A;;FLEMING RANDY G,,https://lens.org/173-460-088-599-442,Granted Patent,yes,30,19,1,2,0,Y10T137/0424;;Y10T137/0324;;B01F23/40;;B01F23/49;;B01F23/59;;B01F23/56;;B01F33/502;;B01F35/831;;Y10T137/0424;;Y10T137/0324;;B01F33/502;;B01F23/49;;B01F23/59;;B01F35/831;;B01F23/40;;B01F23/56,B01F3/08;;B01F3/12;;B01F13/00;;B01F15/04,366/132;;137/2;;137/15;;222/1;;366/134;;366/152;;366/160;;366/177;;366/348,4,0,,,"Dowell Schlumberger Precision Meets Dependability for the Perfect Mix. Introducing the Pod Blender, Only from Dowell Schlumberger , date unknown.;;Dowell Schlumberger, The Pod Has Landed , date unknown.;;Halliburton Services Cementing Technical Data brochure, Lanmarc System , C 1333(Rev.) , date unknown.;;Halliburton Services General Technical Data sheet, Automatic Proppant Control System (APCS) , G 9156(Rev.) , date unknown.",EXPIRED
269,US,A1,US 2011/0173639 A1,014-186-947-145-525,2011-07-14,2011,US 68493810 A,2010-01-09,US 68493810 A,2010-01-09,STORAGE-SYSTEM-BASED DRIVER DISTRIBUTION APPARATUS AND METHOD,"A method for distributing drivers from a storage system to one or more host systems includes maintaining, in a storage system, a driver database containing drivers for different host systems. The drivers enable the different host systems to effectively communicate with the storage system. The method further determines whether a specific host system is configured with an appropriate driver. In the event the specific host system is not configured with the appropriate driver, the method retrieves the appropriate driver from the driver database. The method then transmits the appropriate driver from the storage system to the specific host system for installation thereon. By using the storage system as a central repository for the latest device drivers, the method ensures that connected host systems are always configured with the latest drivers. A corresponding apparatus, system, and computer program product are also disclosed herein.",IBM,CORONADO JUAN A;;FLEMING MARK S;;MARTINEZ LISA R,INTERNATIONAL BUSINESS MACHINES CORPORATION (2009-12-01),https://lens.org/014-186-947-145-525,Patent Application,yes,13,6,2,2,0,G06F9/4411;;G06F9/4411;;G06F8/65;;G06F8/65;;G06F16/93;;G06F16/93,G06F9/44,719/327,0,0,,,,ACTIVE
270,US,B2,US 8924666 B2,156-366-993-341-399,2014-12-30,2014,US 201213602051 A,2012-08-31,CN 201110305476 A,2011-09-30,Managing storage devices in a cloud storage environment,"A method of managing storage devices including storage resources that are virtualized and integrated into corresponding intermediate volumes, wherein the intermediate volumes are virtualized and integrated into individual logical volumes. The method comprises acquiring storage resource requirements presented to the logical volumes where the requirements comprise redundancy, obtaining storage resources available from respective intermediate volumes, selecting intermediate volumes to satisfy the storage resource requirements based on the requirements and available storage resources, where a minimum number of the intermediate volumes is determined based on the required redundancy, and storing user data in selected intermediate volumes based on the required redundancy.",FLEMING MARK S;;PENG JIANG;;ZHANG RONG;;XIN ZHANG;;IBM,FLEMING MARK S;;PENG JIANG;;ZHANG RONG;;XIN ZHANG,INTERNATIONAL BUSINESS MACHINES CORPORATION (2012-08-21),https://lens.org/156-366-993-341-399,Granted Patent,yes,12,0,4,4,0,H04L69/40;;G06F11/2094;;G06F3/0665;;G06F3/067;;G06F3/0605;;G06F3/0665;;G06F3/067;;H04L69/40;;G06F11/2094;;G06F3/0605,G06F12/16;;G06F3/06;;G06F11/20;;H04L69/40,711/161,1,0,,,"Office Action from Chinese Application No. 201110305476.2, dated Nov. 4, 2014.",INACTIVE
271,US,B2,US 8904139 B2,172-114-759-246-851,2014-12-02,2014,US 201313787650 A,2013-03-06,US 201313787650 A;;CN 201110104772 A;;US 201213457245 A,2011-04-26,Migrating virtual machines across sites,"In one embodiment, a method for managing data swapping in a migration of virtual memory data in a virtual machine, wherein the data swapping is from a first storage device at a first site to a second storage device at a second site, and the first and second storage devices have a metro mirror relationship includes sending a fail report in response to a failure to access the first storage device according to a path table, in response to the fail report, modifying a mirror direction between the first and second storage devices, sending a path modifying notification for modifying settings of a first path to the second storage device, and activating the path to the second storage device by modifying the path table according to the path modifying notification, so as to make the second storage device accessible.",IBM,FLEMING MARK S;;PENG JIANG;;XIN ZHANG;;ZHANG RONG,INTERNATIONAL BUSINESS MACHINES CORPORATION (2013-03-04),https://lens.org/172-114-759-246-851,Granted Patent,yes,19,3,8,8,0,G06F2009/4557;;G06F9/45558;;G06F11/2076;;G06F2201/815;;G06F11/1469;;G06F2009/4557;;G06F9/45558;;G06F11/2076;;G06F2201/815;;H04L65/40;;G06F9/455;;G06F11/203;;G06F11/2058,G06F12/00;;G06F9/455;;G06F11/14;;H04L29/08,711/165;;714/6.2;;714/6.23;;714/6.3,3,0,,,"VMware Corporation, ""VMware Vmotion, Live migration for virtual machines without service interruption,"" Product datasheet, 2009.;;Non-Final Office Action from U.S. Appl. No. 13/457,245 dated Apr. 7, 2014.;;Notice of Allowance and Fee(s) Due from U.S. Appl. No. 13/457,245 dated Jul. 25, 2014.",INACTIVE
272,CA,C,CA 2420075 C,045-453-096-233-452,2009-12-15,2009,CA 2420075 A,2001-07-20,AU PQ968800 A;;AU 1991/001008 W,2000-08-25,MICROSTRUCTURED POLYMER OPTICAL WAVEGUIDE,"An optical waveguide in the form of an optical fibre (10) having at least on e longitudinally extending light guiding core region (11) composed at least in part of a polymeric material, a longitudinally extending core-surrounding region (12) composed of a polymeric material, and a plurality of light confining elements (15), such as, for example, channel-like holes, located within the core surrounding region. The light confining elements extend in t he longitudinal direction of the core region and are distributed about the core region, and at least a majority of the light confining elements having a refractive index less than that of the polymeric material from which the cor e- surrounding region is composed. A preform for use in manufacture of the optical waveguide is also disclosed.",UNIV SYDNEY,FLEMING SIMON;;BASSETT IAN;;VAN EIJKELENBORG MARTIJN;;SCEATS MARK,,https://lens.org/045-453-096-233-452,Granted Patent,no,0,0,17,18,0,G02B6/02;;G02B6/02347;;G02B6/02357;;G02B6/02361;;G02B6/02371;;G02B6/00;;G02B6/02347;;G02B6/02;;G02B6/02357;;G02B6/02361;;G02B6/02371,G02B6/00;;G02B6/02;;G02B6/032,,0,0,,,,EXPIRED
273,US,A,US 5659538 A,085-294-660-185-806,1997-08-19,1997,US 41099395 A,1995-03-27,US 41099395 A,1995-03-27,Diaper registration control system,"The automatic registration control system of the present invention is a closed loop system including a driving mechanism for feeding a continuous web of disposable absorbent articles, such as diaper pads, toward a cutter. The cutter may separate completed pads from the web. A sensor is positioned along the manufacturing line, and preferably preceding the cutter, for detecting at least one preselected feature of each diaper pad and producing a detection signal when the feature passes by the sensor. A position resolver determines the angular position of the cutter at the moment when the preselected diaper feature is detected, and the average angular position is calculated from a predetermined number of cutter positions. The average cutter position is compared to and subtracted from a target cutter position to produce an error signal. The error signal is then converted into a control signal and supplied to a phase variator which adjusts the position of the cutter in response to the control signal.",PROCTER & GAMBLE,STUEBE MYRON LEE;;FLEMING JAMES MICHAEL;;WHALEY MARK DAVID,PROCTER & GAMBLE COMPANY THE (1995-03-24),https://lens.org/085-294-660-185-806,Granted Patent,yes,27,99,11,11,0,A61F13/15772;;A61F13/15772;;A61F13/15772;;A61F13/15723;;A61F13/15723;;A61F13/15723;;Y10T83/543;;Y10T83/543,A61F13/49;;A61F5/44;;A61F13/15;;A61F13/472,364/469.02;;83/371,0,0,,,,EXPIRED
274,GB,A,GB 2615062 A,096-743-350-284-358,2023-08-02,2023,GB 202117738 A,2021-12-08,GB 202117738 A,2021-12-08,Hair styling apparatus,"A hair styling apparatus 100 comprising a steam supply system with a water cavity 112, a heating element, and a steam outlet 113, and an airflow path 119. A portion of the airflow path is in thermal communication with the steam supply system for transfer of heat from the steam supply system to air in the airflow path, such that heated air is discharged from an airflow outlet (120, fig.1A). A pump 114 may move water from a reservoir 110 to the cavity, and an air mover 109 may move air along the airflow path. A heat exchanger 111 may provide said thermal communication, which may define the cavity and include fins 121 projecting into the airflow path. The airflow and steam outlets may be provided on an external, hair-facing surface 105 of an elongate arm 101, which also houses the heat exchanger. First and second such relatively movable arms may be provided. A controller 126 may control the apparatus in a steam phase or an air-drying phase.",DYSON TECHNOLOGY LTD,ROBERT LAWRENCE TWEEDIE;;JACOB MARK PARMENTER;;JOHN FLEMING MACFADYEN,,https://lens.org/096-743-350-284-358,Patent Application,no,4,0,3,3,0,A45D2001/008;;A45D2/001;;A45D20/50;;A45D19/16;;A45D1/04;;A45D1/04;;A45D1/06;;A45D2/001;;A45D2/36;;A45D2/367;;A45D19/16;;A45D2001/008,A45D1/04;;A45D1/00;;A45D1/06;;A45D2/00;;A45D2/36;;A45D19/16,,0,0,,,,PENDING
275,WO,A1,WO 2009/109648 A1,104-069-847-250-82X,2009-09-11,2009,EP 2009052647 W,2009-03-06,EP 08152473 A,2008-03-07,PROCESS FOR PREPARING COMPOUNDS CONTAINING A HYDRONAPHTALENE STRUCTURE WITH AN UNSYMMETRICALLY SUBSTITUTED BENZENE RING,"Process for preparing a compound according to formula (I) or (Ia) in a high enantiomeric excess, Formulae (I), (Ia), the process comprising reacting a nucleophile of formula R 1 NHR 2 with a chiral compound of formula (II), in the form of a racemate, Formula (II), in the presence of a rhodium-based catalytic system which comprises a chiral diphosphine ligand, as well as compounds made by that process and the use of that process or those compounds for preparing active pharmaceutical ingredients (APIs).",SOLVIAS AG;;FLEMING MATTHEW J;;LAUTENS MARK;;THOMMEN MARC;;SPIELVOGEL DIRK,FLEMING MATTHEW J;;LAUTENS MARK;;THOMMEN MARC;;SPIELVOGEL DIRK,,https://lens.org/104-069-847-250-82X,Patent Application,yes,1,0,2,2,0,C07D209/48,C07D217/04;;C07D295/04,,3,3,018-255-373-175-46X;;101-627-601-152-618;;052-915-844-154-563,12423131;;10.1021/jo025822o;;10.1021/ja000134c;;14640665;;10.1021/ja034845x,"MARK LAUTENS ET.AL.: ""Remote electronic effects in the Rhodium-catalyzed nucleophilic ring opening of oxabenzonorbornadienes"", J. ORG. CHEM., vol. 67, 2002, pages 8043 - 8053, XP002493634;;MARK LAUTENS ET.AL.: ""Rhodium catalyzed asymmetric alcoholysis and aminolysis of oxabenzonorbornadienes: A new enantioselective carbon-heteroatom bond forming process"", JACS, vol. 122, 2000, pages 5650 - 5651, XP002493635;;MARK LAUTENS ET.AL.: ""Rhodium catalyzed asymmetric ring opening reactions of oxabicyclic alkenes: Application of halide effects in the development of a general process"", JACS, vol. 125, 2003, pages 14884 - 14892, XP002493636",PENDING
276,CN,A,CN 105556912 A,164-179-624-641-456,2016-05-04,2016,CN 201480051986 A,2014-09-19,US 2014/0056576 W;;US 201361880786 P,2013-09-20,"Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping",A method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of a selected number of samples of the signal representing a correlation of the signal to reference functions in the receiver. The presence of the data packet may then be detected and the detected packet decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. The slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.,PROTEUS DIGITAL HEALTH INC,KUSHNER CHERIE;;FLEMING ROBERT;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,,https://lens.org/164-179-624-641-456,Patent Application,no,4,1,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L25/03;;H04L47/43,,0,0,,,,ACTIVE
277,CN,A,CN 110098914 A,016-600-157-709-561,2019-08-06,2019,CN 201910395896 A,2014-09-19,US 201361880786 P;;CN 201480051986 A,2013-09-20,"Method, device and system for receiving and decoding signal",A method may comprise the steps of receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of a selected number of samples of the signal representing a correlation of the signal to reference functions in the receiver. The presence of the data packet may then be detected and the detected packet decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. The slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.,PROTEUS DIGITAL HEALTH INC,KUSHNER CHERIE;;FLEMING ROBERT;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,,https://lens.org/016-600-157-709-561,Patent Application,no,9,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L7/04;;H04L47/43;;H04L27/00;;H04L27/144;;H04L27/148,,0,0,,,,ACTIVE
278,US,B2,US 8978044 B2,058-139-504-891-734,2015-03-10,2015,US 68493810 A,2010-01-09,US 68493810 A,2010-01-09,Storage-system-based driver distribution apparatus and method,"A method for distributing drivers from a storage system to one or more host systems includes maintaining, in a storage system, a driver database containing drivers for different host systems. The drivers enable the different host systems to effectively communicate with the storage system. The method further determines whether a specific host system is configured with an appropriate driver. In the event the specific host system is not configured with the appropriate driver, the method retrieves the appropriate driver from the driver database. The method then transmits the appropriate driver from the storage system to the specific host system for installation thereon. By using the storage system as a central repository for the latest device drivers, the method ensures that connected host systems are always configured with the latest drivers. A corresponding apparatus, system, and computer program product are also disclosed herein.",CORONADO JUAN ALONSO;;FLEMING MARK SEAN;;MARTINEZ LISA R;;IBM,CORONADO JUAN ALONSO;;FLEMING MARK SEAN;;MARTINEZ LISA R,INTERNATIONAL BUSINESS MACHINES CORPORATION (2009-12-01),https://lens.org/058-139-504-891-734,Granted Patent,yes,13,4,2,2,0,G06F9/4411;;G06F9/4411;;G06F8/65;;G06F8/65;;G06F16/93;;G06F16/93,G06F9/46;;G06F7/00;;G06F9/44;;G06F9/445;;G06F17/30,719/317;;707/796,0,0,,,,ACTIVE
279,US,B2,US 10097388 B2,093-008-009-368-339,2018-10-09,2018,US 201715678349 A,2017-08-16,US 201715678349 A;;US 201614989409 A;;US 201414491447 A;;US 201361880786 P,2013-09-20,"Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping","A method may include receiving a signal. The signal may encode a data packet. The method may include further sampling the signal to generate sampled values, and generating a slice record comprising a plurality of slices from the sampled values by correlating the sampled values with first and second reference templates. The first reference template may include a first reference function, and the second reference template may include a second reference function in quadrature with the first reference function. The method may further include cross-correlating the slice record with a stored template to generate cross-correlation terms, and determining when a magnitude of the cross-correlation terms exceeds a predetermined threshold for a width of the stored template.",PROTEUS DIGITAL HEALTH INC,FLEMING ROBERT;;KUSHNER CHERIE;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,PROTEUS DIGITAL HEALTH INC (2013-09-24),https://lens.org/093-008-009-368-339,Granted Patent,yes,1059,1,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L27/148;;H04L47/43;;H04B1/00;;H04L7/04;;H04L25/08;;H04L27/00;;H04L27/144,,68,24,055-061-122-716-256;;078-928-935-877-210;;115-503-002-121-573;;021-105-698-172-720;;020-429-685-293-077;;010-850-715-067-828;;125-568-654-521-572;;006-779-079-382-873;;034-889-687-992-512;;119-428-445-234-356;;083-089-269-400-619;;025-399-612-692-728;;070-806-113-494-855;;058-786-009-599-841;;058-427-408-233-519;;072-268-151-160-087;;016-284-130-373-090;;007-791-330-066-861;;060-836-788-950-075;;106-238-568-760-584;;013-389-953-231-546;;119-603-577-296-247;;022-564-808-245-652;;020-208-605-928-943,10.1016/b978-1-4377-2333-5.00018-3;;10.1109/lcn.2002.1181789;;10.1109/icassp.1997.599620;;10.1088/0967-3334/20/1/004;;10374826;;18790434;;10.1016/j.bpg.2008.06.003;;10.1109/wd.2008.4812855;;18075039;;10.1109/tbme.2007.908332;;10.1109/tcsi.2004.838240;;10.1126/science.134.3486.1196;;17753692;;13440945;;10.1038/1791239a0;;10.1016/j.jtherbio.2004.08.020;;10.1016/0016-5085(85)90342-7;;3891497;;10.1109/mwsym.2002.1011677;;10941095;;10.1002/1521-3773(20000717)39:14<2396::aid-anie2396>3.3.co;2-l;;10.1002/1521-3773(20000717)39:14<2396::aid-anie2396>3.0.co;2-u;;10.1016/s1359-0286(02)00032-3;;10.2174/1874476110801010022;;10.1201/9781420018677.ch12;;10.1007/978-3-540-95948-9_3;;10.1149/1.2086853;;10.1089/tmj.2004.10.s-110;;23570221;;10.1109/4.871321;;17947184;;10.1109/iembs.2006.259862;;10.1147/sj.353.0609;;10.1038/179898a0,"AADE, “AADE 37th Annual Meeting San Antonio Aug. 4-7, 2010” American Association of Diabetes Educators (2010); http://www.diabeteseducator.org/annualmeeting/2010/index.html; 2 pp.;;Arshak et al., A Review and Adaptation of Methods of Object Tracking to Telemetry Capsules IC-Med (2007) vol. 1, No. 1, Issue 1, 12 pp.;;“ASGE Technology Status Evaluation Report: wireless capsule endoscopy” American Soc. for Gastrointestinal Endoscopy (2006) vol. 63, No. 4; 7 pp.;;Au-Yeung, K., et al., “A Networked System for Self-Management of Drug Therapy and Wellness”, Wireless Health '10, Oct. 5-7, 2010, San Diego, 9 pages.;;Aydin et al., “Design and implementation considerations for an advanced wireless interface in miniaturized integrated sensor Microsystems” Sch. of Eng. & Electron., Edinburgh Univ., UK; (2003); abstract.;;Barrie, Heidelberg pH capsule gastric analysis. Texbook of Natural Medicine, (1992), Pizzorno, Murray & Barrie.;;Baskiyar, S. “A Real-time Fault Tolerant Intra-body Network” Dept. of Comp. Sci & Soft Eng; Auburn University; Proceedings of the 27th Annual IEEE Conference; 0742-1303/02 (2002) IEEE; 6 pp.;;Bergogne C., et al., “A new frequency estimator applied to burst transmission”, IEEE International Conference on Acoustics, Speech and Signal Processing, Apr. 21, 1997, vol. 1, pp. 267-270.;;Brock, “Smart Medicine: The Application of Auto-ID Technology to Healthcare” Auto-ID Labs (2002) http://www.autoidlabs.org/uploads/media/MIT-AUTOID-WH-010.pdf.;;Carlson et al., “Evaluation of a non-invasive respiratory monitoring system for sleeping subjects” Physiological Measurement (1999) 20(1): 53.;;Delvaux et al., “Capsule endoscopy: Technique and indications” Clinical Gastoenterology (2008) vol. 22, Issue 5, pp. 813-837.;;Description of ePatch Technology Platform for ECG and EMG, located it http://www.madebydelta.com/imported/images/DELTA_Web/documents/ME/ePatch_ECG_EMG.pdf, Dated Sep. 2, 2010.;;Evanczuk, S., “PIC MCU software library uses human body for secure communications link” EDN Network; edn.com; Feb. 26, 2013 Retrieved from internet Jun. 19, 2013 at http://www.edn.com/electronics-products/other/4407842/PIC-MCU-software-library-uses-human-body-for-secure-communications-link; 5 pp.;;Fawaz et al., “Enhanced Telemetry System using CP-QPSK Band-Pass Modulation Technique Suitable for Smart Pill Medical Application” IFIP IEEE Dubai Conference (2008); http://www.asic.fh-offenburg.de/downloads/ePille/IFIP_IEEE_Dubai_Conference.pdf.;;Gilson, D.R. “Molecular dynamics simulation of dipole interactions”, Department of Physics, Hull University, Dec. (2002), p. 1-43.;;Given Imaging, “Agile Patency Brochure” (2006) http://www.inclino.no/documents/AgilePatencyBrochure_Global_GMB-0118-01.pdf; 4pp.;;Gonzalez-Guillaumin et al., “Ingestible capsule for impedance and pH monitoring in the esophagus” IEEE Trans Biomed Eng. (2007) 54(12: 2231-6; abstract.;;Greene, “Edible RFID microchip monitor can tell if you take your medicine” Bloomberg Businessweek (2010) 2 pp.; http://www.businessweek.com/idg/2010-03-31/edible-rfid-microchip-monitor-can-tell-if-you-take-your-medicine.html.;;Halthion Medical Technologies “Providing Ambulatory Medical Devices Which Monitor, Measure and Record” webpage. Online website: http://www.halthion.com/; downloaded May 30, 2012.;;Heydari et al., “Analysis of the PLL jitter due to power/ground and substrate noise”; IEEE Transactions on Circuits and Systems (2004) 51(12): 2404-16.;;Hoover et al., “Rx for health: Engineers design pill that signals it has been swallowed” University of Florida News (2010) 2pp.; http://news.ufl.edu/2010/03/31/antenna-pill-2/.;;Hotz “The Really Smart Phone” The Wall Street Journal, What They Know (2011); 6 pp.; http://online.wsj.com/article/SB10001424052748704547604576263261679848814.html?mod=djemTECH_t.;;Intromedic, MicroCam Innovative Capsule Endoscope Pamphlet. (2006) 8 pp (http://www.intromedic.com/en/product/productinfo.asp).;;ISFET—Ion Sensitive Field-Effect Transistor; MICROSENS S.A. pdf document. First cited in Office Action dated Jun. 13, 2011 for U.S. Appl. No. 12/238,345; 4pp.;;Jung, S. “Dissolvable ‘Transient Electronics’ Will Be Good for Your Body and the Environment” MedGadget; Oct. 1, 2012; Onlne website: http://medgadget.com/2012/10/dissolvable-transient-electronics-will-be-good-for-your-body-and-the-environment.html; downloaded Oct. 24, 2012; 4 pp.;;Juvenile Diabetes Research Foundation International (JDRF), “Artificial Pancreas Project” (2010); http://www.artificialpancreasproject.com/; 3 pp.;;Li, P-Y, et al. “An electrochemical intraocular drug delivery device”, Sensors and Actuators A 143 (2008) p. 41-48.;;Lifescan, “OneTouch UltraLink™” http://www.lifescan.com/products/meters/ultralink (2010) 2 pp.;;Mackay et al., “Radio Telemetering from within the Body” Inside Information is Revealed by Tiny Transmitters that can be Swallowed or Implanted in Man or Animal Science (1991) 1196-1202; 134; American Association for the Advancement of Science, Washington D.C.;;Mackay et al., “Endoradiosonde” Nature, (1957) 1239-1240, 179 Nature Publishing Group.;;McKenzie et al., “Validation of a new telemetric core temperature monitor” J. Therm. Biol. (2004) 29(7-8):605-11.;;Medtronic, “CareLink Therapy Management Software for Diabetes” (2010); https://carelink.minimed.com/patient/entry.jsp?bhcp=1; 1 pp.;;Medtronic, “Carelink™ USB” (2008) http://www.medtronicdiabetes.com/pdf/carelink_usb_factsheet.pdf 2pp.;;Medtronic “The New MiniMed Paradigm® REAL-Time Revel™ System” (2010) http://www.medtronicdiabetes.com/products/index.html; 2 pp.;;Medtronic, “MINI MED Paradigm® Revel™ Insulin Pump” (2010) http://www.medtronicdiabetes.com/products/insulinpumps/index.html; 2 pp.;;Medtronic, Mini Med Paradigm™ Veo™ System: Factsheet (2010). http://www.medtronic-diabetes.com.au/downloads/Paradigm%20Veo%20Factsheet.pdf ; 4 pp.;;Melanson, “Walkers swallow RFID pills for science” Engadget (2008); http://www.engadget.com/2008/07/29/walkers-swallow-rfid-pills-for-science/.;;Minimitter Co. Inc. “Actiheart” Traditional 510(k) Summary. Sep. 27, 2005.;;Minimitter Co. Inc. Noninvasive technology to help your studies succeed. Mini Mitter.com Mar. 31, 2009.;;Mini Mitter Co, Inc. 510(k) Premarket Notification Mini-Logger for Diagnostic Spirometer. 9-21 (1999).;;Mini Mitter Co, Inc. 510(k) Premarket Notification for VitalSense. Apr. 22, 2004.;;Minimitter Co. Inc. VitalSense Integrated Physiological Monitoring System. Product Description. (2005).;;Minimitter Co. Inc. VitalSense Wireless Vital Signs Monitoring. Temperatures.com Mar. 31, 2009.;;Mojaverian et al., “Estimation of gastric residence time of the Heidelberg capsule in humans: effect of varying food composition” Gastroenterology (1985) 89:(2): 392-7.;;“New ‘smart pill’ to track adherence” E-Health-Insider (2010) http://www.e-health-insider.com/news/5910/new_‘smart_pill’_monitors_medicines.;;Owano, N., “Study proposes smart sutures with sensors for wounds” phys.org. Aug. 2012. http://phys.org/news/2012-08-smart-sutures-sensors-wounds.html.;;Park, “Medtronic to Buy MiniMed for $3.7 Billion” (2001) HomeCare; http://homecaremag.com/mag/medical_medtronic_buy_minimed/; 2 pp.;;Radio Antennae, http://www.erikdeman.de/html/sail018h.htm; (2008) 5 pages.;;“RFID “pill” monitors marchers” RFID News (2008) http://www.rfidnews.org/2008/07/23/rfid-pill-monitors-marchers/.;;Sanduleanu et al., “Octave tunable, highly linear, RC-ring oscillator with differential fine-coarse tuning, quadrature outputs and amplitude control for fiber optic transceivers” (2002) IEEE MTT-S International Microwave Symposium Digest 545-8.;;Santini, J.T. et al, “Microchips as controlled drug delivery-devices”, Agnew. Chem. Int. Ed. (2000), vol. 39, p. 2396-2407.;;“SensiVida minimally invasive clinical systems” Investor Presentation Oct. (2009) 28pp; http://www.sensividamedtech.com/SensiVidaGeneralOctober09.pdf.;;Shawgo, R.S. et al. “BioMEMS from drug delivery”, Current Opinion in Solid State and Material Science 6 (2002), p. 329-334.;;Shrivas et al., “A New Platform for Bioelectronics-Electronic Pill”, Cummins College, (2010).; http://www.cumminscollege.org/downloads/electronics_and_telecommunication/Newsletters/Current%20Newsletters.pdf; First cited in third party client search conducted by Patent Eagle Search May 18, 2010 (2010).;;“Smartlife awarded patent for knitted transducer” Innovation in Textiles News: http://www.innovationintextiles.com/articles/208.php; 2pp. (2009).;;“The SmartPill Wireless Motility Capsule” SMARTPILL, The Measure of GI Health; (2010) http://www.smartpillcorp.com/index.cfm?pagepath=Products/The_SmartPill_Capsule&id=17814.;;Solanas et al., “RFID Technology for the Health Care Sector” Recent Patents on Electrical Engineering (2008) 1, 22-31.;;Soper, S.A. et al. “Bio-Mems Technologies and Applications”, Chapter 12, “MEMS for Drug Delivery”, p. 325-346 (2007).;;Swedberg, “University Team Sees Ingestible RFID Tag as a Boon to Clinical Trials” RFID Journal Apr. 27, 2010; http://www.rfidjournal.com/article/view/7560/1.;;Tajalli et al., “Improving the power-delay performance in subthreshold source-coupled logic circuits” Integrated Circuit and System Design. Power and Timing Modeling, Optimization and Simulation, Springer Berlin Heidelberg (2008) 21-30.;;Tatbul et al., “Confidence-based data management for personal area sensor networks” ACM International Conference Proceeding Series (2004) 72.;;Tierney, M.J. et al “Electroreleasing Composite Membranes for Delivery of Insulin and other Biomacromolecules”, J. Electrochem. Soc., vol. 137, No. 6, Jun. 1990, p. 2005-2006.;;Walkey, “MOSFET Structure and Processing”; 97.398 Physical Electronics Lecture 20, 24 pages, First cited in Office Action dated Jun. 13, 2011 for U.S. Appl. No. 12/238,345.;;Xiaoming et al., “A telemedicine system for wireless home healthcare based on bluetooth and the internet” Telemedicine Journal and e-health (2004) 10(S2): S110-6.;;Yang et al., “Fast-switching frequency synthesizer with a discriminator-aided phase detector” IEEE Journal of Solid-State Circuits (2000) 35(10): 1445-52.;;Yao et al., “Low Power Digital Communication in Implantable Devices Using Volume Conduction of Biological Tissues” Proceedings of the 28th IEEE, EMBS Annual International Conference, Aug. 30-Sep. 3, 2006.;;Zimmerman, “Personal Area Networks: Near-field intrabody communication” IBM Systems Journal (1996) 35 (3-4):609-17.;;Zworykin, “A Radio Pill” Nature, (1957) 898, 179 Nature Publishing Group.",ACTIVE
280,US,A,US 4886367 A,103-891-463-642-218,1989-12-12,1989,US 20008588 A,1988-05-27,US 20008588 A,1988-05-27,Apparatus for adding a selected additive into a mixture,"A complete additive transport and mixing system is carried on a single vehicle. A collection of liquid additive containers, a collection of metering devices, and a mixing system are all mounted on the vehicle, as is a dry additive metering device. A selected liquid additive container can be selectably and changeably connected to a selected liquid additive metering device, and a selected liquid additive metering device can be selectably and changeably connected to a selected input into the mixing system. The metering of the liquid additives is monitored and a concentration display given so that the metering devices can be manually controlled to obtain an actual concentration equal to a desired concentration. A display indicating a desired setting for the dry additive metering device is also given so that the dry additive metering device can be manually controlled to allow a suitable amount of the dry additive to be added into the mixing system to obtain a desired concentration of the dry additive.",HALLIBURTON CO,BRAGG DALE E;;CLARK MARK A;;FLEMING RANDY G,HALLIBURTON COMPANY DUNCAN OK. A DE CORP (1988-09-07),https://lens.org/103-891-463-642-218,Granted Patent,yes,19,47,1,2,0,Y10T137/2529;;B01F23/40;;B01F23/49;;B01F23/59;;B01F23/56;;B01F33/502;;B01F35/831;;Y10T137/2529;;B01F23/59;;B01F23/49;;B01F33/502;;B01F35/831;;B01F23/40;;B01F23/56,B01F3/08;;B01F3/12;;B01F13/00;;B01F15/04,366/132;;137/101.19;;222/57;;222/135;;366/134;;366/152;;366/177;;364/550,4,0,,,"Dowell Schlumberger, Precision Meets Dependability for the Perfect Mix. Introducing the Pod Blender, Only From Dowell Schlumberger. , date unknown.;;Dowell Schlumberger, The Pod Has Landed , date unknown.;;Halliburton Services Cementing Technical Data brochure, Lanmarc System , C 1333(Rev.) , date unknown.;;Halliburton Services General Technical Data Sheet, Automatic Proppant Control System (APCS) , G 9156(Rev.) , date unknown.",EXPIRED
281,AU,A,AU 2001/072230 A,124-465-260-007-011,2002-03-04,2002,AU 2001/072230 A,2001-07-20,AU PQ968800 A;;AU 1991/001008 W;;AU 2001/072230 A,2000-08-25,Polymer optical waveguide,,UNIV SYDNEY,FLEMING SIMON;;BASSETT IAN;;SCEATS MARK;;EIJKELENBORG MARTIJN VAN,,https://lens.org/124-465-260-007-011,Patent Application,no,0,0,1,18,0,,,,0,0,,,,EXPIRED
282,DE,T2,DE 60117021 T2,144-001-732-125-404,2006-09-28,2006,DE 60117021 T,2001-07-20,AU PQ968800 A;;AU 1991/001008 W,2000-08-25,Microstrukturierter optischer Polymerwellenleiter,"An optical waveguide in the form of an optical fibre ( 10 ) having at least one longitudinally extending light guiding core region ( 11 ) composed at least in part of a polymeric material, a longitudinally extending core-surrounding region ( 12 ) composed of a polymeric material, and a plurality of light confining elements ( 15 ), such as, for example, channel-like holes, located within the core surrounding region. The light confining elements extend in the longitudinal direction of the core region and are distributed about the core region, and at least a majority of the light confining elements having a refractive index less than that of the polymeric material from which the core-surrounding region is composed. A preform for use in manufacture of the optical waveguide is also disclosed.",UNIV SYDNEY,FLEMING SIMON;;BASSETT IAN;;SCEATS MARK;;VAN EIJKELENBORG MARTIJN,,https://lens.org/144-001-732-125-404,Granted Patent,no,0,0,17,18,0,G02B6/02;;G02B6/02347;;G02B6/02357;;G02B6/02361;;G02B6/02371;;G02B6/00;;G02B6/02347;;G02B6/02;;G02B6/02357;;G02B6/02361;;G02B6/02371,G02B6/00;;G02B6/028;;G02B6/02;;G02B6/032;;G02B6/036,,0,0,,,,EXPIRED
283,US,A1,US 2004/0039885 A1,160-094-387-038-742,2004-02-26,2004,US 22751802 A,2002-08-22,US 22751802 A,2002-08-22,Method and apparatus for isolating frames in a data processing system,"
   A method, apparatus, and computer instructions for managing frames. Frames intended for isolation are identified in which the frames include in-use frames and free frames. Reservation of free frames from the frames identified as intended for isolation is requested. Successfully reserved frames are moved to an isolation list. In-use frames are marked, and unisolated/unmarked frames are identified. Any free frames in the unisolated frames are moved to the isolation list. In-use frames in the unisolated frames are marked and reservation of the in-use frames in the unisolated frames is released. 
",INTERNATIOAL BUSINESS MACHINES,FLEMING MATTHEW DAVID;;ROGERS MARK DOUGLASS;;SHEFFIELD DAVID WILLIAM,INTERNATIONAL BUSINESS MACHINES CORPORATION (2002-08-15),https://lens.org/160-094-387-038-742,Patent Application,yes,3,1,2,2,0,G06F9/5016;;G06F9/5016,G06F9/50;;G06F12/00;;G06F12/02,711/156;;711/163;;711/165,0,0,,,,EXPIRED
284,US,A1,US 2012/0278571 A1,182-612-157-402-583,2012-11-01,2012,US 201213457245 A,2012-04-26,CN 201110104772 A,2011-04-26,MIGRATING VIRTUAL MACHINES ACROSS SITES,"The invention relates to apparatus and methods for managing data swap in a migration of virtual memory data of a virtual machine. In one embodiment, an apparatus comprises a receiving unit configured to receive a migration instruction and the second site information; a copying unit configured to copy memory data to a sub-logical unit in the first storage device; and a notifying unit configured to send a notification to instruct the second host to read the memory data from a mirror logical unit of a sub-logical unit in the second storage device. The apparatus modifies a mirror direction between the first and second storage devices and modifies a path table related to the first and second storage devices. Data of the virtual machine can be migrated and swapped in a metro mirror manner, thereby the virtual machine data can be migrated across sites without affecting system operation.",FLEMING MARK S;;JIANG PENG;;XIN ZHANG;;ZHANG RONG;;IBM,FLEMING MARK S;;JIANG PENG;;XIN ZHANG;;ZHANG RONG,INTERNATIONAL BUSINESS MACHINES CORPORATION (2012-04-28),https://lens.org/182-612-157-402-583,Patent Application,yes,9,86,8,8,0,G06F2009/4557;;G06F9/45558;;G06F11/2076;;G06F2201/815;;G06F11/1469;;G06F2009/4557;;G06F9/45558;;G06F11/2076;;G06F2201/815;;H04L65/40;;G06F9/455;;G06F11/203;;G06F11/2058,G06F12/02,711/162;;X711E12002,0,0,,,,ACTIVE
285,AU,A1,AU 2014/321320 A1,039-341-376-907-147,2016-02-11,2016,AU 2014/321320 A,2014-09-19,US 201361880786 P;;US 2014/0056576 W,2013-09-20,"Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping",A method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of a selected number of samples of the signal representing a correlation of the signal to reference functions in the receiver. The presence of the data packet may then be detected and the detected packet decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. The slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.,PROTEUS DIGITAL HEALTH INC,KUSHNER CHERIE;;FLEMING ROBERT;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,"OTSUKA PHARMACEUTICAL CO., LTD. (2021-05-13)",https://lens.org/039-341-376-907-147,Patent Application,no,0,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L25/03;;H04L47/43,,0,0,,,,ACTIVE
286,US,A1,US 2003/0190129 A1,021-423-927-342-310,2003-10-09,2003,US 36245203 A,2003-02-25,US 36245203 A;;AU 1990/001008 W;;AU PQ968900 A,2000-08-25,Optical waveguide fibre,"
    An optical fibre ( 1 ) having at least one longitudinally extending light guiding core region ( 11 ), a longitudinally extending core-surrounding region ( 12 ), and a plurality of light confining elements ( 15, 16, 17, 18 ), such as, for example, channel-like holes, located within the core-surrounding region ( 12 ). The light confining elements ( 15, 16, 17, 18 ) extend in the longitudinal direction of the core region and are located geometrically in zones that surround the core region. The aggregate cross-sectional area defined by the light confining elements within the respective zones increases with increasing radial distance of the zones from the core region. A preform for use in manufacture of the optical fibre is also defined. 
",BASSETT IAN;;FLEMING SIMON;;SCEATS MARK;;VAN EIJKELENBORG MARTIJN,BASSETT IAN;;FLEMING SIMON;;SCEATS MARK;;VAN EIJKELENBORG MARTIJN,THE UNIVERSITY OF SYDNEY (2000-08-31),https://lens.org/021-423-927-342-310,Patent Application,yes,2,21,1,4,0,C03B37/01205;;C03B2203/14;;C03B2203/16;;C03B2203/30;;C03B2203/34;;C03B2203/42;;G02B6/02357;;G02B6/02361;;G02B6/02371;;G02B6/02357;;G02B6/02371;;C03B2203/16;;G02B6/02361;;C03B2203/30;;C03B37/01205;;C03B2203/34;;C03B2203/42;;C03B2203/14,C03B37/012;;G02B6/02,385/125,0,0,,,,DISCONTINUED
287,EP,A1,EP 0817602 A1,047-904-736-655-286,1998-01-14,1998,EP 96906574 A,1996-02-21,US 9602385 W;;US 41099395 A,1995-03-27,DIAPER REGISTRATION CONTROL SYSTEM,,PROCTER & GAMBLE,STUEBE MYRON LEE;;FLEMING JAMES MICHAEL;;WHALEY MARK DAVID,,https://lens.org/047-904-736-655-286,Patent Application,yes,0,0,11,11,0,A61F13/15772;;A61F13/15772;;A61F13/15772;;A61F13/15723;;A61F13/15723;;A61F13/15723;;Y10T83/543;;Y10T83/543,A61F13/49;;A61F5/44;;A61F13/15;;A61F13/472,,1,0,,,See references of WO 9629966A1,EXPIRED
288,DK,T3,DK 1320774 T3,047-932-968-127-368,2006-06-12,2006,DK 01951247 T,2001-07-20,AU PQ968800 A,2000-08-25,Mikrostruktureret optisk bölgeleder af polymermateriale,"An optical waveguide in the form of an optical fibre ( 10 ) having at least one longitudinally extending light guiding core region ( 11 ) composed at least in part of a polymeric material, a longitudinally extending core-surrounding region ( 12 ) composed of a polymeric material, and a plurality of light confining elements ( 15 ), such as, for example, channel-like holes, located within the core surrounding region. The light confining elements extend in the longitudinal direction of the core region and are distributed about the core region, and at least a majority of the light confining elements having a refractive index less than that of the polymeric material from which the core-surrounding region is composed. A preform for use in manufacture of the optical waveguide is also disclosed.",UNIV SYDNEY,FLEMING SIMON;;BASSETT IAN;;SCEATS MARK;;VAN EIJKELENBORG MARTIJN,,https://lens.org/047-932-968-127-368,Granted Patent,no,0,0,17,18,0,G02B6/02;;G02B6/02347;;G02B6/02357;;G02B6/02361;;G02B6/02371;;G02B6/00;;G02B6/02347;;G02B6/02;;G02B6/02357;;G02B6/02361;;G02B6/02371,G02B6/00;;G02B6/02;;G02B6/032,,0,0,,,,EXPIRED
289,GB,A,GB 2613605 A,094-739-124-718-256,2023-06-14,2023,GB 202117734 A,2021-12-08,GB 202117734 A,2021-12-08,Hair styling apparatus,"A hair styling apparatus comprising a fluid outlet 112 arranged to discharge fluid and a fluid control device 117 in fluid communication with the fluid outlet. The fluid control device is configured to control the flow rate and/or temperature of the fluid discharged from the fluid outlet. The apparatus also comprises a movement sensing module 118 configured to sense movement of the apparatus and generate a movement signal in response to the sensed movement. The controller is configured to control the fluid control device to control the flow rate and/or temperature of the fluid discharged from the outlet in response to the movement signal generated by the movement sensing module. The movement signal may be indicative of the speed of the movement or of a particular type of movement, such as rotational movement. The movement sensing module may be able to indicate a distance travelled by the device and control the fluid flow or temperature in relation to the distance signal. The fluid discharged may be steam.",DYSON TECHNOLOGY LTD,JACOB MARK PARMENTER;;JOHN FLEMING MACFADYEN;;ROBERT LAWRENCE TWEEDIE,,https://lens.org/094-739-124-718-256,Patent Application,no,5,0,3,3,0,A45D2001/008;;A45D1/04;;A45D2/001;;A45D20/50;;A45D1/00;;A45D1/06;;A45D1/28;;A45D2/001;;A45D2001/008,A45D1/00;;A45D1/06;;A45D1/28,,0,0,,,,PENDING
290,AU,B2,AU 2019/204197 B2,142-860-830-130-955,2021-05-27,2021,AU 2019/204197 A,2019-06-14,AU 2019/204197 A;;AU 2014/321320 A;;US 201361880786 P;;US 2014/0056576 W,2013-09-20,"Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping","A method may comprise receiving a signal, the signal encoding a data packet; sampling the signal to generate sampled values; generating a slice record comprising a plurality of slices from the sampled values by correlating the sampled values with first and second reference templates, the first reference template comprising a first reference function and the second reference template comprising a second reference function in quadrature with the first reference function; cross-correlating the slice record with a stored template to generate cross-correlation terms; and determining when a magnitude of the cross-correlation terms exceeds a predetermined threshold for a width of the stored template. WO 2015/042411 PCT/US2O1-4/056576 mrvI enI fn r-I '-I ca 0' 4 <U U w 0 W) oU 0 I LIEIII LLI- w zr uZ LA*ow-U 0 LL (: 4 -J LA. 0--LIt LL 0' I I-- ""-Lfl tn c = co I Iw Lw I <- w 9= Z : 0 zL z U UU V)c 0L 4A IU- L L 0 Wo z Lin c]",OTSUKA PHARMA CO LTD,KUSHNER CHERIE;;FLEMING ROBERT;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,"OTSUKA PHARMACEUTICAL CO., LTD. (2021-05-13)",https://lens.org/142-860-830-130-955,Granted Patent,no,1,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L25/03;;H04L47/43,,0,0,,,,ACTIVE
291,US,A1,US 2015/0074453 A1,145-375-218-575-157,2015-03-12,2015,US 201414539963 A,2014-11-12,US 201414539963 A;;CN 201110104772 A;;US 201313787650 A;;US 201213457245 A,2011-04-26,MIGRATING VIRTUAL MACHINES ACROSS SITES,"A method for managing data swapping in a migration of virtual memory data in a virtual machine, where the data swapping is from a first host associated with a first storage device to a second host associated with a second storage device, is provided in another embodiment. The method includes receiving a migration instruction indicating the virtual machine to be migrated, and instructing the first host to copy data of the virtual machine to a sub-logical unit in the first storage device, the sub-logical unit having a mirror logical unit in the second storage device. A notification is sent, the notification being usable to instruct the second host to read data from the mirror logical unit.",IBM,FLEMING MARK S;;PENG JIANG;;XIN ZHANG;;ZHANG RONG,INTERNATIONAL BUSINESS MACHINES CORPORATION (2013-03-05),https://lens.org/145-375-218-575-157,Patent Application,yes,0,15,8,8,0,G06F2009/4557;;G06F9/45558;;G06F11/2076;;G06F2201/815;;G06F11/1469;;G06F2009/4557;;G06F9/45558;;G06F11/2076;;G06F2201/815;;H04L65/40;;G06F9/455;;G06F11/203;;G06F11/2058,G06F11/20,714/6.23,0,0,,,,INACTIVE
292,CA,C,CA 2965941 C,164-776-969-602-597,2020-01-28,2020,CA 2965941 A,2014-09-19,US 201361880786 P;;CA 2924815 A,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING A SIGNAL IN THE PRESENCE OF NOISE USING SLICES AND WARPING",A method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of a selected number of samples of the signal representing a correlation of the signal to reference functions in the receiver. The presence of the data packet may then be detected and the detected packet decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. The slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.,PROTEUS DIGITAL HEALTH INC,KUSHNER CHERIE;;FLEMING ROBERT;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,,https://lens.org/164-776-969-602-597,Granted Patent,no,0,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L47/43;;H03D7/00;;H04L27/00;;H04L27/144,,0,0,,,,ACTIVE
293,CA,A1,CA 2965941 A1,170-298-640-754-214,2015-03-26,2015,CA 2965941 A,2014-09-19,US 201361880786 P;;CA 2924815 A,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING A SIGNAL IN THE PRESENCE OF NOISE USING SLICES AND WARPING",,PROTEUS DIGITAL HEALTH INC,KUSHNER CHERIE;;FLEMING ROBERT;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,,https://lens.org/170-298-640-754-214,Patent Application,no,0,1,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L47/43;;H03D7/00;;H04L27/00;;H04L27/144,,0,0,,,,ACTIVE
294,US,A1,US 2013/0198561 A1,015-301-848-054-22X,2013-08-01,2013,US 201313787650 A,2013-03-06,US 201313787650 A;;CN 201110104772 A;;US 201213457245 A,2011-04-26,MIGRATING VIRTUAL MACHINES ACROSS SITES,"In one embodiment, a method for managing data swapping in a migration of virtual memory data in a virtual machine, wherein the data swapping is from a first storage device at a first site to a second storage device at a second site, and the first and second storage devices have a metro mirror relationship includes sending a fail report in response to a failure to access the first storage device according to a path table, in response to the fail report, modifying a mirror direction between the first and second storage devices, sending a path modifying notification for modifying settings of a first path to the second storage device, and activating the path to the second storage device by modifying the path table according to the path modifying notification, so as to make the second storage device accessible.",IBM;;IBM,FLEMING MARK S;;PENG JIANG;;XIN ZHANG;;ZHANG RONG,INTERNATIONAL BUSINESS MACHINES CORPORATION (2013-03-04),https://lens.org/015-301-848-054-22X,Patent Application,yes,9,8,8,8,0,G06F2009/4557;;G06F9/45558;;G06F11/2076;;G06F2201/815;;G06F11/1469;;G06F2009/4557;;G06F9/45558;;G06F11/2076;;G06F2201/815;;H04L65/40;;G06F9/455;;G06F11/203;;G06F11/2058,G06F11/14,714/6.3,0,0,,,,INACTIVE
295,WO,A1,WO 2002/016984 A1,091-627-620-710-784,2002-02-28,2002,AU 1991/001008 W,2001-07-20,AU PQ968800 A,2000-08-25,POLYMER OPTICAL WAVEGUIDE,"An optical waveguide in the form of an optical fibre (10) having at least one longitudinally extending light guiding core region (11) composed at least in part of a polymeric material, a longitudinally extending core-surrounding region (12) composed of a polymeric material, and a plurality of light confining elements (15), such as, for example, channel-like holes, located within the core surrounding region. The light confining elements extend in the longitudinal direction of the core region and are distributed about the core region, and at least a majority of the light confining elements having a refractive index less than that of the polymeric material from which the core-surrounding region is composed. A preform for use in manufacture of the optical waveguide is also disclosed.",UNIV SYDNEY;;FLEMING SIMON;;BASSETT IAN;;SCEATS MARK;;EIJKELENBORG MARTIJN VAN,FLEMING SIMON;;BASSETT IAN;;SCEATS MARK;;VAN EIJKELENBORG MARTIJN,,https://lens.org/091-627-620-710-784,Patent Application,yes,4,14,17,18,0,G02B6/02;;G02B6/02347;;G02B6/02357;;G02B6/02361;;G02B6/02371;;G02B6/00;;G02B6/02347;;G02B6/02;;G02B6/02357;;G02B6/02361;;G02B6/02371,G02B6/02;;G02B6/032;;G02B6/00,,2,0,,,PATENT ABSTRACTS OF JAPAN;;PATENT ABSTRACTS OF JAPAN,PATENTED
296,PH,B1,PH 12016500537 B1,123-383-043-184-884,2016-06-13,2016,PH 12016500537 A,2016-03-21,US 201361880786 P;;US 2014/0056576 W,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING A SIGNAL IN THE PRESENCE OF NOISE USING SLICES AND WARPING",A method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of a selected number of samples of the signal representing a correlation of the signal to reference functions in the receiver. The presence of the data packet may then be detected and the detected packet decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. The slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.,PROTEUS DIGITAL HEALTH INC,KUSHNER CHERIE;;FLEMING ROBERT;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,,https://lens.org/123-383-043-184-884,Granted Patent,no,0,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L25/03;;H04L47/43,,0,0,,,,ACTIVE
297,EP,B1,EP 1320774 B1,174-949-594-067-406,2006-02-01,2006,EP 01951247 A,2001-07-20,AU 1991/001008 W;;AU PQ968800 A,2000-08-25,Microstructured polymer optical waveguide,"An optical waveguide in the form of an optical fibre ( 10 ) having at least one longitudinally extending light guiding core region ( 11 ) composed at least in part of a polymeric material, a longitudinally extending core-surrounding region ( 12 ) composed of a polymeric material, and a plurality of light confining elements ( 15 ), such as, for example, channel-like holes, located within the core surrounding region. The light confining elements extend in the longitudinal direction of the core region and are distributed about the core region, and at least a majority of the light confining elements having a refractive index less than that of the polymeric material from which the core-surrounding region is composed. A preform for use in manufacture of the optical waveguide is also disclosed.",UNIV SYDNEY,FLEMING SIMON;;BASSETT IAN;;SCEATS MARK;;VAN EIJKELENBORG MARTIJN,,https://lens.org/174-949-594-067-406,Granted Patent,yes,4,0,17,18,0,G02B6/02;;G02B6/02347;;G02B6/02357;;G02B6/02361;;G02B6/02371;;G02B6/00;;G02B6/02347;;G02B6/02;;G02B6/02357;;G02B6/02361;;G02B6/02371,G02B6/00;;G02B6/02;;G02B6/032,,4,0,,,"VAN EIJKELENBORG M A ET AL: ""Microstructured polymer optical fibre"" OPTICS EXPRESS OPT. SOC. AMERICA USA, vol. 9, no. 7, , pages 319-327, XP002314921 ISSN: 1094-4087;;ARGYROS A ET AL: ""Ring structures in microstructured polymer optical fibres"" OPTICS EXPRESS OPT. SOC. AMERICA USA, vol. 9, no. 13, 20 January 1217 (1217-01-20), pages 813-820, XP002314922 ISSN: 1094-4087;;PATENT ABSTRACTS OF JAPAN & JP 2000 035521 A (NIPPON TELEGRAPH & TELEPHON CORP) 02 February 2000;;PATENT ABSTRACTS OF JAPAN & JP 08 054 520 A (SUMITOMO ELECTRIC IND LTD) 27 February 1996",EXPIRED
298,CA,C,CA 2924815 C,016-213-775-145-345,2017-06-20,2017,CA 2924815 A,2014-09-19,US 201361880786 P;;US 2014/0056576 W,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING A SIGNAL IN THE PRESENCE OF NOISE USING SLICES AND WARPING",A method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of a selected number of samples of the signal representing a correlation of the signal to reference functions in the receiver. The presence of the data packet may then be detected and the detected packet decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. The slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.,PROTEUS DIGITAL HEALTH INC,KUSHNER CHERIE;;FLEMING ROBERT;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,,https://lens.org/016-213-775-145-345,Granted Patent,no,0,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L25/03;;H04L47/43,,0,0,,,,ACTIVE
299,CA,A1,CA 2430092 A1,041-723-994-476-44X,2004-11-28,2004,CA 2430092 A,2003-05-28,CA 2430092 A,2003-05-28,L4 SECURE COMPUTERIZED SYSTEM,"A computerized system and method for storing distinct data types is disclose d. The computerized system includes a plurality of data storage devices wherein dat a of a first type may be stored on a first one of the data storage devices and data of a second type may be stored on at least another one of the data storage devices, of the da ta storage devices and data of a third type may be stored on at least another one of th e data storage devices, wherein at least one of the data types requires controlling access thereto. The invention provides for ensuring the integrity of the data stored on the data storage devices. It also prevents misappropriation of data stored on the devices. Th e invention includes a switching device which selects one of the data storage devices fo r use with a computerized system. Selecting a data storage device activates and places it in an operational mode. The remaining data storage devices and peripherals are placed into a standby non-operational mode. Upon selection of one of a data storage device , the computerized system implements a standby and complete hardware reset in orde r to ensure data from one storage device cannot be transferred to another one of a storage device and is not available to users of a another storage device. At least o ne of the data storage devices will require authorization in order to gain access.",PRECLARUS TECHNOLOGIES INC,FLEMING JAMES S;;REID MARK A;;ORR DAVID F,,https://lens.org/041-723-994-476-44X,Patent Application,no,0,0,1,1,0,G06F21/6218;;G06F2221/2113,G06F21/62;;G06F13/00;;G06F21/00;;G06F21/85;;H04W88/02,,0,0,,,,DISCONTINUED
300,US,B2,US 7162107 B2,068-320-058-364-182,2007-01-09,2007,US 95346104 A,2004-09-30,US 95346104 A,2004-09-30,Method and apparatus for improving frequency response in mode converters,A semiconductor based electro-optic modulator comprising a capacitively coupled ground allowing for DC biasing of the modulator and a pre-distortion circuit for alleviating RF skin effect and for increasing bandwidth of modulator. Electrical components and functions of modulator partly located on an alumina pane. Reduction of thermally-induced stresses by connecting modulator ground to package ground via alumina pane is also disclosed.,VERSAWAVE TECHNOLOGIES INC,BULL JEFFREY D;;FAIRBURN MARK;;JAEGER NICOLAS AUGUST FLEMING,VERSAWAVE TECHNOLOGIES INC (2006-09-12);;OPTELIAN ACCESS NETWORKS CORPORATION (2011-12-22),https://lens.org/068-320-058-364-182,Granted Patent,yes,7,28,2,2,0,G02F1/0356;;G02F2203/20;;G02F1/0356;;G02F2203/20,G02B6/00,385/2,0,0,,,,ACTIVE
301,JP,A,JP 2017085577 A,071-010-182-689-560,2017-05-18,2017,JP 2016219456 A,2016-11-10,US 201361880786 P,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING SIGNAL IN PRESENCE OF NOISE USING SLICES AND WARPING","PROBLEM TO BE SOLVED: To provide preferable methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping.SOLUTION: The method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of the selected number of samples of the signal, the pair of values representing a correlation of the signal to reference functions in a receiver. The presence of the data packet may then be detected and the detected packet may be decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. A slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.SELECTED DRAWING: Figure 12",PROTEUS DIGITAL HEALTH INC,CHERIE KUSHNER;;ROBERT FLEMING;;WILLIAM H MCALLISTER;;ZDEBLICK MARK,,https://lens.org/071-010-182-689-560,Patent Application,no,6,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04B1/10;;H04L47/43,,0,0,,,,ACTIVE
302,US,B2,US 9057861 B2,086-833-281-984-743,2015-06-16,2015,US 201313957135 A,2013-08-01,US 201313957135 A,2013-08-01,Apparatus for cable organization,"A cable management apparatus includes a flexible planar body and a plurality of channels aligned along a longitudinal axis on a surface of the flexible planar body. The flexible planar body has a plurality of fasteners aligned along a first edge and a second edge of the flexible planar body, the flexible planar body capable of forming a substantially circular bundle along the longitudinal axis. Each channel of the plurality of channels is configured to secure an individual cable to keep the cable from intersecting with another cable.",IBM,FLEMING MARK S;;MCNEAL STEVEN E;;NELSEN MICHAEL A,INTERNATIONAL BUSINESS MACHINES CORPORATION (2013-08-01),https://lens.org/086-833-281-984-743,Granted Patent,yes,5,2,2,2,0,H05K7/1491;;H02G3/0481;;H02G3/30;;G02B6/4471;;G02B6/4454;;G02B6/4455;;G02B6/4453;;G02B6/4452;;H05K7/1491;;H02G3/0481;;H02G3/30;;H02G3/045;;G02B6/4471,G02B6/00;;G02B6/44;;H02G3/04;;H05K7/14,,0,0,,,,INACTIVE
303,CA,A1,CA 2924815 A1,097-429-115-485-193,2015-03-26,2015,CA 2924815 A,2014-09-19,US 201361880786 P;;US 2014/0056576 W,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING A SIGNAL IN THE PRESENCE OF NOISE USING SLICES AND WARPING",A method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of a selected number of samples of the signal representing a correlation of the signal to reference functions in the receiver. The presence of the data packet may then be detected and the detected packet decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. The slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.,PROTEUS DIGITAL HEALTH INC,KUSHNER CHERIE;;FLEMING ROBERT;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,,https://lens.org/097-429-115-485-193,Patent Application,no,0,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L25/03;;H04L47/43,,0,0,,,,ACTIVE
304,RU,C1,RU 2628404 C1,142-697-014-720-212,2017-08-16,2017,RU 2016105831 A,2014-09-19,US 201361880786 P;;US 2014/0056576 W,2013-09-20,"METHODS, DEVICES AND SYSTEMS OF SIGNALS RECEIVING AND DECODING IN THE PRESENCE OF NOISE USING THE SHEARS AND DEFORMATION","FIELD: radio engineering, communication.SUBSTANCE: receiving method includes the signal receiving and discretization in which the data package is encoded. The shear is generated and stored by means of the controller, containing the pair of values for each of the signal selection specified number. The detected package from the stored shears is decoded. The filter is formed from the shears plurality by its integration by means of the controller, it has the set bandwidth. The average frequency of the filter is reset from the first medium frequency to the second medium frequency by deformation of the stored shears, from which the filter is formed by turning the corresponding pairs of its values by the certain amount.EFFECT: increase of the received signal detection and decoding efficiency.29 cl 13 dwg",PROTEUS DIGITAL HEALTH INC,KUSHNER CHERIE;;FLEMING ROBERT;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,,https://lens.org/142-697-014-720-212,Granted Patent,no,0,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L27/148;;H04L47/43,,0,0,,,,ACTIVE
305,MX,A,MX 2016003659 A,038-848-224-044-772,2016-06-24,2016,MX 2016003659 A,2014-09-19,US 201361880786 P;;US 2014/0056576 W,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING A SIGNAL IN THE PRESENCE OF NOISE USING SLICES AND WARPING.",A method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of a selected number of samples of the signal representing a correlation of the signal to reference functions in the receiver. The presence of the data packet may then be detected and the detected packet decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. The slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.,PROTEUS DIGITAL HEALTH INC,ZDEBLICK MARK;;KUSHNER CHERIE;;FLEMING ROBERT;;MCALLISTER WILLIAM H,,https://lens.org/038-848-224-044-772,Patent Application,no,0,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L25/03;;H04L47/43,,0,0,,,,ACTIVE
306,EP,B1,EP 3047618 B1,030-931-930-718-494,2023-11-08,2023,EP 14845438 A,2014-09-19,US 201361880786 P;;US 2014/0056576 W,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING A SIGNAL IN THE PRESENCE OF NOISE USING SLICES AND WARPING",,OTSUKA PHARMA CO LTD,FLEMING ROBERT;;KUSHNER CHERIE;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,"OTSUKA PHARMACEUTICAL CO., LTD. (2021-05-26)",https://lens.org/030-931-930-718-494,Granted Patent,yes,2,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L27/00;;H04B1/00;;H04L7/04;;H04L27/144;;H04L27/148,,0,0,,,,ACTIVE
307,US,A1,US 2020/0259691 A1,152-281-218-924-253,2020-08-13,2020,US 201916600174 A,2019-10-11,US 201916600174 A;;US 201816121736 A;;US 201715678349 A;;US 201614989409 A;;US 201414491447 A;;US 201361880786 P,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING A SIGNAL IN THE PRESENCE OF NOISE USING SLICES AND WARPING",A method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of a selected number of samples of the signal representing a correlation of the signal to reference functions in the receiver. The presence of the data packet may then be detected and the detected packet decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. The slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.,PROTEUS DIGITAL HEALTH INC,FLEMING ROBERT;;KUSHNER CHERIE;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,OTSUKA AMERICA PHARMACEUTICAL INC (2020-12-10);;OTSUKA PHARMACEUTICAL CO. LTD (2020-12-21),https://lens.org/152-281-218-924-253,Patent Application,yes,8,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L27/148;;H04L47/43;;H04B1/00;;H04L7/04;;H04L25/08;;H04L27/00;;H04L27/144,,0,0,,,,ACTIVE
308,WO,A1,WO 1996/029966 A1,181-356-096-725-816,1996-10-03,1996,US 9602385 W,1996-02-21,US 41099395 A,1995-03-27,DIAPER REGISTRATION CONTROL SYSTEM,"The automatic registration control system of the present invention is a closed loop system including a driving mechanism (10) for feeding a continuous web (12) of disposable absorbent articles, such as diaper pads, toward a cutter (14). The cutter (14) may separate completed pads from the web. A sensor (26) is positioned along the manufacturing line, and preferably preceding the cutter (14), for detecting at least one preselected feature of each diaper pad and producing a detection signal when the feature passes by the sensor (26). A position resolver (32) determines the angular position of the cutter (14) at the moment when the preselected diaper feature is detected, and the average angular position is calculated from a predetermined number of cutter (14) positions. The average cutter (14) position is compared to and subtracted from a target cutter (14) position to produce an error signal. The error signal is then converted into a control signal and supplied to a phase variator (44) which adjusts the position of the cutter (14) in response to the control signal.",PROCTER & GAMBLE,STUEBE MYRON LEE;;FLEMING JAMES MICHAEL;;WHALEY MARK DAVID,,https://lens.org/181-356-096-725-816,Patent Application,yes,5,6,11,11,0,A61F13/15772;;A61F13/15772;;A61F13/15772;;A61F13/15723;;A61F13/15723;;A61F13/15723;;Y10T83/543;;Y10T83/543,A61F13/49;;A61F5/44;;A61F13/15;;A61F13/472,,0,0,,,,PATENTED
309,MX,B,MX 356850 B,184-123-396-681-933,2018-06-15,2018,MX 2016003659 A,2014-09-19,US 201361880786 P;;US 2014/0056576 W,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING A SIGNAL IN THE PRESENCE OF NOISE USING SLICES AND WARPING.",A method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of a selected number of samples of the signal representing a correlation of the signal to reference functions in the receiver. The presence of the data packet may then be detected and the detected packet decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. The slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.,PROTEUS DIGITAL HEALTH INC,ZDEBLICK MARK;;CHERIE KUSHNER;;ROBERT FLEMING;;WILLIAM H MCALLISTER,,https://lens.org/184-123-396-681-933,Granted Patent,no,0,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H03K9/00;;H04L47/43;;H04L7/04;;H04L25/03;;H04L25/08;;H04L27/00;;H04L27/144;;H04L27/148,,0,0,,,,ACTIVE
310,AU,A1,AU 2019/204197 A1,000-203-013-837-417,2019-07-04,2019,AU 2019/204197 A,2019-06-14,AU 2019/204197 A;;AU 2014/321320 A;;US 201361880786 P;;US 2014/0056576 W,2013-09-20,"Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping","A method may comprise receiving a signal, the signal encoding a data packet; sampling the signal to generate sampled values; generating a slice record comprising a plurality of slices from the sampled values by correlating the sampled values with first and second reference templates, the first reference template comprising a first reference function and the second reference template comprising a second reference function in quadrature with the first reference function; cross-correlating the slice record with a stored template to generate cross-correlation terms; and determining when a magnitude of the cross-correlation terms exceeds a predetermined threshold for a width of the stored template. WO 2015/042411 PCT/US2O1-4/056576 mrvI enI fn r-I '-I ca 0' 4 <U U w 0 W) oU 0 I LIEIII LLI- w zr uZ LA*ow-U 0 LL (: 4 -J LA. 0--LIt LL 0' I I-- ""-Lfl tn c = co I Iw Lw I <- w 9= Z : 0 zL z U UU V)c 0L 4A IU- L L 0 Wo z Lin c]",OTSUKA PHARMA CO LTD,KUSHNER CHERIE;;FLEMING ROBERT;;MCALLISTER WILLIAM H;;ZDEBLICK MARK,"OTSUKA PHARMACEUTICAL CO., LTD. (2021-05-13)",https://lens.org/000-203-013-837-417,Patent Application,no,0,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L25/03;;H04L47/43,,0,0,,,,ACTIVE
311,DE,D1,DE 60117021 D1,047-444-526-521-349,2006-04-13,2006,DE 60117021 T,2001-07-20,AU PQ968800 A;;AU 1991/001008 W,2000-08-25,Microstrukturierter optischer Polymerwellenleiter,"An optical waveguide in the form of an optical fibre ( 10 ) having at least one longitudinally extending light guiding core region ( 11 ) composed at least in part of a polymeric material, a longitudinally extending core-surrounding region ( 12 ) composed of a polymeric material, and a plurality of light confining elements ( 15 ), such as, for example, channel-like holes, located within the core surrounding region. The light confining elements extend in the longitudinal direction of the core region and are distributed about the core region, and at least a majority of the light confining elements having a refractive index less than that of the polymeric material from which the core-surrounding region is composed. A preform for use in manufacture of the optical waveguide is also disclosed.",UNIV SYDNEY,FLEMING SIMON;;BASSETT IAN;;SCEATS MARK;;VAN EIJKELENBORG MARTIJN,,https://lens.org/047-444-526-521-349,Granted Patent,no,0,0,17,18,0,G02B6/02;;G02B6/02347;;G02B6/02357;;G02B6/02361;;G02B6/02371;;G02B6/00;;G02B6/02347;;G02B6/02;;G02B6/02357;;G02B6/02361;;G02B6/02371,G02B6/00;;G02B6/02;;G02B6/032,,0,0,,,,EXPIRED
312,US,B2,US 6823440 B2,083-094-277-383-27X,2004-11-23,2004,US 22751802 A,2002-08-22,US 22751802 A,2002-08-22,Method and apparatus for isolating frames in a data processing system,"
    A method, apparatus, and computer instructions for managing frames. Frames intended for isolation are identified in which the frames include in-use frames and free frames. Reservation of free frames from the frames identified as intended for isolation is requested. Successfully reserved frames are moved to an isolation list. In-use frames are marked, and unisolated/unmarked frames are identified. Any free frames in the unisolated frames are moved to the isolation list. In-use frames in the unisolated frames are marked and reservation of the in-use frames in the unisolated frames is released. 
",IBM,FLEMING MATTHEW DAVID;;ROGERS MARK DOUGLASS;;SHEFFIELD DAVID WILLIAM,INTERNATIONAL BUSINESS MACHINES CORPORATION (2002-08-15),https://lens.org/083-094-277-383-27X,Granted Patent,yes,3,3,2,2,0,G06F9/5016;;G06F9/5016,G06F9/50;;G06F12/00;;G06F12/02,711/173,0,0,,,,EXPIRED
313,WO,A1,WO 2002/016983 A1,127-003-851-082-825,2002-02-28,2002,AU 1990/001008 W,2001-07-20,AU PQ968900 A,2000-08-25,OPTICAL WAVEGUIDE FIBRE,"An optical fibre (1) having at least one longitudinally extending light guiding core region (11), a longitudinally extending core-surrounding region (12), and a plurality of light confining elements (15, 16, 17, 18), such as, for example, channel-like holes, located within the core-surrounding region (12). The light confining elements (15, 16, 17, 18) extend in the longitudinal direction of the core region and are located geometrically in zones that surround the core region. The aggregate cross-sectional area defined by the light confining elements within the respective zones increases with increasing radial distance of the zones from the core region. A preform for use in manufacture of the optical fibre is also defined.",UNIV SYDNEY;;BASSETT IAN;;FLEMING SIMON;;SCEATS MARK;;EIJKELENBORG MARTIJN VAN,BASSETT IAN;;FLEMING SIMON;;SCEATS MARK;;VAN EIJKELENBORG MARTIJN,,https://lens.org/127-003-851-082-825,Patent Application,yes,2,5,2,4,0,C03B37/01205;;C03B2203/14;;C03B2203/16;;C03B2203/30;;C03B2203/34;;C03B2203/42;;G02B6/02333;;G02B6/02338;;G02B6/02357;;G02B6/02361;;G02B6/02371,C03B37/012;;G02B6/02,,3,1,003-109-338-617-488,10.1126/science.285.5433.1537;;10477511,"PATENT ABSTRACTS OF JAPAN;;GREGAN R.F. ET AL.: ""Single-mode photonic band gap guidance of light in air"", SCIENCE, vol. 285, 3 September 1999 (1999-09-03), pages 1537 - 1539;;SORENSEN T. ET AL.: ""Macro-bending loss properties of photonic crystal fibre"", ELECTRONICS LETTERS, vol. 37, no. 5, 1 March 2001 (2001-03-01), pages 287 - 289",PENDING
314,AT,T1,AT E317131 T1,130-083-335-402-571,2006-02-15,2006,AT 01951247 T,2001-07-20,AU PQ968800 A,2000-08-25,MICROSTRUKTURIERTER OPTISCHER POLYMERWELLENLEITER,"An optical waveguide in the form of an optical fibre ( 10 ) having at least one longitudinally extending light guiding core region ( 11 ) composed at least in part of a polymeric material, a longitudinally extending core-surrounding region ( 12 ) composed of a polymeric material, and a plurality of light confining elements ( 15 ), such as, for example, channel-like holes, located within the core surrounding region. The light confining elements extend in the longitudinal direction of the core region and are distributed about the core region, and at least a majority of the light confining elements having a refractive index less than that of the polymeric material from which the core-surrounding region is composed. A preform for use in manufacture of the optical waveguide is also disclosed.",UNIV SYDNEY,FLEMING SIMON;;BASSETT IAN;;SCEATS MARK;;VAN EIJKELENBORG MARTIJN,,https://lens.org/130-083-335-402-571,Granted Patent,no,0,0,17,18,0,G02B6/02;;G02B6/02347;;G02B6/02357;;G02B6/02361;;G02B6/02371;;G02B6/00;;G02B6/02347;;G02B6/02;;G02B6/02357;;G02B6/02361;;G02B6/02371,G02B6/00;;G02B6/02;;G02B6/032,,0,0,,,,EXPIRED
315,MX,A,MX 2014013677 A,001-659-956-175-289,2015-02-05,2015,MX 2014013677 A,2013-05-13,US 201261647557 P;;US 201313891351 A;;US 2013/0040717 W,2012-05-16,THERMAL DUCTING SYSTEM.,"A thermal ducting system for electronic equipment in an electronic equipment enclosure is provided. The thermal ducting system includes a top duct, a bottom duct spaced apart from the top duct, a side duct extending from the top duct to the bottom duct and along an intake side of the electronic equipment, and at least one baffle positioned in the side duct.",PANDUIT CORP,FLEMING JAMES N;;GOLDSBERRY TIMOTHY;;SHURHAY MARK;;HIBNER MAX W,,https://lens.org/001-659-956-175-289,Patent Application,no,0,0,10,10,0,H05K7/20736;;Y10T29/49826;;H05K7/20145;;B23P19/00;;Y10T29/49826;;H05K7/20736,H05K7/20,,0,0,,,,ACTIVE
316,SG,A1,SG 131090 A1,094-831-289-305-902,2007-04-26,2007,SG 2006066963 A,2006-09-26,US 23613105 A,2005-09-27,COLORANT PRESENTATION FOR PAD PRINTING,,JOHNSON & JOHNSON VISION CARE,WIDMAN MICHAEL F;;RYAN JOSEPH;;FLEMING AIDEN;;POWELL P MARK,,https://lens.org/094-831-289-305-902,Patent Application,no,0,0,13,13,0,B41F17/001;;B41F17/001;;G05D24/02;;G05D24/02,,,0,0,,,,PENDING
317,EP,B1,EP 2087589 B1,098-733-425-535-451,2011-11-23,2011,EP 07839676 A,2007-10-17,US 2007/0022257 W;;US 82983206 P,2006-10-17,LOW VOLTAGE OSCILLATOR FOR MEDICAL DEVICES,"Low voltage oscillators that provide a stable output frequency with varying supply voltage are provided. The subject oscillators find use in a variety of different types of devices, e.g., medical devices, including both implantable and ex-vivo devices.",PROTEUS BIOMEDICAL INC,FLEMING ROBERT;;KUSHNER CHERIE;;JANI NILAY;;WITHRINGTON JONATHAN;;ZDEBLICK MARK,"PROTEUS DIGITAL HEALTH, INC. (2012-10-24);;PROTEUS DIGITAL HEALTH, INC., US (2012-10-08);;PROTEUS DIGITAL HEALTH, INC., REDWOOD CITY, US (2012-10-08)",https://lens.org/098-733-425-535-451,Granted Patent,yes,9,0,9,9,0,H03K3/011;;H03K3/0322;;H03K5/133;;H03K2005/00208;;H03K2005/00234;;H03K3/0322;;H03K3/011;;H03K2005/00234;;H03K5/133;;H03K2005/00208,H03K3/03;;H03K3/011,,4,0,,,"CHING-YUAN YANG; SHEN-IUAN LIU: ""Fast-Switching Frequency Synthesizer with a Discriminator-Aided Phase Detector"" IEEE JOURNAL OF SOLID-STATE CIRCUITS, IEEE SERVICE CENTER, PISCATAWAY, NJ, US, vol. 35, no. 10, 1 October 2000 (2000-10-01), XP011061354 ISSN: 0018-9200;;SANDULEANU M A T; GOOR VAN D; VEENSTRA H ED - HAMILTON R (ED): ""OCTAVE TUNABLE, HIGHLY LINEAR, RC-RING ISCILLATOR WITH DIFFERENTIAL FINE-COARSE TUNING, QUADRATURE OUTPUTS AND AMPLITUDE CONTROL FOR FIBER OPTIC TRANSCEIVERS"" 2002 IEEE MTT-S INTERNATIONAL MICROWAVE SYMPOSIUM DIGEST (CAT. NO.02CH37278) IEEE PISCATAWAY, NJ, USA; 20020602, 2 June 2002 (2002-06-02), pages 545-548, XP001099549;;HEYDARI P: ""Analysis of the PLL Jitter Due to Power/Ground and Substrate Noise"" IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS PART I: REGULAR PAPERS, IEEE SERVICE CENTER, NEW YORK, NY, US, vol. 51, no. 12, 1 December 2004 (2004-12-01), pages 2404-2416, XP011123085 ISSN: 1057-7122;;ARMIN TAJALLI; MASSIMO ALIOTO; ELIZABETH J BRAUER; YUSUF LEBLEBICI ED - LARS SVENSSON; JOSÃ CR MONTEIRO: ""Improving the Power-Delay Performance in Subthreshold Source-Coupled Logic Circuits"" 10 September 2008 (2008-09-10), INTEGRATED CIRCUIT AND SYSTEM DESIGN. POWER AND TIMING MODELING, OPTIMIZATION AND SIMULATION, SPRINGER BERLIN HEIDELBERG, BERLIN, HEIDELBERG, PAGE(S) 21 - 30 , XP019114610 * the whole document *",ACTIVE
318,EP,A3,EP 1681159 A3,112-856-395-299-501,2007-10-03,2007,EP 06250010 A,2006-01-04,US 2956205 A,2005-01-05,Viscosity control and colorant circulation for printing lens molds,"Disclosed are systems including a colorant (14) cup (8) that is adjacent to a cliché (19), wherein the cup (8) includes a vent (31), an interior roof portion, and an air gap beneath the roof portion; a reservoir containing colorant; a feed conduit in fluid communication with the reservoir; and a return conduit (3) in fluid communication with the cup (8). Also disclosed are various methods in which colorants (14) are transferred in the disclosed systems from the reservoir to the colorant cup. The disclosed systems, colorant cups and methods are useful in the preparation of tinted contact lenses.
",JOHNSON & JOHNSON VISION CARE,WIDMAN MICHAEL F;;POWELL PAUL MARK;;FLEMING AIDAN;;RYAN JOSEPH,,https://lens.org/112-856-395-299-501,Search Report,yes,8,0,15,18,0,B29D11/00903;;B41F17/001;;B29D11/00903;;B29D11/00951;;B29D11/00951;;B41F17/001;;B41F31/005;;B41F31/005;;G01N11/00;;G01N11/00,B41F17/00;;B67D7/06;;B67D7/08;;B67D7/78,,0,0,,,,ACTIVE
319,EP,B1,EP 1681159 B1,118-187-183-271-972,2009-06-03,2009,EP 06250010 A,2006-01-04,US 2956205 A,2005-01-05,Viscosity control and colorant circulation for printing lens molds,,JOHNSON & JOHNSON VISION CARE,WIDMAN MICHAEL F;;POWELL PAUL MARK;;FLEMING AIDAN;;RYAN JOSEPH,,https://lens.org/118-187-183-271-972,Granted Patent,yes,8,0,15,18,0,B29D11/00903;;B41F17/001;;B29D11/00903;;B29D11/00951;;B29D11/00951;;B41F17/001;;B41F31/005;;B41F31/005;;G01N11/00;;G01N11/00,B41F17/00;;B67D7/06;;B67D7/08;;B67D7/78,,0,0,,,,ACTIVE
320,HK,A1,HK 1132590 A1,136-080-199-356-121,2010-02-26,2010,HK 10100021 A,2010-01-04,US 2007/0022257 W;;US 82983206 P,2006-10-17,LOW VOLTAGE OSCILLATOR FOR MEDICAL DEVICES,"Low voltage oscillators that provide a stable output frequency with varying supply voltage are provided. The subject oscillators find use in a variety of different types of devices, e.g., medical devices, including both implantable and ex-vivo devices.",PROTEUS BIOMEDICAL INC,FLEMING ROBERT;;KUSHNER CHERIE;;JANI NILAY;;WITHRINGTON JONATHAN;;ZDEBLICK MARK,,https://lens.org/136-080-199-356-121,Patent Application,no,0,0,9,9,0,H03K3/011;;H03K3/0322;;H03K5/133;;H03K2005/00208;;H03K2005/00234;;H03K3/0322;;H03K3/011;;H03K2005/00234;;H03K5/133;;H03K2005/00208,H03K/,,0,0,,,,DISCONTINUED
321,US,B2,US 7655446 B2,140-633-382-655-332,2010-02-02,2010,US 47819406 A,2006-06-28,US 47819406 A;;US 69516105 P,2005-06-28,Crystal structure of Rho-kinase I kinase domain complexes and binding pockets thereof,"The present invention relates to human Rho-kinase I (ROCK I), ROCK I binding pockets, ROCK I-like binding pockets. More particularly, the present invention provides a computer comprising a data storage medium encoded with the structure coordinates of such binding pockets. This invention also relates to methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention relates to methods of using the structure coordinates to screen for and design compounds, including inhibitory compounds, that bind to ROCK I protein or ROCK I protein homologues, or complexes thereof. The invention also relates to crystallizable compositions and crystals comprising ROCK I kinase domain and ROCK I kinase domain complexed with an inhibitor of that domain. The invention also relates to methods of identifying inhibitors of the ROCK I kinase domain.",VERTEX PHARMA,JACOBS MARC;;HAYAKAWA KOTO;;FLEMING MARK;;DORAN JOHN;;MARHEFKA CRAIG,VERTEX PHARMACEUTICALS INCORPORATED (2009-11-15),https://lens.org/140-633-382-655-332,Granted Patent,yes,6,0,2,2,5,C07K2299/00;;C12N9/1205;;C12N9/1205;;C07K2299/00,C12N9/00;;G01N31/00,435/183;;436/4,63,58,087-667-912-261-011;;051-798-597-480-575;;054-871-100-780-845;;010-877-105-694-541;;056-630-990-013-730;;049-948-139-251-846;;020-327-622-694-888;;102-345-845-395-203;;013-049-898-665-286;;023-476-471-521-012;;042-399-108-759-256;;038-753-826-151-143;;025-829-883-919-776;;119-687-205-724-766;;057-917-804-583-081;;062-983-514-324-408;;039-885-201-029-288;;062-672-417-308-555;;008-556-041-358-40X;;054-207-089-106-618;;005-407-101-849-051;;030-042-017-746-591;;131-046-096-401-339;;021-847-701-045-101;;144-611-736-227-756;;032-506-096-317-896;;025-802-799-712-238;;033-912-049-607-022;;127-945-202-748-091;;022-460-122-506-743;;034-371-095-594-864;;067-086-715-999-411;;069-092-932-909-092;;011-909-461-689-378;;036-745-751-836-283;;026-844-000-626-964;;069-450-943-413-364;;038-353-413-875-140;;031-690-810-797-222;;141-777-356-359-483;;038-505-398-849-808;;184-644-637-972-373;;064-406-626-054-484;;001-649-174-814-809;;151-919-600-413-52X;;129-297-815-048-32X;;022-346-066-665-459;;048-312-616-139-567;;140-649-046-294-300;;023-138-895-228-678;;038-330-836-646-807;;017-216-732-209-839;;011-847-430-022-967;;005-116-498-408-886;;069-194-715-668-832;;038-036-177-884-328;;007-816-063-757-761;;054-418-959-978-111,2185018;;10.1111/j.1432-1033.1990.tb15454.x;;10.1007/s00018-003-3260-z;;15004692;;17641629;;10.1038/nprot.2007.198;;10.1074/jbc.271.34.20246;;8702756;;9619630;;10.1046/j.1365-2443.1998.00181.x;;10542285;;10.1074/jbc.274.45.32418;;10.1038/326347a0;;3550471;;1583540;;10.1007/bf00124387;;10.1016/j.str.2003.11.002;;14656443;;10.1107/s0907444998003254;;9757107;;10.1107/s0021889891007240;;15177282;;10.1016/j.pep.2004.03.003;;10.1107/s0021889896013532;;10.1021/jm00165a001;;2407844;;10.1016/0263-7855(84)80031-4;;10.1016/0022-0248(96)00351-x;;10.1042/bj20040344;;15291762;;pmc1134108;;10.1002/prot.340190305;;7937734;;7763517;;10.1038/nbt0493-479;;pmc2143869;;10.1002/pro.5560071102;;9827991;;10.1007/bf00126441;;8320553;;10.1021/jm00145a002;;3892003;;10.1002/prot.340080302;;2281083;;1784176;;10.1016/0076-6879(91)02014-z;;10.1002/(sici)1099-1352(199603)9:2<175::aid-jmr260>3.0.co;2-d;;8877811;;10.1002/elps.1150181505;;9504803;;10.1016/s0959-440x(94)90179-1;;9013646;;10.1074/jbc.272.6.3860;;10.1126/science.3291115;;3291115;;1956325;;10.1016/0076-6879(91)00126-h;;10.1016/s0076-6879(96)66024-8;;8743695;;pmc2133015;;10.1083/jcb.141.7.1625;;9647654;;9119047;;10.1016/s0014-5793(97)00107-5;;10.3109/10409239409086797;;8143488;;2025413;;10.1107/s0108767390010224;;10579722;;10.1083/jcb.147.5.1023;;pmc2169354;;7154081;;10.1016/0022-2836(82)90153-x;;9139666;;10.1074/jbc.272.19.12257;;4079798;;10.1016/0076-6879(85)15007-x;;10.1007/bf00124349;;8035213;;10.1021/jm00090a001;;1613742;;10.1002/jcc.540130412;;10.1002/prot.340110104;;1961699;;11567147;;10.1107/s0907444901012422;;10.1016/0959-440x(92)90147-y;;10.1016/s0040-4020(01)86503-0;;7824526;;10.1002/prot.340200110;;10.1016/0097-8485(92)80005-k;;10.1038/ncb1019;;12844144;;10.1038/nrc725;;12635176;;8642592;;10.1006/jmbi.1996.0119;;10.1016/0196-8858(81)90046-4;;9416773;;10.1016/s0024-3205(97)00717-0;;pmc2175273;;10.1083/jcb.150.4.797;;10953004;;7704670;;10.1093/bioinformatics/10.6.687;;9739089;;10.1016/s0969-2126(98)00100-2;;9478968;;10.1074/jbc.273.9.5146;;10.1107/s0907444994003112;;15299374,"McPherson Eur. J. Biochem. 1990, 189:1-23.;;Kundrot et al. Cell. Mol. Life Sci. 2004, 61: 525-536.;;Benevenuti et al., Nature Protocols, published on-line Jun. 28, 2007, 2(7):1633-1651.;;R. Cudney, Rigaku Journal, 1999, vol. 16, No. 1, pp. 1-7.;;Drenth, ""Principles of Protein X-Ray Crystallography"", 2nd Edition, 1999 Springer-Verlag New York Inc., Chapter 1, p. 19, 4th paragraph, lines 1-2.;;Amano et al., ""Phosphorylation and Activation of Myosin by Rho-associated Kinase (Rho-Kinase),"" The Journal of Biological Chemistry, 271(34):20246-20249 (1996).;;Amano et al., ""Myosin II Activation Promotes Neurite Retraction during the Action of Rho and Rho-kinase,"" Genes to Cells, 3:177-188 (1998).;;Amano et al., The COOH Terminus of Rho-Kinase Negatively Regulates Rho-Kinase Activity, The Journal of Biological Chemistry, 274(45):32418-32424 (1999).;;Balbes et al., ""A Perspective of Modern Methods in Computer-Aided Drug Design,"" Reviews in Computational Chemistry, K.B. Lipkowitz and D.B. Boyd Eds., VCH Publishers, New York, 5:337-379 (1994).;;Bartlett et al., ""CAVEAT: A Program to Facilitate the Structure-derived Design of Biologically Active Molecules,"" Molecular Recognition in Chemical and Biological Problems, S.M. Roberts, Ed., Royal Society of Chemistry, 78:182-196 (1989).;;Blundell et al., ""Knowledge-based Prediction of Protein Structures and the Design of Novel Molecules,"" Nature, 326:347-352 (1987).;;Böhm, ""The Computer Program LUDI: A New Method for the de novo Design of Enzyme Inhibitors,"" Journal of Computer-Aided Molecular Design, 6:61-78 (1992).;;Breitenlechner et al., ""Protein Kinase A in Complex with Rho-Kinase Inhibitors Y-27632, Fasudil, and H-1152P: Structural Basis of Selectivity,"" Structure, 11:1595-1607 (2003).;;Brünger et al., ""Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination,"" Acta Crystallographica, D54:905-921, (1998).;;Carson, ""Ribbons 2.0,"" Journal of Applied Crystallography, 24:958-961 (1991).;;Chambers et al., ""High-throughout Screening for Soluble Recombinant Expressed Kinases in Escherichia coli and Insect Cells,"" Protein Expression and Purification, 36:40-47 (2004).;;Chayen, ""A Novel Technique to Control the Rate of Vapour Diffusion, Giving Larger Protein Crystals,"" Journal of Applied Crystallography, 30:198-202 (1997).;;Cohen et al., ""Molecular Modeling Software and Methods for Medicinal Chemistry,"" Journal of Medicinal Chemistry, 33(3):883-894 (1990).;;Cory and Bentley, ""MATCHMOL, an Interactive Computer Graphics Procedure for Superposition of Molecular Models,"" Journal of Molecular Graphics, 2:39-42 (1984).;;D'Arcy et al., ""A Novel Approach to Crystallising Proteins under Oil,"" Journal of Crystal Growth, 168:175-180 (1996).;;Dayhoff et al., ""A Model of Evolutionary Change in Proteins,"" Atlas of Protein Sequence and Structure, 5(3):345-352 (1978).;;Doran et al., ""New Insights into the Structure-Function Relationships of Rho-associated Kinaså: A Thermodynamic and Hydrodynamic Study of the Dimer-to-Monomer Transition and its Kinetic Implications,"" Biochemical Journal, 384:255-262 (2004).;;Eisen et al., ""HOOK: A Program for Finding Novel Molecular Architectures that Satisfy the Chemical and Steric Requirements of a Macromolecule Binding Site,"" Proteins: Structure, Functions and Genetics, 19:199-221 (1994).;;Fetrow and Bryant, ""New Programs for Protein Tertiary Structure Prediction,"" Bio/Technology, 11:479-484 (1993).;;Fox et al., ""A Single Amino Acid Substitution Makes ERK2 Susceptible to Pyridinyl Imidazole Inhibitors of p38 MAP Kinase,"" Protein Science, 7, 2249-2255 (1998).;;Gillet et al., ""SPROUT: A Program for Structure Generation,"" Journal of Computer-Aided Molecular Design, 7:127-153 (1993).;;Goodford, ""A Computational Procedure for Determining Energetically Favorable Binding Sites on Biologically Important Macromolecules,"" Journal of Medicinal Chemistry, 28:849-857 (1985).;;Goodsell and Olson, ""Automated Docking of Substrates to Proteins by Simulated Annealing,"" Proteins: Structure, Function and Genetics, 8:195-202 (1990).;;Greer, ""Comparative Modeling of Homologous Proteins,"" Methods in Enzymology, 202:239-252 (1991).;;Gschwend et al., ""Molecular Docking Towards Drug Discovery,"" Journal of Molecular Recognition, 9:175-186 (1996).;;Guex and Peitsch, ""Swiss-Model: and the Swiss-PdbViewer: An Environment for Comparative Protein Modeling,"" Electrophoresis, 18:2714-2723 (1997).;;Guida, ""Software for Structured-based Drug Design,"" Current Opinion in Structural Biology, 4:777-781 (1994).;;Hammond et al., ""Characterization of Two Alternately Spliced Forms of Phospholipase D1,"" The Journal of Biological Chemistry, 272(6):3860-3868 (1997).;;Hanks et al., ""The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains,"" Science, 241:42-52 (1988).;;Hanks and Quinn, ""Protein Kinase Catalytic Domain Sequence Database: Identification of Conserved Features of Primary Structure and Classification of Family Members,"" Methods in Enzymology, 200:38-62 (1991).;;Higgins et al., ""Using CLUSTAL for Multiple Sequence Alignments,"" Methods in Enzymology, 266:383-402 (1996).;;Hirose et al., ""Molecular Discussion of the Rho-associated Protein Kinase (p160ROCK)-regulated Neurite Remodeling in Neuroblastoma N1E-115 Cells,"" The Journal of Cell Biology, 141(7):1625-1636 (1998).;;Ishizaki et al., ""p160ROCK, a Rho-associated Coiled-coil Forming Protein Kinase, Works Downstream of Rho and Induces Focal Adhesions,"" FEBS Letters, 404:118-124 (1997).;;Johnson et al., ""Knowledge-Based Protein Modeling,"" Critical Reviews in Biochemistry and Molecular Biology. 29:1-68 (1994).;;Jones et al., ""Improved Methods for Building Protein Models in Electron Density Maps and the Location of Errors in these Models,"" Acta Crystallographica, A47:110-119 (1991).;;Kawano et al., ""Phosphorylation of Myosin-binding Subunit (MBS) of Myosin Phosphatase by Rho-Kinase In Vivo,"" The Journal of Cell Biology, 147(5):1023-1037 (1999).;;Kuntz et al., ""A Geometric Approach to Macromolecule-Ligand Interactions,"" The Journal of Molecular Biology, 161:269-288 (1982).;;Kureishi et al., ""Rho-associated Kinase Directly Induces Smooth Muscle Contraction through Myosin Light Chain Phosphorylation,"" The Journal of Biological Chemistry, 272(19):12257-12260 (1997).;;Lattman, ""Use of the Rotation and Translation Functions,"" Methods in Enzymology, 115:55-77 (1985).;;Lauri and Bartlett, ""CAVEAT: A Program to Facilitate the Design of Organic Molecules,"" Journal of Computer-Aided Molecular Design, 8:51-66 (1994).;;Martin, ""3D Database Searching in Drug Design,"" Journal of Medicinal Chemistry, 35(12):2145-2154 (1992).;;Meng et al., ""Automated Docking with Grid-Based Energy Evaluation,"" Journal of Computational Chemistry, 13(4):505-524 (1992).;;Miranker and Karplus, ""Functionality Maps of Binding Sites: A Multiple Copy Simultaneous Search Method,"" Proteins: Structure, Function and Genetics, 11:29-34 (1991).;;Navaza, ""Implementation of Molecular Replacement in AMoRe,"" Acta Crystallographica, D57:1367-1372 (2001).;;Navia and Murcko, ""Use of Structural Information in Drug Design,"" Current Opinion in Structural Biology, 2:202-210 (1992).;;Nishibata and Itai, ""Automatic Creation of Drug Candidate Structures Based on Receptor Structure. Starting Point for Artificial Lead Generation,"" Tetrahedron, 47(43):8985-8990 (1991).;;Pav et al., ""Microtube Batch Protein Crystallization: Applications to Human Immunodeficiency Virus Type 2 (HIV-2) Protease and Human Renin,"" Proteins: Structure, Function, and Genetics, 20:98-102 (1994).;;Redington, ""MOLFIT: A Computer Program for Molecular Superposition,"" Computers Chemical, 16(3):217-222 (1992).;;Sahai and Marshall, ""Differing Modes of Tumour Cell Invasion Have Distinct Requirements for Rho/ROCK Signalling and Extracellular Proteolysis,"" Nature Cell Biology, 5(8):711-719 (2003).;;Sahai and Marshall, ""RHO-GTPases and Cancer,"" Nature Reviews: Cancer, 2:133-142 (2002).;;Schnare et al., ""Comprehensive Comparison of Structural Characteristics in Eukaryotic Cytoplasmic Large Subunit (23 S-like) Ribosomal RNA,"" Journal of Molecular Biology, 256:701-719 (1996).;;Smith and Waterman, ""Comparison of Biosequences,"" Advances in Applied Mathematics, 2:482-489 (1981).;;Szklarz and Halpert, ""Use of Homology Modeling in Conjunction with Site-Directed Mutagenesis for Analysis of Structure-Function Relationships of Mammalian Cytochromes P450,"" Life Sciences, 61(26):2507-2520 (1997).;;Totsukawa et al., ""Distinct Roles of ROCK (Rho-Kinase) and MLCK in Spatial Regulation of MLC Phosphorylation for Assembly of Stress Fibers and Focal Adhesions in 3T3 Fibroblasts,"" The Journal of Cell Biology, 150(4):797-806 (2000).;;Wishart et al., ""Constrained Multiple Sequence Alignment Using XALIGN,"" CABIOS, 10(6):687-688 (1994).;;Xie et al., ""Crystal Structure of JNK3: A Kinase Implicated in Neuronal Apoptosis,"" Structure, 6:983-991 (1998).;;Yoshioka et al., ""Small GTP-binding Protein Rho Stimulates the Actomyosin System, Leading to Invasion of Tumor Cells,"" The Journal of Biological Chemistry, 273(9):5146-5154 (1998).;;""The CCP4 Suite: Programs for Protein Crystallography,"" Collaborative Computational Project, No. 4, Acta Crystallographica, D50:760-763 (1994).",ACTIVE
322,JP,A,JP 2020115653 A,005-293-649-569-810,2020-07-30,2020,JP 2020055511 A,2020-03-26,JP 2019042240 A;;US 201361880786 P,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING SIGNAL IN PRESENCE OF NOISE USING SLICES AND WARPING","To provide preferable methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping.SOLUTION: The method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of the selected number of samples of the signal, the pair of values representing a correlation of the signal to reference functions in a receiver. The presence of the data packet may then be detected and the detected packet may be decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. A slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.SELECTED DRAWING: Figure 12",PROTEUS DIGITAL HEALTH INC,CHERIE KUSHNER;;ROBERT FLEMING;;WILLIAM H MCALLISTER;;MARK J ZDEBLICK,,https://lens.org/005-293-649-569-810,Patent Application,no,0,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04B1/10;;H04L47/43;;H04L27/14;;H04L27/22,,0,0,,,,ACTIVE
323,US,B2,US 10813582 B2,053-556-621-011-543,2020-10-27,2020,US 201715844975 A,2017-12-18,US 201715844975 A;;US 40977909 A,2009-03-24,Remote delivery and monitoring of health care,"An automated medical apparatus for providing medical care in remote areas to a patient is provided. The apparatus includes a container having corrugated steel enclosure on all sides and transportable using a standardized commercial shipping mechanism, the container having a door with a handle and lock mechanism for secure entry and secure accommodation of the patient for treatment. The container has integrated into an inner ceiling side of the container, a plurality of automated dispensers, the dispensers configured for dispensing sterilization material upon determining by the apparatus that the door has been opened and closed, a first time and a second time respectively, such that the patient is assumed to have completed the treatment and exited the container. Further, the apparatus includes a power management device, a processor, a medical device interface, and a patient interface.",IBM,FLEMING MARK;;LARA CHRISTINA;;COPELAND MICHAEL P;;SANCHEZ CALLINE K,INTERNATIONAL BUSINESS MACHINES CORPORATION (2017-12-05),https://lens.org/053-556-621-011-543,Granted Patent,yes,71,1,8,8,0,A61B5/0059;;A61B10/0045;;A61B2560/0431;;A61B2560/0456;;A61B5/0022;;A61B5/0013;;A61B2090/376;;A61B2090/378;;A61B5/445;;G16H30/40;;G16H40/67;;A61B5/0059;;A61B10/0045;;A61B2560/0431;;A61B2560/0456;;A61B5/0013;;A61B2090/376;;A61B2090/378;;A61B5/0022;;G16H30/40;;A61B5/445;;A61B5/6812;;A61B5/7445;;A61B2560/0475;;A61B5/7207;;A61B5/74;;A61B2560/0214;;G16H40/67,A61B5/00;;A61B10/00;;A61B90/00;;G16H30/40;;G16H40/67,,10,3,007-716-657-059-567;;018-189-798-239-331;;074-623-032-398-574,10.1385/jcd:1:4:369;;15304883;;11055787;;10.1109/42.875195;;10.1109/iembs.2006.259630;;17947114,"Singh et al., “A portable battery operated bone fracture evaluator,” Proceedings—19th International Conference—IEEE/EMBS Oct. 30-Nov. 2, 1997 Chicago, IL, USA.;;Kiebzak, “Radiolucent casting tape allows for accurate measurement of forearm bone mineral density using dual-energy X-ray absorptiometry,” Miller Orthopedic Clinic, Charlotte, NC, PMID: 1534883 [PubMed], 1998.;;Komiya et al., “Natural Color Reproduction System for Telemedicine and Its' Application to Digital Camera,” IEEE, vol. 3, pp. 50-54, 1999.;;Ohya, “Natural Color Reproduction System for Telemedicine,” IEEE, pp. 442-449, 1998.;;Vander Haeghen et al., “An Imaging System with Calibrated Color Image Acquisition for Use in Dermatology,” vol. 19, No. 7, pp. 772-730, Jul. 2000.;;Maar, “Doctor as Inventor and Visionary: Dr. Rhett Drugge, Dermatologist, Fights Skin Cancer with Sophisticated New Invention,” http://www.thebestdermatologist.com/derm/news.html, printed on Mar. 9, 2009.;;Lim et al., “A Novel Image Capture System for Use in Telehealth Applications,” Proceedings of the 28th IEEE EMBS Annual International Conference, New York City, pp. 4743-4746, Aug. 30-Sep. 3, 2006.;;Heying, “City rolls out solar panels on ambulance in order to save a few bucks,” LJWorld.com, 2 pages, Mar. 4, 2009.;;Abel, “Sunstar ambulances tap the sun to tack on power,” Tampa Bay Times, Tampa Bay, FL, USA, 1 page, Dec. 17, 2008.;;English Translation of DE 2944726 A1, 19810604, Hager Reinhard Klaus Ing (7 pages).",ACTIVE
324,GB,B,GB 2596657 B,066-736-861-674-135,2022-08-17,2022,GB 202109581 A,2021-07-02,GB 202020883 A,2020-12-31,Beverage container holder,,SUP DRINKWEAR LTD,DAVID SWEENEY;;MARK LITTLE;;HANS RAMZAN;;ALEX FLEMING;;JAMIE BALFOUR,,https://lens.org/066-736-861-674-135,Granted Patent,no,5,0,7,7,0,A47G23/0266;;A47G23/0216;;A47G2023/0283;;A47G23/0241;;B65D81/3876;;F25D3/08;;F25D2303/0841;;F25D2331/803;;A47G23/02;;A47G2023/0275;;A47G2023/0275;;A47G2200/16;;B65D25/10;;B65D81/3881;;F25D3/08;;F25D2331/803;;A47G23/0266,A47G23/02,,0,0,,,,ACTIVE
325,DK,T3,DK 2859062 T3,090-535-179-765-914,2020-11-09,2020,DK 13729054 T,2013-06-06,GB 201210034 A;;GB 2013051496 W,2012-06-07,Fremgangsmåde til hæmning af stenafsætning i en geologisk formation,,UNIV LEEDS INNOVATIONS LTD,KAPUR NIKIL;;NEVILLE ANNE;;GHORBANI NASSER;;FLEMING NIALL;;WILSON MARK,,https://lens.org/090-535-179-765-914,Granted Patent,no,0,0,12,12,0,C09K8/528;;E21B37/06;;C09K2208/10;;C09K8/528;;C09K2208/10;;F24F11/30;;F24F2110/00;;F24F2110/10;;F24F2110/40;;F24F2140/40;;F24F11/63;;F24F11/61;;F24F11/70;;F24F11/77;;Y02B30/70;;Y02P20/10;;C09K8/528;;C09K2208/10;;F24F11/30;;F24F2110/10;;F24F2140/40;;F24F11/63;;F24F11/61;;F24F11/70;;F24F11/77;;F24F2110/00;;F24F2110/40;;Y02B30/70;;Y02P20/10;;C09K8/52;;E21B43/16,C09K8/528;;F24F11/30;;F24F11/61;;F24F11/63;;F24F11/70;;F24F11/77;;F24F110/00;;F24F110/10;;F24F110/40;;F24F140/40,,0,0,,,,ACTIVE
326,US,A1,US 2010/0214033 A1,158-490-207-916-556,2010-08-26,2010,US 44572307 A,2007-10-17,US 44572307 A;;US 82983206 P;;US 2007/0022257 W,2006-10-17,LOW VOLTAGE OSCILLATOR FOR MEDICAL DEVICES,"Low voltage oscillators that provide a stable output frequency with varying supply voltage are provided. The subject oscillators find use in a variety of different types of devices, e.g., medical devices, including both implantable and ex-vivo devices.",FLEMING ROBERT;;KUSHNER CHERIE;;JANI NILAY;;WITHRINGTON JONATHAN;;ZDEBLICK MARK,FLEMING ROBERT;;KUSHNER CHERIE;;JANI NILAY;;WITHRINGTON JONATHAN;;ZDEBLICK MARK,PROTEUS DIGITAL HEALTH INC (2012-07-05);;OTSUKA AMERICA PHARMACEUTICAL INC (2020-12-10);;OTSUKA PHARMACEUTICAL CO. LTD (2020-12-21),https://lens.org/158-490-207-916-556,Patent Application,yes,99,4,9,9,0,H03K3/011;;H03K3/0322;;H03K5/133;;H03K2005/00208;;H03K2005/00234;;H03K3/0322;;H03K3/011;;H03K2005/00234;;H03K5/133;;H03K2005/00208,H03B5/36;;H03K3/03,331/57;;X331116 FE,0,0,,,,ACTIVE
327,EP,B1,EP 2859062 B1,163-489-602-843-142,2020-09-09,2020,EP 13729054 A,2013-06-06,GB 201210034 A;;GB 2013051496 W,2012-06-07,A METHOD OF INHIBITING SCALE IN A GEOLOGICAL FORMATION,,UNIV LEEDS INNOVATIONS LTD,GHORBANI NASSER;;FLEMING NIALL;;WILSON MARK;;KAPUR NIKIL;;NEVILLE ANNE,,https://lens.org/163-489-602-843-142,Granted Patent,yes,4,0,12,12,0,C09K8/528;;E21B37/06;;C09K2208/10;;C09K8/528;;C09K2208/10;;F24F11/30;;F24F2110/00;;F24F2110/10;;F24F2110/40;;F24F2140/40;;F24F11/63;;F24F11/61;;F24F11/70;;F24F11/77;;Y02B30/70;;Y02P20/10;;C09K8/528;;C09K2208/10;;F24F11/30;;F24F2110/10;;F24F2140/40;;F24F11/63;;F24F11/61;;F24F11/70;;F24F11/77;;F24F2110/00;;F24F2110/40;;Y02B30/70;;Y02P20/10;;C09K8/52;;E21B43/16,C09K8/528;;F24F11/30;;F24F11/61;;F24F11/63;;F24F11/70;;F24F11/77;;F24F110/00;;F24F110/10;;F24F110/40;;F24F140/40,,1,0,,,"N. KAZEMI, M. WILSON, N. KAPUR, UNIVERSITY OF LEEDS, N. FLEMING, STATOIL ASA, A. NEVILLE, UNIVERSITY OF LEEDS: ""Preventing Adhesion of Scale on Rock by Nanoscale Modification of the Surface"", SOCIETY OF PETROLEUM ENGINEERS, 156955, 12 June 2012 (2012-06-12), XP002709721, DOI: 10.2118/156955-MS ISBN: 978-1-61399-206-7",ACTIVE
328,US,A1,US 2013/0185592 A1,195-076-286-538-810,2013-07-18,2013,US 201213352140 A,2012-01-17,US 201213352140 A,2012-01-17,AUTOMATIC PROBLEM DIAGNOSIS,"For automatic problem diagnosis, a data collector module collects log data comprising code sets from a plurality of components in a data processing system. An analysis module translates the log data into at least one predefined symptom. Each symptom is associated with at least one code set of the log data. The analysis module selects from a knowledge base at least one problem that includes each symptom. The analysis module further calculates an influence factor for each problem, and ranks each problem from most likely to least likely based on the influence factor of the problem.",FLEMING MARK S;;HUANG JIN YAN;;YIN WEI;;ZHONG YI;;IBM,FLEMING MARK S;;HUANG JIN YAN;;YIN WEI;;ZHONG YI,INTERNATIONAL BUSINESS MACHINES CORPORATION (2012-01-11),https://lens.org/195-076-286-538-810,Patent Application,yes,6,25,2,2,0,G06F11/0709;;G06F11/0709;;G06F11/079;;G06F11/079;;H04L41/069;;H04L41/069,G06F11/28,714/37;;X714E11178,0,0,,,,INACTIVE
329,BR,A,BR PI0603974 A,042-767-962-985-910,2007-08-21,2007,BR PI0603974 A,2006-09-27,US 23613105 A,2005-09-27,apresentação de corante para impressão por bloco,"APRESENTAçãO DE CORANTE PARA IMPRESSãO POR BLOCO. A presente invenção refere-se istemas e métodos para fornecer corantes para um aparelho de copo de corante que é adjacente a um clichê de impressão por bloco. O corante de fluido é alimentado a partir de um recipiente de corante através de um conduto de alimentação para o copo e um viscómetro em linha fora do recipiente de corante mede a viscosidade do corante dentro do conduto de alimentação. Um mecanismo de controle pode distribuir o silvente de corante para dentro do recipiente de corante com base em uma medição de viscosidade realizada pelo viscómetro em linha. Os sistemas descritos, os copos de corante e métodos são úteis na preparação de lentes de contato tingidas.",JOHNSON & JOHNSON,WIDMAN MICHAEL F;;RYAN JOSEPH;;FLEMING AIDEN;;POWELL PAUL MARK,,https://lens.org/042-767-962-985-910,Patent Application,no,0,0,13,13,0,B41F17/001;;B41F17/001;;G05D24/02;;G05D24/02,B41F17/00;;B41J27/00,,0,0,,,,DISCONTINUED
330,AU,A1,AU 2006/222734 A1,170-367-800-932-187,2007-04-19,2007,AU 2006/222734 A,2006-09-27,US 23613105 A,2005-09-27,Colorant presentation for pad printing,,JOHNSON & JOHNSON VISION CARE,RYAN JOSEPH;;WDMAN MICHAEL F;;FLEMING AIDEN;;POWELL P MARK,,https://lens.org/170-367-800-932-187,Patent Application,no,0,0,13,13,0,B41F17/001;;G05D24/02;;B41F17/001;;G05D24/02,B41F17/00,,0,0,,,,DISCONTINUED
331,US,B2,US 9577864 B2,012-082-174-023-817,2017-02-21,2017,US 201314917834 A,2013-10-03,US 201314917834 A;;US 201361881555 P;;IB 2013059084 W,2013-09-24,Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance,"In a software receiver, a received electromagnetic signal is sampled in “slices”, each having a duration of some multiple of a reference frequency. The samples of each slice are correlated with values in a pair of reference signals, such as sine and cosine, at the reference frequency. This yields a two-tuple for each slice, which two-tuples may be stored. The stored two-tuples can be simply added to arrive at a correlation value of narrower bandwidth than that of any slice taken alone. The stored two-tuples can be taken in sequence, each rotated by some predetermined angle relative to its predecessor in sequence, and the rotated two-tuples summed to arrive at a correlation value with respect to a frequency that is offset from the reference frequency to an extent that relates to the predetermined angle. In this way, the receiver is able to proceed despite the transmitted frequency not being known exactly in advance and does not require prodigious storage or computational resources.",PROTEUS DIGITAL HEALTH INC,FLEMING ROBERT ALAN;;KUSHNER CHERIE ELAINE;;MCALLISTER WILLIAM;;ZDEBLICK MARK,PROTEUS DIGITAL HEALTH INC (2014-01-03),https://lens.org/012-082-174-023-817,Granted Patent,yes,99,7,4,4,0,H04B1/0003;;G06F16/22;;G06F16/22;;H04B1/0003;;H04L27/3416;;H04L27/361,G06F17/30;;H04B1/00;;H04L27/34;;H04L27/36,,68,23,055-061-122-716-256;;078-928-935-877-210;;021-105-698-172-720;;020-429-685-293-077;;010-850-715-067-828;;125-568-654-521-572;;006-779-079-382-873;;034-889-687-992-512;;119-428-445-234-356;;083-089-269-400-619;;025-399-612-692-728;;070-806-113-494-855;;058-786-009-599-841;;058-427-408-233-519;;072-268-151-160-087;;016-284-130-373-090;;007-791-330-066-861;;060-836-788-950-075;;106-238-568-760-584;;013-389-953-231-546;;119-603-577-296-247;;022-564-808-245-652;;020-208-605-928-943,10.1016/b978-1-4377-2333-5.00018-3;;10.1109/lcn.2002.1181789;;10.1088/0967-3334/20/1/004;;10374826;;18790434;;10.1016/j.bpg.2008.06.003;;10.1109/wd.2008.4812855;;18075039;;10.1109/tbme.2007.908332;;10.1109/tcsi.2004.838240;;10.1126/science.134.3486.1196;;17753692;;13440945;;10.1038/1791239a0;;10.1016/j.jtherbio.2004.08.020;;10.1016/0016-5085(85)90342-7;;3891497;;10.1109/mwsym.2002.1011677;;10941095;;10.1002/1521-3773(20000717)39:14<2396::aid-anie2396>3.3.co;2-l;;10.1002/1521-3773(20000717)39:14<2396::aid-anie2396>3.0.co;2-u;;10.1016/s1359-0286(02)00032-3;;10.2174/1874476110801010022;;10.1201/9781420018677.ch12;;10.1007/978-3-540-95948-9_3;;10.1149/1.2086853;;10.1089/tmj.2004.10.s-110;;23570221;;10.1109/4.871321;;17947184;;10.1109/iembs.2006.259862;;10.1147/sj.353.0609;;10.1038/179898a0,"International Search Report and Written Opinion for PCT/IB2013/059084 dated Jun. 20, 2014 (7 pages).;;AADE, ""AADE 37th Annual Meeting San Antonio Aug. 4-7, 2010"" American Association of Diabetes Educators (2010); http://www.diabeteseducator.org/annualmeeting/2010/index.html; 2 pp.;;Arshak et al., A Review and Adaptation of Methods of Object Tracking to Telemetry Capsules IC-Med (2007) vol. 1, No. 1, Issue 1, 12 pp.;;""ASGE Technology Status Evaluation Report: wireless capsule endoscopy"" American Soc. for Gastrointestinal Endoscopy (2006) vol. 63, No. 4; 7 pp.;;Au-Yeung, K., et al., ""A Networked System for Self-Management of Drug Therapy and Wellness"", Wireless Health '10, Oct. 5-7, 2010, San Diego, 9 pages.;;Aydin et al., ""Design and implementation considerations for an advanced wireless interface in miniaturized integrated sensor Microsystems"" Sch. of Eng. & Electron., Edinburgh Univ., UK; (2003); abstract.;;Barrie, Heidelberg pH capsule gastric analysis. Texbook of Natural Medicine, (1992), Pizzorno, Murray & Barrie.;;Baskiyar, S. ""A Real-time Fault Tolerant Intra-body Network"" Dept. of Comp. Sci & Soft Eng; Auburn University; Proceedings of the 27th Annual IEEE Conference; 0742-1303/02 (2002) IEEE; 6 pp.;;Brock, ""Smart Medicine: The Application of Auto-ID Technology to Healthcare"" Auto-ID Labs (2002) http://www.autoidlabs.org/uploads/media/MIT-AUTOID-WH-010.pdf.;;Carlson et al., ""Evaluation of a non-invasive respiratory monitoring system for sleeping subjects"" Physiological Measurement (1999) 20(1): 53.;;Delvaux et al., ""Capsule endoscopy: Technique and indications"" Clinical Gastoenterology (2008) vol. 22, Issue 5, pp. 813-837.;;Description of ePatch Technology Platform for ECG and EMG, located it http://www.madebydelta.com/imported/images/DELTA-Web/documents/ME/ePatch-ECG-EMG.pdf, Dated Sep. 2, 2010.;;Evanczuk, S., ""PIC MCU software library uses human body for secure communications link"" EDN Network; edn.com; Feb. 26 (2013) Retrieved from internet Jun. 19, 2013 at http://www.edn.com/electronics-products/other/4407842/PIC-MCU-software-library-uses-human-body-for-secure-communications-link; 5 pp.;;Fawaz et al., ""Enhanced Telemetry System using CP-QPSK Band-Pass Modulation Technique Suitable for Smart Pill Medical Application"" IFIP IEEE Dubai Conference (2008); http://www.asic.fh-offenburg.de/downloads/ePille/IFIP-IEEE-Dubai-Conference.pdf.;;Gilson, D.R. ""Molecular dynamics simulation of dipole interactions"", Department of Physics, Hull University, Dec. (2002), p. 1-43.;;Given Imaging, ""Agile Patency Brochure"" (2006) http://www.inclino.no/documents/AgilePatencyBrochure-Global-GMB-0118-01.pdf; 4pp.;;Gonzalez-Guillaumin et al., ""Ingestible capsule for impedance and pH monitoring in the esophagus"" IEEE Trans Biomed Eng. (2007) 54(12: 2231-6; abstract.;;Greene, ""Edible RFID microchip monitor can tell if you take your medicine"" Bloomberg Businessweek (2010) 2 pp.; http://www.businessweek.com/idg/2010-03-31/edible-rfid-microchip-monitor-can-tell-if-you-take-your-medicine.html.;;Halthion Medical Technologies ""Providing Ambulatory Medical Devices Which Monitor, Measure and Record"" webpage. Online website: http://www.halthion.com/; downloaded May 30, 2012.;;Heydari et al., ""Analysis of the PLL jitter due to power/ground and substrate noise""; IEEE Transactions on Circuits and Systems (2004) 51(12): 2404-16.;;Hoover et al., ""Rx for health: Engineers design pill that signals it has been swallowed"" University of Florida News (2010) 2pp.; http://news.ufl.edu/2010/03/31/antenna-pill-2/.;;Hotz ""The Really Smart Phone"" The Wall Street Journal, What They Know (2011); 6 pp.; http://online.wsj.com/article/SB10001424052748704547604576263261679848814.html?mod=djemTECH-t.;;Intromedic, MicroCam Innovative Capsule Endoscope Pamphlet. (2006) 8 pp (http://www.intromedic.com/en/product/productinfo.asp).;;ISFET-Ion Sensitive Field-Effect Transistor; Microsens S.A. pdf document. First cited by Examiner in Office Action dated Jun. 13, 2011 for U.S. Appl. No. 12/238,345; 4pp.;;Jung, S. ""Dissolvable 'Transient Electronics' Will Be Good for Your Body and the Environment"" MedGadget; Oct. 1, 2012; Onlne website: http://medgadget.com/2012/10/dissolvable-transient-electronics-will-be-good-for-your-body-and-the-environment.html; downloaded Oct. 24, 2012; 4 pp.;;Juvenile Diabetes Research Foundation International (JDRF), ""Artificial Pancreas Project"" (2010); http://www.artificialpancreasproject.com/; 3 pp.;;Li, P-Y, et al. ""An electrochemical intraocular drug delivery device"", Sensors and Actuators A 143 (2008) p. 41-48.;;Lifescan, ""OneTouch UltraLink(TM)"" http://www.lifescan.com/products/meters/ultralink (2010) 2 pp.;;Mackay et al., ""Radio Telemetering from within the Body"" Inside Information is Revealed by Tiny Transmitters that can be Swallowed or Implanted in Man or Animal Science (1991) 1196-1202; 134; American Association for the Advancement of Science, Washington D.C.;;MacKay et al., ""Endoradiosonde"" Nature, (1957) 1239-1240, 179 Nature Publishing Group.;;McKenzie et al., ""Validation of a new telemetric core temperature monitor"" J. Therm. Biol. (2004) 29(7-8):605-11.;;Medtronic, ""CareLink Therapy Management Software for Diabetes"" (2010); https://carelink.minimed.com/patient/entry.jsp?bhcp=1; 1 pp.;;Medtronic, ""Carelink(TM) USB"" (2008) http://www.medtronicdiabetes.com/pdf/carelink-usb-factsheet.pdf 2pp.;;Medtronic ""The New MiniMed Paradigm� Real-Time Revel(TM) System"" (2010) http://www.medtronicdiabetes.com/products/index.html; 2 pp.;;Medtronic, ""Mini Med Paradigm� Revel(TM) Insulin Pump"" (2010) http://www.medtronicdiabetes.com/products/insulinpumps/index.html; 2 pp.;;Medtronic, Mini Med Paradigm(TM) Veo(TM) System: Factsheet (2010). http://www.medtronic-diabetes.com.au/downloads/Paradigm%20Veo%20Factsheet.pdf ; 4 pp.;;Melanson, ""Walkers swallow RFID pills for science"" Engadget (2008); http://www.engadget.com/2008/07/29/walkers-swallow-rfid-pills-for-science/.;;Minimitter Co. Inc. ""Actiheart"" Traditional 510(k) Summary. Sep. 27, 2005.;;Minimitter Co. Inc. Noninvasive technology to help your studies succeed. Mini Mitter.com Mar. 31, 2009.;;Mini Mitter Co, Inc. 510(k) Premarket Notification Mini-Logger for Diagnostic Spirometer. Sep. 21, 1999.;;Mini Mitter Co, Inc. 510(k) Premarket Notification for VitalSense. Apr. 22, 2004.;;Minimitter Co. Inc. VitalSense Integrated Physiological Monitoring System. Product Description. (2005).;;Minimitter Co. Inc. VitalSense Wireless Vital Signs Monitoring. Temperatures.com Mar. 31, 2009.;;Mojaverian et al., ""Estimation of gastric residence time of the Heidelberg capsule in humans: effect of varying food composition"" Gastroenterology (1985) 89:(2): 392-7.;;""New 'smart pill' to track adherence"" E-Health-Insider (2010) http://www.e-health-insider.com/news/5910/new-'smart-pil'-monitors-medicines.;;Owano, N., ""Study proposes smart sutures with sensors for wounds"" phys.org. Aug. 2012. http://phys.org/news/2012-08-smart-sutures-sensors-wounds.html.;;Park, ""Medtronic to Buy MiniMed for $3.7 Billion"" (2001) HomeCare; http://homecaremag.com/mag/medical-medtronic-buy-minimed/; 2 pp.;;Radio Antennae, http://www.erikdeman.de/html/sail018h.htm; (2008) 5 pages.;;""RFID ""pill"" monitors marchers"" RFID News (2008) http://www.rfidnews.org/2008/07/23/rfid-pill-monitors-marchers/.;;Sanduleanu et al., ""Octave tunable, highly linear, RC-ring oscillator with differential fine-coarse tuning, quadrature outputs and amplitude control for fiber optic transceivers"" (2002) IEEE MTT-S International Microwave Symposium Digest 545-8.;;Santini, J.T. et al, ""Microchips as controlled drug delivery-devices"", Agnew. Chem. Int. Ed. (2000), vol. 39, p. 2396-2407.;;""SensiVida minimally invasive clinical systems"" Investor Presentation Oct. 2009 28pp; http://www.sensividamedtech.com/SensiVidaGeneralOctober09.pdf.;;Shawgo, R.S. et al. ""BioMEMS from drug delivery"", Current Opinion in Solid State and Material Science 6 (2002), p. 329-334.;;Shrivas et al., ""A New Platform for Bioelectronics-Electronic Pill"", Cummins College, (2010).; http://www.cumminscollege.org/downloads/electronics-and-telecommunication/Newsletters/Current%20Newsletters.pdf; First cited in third party client search conducted by Patent Eagle Search May 18, 2010 (2010).;;""Smartlife awarded patent for knitted transducer"" Innovation in Textiles News: http://www.innovationintextiles.com/articles/208.php; 2pp. (2009).;;""The SmartPill Wireless Motility Capsule"" Smartpill, The Measure of GI Health; (2010) http://www.smartpillcorp.com/index.cfm?pagepath=Products/The-SmartPill-Capsule&id=17814.;;Solanas et al., ""RFID Technology for the Health Care Sector"" Recent Patents on Electrical Engineering (2008) 1, 22-31.;;Soper, S.A. et al. ""Bio-Mems Technologies and Applications"", Chapter 12, ""MEMS for Drug Delivery"", p. 325-346 (2007).;;Swedberg, ""University Team Sees Ingestible RFID Tag as a Boon to Clinical Trials"" RFID Journal Apr. 27, 2010; http://www.rfidjournal.com/article/view/7560/1.;;Tajalli et al., ""Improving the power-delay performance in subthreshold source-coupled logic circuits"" Integrated Circuit and System Design. Power and Timing Modeling, Optimization and Simulation, Springer Berlin Heidelberg (2008) 21-30.;;Tatbul et al., ""Confidence-based data management for personal area sensor networks"" ACM International Conference Proceeding Series (2004) 72.;;Tierney, M.J. et al ""Electroreleasing Composite Membranes for Delivery of Insulin and other Biomacromolecules"", J. Electrochem. Soc., vol. 137, No. 6, Jun. 1990, p. 2005-2006.;;Xiaoming et al., ""A telemedicine system for wireless home healthcare based on bluetooth and the internet"" Telemedicine Journal and e-health (2004) 10(S2): S110-6.;;Yang et al., ""Fast-switching frequency synthesizer with a discriminator-aided phase detector"" IEEE Journal of Solid-State Circuits (2000) 35(10): 1445-52.;;Yao et al., ""Low Power Digital Communication in Implantable Devices Using Volume Conduction of Biological Tissues"" Proceedings of the 28th IEEE, EMBS Annual International Conference, Aug. 30-Sep. 3, 2006.;;Zimmerman, ""Personal Area Networks: Near-field intrabody communication"" IBM Systems Journal (1996) 35 (3-4):609-17.;;Zworkin, ""A Radio Pill"" Nature, (1957) 898, 179 Nature Publishing Group.;;Walkey, David J., 97.398, Physical Electronics, Lecture 20, MOSFET Structure and Processing, Carleton University, Ottawa, Canada, Oct. 26, 2008 (24 pages).",ACTIVE
332,HK,A1,HK 1092111 A1,066-742-581-435-624,2007-02-02,2007,HK 06112627 A,2006-11-16,US 2956205 A,2005-01-05,VISCOSITY CONTROL AND COLORANT CIRCULATION FOR PRINTING LENS MOLDS,,JOHNSON & JOHNSON VISION CARE,WIDMAN MICHAEL F;;POWELL PAUL MARK;;FLEMING AIDAN;;RYAN JOSEPH,,https://lens.org/066-742-581-435-624,Patent Application,no,0,0,15,18,0,B29D11/00903;;B41F17/001;;B29D11/00903;;B29D11/00951;;B29D11/00951;;B41F17/001;;B41F31/005;;B41F31/005;;G01N11/00;;G01N11/00,B67D7/06;;B41F/;;B67D7/08;;B67D7/78,,0,0,,,,DISCONTINUED
333,US,B2,US 8892959 B2,126-937-317-873-603,2014-11-18,2014,US 201213352140 A,2012-01-17,US 201213352140 A,2012-01-17,Automatic problem diagnosis,"For automatic problem diagnosis, a data collector module collects log data comprising code sets from a plurality of components in a data processing system. An analysis module translates the log data into at least one predefined symptom. Each symptom is associated with at least one code set of the log data. The analysis module selects from a knowledge base at least one problem that includes each symptom. The analysis module further calculates an influence factor for each problem, and ranks each problem from most likely to least likely based on the influence factor of the problem.",FLEMING MARK S;;HUANG JIN YAN;;YIN WEI;;ZHONG YI;;IBM,FLEMING MARK S;;HUANG JIN YAN;;YIN WEI;;ZHONG YI,INTERNATIONAL BUSINESS MACHINES CORPORATION (2012-01-11),https://lens.org/126-937-317-873-603,Granted Patent,yes,10,1,2,2,0,G06F11/0709;;G06F11/0709;;G06F11/079;;G06F11/079;;H04L41/069;;H04L41/069,G06F11/00,714/47.1,0,0,,,,INACTIVE
334,US,A1,US 2022/0114318 A1,184-677-864-055-082,2022-04-14,2022,US 202117557031 A,2021-12-20,US 202117557031 A,2021-12-20,METHODS AND APPARATUS FOR IN-FIELD THERMAL CALIBRATION,"Methods and apparatus for in-field thermal calibration are disclosed. A disclosed example apparatus includes instructions, memory in the apparatus, and processor circuitry. The processor circuitry is to execute the instructions to determine that a system on chip (SOC) package is deployed, the SOC package deployed with a default first thermal model, in response to the determination that the SOC package is deployed, monitor at least one temperature of the SOC package from a sensor and power usage of the SOC package, calibrate a second thermal model based on the at least one temperature and the power usage, and publish the calibrated second thermal model for control of the SOC package.",INTEL CORP,GALLINA MARK;;ZHU JIANFANG;;FLEMING KRISTOFFER;;RALLABANDI AKHLLESH;;DAI JIANWEI,INTEL CORPORATION (2021-12-21),https://lens.org/184-677-864-055-082,Patent Application,yes,0,0,3,3,0,G06F11/3024;;G06F11/3058;;G06F1/20;;G06F15/7807;;G01K15/005;;Y02D10/00;;G06F30/39;;G01K15/005;;G06F2119/08;;G01K2215/00;;G06F2119/06;;G01K2213/00;;G06F2115/02,G06F30/39;;G01K15/00,,0,0,,,,PENDING
335,EP,A1,EP 1780012 A1,005-371-931-657-663,2007-05-02,2007,EP 06254974 A,2006-09-26,US 23613105 A,2005-09-27,Colorant presentation for pad printing,"The present invention provides systems and methods for providing colorant to a colorant cup apparatus that is adjacent to a pad printing cliché. The fluid colorant is fed from a colorant container through a feed conduit to the cup and an inline viscometer external to the colorant container measures the viscosity of colorant within the feed conduit. A control mechanism can dispense colorant solvent into the colorant container based upon a viscosity measurement performed by the inline viscometer. The disclosed systems, colorant cups and methods are useful in the preparation of tinted contact lenses.
",JOHNSON & JOHNSON VISION CARE,WIDMAN MICHAEL F;;RYAN JOSEPH;;FLEMING AIDEN;;POWELL P MARK,,https://lens.org/005-371-931-657-663,Patent Application,yes,5,1,13,13,0,B41F17/001;;B41F17/001;;G05D24/02;;G05D24/02,B41F17/00;;G05D24/00,,0,0,,,,ACTIVE
336,AT,T1,AT E535057 T1,047-784-084-919-958,2011-12-15,2011,AT 07839676 T,2007-10-17,US 82983206 P;;US 2007/0022257 W,2006-10-17,NIEDERSPANNUNGSOSZILLATOR FÜR MEDIZINISCHE EINRICHTUNGEN,"Low voltage oscillators that provide a stable output frequency with varying supply voltage are provided. The subject oscillators find use in a variety of different types of devices, e.g., medical devices, including both implantable and ex-vivo devices.",PROTEUS BIOMEDICAL INC,FLEMING ROBERT;;KUSHNER CHERIE;;JANI NILAY;;WITHRINGTON JONATHAN;;ZDEBLICK MARK,,https://lens.org/047-784-084-919-958,Granted Patent,no,0,0,9,9,0,H03K3/011;;H03K3/0322;;H03K5/133;;H03K2005/00208;;H03K2005/00234;;H03K3/0322;;H03K3/011;;H03K2005/00234;;H03K5/133;;H03K2005/00208,,,0,0,,,,ACTIVE
337,DE,T5,DE 112004001665 T5,090-394-123-745-598,2006-10-12,2006,DE 112004001665 T,2004-07-29,US 66328403 A;;US 2004/0024498 W,2003-09-16,Kostengünstiges Gasdiffusionsmedium zur Verwendung in PEM-Brennstoffzellen,,GEN MOTORS CORP,MATHIAS MARK F;;ROTH JOERG;;SCHOENEWEISS MICHAEL R;;FLEMING GERALD,,https://lens.org/090-394-123-745-598,Patent Application,no,0,0,6,6,0,C04B35/521;;C04B35/521;;C04B35/83;;C04B35/83;;C04B2235/5256;;C04B2235/5256;;H01M4/8807;;H01M4/8807;;H01M4/881;;H01M4/881;;H01M8/0234;;H01M8/0234;;H01M8/0239;;H01M8/0239;;H01M8/0243;;H01M8/0243;;H01M8/1007;;H01M8/1007;;Y02E60/50;;Y02P70/50;;Y02P70/50,H01M8/02;;H01M4/86;;H01M4/88;;H01M8/10,,0,0,,,,DISCONTINUED
338,EP,B1,EP 2850925 B1,087-147-788-938-224,2019-02-27,2019,EP 13727425 A,2013-05-13,US 201261647557 P;;US 201313891351 A;;US 2013/0040717 W,2012-05-16,THERMAL DUCTING SYSTEM,,PANDUIT CORP,FLEMING JAMES N;;GOLDSBERRY TIMOTHY;;SHURHAY MARK;;HIBNER MAX W,,https://lens.org/087-147-788-938-224,Granted Patent,yes,2,0,10,10,0,H05K7/20736;;Y10T29/49826;;H05K7/20145;;B23P19/00;;Y10T29/49826;;H05K7/20736,H05K7/20;;B23P19/00,,0,0,,,,ACTIVE
339,CN,A,CN 104322158 A,140-246-538-749-643,2015-01-28,2015,CN 201380025131 A,2013-05-13,US 2013/0040717 W;;US 201261647557 P;;US 201313891351 A,2012-05-16,Thermal ducting system,"A thermal ducting system for electronic equipment in an electronic equipment enclosure is provided. The thermal ducting system includes a top duct, a bottom duct spaced apart from the top duct, a side duct extending from the top duct to the bottom duct and along an intake side of the electronic equipment, and at least one baffle positioned in the side duct.",PANDUIT CORP,FLEMING JAMES N;;GOLDSBERRY TIMOTHY;;SHURHAY MARK;;HIBNER MAX W,,https://lens.org/140-246-538-749-643,Patent Application,no,5,0,10,10,0,H05K7/20736;;Y10T29/49826;;H05K7/20145;;B23P19/00;;Y10T29/49826;;H05K7/20736,H05K7/20,,0,0,,,,ACTIVE
340,HK,A1,HK 1223752 A1,146-329-003-447-106,2017-08-04,2017,HK 16111847 A,2016-10-13,US 2014/0056576 W;;US 201361880786 P,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING A SIGNAL IN THE PRESENCE OF NOISE USING SLICES AND WARPING",,PROTEUS DIGITAL HEALTH INC,KUSHNER CHERIE;;FLEMING ROBERT;;MCALLISTER WILLIAM H H;;ZDEBLICK MARK,,https://lens.org/146-329-003-447-106,Patent Application,no,0,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04L47/43,,0,0,,,,PENDING
341,US,A1,US 2009/0036654 A1,176-076-580-394-062,2009-02-05,2009,US 47819406 A,2006-06-28,US 47819406 A;;US 69516105 P,2005-06-28,Crystal structure of Rho-kinase I kinase domain complexes and binding pockets thereof,"The present invention relates to human Rho-kinase I (ROCK I), ROCK I binding pockets, ROCK I-like binding pockets. More particularly, the present invention provides a computer comprising a data storage medium encoded with the structure coordinates of such binding pockets. This invention also relates to methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention relates to methods of using the structure coordinates to screen for and design compounds, including inhibitory compounds, that bind to ROCK I protein or ROCK I protein homologues, or complexes thereof. The invention also relates to crystallizable compositions and crystals comprising ROCK I kinase domain and ROCK I kinase domain complexed with an inhibitor of that domain. The invention also relates to methods of identifying inhibitors of the ROCK I kinase domain.",JACOBS MARC;;HAYAKAWA KOTO;;FLEMING MARK;;DORAN JOHN;;MARHEFKA CRAIG,JACOBS MARC;;HAYAKAWA KOTO;;FLEMING MARK;;DORAN JOHN;;MARHEFKA CRAIG,VERTEX PHARMACEUTICALS INCORPORATED (2009-11-15),https://lens.org/176-076-580-394-062,Patent Application,yes,7,11,2,2,5,C07K2299/00;;C12N9/1205;;C12N9/1205;;C07K2299/00,G06F17/50;;C07K14/00,530/402;;703/1,0,0,,,,ACTIVE
342,US,A1,US 2013/0309957 A1,013-654-855-076-727,2013-11-21,2013,US 201313891351 A,2013-05-10,US 201313891351 A;;US 201261647557 P,2012-05-16,Thermal Ducting System,"A thermal ducting system for electronic equipment in an electronic equipment enclosure is provided. The thermal ducting system includes a top duct, a bottom duct spaced apart from the top duct, a side duct extending from the top duct to the bottom duct and along an intake side of the electronic equipment, and at least one baffle positioned in the side duct.",PANDUIT CORP,FLEMING JAMES N;;GOLDSBERRY TIMOTHY;;SHURHAY MARK;;HIBNER MAX W,PANDUIT CORP (2013-06-05),https://lens.org/013-654-855-076-727,Patent Application,yes,0,36,10,10,0,H05K7/20736;;Y10T29/49826;;H05K7/20145;;B23P19/00;;Y10T29/49826;;H05K7/20736,B23P19/00;;H05K7/20,454/184;;29/428,0,0,,,,ACTIVE
343,WO,A2,WO 2005/036669 A2,079-885-268-755-680,2005-04-21,2005,US 2004/0024498 W,2004-07-29,US 66328403 A,2003-09-16,LOW COST GAS DIFFUSION MEDIA FOR USE IN PEM FUEL CELLS,A gas diffusion media and method of making are provided including the formation of a carbon fiber paper which is heated to a carbonization temperature without exceeding a graphitization temperature. The discovery that a final high temperature heat treatment step in the graphitization temperature zone is not necessary to make effective gas diffusion media for PEM fuel cells greatly reduces the cost associated with the high temperature final heat treatment and also allows for the processing of the diffusion media in a roll.,GEN MOTORS CORP,MATHIAS MARK F;;ROTH JOERG;;SCHOENEWEISS MICHAEL R;;FLEMING GERALD,,https://lens.org/079-885-268-755-680,Patent Application,yes,0,1,6,6,0,C04B35/521;;C04B35/521;;C04B35/83;;C04B35/83;;C04B2235/5256;;C04B2235/5256;;H01M4/8807;;H01M4/8807;;H01M4/881;;H01M4/881;;H01M8/0234;;H01M8/0234;;H01M8/0239;;H01M8/0239;;H01M8/0243;;H01M8/0243;;H01M8/1007;;H01M8/1007;;Y02E60/50;;Y02P70/50;;Y02P70/50,H01M4/86;;H01M4/88;;H01M8/10,,0,0,,,,PENDING
344,CN,A,CN 104520405 A,112-385-948-875-575,2015-04-15,2015,CN 201380041474 A,2013-06-06,GB 2013051496 W;;GB 201210034 A,2012-06-07,Method of inhibiting scale in geological formation,The present invention relates to a method of inhibiting scale in a geological formation such as a hydrocarbon reservoir and a kit of parts for performing the method.,UNIV LEEDS,FLEMING NIALL;;WILSON MARK;;GHORBANI NASSER;;KAPUR NIKIL;;NEVILLE ANNE,,https://lens.org/112-385-948-875-575,Patent Application,no,4,2,12,12,0,C09K8/528;;E21B37/06;;C09K2208/10;;C09K8/528;;C09K2208/10;;F24F11/30;;F24F2110/00;;F24F2110/10;;F24F2110/40;;F24F2140/40;;F24F11/63;;F24F11/61;;F24F11/70;;F24F11/77;;Y02B30/70;;Y02P20/10;;C09K8/528;;C09K2208/10;;F24F11/30;;F24F2110/10;;F24F2140/40;;F24F11/63;;F24F11/61;;F24F11/70;;F24F11/77;;F24F2110/00;;F24F2110/40;;Y02B30/70;;Y02P20/10;;C09K8/52;;E21B43/16,C09K8/528,,0,0,,,,ACTIVE
345,CA,C,CA 2876032 C,163-789-506-420-697,2022-08-23,2022,CA 2876032 A,2013-06-06,GB 201210034 A;;GB 2013051496 W,2012-06-07,A METHOD OF INHIBITING SCALE IN A GEOLOGICAL FORMATION,The present invention relates to a method of inhibiting scale in a geological formation such as a hydrocarbon reser-voir and a kit of parts for perfonning the method. An organosilane is deposited on a surface of the geological fomiation. A nano-material comprising carboxy-functionalised multi-wall carbon nanotubes or fullerene are delivered to the surface fo the geological fomiation. A quantity of the polycarboxylic acid-based scale inhibitor or diethylenetriamine-pentamethylene phosphonic acid is emplaced in the geological fomiation. Scale in the geological fomiation is inhibited by sustained release of the amount of the polycarboxylic acid-based scale inhibitor or hiethylenetriamine-pentamethylene phosphonic acid from the nano-material into the geological fomiation.,UNIV LEEDS INNOVATIONS LTD,GHORBANI NASSER;;FLEMING NIALL;;WILSON MARK;;KAPUR NIKIL;;NEVILLE ANNE,,https://lens.org/163-789-506-420-697,Granted Patent,no,0,0,12,12,0,C09K8/528;;E21B37/06;;C09K2208/10;;C09K8/528;;C09K2208/10;;F24F11/30;;F24F2110/00;;F24F2110/10;;F24F2110/40;;F24F2140/40;;F24F11/63;;F24F11/61;;F24F11/70;;F24F11/77;;Y02B30/70;;Y02P20/10;;C09K8/528;;C09K2208/10;;F24F11/30;;F24F2110/10;;F24F2140/40;;F24F11/63;;F24F11/61;;F24F11/70;;F24F11/77;;F24F2110/00;;F24F2110/40;;Y02B30/70;;Y02P20/10;;C09K8/52;;E21B43/16,C09K8/528,,0,0,,,,PENDING
346,US,B2,US 8054140 B2,164-296-683-768-476,2011-11-08,2011,US 44572307 A,2007-10-17,US 44572307 A;;US 82983206 P;;US 2007/0022257 W,2006-10-17,Low voltage oscillator for medical devices,"Low voltage oscillators that provide a stable output frequency with varying supply voltage are provided. The subject oscillators find use in a variety of different types of devices, e.g., medical devices, including both implantable and ex-vivo devices.",PROTEUS BIOMEDICAL INC,FLEMING ROBERT;;KUSHNER CHERIE;;JANI NILAY;;WITHRINGTON JONATHAN;;ZDEBLICK MARK,PROTEUS DIGITAL HEALTH INC (2012-07-05);;OTSUKA AMERICA PHARMACEUTICAL INC (2020-12-10);;OTSUKA PHARMACEUTICAL CO. LTD (2020-12-21),https://lens.org/164-296-683-768-476,Granted Patent,yes,105,23,9,9,0,H03K3/011;;H03K3/0322;;H03K5/133;;H03K2005/00208;;H03K2005/00234;;H03K3/0322;;H03K3/011;;H03K2005/00234;;H03K5/133;;H03K2005/00208,H03K3/03,331/57;;331/186,30,17,013-255-250-636-439;;006-779-079-382-873;;070-806-113-494-855;;013-389-953-231-546;;058-786-009-599-841;;058-427-408-233-519;;060-836-788-950-075;;034-889-687-992-512;;119-428-445-234-356;;020-208-605-928-943;;119-603-577-296-247;;083-089-269-400-619;;022-564-808-245-652;;055-061-122-716-256;;021-105-698-172-720;;025-399-612-692-728;;106-238-568-760-584,10.1109/jssc.2003.820881;;10.1109/tcsi.2004.838240;;10.1109/mwsym.2002.1011677;;10.1109/4.871321;;10941095;;10.1002/1521-3773(20000717)39:14<2396::aid-anie2396>3.3.co;2-l;;10.1002/1521-3773(20000717)39:14<2396::aid-anie2396>3.0.co;2-u;;10.1016/s1359-0286(02)00032-3;;10.1149/1.2086853;;10.1126/science.134.3486.1196;;17753692;;13440945;;10.1038/1791239a0;;10.1038/179898a0;;17947184;;10.1109/iembs.2006.259862;;10.1016/j.jtherbio.2004.08.020;;10.1147/sj.353.0609;;10.1016/b978-1-4377-2333-5.00018-3;;10.1088/0967-3334/20/1/004;;10374826;;10.1016/0016-5085(85)90342-7;;3891497;;10.1089/tmj.2004.10.s-110;;23570221,"Hwang, et al., ""A CMOS Self-Regulating VCO with Low Supply Sensitivity"", Jan. 2004, IEEE Journal of Solid-State Circuits, vol. 39, No. 1, pp. 42-48.;;Philips Respironics (http/minimitter.com/products.cfm) Products, Noninvasive Technology To Help Your Studies Succeed. 510(k) Permanent Notification for Vital Sense. Apr. 22, 2004.;;Aydin et al., ""Design and implementation considerations for an advanced wireless interface in miniaturized integrated sensor Microsystems"" Sch. of Eng. & Electron., Edinburgh Univ., UK; (2003); abstract.;;Brock, ""Smart Medicine: The Application of Auto-ID Technology to Healthcare"" Auto-ID Labs (2002) http://www.autoidlabs.org/uploads/media/MIT-AUTOID-WH-010.pdf.;;Heydari et al., Analysis of the PLL jitter due to power/ground and substrate noise. IEEE Transactions on Circuits and Systems 2004;51(12):2404-16.;;Sanduleanu et al., Octave tunable, highly linear, RC-ring oscillator with differential fine-coarse tuning, quadrature outputs and amplitude control for fiber optic transceivers. 2002 IEEE MTT-S International Microwave Symposium Digest 2002;545-8.;;Yang et al., Fast-switching frequency synthesizer with a discriminator-aided phase detector. IEEE Journal of Solid-State Circuits 2000;35(10):1445-52.;;Gilson, D.R. ""Molecular dynamics simulation of dipole interactions"", Department of Physics, Hull University, p. 1-43, Dec. 2000.;;Li, P-Y, et al. ""An electrochemical intraocular drug delivery device"", Sensors and Actuators A 143 p. 41-48, Jul. 2007.;;Santini, J.T. et al, ""Microchips as controlled drug delivery-devices"", Agnew. Chem. Int. Ed. 2000, vol. 39, p. 2396-2407.;;Shawgo, R.S. et al. ""BioMEMS from drug delivery"", Current Opinion in Solid State and Material Science 6 (2002), p. 329-334.;;Tierney, M.J. et al ""Electroreleasing Composite Membranes for Delivery of Insulin and other Biomacromolecules"", J. Electrochem. Soc., vol. 137, No. 6, Jun. 1990, p. 2005-2006.;;Description of ePatch Technology Platform for ECG and EMG, located it http://www.madebydelta.com/imported/images/DELTA-Web/documents/ME/ePatch-ECG-EMG.pdf, Dated Sep. 2, 2010.;;Mackay et al., Radio telemetering from within the body: Inside information is revealed by tiny transmitters that can be swallowed or implanted in man or animal. Science 1961;134(3486):1196-1202.;;Mackay et al,. Endoradiosonde, Nature 1957:179(4572):1239-40, 179.;;Zworkin, A 'radio pill.' Nature 1957;179:898.;;Yao et al., Low Power Digital Communication in implantable Devices Using Volume Conduction of Biological Tissues. Proceedings of the 28th IEEE, EMBC Annual International Conference 2006 (Aug. 30-Sep. 3); New York, USA.;;McKenzie et al., Validation of a new telemetric core temperature monitor. J. Therm. Biol. 2004;29(7-8):605-11.;;Tatbul et al., Confidence-based data management for personal area sensor networks. ACM International Conference Proceeding Series 2004;72.;;Zimmerman, Personal Area Networks: Near-field intrabody communication. IBM Systems Journal 1996;35 (3-4):609-17.;;Mini Mitter Co, Inc, 510(k) Premarket Notification Mini-Logger for Diagnostic Spirometer. Sep. 21, 1999.;;Mini Mitter Co, Inc. 510(k) Premarket Notification for VitalSense. Apr. 22, 2004.;;Mini Mitter Co, Inc. Actiheart. Traditional 510(k) Summary. Sep. 27, 2005.;;Mini Mitter Co, Inc. VitalSense Integrated Physiological Monitoring System. Product Description.;;Mini Mitter Co, Inc. VitalSense-Wireless Vital Signs Monitoring. Temperatures.com Mar. 31, 2009.;;Mini Mitter Co, Inc. Noninvasive technology to help your studies succeed. Mini Mitter.com Mar. 31, 2009.;;Barrie, Heidelberg pH capsule gastric analysis. Textbook of Natural Medicine, 1992, Pizzorno, Murray & Barrie.;;Carlson et al., Evaluation of a non-invasive respiratory monitoring system for sleeping subjects. Physiological Measurement 1999;20(1):53.;;Mojaverian et al., Estimation of gastric residence time of the Heidelberg capsule in humans: effect of varying food composition. Gastroenterology 1985;89(2):392-7.;;Xiaoming et al., A telemedicine system for wireless home healthcare based on bluetooth and the internet. Telemedicine Journal and e-health 2004;10(S2):S110-6.",ACTIVE
347,TW,A,TW 200535486 A,183-157-291-006-244,2005-11-01,2005,TW 94100934 A,2005-01-13,US 53654004 P,2004-01-14,Viscosity control and colorant circulation for printing lens molds,"Disclosed are systems including a colorant cup that adjacent to a cliche, wherein the cup includes a vent, an interior roof portion, and an air gap beneath the roof portion; a reservoir containing colorant; a feed conduit in fluid communication with the reservoir; and a return conduit in fluid communication with the cup. Also disclosed are various methods in which colorants are transferred in the disclosed systems from the reservoir to the colorant cup. The disclosed systems, colorant cups and methods are useful in the preparation of tinted contact lenses.",JOHNSON & JOHNSON VISION CARE,WIDMAN MICHAEL FRANCIS;;POWELL PAUL MARK;;FLEMING AIDAN;;RYAN JOSEPH,,https://lens.org/183-157-291-006-244,Patent of Addition,no,0,0,2,18,0,,,,0,0,,,,PENDING
348,GB,A,GB 2596657 A,191-519-389-741-584,2022-01-05,2022,GB 202109581 A,2021-07-02,GB 202020883 A,2020-12-31,Beverage container holder,"A device 200 for holding a beverage container 216 having any size within a range comprises a side wall 202 defining an opening 208 through which the beverage container is insertable and a base 204. A collar 210 is positioned within the opening and the side wall and the base together define a cavity 214 for receiving the beverage container. The collar is pliable and arranged to deform to contact and grip the beverage container. The opening 208 has a first width and the collar has an aperture 212 with a second width, the ratio of the second to first width being 0.9 or lower. The collar may include perforation(s) 218. The collar preferably forms a seal at least part way around an outer surface of the beverage container. A u-shaped insert 224 may be included to assist positioning of the beverage container, fitted in two ways to allow for differing lengths of container. The wall and / or the base may be hollow and include a material for insulating. A material for heating or cooling may also be included in contact with the interior of the cavity. A bottle opener 204 is preferably included in the base.",SUP DRINKWEAR LTD,DAVID SWEENEY;;MARK LITTLE;;HANS RAMZAN;;ALEX FLEMING;;JAMIE BALFOUR,,https://lens.org/191-519-389-741-584,Patent Application,no,5,0,7,7,0,A47G23/0266;;A47G23/0216;;A47G2023/0283;;A47G23/0241;;B65D81/3876;;F25D3/08;;F25D2303/0841;;F25D2331/803;;A47G23/02;;A47G2023/0275;;A47G2023/0275;;A47G2200/16;;B65D25/10;;B65D81/3881;;F25D3/08;;F25D2331/803;;A47G23/0266,A47G23/02,,0,0,,,,ACTIVE
349,BR,A,BR PI0506123 A,001-305-465-617-435,2006-10-17,2006,BR PI0506123 A,2005-12-29,US 2956205 A,2005-01-05,controle de viscosidade e circulação de corante para imprimir moldes de lente,"""'CONTROLE DE VISCOSIDADE E CIRCULAçãO DE CORANTE PARA IMPRIMIR MOLDES DE LENTE"". A presente invenção refere-se a sistemas que incluem um copo de corante que está adjacente a um clichê, em que o copo inclui uma ventilação, uma porção de teto interno e um espaço de ar sob a porção de teto; um reservatório que contém um corante; um conduto de alimentação em comunicação de fluido com o reservatório; e um conduto de retorno em comunicação de fluido com o copo. Estão também descritos vários métodos nos quais os corantes são transferidos nos sistemas descritos do reservatório para o copo de corante. Os sistemas, os copos e os métodos descritos são úteis na preparação de lentes de contato tingidas.",JOHNSON & JOHNSON,WIDMAN MICHAEL F;;POWELL PAUL MARK;;FLEMING AIDAN;;RYAN JOSEPH,,https://lens.org/001-305-465-617-435,Patent Application,no,0,0,15,18,0,B29D11/00903;;B41F17/001;;B29D11/00903;;B29D11/00951;;B29D11/00951;;B41F17/001;;B41F31/005;;B41F31/005;;G01N11/00;;G01N11/00,B67D7/06;;B67D7/08;;B67D7/78,,0,0,,,,DISCONTINUED
350,AU,A1,AU 2005/242225 A1,030-543-127-344-898,2007-06-28,2007,AU 2005/242225 A,2005-12-12,US 2956205 A,2005-01-05,Viscosity control and colorant circulation for printing lens molds,,JOHNSON & JOHNSON VISION CARE,FLEMING AIDAN;;WIDMAN MICHAEL F;;RYAN JOSEPH;;POWELL PAUL MARK,,https://lens.org/030-543-127-344-898,Patent Application,no,0,0,15,18,0,B29D11/00903;;B41F17/001;;B29D11/00903;;B29D11/00951;;B29D11/00951;;B41F17/001;;B41F31/005;;B41F31/005;;G01N11/00;;G01N11/00,B41M1/30;;B67D7/06;;B67D7/08;;B67D7/78;;G02C7/04,,0,0,,,,DISCONTINUED
351,JP,A,JP 2006231912 A,028-688-930-770-939,2006-09-07,2006,JP 2006000205 A,2006-01-04,US 2956205 A,2005-01-05,VISCOSITY ADJUSTMENT AND COLORANT CIRCULATION METHOD FOR PRINTING LENS MOLD,"<P>PROBLEM TO BE SOLVED: To provide colorant circulation management system that circulates the colorant from the reservoir to the cup and then from the cup back to the reservoir while actively adjusting the desired composition or the desired viscosity of the colorant in the reservoir. <P>SOLUTION: The system contains a colorant cup 8 that is adjacent to a clutch plate 19. The cup 8 includes: a vent, an interior roof portion, and an air gap beneath the roof portion; a reservoir 18 containing colorant; a feed conduit 4 in fluid communication with the reservoir 18; and a return conduit 3 in fluid communication with the cup 8. The colorant is transferred in the system from the reservoir 18 to the colorant cup 8. <P>COPYRIGHT: (C)2006,JPO&NCIPI",JOHNSON & JOHNSON VISION CARE,WIDMAN MICHAEL F;;POWELL PAUL MARK;;FLEMING AIDAN;;RYAN JOSEPH,,https://lens.org/028-688-930-770-939,Patent Application,no,0,3,15,18,0,B29D11/00903;;B41F17/001;;B29D11/00903;;B29D11/00951;;B29D11/00951;;B41F17/001;;B41F31/005;;B41F31/005;;G01N11/00;;G01N11/00,B41F31/02;;B67D7/06;;B41F16/00;;B41F17/34;;B67D7/08;;B67D7/78;;G02C7/04,,0,0,,,,DISCONTINUED
352,CN,A,CN 116302779 A,034-217-116-347-315,2023-06-23,2023,CN 202211421240 A,2022-11-14,US 202117557031 A,2021-12-20,Method and apparatus for in-situ thermal calibration,"Methods and apparatus for in-situ thermal calibration are disclosed. A disclosed example apparatus includes instructions, memory in the apparatus, and processor circuitry. The processor circuit executes the instructions to determine that a system-on-chip (SOC) package is deployed, the SOC package being deployed in a default first thermal model, in response to determining that the SOC package is deployed, monitoring at least one temperature of the SOC package from the sensor and a power usage of the SOC package, calibrating a second thermal model based on the at least one temperature and the power usage, and outputting the calibrated second thermal model. And issuing the calibrated second thermal model for control of the SOC package.",INTEL CORP,GALLINA MARK;;ZHU JIANFANG;;FLEMING CHRISTOPHER;;LALABANDI AKHLESH;;DAI JIANWEI,,https://lens.org/034-217-116-347-315,Patent Application,no,0,0,3,3,0,G06F11/3024;;G06F11/3058;;G06F1/20;;G06F15/7807;;G01K15/005;;Y02D10/00;;G06F30/39;;G01K15/005;;G06F2119/08;;G01K2215/00;;G06F2119/06;;G01K2213/00;;G06F2115/02,G06F11/30;;G06F1/20;;G06F15/78,,0,0,,,,PENDING
353,US,A1,US 2023/0173092 A1,043-373-279-929-599,2023-06-08,2023,US 202117999815 A,2021-05-26,GB 202007926 A;;GB 2021051285 W,2020-05-27,ANTIBODY-DRUG CONJUGATES,"The present invention relates to antibody-drug conjugates comprising (i) an antibody or antigen-binding fragment thereof, (ii) a polymer comprising a particular repeat unit comprising an amino acid derivative, which is covalently bound to one or more biologically active moieties, such as small molecule drugs, optionally via a linker, and (iii) a polymer-antibody linker moiety which is covalently bound to both the polymer and the antibody or antigen-binding fragment thereof. Additionally, the present invention relates to pharmaceutical compositions comprising the antibody-drug conjugates and to use of the antibody-drug conjugates in medicine.",SPIREA LTD,OUBERAI MYRIAM;;SIM NEIL;;FLEMING JAMES;;CAMPER NICOLAS;;FRIGERIO MARK,SPIREA LIMITED (2022-09-13),https://lens.org/043-373-279-929-599,Patent Application,yes,0,0,11,11,0,A61K47/6855;;A61P35/00;;A61K47/6889;;C07K16/32;;C07K2317/73;;C07K2317/92;;A61K47/6883;;A61K47/68031;;A61K47/68037;;A61K47/595;;A61K47/60;;A61K47/64;;A61K47/65;;A61K47/6849;;A61K47/6859;;A61K47/6889;;A61P35/00;;A61K47/6889;;A61K47/6803;;C07K2317/92;;C07K2317/73;;A61K47/6855;;A61K47/6883;;C07K16/32;;A61K47/6883;;A61K47/6889;;A61K47/6803;;A61P35/00;;C07K16/32;;C07K2317/73;;C07K2317/92;;A61K47/6889;;A61K47/6883;;A61K47/6803;;A61P35/00;;C07K16/00;;C07K2317/73;;C07K2317/92,A61K47/68;;A61P35/00;;C07K16/00,,0,0,,,,PENDING
354,GB,A,GB 2594753 A,085-275-423-448-752,2021-11-10,2021,GB 202007926 A,2020-05-27,GB 202007926 A,2020-05-27,Antibody-drug conjugates,"An antibody/targeting agent-drug conjugate comprising an antibody, antigen-binding fragment or targeting agent; a polymer comprising a repeat unit of Formula (I); a polymer-antibody/targeting agent linker which is covalently bonded to both the antibody/targeting agent and the polymer; Wherein X is O, NH, NRA or S; Y is C=O, C=NH, C=NRA or C=S; R is H or C1-20 hydrocarbyl; RA is C1-20 hydrocarbyl; each Q is -CH2(NMe(C=O)CH2)o-, -T1O(CH2CH2O)sT2-, T1O(CH2CH2CH2O)sT2-, wherein T1 and T2 are each independently selected from methylene, etheylene, propylene and butylene; o is 0-100; s is 0-150; x is 1-6; and each Z is independently selected from a biologically active linker-moiety group of Formulae (i), (ii), (iii), (iv) or (v) as herein defined. X is preferably O or NH; and Y is preferably C=O. Q is preferably a polyethylene glycol chain comprising 3, 7, 11, 23 or 35 repeat units. Pharmaceutical compositions comprising the antibody-drug conjugates and a pharmaceutically acceptable excipient; and their use in medicine is also disclosed. A method of treating a disease or condition in a human patient comprising the administration of an antibody-drug conjugate defined above is disclosed.",SPIREA LTD,MYRIAM OUBERAI;;NEIL SIM;;JAMES FLEMING;;MARK FRIGERIO;;NICOLAS CAMPER,,https://lens.org/085-275-423-448-752,Patent Application,no,2,0,11,11,0,A61K47/6855;;A61P35/00;;A61K47/6889;;C07K16/32;;C07K2317/73;;C07K2317/92;;A61K47/6883;;A61K47/68031;;A61K47/68037;;A61K47/595;;A61K47/60;;A61K47/64;;A61K47/65;;A61K47/6849;;A61K47/6859;;A61K47/6889;;A61P35/00;;A61K47/6889;;A61K47/6803;;C07K2317/92;;C07K2317/73;;A61K47/6855;;A61K47/6883;;C07K16/32;;A61K47/6883;;A61K47/6889;;A61K47/6803;;A61P35/00;;C07K16/32;;C07K2317/73;;C07K2317/92;;A61K47/6889;;A61K47/6883;;A61K47/6803;;A61P35/00;;C07K16/00;;C07K2317/73;;C07K2317/92,A61K47/68;;A61K47/59;;A61K47/60;;A61K47/64;;A61K47/65,,0,0,,,,ACTIVE
355,US,A1,US 2022/0212856 A1,054-317-188-432-192,2022-07-07,2022,US 202117646357 A,2021-12-29,GB 202020883 A;;GB 202109581 A,2020-12-31,BEVERAGE CONTAINER HOLDER,"A device 200 is disclosed for holding a beverage container 216 having any size within a range of sizes. The holder 200 has a side wall 202 defining an opening 208 through which the beverage container is insertable and a base 204. A collar 210 is positioned within the opening 208, and the side wall 202 and the base 204 together define a cavity 214 for receiving the beverage container 216. The collar 210 is pliable and is arranged to deform to contact and grip the beverage container 216. The opening 208 has a first width and the collar 210 has an aperture 212 formed therein, the aperture 212 having a second width, the first and second widths being selected to adapt the device to the desired range of sizes.",SUP DRINKWEAR LTD,SWEENEY DAVID;;LITTLE MARK;;RAMZAN HANS;;FLEMING ALEX;;BALFOUR JAMIE,LUMA-ID LTD (2022-01-22);;SUP DRINKWEAR LTD (2022-01-24),https://lens.org/054-317-188-432-192,Patent Application,yes,10,3,7,7,0,A47G23/0266;;A47G23/0216;;A47G2023/0283;;A47G23/0241;;B65D81/3876;;F25D3/08;;F25D2303/0841;;F25D2331/803;;A47G23/02;;A47G2023/0275;;A47G2023/0275;;A47G2200/16;;B65D25/10;;B65D81/3881;;F25D3/08;;F25D2331/803;;A47G23/0266,B65D81/38;;A47G23/02;;B65D23/06;;B65D23/08;;B65D25/10;;B65D25/54;;B65D47/40;;F25D3/08,,0,0,,,,PENDING
356,HK,A1,HK 1100912 A1,053-211-154-178-964,2007-10-05,2007,HK 07108653 A,2007-08-09,US 23613105 A,2005-09-27,COLORANT PRESENTATION FOR PAD PRINTING,,JOHNSON & JOHNSON VISION CARE,WIDMAN MICHAEL F;;RYAN JOSEPH;;FLEMING AIDEN;;POWELL P MARK,,https://lens.org/053-211-154-178-964,Patent Application,no,0,0,13,13,0,B41F17/001;;B41F17/001;;G05D24/02;;G05D24/02,B41F/;;G05D/,,0,0,,,,DISCONTINUED
357,CA,A1,CA 2876032 A1,059-717-206-809-761,2013-12-12,2013,CA 2876032 A,2013-06-06,GB 201210034 A;;GB 2013051496 W,2012-06-07,A METHOD OF INHIBITING SCALE IN A GEOLOGICAL FORMATION,The present invention relates to a method of inhibiting scale in a geological formation such as a hydrocarbon reservoir and a kit of parts for performing the method.,UNIV LEEDS,GHORBANI NASSER;;FLEMING NIALL;;WILSON MARK;;KAPUR NIKIL;;NEVILLE ANNE,,https://lens.org/059-717-206-809-761,Patent Application,no,0,0,12,12,0,C09K8/528;;E21B37/06;;C09K2208/10;;C09K8/528;;C09K2208/10;;F24F11/30;;F24F2110/00;;F24F2110/10;;F24F2110/40;;F24F2140/40;;F24F11/63;;F24F11/61;;F24F11/70;;F24F11/77;;Y02B30/70;;Y02P20/10;;C09K8/528;;C09K2208/10;;F24F11/30;;F24F2110/10;;F24F2140/40;;F24F11/63;;F24F11/61;;F24F11/70;;F24F11/77;;F24F2110/00;;F24F2110/40;;Y02B30/70;;Y02P20/10;;C09K8/52;;E21B43/16,C09K8/528,,0,0,,,,PENDING
358,US,B2,US 9890623 B2,067-414-862-945-229,2018-02-13,2018,US 201314406404 A,2013-06-06,GB 201210034 A;;GB 2013051496 W,2012-06-07,Method of inhibiting scale in a geological formation,"A method of inhibiting scale in a geological formation comprising depositing a binder on the formation surface, delivering a nano-material to the surface where it chemically interacts with the binder, emplacing a scale inhibitor on the formation that is absorbed by the nano-material, where a sustained release of the scale inhibitor into the geological formation results.",UNIV LEEDS INNOVATIONS LTD,GHORBANI NASSER;;FLEMING NIALL;;WILSON MARK;;KAPUR NIKIL;;NEVILLE ANNE,UNIVERSITY OF LEEDS (2015-02-17),https://lens.org/067-414-862-945-229,Granted Patent,yes,36,1,12,12,0,C09K8/528;;E21B37/06;;C09K2208/10;;C09K8/528;;C09K2208/10;;F24F11/30;;F24F2110/00;;F24F2110/10;;F24F2110/40;;F24F2140/40;;F24F11/63;;F24F11/61;;F24F11/70;;F24F11/77;;Y02B30/70;;Y02P20/10;;C09K8/528;;C09K2208/10;;F24F11/30;;F24F2110/10;;F24F2140/40;;F24F11/63;;F24F11/61;;F24F11/70;;F24F11/77;;F24F2110/00;;F24F2110/40;;Y02B30/70;;Y02P20/10;;C09K8/52;;E21B43/16,E21B43/16;;C09K8/52;;C09K8/528;;E21B43/22;;F24F11/00,,5,0,,,"Russian Office Action for PCT/GB2013/051496, dated Mar. 2, 2016 (4 pages), incorporating a Search Report (2 pages).;;International Search Report for PCT/GB2013/051496, ISA/EP, dated Aug. 13, 2013.;;International Preliminary Report on Patentability, IB, Geneva, dated Dec. 9, 2014 (8 pages), incorporating the Written Opinion of the ISA, ISA/EP, dated Aug. 13, 2013 (7 pages).;;N. Kazemi, et al., Preventing Adhesion of Scale on Rock by Nanoscale Modification of the Surface, Society of Petroleum Engineers, 2012, XP-00270972.;;Chinese Office Action for China Application No. 201380041474.4, dated Jul. 28, 2016 (14 pages, with English translation).",ACTIVE
359,EP,A2,EP 1681159 A2,087-644-107-989-948,2006-07-19,2006,EP 06250010 A,2006-01-04,US 2956205 A,2005-01-05,Viscosity control and colorant circulation for printing lens molds,"Disclosed are systems including a colorant cup that is adjacent to a cliché, wherein the cup includes a vent, an interior roof portion, and an air gap beneath the roof portion; a reservoir containing colorant; a feed conduit in fluid communication with the reservoir; and a return conduit in fluid communication with the cup. Also disclosed are various methods in which colorants are transferred in the disclosed systems from the reservoir to the colorant cup. The disclosed systems, colorant cups and methods are useful in the preparation of tinted contact lenses.
",JOHNSON & JOHNSON VISION CARE,WIDMAN MICHAEL F;;POWELL PAUL MARK;;FLEMING AIDAN;;RYAN JOSEPH,,https://lens.org/087-644-107-989-948,Patent Application,yes,1,9,15,18,0,B29D11/00903;;B41F17/001;;B29D11/00903;;B29D11/00951;;B29D11/00951;;B41F17/001;;B41F31/005;;B41F31/005;;G01N11/00;;G01N11/00,B41F17/00;;B67D7/06;;B67D7/08;;B67D7/78,,0,0,,,,ACTIVE
360,DE,T2,DE 69629699 T2,143-926-945-937-99X,2004-03-25,2004,DE 69629699 T,1996-06-28,EP 9602831 W;;GB 9513432 A,1995-07-01,VERFAHREN ZUR BESTIMMUNG VON UEBERGABE DER VERBINDUNG IN EINEM MULTIZELLULAREN KOMMUNIKATIONSSYSTEM,,MOTOROLA LTD,JONES PHILIP;;THOMAS JOHN;;ESSAM LESLEI;;LE FLEMING ANDREW MARK,,https://lens.org/143-926-945-937-99X,Granted Patent,no,0,0,13,13,0,H04W36/04;;H04W36/04,H04W36/04,,0,0,,,,EXPIRED
361,EP,A2,EP 2087589 A2,089-023-254-094-512,2009-08-12,2009,EP 07839676 A,2007-10-17,US 2007/0022257 W;;US 82983206 P,2006-10-17,LOW VOLTAGE OSCILLATOR FOR MEDICAL DEVICES,"Low voltage oscillators that provide a stable output frequency with varying supply voltage are provided. The subject oscillators find use in a variety of different types of devices, e.g., medical devices, including both implantable and ex-vivo devices.",PROTEUS BIOMEDICAL INC,FLEMING ROBERT;;KUSHNER CHERIE;;JANI NILAY;;WITHRINGTON JONATHAN;;ZDEBLICK MARK,"PROTEUS DIGITAL HEALTH, INC. (2012-10-24);;PROTEUS DIGITAL HEALTH, INC., US (2012-10-08);;PROTEUS DIGITAL HEALTH, INC., REDWOOD CITY, US (2012-10-08)",https://lens.org/089-023-254-094-512,Patent Application,yes,0,0,9,9,0,H03K3/011;;H03K3/0322;;H03K5/133;;H03K2005/00208;;H03K2005/00234;;H03K3/0322;;H03K3/011;;H03K2005/00234;;H03K5/133;;H03K2005/00208,H03K3/03;;H03K3/011,,0,0,,,,ACTIVE
362,GB,A,GB 2602483 A,108-835-361-247-714,2022-07-06,2022,GB 202020883 A,2020-12-31,GB 202020883 A,2020-12-31,Beverage container holder,"A holder 100 for a beverage container 116 has a side wall 102 defining an opening (108, Fig 5) through which the beverage container is insertable and a base 104. A collar 110 is positioned within the opening and the side wall and base define a cavity (114, Fig 2A). A collar 110, located in the opening, is adjustable between a first configuration for contacting a first size and a second configuration for contacting a second size of beverage container. Preferably an actuator 118 is moveable relative to the side wall to cause the collar to transition between the configurations, which may be in a graduated motion and / or lockable. The collar may be provided on a replaceable cap (128, Fig 5), preferably a plurality of caps with different size collars. The collar may comprise flexible material and / or indents, creases or perforations. Preferable the collar forms a seal around the beverage container and may comprise plastics or rubber. The side wall and/or the base may comprise rigid plastic and/or metal and / or is/are hollow including an insulating means. The holder may include material for cooling and/or heating, a bottle opener and ergonomic grips.",SUP DRINKWEAR LTD,DAVID SWEENEY;;MARK LITTLE;;JAMIE BALFOUR;;HANS RAMZAN;;ALEX FLEMING,,https://lens.org/108-835-361-247-714,Patent Application,no,6,0,7,7,0,A47G23/0266;;A47G23/0216;;A47G2023/0283;;A47G23/0241;;B65D81/3876;;F25D3/08;;F25D2303/0841;;F25D2331/803;;A47G23/02;;A47G2023/0275;;A47G2023/0275;;A47G2200/16;;B65D25/10;;B65D81/3881;;F25D3/08;;F25D2331/803;;A47G23/0266,A47G23/02,,0,0,,,,PENDING
363,WO,A1,WO 2023/047090 A1,102-329-325-423-813,2023-03-30,2023,GB 2022052369 W,2022-09-20,GB 202113450 A,2021-09-21,ANTIBODY-DRUG CONJUGATES,"The present invention relates to antibody-drug conjugates comprising (i) an antibody or antigen- binding fragment thereof, (ii) a polymer comprising a particular repeat unit comprising an amino acid derivative, which is covalently bound to one or more biologically active moieties, such as small molecule drugs, optionally via a linker, and (iii) a polymer-antibody linker moiety which is covalently bound to both the polymer and the antibody or antigen-binding fragment thereof. Additionally, the present invention relates to pharmaceutical compositions comprising the antibody-drug conjugates and to use of the antibody-drug conjugates in medicine.",SPIREA LTD,OUBERAI MYRIAM;;SIM NEIL;;FLEMING JAMES;;CAMPER NICOLAS;;FRIGERIO MARK,,https://lens.org/102-329-325-423-813,Patent Application,yes,4,0,1,1,0,A61K47/6889;;A61K47/6855;;A61P35/00;;A61K47/65;;A61K47/68031;;A61K47/68037,A61K47/68;;A61K47/65;;A61P35/00,,4,3,028-070-864-189-163;;014-507-914-429-50X;;180-951-241-610-952,10.1002/macp.1989.021900904;;10.1002/hep.1840110409;;1691730;;10.1201/9781482242683,"MASAYUKI YOKOYAMA ET AL: ""Molecular design for missile drug: Synthesis of adriamycin conjugated with immunoglobulin G using poly(ethylene glycol)-block-poly(aspartic acid) as intermediate carrier"", MAKROMOL. CHEM AND PHYSICS, WILEY, vol. 190, no. 9, 1 September 1989 (1989-09-01), pages 2041 - 2054, XP000330151, ISSN: 0025-116X, DOI: 10.1002/MACP.1989.021900904;;GALUN E ET AL: ""The effect of anti-[alpha]-fetoprotein-adriamycin conjugate on a human hepatoma"", HEPATOLOGY, JOHN WILEY & SONS, INC, US, vol. 11, no. 4, 1 April 1990 (1990-04-01), pages 578 - 584, XP008103697, ISSN: 0270-9139, [retrieved on 20051205], DOI: 10.1002/HEP.1840110409;;H ZOLA: ""Monoclonal Antibodies; A manual of techniques"", 1988, CRC PRESS;;SGR HURRELL: ""Monoclonal Hybridoma Antibodies: Techniques and Application"", 1982, CRC PRESS",PENDING
364,MX,B,MX 342188 B,134-684-865-838-793,2016-09-20,2016,MX 2014013677 A,2013-05-13,US 201261647557 P;;US 201313891351 A;;US 2013/0040717 W,2012-05-16,THERMAL DUCTING SYSTEM.,"A thermal ducting system for electronic equipment in an electronic equipment enclosure is provided. The thermal ducting system includes a top duct, a bottom duct spaced apart from the top duct, a side duct extending from the top duct to the bottom duct and along an intake side of the electronic equipment, and at least one baffle positioned in the side duct.",PANDUIT CORP,JAMES N FLEMING;;TIMOTHY GOLDSBERRY;;MARK SHURHAY;;MAX W HIBNER,,https://lens.org/134-684-865-838-793,Granted Patent,no,0,0,10,10,0,H05K7/20736;;Y10T29/49826;;H05K7/20145;;B23P19/00;;Y10T29/49826;;H05K7/20736,B23P19/00;;H05K7/20,,0,0,,,,ACTIVE
365,SG,A1,SG 123722 A1,180-409-100-507-230,2006-07-26,2006,SG 200508090 A,2005-12-14,US 2956205 A,2005-01-05,Viscosity control and colorant circulation for printing lens molds,,JOHNSON & JOHNSON VISION CARE,WIDMAN MICHAEL F;;POWELL PAUL MARK;;FLEMING AIDAN;;RYAN JOSEPH,,https://lens.org/180-409-100-507-230,Patent Application,no,0,0,15,18,0,B29D11/00903;;B41F17/001;;B29D11/00903;;B29D11/00951;;B29D11/00951;;B41F17/001;;B41F31/005;;B41F31/005;;G01N11/00;;G01N11/00,B67D7/06;;B67D7/08;;B67D7/78,,0,0,,,,PENDING
366,WO,A3,WO 2013/173210 A3,071-503-462-430-153,2014-01-16,2014,US 2013/0040717 W,2013-05-13,US 201261647557 P;;US 201313891351 A,2012-05-16,THERMAL DUCTING SYSTEM,"A thermal ducting system for electronic equipment in an electronic equipment enclosure is provided. The thermal ducting system includes a top duct, a bottom duct spaced apart from the top duct, a side duct extending from the top duct to the bottom duct and along an intake side of the electronic equipment, and at least one baffle positioned in the side duct.",PANDUIT CORP,FLEMING JAMES N;;GOLDSBERRY TIMOTHY;;SHURHAY MARK;;HIBNER MAX W,,https://lens.org/071-503-462-430-153,Search Report,yes,2,0,10,10,0,H05K7/20736;;Y10T29/49826;;H05K7/20145;;B23P19/00;;Y10T29/49826;;H05K7/20736,H05K7/20,,0,0,,,,PENDING
367,CA,A1,CA 2560962 A1,159-120-887-601-205,2007-03-27,2007,CA 2560962 A,2006-09-26,US 23613105 A,2005-09-27,COLORANT PRESENTATION FOR PAD PRINTING,"The present invention provides systems and methods for providing colorant to a colorant cup apparatus that is adjacent to a pad printing cliche. The fluid colorant is fed from a colorant container through a feed conduit to the cup and an inline viscometer external to the colorant container measures the viscosity of colorant within the feed conduit. A control mechanism can dispense colorant solvent into the colorant container based upon a viscosity measurement performed by the inline viscometer . The disclosed systems, colorant cups and methods are useful in the preparation of tinted contact lenses.",JOHNSON & JOHNSON VISION CARE,FLEMING AIDEN;;RYAN JOSEPH;;WIDMAN MICHAEL F;;POWELL P MARK,,https://lens.org/159-120-887-601-205,Patent Application,no,0,0,13,13,0,B41F17/001;;B41F17/001;;G05D24/02;;G05D24/02,B41K3/54,,0,0,,,,DISCONTINUED
368,EP,A1,EP 2859062 A1,174-653-143-365-84X,2015-04-15,2015,EP 13729054 A,2013-06-06,GB 201210034 A;;GB 2013051496 W,2012-06-07,A METHOD OF INHIBITING SCALE IN A GEOLOGICAL FORMATION,,UNIV LEEDS,GHORBANI NASSER;;FLEMING NIALL;;WILSON MARK;;KAPUR NIKIL;;NEVILLE ANNE,,https://lens.org/174-653-143-365-84X,Patent Application,yes,0,0,12,12,0,C09K8/528;;E21B37/06;;C09K2208/10;;C09K8/528;;C09K2208/10;;F24F11/30;;F24F2110/00;;F24F2110/10;;F24F2110/40;;F24F2140/40;;F24F11/63;;F24F11/61;;F24F11/70;;F24F11/77;;Y02B30/70;;Y02P20/10;;C09K8/528;;C09K2208/10;;F24F11/30;;F24F2110/10;;F24F2140/40;;F24F11/63;;F24F11/61;;F24F11/70;;F24F11/77;;F24F2110/00;;F24F2110/40;;Y02B30/70;;Y02P20/10;;C09K8/52;;E21B43/16,C09K8/528,,0,0,,,,ACTIVE
369,EP,A2,EP 2850925 A2,191-880-743-452-310,2015-03-25,2015,EP 13727425 A,2013-05-13,US 201261647557 P;;US 201313891351 A;;US 2013/0040717 W,2012-05-16,THERMAL DUCTING SYSTEM,,PANDUIT CORP,FLEMING JAMES N;;GOLDSBERRY TIMOTHY;;SHURHAY MARK;;HIBNER MAX W,,https://lens.org/191-880-743-452-310,Patent Application,yes,0,0,10,10,0,H05K7/20736;;Y10T29/49826;;H05K7/20145;;B23P19/00;;Y10T29/49826;;H05K7/20736,H05K7/20,,0,0,,,,ACTIVE
370,DE,A1,DE 102022133148 A1,194-012-335-608-979,2023-06-22,2023,DE 102022133148 A,2022-12-13,US 202117557031 A,2021-12-20,VERFAHREN UND VORRICHTUNGEN FÜR IM-FELD-THERMISCHE-KALIBRIERUNG,"Verfahren und Vorrichtungen für Im-Feld-thermische-Kalibrierung werden offenbart. Eine offenbarte beispielhafte Vorrichtung umfasst Anweisungen, einen Speicher in der Vorrichtung und eine Prozessorschaltungsanordnung. Die Prozessorschaltungsanordnung ist ausgebildet zur Ausführung der Anweisungen, um zu bestimmen, dass ein System-auf-Chip- (SOC-) Package eingesetzt wird, wobei das SOC-Package mit einem standardmäßigen ersten thermischen Modell eingesetzt wird, ansprechend auf die Bestimmung, dass das SOC-Package eingesetzt ist, zumindest eine Temperatur des SOC-Packages von einem Sensor und Leistungsnutzung des SOC-Packages zu überwachen, ein zweites thermisches Modell basierend auf der zumindest einen Temperatur und der Leistungsnutzung zu kalibrieren, und das kalibrierte zweite thermische Modell zur Steuerung des SOC-Packages zu veröffentlichen.",INTEL CORP,GALLINA MARK;;ZHU JIANFANG;;FLEMING KRISTOFFER;;RALLABANDI AKHILESH;;DAI JIANWEI,,https://lens.org/194-012-335-608-979,Patent Application,no,0,0,3,3,0,G06F11/3024;;G06F11/3058;;G06F1/20;;G06F15/7807;;G01K15/005;;Y02D10/00;;G06F30/39;;G01K15/005;;G06F2119/08;;G01K2215/00;;G06F2119/06;;G01K2213/00;;G06F2115/02,G06F11/30,,0,0,,,,PENDING
371,GB,B,GB 2594753 B,185-575-468-408-770,2022-05-18,2022,GB 202007926 A,2020-05-27,GB 202007926 A,2020-05-27,Antibody-drug conjugates,,SPIREA LTD,MYRIAM OUBERAI;;NEIL SIM;;JAMES FLEMING;;MARK FRIGERIO;;NICOLAS CAMPER,,https://lens.org/185-575-468-408-770,Granted Patent,no,2,0,11,11,0,A61K47/6855;;A61P35/00;;A61K47/6889;;C07K16/32;;C07K2317/73;;C07K2317/92;;A61K47/6883;;A61K47/68031;;A61K47/68037;;A61K47/595;;A61K47/60;;A61K47/64;;A61K47/65;;A61K47/6849;;A61K47/6859;;A61K47/6889;;A61P35/00;;A61K47/6889;;A61K47/6803;;C07K2317/92;;C07K2317/73;;A61K47/6855;;A61K47/6883;;C07K16/32;;A61K47/6883;;A61K47/6889;;A61K47/6803;;A61P35/00;;C07K16/32;;C07K2317/73;;C07K2317/92;;A61K47/6889;;A61K47/6883;;A61K47/6803;;A61P35/00;;C07K16/00;;C07K2317/73;;C07K2317/92,A61K47/68;;A61K47/59;;A61K47/60;;A61K47/64;;A61K47/65,,0,0,,,,ACTIVE
372,WO,A3,WO 2005/036669 A3,014-623-369-533-579,2006-04-13,2006,US 2004/0024498 W,2004-07-29,US 66328403 A,2003-09-16,LOW COST GAS DIFFUSION MEDIA FOR USE IN PEM FUEL CELLS,A gas diffusion media and method of making are provided including the formation of a carbon fiber paper which is heated to a carbonization temperature without exceeding a graphitization temperature. The discovery that a final high temperature heat treatment step in the graphitization temperature zone is not necessary to make effective gas diffusion media for PEM fuel cells greatly reduces the cost associated with the high temperature final heat treatment and also allows for the processing of the diffusion media in a roll.,GEN MOTORS CORP,MATHIAS MARK F;;ROTH JOERG;;SCHOENEWEISS MICHAEL R;;FLEMING GERALD,,https://lens.org/014-623-369-533-579,Search Report,yes,1,0,6,6,0,C04B35/521;;C04B35/521;;C04B35/83;;C04B35/83;;C04B2235/5256;;C04B2235/5256;;H01M4/8807;;H01M4/8807;;H01M4/881;;H01M4/881;;H01M8/0234;;H01M8/0234;;H01M8/0239;;H01M8/0239;;H01M8/0243;;H01M8/0243;;H01M8/1007;;H01M8/1007;;Y02E60/50;;Y02P70/50;;Y02P70/50,H01M4/86;;H01M4/88;;H01M8/10,,0,0,,,,PENDING
373,CA,A1,CA 2531348 A1,016-957-057-317-271,2006-07-05,2006,CA 2531348 A,2005-12-21,US 2956205 A,2005-01-05,VISCOSITY CONTROL AND COLORANT CIRCULATION FOR PRINTING LENSMOLDS,"Disclosed are systems including a colorant cup that is adjacent to a cliché, wherein the cup includes a vent, an interior roof portion, and an air gap beneath th e roof portion; a reservoir containing colorant; a feed conduit in fluid communication with th e reservoir; and a return conduit in fluid communication with the cup. Also disclosed are vario us methods in which colorants are transferred in the disclosed systems from the reservoir to the colorant cup. The disclosed systems, colorant cups and methods are useful in the preparation of tinted contact lenses.",JOHNSON & JOHNSON VISION CARE,WIDMAN MICHAEL F;;POWELL PAUL MARK;;FLEMING AIDAN;;RYAN JOSEPH,,https://lens.org/016-957-057-317-271,Patent Application,no,0,0,15,18,0,B29D11/00903;;B41F17/001;;B29D11/00903;;B29D11/00951;;B29D11/00951;;B41F17/001;;B41F31/005;;B41F31/005;;G01N11/00;;G01N11/00,B67D7/06;;B29C33/56;;B29D11/00;;B67D7/08;;B67D7/78,,0,0,,,,DISCONTINUED
374,CN,A,CN 115666653 A,020-763-335-738-279,2023-01-31,2023,CN 202180038130 A,2021-05-26,GB 202007926 A;;GB 2021051285 W,2020-05-27,Antibody-drug conjugates,"The present invention relates to antibody-drug conjugates comprising (i) an antibody or antigen-binding fragment thereof, (ii) a polymer comprising specific repeating units comprising an amino acid derivative optionally covalently bound to one or more bioactive moieties, such as a small molecule drug, via a linker, and (iii) a polymer-antibody linker moiety, such as a small molecule drug, optionally covalently bound to one or more bioactive moieties, such as a small molecule drug, via a linker. It is covalently bound to the polymer and the antibody or antigen-binding fragment thereof. Furthermore, the present invention relates to a pharmaceutical composition comprising the antibody-drug conjugate and to the use of said antibody-drug conjugate in medicine.",SPIREA S R L,UBRA MADHUSUDHAN;;SIM NIGEL;;J FLEMING;;CAMPEAU NICOLAS;;FRIGERIO MARK,,https://lens.org/020-763-335-738-279,Patent Application,no,0,0,11,11,0,A61K47/6855;;A61P35/00;;A61K47/6889;;C07K16/32;;C07K2317/73;;C07K2317/92;;A61K47/6883;;A61K47/68031;;A61K47/68037;;A61K47/595;;A61K47/60;;A61K47/64;;A61K47/65;;A61K47/6849;;A61K47/6859;;A61K47/6889;;A61P35/00;;A61K47/6889;;A61K47/6803;;C07K2317/92;;C07K2317/73;;A61K47/6855;;A61K47/6883;;C07K16/32;;A61K47/6883;;A61K47/6889;;A61K47/6803;;A61P35/00;;C07K16/32;;C07K2317/73;;C07K2317/92;;A61K47/6889;;A61K47/6883;;A61K47/6803;;A61P35/00;;C07K16/00;;C07K2317/73;;C07K2317/92,A61K47/59;;A61K47/60;;A61K47/64;;A61K47/65;;A61K47/68;;A61P35/00;;C07K16/30,,0,0,,,,PENDING
375,WO,A1,WO 2021/240155 A1,051-351-955-303-333,2021-12-02,2021,GB 2021051285 W,2021-05-26,GB 202007926 A,2020-05-27,ANTIBODY-DRUG CONJUGATES,"The present invention relates to antibody-drug conjugates comprising (i) an antibody or antigen-binding fragment thereof, (ii) a polymer comprising a particular repeat unit comprising an amino acid derivative, which is covalently bound to one or more biologically active moieties, such as small molecule drugs, optionally via a linker, and (iii) a polymer-antibody linker moiety which is covalently bound to both the polymer and the antibody or antigen-binding fragment thereof. Additionally, the present invention relates to pharmaceutical compositions comprising the antibody-drug conjugates and to use of the antibody-drug conjugates in medicine.",SPIREA LTD,OUBERAI MYRIAM;;SIM NEIL;;FLEMING JAMES;;CAMPER NICOLAS;;FRIGERIO MARK,,https://lens.org/051-351-955-303-333,Patent Application,yes,3,1,11,11,0,A61K47/6855;;A61P35/00;;A61K47/6889;;C07K16/32;;C07K2317/73;;C07K2317/92;;A61K47/6883;;A61K47/68031;;A61K47/68037;;A61K47/595;;A61K47/60;;A61K47/64;;A61K47/65;;A61K47/6849;;A61K47/6859;;A61K47/6889;;A61P35/00;;A61K47/6889;;A61K47/6803;;C07K2317/92;;C07K2317/73;;A61K47/6855;;A61K47/6883;;C07K16/32;;A61K47/6883;;A61K47/6889;;A61K47/6803;;A61P35/00;;C07K16/32;;C07K2317/73;;C07K2317/92;;A61K47/6889;;A61K47/6883;;A61K47/6803;;A61P35/00;;C07K16/00;;C07K2317/73;;C07K2317/92,A61K47/59;;A61K47/60;;A61K47/64;;A61K47/65;;A61K47/68;;A61P35/00;;C07K16/30,,6,2,028-070-864-189-163;;180-951-241-610-952,10.1002/macp.1989.021900904;;10.1201/9781482242683,"MASAYUKI YOKOYAMA: ""MOLECULAR DESIGN FOR MISSILE DRUG: SYNTHESIS OF ADRIAMYCIN CONJUGATED WITH IMMUNOGLOBULIN G USING POLY(ETHYLENEGLYCOL)-BLOCK-POLY(ASPARTIC ACID) AS INTERMEDIATE CARRIER"", MAKROMOL. CHEM AND PHYSICS, WILEY, vol. 190, no. 9, 1 September 1989 (1989-09-01), pages 2041 - 2054, XP000330151, ISSN: 0025-116X, DOI: 10.1002/MACP.1989.021900904;;AXEL KLEEMANNJURGEN ENGEL: ""Pharmaceutical Substances: Syntheses, Patents, Applications"", THIEME MEDICAL PUBLISHING, 1999;;MERCK INDEX ET AL.: ""An Encyclopedia of Chemicals, Drugs, and Biologicals"", 1996, CRC PRESS;;H ZOLA: ""Monoclonal Antibodies; A manual of techniques"", 1988, CRC PRESS;;SGR HURRELL: ""Monoclonal Hybridoma Antibodies: Techniques and Application"", 1982, CRC PRESS;;""Fiedler Encyclopedia of Excipients for Pharmaceuticals, Cosmetics and Related Areas"", 2002, MARCEL DEKKER",PENDING
376,TW,A,TW 200728799 A,140-222-546-260-788,2007-08-01,2007,TW 95135794 A,2006-09-27,US 23613105 A,2005-09-27,Colorant presentation for pad printing,"The present invention provides systems and methods for providing colorant to a colorant cup apparatus that is adjacent to a pad printing clich. The fluid colorant is fed from a colorant container through a feed conduit to the cup and an inline viscometer external to the colorant container measures the viscosity of colorant within the feed conduit. A control mechanism can dispense colorant solvent into the colorant container based upon a viscosity measurement performed by the inline viscometer. The disclosed systems, colorant cups and methods are useful in the preparation of tinted contact lenses.",JOHNSON & JOHNSON VISION CARE,WIDMAN MICHAEL F;;RYAN JOSEPH;;FLEMING AIDEN;;POWELL P MARK,,https://lens.org/140-222-546-260-788,Patent of Addition,no,0,0,13,13,0,B41F17/001;;B41F17/001;;G05D24/02;;G05D24/02,G02C7/04;;B29D11/00;;C08J3/20,,0,0,,,,PENDING
377,KR,A,KR 20060080554 A,159-701-620-933-011,2006-07-10,2006,KR 20060001197 A,2006-01-05,US 2956205 A,2005-01-05,VISCOSITY CONTROL AND COLORANT CIRCULATION FOR PRINTING LENS MOLDS,,JOHNSON & JOHNSON VISION CARE,WIDMAN MICHAEL F;;POWELL PAUL MARK;;FLEMING AIDAN;;RYAN JOSEPH,,https://lens.org/159-701-620-933-011,Patent Application,no,0,1,15,18,0,B29D11/00903;;B41F17/001;;B29D11/00903;;B29D11/00951;;B29D11/00951;;B41F17/001;;B41F31/005;;B41F31/005;;G01N11/00;;G01N11/00,B67D7/06;;G02C7/04;;B67D7/08;;B67D7/78;;C08J7/04,,0,0,,,,DISCONTINUED
378,WO,A1,WO 2015/044722 A1,171-410-010-517-293,2015-04-02,2015,IB 2013059084 W,2013-10-03,US 201361881555 P,2013-09-24,METHOD AND APPARATUS FOR USE WITH RECEIVED ELECTROMAGNETIC SIGNAL AT A FREQUENCY NOT KNOWN EXACTLY IN ADVANCE,"In a software receiver, a received electromagnetic signal is sampled in ""slices"", each having a duration of some multiple of a reference frequency. The samples of each slice are correlated with values in a pair of reference signals, such as sine and cosine, at the reference frequency. This yields a two-tuple for each slice, which two-tuples may be stored. The stored two-tuples can be simply added to arrive at a correlation value of narrower bandwidth than that of any slice taken alone. The stored two-tuples can be taken in sequence, each rotated by some predetermined angle relative to its predecessor in sequence, and the rotated two-tuples summed to arrive at a correlation value with respect to a frequency that is offset from the reference frequency to an extent that relates to the predetermined angle. In this way, the receiver is able to proceed despite the transmitted frequency not being known exactly in advance and does not require prodigious storage or computational resources.",PROTEUS DIGITAL HEALTH INC,KUSHNER CHERIE ELAINE;;FLEMING ROBERT ALAN;;MCALLISTER WILLIAM;;ZDEBLICK MARK,,https://lens.org/171-410-010-517-293,Patent Application,yes,5,12,4,4,0,H04B1/0003;;G06F16/22;;G06F16/22;;H04B1/0003;;H04L27/3416;;H04L27/361,H04L25/02,,0,0,,,,PENDING
379,DE,D1,DE 602006005880 D1,052-720-823-651-923,2009-05-07,2009,DE 602006005880 T,2006-09-26,US 23613105 A,2005-09-27,Zuführen von Farbe für Tampondruck,,JOHNSON & JOHNSON VISION CARE,WIDMAN MICHAEL F;;RYAN JOSEPH;;FLEMING AIDEN;;POWELL MARK P,,https://lens.org/052-720-823-651-923,Granted Patent,no,0,0,13,13,0,B41F17/001;;B41F17/001;;G05D24/02;;G05D24/02,B41F17/00;;G05D24/00,,0,0,,,,ACTIVE
380,WO,A1,WO 2013/182852 A1,052-799-404-597-031,2013-12-12,2013,GB 2013051496 W,2013-06-06,GB 201210034 A,2012-06-07,A METHOD OF INHIBITING SCALE IN A GEOLOGICAL FORMATION,The present invention relates to a method of inhibiting scale in a geological formation such as a hydrocarbon reservoir and a kit of parts for performing the method.,UNIV LEEDS,FLEMING NIALL;;WILSON MARK;;GHORBANI NASSER;;KAPUR NIKIL;;NEVILLE ANNE,,https://lens.org/052-799-404-597-031,Patent Application,yes,4,5,12,12,0,C09K8/528;;E21B37/06;;C09K2208/10;;C09K8/528;;C09K2208/10;;F24F11/30;;F24F2110/00;;F24F2110/10;;F24F2110/40;;F24F2140/40;;F24F11/63;;F24F11/61;;F24F11/70;;F24F11/77;;Y02B30/70;;Y02P20/10;;C09K8/528;;C09K2208/10;;F24F11/30;;F24F2110/10;;F24F2140/40;;F24F11/63;;F24F11/61;;F24F11/70;;F24F11/77;;F24F2110/00;;F24F2110/40;;Y02B30/70;;Y02P20/10;;C09K8/52;;E21B43/16,C09K8/528,,1,1,127-512-632-557-312,10.2118/156955-ms,"N. KAZEMI, M. WILSON, N. KAPUR, UNIVERSITY OF LEEDS, N. FLEMING, STATOIL ASA, A. NEVILLE, UNIVERSITY OF LEEDS: ""Preventing Adhesion of Scale on Rock by Nanoscale Modification of the Surface"", SOCIETY OF PETROLEUM ENGINEERS, 156955, 12 June 2012 (2012-06-12), XP002709721, ISBN: 978-1-61399-206-7, DOI: 10.2118/156955-MS",PENDING
381,EP,A1,EP 3747972 A1,050-391-402-015-438,2020-12-09,2020,EP 20188759 A,2013-06-06,GB 201210034 A;;EP 13729054 A;;GB 2013051496 W,2012-06-07,A METHOD OF INHIBITING SCALE IN A GEOLOGICAL FORMATION,The present invention relates to a method of inhibiting scale in a geological formation such as a hydrocarbon reservoir and a kit of parts for performing the method.,UNIV LEEDS INNOVATIONS LTD,GHORBANI NASSER;;FLEMING NIALL;;WILSON MARK;;KAPUR NIKIL;;NEVILLE ANNE,,https://lens.org/050-391-402-015-438,Patent Application,yes,6,0,12,12,0,C09K8/528;;E21B37/06;;C09K2208/10;;C09K8/528;;C09K2208/10;;F24F11/30;;F24F2110/00;;F24F2110/10;;F24F2110/40;;F24F2140/40;;F24F11/63;;F24F11/61;;F24F11/70;;F24F11/77;;Y02B30/70;;Y02P20/10;;C09K8/528;;C09K2208/10;;F24F11/30;;F24F2110/10;;F24F2140/40;;F24F11/63;;F24F11/61;;F24F11/70;;F24F11/77;;F24F2110/00;;F24F2110/40;;Y02B30/70;;Y02P20/10;;C09K8/52;;E21B43/16,C09K8/528;;F24F11/30;;F24F11/70;;F24F11/77,,1,1,127-512-632-557-312,10.2118/156955-ms,"N. KAZEMI, M. WILSON, N. KAPUR, UNIVERSITY OF LEEDS, N. FLEMING, STATOIL ASA, A. NEVILLE, UNIVERSITY OF LEEDS: ""Preventing Adhesion of Scale on Rock by Nanoscale Modification of the Surface"", SOCIETY OF PETROLEUM ENGINEERS, 156955, 12 June 2012 (2012-06-12), XP002709721, ISBN: 978-1-61399-206-7, DOI: 10.2118/156955-MS",DISCONTINUED
382,CA,A1,CA 3176362 A1,064-919-103-307-570,2021-12-02,2021,CA 3176362 A,2021-05-26,GB 202007926 A;;GB 2021051285 W,2020-05-27,ANTIBODY-DRUG CONJUGATES,"The present invention relates to antibody-drug conjugates comprising (i) an antibody or antigen-binding fragment thereof, (ii) a polymer comprising a particular repeat unit comprising an amino acid derivative, which is covalently bound to one or more biologically active moieties, such as small molecule drugs, optionally via a linker, and (iii) a polymer-antibody linker moiety which is covalently bound to both the polymer and the antibody or antigen-binding fragment thereof. Additionally, the present invention relates to pharmaceutical compositions comprising the antibody-drug conjugates and to use of the antibody-drug conjugates in medicine.",SPIREA LTD,OUBERAI MYRIAM;;SIM NEIL;;FLEMING JAMES;;CAMPER NICOLAS;;FRIGERIO MARK,,https://lens.org/064-919-103-307-570,Patent Application,no,0,0,11,11,0,A61K47/6855;;A61P35/00;;A61K47/6889;;C07K16/32;;C07K2317/73;;C07K2317/92;;A61K47/6883;;A61K47/68031;;A61K47/68037;;A61K47/595;;A61K47/60;;A61K47/64;;A61K47/65;;A61K47/6849;;A61K47/6859;;A61K47/6889;;A61P35/00;;A61K47/6889;;A61K47/6803;;C07K2317/92;;C07K2317/73;;A61K47/6855;;A61K47/6883;;C07K16/32;;A61K47/6883;;A61K47/6889;;A61K47/6803;;A61P35/00;;C07K16/32;;C07K2317/73;;C07K2317/92;;A61K47/6889;;A61K47/6883;;A61K47/6803;;A61P35/00;;C07K16/00;;C07K2317/73;;C07K2317/92,A61K47/59;;A61K47/60;;A61K47/64;;A61K47/65;;A61K47/68;;C07K16/30,,0,0,,,,PENDING
383,AU,A1,AU 2021/279380 A1,106-165-918-982-810,2022-11-17,2022,AU 2021/279380 A,2021-05-26,GB 202007926 A;;GB 2021051285 W,2020-05-27,Antibody-drug conjugates,"The present invention relates to antibody-drug conjugates comprising (i) an antibody or antigen-binding fragment thereof, (ii) a polymer comprising a particular repeat unit comprising an amino acid derivative, which is covalently bound to one or more biologically active moieties, such as small molecule drugs, optionally via a linker, and (iii) a polymer-antibody linker moiety which is covalently bound to both the polymer and the antibody or antigen-binding fragment thereof. Additionally, the present invention relates to pharmaceutical compositions comprising the antibody-drug conjugates and to use of the antibody-drug conjugates in medicine.",SPIREA LTD,OUBERAI MYRIAM;;SIM NEIL;;FLEMING JAMES;;CAMPER NICOLAS;;FRIGERIO MARK,,https://lens.org/106-165-918-982-810,Patent Application,no,0,0,11,11,0,A61K47/6855;;A61P35/00;;A61K47/6889;;C07K16/32;;C07K2317/73;;C07K2317/92;;A61K47/6883;;A61K47/68031;;A61K47/68037;;A61K47/595;;A61K47/60;;A61K47/64;;A61K47/65;;A61K47/6849;;A61K47/6859;;A61K47/6889;;A61P35/00;;A61K47/6889;;A61K47/6803;;C07K2317/92;;C07K2317/73;;A61K47/6855;;A61K47/6883;;C07K16/32;;A61K47/6883;;A61K47/6889;;A61K47/6803;;A61P35/00;;C07K16/32;;C07K2317/73;;C07K2317/92;;A61K47/6889;;A61K47/6883;;A61K47/6803;;A61P35/00;;C07K16/00;;C07K2317/73;;C07K2317/92,A61K47/59;;A61K47/60;;A61K47/64;;A61K47/65;;A61K47/68;;A61P35/00;;C07K16/30,,0,0,,,,PENDING
384,JP,A,JP 2019110601 A,168-175-546-744-704,2019-07-04,2019,JP 2019042240 A,2019-03-08,US 201361880786 P,2013-09-20,"METHODS, DEVICES AND SYSTEMS FOR RECEIVING AND DECODING SIGNAL IN PRESENCE OF NOISE USING SLICES AND WARPING","To provide preferable methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping.SOLUTION: The method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of the selected number of samples of the signal, the pair of values representing a correlation of the signal to reference functions in a receiver. The presence of the data packet may then be detected and the detected packet may be decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. A slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.SELECTED DRAWING: Figure 12",PROTEUS DIGITAL HEALTH INC,CHERIE KUSHNER;;ROBERT FLEMING;;WILLIAM H MCALLISTER;;MARK J ZDEBLICK,,https://lens.org/168-175-546-744-704,Patent Application,no,0,0,47,47,0,H04L27/0014;;H04L27/144;;H04L7/042;;H04L27/148;;H04L25/08;;H04L7/042;;H04L27/0014;;H04L27/144;;H04L27/148;;H04L69/22;;H04L27/148;;H04L27/0014;;H04L27/144;;H04L7/042;;H04L25/08;;H04L69/22;;H04L27/148;;H04B1/001,H04B1/10;;H04L47/43;;H04L27/14,,0,0,,,,ACTIVE
385,DE,D1,DE 602006007048 D1,019-191-290-049-544,2009-07-16,2009,DE 602006007048 T,2006-01-04,US 2956205 A,2005-01-05,Viskositäts- und Zirkulationssteuerung von Fabstoff für den Druck von Linsengussformen,,JOHNSON & JOHNSON VISION CARE,WIDMAN MICHAEL F;;POWELL PAUL MARK;;FLEMING AIDAN;;RYAN JOSEPH,,https://lens.org/019-191-290-049-544,Granted Patent,no,0,0,15,18,0,B29D11/00903;;B41F17/001;;B29D11/00903;;B29D11/00951;;B29D11/00951;;B41F17/001;;B41F31/005;;B41F31/005;;G01N11/00;;G01N11/00,B41F17/00;;B67D7/06;;B67D7/08;;B67D7/78,,0,0,,,,ACTIVE
386,US,A1,US 2018/0103893 A1,097-286-561-108-333,2018-04-19,2018,US 201715844975 A,2017-12-18,US 201715844975 A;;US 40977909 A,2009-03-24,REMOTE DELIVERY AND MONITORING OF HEALTH CARE,"An automated medical apparatus for providing medical care in remote areas to a patient is provided. The apparatus includes a container having corrugated steel enclosure on all sides and transportable using a standardized commercial shipping mechanism, the container having a door with a handle and lock mechanism for secure entry and secure accommodation of the patient for treatment. The container has integrated into an inner ceiling side of the container, a plurality of automated dispensers, the dispensers configured for dispensing sterilization material upon determining by the apparatus that the door has been opened and closed, a first time and a second time respectively, such that the patient is assumed to have completed the treatment and exited the container. Further, the apparatus includes a power management device, a processor, a medical device interface, and a patient interface.",IBM,FLEMING MARK;;LARA CHRISTINA;;COPELAND MICHAEL P;;SANCHEZ CALLINE K,INTERNATIONAL BUSINESS MACHINES CORPORATION (2017-12-05),https://lens.org/097-286-561-108-333,Patent Application,yes,15,1,8,8,0,A61B5/0059;;A61B10/0045;;A61B2560/0431;;A61B2560/0456;;A61B5/0022;;A61B5/0013;;A61B2090/376;;A61B2090/378;;A61B5/445;;G16H30/40;;G16H40/67;;A61B5/0059;;A61B10/0045;;A61B2560/0431;;A61B2560/0456;;A61B5/0013;;A61B2090/376;;A61B2090/378;;A61B5/0022;;G16H30/40;;A61B5/445;;A61B5/6812;;A61B5/7445;;A61B2560/0475;;A61B5/7207;;A61B5/74;;A61B2560/0214;;G16H40/67,A61B5/00;;A61B10/00;;G16H30/40;;G16H40/67,,0,0,,,,ACTIVE
387,US,A1,US 2008/0131596 A1,102-877-101-731-072,2008-06-05,2008,US 2956205 A,2005-01-05,US 2956205 A;;US 53654004 P,2004-01-14,Viscosity control and colorant circulation for printing lens molds,"Disclosed are systems including a colorant cup that is adjacent to a cliché, wherein the cup includes a vent, an interior roof portion, and an air gap beneath the roof portion; a reservoir containing colorant; a feed conduit in fluid communication with the reservoir; and a return conduit in fluid communication with the cup. Also disclosed are various methods in which colorants are transferred in the disclosed systems from the reservoir to the colorant cup. The disclosed systems, colorant cups and methods are useful in the preparation of tinted contact lenses.",WIDMAN MICHAEL F;;POWELL PAUL MARK;;FLEMING AIDAN;;RYAN JOSEPH,WIDMAN MICHAEL F;;POWELL PAUL MARK;;FLEMING AIDAN;;RYAN JOSEPH,JOHNSON & JOHNSON VISION CARE INC (2005-06-21),https://lens.org/102-877-101-731-072,Patent Application,yes,4,2,1,18,0,B29D11/00317;;B29D11/00317;;B29D11/00038;;B29D11/00903,B05D5/06;;B05C3/02,427/162;;118/401,0,0,,,,DISCONTINUED
388,KR,A,KR 20230017246 A,144-334-563-343-472,2023-02-03,2023,KR 20227044874 A,2021-05-26,GB 202007926 A;;GB 2021051285 W,2020-05-27,항체-약물 접합체,"본 발명은 (i) 항체 또는 이의 항원-결합 단편, (ii) 저분자 약물(small molecule drug)과 같은 1 이상의 생물학적 활성 모이어티(biologically active moiety)에 공유결합된, 선택적으로 링커를 통하여 공유결합된, 아미노산 유도체를 포함하는 특정 반복 단위를 포함하는 중합체, 및 (iii) 중합체 및 항체 또는 이의 항원-결합 단편 모두에 공유결합된 중합체-항체 링커(linker) 모이어티를 포함하는 항체-약물 접합체에 관한 것이다. 또한, 본 발명은 상기 항체-약물 접합체를 포함하는 약제학적 조성물 및 의약에서의 상기 항체-약물 접합체의 용도에 관한 것이다.",SPIREA LTD,OUBERAI MYRIAM;;SIM NEIL;;FLEMING JAMES;;CAMPER NICOLAS;;FRIGERIO MARK,,https://lens.org/144-334-563-343-472,Patent Application,no,0,0,11,11,0,A61K47/6855;;A61P35/00;;A61K47/6889;;C07K16/32;;C07K2317/73;;C07K2317/92;;A61K47/6883;;A61K47/68031;;A61K47/68037;;A61K47/595;;A61K47/60;;A61K47/64;;A61K47/65;;A61K47/6849;;A61K47/6859;;A61K47/6889;;A61P35/00;;A61K47/6889;;A61K47/6803;;C07K2317/92;;C07K2317/73;;A61K47/6855;;A61K47/6883;;C07K16/32;;A61K47/6883;;A61K47/6889;;A61K47/6803;;A61P35/00;;C07K16/32;;C07K2317/73;;C07K2317/92;;A61K47/6889;;A61K47/6883;;A61K47/6803;;A61P35/00;;C07K16/00;;C07K2317/73;;C07K2317/92,A61K47/68;;A61P35/00;;C07K16/32,,0,0,,,,PENDING
389,EP,A1,EP 4157357 A1,167-275-007-362-338,2023-04-05,2023,EP 21731569 A,2021-05-26,GB 202007926 A;;GB 2021051285 W,2020-05-27,ANTIBODY-DRUG CONJUGATES,,SPIREA LTD,OUBERAI MYRIAM;;SIM NEIL;;FLEMING JAMES;;CAMPER NICOLAS;;FRIGERIO MARK,,https://lens.org/167-275-007-362-338,Patent Application,yes,0,0,11,11,0,A61K47/6855;;A61P35/00;;A61K47/6889;;C07K16/32;;C07K2317/73;;C07K2317/92;;A61K47/6883;;A61K47/68031;;A61K47/68037;;A61K47/595;;A61K47/60;;A61K47/64;;A61K47/65;;A61K47/6849;;A61K47/6859;;A61K47/6889;;A61P35/00;;A61K47/6889;;A61K47/6803;;C07K2317/92;;C07K2317/73;;A61K47/6855;;A61K47/6883;;C07K16/32;;A61K47/6883;;A61K47/6889;;A61K47/6803;;A61P35/00;;C07K16/32;;C07K2317/73;;C07K2317/92;;A61K47/6889;;A61K47/6883;;A61K47/6803;;A61P35/00;;C07K16/00;;C07K2317/73;;C07K2317/92,A61K47/59;;A61K47/60;;A61K47/64;;A61K47/65;;A61K47/68;;A61P35/00;;C07K16/30,,0,0,,,,PENDING
390,DE,D1,DE 69629699 D1,186-703-250-679-05X,2003-10-02,2003,DE 69629699 T,1996-06-28,EP 9602831 W;;GB 9513432 A,1995-07-01,VERFAHREN ZUR BESTIMMUNG VON UEBERGABE DER VERBINDUNG IN EINEM MULTIZELLULAREN KOMMUNIKATIONSSYSTEM,,MOTOROLA LTD,JONES PHILIP;;THOMAS JOHN;;ESSAM LESLEI;;LE FLEMING ANDREW MARK,,https://lens.org/186-703-250-679-05X,Granted Patent,no,0,0,13,13,0,H04W36/04;;H04W36/04,H04W36/04,,0,0,,,,EXPIRED
391,US,A1,US 2015/0129225 A1,038-421-463-595-333,2015-05-14,2015,US 201314406404 A,2013-06-06,GB 201210034 A;;GB 2013051496 W,2012-06-07,METHOD OF INHIBITING SCALE IN A GEOLOGICAL FORMATION,The present invention relates to a method of inhibiting scale in a geological formation such as a hydrocarbon reservoir and a kit of parts for performing the method.,UNIV LEEDS,GHORBANI NASSER;;FLEMING NIALL;;WILSON MARK;;KAPUR NIKIL;;NEVILLE ANNE,UNIVERSITY OF LEEDS (2015-02-17),https://lens.org/038-421-463-595-333,Patent Application,yes,1,5,12,12,0,C09K8/528;;E21B37/06;;C09K2208/10;;C09K8/528;;C09K2208/10;;F24F11/30;;F24F2110/00;;F24F2110/10;;F24F2110/40;;F24F2140/40;;F24F11/63;;F24F11/61;;F24F11/70;;F24F11/77;;Y02B30/70;;Y02P20/10;;C09K8/528;;C09K2208/10;;F24F11/30;;F24F2110/10;;F24F2140/40;;F24F11/63;;F24F11/61;;F24F11/70;;F24F11/77;;F24F2110/00;;F24F2110/40;;Y02B30/70;;Y02P20/10;;C09K8/52;;E21B43/16,E21B43/16;;C09K8/52,166/304;;507/219,0,0,,,,ACTIVE
392,EP,A4,EP 2087589 A4,080-042-736-499-367,2009-11-11,2009,EP 07839676 A,2007-10-17,US 2007/0022257 W;;US 82983206 P,2006-10-17,LOW VOLTAGE OSCILLATOR FOR MEDICAL DEVICES,"Low voltage oscillators that provide a stable output frequency with varying supply voltage are provided. The subject oscillators find use in a variety of different types of devices, e.g., medical devices, including both implantable and ex-vivo devices.",PROTEUS BIOMEDICAL INC,FLEMING ROBERT;;KUSHNER CHERIE;;JANI NILAY;;WITHRINGTON JONATHAN;;ZDEBLICK MARK,"PROTEUS DIGITAL HEALTH, INC. (2012-10-24);;PROTEUS DIGITAL HEALTH, INC., US (2012-10-08);;PROTEUS DIGITAL HEALTH, INC., REDWOOD CITY, US (2012-10-08)",https://lens.org/080-042-736-499-367,Search Report,no,2,0,9,9,0,H03K3/011;;H03K3/0322;;H03K5/133;;H03K2005/00208;;H03K2005/00234;;H03K3/0322;;H03K3/011;;H03K2005/00234;;H03K5/133;;H03K2005/00208,H03K3/03;;H03K3/011,,4,4,013-389-953-231-546;;070-806-113-494-855;;006-779-079-382-873;;007-791-330-066-861,10.1109/4.871321;;10.1109/mwsym.2002.1011677;;10.1109/tcsi.2004.838240;;10.1007/978-3-540-95948-9_3,"CHING-YUAN YANG; SHEN-IUAN LIU: ""Fast-Switching Frequency Synthesizer with a Discriminator-Aided Phase Detector"", IEEE JOURNAL OF SOLID-STATE CIRCUITS, IEEE SERVICE CENTER, PISCATAWAY, NJ, US, vol. 35, no. 10, 1 October 2000 (2000-10-01), XP011061354, ISSN: 0018-9200;;SANDULEANU M A T; GOOR VAN D; VEENSTRA H ED - HAMILTON R (ED): ""OCTAVE TUNABLE, HIGHLY LINEAR, RC-RING ISCILLATOR WITH DIFFERENTIAL FINE-COARSE TUNING, QUADRATURE OUTPUTS AND AMPLITUDE CONTROL FOR FIBER OPTIC TRANSCEIVERS"", 2002 IEEE MTT-S INTERNATIONAL MICROWAVE SYMPOSIUM DIGEST (CAT. NO.02CH37278) IEEE PISCATAWAY, NJ, USA; 20020602, 2 June 2002 (2002-06-02), pages 545 - 548, XP001099549;;HEYDARI P: ""Analysis of the PLL Jitter Due to Power/Ground and Substrate Noise"", IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS PART I: REGULAR PAPERS, IEEE SERVICE CENTER, NEW YORK, NY, US, vol. 51, no. 12, 1 December 2004 (2004-12-01), pages 2404 - 2416, XP011123085, ISSN: 1057-7122;;ARMIN TAJALLI; MASSIMO ALIOTO; ELIZABETH J BRAUER; YUSUF LEBLEBICI ED - LARS SVENSSON; JOSÃ CR MONTEIRO: ""Improving the Power-Delay Performance in Subthreshold Source-Coupled Logic Circuits"", 10 September 2008, INTEGRATED CIRCUIT AND SYSTEM DESIGN. POWER AND TIMING MODELING, OPTIMIZATION AND SIMULATION, SPRINGER BERLIN HEIDELBERG, BERLIN, HEIDELBERG, PAGE(S) 21 - 30, XP019114610",ACTIVE
393,US,B2,US 9839155 B2,127-136-033-860-858,2017-12-05,2017,US 201313891351 A,2013-05-10,US 201313891351 A;;US 201261647557 P,2012-05-16,Thermal ducting system,"A thermal ducting system for electronic equipment in an electronic equipment enclosure is provided. The thermal ducting system includes a top duct, a bottom duct spaced apart from the top duct, a side duct extending from the top duct to the bottom duct and along an intake side of the electronic equipment, and at least one baffle positioned in the side duct.",PANDUIT CORP,FLEMING JAMES N;;GOLDSBERRY TIMOTHY;;SHURHAY MARK;;HIBNER MAX W,PANDUIT CORP (2013-06-05),https://lens.org/127-136-033-860-858,Granted Patent,yes,155,5,10,10,0,H05K7/20736;;Y10T29/49826;;H05K7/20145;;B23P19/00;;Y10T29/49826;;H05K7/20736,H05K7/20;;B23P19/00,,2,0,,,"NetShelter® Side Airflow Duct Kit (AR7715) Installation; Schneider Electric; 8 pages; Jul. 2009.;;NetShelter SX Side Airflow Duct Kit (AR7715) drawing No. AR7715; Schneider Electric; 1 page; Nov. 30, 2009.",ACTIVE
394,SG,A1,SG 143264 A1,142-745-703-517-707,2008-06-27,2008,SG 2008037822 A,2005-12-14,US 2956205 A,2005-01-05,VISCOSITY CONTROL AND COLORANT CIRCULATION FOR PRINTING LENS MOLDS,"VISCOSITY CONTROL AND COLORANT CIRCULATION FOR PRINTING LENS MOLDS Disclosed are systems including a colorant cup that is adjacent to a cliche, wherein the cup includes a vent, an interior roof portion, and an air gap beneath the roof portion; a reservoir containing colorant; a feed conduit in fluid communication with the reservoir; and a return conduit in fluid communication with the cup. Also disclosed are various methods in which colorants are transferred in the disclosed systems from the reservoir to the colorant cup. The disclosed systems, colorant cups and methods are useful in the preparation of tinted contact lenses.",JOHNSON & JOHNSON VISION CARE,WIDMAN MICHAEL F;;POWELL PAUL MARK;;FLEMING AIDAN;;RYAN JOSEPH,,https://lens.org/142-745-703-517-707,Patent Application,no,0,0,15,18,0,B29D11/00903;;B41F17/001;;B29D11/00903;;B29D11/00951;;B29D11/00951;;B41F17/001;;B41F31/005;;B41F31/005;;G01N11/00;;G01N11/00,B67D7/06;;B67D7/08;;B67D7/78,,0,0,,,,PENDING
395,CN,B,CN 1846961 B,069-293-187-517-590,2012-07-04,2012,CN 200610002536 A,2006-01-05,US 2956205 A,2005-01-05,Viscosity control and colorant circulation for printing lens molds,"Disclosed are systems including a colorant cup that is adjacent to a cliche, wherein the cup includes a vent, an interior roof portion, and an air gap beneath the roof portion; a reservoir containing colorant; a feed conduit in fluid communication with the reservoir; and a return conduit in fluid communication with the cup. Also disclosed are various methods in which colorants are transferred in the disclosed systems from the reservoir to the colorant cup. The disclosed systems, colorant cups and methods are useful in the preparation of tinted contact lenses.",JOHNSON & JOHNSON VISION CRAE INC,MARK POWELL PAUL;;WIDMAN MICHAEL F;;JOSEPH RYAN;;AIDAN FLEMING,,https://lens.org/069-293-187-517-590,Granted Patent,no,0,0,15,18,0,B29D11/00903;;B41F17/001;;B29D11/00903;;B29D11/00951;;B29D11/00951;;B41F17/001;;B41F31/005;;B41F31/005;;G01N11/00;;G01N11/00,B29C37/00;;B67D7/06;;B29C33/00;;B29L11/00;;B67D7/08;;B67D7/78,,0,0,,,,INACTIVE
396,EP,B1,EP 1780012 B1,149-142-882-386-344,2009-03-25,2009,EP 06254974 A,2006-09-26,US 23613105 A,2005-09-27,Colorant presentation for pad printing,,JOHNSON & JOHNSON VISION CARE,WIDMAN MICHAEL F;;RYAN JOSEPH;;FLEMING AIDEN;;POWELL P MARK,,https://lens.org/149-142-882-386-344,Granted Patent,yes,5,0,13,13,0,B41F17/001;;B41F17/001;;G05D24/02;;G05D24/02,B41F17/00;;G05D24/00,,0,0,,,,ACTIVE
397,WO,A2,WO 2013/173210 A2,177-188-681-229-683,2013-11-21,2013,US 2013/0040717 W,2013-05-13,US 201261647557 P;;US 201313891351 A,2012-05-16,THERMAL DUCTING SYSTEM,"A thermal ducting system for electronic equipment in an electronic equipment enclosure is provided. The thermal ducting system includes a top duct, a bottom duct spaced apart from the top duct, a side duct extending from the top duct to the bottom duct and along an intake side of the electronic equipment, and at least one baffle positioned in the side duct.",PANDUIT CORP,FLEMING JAMES N;;GOLDSBERRY TIMOTHY;;SHURHAY MARK;;HIBNER MAX W,,https://lens.org/177-188-681-229-683,Patent Application,yes,0,0,10,10,0,H05K7/20736;;Y10T29/49826;;H05K7/20145;;B23P19/00;;Y10T29/49826;;H05K7/20736,H05K7/20,,0,0,,,,PENDING
398,CN,A,CN 102216801 A,020-268-249-152-919,2011-10-12,2011,CN 200980145475 A,2009-09-17,GB 2009002231 W;;GB 0817061 A;;GB 0817812 A,2008-09-17,A time reference system,"A time reference system for generating a time reference from signals produced by a global navigation satellite constellation has a satellite signal receiver to receive and down-convert code-modulated signals from a plurality of satellites and a correlator to track and decode the down-converted signals to provide signals containing partial pseudo-range measurements for respective satellites. A data processing arrangement forming part of the system receives assistance data from an external source and performs data-bit synchronisation in which the bit edges of a low frequency data bit stream carried by the received satellite signals are identified, to perform a preliminary position-velocity-time solution to provide an approximate time reference, and to perform auto-correlation of pre-selected data sequency in the data stream to resolve time ambiguities thereby to compute a precise time reference signal in weak received signal conditions. The pre-selected data sequences may be the repeated data preamble in the GPS navigation message constituted by the data stream.",ST ERICSSON SA,PETA BICKERSTAFF JACQUELINE;;OLULU ANYAEGBU ESTHER;;MARK FLEMING PETER;;GERALD WHITWORTH,INTEL CORP . (2014-09-22),https://lens.org/020-268-249-152-919,Patent Application,no,0,3,9,11,0,G01S19/258;;G01S19/42;;G01S19/42;;G01S19/258,G01S1/00;;G01S5/02;;G01S19/00;;G01S19/25;;G01S19/42;;G04R20/00;;G04R20/04;;G04R20/06,,0,0,,,,INACTIVE
399,US,A1,US 2004/0064676 A1,132-273-127-762-169,2004-04-01,2004,US 26186502 A,2002-09-30,US 26186502 A,2002-09-30,Method and apparatus for broadcasting messages to guarantee knowledge of a state within a data processing system,"
   A method, apparatus, and computer instructions for broadcasting information. A change in data used by a number of processors in the data processing system is identified. A message is sent to the number of processors in the data processing system in which the message is sent with a priority level equal to a set of routines that use the data in response to identifying the change. This message is responded to only when the recipient is at an interrupt priority less favored than the priority of the message. A flag is set for each of the number of processors to form a plurality of set flags for the message in which the plurality of set flags are located in memory locations used by the number of processors in which the plurality of set flags remains set until a response is made to the message. 
",IBM,BURUGULA RAMANJANEYA SARMA;;FLEMING MATTHEW DAVID;;JANN JOEFON;;ROGERS MARK DOUGLASS,INTERNATIONAL BUSINESS MACHINES CORPORATION (2002-09-20),https://lens.org/132-273-127-762-169,Patent Application,yes,1,16,2,2,0,G06F9/52;;G06F9/52;;G06F9/4812;;G06F9/4812;;G06F9/544;;G06F9/544;;G06F12/0831;;G06F12/0831,G06F9/46;;G06F9/48;;G06F12/08;;G06F15/00,712 3,0,0,,,,EXPIRED
400,MX,A,MX PA06007303 A,137-024-895-625-129,2007-01-10,2007,MX PA06007303 A,2006-06-23,US 16506305 A,2005-06-24,ONE-PIECE CABLE ARMOR FERRULE.,"A metal cable armor ferrule includes an outer cylindrical portion and an inner cylindrical portion connected at one end by a radial edge surface, wherein at least the outer cylindrical portion is flared outwardly at an opposite end thereof.",GEN ELECTRIC,BERG DAVID CHARLES VAN DEN;;TAHTI THANE FLEMING;;DIETER MARK STEPHEN,,https://lens.org/137-024-895-625-129,Patent Application,no,0,0,10,10,0,H01R9/0518;;H02G15/064;;H02G15/064;;H02G15/103;;H02G15/103;;Y10T24/3916;;Y10T24/3916,F16G11/00,,0,0,,,,ACTIVE
401,CA,A1,CA 2550460 A1,193-219-702-599-78X,2006-12-24,2006,CA 2550460 A,2006-06-15,US 16506305 A,2005-06-24,ONE-PIECE CABLE ARMOR FERRULE,"A metal cable armor ferrule (10) includes an outer cylindrical portion (14) and an inner cylindrical portion (12) connected at one end by a radial edge surface (16), wherein at least the outer cylindrical portion is flared outwardly at an opposite end thereof.",GEN ELECTRIC,DIETER MARK STEPHEN;;VAN DEN BERG DAVID CHARLES;;TAHTI THANE FLEMING,,https://lens.org/193-219-702-599-78X,Patent Application,no,0,0,10,10,0,H01R9/0518;;H02G15/064;;H02G15/064;;H02G15/103;;H02G15/103;;Y10T24/3916;;Y10T24/3916,H02G15/007;;H01B7/18,,0,0,,,,INACTIVE
402,GB,A,GB 2313740 A,048-636-425-990-472,1997-12-03,1997,GB 9611305 A,1996-05-30,GB 9611305 A,1996-05-30,Handover with Variable Thresholds,A handover management method for a cellular radio network of the type in which link quality is monitored (301) and compared against selected thresholds (303) to determine when and to which neighbouring cell handover should occur including threshold adjustment means (304) for dynamically changing the thresholds during the progress of a call.,MOTOROLA LTD,THOMAS HOWARD;;JONES PHILIP EDWIN;;ESSAM KEITH LESLI;;LE FLEMING MARK,,https://lens.org/048-636-425-990-472,Patent Application,no,7,31,4,4,0,H04W36/00837;;H04W36/00837;;H04W36/00835;;H04W36/00835;;H04W36/30;;H04W36/30;;H04W36/305;;H04W36/305,H04W36/00;;H04W36/30,H4L LDSHX         NONE;;H4L LRPMD         LRPMD;;H4L LRPMW         NONE;;H4L L1H10         LRPMD;;H4L L1H10         NONE,0,0,,,,EXPIRED
403,EP,B1,EP 2329287 B1,115-488-503-870-377,2015-04-22,2015,EP 09785128 A,2009-09-17,GB 2009002231 W;;GB 0817061 A;;GB 0817812 A,2008-09-17,A TIME REFERENCE SYSTEM,,INTEL CORP,BICKERSTAFF JACQUELINE PETA;;ANYAEGBU ESTHER OLULU;;FLEMING PETER MARK;;WHITWORTH GERALD,"APPLE INC., CUPERTINO, US (2020-07-13);;INTEL CORPORATION (2014-05-07)",https://lens.org/115-488-503-870-377,Granted Patent,yes,1,0,9,11,0,G01S19/258;;G01S19/42;;G01S19/42;;G01S19/258,G01S19/25;;G01S5/02;;G01S19/42;;G04R20/00;;G04R20/04;;G04R20/06,,0,0,,,,ACTIVE
404,CN,A,CN 104834441 A,153-321-568-370-270,2015-08-12,2015,CN 201410047332 A,2014-02-11,CN 201410047332 A,2014-02-11,Touch screen unlocking method and apparatus,"The present invention discloses a touch screen unlocking method and apparatus. The method comprises: in response to entry into a touch screen unlock interface, displaying a slide unlock button at an initial position of the slide unlock button on the touch screen, the slide unlocking button comprising two portions; in response to an action that a first portion of the slide unlock button is pressed and the slide unlock button slides along a predetermined trajectory, displaying position-relevant information of sliding of the slide unlock button on the predetermined trajectory on a second portion of the slid unlock button; and in response to performing a first action by the pressed first portion of the slide unlock button, receiving information relevant to a position to which the slide unlock button slides on the predetermined trajectory when the first portion of the slide unlock button performs the first action. The method and apparatus can enhance security and convenience of the touch screen unlock operations.",IBM,WEI ZHIQIANG;;FU ZHENDE;;LI JIANZHONG;;JIANG TAO;;MARK S FLEMING,,https://lens.org/153-321-568-370-270,Patent Application,no,3,5,4,4,0,G06F21/36;;G06F21/36;;G06F3/0488;;G06F3/0488,G06F3/0484;;G06F3/0488,,0,0,,,,ACTIVE
405,US,B2,US 8793450 B2,078-561-671-150-30X,2014-07-29,2014,US 201113330673 A,2011-12-20,US 201113330673 A;;US 77311110 A;;US 95438004 A,2004-09-29,Method and apparatus for an improved file repository,A method and apparatus for of storing data comprising monitoring a plurality of storage units within a mass storage area and detecting when a storage unit within the mass storage area is overloaded. The method further comprising randomly distributing the data on the overloaded storage unit to the other storage units within the mass storage area.,BODMER BRIAN;;BODNAR ERIC;;TARANTINO MARK;;FLEMING JONAH KAJ;;SHETH DEVDUTT;;VERISIGN INC,BODMER BRIAN;;BODNAR ERIC;;TARANTINO MARK;;FLEMING JONAH KAJ;;SHETH DEVDUTT,RPX CORPORATION (2015-02-17);;VERISIGN INC (2006-12-20),https://lens.org/078-561-671-150-30X,Granted Patent,yes,37,1,7,7,0,G06F11/3485;;G06F11/1451;;G06F11/1469;;G06F11/3433;;G06F2201/81;;G06F11/3485;;G06F11/1451;;G06F11/1469;;G06F11/3433;;G06F2201/81;;G06F11/3034,G06F12/00;;G01N37/00;;G06F7/00,711/162;;707/638;;707/695;;702/81;;X711E12103,0,0,,,,INACTIVE
406,US,A1,US 2012/0096311 A1,091-557-550-340-878,2012-04-19,2012,US 201113330673 A,2011-12-20,US 201113330673 A;;US 77311110 A;;US 95438004 A,2004-09-29,METHOD AND APPARATUS FOR AN IMPROVED FILE REPOSITORY,A method and apparatus for of storing data comprising monitoring a plurality of storage units within a mass storage area and detecting when a storage unit within the mass storage area is overloaded. The method further comprising randomly distributing the data on the overloaded storage unit to the other storage units within the mass storage area.,BODRNER BRIAN;;BODGAR ERIC;;TARANTINO MARK;;FLEMING JONAH KAI;;SHETH DEVDUTT;;VERISIGN INC,BODRNER BRIAN;;BODGAR ERIC;;TARANTINO MARK;;FLEMING JONAH KAI;;SHETH DEVDUTT,RPX CORPORATION (2015-02-17);;VERISIGN INC (2006-12-20),https://lens.org/091-557-550-340-878,Patent Application,yes,13,9,7,7,0,G06F11/3485;;G06F11/1451;;G06F11/1469;;G06F11/3433;;G06F2201/81;;G06F11/3485;;G06F11/1451;;G06F11/1469;;G06F11/3433;;G06F2201/81;;G06F11/3034,G06F17/30;;G06F11/14,714/19;;707/609;;X707E17005;;X714E11113,0,0,,,,INACTIVE
407,US,B2,US 9075838 B2,131-871-861-569-463,2015-07-07,2015,US 201414307844 A,2014-06-18,US 201414307844 A;;US 201113330673 A;;US 77311110 A;;US 95438004 A,2004-09-29,Method and apparatus for an improved file repository,A method and apparatus for of storing data comprising monitoring a plurality of storage units within a mass storage area and detecting when a storage unit within the mass storage area is overloaded. The method further comprising randomly distributing the data on the overloaded storage unit to the other storage units within the mass storage area.,RPX CORP,BODMER BRIAN;;BODNAR ERIC;;FLEMING JONAH KAJ;;SHETH DEVUTT;;TARANTINO MARK,RPX CORPORATION (2015-02-17);;LIGHTSURF TECHNOLOGIES INC (2004-12-14);;VERISIGN INC (2006-12-20),https://lens.org/131-871-861-569-463,Granted Patent,yes,43,0,7,7,0,G06F11/3485;;G06F11/1451;;G06F11/1469;;G06F11/3433;;G06F2201/81;;G06F11/3485;;G06F11/1451;;G06F11/1469;;G06F11/3433;;G06F2201/81;;G06F11/3034,G06F12/00;;G06F11/00;;G06F11/14;;G06F11/30;;G06F11/34,,0,0,,,,INACTIVE
408,GB,A,GB 2427763 A,177-695-896-475-159,2007-01-03,2007,GB 0612381 A,2006-06-22,US 16506305 A,2005-06-24,One-piece cable armour ferrule,"A metal cable armour ferrule 10 includes an outer cylindrical portion 14 and an inner cylindrical portion 12 connected at one end by a radial edge surface 16. The outer cylindrical portion is flared outwardly at the other end, and the inner cylindrical portion may do too. The inner portion may be about twice as long as the outer portion.",GEN ELECTRIC,BERG DAVID CHARLES VAN DEN;;TAHTI THANE FLEMING;;DIETER MARK STEPHEN,,https://lens.org/177-695-896-475-159,Patent Application,no,2,1,10,10,0,H01R9/0518;;H02G15/064;;H02G15/064;;H02G15/103;;H02G15/103;;Y10T24/3916;;Y10T24/3916,H01R9/05,H2E EDGX          EDGX;;H2E EEGA          EEGA,0,0,,,,INACTIVE
409,CN,B,CN 102216801 B,000-593-293-615-777,2013-07-17,2013,CN 200980145475 A,2009-09-17,GB 2009002231 W;;GB 0817061 A;;GB 0817812 A,2008-09-17,A time reference system,,ST ERICSSON SA,BICKERSTAFF JACQUELINE PETA;;ANYAEGBU ESTHER OLULU;;FLEMING PETER MARK;;WHITWORTH GERALD,INTEL CORP . (2014-09-22),https://lens.org/000-593-293-615-777,Granted Patent,no,0,0,9,11,0,G01S19/258;;G01S19/42;;G01S19/42;;G01S19/258,G01S1/00;;G01S5/02;;G01S19/00;;G01S19/25;;G01S19/42;;G04R20/00;;G04R20/04;;G04R20/06,,0,0,,,,INACTIVE
410,US,A,US 4567438 A,183-516-374-071-449,1986-01-28,1986,US 48209383 A,1983-04-04,US 48209383 A,1983-04-04,SQUID Canister with conical coupling cavity,"A type of Superconducting Quantum Interference Device (SQUID) requires that relatively large, circular, toroidally wound wire coils within a first cavity of a superconducting canister should be inductively coupled to a relatively small SQUID created as an annular ring plus Josephson junctions upon a substrate within a second cavity of the superconducting canister. The required inductive coupling is through a dielectric filled cavity called a coupling cavity which is conical in the shape of a dunce's cap. The conically shaped coupling cavity within the superconducting canister minimizes the parasitic stray inductance which is coupled to the SQUID, and thusly improves the noise performance of the SQUID.",SPERRY CORP,GERSHENSON MEIR;;SWEENY MARK F;;LONG DENNIS D;;FLEMING DAVID L,SPERRY CORPORATION 1290 AVENUE OF THE AMERICAS NEW YORK NEW YORK 10019 A CORP OF DE (1983-03-28),https://lens.org/183-516-374-071-449,Granted Patent,yes,1,13,1,1,0,G01R33/0358;;G01R33/0358;;Y10S505/846;;Y10S505/846,G01R33/035,324/248;;307/306,0,0,,,,EXPIRED
411,GB,B,GB 2427763 B,094-522-247-969-277,2009-11-11,2009,GB 0612381 A,2006-06-22,US 16506305 A,2005-06-24,One-piece cable armor ferrule,,GEN ELECTRIC,BERG DAVID CHARLES VAN DEN;;TAHTI THANE FLEMING;;DIETER MARK STEPHEN,,https://lens.org/094-522-247-969-277,Granted Patent,no,7,0,10,10,0,H01R9/0518;;H02G15/064;;H02G15/064;;H02G15/103;;H02G15/103;;Y10T24/3916;;Y10T24/3916,H01R9/05,,0,0,,,,INACTIVE
412,CA,C,CA 2550460 C,004-849-717-815-513,2014-10-21,2014,CA 2550460 A,2006-06-15,US 16506305 A,2005-06-24,ONE-PIECE CABLE ARMOR FERRULE,"A metal cable armor ferrule (10) includes an outer cylindrical portion (14) and an inner cylindrical portion (12) connected at one end by a radial edge surface (16), wherein at least the outer cylindrical portion is flared outwardly at an opposite end thereof.",GEN ELECTRIC,VAN DEN BERG DAVID CHARLES;;TAHTI THANE FLEMING;;DIETER MARK STEPHEN,,https://lens.org/004-849-717-815-513,Granted Patent,no,0,0,10,10,0,H01R9/0518;;H02G15/064;;H02G15/064;;H02G15/103;;H02G15/103;;Y10T24/3916;;Y10T24/3916,H02G15/007;;H01B7/18,,0,0,,,,INACTIVE
413,US,A1,US 2005/0058869 A1,067-549-808-914-921,2005-03-17,2005,US 66328403 A,2003-09-16,US 66328403 A,2003-09-16,Low cost gas diffusion media for use in PEM fuel cells,A gas diffusion media and method of making are provided including the formation of a carbon fiber paper which is heated to a carbonization temperature without exceeding a graphitization temperature. The discovery that a final high temperature heat treatment step in the graphitization temperature zone is not necessary to make effective gas diffusion media for PEM fuel cells greatly reduces the cost associated with the high temperature final heat treatment and also allows for the processing of the diffusion media in a roll.,MATHIAS MARK F.;;ROTH JOERG;;SCHOENEWEISS MICHAEL R.;;FLEMING GERALD J.,MATHIAS MARK F;;ROTH JOERG;;SCHOENEWEISS MICHAEL R;;FLEMING GERALD J,GENERAL MOTORS CORPORATION (2003-04-08),https://lens.org/067-549-808-914-921,Patent Application,yes,10,10,6,6,0,C04B35/521;;C04B35/521;;C04B35/83;;C04B35/83;;C04B2235/5256;;C04B2235/5256;;H01M4/8807;;H01M4/8807;;H01M4/881;;H01M4/881;;H01M8/0234;;H01M8/0234;;H01M8/0239;;H01M8/0239;;H01M8/0243;;H01M8/0243;;H01M8/1007;;H01M8/1007;;Y02E60/50;;Y02P70/50;;Y02P70/50,H01M4/86;;H01M4/88;;H01M8/10,429 3;;502/101;;429/44,0,0,,,,DISCONTINUED
414,US,A1,US 2014/0298116 A1,178-810-837-343-639,2014-10-02,2014,US 201414307844 A,2014-06-18,US 201414307844 A;;US 201113330673 A;;US 77311110 A;;US 95438004 A,2004-09-29,METHOD AND APPARATUS FOR AN IMPROVED FILE REPOSITORY,"A method and apparatus for of storing data comprising monitoring a plurality f storage units within a mass storage area and detecting when a storage unit within the mass storage area is overloaded, The method further comprising randomly distributing the data on the overloaded storage unit to the other storage units within the mass storage area.",VERISIGN INC,BODMER BRIAN;;BODNAR ERIC;;FLEMING JONAH KAJ;;SHETH DEVUTT;;TARANTINO MARK,RPX CORPORATION (2015-02-17);;LIGHTSURF TECHNOLOGIES INC (2004-12-14);;VERISIGN INC (2006-12-20),https://lens.org/178-810-837-343-639,Patent Application,yes,3,3,7,7,0,G06F11/3485;;G06F11/1451;;G06F11/1469;;G06F11/3433;;G06F2201/81;;G06F11/3485;;G06F11/1451;;G06F11/1469;;G06F11/3433;;G06F2201/81;;G06F11/3034,G06F11/30,714/54,0,0,,,,INACTIVE
415,US,B2,US 8082412 B2,034-797-443-251-277,2011-12-20,2011,US 77311110 A,2010-05-04,US 77311110 A;;US 95438004 A,2004-09-29,Method and apparatus for an improved file repository,A method and apparatus for of storing data comprising monitoring a plurality of storage units within a mass storage area and detecting when a storage unit within the mass storage area is overloaded. The method further comprising randomly distributing the data on the overloaded storage unit to the other storage units within the mass storage area.,BODMER BRIAN;;BODNAR ERIC;;TARANTINO MARK;;FLEMING JONAH KAJ;;SHETH DEVDUTT;;VERISIGN INC,BODMER BRIAN;;BODNAR ERIC;;TARANTINO MARK;;FLEMING JONAH KAJ;;SHETH DEVDUTT,RPX CORPORATION (2015-02-17);;LIGHTSURF TECHNOLOGIES INC (2004-12-14);;VERISIGN INC (2006-12-20),https://lens.org/034-797-443-251-277,Granted Patent,yes,26,7,7,7,0,G06F11/3485;;G06F11/1451;;G06F11/1469;;G06F11/3433;;G06F2201/81;;G06F11/3485;;G06F11/1451;;G06F11/1469;;G06F11/3433;;G06F2201/81;;G06F11/3034,G06F12/00;;G06F11/00,711/165;;711/114;;711/162;;X711E12002;;714/7;;X714E11024,0,0,,,,INACTIVE
416,US,B2,US 7103752 B2,043-511-872-080-744,2006-09-05,2006,US 26186502 A,2002-09-30,US 26186502 A,2002-09-30,Method and apparatus for broadcasting messages with set priority to guarantee knowledge of a state within a data processing system,"A method, apparatus, and computer instructions for broadcasting information. A change in data used by a number of processors in the data processing system is identified. A message is sent to the number of processors in the data processing system in which the message is sent with a priority level equal to a set of routines that use the data in response to identifying the change. This message is responded to only when the recipient is at an interrupt priority less favored than the priority of the message. A flag is set for each of the number of processors to form a plurality of set flags for the message in which the plurality of set flags are located in memory locations used by the number of processors in which the plurality of set flags remains set until a response is made to the message.",IBM,BURUGULA RAMANJANEYA SARMA;;FLEMING MATTHEW DAVID;;JANN JOEFON;;ROGERS MARK DOUGLASS,INTERNATIONAL BUSINESS MACHINES CORPORATION (2002-09-20),https://lens.org/043-511-872-080-744,Granted Patent,yes,9,0,2,2,0,G06F9/52;;G06F9/52;;G06F9/4812;;G06F9/4812;;G06F9/544;;G06F9/544;;G06F12/0831;;G06F12/0831,G06F15/163;;G06F9/46;;G06F9/48;;G06F12/08;;G06F15/00,712/30;;711/141;;712/28;;712/29,3,0,,,"Short, Kenneth L. Embedded Microprocessor Systems Design, An Introduction Using the Intel 80C188EB. Prentice Hall, 1998. p. 465.;;Fleming et al., Apparatus and Method for Removing Elements from a Linked List, Aug. 22, 2002.;;Fleming et al., Method and Apparatus for Isolating Frames in a Data Processing System, Aug. 22, 2002.",INACTIVE
417,US,A1,US 2010/0218040 A1,122-218-908-838-758,2010-08-26,2010,US 77311110 A,2010-05-04,US 77311110 A;;US 95438004 A,2004-09-29,Method and Apparatus for an Improved File Repository,A method and apparatus for of storing data comprising monitoring a plurality of storage units within a mass storage area and detecting when a storage unit within the mass storage area is overloaded. The method further comprising randomly distributing the data on the overloaded storage unit to the other storage units within the mass storage area.,VERISIGN INC,BODMER BRIAN;;BODNAR ERIC;;TARANTINO MARK;;FLEMING JONAH KAJ;;SHETH DEVDUTT,RPX CORPORATION (2015-02-17);;LIGHTSURF TECHNOLOGIES INC (2004-12-14);;VERISIGN INC (2006-12-20),https://lens.org/122-218-908-838-758,Patent Application,yes,25,37,7,7,0,G06F11/3485;;G06F11/1451;;G06F11/1469;;G06F11/3433;;G06F2201/81;;G06F11/3485;;G06F11/1451;;G06F11/1469;;G06F11/3433;;G06F2201/81;;G06F11/3034,G06F11/20;;G06F11/00;;G06F12/00;;G06F12/02,714/7;;711/114;;714/48;;714/47;;X711E12001;;X711E12002;;X714E11085;;X714E11089,0,0,,,,INACTIVE
418,EP,A1,EP 2329287 A1,005-138-854-158-121,2011-06-08,2011,EP 09785128 A,2009-09-17,GB 2009002231 W;;GB 0817061 A;;GB 0817812 A,2008-09-17,A TIME REFERENCE SYSTEM,,ST ERICSSON SA,BICKERSTAFF JACQUELINE PETA;;ANYAEGBU ESTHER OLULU;;FLEMING PETER MARK;;WHITWORTH GERALD,"APPLE INC., CUPERTINO, US (2020-07-13);;INTEL CORPORATION (2014-05-07)",https://lens.org/005-138-854-158-121,Patent Application,yes,0,0,9,11,0,G01S19/258;;G01S19/42;;G01S19/42;;G01S19/258,G01S19/25;;G01S5/02;;G01S19/42;;G04R20/00;;G04R20/04;;G04R20/06,,0,0,,,,ACTIVE
419,HK,A1,HK 1005535 A1,074-055-550-012-333,1999-01-15,1999,HK 98104752 A,1998-06-02,GB 9611305 A,1996-05-30,HANDOVER MANAGEMENT SYSTEM FOR CELLULAR NETWORK,,MOTOROLA LTD,THOMAS HOWARD;;JONES PHILIP EDWIN;;ESSAM KEITH LESLIE;;LE FLEMING MARK,,https://lens.org/074-055-550-012-333,Patent Application,no,0,0,4,4,0,H04W36/00837;;H04W36/00837;;H04W36/00835;;H04W36/00835;;H04W36/30;;H04W36/30;;H04W36/305;;H04W36/305,H04W36/00;;H04W36/30,,0,0,,,,EXPIRED
420,US,B2,US 7307218 B2,077-508-040-323-586,2007-12-11,2007,US 16506305 A,2005-06-24,US 16506305 A,2005-06-24,One-piece cable armor ferrule,"A metal cable armor ferrule includes an outer cylindrical portion and an inner cylindrical portion connected at one end by a radial edge surface, wherein at least the outer cylindrical portion is flared outwardly at an opposite end thereof.",GEN ELECTRIC,VAN DEN BERG DAVID CHARLES;;TAHTI THANE FLEMING;;DIETER MARK STEPHEN,GENERAL ELECTRIC COMPANY (2005-06-20),https://lens.org/077-508-040-323-586,Granted Patent,yes,15,1,10,10,0,H01R9/0518;;H02G15/064;;H02G15/064;;H02G15/103;;H02G15/103;;Y10T24/3916;;Y10T24/3916,H02G15/02,174 74R;;174/78,0,0,,,,INACTIVE
421,US,A1,US 2010/0188286 A1,063-967-065-787-314,2010-07-29,2010,US 56209909 A,2009-09-17,US 56209909 A;;GB 0817061 A;;GB 0817812 A;;US 10943808 P,2008-09-17,TIME REFERENCE SYSTEM,"A time reference system for generating a time reference from signals produced by a global navigation satellite constellation has a satellite signal receiver to receive and down-convert code-modulated signals from a plurality of satellites and a correlator to track and decode the down-converted signals to provide signals containing partial pseudo-range measurements for respective satellites. A data processing arrangement receives assistance data from an external source and performs data-bit synchronisation in which bit edges of a low frequency data bit stream carried by the received satellite signals are identified, to perform a preliminary position-velocity-time solution to provide an approximate time reference, and to perform auto-correlation of pre-selected data sequences in the data stream to resolve time ambiguities thereby to compute a precise time reference signal in weak received signal conditions. The pre-selected data sequences may be the repeated data preamble in the GPS navigation message constituted by the data stream.",ST ERICSSON SA,BICKERSTAFF JACQUELINE PETA;;ANYAEGBU ESTHER OLULU;;FLEMING PETER MARK;;WHITWORTH GERALD,ST-ERICSSON SA (2010-05-13);;APPLE INC (2019-11-30);;INTEL CORPORATION (2013-07-18);;INTEL IP CORPORATION (2013-07-18),https://lens.org/063-967-065-787-314,Patent Application,yes,13,32,9,11,0,G01S19/258;;G01S19/42;;G01S19/42;;G01S19/258,G01S5/02;;G01S19/44;;G01S19/03;;G01S19/25;;G01S19/42;;G04R20/00;;G04R20/04;;G04R20/06,342/357.04;;342/357.02,0,0,,,,ACTIVE
422,US,B1,US 7761678 B1,128-310-970-399-039,2010-07-20,2010,US 95438004 A,2004-09-29,US 95438004 A,2004-09-29,Method and apparatus for an improved file repository,A method and apparatus for of storing data comprising monitoring a plurality of storage units within a mass storage area and detecting when a storage unit within the mass storage area is overloaded. The method further comprising randomly distributing the data on the overloaded storage unit to the other storage units within the mass storage area.,VERISIGN INC,BODMER BRIAN;;BODNAR ERIC;;TARANTINO MARK;;FLEMING JONAH KAJ;;SHETH DEVDUTT,RPX CORPORATION (2015-02-17);;LIGHTSURF TECHNOLOGIES INC (2004-12-14);;VERISIGN INC (2006-12-20),https://lens.org/128-310-970-399-039,Granted Patent,yes,25,93,7,7,0,G06F11/3485;;G06F11/1451;;G06F11/1469;;G06F11/3433;;G06F2201/81;;G06F11/3485;;G06F11/1451;;G06F11/1469;;G06F11/3433;;G06F2201/81;;G06F11/3034,G06F12/00;;G06F11/00,711/165;;711/114;;X711E12002;;714/7;;X714E11024,0,0,,,,INACTIVE
423,US,A,US 4660061 A,049-481-639-825-299,1987-04-21,1987,US 80838585 A,1985-12-16,US 80838585 A;;US 56261883 A,1983-12-19,Intermediate normal metal layers in superconducting circuitry,"A thin, nominally 150 angstroms, normal metal layer, nominally the noble normal metal palladium, sandwiched intermediate between two superconducting layers, nominally niobium, supports totally superconducting current flow therethrough such normal metal layer by the quantum mechanical tunneling effect. Such a thin normal metal layer is useful as a stop etch layer for fabrication process control, including especially the selective niobium anodization process, as an oxidation resistant or immune layer to which totally superconducting electrical contact may be reliably made such as by soldering, and as a patterned resistor in those regions of the substrate plane where such thin normal metal layer is not sandwiched by superconducting layers. Particularly concerning such stop etch function, a thin normal layer of palladium will serve as a stop etch layer to the etching of niobium while not precluding totally superconducting contact therethrough such thin palladium layer. Particularly concerning the electrical contact function, a superconducting wire, nominally niobium, may be soldered with lead-tin or indium-tin to a thin normal metal layer of palladium in the formation of a totally superconducting connection therethrough such thin palladium layer. Particularly concerning such patterned resistor, terminus superconducting sandwiches of niobium-thin palladium-niobium may be electrically resistively interconnected by such thin palladium layer precisely patterned in the region(s) wherein it is not sandwiched, only such unsandwiched region(s) of such thin palladium layer contributing controllably determinable resistance to the interconnection(s).",SPERRY CORP,SWEENY MARK F;;GERSHENSON MEIR;;FLEMING DAVID L;;BARTA ROBERT E,SPERRY CORPORATION A CORP OF DE (1983-12-15),https://lens.org/049-481-639-825-299,Granted Patent,yes,3,43,1,1,0,Y10S505/874;;H10N60/81;;Y10S505/874;;H10N60/81,H01L39/04,357/5;;357/4,1,0,,,"Basavaiah, IBM Tech. Discl. Bull; vol. 4, No. 9, Feb. 1972.",EXPIRED
424,WO,A1,WO 2010/032014 A1,146-542-363-077-21X,2010-03-25,2010,GB 2009002231 W,2009-09-17,GB 0817061 A;;GB 0817812 A,2008-09-17,A TIME REFERENCE SYSTEM,"A time reference system for generating a time reference from signals produced by a global navigation satellite constellation has a satellite signal receiver to receive and down-convert code-modulated signals from a plurality of satellites and a correlator to track and decode the down-converted signals to provide signals containing partial pseudo-range measurements for respective satellites. A data processing arrangement forming part of the system receives assistance data from an external source and performs data-bit synchronisation in which the bit edges of a low frequency data bit stream carried by the received satellite signals are identified, to perform a preliminary position-velocity-time solution to provide an approximate time reference, and to perform auto-correlation of pre-selected data sequency in the data stream to resolve time ambiguities thereby to compute a precise time reference signal in weak received signal conditions. The pre-selected data sequences may be the repeated data preamble in the GPS navigation message constituted by the data stream.",ST ERICSSON SA;;BICKERSTAFF JACQUELINE PETA;;ANYAEGBU ESTHER OLULU;;FLEMING PETER MARK;;WHITWORTH GERALD,BICKERSTAFF JACQUELINE PETA;;ANYAEGBU ESTHER OLULU;;FLEMING PETER MARK;;WHITWORTH GERALD,,https://lens.org/146-542-363-077-21X,Patent Application,yes,3,3,9,11,0,G01S19/258;;G01S19/42;;G01S19/42;;G01S19/258,G01S1/00;;G01S5/02;;G01S19/00;;G01S19/25;;G01S19/42;;G04R20/00;;G04R20/04;;G04R20/06,,4,1,008-016-291-554-799,10.1023/a:1007906014916,"N.I. ZIEDAN ET AL.: ""Bit Synchronization and Doppler Frequency Removal at Very Low Carrier to Noise Ratio Using a Combination of the Viterbi Algorithm with an Extended Kalman Filter"", ION GPS/GNSS 2003, 12 September 2003 (2003-09-12), U.S.A., pages 616 - 627, XP002569859;;DANA P H: ""GLOBAL POSITIONING SYSTEM (GPS) TIME DISSEMINATION FOR REAL-TIME APPLICATIONS"", REAL TIME SYSTEMS, KLUWER ACADEMIC PUBLISHERS, DORDRECHT, NL, vol. 12, no. 1, 1 January 1997 (1997-01-01), pages 9 - 40, XP000695933, ISSN: 0922-6443;;E. ANYAEGBU, J.P. BICKERSTAFF, ET AL.: ""Precise Timing using a High Sensitivity Receiver in Indoor Environments"", ION GNSS 21ST. INTERNATIONAL TECHNICAL MEETING OF THE SATELLITE DIVISION, 19 September 2008 (2008-09-19), U.S.A., pages 590 - 601, XP002569742;;N.I. ZIEDAN ET AL.: ""Bit Synchronization and Doppler Frequency Removal at Very Low Carrier to Noise Ratio Using a Combination of the Viterbi Algorithm with an Extended Kalman Filter"", ION GPS/GNSS 2003, 12 September 2003 (2003-09-12), pages 616 - 627",PENDING
425,US,B2,US 8184046 B2,021-723-313-866-931,2012-05-22,2012,US 56209909 A,2009-09-17,US 56209909 A;;GB 0817061 A;;GB 0817812 A;;US 10943808 P,2008-09-17,Time reference system,"A time reference system for generating a time reference from signals produced by a global navigation satellite constellation has a satellite signal receiver to receive and down-convert code-modulated signals from a plurality of satellites and a correlator to track and decode the down-converted signals to provide signals containing partial pseudo-range measurements for respective satellites. A data processing arrangement receives assistance data from an external source and performs data-bit synchronization in which bit edges of a low frequency data bit stream carried by the received satellite signals are identified, to perform a preliminary position-velocity-time solution to provide an approximate time reference, and to perform auto-correlation of pre-selected data sequences in the data stream to resolve time ambiguities thereby to compute a precise time reference signal in weak received signal conditions. The pre-selected data sequences may be the repeated data preamble in the GPS navigation message constituted by the data stream.",BICKERSTAFF JACQUELINE PETA;;ANYAEGBU ESTHER OLULU;;FLEMING PETER MARK;;WHITWORTH GERALD;;ST ERICSSON SA,BICKERSTAFF JACQUELINE PETA;;ANYAEGBU ESTHER OLULU;;FLEMING PETER MARK;;WHITWORTH GERALD,ST-ERICSSON SA (2010-05-13);;APPLE INC (2019-11-30);;INTEL CORPORATION (2013-07-18);;INTEL IP CORPORATION (2013-07-18),https://lens.org/021-723-313-866-931,Granted Patent,yes,14,1,9,11,0,G01S19/258;;G01S19/42;;G01S19/42;;G01S19/258,G01S19/25;;G01S5/02;;G01S19/42;;G04R20/00;;G04R20/04;;G04R20/06,342/357.64,6,1,008-016-291-554-799,10.1023/a:1007906014916,"Dana, P.H., ""Global Positioning System (GPS) Time Dissemination for Real-Time Applications"" Real Time Systems 1997, 12(1):9-40, XP000695933.;;Ziedan, et al., ""Bit Synchronization and Doppler Frequency Removal at Very Low Carrier to Noise Ratio Using a Combination of the Viterbi Algorithm with an Extended Kalman Filter"" ION GPS/GNSS Sep. 9-12, 2003, pp. 616-627, XP02569859.;;Anyagbu, et al., ""Precise Timing using a High Sensitivity Receiver in Indoor Environments"" ION GNSS 21st, International Technical Meeting of the Satellite Division, Sep. 16-19, 2008, Savannah, GA, pp. 590-601, XP002569742.;;Search Report under Section 17, Application No. GB0817061.5, dated Jan. 9, 2009.;;Search Report under Section 17, Application No. GB0817061.5, dated Sep. 15, 2009.;;International Search Report and Written Opinion of the International Searching Authority, Application No. PCT/GB2009/002231, Mar. 25, 2010.",ACTIVE
426,US,A1,US 2010/0082282 A1,147-787-462-744-614,2010-04-01,2010,US 24043808 A,2008-09-29,US 24043808 A,2008-09-29,REDUCTION OF THE NUMBER OF INTEROPERABILITY TEST CANDIDATES AND THE TIME FOR INTEROPERABILITY TESTING,"Provided are a method, system, and article of manufacture wherein a determination is made of a subset of all possible interoperable combinations of components of a computing system, wherein the components comprise selected elements of the computing system. One or more testing criteria are stored, wherein a testing criteria provides indications of characteristics of one or more of the components of the computing system. A selection is made of a number of interoperable combinations of the components from the subset of interoperable combinations of the components, based on the stored one or more testing criteria. The selected interoperable combinations are tested, wherein the selected interoperable combinations are fewer in number than the subset of interoperable combinations.",IBM,BALSTAD MARK ALLEN;;FLEMING MARK SEAN;;MADDERN KEITH BRIAN;;MELCHING JEFFREY ALAN;;NELSEN MICHAEL ALLAN,INTERNATIONAL BUSINESS MACHINES CORPORATION (2008-09-23),https://lens.org/147-787-462-744-614,Patent Application,yes,21,0,2,2,0,G06F11/2247;;G06F11/2247,G01R31/00,702/118,0,0,,,,INACTIVE
427,GB,A,GB 2435609 A,058-131-172-364-869,2007-09-05,2007,GB 0617766 A,2006-09-08,GB 0604290 A,2006-03-03,Hand-held coffee grinder and infusion apparatus,"A hand-held coffee making apparatus designed for making individual measures of coffee beverage directly from coffee beans where coffee is ground directly into the infusion means for immersion into a cup or mug of hot water. The apparatus consists of a hand-held coffee grinder comprising a coffee bean chamber 4 and a grinding chamber 5 housing grinding means 6. Infusion means 7 is detachably mounted to the grinding chamber. Gate means 9 is provided between the grinding means 6 and the infusion means 7 operable between open and closed positions. A central shaft 13 runs through the centre of the coffee bean chamber 4, the grinding chamber 5 and the grinding means 6 ending at its connection with the gate means 9. A quantity of coffee beans 10 may be retained within the coffee bean chamber 4 in preparation for passage to the grinding chamber 5. Various alternative embodiments are disclosed.",NORTON JAMES RICHARD;;FLEMING JIM;;COLYER MARK;;GREEN MARTIN;;JACOBSEN JENS,NORTON JAMES RICHARD;;FLEMING JIM;;COLYER MARK;;GREEN MARTIN;;JACOBSEN JENS,,https://lens.org/058-131-172-364-869,Patent Application,no,6,9,3,3,0,A47J31/42;;A47J42/30;;A47J31/005;;A47J42/06,A47J31/42,A4E E108          EZ;;A4E E112          EZ;;A4E E118          EZ;;A4E E120          EZ;;A4E E126          EZ;;A4E E138          EZ;;A4E E142          EZ;;A4E E160          EZ;;A4E E164          EZ,0,0,,,,DISCONTINUED
428,GB,B,GB 2313740 B,137-630-773-761-309,2000-08-02,2000,GB 9611305 A,1996-05-30,GB 9611305 A,1996-05-30,Handover management system for cellular network,,MOTOROLA LTD,THOMAS HOWARD;;JONES PHILIP EDWIN;;ESSAM KEITH LESLIE;;LE FLEMING MARK,,https://lens.org/137-630-773-761-309,Granted Patent,no,7,0,4,4,0,H04W36/00837;;H04W36/00837;;H04W36/00835;;H04W36/00835;;H04W36/30;;H04W36/30;;H04W36/305;;H04W36/305,H04W36/00;;H04W36/30,H4L LDSHX         LDSHX;;H4L L1H10         LDSHX;;H4L L1H10         NONE,0,0,,,,EXPIRED
429,US,B2,US 8875101 B2,063-246-135-145-123,2014-10-28,2014,US 24043808 A,2008-09-29,US 24043808 A,2008-09-29,Reduction of the number of interoperability test candidates and the time for interoperability testing,"Provided are a method, system, and article of manufacture wherein a determination is made of a subset of all possible interoperable combinations of components of a computing system, wherein the components comprise selected elements of the computing system. One or more testing criteria are stored, wherein a testing criteria provides indications of characteristics of one or more of the components of the computing system. A selection is made of a number of interoperable combinations of the components from the subset of interoperable combinations of the components, based on the stored one or more testing criteria. The selected interoperable combinations are tested, wherein the selected interoperable combinations are fewer in number than the subset of interoperable combinations.",BALSTAD MARK ALLEN;;FLEMING MARK SEAN;;MADDERN KEITH BRIAN;;MELCHING JEFFREY ALAN;;NELSEN MICHAEL ALLAN;;IBM,BALSTAD MARK ALLEN;;FLEMING MARK SEAN;;MADDERN KEITH BRIAN;;MELCHING JEFFREY ALAN;;NELSEN MICHAEL ALLAN,INTERNATIONAL BUSINESS MACHINES CORPORATION (2008-09-23),https://lens.org/063-246-135-145-123,Granted Patent,yes,21,0,2,2,0,G06F11/2247;;G06F11/2247,G06F9/44;;G06F11/22,717/124;;702/108;;714/25,16,1,018-834-996-687-783,10.1109/policy.2004.1309152,"US Patent Application entitled ""Acquisition and Expansion of Storage Area Network Interoperation Relationships"", U.S. Appl. No. 11/872,535, filed Oct. 15, 2007, by inventors D.L. Chen, M.A. Nelsen, V.J. Rooney and F.H.S. Tang.;;Amendment 1, Mar. 25, 2010, for U.S. Appl. No. 11/872,535, filed on Oct. 15, 2007 by D.L. Chen et al., Total 14 pp. [Amend1 (18.232)].;;Amendment 2, Aug. 27, 2010, for U.S. Appl. No. 11/872,535, filed on Oct. 15, 2007 by D.L. Chen et al., Total 14 pp. [Amend2 (18.232)].;;Amendment 3, Jan. 20, 2011, for U.S. Appl. No. 11/872,535, filed on Oct. 15, 2007 by D.L. Chen et al., Total 19 pp. [Amend3 (18.232)].;;Amendment 4, Jun. 28, 2011, for U.S. Appl. No. 11/872,535, filed on Oct. 15, 2007 by D.L. Chen et al., Total 17 pp. [Amend4 (18.232)].;;Amendment 5, Nov. 9, 2011, for U.S. Appl. No. 11/872,535, filed on Oct. 15, 2007 by D.L. Chen et al., Total 19 pp. [Amend5 (18.232)].;;Final Office Action 1, May 27, 2010, for U.S. Appl. No. 11/872,535, filed on Oct. 15, 2007 by D.L. Chen et al., Total 21 pp. [FOA1 (18.232)].;;Final Office Action 2, Mar. 28, 2011, for U.S. Appl. No. 11/872,535, filed on Oct. 15, 2007 by D.L. Chen et al., Total 37 pp. [FOA2 (18.232)].;;Notice of Allowance 1, Dec. 13, 2011, for U.S. Appl. No. 11/872,535, filed on Oct. 15, 2007 by D.L. Chen et al., Total 8 pp. [NOA1 (18.232)].;;Office Action 1, Feb. 23, 2010, for U.S. Appl. No. 11/872,535, filed on Oct. 15, 2007 by D.L. Chen et al., Total 22 pp. [OA1 (18.232)].;;Office Action 3, Oct. 20, 2010, for U.S. Appl. No. 11/872,535, filed on Oct. 15, 2007 by D.L. Chen et al., Total 32 pp. [OA3 (18.232)].;;Office Action 5, Aug. 9, 2011, for U.S. Appl. No. 11/872,535, filed on Oct. 15, 2007 by D.L. Chen et al., Total 41 pp. [OA5 (18.232)].;;EPO Communication pursuant to Rules 161(1) and 162 EPC action dated May 28, 2010 for Application No. 08838618.0-2413 PCT/EP2008063775.;;Response dated Jun. 24, 2010 to EPO Communication pursuant to Rules 161(1) and 162 EPC action dated May 28, 2010 for Application No. 08838618.0-2413 PCT/EP2008063775.;;D. Agrawal et al., ""Policy-Based Validation of San Configuration"", Proceedings of the Fifth IEEE International Workshop on Policies for Distributed Systems and Networks (POLICY'04), 2004, pp. 1-10.;;R. Fileto, et al., ""A Survey on Information Systems Interoperability"", Technical Report #IC-03-030, Dec. 2003, pp. 1-47.",INACTIVE
430,US,B2,US 7362223 B2,013-063-706-084-008,2008-04-22,2008,US 88199404 A,2004-06-30,US 88199404 A,2004-06-30,"Chemical, biological, radiological, and nuclear weapon detection system with environmental acuity","A chemical, biological, radiological, and nuclear weapon detection system is disclosed that heightens its acuity and alertness when it senses that a chemical, biological, radiological, or nuclear weapon attack is more likely. For example, it is well understood that a chemical gas attack is likely to be less effective when it is raining than when it is clear because the rain will suppress and dilute the chemical agent. Therefore, the likelihood of a chemical gas attack is higher when it is clear. In light of this and similar knowledge, the illustrative embodiment checks for evidence of an attack more frequently and with great acuity than when the ambient environmental (e.g., meteorological, etc.) characteristics (e.g., whether is it precipitating or not, whether it is sunny or not, etc) suggest that an attack is more likely. This enables the embodiment to conserve consumables that are used in detecting attacks for when the attacks are more likely.",LOCKHEED CORP,MAURER SCOTT M;;DERKSEN MARK J;;FLEMING ROBERT H;;KOFLER KEVIN J,LOCKHEED MARTIN (2004-06-29),https://lens.org/013-063-706-084-008,Granted Patent,yes,10,3,2,2,0,G08B21/12;;G08B21/12,G01N33/50;;G01N33/48;;G06F15/00;;G06F19/00;;H04B15/00,340/540;;340/545.2;;702/193;;702/19,0,0,,,,INACTIVE
431,PH,A1,PH 12019501509 A1,027-752-200-097-217,2020-06-29,2020,PH 12019501509 A,2019-06-27,US 201762442155 P;;US 2017/0064897 W,2017-01-04,COMPOSITIONS AND METHODS FOR CONTROLLING PLANT PESTS,Novel insecticidal proteins that are toxic to lepidopteran pests are disclosed. The polynucleotides encoding the insecticidal proteins can be used to transform prokaryotic and eukaryotic organisms to express the insecticidal proteins. The recombinant organisms or compositions containing the recombinant organisms or the insecticidal proteins alone or in combination with other pest control agents and an appropriate agricultural carrier can be used to control lepidopteran pests in various environments.,SYNGENTA PARTICIPATIONS AG,SEGUIN KATHERINE;;ROSE MARK SCOTT;;JUCOVIC MILAN;;BRAMLETT MATTHEW RICHARD;;FLEMING CHRISTOPHER,,https://lens.org/027-752-200-097-217,Patent Application,no,0,0,17,17,0,C12N15/8286;;A01N37/46;;C07K14/325;;Y02A40/146;;C07K14/325;;C12N15/8286;;Y02A40/146,A01H5/10;;A01N63/00,,0,0,,,,PENDING
432,US,B1,US 7216041 B1,052-721-523-134-857,2007-05-08,2007,US 67801600 A,2000-10-02,US 67801600 A;;US 64016496 A,1996-04-30,Methods of using the structure coordinates of molecules comprising an IMPDH-like binding pocket,"The present invention relates to a data storage medium encoded with the corresponding structure coordinates of molecules and molecular complexes which comprise the active site binding pockets of IMPDH. Such data storage material is capable of displaying such molecules and molecular complexes, or their structural homologues, as a graphical three-dimensional representation on a computer screen. This invention also relates to methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention relates to methods of using the structure coordinates to screen and design compounds, including inhibitory compounds, that bind to IMPDH or homologues thereof. This invention also relates to molecules and molecular complexes which comprise the active site binding pockets of IMPDH or close structural homologues of the active site binding pockets. This invention also relates to compounds and pharmaceutical compositions which are inhibitors of IMPDH.",VERTEX PHARMA,WILSON KEITH P;;SINTCHAK MICHAEL D;;FLEMING MARK ANDREW;;ARMISTEAD DAVID M,,https://lens.org/052-721-523-134-857,Granted Patent,yes,11,0,12,14,0,C07K2299/00;;C12N9/0006;;C12Q1/32;;C12Y101/01205;;G16C20/50;;A61P43/00;;C12Q1/32;;C12N9/0006;;C12Y101/01205;;C07K2299/00;;G16C20/50,A61K31/00;;A61K31/365;;A61K45/00;;A61P43/00;;C07K1/00;;C07K1/14;;C12N9/04;;C12Q1/32;;G06F17/30;;G06F17/50;;G06F19/00,702/27;;702/19;;702/20,35,32,102-345-845-395-203;;039-552-242-337-337;;119-687-205-724-766;;106-592-332-128-285;;083-114-214-469-960;;017-078-745-731-930;;157-895-621-716-196;;050-930-610-164-868;;047-400-147-891-425;;019-060-914-883-538;;038-505-398-849-808;;109-834-226-854-281;;022-809-176-435-804;;096-868-520-405-378;;054-552-908-520-562;;022-716-513-472-962;;104-418-321-438-329;;089-550-035-419-975;;057-355-233-717-557;;045-990-825-024-671;;004-306-632-688-008;;062-672-417-308-555;;005-407-101-849-051;;030-042-017-746-591;;131-046-096-401-339;;025-802-799-712-238;;069-450-943-413-364;;141-777-356-359-483;;064-406-626-054-484;;184-644-637-972-373;;151-919-600-413-52X;;129-297-815-048-32X,1583540;;10.1007/bf00124387;;14547224;;10.1016/0734-9750(87)90319-3;;10.1021/jm00165a001;;2407844;;7533955;;10.1097/00007890-199503150-00002;;6809941;;10.1021/jm00349a003;;7577983;;10.1021/bi00042a021;;10.1107/s0021889891004430;;10.1093/protein/6.6.615;;8234231;;10.1002/qsar.19820010102;;8632430;;10.1021/jm950600m;;10.1021/jm00090a001;;1613742;;10.1016/0009-8981(95)06088-u;;7586576;;10.1002/prot.340110409;;1758885;;7508752;;pmc452927;;10.1002/j.1460-2075.1991.tb07771.x;;10.2210/pdb1huc/pdb;;1868826;;10.1038/328496a0;;3302724;;2493678;;10.1126/science.2493678;;8681386;;0008681386;;10.1016/s0092-8674(00)81275-1;;10.2210/pdb1jr1/pdb;;10.1016/0014-5793(93)81629-e;;8262199;;10.1002/prot.340230417;;8749858;;10.1038/221235a0;;5763076;;10.1002/prot.340190305;;7937734;;10.1007/bf00126441;;8320553;;10.1021/jm00145a002;;3892003;;10.1002/prot.340080302;;2281083;;10.1016/s0959-440x(94)90179-1;;7154081;;10.1016/0022-2836(82)90153-x;;10.1007/bf00124349;;8035213;;10.1002/prot.340110104;;1961699;;10.1002/jcc.540130412;;10.1016/0959-440x(92)90147-y;;10.1016/s0040-4020(01)86503-0,"H.J. Bohm, ""The Computer Program LUDI: A New Method For The De Novo Design of Enzyme Inhibitors"", Journal of Computer-Aided Molecular Design, 6, pp. 61-78 (1992).;;P.N. Bryan, ""Protein Engineering"", Biotech Adv., 5, pp. 221-234 (1987).;;I.D. Campbell et al., ""Diffraction, in Biological Spectroscopy"", The Benjamin/Cummings Publishing Company, Inc., Menlo Park, CA, pp. 299-326 (1984).;;N. Claude Cohen et al., ""Molecular Modeling Software and Methods for Medicinal Chemistry"", Journal of Medicinal Chemistry, 33(3), pp. 883-894 (1990).;;C.R. Gregory et al., ""Treatment With Rapamycin and Mycophenolic Acid Reduces Arterial Intimal Thickening Produced by Mechanical Injury and Allows Endothelial Replacement"", Transplantation, 59(5), pp. 655-661 (Mar. 1995).;;C. Hansch et al., ""Comparison of the Inhibition of Escherichia coli and Lactobacillus casei Dihydrofolate Reductase by 2,4-diamino-5-(substituted-benzyl) pyrimidines; quantitative Structure-Activity Relationships, X-Ray Crystallography and Computer Graphics in Structure-Activity Analysis"", Chemical Abstracts, 97:298f, p. 29 (1982); Journal of Medicinal Chemistry, 25, pp. 777-784 (1982).;;J.A. Huete-Pérez et al., ""Identification of the IMP Binding Site in the IMP Dehydrogenase From Tritrichomonas foetus"", Biochemistry, 34(42), pp. 13889-13894 (1995).;;J. Jancarik et al., ""Sparse Matrix Sampling: A Screening Method for Crystallization of Proteins"", J. Appl. Cryst., 24, pp. 409-411 (1991).;;A. Kajihara et al., ""Protein Modelling Using a Chimera Reference Protein Derived From Exons"", Protein Eng'g, 6, pp. 615-620 (1993).;;R. Li, et al., ""A comparison by QSAR, Crystallography, and Computer Graphics of the Inhibition of Various Dihydrofolate Reductases by 5-(x-benzyl)-2,4-diaminopyrimidines"", Chemical Abstracts, 98:172570a, p. 28 (1983); Quantitative Structure Activity Relationships Pharmacol. Chem. Biol., 1, pp. 1-7 (1982).;;G.M. Makara et al., ""Nuclear Magnetic Resonance and Molecular Modeling Study on Mycophenolic Acid: Implications for Binding to Inosine Monophosphate Dehydrogenase"", J. Med. Chem., 39(6), pp. 1236-1242 (1996).;;Y.C. Martin, ""3D Database Searching In Drug Design"", Journal of Medicinal Chemistry, 35 (12), pp. 2145-2154 (Jun. 12, 1992).;;C. Montero et al., ""Demonstration of Induction of Erythrocyte Inosine Monophospate Dehydrogenase Activity in Ribavirin-Treated Patients Using a High Performance Liquid Chromatography Linked Method"", Clinica Chimica Acta, 238, pp. 169-178 (1995).;;J.B. Moon et al., ""Computer Design of Bioactive Molecules: A Method for Receptor-Based De Novo Ligand Design"", Proteins: Structure, Function, and Genetics, 11, pp. 314-328 (1991).;;R.E. Morris, ""New Small Molecule Immunosuppressants for Transplantation: Review of Essential Concepts"", The Journal of Heart and Lung Transplantation, Nov./Dec., pp. S275-S286 (1993).;;D. Musil et al., ""The refined 2.15 Å X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity"", EMBO J., 10(9), pp. 2321-2330 (1991).;;A.J. Rusell et al., ""Rational Modification of Enzyme Catalysis by Engineering Surface Charge"", Nature, 328, pp. 496-500 (Aug. 6, 1987).;;A.R. Sielecki et al., ""Structure of Recombinant Human Renin, a Target for Cardiovascular-Active Drugs, at 2.5 Å Resolution"", Science, 243, pp. 1346-1351 (Mar. 1989).;;M.D. Sintchak et al., ""Structure and Mechanism of Inosine Monophosphate Dehydrogenase in Complex with the Immunosuppressant Mycophenolic Acid"", Cell, 85, pp. 921-930 (Jun. 14, 1996).;;U. Uhlin et al., ""Crystallization and crystallographic investigations of ribonucleotide reductase protein R1 from Escherichia coli"", Federation of European Biochemical Societies, 336(1), pp. 148-152 (1993).;;F.G. Whitby et al., ""Preliminary X-Ray Crystallographic Analysis of Tritrichomonas foetus Inosine-5'-Monophosphate Dehydrogenase"", Proteins: Structure, Function, and Genetics, 23, pp. 598-603 (1995).;;C.S. Wright et al., ""Structure of Subtilisin BPN' at 2.5 Å Resolution"", Nature, 221, pp. 235-242 (Jan. 18, 1969).;;Balbes, L.M. et al., ""A Perspective of Modern Methods in Computer-Aided Drug Design,"" in Reviews in Computational Chemistry, K.B. Lipkowitz and D.B. Boyd, Eds., VCH Publishers, New York, 5, pp. 337-379 (1994).;;Bartlett, P.A. et al., ""CAVEAT: A Program to Facilitate the Structure-Derived Design of Biologically Active Molecules,"" in Molecular Recognition in Chemical and Biological Problems, S.M. Roberts, Ed., Royal Society of Chemistry, Special Publication No. 78, pp. 182-196 (1989).;;Eisen, M.B. et al., ""HOOK: A Program for Finding Novel Molecular Architectures that Satisfy the Chemical and Steric Requirements of a Macromolecule Binding Site,"" Proteins Struct. Funct. Genet., 19, pp. 199-221 (1994).;;Gillet, V. et al., ""SPROUT: A Program for Structure Generation,"" J. Comp. Aid. Molec. Design, 7, pp. 127-153 (1993).;;Goodford, P.J., ""A Computational Procedure for Determining Energetically Favorable Binding Sites on Biologically Important Macromolecules,"" J. Med. Chem., 28, pp. 849-857 (1985).;;Goodsell, D.S. et al., ""Automated Docking of Substrates to Proteins by Simulated Annealing,"" Proteins Struct. Funct. Genet., 8, pp. 195-202 (1990).;;Guida, W.C., ""Software for Structure-Based Drug Design,"" Curr. Opin. Struct. Biology, 4, pp. 777-781 (1994).;;Kuntz, I.D. et al., ""A Geometric Approach to Macromolecule-Ligand Interactions,"" J. Mol. Biol., 161, pp. 269-288 (1982).;;Lauri, G. and Bartlett, P.A., ""CAVEAT: A Program to Facilitate the Design of Organic Molecules,"" J. Comp. Aid. Molec. Design, 8, pp. 51-66 (1994).;;Miranker, A. and Karplus, M., ""Functionality Maps of Binding Sites: A Multiple Copy Simultaneous Search Method,"" Proteins Struct. Funct. Genet., 11, pp. 29-34 (1991).;;Meng, E.C. et al., ""Automated Docking with Grid-Based Energy Evaluation,"" Journal of Computational Chemistry, 13, pp. 505-524 (1992).;;Navia, M.A. and Murcko, M.A., ""Use of Structural Information in Drug Design,"" Current Opinion in Structural Biology, 2, pp. 202-210 (1992).;;Nishibata, Y. and Itai, A., ""Automatic Creation of Drug Candidate Structures Based on Receptor Structure. Starting Point for Artificial Lead Generation,"" Tetrahedron, 47, pp. 8985-8990 (1991).",EXPIRED
433,US,A1,US 2022/0251599 A1,086-347-452-069-061,2022-08-11,2022,US 202217729223 A,2022-04-26,US 202217729223 A;;US 201916473467 A;;US 2017/0064897 W;;US 201762442155 P,2017-01-04,Compositions and Methods for Control of Insect Pests,Novel insecticidal proteins that are toxic to lepidopteran pests are disclosed. The polynucleotides encoding the insecticidal proteins can be used to transform prokaryotic and eukaryotic organisms to express the insecticidal proteins. The recombinant organisms or compositions containing the recombinant organisms or the insecticidal proteins alone or in combination with other pest control agents and an appropriate agricultural carrier can be used to control lepidopteran pests in various environments.,SYNGENTA PARTICIPATIONS AG,SEGUIN KATHERINE;;ROSE MARK SCOTT;;JUCOVIC MILAN;;BRAMLETT MATTHEW RICHARD;;FLEMING CHRISTOPHER,SYGENTA PARTICIPATIONS AG (2021-08-16),https://lens.org/086-347-452-069-061,Patent Application,yes,0,0,17,17,31,C12N15/8286;;A01N37/46;;C07K14/325;;Y02A40/146;;C07K14/325;;C12N15/8286;;Y02A40/146,C12N15/82;;C07K14/325,,0,0,,,,PENDING
434,US,A1,US 2016/0015310 A1,153-035-876-049-166,2016-01-21,2016,US 201514866507 A,2015-09-25,US 201514866507 A;;US 40977909 A,2009-03-24,REMOTE DELIVERY AND MONITORING OF HEALTH CARE,"Various embodiments for providing remote delivery and monitoring of health care are provided. In one embodiment, A portable apparatus for dermatological monitoring, comprising a housing; an imaging device integrated into the housing, wherein the imaging device is adapted for obtaining a digital, high-resolution, dermatological image of a patient; a processor device integrated into the housing and in communication with the imaging device, wherein the processor device is adapted for applying an anti-motion algorithm to the dermatological image to enhance image quality; and a wireless communications interface integrated into the housing and coupled to the processor device, wherein the wireless communications interface is adapted to upload the dermatological image to a remote server to be viewed by a medical professional.",IBM,COPELAND MICHAEL P;;FLEMING MARK S;;LARA CHRISTINA A;;SANCHEZ CALLINE K,INTERNATIONAL BUSINESS MACHINES CORPORATION (2015-09-13),https://lens.org/153-035-876-049-166,Patent Application,yes,11,0,8,8,0,A61B5/0059;;A61B10/0045;;A61B2560/0431;;A61B2560/0456;;A61B5/0022;;A61B5/0013;;A61B2090/376;;A61B2090/378;;A61B5/445;;G16H30/40;;G16H40/67;;A61B5/0059;;A61B10/0045;;A61B2560/0431;;A61B2560/0456;;A61B5/0013;;A61B2090/376;;A61B2090/378;;A61B5/0022;;G16H30/40;;A61B5/445;;A61B5/6812;;A61B5/7445;;A61B2560/0475;;A61B5/7207;;A61B5/74;;A61B2560/0214;;G16H40/67,G16H30/40;;A61B5/00;;G16H40/67,,0,0,,,,INACTIVE
435,US,B2,US 11478766 B2,185-595-945-283-543,2022-10-25,2022,US 201816022789 A,2018-06-29,US 201816022789 A;;US 201762527781 P,2017-06-30,Intelligent blending system,A blending system includes a blender base and a container. The blender base includes a housing that houses a motor. The container is attachable to the blender base. The blending system includes a user device that communicates with the blender base. The user device may communicate with a remote computing device. The user device generates instructions and recipes for the blender base.,VITA MIX MAN CORP,CIEPIEL ANTHONY;;KOLAR DAVID;;ZHANG KANG;;MARKOVICH CHAD;;CUMMINS JUDSON;;FLEMING MARK,VITA-MIX MANAGEMENT CORPORATION (2018-06-06),https://lens.org/185-595-945-283-543,Granted Patent,yes,150,2,3,3,0,A47J43/0716;;A47J31/521;;A47J36/321;;G07F17/0064;;G06Q20/3278;;G06Q20/20;;G07F9/002;;G07F9/001;;G05B2219/39242;;G06K7/10722;;G06K7/1413;;G06Q20/20;;A47J43/0716;;A47J31/521;;A47J36/321;;G07F17/0064;;G06Q20/3278;;G07F9/002;;G07F9/001;;B01F33/8442;;B01F33/848;;B01F35/2117;;B01F35/2209;;B01F2101/14,B01F33/00;;A47J31/52;;A47J36/32;;A47J43/07;;B01F33/84;;B01F35/21;;B01F35/22;;B01F101/14;;G06K7/10;;G06K7/14;;G06Q20/20;;G06Q20/32;;G07F9/00;;G07F17/00,,10,0,,,"Supplementary European Search Report for Application No. 16752897.5 relating to PCT/US2016018053, dated Nov. 14, 2018.;;International Search Report and the Written Opinion of the International Searching Authority, PCT/US2016/018053, Vita-Mix Management Corporation, dated Jul. 26, 2016.;;Copenheaver, Blaine, International Search Report and Written Opinion, PCT/US2014/029134, dated Aug. 1, 2014, International Search Authority/USA.;;Young, Lee W., International Search Report and Written Opinion, PCT/US2014/029384, dated Aug. 11, 2014, International Search Authority/USA.;;Gaggia Espanola, S.A., Ipanema, brochure, undated.;;Gaggia Espanola, S.A., Copacabana, brochure, undated.;;Gaggia Espanola, S.A., Ipanema Space-Saving High Technology, brochure, undated.;;Communication of the European Patent Office for Application No. 14756728.3 dated Nov. 22, 2018; 4 pages.;;Young, Lee W., International Search Report and Written Opinion, PCT/US/2014/29446, dated Aug. 5, 2014, International Search Authority/USA.;;International Search Report and the Written Opinion of the International Searching Authority, PCT/US2014/019866, Vita-Mix Corporation, dated Jun. 25, 2014.",ACTIVE
436,US,A1,US 2019/0001288 A1,113-959-744-701-385,2019-01-03,2019,US 201816022789 A,2018-06-29,US 201816022789 A;;US 201762527781 P,2017-06-30,INTELLIGENT BLENDING SYSTEM,A blending system includes a blender base and a container. The blender base includes a housing that houses a motor. The container is attachable to the blender base. The blending system includes a user device that communicates with the blender base. The user device may communicate with a remote computing device. The user device generates instructions and recipes for the blender base.,VITA MIX MAN CORP,CIEPIEL ANTHONY;;KOLAR DAVID;;ZHANG KEN;;MARKOVICH CHAD;;CUMMINS JUDSON;;FLEMING MARK,VITA-MIX MANAGEMENT CORPORATION (2018-06-06),https://lens.org/113-959-744-701-385,Patent Application,yes,2,58,3,3,0,A47J43/0716;;A47J31/521;;A47J36/321;;G07F17/0064;;G06Q20/3278;;G06Q20/20;;G07F9/002;;G07F9/001;;G05B2219/39242;;G06K7/10722;;G06K7/1413;;G06Q20/20;;A47J43/0716;;A47J31/521;;A47J36/321;;G07F17/0064;;G06Q20/3278;;G07F9/002;;G07F9/001;;B01F33/8442;;B01F33/848;;B01F35/2117;;B01F35/2209;;B01F2101/14,B01F13/10;;B01F15/00;;G06K7/10;;G06K7/14;;G06Q20/20,,0,0,,,,ACTIVE
437,CA,A1,CA 2815416 A1,139-341-142-687-415,2012-04-26,2012,CA 2815416 A,2011-10-21,US 40561910 P;;US 2011/0057347 W,2010-10-21,BIOMARKERS FOR HCV INFECTED PATIENTS,The invention relates to biomarkers measurable in a human subject that have prognostic value with respect to efficacy of therapeutic treatments for Hepatitis C viral infection. The markers also are believed to have value for diagnosis liver health/liver damage.,VERTEX PHARMA,FLEMING MARK ANDREW;;HARE BRIAN J;;PARAMITHIOTIS EUSTACHE;;CHELSKY DANIEL;;ALLARD RENE,,https://lens.org/139-341-142-687-415,Patent Application,no,0,0,5,5,0,G01N33/5767;;G16H50/30;;A61K38/08;;A61K38/21;;G01N33/5767;;G16H50/30;;A61K31/7056;;A61K38/08;;A61K38/21;;C12Q1/32;;C12Q1/48;;C12Q1/485;;G01N33/53;;G01N33/573,G01N33/576;;A61K38/08,,0,0,,,,DISCONTINUED
438,US,A1,US 2017/0078426 A1,010-031-932-528-740,2017-03-16,2017,US 201615245414 A,2016-08-24,US 201615245414 A;;US 201615067675 A;;US 201514851406 A,2015-09-11,CRITERIA-BASED DATA PUSH,"Embodiments relate to criteria-based data push. An aspect includes receiving, by a criteria request server, a data push request from a user, the data push request specifying criteria for particular data to be pushed and a user device to receive the particular data. Another aspect includes forwarding the data push request to an incoming data monitor. Another aspect includes monitoring, by the incoming data monitor, incoming data received from one or more content providers. Yet another aspect includes, based on detecting the particular data that is specified by the data push request in the incoming data by the incoming data monitor, pushing the particular data to the user device.",IBM,DICKENS LOUIE A;;FLEMING MARK S;;GRAY MICHAEL T;;MARKOS GEORGE B,INTERNATIONAL BUSINESS MACHINES CORPORATION (2015-09-04),https://lens.org/010-031-932-528-740,Patent Application,yes,0,6,5,5,0,G06F9/45533;;H04L67/55;;G06F9/45533;;H04L67/55;;G06F9/50;;H04L43/0876;;H04L43/08;;H04L67/125,H04L29/08;;H04L12/26,,0,0,,,,INACTIVE
439,GB,A,GB 2303024 A,009-752-022-274-416,1997-02-05,1997,GB 9513432 A,1995-07-01,GB 9513432 A,1995-07-01,Method for determining handover in a multicellular mobile radio system,"The method is indirectly sensitive to the rate at which a mobile (1, Fig. 1) crosses cell boundaries in a system having microcells (3, 4, 5) and at least one macrocell (2). The mobile 1 monitors levels of signals received from its current serving cell (3) and from neighbour cells (2, 4). If the signal from a handover target neighbour cell (eg. cell 4) exceeds a threshold, step 21, a timer is started, step 22, and then the level from the target cell (4) is compared with that from a control cell (5), that is a further out cell. If the level from the control cell (5) is greater than that from the target cell (4), the mobile is determined to be fast moving and is handed over to the macrocell (2). If the target cell level is greater than the control cell level, then the mobile is handed over to the target cell (4) if that cell achieves a power budget handover margin, steps 27, 28. The timer introduces a delay which eliminates the case where handover occurs to a cell that has already been passed through. In an alternative method, a handover request is triggered when the power budget expression for a neighbour cell meets certain requirements; a negative power budget handover margin may apply. The handover is executed to a cell (eg. the macrocell 2) which may be different from that which triggered the handover request. This method may overcome problems associated with a mobile turning a street corner (Fig. 3).",MOTOROLA LTD,JONES PHILIP EDWIN;;THOMAS HOWARD;;ESSAM KEITH LESLI;;LE FLEMING ANDREW MARK,,https://lens.org/009-752-022-274-416,Patent Application,no,3,6,13,13,0,H04W36/04;;H04W36/04,H04W36/04,H4L LDSH          NONE;;H4L LDSHE         NONE;;H4L LDSHL         NONE;;H4L LRPML         LRPML;;H4L L1H10         LRPML,0,0,,,,EXPIRED
440,US,A1,US 2014/0308242 A1,038-545-312-643-398,2014-10-16,2014,US 201113879736 A,2011-10-21,US 201113879736 A;;US 40561910 P;;US 2011/0057347 W,2010-10-21,BIOMARKERS FOR HCV INFECTED PATIENTS,The invention relates to biomarkers measurable in a human subject that have prognostic value with respect to efficacy of therapeutic treatments for Hepatitis C viral infection. The markers also are believed to have value for diagnosis liver health/liver damage.,FLEMING MARK ANDREW;;HARE BRAIN J;;CHELSKY DANIEL;;ALLARD RENE;;PARAMITHIOTIS EUSTACHE;;VERTEX PHARMA,FLEMING MARK ANDREW;;HARE BRAIN J;;CHELSKY DANIEL;;ALLARD RENE;;PARAMITHIOTIS EUSTACHE,CAPRION PROTEOMICS INC (2013-04-08);;VERTEX PHARMACEUTICALS INCORPORATED (2011-08-30),https://lens.org/038-545-312-643-398,Patent Application,yes,0,1,5,5,42,G01N33/5767;;G16H50/30;;A61K38/08;;A61K38/21;;G01N33/5767;;G16H50/30;;A61K31/7056;;A61K38/08;;A61K38/21;;C12Q1/32;;C12Q1/48;;C12Q1/485;;G01N33/53;;G01N33/573,G01N33/53;;A61K31/7056;;A61K38/08;;A61K38/21;;C12Q1/32;;C12Q1/48;;G01N33/573,424/85.4;;435/26;;435/7.92;;514/4.3;;435/7.4;;435/23;;435/15;;702/19,0,0,,,,DISCONTINUED
441,WO,A1,WO 1997/041211 A1,092-802-556-701-032,1997-11-06,1997,US 9707184 W,1997-04-28,US 64016496 A,1996-04-30,MOLECULES COMPRISING AN IMPDH-LIKE BINDING POCKET AND ENCODED DATA STORAGE MEDIUM CAPABLE OF GRAPHICALLY DISPLAYING THEM,"The present invention relates to a data storage medium encoded with the corresponding structure coordinates of molecules and molecular complexes which comprise the active site binding pockets of IMPDH. Such data storage material is capable of displaying such molecules and molecular complexes, or their structural homologues, as a graphical three-dimensional representation on a computer screen. This invention also relates to methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention relates to methods of using the structure coordinates to screen and design compounds, including inhibitory compounds, that bind to IMPDH or homologues thereof. This invention also relates to molecules and molecular complexes which comprise the active site binding pockets of IMPDH or close structural homologues of the active site binding pockets. This invention also relates to compounds and pharmaceutical compositions which are inhibitors of IMPDH.",VERTEX PHARMA,WILSON KEITH P;;SINTCHAK MICHAEL D;;FLEMING MARK ANDREW;;ARMISTEAD DAVID M,,https://lens.org/092-802-556-701-032,Patent Application,yes,2,41,12,14,0,C07K2299/00;;C12N9/0006;;C12Q1/32;;C12Y101/01205;;G16C20/50;;A61P43/00;;C12Q1/32;;C12N9/0006;;C12Y101/01205;;C07K2299/00;;G16C20/50,A61K31/00;;A61K31/365;;A61K45/00;;A61P43/00;;C07K1/00;;C07K1/14;;C12N9/04;;C12Q1/32;;G06F17/30;;G06F17/50;;G06F19/00,,6,4,102-345-845-395-203;;022-809-176-435-804;;038-505-398-849-808;;089-550-035-419-975,1583540;;10.1007/bf00124387;;10.1002/prot.340110409;;1758885;;10.1021/jm00090a001;;1613742;;8681386;;0008681386;;10.1016/s0092-8674(00)81275-1;;10.2210/pdb1jr1/pdb,"BOHM H - J: ""THE COMPUTER LUDI: A NEW METHOD FOR THE DE NOVO DESIGN OF ENZYME INHIBITORS"", JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, vol. 6, no. 1, 1 February 1992 (1992-02-01), pages 61 - 78, XP000560808;;MOON J B ET AL: ""COMPUTER DESIGN OF BIOACTIVE MOLECULES: A METHOD FOR RECEPTOR- BASED DE NOVO LIGAND DESIGN"", PROTEINS STRUCTURE, FUNCTION, AND GENETICS, vol. 11, 1 January 1991 (1991-01-01), pages 314 - 328, XP000560842;;YVONNE C. MARTIN: ""Database searching in drug design"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 35, no. 12, 12 June 1992 (1992-06-12), pages 2145 - 2154, XP000676670;;CHEMICAL ABSTRACTS, vol. 97, no. 1, 5 July 1982, Columbus, Ohio, US; abstract no. 298, HANSCH, CORWIN ET AL: ""Comparison of the inhibition of Escherichia coli and Lactobacillus casei dihydrofolate reductase by 2,4-diamino-5-(substituted- benzyl)pyrimidines: quantitative structure-activity relationships, x - ray crystallography, and computer graphics in structure-activity analysis"" XP002039017;;CHEMICAL ABSTRACTS, vol. 98, no. 21, 23 May 1983, Columbus, Ohio, US; abstract no. 172570, LI, RENLI ET AL: ""A comparison by QSAR, crystallography, and computer graphics of the inhibition of various dihydrofolate reductases by 5-(x-benzyl)-2,4-diaminopyrimidines"" XP002039058;;SINTCHAK, MICHAEL D. ET AL: ""Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppression mycophenolic acid"", CELL (CAMBRIDGE, MASS.) (1996), 85(6), 921-930 CODEN: CELLB5;ISSN: 0092-8674, XP002039016",PENDING
442,CA,A1,CA 2252455 A1,109-931-421-079-633,1997-11-06,1997,CA 2252455 A,1997-04-28,US 64016496 A,1996-04-30,MOLECULES COMPRISING AN IMPDH-LIKE BINDING POCKET AND ENCODED DATA STORAGE MEDIUM CAPABLE OF GRAPHICALLY DISPLAYING THEM,"The present invention relates to a data storage medium encoded with the corresponding structure coordinates of molecules and molecular complexes which comprise the active site binding pockets of IMPDH. Such data storage material is capable of displaying such molecules and molecular complexes, or their structural homologues, as a graphical three-dimensional representation on a computer screen. This invention also relates to methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention relates to methods of using the structure coordinates to screen and design compounds, including inhibitory compounds, that bind to IMPDH or homologues thereof. This invention also relates to molecules and molecular complexes which comprise the active site binding pockets of IMPDH or close structural homologues of the active site binding pockets. This invention also relates to compounds and pharmaceutical compositions which are inhibitors of IMPDH.",VERTEX PHARMA,ARMISTEAD DAVID M;;FLEMING MARK ANDREW;;WILSON KEITH P;;SINTCHAK MICHAEL D,,https://lens.org/109-931-421-079-633,Patent Application,no,0,0,12,14,0,C07K2299/00;;C12N9/0006;;C12Q1/32;;C12Y101/01205;;G16C20/50;;A61P43/00;;C12Q1/32;;C12N9/0006;;C12Y101/01205;;C07K2299/00;;G16C20/50,A61K31/00;;A61K31/365;;A61K45/00;;A61P43/00;;C07K1/00;;C07K1/14;;C12N9/04;;C12Q1/32;;G06F17/30;;G06F17/50;;G06F19/00,,0,0,,,,DISCONTINUED
443,EP,A1,EP 0906416 A1,163-873-084-025-84X,1999-04-07,1999,EP 97923493 A,1997-04-28,US 9707184 W;;US 64016496 A,1996-04-30,MOLECULES COMPRISING AN IMPDH-LIKE BINDING POCKET AND ENCODED DATA STORAGE MEDIUM CAPABLE OF GRAPHICALLY DISPLAYING THEM,,VERTEX PHARMA,WILSON KEITH P;;SINTCHAK MICHAEL D;;FLEMING MARK ANDREW;;ARMISTEAD DAVID M,,https://lens.org/163-873-084-025-84X,Patent Application,yes,0,0,12,14,0,C07K2299/00;;C12N9/0006;;C12Q1/32;;C12Y101/01205;;G16C20/50;;A61P43/00;;C12Q1/32;;C12N9/0006;;C12Y101/01205;;C07K2299/00;;G16C20/50,A61K31/00;;A61K31/365;;A61K45/00;;A61P43/00;;C07K1/00;;C07K1/14;;C12N9/04;;C12Q1/32;;G06F17/30;;G06F17/50;;G06F19/00,,0,0,,,,DISCONTINUED
444,US,A1,US 2021/0261631 A1,189-383-715-714-433,2021-08-26,2021,US 201716473467 A,2017-12-06,US 201716473467 A;;US 201762442155 P;;US 2017/0064897 W,2017-01-04,Compositions and Methods for Control of Insect Pests,Novel insecticidal proteins that are toxic to lepidopteran pests are disclosed. The polynucleotides encoding the insecticidal proteins can be used to transform prokaryotic and eukaryotic organisms to express the insecticidal proteins. The recombinant organisms or compositions containing the recombinant organisms or the insecticidal proteins alone or in combination with other pest control agents and an appropriate agricultural carrier can be used to control lepidopteran pests in various environments.,SYNGENTA PARTICIPATIONS AG,SEGUIN KATHERINE;;ROSE MARK SCOTT;;JUCOVIC MILAN;;BRAMLETT MATTHEW RICHARD;;FLEMING CHRISTOPHER,SYNGENTA PARTICIPATIONS AG (2021-08-16),https://lens.org/189-383-715-714-433,Patent Application,yes,0,0,17,17,31,C12N15/8286;;A01N37/46;;C07K14/325;;Y02A40/146;;C07K14/325;;C12N15/8286;;Y02A40/146,C07K14/325;;A01N63/50;;C12N15/82,,0,0,,,,ACTIVE
445,US,A1,US 2023/0040750 A1,011-128-614-172-723,2023-02-09,2023,US 202217972086 A,2022-10-24,US 202217972086 A;;US 201816022789 A;;US 201762527781 P,2017-06-30,INTELLIGENT BLENDING SYSTEM,A blending system includes a blender base and a container. The blender base includes a housing that houses a motor. The container is attachable to the blender base. The blending system includes a user device that communicates with the blender base. The user device may communicate with a remote computing device. The user device generates instructions and recipes for the blender base.,VITA MIX MAN CORP,CIEPIEL ANTHONY;;KOLAR DAVID;;ZHANG KANG;;MARKOVICH CHAD;;CUMMINS JUDSON;;FLEMING MARK,VITA-MIX MANAGEMENT CORPORATION (2018-07-10),https://lens.org/011-128-614-172-723,Patent Application,yes,3,0,3,3,0,A47J43/0716;;A47J31/521;;A47J36/321;;G07F17/0064;;G06Q20/3278;;G06Q20/20;;G07F9/002;;G07F9/001;;G05B2219/39242;;G06K7/10722;;G06K7/1413;;G06Q20/20;;A47J43/0716;;A47J31/521;;A47J36/321;;G07F17/0064;;G06Q20/3278;;G07F9/002;;G07F9/001;;B01F33/8442;;B01F33/848;;B01F35/2117;;B01F35/2209;;B01F2101/14,B01F33/84;;A47J36/32;;A47J43/07;;B01F35/21;;B01F35/22;;G06K7/10;;G06K7/14;;G06Q20/32;;G07F9/00;;G07F17/00,,0,0,,,,PENDING
446,US,B2,US 7088230 B2,015-352-245-391-315,2006-08-08,2006,US 88199504 A,2004-06-30,US 88199504 A,2004-06-30,"Chemical, biological, radiological, and nuclear weapon detection system with alarm thresholds based on environmental factors","A chemical, biological, radiological, and nuclear weapon detection system is disclosed that incorporates a mechanism to reduce the probability that a false alarm will be issued. In particular, the mechanism causes an alarm to be triggered when the amount of a hazardous material reaches a threshold, but changes the threshold based, at least in part, on environmental (e.g., meteorological, etc.) characteristics (e.g., whether is it precipitating or not, whether it is sunny or not, etc) that effect the efficacy of a chemical, biological, radiological, or nuclear weapon. Given that there are environmental factors that make an attack less effective, and given that terrorists are aware of this, the illustrative embodiment is less likely to issue an alarm when the environmental factors suggest that an attack is less effective, and, therefore, less likely. The illustrative embodiment accomplishes this by changing the threshold needed to issue an alarm based on one or more the environmental factors.",LOCKHEED CORP,MAURER SCOTT M;;DERKSEN MARK J;;KOFLER KEVIN J;;FLEMING ROBERT H,LOCKHEED MARTIN (2004-06-29),https://lens.org/015-352-245-391-315,Granted Patent,yes,6,2,2,2,0,G08B21/12;;G08B31/00;;G16H50/80;;G08B31/00;;G08B21/12;;G16H50/80,G08B29/00,340/511;;340/522,0,0,,,,ACTIVE
447,US,B2,US 11141099 B2,058-518-141-044-965,2021-10-12,2021,US 201514866517 A,2015-09-25,US 201514866517 A;;US 40977909 A,2009-03-24,Remote delivery and monitoring of health care,"Various embodiments for providing remote delivery and monitoring of health care are provided. In one embodiment, a portable apparatus for orthopedic monitoring of a patient is provided and comprises: a housing adapted for one of positioning adjacent to and positioning within an orthopedic cast; a diagnostic biomedical device integrated into the housing, wherein the diagnostic biomedical device is adapted for obtaining an orthopedic image of a portion of the patient treated with the orthopedic cast; and a wireless communications interface coupled to the diagnostic biomedical device, wherein the wireless communications interface is adapted to upload the orthopedic image to a remote server to be viewed by a medical professional.",IBM,COPELAND MICHAEL P;;FLEMING MARK S;;LARA CHRISTINA A;;SANCHEZ CALLINE K,INTERNATIONAL BUSINESS MACHINES CORPORATION (2015-09-13),https://lens.org/058-518-141-044-965,Granted Patent,yes,77,0,8,8,0,A61B5/0059;;A61B10/0045;;A61B2560/0431;;A61B2560/0456;;A61B5/0022;;A61B5/0013;;A61B2090/376;;A61B2090/378;;A61B5/445;;G16H30/40;;G16H40/67;;A61B5/0059;;A61B10/0045;;A61B2560/0431;;A61B2560/0456;;A61B5/0013;;A61B2090/376;;A61B2090/378;;A61B5/0022;;G16H30/40;;A61B5/445;;A61B5/6812;;A61B5/7445;;A61B2560/0475;;A61B5/7207;;A61B5/74;;A61B2560/0214;;G16H40/67,A61B5/00;;A61B10/00;;A61B90/00;;G16H30/40;;G16H40/67,,10,3,074-623-032-398-574;;018-189-798-239-331;;007-716-657-059-567,10.1109/iembs.2006.259630;;17947114;;11055787;;10.1109/42.875195;;10.1385/jcd:1:4:369;;15304883,"Lim et al., “A Novel Image Capture System for Use in Telehealth Applications” pp. 4743-4746, Proceedings of the 28th IEEE EMBS Annual International Conference, New York City, Aug. 30-Sep. 3, 2006.;;“A portable battery operated bone fracture evaluator” Proceedings—19th International Conference—IEEE/EMBS Oct. 30-Nov. 2, 1997 Chicago, IL, USA.;;Vander Haeghen et al., “An Imaging System with Calibrated Color Image Acquisition for Use in Dematology” pp. 772-730, vol. 19, No. 7, Jul. 2000.;;Maar, “Doctor as Inventor and Visionary: Dr. Rhett Drugge, Dermatologist, Fights Skin Cancer with Sophisticated New Invention” http://www.thebestdermatologist.com/derm/news.html, printed on Mar. 9, 2009.;;Komiya et al., “Natural Color Reproduction System for Telemedicine and Its' Application to Digital Camera” IEEE, 1999, pp. 50-54 vol. 3.;;Ohya, “Natural Color Reproduction System for Telemedicine” pp. 442-449, IEEE, 1998.;;Kiebzak, “Radiolucent casting tape allows for accurate measurement of forearm bone mineral density using dual energy X-ray absorptiometry” Miller Orthopedic Clinic, Charlotte, NC, PMID: 1534883 [PubMed], 1998.;;Heying, Philip, “City rolls out solar panels on ambulance in order to save a few bucks”, Mar. 4, 2009, 2 pages, LJWorld.com.;;Abel, Jonathan, “Sunstar ambulances tap the sun to tack on power”, Dec. 17, 2008, 1 page, Tampa Bay Times, Tampa Bay, FL, USA.;;English Translation of DE2944726, Hager Reinhard Klaus Ing, Jun. 4, 1981 (7 pages).",ACTIVE
448,MX,A,MX 2019007704 A,168-991-897-894-750,2019-09-09,2019,MX 2019007704 A,2017-12-06,US 201762442155 P;;US 2017/0064897 W,2017-01-04,COMPOSITIONS AND METHODS FOR CONTROLLING PLANT PESTS.,Novel insecticidal proteins that are toxic to lepidopteran pests are disclosed. The polynucleotides encoding the insecticidal proteins can be used to transform prokaryotic and eukaryotic organisms to express the insecticidal proteins. The recombinant organisms or compositions containing the recombinant organisms or the insecticidal proteins alone or in combination with other pest control agents and an appropriate agricultural carrier can be used to control lepidopteran pests in various environments.,SYNGENTA PARTICIPATIONS AG,MATTHEW RICHARD BRAMLETT;;KATHERINE SEGUIN;;MARK SCOTT ROSE;;MILAN JUCOVIC;;CHRISTOPHER FLEMING,,https://lens.org/168-991-897-894-750,Patent Application,no,0,0,17,17,0,C12N15/8286;;A01N37/46;;C07K14/325;;Y02A40/146;;C07K14/325;;C12N15/8286;;Y02A40/146,A01H5/10;;A01N63/00;;A01N63/02,,0,0,,,,PENDING
449,US,A1,US 2007/0124083 A1,073-495-547-804-164,2007-05-31,2007,US 64528906 A,2006-12-21,US 64528906 A;;US 67801600 A;;US 64016496 A,1996-04-30,Molecules comprising an IMPDH-like binding pocket and encoded data storage medium capable of graphically displaying them,"The present invention relates to a data storage medium encoded with the corresponding structure coordinates of molecules and molecular complexes which comprise the active site binding pockets of IMPDH. Such data storage material is capable of displaying such molecules and molecular complexes, or their structural homologues, as a graphical three-dimensional representation on a computer screen. This invention also relates to methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention relates to methods of using the structure coordinates to screen and design compounds, including inhibitory compounds, that bind to IMPDH or homologues thereof. This invention also relates to molecules and molecular complexes which comprise the active site binding pockets of IMPDH or close structural homologues of the active site binding pockets. This invention also relates to compounds and pharmaceutical compositions which are inhibitors of IMPDH.",VERTEX PHARMA,WILSON KEITH P;;SINTCHAK MICHAEL D;;FLEMING MARK A;;ARMISTEAD DAVID M,,https://lens.org/073-495-547-804-164,Patent Application,yes,8,0,12,14,0,C07K2299/00;;C12N9/0006;;C12Q1/32;;C12Y101/01205;;G16C20/50;;A61P43/00;;C12Q1/32;;C12N9/0006;;C12Y101/01205;;C07K2299/00;;G16C20/50,A61K31/00;;A61K31/365;;A61K45/00;;A61P43/00;;C07K1/00;;C07K1/14;;C12N9/04;;C12Q1/32;;G06F17/30;;G06F17/50;;G06F19/00,702/19,0,0,,,,EXPIRED
450,AU,B2,AU 717261 B2,089-615-413-079-379,2000-03-23,2000,AU 1997/029284 A,1997-04-28,US 64016496 A;;US 9707184 W,1996-04-30,Molecules comprising an impdh-like binding pocket and encoded data storage medium capable of graphically displaying them,,VERTEX PHARMA,WILSON KEITH P;;SINTCHAK MICHAEL D;;FLEMING MARK ANDREW;;ARMISTEAD DAVID M,,https://lens.org/089-615-413-079-379,Granted Patent,no,0,0,12,14,0,C07K2299/00;;C12N9/0006;;C12Q1/32;;C12Y101/01205;;G16C20/50;;A61P43/00;;C12Q1/32;;C12N9/0006;;C12Y101/01205;;C07K2299/00;;G16C20/50,A61K31/00;;A61K31/365;;A61K45/00;;A61P43/00;;C07K1/00;;C07K1/14;;C12N9/04;;C12Q1/32;;G06F17/30;;G06F17/50;;G06F19/00,,0,0,,,,EXPIRED
451,US,B1,US 9609076 B1,192-533-257-763-834,2017-03-28,2017,US 201615245414 A,2016-08-24,US 201615245414 A;;US 201615067675 A;;US 201514851406 A,2015-09-11,Criteria-based data push,"Embodiments relate to criteria-based data push. An aspect includes receiving, by a criteria request server, a data push request from a user, the data push request specifying criteria for particular data to be pushed and a user device to receive the particular data. Another aspect includes forwarding the data push request to an incoming data monitor. Another aspect includes monitoring, by the incoming data monitor, incoming data received from one or more content providers. Yet another aspect includes, based on detecting the particular data that is specified by the data push request in the incoming data by the incoming data monitor, pushing the particular data to the user device.",IBM,DICKENS LOUIE A;;FLEMING MARK S;;GRAY MICHAEL T;;MARKOS GEORGE B,INTERNATIONAL BUSINESS MACHINES CORPORATION (2015-09-04),https://lens.org/192-533-257-763-834,Granted Patent,yes,5,0,5,5,0,G06F9/45533;;H04L67/55;;G06F9/45533;;H04L67/55;;G06F9/50;;H04L43/0876;;H04L43/08;;H04L67/125,G06F15/16;;H04L12/26;;H04L29/08,,0,0,,,,INACTIVE
452,US,B2,US 7527952 B2,018-815-319-254-979,2009-05-05,2009,US 64528906 A,2006-12-21,US 64528906 A;;US 67801600 A;;US 64016496 A,1996-04-30,Crystals of inosine monophosphate dehydrogenase/oxidized inosine monophosphate thiomidate intermediate/mycophenolic acid (IIMPDH/XMP*/MPA),"The present invention relates to a data storage medium encoded with the corresponding structure coordinates of molecules and molecular complexes which comprise the active site binding pockets of IMPDH. Such data storage material is capable of displaying such molecules and molecular complexes, or their structural homologues, as a graphical three-dimensional representation on a computer screen. This invention also relates to methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention relates to methods of using the structure coordinates to screen and design compounds, including inhibitory compounds, that bind to IMPDH or homologues thereof. This invention also relates to molecules and molecular complexes which comprise the active site binding pockets of IMPDH or close structural homologues of the active site binding pockets. This invention also relates to compounds and pharmaceutical compositions which are inhibitors of IMPDH.",VERTEX PHARMA,WILSON KEITH P;;SINTCHAK MICHAEL D;;FLEMING MARK ANDREW;;ARMISTEAD DAVID M,,https://lens.org/018-815-319-254-979,Granted Patent,yes,13,0,12,14,0,C07K2299/00;;C12N9/0006;;C12Q1/32;;C12Y101/01205;;G16C20/50;;A61P43/00;;C12Q1/32;;C12N9/0006;;C12Y101/01205;;C07K2299/00;;G16C20/50,C12P21/06;;A61K31/00;;A61K31/365;;A61K45/00;;A61P43/00;;C07K1/00;;C07K1/14;;C12N9/04;;C12Q1/32;;G06F17/30;;G06F17/50;;G06F19/00,435/190;;435/69.1,35,32,102-345-845-395-203;;039-552-242-337-337;;119-687-205-724-766;;062-672-417-308-555;;005-407-101-849-051;;030-042-017-746-591;;131-046-096-401-339;;106-592-332-128-285;;025-802-799-712-238;;083-114-214-469-960;;017-078-745-731-930;;157-895-621-716-196;;050-930-610-164-868;;069-450-943-413-364;;141-777-356-359-483;;047-400-147-891-425;;019-060-914-883-538;;038-505-398-849-808;;064-406-626-054-484;;184-644-637-972-373;;109-834-226-854-281;;022-809-176-435-804;;096-868-520-405-378;;054-552-908-520-562;;151-919-600-413-52X;;129-297-815-048-32X;;022-716-513-472-962;;104-418-321-438-329;;089-550-035-419-975;;057-355-233-717-557;;045-990-825-024-671;;004-306-632-688-008,1583540;;10.1007/bf00124387;;14547224;;10.1016/0734-9750(87)90319-3;;10.1021/jm00165a001;;2407844;;10.1002/prot.340190305;;7937734;;10.1007/bf00126441;;8320553;;10.1021/jm00145a002;;3892003;;10.1002/prot.340080302;;2281083;;7533955;;10.1097/00007890-199503150-00002;;10.1016/s0959-440x(94)90179-1;;6809941;;10.1021/jm00349a003;;7577983;;10.1021/bi00042a021;;10.1107/s0021889891004430;;10.1093/protein/6.6.615;;8234231;;7154081;;10.1016/0022-2836(82)90153-x;;10.1007/bf00124349;;8035213;;10.1002/qsar.19820010102;;8632430;;10.1021/jm950600m;;10.1021/jm00090a001;;1613742;;10.1002/prot.340110104;;1961699;;10.1002/jcc.540130412;;10.1016/0009-8981(95)06088-u;;7586576;;10.1002/prot.340110409;;1758885;;7508752;;pmc452927;;10.1002/j.1460-2075.1991.tb07771.x;;10.2210/pdb1huc/pdb;;1868826;;10.1016/0959-440x(92)90147-y;;10.1016/s0040-4020(01)86503-0;;10.1038/328496a0;;3302724;;2493678;;10.1126/science.2493678;;8681386;;0008681386;;10.1016/s0092-8674(00)81275-1;;10.2210/pdb1jr1/pdb;;10.1016/0014-5793(93)81629-e;;8262199;;10.1002/prot.340230417;;8749858;;10.1038/221235a0;;5763076,"Balbes et al., ""A Perspective of Modern Methods in Computer-Aided Drug Design,"" Reviews in Computational Chemistry, K.B. Lipkowitz and D.B. Boyd, Eds., VCH Publishers, New York, 5:337-379 (1994).;;Bartlett et al., ""CAVEAT: A Program to Facilitate the Structure-Derived Design of Biologically Active Molecules,"" Molecular Recognition in Chemical and Biological Problems, S.M. Roberts, Ed., Royal Society of Chemistry, Special Publication No. 78:182-196 (1989).;;Böhm, ""The Computer Program LUDI: A New Method For The De Novo Design of Enzyme Inhibitors,"" Journal of Computer-Aided Molecular Design, 6:61-78 (1992).;;Bryan, ""Protein Engineering,"" Biotech. Adv., 5:221-234 (1987).;;Campbell et al., ""Diffraction, in Biological Spectroscopy,"" The Benjamin/Cummings Publishing Company, Inc., Menlo Park, CA, pp. 299-326 (1984).;;Cohen et al., ""Molecular Modeling Software and Methods for Medicinal Chemistry,"" Journal of Medicinal Chemistry, 33(3):883-894 (1990).;;Eisen et al., ""HOOK: A Program for Finding Novel Molecular Architectures that Satisfy the Chemical and Steric Requirements of a Macromolecule Binding Site,"" Proteins Struct. Funct. Genet., 19:199-221 (1994).;;Gillet et al., ""SPROUT: A Program for Structure Generation,"" J. Comp. Aid. Molec. Design, 7:127-153 (1993).;;Goodford, ""A Computational Procedure for Determining Energetically Favorable Binding Sites on Biologically Important Macromolecules,"" J. Med. Chem., 28:849-857 (1985).;;Goodsell et al., ""Automated Docking of Substrates to Proteins by Simulated Annealing,"" Proteins Struct. Funct. Genet., 8:195-202 (1990).;;Gregory et al., ""Treatment With Rapamycin and Mycophenolic Acid Reduces Arterial Intimal Thickening Produced by Mechanical Injury and Allows Endothelial Replacement,"" Transplantation, 59(5):655-661 (1995).;;Guida, ""Software for Structure-Based Drug Design,"" Curr. Opin. Struct. Biology, 4:777-781 (1994).;;Hansch et al., ""Comparison of the Inhibition of Escherichia coli and Lactobacillus casei Dihydrofolate Reductase by 2,4-diamino-5-(substituted-benzyl) pyrimidines; quantitative Structure-Activity Relationships, X-Ray Crystallography and Computer Graphics in Structure-Activity Analysis,"" Chemical Abstracts, 97:298f: 29 (1982); Journal of Medicinal Chemistry, 25:777-84 (1982).;;Huete-Pérez, et al., ""Identification of the IMP Binding Site in the IMP Dehydrogenase From Tritrichomonas foetus,"" Biochemistry, 34:13889-13894 (1995).;;Jancarik et al., ""Sparse Matrix Sampling: A Screening Method for Crystallization of Proteins,"" J. Appl. Cryst., 24:409-411 (1991).;;Kajihara et al., ""Protein Modelling Using a Chimera Reference Protein Derived From Exons,"" Protein Eng., 6:615-620 (1993).;;Kuntz et al., ""A Geometric Approach to Macromolecule-Ligand Interactions,"" J. Mol. Biol., 161:269-288 (1982).;;Lauri et al., ""CAVEAT: A Program to Facilitate the Design of Organic Molecules,"" J. Comp. Aid. Molec. Design, 8:51-66 (1994).;;Li et al., ""A comparison by QSAR Crystallography and Computer Graphics of the Inhibition of Various Dihydrofolate Reductases b 5-(x-benzyl)-2,4-diaminopyrimidines,"" Chemical Abstracts, 98:17257a:28 (1983); Quantitative Structure Activity Relationships Pharmacol. Chem. Bil., 1:1-7 (1982).;;Makara et al., ""Nuclear Magnetic Resonance and Molecular Modeling Study on Mycophenolic Acid: Implications for Binding to Inosine Monophosphate Dehydrogenase,"" J. Med. Chem., 39:1236-1242 (1996).;;Martin, ""3D Database Searching In Drug Design,"" Journal of Medicinal Chemistry, 35(12):2145-54 (1992).;;Miranker et al., M., ""Functionality Maps of Binding Sites: A Multiple Copy Simultaneous Search Method,"" Proteins Struct. Funct. Genet., 11:29-34 (1991).;;Meng et al., ""Automated Docking with Grid-Based Energy Evaluation,"" Journal of Computational Chemistry, 13:505-524 (1992).;;Montero et al., ""Demonstration of Induction of Erythrocyte Inosine Monophospate Dehydrogenase Activity in Ribavirin-Treated Patients Using a High Performance Liquid Chromatography Linked Method,"" Clinica Chimica Acta, 238:169-178 (1995).;;Moon et al., ""Computer Design of Bioactive Molecules: A method for Receptor-Based De Novo Ligand Design,"" Proteins, Structure, Functions, and Genetics, 11:314-328 (1991).;;Morris, ""New Small Molecule Immunosuppressants for Transplantation: Review of Essential Concepts,"" The Journal of Heart and Lung Transplantation, 12:S275-S286 (1993).;;Musil et al., ""The Refined 2.15 Å X-Ray Crystal Structure of Human Liver Cathepsin B: the Structural Basis for its Specificity,"" EMBO J., 10(9):2321-2330 (1991).;;Navia et al., ""Use of Structural Information in Drug Design,"" Current Opinion in Structural Biology, 2:202-210 (1992).;;Nishibata et al., ""Automatic Creation of Drug Candidate Structures Based on Receptor Structure. Starting Point for Artificial Lead Generation,"" Tetrahedron, 47:8985-8990 (1991).;;Russell et al., ""Rational Modification of Enzyme Catalysis by Engineering Surface Charge,"" Nature, 328:496-500 (1987).;;Sielecki et al., ""Structure of Recombinant Human Renin, a Target for Cardiovascular-Active Drugs, at 2.5 Å Resolution,"" Science, 243:1346-1351 (1989).;;Sintchak et al., ""Structure and Mechanism of Inosine Monophosphate Dehydrogenase in Complex with the Immunosuppressant Mycophenolic Acid,"" Cell, 85:921-930 (1996).;;Uhlin et al., ""Crystallization and Crystallographic Investigations of Ribonucleotide Reductase Protein R1 From Escherichia coli,"" FEBS Lett., 336(1):148-152 (1993).;;Whitby et al., ""Preliminary X-Ray Crystallographic Analysis of Tritrichomonas foetus Inosine-5'-Monophosphate Dehydrogenase,"" Proteins: Structure, Function, and Genetics, 23:598-603 (1995).;;Wright et al., ""Structure of Subtilisin BPN'at 2.5 Å Resolution,"" Nature, 221:235-242 (1969).",EXPIRED
453,US,A1,US 2007/0244653 A1,102-744-246-326-730,2007-10-18,2007,US 88199404 A,2004-06-30,US 88199404 A,2004-06-30,"Chemical, biological, radiological, and nuclear weapon detection system with environmental acuity","A chemical, biological, radiological, and nuclear weapon detection system is disclosed that heightens its acuity and alertness when it senses that a chemical, biological, radiological, or nuclear weapon attack is more likely. For example, it is well understood that a chemical gas attack is likely to be less effective when it is raining than when it is clear because the rain will suppress and dilute the chemical agent. Therefore, the likelihood of a chemical gas attack is higher when it is clear. In light of this and similar knowledge, the illustrative embodiment checks for evidence of an attack more frequently and with great acuity than when the ambient environmental (e.g., meteorological, etc.) characteristics (e.g., whether is it precipitating or not, whether it is sunny or not, etc) suggest that an attack is more likely. This enables the embodiment to conserve consumables that are used in detecting attacks for when the attacks are more likely.",MAURER SCOTT M;;DERKSEN MARK J;;FLEMING ROBERT H;;KOFLER KEVIN J,MAURER SCOTT M;;DERKSEN MARK J;;FLEMING ROBERT H;;KOFLER KEVIN J,LOCKHEED MARTIN (2004-06-29),https://lens.org/102-744-246-326-730,Patent Application,yes,10,9,2,2,0,G08B21/12;;G08B21/12,G06F19/00,702/30,0,0,,,,INACTIVE
454,EP,A4,EP 3565404 A4,127-827-515-467-242,2021-01-20,2021,EP 17890754 A,2017-12-06,US 201762442155 P;;US 2017/0064897 W,2017-01-04,COMPOSITIONS AND METHODS FOR CONTROLLING PLANT PESTS,,SYNGENTA PARTICIPATIONS AG,SEGUIN KATHERINE;;ROSE MARK SCOTT;;JUCOVIC MILAN;;BRAMLETT MATTHEW RICHARD;;FLEMING CHRISTOPHER,,https://lens.org/127-827-515-467-242,Search Report,no,4,0,17,17,0,C12N15/8286;;A01N37/46;;C07K14/325;;Y02A40/146;;C07K14/325;;C12N15/8286;;Y02A40/146,A01H5/10;;A01N63/00,,2,2,100-978-719-715-859;;024-216-744-930-74X,pmc4147589;;10.3390/toxins6082393;;25123558;;21376122;;10.1016/j.ibmb.2011.02.006;;pmc3689885,"WAGNER LUCENA ET AL: ""Molecular Approaches to Improve the Insecticidal Activity of Bacillus thuringiensis Cry Toxins"", TOXINS, vol. 6, no. 8, 13 August 2014 (2014-08-13), pages 2393 - 2423, XP055238443, DOI: 10.3390/toxins6082393;;ALEJANDRA BRAVO ET AL: ""Bacillus thuringiensis: A story of a successful bioinsecticide"", INSECTS BIOCHEMISTRY AND MOLECULAR BIOLOGY, vol. 41, no. 7, 1 July 2011 (2011-07-01), AMSTERDAM, NL, pages 423 - 431, XP055281787, ISSN: 0965-1748, DOI: 10.1016/j.ibmb.2011.02.006",PENDING
455,WO,A1,WO 1997/002716 A1,173-559-129-577-056,1997-01-23,1997,EP 9602831 W,1996-06-28,GB 9513432 A,1995-07-01,METHOD FOR DETERMINING HANDOVER IN A MULTICELLULAR COMMUNICATIONS SYSTEM,"A method as shown in Figure for determining a handover for a mobile station in a multicellular communications system having a serving cell, a plurality of neighbouring cells and at least one control cell where the cells include at least one macrocell and a plurality of microcells. The method includes the steps of comparing the received signal of the control cell with a parameter value.",MOTOROLA LTD;;JONES PHILIP;;THOMAS HOWARD JOHN;;ESSAM KEITH LESLEI;;LE FLEMING ANDREW MARK,JONES PHILIP;;THOMAS HOWARD JOHN;;ESSAM KEITH LESLEI;;LE FLEMING ANDREW MARK,,https://lens.org/173-559-129-577-056,Patent Application,yes,2,5,13,13,0,H04W36/04;;H04W36/04,H04W36/04,,0,0,,,,PATENTED
456,CN,A,CN 110022676 A,143-063-897-400-723,2019-07-16,2019,CN 201780074747 A,2017-12-06,US 201762442155 P;;US 2017/0064897 W,2017-01-04,COMPOSITIONS AND METHODS FOR CONTROLLING PLANT PESTS,Novel insecticidal proteins that are toxic to lepidopteran pests are disclosed. The polynucleotides encoding the insecticidal proteins can be used to transform prokaryotic and eukaryotic organisms toexpress the insecticidal proteins. The recombinant organisms or compositions containing the recombinant organisms or the insecticidal proteins alone or in combination with other pest control agents and an appropriate agricultural carrier can be used to control lepidopteran pests in various environments.,SYNGENTA PARTICIPATIONS AG,SEGUIN KATHERINE;;ROSE MARK SCOTT;;JUCOVIC MILAN;;BRAMLETT MATTHEW RICHARD;;FLEMING CHRISTOPHER,,https://lens.org/143-063-897-400-723,Patent Application,no,3,0,17,17,0,C12N15/8286;;A01N37/46;;C07K14/325;;Y02A40/146;;C07K14/325;;C12N15/8286;;Y02A40/146,A01H5/10;;A01N63/00;;A01N63/02,,0,0,,,,ACTIVE
457,US,B2,US 11359209 B2,151-514-658-025-022,2022-06-14,2022,US 201716473467 A,2017-12-06,US 201716473467 A;;US 201762442155 P;;US 2017/0064897 W,2017-01-04,Compositions and methods for control of insect pests,Novel insecticidal proteins that are toxic to lepidopteran pests are disclosed. The polynucleotides encoding the insecticidal proteins can be used to transform prokaryotic and eukaryotic organisms to express the insecticidal proteins. The recombinant organisms or compositions containing the recombinant organisms or the insecticidal proteins alone or in combination with other pest control agents and an appropriate agricultural carrier can be used to control lepidopteran pests in various environments.,SYNGENTA PARTICIPATIONS AG,SEGUIN KATHERINE;;ROSE MARK SCOTT;;JUCOVIC MILAN;;BRAMLETT MATTHEW RICHARD;;FLEMING CHRISTOPHER,SYNGENTA PARTICIPATIONS AG (2021-08-16),https://lens.org/151-514-658-025-022,Granted Patent,yes,7,0,17,17,34,C12N15/8286;;A01N37/46;;C07K14/325;;Y02A40/146;;C07K14/325;;C12N15/8286;;Y02A40/146,C12N15/82;;C07K14/325,,8,5,135-855-186-198-114;;024-216-744-930-74X;;100-978-719-715-859;;024-216-744-930-74X;;115-613-804-184-960,10.3390/insects5010062;;pmc4592628;;26462580;;21376122;;10.1016/j.ibmb.2011.02.006;;pmc3689885;;pmc4147589;;10.3390/toxins6082393;;25123558;;21376122;;10.1016/j.ibmb.2011.02.006;;pmc3689885;;10.1128/mmbr.62.3.807-813.1998;;pmc98935;;9729610,"GenBank Accession No. AAA22341 (1994, https://www.ncbi.nlm.nih.gov/protein/AAA22341).;;Argolo-Filho et al, 2014, Insects 5:62-91.;;Bravo et al, 2001, Insect Biochem. Mol. Biol. 41:423-431.;;Extended EP Search Report for EP Application No. 17890754.9 dated Dec. 18, 2020.;;Lucena, Wagner et al: “Molecular Approaches to Improve the Insecticidal Activity of Bacillus thuringiensis Cry Toxins”, Toxins, vol. 6(8), Aug. 13, 2014, pp. 2393-2423.;;ALEJANDRA BRAVO, SUPAPORN LIKITVIVATANAVONG, SARJEET S. GILL, MARIO SOBERÓN: ""Bacillus thuringiensis: A story of a successful bioinsecticide"", INSECTS BIOCHEMISTRY AND MOLECULAR BIOLOGY, ELSEVIER LTD., AMSTERDAM, NL, vol. 41, no. 7, 1 July 2011 (2011-07-01), AMSTERDAM, NL , pages 423 - 431, XP055281787, ISSN: 0965-1748, DOI: 10.1016/j.ibmb.2011.02.006;;“Revision of the Nomenciature for the Bacillus Thuringiensis Pesticidal Crystal Proteinds”, Crickmore et al., Microbiology and Molecular Biology Reviews, Sep. 1998, pp. 807-813, p. 809, Table 1.;;Notification of Transmittal of the International Search Report dated Apr. 9, 2018, mailed in Application No. PCT/US2017/064897 filed Dec. 6, 2017.",ACTIVE
458,US,B2,US 8788141 B2,164-628-905-504-723,2014-07-22,2014,US 56708506 A,2006-12-05,US 56708506 A,2006-12-05,Systems and methods for remote monitoring of vehicle inspections,"Systems and methods for remote monitoring of vehicle inspections are provided. Using a wireless, network-enabled device, an inspection monitor may access a centralized vehicle inspection database, such as a motor vehicle administration and/or transportation department computer system tied into all the vehicle inspection stations in a jurisdiction. The inspection monitor may access the real time inspection records for a particular station and analyze the data for suspicion of fraudulent inspection practices.",ISAACS MARK R;;FLEMING DANIEL A;;CULP WILLIAM D;;LANG GARY S;;VERIZON PATENT & LICENSING INC,ISAACS MARK R;;FLEMING DANIEL A;;CULP WILLIAM D;;LANG GARY S,VERIZON BUSINESS NETWORK SERVICES INC (2006-12-05);;VERIZON PATENT AND LICENSING INC (2009-08-01),https://lens.org/164-628-905-504-723,Granted Patent,yes,2,3,2,2,0,G06Q10/06;;G06Q10/06,G01M15/04,701/33.5;;701/29.1;;701/31.4,3,0,,,"New York State Program Evaluation Report, Enhanced Inspection/Maintenance (I/M) Programs: NYTEST and NYVIP, Period of Jun. 30, 2004-Jun. 30, 2006, Published: Feb. 2007, New York State Department of Environmental Conservation, http://www.dec.ny.gov/docs/air-pdf/Enhanced-IM-Program-2004-2006-final.pdf.;;Evaluation of Test Data Collected in 2004 and 2005 from Connecticut's Inspection/Maintenance Program, Oct. 2006, dKC-de la Torre Klasmeier Consulting, http://www.ct.gov/dep/lib/dep/air/vehicle-emissions/imreport2004&2005.pdf.;;Hodge et al, A Survey of Outlier Detection Methodologies, Jan. 2004, University of New York, Department of Computer Science, http://www.geo.upm.es/postgrado/CarlosLopez/papers/Hodge+Austin-OutlierDetection-AIRE381.pdf.",INACTIVE
459,AU,A,AU 1997/029284 A,009-081-506-937-226,1997-11-19,1997,AU 1997/029284 A,1997-04-28,US 64016496 A;;US 9707184 W,1996-04-30,Molecules comprising an impdh-like binding pocket and encoded data storage medium capable of graphically displaying them,,VERTEX PHARMA,WILSON KEITH P;;SINTCHAK MICHAEL D;;FLEMING MARK ANDREW;;ARMISTEAD DAVID M,,https://lens.org/009-081-506-937-226,Patent Application,no,0,0,12,14,0,C07K2299/00;;C12N9/0006;;C12Q1/32;;C12Y101/01205;;G16C20/50;;A61P43/00;;C12Q1/32;;C12N9/0006;;C12Y101/01205;;C07K2299/00;;G16C20/50,A61K31/00;;A61K31/365;;A61K45/00;;A61P43/00;;C07K1/00;;C07K1/14;;C12N9/04;;C12Q1/32;;G06F17/30;;G06F17/50;;G06F19/00,,0,0,,,,EXPIRED
460,US,B1,US 9456045 B1,138-572-141-469-098,2016-09-27,2016,US 201615067675 A,2016-03-11,US 201615067675 A;;US 201514851406 A,2015-09-11,Criteria-based data push,"Embodiments relate to criteria-based data push. An aspect includes receiving, by a criteria request server, a data push request from a user, the data push request specifying criteria for particular data to be pushed and a user device to receive the particular data. Another aspect includes forwarding the data push request to an incoming data monitor. Another aspect includes monitoring, by the incoming data monitor, incoming data received from one or more content providers. Yet another aspect includes, based on detecting the particular data that is specified by the data push request in the incoming data by the incoming data monitor, pushing the particular data to the user device.",IBM,DICKENS LOUIE A;;FLEMING MARK S;;GRAY MICHAEL T;;MARKOS GEORGE B,INTERNATIONAL BUSINESS MACHINES CORPORATION (2015-09-04),https://lens.org/138-572-141-469-098,Granted Patent,yes,5,4,5,5,0,G06F9/45533;;H04L67/55;;G06F9/45533;;H04L67/55;;G06F9/50;;H04L43/0876;;H04L43/08;;H04L67/125,G06F15/16;;H04L29/08,,1,0,,,Cloud Data Management Interface (CDMI) Version 1.0.2 (Jun. 2012).,INACTIVE
461,US,A1,US 2017/0078424 A1,157-039-778-387-974,2017-03-16,2017,US 201514851406 A,2015-09-11,US 201514851406 A,2015-09-11,CRITERIA-BASED DATA PUSH,"Embodiments relate to criteria-based data push. An aspect includes receiving, by a criteria request server, a data push request from a user, the data push request specifying criteria for particular data to be pushed and a user device to receive the particular data. Another aspect includes forwarding the data push request to an incoming data monitor. Another aspect includes monitoring, by the incoming data monitor, incoming data received from one or more content providers. Yet another aspect includes, based on detecting the particular data that is specified by the data push request in the incoming data by the incoming data monitor, pushing the particular data to the user device.",IBM,DICKENS LOUIE A;;FLEMING MARK S;;GRAY MICHAEL T;;MARKOS GEORGE B,INTERNATIONAL BUSINESS MACHINES CORPORATION (2015-09-04),https://lens.org/157-039-778-387-974,Patent Application,yes,2,0,5,5,0,G06F9/45533;;H04L67/55;;G06F9/45533;;H04L67/55;;G06F9/50;;H04L43/0876;;H04L43/08;;H04L67/125,H04L29/08;;H04L12/26,,0,0,,,,ACTIVE
462,EP,A1,EP 0836789 A1,186-087-608-773-213,1998-04-22,1998,EP 96926332 A,1996-06-28,EP 9602831 W;;GB 9513432 A,1995-07-01,METHOD FOR DETERMINING HANDOVER IN A MULTICELLULAR COMMUNICATIONS SYSTEM,,MOTOROLA LTD,JONES PHILIP;;THOMAS HOWARD JOHN;;ESSAM KEITH LESLEI;;LE FLEMING ANDREW MARK,"MOTOROLA MOBILITY, INC., LIBERTYVILLE, US (2012-06-18);;MOTOROLA MOBILITY, INC., US (2012-07-16)",https://lens.org/186-087-608-773-213,Patent Application,yes,0,0,13,13,0,H04W36/04;;H04W36/04,H04W36/04,,0,0,,,,EXPIRED
463,WO,A1,WO 2014/015217 A1,024-100-878-521-621,2014-01-23,2014,US 2013/0051217 W,2013-07-19,US 201261673625 P,2012-07-19,BIOMARKERS FOR HCV INFECTED PATIENTS,"The invention relates to biomarkers measurable in a human subject that have prognostic value with respect to efficacy of therapeutic treatments for Hepatitis C viral infection. The markers also are believed to have value for diagnosis liver health/liver damage. Disclosed are methods of evaluating the likelihood that a human subject infected with HCV will benefit from an HCV therapy, based on the biomarker parvin alpha (PARVA).",VERTEX PHARMA,FLEMING MARK ANDREW;;HARE BRIAN J;;CHELSKY DANIEL;;ALLARD RENE;;PARAMITHIOTIS EUSTACHE,,https://lens.org/024-100-878-521-621,Patent Application,yes,39,3,1,1,64,G01N33/5767,G01N33/576,,60,47,106-044-631-970-758;;154-838-840-689-466;;016-712-463-929-438;;071-927-443-606-319;;103-646-040-125-99X;;090-068-075-577-142;;006-255-774-333-726;;039-668-643-193-383;;024-751-383-662-691;;031-049-514-664-480;;013-997-361-311-947;;086-686-689-616-146;;071-931-952-211-261;;009-914-034-889-417;;008-978-599-841-396;;031-479-116-009-093;;043-599-710-962-348;;073-200-013-951-425;;100-964-379-581-462;;194-029-211-108-156;;069-102-844-790-593;;077-532-829-551-519;;015-339-909-605-122;;019-941-060-457-50X;;111-624-689-261-964;;099-900-812-708-588;;103-621-044-191-088;;022-431-699-856-26X;;093-998-397-567-158;;020-449-071-784-742;;057-156-304-558-548;;031-912-631-962-342;;031-501-930-831-338;;179-750-649-462-942;;007-384-333-132-029;;062-967-721-247-716;;101-092-734-598-13X;;057-430-966-859-998;;038-020-569-130-529;;027-744-779-247-412;;015-322-496-399-787;;033-322-978-725-55X;;019-037-052-772-934;;070-265-761-998-411;;036-444-793-633-629;;073-302-114-702-046;;033-471-818-914-254,15284246;;10.1074/jbc.m401563200;;17385211;;10.1002/hep.21540;;17267482;;10.1128/jvi.02640-06;;pmc1866036;;10.1016/s0168-8278(99)80369-9;;10622555;;10.1073/pnas.88.6.2451;;pmc51250;;1848704;;2175903;;pmc55204;;10.1073/pnas.87.24.9524;;10.1128/jvi.65.3.1105-1113.1991;;pmc239876;;1847440;;2523562;;10.1126/science.2523562;;1648221;;10.1073/pnas.88.13.5547;;pmc51914;;pmc236449;;7518529;;10.1128/jvi.68.8.5063-5073.1994;;8389908;;10.1128/jvi.67.7.3835-3844.1993;;pmc237748;;10.1128/jvi.71.11.8416-8428.1997;;pmc192304;;9343198;;9740782;;10.1006/viro.1998.9311;;10.1128/jvi.74.4.2046-2051.2000;;10644379;;pmc111684;;pmc390718;;10.1073/pnas.82.19.6374;;3931073;;10.1056/nejm199811193392101;;0009819446;;9819446;;10.1056/nejm199811193392102;;9819447;;10.1053/jhep.2001.21747;;11172346;;11197053;;10.1046/j.1440-1746.2000.02371.x;;10418039;;10.1201/9781351071840;;10.1038/nbt1142;;16151406;;1696564;;10.1002/ijc.2910460228;;10.1016/s1046-2023(05)80210-5;;14427334;;10.1016/0003-9861(60)90049-7;;pmc1197021;;10.1042/bj0730119;;14434282;;10.1074/jbc.m209764200;;12473676;;10.1023/a:1026036521852;;14619983;;10.1093/clinchem/32.8.1563;;3731453;;10.1111/j.1365-2893.2009.01083.x;;19226329;;10.1159/000232486;;19729943;;10.1373/clinchem.2007.089144;;17702858;;10.1371/journal.pone.0010484;;pmc2864746;;20463963;;10.1515/cclm.2001.155;;11758611;;19432394;;10.1021/pr9002504;;10.1111/j.1742-4658.2010.07640.x;;20402763;;10.2174/092986709789909620;;19929783;;10.2210/pdb2nsm/pdb;;17157876;;10.1016/j.jmb.2006.11.025;;10.1016/j.jhep.2008.06.029;;18809223;;pmc2644636;;10905755;;10.1515/cclm.2000.029;;2814926;;10.1055/s-0038-1646905;;10.1016/s0165-2478(01)00288-7;;11600203;;19857204;;10.1042/bc20090125;;10.1373/49.3.450;;12600957;;10.1016/j.bbrc.2007.03.174;;17434454;;10.1007/s00428-006-0257-7;;16941151;;pmc2850332;;10.1186/1477-5956-8-12;;20222986,"ZHANG YONGJUN ET AL: ""Distinct roles of two structurally closely related focal adhesion proteins, alpha-parvins and beta-parvins, in regulation of cell morphology and survival"", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 279, no. 40, 1 October 2004 (2004-10-01), pages 41695 - 41705, XP002713170, ISSN: 0021-9258;;VASILIKI GKRETSI ET AL: ""Loss of integrin linked kinase from mouse hepatocytesin vitro and in vivo results in apoptosis and hepatitis"", HEPATOLOGY, vol. 45, no. 4, 1 April 2007 (2007-04-01), pages 1025 - 1034, XP055079233, ISSN: 0270-9139, DOI: 10.1002/hep.21540;;TAYLOR MILTON W ET AL: ""Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy"", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 81, no. 7, 1 April 2007 (2007-04-01), pages 3391 - 3401, XP002474027, ISSN: 0022-538X, DOI: 10.1128/JVI.02640-06;;ALBERTI ET AL., J. HEPATOLOGY, vol. 31, no. 1, 1999, pages 17 - 24;;CHOO ET AL., PROC. NATL. ACAD. SCI. USA, vol. 88, 1991, pages 2451 - 2455;;KATO ET AL., PROC. NATL. ACAD. SCI. USA, vol. 87, 1990, pages 9524 - 9528;;TAKAMIZAWA ET AL., J. VIROL., vol. 65, 1991, pages 1105 - 1113;;CHOO ET AL., SCIENCE, vol. 244, 1989, pages 359 - 362;;HIJIKATA ET AL., PROC. NATL. ACAD. SCI. USA, vol. 88, 1991, pages 5547 - 5551;;LIN ET AL., J. VIROL., vol. 68, 1994, pages 5063 - 5073;;BARTENSCHLAGER ET AL., J. VIROL., vol. 67, 1993, pages 3835 - 3844;;LOHMANN ET AL., J. VIROL., vol. 71, 1997, pages 8416 - 8428;;LOHMANN ET AL., VIROLOGY, vol. 249, 1998, pages 108 - 118;;KOLYKHALOV ET AL., J. VIROL., vol. 74, no. 4, 2000, pages 2046 - 2051;;""Management of Hepatitis C: 2002. National Institutes of Health Consensus Development Conference Update."", HEPATOLOGY, vol. 36, 10 June 2002 (2002-06-10);;KARATHANASIS, PNAS USA, vol. 82, 1985, pages 6374 - 6378;;MCHUTCHISON ET AL., N. ENGL. J. MED., vol. 339, 1998, pages 1485 - 1492;;DAVIS ET AL., N. ENGL. J. MED., vol. 339, 1998, pages 1493 - 1499;;MCHUTCHINSON ET AL., N. ENGL. J. MED., vol. 361, 2009, pages 580 - 539;;""American Hospital Formulary Service- Drug Information"", 2005, AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS, INC., pages: 811;;REDDY, K.R. ET AL.: ""Efficacy and Safety of Pegylated (40-kd) Interferon alpha-2a Compared with Interferon alpha-2a in Noncirrhotic Patients with Chronic Hepatitis C"", HEPATOLOGY, vol. 33, 2001, pages 433 - 438;;KAO, J.H. ET AL.: ""Efficacy of Consensus Interferon in the Treatment of Chronic Hepatitis"", GASTROENTEROL. HEPA.TOL, vol. 15, 2000, pages 1418 - 1423;;CLAYETTE, P. ET AL.: ""IFN-tau, A New Interferon Type I with Antiretroviral activity"", PATHOL. BIOL. (PARIS, vol. 47, 1999, pages 553 - 559;;""Remington's Pharmaceutical Sciences"", MACK PUBLISHING CO.;;E. MAGGIO: ""Enzyme- Immunoassay"", 1980, CRC PRESS, INC.;;HOLLINGER; HUDSON, NATURE BIOTECHNOLOGY, vol. 23, no. 9, 2005, pages 1126 - 1136;;LOSMAN ET AL., INT. J. CANCER, vol. 46, 1990, pages 310;;""Monoclonal Antibodies: Production, Engineering and Clinical Application"", 1995, CAMBRIDGE UNIVERSITY PRESS, article ""Genetic Manipulation of Monoclonal Antibodies"", pages: 166;;WARD ET AL.: ""Monoclonal Antibodies: Principles and Applications"", 1995, WILEY-LISS, INC., article ""Genetic Manipulation and Expression of Antibodies"", pages: 137;;LARRICK ET AL., METHODS: A COMPANION TO METHODS IN ENZYMOLOGY, vol. 2, 1991, pages 106 - 110;;""Current Protocols in Immunology"", vol. 1, 1991, JOHN WILEY & SONS, pages: 2.5.12.6;;""Monoclonal Antibodies, Hybridomas: A New Dimension in Biological Analyses"", 1980, PLENUM PRESS;;HARLOW AND LANE: ""Antibodies: A Laboratory Manual"", 1988, COLD SPRING HARBOR LABORATORY PRESS;;PICKSLEY ET AL.: ""DNA Cloning 2: Expression Systems"", 1995, OXFORD UNIVERSITY PRESS, article ""Production of monoclonal antibodies against proteins expressed in E. coli"", pages: 93;;EDELMAN ET AL.: ""Methods in Enzymology"", vol. 1, 1967, ACADEMIC PRESS, pages: 422;;NISONOFF ET AL., ARCH. BIOCHEM. BIOPHYS., vol. 89, 1960, pages 230 - 244;;PORTER, BIOCHEM. J., vol. 73, 1959, pages 119 - 127;;ANDREWS, S.M.; TITUS, J.A. ET AL.: ""Current Protocols in Immunology"", 2003, JOHN WILEY & SONS, pages: 2.8.1 - 2.8.10,2;;AUSUBEL ET AL.,: ""Current Protocols in Molecular Biology"", 2007, JOHN WILEY & SONS;;TEUFEL ET AL.: ""Sequence Identification and Characterization of Human Carnosinase and a Closely Related Non-specific Dipeptidase"", J. BIOL. CHERN., vol. 278, no. 8, 2003, pages 6521 - 31;;ALIYA S; REDDANNA P; THYAGARAJU K.: ""Does glutathione S-transferase Pi (GST-Pi) a marker protein for cancer?"", MOL CELL BIOCHEM., vol. 253, no. 1-2, 2003, pages 319 - 27;;BANDO K; ICHIHARA K; TOYOSHIMA H; SHIMOTUJI T; KODA K; HAYASHI C; MIYAI K: ""Decreased activity of carnosinase in serum of patients with chronic liver disorders"", CLIN CHEM., vol. 32, no. 8, 1986, pages 1563 - 5;;CHEUNG KJ; TILLEMAN K; DEFORCE D; COLLE I; VAN VLIERBERGHE H: ""The HCV serum proteome: a search for fibrosis protein markers"", J VIRAL HEPAT., vol. 16, no. 6, 2009, pages 418 - 29;;DOMENE HM; HWA V; ARGENTE J; WIT JM; CAMACHO-HÜBNER C; JASPER HG; POZO J; VAN DUYVENVOORDE HA; YAKAR S; FOFANOVA-GAMBETTI OV: ""International ALS Collaborative Group. Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences"", HORM RES., vol. 72, no. 3, 2009, pages 129 - 41;;GANGADHARAN B; ANTROBUS R; DWEK RA; ZITZMANN N: ""Novel serum biomarker candidates for liver fibrosis in hepatitis C patients"", CLIN CHEM., vol. 53, no. 10, 2007, pages 1792 - 9;;GANDHI KS; MCKAY FC; DIEFENBACH E; CROSSETT B; SCHIBECI SD; HEARD RN; STEWART GJ; BOOTH DR; ARTHUR JW.: ""Novel approaches to detect serum biomarkers for clinical response to interferon-beta treatment in multiple sclerosis"", PLOS ONE, vol. 5, no. 5, 2010, pages 10484;;LACOVAZZI PA; TRISOLINI A; BARLETTA D; ELBA S; MANGHISI OG; CORREALE M: ""Serum 90K/MAC- 2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein"", CLIN CHEM LAB MED., vol. 39, no. 10, 2001, pages 961 - 5;;JOHANSSON ME; THOMSSON KA; HANSSON GC: ""Proteomic analyses of the two mucus layers of the colon barrier reveal that their main component, the Muc2 mucin, is strongly bound to the Fcgbp protein"", J PROTEOME RES., vol. 8, no. 7, 2009, pages 3549 - 57;;KATAOKA H; KAWAGUCHI M.: ""Hepatocyte growth factor activator (HGFA): pathophysiological functions in vivo"", FEBS J., vol. 277, no. 10, 2010, pages 2230 - 7;;KAWAGUCHI T; YAMAGISHI S; SATA M: ""Branched-chain amino acids and pigment epithelium- derived factor: novel therapeutic agents for hepatitis c virus-associated insulin resistance"", CURR MED CHEM., vol. 16, no. 36, 2009, pages 4843 - 57;;KEIL C; MASKOS K; THAN M; HOOPES JT; HUBER R; TAN F; DEDDISH PA; ERDOS EG; SKIDGEL RA; BODE W: ""Crystal structure of the human carboxypeptidase N (kininase 1) catalytic domain"", J MOL BIOL., vol. 366, no. 2, 2007, pages 504 - 16;;KIM E; LI K; LIEU C; TONG S; KAWAI S; FUKUTOMI T; ZHOU Y; WANDS J; LI J.: ""Expression of apolipoprotein C-IV is regulated by Ku antigen/peroxisome proliferator-activated receptor gamma complex and correlates with liver steatosis"", J HEPATOL., vol. 49, no. 5, 2008, pages 787 - 98;;KITTL EM; HOFMANN J; HARTMANN G; SEBESTA C; BEER F; BAUER K; HUBER KR: ""Serum protein 90K/Mac-2BP is an independent predictor of disease severity during hepatitis C virus infection"", CLIN CHEM LAB MED., vol. 38, no. 3, 2000, pages 205 - 8;;KLUFT C; LOS P; CLEMMENSEN I; BROMMER EJ; GEVERS LEUVEN JA; BOKS AL; VELLENGA E: ""Quantitation of plasma levels of tetranectin--effects of oral contraceptives, pregnancy, treatment with L-asparaginase and liver cirrhosis"", THROMB HAEMOST., vol. 62, no. 2, 1989, pages 792 - 6;;KOBAYASHI K; YAGASAKI M; HARADA N; CHICHIBU K; HIBI T; YOSHIDA T; BROWN WR; MORIKAWA M: ""Detection of Fcgamma binding protein antigen in human sera and its relation with autoimmune diseases"", IMMUNOL LETT., vol. 79, no. 3, 2001, pages 229 - 35;;POPESCU CI; DUBUISSON J.: ""Role of lipid metabolism in hepatitis C virus assembly and entry"", BIOL CELL, vol. 102, no. 1, 2009, pages 63 - 74;;ROSSI E; ADAMS L; PRINS A; BULSARA M; DE BOER B; GARAS G; MACQUILLAN G; SPEERS D; JEFFREY G.: ""Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients"", CLIN CHEM., vol. 49, no. 3, 2003, pages 450 - 4;;SAKAI M; MURAMATSU M.: ""Regulation of glutathione transferase P: a tumor marker of hepatocarcinogenesis"", BIOCHEM BIOPHYS RES COMMUN., vol. 357, no. 3, 2007, pages 575 - 8;;SASAKI M; LKEDA H; KATAOKA H; NAKANUMA Y: ""Augmented expression of hepatocytes growth factor activator inhibitor type 1 (HAI-1) in intrahepatic small bile ducts in primary biliary cirrhosis"", VIRCHOWS ARCH., vol. 449, no. 4, 2006, pages 462 - 71;;ZHANG L; JIA X; ZHANG X; SUN J; PENG X; QI T; MA F; YIN L; YAO Y; QIU C: ""Proteomic analysis of PBMCs: characterization of potential HIV-associated proteins"", PROTEOME SCI., vol. 8, 2010, pages 12 - 23",PENDING
464,US,B2,US 9844333 B2,034-723-958-719-711,2017-12-19,2017,US 40977909 A,2009-03-24,US 40977909 A,2009-03-24,Remote delivery and monitoring of health care,"Various embodiments for providing remote delivery and monitoring of health care are provided. In one embodiment, an apparatus for providing unmanned medical care in remote areas to a patient is provided. A container is adapted for transport using a standardized shipping mechanism. The container is adapted to provide remote delivery of health care. In an additional embodiment, a portable apparatus for dermatological monitoring is provided. An imaging device is integrated into a housing. The imaging device is adapted to obtain a digital, high-resolution image of a patient. In still another embodiment, a portable apparatus for orthopedic monitoring of a patient is provided. A housing is adapted for one of positioning adjacent to and positioning within an orthopedic cast. A diagnostic biomedical device integrated into the housing. The diagnostic biomedical device is adapted for obtaining an orthopedic image of a portion of the patient treated with the orthopedic cast.",COPELAND MICHAEL PRESTON;;FLEMING MARK SEAN;;LARA CHRISTINA ANN;;SANCHEZ CALLINE KRIS;;IBM,COPELAND MICHAEL PRESTON;;FLEMING MARK SEAN;;LARA CHRISTINA ANN;;SANCHEZ CALLINE KRIS,INTERNATIONAL BUSINESS MACHINES CORPORATION (2009-03-23),https://lens.org/034-723-958-719-711,Granted Patent,yes,52,3,8,8,0,A61B5/0059;;A61B10/0045;;A61B2560/0431;;A61B2560/0456;;A61B5/0022;;A61B5/0013;;A61B2090/376;;A61B2090/378;;A61B5/445;;G16H30/40;;G16H40/67;;A61B5/0059;;A61B10/0045;;A61B2560/0431;;A61B2560/0456;;A61B5/0013;;A61B2090/376;;A61B2090/378;;A61B5/0022;;G16H30/40;;A61B5/445;;A61B5/6812;;A61B5/7445;;A61B2560/0475;;A61B5/7207;;A61B5/74;;A61B2560/0214;;G16H40/67,A61B5/00;;A61B10/00;;A61B90/00;;G16H30/40;;G16H40/67,,10,3,007-716-657-059-567;;018-189-798-239-331;;074-623-032-398-574,10.1385/jcd:1:4:369;;15304883;;11055787;;10.1109/42.875195;;10.1109/iembs.2006.259630;;17947114,"Jonathan Abel, Sunstar ambulances tap the sun to tack on power, Tampa Bay Times, Wednesday, Dec. 17, 2008 8:12pm.;;Philip Heying, City rolls out solar panels on ambulance in order to save a few bucks, LJWorld.com, Mar. 4, 2009.;;English Translation of DE 2944726 A1, Jun. 4, 1981, Hager Reinhard Klaus Ing.;;Kanika Singh et al., “A portable battery operated bone fracture evaluator,” Proceedings—19th International Conference—IEEE / EMBS Oct. 30-Nov. 2, 1997 Chicago, IL. USA.;;Kiebzak, “Radiolucent casting tape allows for accurate measurement of forearm bone mineral density using dual-energy X-ray absorptiometry,” Miller Orthopedic Clinic, Charlotte, NC, PMID: 15304883 [PubMed], 1998.;;Yahuhiro Komiya et al., “Natural Color Reproduction System for Telemedicine and Its' Application to Digital Camera,” IEEE, 1999, pp. 50-54 vol. 3.;;Yuri Ohya, “Natural Color Reproduction System for Telemedicine,” IEEE, 1998, pp. 442-449.;;Yves Vander Haeghen et al., “An Imaging System with Calibrated Color Image Acquisition for Use in Dermatology,” IEEE, vol. 19, No. 7, Jul. 2000, pp. 772-730.;;Nancy T. Maar, “Doctor as Inventor and Visionary: Dr. Rhett Drugge, Dermatologist, Fights Skin Cancer with Sophisticated New Invention,” http://www.thebestdermatologist.com/derm/news.html, printed on Mar. 9, 2009.;;Ed W. Lim et al., “A Novel Image Capture System for Use in Telehealth Applications,” Proceedings of the 28th IEEE EMBS Annual International Conference, New York City, Aug. 30-Sep. 3, 2006, pp. 4743-4746.",ACTIVE
465,BR,A2,BR 112019013710 A2,087-582-357-072-955,2020-03-03,2020,BR 112019013710 A,2017-12-06,US 2017/0064897 W;;US 201762442155 P,2017-01-04,composições e métodos para controle de pragas de plantas,são divulgadas novas proteínas inseticidas que são tóxicas para pragas de lepidópteros. os polinucleotídeos codificando as proteínas inseticidas podem ser usados para transformar organismos procarióticos e eucarióticos para expressarem as proteínas inseticidas. os organismos recombinantes ou composições contendo os organismos recombinantes ou as proteínas inseticidas sozinhos ou em combinação com outros agentes de controle de pragas e um transportador agrícola apropriado podem ser usados para controlar pragas de lepidópteros em vários ambientes.,SYNGENTA PARTICIPATIONS AG,CHRISTOPHER FLEMING;;KATHERINE SEGUIN;;MARK SCOTT ROSE;;MATTHEW RICHARD BRAMLETT;;MILAN JUCOVIC,,https://lens.org/087-582-357-072-955,Patent Application,no,0,0,17,17,0,C12N15/8286;;A01N37/46;;C07K14/325;;Y02A40/146;;C07K14/325;;C12N15/8286;;Y02A40/146,A01H5/10;;A01N63/00,,0,0,,,,PENDING
466,AR,A1,AR 110667 A1,133-476-401-394-394,2019-04-17,2019,AR P170103697 A,2017-12-28,US 201762442155 P,2017-01-04,COMPOSICIONES Y MÉTODOS PARA CONTROLAR PLAGAS DE PLANTAS,"Reivindicación 1: Una proteína Cry recombinante que es tóxica para una plaga de lepidópteros, en donde la proteína Cry comprende (a) una secuencia de aminoácidos que tiene de al menos un 95% a al menos un 99% de identidad de secuencia con una secuencia de aminoácidos de cualquiera de las SEQ ID Nº 1 - 3, o fragmentos de toxina de las mismas; o (b) una secuencia de aminoácidos que está codificada por una secuencia de nucleótidos que tiene de al menos un 95% a al menos un 99% de identidad de secuencia con una secuencia de nucleótidos de cualquiera de las SEQ ID Nº 14 - 29 o fragmentos codificantes de toxina de las mismas. Reivindicación 5: Un polinucleótido que comprende una secuencia de nucleótidos que a) codifica una proteína Cry de cualquiera de las reivindicaciones 1 - 4; o b) comprende cualquiera de las SEQ ID Nº 14 - 29 o fragmentos codificantes de toxina de las mismas. Reivindicación 9: Un vector recombinante que comprende el polinucleótido de la reivindicación 5. Reivindicación 11: La célula vegetal transgénica de la reivindicación 10, en donde la célula vegetal es a) una célula vegetal dicotiledónea; o b) una célula vegetal monocotiledónea; o c) una célula vegetal dicotiledónea seleccionada del grupo que consiste en una célula de soja, una célula de girasol, una célula de tomate, una célula de cultivos de coles, una célula de algodón, una célula de remolacha azucarera y una célula de tabaco; o d) una célula vegetal monocotiledónea seleccionada del grupo que consiste en una célula de cebada, una célula de maíz, una célula de avena, una célula de arroz, una célula de sorgo, una célula de caña de azúcar y una célula de trigo. Reivindicación 17: Un método para producir una planta transgénica resistente a insectos que comprende: introducir en una planta el gen quimérico de la reivindicación 6, en donde la proteína Cry se expresa en la planta y, de esta manera, produce una planta transgénica resistente a insectos. Reivindicación 19: Un método para controlar una plaga de lepidópteros que comprende suministrar a la plaga de lepidópteros o al ambiente de la misma una composición que comprende una cantidad eficaz de la proteína Cry de cualquiera de las reivindicaciones 1 - 4. Reivindicación 20: Una proteína Cry1J híbrida que comprende, del extremo N-terminal al extremo C-terminal, una porción de Cry1Ja que corresponde a los aminoácidos 1 - 89 de la SEQ ID Nº 1, una porción Cry1Jc correspondiente a las posiciones de aminoácidos 90 - 201 de la SEQ ID Nº 1 y una porción Cry1Ja correspondiente a las posiciones 202 - 1167 de la SEQ ID Nº 1.",SYNGENTA PARTICIPATIONS AG,FLEMING CHRISTOPHER;;BRAMLETT MATTHEW RICHARD;;JUCOVIC MILAN;;ROSE MARK SCOTT;;SEGUIN KATHERINE,,https://lens.org/133-476-401-394-394,Patent Application,no,0,0,17,17,0,C12N15/8286;;A01N37/46;;C07K14/325;;Y02A40/146;;C07K14/325;;C12N15/8286;;Y02A40/146,C07K14/325;;A01H5/00;;A01H5/10;;A01N63/02;;C07K19/00;;C12N5/04;;C12N15/32;;C12N15/63,,0,0,,,,PENDING
467,EP,A1,EP 3565404 A1,172-366-760-837-318,2019-11-13,2019,EP 17890754 A,2017-12-06,US 201762442155 P;;US 2017/0064897 W,2017-01-04,COMPOSITIONS AND METHODS FOR CONTROLLING PLANT PESTS,,SYNGENTA PARTICIPATIONS AG,SEGUIN KATHERINE;;ROSE MARK SCOTT;;JUCOVIC MILAN;;BRAMLETT MATTHEW RICHARD;;FLEMING CHRISTOPHER,,https://lens.org/172-366-760-837-318,Patent Application,yes,0,0,17,17,31,C12N15/8286;;A01N37/46;;C07K14/325;;Y02A40/146;;C07K14/325;;C12N15/8286;;Y02A40/146,A01H5/10;;A01N63/00;;A01N63/02,,0,0,,,,PENDING
468,WO,A1,WO 2018/128744 A1,198-427-083-372-882,2018-07-12,2018,US 2017/0064897 W,2017-12-06,US 201762442155 P,2017-01-04,COMPOSITIONS AND METHODS FOR CONTROLLING PLANT PESTS,Novel insecticidal proteins that are toxic to lepidopteran pests are disclosed. The polynucleotides encoding the insecticidal proteins can be used to transform prokaryotic and eukaryotic organisms to express the insecticidal proteins. The recombinant organisms or compositions containing the recombinant organisms or the insecticidal proteins alone or in combination with other pest control agents and an appropriate agricultural carrier can be used to control lepidopteran pests in various environments.,SYNGENTA PARTICIPATIONS AG;;SYNGENTA CROP PROTECTION LLC,SEGUIN KATHERINE;;ROSE MARK SCOTT;;JUCOVIC MILAN;;BRAMLETT MATTHEW RICHARD;;FLEMING CHRISTOPHER,,https://lens.org/198-427-083-372-882,Patent Application,yes,4,3,17,17,31,C12N15/8286;;A01N37/46;;C07K14/325;;Y02A40/146;;C07K14/325;;C12N15/8286;;Y02A40/146,A01H5/10;;A01N63/00;;A01N63/02,,1,1,115-613-804-184-960,10.1128/mmbr.62.3.807-813.1998;;pmc98935;;9729610,"CRICKMORE ET AL.: ""Revision of the Nomenclature for the Bacillus thuringiensis Pesticidal Crystal Proteins"", MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, vol. 62, no. 3, September 1998 (1998-09-01), pages 807 - 813, XP002943531",PENDING
469,US,A,US 6128582 A,028-762-380-276-735,2000-10-03,2000,US 64016496 A,1996-04-30,US 64016496 A,1996-04-30,Molecules comprising an IMPDH-like binding pocket and encoded data storage medium capable of graphically displaying them,"The present invention relates to a data storage medium encoded with the corresponding structure coordinates of molecules and molecular complexes which comprise the active site binding pockets of IMPDH. Such data storage material is capable of displaying such molecules and molecular complexes, or their structural homologues, as a graphical three-dimensional representation on a computer screen. This invention also relates to methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention relates to methods of using the structure coordinates to screen and design compounds, including inhibitory compounds, that bind to IMPDH or homologues thereof. This invention also relates to molecules and molecular complexes which comprise the active site binding pockets of IMPDH or close structural homologues of the active site binding pockets. This invention also relates to compounds and pharmaceutical compositions which are inhibitors of IMPDH.",VERTEX PHARMA,WILSON KEITH P;;SINTCHAK MICHAEL D;;FLEMING MARK ANDREW;;ARMISTEAD DAVID M,VERTEX PHARMACEUTICALS INC (1996-09-20),https://lens.org/028-762-380-276-735,Granted Patent,yes,10,32,12,14,0,C07K2299/00;;C12N9/0006;;C12Q1/32;;C12Y101/01205;;G16C20/50;;A61P43/00;;C12Q1/32;;C12N9/0006;;C12Y101/01205;;C07K2299/00;;G16C20/50,A61K31/00;;A61K31/365;;A61K45/00;;A61P43/00;;C07K1/00;;C07K1/14;;C12N9/04;;C12Q1/32;;G06F17/30;;G06F17/50;;G06F19/00,702/27;;364/578,21,19,102-345-845-395-203;;083-114-214-469-960;;047-400-147-891-425;;038-505-398-849-808;;022-809-176-435-804;;089-550-035-419-975;;039-552-242-337-337;;017-078-745-731-930;;106-592-332-128-285;;157-895-621-716-196;;050-930-610-164-868;;019-060-914-883-538;;109-834-226-854-281;;096-868-520-405-378;;054-552-908-520-562;;022-716-513-472-962;;104-418-321-438-329;;057-355-233-717-557;;004-306-632-688-008,1583540;;10.1007/bf00124387;;6809941;;10.1021/jm00349a003;;10.1002/qsar.19820010102;;10.1021/jm00090a001;;1613742;;10.1002/prot.340110409;;1758885;;8681386;;0008681386;;10.1016/s0092-8674(00)81275-1;;10.2210/pdb1jr1/pdb;;14547224;;10.1016/0734-9750(87)90319-3;;7577983;;10.1021/bi00042a021;;7533955;;10.1097/00007890-199503150-00002;;10.1107/s0021889891004430;;10.1093/protein/6.6.615;;8234231;;8632430;;10.1021/jm950600m;;10.1016/0009-8981(95)06088-u;;7586576;;7508752;;pmc452927;;10.1002/j.1460-2075.1991.tb07771.x;;10.2210/pdb1huc/pdb;;1868826;;10.1038/328496a0;;3302724;;2493678;;10.1126/science.2493678;;10.1016/0014-5793(93)81629-e;;8262199;;10.1038/221235a0;;5763076,"http://www.pdb.bnl.gov/, May 1994.;;H.J. Bohn, The Computer Program LUDI: A New Method For The De Novo Design Of Enzyme Inhibitors , Journal of Computer Aided Molecular Design , 6, pp. 61 78 (1992).;;C. Hansch et al., Comparison of the Inhibition of Escherichia coli and Lactobacillus Casei Dihydrofolate Reductase by 2,4 diamino 5 (substituted benzyl) pyrimidines: quantitative Stucture Activity Relationships, X Ray Crystallography and Computer Graphics in Structure Activity Analysis , Chemical Abstracts , 97:298f, p. 29 (1982); Journal of Medicinal Chemistry , 25, pp. 777 784 (1982).;;R. Li, et al, A Comparison by QSAR Crystallography and Computer Graphics of the Inhibition of Various Dihydrofolate Reductases by 5 (x benzyl) 2,4 diaminopyrimidines , Chemical Abstracts , 98:17257a, p. 28 (1983); Quantitative Structure Activity Relationships Pharmacol. Chem. Biol. , 1, pp. 1 7 (1982).;;Y.C. Martin, 3D Database Searching in Drug Design , Journal of Medicinal Chemistry , 35 (12), pp. 2145 2154, (Jun. 12, 1992).;;J.B. Moon et al., Computer Design of Bioactive Molecules: A Method for Receptor Based De Novo Ligand Design , Proteins, Structure, Functions and Genetics , 11, pp. 314 328 (1991).;;M.D. Sintchak et a., Structure and Mechanism of Inosine Monophosphate Dehydrogenase in Complex with the Immunosuppressant Mycophenolic Acid , Cell , 85, pp. 921 930 (Jun. 14, 1996).;;P.N. Bryan, Protein Engineering , Biotech Adv. , 5, pp. 221 234 (1987).;;I.D. Campbell et al., Diffraction in Biological Spectroscopy , The Benjamin/Cummings Publishing Company, Inc. , Menlo Park, CA, pp. 299 326 (1984).;;J.A. Huete P e rez et al., Identification of the IMP Binding Site in the IMP Dehydrogenase From Tritrichomonas Foetus , Biochemistry , 34, pp. 13889 13894 (Oct., 1995).;;C.R. Gregory et al., Treatment With Rapamycin and Mycophenolic Acid Reduces Arterial Intimal Thickening Produced by Mechanical Injury and Allows Endothelial Replacement , Transplantation , 59(5), pp. 655 661 (Mar., 1995).;;J. Jancarik et al., Sparse Matrix Sampling: A Screening Method for Crystallization of Proteins , J. Appl. Cryst. , 24, pp. 409 411 (1991).;;A. Kajihara et al., Protein Modelling Using a Chimera Reference Protein Derived From Exons , Protein Eng g , 6, pp. 615 620 (1993).;;G.M. Makara et al., Nuclear Magnetic Resonance and Molecular Modeling Study on Mycophenolic Acid: Implications for Binding to Inosine Monophosphate Dehydrogenase , J. Med. Chem. , 39, pp. 1236 1242 (Mar., 1996).;;C. Montero et al., Demonstration of Induction of Erythrocyte Inosine Monophosphate Dehydrogenase Activity in Ribavirin Treated Patients Using a High Performance Liquid Chromatography Linked Method , Clinica Chimica Acta , 238, pp. 169 178 (Aug., 1995).;;R.E. Morris, New Small Molecule Immunosuppressants for Transplantation: Review of Essential Concepts , The Journal of Heart and Lung Transplantation , 12, pp. S275 S286 (1993).;;D. Musil et al., The Refined 2.15 X Ray Crystal Structure of Human Liver Cathepsin B: the Structural Basis for its Specificity , EMBO J. , 10(9), pp. 2321 2330 (1991).;;A.J. Russell et al., Rational Modification of Enzyme Catalysis by Engineering Surface Charge , Nature , 328, pp. 496 500 (1987).;;A.R. Sielecki et al., Structure of Recombinant Human Renin, a Target for Cardiovascular Active Drugs, at 2.5 Resolution , Science , 243, pp. 1346 1351 (1989).;;U. Uhlin et al., Crystallization and Crystallographic Investigations of Ribonucleotide Reductase Protein R1 From Escherichia Coli , 336(1), pp. 148 152 (1993).;;C.S. Wright et al., Structure of Subtilisin BPN at 2.5 Resolution , Nature , 221, pp. 235 242 (1969).",EXPIRED
470,EP,A2,EP 2630499 A2,087-644-072-412-312,2013-08-28,2013,EP 11778760 A,2011-10-21,US 40561910 P;;US 2011/0057347 W,2010-10-21,BIOMARKERS FOR HCV INFECTED PATIENTS,,VERTEX PHARMA,FLEMING MARK ANDREW;;HARE BRIAN J;;PARAMITHIOTIS EUSTACHE;;ALLARD RENE;;CHELSKY DANIEL,VERTEX PHARMACEUTICALS INC. (2014-02-26);;VERTEX PHARMACEUTICALS INCORPORATED (2014-08-27),https://lens.org/087-644-072-412-312,Patent Application,yes,0,0,5,5,0,G01N33/5767;;G16H50/30;;A61K38/08;;A61K38/21;;G01N33/5767;;G16H50/30;;A61K31/7056;;A61K38/08;;A61K38/21;;C12Q1/32;;C12Q1/48;;C12Q1/485;;G01N33/53;;G01N33/573,G01N33/576;;A61K38/08,,0,0,,,,DISCONTINUED
471,ZA,B,ZA 201904125 B,196-956-642-284-434,2021-01-27,2021,ZA 201904125 A,2019-06-25,US 201762442155 P;;US 2017/0064897 W,2017-01-04,COMPOSITIONS AND METHODS FOR CONTROLLING PLANT PESTS,,SYNGENTA PARTICIPATIONS AG,SEGUIN KATHERINE;;ROSE MARK SCOTT;;JUCOVIC MILAN;;BRAMLETT MATTHEW RICHARD;;FLEMING CHRISTOPHER,,https://lens.org/196-956-642-284-434,Granted Patent,no,0,0,17,17,0,C12N15/8286;;A01N37/46;;C07K14/325;;Y02A40/146;;C07K14/325;;C12N15/8286;;Y02A40/146,,,0,0,,,,ACTIVE
472,CA,A1,CA 3044425 A1,135-772-482-751-574,2018-07-12,2018,CA 3044425 A,2017-12-06,US 201762442155 P;;US 2017/0064897 W,2017-01-04,COMPOSITIONS AND METHODS FOR CONTROLLING PLANT PESTS,Novel insecticidal proteins that are toxic to lepidopteran pests are disclosed. The polynucleotides encoding the insecticidal proteins can be used to transform prokaryotic and eukaryotic organisms to express the insecticidal proteins. The recombinant organisms or compositions containing the recombinant organisms or the insecticidal proteins alone or in combination with other pest control agents and an appropriate agricultural carrier can be used to control lepidopteran pests in various environments.,SYNGENTA PARTICIPATIONS AG,SEGUIN KATHERINE;;ROSE MARK SCOTT;;JUCOVIC MILAN;;BRAMLETT MATTHEW RICHARD;;FLEMING CHRISTOPHER,,https://lens.org/135-772-482-751-574,Patent Application,no,0,0,17,17,31,C12N15/8286;;A01N37/46;;C07K14/325;;Y02A40/146;;C07K14/325;;C12N15/8286;;Y02A40/146,C07K14/325;;A01H5/00;;A01H5/10;;A01N63/02;;C12N1/21;;C12N5/10;;C12N15/32;;C12N15/63;;C12N15/82,,0,0,,,,PENDING
473,US,A1,US 2016/0007920 A1,195-535-232-807-747,2016-01-14,2016,US 201514866517 A,2015-09-25,US 201514866517 A;;US 40977909 A,2009-03-24,REMOTE DELIVERY AND MONITORING OF HEALTH CARE,"Various embodiments for providing remote delivery and monitoring of health care are provided. In one embodiment, a portable apparatus for orthopedic monitoring of a patient is provided and comprises: a housing adapted for one of positioning adjacent to and positioning within an orthopedic cast; a diagnostic biomedical device integrated into the housing, wherein the diagnostic biomedical device is adapted for obtaining an orthopedic image of a portion of the patient treated with the orthopedic cast; and a wireless communications interface coupled to the diagnostic biomedical device, wherein the wireless communications interface is adapted to upload the orthopedic image to a remote server to be viewed by a medical professional.",IBM,COPELAND MICHAEL P;;FLEMING MARK S;;LARA CHRISTINA A;;SANCHEZ CALLINE K,INTERNATIONAL BUSINESS MACHINES CORPORATION (2015-09-13),https://lens.org/195-535-232-807-747,Patent Application,yes,8,0,8,8,0,A61B5/0059;;A61B10/0045;;A61B2560/0431;;A61B2560/0456;;A61B5/0022;;A61B5/0013;;A61B2090/376;;A61B2090/378;;A61B5/445;;G16H30/40;;G16H40/67;;A61B5/0059;;A61B10/0045;;A61B2560/0431;;A61B2560/0456;;A61B5/0013;;A61B2090/376;;A61B2090/378;;A61B5/0022;;G16H30/40;;A61B5/445;;A61B5/6812;;A61B5/7445;;A61B2560/0475;;A61B5/7207;;A61B5/74;;A61B2560/0214;;G16H40/67,A61B5/00;;G16H30/40;;G16H40/67,,0,0,,,,ACTIVE
474,US,A1,US 2010/0249545 A1,000-309-884-730-653,2010-09-30,2010,US 40977909 A,2009-03-24,US 40977909 A,2009-03-24,REMOTE DELIVERY AND MONITORING OF HEALTH CARE,"Various embodiments for providing remote delivery and monitoring of health care are provided. In one embodiment, an apparatus for providing unmanned medical care in remote areas to a patient is provided. A container is adapted for transport using a standardized shipping mechanism. The container is adapted to provide remote delivery of health care. In an additional embodiment, a portable apparatus for dermatological monitoring is provided. An imaging device is integrated into a housing. The imaging device is adapted to obtain a digital, high-resolution image of a patient. In still another embodiment, a portable apparatus for orthopedic monitoring of a patient is provided. A housing is adapted for one of positioning adjacent to and positioning within an orthopedic cast. A diagnostic biomedical device integrated into the housing. The diagnostic biomedical device is adapted for obtaining an orthopedic image of a portion of the patient treated with the orthopedic cast.",IBM,COPELAND MICHAEL PRESTON;;FLEMING MARK SEAN;;LARA CHRISTINA ANN;;SANCHEZ CALLINE KRIS,INTERNATIONAL BUSINESS MACHINES CORPORATION (2009-03-23),https://lens.org/000-309-884-730-653,Patent Application,yes,41,11,8,8,0,A61B5/0059;;A61B10/0045;;A61B2560/0431;;A61B2560/0456;;A61B5/0022;;A61B5/0013;;A61B2090/376;;A61B2090/378;;A61B5/445;;G16H30/40;;G16H40/67;;A61B5/0059;;A61B10/0045;;A61B2560/0431;;A61B2560/0456;;A61B5/0013;;A61B2090/376;;A61B2090/378;;A61B5/0022;;G16H30/40;;A61B5/445;;A61B5/6812;;A61B5/7445;;A61B2560/0475;;A61B5/7207;;A61B5/74;;A61B2560/0214;;G16H40/67,A61B5/00;;A61B8/00;;G01N23/00;;G16H30/40;;G16H40/67,600/306;;600/300;;600/437;;378/1,3,0,,,"Jonathan Abel, Sunstar ambulances tap the sun to tack on power, Tampa Bay Times, Wednesday, December 17, 2008 8:12pm;;Philip Heying, City rolls out solar panels on ambulance in order to save a few bucks, LJWorld.com, March 4, 2009;;English Translation of DE 2944726 A1, 19810604, HAGER REINHARD KLAUS ING (see attached)",ACTIVE
475,EP,B1,EP 0836789 B1,053-229-490-493-029,2003-08-27,2003,EP 96926332 A,1996-06-28,EP 9602831 W;;GB 9513432 A,1995-07-01,METHOD FOR DETERMINING HANDOVER IN A MULTICELLULAR COMMUNICATIONS SYSTEM,,MOTOROLA LTD,JONES PHILIP;;THOMAS HOWARD JOHN;;ESSAM KEITH LESLEI;;LE FLEMING ANDREW MARK,"MOTOROLA MOBILITY, INC., LIBERTYVILLE, US (2012-06-18);;MOTOROLA MOBILITY, INC., US (2012-07-16)",https://lens.org/053-229-490-493-029,Granted Patent,yes,2,0,13,13,0,H04W36/04;;H04W36/04,H04W36/04,,0,0,,,,EXPIRED
476,US,B2,US 9999385 B2,085-961-182-544-830,2018-06-19,2018,US 201514866507 A,2015-09-25,US 201514866507 A;;US 40977909 A,2009-03-24,Remote delivery and monitoring of health care,"Various embodiments for providing remote delivery and monitoring of health care are provided. In one embodiment, a portable apparatus is provided for dermatological monitoring, comprising a housing and an imaging device integrated into the housing. The imaging device obtains a digital, high-resolution, dermatological image of a patient and a processor device integrated into the housing applies an anti-motion algorithm to the dermatological image to enhance image quality. A wireless communications interface is additionally integrated into the housing and coupled to the processor device, to upload the dermatological image to a remote server to be viewed by a medical professional.",IBM,COPELAND MICHAEL P;;FLEMING MARK S;;LARA CHRISTINA A;;SANCHEZ CALLINE K,INTERNATIONAL BUSINESS MACHINES CORPORATION (2015-09-13),https://lens.org/085-961-182-544-830,Granted Patent,yes,53,5,8,8,0,A61B5/0059;;A61B10/0045;;A61B2560/0431;;A61B2560/0456;;A61B5/0022;;A61B5/0013;;A61B2090/376;;A61B2090/378;;A61B5/445;;G16H30/40;;G16H40/67;;A61B5/0059;;A61B10/0045;;A61B2560/0431;;A61B2560/0456;;A61B5/0013;;A61B2090/376;;A61B2090/378;;A61B5/0022;;G16H30/40;;A61B5/445;;A61B5/6812;;A61B5/7445;;A61B2560/0475;;A61B5/7207;;A61B5/74;;A61B2560/0214;;G16H40/67,A61B5/00;;A61B10/00;;A61B90/00;;G16H30/40;;G16H40/67,,10,3,074-623-032-398-574;;018-189-798-239-331;;007-716-657-059-567,10.1109/iembs.2006.259630;;17947114;;11055787;;10.1109/42.875195;;10.1385/jcd:1:4:369;;15304883,"Lim et al, “A Novel Image Capture System for Use in Telehealth Applications” pp. 4743-4746, Proceedings of the 28th IEEE EMBS Annual International Conference, New York City, Aug. 30-Sep. 3, 2006.;;“A portable battery operated bone fracture evaluator” Proceedings—19th International Conference—IEEE/EMBS Oct.30-Nov. 2, 1997 Chicago, IL, USA.;;Vander Haeghen et al., “An Imaging System with Calibrated Color Image Acquisition for Use in Dematology” pp. 772-730, vol. 19, No. 7, Jul. 2000.;;Maar, “Doctor as Inventor and Visionary: Dr. Rhett Drugge, Dermatologist, Fights Skin Cancer with Sophisticated New Invention” http://www.thebestdermatologist.com/derm/news.html, printed on Mar. 9, 2009.;;Komiya et al., “Natural Color Reproduction System for Telemedicine and Its' Application to Digital Camera” IEEE, 1999, pp. 50-54 vol. 3.;;Ohya, “Natural Color Reproduction System for Telemedicine” pp. 442-449, IEEE, 1998.;;Kiebzak, “Radiolucent casting tape allows for accurate measurement of forearm bone mineral density using dual-energy X-ray absorptiometry” Miller Orthopedic Clinic, Charlotte, NC, PMID: 1534883 [PubMed], 1998.;;Heying, Philip, “City rolls out solar panels on ambulance in order to save a few bucks”, Mar. 4, 2009, 2 pages, LJWorld.com.;;Abel, Jonathan, “Sunstar ambulances tap the sun to tack on power”, Dec. 17, 2008, 1 page, Tampa Bay Times, Tampa Bay, FL, USA.;;English Translation of DE2944726A1, Hager Reinhard Klaus Ing, Jun. 4, 1981 (7 pages).",INACTIVE
477,US,B2,US 10069926 B2,159-312-587-039-480,2018-09-04,2018,US 201514851406 A,2015-09-11,US 201514851406 A,2015-09-11,Criteria-based data push,"Embodiments relate to criteria-based data push. An aspect includes receiving, by a criteria request server, a data push request from a user, the data push request specifying criteria for particular data to be pushed and a user device to receive the particular data. Another aspect includes forwarding the data push request to an incoming data monitor. Another aspect includes monitoring, by the incoming data monitor, incoming data received from one or more content providers. Yet another aspect includes, based on detecting the particular data that is specified by the data push request in the incoming data by the incoming data monitor, pushing the particular data to the user device.",IBM,DICKENS LOUIE A;;FLEMING MARK S;;GRAY MICHAEL T;;MARKOS GEORGE B,INTERNATIONAL BUSINESS MACHINES CORPORATION (2015-09-04),https://lens.org/159-312-587-039-480,Granted Patent,yes,4,0,5,5,0,G06F9/45533;;H04L67/55;;G06F9/45533;;H04L67/55;;G06F9/50;;H04L43/0876;;H04L43/08;;H04L67/125,G06F15/16;;G06F9/455;;G06F9/50;;H04L12/26;;H04L29/08,,4,0,,,"List of IBM Patents or Patent Applictions Treated as Related; (Appendix P), Date Filed Aug. 24, 2016; 2 pages.;;U.S. Appl. No. 15/245,414, filed Aug. 24, 2016 Entitled: Criteria-Based Data Push.;;List of IBM Patents or Patent Applictions Treated as Related; (Appendix P), Date Filed Jul. 8, 2016; 2 pages.;;U.S. Appl. No. 15/067,675, filed Mar. 11, 2016; Entitled: Criteria-Based Data Push.",ACTIVE
478,US,A1,US 2008/0133080 A1,156-491-973-877-690,2008-06-05,2008,US 56708506 A,2006-12-05,US 56708506 A,2006-12-05,SYSTEMS AND METHODS FOR REMOTE MONITORING OF VEHICLE INSPECTIONS,"Systems and methods for remote monitoring of vehicle inspections are provided. Using a wireless, network-enabled device, an inspection monitor may access a centralized vehicle inspection database, such as a motor vehicle administration and/or transportation department computer system tied into all the vehicle inspection stations in a jurisdiction. The inspection monitor may access the real time inspection records for a particular station and analyze the data for suspicion of fraudulent inspection practices.",VERIZON BUSINESS NETWORK SERV,ISAACS MARK R;;FLEMING DANIEL A;;CULP WILLIAM D;;LANG GARY S,VERIZON BUSINESS NETWORK SERVICES INC (2006-12-05);;VERIZON PATENT AND LICENSING INC (2009-08-01),https://lens.org/156-491-973-877-690,Patent Application,yes,2,7,2,2,0,G06Q10/06;;G06Q10/06,G06F19/00,701/33;;701/29;;340/438,0,0,,,,INACTIVE
479,AT,T1,AT E441099 T1,153-332-905-917-77X,2009-09-15,2009,AT 00973952 T,2000-10-27,US 43011799 A;;US 43019699 A;;US 43019899 A;;US 43011699 A;;US 0029670 W,1999-10-29,ZYTOLOGISCHES ABBILDUNGSSYSTEM UND VERFAHREN,,CYTYC CORP,ZAHNISER DAVID;;ZELINSKI MATTHEW;;DOLASH THOMAS;;MAENLE GARRICK;;FLEMING MARK;;LAUDO JOHN,,https://lens.org/153-332-905-917-77X,Granted Patent,no,0,0,10,81,0,G06T7/73;;G01N1/30;;G01N15/1468;;G01N15/147;;G01N15/1484;;G01N21/3151;;G01N2015/1006;;G01N2015/1472;;G01N2015/1488;;G06T7/0012;;G06T2207/20104;;G06T2207/30016;;G06T2207/30024;;G02B21/34;;G06V20/693;;G06V10/245;;G01N15/1433;;G06T7/73;;G06V20/693;;G06V10/245,G01N33/48;;C12Q1/02;;G01N1/28;;G01N1/30;;G01N15/10;;G01N15/14;;G01N21/01;;G01N21/27;;G01N21/31;;G01N33/483;;G06K9/00;;G06K9/32;;G06T1/00;;G06T7/00,,0,0,,,,EXPIRED
480,US,A1,US 2006/0001536 A1,180-176-262-572-831,2006-01-05,2006,US 88199504 A,2004-06-30,US 88199504 A,2004-06-30,"Chemical, biological, radiological, and nuclear weapon detection system with alarm thresholds based on environmental factors","A chemical, biological, radiological, and nuclear weapon detection system is disclosed that incorporates a mechanism to reduce the probability that a false alarm will be issued. In particular, the mechanism causes an alarm to be triggered when the amount of a hazardous material reaches a threshold, but changes the threshold based, at least in part, on environmental (e.g., meteorological, etc.) characteristics (e.g., whether is it precipitating or not, whether it is sunny or not, etc) that effect the efficacy of a chemical, biological, radiological, or nuclear weapon. Given that there are environmental factors that make an attack less effective, and given that terrorists are aware of this, the illustrative embodiment is less likely to issue an alarm when the environmental factors suggest that an attack is less effective, and, therefore, less likely. The illustrative embodiment accomplishes this by changing the threshold needed to issue an alarm based on one or more the environmental factors.",MAURER SCOTT M;;DERKSEN MARK J;;KOFLER KEVIN J;;FLEMING ROBERT H,MAURER SCOTT M;;DERKSEN MARK J;;KOFLER KEVIN J;;FLEMING ROBERT H,LOCKHEED MARTIN (2004-06-29),https://lens.org/180-176-262-572-831,Patent Application,yes,6,3,2,2,0,G08B21/12;;G08B31/00;;G16H50/80;;G08B31/00;;G08B21/12;;G16H50/80,G08B29/00;;G01N31/00;;G01N33/48;;G06G7/48;;G08B17/10,340/511;;340/632;;702/19;;702/22;;703/11;;703/12,0,0,,,,ACTIVE
481,CL,A1,CL 2019001778 A1,188-312-982-631-304,2019-10-04,2019,CL 2019001778 A,2019-06-25,US 201762442155 P,2017-01-04,Composiciones y métodos para controlar plagas de plantas.,SE DIVULGAN PROTEÍNAS INSECTICIDAS NOVEDOSAS QUE SON TÓXICAS PARA PLAGAS DE LEPIDÓPTEROS. LOS POLINUCLEÓTIDOS QUE CODIFICAN LAS PROTEÍNAS INSECTICIDAS PUEDEN USARSE PARA TRANSFORMAR ORGANISMOS PROCARIOTAS Y EUCARIOTAS PARA EXPRESAR LAS PROTEÍNAS INSECTICIDAS. LOS ORGANISMOS RECOMBINANTES O LAS COMPOSICIONES QUE COMPRENDEN LOS ORGANISMOS RECOMBINANTES O LAS PROTEÍNAS INSECTICIDAS SOLAS O EN COMBINACIÓN CON OTROS AGENTES PARA EL CONTROL DE PLAGAS Y UN PORTADOR AGRÍCOLA ADECUADO PUEDEN USARSE PARA CONTROLAR PLAGAS DE LEPIDÓPTEROS EN VARIOS ENTORNOS.,SYNGENTA PARTICIPATIONS AG,SEGUIN KATHERINE;;ROSE MARK SCOTT;;JUCOVIC MILAN;;BRAMLETT MATTHEW RICHARD;;FLEMING CHRISTOPHER,,https://lens.org/188-312-982-631-304,Patent Application,no,0,0,17,17,0,C12N15/8286;;A01N37/46;;C07K14/325;;Y02A40/146;;C07K14/325;;C12N15/8286;;Y02A40/146,A01H5/10;;A01N63/00;;A01N63/02,,0,0,,,,PENDING
482,US,A1,US 2003/0163417 A1,192-500-888-905-586,2003-08-28,2003,US 32178302 A,2002-12-16,US 32178302 A;;US 39897302 P;;US 34636302 P;;US 34279901 P,2001-12-19,Methods and systems for processing transaction requests,"
   Methods and systems are provided for processing money-order requests and other transactions. A list of prohibited persons is maintained, such as a copy of an OFAC SDN list. When a request is made to execute the transaction, name information is collected from a customer and compared with the list. If the name information matches an entry on the list, the transaction request is declined. 
",FIRST DATA CORP,CACHEY JOSEPH;;SEIFERT DEAN;;THOMPSON MARK;;FLEMING JUDY;;DARLAND CAROL;;ALGIENE KENNETH,FIRST DATA CORPORATION (2003-04-07);;THE WESTERN UNION COMPANY (2006-10-19),https://lens.org/192-500-888-905-586,Patent Application,yes,55,26,5,5,0,G06Q20/02;;G06Q20/02;;G06Q20/04;;G06Q20/04;;G06Q20/10;;G06Q20/10,G06Q20/02;;G06Q20/04;;G06Q20/10,705/39,0,0,,,,DISCONTINUED
483,EP,A2,EP 3708087 A2,142-627-802-145-69X,2020-09-16,2020,EP 20162816 A,2020-03-12,US 201916351094 A,2019-03-12,IMAGING DEVICE,"Provided is an imaging device (16) including a body (40), an x-ray detector assembly (42) attached to the body (40), and an x-ray source assembly (44) attached to the body (40). The x-ray detector assembly (42) includes a telescopic actuator (92) movable between a retracted position and an extended position, and an x-ray detector (90) attached to the telescopic actuator (92).
",OMEGA MEDICAL IMAGING LLC,RAY MARK;;YUAN CHARLIE;;HENNING CHRIS;;GRIBBEN THOMAS;;SCHMIDT JEFFREY C;;FLEMING BRIAN,,https://lens.org/142-627-802-145-69X,Patent Application,yes,0,0,4,4,0,A61B6/4441;;A61B6/4452;;A61B6/032;;A61B6/4208;;A61B6/588;;A61B6/4208;;A61B6/4441;;A61B6/4452;;A61B6/588,A61B6/00;;A61B6/03,,0,0,,,,PENDING
484,US,A1,US 2002/0135794 A1,175-047-900-882-999,2002-09-26,2002,US 81400901 A,2001-03-20,US 81400901 A,2001-03-20,Internet delivery of digitized photographs,"
   An improved Internet delivery system for digitized photographs is described. The system embodies methodologies that speed the delivery of digitized images from photographic film scan centers to consumers across the Internet with high reliability. By delivering all the digital images to a more powerful centralized server infrastructure prior to the consumer's earliest opportunity to view them on-line, these images or pictures can be downloaded to a viewer of interest (e.g., user or family member) quickly enough to provide an appropriate Web response. Optimizations are also described that streamline the throughput with load balancing and provide virtually guaranteed uniform service with fail-over. In this manner, the system provides improved access, storage, and on-line availability of digital images. 
",RODRIGUEZ JOHN;;BODMER BRIAN;;DUBE BRYAN;;TARANTINO MARK;;FLEMING JONAH KAJ;;KIRANI SHEKHAR,RODRIGUEZ JOHN;;BODMER BRIAN;;DUBE BRYAN;;TARANTINO MARK;;FLEMING JONAH KAJ;;KIRANI SHEKHAR,LIGHTSURF TECHNOLOGIES INC. A CORPORATION OF CALIFORNIA (2001-05-04);;RPX CORPORATION (2015-02-17);;VERISIGN INC (2006-12-20),https://lens.org/175-047-900-882-999,Patent Application,yes,16,61,2,2,0,H04N1/00132;;H04N1/00135;;H04N1/00137;;H04N1/00148;;H04N1/00164;;G06F16/9574;;H04N1/00132;;H04N1/00148;;H04N1/00137;;H04N1/00164;;H04N1/00135;;G06F16/9574,G06F17/30;;H04L29/06;;H04N1/00,358/1.15;;358/402,0,0,,,,EXPIRED
485,GB,A,GB 2613606 A,008-345-993-096-03X,2023-06-14,2023,GB 202117737 A,2021-12-08,GB 202117737 A,2021-12-08,Hair styling apparatus,"A hair styling apparatus (100, fig.1A) comprising leading and trailing portions 106, 107 which lead and trail, respectively, in movement along hair in use, with a movement axis extending therebetween. An airflow opening 120, in fluid communication with an air mover (109, fig.1B), and a steam outlet 113, in fluid communication with a steam generator, are spaced along the movement axis, where the steam outlet may be closer to the leading portion. The air opening may be an outlet, which as well as the steam outlet, may provide flow angled towards the leading portion and may comprise an elongate slot or a plurality of apertures extending substantially perpendicularly to the movement axis. A hair gripping portion 123 and a discharged air extraction portion (139, fig.4) may be provided. Outlets may be provided on one or both hair-facing surfaces 105 of two openable and closable arms 101. Sealing portions 124, 125 may seal discharged air from discharged steam. Also disclosed is a method of using the apparatus.",DYSON TECHNOLOGY LTD,JACOB MARK PARMENTER;;ROBERT LAWRENCE TWEEDIE;;JOHN FLEMING MACFADYEN;;NATHAN HARUNA WATERS IMHASLY,,https://lens.org/008-345-993-096-03X,Patent Application,no,5,0,3,3,0,A45D1/04;;A45D2/001;;A45D1/04;;A45D1/06;;A45D2/001;;A45D2/36;;A45D2/367;;A45D19/16;;A45D2001/008,A45D1/04;;A45D1/00;;A45D1/06;;A45D2/00;;A45D2/36;;A45D19/16,,0,0,,,,PENDING
486,GB,A,GB 2617075 A,023-683-671-765-654,2023-10-04,2023,GB 202204351 A,2022-03-28,GB 202204351 A,2022-03-28,Hair styling apparatus,"A hair styling apparatus 100 comprises a steam generator 12 for generating steam and one or more steam outlets 6 in fluid communication with the steam generator. The steam outlets are arranged to discharge steam onto hair being styled by the apparatus in use. The apparatus further comprises an air mover 13 for moving an airflow through the apparatus, and one or more airflow outlets 7 in fluid communication with the air mover. The one or more airflow outlets 7 are arranged to discharge air at or proximate to the discharged steam so as to provide a barrier to the passage of the steam. The apparatus further comprises a flow diverter 16 moveable between a first position in which the flow diverter directs airflow to the one or more airflow outlets and a second position in which the flow diverter directs airflow to the one or more steam outlets, or to one or more further airflow outlets (not shown) arranged to discharge air onto hair being styled by the apparatus in use.",DYSON TECHNOLOGY LTD,GEORGIA KATE BERRY HOWES;;JOHN FLEMING MACFADYEN;;JACOB MARK PARMENTER;;ROBERT LAWRENCE TWEEDIE,,https://lens.org/023-683-671-765-654,Patent Application,no,2,0,3,12,0,A45D2001/008;;A45D1/16;;A45D1/28;;A45D20/10;;A45D20/12;;A45D20/50;;A45D1/18;;A45D1/00;;A45D1/04;;A45D2/00;;A45D20/50;;A45D2001/008,A45D1/00;;A45D1/04;;A45D2/00;;A45D20/50,,0,0,,,,PENDING
487,US,S,US D0852947 S,101-615-833-339-889,2019-07-02,2019,US 201629581768 F,2016-10-21,US 201629581768 F,2016-10-21,Inhaler,,NORTON WATERFORD LTD,DETHLEFS SVEN;;FLEMING FREDERIC SCOTT;;MILTON-EDWARDS MARK;;OLIVERAS ENRIQUE CALDERON;;ROCHE JAMES,TEVA PHARMACEUTICALS EUROPE B.V (2017-01-25);;NORTON (WATERFORD) LIMITED (2017-01-19),https://lens.org/101-615-833-339-889,Design Right,no,70,12,1,1,0,,,2902;;D24/110,24,0,,,"U.S. Appl. No. 29/487,265, filed Apr. 7, 2014, Fosbury et al.;;U.S. Appl. No. 29/487,267, filed Apr. 7, 2014, Fosbury et al.;;U.S. Appl. No. 29/487,272, filed Apr. 7, 2014, Fosbury et al.;;U.S. Appl. No. 29/487,274, filed Apr. 7, 2014, Cottam.;;U.S. Appl. No. 29/487,276, filed Apr. 7, 2014, Fosbury et al.;;U.S. Appl. No. 29/487,277, filed Apr. 7, 2014, Fosbury et al.;;U.S. Appl. No. 29/487,280, filed Apr. 7, 2014, Cottam.;;U.S. Appl. No. 29/487,285, filed Apr. 7, 2014, Cottam.;;U.S. Appl. No. 29/487,287, filed Apr. 7, 2014, Fosbury et al.;;U.S. Appl. No. 29/487,289, filed Apr. 7, 2014, Cottam.;;U.S. Appl. No. 29/487,290, filed Apr. 7, 2014, Fosbury et al.;;U.S. Appl. No. 29/487,291, filed Apr. 7, 2014, Milton-Edwards et al.;;U.S. Appl. No. 29/487,293, filed Apr. 7, 2014, Milton-Edwards et al.;;U.S. Appl. No. 29/487,294, filed Apr. 7, 2014, Fosbury et al.;;U.S. Appl. No. 29/487,295, filed Apr. 7, 2014, Fosbury.;;U.S. Appl. No. 29/487,296, filed Apr. 7, 2014, Milton-Edwards et al.;;U.S. Appl. No. 29/487,298, filed Apr. 7, 2014, Milton-Edwards.;;U.S. Appl. No. 29/487,299, filed Apr. 7, 2014, Milton-Edwards et al.;;U.S. Appl. No. 29/487,300, filed Apr. 7, 2014, Milton-Edwards et al.;;U.S. Appl. No. 29/487,301, filed Apr. 7, 2014, Milton-Edwards et al.;;U.S. Appl. No. 29/487,302, filed Apr. 7, 2014, Fosbury et al.;;U.S. Appl. No. 29/487,303, filed Apr. 7, 2014, Fosbury et al.;;U.S. Appl. No. 29/487,304, filed Apr. 7, 2014, Fosbury et al.;;U.S. Appl. No. 29/487,305, filed Apr. 7, 2014, Fosbury et al.",ACTIVE
488,GB,A,GB 2617052 A,192-309-526-847-811,2023-10-04,2023,GB 202117733 A,2021-12-08,GB 202117733 A,2021-12-08,Hair styling apparatus,"A hair styling apparatus 100 comprising first and second elongate arms 101, each with opposing inner and outer surfaces 105, 104, the inner surfaces defining a hair-receiving space therebetween. One of the inner surfaces has an internal fluid outlet 120 to discharge fluid into the hair-receiving space, and one of the outer surfaces has an external fluid outlet 145 to discharge fluid externally. An extraction outlet (140, fig.4) may extract fluid from the hair-receiving space, which may be in communication with the external fluid outlet. Preferably, a flow director is movable via an actuator to direct fluid to the internal or external fluid outlet. The external fluid outlet may be a diffuser, a slot, or a row of apertures, and may discharge fluid along a curve of the outer surface or across a trailing or leading opening 146, 147 of the hair-receiving space. The fluid outlets may be hot airflow outlets, and an inner surface may also have a steam outlet 113.",DYSON TECHNOLOGY LTD,JACOB MARK PARMENTER;;ROBERT LAWRENCE TWEEDIE;;JOHN FLEMING MACFADYEN;;NATHAN HARUNA WATERS IMHASLY,,https://lens.org/192-309-526-847-811,Patent Application,no,2,0,3,3,0,A45D2001/008;;A45D1/06;;A45D1/02;;A45D2/001;;A45D20/10;;A45D2/367;;A45D1/04;;A45D1/06;;A45D2/001;;A45D2/36,A45D2/36;;A45D1/04;;A45D1/06;;A45D2/00,,0,0,,,,PENDING
489,US,A1,US 2015/0227306 A1,079-205-241-660-698,2015-08-13,2015,US 201514613428 A,2015-02-04,CN 201410047332 A,2014-02-11,PRIVATELY UNLOCKING A TOUCHSCREEN,"A device, method and computer program product are provided for unlocking a touchscreen. In response to entering a touchscreen unlocking interface, a slide-to-unlock button is displayed on a touchscreen at its initial position, wherein the slide-to-unlock button is divided into two portions. In response to pressing a first portion of the slide-to-unlock button and sliding the slide-to-unlock button along a specified trace, information about a position of the slide-to-unlock button on the specified trace is displayed on a second portion of the slide-to-unlock button. In response to performing a first action on the pressed first portion of the slide-to-unlock button, information about a position of the slide-to-unlock button on the specified trace when the first action is performed on the first portion of the slide-to-unlock button is received.",LENOVO ENTPR SOLUTIONS SINGAPORE PTE LTD,FLEMING MARK S;;FU ZHENDE;;JIANG TAO;;LI JIAN ZHONG;;WEI ZHI QIANG,LENOVO ENTERPRISE SOLUTIONS (SINGAPORE) PTE. LTD (2015-01-22),https://lens.org/079-205-241-660-698,Patent Application,yes,14,1,4,4,0,G06F21/36;;G06F21/36;;G06F3/0488;;G06F3/0488,G06F3/0484;;G06F3/0488,,0,0,,,,INACTIVE
490,US,B2,US 10888287 B2,157-970-621-989-976,2021-01-12,2021,US 201916351094 A,2019-03-12,US 201916351094 A,2019-03-12,Imaging device,"Provided is an imaging device including a body, an x-ray detector assembly attached to the body, and an x-ray source assembly attached to the body. The x-ray detector assembly includes a telescopic actuator movable between a retracted position and an extended position, and an x-ray detector attached to the telescopic actuator.",OMEGA MEDICAL IMAGING LLC,RAY MARK;;YUAN CHARLIE;;HENNING CHRIS;;GRIBBEN THOMAS;;SCHMIDT JEFFREY C;;FLEMING BRIAN,OMEGA MEDICAL IMAGING LLC (2019-03-11),https://lens.org/157-970-621-989-976,Granted Patent,yes,35,0,4,4,0,A61B6/4441;;A61B6/4452;;A61B6/032;;A61B6/4208;;A61B6/588;;A61B6/4208;;A61B6/4441;;A61B6/4452;;A61B6/588,A61B6/00,,3,0,,,"Soma Technology, Inc., “Siemens Arcadia Varic C-Arm,” https://www.somatechnology.com/C-Arms/Siemens-Arcadis-Varic.aspx, Mar. 13, 2019, 2 pages.;;Siemens Healthineers, “Cios Spin,” https://www.healthcare.siemens.com/surgical-c-arms-and-navigation/mobile-c-arms/cios-spin, Mar. 13, 2019, 5 pages.;;European Search Report for the corresponding EP Application No. 20162816.1, dated Aug. 3, 2020, 13 pages.",ACTIVE
491,GB,A,GB 2617073 A,060-474-218-095-032,2023-10-04,2023,GB 202204346 A,2022-03-28,GB 202204346 A,2022-03-28,Hair styling apparatus,"A hair styling apparatus comprises a body 3 from which a plurality of spaced projections 17 project. The projections are in the form of comb teeth or brush bristles. A steam generator (12, fig. 2A) is provided for generating a flow of steam to one or more steam outlets 6. The one or more steam outlets are arranged to discharge steam onto hair through which the projections are passed in use. An air mover (12, fig.2A) is also provided, for moving an airflow through the apparatus to one or more airflow outlets 7. The one or more airflow outlets are arranged to discharge air at or proximate to the discharged steam so as to provide a barrier to the passage of the steam. The steam may be discharged into spaces between the projections, or it may be discharged from a leading edge (29, fig. 6C) of a projection. Air may be discharged from the distal end of the projections. A flow diverter (16, fig. 2A) may be provided to divert airflow to the steam outlets.",DYSON TECHNOLOGY LTD,GEORGIA KATE BERRY HOWES;;JOHN FLEMING MACFADYEN;;JACOB MARK PARMENTER;;ROBERT LAWRENCE TWEEDIE,,https://lens.org/060-474-218-095-032,Patent Application,no,8,0,3,12,0,A45D2001/008;;A45D1/18;;A45D1/16;;A45D20/10;;A45D20/50;;A45D1/00;;A45D1/04;;A45D2/00;;A45D20/50;;A45D2001/008,A45D1/00;;A45D1/04;;A45D2/00;;A45D20/50,,0,0,,,,PENDING
492,US,B2,US 9652605 B2,128-250-252-358-222,2017-05-16,2017,US 201514613428 A,2015-02-04,CN 201410047332 A,2014-02-11,Privately unlocking a touchscreen,"A device, method and computer program product are provided for unlocking a touchscreen. In response to entering a touchscreen unlocking interface, a slide-to-unlock button is displayed on a touchscreen at its initial position, wherein the slide-to-unlock button is divided into two portions. In response to pressing a first portion of the slide-to-unlock button and sliding the slide-to-unlock button along a specified trace, information about a position of the slide-to-unlock button on the specified trace is displayed on a second portion of the slide-to-unlock button. In response to performing a first action on the pressed first portion of the slide-to-unlock button, information about a position of the slide-to-unlock button on the specified trace when the first action is performed on the first portion of the slide-to-unlock button is received.",LENOVO ENTPR SOLUTIONS SINGAPORE PTE LTD,FLEMING MARK S;;FU ZHENDE;;JIANG TAO;;LI JIAN ZHONG;;WEI ZHI QIANG,LENOVO ENTERPRISE SOLUTIONS (SINGAPORE) PTE. LTD (2015-01-22),https://lens.org/128-250-252-358-222,Granted Patent,yes,18,0,4,4,0,G06F3/0488;;G06F21/36;;G06F3/0488;;G06F21/36,G06F3/048;;G06F3/0488;;G06F21/36,,1,0,,,"Zhijun Zhang et al., “Unlocking Method and Device for Touch Screen”, English Abstract of CN102768587A, Nov. 7, 2012, 10 pages.",INACTIVE
493,US,A1,US 2020/0289073 A1,111-961-769-479-485,2020-09-17,2020,US 201916351094 A,2019-03-12,US 201916351094 A,2019-03-12,IMAGING DEVICE,"Provided is an imaging device including a body, an x-ray detector assembly attached to the body, and an x-ray source assembly attached to the body. The x-ray detector assembly includes a telescopic actuator movable between a retracted position and an extended position, and an x-ray detector attached to the telescopic actuator.",OMEGA MEDICAL IMAGING LLC,RAY MARK;;YUAN CHARLIE;;HENNING CHRIS;;GRIBBEN THOMAS;;SCHMIDT JEFFREY C;;FLEMING BRIAN,OMEGA MEDICAL IMAGING LLC (2019-03-11),https://lens.org/111-961-769-479-485,Patent Application,yes,1,1,4,4,0,A61B6/4441;;A61B6/4452;;A61B6/032;;A61B6/4208;;A61B6/588;;A61B6/4208;;A61B6/4441;;A61B6/4452;;A61B6/588,A61B6/00,,0,0,,,,ACTIVE
494,GB,B,GB 2303024 B,169-306-788-404-458,2000-04-12,2000,GB 9513432 A,1995-07-01,GB 9513432 A,1995-07-01,Method for determining handover in a multicellular communications system,,MOTOROLA LTD,JONES PHILIP EDWIN;;THOMAS HOWARD JOHN;;ESSAM KEITH LESLIE;;LE FLEMING ANDREW MARK,,https://lens.org/169-306-788-404-458,Granted Patent,no,3,0,13,13,0,H04W36/04;;H04W36/04,H04W36/04,H4L LDSHL         LDSHL;;H4L L1H10         LDSHE,0,0,,,,EXPIRED
495,US,B2,US 7154621 B2,128-685-769-671-505,2006-12-26,2006,US 81400901 A,2001-03-20,US 81400901 A,2001-03-20,Internet delivery of digitized photographs,"An improved Internet delivery system for digitized photographs is described. The system embodies methodologies that speed the delivery of digitized images from photographic film scan centers to consumers across the Internet with high reliability. By delivering all the digital images to a more powerful centralized server infrastructure prior to the consumer's earliest opportunity to view them on-line, these images or pictures can be downloaded to a viewer of interest (e.g., user or family member) quickly enough to provide an appropriate Web response. Optimizations are also described that streamline the throughput with load balancing and provide virtually guaranteed uniform service with fail-over. In this manner, the system provides improved access, storage, and on-line availability of digital images.",LIGHTSURF TECHNOLOGIES INC,RODRIGUEZ JOHN;;BODMER BRIAN;;DUBE BRYAN;;TARANTINO MARK;;FLEMING JONAH KAJ;;KIRANI SHEKHAR,LIGHTSURF TECHNOLOGIES INC. A CORPORATION OF CALIFORNIA (2001-05-04);;RPX CORPORATION (2015-02-17);;VERISIGN INC (2006-12-20),https://lens.org/128-685-769-671-505,Granted Patent,yes,16,83,2,2,0,H04N1/00132;;H04N1/00135;;H04N1/00137;;H04N1/00148;;H04N1/00164;;G06F16/9574;;H04N1/00132;;H04N1/00148;;H04N1/00137;;H04N1/00164;;H04N1/00135;;G06F16/9574,G06K15/00;;G06F17/30;;H04L29/06;;H04N1/00,358/1.15;;358/1.2,0,0,,,,EXPIRED
496,EP,A3,EP 3708087 A3,163-664-776-405-797,2020-12-02,2020,EP 20162816 A,2020-03-12,US 201916351094 A,2019-03-12,IMAGING DEVICE,"Provided is an imaging device (16) including a body (40), an x-ray detector assembly (42) attached to the body (40), and an x-ray source assembly (44) attached to the body (40). The x-ray detector assembly (42) includes a telescopic actuator (92) movable between a retracted position and an extended position, and an x-ray detector (90) attached to the telescopic actuator (92).
",OMEGA MEDICAL IMAGING LLC,RAY MARK;;YUAN CHARLIE;;HENNING CHRIS;;GRIBBEN THOMAS;;SCHMIDT JEFFREY C;;FLEMING BRIAN,,https://lens.org/163-664-776-405-797,Search Report,yes,0,0,4,4,0,A61B6/4441;;A61B6/4452;;A61B6/032;;A61B6/4208;;A61B6/588;;A61B6/4208;;A61B6/4441;;A61B6/4452;;A61B6/588,A61B6/00;;A61B6/03,,0,0,,,,PENDING
497,US,S,US D0832997 S,034-743-698-443-656,2018-11-06,2018,US 201629581777 F,2016-10-21,US 201629581777 F,2016-10-21,Inhaler,,NORTON WATERFORD LTD,DETHLEFS SVEN;;FLEMING FREDERIC SCOTT;;MILTON-EDWARDS MARK;;OLIVERAS ENRIQUE CALDERON;;ROCHE JAMES,TEVA PHARMACEUTICALS EUROPE B.V (2017-01-25);;NORTON (WATERFORD) LIMITED (2017-01-19),https://lens.org/034-743-698-443-656,Design Right,no,67,11,1,1,0,,,2902;;D24/110,24,0,,,"U.S. Appl. No. 29/487,265, filed Apr. 7, 2014, Fosbury et al.;;U.S. Appl. No. 29/487,267, filed Apr. 7, 2014, Fosbury et al.;;U.S. Appl. No. 29/487,272, filed Apr. 7, 2014, Fosbury et al.;;U.S. Appl. No. 29/487,274, filed Apr. 7, 2014, Cottam.;;U.S. Appl. No. 29/487,276, filed Apr. 7, 2014, Fosbury et al.;;U.S. Appl. No. 29/487,277, filed Apr. 7, 2014, Fosbury et al.;;U.S. Appl. No. 29/487,280, filed Apr. 7, 2014, Cottam.;;U.S. Appl. No. 29/487,285, filed Apr. 7, 2014, Cottam.;;U.S. Appl. No. 29/487,287, filed Apr. 7, 2014, Fosbury et al.;;U.S. Appl. No. 29/487,289, filed Apr. 7, 2014, Cottam.;;U.S. Appl. No. 29/487,290, filed Apr. 7, 2014, Fosbury et al.;;U.S. Appl. No. 29/487,291, filed Apr. 7, 2014, Milton-Edwards et al.;;U.S. Appl. No. 29/487,293, filed Apr. 7, 2014, Milton-Edwards et al.;;U.S. Appl. No. 29/487,294, filed Apr. 7, 2014, Fosbury et al.;;U.S. Appl. No. 29/487,295, filed Apr. 7, 2014, Fosbury.;;U.S. Appl. No. 29/487,296, filed Apr. 7, 2014, Milton-Edwards et al.;;U.S. Appl. No. 29/487,298, filed Apr. 7, 2014, Milton-Edwards.;;U.S. Appl. No. 29/487,299, filed Apr. 7, 2014, Milton-Edwards et al.;;U.S. Appl. No. 29/487,300, filed Apr. 7, 2014, Milton-Edwards et al.;;U.S. Appl. No. 29/487,301, filed Apr. 7, 2014, Milton-Edwards et al.;;U.S. Appl. No. 29/487,302, filed Apr. 7, 2014, Fosbury et al.;;U.S. Appl. No. 29/487,303, filed Apr. 7, 2014, Fosbury et al.;;U.S. Appl. No. 29/487,304, filed Apr. 7, 2014, Fosbury et al.;;U.S. Appl. No. 29/487,305, filed Apr. 7, 2014, Fosbury et al.",ACTIVE
498,GB,A,GB 2617074 A,126-546-738-036-16X,2023-10-04,2023,GB 202204348 A,2022-03-28,GB 202204348 A,2022-03-28,Hair styling apparatus,"A hair styling apparatus comprises a barrel 1, a steam generator (12, fig.2A) and one or more steam outlets 6 arranged to discharge steam onto a tress of hair when wrapped about the barrel. An air mover (13, fig. 2A) provides an airflow through the apparatus to one or more airflow outlets 7. The airflow outlets are arranged to discharge air in a 10 direction along the barrel to provide a barrier to the passage of the discharged steam. The airflow outlets 7 may discharge air in the form of an air curtain that is spaced radially from the circumferential surface. The air curtain may extend entirely around the surface. The air may be discharged at an angle to the barrel. A flow diverter (16, fig. 2A, 2B) which is moveable between two positions may be provided in communication with the steam generator (12, fig.2A) and the air mover (13, fig 2A). A first position allows steam to be discharged from the steam outlets and air to be discharged from the air outlets. In a second position air is discharged from both the steam and air outlets.",DYSON TECHNOLOGY LTD,GEORGIA KATE BERRY HOWES;;JOHN FLEMING MACFADYEN;;JACOB MARK PARMENTER;;ROBERT LAWRENCE TWEEDIE,,https://lens.org/126-546-738-036-16X,Patent Application,no,4,0,3,12,0,A45D2001/008;;A45D1/28;;A45D1/16;;A45D20/12;;A45D20/10;;A45D1/18;;A45D20/50;;A45D1/00;;A45D1/04;;A45D2/00;;A45D20/50;;A45D2001/008,A45D1/00;;A45D1/04;;A45D2/00;;A45D20/50,,0,0,,,,PENDING
499,US,B2,US 7208051 B2,031-967-447-842-381,2007-04-24,2007,US 80322804 A,2004-03-18,US 80322804 A,2004-03-18,Underbody car wash for home-use,"An underbody car wash sprayer for home-use, which can be hooked up solely to a garden hose or in combination with a pressure washer. The device utilizes a three nozzled “I” design, supported by four swiveling casters. In addition, it is connected to an ergonomically effective wand system to allow easy maneuverability under the vehicle. Finally, in some embodiments a trigger spray gun acts as a handle and pressure regulator. The compactness of the specific design allows for significant material reduction and hence a reduction in production costs, providing the consumer with a more economical choice. Additionally, the concentrated pressure and spray pattern of the “I” design along with its precision maneuverability allows the consumer to easily access and forcefully remove sediment adhesions to the vehicle underbody while controlling water flow at all times with a trigger spray gun.",ZMZ IMP S LLC,ZINSKI MARK J;;ROSSON DALE R;;FLEMING JAMES W;;ARBITURE AARON B;;HERRIED DAN,ZMZ IMPORTS LLC (2005-03-14),https://lens.org/031-967-447-842-381,Granted Patent,yes,7,8,3,3,0,B08B3/024;;B08B3/026;;B08B3/028;;B60S3/042;;B05B1/202;;B05B9/007;;B05B9/01;;B05B1/205;;B05B13/04;;B05B15/65;;B08B3/024;;B08B3/028;;B08B3/026;;B60S3/042;;B05B9/01;;B05B1/202;;B05B13/04;;B05B1/205;;B05B9/007;;B05B15/65,B08B3/00;;B08B3/02;;B60S3/04,134/34;;134/99.2;;134/123;;239/722,0,0,,,,INACTIVE
500,US,B2,US 8473787 B2,049-874-534-400-670,2013-06-25,2013,US 201213450408 A,2012-04-18,US 201213450408 A;;US 75787610 A,2010-04-09,Intelligent LUN generation and management,"A method for generating and managing logical units (LUNs) in a storage network environment is disclosed herein. In one embodiment, such a method includes determining a type of LUN, identifying one or more servers that will access the LUN, and identifying a storage system that will host the LUN. The method then generates a LUN name that encapsulates the type, the one or more servers, and the storage system. The method then assigns the LUN name to the LUN. A corresponding apparatus and computer program product are also disclosed herein.",FINNEGAN MICHAEL GERARD;;FLEMING MARK SEAN;;HUANG JIN YAN;;NELSEN MICHAEL ALLAN;;YIN WEI;;IBM,FINNEGAN MICHAEL GERARD;;FLEMING MARK SEAN;;HUANG JIN YAN;;NELSEN MICHAEL ALLAN;;YIN WEI,,https://lens.org/049-874-534-400-670,Granted Patent,yes,13,0,4,4,0,G06F3/0605;;G06F3/0605;;G06F3/0632;;G06F3/0632;;G06F3/067;;G06F3/067,G06F11/00;;G06F15/177,714/42;;709/220;;709/221;;709/222,2,0,,,"Media Robot Utility, Version 1.8A, Guide to Installation, Connectivity, and Operation, Tenth Edition (Oct. 2005), Hewlett-Packard Development Company, LP., 1. http://h71000.www7.hp.com/doc/robot18a-iguide.pdf.;;SCSI, RAID-Small Computer System Interface, University of California Irvine, http://www.nacs.uci.edu/dcslib/digital-unix/digital-v40g/Man/MAN7/0003-.HTM, last accessed Dec. 22, 2009.",ACTIVE
501,US,A1,US 2012/0203876 A1,057-396-655-601-846,2012-08-09,2012,US 201213450408 A,2012-04-18,US 201213450408 A;;US 75787610 A,2010-04-09,INTELLIGENT LUN GENERATION AND MANAGEMENT,"A method for generating and managing logical units (LUNs) in a storage network environment is disclosed herein. In one embodiment, such a method includes determining a type of LUN, identifying one or more servers that will access the LUN, and identifying a storage system that will host the LUN. The method then generates a LUN name that encapsulates the type, the one or more servers, and the storage system. The method then assigns the LUN name to the LUN. A corresponding apparatus and computer program product are also disclosed herein.",FINNEGAN MICHAEL G;;FLEMING MARK S;;HUANG JIN Y;;NELSEN MICHAEL A;;YIN WEI;;IBM,FINNEGAN MICHAEL G;;FLEMING MARK S;;HUANG JIN Y;;NELSEN MICHAEL A;;YIN WEI,,https://lens.org/057-396-655-601-846,Patent Application,yes,13,1,4,4,0,G06F3/0605;;G06F3/0605;;G06F3/0632;;G06F3/0632;;G06F3/067;;G06F3/067,G06F15/177,709/220,0,0,,,,ACTIVE
502,AU,B2,AU 711701 B2,064-212-793-875-84X,1999-10-21,1999,AU 1995/038646 A,1995-11-17,AU 1995/038646 A;;AU PM956694 A;;AU 1966/095007 W,1994-11-18,Inducing or enhancing electro-optical properties in optically transmissive material,,UNIV SYDNEY,FUJIWARA TAKUMI;;WONG DANNY;;FLEMING SIMON;;ZHAO YUXING;;SCEATS MARK;;POOLE SIMON;;TOWN GRAHAM,,https://lens.org/064-212-793-875-84X,Granted Patent,no,3,0,9,9,0,G02F1/011;;G02F1/3558;;G02F1/377;;G02F1/383;;G02F1/0113;;G02F1/011;;G02F1/3558;;G02F1/383;;G02F1/377;;G02F1/0113,G02F1/01;;G02F1/035;;G02F1/35;;G02F1/355;;G02F1/377;;G02F1/383,,0,0,,,,EXPIRED
503,US,A1,US 2014/0176441 A1,106-263-451-233-689,2014-06-26,2014,US 201213725552 A,2012-12-21,US 201213725552 A,2012-12-21,Architecture for Variable Pressure Mouse,"User input devices with variable pressure buttons are configured. A user may specify a range of pressure to be associated with a pressure level. In some embodiments, a user may also associate a command or other instruction to an application with an identity of a variable pressure button and a pressure level of the button. In some embodiments, the associations may be represented in a configuration profile. In further embodiments, a microcontroller for a mouse may translate signals from variable pressure buttons into pressure levels based upon the configuration file. In many embodiments, a user may associate a reporting rate with a variable pressure button. A legacy application may receive reports of the state of the variable pressure button at the associated reporting rate.",DELL PRODUCTS LP,CASPARIAN MARK A;;ROSS CARLOS L;;SIERRA DANAE;;AZOR FRANK C;;SEAY A FLEMING,DELL PRODUCTS LP (2012-12-17),https://lens.org/106-263-451-233-689,Patent Application,yes,7,12,4,4,0,G06F3/038;;G06F3/038;;G06F3/03543;;G06F3/03543;;G06F3/0383;;G06F3/0383,G06F3/033;;G06F3/01,345/163;;345/156,0,0,,,,ACTIVE
504,EP,A4,EP 0792473 A4,177-927-318-631-711,1998-05-06,1998,EP 95937727 A,1995-11-17,AU 1966/095007 W;;AU PM956694 A,1994-11-18,INDUCING OR ENHANCING ELECTRO-OPTICAL PROPERTIES IN OPTICALLY TRANSMISSIVE MATERIAL,,UNIV SYDNEY,FUJIWARA TAKUMI;;WONG DANNY;;FLEMING SIMON;;ZHAO YUXING;;SCEATS MARK;;POOLE SIMON;;TOWN GRAHAM,,https://lens.org/177-927-318-631-711,Search Report,no,0,0,9,9,0,G02F1/011;;G02F1/3558;;G02F1/377;;G02F1/383;;G02F1/0113;;G02F1/011;;G02F1/3558;;G02F1/383;;G02F1/377;;G02F1/0113,G02F1/01;;G02F1/035;;G02F1/35;;G02F1/355;;G02F1/377;;G02F1/383,,3,2,075-660-929-276-95X;;133-946-947-603-112,10.1117/12.188711;;10.1049/el:19950384,"DELL J M ET AL: ""Erasure of poling induced second order optical nonlinearities in silica by UV exposure"", DOPED FIBER DEVICES AND SYSTEMS, SAN DIEGO, CA, USA, 25-26 JULY 1994, vol. 2289, ISSN 0277-786X, PROCEEDINGS OF THE SPIE - THE INTERNATIONAL SOCIETY FOR OPTICAL ENGINEERING, 1994, USA, pages 185 - 193, XP002056751;;FUJIWARA T ET AL: ""ELECTRO-OPTIC MODULATION IN GERMANOSILICATE FIBRE WITH UV-EXCITED POLING"", ELECTRONICS LETTERS, vol. 31, no. 7, 30 March 1995 (1995-03-30), pages 573 - 575, XP000504320;;See also references of WO 9616344A1",DISCONTINUED
505,US,A,US 5966233 A,122-734-718-990-047,1999-10-12,1999,US 83683797 A,1997-08-19,AU PM956694 A;;AU 1966/095007 W,1994-11-18,Inducing or enhancing electro-optic properties in optically transmissive material with simultaneous UV irradiation and electric field application,A method of inducing or enhancing the electro-optic properties of an optically transmissive material such as an optical fiber (1) which comprises applying an electric field by means of electrodes (4) to the optical fiber and subjecting the material to UV radiation (9).,UNIV SYDNEY,FUJIWARA TAKUMI;;WONG DANNY;;FLEMING SIMON;;ZHAO YUXING;;SCEATS MARK;;POOLE SIMON;;TOWN GRAHAM,UNIVERSITY OF SYDNEY THE (1997-08-11),https://lens.org/122-734-718-990-047,Granted Patent,yes,20,32,9,9,0,G02F1/011;;G02F1/3558;;G02F1/377;;G02F1/383;;G02F1/0113;;G02F1/011;;G02F1/3558;;G02F1/383;;G02F1/377;;G02F1/0113,G02F1/01;;G02F1/035;;G02F1/35;;G02F1/355;;G02F1/377;;G02F1/383,359/240;;359/241;;359/245;;359/321;;264/1.36;;264/1.38;;250/492.1,15,13,071-701-091-561-812;;069-163-205-833-023;;133-946-947-603-112;;039-831-080-997-958;;018-111-971-073-065;;011-929-442-801-473;;011-995-150-497-428;;027-883-494-432-77X;;016-693-863-757-443;;052-281-276-581-53X;;069-163-205-833-023;;035-205-061-417-416;;133-946-947-603-112,10.1364/ol.16.000796;;19776788;;10.1364/ol.13.000592;;19745974;;10.1049/el:19950384;;10.1049/el:19950036;;10.1049/el:19941464;;10.1364/ol.19.001819;;19855664;;19784122;;10.1364/ol.16.001732;;10.1063/1.106845;;19738674;;10.1364/ol.11.000516;;10.1364/ol.12.000585;;19741806;;10.1364/ol.13.000592;;19745974;;10.1088/0022-3727/25/9/004;;10.1049/el:19950384,"Anderson, Dana Z. et al., Model for second harmonic generation in glass optical fibers based on asymmetric photoelectron emission from defect sites, Optics Letters , 16(11):796 798 (Jun. 1, 1991).;;Bergot, M. V. et al., Generation of permanent optically induced second order nonlinearities in optical fibers by poling, Optics Letters , 13(7):592 594 (Jul., 1988).;;Fujiwars, T. et al., Electro optic modulation in germanosilicate fibre with UV excited poling, Electronics Letters 31(7):573 574 (Mar. 30, 1995).;;Kazansky, P.G. et al., Pockels effect in thermally poled silica optical fibres, Electronics Letters , 31(1):62 63 (Jan. 5, 1995).;;Long, X.C. et al., Measurement of linear electro optic effect in temperature/electric field poled optical fibres, Electronics Letters , 30(25):2162 2163 (Dec. 8, 1994).;;Long, X.C., et al., Measurement of the linear electro optic coefficient in poled amorphous silica, Optics Letters , 19(32):1819 1821 (Nov. 15, 1994).;;Luksun U. et al., Generation of permanent second order susceptibility in lead silicate glass fibers, Ionics Research. estimated publication date:1991.;;Myers, R.A. et al., Large second order nonlinerarity in poled fused silica, Optics Letters , 15(22):1732 1734 (Nov. 15, 1991).;;Okada, A. et al., Phase matched second harmonic generation in novel corona poled glass waveguides, Appl. Phys. Lett 60(23):2853 2855 (Jun. 8, 1992).;;Osterberg, U. et al., Dye laser pumped by Nd:YAG laser pulses frequency doubled in a glass optical fiber, Optics Lertters 11(8):516 518 (Aug., 1986).;;Stolen, R.H. et al., Self organized phase matched harmonic generation in optical fibers, Optics Letters , 12(5):585 587 (Aug., 1987).;;Optical Society of America: M.V. Bergot, et al, Generation of permanent optically induced second order nonlinearities in optical fibers by poliing .;;Journal of physics D: Applied physics (Institute of Physics and the Physical Society, London), Mohjerani et al, Stability of NLO chromophores in doped polymer films during electric field poling , pp. 1304 1310 Fig. 6.;;J.M. Dell et al.; Erasure of poling induced second order optical nonlinearities in silica by UV exposure ; Doped Fiber Devices and Systems, SPIE; 1994; vol. 2289 pp. 185 193.;;T. Fujiwara et al.; Electro optic modulation in germanosilicate fibre with UV excited poling ; Electronics Letters , Mar. 30, 1995; vol. 31, No. 7, pp. 573 575.",EXPIRED
506,US,A1,US 2005/0205116 A1,164-020-658-360-615,2005-09-22,2005,US 80322804 A,2004-03-18,US 80322804 A,2004-03-18,Underbody car wash for home-use,"An underbody car wash sprayer for home-use, which can be hooked up solely to a garden hose or in combination with a pressure washer. The device utilizes a three nozzled “I” design, supported by four swiveling casters. In addition, it is connected to an ergonomically effective wand system to allow easy maneuverability under the vehicle. Finally, in some embodiments a trigger spray gun acts as a handle and pressure regulator. The compactness of the specific design allows for significant material reduction and hence a reduction in production costs, providing the consumer with a more economical choice. Additionally, the concentrated pressure and spray pattern of the “I” design along with its precision maneuverability allows the consumer to easily access and forcefully remove sediment adhesions to the vehicle underbody while controlling water flow at all times with a trigger spray gun.",ZINSKI MARK J;;ROSSON DALE R;;FLEMING JAMES W;;ARBITURE AARON B;;HERRIED DAN,ZINSKI MARK J;;ROSSON DALE R;;FLEMING JAMES W;;ARBITURE AARON B;;HERRIED DAN,ZMZ IMPORTS LLC (2005-03-14),https://lens.org/164-020-658-360-615,Patent Application,yes,6,7,3,3,0,B08B3/024;;B08B3/026;;B08B3/028;;B60S3/042;;B05B1/202;;B05B9/007;;B05B9/01;;B05B1/205;;B05B13/04;;B05B15/65;;B08B3/024;;B08B3/028;;B08B3/026;;B60S3/042;;B05B9/01;;B05B1/202;;B05B13/04;;B05B1/205;;B05B9/007;;B05B15/65,B08B3/00;;B08B3/02;;B60S3/04,134/34;;134/123,0,0,,,,INACTIVE
507,US,B2,US 7118574 B2,039-990-239-296-749,2006-10-10,2006,US 17273802 A,2002-06-14,US 17273802 A,2002-06-14,Arthroscopic bone burr device,"An arthroscopic bone burr having an articulated sheath tube. The sheath tube may be articulated angularly and transversely relative to the housing by a ball-type joint, a flange-in-socket joint with sufficient play to permit displacement of the sheath tube, or by use of an elastomer. Anti-rotation means are provided to prevent the sheath tube from rotating relative to the housing.",ETHICON INC,PATEL SAMIT J;;RYAN THOMAS;;COHN SIMON;;NOHILLY MARTIN;;EBBUTT JULIAN MARK;;FLEMING ALISTAIR,ETHICON INC (2002-08-07),https://lens.org/039-990-239-296-749,Granted Patent,yes,2,40,2,2,0,A61B17/32002;;A61B2017/1602;;A61B2017/320032;;A61B17/32002;;A61B2017/1602;;A61B2017/320032,A61B17/16;;A61B17/32,606/80,0,0,,,,ACTIVE
508,WO,A1,WO 1996/016344 A1,018-486-933-181-031,1996-05-30,1996,AU 1966/095007 W,1995-11-17,AU PM956694 A,1994-11-18,INDUCING OR ENHANCING ELECTRO-OPTICAL PROPERTIES IN OPTICALLY TRANSMISSIVE MATERIAL,A method of inducing or enhancing the electro-optic properties of an optically transmissive material such as an optical fibre (1) which comprises applying an electric field by means of electrodes (4) to the optical fibre and subjecting the material to UV radiation (9).,UNIV SYDNEY;;FUJIWARA TAKUMI;;WONG DANNY;;FLEMING SIMON;;ZHAO YUXING;;SCEATS MARK;;POOLE SIMON;;TOWN GRAHAM,FUJIWARA TAKUMI;;WONG DANNY;;FLEMING SIMON;;ZHAO YUXING;;SCEATS MARK;;POOLE SIMON;;TOWN GRAHAM,,https://lens.org/018-486-933-181-031,Patent Application,yes,15,23,9,9,0,G02F1/011;;G02F1/3558;;G02F1/377;;G02F1/383;;G02F1/0113;;G02F1/011;;G02F1/3558;;G02F1/383;;G02F1/377;;G02F1/0113,G02F1/01;;G02F1/035;;G02F1/35;;G02F1/355;;G02F1/377;;G02F1/383,,2,1,035-205-061-417-416,10.1088/0022-3727/25/9/004,"JOURNAL OF PHYSICS D: APPLIED PHYSICS (INSTISTUTE OF PHYSICS AND THE PHYSICAL SOCIETY, LONDON), MOHJERANI et al., ""Stability of NLO Chromophores in Doped Polymer Films During Electric Field Poling"", pages 1304-1310.;;See also references of EP 0792473A4",PENDING
509,EP,A1,EP 0792473 A1,099-909-457-809-990,1997-09-03,1997,EP 95937727 A,1995-11-17,AU 1966/095007 W;;AU PM956694 A,1994-11-18,INDUCING OR ENHANCING ELECTRO-OPTICAL PROPERTIES IN OPTICALLY TRANSMISSIVE MATERIAL,,UNIV SYDNEY,FUJIWARA TAKUMI;;WONG DANNY;;FLEMING SIMON;;ZHAO YUXING;;SCEATS MARK;;POOLE SIMON;;TOWN GRAHAM,,https://lens.org/099-909-457-809-990,Patent Application,yes,0,0,9,9,0,G02F1/011;;G02F1/3558;;G02F1/377;;G02F1/383;;G02F1/0113;;G02F1/011;;G02F1/3558;;G02F1/383;;G02F1/377;;G02F1/0113,G02F1/01;;G02F1/035;;G02F1/35;;G02F1/355;;G02F1/377;;G02F1/383,,0,0,,,,DISCONTINUED
510,US,A1,US 2016/0299573 A1,118-767-788-249-517,2016-10-13,2016,US 201615188291 A,2016-06-21,US 201615188291 A;;US 201213725552 A,2012-12-21,Architecture for Variable Pressure Mouse,"User input devices with variable pressure buttons are configured. A user may specify a range of pressure to be associated with a pressure level. In some embodiments, a user may also associate a command or other instruction to an application with an identity of a variable pressure button and a pressure level of the button. In some embodiments, the associations may be represented in a configuration profile. In further embodiments, a microcontroller for a mouse may translate signals from variable pressure buttons into pressure levels based upon the configuration file. In many embodiments, a user may associate a reporting rate with a variable pressure button. A legacy application may receive reports of the state of the variable pressure button at the associated reporting rate.",DELL PRODUCTS LP,CASPARIAN MARK A;;ROSS CARLOS L;;SIERRA DANAE;;AZOR FRANK C;;SEAY A FLEMING,,https://lens.org/118-767-788-249-517,Patent Application,yes,0,0,4,4,0,G06F3/038;;G06F3/038;;G06F3/03543;;G06F3/03543;;G06F3/0383;;G06F3/0383,G06F3/038;;G06F3/0354,,0,0,,,,ACTIVE
511,US,B2,US 9389711 B2,160-499-693-479-891,2016-07-12,2016,US 201213725552 A,2012-12-21,US 201213725552 A,2012-12-21,Architecture for variable pressure mouse,"User input devices with variable pressure buttons are configured. A user may specify a range of pressure to be associated with a pressure level. In some embodiments, a user may also associate a command or other instruction to an application with an identity of a variable pressure button and a pressure level of the button. In some embodiments, the associations may be represented in a configuration profile. In further embodiments, a microcontroller for a mouse may translate signals from variable pressure buttons into pressure levels based upon the configuration file. In many embodiments, a user may associate a reporting rate with a variable pressure button. A legacy application may receive reports of the state of the variable pressure button at the associated reporting rate.",DELL PRODUCTS LP,CASPARIAN MARK A;;ROSS CARLOS L;;SIERRA DANAE;;AZOR FRANK C;;SEAY A FLEMING,DELL PRODUCTS LP (2012-12-17),https://lens.org/160-499-693-479-891,Granted Patent,yes,26,3,4,4,0,G06F3/038;;G06F3/038;;G06F3/03543;;G06F3/03543;;G06F3/0383;;G06F3/0383,G06F3/038;;G06F3/0354,,0,0,,,,ACTIVE
512,US,A1,US 2008/0099588 A1,142-603-861-633-03X,2008-05-01,2008,US 73742007 A,2007-04-19,US 73742007 A;;US 80322804 A,2004-03-18,UNDERBODY CAR WASH FOR HOME USE,"An underbody car wash sprayer for home-use, which can be hooked up solely to a garden hose or in combination with a pressure washer. The device utilizes a three nozzled “I” design, supported by four swiveling casters. In addition, it is connected to an ergonomically effective wand system to allow easy maneuverability under the vehicle. Finally, in some embodiments a trigger spray gun acts as a handle and pressure regulator. The compactness of the specific design allows for significant material reduction and hence a reduction in production costs, providing the consumer with a more economical choice. Additionally, the concentrated pressure and spray pattern of the “I” design along with its precision maneuverability allows the consumer to easily access and forcefully remove sediment adhesions to the vehicle underbody while controlling water flow at all times with a trigger spray gun.",ZINSKI MARK J;;ROSSON DALE R;;FLEMING JAMES W;;ARBITURE AARON B;;HERRIED DAN,ZINSKI MARK J;;ROSSON DALE R;;FLEMING JAMES W;;ARBITURE AARON B;;HERRIED DAN,,https://lens.org/142-603-861-633-03X,Patent Application,yes,8,4,3,3,0,B08B3/024;;B08B3/026;;B08B3/028;;B60S3/042;;B05B1/202;;B05B9/007;;B05B9/01;;B05B1/205;;B05B13/04;;B05B15/65;;B08B3/024;;B08B3/028;;B08B3/026;;B60S3/042;;B05B9/01;;B05B1/202;;B05B13/04;;B05B1/205;;B05B9/007;;B05B15/65,B08B3/00;;B05B3/00;;B08B3/02;;B60S3/04,239/722;;134/123;;239/532,0,0,,,,DISCONTINUED
513,CA,A1,CA 2206018 A1,064-538-699-570-775,1996-05-30,1996,CA 2206018 A,1995-11-17,AU PM956694 A,1994-11-18,INDUCING OR ENHANCING ELECTRO-OPTICAL PROPERTIES IN OPTICALLY TRANSMISSIVE MATERIAL,A method of inducing or enhancing the electro-optic properties of an optically transmissive material such as an optical fibre (1) which comprises applying an electric field by means of electrodes (4) to the optical fibre and subjecting the material to UV radiation (9).,UNIV SYDNEY,POOLE SIMON;;FLEMING SIMON;;TOWN GRAHAM;;SCEATS MARK;;WONG DANNY;;FUJIWARA TAKUMI;;ZHAO YUXING,,https://lens.org/064-538-699-570-775,Patent Application,no,0,0,9,9,0,G02F1/011;;G02F1/3558;;G02F1/377;;G02F1/383;;G02F1/0113;;G02F1/011;;G02F1/3558;;G02F1/383;;G02F1/377;;G02F1/0113,G02F1/01;;G02F1/035;;G02F1/35;;G02F1/355;;G02F1/377;;G02F1/383,,0,0,,,,DISCONTINUED
514,US,B2,US 9665191 B2,105-785-603-069-964,2017-05-30,2017,US 201615188291 A,2016-06-21,US 201615188291 A;;US 201213725552 A,2012-12-21,Architecture for variable pressure mouse,"User input devices with variable pressure buttons are configured. A user may specify a range of pressure to be associated with a pressure level. In some embodiments, a user may also associate a command or other instruction to an application with an identity of a variable pressure button and a pressure level of the button. In some embodiments, the associations may be represented in a configuration profile. In further embodiments, a microcontroller for a mouse may translate signals from variable pressure buttons into pressure levels based upon the configuration file. In many embodiments, a user may associate a reporting rate with a variable pressure button. A legacy application may receive reports of the state of the variable pressure button at the associated reporting rate.",DELL PRODUCTS LP,CASPARIAN MARK A;;ROSS CARLOS L;;SIERRA DANAE;;AZOR FRANK C;;SEAY A FLEMING,,https://lens.org/105-785-603-069-964,Granted Patent,yes,19,0,4,4,0,G06F3/038;;G06F3/038;;G06F3/03543;;G06F3/03543;;G06F3/0383;;G06F3/0383,G06F3/038;;G06F3/0354,,0,0,,,,ACTIVE
515,US,B2,US 8402118 B2,122-518-033-468-989,2013-03-19,2013,US 75787610 A,2010-04-09,US 75787610 A,2010-04-09,Intelligent LUN generation and management,"An apparatus for generating and managing logical units (LUNs) in a storage network environment is disclosed herein. In one embodiment, such an apparatus includes an identification module to identify a type of LUN, one or more servers that will access the LUN, and a storage system that will host the LUN. A mapping module maps the type, the one or more servers, and the storage system to one more abbreviations. A naming module then generates a LUN name that encapsulates the abbreviations. An assignment module may then assign the LUN name to the LUN. A corresponding method and computer program product are also disclosed herein.",FINNEGAN MICHAEL GERARD;;FLEMING MARK SEAN;;HUANG JIN YAN;;NELSEN MICHAEL ALLAN;;YIN WEI;;IBM,FINNEGAN MICHAEL GERARD;;FLEMING MARK SEAN;;HUANG JIN YAN;;NELSEN MICHAEL ALLAN;;YIN WEI,INTERNATIONAL BUSINESS MACHINES CORPORATION (2010-04-08),https://lens.org/122-518-033-468-989,Granted Patent,yes,13,15,4,4,0,G06F3/0605;;G06F3/0605;;G06F3/0632;;G06F3/0632;;G06F3/067;;G06F3/067,G06F15/177,709/220,2,0,,,"Media Robot Utility, Version 1.8A, Guide to Installation, Connectivity, and Operation, Tenth Edition (Oct. 2005), Hewlett-Packard Development Company, L.P., 1. http://h71000.www7.hp.com/doc/robot18a-iguide.pdf.;;SCSI, RAID-Small Computer System Interface, University of California Irvine, http://www.nacs.uci.edu/dcslib/digital-unix/digital-v40g/MAN/MAN7/0003-.HTM, last accessed Dec. 22, 2009.",INACTIVE
516,AU,A,AU 1995/038646 A,140-140-822-842-567,1996-06-17,1996,AU 1995/038646 A,1995-11-17,AU 1995/038646 A;;AU PM956694 A;;AU 1966/095007 W,1994-11-18,Inducing or enhancing electro-optical properties in optically transmissive material,,UNIVERSITY OF SYDNEY THE,FUJIWARA TAKUMI;;WONG DANNY;;FLEMING SIMON;;ZHAO YUXING;;SCEATS MARK;;POOLE SIMON;;TOWN GRAHAM,,https://lens.org/140-140-822-842-567,Patent Application,no,0,0,9,9,0,G02F1/011;;G02F1/3558;;G02F1/377;;G02F1/383;;G02F1/0113;;G02F1/011;;G02F1/3558;;G02F1/383;;G02F1/377;;G02F1/0113,G02F1/01;;G02F1/035;;G02F1/35;;G02F1/355;;G02F1/377;;G02F1/383,,0,0,,,,EXPIRED
517,US,A1,US 2011/0252280 A1,120-520-514-896-810,2011-10-13,2011,US 75787610 A,2010-04-09,US 75787610 A,2010-04-09,INTELLIGENT LUN GENERATION AND MANAGEMENT,"An apparatus for generating and managing logical units (LUNs) in a storage network environment is disclosed herein. In one embodiment, such an apparatus includes an identification module to identify a type of LUN, one or more servers that will access the LUN, and a storage system that will host the LUN. A mapping module maps the type, the one or more servers, and the storage system to one more abbreviations. A naming module then generates a LUN name that encapsulates the abbreviations. An assignment module may then assign the LUN name to the LUN. A corresponding method and computer program product are also disclosed herein.",IBM,FINNEGAN MICHAEL G;;FLEMING MARK S;;HUANG JIN Y;;NELSEN MICHAEL A;;YIN WEI,INTERNATIONAL BUSINESS MACHINES CORPORATION (2010-04-08),https://lens.org/120-520-514-896-810,Patent Application,yes,12,7,4,4,0,G06F3/0605;;G06F3/0605;;G06F3/0632;;G06F3/0632;;G06F3/067;;G06F3/067,G06F15/177;;G06F11/26,714/42;;709/222;;X714E11159,0,0,,,,INACTIVE
518,WO,A1,WO 2023/122058 A1,007-991-287-977-438,2023-06-29,2023,US 2022/0053460 W,2022-12-20,US 202163292063 P,2021-12-21,URINARY PLACEMENT CATHETER FOR INTRAVESICAL DEVICES,"An inserter assembly (200) for deploying an intravesical device into a urinary bladder of a patient includes a placement catheter (210), a receiving funnel (220), and a stylet (230). The placement catheter defines a lumen extending from a proximal catheter end to an exit opening. The receiving funnel is secured to the placement catheter. The stylet is removably received through the receiving funnel within the lumen. The stylet includes a stylet body and a paddle (238). The stylet body is dimensioned to drive the intravesical device through the lumen and the exit opening into the bladder. The paddle is fixed to the stylet body about the proximal stylet end and is engageable with the receiving funnel. The paddle optionally includes a fitting (242) being lockably engageable with the receiving funnel to removably secure the stylet to the placement catheter.",TARIS BIOMEDICAL LLC,DIUBALDI ANTHONY;;FLEMING JAMES;;HO DUC HONG LINH;;JOHNSON WAYNE;;LEWIS MARK;;MELLO JASON,,https://lens.org/007-991-287-977-438,Patent Application,yes,13,0,2,2,0,A61M31/007;;A61M31/002,A61M31/00,,0,0,,,,PENDING
519,US,A1,US 2003/0233111 A1,034-518-394-510-118,2003-12-18,2003,US 17273802 A,2002-06-14,US 17273802 A,2002-06-14,Arthroscopic bone burr device,"
   An arthroscopic bone burr having an articulated sheath tube. The sheath tube may be articulated angularly and transversely relative to the housing by a ball-type joint, a flange-in-socket joint with sufficient play to permit displacement of the sheath tube, or by use of an elastomer. Anti-rotation means are provided to prevent the sheath tube from rotating relative to the housing. 
",ETHICON INC,PATEL SAMIT J;;RYAN THOMAS;;COHN SIMON;;NOHILLY MARTIN;;EBBUTT JULIAN MARK;;FLEMING ALISTAIR,ETHICON INC (2002-08-07),https://lens.org/034-518-394-510-118,Patent Application,yes,2,7,2,2,0,A61B17/32002;;A61B2017/1602;;A61B2017/320032;;A61B17/32002;;A61B2017/1602;;A61B2017/320032,A61B17/16;;A61B17/32,60617,0,0,,,,EXPIRED
520,TW,A,TW 202339815 A,040-145-154-633-950,2023-10-16,2023,TW 111148991 A,2022-12-20,US 202163292063 P,2021-12-21,Urinary placement catheter for intravesical devices,"An inserter assembly for deploying an intravesical device into a urinary bladder of a patient includes a placement catheter, a receiving funnel, and a stylet. The placement catheter defines a lumen extending from a proximal catheter end to an exit opening. The receiving funnel is secured to the placement catheter. The stylet is removably received through the receiving funnel within the lumen. The stylet includes a stylet body and a paddle. The stylet body extends between a proximal stylet end and a distal stylet end. The stylet body is dimensioned to drive the intravesical device through the lumen and the exit opening into the bladder. The paddle is fixed to the stylet body about the proximal stylet end and is engageable with the receiving funnel. The paddle optionally includes a fitting being lockably engageable with the receiving funnel to removably secure the stylet to the placement catheter.",TARIS BIOMEDICAL LLC,DIUBALDI ANTHONY;;FLEMING JAMES;;HO DUC HONG LINH;;JOHNSON WAYNE;;LEWIS MARK;;MELLO JASON,,https://lens.org/040-145-154-633-950,Patent of Addition,no,0,0,2,2,0,A61M31/007;;A61M31/002,A61M31/00;;A61B1/307,,0,0,,,,PENDING
521,US,B1,US 8070044 B1,014-815-962-080-335,2011-12-06,2011,US 95848010 A,2010-12-02,US 95848010 A,2010-12-02,Polyamine flux composition and method of soldering,"A polyamine flux composition is provided, comprising, as an initial component: a polyamine fluxing agent represented by formula I: wherein R 1 , R 2 , R 3 and R 4 are independently selected from a hydrogen, a substituted C 1-80 alkyl group, an unsubstituted C 1-80 alkyl group, a substituted C 7-80 arylalkyl group and an unsubstituted C 7-80 arylalkyl group; wherein R 7 comprises at least two tertiary carbons and is selected from an unsubstituted C 5-80 alkyl group, a substituted C 5-80 alkyl group, an unsubstituted C 12-80 arylalkyl group and a substituted C 12-80 arylalkyl group; and, wherein the two nitrogens shown in formula I are each separately bound to one of the at least two tertiary carbons of R 7 ; with the proviso that when the polyamine fluxing agent of formula I is represented by formula Ia: then zero to three of R 1 , R 2 , R 3 and R 4 is(are) hydrogen. Also provided is a method of soldering an electrical contact using the polyamine flux composition.",FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;WINKLE MARK R;;ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;WINKLE MARK R,ROHM AND HAAS ELECTRONIC MATERIALS LLC (2011-02-11),https://lens.org/014-815-962-080-335,Granted Patent,yes,49,4,9,9,0,B22F2998/00;;B23K35/025;;B23K35/262;;B23K35/36;;B23K35/3612;;B23K35/362;;C22C12/00;;C22C13/00;;B23K35/36;;C22C12/00;;C22C13/00;;B23K35/262;;B22F2998/00;;B23K35/025;;B23K35/3612;;B23K35/362,B23K31/02;;B23K35/34,228/180.21;;228/207;;228/223;;228/224;;228/248.1;;148/23;;148/24,5,0,,,"STIC search (no date available).;;Copending U.S. Appl. No. 12/958,495.;;Copending U.S. Appl. No. 12/958,487.;;Copending U.S. Appl. No. 12/958,493.;;Copending U.S. Appl. No. 12/958,473.",INACTIVE
522,CN,A,CN 102554512 A,088-691-417-720-31X,2012-07-11,2012,CN 201110463043 A,2011-12-02,US 95847310 A,2010-12-02,Curable flux composition and method of soldering,"A curable flux composition and a soldering method are provided. The curable flux composition provided by the invention comprises, as initial components: a resin component having at least two oxirane groups per molecule; a fluxing agent represented by formula I: wherein R1, R2, R3 and R4 are independently selected from a hydrogen, a substituted C1-80 alkyl group, an unsubstituted C1-80 alkyl group, a substituted C7-80 arylalkyl group and an unsubstituted C7-80 arylalkyl group; and wherein zero to three of R1, R2, R3 and R4 is(are) hydrogen; and, optionally, a curing agent. Also provided is a method of soldering an electrical contact using the curable flux composition.",ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;SANG HO KIM;;XIANG-QIAN LIU;;WINKLE MARK R,,https://lens.org/088-691-417-720-31X,Patent Application,no,6,3,15,15,0,B23K35/3613;;B23K35/362;;C08G59/184;;C08G59/5026;;C08L63/00;;H05K3/3489;;C08K5/17;;C07C217/52;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/362;;C08G59/5026;;B23K35/3613;;H05K3/3489;;C08L63/00;;C08G59/184;;C08K5/17,B23K35/362;;B23K1/00,,0,0,,,,INACTIVE
523,TW,B,TW I438178 B,145-379-650-174-545,2014-05-21,2014,TW 100144125 A,2011-12-01,US 95848010 A,2010-12-02,A polyamine flux composition and method of soldering,,ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XINAG-QIAN;;WINKLE MARK R,,https://lens.org/145-379-650-174-545,Granted Patent,no,0,0,9,9,0,B22F2998/00;;B23K35/025;;B23K35/262;;B23K35/36;;B23K35/3612;;B23K35/362;;C22C12/00;;C22C13/00;;B23K35/36;;C22C12/00;;C22C13/00;;B23K35/262;;B22F2998/00;;B23K35/025;;B23K35/3612;;B23K35/362,,,0,0,,,,INACTIVE
524,TW,A,TW 201231441 A,189-064-693-447-611,2012-08-01,2012,TW 100144123 A,2011-12-01,US 95849510 A,2010-12-02,A flux composition and method of soldering,"A flux composition is provided, comprising, as an initial component: a fluxing agent represented by formula I: wherein R1, R2, R3 and R4 are independently selected from a hydrogen, a substituted C1-80 alkyl group, an unsubstituted C1-80 alkyl group, a substituted C7-80 arylalkyl group and an unsubstituted C7-80 arylalkyl group; and wherein zero to three of R1, R2, R3 and R4 is(are) hydrogen. Also provided is a method of soldering an electrical contact using the flux composition.",ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;WINKLE MARK R;;LIU XIANG-QIAN,,https://lens.org/189-064-693-447-611,Patent of Addition,no,0,0,12,12,0,B23K1/0016;;B23K1/203;;B23K35/3615;;B23K35/362;;B23K2101/42;;C07C217/52;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/3615;;B23K1/0016;;B23K35/362;;B23K1/203;;B23K2101/42,B23K35/362;;C07C217/42;;C07C217/46;;C07C217/74;;H05K3/34,,0,0,,,,INACTIVE
525,CN,A,CN 116302471 A,112-142-074-638-07X,2023-06-23,2023,CN 202211651236 A,2022-12-21,US 202117558118 A,2021-12-21,"Apparatus, system and method for intelligent tuning of overclocking frequencies","Devices, systems, and methods for intelligent tuning of overclocking frequencies are disclosed. Apparatuses, systems, and methods for intelligently tuning overclocking frequencies are disclosed. An example apparatus includes trial control circuitry to execute an optimization model to select a first value for an overclocking parameter of a processor, the first value associated with a first trial, and to execute a benchmark test of the processor when the processor operates based on the first value; test evaluation circuitry to calculate a first score for the first test based on the benchmark detection test; and model update circuitry to perform a comparison of the first score and a second score, the second score associated with a second trial corresponding to a second value of the overclocking parameter, the second value being different from the first value, and to select one of the first value or the second value to overclocking the processor based on the comparison.",INTEL CORP,YAN JOHN;;XIONG HUI;;JOO JAKE;;GONZALEZ FERNANDO;;MACDONALD MARK;;RAGLAND DANNY;;RODRIGUEZ RODOLFO;;FYFE MARK;;LI YUZHUO;;FLEMING KERMIN,,https://lens.org/112-142-074-638-07X,Patent Application,no,0,0,3,3,0,G06F9/5027;;G06F1/08;;G06F1/206;;G06F1/3243;;Y02D10/00;;G06F1/206;;G06F1/08,G06F9/50;;G06F1/08,,0,0,,,,PENDING
526,TW,B,TW I495628 B,052-340-431-539-081,2015-08-11,2015,TW 104100911 A,2011-12-01,US 95847310 A,2010-12-02,A CURABLE FLUX COMPOSITION AND METHOD OF SOLDERING,,ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;WINKLE MARK R;;LIU XIANG-QIAN,,https://lens.org/052-340-431-539-081,Granted Patent,no,2,0,15,15,0,B23K35/3613;;B23K35/362;;C08G59/184;;C08G59/5026;;C08L63/00;;H05K3/3489;;C08K5/17;;C07C217/52;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/362;;C08G59/5026;;B23K35/3613;;H05K3/3489;;C08L63/00;;C08G59/184;;C08K5/17,,,0,0,,,,INACTIVE
527,FR,A1,FR 2968228 A1,143-928-509-216-001,2012-06-08,2012,FR 1161086 A,2011-12-02,US 95848010 A,2010-12-02,COMPOSITION DE FONDANT DE POLYAMINE ET PROCEDE DE BRASAGE,"Une composition de fondant de polyamine comprend un agent de ouverture de fondant de polyamine représenté par la formule I : dans laquelle R , R , R et R sont indépendamment choisis parmi un hydrogène, un groupe alkyle en C substitué, un groupe alkyle en C non substitué, un groupe arylalkyle en C substitué et un groupe arylalkyle en C non substitué ; dans laquelle R comprend au moins deux atomes de carbone tertiaire et est choisi parmi un groupe alkyle en C non substitué, un groupe alkyle en C substitué, un groupe arylalkyle en C non substitué et un groupe arylalkyle en C substitué ; et, dans lequel les deux atomes d'azote représentés dans la formule I sont chacun séparément liés à l'un des au moins deux atomes de carbone tertiaire de R ; à condition que lorsque l'agent de couverture de fondant de polyamine de la formule I est représenté par la formule la : alors de zéro à trois parmi R , R , R et R est(sont) l'hydrogène.",ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;WINKLE MARK R,,https://lens.org/143-928-509-216-001,Patent Application,no,4,0,9,9,0,B22F2998/00;;B23K35/025;;B23K35/262;;B23K35/36;;B23K35/3612;;B23K35/362;;C22C12/00;;C22C13/00;;B23K35/36;;C22C12/00;;C22C13/00;;B23K35/262;;B22F2998/00;;B23K35/025;;B23K35/3612;;B23K35/362,B23K35/363;;C08K5/17;;C08L63/00;;H05K3/32,,0,0,,,,INACTIVE
528,CN,A,CN 102554513 A,048-442-090-219-84X,2012-07-11,2012,CN 201110463044 A,2011-12-02,US 95848010 A,2010-12-02,Polyamine flux composition and method of soldering,"The invention relates to a polyamine flux composition and a method of soldering. The composition comprises: as an initial component, a polyamine fluxing agent represented by formula I, wherein R<1>, R<2>, R<3> and R<4> are independently selected from a hydrogen, a substituted C1-80 alkyl group, an unsubstituted C1-80 alkyl group, a substituted C7-80 arylalkyl group and an unsubstituted C7-80 arylalkyl group; wherein R<7> comprises at least two tertiary carbons and is selected from an unsubstituted C5-80 alkyl group, a substituted C5-80 alkyl group, an unsubstituted C12-80 arylalkyl group and a substituted C12-80 arylalkyl group; and, wherein the two nitrogens shown in formula I are each separately bound to one of the at least two tertiary carbons of R7; with the proviso that when the polyamine fluxing agent of formula I is represented by formula Ia: then zero to three of R<1>, R<2>, R<3> and R<4> is(are) hydrogen. Also provided is a method of soldering an electrical contact using the polyamine flux composition.",ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;SANG HO KIM;;XIANG-QIAN LIU;;WINKLE MARK R,,https://lens.org/048-442-090-219-84X,Patent Application,no,4,0,9,9,0,B22F2998/00;;B23K35/025;;B23K35/262;;B23K35/36;;B23K35/3612;;B23K35/362;;C22C12/00;;C22C13/00;;B23K35/36;;C22C12/00;;C22C13/00;;B23K35/262;;B22F2998/00;;B23K35/025;;B23K35/3612;;B23K35/362,B23K35/362;;B23K1/00,,0,0,,,,INACTIVE
529,US,S,US D0886267 S,063-111-182-336-987,2020-06-02,2020,US 201629584852 F,2016-11-17,US 201629584852 F;;US 201529521116 F,2015-03-19,Humidifier heaterbase,,FISHER & PAYKEL HEALTHCARE LTD,HAMILTON MARK SAMUEL;;BUCKLEY PAUL FLEMING;;EVANS STEPHEN DAVID;;HOLYOAKE BRUCE GORDON;;KLENNER JASON ALLAN,FISHER & PAYKEL HEALTHCARE LIMITED (2015-04-07),https://lens.org/063-111-182-336-987,Design Right,no,23,4,5,5,0,,,2304;;D23/356,0,0,,,,ACTIVE
530,CN,A,CN 104675501 A,082-701-806-097-339,2015-06-03,2015,CN 201410693420 A,2014-11-26,US 201314092546 A,2013-11-27,Method for adjusting vehicle grille shutters based on vehicle speed and direction of grille shutter adjustment,"Methods and systems are provided for adjusting vehicle grille shutters based on a direction of motion of the grille shutters. In one example, a method includes adjusting a motor coupled to the grille shutters based on the direction of motion of the grille shutters, a desired opening of the grille shutters, and vehicle speed. Further, the method may include determining the direction of motion of the grille shutters based on a desired motor position relative to an actual motor position.",FORD GLOBAL TECH LLC,CHRISTOPHER SEMANSON;;ROBERT ROY JENTZ;;JOSEPH JAMES GALLO;;MARK FLEMING;;KEVIN MACFARLANE;;COLBY JASON BUCKMAN,,https://lens.org/082-701-806-097-339,Patent Application,no,9,2,8,8,0,B60K11/085;;B60K11/085;;B60K11/085;;F01P7/10;;F01P7/10;;F01P7/10;;F01P7/10;;Y02T10/88;;Y02T10/88,F01P7/10,,0,0,,,,ACTIVE
531,CN,A,CN 102615453 A,088-088-699-285-582,2012-08-01,2012,CN 201110463357 A,2011-12-02,US 95849510 A,2010-12-02,Flux composition and method of soldering,"A flux composition and a soldering method are provided. The invention provides the flux composition comprising, as an initial component: a fluxing agent represented by formula I: wherein R1, R2, R3 and R4 are independently selected from a hydrogen, a substituted C1-80 alkyl group, an unsubstituted C1-80 alkyl group, a substituted C7-80 arylalkyl group and an unsubstituted C7-80 arylalkyl group; and wherein zero to three of R1, R2, R3 and R4 is(are) hydrogen. Also provided is a method of soldering an electrical contact using the flux composition.",ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;SANG HO KIM;;XIANG-QIAN LIU;;WINKLE MARK R,,https://lens.org/088-088-699-285-582,Patent Application,no,4,0,12,12,0,B23K1/0016;;B23K1/203;;B23K35/3615;;B23K35/362;;B23K2101/42;;C07C217/52;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/3615;;B23K1/0016;;B23K35/362;;B23K1/203;;B23K2101/42,B23K35/363;;B23K1/00,,0,0,,,,INACTIVE
532,JP,A,JP 2012135815 A,018-035-319-931-100,2012-07-19,2012,JP 2011260170 A,2011-11-29,US 95848010 A,2010-12-02,POLYAMINE FLUX COMPOSITION AND METHOD OF SOLDERING,"PROBLEM TO BE SOLVED: To provide a flux composition which is non-hardenability, facilitates soldering connection that can be trusted, and can be customized to facilitate compatibility with an underfill material of a conventional epoxy base, and also to provide a method of soldering an electrical contact using the polyamine flux composition.SOLUTION: The polyamine flux composition comprises, as an initial component: a polyamine fluxing agent represented by formula I, and is used. In the formula, R, R, Rand Rare independently selected from a hydrogen or the like, and Rcomprises at least two tertiary carbons and is selected from an unsubstituted C5-80 alkyl group or the like. The polyamine flux composition is designed such that compatibility with various underfill materials is facilitated, as a result, a soldered surface does not require cleaning before applying an underfill composition to form a finished electric connection.",ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;MARK R WINKLE,,https://lens.org/018-035-319-931-100,Patent Application,no,0,8,9,9,0,B22F2998/00;;B23K35/025;;B23K35/262;;B23K35/36;;B23K35/3612;;B23K35/362;;C22C12/00;;C22C13/00;;B23K35/36;;C22C12/00;;C22C13/00;;B23K35/262;;B22F2998/00;;B23K35/025;;B23K35/3612;;B23K35/362,B23K35/363;;B23K1/00;;B23K35/26;;B23K101/42;;C22C12/00;;C22C13/00;;H05K3/34,,0,0,,,,DISCONTINUED
533,DE,A1,DE 102011120100 A1,056-463-893-226-819,2012-06-06,2012,DE 102011120100 A,2011-12-02,US 95849510 A,2010-12-02,Flussmittelzusammensetzung und Lötverfahren,"Es wird eine Flussmittelzusammensetzung bereitgestellt, die als eine ursprüngliche Komponente ein Flussmittel umfasst, das durch die Formel I dargestellt ist,worin R1, R2, R3 und R4 unabhängig aus Wasserstoff, einer substituierten C1-80-Alkylgruppe, einer unsubstituierten C1-80-Alkylgruppe, einer substituierten C7-80-Arylalkylgruppe und einer unsubstituierten C7-80-Arylalkylgruppe ausgewählt sind, und worin null bis drei von R1, R2, R3 und R4 Wasserstoff ist (sind). Es wird auch ein Verfahren zum Löten eines elektrischen Kontakts unter Verwendung der Flussmittelzusammensetzung bereitgestellt.",ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;WINKLE MARK R;;LIU XIANG-QIAN,,https://lens.org/056-463-893-226-819,Patent Application,no,0,0,12,12,0,B23K1/0016;;B23K1/203;;B23K35/3615;;B23K35/362;;B23K2101/42;;C07C217/52;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/3615;;B23K1/0016;;B23K35/362;;B23K1/203;;B23K2101/42,B23K35/362,,0,0,,,,DISCONTINUED
534,US,S,US D0926958 S,077-960-776-927-332,2021-08-03,2021,US 202029733398 F,2020-05-01,US 202029733398 F;;US 201629584852 F;;US 201529521116 F,2015-03-19,Humidifier heaterbase,,FISHER & PAYKEL HEALTHCARE LTD,HAMILTON MARK SAMUEL;;BUCKLEY PAUL FLEMING;;EVANS STEPHEN DAVID;;HOLYOAKE BRUCE GORDON;;KLENNER JASON ALLAN,FISHER & PAYKEL HEALTHCARE LIMITED (2015-04-07),https://lens.org/077-960-776-927-332,Design Right,no,37,1,5,5,0,,,2304;;D23/356,0,0,,,,ACTIVE
535,TW,A,TW 201231440 A,179-202-598-029-075,2012-08-01,2012,TW 100144125 A,2011-12-01,US 95848010 A,2010-12-02,A polyamine flux composition and method of soldering,"A polyamine flux composition is provided, comprising, as an initial component: a polyamine fluxing agent represented by formula I: wherein R1, R2, R3 and R4 are independently selected from a hydrogen, a substituted C1-80 alkyl group, an unsubstituted C1-80 alkyl group, a substituted C7-80 arylalkyl group and an unsubstituted C7-80 arylalkyl group; wherein R7 comprises at least two tertiary carbons and is selected from an unsubstituted C5-80 alkyl group, a substituted C5-80 alkyl group, an unsubstituted C12-80 arylalkyl group and a substituted C12-80 arylalkyl group; and, wherein the two nitrogens shown in formula I are each separately bound to one of the at least two tertiary carbons of R7; with the proviso that when the polyamine fluxing agent of formula I is represented by formula Ia: then zero to three of R1, R2, R3 and R4 is(are) hydrogen. Also provided is a method of soldering an electrical contact using the polyamine flux composition.",ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XINAG-QIAN;;WINKLE MARK R,,https://lens.org/179-202-598-029-075,Patent of Addition,no,0,0,9,9,0,B22F2998/00;;B23K35/025;;B23K35/262;;B23K35/36;;B23K35/3612;;B23K35/362;;C22C12/00;;C22C13/00;;B23K35/36;;C22C12/00;;C22C13/00;;B23K35/262;;B22F2998/00;;B23K35/025;;B23K35/3612;;B23K35/362,B23K35/362;;C07C215/18;;C07C215/30;;C07C217/42;;C07C217/46;;C07C217/74;;C08L63/00;;H05K3/34,,0,0,,,,INACTIVE
536,FR,A1,FR 2968230 A1,192-711-688-719-797,2012-06-08,2012,FR 1161089 A,2011-12-02,US 95847310 A,2010-12-02,COMPOSITION DE FONDANT DURCISSABLE ET PROCEDE DE SOUDAGE,"Une composition de fondant durcissable est fournie, comprenant, en tant que composants initiaux : un composant de résine comportant au moins deux groupes oxirane par molécule ; un fondant représenté par la formule I : dans laquelle R , R , R et R sont indépendamment choisis parmi un atome d'hydrogène, un groupe alkyle substitué en C à C , un groupe alkyle non substitué en C à C , un groupe arylalkyle substitué en C à C et un groupe arylalkyle non substitué en C à C ; et dans laquelle de zéro à trois des radicaux R , R , R et R représente(nt) un atome d'hydrogène ; et optionnellement, un agent de durcissement. Est également fourni un procédé de soudage d'un contact électrique utilisant la composition de fondant durcissable.",ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;WINKLE MARK R;;LIU XIANG-QIAN,,https://lens.org/192-711-688-719-797,Patent Application,no,2,0,15,15,0,B23K35/3613;;B23K35/362;;C08G59/184;;C08G59/5026;;C08L63/00;;H05K3/3489;;C08K5/17;;C07C217/52;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/362;;C08G59/5026;;B23K35/3613;;H05K3/3489;;C08L63/00;;C08G59/184;;C08K5/17,B23K35/363;;C08K5/17;;C08L63/00;;H01L21/56;;H05K3/32,,0,0,,,,INACTIVE
537,CA,A1,CA 2583841 A1,013-872-543-529-200,2007-10-04,2007,CA 2583841 A,2007-04-03,US 39654906 A,2006-04-04,VACUUM BASED NAPKIN DISPENSER,"The invention provides a novel system for dispensing paper products, particularly paper napkins. The system includes a moveable napkin carrier platform and a vacuum roller that picks up and dispenses a paper product.</S DOAB>",SCOTT PAPER LTD,PURSE JOHN;;VIEGAS FLEMING;;ALMAS PAUL R;;SANDERS STEPHEN MARK;;GOODFELLOW TOM B;;SCOTT ADRIAN,,https://lens.org/013-872-543-529-200,Patent Application,no,0,0,2,2,0,B65D83/0858;;A47K10/44;;A47K10/426;;B65D83/0858,A47K10/42,,0,0,,,,DISCONTINUED
538,TW,B,TW I492918 B,022-795-838-818-704,2015-07-21,2015,TW 100144128 A,2011-12-01,US 95847310 A,2010-12-02,A curable flux composition and method of soldering,,ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;WINKLE MARK R;;LIU XIANG-QIAN,,https://lens.org/022-795-838-818-704,Granted Patent,no,2,0,15,15,0,B23K35/3613;;B23K35/362;;C08G59/184;;C08G59/5026;;C08L63/00;;H05K3/3489;;C08K5/17;;C07C217/52;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/362;;C08G59/5026;;B23K35/3613;;H05K3/3489;;C08L63/00;;C08G59/184;;C08K5/17,,,0,0,,,,INACTIVE
539,KR,A,KR 20120060766 A,041-709-947-134-278,2012-06-12,2012,KR 20110128129 A,2011-12-02,US 95849510 A,2010-12-02,A FLUX COMPOSITION AND METHOD OF SOLDERING,"PURPOSE: A flux composition is provided to be compatible with various epoxy based underfill material, and not to require cleansing soldering surface before introducing underfill composition for forming final electric conjugation part. CONSTITUTION: A flux composition comprises a fluxing agent in chemical formula 1 as an initial component. In chemical formula 1, R^1, R^2, R^3 and R^4 is respectively and independently selected from a substituted or unsubstituted C1-80 alkyl group, and a substituted or unsubstituted C7-80 arylalkyl group. 0-3 of the R^1, R^2, R^3 and R^4 are hydrogen. The composition additionally comprises solvent, and the solvent is an organic solvent selected from hydrocarbon, aromatic hydrocarbon, ketone, ether, alcohol, ester, amide, glycol, glycol ether, glycol derivative, and petroleum solvent.",ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;KIM SANG HO;;WINKLE MARK R;;LIU XIANG QIAN,,https://lens.org/041-709-947-134-278,Patent Application,no,2,2,12,12,0,B23K1/0016;;B23K1/203;;B23K35/3615;;B23K35/362;;B23K2101/42;;C07C217/52;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/3615;;B23K1/0016;;B23K35/362;;B23K1/203;;B23K2101/42,C07C217/52;;B23K35/363,,0,0,,,,ACTIVE
540,CN,B,CN 102554512 B,076-036-991-661-389,2014-12-24,2014,CN 201110463043 A,2011-12-02,US 95847310 A,2010-12-02,Curable flux composition and method of soldering,,ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;WINKLE MARK R,,https://lens.org/076-036-991-661-389,Granted Patent,no,0,0,15,15,0,B23K35/3613;;B23K35/362;;C08G59/184;;C08G59/5026;;C08L63/00;;H05K3/3489;;C08K5/17;;C07C217/52;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/362;;C08G59/5026;;B23K35/3613;;H05K3/3489;;C08L63/00;;C08G59/184;;C08K5/17,B23K35/362;;B23K1/00,,0,0,,,,INACTIVE
541,US,S,US D0772388 S,097-044-940-758-908,2016-11-22,2016,US 201529521116 F,2015-03-19,US 201529521116 F,2015-03-19,Humidifier heaterbase,,FISHER & PAYKEL HEALTHCARE LTD,HAMILTON MARK SAMUEL;;BUCKLEY PAUL FLEMING;;EVANS STEPHEN DAVID;;HOLYOAKE BRUCE GORDON;;KLENNER JASON ALLAN,FISHER & PAYKEL HEALTHCARE LIMITED (2015-04-07),https://lens.org/097-044-940-758-908,Design Right,no,0,6,5,5,0,,,2304;;D23/356,0,0,,,,ACTIVE
542,JP,A,JP 2012135813 A,104-504-476-928-331,2012-07-19,2012,JP 2011260164 A,2011-11-29,US 95849510 A,2010-12-02,FLUX COMPOSITION AND METHOD OF SOLDERING,"PROBLEM TO BE SOLVED: To provide a flux composition which is non-hardenability, facilitates soldering connection that can be trusted, and can be customized to facilitate compatibility with an underfill material of a conventional epoxy base.SOLUTION: The flux composition comprises, as an initial component: a fluxing agent represented by formula I: wherein R, R, Rand Rare each independently selected from hydrogen, a substituted 1-80C alkyl group, an unsubstituted 1-80C alkyl group, a substituted 7-80C arylalkyl group and an unsubstituted 7-80C arylalkyl group; and wherein zero to three of R, R, Rand Ris (are) hydrogen. Also disclosed is a method of soldering an electrical contact using the flux composition.",ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;MARK R WINKLE;;LIU XIANG-QIAN,,https://lens.org/104-504-476-928-331,Patent Application,no,7,2,12,12,0,B23K1/0016;;B23K1/203;;B23K35/3615;;B23K35/362;;B23K2101/42;;C07C217/52;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/3615;;B23K1/0016;;B23K35/362;;B23K1/203;;B23K2101/42,B23K35/363;;B23K1/00;;B23K3/00;;B23K35/26;;B23K101/42;;C22C12/00;;C22C13/00;;H05K3/34,,0,0,,,,INACTIVE
543,KR,A,KR 20120060770 A,131-948-739-639-483,2012-06-12,2012,KR 20110128202 A,2011-12-02,US 95847310 A,2010-12-02,A Curable Flux Composition and Method of Soldering,"PURPOSE: A curable flux composition is provided to facilitate the production of electric components which has cured and capsulated electrical inner connection, and to be able to be used as a no flow underfill composition in semiconductor device production. CONSTITUTION: A curable flux composition comprises a resin component has at least two oxirane goups per molecule, a flux agent in chemical formula 1, and randomly comprises a curing agent. In chemical formula 1, R^1, R^2, R^3 and R^4 is respectively and independently selected from hydrogen, a substituted or unsubstituted C1-80 alkyl group, and a substituted or unsubstituted C7-80 arylalkyl group, and 0-3 of the R^1, R^2, R^3 and R^4 are hydrogen.",ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;KIM SANG HO;;WINKLE MARK R;;LIU XIANG QIAN,,https://lens.org/131-948-739-639-483,Patent Application,no,1,2,15,15,0,B23K35/3613;;B23K35/362;;C08G59/184;;C08G59/5026;;C08L63/00;;H05K3/3489;;C08K5/17;;C07C217/52;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/362;;C08G59/5026;;B23K35/3613;;H05K3/3489;;C08L63/00;;C08G59/184;;C08K5/17,C07C217/52;;B23K1/00;;B23K35/363,,0,0,,,,ACTIVE
544,GB,A,GB 2470708 A,182-249-438-472-912,2010-12-01,2010,GB 201017426 A,2009-05-13,GB 2009001199 W;;GB 0809160 A,2008-05-20,A surgical instrument,"A device for morcellating tissue within a body cavity of a patient comprises a stationary tube (8) having a distal end portion (12), and a bipolar electrosurgical electrode assembly (13) located at the distal end of the tube. The electrosurgical electrode assembly (13) comprises first and second electrodes (14, 16) separated by an insulation member (15). When an electrosurgical cutting voltage is applied to the electrode assembly (13), and relative movement is initiated between the tube (8) and the tissue, a core of severed tissue is formed within the tube such that it can be removed from the body cavity of the patient. The tube (8) comprises a twin-walled construction with an inner wall (27), an outer wall (28) and an air gap (23) therebetween. This twin-walled construction reduces the heat that is able to travel proximally along the tube (8).",GYRUS MEDICAL LTD,FLEMING ALISTAIR I;;EBBUTT JULIAN MARK;;JENKINS ANDREW E;;JOHNSTON HOLLIE E;;JAMES RHODRI G,,https://lens.org/182-249-438-472-912,Patent Application,no,5,0,10,10,0,A61B17/32002;;A61B17/32053;;A61B18/1445;;A61B18/16;;A61B2017/320024;;A61B2018/00005;;A61B2018/00083;;A61B2218/008;;A61B18/1445;;A61B17/32;;A61B17/42;;A61B18/14;;A61B2017/320024;;A61B2018/00339;;A61B2018/00005;;A61B2018/00083;;A61B2218/008;;A61B17/32053;;A61B18/1482;;A61B18/16;;A61B18/1485;;A61B18/1445;;A61B2018/00005;;A61B17/32002;;A61B2218/008;;A61B18/16;;A61B2018/00083;;A61B2017/320024;;A61B17/32053,A61B18/14;;A61B17/32;;A61B17/42,,0,0,,,,ACTIVE
545,CN,B,CN 102615453 B,186-936-849-156-658,2014-12-03,2014,CN 201110463357 A,2011-12-02,US 95849510 A,2010-12-02,Flux composition and method of soldering,,ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;WINKLE MARK R,,https://lens.org/186-936-849-156-658,Granted Patent,no,0,0,12,12,0,B23K1/0016;;B23K1/203;;B23K35/3615;;B23K35/362;;B23K2101/42;;C07C217/52;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/3615;;B23K1/0016;;B23K35/362;;B23K1/203;;B23K2101/42,B23K35/363;;B23K1/00,,0,0,,,,INACTIVE
546,US,B1,US 8070047 B1,095-077-627-547-360,2011-12-06,2011,US 95849510 A,2010-12-02,US 95849510 A,2010-12-02,Flux composition and method of soldering,"A flux composition is provided, comprising, as an initial component: a fluxing agent represented by formula I: wherein R 1 , R 2 , R 3 and R 4 are independently selected from a hydrogen, a substituted C 1-80 alkyl group, an unsubstituted C 1-80 alkyl group, a substituted C 7-80 arylalkyl group and an unsubstituted C 7-80 arylalkyl group; and wherein zero to three of R 1 , R 2 , R 3 and R 4 is(are) hydrogen. Also provided is a method of soldering an electrical contact using the flux composition.",FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;WINKLE MARK R;;ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;WINKLE MARK R,ROHM AND HAAS ELECTRONIC MATERIALS LLC (2011-02-11),https://lens.org/095-077-627-547-360,Granted Patent,yes,49,1,12,12,0,B23K1/0016;;B23K1/203;;B23K35/3615;;B23K35/362;;B23K2101/42;;C07C217/52;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/3615;;B23K1/0016;;B23K35/362;;B23K1/203;;B23K2101/42,B23K31/02;;B23K35/34,228/180.21;;228/207;;228/223;;228/224;;228/248.1;;148/23;;148/24,5,0,,,"STIC search (no date available).;;Copending U.S. Appl. No. 12/958,487.;;Copending U.S. Appl. No. 12/958,480.;;Copending U.S. Appl. No. 12/958,493.;;Copending U.S. Appl. No. 12/958,473.",INACTIVE
547,US,B2,US 10364735 B2,127-360-981-640-210,2019-07-30,2019,US 201314092546 A,2013-11-27,US 201314092546 A,2013-11-27,Method for adjusting vehicle grille shutters based on vehicle speed and direction of grille shutter adjustment,"Methods and systems are provided for adjusting vehicle grille shutters based on a direction of motion of the grille shutters. In one example, a method includes adjusting a motor coupled to the grille shutters based on the direction of motion of the grille shutters, a desired opening of the grille shutters, and vehicle speed. Further, the method may include determining the direction of motion of the grille shutters based on a desired motor position relative to an actual motor position.",FORD GLOBAL TECH LLC,MACFARLANE KEVIN;;SEMANSON CHRISTOPHER;;GALLO JOSEPH JAMES;;FLEMING MARK;;BUCKMAN COLBY JASON;;JENTZ ROBERT ROY,FORD GLOBAL TECHNOLOGIES LLC (2013-11-25),https://lens.org/127-360-981-640-210,Granted Patent,yes,43,4,8,8,0,B60K11/085;;B60K11/085;;B60K11/085;;F01P7/10;;F01P7/10;;F01P7/10;;F01P7/10;;Y02T10/88;;Y02T10/88,F01P1/06;;B60K11/08;;F01P7/10,,7,1,093-942-267-927-917,10.4271/2011-01-0155,"MacFarlane, Kevin et al., “Method and Systems for Adjusting Grille Shutters Based on Temperature and Position Feedback,” U.S. Appl. No. 14/092,546, filed Nov. 27, 2013, 51 pages.;;Pursifull, Ross D., “Method and System for Reducing Charge Air Cooler Condensate Using a Secondary Intake Throttle,” U.S. Appl. No. 14/084,295, filed Nov. 19, 2013, 38 pages.;;Sowards, John et al., “Active Grille Shutter System with a Staged Progressive Linkage to Reduce Engine Misfire From Charge Air Cooler Condensation,” U.S. Appl. No. 13/857,365, filed Apr. 5, 2013, 43 pages.;;Styles, Daniel J. et al., “Engine Cooling Fan to Reduce Charge Air Cooler Corrosion,” U.S. Appl. No. 13/656,471, filed Oct. 19, 2012, 44 pages.;;Surnilla, Gopichandra et al., “Engine Control Coordination With Grille Shutter Adjustment and Ambient Conditions,” U.S. Appl. No. 13/656,542, filed Oct. 19, 2012, 33 pages.;;Styles, Daniel J. et al., “Charge Air Cooler (CAC) Corrosion Reduction Utilizing Grille Shutters,” U.S. Appl. No. 13/656,524, filed Oct. 19, 2012, 33 pages.;;Shigarkanthi, V. et al., “Application of Design of Experiments and Physics Based Approach in the Development of Aero Shutter Control Algorithm,” SAE International Paper Series No. 2011-01-0155, SAE International, Apr. 12, 2011, 8 pages.",INACTIVE
548,FR,B1,FR 2968228 B1,055-747-751-339-648,2014-07-18,2014,FR 1161086 A,2011-12-02,US 95848010 A,2010-12-02,COMPOSITION DE FONDANT DE POLYAMINE ET PROCEDE DE BRASAGE,,ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;WINKLE MARK R,,https://lens.org/055-747-751-339-648,Granted Patent,no,0,0,9,9,0,B22F2998/00;;B23K35/025;;B23K35/262;;B23K35/36;;B23K35/3612;;B23K35/362;;C22C12/00;;C22C13/00;;B23K35/36;;C22C12/00;;C22C13/00;;B23K35/262;;B22F2998/00;;B23K35/025;;B23K35/3612;;B23K35/362,B23K35/363;;C08K5/17;;C08L63/00;;H05K3/32,,0,0,,,,INACTIVE
549,DE,A1,DE 102011120049 A1,010-240-876-106-578,2012-06-06,2012,DE 102011120049 A,2011-12-02,US 95848010 A,2010-12-02,Polyamin-Flussmittelzusammensetzung und Lötverfahren,"Es wird eine Polyamin-Flussmittelzusammensetzung bereitgestellt, die als eine ursprüngliche Komponente ein Polyamin-Flussmittel umfasst, das durch die Formel Idargestellt ist, worin R1, R2, R3 und R4 unabhängig aus Wasserstoff, einer substituierten C1-80-Alkylgruppe, einer unsubstituierten C1-80-Alkylgruppe, einer substituierten C7-80-Arylalkylgruppe und einer unsubstituierten C7-80-Arylalkylgruppe ausgewählt sind, worin R7 mindestens zwei tertiäre Kohlenstoffatome umfasst und aus einer unsubstituierten C5-80-Alkylgruppe, einer substituierten C5-80-Alkylgruppe, einer unsubstituierten C12-80-Arylalkylgruppe und einer substituierten C12-80-Arylalkylgruppe ausgewählt ist, und wobei die in der Formel I gezeigten zwei Stickstoffatome jeweils separat an eines der mindestens zwei tertiären Kohlenstoffatome von R7 gebunden sind, mit der Maßgabe, dass dann, wenn das Polyamin-Flussmittel der Formel I durch die Formel Iadargestellt ist, null bis drei von R1, R2, R3 und R4 Wasserstoff ist (sind). Es wird auch ein Verfahren zum Löten eines elektrischen Kontakts unter Verwendung der Polyamin-Flussmittelzusammensetzung bereitgestellt.",ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;WINKLE MARK R,,https://lens.org/010-240-876-106-578,Patent Application,no,0,0,9,9,0,B22F2998/00;;B23K35/025;;B23K35/262;;B23K35/36;;B23K35/3612;;B23K35/362;;C22C12/00;;C22C13/00;;B23K35/36;;C22C12/00;;C22C13/00;;B23K35/262;;B22F2998/00;;B23K35/025;;B23K35/3612;;B23K35/362,C07C211/09;;B23K35/36,,0,0,,,,DISCONTINUED
550,DE,B4,DE 102011120404 B4,164-883-708-593-163,2023-01-19,2023,DE 102011120404 A,2011-12-02,US 95847310 A,2010-12-02,Härtbare Flussmittelzusammensetzung und Lötverfahren,"Härtbare Flussmittelzusammensetzung, die als ursprüngliche Komponenten eine Harzkomponente mit mindestens zwei Oxirangruppen pro Molekül, ein Flussmittel, das durch die Formel I dargestellt ist,worin R1, R2, R3und R4unabhängig aus Wasserstoff, einer substituierten C1-80-Alkylgruppe, einer unsubstituierten C1-80-Alkylgruppe, einer substituierten C7-80-Arylalkylgruppe und einer unsubstituierten C7-80-Arylalkylgruppe ausgewählt sind, und worin null bis drei von R1, R2, R3und R4Wasserstoff ist (sind), und gegebenenfalls ein Härtungsmittel umfasst.",ROHM AND HAAS ELECTRONIC MAT L L C,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;WINKLE MARK R;;LIU XIANG-QIAN,,https://lens.org/164-883-708-593-163,Granted Patent,no,5,0,15,15,0,B23K35/3613;;B23K35/362;;C08G59/184;;C08G59/5026;;C08L63/00;;H05K3/3489;;C08K5/17;;C07C217/52;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/362;;C08G59/5026;;B23K35/3613;;H05K3/3489;;C08L63/00;;C08G59/184;;C08K5/17,B23K35/362;;B23K1/20;;C07C217/52;;C08G59/18;;C08G59/50;;C08K5/17;;C08L63/00;;H01L23/488;;H05K3/34,,0,0,,,,ACTIVE
551,DE,A1,DE 102014224029 A1,181-697-627-324-671,2015-05-28,2015,DE 102014224029 A,2014-11-25,US 201314092546 A,2013-11-27,Verfahren zum Einstellen der Kühlergrillverschlüsse eines Fahrzeugs basierend auf der Fahrzeuggeschwindigkeit und der Richtung der Einstellung der Kühlergrillverschlüsse,"Es werden Verfahren und Systeme zum Einstellen der Kühlergrillverschlüsse eines Fahrzeugs basierend auf einer Bewegungsrichtung der Kühlergrillverschlüsse bereitgestellt. In einem Beispiel enthält ein Verfahren das Einstellen eines an die Kühlergrillverschlüsse gekoppelten Motors basierend auf der Bewegungsrichtung der Kühlergrillverschlüsse, einer Sollöffnung der Kühlergrillverschlüsse und der Fahrzeuggeschwindigkeit. Ferner kann das Verfahren das Bestimmen der Bewegungsrichtung der Kühlergrillverschlüsse basierend auf einer Soll-Motorposition bezüglich einer tatsächlichen Motorposition enthalten.",FORD GLOBAL TECH LLC,MACFARLANE KEVIN;;SEMANSON CHRISTOPHER;;GALLO JOSEPH JAMES;;FLEMING MARK;;BUCKMAN COLBY JASON;;JENTZ ROBERT ROY,,https://lens.org/181-697-627-324-671,Patent Application,no,1,0,8,8,0,B60K11/085;;B60K11/085;;B60K11/085;;F01P7/10;;F01P7/10;;F01P7/10;;F01P7/10;;Y02T10/88;;Y02T10/88,F01P7/10;;F01P11/10,,0,0,,,,PENDING
552,TW,A,TW 201514134 A,033-651-271-472-365,2015-04-16,2015,TW 104100911 A,2011-12-01,US 95847310 A,2010-12-02,A curable flux composition and method of soldering,"A curable flux composition is provided, comprising, as initial components: a resin component having at least two oxirane groups per molecule; a fluxing agent represented by formula I: wherein R1, R2, R3 and R4 are independently selected from a hydrogen, a substituted C1-80 alkyl group, an unsubstituted C1-80 alkyl group, a substituted C7-80 arylalkyl group and an unsubstituted C7-80 arylalkyl group; and wherein zero to three of R1, R2, R3 and R4 is(are) hydrogen; and, optionally, a curing agent. Also provided is a method of soldering an electrical contact using the curable flux composition.",ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;WINKLE MARK R;;LIU XIANG-QIAN,,https://lens.org/033-651-271-472-365,Patent of Addition,no,0,0,15,15,0,B23K35/3613;;B23K35/362;;C08G59/184;;C08G59/5026;;C08L63/00;;H05K3/3489;;C08K5/17;;C07C217/52;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/362;;C08G59/5026;;B23K35/3613;;H05K3/3489;;C08L63/00;;C08G59/184;;C08K5/17,C07C211/50;;B23K35/362;;H05K3/34,,0,0,,,,INACTIVE
553,TW,A,TW 201229009 A,080-432-216-902-857,2012-07-16,2012,TW 100144128 A,2011-12-01,US 95847310 A,2010-12-02,A curable flux composition and method of soldering,"A curable flux composition is provided, comprising, as initial components: a resin component having at least two oxirane groups per molecule; a fluxing agent represented by formula I: wherein R1, R2, R3 and R4 are independently selected from a hydrogen, a substituted C1-80 alkyl group, an unsubstituted C1-80 alkyl group, a substituted C7-80 arylalkyl group and an unsubstituted C7-80 arylalkyl group; and wherein zero to three of R1, R2, R3 and R4 is (are) hydrogen; and, optionally, a curing agent. Also provided is a method of soldering an electrical contact using the curable flux composition.",ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;WINKLE MARK R;;LIU XIANG-QIAN,,https://lens.org/080-432-216-902-857,Patent of Addition,no,0,0,15,15,0,B23K35/3613;;B23K35/362;;C08G59/184;;C08G59/5026;;C08L63/00;;H05K3/3489;;C08K5/17;;C07C217/52;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/362;;C08G59/5026;;B23K35/3613;;H05K3/3489;;C08L63/00;;C08G59/184;;C08K5/17,C07C211/50;;B23K35/362;;H05K3/34,,0,0,,,,INACTIVE
554,US,S,US D0984616 S,084-190-464-421-290,2023-04-25,2023,US 202129788585 F,2021-06-29,US 202129788585 F;;US 202029733398 F;;US 201629584852 F;;US 201529521116 F,2015-03-19,Humidifier heaterbase,,FISHER & PAYKEL HEALTHCARE LTD,HAMILTON MARK SAMUEL;;BUCKLEY PAUL FLEMING;;EVANS STEPHEN DAVID;;HOLYOAKE BRUCE GORDON;;KLENNER JASON ALLAN,FISHER & PAYKEL HEALTHCARE LIMITED (2015-04-07),https://lens.org/084-190-464-421-290,Design Right,no,49,0,5,5,0,,,2304;;D23/356,0,0,,,,ACTIVE
555,DE,B4,DE 112009001261 B4,120-096-813-591-953,2018-06-28,2018,DE 112009001261 T,2009-05-13,GB 0809160 A;;GB 2009001199 W,2008-05-20,Chirurgisches Instrument,"In Kombination, eine Vorrichtung (1) zum Morcellieren von Gewebe innerhalb einer Körperhöhle eines Patienten und eine Gewebeziehvorrichtung (2), von denen die Vorrichtung zum Morcellieren von Gewebe einen feststehenden Schaft in Form einer Röhre (8) mit einem proximalen Endabschnitt (10) und einem distalen Endabschnitt (12) umfasst, wobei die Röhre eine an ihrem distalen Endabschnitt angeordnete bipolare elektrochirurgische Elektrodenanordnung (13) aufweist und die bipolare elektrochirurgische Elektrodenanordnung eine durch ein Isolationselement (15) getrennte erste und zweite Elektrode (14, 16) umfasst, wobei sich die bipolare elektrochirurgische Elektrodenanordnung wenigstens teilweise um den Umfang des distalen Endabschnitts der Röhre herum erstreckt, wobei wenigstens der Großteil der Schaftlänge durch einen doppelwandigen Aufbau gebildet ist und die Röhre hohl ist, sodass die Gewebeziehvorrichtung derart Gewebe gegen den distalen Endabschnitt der Röhre ziehen kann, dass die Vorrichtung zum Morcellieren von Gewebe ein Stück vom Gewebe abtrennt, und die Gewebeziehvorrichtung dieses danach zum Zwecke des Entfernens über den proximalen Endabschnitt der Röhre durch die Röhre hindurch ziehen kann.",GYRUS MEDICAL LTD,FLEMING ALISTAIR I;;EBBUTT JULIAN MARK;;JENKINS ANDREW E;;JOHNSTON HOLLIE E;;JAMES RHODRI G,,https://lens.org/120-096-813-591-953,Granted Patent,no,9,0,10,10,0,A61B17/32002;;A61B17/32053;;A61B18/1445;;A61B18/16;;A61B2017/320024;;A61B2018/00005;;A61B2018/00083;;A61B2218/008;;A61B18/1445;;A61B17/32;;A61B17/42;;A61B18/14;;A61B2017/320024;;A61B2018/00339;;A61B2018/00005;;A61B2018/00083;;A61B2218/008;;A61B17/32053;;A61B18/1482;;A61B18/16;;A61B18/1485;;A61B18/1445;;A61B2018/00005;;A61B17/32002;;A61B2218/008;;A61B18/16;;A61B2018/00083;;A61B2017/320024;;A61B17/32053,A61B18/14;;A61B17/32;;A61B17/42,,0,0,,,,ACTIVE
556,RU,C2,RU 2678384 C2,144-358-264-311-573,2019-01-28,2019,RU 2014146780 A,2014-11-20,US 201314092546 A,2013-11-27,METHOD (VERSIONS) AND SYSTEM FOR ADJUSTING THE GRILLE SHUTTERS OF THE VEHICLE,"FIELD: motor vehicle industry.SUBSTANCE: group of inventions relates to variants of the method and system for adjusting the grille shutters of the vehicle based on the direction of movement of the grille shutters. In one example, the method includes adjusting an electric motor connected to the grille shutters, based on the direction of movement of the grille shutters, the required opening of the grille shutters and the speed of the vehicle. Additionally, the method may include determining the direction of movement of the grille shutters based on the desired position of the electric motor relative to the current position of the electric motor.EFFECT: optimal engine cooling and comfortable driving.19 cl, 6 dwg",FORD GLOUBAL TEKNOLODZHIZ ELELSI,MAKFARLIN KEVIN;;SEMANSON KRISTOFER;;GALLO DZHOZEF DZHEJMS;;FLEMING MARK;;BAKMEN KOLBI DZHEJSON;;DZHENTTS ROBERT ROJ,,https://lens.org/144-358-264-311-573,Granted Patent,no,4,2,8,8,0,B60K11/085;;B60K11/085;;B60K11/085;;F01P7/10;;F01P7/10;;F01P7/10;;F01P7/10;;Y02T10/88;;Y02T10/88,B60K11/08;;F01P7/10,,0,0,,,,ACTIVE
557,CN,B,CN 102554513 B,060-784-897-754-709,2015-05-06,2015,CN 201110463044 A,2011-12-02,US 95848010 A,2010-12-02,Polyamine flux composition and method of soldering,,ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;WINKLE MARK R,,https://lens.org/060-784-897-754-709,Granted Patent,no,0,0,9,9,0,B22F2998/00;;B23K35/025;;B23K35/262;;B23K35/36;;B23K35/3612;;B23K35/362;;C22C12/00;;C22C13/00;;B23K35/36;;C22C12/00;;C22C13/00;;B23K35/262;;B22F2998/00;;B23K35/025;;B23K35/3612;;B23K35/362,B23K35/362;;B23K1/00,,0,0,,,,INACTIVE
558,DE,T5,DE 112009001261 T5,103-617-725-153-042,2011-04-07,2011,DE 112009001261 T,2009-05-13,GB 0809160 A;;GB 2009001199 W,2008-05-20,Chirurgisches Instrument,,GYRUS MEDICAL LTD,FLEMING ALISTAIR I;;EBBUTT JULIAN MARK;;JENKINS ANDREW E;;JOHNSTON HOLLIE E;;JAMES RHODRI G,,https://lens.org/103-617-725-153-042,Patent Application,no,3,0,10,10,0,A61B17/32002;;A61B17/32053;;A61B18/1445;;A61B18/16;;A61B2017/320024;;A61B2018/00005;;A61B2018/00083;;A61B2218/008;;A61B18/1445;;A61B17/32;;A61B17/42;;A61B18/14;;A61B2017/320024;;A61B2018/00339;;A61B2018/00005;;A61B2018/00083;;A61B2218/008;;A61B17/32053;;A61B18/1482;;A61B18/16;;A61B18/1485;;A61B18/1445;;A61B2018/00005;;A61B17/32002;;A61B2218/008;;A61B18/16;;A61B2018/00083;;A61B2017/320024;;A61B17/32053,A61B18/14;;A61B17/32;;A61B17/42,,0,0,,,,ACTIVE
559,JP,A,JP 2012117063 A,177-065-086-087-430,2012-06-21,2012,JP 2011260178 A,2011-11-29,US 95847310 A,2010-12-02,CURABLE FLUX COMPOSITION AND METHOD OF SOLDERING,"PROBLEM TO BE SOLVED: To provide a curable flux composition comprising: a fluxing agent represented by a resin component having at least two oxirane groups per molecule; and a curing agent.SOLUTION: This invention relates to: the flux agent represented by the formula (I); the curable flux composition comprising, optionally, the curing agent; and a method of forming an encapsulated metal contact, including curing a curable thermosetting resin composition and encapsulating electrical interconnects.",ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;MARK R WINKLE;;LIU XIANG-QIAN,,https://lens.org/177-065-086-087-430,Patent Application,no,7,2,15,15,0,B23K35/3613;;B23K35/362;;C08G59/184;;C08G59/5026;;C08L63/00;;H05K3/3489;;C08K5/17;;C07C217/52;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/362;;C08G59/5026;;B23K35/3613;;H05K3/3489;;C08L63/00;;C08G59/184;;C08K5/17,C08G59/50;;H01L21/60,,0,0,,,,INACTIVE
560,TW,B,TW I438179 B,196-522-060-702-028,2014-05-21,2014,TW 100144123 A,2011-12-01,US 95849510 A,2010-12-02,A flux composition and method of soldering,,ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;WINKLE MARK R;;LIU XIANG-QIAN,,https://lens.org/196-522-060-702-028,Granted Patent,no,0,0,12,12,0,B23K1/0016;;B23K1/203;;B23K35/3615;;B23K35/362;;B23K2101/42;;C07C217/52;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/3615;;B23K1/0016;;B23K35/362;;B23K1/203;;B23K2101/42,,,0,0,,,,INACTIVE
561,KR,A,KR 20120060774 A,047-688-641-833-875,2012-06-12,2012,KR 20110128473 A,2011-12-02,KR 20110128473 A,2011-12-02,Polyamine flux Composition and Method of Soldering,"PURPOSE: A polyamine flux composition is provided to have non-curing property, to connect reliable soldering connection, and to be customizable in order to be compatible with normal epoxy-based under fill material. CONSTITUTION: A polyamine flux composition comprises polyamine fluxing agent in chemical formula 1 as an initial component. In chemical formula 1, R^1, R^2, R^3 and R^4 is respectively and independently selected from hydrogen, a substituted or unsubstituted C1-80 alkyl group, and a substituted or unsubstituted C7-80 arylalkyl group, and R^7 is selected from a substituted or unsubstituted C5-80 alkyl group having at least two tertiary carbon elements, and a substituted or unsubstituted C12-80 arylalkyl group selected from the group consisting of at least two tertiary carbon.",ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;KIM SANG HO;;WINKLE MARK R;;LIU XIANG QIAN,,https://lens.org/047-688-641-833-875,Patent Application,no,1,1,1,1,0,B23K1/203;;B23K35/3615;;B23K35/365;;C07C215/18,C07C215/18;;B23K1/00;;B23K35/363;;C07C215/30,,0,0,,,,DISCONTINUED
562,US,A1,US 2015/0147949 A1,050-041-003-988-611,2015-05-28,2015,US 201314092546 A,2013-11-27,US 201314092546 A,2013-11-27,METHOD FOR ADJUSTING VEHICLE GRILLE SHUTTERS BASED ON VEHICLE SPEED AND DIRECTION OF GRILLE SHUTTER ADJUSTMENT,"Methods and systems are provided for adjusting vehicle grille shutters based on a direction of motion of the grille shutters. In one example, a method includes adjusting a motor coupled to the grille shutters based on the direction of motion of the grille shutters, a desired opening of the grille shutters, and vehicle speed. Further, the method may include determining the direction of motion of the grille shutters based on a desired motor position relative to an actual motor position.",FORD GLOBAL TECH LLC,MACFARLANE KEVIN;;SEMANSON CHRISTOPHER;;GALLO JOSEPH JAMES;;FLEMING MARK;;BUCKMAN COLBY JASON;;JENTZ ROBERT ROY,FORD GLOBAL TECHNOLOGIES LLC (2013-11-25),https://lens.org/050-041-003-988-611,Patent Application,yes,66,17,8,8,0,B60K11/085;;B60K11/085;;B60K11/085;;F01P7/10;;F01P7/10;;F01P7/10;;F01P7/10;;Y02T10/88;;Y02T10/88,F01P1/06,454/75;;454/155,0,0,,,,INACTIVE
563,DE,A1,DE 102011120404 A1,063-926-206-656-879,2012-06-06,2012,DE 102011120404 A,2011-12-02,US 95847310 A,2010-12-02,Härtbare Flussmittelzusammensetzung und Lötverfahren,"Es wird eine härtbare Flussmittelzusammensetzung bereitgestellt, die als ursprüngliche Komponenten eine Harzkomponente mit mindestens zwei Oxirangruppen pro Molekül, ein Flussmittel, das durch die Formel I dargestellt ist,worin R1, R2, R3 und R4 unabhängig aus Wasserstoff, einer substituierten C1-80-Alkylgruppe, einer unsubstituierten C1-80-Alkylgruppe, einer substituierten C7-80-Arylalkylgruppe und einer unsubstituierten C7-80-Arylalkylgruppe ausgewählt sind, und worin null bis drei von R1, R2, R3 und R4 Wasserstoff ist (sind), und gegebenenfalls ein Härtungsmittel umfasst. Es wird auch ein Verfahren zum Löten eines elektrischen Kontakts unter Verwendung der härtbaren Flussmittelzusammensetzung bereitgestellt.",ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;WINKLE MARK R;;LIU XIANG-QIAN,,https://lens.org/063-926-206-656-879,Patent Application,no,2,0,15,15,0,B23K35/3613;;B23K35/362;;C08G59/184;;C08G59/5026;;C08L63/00;;H05K3/3489;;C08K5/17;;C07C217/52;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/362;;C08G59/5026;;B23K35/3613;;H05K3/3489;;C08L63/00;;C08G59/184;;C08K5/17,B23K35/362;;H01L23/488,,0,0,,,,ACTIVE
564,SG,A,SG 11201807011S A,073-970-989-860-753,2018-09-27,2018,SG 11201807011S A,2017-03-20,EP 16163191 A;;EP 17160796 A;;US 2017/0023144 W,2016-03-31,RAZOR CARTRIDGE WITH FLUID MANAGEMENT,,GILLETTE CO LLC,JOLLEY WILLIAM;;PETERSON MARK;;SPOONER-FLEMING JOIA;;STEPHENS ALISON;;TANDY JAMES;;WARRICK PAUL;;WASHINGTON JACK,,https://lens.org/073-970-989-860-753,Unknown,no,0,0,17,17,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,PENDING
565,US,B1,US 6665060 B1,158-945-282-043-722,2003-12-16,2003,US 43011799 A,1999-10-29,US 43011799 A,1999-10-29,Cytological imaging system and method,"
    The present invention relates to the analysis of cytological material. Specifically, the invention relates to stains and methods of producing the stains, methods of staining cells for cytological or histological analysis to contrast the nuclear portion of the cell from the cytoplasmic portion, and systems and methods for illuminating a cytological sample. The analysis can be automated or manual. 
",CYTYC CORP,ZAHNISER DAVID J;;ZELINSKI MATTHEW S;;DOLASH THOMAS;;MAENLE GARRICK L;;FLEMING MARK;;LAUDO JOHN,CYTYC CORPORATION (2000-06-13),https://lens.org/158-945-282-043-722,Granted Patent,yes,83,51,5,81,0,G01N1/30;;G01N15/147;;G01N15/1484;;G01N21/3151;;G01N2015/1472;;G01N2015/1488;;G01N15/1433;;G01N21/3151;;G01N15/1484;;G01N15/147;;G01N2015/1472;;G01N2015/1488;;G01N1/30;;G01N15/1433,G01N1/30;;G01N15/14;;G01N21/31;;G06T7/00,356/39;;422/82.01;;436/164,2,2,061-327-152-657-755;;064-992-221-005-275,8289227;;10.1111/j.1365-2818.1993.tb03391.x;;10.1016/s0143-4160(97)90097-x;;9056078,"Beach et al., ""A light-emitting diode light standard for photo-and videomicroscopy,"" Journal of Microscopy, vol. 172, Pt. 1, Oct. 1993, pp. 41-48.;;Beach, ""A LED light calibration source for dual-wavelength microscopy,"" Cell Calcium, vol. 21, Pt. 1, 1997, pp. 63-68.",EXPIRED
566,WO,A1,WO 2006/125057 A1,070-718-390-089-911,2006-11-23,2006,US 2006/0019187 W,2006-05-16,US 68137505 P,2005-05-16,HEMOSTASIS ANALYSIS DEVICE AND METHOD,"Apparatus for measuring hemostasis includes a container for holding a sample to be tested and a bobber configured to be buoyantly suspended on the sample. A magnet is secured to the bobber. A drive assembly is coupled to the container for driving the container in an oscillating motion. A magnetic field generator is disposed adjacent the container and configured to generate a magnetic field in the vicinity of the magnet. A magnetic field strength detector is disposed adjacent the container, and the magnetic field strength detector is configured to sense changes in the magnetic field as a result of movement of the bobber and magnet responsive to the oscillating motion of the container and clotting of the sample.",HAEMOSCOPE CORP;;RAVIV RONNIE;;CONTINI VINCENT;;DELMENICO PETER;;FLEMING MATTHEW;;HAUBERT THOM;;RAVIV GABRIEL;;WILSON MARK R,RAVIV RONNIE;;CONTINI VINCENT;;DELMENICO PETER;;FLEMING MATTHEW;;HAUBERT THOM;;RAVIV GABRIEL;;WILSON MARK R,,https://lens.org/070-718-390-089-911,Patent Application,yes,6,7,2,2,0,G01N33/4905;;G01N2011/147;;G01N33/4905;;G01N2011/147,G01N11/16;;G01N33/49,,0,0,,,,PENDING
567,FR,A1,FR 2968226 A1,158-932-287-155-472,2012-06-08,2012,FR 1161084 A,2011-12-02,US 95849510 A,2010-12-02,COMPOSITION DE FONDANT ET PROCEDE DE SOUDAGE,"Une composition de fondant est fournie, comprenant, en tant que composant initial : un fondant représenté par la formule I : dans laquelle R , R , R et R sont indépendamment choisis parmi un atome d'hydrogène, un groupe alkyle substitué en C à C , un groupe alkyle non substitué en C à C , un groupe arylalkyle substitué en C à C et un groupe arylalkyle non substitué en C à C ; et dans laquelle de zéro à trois des radicaux R , R , R et R représente(nt) un atome d'hydrogène. Est également fourni un procédé de soudage d'un contact électrique utilisant la composition de fondant.",ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;WINKLE MARK R;;LIU XIANG-QIAN,,https://lens.org/158-932-287-155-472,Patent Application,no,2,0,12,12,0,B23K1/0016;;B23K1/203;;B23K35/3615;;B23K35/362;;B23K2101/42;;C07C217/52;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/3615;;B23K1/0016;;B23K35/362;;B23K1/203;;B23K2101/42,B23K35/363;;C07C211/36;;H05K3/32,,0,0,,,,INACTIVE
568,WO,A1,WO 2009/141579 A1,188-379-548-940-012,2009-11-26,2009,GB 2009001199 W,2009-05-13,GB 0809160 A,2008-05-20,A SURGICAL INSTRUMENT,"A device for morcellating tissue within a body cavity of a patient comprises a stationary tube (8) having a distal end portion (12), and a bipolar electrosurgical electrode assembly (13) located at the distal end of the tube. The electrosurgical electrode assembly (13) comprises first and second electrodes (14, 16) separated by an insulation member (15). When an electrosurgical cutting voltage is applied to the electrode assembly (13), and relative movement is initiated between the tube (8) and the tissue, a core of severed tissue is formed within the tube such that it can be removed from the body cavity of the patient. The tube (8) comprises a twin-walled construction with an inner wall (27), an outer wall (28) and an air gap (23) therebetween. This twin- walled construction reduces the heat that is able to travel proximally along the tube (8).",GYRUS MEDICAL LTD,FLEMING ALISTAIR I;;EBBUTT JULIAN MARK;;JENKINS ANDREW E;;JOHNSTON HOLLIE E;;JAMES RHODRI G,,https://lens.org/188-379-548-940-012,Patent Application,yes,5,5,10,10,0,A61B17/32002;;A61B17/32053;;A61B18/1445;;A61B18/16;;A61B2017/320024;;A61B2018/00005;;A61B2018/00083;;A61B2218/008;;A61B18/1445;;A61B17/32;;A61B17/42;;A61B18/14;;A61B2017/320024;;A61B2018/00339;;A61B2018/00005;;A61B2018/00083;;A61B2218/008;;A61B17/32053;;A61B18/1482;;A61B18/16;;A61B18/1485;;A61B18/1445;;A61B2018/00005;;A61B17/32002;;A61B2218/008;;A61B18/16;;A61B2018/00083;;A61B2017/320024;;A61B17/32053,A61B18/14;;A61B17/32;;A61B17/42,,0,0,,,,PENDING
569,GB,B,GB 2470708 B,047-190-008-900-421,2012-09-26,2012,GB 201017426 A,2009-05-13,GB 2009001199 W;;GB 0809160 A,2008-05-20,Device for morcellating tissue,,GYRUS MEDICAL LTD,FLEMING ALISTAIR I;;EBBUTT JULIAN MARK;;JENKINS ANDREW E;;JOHNSTON HOLLIE E;;JAMES RHODRI G,,https://lens.org/047-190-008-900-421,Granted Patent,no,5,0,10,10,0,A61B17/32002;;A61B17/32053;;A61B18/1445;;A61B18/16;;A61B2017/320024;;A61B2018/00005;;A61B2018/00083;;A61B2218/008;;A61B18/1445;;A61B17/32;;A61B17/42;;A61B18/14;;A61B2017/320024;;A61B2018/00339;;A61B2018/00005;;A61B2018/00083;;A61B2218/008;;A61B17/32053;;A61B18/1482;;A61B18/16;;A61B18/1485;;A61B18/1445;;A61B2018/00005;;A61B17/32002;;A61B2218/008;;A61B18/16;;A61B2018/00083;;A61B2017/320024;;A61B17/32053,A61B18/14;;A61B17/32;;A61B17/42,,0,0,,,,ACTIVE
570,US,A,US 4666849 A,056-207-990-215-078,1987-05-19,1987,US 53902883 A,1983-10-04,US 53902883 A,1983-10-04,Lactic acid bacteria which do not decarboxylate malic acid and fermentation therewith,"Bloating of brine fermented cucumbers can be greatly reduced by using lactic acid bacteria which do not decarboxylate malic acid and therefore do not produce carbon dioxide during fermentation. Also, certain high acid wines can be improved by fermenting fruit with bacteria which do decarboxylate malic acid. A method has been discovered of differentiating between species of lactic acid bacteria which do and do not decarboxylate malic acid. This method comprises growing a lactic acid bacterium in a suitable malic acid-containing nutritive growth medium under conditions suitable for growth and monitoring the pH of the medium during growth. The pH will decrease only when a lactic acid bacterium is present which does not decarboxylate malic acid. When malic acid is decarboxylated, a proton is removed from the solution in accordance with the following equation: ##STR1## Therefore, the pH of the medium either remains the same by neutralizing lactic acid produced by the fermentation of the carbohydrate source or increases when insufficient lactic acid is present. The above method is particularly fast and easy for screening bacteria obtained from purposely mutated species of lactic acid bacteria. Many strains of bacteria can be tested together by streaking them on a single layer agar plate.",US AGRICULTURE,DAESCHEL MARK A;;MCFEETERS ROGER F;;FLEMING HENRY P;;KLAENHAMMER TODD R;;SANOZKY ROSEMARY B,UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE THE (1983-09-27),https://lens.org/056-207-990-215-078,Granted Patent,yes,1,13,1,1,0,A23B7/10;;C12G1/0203;;C12H1/006;;C12N1/20;;C12R2001/25;;C12N1/205;;A23V2400/169;;C12N1/20;;C12G1/0203;;C12H1/006;;A23B7/10;;C12N1/205;;C12R2001/25;;A23V2400/169,A23B7/10;;C12G1/022;;C12H1/00;;C12N1/20,435/253;;435/172.1;;435/139;;435/34;;426/49;;426/52;;426/61,22,12,083-727-606-723-480;;050-382-882-892-282;;009-172-731-377-396;;042-245-453-595-553;;049-187-270-041-242;;087-581-360-194-473;;091-897-964-902-261;;015-898-682-845-957;;051-815-811-184-147;;102-764-048-887-316;;037-051-813-833-775;;018-500-501-634-891,10.1111/j.1365-2621.1982.tb12900.x;;10.1111/j.1365-2621.1982.tb12899.x;;10.1111/j.1365-2621.1977.tb12642.x;;10.1111/j.1365-2621.1980.tb07570.x;;10.1111/j.1365-2621.1973.tb01466.x;;10.1111/j.1365-2621.1973.tb01467.x;;4706775;;10.1007/bf00424825;;16345559;;10.1128/aem.39.4.926-927.1980;;pmc291446;;10.1128/jb.62.1.132-133.1951;;14861168;;pmc386093;;4732222;;10.1007/bf00408907;;10.1139/m82-131;;10.1099/00221287-38-2-279;;14287205,"McFeeters et al., (1982) Malic Acid as a Source of Carbon Dioxide in Cucumber Juice Fermentations , J. of Food Sci. 47, 1862 1865.;;McFeeters et al., (1982) Malic and Citric Acids in Pickling Cucumbers, J. of Food Sci. 47: 1859 1861, 1865.;;Stainer et al., (1976) The Microbial World, 4th ed., pp. 678 684.;;Sharp, (1981) The Prokaryotes, Chap. 131 The Genus Lactobacillus, Starr et al., (eds), pp. 1658 1666.;;Levine et al., (1930) A Compilation of Culture Media, p. 175.;;Chalfan, Y., I. Goldberg and R. Mateles; Isolation and Characterization of Malo Lactic Bacteria from Israeli Red Wines ; Journal of Food Science, vol. 42, pp. 939 943, (1977).;;Buchanan, R. E. and N. E. Gibbons (eds.); Bergey s Manual of Determinative Bacteriology, 8th ed., pp. 576 593, The Williams & Wilkins Co., Baltimore, MD (1974).;;Fleming, H. P. and D. M. Pharr; Mechanism for Bloater Formation in Brined Cucumbers ; Journal of Food Science; vol. 45, pp. 1595 1600, (1980).;;H. P. Fleming et al., Bloater Formation in Brined Cucumbers Fermented by Lactobacillis plantarum ; Journal of Food Science, vol. 38, pp. 499 503, (1973).;;H. P. Fleming et al., Carbon Dioxide Production in the Fermentation of Brined Cucumbers ; Journal of Food Science, vol. 38, pp. 504 506, (1973).;;Kandler et al, Zur Frange de beeinflussung der Glucosevergarung durch L Malat bei Leuconostoc mesenteroides , Arch. Mikrobiol., vol. 90, p. 65, (1973).;;Keddie, R. M.; The Properties and Classification of Lactobacilli Isolated from Grass and Silage , Journal of Applied Bacteriology, vol. 22, pp. 403 416, (1959).;;Kempler et al, Improved Medium for Detection of Citrate Fermenting Streptococcus lactis subsp. diacetylactis ; Applied and Environmental Microbiology, vol. 39, pp. 926 927, (1980).;;Miller, J. H.; Experiments in Molecular Genetics; pp. 125 127, Cold Spring Harbor Laboratory, New York, (1972).;;Rogosa et al; A Selective Medium for the Isolation and Enumeration of Oral and Faecal Lactobacilli ; Journal of Bacteriology, vol. 62, pp. 132 133, (1951).;;Schultz et al, Das Malatenzyme Lactobacillus plantarum und Leuconostoc mesenteroides ; Arch. Mikrobiol., vol. 91, pp. 183 202, (1973).;;Subden et al; An L Lactic Acid Dehydrogenase Based Method for Detecting Microbial Colonies Performing a Malo Lactic Fermentation ; Canadian Journal of Microbiology, vol. 28, pp. 883 886, (1982).;;Van der Westhuizen et al; Comparison of Procedures for Isolation of Malolactic Bacteria from Wine ; American Journal of Enol. Vitic., vol. 32, pp. 168 170, (1981).;;Whittenbury, R.; The Differentiation of Streptococcus faecalis and S. faecium , Journal of General Microbiology, vol. 38, pp. 279 287, (1965).;;The Biochemistry of Silage, P. McDonald (ed), John Wiley and Sons, New York, N.Y., p. 131, (1981).;;Manual of Methods for General Bacteriology, P. Gerhart (ed), American Society for Microbiology, Washington, D.C., p. 225, (1981).;;Fleming et al; Determination of Carbon Dioxide in Cucumber Brines ; Journal of the Association of Official Analytical Chemist ; vol. 57, pp. 130 133, (1974).",EXPIRED
571,FR,B1,FR 2968226 B1,049-789-871-745-497,2014-07-18,2014,FR 1161084 A,2011-12-02,US 95849510 A,2010-12-02,COMPOSITION DE FONDANT ET PROCEDE DE SOUDAGE,,ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;WINKLE MARK R;;LIU XIANG-QIAN,,https://lens.org/049-789-871-745-497,Granted Patent,no,0,0,12,12,0,B23K1/0016;;B23K1/203;;B23K35/3615;;B23K35/362;;B23K2101/42;;C07C217/52;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/3615;;B23K1/0016;;B23K35/362;;B23K1/203;;B23K2101/42,B23K35/363;;C07C211/36;;H05K3/32,,0,0,,,,INACTIVE
572,US,A1,US 2003/0117891 A1,089-100-244-611-762,2003-06-26,2003,US 31863602 A,2002-12-13,US 31863602 A;;US 90555301 A,2001-07-16,Slurry mixer outlet,"
   An apparatus configured for connection to a mixer for receiving a slurry and altering the flow characteristics of the slurry includes a conduit having a main inlet in slurry receiving communication with the mixer outlet and extending to a spout for discharging the slurry, at least one conduit restrictor associated with the conduit for creating back-pressure between the conduit restrictor and the mixer outlet for keeping the mixer full, and at least one pressure reducer associated with the discharge spout and configured for reducing the pressure of the slurry dispensed from the discharge spout. The apparatus is configured for maintaining a generally laminar flow from the mixer outlet to the discharge spout. 
",UNITED STATES GYPSUM CO,WITTBOLD JAMES R;;DUVEDI AMIT P;;SHAKE MICHAEL P;;HEMPHILL MARK K;;FLEMING WAYNE A,UNITED STATES GYPSUM COMPANY (2003-01-03),https://lens.org/089-100-244-611-762,Patent Application,yes,26,32,12,12,0,B28B19/0092;;B28C5/16;;B28C5/386;;B28C7/16;;B01F23/53;;B01F2025/917;;B01F27/811;;B01F35/75;;B01F2101/28;;B28C5/06;;C04B28/14;;C04B2111/0062;;B28B19/0092;;B28C5/16;;B28C5/386;;B28C7/16;;B01F35/75;;B01F23/53;;B01F27/811;;B01F2025/917;;B01F2101/28,B01F3/12;;B01F5/00;;B01F7/16;;B01F15/02;;B28B19/00;;B28C5/16;;B28C5/38;;B28C7/16,366/192;;366/194;;366/315,0,0,,,,EXPIRED
573,US,B1,US 8070043 B1,134-702-029-126-383,2011-12-06,2011,US 95847310 A,2010-12-02,US 95847310 A,2010-12-02,Curable flux composition and method of soldering,"A curable flux composition is provided, comprising, as initial components: a resin component having at least two oxirane groups per molecule; a fluxing agent represented by formula I: wherein R 1 , R 2 , R 3 and R 4 are independently selected from a hydrogen, a substituted C 1-80 alkyl group, an unsubstituted C 1-80 alkyl group, a substituted C 7-80 arylalkyl group and an unsubstituted C 7-80 arylalkyl group; and wherein zero to three of R 1 , R 2 , R 3 and R 4 is(are) hydrogen; and, optionally, a curing agent. Also provided is a method of soldering an electrical contact using the curable flux composition.",FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;WINKLE MARK R;;ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;WINKLE MARK R,ROHM AND HAAS ELECTRONIC MATERIALS LLC (2011-02-11),https://lens.org/134-702-029-126-383,Granted Patent,yes,48,4,15,15,0,B23K35/3613;;B23K35/362;;C08G59/184;;C08G59/5026;;C08L63/00;;H05K3/3489;;C08K5/17;;C07C217/52;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/362;;C08G59/5026;;B23K35/3613;;H05K3/3489;;C08L63/00;;C08G59/184;;C08K5/17,B23K31/02;;B23K35/34,228/180.21;;228/207;;228/223;;228/224;;228/248.1;;148/23;;148/24,5,0,,,"STIC search (no date available).;;Copending U.S. Appl. No. 12/958,495.;;Copending U.S. Appl. No. 12/958,487.;;Copending U.S. Appl. No. 12/958,480.;;Copending U.S. Appl. No. 12/958,493.",INACTIVE
574,US,B2,US 6874930 B2,149-705-541-618-238,2005-04-05,2005,US 31863602 A,2002-12-13,US 31863602 A;;US 90555301 A,2001-07-16,Slurry mixer outlet,"An apparatus configured for connection to a mixer for receiving a slurry and altering the flow characteristics of the slurry includes a conduit having a main inlet in slurry receiving communication with the mixer outlet and extending to a spout for discharging the slurry, at least one conduit restrictor associated with the conduit for creating back-pressure between the conduit restrictor and the mixer outlet for keeping the mixer full, and at least one pressure reducer associated with the discharge spout and configured for reducing the pressure of the slurry dispensed from the discharge spout. The apparatus is configured for maintaining a generally laminar flow from the mixer outlet to the discharge spout.",UNITED STATES GYPSUM CO,WITTBOLD JAMES R;;DUVEDI AMIT P;;SHAKE MICHAEL P;;HEMPHILL MARK K;;FLEMING WAYNE A,UNITED STATES GYPSUM COMPANY (2003-01-03),https://lens.org/149-705-541-618-238,Granted Patent,yes,27,147,12,12,0,B28B19/0092;;B28C5/16;;B28C5/386;;B28C7/16;;B01F23/53;;B01F2025/917;;B01F27/811;;B01F35/75;;B01F2101/28;;B28C5/06;;C04B28/14;;C04B2111/0062;;B28B19/0092;;B28C5/16;;B28C5/386;;B28C7/16;;B01F35/75;;B01F23/53;;B01F27/811;;B01F2025/917;;B01F2101/28,B01F3/12;;B01F5/00;;B01F7/16;;B01F15/02;;B28B19/00;;B28C5/16;;B28C5/38;;B28C7/16,366/192;;366/194;;366/315,0,0,,,,EXPIRED
575,FR,B1,FR 2968230 B1,146-390-812-327-457,2014-07-18,2014,FR 1161089 A,2011-12-02,US 95847310 A,2010-12-02,COMPOSITION DE FONDANT DURCISSABLE ET PROCEDE DE SOUDAGE,,ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;WINKLE MARK R;;LIU XIANG-QIAN,,https://lens.org/146-390-812-327-457,Granted Patent,no,0,0,15,15,0,B23K35/3613;;B23K35/362;;C08G59/184;;C08G59/5026;;C08L63/00;;H05K3/3489;;C08K5/17;;C07C217/52;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/362;;C08G59/5026;;B23K35/3613;;H05K3/3489;;C08L63/00;;C08G59/184;;C08K5/17,B23K35/363;;C08K5/17;;C08L63/00;;H01L21/56;;H05K3/32,,0,0,,,,INACTIVE
576,US,A1,US 2004/0132197 A1,184-373-670-854-887,2004-07-08,2004,US 72633603 A,2003-12-01,US 72633603 A;;US 43011799 A,1999-10-29,Cytological imaging system and method,"
   The present invention relates to the analysis of cytological material. Specifically, the invention relates to stains and methods of producing the stains, methods of staining cells for cytological or histological analysis to contrast the nuclear portion of the cell from the cytoplasmic portion, and systems and methods for illuminating a cytological sample. The analysis can be automated or manual. 
",CYTYC CORP,ZAHNISER DAVID J;;ZELINSKI MATTHEW S;;DOLASH THOMAS;;MAENLE GARRICK L;;FLEMING MARK;;LAUDO JOHN S,,https://lens.org/184-373-670-854-887,Patent Application,yes,95,18,5,81,0,G01N1/30;;G01N15/147;;G01N15/1484;;G01N21/3151;;G01N2015/1472;;G01N2015/1488;;G01N15/1433;;G01N21/3151;;G01N15/1484;;G01N15/147;;G01N2015/1472;;G01N2015/1488;;G01N1/30;;G01N15/1433,G01N1/30;;G01N15/14;;G01N21/31;;G06T7/00,436/63;;422/82.05,0,0,,,,EXPIRED
577,DE,D1,DE 60042835 D1,061-799-781-258-058,2009-10-08,2009,DE 60042835 T,2000-10-27,US 43011799 A;;US 43019699 A;;US 43019899 A;;US 43011699 A;;US 0029670 W,1999-10-29,ZYTOLOGISCHES ABBILDUNGSSYSTEM UND VERFAHREN,,CYTYC CORP,ZAHNISER DAVID J;;ZELINSKI MATTHEW S;;DOLASH THOMAS;;MAENLE GARRICK L;;FLEMING MARK;;LAUDO JOHN S,,https://lens.org/061-799-781-258-058,Granted Patent,no,0,0,10,81,0,G06T7/73;;G01N1/30;;G01N15/1468;;G01N15/147;;G01N15/1484;;G01N21/3151;;G01N2015/1006;;G01N2015/1472;;G01N2015/1488;;G06T7/0012;;G06T2207/20104;;G06T2207/30016;;G06T2207/30024;;G02B21/34;;G06V20/693;;G06V10/245;;G01N15/1433;;G06T7/73;;G06V20/693;;G06V10/245,G01N1/30;;G01N33/48;;C12Q1/02;;G01N1/28;;G01N15/10;;G01N15/14;;G01N21/01;;G01N21/27;;G01N21/31;;G01N33/483;;G06K9/00;;G06K9/32;;G06T1/00;;G06T7/00,,0,0,,,,EXPIRED
578,WO,A1,WO 2001/033191 A1,033-326-487-598-718,2001-05-10,2001,US 0029670 W,2000-10-27,US 43011799 A;;US 43019699 A;;US 43019899 A;;US 43011699 A;;US 0029670 W,1999-10-29,CYTOLOGICAL IMAGING SYSTEM AND METHOD,"The present invention relates to the analysis of cytological material. Specifically, the invention relates to stains and methods of producing the stains, methods of staining cells for cytological or histological analysis to contrast the nuclear portion of the cell from the cytoplasmic portion, and systems and methods for illuminating a cytological sample. The analysis can be automated or manual.",CYTYC CORP,ZAHNISER DAVID J;;ZELINSKI MATTHEW S;;DOLASH THOMAS;;MAENLE GARRICK L;;FLEMING MARK;;LAUDO JOHN S,,https://lens.org/033-326-487-598-718,Patent Application,yes,4,0,10,81,0,G06T7/73;;G01N1/30;;G01N15/1468;;G01N15/147;;G01N15/1484;;G01N21/3151;;G01N2015/1006;;G01N2015/1472;;G01N2015/1488;;G06T7/0012;;G06T2207/20104;;G06T2207/30016;;G06T2207/30024;;G02B21/34;;G06V20/693;;G06V10/245;;G01N15/1433;;G06T7/73;;G06V20/693;;G06V10/245,C12Q1/02;;G01N1/28;;G01N33/48;;G01N1/30;;G01N15/10;;G01N15/14;;G01N21/01;;G01N21/27;;G01N21/31;;G01N33/483;;G06K9/00;;G06K9/32;;G06T1/00;;G06T7/00,,2,0,,,"PATENT ABSTRACTS OF JAPAN vol. 1998, no. 12 31 October 1998 (1998-10-31);;PATENT ABSTRACTS OF JAPAN vol. 1997, no. 03 31 March 1997 (1997-03-31)",PATENTED
579,CN,B,CN 101423993 B,086-346-857-490-351,2012-07-18,2012,CN 200810173970 A,2008-10-31,US 93197307 A,2007-10-31,High extensible cut-resistant barrier,"A tire including a carcass, a crown portion, shoulders, sidewalls, a bead region, two beads, the beads being within the bead region, and at least one cord, the cord being at least two of the group comprising aramid fibers, polyamide fibers, liquid crystalline aromatic polyesters, carbon fibers, fiberglass, and metallic fibers, is herein described.",GOODYEAR TIRE & RUBBER;;DU PONT,KEVIN WESTGATE WALTER;;ANNE TWEEDIE JUDITH;;FLEMING BRAINERD JOHN II;;ALLAN LAMONTIA MARK;;LIM GOPEZ FLORENCIO,E.I. DU PONT DE NEMOURS AND CO. (2012-03-13),https://lens.org/086-346-857-490-351,Granted Patent,no,0,0,8,8,0,B60C9/06;;D02G3/48;;B60C9/005;;B60C2009/0475;;Y10T152/10855;;Y10T428/249921;;B60C9/08;;B60C9/02;;B60C1/00;;Y10T152/10855;;Y10T428/249921;;D02G3/48;;B60C9/06;;B60C9/005;;B60C2009/0475,D02G3/48;;B60C9/02;;B60C9/09;;B60C9/18;;D02G3/02;;D02G3/22,,0,0,,,,INACTIVE
580,EP,A1,EP 2434036 A1,093-047-643-015-479,2012-03-28,2012,EP 11189802 A,2008-10-27,EP 08167630 A;;US 93197307 A,2007-10-31,Tire comprising a high extensible cut-resistant barrier,"The invention relates to a Kevlar/Nylon core core insertion cord (36) having the cord construction 3/1 and to a tire comprising such a cord (36).
",GOODYEAR TIRE & RUBBER,WESTGATE WALTER KEVIN;;TWEEDIE JUDITH ANNE;;BRAINERD II JOHN FLEMING;;LAMONTIA MARK ALLAN;;GOPEZ FLORENCIO LIM,THE GOODYEAR TIRE & RUBBER COMPANY (2012-06-27);;E.I. DU PONT DE NEMOURS AND COMPANY (2012-06-27),https://lens.org/093-047-643-015-479,Patent Application,yes,5,0,8,8,0,B60C9/06;;D02G3/48;;B60C9/005;;B60C2009/0475;;Y10T152/10855;;Y10T428/249921;;B60C9/08;;B60C9/02;;B60C1/00;;Y10T152/10855;;Y10T428/249921;;D02G3/48;;B60C9/06;;B60C9/005;;B60C2009/0475,D02G3/48;;B60C9/00,,0,0,,,,DISCONTINUED
581,EP,A1,EP 2055817 A1,152-229-645-091-163,2009-05-06,2009,EP 08167630 A,2008-10-27,US 93197307 A,2007-10-31,Tire comprising a high extensible cut-resistant barrier and fabric therefor,"The invention relates to a tire comprising at least one cord, the cord comprising at least two different fibers of the group comprising aramid fibers, polyamide fibers, liquid crystalline aromatic polyesters, carbon fibers, fiberglass, and metallic fibers. In one aspect, the tire comprises a ply (20) comprising a fabric which comprises an aramid/polyamide 6,6 merged cord (16) and wherein the fabric is at an angle of between 0° and 180° to the ply angle. The invention further relates to an unidirectional fabric for use in an associated vehicle tire, the fabric comprising an aramid/polyamide 6,6 merged cord (16) or core insertion cord (36).
",GOODYEAR TIRE & RUBBER,WESTGATE WALTER KEVIN;;TWEEDIE JUDITH ANNE;;BRAINERD JOHN FLEMING II;;LAMONTIA MARK ALLAN;;GOPEZ FLORENCIO LIM,THE GOODYEAR TIRE & RUBBER COMPANY (2012-05-02);;E. I. DU PONT DE NEMOURS AND COMPANY (2012-05-02),https://lens.org/152-229-645-091-163,Patent Application,yes,17,9,8,8,0,B60C9/06;;D02G3/48;;B60C9/005;;B60C2009/0475;;Y10T152/10855;;Y10T428/249921;;B60C9/08;;B60C9/02;;B60C1/00;;Y10T152/10855;;Y10T428/249921;;D02G3/48;;B60C9/06;;B60C9/005;;B60C2009/0475,D02G3/48;;B60C9/00,,1,0,,,"BARRON E R: ""Hybrid Tire Cords Containing Kevlar Aramid"", KAUTSCHUK UND GUMMI - KUNSTSTOFFE, HUTHIG VERLAG, HEIDELBERG, DE, vol. 40, no. 2, 1 January 1987 (1987-01-01), pages 130 - 135, XP002232349, ISSN: 0948-3276",DISCONTINUED
582,HK,B,HK 1049204 B,051-274-604-860-705,2009-11-13,2009,HK 03100098 A,2003-01-03,US 0029670 W;;US 43011799 A;;US 43019699 A;;US 43019899 A;;US 43011699 A,1999-10-29,CYTOLOGICAL IMAGING SYSTEM AND METHOD,,CYTYC CORP,ZAHNISER DAVID J;;ZELINSKI MATTHEW S;;DOLASH THOMAS;;MAENLE GARRICK L;;FLEMING MARK;;LAUDO JOHN S,,https://lens.org/051-274-604-860-705,Granted Patent,no,0,0,10,81,0,G06T7/73;;G01N1/30;;G01N15/1468;;G01N15/147;;G01N15/1484;;G01N21/3151;;G01N2015/1006;;G01N2015/1472;;G01N2015/1488;;G06T7/0012;;G06T2207/20104;;G06T2207/30016;;G06T2207/30024;;G02B21/34;;G06V20/693;;G06V10/245;;G01N15/1433;;G06T7/73;;G06V20/693;;G06V10/245,G01N/;;G01N33/48;;C12Q1/02;;G01N1/28;;G01N1/30;;G01N15/10;;G01N15/14;;G01N21/01;;G01N21/27;;G01N21/31;;G01N33/483;;G06K9/00;;G06K9/32;;G06T1/00;;G06T7/00,,0,0,,,,EXPIRED
583,AU,B2,AU 780529 B2,044-218-032-896-787,2005-03-24,2005,AU 2001/012392 A,2000-10-27,US 43011799 A;;US 43019699 A;;US 43019899 A;;US 43011699 A;;US 0029670 W,1999-10-29,Cytological imaging system and method,,CYTYC CORP,ZAHNISER DAVID J;;ZELINSKI MATTHEW S;;DOLASH THOMAS;;MAENLE GARRICK L;;FLEMING MARK;;LAUDO JOHN S,,https://lens.org/044-218-032-896-787,Granted Patent,no,3,0,10,81,0,G06T7/73;;G01N1/30;;G01N15/1468;;G01N15/147;;G01N15/1484;;G01N21/3151;;G01N2015/1006;;G01N2015/1472;;G01N2015/1488;;G06T7/0012;;G06T2207/20104;;G06T2207/30016;;G06T2207/30024;;G02B21/34;;G06V20/693;;G06V10/245;;G01N15/1433;;G06T7/73;;G06V20/693;;G06V10/245,G01N33/48;;C12Q1/02;;G01N1/28;;G01N1/30;;G01N15/10;;G01N15/14;;G01N21/01;;G01N21/27;;G01N21/31;;G01N33/483;;G06K9/00;;G06K9/32;;G06T1/00;;G06T7/00,,0,0,,,,EXPIRED
584,JP,A,JP 2012017651 A,164-975-625-506-077,2012-01-26,2012,JP 2011198330 A,2011-09-12,US 74682903 A,2003-12-24,ENERGY EFFICIENT BUILDING SURFACE,"PROBLEM TO BE SOLVED: To provide reflection coats used on external surfaces such as asphalt shingles and rooftop tiles for increasing solar reflectance and a method to extend the effective life of the coats.SOLUTION: A non-white building surface in this invention comprises a base material, a primary reflection coat which is on at least part of external surface of the base material and provides the base material with a minimum direct solar reflectance value of at least around 25%, and a secondary reflection coat on at least part of the primary reflection coat. The combination of the primary and secondary reflection coats provide the base material with a reflectance of at least around 20% at virtually every point of a wavelength range of 770-2500 nm.",THREE M INNOVATIVE PROPERTIES,MARK T ANDERSON;;PETER P FLEMING;;RACHEL AT GURD;;CHRISTOPHER L GROSS;;DANIEL B PENDERGRASS JR,,https://lens.org/164-975-625-506-077,Patent Application,no,9,0,15,15,0,E04D2001/005;;G02B5/0816;;Y10T428/24372;;Y02A30/254;;Y02B80/00;;E04D1/28;;G02B5/0816;;E04D2001/005;;E04D1/22;;Y10T428/24372;;E04D2001/005;;G02B5/0816;;Y02A30/254;;Y02B80/00;;E04D1/28,E04D1/28;;E04D1/22;;G02B5/08,,0,0,,,,PENDING
585,EP,A1,EP 1226416 A1,187-710-301-053-834,2002-07-31,2002,EP 00973952 A,2000-10-27,US 0029670 W;;US 43011799 A;;US 43019699 A;;US 43019899 A;;US 43011699 A,1999-10-29,CYTOLOGICAL IMAGING SYSTEM AND METHOD,,CYTYC CORP,ZAHNISER DAVID J;;ZELINSKI MATTHEW S;;DOLASH THOMAS;;MAENLE GARRICK L;;FLEMING MARK;;LAUDO JOHN S,CYTYC CORPORATION (2009-08-12),https://lens.org/187-710-301-053-834,Patent Application,yes,0,0,10,81,0,G06T7/73;;G01N1/30;;G01N15/1468;;G01N15/147;;G01N15/1484;;G01N21/3151;;G01N2015/1006;;G01N2015/1472;;G01N2015/1488;;G06T7/0012;;G06T2207/20104;;G06T2207/30016;;G06T2207/30024;;G02B21/34;;G06V20/693;;G06V10/245;;G01N15/1433;;G06T7/73;;G06V20/693;;G06V10/245,G01N33/48;;C12Q1/02;;G01N1/28;;G01N1/30;;G01N15/10;;G01N15/14;;G01N21/01;;G01N21/27;;G01N21/31;;G01N33/483;;G06K9/00;;G06K9/32;;G06T1/00;;G06T7/00,,0,0,,,,EXPIRED
586,HK,A1,HK 1049204 A1,145-602-278-859-503,2003-05-02,2003,HK 03100098 A,2003-01-03,US 0029670 W;;US 43011799 A;;US 43019699 A;;US 43019899 A;;US 43011699 A,1999-10-29,CYTOLOGICAL IMAGING SYSTEM AND METHOD,,CYTYC CORP,ZAHNISER DAVID J;;ZELINSKI MATTHEW S;;DOLASH THOMAS;;MAENLE GARRICK L;;FLEMING MARK;;LAUDO JOHN S,,https://lens.org/145-602-278-859-503,Patent Application,no,0,0,10,81,0,G06T7/73;;G01N1/30;;G01N15/1468;;G01N15/147;;G01N15/1484;;G01N21/3151;;G01N2015/1006;;G01N2015/1472;;G01N2015/1488;;G06T7/0012;;G06T2207/20104;;G06T2207/30016;;G06T2207/30024;;G02B21/34;;G06V20/693;;G06V10/245;;G01N15/1433;;G06T7/73;;G06V20/693;;G06V10/245,G01N33/48;;C12Q1/02;;G01N/;;G01N1/28;;G01N1/30;;G01N15/10;;G01N15/14;;G01N21/01;;G01N21/27;;G01N21/31;;G01N33/483;;G06K9/00;;G06K9/32;;G06T1/00;;G06T7/00,,0,0,,,,EXPIRED
587,EP,B1,EP 1226416 B1,191-779-591-662-098,2009-08-26,2009,EP 00973952 A,2000-10-27,US 0029670 W;;US 43011799 A;;US 43019699 A;;US 43019899 A;;US 43011699 A,1999-10-29,CYTOLOGICAL IMAGING SYSTEM AND METHOD,,CYTYC CORP,ZAHNISER DAVID J;;ZELINSKI MATTHEW S;;DOLASH THOMAS;;MAENLE GARRICK L;;FLEMING MARK;;LAUDO JOHN S,CYTYC CORPORATION (2009-08-12),https://lens.org/191-779-591-662-098,Granted Patent,yes,4,0,10,81,0,G06T7/73;;G01N1/30;;G01N15/1468;;G01N15/147;;G01N15/1484;;G01N21/3151;;G01N2015/1006;;G01N2015/1472;;G01N2015/1488;;G06T7/0012;;G06T2207/20104;;G06T2207/30016;;G06T2207/30024;;G02B21/34;;G06V20/693;;G06V10/245;;G01N15/1433;;G06T7/73;;G06V20/693;;G06V10/245,G01N1/30;;G01N33/48;;C12Q1/02;;G01N1/28;;G01N15/10;;G01N15/14;;G01N21/01;;G01N21/27;;G01N21/31;;G01N33/483;;G06K9/00;;G06K9/32;;G06T1/00;;G06T7/00,,2,0,,,"PATENT ABSTRACTS OF JAPAN vol. 1998, no. 12, 31 October 1998 (1998-10-31) & JP 10 186272 A (SANYO ELECTRIC CO LTD), 14 July 1998 (1998-07-14);;PATENT ABSTRACTS OF JAPAN vol. 1997, no. 03, 31 March 1997 (1997-03-31) & JP 08 317192 A (RICOH ELEMEX CORP), 29 November 1996 (1996-11-29)",EXPIRED
588,AU,A,AU 2001/012392 A,081-445-690-745-181,2001-05-14,2001,AU 2001/012392 A,2000-10-27,US 43011799 A;;US 43019699 A;;US 43019899 A;;US 43011699 A;;US 0029670 W,1999-10-29,Cytological imaging system and method,,CYTYC CORP,ZAHNISER DAVID J;;ZELINSKI MATTHEW S;;DOLASH THOMAS;;MAENLE GARRICK L;;FLEMING MARK;;LAUDO JOHN S,,https://lens.org/081-445-690-745-181,Patent Application,no,0,0,10,81,0,G06T7/73;;G01N1/30;;G01N15/1468;;G01N15/147;;G01N15/1484;;G01N21/3151;;G01N2015/1006;;G01N2015/1472;;G01N2015/1488;;G06T7/0012;;G06T2207/20104;;G06T2207/30016;;G06T2207/30024;;G02B21/34;;G06V20/693;;G06V10/245;;G01N15/1433;;G06T7/73;;G06V20/693;;G06V10/245,G01N33/48;;C12Q1/02;;G01N1/28;;G01N1/30;;G01N15/10;;G01N15/14;;G01N21/01;;G01N21/27;;G01N21/31;;G01N33/483;;G06K9/00;;G06K9/32;;G06T1/00;;G06T7/00,,0,0,,,,EXPIRED
589,US,A1,US 2008/0278707 A1,062-024-705-376-397,2008-11-13,2008,US 17700308 A,2008-07-21,US 17700308 A;;US 72633603 A;;US 43011799 A,1999-10-29,CYTOLOGICAL IMAGING SYSTEM AND METHOD,"The present invention relates to the analysis of cytological material. Specifically, the invention relates to stains and methods of producing the stains, methods of staining cells for cytological or histological analysis to contrast the nuclear portion of the cell from the cytoplasmic portion, and systems and methods for illuminating a cytological sample. The analysis can be automated or manual.",CYTYC CORP,ZAHNISER DAVID J;;ZELINSKI MATTHEW S;;DOLASH THOMAS;;MAENLE GARRICK L;;FLEMING MARK;;LAUDO JOHN S,,https://lens.org/062-024-705-376-397,Patent Application,yes,3,4,5,81,0,G01N1/30;;G01N15/147;;G01N15/1484;;G01N21/3151;;G01N2015/1472;;G01N2015/1488;;G01N15/1433;;G01N21/3151;;G01N15/1484;;G01N15/147;;G01N2015/1472;;G01N2015/1488;;G01N1/30;;G01N15/1433,G01N1/30;;G01N33/48;;G01N15/14;;G01N21/31;;G06T7/00,356/39,0,0,,,,EXPIRED
590,US,A1,US 2018/0022731 A1,061-122-312-304-715,2018-01-25,2018,US 201615548925 A,2016-02-05,US 201615548925 A;;US 201562112897 P;;US 2016/0016808 W,2015-02-06,2-(PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES AS RET INHIBITORS,"Described herein are compounds that inhibit wild-type RET and its resistant mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.",BLUEPRINT MEDICINES CORP,BROOIJMANS NATASJA;;DIPIETRO LUCIAN V;;FLEMING PAUL E;;KIM JOSEPH L;;WENGLOWSKY STEVEN MARK;;ZHANG YULIAN,BLUEPRINT MEDICINES CORPORATION (2016-08-29),https://lens.org/061-122-312-304-715,Patent Application,yes,0,21,5,5,0,A61K31/506;;A61K31/506;;A61K45/06;;A61P35/00;;C07D401/14;;C07D401/14;;C07D403/04;;C07D403/04;;C07D403/12;;C07D403/12;;C07D405/14;;C07D405/14;;C07D417/14;;C07D417/14,C07D401/14;;A61K31/506;;A61K45/06;;C07D405/14;;C07D417/14,,0,0,,,,ACTIVE
591,US,A1,US 2005/0280813 A1,126-293-776-737-028,2005-12-22,2005,US 15359605 A,2005-06-15,US 15359605 A;;US 58007704 P,2004-06-16,Infrared spectroscopy as an assist for cytological investigation,"The present invention provides a method for using infrared light either alone or in conjunction with visible light to create an improved system for cytologic examination. As stated above, infrared light is sensitive to molecular and biochemical changes and can thus be used to identify specific chemical species or substances. This characteristic can be used to identify areas on a slide most likely to contain an abnormality, and can further provide information to overlay on an image of the slide to enhance the visual contrast for the human screener. This process of image enhancement via the use of multivariate spectroscopy can be used to dramatically enhance the information content provided to the medical professional.",JONES HOWLAND D T;;ROBINSON MARK R;;JOHNSON ROBERT D;;FLEMING CLIONA M;;BROWN CHRISTEPHER D,JONES HOWLAND D T;;ROBINSON MARK R;;JOHNSON ROBERT D;;FLEMING CLIONA M;;BROWN CHRISTEPHER D,INLIGHT SOLUTIONS INC (2005-06-24),https://lens.org/126-293-776-737-028,Patent Application,yes,10,9,1,1,0,G01J3/108;;G01J3/108;;G01N21/253;;G01N21/253;;G01N21/3563;;G01N21/3563,G01J3/00;;G01J3/10;;G01N21/25;;G01N21/35,356/300,0,0,,,,DISCONTINUED
592,US,B2,US 10774070 B2,049-748-938-768-722,2020-09-15,2020,US 201816228381 A,2018-12-20,US 201816228381 A;;US 201715548925 A;;US 2016/0016808 W;;US 201562112897 P,2015-02-06,2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors,"Described herein are compounds, such as compounds of Formula (I) and pharmaceutically acceptable salts thereof, that inhibit wild-type RET and its resistant mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions, e.g., for treating a condition mediated by aberrant RET activity",BLUEPRINT MEDICINES CORP,BROOIJMANS NATASJA;;DIPIETRO LUCIAN V;;FLEMING PAUL E;;KIM JOSEPH L;;WENGLOWSKY STEVEN MARK;;ZHANG YULIAN,BLUEPRINT MEDICINES CORPORATION (2016-08-29),https://lens.org/049-748-938-768-722,Granted Patent,yes,93,3,5,5,0,A61K31/506;;A61K31/506;;A61K45/06;;A61P35/00;;C07D401/14;;C07D401/14;;C07D403/04;;C07D403/04;;C07D403/12;;C07D403/12;;C07D405/14;;C07D405/14;;C07D417/14;;C07D417/14,A61K31/506;;A61K45/06;;C07D401/14;;C07D403/04;;C07D403/12;;C07D405/14;;C07D417/14,,102,64,025-887-342-195-096;;038-461-963-767-185;;011-016-624-525-450;;071-112-627-968-309;;063-026-403-464-16X;;017-168-184-325-965;;084-446-756-734-746;;020-039-295-806-005;;016-866-638-789-070;;120-738-288-740-114;;068-418-696-833-129;;002-547-406-808-715;;004-134-293-693-153;;026-676-687-727-859;;050-593-709-134-736;;064-746-930-221-401;;028-903-028-573-104;;056-889-703-126-090;;118-907-933-551-256;;010-889-627-397-489;;031-946-300-510-005;;000-626-106-220-736;;054-218-399-761-152;;029-098-872-907-074;;092-163-195-558-761;;046-448-894-392-546;;097-489-380-533-461;;078-535-432-813-525;;018-164-678-420-792;;003-772-781-925-494;;072-862-909-328-771;;058-058-973-421-909;;082-000-982-226-45X;;065-114-135-541-570;;024-743-816-718-970;;017-133-122-188-272;;052-308-676-552-954;;147-347-874-645-429;;001-236-533-707-576;;039-484-264-887-186;;036-676-350-527-31X;;016-105-425-428-590;;067-792-990-916-922;;093-985-357-437-882;;080-024-344-526-62X;;088-479-253-105-637;;039-189-520-016-338;;011-376-199-309-747;;020-603-188-037-807;;058-900-866-921-002;;021-917-964-109-542;;000-623-982-398-418;;025-736-846-484-723;;023-079-101-437-105;;015-118-134-068-632;;124-323-575-198-795;;024-104-567-234-64X;;054-256-920-226-319;;058-121-900-065-340;;095-463-715-249-123;;082-986-028-696-918;;103-039-331-117-362;;018-114-661-906-053;;101-048-263-486-116,10.1016/j.critrevonc.2014.06.003;;25028151;;pmc4465992;;25723109;;10.1097/pas.0000000000000404;;10.1016/j.cytogfr.2005.05.010;;15982921;;10.1200/jco.2005.08.326;;15939921;;10.1089/thy.2013.0137;;pmc3868259;;23705946;;10.1016/j.ejmech.2010.03.017;;20409618;;10.1006/bbrc.1995.1287;;7864888;;9191060;;10.1038/sj.onc.1201079;;11287972;;10.1056/nejm200104053441401;;19097774;;10.1016/j.ejca.2008.10.026;;10.1210/jc.2007-1714;;10.3410/f.1104639.559451;;18073307;;10.1210/jc.2014-4153;;25546157;;pmc4333032;;10.1016/j.humpath.2015.08.013;;26472164;;11002419;;10.1038/sj.onc.1203799;;10.1016/j.lungcan.2015.12.011;;26898613;;10.1111/his.12902;;26568156;;10.1515/prilozi-2015-0034;;26076779;;27099842;;pmc4836117;;10.1159/000443730;;27683183;;10.1158/1078-0432.ccr-16-1679;;10.4183/aeb.2015.189;;24699901;;10.1002/cncr.28661;;10.1210/jc.2015-2948;;26765577;;26078337;;10.18632/oncotarget.4325;;pmc4745701;;27167191;;10.18632/oncotarget.9153;;pmc5129956;;pmc2708317;;10.1038/nbt.1549;;19581876;;27544060;;10.1016/j.jtho.2016.08.126;;22327622;;10.1038/nm.2673;;pmc3916180;;10.1056/nejmoa012915;;14561794;;10.1016/j.bmc.2010.01.011;;20117004;;23811235;;10.1016/j.mce.2013.06.025;;10.1080/13543776.2017.1238073;;27646564;;19401695;;10.1038/sj.bjc.6605056;;pmc2695700;;0008099202;;8099202;;10.1038/363458a0;;10.1111/j.1365-2796.1995.tb01208.x;;7595170;;24561444;;10.1038/nrc3680;;10.1016/j.cellsig.2014.03.032;;24705026;;pmc4700226;;10.3978/j.issn.2218-6751.2015.03.08;;26798590;;26356818;;10.18632/oncotarget.4992;;pmc4741820;;10.1158/1538-7445.am2016-2641;;17884497;;10.1016/j.bmcl.2007.07.104;;26868437;;10.1038/nrendo.2016.11;;10.1111/cas.12941;;pmc4968599;;27027665;;10.1016/s0065-230x(06)96008-4;;17161682;;26497911;;10.1507/endocrj.ej15-0399;;10.1007/s12020-015-0559-0;;25725622;;pmc4234119;;10.1158/1078-0432.ccr-12-0838;;23052255;;23578175;;10.1111/cas.12175;;pmc7657251;;pmc4175590;;25204415;;10.1038/ncomms5846;;22327623;;10.1038/nm.2658;;10.1097/ppo.0b013e3181bd0445;;19826361;;10.1158/1078-0432.ccr-14-2329;;26078430;;10.1002/gcc.20937;;22034177;;pmc3235801;;23150706;;10.1200/jco.2012.44.1477;;10.1089/thy.2014.0335;;pmc4490627;;25810047;;10.18632/oncotarget.1706;;pmc4058012;;24796583;;23828865;;pmc4375728;;10.1530/erc-13-0085;;21831957;;10.1158/1078-0432.ccr-11-0933;;pmc4828042;;pmc4998046;;10.1016/j.lungcan.2015.04.004;;25982012;;28841389;;10.1200/jco.2017.74.7576;;26187428;;10.1016/j.lungcan.2015.06.021;;10.1210/jc.2009-2461;;pmc2902067;;20371662;;10.1158/2159-8290.cd-18-0338;;29657135;;10.1158/1538-7445.am2018-ct043;;10.1158/2159-8290.cd-nb2018-050;;29657136,"U.S. Appl. No. 15/340,428 U.S. Pat. No. 10,030,005, Inhibitors of RET, filed Nov. 1, 2016, Patented.;;U.S. Appl. No. 16/041,719 US 2019-0185454, Inhibitors of RET, filed Jul. 20, 2018, Pending.;;U.S. Appl. No. 15/548,925 U.S. Pat. No. 10,202,365, 2-(Pyridin-3-yl)-pyrirnidine Derivatives as RET Inhibitors, filed Aug. 4, 2017, Patented.;;U.S. Appl. No. 15/462,255 U.S. Pat. No. 10,183,928, Inhibitors of RET, filed Mar. 17, 2017, Patented.;;U.S. Appl. No. 15/657,057 U.S. Pat. No. 10,227,329, Compounds Useful for Treating Disorders Related to RET, filed Jul. 21, 2017, Patented.;;U.S. Appl. No. 15/660,840 U.S. Pat. No. 10,035,789, Compounds Useful for Treating Disorders Related to RET, filed Jul. 26, 2017, Patented.;;Abdel-Rahman, O. and M. Fouad (2014) “Risk of cardiovascular toxicities in patients with solid tumors treated with sunitinib, axitinib, cediranib or regorafenib: an updated systematic review and comparative meta-analysis” Crit Rev Oncol Hematol, 92:194-207.;;Antonescu, C.R. et al. (Jul. 2015) “Molecular Characterization of Inflammatory Myofibroblastic Tumors with Frequent ALK and ROS1 Fusions and Rare Novel RET Gene Rearrangement” Am J Surg Pathol, 39(7):957-967. HHS Public Access Author Manuscript; available in PMC Jul. 1, 2015 (19 pages).;;Arighi, E. et al. (2005) “RET tyrosine kinase signaling in development and cancer” Cytokine Growth Factor Rev, 16:441-467.;;Baselga, J. et al. (2005) “Phase II and Tumor Pharmacodynamic Study of Gefitinib in Patients with Advanced Breast Cancer” J Clin Oncol, 23(23):5323-5333.;;Bentzien, F. et al. (2013) “In Vitro and In Vivo Activity of Cabozantinib (XL184), an Inhibitor of RET, MET, and VEGFR2, in a Model of Medullary Thyroid Cancer” Thyroid, 23(12):1569-1577.;;Brandt, W. et al. (2010) “Inhibitors of the RET tyrosine kinase based on a 2-(alkylsulfanyl)-4-(3-thienyl)nicotinonitrile scaffold” Eur J Med Chem, 45:2919-2927.;;Caprelsa (vandetanib) “Full Prescribing Information” Reference ID: 3964956, Cambridge, MA: Sanofi Genzyme; 2016.;;Carlomagno, F. et al. (Feb. 1995) “Point Mutation of the RET Proto-Oncogene in the TT Human Medullary Thyroid Carcinoma Cell Line” Biochem Biophys Res Commun, 207(3):1022-1028.;;Ceccherini, I. et al. (1997) “Somatic in frame deletions not involving juxtamerribranous cysteine residues strongly activate the RET proto-oncogene” Oncogene, 14:2609-2612.;;Chalice Software 'Technical Guide, Horizon CombinatoRx Inc., Cambridge, MA, USA (downloaded Jul. 2018).;;Cometriq (cabozantinib)“Full Prescribing information” Reference ID: 3964956, South San Francisco, CA: Exelixix, Inc.; 2018.;;Druker, B.J. et al. (2001) “Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia” New Engl J Med, 344(14):1031-1037.;;Eisenhauer, E.A. et al. (2009) “New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)” Eur J Cancer, 45:228-247.;;Elisei, R. et al. (2008) “Prognostic Significance of Somatic RET Oncogene Mutations in Sporadic Medullary Thyroid Cancer: A 10-Year Follow-Up Study” J Clin Endocrinol Metab, 93(3):682-687.;;Evans, E. (May 1, 2016) “The Development of Potent and Selective RET Inhibitors” Slides presented at the 2016 Annual Meeting of the International Thyroid Oncology Group at the University of Colorado (19 pages).;;Fang, P. et al. (Feb. 2016) “Detection of a novel RET gene fusion in a non-small cell lung cancer patient using AMP chemistry” J Thorac Oncol, 11.2:S21-S22.;;Gautschi, O. et al. (2016) “Targeting RET in patients with RET-rearranged lung cancers: Results from a global registry” J Clin Oncol, 34(15S) (suppl; abstr 9014).;;Grubbs, E.G. et al. (Mar. 2015) “RET Fusion as a Novel Driver of Medullary Thyroid Carcinoma” J Clin Encloctinol Metab, 100:788-793.;;Halkova, T. et al. (2015) “A novel RET/PTC variant detected in a pediatric patient with papillary thyroid cancer without ionization history” Hum Pathol, 46:1962-1969.;;Hayashi, H. et al. (2000) “Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor” Oncogene, 19:4469-4475.;;Horiike, A. et al. (2016) “Sorafenib treatment for patients with RET fusion-positive non-small cell lung cancer” Lung Cancer, 93:43-46.;;International Search Report and Written Opinion dated Apr. 29, 2016, in International Patent Application No. PCT/US2016/016808, filed Feb. 5, 2016, by Blueprint Medicines Corp. (8 pages).;;International Search Report and Written Opinion dated Jan. 18, 2017, in International Patent Application No. PCT/US2016/059879, filed Nov. 1, 2016, by Blueprint Medicines Corp. (12 pages).;;International Search Report and Written Opinion dated Jun. 12, 2017, in international Patent Application No. PCT/US2017/022969, filed Mar. 17, 2017, by Blueprint Medicines Corp. (12 pages).;;International Search Report and Written Opinion dated Oct. 12, 2017, in International Patent Application No. PCT/US2017/043964, filed Jul. 26, 2017, by Blueprint Medicines Corp. (13 pages).;;International Search Report and Written Opinion dated Oct. 25, 2017, in International Patent Application No. PCT/US2017/043340, filed Jul. 21, 2017, by Blueprint Medicines Corp. (14 pages).;;Joung, J.Y. et al. (2016) “Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications” Histopathology, 69:45-53.;;Jovanovic, R. et al. (2015) “Novel RET Mutations in Macedonian Patients with Medullary Thyroid Carcinoma: Genotype-Phenotype Correlations” Prilozi, 36(1):93-107.;;Karrasch, T. et al. (2016) “How to Assess the Clinical Relevance of Novel RET Missense Variants in the Absence of Functional Studies?” Eur Thyroid J, 5:73-77.;;Kato, S. et al. (Apr. 15, 2017) “RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients” Clin Cancer Res, 23(8):1988-1997.;;Kim, S.H. et al. (2015) “A New Germline ALA641THR Variant in the Transmembrane Domain of the RET Gene Associated with Medullary Thyroid Cancer” Acta Endocrinologica (Buc), 11.2:189-194.;;Krampitz, G.W. and J.A. Norton (2014) “RET Gene Mutations (Genotype and Phenotype) of Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma” Cancer, 120:1920-1931.;;Kuster, B. (Ed.) (2012) Kinase Inhibitors. Methods and Protocols. Humana Press; Chapters 1 and 2, pp. 1-44.;;Latteyer, S. et al. (Mar. 2016) “A 6-Base Pair in Frame Germline Deletion in Exon 7 of RET Leads to Increased RET Phosphorylation, ERK Activation, and MEN2A” J Clin Endocrinol Metab, 101(3):1016-1022.;;Le Rolle, A. et al. (2015) “Identification and characterization of RET fusions in advanced colorectal cancer” Oncotarget, 6(30):28929-28937.;;Lee, M.S. et al. (2016) “Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models” Oncotarget, 7(26):39595-39608.;;Lehar, J. et al. (2009) “Synergistic drug combinations improve therapeutic selectivity” Nat Biotechnol, 27(7):659-666. HHS Public Access Author Manuscript; available in PMC Jan. 1, 2010 (23 pages).;;Lin, J.J. et al. (2016) “Clinical Activity of Alectinib in Advanced RET-Rearranged Non-Small Cell Lung Cancer” J Thorac Oncol, 11(11):2027-2032.;;Lipson, D. et al. (2012) “Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies” Nat Med, 18(3):382-384. HHS Public Access Author Manuscript; available in PMC Feb. 6, 2014 (7 pages).;;Machens, A et al. (2003) “Early Malignant Progression of Hereditary Medullary Thyroid Cancer” New Engl J Med, 349:1517-1525.;;Mologni, L. et al. (2010) “Synthesis, structure-activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors” Bioorg Med Chem, 18:1482-1496.;;Mologni, L. et al. (2013) “Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinase” Mol Cell Endocrinol, 377:1-6.;;Mologni, L. et al. (2017) “RET kinase inhibitors: a review of recent patents (2012-2015)” Exp Opin Ther Patents, 27(1):91-99.;;Moura, M.M. et al. (2009) “Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas” Br J Cancer, 100:1777-1783.;;Mulligan, L.M. et al. (Jun. 3, 1993) “Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A” Nature, 363:458-460.;;Mulligan, L.M. et al. (1995) “Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium” J Int Med, 238:343-346.;;Mulligan, L.M. (Mar. 2014) “RET revisited: expanding the oncogenic portfolio” Nat Rev Cancer, 14:173-186.;;Notice of Allowance dated Aug. 6, 2018, in U.S. Appl. No. 15/462,255, filed Mar. 17, 2017, by Blueprint Medicines Corp.;;Notice of Allowance dated Sep. 26, 2018, in U.S. Appl. No. 15/867,637, filed Jan. 10, 2018, by Blueprint Medicines Corp.;;Notice of Allowance dated Oct. 11, 2018, in U.S. Appl. No. 15/222,523, filed Jul. 28, 2016, by Blueprint Medicines Corp.;;Notice of Allowance dated Oct. 19, 2018, in U.S. Appl. No. 15/657,057, filed Jul. 21, 2017, by Blueprint Medicines Corp.;;Notice of Allowance dated Dec. 6, 2018, in U.S. Appl. No. 15/488,257, filed Apr. 14, 2017, by Blueprint Medicines Corp.;;Plaza-Menacho, I. et al. (2014) “Mechanisms of RET signaling in cancer: Current and future implications for targeted therapy” Cell Signal, 26:1743-1752.;;Pirker, R. and M. Filipits (2015) “Alectinib in RET-rearranged non-small cell lung cancer—Another progress in precision medicine?” Transl Lung Cancer Res, 4(6):797-800.;;Qi, X. et al. (2015) “RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D” Oncotarget, 6(32):33993-34003.;;Rahal, R. et al. (2016) “The development of potent, selective RET inhibitors that target both wild-type RET and prospectively identified resistance mutations to multi-kinase inhibitors” Abstract submitted to the American Association for Cancer Research (AACR) Annual Meeting, Apr. 16-20, 2016, New Orleans; submission date Dec. 1, 2015 (2 pages).;;Rahal, R. (Apr. 18, 2016) “The development of potent, selective RET inhibitors” Slides of a Presentation at the American Association for Cancer Research (AACR) Annual Meeting, Apr. 16-20, 2016, New Orleans (15 pages).;;Robinett, R.G. et al. (2007) “The discovery of substituted 4-(3-hyroxyanilino)-quinolines as potent RET kinase inhibitors” Bioorg Med Chem Lett, 17:5886-5893.;;Romei, C. et al. (Apr. 2016) “A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma” Nat Rev Endocrinol, 12:192-202.;;Saito, M. et al. (Jun. 2016) “Gene aberrations for precision medicine against lung adenocarcinoma” Cancer Sci, 107(6):713-720.;;Sarker, D. and P. Workman (2007) “Pharmacodynamic Biomarkers for Molecular Cancer Therapeutics” Adv Cancer Res, 96:213-268.;;Scollo, C. et al. (2016) “A novel RET gene mutation in a patient with apparently sporadic pheochromocytoma” Endocr J, 63(1):87-91.;;Silva, A.L. et al. (2015) “Identification and characterization of two novel germline RET variants associated with medullary thyroid carcinoma” Endocrine, 49:366-372.;;Suehara, Y. et al. (Dec. 15, 2012) “Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions” Clin Cancer Res, 18(24):6599-6608. HHS Public Access Author Manuscript; available in PMC Nov. 17, 2014 (18 pages).;;Suzuki, M. et al. (Jul. 2013) “identification of a lung adenocarcinorna cell line with CCDC6-RET fusion gene and the effect of RET inhibitors in vitro and in vivo” Cancer Sci, 104(7):896-903.;;Stransky, N. et al. (2014) “The landscape of kinase fusions in cancer” Nat Commun, 5:4846 (10 pages).;;Takeuchi, K. et al. (Mar. 2012) “RET, ROS1 and ALK fusions in lung cancer” Nat Med, 18(3):378-381.;;Tan, D.S. et al. (2009) “Biomarker-Driven Early Clinical Trials in Oncology” Cancer J, 15(5):406-420.;;Touat, M. et al. (2015) “Targeting FGFR Signaling in Cancer” Clin Cancer Res, 21(12):2684-2694.;;U.S. Nat'l Library of Med., A Phase 1 Trial of Vandetanib (a Muiti-kinase Inhibitor of EGFR, VEGFR and RET Inhibitor) in Combination With Everolimus (an mTOR Inhibitor) in Advanced Cancer, ClinicalTrials.gov, https://clinicaltrials.gov/ct2/show/NCT01582191 (last updated Jul. 3, 2018) (7 pages).;;U.S. Nat'l Library of Med., Phase 1 Study of the Highly-Selective RET Inhibitor BLU-667 in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors, ClinicalTrials.gov, https://clinicaltrials.gov/ct2/show/NCT03037385 (last updated Jun. 27, 2018) (8 pages).;;U.S. Appl. No. 15/867,637, filed Jan. 10, 2018, by Blueprint Medicines Corp.;;U.S. Appl. No. 15/973,340, filed May 7, 2018, by Blueprint Medicines Corp.;;U.S. Appl. No. 15/973,378, filed May 7, 2018, by Blueprint Medicines Corp.;;U.S. Appl. No. 16/002,587, filed Jun. 7, 2018, by Blueprint Medicines Corp.;;U.S. Appl. No. 16/027,166, filed Jul. 3, 2018, by Blueprint Medicines Corp.;;U.S. Appl. No. 16/041,719, filed Jul. 20, 2018, by Blueprint Medicines Corp.;;Wang, L. et al. (2012) “Identification of a Novel, Recurrent HEY1-NCOA2 Fusion in Mesenchymal Chondrosarcorna based on a Genome-wide Screen of Exon-level Expression Data” Genes Chromosomes Cancer, 51(2):127-139. HHS Public Access Author Manuscript; available in PMC Feb. 1, 2013 (24 pages).;;Wang, R. et al. (Dec. 10, 2012) “RET Fusions Define a Unique Molecular and Clinicopathologic Subtype of Non-Small-Cell Lung Cancer” J Clin Oncol, 30(35):4352-4359.;;Wells, S.A. et al. (2015) “Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma” Thyroid, 25(6):567-610.;;Chen, M-H et al. (2014) “Antitumor activity of the combination of a HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma,” Oncotarget, 5(8):2372-2389.;;Gild, M.L. et al. (Oct. 2013) “Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells” Endocr Re/at Cancer, 20(5):659-667. HHS Public Access Author Manuscript; available in PMC Mar. 27, 2015 (16 pages).;;International Search Report and Written Opinion dated Aug. 21, 2018, in International Patent Application No. PCT/US2018/032794, filed May 15, 2018, by Blueprint Medicines Corp. (18 pages).;;Jin N. et al. (Oct. 15, 2011), “Synergistic Action of a RAF Inhibitor and a Dual PI3K/mTOR Inhibitor in Thyroid Cancer,” Clin Cancer Res, 17(20):6482-6489.;;Subbiah, V. et al. (Jul. 2015) “Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged Non-Small Cell Lung Cancer with brain metastases” Lung Cancer, 89(1):76-79. HHS Public Access Author Manuscript; available in PMC Aug. 25, 2016 (10 pages).;;International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2019/045919 dated Jan. 22, 2020 (11 pages).;;Ramalingam et al. “Osimertinib as First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer” Journal of Clinical Oncology, Mar. 20, 2018, vol. 36, No. 9, p. 841-849; abstract.;;Klempner et al. “Emergence of RET rearrangement co-existing with activated EGFR mutation in EGFR-mutated NSCLC patients who had progressed on first- or second-generation EGFR TKI” Lung Cancer, Sep. 2015, vol. 89, No. 3, pp. 357-359; abstract, p. 358, col. 1, para 2, p. 359, col. 1, para 2.;;International Search Report and Written Opinion of the International Searching Authority for Intenational Application No. PCT/US2019/025655 dated Jul. 23, 2019 (16 pages).;;BRUCE G. ROBINSON, LUIS PAZ-ARES, ANNETTA KREBS, JAMES VASSELLI, ROBERT HADDAD: ""Vandetanib (100 mg) in Patients with Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer"", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, THE ENDOCRINE SOCIETY, US, vol. 95, no. 6, 1 June 2010 (2010-06-01), US, pages 2664 - 2671, XP055599340, ISSN: 0021-972X, DOI: 10.1210/jc.2009-2461;;Anonymous, “Phase 1 Study of the Highly-selective RET Inhibitor BLU-667 in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors,” ClinicalTrials.org Internet Citation, Apr. 21, 2017 (Apr. 21, 2017), p. 8pp, XP002783685, Retrieved from the Internet: URL:https://www.clinicaltrials.gov/ct2/his tory/NCT03037385?V3=View#StudyPageTop.;;VIVEK SUBBIAH, JUSTIN F. GAINOR, RAMI RAHAL, JASON D. BRUBAKER, JOSEPH L. KIM, MICHELLE MAYNARD, WEI HU, QIONGFANG CAO, MICHAEL P.: ""Precision Targeted Therapy with BLU-667 for RET -Driven Cancers"", CANCER DISCOVERY, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 8, no. 7, 1 July 2018 (2018-07-01), US, pages 836 - 849, XP055599279, ISSN: 2159-8274, DOI: 10.1158/2159-8290.CD-18-0338;;SUBBIAH V: ""Highly potent and selective RET inhibitor, BLU-667, achieves proof of concept in a phase I study of advanced, RET-altered solid tumors"", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 78, no. 13, Supplement 1, 1 July 2018 (2018-07-01), US, XP002792435, ISSN: 1538-7445, DOI: 10.1158/1538-7445.AM2018-CT043;;ANONYMOUS: ""BLU-667 Targets RET-Altered Cancers."", CANCER DISCOVERY, vol. 8, no. 6, 1 June 2018 (2018-06-01), pages 5pp, XP002792436, ISSN: 2159-8290, Retrieved from the Internet <URL:http://cancerdiscovery.aacrjournals.org/content/8/6/OF8.long> DOI: 10.1158/2159-8290.CD-NB2018-050;;U.S. Appl. No. 16/775,646, Inhibitors of RET, filed Jan. 29, 2020, Pending.;;U.S. Appl. No. 16/613,625, Combinations of RET Inhibitors and MTORC1 Inhibitors and Uses Thereof for the Treatment of Cancer Mediated by Aberrant RET Activity, filed Nov. 14, 2019, Pending.",ACTIVE
593,US,A1,US 2019/0359591 A1,075-433-121-529-483,2019-11-28,2019,US 201816228381 A,2018-12-20,US 201816228381 A;;US 201715548925 A;;US 2016/0016808 W;;US 201562112897 P,2015-02-06,2-(PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES AS RET INHIBITORS,"Described herein are compounds, such as compounds of Formula (I) and pharmaceutically acceptable salts thereof, that inhibit wild-type RET and its resistant mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions, e.g., for treating a condition mediated by aberrant RET activity",BLUEPRINT MEDICINES CORP,BROOIJMANS NATASJA;;DIPIETRO LUCIAN V;;FLEMING PAUL E;;KIM JOSEPH L;;WENGLOWSKY STEVEN MARK;;ZHANG YULIAN,BLUEPRINT MEDICINES CORPORATION (2016-08-29),https://lens.org/075-433-121-529-483,Patent Application,yes,1,0,5,5,0,A61K31/506;;A61K31/506;;A61K45/06;;A61P35/00;;C07D401/14;;C07D401/14;;C07D403/04;;C07D403/04;;C07D403/12;;C07D403/12;;C07D405/14;;C07D405/14;;C07D417/14;;C07D417/14,C07D401/14;;A61K31/506;;A61K45/06;;C07D403/04;;C07D403/12;;C07D405/14;;C07D417/14,,0,0,,,,ACTIVE
594,US,B2,US 10202365 B2,108-001-819-377-22X,2019-02-12,2019,US 201615548925 A,2016-02-05,US 201615548925 A;;US 201562112897 P;;US 2016/0016808 W,2015-02-06,2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors,"Described herein are compounds, such as compounds of Formula (I) and pharmaceutically acceptable salts thereof, that inhibit wild-type RET and its resistant mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions, e.g., for treating a condition mediated by aberrant RET activity",BLUEPRINT MEDICINES CORP,BROOIJMANS NATASJA;;DIPIETRO LUCIAN V;;FLEMING PAUL E;;KIM JOSEPH L;;WENGLOWSKY STEVEN MARK;;ZHANG YULIAN,BLUEPRINT MEDICINES CORPORATION (2016-08-29),https://lens.org/108-001-819-377-22X,Granted Patent,yes,71,13,5,5,0,A61K31/506;;A61K31/506;;A61K45/06;;A61P35/00;;C07D401/14;;C07D401/14;;C07D403/04;;C07D403/04;;C07D403/12;;C07D403/12;;C07D405/14;;C07D405/14;;C07D417/14;;C07D417/14,A61K31/506;;A61K45/06;;C07D401/14;;C07D403/04;;C07D403/12;;C07D405/14;;C07D417/14,,89,54,011-016-624-525-450;;017-168-184-325-965;;018-164-678-420-792;;003-772-781-925-494;;072-862-909-328-771;;017-133-122-188-272;;039-484-264-887-186;;038-461-963-767-185;;071-112-627-968-309;;020-039-295-806-005;;016-866-638-789-070;;120-738-288-740-114;;068-418-696-833-129;;002-547-406-808-715;;004-134-293-693-153;;050-593-709-134-736;;064-746-930-221-401;;028-903-028-573-104;;056-889-703-126-090;;118-907-933-551-256;;010-889-627-397-489;;031-946-300-510-005;;000-626-106-220-736;;054-218-399-761-152;;029-098-872-907-074;;092-163-195-558-761;;046-448-894-392-546;;097-489-380-533-461;;078-535-432-813-525;;058-058-973-421-909;;082-000-982-226-45X;;065-114-135-541-570;;024-743-816-718-970;;052-308-676-552-954;;147-347-874-645-429;;036-676-350-527-31X;;016-105-425-428-590;;067-792-990-916-922;;093-985-357-437-882;;080-024-344-526-62X;;088-479-253-105-637;;011-376-199-309-747;;020-603-188-037-807;;058-900-866-921-002;;000-623-982-398-418;;025-736-846-484-723;;023-079-101-437-105;;025-887-342-195-096;;063-026-403-464-16X;;084-446-756-734-746;;026-676-687-727-859;;001-236-533-707-576;;039-189-520-016-338;;021-917-964-109-542,10.1016/j.cytogfr.2005.05.010;;15982921;;10.1016/j.ejmech.2010.03.017;;20409618;;10.1016/j.bmc.2010.01.011;;20117004;;23811235;;10.1016/j.mce.2013.06.025;;10.1080/13543776.2017.1238073;;27646564;;10.1016/j.cellsig.2014.03.032;;24705026;;17884497;;10.1016/j.bmcl.2007.07.104;;pmc4465992;;25723109;;10.1097/pas.0000000000000404;;10.1200/jco.2005.08.326;;15939921;;9191060;;10.1038/sj.onc.1201079;;11287972;;10.1056/nejm200104053441401;;19097774;;10.1016/j.ejca.2008.10.026;;10.1210/jc.2007-1714;;10.3410/f.1104639.559451;;18073307;;10.1210/jc.2014-4153;;25546157;;pmc4333032;;10.1016/j.humpath.2015.08.013;;26472164;;10.1016/j.lungcan.2015.12.011;;26898613;;10.1111/his.12902;;26568156;;10.1515/prilozi-2015-0034;;26076779;;27099842;;pmc4836117;;10.1159/000443730;;27683183;;10.1158/1078-0432.ccr-16-1679;;10.4183/aeb.2015.189;;24699901;;10.1002/cncr.28661;;10.1210/jc.2015-2948;;26765577;;26078337;;10.18632/oncotarget.4325;;pmc4745701;;27167191;;10.18632/oncotarget.9153;;pmc5129956;;pmc2708317;;10.1038/nbt.1549;;19581876;;27544060;;10.1016/j.jtho.2016.08.126;;22327622;;10.1038/nm.2673;;pmc3916180;;10.1056/nejmoa012915;;14561794;;19401695;;10.1038/sj.bjc.6605056;;pmc2695700;;0008099202;;8099202;;10.1038/363458a0;;10.1111/j.1365-2796.1995.tb01208.x;;7595170;;24561444;;10.1038/nrc3680;;pmc4700226;;10.3978/j.issn.2218-6751.2015.03.08;;26798590;;26356818;;10.18632/oncotarget.4992;;pmc4741820;;26868437;;10.1038/nrendo.2016.11;;10.1111/cas.12941;;pmc4968599;;27027665;;10.1016/s0065-230x(06)96008-4;;17161682;;26497911;;10.1507/endocrj.ej15-0399;;10.1007/s12020-015-0559-0;;25725622;;pmc4234119;;10.1158/1078-0432.ccr-12-0838;;23052255;;pmc4175590;;25204415;;10.1038/ncomms5846;;22327623;;10.1038/nm.2658;;10.1097/ppo.0b013e3181bd0445;;19826361;;10.1002/gcc.20937;;22034177;;pmc3235801;;23150706;;10.1200/jco.2012.44.1477;;10.1089/thy.2014.0335;;pmc4490627;;25810047;;10.1016/j.critrevonc.2014.06.003;;25028151;;10.1089/thy.2013.0137;;pmc3868259;;23705946;;10.1006/bbrc.1995.1287;;7864888;;11002419;;10.1038/sj.onc.1203799;;10.1158/1538-7445.am2016-2641;;23578175;;10.1111/cas.12175;;pmc7657251;;10.1158/1078-0432.ccr-14-2329;;26078430,"Arighi, E. et al. (2005) “RET tyrosine kinase signaling in development and cancer” Cytokine & Growth Factor Reviews, 16:441-467.;;Brandt, W. et al. (2010) “Inhibitors of the RET tyrosine kinase based on a 2-(alkylsulfanyl)-4-(3-thienyl) nicotinonitrile scaffold” Eur J Med Chem, 45:2919-2927.;;International Search Report and Written Opinion dated Apr. 29, 2016, in International Patent Application No. PCT/US2016/016808, filed Feb. 5, 2016, by Blueprint Medicines Corp. (8 pages).;;International Search Report and Written Opinion dated Jan. 18, 2017, in International Patent Application No. PCT/US2016/059879, filed Nov. 1, 2016, by Blueprint Medicines Corp. (12 pages).;;International Search Report and Written Opinion dated Jun. 12, 2017, in International Patent Application No. PCT/US2017/022969, filed Mar. 17, 2017, by Blueprint Medicines Corp. (12 pages).;;Kuster, B. (Ed.) (2012) Kinase inhibitors. Methods and Protocols. Humana Press; Chapters 1 and 2, pp. 1-44.;;Mologni, L. et al. (2010) “Synthesis, structure-activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors” Bioorg Med Chem, 18:1482-1496.;;Mologni, L. et al. (2013) “Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinase” Mol Cell Endocrinol, 377:1-6.;;Mologni, L. et al. (2017) “RET kinase inhibitors: a review of recent patents (2012-2015)” Exp Opin Ther Patents, 27(1):91-99.;;Notice of Allowance dated Sep. 26, 2017, in U.S. Appl. No. 15/093,354, filed Apr. 7, 2016, by Blueprint Medicines Corp.;;Notice of Allowance dated Sep. 5, 2017, in U.S. Appl. No. 15/217,503, filed Jul. 22, 2016, by Blueprint Medicines Corp.;;Notice of Allowance dated Aug. 3, 2017, in U.S. Appl. No. 15/479,145, filed Apr. 4, 2017, by Blueprint Medicines Corp.;;Notice of Allowance dated Oct. 25, 2017, in U.S. Appl. No. 15/340,428, filed Nov. 1, 2016, by Blueprint Medicines Corp.;;Plaza-Menacho, I. et al. (2014) “Mechanisms of RET signaling in cancer: Current and future implications for targeted therapy” Cellular Signalling, 26:1743-1752.;;Robinett, R.G. et al. (2007) “The discovery of substituted 4-(3-hyroxyanilino)-quinolines as potent RET kinase inhibitors” Bioorg Med Chem Lett, 17:5886-5893.;;U.S. Appl. No. 15/657,057, filed Jul. 21, 2017, by Brubaker et al.;;U.S. Appl. No. 15/660,840, filed Jul. 26, 2017, by Brubaker et al.;;Antonescu, C.R. et al. (Jul. 2015) “Molecular Characterization of Inflammatory Myofibroblastic Tumors with Frequent ALK and ROS1 Fusions and Rare Novel RET Gene Rearrangement” Am J Surg Pathol, 39(7):957-967. HHS Public Access Author Manuscript; available in PMC Jul. 1, 2015 (19 pages).;;Baselga, J. et al. (2005) “Phase II and Tumor Pharmacodynamic Study of Gefitinib in Patients with Advanced Breast Cancer” J Clin Oncol, 23(23):5323-5333.;;Caprelsa (vandetanib) “Full Prescribing Information” Reference ID: 3964956, Cambridge, MA: Sanofi Genzyme; 2016.;;Ceccherini, I. et al. (1997) “Somatic in frame deletions not involving juxtamembranous cysteine residues strongly activate the RET proto-oncogene” Oncogene, 14:2609-2612.;;Chalice Software Technical Guide, Horizon CombinatoRx Inc., Cambridge, MA, USA (downloaded Jul. 2018).;;Cometriq (cabozantinib)“Full Prescribing Information” Reference ID: 3964956, South San Francisco, CA: Exelixix, Inc.; 2018.;;Druker, B.J. et al. (2001) “Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia” New Engl J Med, 344(14):1031-1037.;;Eisenhauer, E.A. et al. (2009) “New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)” Eur J Cancer, 45:228-247.;;Elisei, R. et al. (2008) “Prognostic Significance of Somatic RET Oncogene Mutations in Sporadic Medullary Thyroid Cancer: A 10-Year Follow-Up Study” J Clin Endocrinol Metab, 93(3):682-687.;;Fang, P. et al. (Feb. 2016) “Detection of a novel RET gene fusion in a non-small cell lung cancer patient using AMP chemistry” J Thorac Oncol, 11.2:S21-S22.;;Gautschi, O. et al. (2016) “Targeting RET in patients with RET-rearranged lung cancers: Results from a global registry” J Clin Oncol, 34(15S) (suppl; abstr 9014).;;Grubbs, E.G. et al. (Mar. 2015) “RET Fusion as a Novel Driver of Medullary Thyroid Carcinoma” J Clin Endocrinol Metab, 100:788-793.;;Halkova, T. et al. (2015) “A novel RET/PTC variant detected in a pediatric patient with papillary thyroid cancer without ionization history” Hum Pathol, 46:1962-1969.;;Horiike, A. et al. (2016) “Sorafenib treatment for patients with RET fusion-positive non-small cell lung cancer” Lung Cancer, 93:43-46.;;Joung, J.Y. et al. (2016) “Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications” Histopathology, 69:45-53.;;Jovanovic, R. et al. (2015) “Novel RET Mutations in Macedonian Patients with Medullary Thyroid Carcinoma: Genotype-Phenotype Correlations” Prilozi, 36(1):93-107.;;Karrasch, T. et al. (2016) “How to Assess the Clinical Relevance of Novel RET Missense Variants in the Absence of Functional Studies?” Eur Thyroid J, 5:73-77.;;Kato, S. et al. (Apr. 15, 2017) “RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients” Clin Cancer Res, 23(8):1988-1997.;;Kim, S.H. et al. (2015) “A New Germline ALA641THR Variant in the Transmembrane Domain of the RET Gene Associated with Medullary Thyroid Cancer” Acta Endocrinologica (Buc), 11.2:189-194.;;Krampitz, G.W. and J.A. Norton (2014) “RET Gene Mutations (Genotype and Phenotype) of Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma” Cancer, 120:1920-1931.;;Latteyer, S. et al. (Mar. 2016) “A 6-Base Pair in Frame Germline Deletion in Exon 7 of RET Leads to Increased RET Phosphorylation, ERK Activation, and MEN2A” J Clin Endocrinol Metab, 101(3):1016-1022.;;Le Rolle, A. et al. (2015) “Identification and characterization of RET fusions in advanced colorectal cancer” Oncotarget, 6(30):28929-28937.;;Lee, M.S. et al. (2016) “Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models” Oncotarget, 7(26):39595-39608.;;Lehar, J. et al. (2009) “Synergistic drug combinations improve therapeutic selectivity” Nat Biotechnol, 27(7):659-666. HHS Public Access Author Manuscript; available in PMC Jan. 1, 2010 (23 pages).;;Lin, J.J. et al. (2016) “Clinical Activity of Alectinib in Advanced RET-Rearranged Non-Small Cell Lung Cancer” J Thorac Oncol, 11(11):2027-2032.;;Lipson, D. et al. (2012) “Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies” Nat Med, 18(3):382-384. HHS Public Access Author Manuscript; available in PMC Feb. 6, 2014 (7 pages).;;Machens, A et al. (2003) “Early Malignant Progression of Hereditary Medullary Thyroid Cancer” New Engl J Med, 349:1517-1525.;;Moura, M.M. et al. (2009) “Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas” Br J Cancer, 100:1777-1783.;;Mulligan, L.M. et al. (Jun. 3, 1993) “Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A” Nature, 363:458-460.;;Mulligan, L.M. et al. (1995) “Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium” J Int Med, 238:343-346.;;Mulligan, L.M. (Mar. 2014) “RET revisited: expanding the oncogenic portfolio” Nat Rev Cancer, 14:173-186.;;Notice of Allowance dated Jun. 5, 2018, in U.S. Appl. No. 15/340,428, filed Nov. 1, 2016, by Blueprint Medicines Corp.;;Notice of Allowance dated Jun. 27, 2018, in U.S. Appl. No. 15/222,523, filed Jul. 28, 2016, by Blueprint Medicines Corp.;;Notice of Allowance dated Apr. 25, 2018, in U.S. Appl. No. 15/462,255, filed Mar. 17, 2017, by Blueprint Medicines Corp.;;Notice of Allowance dated Apr. 2, 2018, in U.S. Appl. No. 15/660,840, filed Jul. 26, 2017, by Blueprint Medicines Corp.;;Pirker, R. and M. Filipits (2015) “Alectinib in RET-rearranged non-small cell lung cancer—Another progress in precision medicine?” Transl Lung Cancer Res, 4(6):797-800.;;Qi, X. et al. (2015) “RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D” Oncotarget, 6(32):33993-34003.;;Romei, C. et al. (Apr. 2016) “A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma” Nat Rev Endocrinol, 12:192-202.;;Saito, M. et al. (Jun. 2016) “Gene aberrations for precision medicine against lung adenocarcinoma” Cancer Sci, 107(6):713-720.;;Sarker, D. and P. Workman (2007) “Pharmacodynamic Biomarkers for Molecular Cancer Therapeutics” Adv Cancer Res, 96:213-268.;;Scollo, C. et al. (2016) “A novel RET gene mutation in a patient with apparently sporadic pheochromocytoma” Endocr J, 63(1):87-91.;;Silva, A.L. et al. (2015) “Identification and characterization of two novel germline RET variants associated with medullary thyroid carcinoma” Endocrine, 49:366-372.;;Suehara, Y. et al. (Dec. 15, 2012) “Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions” Clin Cancer Res, 18(24):6599-6608. HHS Public Access Author Manuscript; available in PMC Nov. 17, 2014 (18 pages).;;Stransky, N. et al. (2014) “The landscape of kinase fusions in cancer” Nat Commun, 5:4846 (10 pages).;;Takeuchi, K. et al. (Mar. 2012) “RET, ROS1 and ALK fusions in lung cancer” Nat Med, 18(3):378-381.;;Tan, D.S. et al. (2009) “Biomarker-Driven Early Clinical Trials in Oncology” Cancer J, 15(5):406-420.;;U.S. Nat'l Library of Med., A Phase 1 Trial of Vandetanib (a Multi-kinase Inhibitor of EGFR, VEGFR and RET Inhibitor) in Combination With Everolimus (an mTOR Inhibitor) in Advanced Cancer, ClinicalTrials.gov, https://clinicaltrials.gov/ct2/show/NCT01582191 (last updated Jul. 3, 2018) (7 pages).;;U.S. Nat'l Library of Med., Phase 1 Study of the Highly-selective RET Inhibitor BLU-667 in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors, ClinicalTrials.gov, https://clinicaltrials.gov/ct2/show/NCT03037385 (last updated Jun. 27, 2018) (8 pages).;;U.S. Appl. No. 15/867,637, filed Jan. 10, 2018, by Blueprint Medicines Corp.;;U.S. Appl. No. 15/973,340, filed May 7, 2018, by Blueprint Medicines Corp.;;U.S. Appl. No. 15/973,378, filed May 7, 2018, by Blueprint Medicines Corp.;;U.S. Appl. No. 16/002,587, filed Jun. 7, 2018, by Blueprint Medicines Corp.;;U.S. Appl. No. 16/027,166, filed Jul. 3, 2018, by Blueprint Medicines Corp.;;Wang, L. et al. (2012) “Identification of a Novel, Recurrent HEY1-NCOA2 Fusion in Mesenchymal Chondrosarcoma based on a Genome-wide Screen of Exon-level Expression Data” Genes Chromosomes Cancer, 51(2):127-139. HHS Public Access Author Manuscript; available in PMC Feb. 1, 2013 (24 pages).;;Wang, R. et al. (Dec. 10, 2012) “RET Fusions Define a Unique Molecular and Clinicopathologic Subtype of Non-Small-Cell Lung Cancer” J Clin Oncol, 30(35):4352-4359.;;Wells, S.A. et al. (2015) “Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma” Thyroid, 25(6):567-610.;;Abdel-Rahman, O. and M. Fouad (2014) “Risk of cardiovascular toxicities in patients with solid tumors treated with sunitinib. axitinib, cediranib or regorafenib: an updated systematic review and comparative meta-analysis” Crit Rev Oncol Hematol, 92:194-207.;;Bentzien, F. et al. (2013) “In Vitro and in Vivo Activity of Cabozantinib (XL184), an Inhibitor of RET, MET, and VEGFR2, in a Model of Medullary Thyroid Cancer” Thyroid, 23(12):1569 1577.;;Carlomagno, F et al. (Feb. 1995) “Point Mutation of the Ret Proto-oncogene in the TT Human Medullary Thyroid Carcinoma Cell Line” Biochem Biophys Res Common, 207(3):1022-1028.;;Evans, E. (May 1, 2016) “The Development of Potent and Selective RET Inhibitors” Slides presented at the 2016 Annual Meeting of the International Thyroid Oncology Group at the University of Colorado (19 pages).;;Hayashi, H. et al. (2000) “Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor” Oncogene, 19:4469-4475.;;International Search Report and Written Opinion dated Oct. 12, 2017, in International Patent Application No. PCT/US2017/043964, filed Jul. 26, 2017, by Blueprint Medicines Corp. (13 pages).;;International Search Report and Written Opinion dated Oct. 25, 2017, in International Patent Application No. PCT/US2017/043340, filed Jul. 21, 2017, by Blueprint Medicines Corp. (14 pages).;;Notice of Allowance dated Jan. 17. 2018, in U.S. Appl. No. 14/887,614, filed Oct. 20, 2015, by Blueprint Medicines Corp.;;Notice of Allowance dated Jan. 16, 2018, in U.S. Appl. No. 15/217,503, filed Jul. 22, 2016, by Blueprint Medicines Corp.;;Notice of Allowance dated Dec. 15, 2017, in U.S. Appl. No. 15/462,255, filed Mar. 17, 2017, by Blueprint Medicines Corp.;;Notice of Allowance dated Nov. 30, 2017, in U.S. Appl. No. 15/479,145, filed Apr. 4, 2017, by Blueprint Medicines Corp.;;Notice of Allowance dated Jan. 17, 2018, in U.S. Appl. No. 15/660,840, filed Jul. 26, 2017, by Blueprint Medicines Corp.;;Rahal, R. et al. (2016) “The development of potent, selective RET inhibitors that target both wild-type RET and prospectively identified resistance mutations to multi-kinase inhibitors” Abstract submitted to the American Association for Cancer Research (AACR) Annual Meeting, Apr. 16-20, 2016, New Orleans; submission date Dec. 1, 2015 (2 pages).;;Rahal, R. (Apr. 18, 2016) “The development of potent, selective RET inhibitors” Slides of a Presentation at the American Association for Cancer Research (AACR) Annual Meeting, Apr. 16-20, 2016. New Orleans (15 pages).;;Suzuki, M. et al. (Jul. 2013) “Identification of a lung adenocarcinoma cell line with CCDC6-RET fusion gene and the effect of RET inhibitors in vitro and in vivo” Cancer Sci, 104(7):896-903.;;Touat, M. et al. (2015) “Targeting FGFR Signaling in Cancer” Clin Cancer Res, 21(12):2684-2694.",ACTIVE
595,KR,A,KR 20020084059 A,039-694-578-839-449,2002-11-04,2002,KR 20027004084 A,2002-03-29,AU PQ320799 A,1999-09-30,SINGLE MODE OPTICAL WAVEGUIDE FIBER,"PURPOSE: A single mode optical waveguide fiber is provided to improve geometric structure of optical fiber to allow a high degree of freedom in designing non-zero dispersion shifted fiber. CONSTITUTION: A single mode optical waveguide fiber comprises an optical waveguide region including a central core region(11); a peripheral region(14) surrounding the central core region; and at least three side core regions(13) disposed outside in a radial direction from the central core region. The central core region has a mean index of refraction of r1, the peripheral region has a mean index of refraction of r1 < n0, and each side core region has a mean index of refraction of n2 ≠ n1. The side core region is formed of a transparent medium or a doped silica.",AUSTRALIAN PHOTONICS PTY LTD;;KT CORP;;UNIV AUSTRALIAN;;UNIV SYDNEY,BAILEY RONALD;;FLEMING SIMON;;KRUG PETER;;LARGE MICHAEL;;POLADIAN LEON;;REOBEUJON;;RYAN THOMAS;;SCEATS MARK;;THORNCRAFT DAVID,,https://lens.org/039-694-578-839-449,Patent Application,no,0,0,4,6,0,C03B37/01861;;C03B2203/10;;C03B2203/22;;C03B2203/24;;G02B6/02019;;G02B6/02242;;G02B6/03611;;G02B6/03627;;G02B6/03644;;G02B6/03666;;G02B6/02,C03B37/018;;G02B6/02;;G02B6/036,,0,0,,,,EXPIRED
596,AU,A1,AU 2012/200879 A1,102-423-008-234-702,2012-03-08,2012,AU 2012/200879 A,2012-02-15,AU 2011/202368 A;;AU 2012/200879 A,2011-05-20,Energy efficient construction surfaces,,3M INNOVATIVE PROPERTIES CO,ANDERSON MARK T;;GOULD RACHAEL A T;;PENDERGRASS DANIEL B JR;;FLEMING PETER B;;GROSS CHRISTOPHER L,,https://lens.org/102-423-008-234-702,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
597,CN,A,CN 103028867 A,007-514-017-942-807,2013-04-10,2013,CN 201210496913 A,2012-09-29,US 201113250007 A,2011-09-30,Flux composition and method of soldering,"The invention relates to a flux composition and a method of soldering. The flux composition is provided, comprising, as an initial component: a carboxylic acid; and, a fluxing agent represented by formula I: wherein R<1>, R<2>, R<3> and R<4> are independently selected from a hydrogen, a substituted C1-80 alkyl group, an unsubstituted C1-80 alkyl group, a substituted C7-80 arylalkyl group and an unsubstituted C7-80 arylalkyl group; and wherein zero to three of R<1>, R<2>, R<3> and R<4> is(are) a hydrogen. Also provided is a method of soldering an electrical contact using the flux composition.",ROHM & HAAS ELECT MAT,KIM S HO;;MICHAEL K GALLAGHER;;AVIN V DHOBLE;;MARK R WINKLE;;LIU XIANGQIAN;;DAVID D FLEMING,,https://lens.org/007-514-017-942-807,Patent Application,no,6,0,13,13,0,B23K1/203;;B23K1/203;;B23K35/362;;B23K1/0016;;B23K1/0016;;B23K1/008;;B23K1/008;;B23K35/0244;;B23K35/0244;;B23K35/26;;B23K35/26;;B23K35/34;;B23K35/34;;B23K35/3601;;B23K35/3601;;B23K35/362;;B23K35/362;;B23K2101/42;;B23K2101/42;;C07C217/52;;H05K3/3489;;H05K3/3489,B23K35/363;;B23K1/00,,0,0,,,,INACTIVE
598,US,B2,US 7538861 B2,036-904-243-580-23X,2009-05-26,2009,US 17700308 A,2008-07-21,US 17700308 A;;US 72633603 A;;US 43011799 A,1999-10-29,Cytological imaging system and method,"The present invention relates to the analysis of cytological material. Specifically, the invention relates to stains and methods of producing the stains, methods of staining cells for cytological or histological analysis to contrast the nuclear portion of the cell from the cytoplasmic portion, and systems and methods for illuminating a cytological sample. The analysis can be automated or manual.",CYTYC CORP,ZAHNISER DAVID J;;ZELINSKI MATTHEW S;;DOLASH THOMAS M;;MAENLE GARRICK L;;FLEMING MARK;;LAUDO JOHN S,,https://lens.org/036-904-243-580-23X,Granted Patent,yes,102,1,5,81,0,G01N1/30;;G01N15/147;;G01N15/1484;;G01N21/3151;;G01N2015/1472;;G01N2015/1488;;G01N15/1433;;G01N21/3151;;G01N15/1484;;G01N15/147;;G01N2015/1472;;G01N2015/1488;;G01N1/30;;G01N15/1433,G01N33/48;;F21V9/00;;G01N1/30;;G01N15/14;;G01N21/00;;G01N21/31;;G01N21/75;;G02B21/06;;G06T7/00,356/39;;359/385;;362/231;;422/82.05;;436/63;;436/164,3,2,061-327-152-657-755;;064-992-221-005-275,8289227;;10.1111/j.1365-2818.1993.tb03391.x;;10.1016/s0143-4160(97)90097-x;;9056078,"Beach et al., ""A light-emitting diode light standard for photo- and videomicroscopy"". Journal of Microscopy, vol. 172, Pt. 1, Oct. 1993, pp. 41-48.;;Beach, ""A LED light calibration source for dual-wavelength microscopy"", Cell Calcium, vol. 21, Pt. 1, 1997, pp. 63-68.;;United States Statutory Invention Registration No. H445, Published Mar. 1, 1988, Bock et al. 6 pages.",EXPIRED
599,US,B2,US 7411664 B2,039-991-518-539-189,2008-08-12,2008,US 72633603 A,2003-12-01,US 72633603 A;;US 43011799 A,1999-10-29,Cytological imaging system and method,"The present invention relates to the analysis of cytological material. Specifically, the invention relates to stains and methods of producing the stains, methods of staining cells for cytological or histological analysis to contrast the nuclear portion of the cell from the cytoplasmic portion, and systems and methods for illuminating a cytological sample. The analysis can be automated or manual.",CYTYC CORP,ZAHNISER DAVID J;;ZELINSKI MATTHEW S;;DOLASH THOMAS M;;MAENLE GARRICK L;;FLEMING MARK;;LAUDO JOHN S,,https://lens.org/039-991-518-539-189,Granted Patent,yes,105,3,5,81,0,G01N1/30;;G01N15/147;;G01N15/1484;;G01N21/3151;;G01N2015/1472;;G01N2015/1488;;G01N15/1433;;G01N21/3151;;G01N15/1484;;G01N15/147;;G01N2015/1472;;G01N2015/1488;;G01N1/30;;G01N15/1433,G01N33/48;;F21V9/00;;G01N1/30;;G01N15/14;;G01N21/00;;G01N21/31;;G01N21/75;;G02B21/06;;G06T7/00,356/39;;359/385;;362/231;;422/82.05;;436/63;;436/164,2,2,061-327-152-657-755;;064-992-221-005-275,8289227;;10.1111/j.1365-2818.1993.tb03391.x;;10.1016/s0143-4160(97)90097-x;;9056078,"Beach et al., ""A light-emitting diode light standard for photo- and videomicroscopy,"" Journal of Microscopy, vol. 172, Pt. 1, Oct. 1993, pp. 41-48.;;Beach, ""A LED light calibration source for dual-wavelength microscopy,"" Cell Calcium, vol. 21, Pt. 1, 1997, pp. 63-68.",EXPIRED
600,CN,A,CN 103028868 A,186-597-407-936-098,2013-04-10,2013,CN 201210517250 A,2012-09-29,US 201113250226 A,2011-09-30,"Polyamine, carboxylic acid flux composition and method of soldering","The invention relates to a polyamine, a carboxylic acid flux composition and a method of soldering. The flux composition is provided, comprising, as initial components: a carboxylic acid; and, a polyamine fluxing agent represented by formula I: with the proviso that when the polyamine fluxing agent represented by formula I is according to formula Ia: then zero to three of R<1>, R<2>, R<3> and R<4> is(are) a hydrogen. Also provided is a method of soldering an electrical contact using the flux composition.",ROHM & HAAS ELECT MAT,WINKLE MARK R;;DHOBLE AVIN V;;HO KIM S;;GALLAGHER MICHAEL K;;LIU XIANG-QIAN;;FLEMING DAVID,,https://lens.org/186-597-407-936-098,Patent Application,no,6,3,12,12,0,B23K35/362;;B23K1/0016;;B23K1/0016;;B23K1/008;;B23K1/008;;B23K1/203;;B23K1/203;;B23K35/3601;;B23K35/3601;;B23K35/3618;;B23K35/3618;;B23K35/362;;B23K35/362;;B23K2101/42;;B23K2101/42;;C07C211/36;;H05K3/3489;;H05K3/3489,B23K35/363;;B23K1/00,,0,0,,,,INACTIVE
601,WO,A2,WO 2005/065153 A2,173-840-951-847-932,2005-07-21,2005,US 2004/0041595 W,2004-12-13,US 74682903 A,2003-12-24,ENERGY EFFICIENT CONSTRUCTION SURFACES,"The present invention provides a non-white construction surface comprising a substrate, a first reflective coating on at least a portion of an outer surface of a substrate, such that the substrate with this first reflective coating exhibits a minimum direct solar reflectance value of at least about 25%, and a second reflective coating on at least a portion of the first reflective coating, wherein the combination of the first reflective coating and the second reflective coating provide the substrate with a reflectivity of at least about 20% at substantially all points in the wavelength range between 770 and 2500 nm.",3M INNOVATIVE PROPERTIES CO,ANDERSON MARK T;;FLEMING PETER B;;GOULD RACHAEL A T;;GROSS CHRISTOPHER L;;PENDERGRASS DANIEL B JR,,https://lens.org/173-840-951-847-932,Patent Application,yes,0,2,15,15,0,E04D2001/005;;G02B5/0816;;Y10T428/24372;;Y02A30/254;;Y02B80/00;;E04D1/28;;G02B5/0816;;E04D2001/005;;E04D1/22;;Y10T428/24372;;E04D2001/005;;G02B5/0816;;Y02A30/254;;Y02B80/00;;E04D1/28,E04D1/22;;G02B5/08,,0,0,,,,PENDING
602,CN,B,CN 103028867 B,011-974-758-917-782,2015-04-01,2015,CN 201210496913 A,2012-09-29,US 201113250007 A,2011-09-30,Flux composition and method of soldering,,ROHM & HAAS ELECT MAT,KIM S HO;;MICHAEL K GALLAGHER;;AVIN V DHOBLE;;MARK R WINKLE;;LIU XIANGQIAN;;DAVID D FLEMING,,https://lens.org/011-974-758-917-782,Granted Patent,no,0,0,13,13,0,B23K1/203;;B23K1/203;;B23K35/362;;B23K1/0016;;B23K1/0016;;B23K1/008;;B23K1/008;;B23K35/0244;;B23K35/0244;;B23K35/26;;B23K35/26;;B23K35/34;;B23K35/34;;B23K35/3601;;B23K35/3601;;B23K35/362;;B23K35/362;;B23K2101/42;;B23K2101/42;;C07C217/52;;H05K3/3489;;H05K3/3489,B23K35/363;;B23K1/00,,0,0,,,,INACTIVE
603,CA,A1,CA 2550622 A1,060-639-060-353-259,2005-07-21,2005,CA 2550622 A,2004-12-13,US 74682903 A;;US 2004/0041595 W,2003-12-24,ENERGY EFFICIENT CONSTRUCTION SURFACES,"The present invention provides a non-white construction surface comprising a substrate, a first reflective coating on at least a portion of an outer surface of a substrate, such that the substrate with this first reflective coating exhibits a minimum direct solar reflectance value of at least about 25%, and a second reflective coating on at least a portion of the first reflective coating, wherein the combination of the first reflective coating and the second reflective coating provide the substrate with a reflectivity of at least about 20% at substantially all points in the wavelength range betwe en 770 and 2500 nm.",3M INNOVATIVE PROPERTIES CO,FLEMING PETER B;;PENDERGRASS DANIEL B JR;;GROSS CHRISTOPHER L;;GOULD RACHAEL A T;;ANDERSON MARK T,,https://lens.org/060-639-060-353-259,Patent Application,no,0,0,15,15,0,E04D2001/005;;G02B5/0816;;Y10T428/24372;;Y02A30/254;;Y02B80/00;;E04D1/28;;G02B5/0816;;E04D2001/005;;E04D1/22;;Y10T428/24372;;E04D2001/005;;G02B5/0816;;Y02A30/254;;Y02B80/00;;E04D1/28,B32B1/00;;E04D1/22;;G02B5/08,,0,0,,,,DISCONTINUED
604,WO,A3,WO 2005/065153 A3,010-342-444-607-448,2005-12-08,2005,US 2004/0041595 W,2004-12-13,US 74682903 A,2003-12-24,ENERGY EFFICIENT CONSTRUCTION SURFACES,"The present invention provides a non-white construction surface comprising a substrate, a first reflective coating on at least a portion of an outer surface of a substrate, such that the substrate with this first reflective coating exhibits a minimum direct solar reflectance value of at least about 25%, and a second reflective coating on at least a portion of the first reflective coating, wherein the combination of the first reflective coating and the second reflective coating provide the substrate with a reflectivity of at least about 20% at substantially all points in the wavelength range between 770 and 2500 nm.",3M INNOVATIVE PROPERTIES CO,ANDERSON MARK T;;FLEMING PETER B;;GOULD RACHAEL A T;;GROSS CHRISTOPHER L;;PENDERGRASS DANIEL B JR,,https://lens.org/010-342-444-607-448,Search Report,yes,3,0,15,15,0,E04D2001/005;;G02B5/0816;;Y10T428/24372;;Y02A30/254;;Y02B80/00;;E04D1/28;;G02B5/0816;;E04D2001/005;;E04D1/22;;Y10T428/24372;;E04D2001/005;;G02B5/0816;;Y02A30/254;;Y02B80/00;;E04D1/28,E04D1/22;;G02B5/08,,0,0,,,,PENDING
605,CN,B,CN 1898077 B,100-831-098-558-494,2010-10-27,2010,CN 200480039003 A,2004-12-13,US 2004/0041595 W;;US 74682903 A,2003-12-24,Energy efficient construction surfaces,"The present invention provides a non-white construction surface comprising a substrate, a first reflective coating on at least a portion of an outer surface of a substrate, such that the substrate with this first reflective coating exhibits a minimum direct solar reflectance value of at least about 25%, and a second reflective coating on at least a portion of the first reflective coating, whereinthe combination of the first reflective coating and the second reflective coating provide the substrate with a reflectivity of at least about 20% at substantially all points in the wavelength range between 770 and 2500 nm.",3M INNOVATION CO LTD,ANDERSON MARK T;;GROSS CHRISTOPHER L;;PENDERGRASS DANIEL B JR;;FLEMING PETER B;;GOULD RACHAEL A T,,https://lens.org/100-831-098-558-494,Granted Patent,no,0,0,15,15,0,E04D2001/005;;G02B5/0816;;Y10T428/24372;;Y02A30/254;;Y02B80/00;;E04D1/28;;G02B5/0816;;E04D2001/005;;E04D1/22;;Y10T428/24372;;E04D2001/005;;G02B5/0816;;Y02A30/254;;Y02B80/00;;E04D1/28,B32B1/00;;E04D1/22;;G02B5/08,,0,0,,,,INACTIVE
606,US,B2,US 8434666 B2,153-316-879-536-075,2013-05-07,2013,US 201113250007 A,2011-09-30,US 201113250007 A,2011-09-30,Flux composition and method of soldering,"A flux composition is provided, comprising, as an initial component: a carboxylic acid; and, a fluxing agent represented by formula I: wherein R 1 , R 2 , R 3 and R 4 are independently selected from a hydrogen, a substituted C 1-80 alkyl group, an unsubstituted C 1-80 alkyl group, a substituted C 7-80 arylalkyl group and an unsubstituted C 7-80 arylalkyl group; and wherein zero to three of R 1 , R 2 , R 3 and R 4 is(are) a hydrogen. Also provided is a method of soldering an electrical contact using the flux composition.",HO KIM S;;GALLAGHER MICHAEL K;;DHOBLE AVIN V;;WINKLE MARK R;;LIU XIANG-QIAN;;FLEMING DAVID;;ROHM & HAAS ELECT MAT,HO KIM S;;GALLAGHER MICHAEL K;;DHOBLE AVIN V;;WINKLE MARK R;;LIU XIANG-QIAN;;FLEMING DAVID,ROHM AND HAAS ELECTRONIC MATERIALS LLC (2011-11-17),https://lens.org/153-316-879-536-075,Granted Patent,yes,57,1,13,13,0,B23K1/203;;B23K1/203;;B23K35/362;;B23K1/0016;;B23K1/0016;;B23K1/008;;B23K1/008;;B23K35/0244;;B23K35/0244;;B23K35/26;;B23K35/26;;B23K35/34;;B23K35/34;;B23K35/3601;;B23K35/3601;;B23K35/362;;B23K35/362;;B23K2101/42;;B23K2101/42;;C07C217/52;;H05K3/3489;;H05K3/3489,B23K31/02;;B23K35/34,228/180.21;;228/207;;228/223;;228/224;;228/248.1;;148/23;;148/24,9,0,,,"Co-pending U.S. Appl. No. 12/958,495.;;Co-pending U.S. Appl. No. 12/958,487.;;Co-pending U.S. Appl. No. 12/958,480.;;Co-pending U.S. Appl. No. 12/958,493.;;Co-pending U.S. Appl. No. 12/958,473.;;Co-pending U.S. Appl. No. 13/250,226.;;Co-pending U.S. Appl. No. 13/250,297.;;Co-pending U.S. Appl. No. 13/250,184.;;Co-pending U.S. Appl. No. 13/250,125.",INACTIVE
607,TW,A,TW 200535458 A,192-410-114-131-143,2005-11-01,2005,TW 93141406 A,2004-12-30,US 53396203 P,2003-12-30,Color shifting retroreflector and method of making same,"Color shifting retroreflective articles can provide features such as decorative effects, evidence of tampering, security authentication or positional information. In some embodiments, the color shifting retroreflective article includes a layer of microspheres, and a reflective coating that is disposed in optical association with the layer of microspheres. The reflective coating includes a spacer layer disposed between a semitransparent first reflective layer and a second reflective layer. The first reflective layer includes a reflective layer disposed adjacent the layer of microspheres. At least one layer of the reflective coating includes a non-uniform thickness associated with each of a plurality of microspheres such that light incident on the article from a first direction is retroreflected at a first color and light incident on the article from a second direction is retroreflected at a second color visibly different from the first color.",3M INNOVATIVE PROPERTIES CO,FLEMING ROBERT JAMES;;LYONS CHRISTOPHER STEWART;;MCGRATH JOSEPH MICHAEL;;RAMOS JESUS;;ROEHRIG MARK AUGUST;;CLARK IVAN BRIGHT,,https://lens.org/192-410-114-131-143,Patent of Addition,no,0,0,10,10,0,G02B5/128;;Y10T428/24479;;Y10T428/24579;;G02B5/128;;Y10T428/24479;;Y10T428/24579;;G02B5/128,G02B5/128,,0,0,,,,PENDING
608,US,B2,US 8430295 B2,001-426-369-766-490,2013-04-30,2013,US 201113250297 A,2011-09-30,US 201113250297 A,2011-09-30,Curable flux composition and method of soldering,"A curable flux composition is provided, comprising, as initial components: a resin component having at least two oxirane groups per molecule; a carboxylic acid; a fluxing agent represented by formula I: wherein R 1 , R 2 , R 3 and R 4 are independently selected from a hydrogen, a substituted C 1-80 alkyl group, an unsubstituted C 1-80 alkyl group, a substituted C 7-80 arylalkyl group and an unsubstituted C 7-80 arylalkyl group; and wherein zero to three of R 1 , R 2 , R 3 and R 4 is(are) a hydrogen; and, optionally, a curing agent. Also provided is a method of soldering an electrical contact using the curable flux composition.",GALLAGHER MICHAEL K;;HO KIM S;;DHOBLE AVIN V;;WINKLE MARK R;;LIU XIANG-QIAN;;FLEMING DAVID;;ROHM & HAAS ELECT MAT,GALLAGHER MICHAEL K;;HO KIM S;;DHOBLE AVIN V;;WINKLE MARK R;;LIU XIANG-QIAN;;FLEMING DAVID,ROHM AND HAAS ELECTRONIC MATERIALS LLC (2011-11-17),https://lens.org/001-426-369-766-490,Granted Patent,yes,57,3,13,13,0,B23K1/0016;;B23K1/0016;;B23K35/362;;B23K1/203;;B23K1/203;;C07C211/36;;C08K5/09;;C08K5/09;;C08K5/17;;C08K5/17;;H01L24/11;;H01L24/11;;H01L24/13;;H01L24/13;;H01L24/16;;H01L24/16;;H01L24/27;;H01L24/27;;H01L24/29;;H01L24/29;;H01L24/32;;H01L24/32;;H01L24/81;;H01L24/81;;H01L24/83;;H01L24/83;;H01L24/92;;H01L24/92;;H01L2224/11334;;H01L2224/11334;;H01L2224/131;;H01L2224/131;;H01L2224/13111;;H01L2224/13111;;H01L2224/16225;;H01L2224/16225;;H01L2224/16227;;H01L2224/16227;;H01L2224/2732;;H01L2224/2732;;H01L2224/2741;;H01L2224/2741;;H01L2224/27418;;H01L2224/27418;;H01L2224/27422;;H01L2224/27422;;H01L2224/2929;;H01L2224/2929;;H01L2224/29294;;H01L2224/29294;;H01L2224/29311;;H01L2224/29311;;H01L2224/29387;;H01L2224/29387;;H01L2224/2939;;H01L2224/2939;;H01L2224/32225;;H01L2224/32225;;H01L2224/73204;;H01L2224/73204;;H01L2224/81011;;H01L2224/81011;;H01L2224/81024;;H01L2224/81024;;H01L2224/81143;;H01L2224/81143;;H01L2224/81191;;H01L2224/81191;;H01L2224/81192;;H01L2224/81192;;H01L2224/81815;;H01L2224/81815;;H01L2224/83192;;H01L2224/83192;;H01L2224/83862;;H01L2224/83862;;H01L2224/9211;;H01L2224/9211;;H05K3/3436;;H05K3/3436;;H05K3/3489;;H05K3/3489;;H05K2201/10674;;H05K2201/10674;;H05K2201/10977;;H05K2201/10977,B23K31/02;;B23K35/34,228/180.21;;228/207;;228/223;;228/224;;228/248.1;;148/23;;148/24,9,0,,,"Copending U.S. Appl. No. 12/958,495.;;Copending U.S. Appl. No. 12/958,487.;;Copending U.S. Appl. No. 12/958,480.;;Copending U.S. Appl. No. 12/958,493.;;Copending U.S. Appl. No. 12/958,473.;;Copending U.S. Appl. No. 13/250,226.;;Copending U.S. Appl. No. 13/250,007.;;Copending U.S. Appl. No. 13/250,184.;;Copending U.S. Appl. No. 13/250,125.",INACTIVE
609,SG,A,SG 11201806826P A,176-708-640-178-277,2018-09-27,2018,SG 11201806826P A,2017-03-20,EP 16163187 A;;EP 17160791 A;;US 2017/0023143 W,2016-03-31,RAZOR CARTRIDGE WITH FLUID MANAGEMENT SYSTEM,,GILLETTE CO LLC,HAINES RODERICK;;OLIVER JAMES;;PETERSON MARK;;SPOONER-FLEMING JOIA;;STEPHENS ALISON;;TANDY JAMES;;WARRICK PAUL;;WILLIAMSON FINBARR,,https://lens.org/176-708-640-178-277,Unknown,no,0,0,18,18,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,PENDING
610,EP,A4,EP 1697119 A4,106-180-633-776-090,2007-06-20,2007,EP 04813853 A,2004-12-13,US 2004/0041595 W;;US 74682903 A,2003-12-24,ENERGY EFFICIENT CONSTRUCTION SURFACES,,3M INNOVATIVE PROPERTIES CO,ANDERSON MARK T;;FLEMING PETER B;;GOULD RACHAEL A T;;GROSS CHRISTOPHER L;;PENDERGRASS DANIEL B JR,,https://lens.org/106-180-633-776-090,Search Report,no,2,0,15,15,0,E04D2001/005;;G02B5/0816;;Y10T428/24372;;Y02A30/254;;Y02B80/00;;E04D1/28;;G02B5/0816;;E04D2001/005;;E04D1/22;;Y10T428/24372;;E04D2001/005;;G02B5/0816;;Y02A30/254;;Y02B80/00;;E04D1/28,B32B1/00;;E04D1/22;;G02B5/08,,0,0,,,,DISCONTINUED
611,KR,A,KR 20060134028 A,139-717-618-296-931,2006-12-27,2006,KR 20067014700 A,2004-12-13,US 74682903 A;;US 2004/0041595 W,2003-12-24,ENERGY EFFICIENT CONSTRUCTION SURFACES,"The present invention provides a non-white construction surface comprising a substrate, a first reflective coating on at least a portion of an outer surface of a substrate, such that the substrate with this first reflective coating exhibits a minimum direct solar reflectance value of at least about 25%, and a second reflective coating on at least a portion of the first reflective coating, wherein the combination of the first reflective coating and the second reflective coating provide the substrate with a reflectivity of at least about 20% at substantially all points in the wavelength range between 770 and 2500 nm.",3M INNOVATIVE PROPERTIES CO,ANDERSON MARK T;;FLEMING PETER B;;GOULD RACHAEL A T;;GROSS CHRISTOPHER L;;PENDERGRASS DANIEL B JR,,https://lens.org/139-717-618-296-931,Patent Application,no,0,0,15,15,0,E04D2001/005;;G02B5/0816;;Y10T428/24372;;Y02A30/254;;Y02B80/00;;E04D1/28;;G02B5/0816;;E04D2001/005;;E04D1/22;;Y10T428/24372;;E04D2001/005;;G02B5/0816;;Y02A30/254;;Y02B80/00;;E04D1/28,B32B7/02;;E04D1/12;;E04D1/22;;G02B5/08,,0,0,,,,INACTIVE
612,KR,A,KR 20130042666 A,089-726-859-152-923,2013-04-26,2013,KR 20137009541 A,2004-12-13,US 74682903 A;;US 2004/0041595 W,2003-12-24,ENERGY EFFICIENT ROOFING GRANULE,,3M INNOVATIVE PROPERTIES CO,ANDERSON MARK T;;FLEMING PETER B;;GOULD RACHAEL A T;;GROSS CHRISTOPHER L;;PENDERGRASS DANIEL B JR,,https://lens.org/089-726-859-152-923,Patent Application,no,0,0,15,15,0,E04D2001/005;;G02B5/0816;;Y10T428/24372;;Y02A30/254;;Y02B80/00;;E04D1/28;;G02B5/0816;;E04D2001/005;;E04D1/22;;Y10T428/24372;;E04D2001/005;;G02B5/0816;;Y02A30/254;;Y02B80/00;;E04D1/28,B32B7/02;;E04D1/12;;E04D1/22;;G02B5/08,,0,0,,,,ACTIVE
613,AU,A1,AU 2004/311705 A1,129-944-254-938-127,2005-07-21,2005,AU 2004/311705 A,2004-12-13,US 74682903 A;;US 2004/0041595 W,2003-12-24,Energy efficient construction surfaces,,3M INNOVATIVE PROPERTIES CO,ANDERSON MARK T;;GOULD RACHAEL A T;;PENDERGRASS DANIEL B JR;;FLEMING PETER B;;GROSS CHRISTOPHER L,,https://lens.org/129-944-254-938-127,Patent Application,no,0,0,15,15,0,E04D2001/005;;G02B5/0816;;Y10T428/24372;;Y02A30/254;;Y02B80/00;;E04D1/28;;G02B5/0816;;E04D2001/005;;E04D1/22;;Y10T428/24372;;E04D2001/005;;G02B5/0816;;Y02A30/254;;Y02B80/00;;E04D1/28,E04D1/22;;G02B5/08,,0,0,,,,DISCONTINUED
614,CN,B,CN 103028868 B,157-395-882-579-088,2015-07-01,2015,CN 201210517250 A,2012-09-29,US 201113250226 A,2011-09-30,"Polyamine, carboxylic acid flux composition and method of soldering",,ROHM & HAAS ELECT MAT,WINKLE MARK R;;DHOBLE AVIN V;;HO KIM S;;GALLAGHER MICHAEL K;;LIU XIANG-QIAN;;FLEMING DAVID,,https://lens.org/157-395-882-579-088,Granted Patent,no,0,0,12,12,0,B23K35/362;;B23K1/0016;;B23K1/0016;;B23K1/008;;B23K1/008;;B23K1/203;;B23K1/203;;B23K35/3601;;B23K35/3601;;B23K35/3618;;B23K35/3618;;B23K35/362;;B23K35/362;;B23K2101/42;;B23K2101/42;;C07C211/36;;H05K3/3489;;H05K3/3489,B23K35/363;;B23K1/00,,0,0,,,,INACTIVE
615,US,A1,US 2013/0082094 A1,179-051-523-136-444,2013-04-04,2013,US 201113250226 A,2011-09-30,US 201113250226 A,2011-09-30,"POLYAMINE, CARBOXYLIC ACID FLUX COMPOSITION AND METHOD OF SOLDERING","A flux composition is provided, comprising, as initial components: a carboxylic acid; and, a polyamine fluxing agent represented by formula I: with the proviso that when the polyamine fluxing agent represented by formula I is according to formula Ia: then zero to three of R 1 , R 2 , R 3 and R 4 is(are) a hydrogen. Also provided is a method of soldering an electrical contact using the flux composition.",WINKLE MARK R;;DHOBLE AVIN V;;HO KIM S;;GALLAGHER MICHAEL K;;LIU XIANG-QIAN;;FLEMING DAVID;;ROHM & HAAS ELECT MAT,WINKLE MARK R;;DHOBLE AVIN V;;HO KIM S;;GALLAGHER MICHAEL K;;LIU XIANG-QIAN;;FLEMING DAVID,ROHM AND HAAS ELECTRONIC MATERIALS LLC (2011-11-17),https://lens.org/179-051-523-136-444,Patent Application,yes,0,5,12,12,0,B23K35/362;;B23K1/0016;;B23K1/0016;;B23K1/008;;B23K1/008;;B23K1/203;;B23K1/203;;B23K35/3601;;B23K35/3601;;B23K35/3618;;B23K35/3618;;B23K35/362;;B23K35/362;;B23K2101/42;;B23K2101/42;;C07C211/36;;H05K3/3489;;H05K3/3489,B23K1/20;;B23K35/363,228/223;;148/23;;148/24,0,0,,,,INACTIVE
616,US,B2,US 7140741 B2,076-984-082-519-027,2006-11-28,2006,US 2420104 A,2004-12-28,US 2420104 A;;US 53396203 P,2003-12-30,Color shifting retroreflector and method of making same,"Color shifting retroreflective articles can provide features such as decorative effects, evidence of tampering, security authentication or positional information. In some embodiments, the color shifting retroreflective article includes a layer of microspheres, and a reflective coating that is disposed in optical association with the layer of microspheres. The reflective coating includes a spacer layer disposed between a semitransparent first reflective layer and a second reflective layer. The first reflective layer includes a reflective layer disposed adjacent the layer of microspheres. At least one layer of the reflective coating includes a non-uniform thickness associated with each of a plurality of microspheres such that light incident on the article from a first direction is retroreflected at a first color and light incident on the article from a second direction is retroreflected at a second color visibly different from the first color.",3M INNOVATIVE PROPERTIES CO,FLEMING ROBERT J;;LYONS CHRISTOPHER S;;MCGRATH JOSEPH M;;RAMOS JESUS;;ROEHRIG MARK A;;BRIGHT CLARK I,3M INNOVATIVE PROPERTIES COMPANY (2005-04-08),https://lens.org/076-984-082-519-027,Granted Patent,yes,56,34,10,10,0,G02B5/128;;Y10T428/24479;;Y10T428/24579;;G02B5/128;;Y10T428/24479;;Y10T428/24579;;G02B5/128,G02B5/128,359/536;;359/534;;359/535;;359/537;;428/156;;428/168;;427/256;;427/258,4,3,031-983-171-301-049;;041-803-355-776-665;;030-640-891-815-987,20555586;;10.1364/ao.28.002702;;10.1016/0040-6090(95)06853-8;;10.1080/713818726,"Dobrowolski et al., ""Reasearch on thin film anticounterfeiting coatings at the National Reasearch Council of Canada,"" Applied Optics, vol. 28, No. 14, Jul. 15, 1989, pp. 2702-2717, & 2685.;;Simonsis, ""The Dawn of a New Age in Coating Technology,"" Paper Film Foil Converter, Feb. 1998, pp. 51-52, 54, & 56.;;Affinito et al., ""Vacuum deposited polymer/metal multilayer fibers for optical application"", Thin Solid Folms 270, 1995, pp. 43-48.;;Dobrowolski et al., ""Optical Interference Coatings for Inhibiting Counterfeiting"", Opt. Acta, 1973, pp. 925-937.",ACTIVE
617,US,B2,US 8434667 B2,100-695-444-648-027,2013-05-07,2013,US 201113250226 A,2011-09-30,US 201113250226 A,2011-09-30,"Polyamine, carboxylic acid flux composition and method of soldering","A flux composition is provided, comprising, as initial components: a carboxylic acid; and, a polyamine fluxing agent represented by formula I: with the proviso that when the polyamine fluxing agent represented by formula I is according to formula Ia: then zero to three of R 1 , R 2 , R 3 and R 4 is(are) a hydrogen. Also provided is a method of soldering an electrical contact using the flux composition.",WINKLE MARK R;;DHOBLE AVIN V;;HO KIM S;;GALLAGHER MICHAEL K;;LIU XIANG-QIAN;;FLEMING DAVID;;ROHM & HAAS ELECT MAT,WINKLE MARK R;;DHOBLE AVIN V;;HO KIM S;;GALLAGHER MICHAEL K;;LIU XIANG-QIAN;;FLEMING DAVID,ROHM AND HAAS ELECTRONIC MATERIALS LLC (2011-11-17),https://lens.org/100-695-444-648-027,Granted Patent,yes,57,2,12,12,0,B23K35/362;;B23K1/0016;;B23K1/0016;;B23K1/008;;B23K1/008;;B23K1/203;;B23K1/203;;B23K35/3601;;B23K35/3601;;B23K35/3618;;B23K35/3618;;B23K35/362;;B23K35/362;;B23K2101/42;;B23K2101/42;;C07C211/36;;H05K3/3489;;H05K3/3489,B23K31/02;;B23K35/34,228/180.21;;228/207;;228/223;;228/224;;228/248.1;;148/23;;148/24,9,0,,,"Copending U.S. Appl. No. 12/958,495.;;Copending U.S. Appl. No. 12/958,487.;;Copending U.S. Appl. No. 12/958,480.;;Copending U.S. Appl. No. 12/958,493.;;Copending U.S. Appl. No. 12/958,473.;;Copending U.S. Appl. No. 13/250,297.;;Copending U.S. Appl. No. 13/250,007.;;Copending U.S. Appl. No. 13/250,184.;;Copending U.S. Appl. No. 13/250,125.",INACTIVE
618,CN,B,CN 103042320 B,038-426-667-100-198,2015-07-01,2015,CN 201210504385 A,2012-09-29,US 201113250297 A,2011-09-30,Curable flux composition and method of soldering,,ROHM & HAAS ELECT MAT,GALLAGHER MICHAEL K;;HO KIM S;;DHOBLE AVIN V;;WINKLE MARK R;;LIU XIANG-QIAN;;FLEMING DAVID,,https://lens.org/038-426-667-100-198,Granted Patent,no,0,0,13,13,0,B23K1/0016;;B23K1/0016;;B23K35/362;;B23K1/203;;B23K1/203;;C07C211/36;;C08K5/09;;C08K5/09;;C08K5/17;;C08K5/17;;H01L24/11;;H01L24/11;;H01L24/13;;H01L24/13;;H01L24/16;;H01L24/16;;H01L24/27;;H01L24/27;;H01L24/29;;H01L24/29;;H01L24/32;;H01L24/32;;H01L24/81;;H01L24/81;;H01L24/83;;H01L24/83;;H01L24/92;;H01L24/92;;H01L2224/11334;;H01L2224/11334;;H01L2224/131;;H01L2224/131;;H01L2224/13111;;H01L2224/13111;;H01L2224/16225;;H01L2224/16225;;H01L2224/16227;;H01L2224/16227;;H01L2224/2732;;H01L2224/2732;;H01L2224/2741;;H01L2224/2741;;H01L2224/27418;;H01L2224/27418;;H01L2224/27422;;H01L2224/27422;;H01L2224/2929;;H01L2224/2929;;H01L2224/29294;;H01L2224/29294;;H01L2224/29311;;H01L2224/29311;;H01L2224/29387;;H01L2224/29387;;H01L2224/2939;;H01L2224/2939;;H01L2224/32225;;H01L2224/32225;;H01L2224/73204;;H01L2224/73204;;H01L2224/81011;;H01L2224/81011;;H01L2224/81024;;H01L2224/81024;;H01L2224/81143;;H01L2224/81143;;H01L2224/81191;;H01L2224/81191;;H01L2224/81192;;H01L2224/81192;;H01L2224/81815;;H01L2224/81815;;H01L2224/83192;;H01L2224/83192;;H01L2224/83862;;H01L2224/83862;;H01L2224/9211;;H01L2224/9211;;H05K3/3436;;H05K3/3436;;H05K3/3489;;H05K3/3489;;H05K2201/10674;;H05K2201/10674;;H05K2201/10977;;H05K2201/10977,B23K35/363;;B23K1/00,,0,0,,,,INACTIVE
619,EP,A2,EP 1697119 A2,024-072-579-488-256,2006-09-06,2006,EP 04813853 A,2004-12-13,US 2004/0041595 W;;US 74682903 A,2003-12-24,ENERGY EFFICIENT CONSTRUCTION SURFACES,,3M INNOVATIVE PROPERTIES CO,ANDERSON MARK T;;FLEMING PETER B;;GOULD RACHAEL A T;;GROSS CHRISTOPHER L;;PENDERGRASS DANIEL B JR,,https://lens.org/024-072-579-488-256,Patent Application,yes,0,0,15,15,0,E04D2001/005;;G02B5/0816;;Y10T428/24372;;Y02A30/254;;Y02B80/00;;E04D1/28;;G02B5/0816;;E04D2001/005;;E04D1/22;;Y10T428/24372;;E04D2001/005;;G02B5/0816;;Y02A30/254;;Y02B80/00;;E04D1/28,E04D1/22;;B32B1/00;;G02B5/08,,0,0,,,,DISCONTINUED
620,US,A1,US 2013/0082095 A1,022-647-202-373-880,2013-04-04,2013,US 201113250007 A,2011-09-30,US 201113250007 A,2011-09-30,Flux Composition And Method Of Soldering,"A flux composition is provided, comprising, as an initial component: a carboxylic acid; and, a fluxing agent represented by formula I: wherein R 1 , R 2 , R 3 and R 4 are independently selected from a hydrogen, a substituted C 1-80 alkyl group, an unsubstituted C 1-80 alkyl group, a substituted C 7-80 arylalkyl group and an unsubstituted C 7-80 arylalkyl group; and wherein zero to three of R 1 , R 2 , R 3 and R 4 is(are) a hydrogen. Also provided is a method of soldering an electrical contact using the flux composition.",HO KIM S;;GALLAGHER MICHAEL K;;DHOBLE AVIN V;;WINKLE MARK R;;LIU XIANG-QIAN;;FLEMING DAVID;;ROHM & HAAS ELECT MAT,HO KIM S;;GALLAGHER MICHAEL K;;DHOBLE AVIN V;;WINKLE MARK R;;LIU XIANG-QIAN;;FLEMING DAVID,ROHM AND HAAS ELECTRONIC MATERIALS LLC (2011-11-17),https://lens.org/022-647-202-373-880,Patent Application,yes,0,4,13,13,0,B23K1/203;;B23K1/203;;B23K35/362;;B23K1/0016;;B23K1/0016;;B23K1/008;;B23K1/008;;B23K35/0244;;B23K35/0244;;B23K35/26;;B23K35/26;;B23K35/34;;B23K35/34;;B23K35/3601;;B23K35/3601;;B23K35/362;;B23K35/362;;B23K2101/42;;B23K2101/42;;C07C217/52;;H05K3/3489;;H05K3/3489,B23K1/20;;B23K35/363,228/224;;148/23;;148/24,0,0,,,,INACTIVE
621,US,A1,US 2013/0082089 A1,069-311-916-542-718,2013-04-04,2013,US 201113250297 A,2011-09-30,US 201113250297 A,2011-09-30,CURABLE FLUX COMPOSITION AND METHOD OF SOLDERING,"A curable flux composition is provided, comprising, as initial components: a resin component having at least two oxirane groups per molecule; a carboxylic acid; a fluxing agent represented by formula I: wherein R 1 , R 2 , R 3 and R 4 are independently selected from a hydrogen, a substituted C 1-80 alkyl group, an unsubstituted C 1-80 alkyl group, a substituted C 7-80 arylalkyl group and an unsubstituted C 7-80 arylalkyl group; and wherein zero to three of R 1 , R 2 , R 3 and R 4 is(are) a hydrogen; and, optionally, a curing agent. Also provided is a method of soldering an electrical contact using the curable flux composition.",GALLAGHER MICHAEL K;;HO KIM S;;DHOBLE AVIN V;;WINKLE MARK R;;LIU XIANG-QIAN;;FLEMING DAVID;;ROHM & HAAS ELECT MAT,GALLAGHER MICHAEL K;;HO KIM S;;DHOBLE AVIN V;;WINKLE MARK R;;LIU XIANG-QIAN;;FLEMING DAVID,ROHM AND HAAS ELECTRONIC MATERIALS LLC (2011-11-17),https://lens.org/069-311-916-542-718,Patent Application,yes,0,4,13,13,0,B23K1/0016;;B23K1/0016;;B23K35/362;;B23K1/203;;B23K1/203;;C07C211/36;;C08K5/09;;C08K5/09;;C08K5/17;;C08K5/17;;H01L24/11;;H01L24/11;;H01L24/13;;H01L24/13;;H01L24/16;;H01L24/16;;H01L24/27;;H01L24/27;;H01L24/29;;H01L24/29;;H01L24/32;;H01L24/32;;H01L24/81;;H01L24/81;;H01L24/83;;H01L24/83;;H01L24/92;;H01L24/92;;H01L2224/11334;;H01L2224/11334;;H01L2224/131;;H01L2224/131;;H01L2224/13111;;H01L2224/13111;;H01L2224/16225;;H01L2224/16225;;H01L2224/16227;;H01L2224/16227;;H01L2224/2732;;H01L2224/2732;;H01L2224/2741;;H01L2224/2741;;H01L2224/27418;;H01L2224/27418;;H01L2224/27422;;H01L2224/27422;;H01L2224/2929;;H01L2224/2929;;H01L2224/29294;;H01L2224/29294;;H01L2224/29311;;H01L2224/29311;;H01L2224/29387;;H01L2224/29387;;H01L2224/2939;;H01L2224/2939;;H01L2224/32225;;H01L2224/32225;;H01L2224/73204;;H01L2224/73204;;H01L2224/81011;;H01L2224/81011;;H01L2224/81024;;H01L2224/81024;;H01L2224/81143;;H01L2224/81143;;H01L2224/81191;;H01L2224/81191;;H01L2224/81192;;H01L2224/81192;;H01L2224/81815;;H01L2224/81815;;H01L2224/83192;;H01L2224/83192;;H01L2224/83862;;H01L2224/83862;;H01L2224/9211;;H01L2224/9211;;H05K3/3436;;H05K3/3436;;H05K3/3489;;H05K3/3489;;H05K2201/10674;;H05K2201/10674;;H05K2201/10977;;H05K2201/10977,B23K35/363;;B23K1/20;;B23K31/02,228/176;;148/23;;148/24,0,0,,,,INACTIVE
622,US,A1,US 2005/0162742 A1,117-275-209-887-040,2005-07-28,2005,US 2420104 A,2004-12-28,US 2420104 A;;US 53396203 P,2003-12-30,Color shifting retroreflector and method of making same,"Color shifting retroreflective articles can provide features such as decorative effects, evidence of tampering, security authentication or positional information. In some embodiments, the color shifting retroreflective article includes a layer of microspheres, and a reflective coating that is disposed in optical association with the layer of microspheres. The reflective coating includes a spacer layer disposed between a semitransparent first reflective layer and a second reflective layer. The first reflective layer includes a reflective layer disposed adjacent the layer of microspheres. At least one layer of the reflective coating includes a non-uniform thickness associated with each of a plurality of microspheres such that light incident on the article from a first direction is retroreflected at a first color and light incident on the article from a second direction is retroreflected at a second color visibly different from the first color.",FLEMING ROBERT J.;;LYONS CHRISTOPHER S.;;MCGRATH JOSEPH M.;;RAMOS JESUS;;ROEHRIG MARK A.;;BRIGHT CLARK I.,FLEMING ROBERT J;;LYONS CHRISTOPHER S;;MCGRATH JOSEPH M;;RAMOS JESUS;;ROEHRIG MARK A;;BRIGHT CLARK I,3M INNOVATIVE PROPERTIES COMPANY (2005-04-08),https://lens.org/117-275-209-887-040,Patent Application,yes,54,18,10,10,0,G02B5/128;;Y10T428/24479;;Y10T428/24579;;G02B5/128;;Y10T428/24479;;Y10T428/24579;;G02B5/128,G02B5/128,359/536;;359/540,0,0,,,,ACTIVE
623,CN,A,CN 103042320 A,193-626-915-404-155,2013-04-17,2013,CN 201210504385 A,2012-09-29,US 201113250297 A,2011-09-30,Curable flux composition and method of soldering,"A curable flux composition is provided, comprising, as initial components: a resin component having at least two oxirane groups per molecule,a carboxylic acid,a fluxing agent represented by formula I, wherein R<1>, R<2>, R<3> and R<4> are independently selected from a hydrogen, a substituted C1-80 alkyl group, an unsubstituted C1-80 alkyl group, a substituted C7-80 arylalkyl group and an unsubstituted C7-80 arylalkyl group,and wherein zero to three of R<1>, R<2>, R<3> and R<4> is(are) a hydrogen,and, optionally, a curing agent. Also provided is a method of soldering an electrical contact using the curable flux composition.",ROHM & HAAS ELECT MAT,GALLAGHER MICHAEL K;;HO KIM S;;DHOBLE AVIN V;;WINKLE MARK R;;LIU XIANG-QIAN;;FLEMING DAVID,,https://lens.org/193-626-915-404-155,Patent Application,no,6,3,13,13,0,B23K1/0016;;B23K1/0016;;B23K35/362;;B23K1/203;;B23K1/203;;C07C211/36;;C08K5/09;;C08K5/09;;C08K5/17;;C08K5/17;;H01L24/11;;H01L24/11;;H01L24/13;;H01L24/13;;H01L24/16;;H01L24/16;;H01L24/27;;H01L24/27;;H01L24/29;;H01L24/29;;H01L24/32;;H01L24/32;;H01L24/81;;H01L24/81;;H01L24/83;;H01L24/83;;H01L24/92;;H01L24/92;;H01L2224/11334;;H01L2224/11334;;H01L2224/131;;H01L2224/131;;H01L2224/13111;;H01L2224/13111;;H01L2224/16225;;H01L2224/16225;;H01L2224/16227;;H01L2224/16227;;H01L2224/2732;;H01L2224/2732;;H01L2224/2741;;H01L2224/2741;;H01L2224/27418;;H01L2224/27418;;H01L2224/27422;;H01L2224/27422;;H01L2224/2929;;H01L2224/2929;;H01L2224/29294;;H01L2224/29294;;H01L2224/29311;;H01L2224/29311;;H01L2224/29387;;H01L2224/29387;;H01L2224/2939;;H01L2224/2939;;H01L2224/32225;;H01L2224/32225;;H01L2224/73204;;H01L2224/73204;;H01L2224/81011;;H01L2224/81011;;H01L2224/81024;;H01L2224/81024;;H01L2224/81143;;H01L2224/81143;;H01L2224/81191;;H01L2224/81191;;H01L2224/81192;;H01L2224/81192;;H01L2224/81815;;H01L2224/81815;;H01L2224/83192;;H01L2224/83192;;H01L2224/83862;;H01L2224/83862;;H01L2224/9211;;H01L2224/9211;;H05K3/3436;;H05K3/3436;;H05K3/3489;;H05K3/3489;;H05K2201/10674;;H05K2201/10674;;H05K2201/10977;;H05K2201/10977,B23K35/363;;B23K1/00,,0,0,,,,INACTIVE
624,AU,A1,AU 2011/202368 A1,178-250-744-223-600,2011-06-09,2011,AU 2011/202368 A,2011-05-20,AU 2004/311705 A;;AU 2011/202368 A;;US 74682903 A;;US 2004/0041595 W,2003-12-24,Energy efficient construction surfaces,,3M INNOVATIVE PROPERTIES CO,GROSS CHRISTOPHER L;;PENDERGRASS DANIEL B JR;;GOULD RACHAEL A T;;FLEMING PETER B;;ANDERSON MARK T,,https://lens.org/178-250-744-223-600,Patent Application,no,0,0,15,15,0,E04D2001/005;;G02B5/0816;;Y10T428/24372;;Y02A30/254;;Y02B80/00;;E04D1/28;;G02B5/0816;;E04D2001/005;;E04D1/22;;Y10T428/24372;;E04D2001/005;;G02B5/0816;;Y02A30/254;;Y02B80/00;;E04D1/28,E04D1/22;;G02B5/08,,0,0,,,,DISCONTINUED
625,US,A1,US 2005/0142329 A1,010-365-514-107-468,2005-06-30,2005,US 74682903 A,2003-12-24,US 74682903 A,2003-12-24,Energy efficient construction surfaces,"The present invention provides a non-white construction surface comprising a substrate, a first reflective coating on at least a portion of an outer surface of a substrate, such that the substrate with this first reflective coating exhibits a minimum direct solar reflectance value of at least about 25%, and a second reflective coating on at least a portion of the first reflective coating, wherein the combination of the first reflective coating and the second reflective coating provide the substrate with a reflectivity of at least about 20% at substantially all points in the wavelength range between 770 and 2500 nm.",ANDERSON MARK T.;;FLEMING PETER B.;;GOULD RACHEL A.T.;;GROSS CHRISTOPHER L.;;PENDERGRASS DANIEL B.JR.,ANDERSON MARK T;;FLEMING PETER B;;GOULD RACHEL A T;;GROSS CHRISTOPHER L;;PENDERGRASS DANIEL B JR,3M INNOVATIVE PROPERTIES COMPANY (2004-06-22),https://lens.org/010-365-514-107-468,Patent Application,yes,99,36,15,15,0,E04D2001/005;;G02B5/0816;;Y10T428/24372;;Y02A30/254;;Y02B80/00;;E04D1/28;;G02B5/0816;;E04D2001/005;;E04D1/22;;Y10T428/24372;;E04D2001/005;;G02B5/0816;;Y02A30/254;;Y02B80/00;;E04D1/28,E04D1/22;;G02B5/08,428/143,0,0,,,,DISCONTINUED
626,US,A1,US 2020/0311058 A1,007-189-397-366-277,2020-10-01,2020,US 202016830465 A,2020-03-26,US 201962823995 P;;US 202016830465 A,2019-03-26,SYSTEMS AND METHODS FOR STRUCTURAL DATA ANALYSIS,"Systems and methods for viewing, tracking, and analyzing data structure. Particularly, systems and methods for recognizing and grouping structural components of data into data shapes for viewing, tracking, and analyzing the data structure irrespective of the data content. An example method of analyzing data may include receiving document data comprising a plurality of data fields and defining a data shape from the document data, the data shape having one or more of the plurality of data fields. The data shape is defined agnostic to data content. The data shape may further include a qualifier associated with a data field. The data shape may be a first data shape, and the method may further include defining a second data shape from the document data, the second data shape having one or more of the plurality of data fields. The second shape may comprise the first data shape and an additional element.",SPS COMMERCE INC,ZIELIEKE LAMOINE;;HENNING JEREMY;;ARTHUR ANTHONY;;MOSES DOUGLAS;;FLEMING CORY;;GRANRUD LARS;;PETERSON MATTHEW CHARLES;;DYMOND MARK WILLIAM,SPS COMMERCE INC (2020-04-17),https://lens.org/007-189-397-366-277,Patent Application,yes,0,1,3,3,0,G06Q10/10;;G06F16/93;;G06V30/414;;G06V30/1456;;G06F16/245;;G06Q10/10;;G06F16/2379;;G06Q10/0875;;G06F16/5854;;G06V30/414;;G06V30/1456,G06F16/245;;G06F16/23;;G06K9/00;;G06Q10/10,,0,0,,,,DISCONTINUED
627,EP,B1,EP 1334404 B1,031-299-258-317-421,2007-12-19,2007,EP 01909016 A,2001-02-09,US 0104184 W;;US 67819100 A,2000-10-04,ELECTRICALLY/MAGNETICALLY RESPONSIVE PARTICLE ASSEMBLY,"Assemblies containing a substrate with pockets for electromagnetically responsive particles can be made for a variety of uses, including, for example, display media, lenses, and color-changing fabric. The arrangement of these pockets can be selected to provide higher particle density than previously realized. The assembly includes an assembly substrate, particles, and a top coat layer.",3M INNOVATIVE PROPERTIES CO,BASTIAENS WILLEM V;;BIERNATH ROLF W;;DOLAN MARK P;;ENGLE LORI P;;FLEMING PATRICK K;;WOLF ROBERT J,,https://lens.org/031-299-258-317-421,Granted Patent,yes,3,0,11,11,0,G02B26/026;;G02F1/167;;G09F9/372;;G09F9/375;;Y10T428/25;;Y10T428/259;;B33Y80/00;;G02F1/167;;Y10T428/25;;Y10T428/259;;B33Y80/00;;G09F9/375;;G02B26/026;;G09F9/372;;G02F1/167,G02B26/02;;G02F1/167;;G09F9/37,,1,0,,,"PATENT ABSTRACTS OF JAPAN vol. 017, no. 372 (P-1573), 13 July 1993 (1993-07-13) -& JP 05 061075 A (TOYOTA MOTOR CORP), 12 March 1993 (1993-03-12)",EXPIRED
628,EP,A1,EP 1334404 A1,024-050-393-878-160,2003-08-13,2003,EP 01909016 A,2001-02-09,US 0104184 W;;US 67819100 A,2000-10-04,ELECTRICALLY/MAGNETICALLY RESPONSIVE PARTICLE ASSEMBLY,"Assemblies containing a substrate with pockets for electromagnetically responsive particles can be made for a variety of uses, including, for example, display media, lenses, and color-changing fabric. The arrangement of these pockets can be selected to provide higher particle density than previously realized. The assembly includes an assembly substrate, particles, and a top coat layer.",3M INNOVATIVE PROPERTIES CO,BASTIAENS WILLEM V;;BIERNATH ROLF W;;DOLAN MARK P;;ENGLE LORI P;;FLEMING PATRICK K;;WOLF ROBERT J,,https://lens.org/024-050-393-878-160,Patent Application,yes,0,0,11,11,0,G02B26/026;;G02F1/167;;G09F9/372;;G09F9/375;;Y10T428/25;;Y10T428/259;;B33Y80/00;;G02F1/167;;Y10T428/25;;Y10T428/259;;B33Y80/00;;G09F9/375;;G02B26/026;;G09F9/372;;G02F1/167,G02B26/02;;G02F1/167;;G09F9/37,,0,0,,,,EXPIRED
629,WO,A1,WO 2001/031393 A1,045-378-573-889-204,2001-05-03,2001,US 0004233 W,2000-02-18,US 42576599 A,1999-10-22,DISPLAY APPARATUS WITH CORROSION-RESISTANT LIGHT DIRECTING FILM,"The present invention is a display apparatus that provides protection against damage for a metallic layer. The display apparatus includes a light modulating layer, a polarizer, and a light directing film. The light directing film includes a prismatic structure having two sides, where one side includes saw tooth formations having tilted surfaces and a metal layer on the side of the prismatic substrate having the saw-tooth formations. A tilt angle of the tilted surfaces offsets an optimal viewing angle for the display from a glare angle for the display. In a first embodiment of the invention, the light directing film of the display apparatus further includes an inorganic protective layer formed on the metal layer, wherein the inorganic protective layer inhibits molecular transfer to the metal layer and balances the color of reflected and transmitted light. The light directing film of the first embodiment further includes a pressure sensitive adhesive layer between a polarizer and the inorganic protective layer. Alternatively, the light directing film of the display apparatus of the present invention includes a polymer protective layer formed over the metal layer to protect the metal layer from damage in a second embodiment. The light directing film of the second embodiment also includes a diffuse adhesive layer formed over the polymer layer, attached to the polarizer. The polymer protective layer protects the metal layer from the adhesive layer. The display apparatus may include both the inorganic protective layer and the polymer protective layer, in one embodiment.",3M INNOVATIVE PROPERTIES CO,EPSTEIN KENNETH A;;FLEMING ROBERT J;;GARDNER TIMOTHY J;;LYONS CHRISTOPHER S;;MAKI STEPHEN P;;NACHBOR MARK D,,https://lens.org/045-378-573-889-204,Patent Application,yes,5,19,13,13,0,G02F1/133345;;G02F1/133504;;G02F1/133553;;G02F2202/022;;G02F1/1335;;G02F1/133553;;G02F1/133504;;G02F2202/022;;G02F1/133345,G02B5/04;;G02F1/1333;;G02B5/02;;G02F1/1335;;G02F1/13357;;G09F9/00,,1,0,,,"PATENT ABSTRACTS OF JAPAN vol. 1999, no. 13 30 November 1999 (1999-11-30)",PATENTED
630,AU,A,AU 2000/032361 A,043-316-682-951-306,2001-05-08,2001,AU 2000/032361 A,2000-02-18,US 42576599 A;;US 0004233 W,1999-10-22,Display apparatus with corrosion-resistant light directing film,,3M INNOVATIVE PROPERTIES CO,EPSTEIN KENNETH A;;FLEMING ROBERT J;;GARDNER TIMOTHY J;;LYONS CHRISTOPHER S;;MAKI STEPHEN P;;NACHBOR MARK D,,https://lens.org/043-316-682-951-306,Patent Application,no,0,0,13,13,0,G02F1/133345;;G02F1/133504;;G02F1/133553;;G02F2202/022;;G02F1/1335;;G02F1/133553;;G02F1/133504;;G02F2202/022;;G02F1/133345,G02B5/02;;G02B5/04;;G02F1/1333;;G02F1/1335;;G02F1/13357;;G09F9/00,,0,0,,,,DISCONTINUED
631,WO,A1,WO 2001/023926 A1,048-740-163-186-520,2001-04-05,2001,AU 1919/000009 W,2000-08-02,AU PQ320799 A,1999-09-30,SINGLE MODE OPTICAL WAVEGUIDE FIBRE,"A single mode optical waveguide fibre is disclosed which preferably is formed to exhibit low but non-zero dispersion at a wavelength μ in the order of 1550 nm. The fibre has a light guiding region that includes a central core region (11), a core-surrounding region (14) and at least three angularly separated side core regions (13) that are disposed radially outwardly from the central core region. The central core region (11) has an average refractive region n0, the surrounding region (14) has an average refractive index n1ឬn0, and each of the angularly separated regions (13) have an average refractive index n2n1.",UNIV SYDNEY;;UNIV AUSTRALIAN;;AUSTRALIAN PHOTONICS PTY LTD;;KOREA TELECOM RES AND DEV GROU;;LOVE JOHN;;BAILEY RONALD;;FLEMING SIMON;;SCEATS MARK;;THORNCRAFT DAVID;;KRUG PETER;;POLADIAN LEON;;LARGE MICHAEL;;RYAN THOMAS,LOVE JOHN;;BAILEY RONALD;;FLEMING SIMON;;SCEATS MARK;;THORNCRAFT DAVID;;KRUG PETER;;POLADIAN LEON;;LARGE MICHAEL;;RYAN THOMAS,,https://lens.org/048-740-163-186-520,Patent Application,yes,4,0,4,6,0,C03B37/01861;;C03B2203/10;;C03B2203/22;;C03B2203/24;;G02B6/02019;;G02B6/02242;;G02B6/03611;;G02B6/03627;;G02B6/03644;;G02B6/03666;;G02B6/02,C03B37/018;;G02B6/036;;G02B6/02,,1,0,,,"DATABASE WPI Derwent World Patents Index; Class V07, AN 1994-037528/05",PATENTED
632,TW,A,TW 201319140 A,065-409-341-526-871,2013-05-16,2013,TW 101135055 A,2012-09-25,US 201113250297 A,2011-09-30,Curable flux composition and method of soldering,"A curable flux composition is provided, comprising, as initial components: a resin component having at least two oxirane groups per molecule; a carboxylic acid; a fluxing agent represented by formula I: wherein R1, R2, R3 and R4 are independently selected from a hydrogen, a substituted C1-80 alkyl group, an unsubstited C1-80 alkyl group, a substituted C7-80 arylalkyl group and an unsubstited C7-80 arylalkyl group; and wherein aero to three of R1, R2, R3 and R4 is (are) a hydrogen; and, optionally, a curing agent. Also provided is a method of soldering an electrical contact using the curable flux composition.",ROHM & HAAS ELECT MAT,GALLAGHER MICHAEL K;;HO KIM SANG;;DHOBLE AVIN V;;WINKLE MARK R;;LIU XIANG-QIAN;;FLEMING DAVID D,,https://lens.org/065-409-341-526-871,Patent of Addition,no,0,1,13,13,0,B23K1/0016;;B23K1/0016;;B23K35/362;;B23K1/203;;B23K1/203;;C07C211/36;;C08K5/09;;C08K5/09;;C08K5/17;;C08K5/17;;H01L24/11;;H01L24/11;;H01L24/13;;H01L24/13;;H01L24/16;;H01L24/16;;H01L24/27;;H01L24/27;;H01L24/29;;H01L24/29;;H01L24/32;;H01L24/32;;H01L24/81;;H01L24/81;;H01L24/83;;H01L24/83;;H01L24/92;;H01L24/92;;H01L2224/11334;;H01L2224/11334;;H01L2224/131;;H01L2224/131;;H01L2224/13111;;H01L2224/13111;;H01L2224/16225;;H01L2224/16225;;H01L2224/16227;;H01L2224/16227;;H01L2224/2732;;H01L2224/2732;;H01L2224/2741;;H01L2224/2741;;H01L2224/27418;;H01L2224/27418;;H01L2224/27422;;H01L2224/27422;;H01L2224/2929;;H01L2224/2929;;H01L2224/29294;;H01L2224/29294;;H01L2224/29311;;H01L2224/29311;;H01L2224/29387;;H01L2224/29387;;H01L2224/2939;;H01L2224/2939;;H01L2224/32225;;H01L2224/32225;;H01L2224/73204;;H01L2224/73204;;H01L2224/81011;;H01L2224/81011;;H01L2224/81024;;H01L2224/81024;;H01L2224/81143;;H01L2224/81143;;H01L2224/81191;;H01L2224/81191;;H01L2224/81192;;H01L2224/81192;;H01L2224/81815;;H01L2224/81815;;H01L2224/83192;;H01L2224/83192;;H01L2224/83862;;H01L2224/83862;;H01L2224/9211;;H01L2224/9211;;H05K3/3436;;H05K3/3436;;H05K3/3489;;H05K3/3489;;H05K2201/10674;;H05K2201/10674;;H05K2201/10977;;H05K2201/10977,C08K5/17;;B23K35/362;;C08K5/09;;C08L63/00;;H05K3/14,,0,0,,,,INACTIVE
633,FR,A1,FR 2980728 A1,149-634-009-774-01X,2013-04-05,2013,FR 1259148 A,2012-09-28,US 201113250007 A,2011-09-30,COMPOSITION DE FONDANT ET PROCEDE DE SOUDAGE,"Il est fourni une composition de fondant, comprenant, comme composant initial: un acide carboxylique; et un agent fondant représenté par la formule I: où R , R , R et R sont choisis indépendamment parmi un hydrogène, un groupe C alkyle substitué, un groupe C alkyle non substitué, un groupe C arylalkyle substitué et un groupe C arylalkyle non substitué; et où zéro à trois de R , R , R et R est (sont) un hydrogène. Un procédé de soudage d'un contact électrique utilisant la composition de fondant est également fourni.",ROHM & HAAS ELECT MAT,HO KIM SANG;;GALLAGHER MICHAEL K;;DHOBLE AVIN V;;WINKLE MARK R;;LIU XIANG-QIAN;;FLEMING DAVID D,,https://lens.org/149-634-009-774-01X,Patent Application,no,2,0,13,13,0,B23K1/203;;B23K1/203;;B23K35/362;;B23K1/0016;;B23K1/0016;;B23K1/008;;B23K1/008;;B23K35/0244;;B23K35/0244;;B23K35/26;;B23K35/26;;B23K35/34;;B23K35/34;;B23K35/3601;;B23K35/3601;;B23K35/362;;B23K35/362;;B23K2101/42;;B23K2101/42;;C07C217/52;;H05K3/3489;;H05K3/3489,B23K35/363;;C07C211/36;;H05K3/34,,0,0,,,,INACTIVE
634,BR,A,BR PI0418341 A,193-241-175-377-392,2007-05-02,2007,BR PI0418341 A,2004-12-28,US 53396203 P;;US 2004/0043549 W,2003-12-30,artigo retrorreflexivo com variação de cor e método para produzir um artigo retrorreflexivo com variação de cor,"ARTIGO RETRORREFLEXIVO COM VARIAçãO DE COR E MéTODO PARA PRODUZIR UM ARTIGO RETRORREFLEXIVO COM VARIAçãO DE COR Artigos retrorreflexivos com variação de cor podem prover características tais efeitos decorativos, evidência adulteração, autenticação de segurança ou informação de posição. Em algumas modalidades, o artigo retrorreflexivo com variação de cor compreende uma camada de microesfera (14), e um revestimento reflexivo que está disposto em associação óptica com a camada de microesferas. O revestimento reflexivo inclui uma camada espaçadora (24) disposta entre uma primeira camada reflexiva semitransparente (22) e uma segunda camada reflexiva (26) . A primeira camada reflexiva unclui uma camada reflxiva disposta adjacente à camada de microesferas (tl, t2). Pelo menos uma camada do revestimento reflexivo inclui um espessura não uniformes associada com cada uma de uma pluraridade de de microesferas de tal modo que a luz incidente sobre o artigo a partir de uma primeira direção é retrorreflexitida a um primeira cor e a luz incidente sobre o artigo a partir de uma segunda direção é retrorrefletida a uma segunda cor visivelmente diferente da primeira cor.",3M INNOVATIVE PROPERTIES CO,FLEMING ROBERT J;;LYONS CHRISTOPHER S;;MCGRATH JOSEPH M;;RAMOS JESUS R;;ROEHRIG MARK A;;BRIGHT CLARK I,,https://lens.org/193-241-175-377-392,Patent Application,no,0,0,10,10,0,G02B5/128;;Y10T428/24479;;Y10T428/24579;;G02B5/128;;Y10T428/24479;;Y10T428/24579;;G02B5/128,G02B5/128,,0,0,,,,DISCONTINUED
635,DE,A1,DE 102012019198 A1,199-916-957-230-804,2013-04-04,2013,DE 102012019198 A,2012-09-28,US 201113250226 A,2011-09-30,"Polyamin-, Carbonsäure-Flussmittelzusammensetzung und Lötverfahren","Es wird eine Flussmittelzusammensetzung bereitgestellt, umfassend als Ausgangskomponenten: eine Carbonsäure und ein Polyaminflussmittel, dargestellt durch die Formel I:mit der Maßgabe, dass, wenn das Polyaminflussmittel, dargestellt durch die Formel I, die Formel Ia aufweist:dann null bis drei von R1, R2, R3 und R4 Wasserstoff sind. Ebenso wird ein Verfahren zum Löten eines elektrischen Kontaktes unter Verwendung der Flussmittelzusammensetzung bereitgestellt.",ROHM & HAAS ELECT MAT,HO KIM S;;GALLAGHER MICHAEL K;;DHOBLE AVIN V;;WINKLE MARK R;;LIU XIANG-QIAN;;FLEMING DAVID D,,https://lens.org/199-916-957-230-804,Patent Application,no,0,3,12,12,0,B23K35/362;;B23K1/0016;;B23K1/0016;;B23K1/008;;B23K1/008;;B23K1/203;;B23K1/203;;B23K35/3601;;B23K35/3601;;B23K35/3618;;B23K35/3618;;B23K35/362;;B23K35/362;;B23K2101/42;;B23K2101/42;;C07C211/36;;H05K3/3489;;H05K3/3489,B23K35/362,,1,0,,,Duchesne et al.,DISCONTINUED
636,US,B2,US 6357880 B2,136-321-395-162-927,2002-03-19,2002,US 83416401 A,2001-04-12,US 83416401 A;;US 42576599 A,1999-10-22,Display apparatus with corrosion-resistant light directing film,"
    The present invention is a display apparatus that provides protection against damage for a metallic layer. The display apparatus includes a light modulating layer, a polarizer, and a light directing film. The light directing film includes a prismatic structure having two sides, where one side includes saw tooth formations having tilted surfaces and a metal layer on the side of the prismatic substrate having the saw-tooth formations. A tilt angle of the tilted surfaces offsets an optimal viewing angle for the display from a glare angle for the display. In a first embodiment of the invention, the light directing film of the display apparatus further includes an inorganic protective layer formed on the metal layer, wherein the inorganic protective layer inhibits molecular transfer to the metal layer and balances the color of reflected and transmitted light. The light directing film further includes a pressure sensitive adhesive layer between a polarizer and the inorganic protective layer. Alternatively, the light directing film of the display apparatus of the present invention includes a polymer protective layer formed over the metal layer to protect the metal layer from damage. The light directing film also includes a diffuse adhesive layer formed over the polymer layer, attached to the polarizer. The polymer protective layer protects the metal layer from the adhesive layer. The display apparatus may include both the inorganic protective layer and the polymer protective layer, in one embodiment. 
",3M INNOVATIVE PROPERTIES CO,EPSTEIN KENNETH A;;FLEMING ROBERT J;;GARDNER TIMOTHY J;;LYONS CHRISTOPHER S;;MAKI STEPHEN P;;NACHBOR MARK D,,https://lens.org/136-321-395-162-927,Granted Patent,yes,87,23,13,13,0,G02F1/133345;;G02F1/133504;;G02F1/133553;;G02F2202/022;;G02F1/1335;;G02F1/133553;;G02F1/133504;;G02F2202/022;;G02F1/133345,G02B5/04;;G02B5/02;;G02F1/1333;;G02F1/1335;;G02F1/13357;;G09F9/00,359/606;;359/607;;359/608;;359/599;;359/850;;359/851;;359/852,6,0,,,"Hoeji, H.K., ""Design of reflectors for reflective LCDs"", Journal of the Optical Society of Korea-Korean Edition, vol. 9, No. 6.7 pages (Dec. 1998).;;Clabburn, R.J.T. et a., ""Asymmetric Reflective Difusers for Hand-held Displays"", Microsharp Corporation Limited, Swindon, U.K. (1999).;;Schrenk, W.J. et al., ""Nanolayer polymeric optical films"", Tappi Journal, pp. 169-174 (Jun. 1992).;;U.S. Patent Application Docket No. 54168USA6A, ""Method of Coating Microstrucred Substrates with Polymeric Layer(s), Allowing Preservation of Surface Feature Profile"", 50 pages.;;U.S. Patent Application Docket No. 54701USA4A, ""Retroreflective Articles Having Polymer Multilayer Reflective Coatings"", 30 pages.;;U.S. Patent Application Docket No. 7780.453US01 ""Optical Devices Using Reflecting Polarizing Materials"", 59 pages.",EXPIRED
637,FR,A1,FR 2980729 A1,035-895-160-791-316,2013-04-05,2013,FR 1259149 A,2012-09-28,US 201113250226 A,2011-09-30,"COMPOSITION DE FONDANT POLYAMINE, ACIDE CARBOXYLIQUE ET PROCEDE DE SOUDAGE","Il est fourni une composition de fondant, comprenant, comme composants initiaux: un acide carboxylique; et un agent fondant polyamine représenté par la formule I: à condition que quand l'agent fondant polyamine représenté par la formule I est selon la formule la: zéro à trois de R , R , R et R est (sont) un hydrogène. Il est fourni aussi un procédé de soudage d'un contact électrique utilisant la composition de fondant.",ROHM & HAAS ELECT MAT,WINKLE MARK R;;DHOBLE AVIN V;;HO KIM SANG;;GALLAGHER MICHAEL K;;LIU XIANG-QIAN;;FLEMING DAVID D,,https://lens.org/035-895-160-791-316,Patent Application,no,2,0,12,12,0,B23K35/362;;B23K1/0016;;B23K1/0016;;B23K1/008;;B23K1/008;;B23K1/203;;B23K1/203;;B23K35/3601;;B23K35/3601;;B23K35/3618;;B23K35/3618;;B23K35/362;;B23K35/362;;B23K2101/42;;B23K2101/42;;C07C211/36;;H05K3/3489;;H05K3/3489,B23K35/363;;C07C211/36;;C07C215/06;;H05K3/34,,0,0,,,,INACTIVE
638,KR,A,KR 20130035948 A,089-000-337-088-554,2013-04-09,2013,KR 20120108726 A,2012-09-28,US 201113250007 A,2011-09-30,FLUX COMPOSITION AND METHOD OF SOLDERING,"PURPOSE: A flux composite and a soldering method are provided to constitute the flux to obtain compatibility with various under fill composites so that cleaning a soldering surface is not necessary before applying the under fill composites for forming a final electric connector. CONSTITUTION: A flux composite comprises a carboxylic acid and an amine fluxing agent as initial components. A soldering method is as follows; supplying the flux composite with an electric contact, applying the flux composition to the electric contact, supplying solder, and displacing the flux composite supplied to the electric contact with molten solder. The molten solder is in physical contact with the electric contact and joined to the electric contact.",ROHM & HAAS ELECT MAT,KIM SANG HO;;MICHAEL K GALLAGHER;;AVIN V DHOBLE;;MARK R WINKLE;;XIANG QIAN LIU;;DAVID D FLEMING,,https://lens.org/089-000-337-088-554,Patent Application,no,3,0,13,13,0,B23K1/203;;B23K1/203;;B23K35/362;;B23K1/0016;;B23K1/0016;;B23K1/008;;B23K1/008;;B23K35/0244;;B23K35/0244;;B23K35/26;;B23K35/26;;B23K35/34;;B23K35/34;;B23K35/3601;;B23K35/3601;;B23K35/362;;B23K35/362;;B23K2101/42;;B23K2101/42;;C07C217/52;;H05K3/3489;;H05K3/3489,B23K35/362;;C07C217/52,,0,0,,,,ACTIVE
639,WO,A1,WO 2002/029485 A1,150-470-310-867-888,2002-04-11,2002,US 0104184 W,2001-02-09,US 67819100 A,2000-10-04,ELECTRICALLY/MAGNETICALLY RESPONSIVE PARTICLE ASSEMBLY AND METHODS FOR MANUFACTURE THEREOF,"Assemblies containing a substrate with pockets for electromagnetically responsive particles can be made for a variety of uses, including, for example, display media, lenses, and color-changing fabric. The arrangement of these pockets can be selected to provide higher particle density than previously realized. The assembly includes an assembly substrate (840), particles, and a top coat layer (848).",3M INNOVATIVE PROPERTIES CO,BASTIAENS WILLEM V;;BIERNATH ROLF W;;DOLAN MARK P;;ENGLE LORI P;;FLEMING PATRICK K;;WOLF ROBERT J,,https://lens.org/150-470-310-867-888,Patent Application,yes,3,12,11,11,0,G02B26/026;;G02F1/167;;G09F9/372;;G09F9/375;;Y10T428/25;;Y10T428/259;;B33Y80/00;;G02F1/167;;Y10T428/25;;Y10T428/259;;B33Y80/00;;G09F9/375;;G02B26/026;;G09F9/372;;G02F1/167,G02B26/02;;G02F1/167;;G09F9/37,,1,0,,,"PATENT ABSTRACTS OF JAPAN vol. 017, no. 372 (P - 1573) 13 July 1993 (1993-07-13)",PATENTED
640,US,A2,US 2022/0107941 A2,029-713-564-188-09X,2022-04-07,2022,US 202016830465 A,2020-03-26,US 201962823995 P;;US 202016830465 A,2019-03-26,SYSTEM ANDMETHODS FORSTRUCTURALDATA ANALYSIS,"Systems and methods for viewing, tracking, and analyzing data structure. Particularly, systems and methods for recognizing and grouping structural components of data into data shapes for viewing, tracking, and analyzing the data structure irrespective of the data content. An example method of analyzing data may include receiving document data comprising a plurality of data fields and defining a data shape from the document data, the data shape having one or more of the plurality of data fields. The data shape is defined agnostic to data content. The data shape may further include a qualifier associated with a data field. The data shape may be a first data shape, and the method may further include defining a second data shape from the document data, the second data shape having one or more of the plurality of data fields. The second shape may comprise the first data shape and an additional element.",SPS COMMERCE INC,ZIELIEKE LAMOINE;;HENNING JEREMY;;ARTHUR ANTHONY;;MOSES DOUGLAS;;FLEMING CORY;;GRANRUD LARS;;PETERSON MATTHEW CHARLES;;DYMOND MARK WILLIAM,SPS COMMERCE INC (2020-04-17),https://lens.org/029-713-564-188-09X,Amended Application,yes,0,0,3,3,0,G06Q10/10;;G06F16/93;;G06V30/414;;G06V30/1456;;G06F16/245;;G06Q10/10;;G06F16/2379;;G06Q10/0875;;G06F16/5854;;G06V30/414;;G06V30/1456,G06F16/245;;G06F16/23;;G06K9/00;;G06Q10/10,,0,0,,,,DISCONTINUED
641,AU,A,AU 2001/036813 A,061-699-068-504-593,2002-04-15,2002,AU 2001/036813 A,2001-02-09,US 67819100 A;;US 0104184 W,2000-10-04,Electrically/magnetically responsive particle assembly and methods for manufacture thereof,"Assemblies containing a substrate with pockets for electromagnetically responsive particles can be made for a variety of uses, including, for example, display media, lenses, and color-changing fabric. The arrangement of these pockets can be selected to provide higher particle density than previously realized. The assembly includes an assembly substrate, particles, and a top coat layer.",3M INNOVATIVE PROPERTIES CO,BASTIAENS WILLEM V;;BIERNATH ROLF W;;DOLAN MARK P;;ENGLE LORI P;;FLEMING PATRICK K;;WOLF ROBERT J,,https://lens.org/061-699-068-504-593,Patent Application,no,0,0,11,11,0,G02B26/026;;G02F1/167;;G09F9/372;;G09F9/375;;Y10T428/25;;Y10T428/259;;B33Y80/00;;G02F1/167;;Y10T428/25;;Y10T428/259;;B33Y80/00;;G09F9/375;;G02B26/026;;G09F9/372;;G02F1/167,G02B26/02;;G02F1/167;;G09F9/37,,0,0,,,,PENDING
642,US,B2,US 9426221 B2,105-599-769-713-837,2016-08-23,2016,US 201414307802 A,2014-06-18,US 201414307802 A,2014-06-18,Dynamic proximity based networked storage,"A computer implemented method of storing data in at least one mobile node according to mobile node location may include identifying a first qualified mobile node and determining a first geographic position of the first qualified mobile node. The method may include determining a user geographic position of a user device, determining whether the first geographic position is within a first proximity relative to the user device, and causing storage of a first data portion in the first qualified mobile node in response to determining that the first geographic position is within the first proximity.",IBM,FLEMING MARK S;;MCNEAL STEVEN E;;WEI ZHI QIANG;;WINDSOR GREGORY C;;XU JIN YU;;ZHU ZHE YI,INTERNATIONAL BUSINESS MACHINES CORPORATION (2014-06-09),https://lens.org/105-599-769-713-837,Granted Patent,yes,8,1,4,4,0,H04L67/1097;;H04L67/52;;H04L67/1097;;H04L67/52;;G06F12/1408;;G06F2212/1052;;G06F2212/154;;G06F2212/402,G06F15/167;;H04L29/08,,2,1,144-812-883-054-155,10.1145/1810931.1810932,"Stuedi et al., ""WhereStore: Location-based Data Storage for Mobile Devices Interacting with the Cloud"", MCS '10: Proceedings of the 1st ACM Workshop on Mobile Cloud Computing & Services: Social Networks and Beyond, Jun. 2010, pp. 1-8, San Francisco, CA, USA.;;Mell et al., ""The NIST Definition of Cloud Computing"", Recommendations of the National Institute of Standards and Technology, NIST Special Publication 800-145, Sep. 2011, 7 pages, US Department of Commerce, Gaithersburg, MD.",INACTIVE
643,US,A1,US 2016/0337452 A1,108-928-872-920-010,2016-11-17,2016,US 201615219575 A,2016-07-26,US 201615219575 A;;US 201414307802 A,2014-06-18,DYNAMIC PROXIMITY BASED NETWORKED STORAGE,"A computer implemented method of storing data in at least one mobile node according to mobile node location may include identifying a first qualified mobile node and determining a first geographic position of the first qualified mobile node. The method may include determining a user geographic position of a user device, determining whether the first geographic position is within a first proximity relative to the user device, and causing storage of a first data portion in the first qualified mobile node in response to determining that the first geographic position is within the first proximity.",IBM,FLEMING MARK S;;MCNEAL STEVEN E;;WEI ZHI QIANG;;WINDSOR GREGORY C;;XU JIN YU;;ZHU ZHE YI,INTERNATIONAL BUSINESS MACHINES CORPORATION (2014-06-09),https://lens.org/108-928-872-920-010,Patent Application,yes,0,0,4,4,0,H04L67/1097;;H04L67/52;;H04L67/1097;;H04L67/52;;G06F12/1408;;G06F2212/1052;;G06F2212/154;;G06F2212/402,H04L29/08;;G06F12/14,,0,0,,,,INACTIVE
644,US,B1,US 6462859 B1,142-088-232-700-160,2002-10-08,2002,US 67819100 A,2000-10-04,US 67819100 A,2000-10-04,Electromagnetically responsive particle assembly and methods and articles for manufacture and use,"
    Assemblies containing a substrate with pockets for electromagnetically responsive particles can be made for a variety of uses, including, for example, display media, lenses, and color-changing fabric. The arrangement of these pockets can be selected to provide higher particle density than previously realized. The assembly includes an assembly substrate, particles, and a top coat layer. 
",3M INNOVATIVE PROPERTIES CO,BASTIAENS WILLEM V;;BIERNATH ROLF W;;DOLAN MARK P;;ENGLE LORI P;;FLEMING PATRICK R;;WOLF ROBERT J,3M INNOVATIVE PROPERTIES COMPANY (2001-01-18),https://lens.org/142-088-232-700-160,Granted Patent,yes,21,61,11,11,0,G02B26/026;;G02F1/167;;G09F9/372;;G09F9/375;;Y10T428/25;;Y10T428/259;;B33Y80/00;;G02F1/167;;Y10T428/25;;Y10T428/259;;B33Y80/00;;G09F9/375;;G02B26/026;;G09F9/372;;G02F1/167,G02B26/02;;G02F1/167;;G09F9/37,359/296;;359/298;;345/107;;428/323;;428/331,1,1,117-310-462-952-388,10.1021/la00009a012,"Micheletto, R. et al., ""A Simple Method for the Production of a Two-Dimensional, Ordered Array of Small Latex Particles"", Langmuir, vol. 11, No. 9, pp. 3333-3336 (Sep. 1995).",EXPIRED
645,AU,B2,AU 767621 B2,161-126-760-019-09X,2003-11-20,2003,AU 2000/061408 A,2000-08-02,AU 2000/061408 A;;AU PQ320799 A;;AU 1919/000009 W,1999-09-30,Single mode optical waveguide fibre,,UNIV SYDNEY;;UNIV AUSTRALIAN;;AUSTRALIAN PHOTONICS PTY LTD;;KOREA TELECOM RES AND DEV GROU,LOVE JOHN;;BAILEY RONALD;;FLEMING SIMON;;SCEATS MARK;;THORNCRAFT DAVID;;KRUG PETER;;POLADIAN LEON;;LARGE MICHAEL;;RYAN THOMAS,,https://lens.org/161-126-760-019-09X,Granted Patent,no,3,0,2,6,0,,,,0,0,,,,EXPIRED
646,WO,A3,WO 2008/010923 A3,111-711-036-591-320,2008-03-06,2008,US 2007/0015617 W,2007-07-09,US 48984506 A,2006-07-20,METHOD FOR REMOVING ASPHALTENE DEPOSITS,"Compositions comprising at least one C 4 -Q 30 olefin or oxidation product thereof and kerosene or an aromatic solvent are particularly effective for use in removing asphaltene and asph.altene-containing organic deposits and in preventing or reducing the precipitation and deposition of asphaltenes from hydrocarbon fluids. When added to heavy oils comprising asphaltenes, alone or in combination with dispersants and further inhibitors, the invented compositions lower viscosity and pour point, and aid in preventing asphaltene precipitation during transport and in combustion...",INEOS USA LLC,TRIMBLE MARVIN I;;FLEMING MARK A;;ANDREW BLAIR L;;TOMUSIAK GREG A;;DIGIACINTO PETER M;;HEYMANS LUC M,,https://lens.org/111-711-036-591-320,Search Report,yes,2,0,5,5,0,C09K8/524;;C10G75/00;;C09K8/524;;C10G75/00,E21B37/00;;E21B37/06,,0,0,,,,PENDING
647,TW,B,TW I473850 B,145-457-051-921-554,2015-02-21,2015,TW 101135055 A,2012-09-25,US 201113250297 A,2011-09-30,Curable flux composition and method of soldering,,ROHM & HAAS ELECT MAT,GALLAGHER MICHAEL K;;HO KIM SANG;;DHOBLE AVIN V;;WINKLE MARK R;;LIU XIANG-QIAN;;FLEMING DAVID D,,https://lens.org/145-457-051-921-554,Granted Patent,no,2,0,13,13,0,B23K1/0016;;B23K1/0016;;B23K35/362;;B23K1/203;;B23K1/203;;C07C211/36;;C08K5/09;;C08K5/09;;C08K5/17;;C08K5/17;;H01L24/11;;H01L24/11;;H01L24/13;;H01L24/13;;H01L24/16;;H01L24/16;;H01L24/27;;H01L24/27;;H01L24/29;;H01L24/29;;H01L24/32;;H01L24/32;;H01L24/81;;H01L24/81;;H01L24/83;;H01L24/83;;H01L24/92;;H01L24/92;;H01L2224/11334;;H01L2224/11334;;H01L2224/131;;H01L2224/131;;H01L2224/13111;;H01L2224/13111;;H01L2224/16225;;H01L2224/16225;;H01L2224/16227;;H01L2224/16227;;H01L2224/2732;;H01L2224/2732;;H01L2224/2741;;H01L2224/2741;;H01L2224/27418;;H01L2224/27418;;H01L2224/27422;;H01L2224/27422;;H01L2224/2929;;H01L2224/2929;;H01L2224/29294;;H01L2224/29294;;H01L2224/29311;;H01L2224/29311;;H01L2224/29387;;H01L2224/29387;;H01L2224/2939;;H01L2224/2939;;H01L2224/32225;;H01L2224/32225;;H01L2224/73204;;H01L2224/73204;;H01L2224/81011;;H01L2224/81011;;H01L2224/81024;;H01L2224/81024;;H01L2224/81143;;H01L2224/81143;;H01L2224/81191;;H01L2224/81191;;H01L2224/81192;;H01L2224/81192;;H01L2224/81815;;H01L2224/81815;;H01L2224/83192;;H01L2224/83192;;H01L2224/83862;;H01L2224/83862;;H01L2224/9211;;H01L2224/9211;;H05K3/3436;;H05K3/3436;;H05K3/3489;;H05K3/3489;;H05K2201/10674;;H05K2201/10674;;H05K2201/10977;;H05K2201/10977,,,0,0,,,,INACTIVE
648,JP,A,JP 2013078799 A,179-832-832-387-230,2013-05-02,2013,JP 2012210451 A,2012-09-25,US 201113250007 A,2011-09-30,FLUX COMPOSITION AND SOLDERING METHOD,"PROBLEM TO BE SOLVED: To provide a flux composition which is non-hardenable, easy mixable with conventional epoxy-based underfill material.SOLUTION: The flux composition includes, as initial components, carboxylic acid and a fluxing agent represented by formula I (wherein R, R, Rand Rare independently selected from hydrogen, a substituted 1-80C alkyl group, an unsubstituted 1-80C alkyl group, a substituted 7-80C arylalkyl group and an unsubstituted 7-80C arylalkyl group; and wherein zero to three of R, R, Rand Rare hydrogen).",ROHM & HAAS ELECT MAT,KIM S HO;;GALLAGHER MICHAEL K;;DHOBLE AVIN V;;MARK R WINKLE;;LIU XIANG-QIAN;;FLEMING DAVID D,,https://lens.org/179-832-832-387-230,Patent Application,no,8,4,13,13,0,B23K1/203;;B23K1/203;;B23K35/362;;B23K1/0016;;B23K1/0016;;B23K1/008;;B23K1/008;;B23K35/0244;;B23K35/0244;;B23K35/26;;B23K35/26;;B23K35/34;;B23K35/34;;B23K35/3601;;B23K35/3601;;B23K35/362;;B23K35/362;;B23K2101/42;;B23K2101/42;;C07C217/52;;H05K3/3489;;H05K3/3489,B23K35/363;;B23K1/00;;B23K3/00;;B23K35/22;;B23K35/26;;B23K101/42;;C22C12/00;;C22C13/00;;H05K3/34,,0,0,,,,INACTIVE
649,TW,A,TW 201319020 A,039-072-443-622-270,2013-05-16,2013,TW 101135054 A,2012-09-25,US 201113250226 A,2011-09-30,"Polyamine, carboxylic acid flux composition and method of soldering","A flux composition is provided, comprising, as initial components: a carboxylic acid; and, a polyamine fluxing agent represented by formula I: with the proviso that when the polyamine fluxing agent represented by formula I is according to formula Ia: then zero to three of R1, R2, R3 and R4 is(are) a hydrogen. Also provided is a method of soldering an electrical contact using the flux composition.",ROHM & HAAS ELECT MAT,WINKLE MARK R;;DHOBLE AVIN V;;HO KIM S;;GALLAGHER MICHAEL K;;LIU XIANG-QIAN;;FLEMING DAVID D,,https://lens.org/039-072-443-622-270,Patent of Addition,no,0,0,12,12,0,B23K35/362;;B23K1/0016;;B23K1/0016;;B23K1/008;;B23K1/008;;B23K1/203;;B23K1/203;;B23K35/3601;;B23K35/3601;;B23K35/3618;;B23K35/3618;;B23K35/362;;B23K35/362;;B23K2101/42;;B23K2101/42;;C07C211/36;;H05K3/3489;;H05K3/3489,C07C211/36;;B23K35/362;;C07C53/126;;C07C57/04;;H05K3/34,,0,0,,,,INACTIVE
650,US,B2,US 9712620 B2,082-676-579-126-31X,2017-07-18,2017,US 201615219575 A,2016-07-26,US 201615219575 A;;US 201414307802 A,2014-06-18,Dynamic proximity based networked storage,"A computer implemented method of storing data in at least one mobile node according to mobile node location may include identifying a first qualified mobile node and determining a first geographic position of the first qualified mobile node. The method may include determining a user geographic position of a user device, determining whether the first geographic position is within a first proximity relative to the user device, and causing storage of a first data portion in the first qualified mobile node in response to determining that the first geographic position is within the first proximity.",IBM,FLEMING MARK S;;MCNEAL STEVEN E;;WEI ZHI QIANG;;WINDSOR GREGORY C;;XU JIN YU;;ZHU ZHE YI,INTERNATIONAL BUSINESS MACHINES CORPORATION (2014-06-09),https://lens.org/082-676-579-126-31X,Granted Patent,yes,9,2,4,4,0,H04L67/1097;;H04L67/52;;H04L67/1097;;H04L67/52;;G06F12/1408;;G06F2212/1052;;G06F2212/154;;G06F2212/402,G06F15/167;;G06F12/14;;H04L29/08,,3,1,144-812-883-054-155,10.1145/1810931.1810932,"Stuedi et al., “WhereStore: Location-based Data Storage for Mobile Devices Interacting with the Cloud”, MCS '10: Proceedings of the 1st ACM Workshop on Mobile Cloud Computing & Services: Social Networks and Beyond, Jun. 2010, pp. 1-8, San Francisco, CA, USA.;;Mell et al., “The NIST Definition of Cloud Computing”, Recommendations of the National Institute of Standards and Technology, NIST Special Publication 800-145, Sep. 2011, 7 pages, US Department of Commerce, Gaithersburg, MD.;;List of IBM Patents or Patent Applications Treated as Related, dated Jul. 21, 2016, pp. 1-2.",INACTIVE
651,DE,A1,DE 102012019197 A1,009-991-866-627-494,2013-04-04,2013,DE 102012019197 A,2012-09-28,US 201113250007 A,2011-09-30,Flussmittelzusammensetzung und Lötverfahren,"Es wird eine Flussmittelzusammensetzung bereitgestellt, die als Ausgangskomponente: eine Carbonsäure und ein Flussmittel, dargestellt durch die Formel I:worin R1, R2, R3 und R4 unabhängig ausgewählt sind aus einem Wasserstoff, einer substituierten C1-80-Alkylgruppe, einer unsubstituierten C1-80-Alkylgruppe, einer substituierten C7-80-Arylalkylgruppe und einer unsubstituierten C7-80-Arylalkylgruppe; und wobei null bis drei von R1, R2, R3 und R4 Wasserstoff sind, umfasst. Ebenso wird ein Verfahren zum Löten eines elektrischen Kontaktes unter Verwendung der Flussmittelzusammensetzung bereitgestellt.",ROHM & HAAS ELECT MAT,HO KIM S;;GALLAGHER MICHAEL K;;DHOBLE AVIN V;;WINKLE MARK R;;LIU XIANG-QIAN;;FLEMING DAVID D,,https://lens.org/009-991-866-627-494,Patent Application,no,0,0,13,13,0,B23K1/203;;B23K1/203;;B23K35/362;;B23K1/0016;;B23K1/0016;;B23K1/008;;B23K1/008;;B23K35/0244;;B23K35/0244;;B23K35/26;;B23K35/26;;B23K35/34;;B23K35/34;;B23K35/3601;;B23K35/3601;;B23K35/362;;B23K35/362;;B23K2101/42;;B23K2101/42;;C07C217/52;;H05K3/3489;;H05K3/3489,B23K35/34;;B23K35/363,,0,0,,,,DISCONTINUED
652,WO,A2,WO 2008/010923 A2,139-931-613-381-27X,2008-01-24,2008,US 2007/0015617 W,2007-07-09,US 48984506 A,2006-07-20,METHOD FOR REMOVING ASPHALTENE DEPOSITS,"Compositions comprising at least one C 4 -Q 30 olefin or oxidation product thereof and kerosene or an aromatic solvent are particularly effective for use in removing asphaltene and asph.altene-containing organic deposits and in preventing or reducing the precipitation and deposition of asphaltenes from hydrocarbon fluids. When added to heavy oils comprising asphaltenes, alone or in combination with dispersants and further inhibitors, the invented compositions lower viscosity and pour point, and aid in preventing asphaltene precipitation during transport and in combustion...",INEOS USA LLC,TRIMBLE MARVIN I;;FLEMING MARK A;;ANDREW BLAIR L;;TOMUSIAK GREG A;;DIGIACINTO PETER M;;HEYMANS LUC M,,https://lens.org/139-931-613-381-27X,Patent Application,yes,0,0,5,5,0,C09K8/524;;C10G75/00;;C09K8/524;;C10G75/00,C09K8/68,,0,0,,,,PENDING
653,US,B2,US 7754657 B2,034-977-091-971-307,2010-07-13,2010,US 48984506 A,2006-07-20,US 48984506 A,2006-07-20,Method for removing asphaltene deposits,"Compositions comprising at least one C 4 -C 30 olefin or oxidation product thereof and kerosene or an aromatic solvent are particularly effective for use in removing asphaltene and asphaltene-containing organic deposits and in preventing or reducing the precipitation and deposition of asphaltenes from hydrocarbon fluids. When added to heavy oils comprising asphaltenes, alone or in combination with dispersants and further inhibitors, the invented compositions lower viscosity and pour point, and aid in preventing asphaltene precipitation during transport and in combustion.",INEOS USA LLC,TRIMBLE MARVIN I;;FLEMING MARK A;;ANDREW BLAIR L;;TOMUSIAK GREG A;;DIGIACINTO PETER M;;HEYMANS LUC M,INEOS USA LLC (2006-08-02),https://lens.org/034-977-091-971-307,Granted Patent,yes,6,17,5,5,0,C09K8/524;;C10G75/00;;C09K8/524;;C10G75/00,C09K8/32;;C09K8/04;;C09K8/64;;C09K8/68,507/118;;507/203;;507/126;;507/232,0,0,,,,INACTIVE
654,US,A1,US 2001/0019452 A1,053-389-906-496-630,2001-09-06,2001,US 83416401 A,2001-04-12,US 83416401 A;;US 42576599 A,1999-10-22,Display apparatus with corrosion-resistant light directing film,"
   The present invention is a display apparatus that provides protection against damage for a metallic layer. The display apparatus includes a light modulating layer, a polarizer, and a light directing film. The light directing film includes a prismatic structure having two sides, where one side includes saw tooth formations having tilted surfaces and a metal layer on the side of the prismatic substrate having the saw-tooth formations. A tilt angle of the tilted surfaces offsets an optimal viewing angle for the display from a glare angle for the display. In a first embodiment of the invention, the light directing film of the display apparatus further includes an inorganic protective layer formed on the metal layer, wherein the inorganic protective layer inhibits molecular transfer to the metal layer and balances the color of reflected and transmitted light. The light directing film further includes a pressure sensitive adhesive layer between a polarizer and the inorganic protective layer. Alternatively, the light directing film of the display apparatus of the present invention includes a polymer protective layer formed over the metal layer to protect the metal layer from damage. The light directing film also includes a diffuse adhesive layer formed over the polymer layer, attached to the polarizer. The polymer protective layer protects the metal layer from the adhesive layer. The display apparatus may include both the inorganic protective layer and the polymer protective layer, in one embodiment. 
",3M INNOVATIVE PROPERTIES CO,EPSTEIN KENNETH A;;FLEMING ROBERT J;;GARDNER TIMOTHY J;;LYONS CHRISTOPHER S;;MAKI STEPHEN P;;NACHBOR MARK D,,https://lens.org/053-389-906-496-630,Patent Application,yes,0,8,13,13,0,G02F1/133345;;G02F1/133504;;G02F1/133553;;G02F2202/022;;G02F1/1335;;G02F1/133553;;G02F1/133504;;G02F2202/022;;G02F1/133345,G02B5/04;;G02F1/1333;;G02F1/1335;;G02F1/13357;;G09F9/00;;G02B5/02,359/606;;359/614;;359/615;;359/483;;359/831,0,0,,,,EXPIRED
655,EP,A1,EP 1222493 A1,062-961-275-525-271,2002-07-17,2002,EP 00910235 A,2000-02-18,US 0004233 W;;US 42576599 A,1999-10-22,DISPLAY APPARATUS WITH CORROSION-RESISTANT LIGHT DIRECTING FILM,,3M INNOVATIVE PROPERTIES CO,EPSTEIN KENNETH A;;FLEMING ROBERT J;;GARDNER TIMOTHY J;;LYONS CHRISTOPHER S;;MAKI STEPHEN P;;NACHBOR MARK D,,https://lens.org/062-961-275-525-271,Patent Application,yes,0,0,13,13,0,G02F1/133345;;G02F1/133504;;G02F1/133553;;G02F2202/022;;G02F1/1335;;G02F1/133553;;G02F1/133504;;G02F2202/022;;G02F1/133345,G02B5/02;;G02B5/04;;G02F1/1333;;G02F1/1335;;G02F1/13357;;G09F9/00,,0,0,,,,DISCONTINUED
656,US,A1,US 2008/0020949 A1,171-245-904-353-13X,2008-01-24,2008,US 48984506 A,2006-07-20,US 48984506 A,2006-07-20,Method for removing asphaltene deposits,"Compositions comprising at least one C 4 -C 30 olefin or oxidation product thereof and kerosene or an aromatic solvent are particularly effective for use in removing asphaltene and asphaltene-containing organic deposits and in preventing or reducing the precipitation and deposition of asphaltenes from hydrocarbon fluids. When added to heavy oils comprising asphaltenes, alone or in combination with dispersants and further inhibitors, the invented compositions lower viscosity and pour point, and aid in preventing asphaltene precipitation during transport and in combustion.",TRIMBLE MARVIN I;;FLEMING MARK A;;ANDREW BLAIR L;;TOMUSIAK GREG A;;DIGIACINTO PETER M;;HEYMANS LUC M,TRIMBLE MARVIN I;;FLEMING MARK A;;ANDREW BLAIR L;;TOMUSIAK GREG A;;DIGIACINTO PETER M;;HEYMANS LUC M,INEOS USA LLC (2006-08-02),https://lens.org/171-245-904-353-13X,Patent Application,yes,6,32,5,5,0,C09K8/524;;C10G75/00;;C09K8/524;;C10G75/00,C09K8/68,507/203;;134/40;;208/44,0,0,,,,INACTIVE
657,AU,A,AU 2000/061408 A,090-317-393-877-292,2001-04-30,2001,AU 2000/061408 A,2000-08-02,AU 2000/061408 A;;AU PQ320799 A;;AU 1919/000009 W,1999-09-30,Single mode optical waveguide fibre,,AUSTRALIAN NATIONAL UNIVERSITY THE;;AUSTRALIAN PHOTONICS PTY LTD;;KOREA TELECOM RES AND DEVELOPMENT GROUP;;UNIVERSITY OF SYDNEY THE,LOVE JOHN;;BAILEY RONALD;;FLEMING SIMON;;SCEATS MARK;;THORNCRAFT DAVID;;KRUG PETER;;POLADIAN LEON;;LARGE MICHAEL;;RYAN THOMAS,,https://lens.org/090-317-393-877-292,Patent Application,no,0,0,2,6,0,,,,0,0,,,,EXPIRED
658,US,A9,US 2022/0215016 A9,111-415-333-230-541,2022-07-07,2022,US 202016830465 A,2020-03-26,US 201962823995 P;;US 202016830465 A,2019-03-26,SYSTEMS AND METHODS FOR STRUCTURAL DATA ANALYSIS,"Systems and methods for viewing, tracking, and analyzing data structure. Particularly, systems and methods for recognizing and grouping structural components of data into data shapes for viewing, tracking, and analyzing the data structure irrespective of the data content. An example method of analyzing data may include receiving document data comprising a plurality of data fields and defining a data shape from the document data, the data shape having one or more of the plurality of data fields. The data shape is defined agnostic to data content. The data shape may further include a qualifier associated with a data field. The data shape may be a first data shape, and the method may further include defining a second data shape from the document data, the second data shape having one or more of the plurality of data fields. The second shape may comprise the first data shape and an additional element.",SPS COMMERCE INC,ZIELIEKE LAMOINE;;HENNING JEREMY;;ARTHUR ANTHONY;;MOSES DOUGLAS;;FLEMING CORY;;GRANRUD LARS;;PETERSON MATTHEW CHARLES;;DYMOND MARK WILLIAM,SPS COMMERCE INC (2020-04-17),https://lens.org/111-415-333-230-541,Amended Application,yes,2,0,3,3,0,G06Q10/10;;G06F16/93;;G06V30/414;;G06V30/1456;;G06F16/245;;G06Q10/10;;G06F16/2379;;G06Q10/0875;;G06F16/5854;;G06V30/414;;G06V30/1456,G06F16/245;;G06F16/23;;G06K9/00;;G06Q10/10,,0,0,,,,DISCONTINUED
659,FR,B1,FR 2980728 B1,156-410-083-336-414,2014-11-28,2014,FR 1259148 A,2012-09-28,US 201113250007 A,2011-09-30,COMPOSITION DE FONDANT ET PROCEDE DE SOUDAGE,,ROHM & HAAS ELECT MAT,HO KIM SANG;;GALLAGHER MICHAEL K;;DHOBLE AVIN V;;WINKLE MARK R;;LIU XIANG-QIAN;;FLEMING DAVID D,,https://lens.org/156-410-083-336-414,Granted Patent,no,0,0,13,13,0,B23K1/203;;B23K1/203;;B23K35/362;;B23K1/0016;;B23K1/0016;;B23K1/008;;B23K1/008;;B23K35/0244;;B23K35/0244;;B23K35/26;;B23K35/26;;B23K35/34;;B23K35/34;;B23K35/3601;;B23K35/3601;;B23K35/362;;B23K35/362;;B23K2101/42;;B23K2101/42;;C07C217/52;;H05K3/3489;;H05K3/3489,B23K35/363;;C07C211/36;;H05K3/34,,0,0,,,,INACTIVE
660,US,A1,US 2015/0373108 A1,183-058-894-924-42X,2015-12-24,2015,US 201414307802 A,2014-06-18,US 201414307802 A,2014-06-18,DYNAMIC PROXIMITY BASED NETWORKED STORAGE,"A computer implemented method of storing data in at least one mobile node according to mobile node location may include identifying a first qualified mobile node and determining a first geographic position of the first qualified mobile node. The method may include determining a user geographic position of a user device, determining whether the first geographic position is within a first proximity relative to the user device, and causing storage of a first data portion in the first qualified mobile node in response to determining that the first geographic position is within the first proximity.",IBM,FLEMING MARK S;;MCNEAL STEVEN E;;WEI ZHI QIANG;;WINDSOR GREGORY C;;XU JIN YU;;ZHU ZHE YI,INTERNATIONAL BUSINESS MACHINES CORPORATION (2014-06-09),https://lens.org/183-058-894-924-42X,Patent Application,yes,2,84,4,4,0,H04L67/1097;;H04L67/52;;H04L67/1097;;H04L67/52;;G06F12/1408;;G06F2212/1052;;G06F2212/154;;G06F2212/402,H04L29/08;;G06F15/167,,0,0,,,,INACTIVE
661,DE,T2,DE 60132007 T2,072-519-527-889-196,2009-01-15,2009,DE 60132007 T,2001-02-09,US 67819100 A;;US 0104184 W,2000-10-04,ELEKTRISCH/MAGNETISCH GESTEUERTE PARTIKELANORDNUNG,"Assemblies containing a substrate with pockets for electromagnetically responsive particles can be made for a variety of uses, including, for example, display media, lenses, and color-changing fabric. The arrangement of these pockets can be selected to provide higher particle density than previously realized. The assembly includes an assembly substrate, particles, and a top coat layer.",3M INNOVATIVE PROPERTIES CO,BASTIAENS WILLEM V;;BIERNATH ROLF W;;DOLAN MARK P;;ENGLE LORI P;;FLEMING PATRICK K;;WOLF ROBERT J,,https://lens.org/072-519-527-889-196,Granted Patent,no,0,0,11,11,0,G02B26/026;;G02F1/167;;G09F9/372;;G09F9/375;;Y10T428/25;;Y10T428/259;;B33Y80/00;;G02F1/167;;Y10T428/25;;Y10T428/259;;B33Y80/00;;G09F9/375;;G02B26/026;;G09F9/372;;G02F1/167,G02B26/02;;G02F1/167;;G09F9/37,,0,0,,,,EXPIRED
662,JP,A,JP 2013079377 A,065-423-435-888-823,2013-05-02,2013,JP 2012210464 A,2012-09-25,US 201113250297 A,2011-09-30,CURABLE FLUX COMPOSITION AND METHOD OF SOLDERING,"PROBLEM TO BE SOLVED: To provide a no-flow underfill material which allows easy production of reliable and soldered and sealed interconnection in electric parts.SOLUTION: A curable flux composition is provided, which includes, as initial components: a resin component having at least two oxirane groups per molecule; a carboxylic acid; a fluxing agent represented by formula (I) ; and optionally, a curing agent. In formula, R, R, Rand Rare each independently selected from hydrogen etc., and zero to three of R, R, Rand Ris (are) hydrogen. A method of soldering an electrical contact using the curable flux composition is also provided.",ROHM & HAAS ELECT MAT,GALLAGHER MICHAEL K;;KIM S HO;;DHOBLE AVIN V;;MARK R WINKLE;;LIU XIANG-QIAN;;FLEMING DAVID D,,https://lens.org/065-423-435-888-823,Patent Application,no,9,3,13,13,0,B23K1/0016;;B23K1/0016;;B23K35/362;;B23K1/203;;B23K1/203;;C07C211/36;;C08K5/09;;C08K5/09;;C08K5/17;;C08K5/17;;H01L24/11;;H01L24/11;;H01L24/13;;H01L24/13;;H01L24/16;;H01L24/16;;H01L24/27;;H01L24/27;;H01L24/29;;H01L24/29;;H01L24/32;;H01L24/32;;H01L24/81;;H01L24/81;;H01L24/83;;H01L24/83;;H01L24/92;;H01L24/92;;H01L2224/11334;;H01L2224/11334;;H01L2224/131;;H01L2224/131;;H01L2224/13111;;H01L2224/13111;;H01L2224/16225;;H01L2224/16225;;H01L2224/16227;;H01L2224/16227;;H01L2224/2732;;H01L2224/2732;;H01L2224/2741;;H01L2224/2741;;H01L2224/27418;;H01L2224/27418;;H01L2224/27422;;H01L2224/27422;;H01L2224/2929;;H01L2224/2929;;H01L2224/29294;;H01L2224/29294;;H01L2224/29311;;H01L2224/29311;;H01L2224/29387;;H01L2224/29387;;H01L2224/2939;;H01L2224/2939;;H01L2224/32225;;H01L2224/32225;;H01L2224/73204;;H01L2224/73204;;H01L2224/81011;;H01L2224/81011;;H01L2224/81024;;H01L2224/81024;;H01L2224/81143;;H01L2224/81143;;H01L2224/81191;;H01L2224/81191;;H01L2224/81192;;H01L2224/81192;;H01L2224/81815;;H01L2224/81815;;H01L2224/83192;;H01L2224/83192;;H01L2224/83862;;H01L2224/83862;;H01L2224/9211;;H01L2224/9211;;H05K3/3436;;H05K3/3436;;H05K3/3489;;H05K3/3489;;H05K2201/10674;;H05K2201/10674;;H05K2201/10977;;H05K2201/10977,C08L63/00;;C08K5/09;;C08K5/17,,0,0,,,,INACTIVE
663,AT,T1,AT E381724 T1,099-185-314-284-946,2008-01-15,2008,AT 01909016 T,2001-02-09,US 67819100 A,2000-10-04,ELEKTRISCH/MAGNETISCH GESTEUERTE PARTIKELANORDNUNG,"Assemblies containing a substrate with pockets for electromagnetically responsive particles can be made for a variety of uses, including, for example, display media, lenses, and color-changing fabric. The arrangement of these pockets can be selected to provide higher particle density than previously realized. The assembly includes an assembly substrate, particles, and a top coat layer.",3M INNOVATIVE PROPERTIES CO,BASTIAENS WILLEM V;;BIERNATH ROLF W;;DOLAN MARK P;;ENGLE LORI P;;FLEMING PATRICK K;;WOLF ROBERT J,,https://lens.org/099-185-314-284-946,Granted Patent,no,0,0,11,11,0,G02B26/026;;G02F1/167;;G09F9/372;;G09F9/375;;Y10T428/25;;Y10T428/259;;B33Y80/00;;G02F1/167;;Y10T428/25;;Y10T428/259;;B33Y80/00;;G09F9/375;;G02B26/026;;G09F9/372;;G02F1/167,G02B26/02;;G09F9/37,,0,0,,,,EXPIRED
664,EP,A1,EP 1700142 A1,119-876-751-410-492,2006-09-13,2006,EP 04815604 A,2004-12-28,US 2004/0043549 W;;US 53396203 P,2003-12-30,COLOR SHIFTING RETROREFLECTOR AND METHOD OF MAKING SAME,,3M INNOVATIVE PROPERTIES CO,FLEMING ROBERT J;;LYONS CHRISTOPHER S;;MCGRATH JOSEPH M;;RAMOS JESUS R;;ROEHRIG MARK A;;BRIGHT CLARK I,,https://lens.org/119-876-751-410-492,Patent Application,yes,0,0,10,10,0,G02B5/128;;Y10T428/24479;;Y10T428/24579;;G02B5/128;;Y10T428/24479;;Y10T428/24579;;G02B5/128,G02B5/128,,0,0,,,,DISCONTINUED
665,DE,D1,DE 60132007 D1,143-957-513-569-232,2008-01-31,2008,DE 60132007 T,2001-02-09,US 67819100 A;;US 0104184 W,2000-10-04,ELEKTRISCH/MAGNETISCH GESTEUERTE PARTIKELANORDNUNG,"Assemblies containing a substrate with pockets for electromagnetically responsive particles can be made for a variety of uses, including, for example, display media, lenses, and color-changing fabric. The arrangement of these pockets can be selected to provide higher particle density than previously realized. The assembly includes an assembly substrate, particles, and a top coat layer.",3M INNOVATIVE PROPERTIES CO,BASTIAENS WILLEM V;;BIERNATH ROLF W;;DOLAN MARK P;;ENGLE LORI P;;FLEMING PATRICK K;;WOLF ROBERT J,,https://lens.org/143-957-513-569-232,Granted Patent,no,0,0,11,11,0,G02B26/026;;G02F1/167;;G09F9/372;;G09F9/375;;Y10T428/25;;Y10T428/259;;B33Y80/00;;G02F1/167;;Y10T428/25;;Y10T428/259;;B33Y80/00;;G09F9/375;;G02B26/026;;G09F9/372;;G02F1/167,G02B26/02;;G02F1/167;;G09F9/37,,0,0,,,,EXPIRED
666,KR,A,KR 20130035955 A,146-415-456-114-487,2013-04-09,2013,KR 20120108945 A,2012-09-28,US 201113250226 A,2011-09-30,"POLYAMINE, CARBOXYLIC ACID FLUX COMPOSITION AND METHOD OF SOLDERING",PURPOSE: An amine-carboxylic acid flux composite and a soldering method are provided to easily obtain compatibility with various underfill composites in order to omit a soldered surface washing process before applying the underfill composites to form a final electric joint. CONSTITUTION: An amine-carboxylic acid flux composite and a soldering method comprise a carboxylic acid and a polyamine fluxing agent as initial components. A soldering method comprises: a step for providing an electrical contact and a flux composite; a step for providing solder and melting the solder; and a step for displacing the flux composite applied to the electric contact with the molten solder. The molten solder is in physical contact with the electric contact and thereby joined to the electric contact.,ROHM & HAAS ELECT MAT,MARK R WINKLE;;AVIN V DHOBLE;;KIM SANG HO;;MICHAEL K GALLAGHER;;XIANG QIAN LIU;;DAVID D FLEMING,,https://lens.org/146-415-456-114-487,Patent Application,no,3,0,12,12,0,B23K35/362;;B23K1/0016;;B23K1/0016;;B23K1/008;;B23K1/008;;B23K1/203;;B23K1/203;;B23K35/3601;;B23K35/3601;;B23K35/3618;;B23K35/3618;;B23K35/362;;B23K35/362;;B23K2101/42;;B23K2101/42;;C07C211/36;;H05K3/3489;;H05K3/3489,B23K35/362;;C07C211/36,,0,0,,,,ACTIVE
667,TW,A,TW 201323377 A,160-974-745-187-55X,2013-06-16,2013,TW 101135053 A,2012-09-25,US 201113250007 A,2011-09-30,Flux composition and method of soldering,"A flux composition is provided, comprising, as an initial component: a carboxylic acid; and, a fluxing agent represented by formula I: wherein R1, R2, R3 and R4 are independently selected from a hydrogen, a substituted C1-80 alkyl group, an unsubstituted C1-80 alkyl group, a substituted C7-80 arylalkyl group and an unsubstituted C7-80 arylalkyl group; and wherein zero to three of R1, R2, R3 and R4 is(are) a hydrogen. Also provided is a method of soldering an electrical contact using the flux composition.",ROHM & HAAS ELECT MAT,HO KIM SANG;;GALLAGHER MICHAEL K;;DHOBLE AVIN V;;WINKLE MARK R;;LIU XIANG-QIAN;;FLEMING DAVID D,,https://lens.org/160-974-745-187-55X,Patent of Addition,no,0,0,13,13,0,B23K1/203;;B23K1/203;;B23K35/362;;B23K1/0016;;B23K1/0016;;B23K1/008;;B23K1/008;;B23K35/0244;;B23K35/0244;;B23K35/26;;B23K35/26;;B23K35/34;;B23K35/34;;B23K35/3601;;B23K35/3601;;B23K35/362;;B23K35/362;;B23K2101/42;;B23K2101/42;;C07C217/52;;H05K3/3489;;H05K3/3489,C07C211/36;;B23K35/363;;H05K3/34,,0,0,,,,INACTIVE
668,FR,B1,FR 2980730 B1,097-335-854-551-097,2014-11-28,2014,FR 1259150 A,2012-09-28,US 201113250297 A,2011-09-30,COMPOSITION DE FONDANT DURCISSABLE ET PROCEDE DE SOUDAGE,,ROHM & HAAS ELECT MAT,GALLAGHER MICHAEL K;;HO KIM SANG;;DHOBLE AVIN V;;WINKLE MARK R;;LIU XIANG-QIAN;;FLEMING DAVID D,,https://lens.org/097-335-854-551-097,Granted Patent,no,0,0,13,13,0,B23K1/0016;;B23K1/0016;;B23K35/362;;B23K1/203;;B23K1/203;;C07C211/36;;C08K5/09;;C08K5/09;;C08K5/17;;C08K5/17;;H01L24/11;;H01L24/11;;H01L24/13;;H01L24/13;;H01L24/16;;H01L24/16;;H01L24/27;;H01L24/27;;H01L24/29;;H01L24/29;;H01L24/32;;H01L24/32;;H01L24/81;;H01L24/81;;H01L24/83;;H01L24/83;;H01L24/92;;H01L24/92;;H01L2224/11334;;H01L2224/11334;;H01L2224/131;;H01L2224/131;;H01L2224/13111;;H01L2224/13111;;H01L2224/16225;;H01L2224/16225;;H01L2224/16227;;H01L2224/16227;;H01L2224/2732;;H01L2224/2732;;H01L2224/2741;;H01L2224/2741;;H01L2224/27418;;H01L2224/27418;;H01L2224/27422;;H01L2224/27422;;H01L2224/2929;;H01L2224/2929;;H01L2224/29294;;H01L2224/29294;;H01L2224/29311;;H01L2224/29311;;H01L2224/29387;;H01L2224/29387;;H01L2224/2939;;H01L2224/2939;;H01L2224/32225;;H01L2224/32225;;H01L2224/73204;;H01L2224/73204;;H01L2224/81011;;H01L2224/81011;;H01L2224/81024;;H01L2224/81024;;H01L2224/81143;;H01L2224/81143;;H01L2224/81191;;H01L2224/81191;;H01L2224/81192;;H01L2224/81192;;H01L2224/81815;;H01L2224/81815;;H01L2224/83192;;H01L2224/83192;;H01L2224/83862;;H01L2224/83862;;H01L2224/9211;;H01L2224/9211;;H05K3/3436;;H05K3/3436;;H05K3/3489;;H05K3/3489;;H05K2201/10674;;H05K2201/10674;;H05K2201/10977;;H05K2201/10977,B23K35/363;;C08K5/09;;C08K5/17;;C08L63/00;;H01L21/56;;H05K3/34,,0,0,,,,INACTIVE
669,WO,A1,WO 2005/066667 A1,121-138-309-110-582,2005-07-21,2005,US 2004/0043549 W,2004-12-28,US 53396203 P,2003-12-30,COLOR SHIFTING RETROREFLECTOR AND METHOD OF MAKING SAME,"Color shifting retroreflective articles can provide features such as decorative effects, evidence of tampering, security authentication or positional information. In some embodiments, the color shifting retroreflective article includes a layer of microspheres (14), and a reflective coating that is disposed in optical association with the layer of microspheres. The reflective coating includes a spacer layer (24) disposed between a semitransparent first reflective layer (22) and a second reflective layer (26). The first reflective layer includes a reflective layer disposed adjacent the layer of microspheres (t1, t2). At least one layer of the reflective coating includes a non-uniform thickness associated with each of a plurality of microspheres such that light incident on the article from a first direction is retroreflected at a first color and light incident on the article from a second direction is retroreflected at a second color visibly different from the first color.",3M INNOVATIVE PROPERTIES CO,FLEMING ROBERT J;;LYONS CHRISTOPHER S;;MCGRATH JOSEPH M;;RAMOS JESUS R;;ROEHRIG MARK A;;BRIGHT CLARK I,,https://lens.org/121-138-309-110-582,Patent Application,yes,4,11,10,10,0,G02B5/128;;Y10T428/24479;;Y10T428/24579;;G02B5/128;;Y10T428/24479;;Y10T428/24579;;G02B5/128,G02B5/128,,1,0,,,"PATENT ABSTRACTS OF JAPAN vol. 2002, no. 03 3 April 2002 (2002-04-03)",PENDING
670,DE,A1,DE 102012019199 A1,153-895-689-005-029,2013-04-04,2013,DE 102012019199 A,2012-09-28,US 201113250297 A,2011-09-30,Härtbare Flussmittelzusammensetzung und Lötverfahren,"Es wird eine härtbare Flussmittelzusammensetzung bereitgestellt, die als Ausgangskomponenten: eine Harzkomponente mit mindestens zwei Oxiran-Gruppen pro Molekül; eine Carbonsäure; ein Flussmittel, dargestellt durch die Formel I:worin R1, R2, R3 und R4 unabhängig ausgewählt sind aus einem Wasserstoff, einer substituierten C1-80-Alkylgruppe, einer unsubstituierten C1-80-Alkylgruppe, einer substituierten C7-80-Arylalkylgruppe und einer unsubstituierten C7-80-Arylalkylgruppe; und worin null bis drei von R1, R2, R3 und R4 Wasserstoff sind; und gegebenenfalls ein Härtungsmittel umfasst. Ebenso bereitgestellt wird ein Verfahren zum Löten eines elektrischen Kontaktes unter Verwendung der härtbaren Flussmittelzusammensetzung.",ROHM & HAAS ELECT MAT,HO KIM S;;GALLAGHER MICHAEL K;;DHOBLE AVIN V;;WINKLE MARK R;;LIU XIANG-QIAN;;FLEMING DAVID D,,https://lens.org/153-895-689-005-029,Patent Application,no,2,0,13,13,0,B23K1/0016;;B23K1/0016;;B23K35/362;;B23K1/203;;B23K1/203;;C07C211/36;;C08K5/09;;C08K5/09;;C08K5/17;;C08K5/17;;H01L24/11;;H01L24/11;;H01L24/13;;H01L24/13;;H01L24/16;;H01L24/16;;H01L24/27;;H01L24/27;;H01L24/29;;H01L24/29;;H01L24/32;;H01L24/32;;H01L24/81;;H01L24/81;;H01L24/83;;H01L24/83;;H01L24/92;;H01L24/92;;H01L2224/11334;;H01L2224/11334;;H01L2224/131;;H01L2224/131;;H01L2224/13111;;H01L2224/13111;;H01L2224/16225;;H01L2224/16225;;H01L2224/16227;;H01L2224/16227;;H01L2224/2732;;H01L2224/2732;;H01L2224/2741;;H01L2224/2741;;H01L2224/27418;;H01L2224/27418;;H01L2224/27422;;H01L2224/27422;;H01L2224/2929;;H01L2224/2929;;H01L2224/29294;;H01L2224/29294;;H01L2224/29311;;H01L2224/29311;;H01L2224/29387;;H01L2224/29387;;H01L2224/2939;;H01L2224/2939;;H01L2224/32225;;H01L2224/32225;;H01L2224/73204;;H01L2224/73204;;H01L2224/81011;;H01L2224/81011;;H01L2224/81024;;H01L2224/81024;;H01L2224/81143;;H01L2224/81143;;H01L2224/81191;;H01L2224/81191;;H01L2224/81192;;H01L2224/81192;;H01L2224/81815;;H01L2224/81815;;H01L2224/83192;;H01L2224/83192;;H01L2224/83862;;H01L2224/83862;;H01L2224/9211;;H01L2224/9211;;H05K3/3436;;H05K3/3436;;H05K3/3489;;H05K3/3489;;H05K2201/10674;;H05K2201/10674;;H05K2201/10977;;H05K2201/10977,B23K35/362,,0,0,,,,DISCONTINUED
671,JP,A,JP 2013091100 A,186-465-746-470-929,2013-05-16,2013,JP 2012210452 A,2012-09-25,US 201113250226 A,2011-09-30,"POLYAMINE, CARBOXYLIC ACID FLUX COMPOSITION AND METHOD OF SOLDERING","PROBLEM TO BE SOLVED: To provide a flux agent which is non-curable, facilitates reliable soldering connection, and also can be customized in such a manner that its mixing with the conventional epoxy-base under fill material is facilitated.SOLUTION: The flux composition is provided, comprising, as initial components: a carboxylic acid; and, a polyamine fluxiing agent represented by formula (I), wherein R, R, Rand Rare independently selected from a hydrogen, a substituted 1 to 80C alkyl group, an unsubstituted 1 to 80C alkyl group or the like. Ris selected from an unsubstituted 5 to 80C alkyl group with at least two tertiary carbons, a substituted 5 to 80C alkyl group with at least two tertiary carbons or the like.",ROHM & HAAS ELECT MAT,MARK R WINKLE;;DHOBLE AVIN V;;KIM S HO;;GALLAGHER MICHAEL K;;LIU XIANG-QIAN;;FLEMING DAVID D,,https://lens.org/186-465-746-470-929,Patent Application,no,2,6,12,12,0,B23K35/362;;B23K1/0016;;B23K1/0016;;B23K1/008;;B23K1/008;;B23K1/203;;B23K1/203;;B23K35/3601;;B23K35/3601;;B23K35/3618;;B23K35/3618;;B23K35/362;;B23K35/362;;B23K2101/42;;B23K2101/42;;C07C211/36;;H05K3/3489;;H05K3/3489,B23K35/363;;B23K1/00;;B23K3/00;;B23K35/26;;B23K101/42;;C22C12/00;;C22C13/00;;C22C13/02,,0,0,,,,DISCONTINUED
672,TW,B,TW I450880 B,023-280-867-522-316,2014-09-01,2014,TW 101135054 A,2012-09-25,US 201113250226 A,2011-09-30,"Polyamine, carboxylic acid flux composition and method of soldering",,ROHM & HAAS ELECT MAT,WINKLE MARK R;;DHOBLE AVIN V;;HO KIM S;;GALLAGHER MICHAEL K;;LIU XIANG-QIAN;;FLEMING DAVID D,,https://lens.org/023-280-867-522-316,Granted Patent,no,3,0,12,12,0,B23K35/362;;B23K1/0016;;B23K1/0016;;B23K1/008;;B23K1/008;;B23K1/203;;B23K1/203;;B23K35/3601;;B23K35/3601;;B23K35/3618;;B23K35/3618;;B23K35/362;;B23K35/362;;B23K2101/42;;B23K2101/42;;C07C211/36;;H05K3/3489;;H05K3/3489,,,0,0,,,,INACTIVE
673,KR,A,KR 20060129335 A,068-244-394-158-466,2006-12-15,2006,KR 20067015262 A,2004-12-28,US 2004/0043549 W;;US 53396203 P,2003-12-30,COLOR SHIFTING RETROREFLECTOR AND METHOD OF MAKING SAME,"Color shifting retroreflective articles can provide features such as decorative effects, evidence of tampering, security authentication or positional information. In some embodiments, the color shifting retroreflective article includes a layer of microspheres (14), and a reflective coating that is disposed in optical association with the layer of microspheres. The reflective coating includes a spacer layer (24) disposed between a semitransparent first reflective layer (22) and a second reflective layer (26). The first reflective layer includes a reflective layer disposed adjacent the layer of microspheres (t1, t2). At least one layer of the reflective coating includes a non-uniform thickness associated with each of a plurality of microspheres such that light incident on the article from a first direction is retroreflected at a first color and light incident on the article from a second direction is retroreflected at a second color visibly different from the first color.",3M INNOVATIVE PROPERTIES CO,FLEMING ROBERT J;;LYONS CHRISTOPHER S;;MCGRATH JOSEPH M;;RAMOS JESUS R;;ROEHRIG MARK A;;BRIGHT CLARK I,,https://lens.org/068-244-394-158-466,Patent Application,no,0,0,10,10,0,G02B5/128;;Y10T428/24479;;Y10T428/24579;;G02B5/128;;Y10T428/24479;;Y10T428/24579;;G02B5/128,G02B5/128,,0,0,,,,INACTIVE
674,FR,A1,FR 2980730 A1,101-906-000-981-498,2013-04-05,2013,FR 1259150 A,2012-09-28,US 201113250297 A,2011-09-30,COMPOSITION DE FONDANT DURCISSABLE ET PROCEDE DE SOUDAGE,"Il est fourni une composition de fondant durcissable comprenant, comme composants initiaux: un composant résine ayant au moins deux groupes oxirane par molécule; un acide carboxylique; un agent fondant représenté par la formule I: où R , R , R et R sont choisis indépendamment parmi un hydrogène, un groupe C alkyle substitué, un groupe C alkyle non substitué, un groupe C arylalkyle substitué et un groupe C arylalkyle non substitué; et où zéro à trois de R , R , R et R est (sont) un hydrogène; et, éventuellement, un agent durcisseur. Il est également fourni un procédé de soudage d'un contact électrique utilisant la composition de fondant durcissable.",ROHM & HAAS ELECT MAT,GALLAGHER MICHAEL K;;HO KIM SANG;;DHOBLE AVIN V;;WINKLE MARK R;;LIU XIANG-QIAN;;FLEMING DAVID D,,https://lens.org/101-906-000-981-498,Patent Application,no,2,0,13,13,0,B23K1/0016;;B23K1/0016;;B23K35/362;;B23K1/203;;B23K1/203;;C07C211/36;;C08K5/09;;C08K5/09;;C08K5/17;;C08K5/17;;H01L24/11;;H01L24/11;;H01L24/13;;H01L24/13;;H01L24/16;;H01L24/16;;H01L24/27;;H01L24/27;;H01L24/29;;H01L24/29;;H01L24/32;;H01L24/32;;H01L24/81;;H01L24/81;;H01L24/83;;H01L24/83;;H01L24/92;;H01L24/92;;H01L2224/11334;;H01L2224/11334;;H01L2224/131;;H01L2224/131;;H01L2224/13111;;H01L2224/13111;;H01L2224/16225;;H01L2224/16225;;H01L2224/16227;;H01L2224/16227;;H01L2224/2732;;H01L2224/2732;;H01L2224/2741;;H01L2224/2741;;H01L2224/27418;;H01L2224/27418;;H01L2224/27422;;H01L2224/27422;;H01L2224/2929;;H01L2224/2929;;H01L2224/29294;;H01L2224/29294;;H01L2224/29311;;H01L2224/29311;;H01L2224/29387;;H01L2224/29387;;H01L2224/2939;;H01L2224/2939;;H01L2224/32225;;H01L2224/32225;;H01L2224/73204;;H01L2224/73204;;H01L2224/81011;;H01L2224/81011;;H01L2224/81024;;H01L2224/81024;;H01L2224/81143;;H01L2224/81143;;H01L2224/81191;;H01L2224/81191;;H01L2224/81192;;H01L2224/81192;;H01L2224/81815;;H01L2224/81815;;H01L2224/83192;;H01L2224/83192;;H01L2224/83862;;H01L2224/83862;;H01L2224/9211;;H01L2224/9211;;H05K3/3436;;H05K3/3436;;H05K3/3489;;H05K3/3489;;H05K2201/10674;;H05K2201/10674;;H05K2201/10977;;H05K2201/10977,B23K35/363;;C08K5/09;;C08K5/17;;C08L63/00;;H01L21/56;;H05K3/34,,0,0,,,,INACTIVE
675,CA,A1,CA 2658189 A1,141-520-394-536-803,2008-01-24,2008,CA 2658189 A,2007-07-09,US 48984506 A;;US 2007/0015617 W,2006-07-20,METHOD FOR REMOVING ASPHALTENE DEPOSITS,"Compositions comprising at least one C4-Q30 olefin or oxidation product t hereof and kerosene or an aromatic solvent are particularly effective for us e in removing asphaltene and asph.altene-containing organic deposits and in preventing or reducing the precipitation and deposition of asphaltenes from hydrocarbon fluids. When added to heavy oils comprising asphaltenes, alone o r in combination with dispersants and further inhibitors, the invented compo sitions lower viscosity and pour point, and aid in preventing asphaltene pre cipitation during transport and in combustion...",INEOS USA LLC,DIGIACINTO PETER M;;HEYMANS LUC M;;ANDREW BLAIR L;;TRIMBLE MARVIN L;;TOMUSIAK GREG A;;FLEMING MARK A,,https://lens.org/141-520-394-536-803,Patent Application,no,0,0,5,5,0,C09K8/524;;C10G75/00;;C09K8/524;;C10G75/00,E21B37/06,,0,0,,,,DISCONTINUED
676,FR,B1,FR 2980729 B1,155-129-745-942-27X,2014-11-28,2014,FR 1259149 A,2012-09-28,US 201113250226 A,2011-09-30,"COMPOSITION DE FONDANT POLYAMINE, ACIDE CARBOXYLIQUE ET PROCEDE DE SOUDAGE",,ROHM & HAAS ELECT MAT,WINKLE MARK R;;DHOBLE AVIN V;;HO KIM SANG;;GALLAGHER MICHAEL K;;LIU XIANG-QIAN;;FLEMING DAVID D,,https://lens.org/155-129-745-942-27X,Granted Patent,no,0,0,12,12,0,B23K35/362;;B23K1/0016;;B23K1/0016;;B23K1/008;;B23K1/008;;B23K1/203;;B23K1/203;;B23K35/3601;;B23K35/3601;;B23K35/3618;;B23K35/3618;;B23K35/362;;B23K35/362;;B23K2101/42;;B23K2101/42;;C07C211/36;;H05K3/3489;;H05K3/3489,B23K35/363;;C07C211/36;;C07C215/06;;H05K3/34,,0,0,,,,INACTIVE
677,TW,B,TW I458696 B,158-072-234-432-678,2014-11-01,2014,TW 101135053 A,2012-09-25,US 201113250007 A,2011-09-30,Flux composition and method of soldering,,ROHM & HAAS ELECT MAT,HO KIM SANG;;GALLAGHER MICHAEL K;;DHOBLE AVIN V;;WINKLE MARK R;;LIU XIANG-QIAN;;FLEMING DAVID D,,https://lens.org/158-072-234-432-678,Granted Patent,no,3,0,13,13,0,B23K1/203;;B23K1/203;;B23K35/362;;B23K1/0016;;B23K1/0016;;B23K1/008;;B23K1/008;;B23K35/0244;;B23K35/0244;;B23K35/26;;B23K35/26;;B23K35/34;;B23K35/34;;B23K35/3601;;B23K35/3601;;B23K35/362;;B23K35/362;;B23K2101/42;;B23K2101/42;;C07C217/52;;H05K3/3489;;H05K3/3489,,,0,0,,,,INACTIVE
678,KR,A,KR 20130035956 A,181-003-510-916-172,2013-04-09,2013,KR 20120108966 A,2012-09-28,US 201113250297 A,2011-09-30,CURABLE FLUX COMPOSITION AND METHOD OF SOLDERING,"PURPOSE: A curable flux composite and a soldering method suitable for soldering an electric contact are provided to easily form soldered, encapsulated internal electric connections reliable for electric parts. CONSTITUTION: A curable flux composite comprises a resin component with at least two oxirane groups per molecule, a flux agent, and an auxiliary curing agent as initial components. A soldering method comprises: providing a curable flux composite, a plurality of primary electric contact points, a plurality of secondary electric contact points, and solder; a step for applying the curable flux composite to the plurality of primary electric contact points and secondary electric contact points; and a step for positioning the primary electric contact points to the secondary electric contact points to be close; a step for positioning the primary electric contact points to the secondary electric contact points to be close; a step for forming molten solder by heating the solder over a reflow temperature; a step for exposing the molten solder to the primary electric contact points and the secondary electric contact points; a step for displacing the curable flux composite with the molten solder; a step for forming a plurality of electric inner connections between the primary electric contact points and the secondary electric contact points; and a step for curing the resin component and encapsulating the electric inner connections.",ROHM & HAAS ELECT MAT,MICHAEL K GALLAGHER;;KIM SANG HO;;AVIN V DHOBLE;;MARK R WINKLE;;XIANG QIAN LIU;;DAVID D FLEMING,,https://lens.org/181-003-510-916-172,Patent Application,no,0,0,13,13,0,B23K1/0016;;B23K1/0016;;B23K35/362;;B23K1/203;;B23K1/203;;C07C211/36;;C08K5/09;;C08K5/09;;C08K5/17;;C08K5/17;;H01L24/11;;H01L24/11;;H01L24/13;;H01L24/13;;H01L24/16;;H01L24/16;;H01L24/27;;H01L24/27;;H01L24/29;;H01L24/29;;H01L24/32;;H01L24/32;;H01L24/81;;H01L24/81;;H01L24/83;;H01L24/83;;H01L24/92;;H01L24/92;;H01L2224/11334;;H01L2224/11334;;H01L2224/131;;H01L2224/131;;H01L2224/13111;;H01L2224/13111;;H01L2224/16225;;H01L2224/16225;;H01L2224/16227;;H01L2224/16227;;H01L2224/2732;;H01L2224/2732;;H01L2224/2741;;H01L2224/2741;;H01L2224/27418;;H01L2224/27418;;H01L2224/27422;;H01L2224/27422;;H01L2224/2929;;H01L2224/2929;;H01L2224/29294;;H01L2224/29294;;H01L2224/29311;;H01L2224/29311;;H01L2224/29387;;H01L2224/29387;;H01L2224/2939;;H01L2224/2939;;H01L2224/32225;;H01L2224/32225;;H01L2224/73204;;H01L2224/73204;;H01L2224/81011;;H01L2224/81011;;H01L2224/81024;;H01L2224/81024;;H01L2224/81143;;H01L2224/81143;;H01L2224/81191;;H01L2224/81191;;H01L2224/81192;;H01L2224/81192;;H01L2224/81815;;H01L2224/81815;;H01L2224/83192;;H01L2224/83192;;H01L2224/83862;;H01L2224/83862;;H01L2224/9211;;H01L2224/9211;;H05K3/3436;;H05K3/3436;;H05K3/3489;;H05K3/3489;;H05K2201/10674;;H05K2201/10674;;H05K2201/10977;;H05K2201/10977,B23K35/362;;C07C211/36,,0,0,,,,ACTIVE
679,AU,B2,AU 2017/241256 B2,132-044-306-179-703,2020-01-23,2020,AU 2017/241256 A,2017-03-20,EP 16163191 A;;EP 17160796 A;;US 2017/0023144 W,2016-03-31,Razor cartridge with fluid management,A razor cartridge comprising a housing (20) having elongated skin contacting elements (60) having a plurality of channels (62) extending there through to facilitate fluid flow.,GILLETTE CO LLC,JOLLEY WILLIAM OWEN;;PETERSON MARK;;SPOONER-FLEMING JOIA KIRIN;;STEPHENS ALISON FIONA;;TANDY JAMES;;WARRICK PAUL LESLIE;;WASHINGTON JACK ANTHONY,,https://lens.org/132-044-306-179-703,Granted Patent,no,4,0,17,17,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,ACTIVE
680,US,A1,US 2021/0281618 A1,185-704-377-412-393,2021-09-09,2021,US 202117313353 A,2021-05-06,US 202117313353 A;;US 202063113105 P,2020-11-12,"SYSTEM, APPARATUS, AND METHOD FOR STREAMING INPUT/OUTPUT DATA","In one embodiment, a system includes a device and a host. The device includes a device stream buffer. The host includes a processor to execute at least a first application and a second application, a host stream buffer, and a host scheduler. The first application is associated with a first transmit streaming channel to stream first data from the first application to the device stream buffer. The first transmit streaming channel has a first allocated amount of buffer space in the device stream buffer. The host scheduler schedules enqueue of the first data from the first application to the first transmit streaming channel based at least in part on availability of space in the first allocated amount of buffer space in the device stream buffer. Other embodiments are described and claimed.",INTEL CORP,MOSUR LOKPRAVEEN;;GANGA ILANGO;;CONE ROBERT;;DOSHI KSHITIJ ARUN;;BROWNE JOHN J;;DEBBAGE MARK;;DOYLE STEPHEN;;FLEMING PATRICK;;JAYASIMHA DODDABALLAPUR,INTEL CORPORATION (2021-04-29),https://lens.org/185-704-377-412-393,Patent Application,yes,0,5,3,3,0,G06F15/17;;G06F15/17306;;G06F9/4881;;G06F9/5038;;G06F2209/484;;G06F2209/5021;;H04L47/621;;H04L47/6255;;H04L47/6275;;H04L47/2416;;H04L47/39;;G06F9/544;;H04L47/50;;H04L65/61;;H04L49/9005,H04L29/06;;H04L12/863,,0,0,,,,PENDING
681,US,A1,US 2022/0113757 A1,165-929-351-943-032,2022-04-14,2022,US 202117558118 A,2021-12-21,US 202117558118 A,2021-12-21,"APPARATUS, SYSTEMS, AND METHODS FOR INTELLIGENT TUNING OF OVERCLOCKING FREQUENCY","Apparatus, systems, and methods for intelligent tuning of overclocking frequency are disclosed. An example apparatus includes trial control circuitry to execute an optimization model to select first values for overclocking parameters of a processor, the first values associated with a first trial, and perform benchmark testing of the processor when the processor is operating based on the first values; trial evaluation circuitry to calculate a first score for the first trial based on the benchmark testing; and model updating circuitry to perform a comparison of the first score to a second score, the second score associated with a second trial for second values for the overclocking parameters, the second values different than the first values; and select one of the first values or the second values to overclock the processor based on the comparison.",INTEL CORP,YAN JIN;;XIONG HUI;;ZHU JIANFANG;;GONZALEZ FELIPE;;MACDONALD MARK;;RAGLAND DANIEL;;RODRIGUEZ RODNY;;FIFE MATTHEW;;LI YIFAN;;FLEMING KRISTOFFER,INTEL CORPORATION (2021-12-17),https://lens.org/165-929-351-943-032,Patent Application,yes,0,1,3,3,0,G06F9/5027;;G06F1/08;;G06F1/206;;G06F1/3243;;Y02D10/00;;G06F1/206;;G06F1/08,G06F1/08;;G06F1/20,,0,0,,,,PENDING
682,HU,T2,HU E063042 T2,183-917-224-677-944,2023-12-28,2023,HU E17733108 A,2017-04-14,US 201662322948 P;;US 201662411172 P,2016-04-15,INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE,,BLUEPRINT MEDICINES CORP,BROOIJMANS NATASJA;;BRUBAKER JASON;;FLEMING PAUL;;HODOUS BRIAN;;KIM JOSEPH;;WAETZIG JOSH;;WILLIAMS BRETT;;WILSON DOUGLAS;;WILSON KEVIN;;CRONIN MARK,,https://lens.org/183-917-224-677-944,Amended Patent,no,0,0,33,34,0,C07D487/04;;C07D519/00;;A61P19/00;;A61P25/00;;A61P35/00;;A61P43/00;;C07D487/04;;A61K31/5025;;C07D519/00;;A61P19/00;;A61K31/5025;;C07D487/04;;C07D519/00;;A61P35/00;;A61K31/5025;;A61K31/5377;;A61K31/5383;;C07D487/04;;C07D519/00,C07D487/04;;A61P19/00;;C07D519/00,,0,0,,,,PENDING
683,CN,A,CN 109070370 A,169-297-215-885-619,2018-12-21,2018,CN 201780020310 A,2017-03-20,EP 16163191 A;;EP 17160796 A;;US 2017/0023144 W,2016-03-31,RAZOR CARTRIDGE WITH FLUID MANAGEMENT,A razor cartridge comprising a housing (20) having elongated skin contacting elements (60) having a plurality of channels (62) extending there through to facilitate fluid flow.,GILLETTE CO LLC,JOLLEY WILLIAM OWEN;;PETERSON MARK;;SPOONER-FLEMING JOIA KIRIN;;STEPHENS ALISON FIONA;;TANDY JAMES;;WARRICK PAUL LESLIE;;WASHINGTON JACK ANTHONY,,https://lens.org/169-297-215-885-619,Patent Application,no,6,1,17,17,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,DISCONTINUED
684,US,A1,US 2017/0282389 A1,018-471-796-888-150,2017-10-05,2017,US 201715464754 A,2017-03-21,EP 16163191 A;;EP 17160796 A,2016-03-31,RAZOR CARTRIDGE WITH FLUID MANAGEMENT,A razor cartridge comprising a housing having elongated skin contacting elements having a plurality of channels extending there through to facilitate fluid flow.,GILLETTE CO LLC,JOLLEY WILLIAM OWEN;;PETERSON MARK;;SPOONER-FLEMING JOIA KIRIN;;STEPHENS ALISON FIONA;;TANDY JAMES;;WARRICK PAUL LESLIE;;WASHINGTON JACK ANTHONY,THE GILLETTE COMPANY LLC (2018-10-31),https://lens.org/018-471-796-888-150,Patent Application,yes,20,20,17,17,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/44,,0,0,,,,DISCONTINUED
685,EP,A1,EP 3231565 A1,154-782-535-843-666,2017-10-18,2017,EP 17160796 A,2017-03-14,EP 16163191 A,2016-03-31,RAZOR CARTRIDGE WITH FLUID MANAGEMENT,"A razor cartridge comprising a housing (20) having elongated skin contacting elements (60) having a plurality of channels (62) extending there through to facilitate fluid flow.
",GILLETTE CO LLC,JOLLEY WILLIAM OWEN;;PETERSON MARK;;SPOONER-FLEMING JOIA KIRIN;;STEPHENS ALISON FIONA;;TANDY JAMES;;WARRICK PAUL LESLIE;;WASHINGTON JACK ANTHONY,,https://lens.org/154-782-535-843-666,Patent Application,yes,11,0,17,17,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,ACTIVE
686,WO,A1,WO 2017/172396 A1,192-693-616-778-687,2017-10-05,2017,US 2017/0023144 W,2017-03-20,EP 16163191 A;;EP 17160796 A,2016-03-31,RAZOR CARTRIDGE WITH FLUID MANAGEMENT,A razor cartridge comprising a housing (20) having elongated skin contacting elements (60) having a plurality of channels (62) extending there through to facilitate fluid flow.,GILLETTE CO LLC,JOLLEY WILLIAM OWEN;;PETERSON MARK;;SPOONER-FLEMING JOIA KIRIN;;STEPHENS ALISON FIONA;;TANDY JAMES;;WARRICK PAUL LESLIE;;WASHINGTON JACK ANTHONY,,https://lens.org/192-693-616-778-687,Patent Application,yes,11,0,17,17,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,PENDING
687,DE,D1,DE 60238259 D1,066-310-837-000-589,2010-12-23,2010,DE 60238259 T,2002-07-03,US 90555301 A;;US 0221263 W,2001-07-16,VORRICHTUNG UND VERFAHREN ZUM MISCHEN UND ABGEBEN EINER DURCH EIN ADDITIV VERBESSERTEN AUFSCHLÄMMUNG,,UNITED STATES GYPSUM CO,WITTBOLD JAMES R;;DUVEDI AMIT P;;HEMPHILL MARK K;;FLEMING WAYNE A;;PITTMAN WILFORD GARY;;MOORE KIRK S;;NELSON CHRISTOPHER,,https://lens.org/066-310-837-000-589,Granted Patent,no,0,0,12,12,0,B28B19/0092;;B28C5/16;;B28C5/386;;B28C7/16;;B01F23/53;;B01F2025/917;;B01F27/811;;B01F35/75;;B01F2101/28;;B28C5/06;;C04B28/14;;C04B2111/0062;;B28B19/0092;;B28C5/16;;B28C5/386;;B28C7/16;;B01F35/75;;B01F23/53;;B01F27/811;;B01F2025/917;;B01F2101/28,B28C5/00;;B01F3/12;;B01F5/00;;B01F7/16;;B01F15/02;;B28B19/00;;B28C5/08;;B28C5/12;;B28C5/16;;B28C5/38;;B28C7/16,,0,0,,,,EXPIRED
688,CA,A1,CA 3015380 A1,183-680-442-183-878,2017-10-05,2017,CA 3015380 A,2017-03-20,EP 16163191 A;;EP 17160796 A;;US 2017/0023144 W,2016-03-31,RAZOR CARTRIDGE WITH FLUID MANAGEMENT,A razor cartridge comprising a housing (20) having elongated skin contacting elements (60) having a plurality of channels (62) extending there through to facilitate fluid flow.,GILLETTE CO LLC,JOLLEY WILLIAM OWEN;;PETERSON MARK;;SPOONER-FLEMING JOIA KIRIN;;STEPHENS ALISON FIONA;;TANDY JAMES;;WARRICK PAUL LESLIE;;WASHINGTON JACK ANTHONY,,https://lens.org/183-680-442-183-878,Patent Application,no,0,0,17,17,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,ACTIVE
689,AU,B2,AU 2002/346070 B2,098-326-190-235-48X,2008-01-10,2008,AU 2002/346070 A,2002-07-03,US 90555301 A;;US 0221263 W,2001-07-16,Apparatus and method for mixing and dispensing an additive-enhanced slurry,,UNITED STATES GYPSUM CO,DUVEDI AMIT P;;MOORE KIRK S;;FLEMING WAYNE A;;PITTMAN WILFORD GARY;;NELSON CHRISTOPHER;;WITTBOLD JAMES R;;HEMPHILL MARK K,,https://lens.org/098-326-190-235-48X,Granted Patent,no,0,1,12,12,0,B28B19/0092;;B28C5/16;;B28C5/386;;B28C7/16;;B01F23/53;;B01F2025/917;;B01F27/811;;B01F35/75;;B01F2101/28;;B28C5/06;;C04B28/14;;C04B2111/0062;;B28B19/0092;;B28C5/16;;B28C5/386;;B28C7/16;;B01F35/75;;B01F23/53;;B01F27/811;;B01F2025/917;;B01F2101/28,B28C5/16;;B01F3/12;;B01F5/00;;B01F7/16;;B01F15/02;;B28B19/00;;B28C5/38;;B28C7/16,,0,0,,,,EXPIRED
690,CA,C,CA 2446672 C,146-530-274-676-319,2011-01-11,2011,CA 2446672 A,2002-07-03,US 90555301 A;;US 0221263 W,2001-07-16,APPARATUS AND METHOD FOR MIXING AND DISPENSING AN ADDITIVE-ENHANCED SLURRY,"An apparatus and method for delivering an additive-enhanced slurry for use in making gypsum wallboard, and configured for connection to a centrifugal mixer with a tangential discharge outlet, includes a conduit having a main inlet in slurry receiving communication with the mixer outlet and extending to a discharge spout for discharging the slurry proximate a wallboard forming area. At least one volume restrictor is associated with the conduit for creating back pressure between the volume restrictor and the outlet for keeping the mixer full, and at least one pressure reducer associated with the discharge spout and configured for reducing the pressure of the slurry dispensed from the discharge spout. The apparatus is configured for maintaining a generally laminar flow from the mixer outlet to the discharge spout.",UNITED STATES GYPSUM CO,WITTBOLD JAMES R;;DUVEDI AMIT P;;PITTMAN WILFORD GARY;;MOORE KIRK S;;NELSON CHRISTOPHER;;FLEMING WAYNE A;;HEMPHILL MARK K,,https://lens.org/146-530-274-676-319,Granted Patent,no,0,0,12,12,0,B28B19/0092;;B28C5/16;;B28C5/386;;B28C7/16;;B01F23/53;;B01F2025/917;;B01F27/811;;B01F35/75;;B01F2101/28;;B28C5/06;;C04B28/14;;C04B2111/0062;;B28B19/0092;;B28C5/16;;B28C5/386;;B28C7/16;;B01F35/75;;B01F23/53;;B01F27/811;;B01F2025/917;;B01F2101/28,B28C5/00;;B01F3/12;;B01F5/00;;B01F7/16;;B01F15/02;;B28B19/00;;B28C5/08;;B28C5/12;;B28C5/16;;B28C5/38;;B28C7/16,,0,0,,,,EXPIRED
691,WO,A1,WO 2023/147157 A1,183-818-932-452-726,2023-08-03,2023,US 2023/0011945 W,2023-01-31,US 202217589876 A,2022-01-31,MICRO-OLED DISPLAY MODULE THERMAL MANAGEMENT,"A device includes a micro-organic light emitting diode (µ-OLED) display panel and an electronic component. An electrical connector electrically couples the µ-OLED display panel and the electronic component. A standoff is disposed between the electronic component and the µ-OLED display panel. The standoff physically couples the electronic component and the µ-OLED display panel with a gap therebetween. The gap thermally decouples the electronic component from the µ-OLED display panel. A fan that is integrated with the µ-OLED display panel is placed in the standoff and actively cools the display panel. When the fan provides air flow over the µ-OLED display panel, heat generated by the µ-OLED display is mitigated by cooling air.",META PLATFORMS TECH LLC,ANDO MARK SHINTARO;;MOGHADDAM GITI KARIMI;;PARK KYUNG WON;;KLEMENT ALEXANDER;;FLEMING RYAN;;NAM DONGHEE;;KUO YI CHEN;;MOSKOWITZ DOUGLAS,,https://lens.org/183-818-932-452-726,Patent Application,yes,3,0,3,3,0,G06F1/163;;G06F1/1637;;G06F1/203;;G02B27/0176;;G06F3/011;;G02B27/0172;;H10K50/87;;G02B27/0176;;H05K7/20972;;G06F1/163,G06F1/20;;G06F1/16,,0,0,,,,PENDING
692,US,A1,US 2023/0276595 A1,186-640-359-567-590,2023-08-31,2023,US 202217589880 A,2022-01-31,US 202217589880 A,2022-01-31,MICRO-OLED DISPLAY MODULE THERMAL MANAGEMENT,"A device includes a micro-organic light emitting diode (µ-OLED) display panel and an electronic component. An electrical connector electrically couples the µ-OLED display panel and the electronic component. An air duct is physically coupled to the µ-OLED display panel and the electronic component. The air duct functions to cool the µ-OLED display panel when air flows through the air duct. A system fan provides air flow to the air duct and dissipates heat away from the display panel. A system fan can be located disconnected from the µ-OLED display panel and can provide air flow to the air duct to dissipate heat away from the display panel. The device can be implemented with a single fan solution or a multiple fan solution (e.g., two or more fans).",FACEBOOK TECH LLC,MOGHADDAM GITI KARIMI;;MOSKOWITZ DOUGLAS;;PARK KYUNG WON;;FLEMING RYAN;;KLEMENT ALEXANDER;;NAM DONGHEE;;KUO YI-CHEN;;ANDO MARK SHINTARO,META PLATFORMS TECHNOLOGIES LLC (2015-10-02),https://lens.org/186-640-359-567-590,Patent Application,yes,0,0,2,2,0,G02B27/0176;;G06F1/163;;G06F1/1637;;G06F1/203;;H10K50/87;;G06F1/163;;H05K5/0017;;H05K7/20145;;H05K7/2039,H05K7/20;;G06F1/16;;H05K5/00,,0,0,,,,PENDING
693,ES,T3,ES 2957233 T3,105-336-261-049-977,2024-01-15,2024,ES 17733108 T,2017-04-14,US 201662322948 P;;US 201662411172 P;;US 2017/0027775 W,2016-04-15,Inhibidores de quinasa tipo receptor de activina,"En el presente documento se describen compuestos que inhiben ALK2 y sus mutantes, composiciones farmacéuticas que incluyen dichos compuestos y métodos para usar dichos compuestos y composiciones. (Traducción automática con Google Translate, sin valor legal)",BLUEPRINT MEDICINES CORP,BROOIJMANS NATASJA;;BRUBAKER JASON;;FLEMING PAUL;;HODOUS BRIAN;;KIM JOSEPH;;WAETZIG JOSH;;WILLIAMS BRETT;;WILSON DOUGLAS;;WILSON KEVIN;;CRONIN MARK,,https://lens.org/105-336-261-049-977,Granted Patent,no,0,0,33,34,0,C07D487/04;;C07D519/00;;A61P19/00;;A61P25/00;;A61P35/00;;A61P43/00;;C07D487/04;;A61K31/5025;;C07D519/00;;A61P19/00;;A61K31/5025;;C07D487/04;;C07D519/00;;A61P35/00;;A61K31/5025;;A61K31/5377;;A61K31/5383;;C07D487/04;;C07D519/00,C07D487/04;;A61K31/5025;;A61P19/00;;C07D519/00,,0,0,,,,ACTIVE
694,WO,A1,WO 2003/008167 A1,104-642-085-191-323,2003-01-30,2003,US 0221263 W,2002-07-03,US 90555301 A,2001-07-16,APPARATUS AND METHOD FOR MIXING AND DISPENSING AN ADDITIVE-ENHANCED SLURRY,"An apparatus and method for delivering an additive-enhanced slurry for use in making gypsum wallboard, and configured for connection to a centrifugal mixer with a tangential discharge outlet, includes a conduit having a main inlet in slurry receiving communication with the mixer outlet and extending to a discharge spout for discharging the slurry proximate a wallboard forming area. At least one volume restrictor is associated with the conduit for creating back pressure between the volume restrictor and the outlet for keeping the mixer full, and at least one pressure reducer associated with the discharge spout and configured for reducing the pressure of the slurry dispensed from the discharge spout. The apparatus is configured for maintaining a generally laminar flow from the mixer outlet to the discharge spout.",UNITED STATES GYPSUM CO,WITTBOLD JAMES R;;DUVEDI AMIT P;;HEMPHILL MARK K;;FLEMING WAYNE A;;PITTMAN WILFORD GARY;;MOORE KIRK S;;NELSON CHRISTOPHER,,https://lens.org/104-642-085-191-323,Patent Application,yes,6,0,12,12,0,B28B19/0092;;B28C5/16;;B28C5/386;;B28C7/16;;B01F23/53;;B01F2025/917;;B01F27/811;;B01F35/75;;B01F2101/28;;B28C5/06;;C04B28/14;;C04B2111/0062;;B28B19/0092;;B28C5/16;;B28C5/386;;B28C7/16;;B01F35/75;;B01F23/53;;B01F27/811;;B01F2025/917;;B01F2101/28,B01F3/12;;B01F5/00;;B01F7/16;;B01F15/02;;B28B19/00;;B28C5/16;;B28C5/38;;B28C7/16,,0,0,,,,PATENTED
695,EP,A1,EP 4002119 A1,151-423-087-102-560,2022-05-25,2022,EP 21194690 A,2021-09-03,US 202063113105 P;;US 202117313353 A,2020-11-12,"SYSTEM, APPARATUS, AND METHOD FOR STREAMING INPUT/OUTPUT DATA","In one embodiment, a system includes a device and a host. The device includes a device stream buffer. The host includes a processor to execute at least a first application and a second application, a host stream buffer, and a host scheduler. The first application is associated with a first transmit streaming channel to stream first data from the first application to the device stream buffer. The first transmit streaming channel has a first allocated amount of buffer space in the device stream buffer. The host scheduler schedules enqueue of the first data from the first application to the first transmit streaming channel based at least in part on availability of space in the first allocated amount of buffer space in the device stream buffer. Other embodiments are described and claimed.
",INTEL CORP,MOSUR LOKPRAVEEN;;GANGA ILANGO;;CONE ROBERT;;DOSHI KSHITIJ ARUN;;BROWNE JOHN J;;DEBBAGE MARK;;DOYLE STEPHEN;;FLEMING PATRICK;;JAYASIMHA DODDABALLAPUR,,https://lens.org/151-423-087-102-560,Patent Application,yes,3,0,3,3,0,G06F15/17;;G06F15/17306;;G06F9/4881;;G06F9/5038;;G06F2209/484;;G06F2209/5021;;H04L47/621;;H04L47/6255;;H04L47/6275;;H04L47/2416;;H04L47/39;;G06F9/544;;H04L47/50;;H04L65/61;;H04L49/9005,H04L47/625;;G06F9/54,,0,0,,,,PENDING
696,BR,A2,BR 112018070030 A2,076-658-508-386-994,2019-02-05,2019,BR 112018070030 A,2017-03-20,US 2017/0023144 W;;EP 16163191 A;;EP 17160796 A,2016-03-31,cartucho de aparelho de barbear ou depilar com sistema de gerenciamento de fluidos,a presente invenção refere-se a um cartucho de aparelho de barbear ou depilar que compreende um invólucro (20) que tem elementos alongados de contato com a pele (60) com uma pluralidade de canais (62) que se estendem através dos mesmos para facilitar o fluxo de fluidos.,GILLETTE CO LLC,ALISON FIONA STEPHENS;;JACK ANTHONY WASHINGTON;;JAMES TANDY;;JOIA KIRIN SPOONER-FLEMING;;MARK PETERSON;;PAUL LESLIE WARRICK;;WILLIAM OWEN JOLLEY,,https://lens.org/076-658-508-386-994,Patent Application,no,0,0,17,17,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,ACTIVE
697,DE,A1,DE 102022133747 A1,123-840-859-424-60X,2023-06-22,2023,DE 102022133747 A,2022-12-16,US 202117558118 A,2021-12-21,"VORRICHTUNGEN, SYSTEME UND VERFAHREN FÜR DAS INTELLIGENTE ABSTIMMEN VON ÜBERTAKTUNGSFREQUENZ","Vorrichtungen, Systeme und Verfahren für das intelligente Abstimmen von Übertaktungsfrequenz werden offenbart. Eine beispielhafte Vorrichtung umfasst eine Versuchssteuerungs-Schaltungsanordnung, die ausgebildet ist, ein Optimierungsmodell auszuführen, um erste Werte für Übertaktungsparameter eines Prozessors auszuwählen, wobei die ersten Werte einem ersten Versuch zugeordnet sind; und einen Benchmark-Test des Prozessors durchzuführen, wenn der Prozessor basierend auf den ersten Werten arbeitet; eine Versuchsauswertungs-Schaltungsanordnung, die ausgebildet ist, eine erste Punktzahl für den ersten Versuch basierend auf dem Benchmark-Test zu berechnen; und eine Modellaktualisierungs-Schaltungsanordnung, die ausgebildet ist, einen Vergleich der ersten Punktzahl mit einer zweiten Punktzahl durchzuführen, wobei die zweite Punktzahl einem zweiten Versuch für zweite Werte für die Übertaktungsparameter zugeordnet ist, wobei sich die zweiten Werte von den ersten Werten unterscheiden; und eines von den ersten Werten oder den zweiten Werten auszuwählen, um den Prozessor zu übertakten, basierend auf dem Vergleich.",INTEL CORP,YAN JIN;;XIONG HUI;;ZHU JIANFANG;;GONZALEZ FELIPE;;MACDONALD MARK;;RAGLAND DANIEL;;RODRIGUEZ RODNY;;FIFE MATTHEW;;LI YIFAN;;FLEMING KRISTOFFER,,https://lens.org/123-840-859-424-60X,Patent Application,no,0,0,3,3,0,G06F9/5027;;G06F1/08;;G06F1/206;;G06F1/3243;;Y02D10/00;;G06F1/206;;G06F1/08,G06F1/324,,0,0,,,,PENDING
698,US,A1,US 2007/0059840 A1,004-250-615-420-464,2007-03-15,2007,US 38356706 A,2006-05-16,US 38356706 A;;US 68137505 P,2005-05-16,Hemostasis Analysis Device and Method,"Apparatus for measuring hemostasis includes a container for holding a sample to be tested and a bobber configured to be buoyantly suspended on the sample. A magnet is secured to the bobber. A drive assembly is coupled to the container for driving the container in an oscillating motion. A magnetic field generator is disposed adjacent the container and configured to generate a magnetic field in the vicinity of the magnet. A magnetic field strength detector is disposed adjacent the container, and the magnetic field strength detector is configured to sense changes in the magnetic field as a result of movement of the bobber and magnet responsive to the oscillating motion of the container and clotting of the sample.",HAEMOSCOPE CORP,COHEN ELI;;CONTINI VINCENT J;;DELMENICO PETER;;FLEMING MATTHEW S;;HAUBERT THOMAS D;;RAVIV GABRIEL;;RAVIV RONNIE;;WILSON MARK R,CORA HEALTHCARE INC (2007-11-20);;HAEMONETICS CORPORATION (2020-01-10);;BATTELLE MEMORIAL INSTITUTE (2006-11-13);;CORAMED TECHNOLOGIES LLC (2008-05-20);;HAEMOSCOPE CORPORATION A DELAWARE CORPORATION (2006-04-18),https://lens.org/004-250-615-420-464,Patent Application,yes,7,72,2,2,0,G01N33/4905;;G01N2011/147;;G01N33/4905;;G01N2011/147,G01N33/86,436/69,0,0,,,,DISCONTINUED
699,EP,B1,EP 1417081 B1,052-377-785-811-58X,2010-11-10,2010,EP 02744828 A,2002-07-03,US 0221263 W;;US 90555301 A,2001-07-16,APPARATUS AND METHOD FOR MIXING AND DISPENSING AN ADDITIVE-ENHANCED SLURRY,,UNITED STATES GYPSUM CO,WITTBOLD JAMES R;;DUVEDI AMIT P;;HEMPHILL MARK K;;FLEMING WAYNE A;;PITTMAN WILFORD GARY;;MOORE KIRK S;;NELSON CHRISTOPHER,UNITED STATES GYPSUM COMPANY (2008-03-26),https://lens.org/052-377-785-811-58X,Granted Patent,yes,6,1,12,12,0,B28B19/0092;;B28C5/16;;B28C5/386;;B28C7/16;;B01F23/53;;B01F2025/917;;B01F27/811;;B01F35/75;;B01F2101/28;;B28C5/06;;C04B28/14;;C04B2111/0062;;B28B19/0092;;B28C5/16;;B28C5/386;;B28C7/16;;B01F35/75;;B01F23/53;;B01F27/811;;B01F2025/917;;B01F2101/28,B28C5/00;;B01F3/12;;B01F5/00;;B01F7/16;;B01F15/02;;B28B19/00;;B28C5/08;;B28C5/12;;B28C5/16;;B28C5/38;;B28C7/16,,0,0,,,,EXPIRED
700,AU,A1,AU 2017/241256 A1,132-202-063-493-300,2018-08-30,2018,AU 2017/241256 A,2017-03-20,EP 16163191 A;;EP 17160796 A;;US 2017/0023144 W,2016-03-31,Razor cartridge with fluid management,A razor cartridge comprising a housing (20) having elongated skin contacting elements (60) having a plurality of channels (62) extending there through to facilitate fluid flow.,GILLETTE CO LLC,JOLLEY WILLIAM OWEN;;PETERSON MARK;;SPOONER-FLEMING JOIA KIRIN;;STEPHENS ALISON FIONA;;TANDY JAMES;;WARRICK PAUL LESLIE;;WASHINGTON JACK ANTHONY,,https://lens.org/132-202-063-493-300,Patent Application,no,0,0,17,17,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,ACTIVE
701,NZ,A,NZ 529470 A,130-782-726-254-513,2005-10-28,2005,NZ 52947002 A,2002-07-03,US 90555301 A;;US 0221263 W,2001-07-16,Apparatus and method for mixing and dispensing an additive-enhanced slurry,"An apparatus and method for delivering an additive-enhanced slurry for use in making gypsum wallboard, and configured for connection to a centrifugal mixer with a tangential discharge outlet, includes a conduit having a main inlet in slurry receiving communication with the mixer outlet and extending to a discharge spout for discharging the slurry proximate a wallboard forming area. At least one volume restrictor is associated with the conduit for creating back pressure between the volume restrictor and the outlet for keeping the mixer full, and at least one pressure reducer associated with the discharge spout and configured for reducing the pressure of the slurry dispensed from the discharge spout. The apparatus is configured for maintaining a generally laminar flow from the mixer outlet to the discharge spout.",UNITED STATES GYPSUM CO,WITTBOLD JAMES R;;DUVEDI AMIT P;;HEMPHILL MARK K;;FLEMING WAYNE A;;PITTMAN WILFORD GARY;;MOORE KIRK S;;NELSON CHRISTOPHER,,https://lens.org/130-782-726-254-513,Patent Application,no,0,0,12,12,0,B28B19/0092;;B28C5/16;;B28C5/386;;B28C7/16;;B01F23/53;;B01F2025/917;;B01F27/811;;B01F35/75;;B01F2101/28;;B28C5/06;;C04B28/14;;C04B2111/0062;;B28B19/0092;;B28C5/16;;B28C5/386;;B28C7/16;;B01F35/75;;B01F23/53;;B01F27/811;;B01F2025/917;;B01F2101/28,B01F3/12;;B01F5/00;;B01F7/16;;B01F15/02;;B28B19/00;;B28C5/16;;B28C5/38;;B28C7/16,,0,0,,,,DISCONTINUED
702,WO,A1,WO 2023/147156 A1,151-456-172-892-30X,2023-08-03,2023,US 2023/0011940 W,2023-01-31,US 202217589872 A,2022-01-31,MICRO-OLED DISPLAY MODULE THERMAL MANAGEMENT,"A device includes a micro-organic light emitting diode (µ-OLED) display panel and an electronic component. An electrical connector electrically couples the µ-OLED display panel and the electronic component. A standoff is disposed between the electronic component and the µ-OLED display panel. The standoff physically couples the electronic component and the µ-OLED display panel with a gap therebetween. The gap thermally decouples the electronic component from the µ-OLED display panel. A U-shaped heat sink can be disposed in the standoff, and heat generated by the µ-OLED display can be mitigated by a system fan when a U-shaped heat sink is disposed in the standoff.",META PLATFORMS TECH LLC,ANDO MARK SHINTARO;;MOGHADDAM GITI KARIMI;;PARK KYUNG WON;;KLEMENT ALEXANDER;;FLEMING RYAN;;NAM DONGHEE;;KUO YI CHEN;;MOSKOWITZ DOUGLAS,,https://lens.org/151-456-172-892-30X,Patent Application,yes,3,0,2,2,0,G06F1/163;;G06F1/203;;G06F1/1637;;G02B27/0176;;G02B7/008;;H10K50/87;;H01L25/18;;H05K1/0204;;H05K1/189;;H05K7/20972;;H05K7/2099;;H05K2201/056;;H05K2201/10128;;H05K2201/10159;;H05K2201/2036,G06F1/20;;G06F1/16,,0,0,,,,PENDING
703,CA,C,CA 3015380 C,091-893-307-523-036,2020-09-29,2020,CA 3015380 A,2017-03-20,EP 16163191 A;;EP 17160796 A;;US 2017/0023144 W,2016-03-31,RAZOR CARTRIDGE WITH FLUID MANAGEMENT,A razor cartridge comprising a housing (20) having elongated skin contacting elements (60) having a plurality of channels (62) extending there through to facilitate fluid flow.,GILLETTE CO LLC,JOLLEY WILLIAM OWEN;;PETERSON MARK;;SPOONER-FLEMING JOIA KIRIN;;STEPHENS ALISON FIONA;;TANDY JAMES;;WARRICK PAUL LESLIE;;WASHINGTON JACK ANTHONY,,https://lens.org/091-893-307-523-036,Granted Patent,no,0,0,17,17,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,ACTIVE
704,CA,A1,CA 2446672 A1,130-178-274-953-645,2003-01-30,2003,CA 2446672 A,2002-07-03,US 90555301 A;;US 0221263 W,2001-07-16,APPARATUS AND METHOD FOR MIXING AND DISPENSING AN ADDITIVE-ENHANCED SLURRY,"An apparatus and method for delivering an additive-enhanced slurry for use i n making gypsum wallboard, and configured for connection to a centrifugal mixe r with a tangential discharge outlet, includes a conduit having a main inlet i n slurry receiving communication with the mixer outlet and extending to a discharge spout for discharging the slurry proximate a wallboard forming are a. At least one volume restrictor is associated with the conduit for creating back pressure between the volume restrictor and the outlet for keeping the mixer full, and at least one pressure reducer associated with the discharge spout and configured for reducing the pressure of the slurry dispensed from the discharge spout. The apparatus is configured for maintaining a generally laminar flow from the mixer outlet to the discharge spout.",UNITED STATES GYPSUM CO,WITTBOLD JAMES R;;DUVEDI AMIT P;;PITTMAN WILFORD GARY;;MOORE KIRK S;;NELSON CHRISTOPHER;;HEMPHILL MARK K;;FLEMING WAYNE A,,https://lens.org/130-178-274-953-645,Patent Application,no,0,0,12,12,0,B28B19/0092;;B28C5/16;;B28C5/386;;B28C7/16;;B01F23/53;;B01F2025/917;;B01F27/811;;B01F35/75;;B01F2101/28;;B28C5/06;;C04B28/14;;C04B2111/0062;;B28B19/0092;;B28C5/16;;B28C5/386;;B28C7/16;;B01F35/75;;B01F23/53;;B01F27/811;;B01F2025/917;;B01F2101/28,B01F3/12;;B01F5/00;;B01F7/16;;B01F15/02;;B28B19/00;;B28C5/16;;B28C5/38;;B28C7/16,,0,0,,,,EXPIRED
705,KR,A,KR 20180115713 A,198-080-362-018-106,2018-10-23,2018,KR 20187024905 A,2017-03-20,EP 16163191 A;;EP 17160796 A;;US 2017/0023144 W,2016-03-31,유체 관리를 갖는 면도기 카트리지,유체 유동을 용이하게 하기 위해 관통 연장되는 복수의 채널(62)을 갖는 긴 피부 접촉 요소(60)를 갖는 하우징(20)을 포함하는 면도기 카트리지.,GILLETTE CO LLC,JOLLEY WILLIAM OWEN;;PETERSON MARK;;SPOONER FLEMING JOIA KIRIN;;STEPHENS ALISON FIONA;;TANDY JAMES;;WARRICK PAUL LESLIE;;WASHINGTON JACK ANTHONY,,https://lens.org/198-080-362-018-106,Patent Application,no,2,1,17,17,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40;;B26B21/44,,0,0,,,,ACTIVE
706,EP,B1,EP 3231565 B1,174-765-445-952-966,2019-09-18,2019,EP 17160796 A,2017-03-14,EP 16163191 A,2016-03-31,RAZOR CARTRIDGE WITH FLUID MANAGEMENT,,GILLETTE CO LLC,JOLLEY WILLIAM OWEN;;PETERSON MARK;;SPOONER-FLEMING JOIA KIRIN;;STEPHENS ALISON FIONA;;TANDY JAMES;;WARRICK PAUL LESLIE;;WASHINGTON JACK ANTHONY,,https://lens.org/174-765-445-952-966,Granted Patent,yes,5,0,17,17,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,ACTIVE
707,SG,A,SG 11201808907P A,008-088-425-389-550,2018-11-29,2018,SG 11201808907P A,2017-04-14,US 201662322948 P;;US 201662411172 P;;US 2017/0027775 W,2016-04-15,INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE,,BLUEPRINT MEDICINES CORP,BROOIJMANS NATASJA;;BRUBAKER JASON;;CRONIN MARK;;FLEMING PAUL;;HODOUS BRIAN;;KIM JOSEPH;;WAETZIG JOSH;;WILLIAMS BRETT;;WILSON DOUGLAS;;WILSON KEVIN,,https://lens.org/008-088-425-389-550,Unknown,no,0,0,33,34,0,C07D487/04;;C07D519/00;;A61P19/00;;A61P25/00;;A61P35/00;;A61P43/00;;C07D487/04;;A61K31/5025;;C07D519/00;;A61P19/00;;A61K31/5025;;C07D487/04;;C07D519/00;;A61P35/00;;A61K31/5025;;A61K31/5377;;A61K31/5383;;C07D487/04;;C07D519/00,C07D487/04;;A61K31/5025;;A61P19/00;;C07D519/00,,0,0,,,,PENDING
708,BR,B1,BR 112018070030 B1,011-819-651-320-900,2022-03-08,2022,BR 112018070030 A,2017-03-20,US 2017/0023144 W;;EP 16163191 A;;EP 17160796 A,2016-03-31,Cartucho de aparelho de barbear ou depilar com sistema de gerenciamento de fluidos,a presente invenção refere-se a um cartucho de aparelho de barbear ou depilar que compreende um invólucro (20) que tem elementos alongados de contato com a pele (60) com uma pluralidade de canais (62) que se estendem através dos mesmos para facilitar o fluxo de fluidos.,GILLETTE CO LLC,ALISON FIONA STEPHENS;;JACK ANTHONY WASHINGTON;;TANDY JAMES;;JOIA KIRIN SPOONER-FLEMING;;PETERSON MARK;;PAUL LESLIE WARRICK;;WILLIAM OWEN JOLLEY,,https://lens.org/011-819-651-320-900,Granted Patent,no,0,0,17,17,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,ACTIVE
709,US,A1,US 2023/0247861 A1,011-234-536-203-094,2023-08-03,2023,US 202217589872 A,2022-01-31,US 202217589872 A,2022-01-31,MICRO-OLED DISPLAY MODULE THERMAL MANAGEMENT,"A device includes a micro-organic light emitting diode (μ-OLED) display panel and an electronic component. An electrical connector electrically couples the μ-OLED display panel and the electronic component. A standoff is disposed between the electronic component and the μ-OLED display panel. The standoff physically couples the electronic component and the μ-OLED display panel with a gap therebetween. The gap thermally decouples the electronic component from the μ-OLED display panel. A U-shaped heat sink can be disposed in the standoff, and heat generated by the μ-OLED display can be mitigated by a system fan when a U-shaped heat sink is disposed in the standoff.",FACEBOOK TECH LLC,MOGHADDAM GITI KARIMI;;MOSKOWITZ DOUGLAS;;PARK KYUNG WON;;FLEMING RYAN;;KLEMENT ALEXANDER;;NAM DONGHEE;;KUO YI-CHEN;;ANDO MARK SHINTARO,META PLATFORMS TECHNOLOGIES LLC (2015-10-02),https://lens.org/011-234-536-203-094,Patent Application,yes,0,0,2,2,0,G06F1/163;;G06F1/203;;G06F1/1637;;G02B27/0176;;G02B7/008;;H10K50/87;;H01L25/18;;H05K1/0204;;H05K1/189;;H05K7/20972;;H05K7/2099;;H05K2201/056;;H05K2201/10128;;H05K2201/10159;;H05K2201/2036,H01L25/18;;H05K1/02;;H05K1/18;;H05K7/20,,0,0,,,,PENDING
710,CN,A,CN 114490499 A,155-843-654-922-335,2022-05-13,2022,CN 202111188982 A,2021-10-12,US 202063113105 P;;US 202117313353 A,2020-11-12,"Systems, apparatuses, and methods for streaming input/output data","In one embodiment, a system includes a device and a host. The device includes a device stream buffer. The host comprises: a processor for executing at least a first application and a second application; a host stream buffer; and a host scheduler. The first application is associated with a first transmit streaming channel to stream first data from the first application to a device streaming buffer. The first transmit streaming channel has a first allocated amount of buffer space in the device streaming buffer. The host scheduler schedules enqueuing of the first data from the first application to the first transmit streaming channel based at least in part on spatial availability in a first allocated amount of buffer space in the device streaming buffer. Other embodiments are described and claimed.",INTEL COMPANY,MAUCHOUR LAURENT;;GANGA ILANGO;;COHEN RON;;DOSHI KSHITIJ A;;BROWNE JOHN J;;DEBBAGE MARK;;DOYLE STEPHEN;;FLEMING PAUL;;JAYASMUKHA DEEPAK,,https://lens.org/155-843-654-922-335,Patent Application,no,0,1,3,3,0,G06F15/17;;G06F15/17306;;G06F9/4881;;G06F9/5038;;G06F2209/484;;G06F2209/5021;;H04L47/621;;H04L47/6255;;H04L47/6275;;H04L47/2416;;H04L47/39;;G06F9/544;;H04L47/50;;H04L65/61;;H04L49/9005,G06F15/17;;G06F9/48;;G06F9/50;;G06F15/173,,0,0,,,,PENDING
711,WO,A1,WO 2023/147153 A1,161-170-098-981-337,2023-08-03,2023,US 2023/0011935 W,2023-01-31,US 202217589880 A,2022-01-31,MICRO-OLED DISPLAY MODULE THERMAL MANAGEMENT,"A device includes a micro-organic light emitting diode (µ-OLED) display panel and an electronic component. An electrical connector electrically couples the µ-OLED display panel and the electronic component. An air duct is physically coupled to the µ-OLED display panel and the electronic component. The air duct functions to cool the µ-OLED display panel when air flows through the air duct. A system fan provides air flow to the air duct and dissipates heat away from the display panel. A system fan can be located disconnected from the µ-OLED display panel and can provide air flow to the air duct to dissipate heat away from the display panel. The device can be implemented with a single fan solution or a multiple fan solution (e.g., two or more fans).",META PLATFORMS TECH LLC,ANDO MARK SHINTARO;;MOGHADDAM GITI KARIMI;;PARK KYUNG WON;;KLEMENT ALEXANDER;;FLEMING RYAN;;NAM DONGHEE;;KUO YI-CHEN;;MOSKOWITZ DOUGLAS,,https://lens.org/161-170-098-981-337,Patent Application,yes,4,0,2,2,0,G02B27/0176;;G06F1/163;;G06F1/1637;;G06F1/203;;H10K50/87;;G06F1/163;;H05K5/0017;;H05K7/20145;;H05K7/2039,G06F1/20;;G06F1/16,,0,0,,,,PENDING
712,EP,A1,EP 1417081 A1,121-268-792-915-465,2004-05-12,2004,EP 02744828 A,2002-07-03,US 0221263 W;;US 90555301 A,2001-07-16,APPARATUS AND METHOD FOR MIXING AND DISPENSING AN ADDITIVE-ENHANCED SLURRY,,UNITED STATES GYPSUM CO,WITTBOLD JAMES R;;DUVEDI AMIT P;;HEMPHILL MARK K;;FLEMING WAYNE A;;PITTMAN WILFORD GARY;;MOORE KIRK S;;NELSON CHRISTOPHER,UNITED STATES GYPSUM COMPANY (2008-03-26),https://lens.org/121-268-792-915-465,Patent Application,yes,0,0,12,12,0,B28B19/0092;;B28C5/16;;B28C5/386;;B28C7/16;;B01F23/53;;B01F2025/917;;B01F27/811;;B01F35/75;;B01F2101/28;;B28C5/06;;C04B28/14;;C04B2111/0062;;B28B19/0092;;B28C5/16;;B28C5/386;;B28C7/16;;B01F35/75;;B01F23/53;;B01F27/811;;B01F2025/917;;B01F2101/28,B01F3/12;;B01F5/00;;B01F7/16;;B01F15/02;;B28B19/00;;B28C5/16;;B28C5/38;;B28C7/16,,0,0,,,,EXPIRED
713,US,B1,US 6494609 B1,138-165-903-467-673,2002-12-17,2002,US 90555301 A,2001-07-16,US 90555301 A,2001-07-16,Slurry mixer outlet,"
    An apparatus and method for delivering an additive-enhanced slurry for use in making gypsum wallboard, and configured for connection to a centrifugal mixer with a tangential discharge outlet, includes a conduit having a main inlet in slurry receiving communication with the mixer outlet and extending to a discharge spout for discharging the slurry proximate a wallboard forming area. At least one volume restrictor is associated with the conduit for creating back pressure between the volume restrictor and the outlet for keeping the mixer fill, and at least one pressure reducer associated with the discharge spout and configured for reducing the pressure of the slurry dispensed from the discharge spout. The apparatus is configured for maintaining a generally laminar flow from the mixer outlet to the discharge spout. 
",UNITED STATES GYPSUM CO,WITTBOLD JAMES R;;DUVEDI AMIT P;;HEMPHILL MARK K;;FLEMING WAYNE A;;PITTMAN WILFORD GARY;;MOORE KIRK S;;NELSON CHRISTOPHER,UNITED STATES GYPSUM COMPANY (2001-08-23),https://lens.org/138-165-903-467-673,Granted Patent,yes,20,201,12,12,0,B28B19/0092;;B28C5/16;;B28C5/386;;B28C7/16;;B01F23/53;;B01F2025/917;;B01F27/811;;B01F35/75;;B01F2101/28;;B28C5/06;;C04B28/14;;C04B2111/0062;;B28B19/0092;;B28C5/16;;B28C5/386;;B28C7/16;;B01F35/75;;B01F23/53;;B01F27/811;;B01F2025/917;;B01F2101/28,B01F3/12;;B01F5/00;;B01F7/16;;B01F15/02;;B28B19/00;;B28C5/16;;B28C5/38;;B28C7/16,366/192;;366/194;;366/315,0,0,,,,EXPIRED
714,US,A1,US 2023/0247811 A1,095-792-580-480-252,2023-08-03,2023,US 202217589876 A,2022-01-31,US 202217589876 A,2022-01-31,MICRO-OLED DISPLAY MODULE THERMAL MANAGEMENT,"A device includes a micro-organic light emitting diode (µ-OLED) display panel and an electronic component. An electrical connector electrically couples the µ-OLED display panel and the electronic component. A standoff is disposed between the electronic component and the µ-OLED display panel. The standoff physically couples the electronic component and the µ-OLED display panel with a gap therebetween. The gap thermally decouples the electronic component from the µ-OLED display panel. A fan that is integrated with the µ-OLED display panel is placed in the standoff and actively cools the display panel. When the fan provides air flow over the µ-OLED display panel, heat generated by the µ-OLED display is mitigated by cooling air.",FACEBOOK TECH LLC,MOGHADDAM GITI KARIMI;;MOSKOWITZ DOUGLAS;;PARK KYUNG WON;;FLEMING RYAN;;KLEMENT ALEXANDER;;NAM DONGHEE;;KUO YI-CHEN;;ANDO MARK SHINTARO,META PLATFORMS TECHNOLOGIES LLC (2022-04-27),https://lens.org/095-792-580-480-252,Patent Application,yes,0,0,3,3,0,G06F1/163;;G06F1/1637;;G06F1/203;;G02B27/0176;;G06F3/011;;G02B27/0172;;H10K50/87;;G02B27/0176;;H05K7/20972;;G06F1/163,G02B27/01;;H05K7/20,,0,0,,,,PENDING
715,FI,T3,FI 3442977 T3,026-126-960-440-538,2023-09-26,2023,FI 17733108 T,2017-04-14,US 201662322948 P;;US 201662411172 P;;US 2017/0027775 W,2016-04-15,INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE,,BLUEPRINT MEDICINES CORP,BROOIJMANS NATASJA;;BRUBAKER JASON;;FLEMING PAUL;;HODOUS BRIAN;;KIM JOSEPH;;WAETZIG JOSH;;WILLIAMS BRETT;;WILSON DOUGLAS;;WILSON KEVIN;;CRONIN MARK,,https://lens.org/026-126-960-440-538,Unknown,no,0,0,33,34,0,C07D487/04;;C07D519/00;;A61P19/00;;A61P25/00;;A61P35/00;;A61P43/00;;C07D487/04;;A61K31/5025;;C07D519/00;;A61P19/00;;A61K31/5025;;C07D487/04;;C07D519/00;;A61P35/00;;A61K31/5025;;A61K31/5377;;A61K31/5383;;C07D487/04;;C07D519/00,C07D487/04;;A61K31/5025;;A61P19/00;;C07D519/00,,0,0,,,,PENDING
716,MX,A,MX 2018011829 A,137-527-370-154-058,2019-02-13,2019,MX 2018011829 A,2017-03-20,EP 16163191 A;;EP 17160796 A;;US 2017/0023144 W,2016-03-31,RAZOR CARTRIDGE WITH FLUID MANAGEMENT.,A razor cartridge comprising a housing (20) having elongated skin contacting elements (60) having a plurality of channels (62) extending there through to facilitate fluid flow.,GILLETTE CO LLC,MARK PETERSON;;JACK ANTHONY WASHINGTON;;ALISON FIONA STEPHENS;;PAUL LESLIE WARRICK;;WILLIAM OWEN JOLLEY;;JOIA KIRIN SPOONER-FLEMING;;JAMES TANDY,,https://lens.org/137-527-370-154-058,Patent Application,no,0,0,17,17,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,PENDING
717,US,B2,US 10606751 B2,072-751-708-037-087,2020-03-31,2020,US 201615201348 A,2016-07-01,US 201615201348 A,2016-07-01,Techniques for cache delivery,"An input/output (I/O) device arranged to receive an information element including a payload, determine control information from the information element, classify the information element based on the control information, and issue a write to one of a plurality of computer-readable media based on the classification of the information element, the write to cause the payload to be written to the one of the plurality of computer-readable media.",INTEL CORP,CUNNINGHAM ANDREW;;GRAY MARK D;;LECKEY ALEXANDER;;MACNAMARA CHRIS;;PALERMO STEPHEN T;;LAURENT PIERRE;;MCDONNELL NIALL D;;KANTECKI TOMASZ;;FLEMING PATRICK,INTEL CORPORATION (2016-11-07),https://lens.org/072-751-708-037-087,Granted Patent,yes,6,0,2,2,0,G06F12/06;;G06F12/0811;;G06F12/0831;;G06F12/126;;G06F2212/283;;G06F2212/621,G06F12/0811;;G06F12/0831,,0,0,,,,ACTIVE
718,US,A1,US 2021/0138035 A1,025-617-632-271-309,2021-05-13,2021,US 201816618021 A,2018-05-30,US 201816618021 A;;US 201862675659 P;;US 201862675680 P;;US 201862675714 P;;US 201762512661 P;;US 201762512673 P;;US 201762512695 P;;US 2018/0035144 W,2017-05-30,C3 FUSION PROTEIN AND METHODS OF MAKING AND USING THEREOF,"The present invention provides, among other things, improved therapeutic compositions comprising a C3 fusion protein and methods of making and using the same. In particular, the present invention provides improved methods for the treatment of spinal cord injury and other CNS trauma and/or facilitate axon growth or other tissue repair.",BIOAXONE BIOSCIENCES INC,BORJAS RICARDO;;FLEMING MARK;;HUANG MEI;;JAIN MAYUR;;SANGHVI TAPAN;;SAXENA KUMKUM;;TORRES-DELGADO AMARIS;;YIN PING;;MCKERRACHER LISA;;RYU ELIZABETH,,https://lens.org/025-617-632-271-309,Patent Application,yes,0,1,6,6,28,A61K38/363;;A61K38/45;;C12Y204/02036;;C12N9/1077;;C07K2319/10;;A61P25/02;;A61P25/28;;Y02A50/30;;A61K38/1725;;A61K38/363;;A61K38/38;;A61K38/57;;C07K14/472;;C07K2319/70;;C12N9/1077;;C12Y204/02036,A61K38/17;;A61K38/36;;A61K38/38;;A61K38/57;;C07K14/47;;C12N9/10,,0,0,,,,ACTIVE
719,US,A1,US 2018/0004662 A1,064-234-604-750-288,2018-01-04,2018,US 201615201348 A,2016-07-01,US 201615201348 A,2016-07-01,TECHNIQUES FOR CACHE DELIVERY,"An input/output (I/O) device arranged to receive an information element including a payload, determine control information from the information element, classify the information element based on the control information, and issue a write to one of a plurality of computer-readable media based on the classification of the information element, the write to cause the payload to be written to the one of the plurality of computer-readable media.",INTEL CORP,CUNNINGHAM ANDREW;;GRAY MARK D;;LECKEY ALEXANDER;;MACNAMARA CHRIS;;PALERMO STEPHEN T;;LAURENT PIERRE;;MCDONNELL NIALL D;;KANTECKI TOMASZ;;FLEMING PATRICK,INTEL CORPORATION (2016-11-07),https://lens.org/064-234-604-750-288,Patent Application,yes,10,1,2,2,0,G06F12/06;;G06F12/0811;;G06F12/0831;;G06F12/126;;G06F2212/283;;G06F2212/621,G06F12/0811;;G06F12/0831,,0,0,,,,ACTIVE
720,WO,A1,WO 2018/222723 A1,014-465-078-568-455,2018-12-06,2018,US 2018/0035144 W,2018-05-30,US 201862675659 P;;US 201862675680 P;;US 201862675714 P;;US 201762512661 P;;US 201762512673 P;;US 201762512695 P,2017-05-30,C3 FUSION PROTEIN AND METHODS OF MAKING AND USING THEREOF,"The present invention provides, among other things, improved therapeutic compositions comprising a C3 fusion protein and methods of making and using the same. In particular, the present invention provides improved methods for the treatment of spinal cord injury and other CNS trauma and/or facilitate axon growth or other tissue repair.",VERTEX PHARMA;;BIOAXONE BIOSCIENCES INCORPORATED,BORJAS RICARDO;;FLEMING MARK;;HUANG MEI;;JAIN MAYUR;;SANGHVI TAPAN;;SAXENA KUMKUM;;TORRES-DELGADO AMARIS;;YIN PING;;MCKERRACHER LISA;;RYU ELIZABETH,,https://lens.org/014-465-078-568-455,Patent Application,yes,3,0,6,6,28,A61K38/363;;A61K38/45;;C12Y204/02036;;C12N9/1077;;C07K2319/10;;A61P25/02;;A61P25/28;;Y02A50/30;;A61K38/1725;;A61K38/363;;A61K38/38;;A61K38/57;;C07K14/472;;C07K2319/70;;C12N9/1077;;C12Y204/02036,C12N9/10;;A61K38/45,,11,9,008-587-496-850-953;;051-940-176-386-905;;065-430-968-783-392;;021-430-782-622-770;;037-487-530-502-017;;010-511-971-314-449;;037-487-530-502-017;;033-085-765-353-127;;016-211-023-381-848,886304;;10.1099/0022-1317-36-1-59;;10.1073/pnas.77.7.4216;;pmc349802;;6933469;;10.1095/biolreprod23.1.243;;6774781;;10.1111/j.1749-6632.1982.tb23161.x;;7046561;;10.1074/jbc.m910362199;;10748216;;10.1074/jbc.m201195200;;12091381;;10.1074/jbc.m910362199;;10748216;;10.1074/jbc.m011035200;;11124969;;10.1001/jama.1944.02850140022006,"GRAHAM ET AL., J. GEN VIROL., vol. 36, 1977, pages 59;;URLAUB; CHASIN, PROC. NATL. ACAD. SCI. USA, vol. 77, 1980, pages 4216;;MATHER, BIOL. REPROD., vol. 23, 1980, pages 243 - 251;;MATHER ET AL., ANNALS N.Y. ACAD. SCI., vol. 383, 1982, pages 44 - 68;;SAITO ET AL., FEES LETT, vol. 371, 1995, pages 105 - 109;;WILDE ET AL., J. BIOL. CHEM., vol. 275, 2000, pages 16478;;WINTON ET AL., J. BIOL. CHEM., vol. 277, 2002, pages 32820 - 32829;;WILDE ET AL., BIOL. CHEM., vol. 275, 2001, pages 16478 - 16483;;WILDE ET AL., J. BIOL. CHEM., vol. 276, 2001, pages 9537 - 9542;;CRONKITE, E. P. ET AL., J.A.M.A., vol. 124, 1944, pages 976;;TIDRICK, R. T.; WARNER, E. D., SURGERY, vol. 15, 1944, pages 90",PENDING
721,EP,A3,EP 2246925 A3,018-236-377-566-448,2010-12-22,2010,EP 10159389.5,2010-04-08,,,Inhibitor for prevention of braze migration in solid oxide fuel cells,"During manufacture of an SOFC assembly, an inhibitor is included to prevent migration of silver braze during subsequent use of the SOFC assembly. The inhibitor may take any of several forms, either individually or in combination. Inhibitors comprehended by the present invention include, but are not limited to: a) a mechanical barrier (146) that can be printed or dispensed onto one or more SOFC stack elements around the braze (38) areas to prevent mechanically-driven migration; b) an electrically insulating feature (150) in the electrolyte or interlayer over the electrolyte layer (34) in the seal margins to prevent electrical potential-driven migration; and c) chemical modification of the braze (138) itself as by addition of an alloying metal such as palladium.
","Delphi Technologies, Inc.","DeRose, Anthony J.;;Maczinski, Stefan Mark;;Fleming, Carolyn Deborah;;Mukerjee, Subhasish;;Kerr, Rick Daniel;;Haltiner JR., Karl Jacob;;Keller, Joseph Michael",,https://lens.org/018-236-377-566-448,Search Report,yes,0,0,1,1,0,,H01M8/02;;H01M8/12,,0,0,,,,UNKNOWN
722,EP,A1,EP 3630963 A1,043-401-176-950-155,2020-04-08,2020,EP 18733071 A,2018-05-30,US 201762512695 P;;US 201762512673 P;;US 201762512661 P;;US 201862675659 P;;US 201862675680 P;;US 201862675714 P;;US 2018/0035144 W,2017-05-30,C3 FUSION PROTEIN AND METHODS OF MAKING AND USING THEREOF,,BIOAXONE BIOSCIENCES INC,BORJAS RICARDO;;FLEMING MARK;;HUANG MEI;;JAIN MAYUR;;SANGHVI TAPAN;;SAXENA KUMKUM;;TORRES-DELGADO AMARIS;;YIN PING;;MCKERRACHER LISA;;RYU ELIZABETH,,https://lens.org/043-401-176-950-155,Patent Application,yes,0,0,6,6,0,A61K38/363;;A61K38/45;;C12Y204/02036;;C12N9/1077;;C07K2319/10;;A61P25/02;;A61P25/28;;Y02A50/30;;A61K38/1725;;A61K38/363;;A61K38/38;;A61K38/57;;C07K14/472;;C07K2319/70;;C12N9/1077;;C12Y204/02036,C12N9/10;;A61K38/45,,0,0,,,,PENDING
723,EP,A3,EP 2246925 A3,062-809-782-257-244,2011-08-03,2011,EP 10159389 A,2010-04-08,US 43392009 A,2009-05-01,Inhibitor for prevention of braze migration in solid oxide fuel cells,"During manufacture of an SOFC assembly, an inhibitor is included to prevent migration of silver braze during subsequent use of the SOFC assembly. The inhibitor may take any of several forms, either individually or in combination. Inhibitors comprehended by the present invention include, but are not limited to: a) a mechanical barrier (146) that can be printed or dispensed onto one or more SOFC stack elements around the braze (38) areas to prevent mechanically-driven migration; b) an electrically insulating feature (150) in the electrolyte or interlayer over the electrolyte layer (34) in the seal margins to prevent electrical potential-driven migration; and c) chemical modification of the braze (138) itself as by addition of an alloying metal such as palladium.
",DELPHI TECH INC,DEROSE ANTHONY J;;MACZINSKI STEFAN MARK;;FLEMING CAROLYN DEBORAH;;MUKERJEE SUBHASISH;;KERR RICK DANIEL;;HALTINER JR KARL JACOB;;KELLER JOSEPH MICHAEL,,https://lens.org/062-809-782-257-244,Search Report,yes,8,0,4,4,0,H01M8/0282;;H01M8/0286;;H01M8/124;;H01M2008/1293;;Y02P70/50;;Y02E60/50;;H01M8/0273;;H01M2008/1293;;H01M8/124;;H01M8/0282;;H01M8/0271;;H01M8/0286;;Y02P70/50,H01M8/12;;H01M8/02,,3,3,146-350-860-805-752;;115-631-185-552-443;;021-484-388-674-592,10.1149/1.1590325;;10.1016/j.msea.2007.08.032;;10.1007/s11661-008-9565-7,"ZHENGUO YANG ET AL: ""Chemical Compatibility of Barium-Calcium-Aluminosilicate-Based Sealing Glasses with the Ferritic Stainless Steel Interconnect in SOFCs"", JOURNAL OF THE ELECTROCHEMICAL SOCIETY, vol. 150, no. 8, 23 June 2003 (2003-06-23), pages A1095 - A1101, XP002597307;;SINGH, M.A EMAIL THIS AUTHOR, SHPARGEL, T.P.B , ASTHANA, R.C: ""Braze oxidation behavior and joint microstructure in YSZ/steel joints made using palladium brazes for SOFC applications"", MATERIALS SCIENCE AND ENGINEERING A, vol. 485, 25 June 2008 (2008-06-25), pages 695 - 702, XP002640051, DOI: 10.1016/j.msea.2007.08.032;;DARSELL, J.T.A B , WEIL, K.S.B: ""Effect of filler metal composition on the strength of Yttria stabilized zirconia joints brazed with Pd-Ag-CuOx"", METALLURGICAL AND MATERIALS TRANSACTIONS A: PHYSICAL METALLURGY AND MATERIALS SCIENCE, vol. 39, no. 9, 9 September 2008 (2008-09-09), pages 2095 - 2105, XP002640052, DOI: 10.1007/s11661-008-9565-7",DISCONTINUED
724,EP,A2,EP 2246925 A2,071-855-884-310-994,2010-11-03,2010,EP 10159389 A,2010-04-08,US 43392009 A,2009-05-01,Inhibitor for prevention of braze migration in solid oxide fuel cells,"During manufacture of an SOFC assembly, an inhibitor is included to prevent migration of silver braze during subsequent use of the SOFC assembly. The inhibitor may take any of several forms, either individually or in combination. Inhibitors comprehended by the present invention include, but are not limited to: a) a mechanical barrier (146) that can be printed or dispensed onto one or more SOFC stack elements around the braze (38) areas to prevent mechanically-driven migration; b) an electrically insulating feature (150) in the electrolyte or interlayer over the electrolyte layer (34) in the seal margins to prevent electrical potential-driven migration; and c) chemical modification of the braze (138) itself as by addition of an alloying metal such as palladium.
",DELPHI TECH INC,DEROSE ANTHONY J;;MACZINSKI STEFAN MARK;;FLEMING CAROLYN DEBORAH;;MUKERJEE SUBHASISH;;KERR RICK DANIEL;;HALTINER JR KARL JACOB;;KELLER JOSEPH MICHAEL,,https://lens.org/071-855-884-310-994,Patent Application,yes,2,2,4,4,0,H01M8/0282;;H01M8/0286;;H01M8/124;;H01M2008/1293;;Y02P70/50;;Y02E60/50;;H01M8/0273;;H01M2008/1293;;H01M8/124;;H01M8/0282;;H01M8/0271;;H01M8/0286;;Y02P70/50,H01M8/02;;H01M8/12,,0,0,,,,DISCONTINUED
725,US,B2,US 11324802 B2,178-836-893-911-317,2022-05-10,2022,US 201816618021 A,2018-05-30,US 201816618021 A;;US 201862675659 P;;US 201862675680 P;;US 201862675714 P;;US 201762512661 P;;US 201762512673 P;;US 201762512695 P;;US 2018/0035144 W,2017-05-30,C3 fusion protein and methods of making and using thereof,"The present invention provides, among other things, improved therapeutic compositions comprising a C3 fusion protein and methods of making and using the same. In particular, the present invention provides improved methods for the treatment of spinal cord injury and other CNS trauma and/or facilitate axon growth or other tissue repair.",BIOAXONE BIOSCIENCES INC,BORJAS RICARDO;;FLEMING MARK;;HUANG MEI;;JAIN MAYUR;;SANGHVI TAPAN;;SAXENA KUMKUM;;TORRES-DELGADO AMARIS;;YIN PING;;MCKERRACHER LISA;;RYU ELIZABETH,,https://lens.org/178-836-893-911-317,Granted Patent,yes,12,0,6,6,28,A61K38/363;;A61K38/45;;C12Y204/02036;;C12N9/1077;;C07K2319/10;;A61P25/02;;A61P25/28;;Y02A50/30;;A61K38/1725;;A61K38/363;;A61K38/38;;A61K38/57;;C07K14/472;;C07K2319/70;;C12N9/1077;;C12Y204/02036,A61K38/17;;A61K38/36;;A61K38/38;;A61K38/57;;C07K14/47;;C12N9/10,,60,55,056-331-009-417-186;;089-802-358-104-618;;040-668-904-374-533;;005-807-326-459-612;;089-424-344-771-318;;110-765-241-960-807;;099-352-760-061-502;;091-771-858-210-09X;;013-654-491-707-080;;030-731-395-248-681;;089-588-128-384-306;;021-596-058-470-665;;099-445-964-487-33X;;013-073-888-551-015;;002-751-464-503-90X;;042-484-028-937-573;;044-539-642-373-42X;;028-210-680-408-263;;035-003-295-189-836;;094-555-138-565-717;;116-035-360-234-545;;033-952-167-546-490;;061-490-400-379-011;;040-526-476-182-354;;169-691-184-356-09X;;011-003-942-511-553;;018-153-023-672-776;;014-175-533-400-190;;148-473-048-671-450;;028-118-102-633-352;;014-983-112-571-130;;003-330-348-613-846;;083-199-152-082-343;;057-860-883-496-378;;012-110-104-015-075;;011-601-783-400-636;;031-572-126-430-11X;;045-255-770-550-162;;080-623-403-054-445;;063-676-240-224-405;;024-937-137-642-690;;001-050-356-149-589;;080-628-440-184-41X;;023-274-796-284-670;;089-595-635-124-301;;005-912-082-145-645;;080-855-703-935-212;;144-404-938-706-753;;094-392-245-890-191;;028-700-499-776-629;;061-966-985-403-670;;038-050-001-380-557;;159-464-552-763-455;;006-353-894-731-664;;019-229-551-198-769,15215523;;pmc2279930;;10.1110/ps.04679104;;10.1038/nrn1955;;16858391;;12450290;;10.3171/spi.2002.96.2.0250;;10.1002/glia.22278;;22139636;;20478597;;10.1016/j.juro.2010.03.008;;7717822;;10.1016/s0003-9993(95)80615-6;;20581748;;10.1097/brs.0b013e3181c3e963;;10952316;;10.1038/35020106;;20698759;;10.1089/neu.2010.1441;;10.1682/jrrd.2005.02.0045;;16586184;;10.1038/nm1007;;15004554;;21097398;;12151536;;20026637;;pmc6758168;;10.1523/jneurosci.22-15-06570.2002;;12860969;;pmc2172802;;10.1083/jcb.200301080;;16448651;;10.1016/j.expneurol.2005.12.002;;10.1089/neu.2011.1765;;21381984;;10.1038/sc.2009.10;;19255587;;12598630;;pmc6742251;;10.1523/jneurosci.23-04-01416.2003;;10.1016/j.brainres.2009.07.087;;19651108;;10.1517/14728222.2011.553605;;21281256;;14637115;;10.1016/s0014-4886(03)00257-7;;10.1523/jneurosci.5343-03.2004;;pmc6729422;;15102919;;12165135;;10.1089/08977150260139129;;15910245;;10.1089/scd.2005.14.188;;17364894;;10.1080/10623320601177288;;10757326;;10.1089/neu.2000.17.203;;10.1038/nm1060;;15195086;;10.1016/s0065-230x(02)84003-9;;11883532;;10.1089/089771503767869944;;12965050;;10.3171/2010.4.spine09685;;20887153;;10.1002/jnr.21502;;17828770;;10.1016/j.jns.2010.09.025;;21071039;;15087796;;10.1097/01.brs.0000112068.16108.3a;;17679775;;pmc2868135;;10.4142/jvs.2007.8.3.275;;10.1007/s11884-007-0012-1;;10.1089/neu.2008.0613;;19061375;;10.1007/978-94-007-2801-1_2;;11826115;;10.1523/jneurosci.22-03-00854.2002;;pmc6758473;;21375803;;10.3727/096368911x566163;;22500090;;pmc3304690;;10.1155/2012/362473;;10.1038/nm1056;;15156204;;12895439;;10.1016/s0014-4886(03)00120-1;;pmc6730209;;15574730;;10.1523/jneurosci.3337-04.2004;;10.1093/brain/awr222;;21903726;;10.1016/s0304-3959(99)00023-8;;10353507;;10.1016/s0304-3959(02)00452-9;;12791431;;10.1016/s0006-8993(02)03717-4;;12480155;;10.1046/j.1471-4159.1996.66020549.x;;8592124;;17529971;;10.1038/nbt1310;;10.1016/s0079-6123(02)37009-2;;12440361;;10.1038/sc.2010.69;;20531359;;21323535;;10.1056/nejmp1101548;;10.1038/sc.2011.126;;22105463;;10.1089/neu.2004.21.932;;10.1089/0897715041526221;;15307905;;10.3727/096368909x471251;;19523343,"TISSEEL (Highlights of prescribing information; 2013).;;You-Di Liao et al. (Protein Science (2004), 13:1802-1810).;;International Search Report and Written Opinion for International Application No. PCT/US2018/035144, dated Oct. 4, 2018 (12 pages).;;Thuret et al., “Therapeutic Interventions After Spinal Cord Injury,” Nat Rev Neurosci. 7(11): 628-643 (2006).;;Black, “Cerebrospinal Fluid Leaks Following Spinal Surgery: Use of Fat Grafts for Prevention and Repair. Technical Note,” J Neurosurg. 96(2):250-252 (2002).;;Boomkamp et al., “The Development of a Rat in Vitro Model of Spinal Cord Injury Demonstrating the Additive Effects of Rho and ROCK Inhibitors on Neurite Outgrowth and Myelination,” Glia. 60(3): 441-56 (2012).;;Cameron et al., “Bladder Management After Spinal Cord Injury in the United States 1972 to 2005,” J Urol. 184(1): 213-7 (2010).;;Campagnolo et al., Acute medical and surgical management of spinal cord injury. Spinal Cord Medicine, Philadelphia: Lippincott, Williams & Wilkins 96-107 (2002).;;Cardenas et al., “Urinary Tract Infection in Persons With Spinal Cord Injury,” Arch Phys Med Rehabil. 76(3): 272-80 (1995).;;Chua et al., “The Effect of Umbilical Cord Blood Cells on Outcomes After Experimental Traumatic Spinal Cord Injury,” Spine. 35(16): 1520-6 (2010).;;Clark et al., “Genomic Analysis of Metastasis Reveals an Essential Role for RhoC,” Nature. 406(6795): 532-5 (2000).;;Cormier et al., “Development of Autonomic Dysreflexia After Spinal Cord Injury Is Associated With a Lack of Serotonergic Axons in the Intermediolateral Cell Column,” J Neurotrauma. 27(10): 1805-18 (2010).;;Cruz-Almeida et al., “Chronicity of Pain Associated With Spinal Cord Injury: A Longitudinal Analysis,” J Rehabil Res Dev. 42(5): 585-94 (2005).;;Demjen et al., “Neutralization of CD95 Ligand Promotes Regeneration and Functional Recovery After Spinal Cord Injury,” Nat Med. 10(4): 389-95 (2004).;;Deng et al., “Lithium Chloride Combined With Human Umbilical Cord Blood Mesenchymal Stem Cell Transplantation for Treatment of Spinal Cord Injury in Rats,” J Southern Med. 30(11): 2436-9 (Translated abstract) (2010).;;Dergham et al., “Rho Signaling Pathway Targeted to Promote Spinal Cord Repair,” J Neurosci. 22(15): 6570-7 (2002).;;Dubreuil et al., “Rho Activation Patterns After Spinal Cord Injury and the Role of Activated Rho in Apoptosis in the Central Nervous System,” J Cell Biol. 162(2): 233-43 (2003).;;Dubreuil et al., “Activation of Rho After Traumatic Brain Injury and Seizure in Rats,” Exp Neurol. 198(2): 361-9 (2006).;;Fehlings et al., “A Phase I/IIa Clinical Trial of a Recombinant Rho Protein Antagonist in Acute Spinal Cord Injury,” J Neurotrauma. 28(5): 787-96 (2011).;;Fouad et al., “Transplantation and Repair: Combined Cell Implantation and Chondroitinase Delivery Prevents Deterioration of Bladder Function in Rats With Complete Spinal Cord Injury,” Spinal Cord. 47(10): 727-32 (2009).;;Fournier et al., “Rho Kinase Inhibition Enhances Axonal Regeneration in the Injured CNS,” J Neurosci 23(4): 1416-23 (2003).;;Furuya et al., “Treatment of Rat Spinal Cord Injury With a Rho-kinase Inhibitor and Bone Marrow Stromal Cell Transplantation,” Brain Res. 1295: 192-202 (2009).;;Gensel et al., “Spinal Cord Injury Therapies in Humans: An Overview of Current Clinical Trials and Their Potential Effects on Intrinsic CNS Macrophages,” Expert Opin Ther Targets. 15(4): 505-18 (2011).;;Gonzalez et al., “Reducing Inflammation Decreases Secondary Degeneration and Functional Deficit After Spinal Cord Injury,” Exp Neurol 184(1): 456-63 (2003).;;Gris et al., “Transient Blockade of the CD11d/CD18 Integrin Reduces Secondary Damage After Spinal Cord Injury, Improving Sensory, Autonomic, and Motor Function,” J Neurosci. 24(16): 4043-51 (2004).;;Hayes et al., “Elevated Serum Titers of Proinflammatory Cytokines and CNS Autoantibodies in Patients With Chronic Spinal Cord Injury,” J Neurotrauma. 19(6): 753-61 (2002).;;He et al., “Differential Gene Expression Profiling of CD34+ CD133+ Umbilical Cord Blood Hematopoietic Stem Progenitor Cells,” Stem Cells Dev. 14(2): 188-98 (2005).;;Huang et al., “A Novel Lysophospholipid- And pH-sensitive Receptor, GPR4, in Brain Endothelial Cells Regulates Monocyte Transmigration,” Endothelium. 14(1): 25-34 (2007).;;Hayashi et al., “Sequential mRNA Expression for Immediate Early Genes, Cytokines, and Neurotrophins in Spinal Cord Injury,” J Neurotrauma. 17(3): 203-18 (2000).;;Inoue et al., “Initiation of Neuropathic Pain Requires Lysophosphatidic Acid Receptor Signaling,” Nat Med. 10(7): 712-8 (2004).;;Jaffe et al., “Rho GTPases in Transformation and Metastasis,” Adv Cancer Res. 84: 57-80 (2002).;;Krassioukov et al., “Autonomic Dysreflexia in Acute Spinal Cord Injury: An Under-Recognized Clinical Entity,” J Neurotrauma. 20(8): 707-16 (2003).;;Kaner et al., “The Effects of Human Umbilical Cord Blood Transplantation in Rats With Experimentally Induced Spinal Cord Injury,” J Neurosurg Spine 13(4): 543-51 (2010).;;Koyanagi et al., “Inhibition of the Rho/ROCK Pathway Reduces Apoptosis During Transplantation of Embryonic Stem Cell-Derived Neural Precursors,” J Neurosci Res. 86(2): 270-80 (2008).;;Lee et al., “Schwann Cell-Like Remyelination Following Transplantation of Human Umbilical Cord Blood (hUCB)-derived Mesenchymal Stem Cells in Dogs With Acute Spinal Cord Injury,” J Neurol Sci. 300(1-2): 86-96 (2011).;;Levendoglu et al., “Gabapentin Is a First Line Drug for the Treatment of Neuropathic Pain in Spinal Cord Injury,” Spine 29(7): 743-51 (2004).;;Lim et al., “Transplantation of Canine Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Experimentally Induced Spinal Cord Injured Dogs,” J Vet Sci. 8(3): 275-82 (2007).;;Linsenmeyer, Neurogenic bladder following spinal cord injury. Spinal Cord Medicine, Philadelphia: Lippincoat, Williams & Wilkins 181-206 (2002).;;Linsenmeyer, Update on bladder evaluation recommendations and bladder management guidline in patients with spinal cord injury, Current bladder dysfunction reports. 2:134-40 (2007).;;Lord-Fontain et al., “Local inhibition of Rho Signaling by cell-permeable recombinant protein BA-210 prevents secondary damage and promotes functional recovery following acute spinal cord injury,” J. Neurotrauma 25:1309-22 (2008).;;Maksymowicz et al., “The perspectives of stem cell-based therapy in neurological disease,” Stem Cells and Human Diseases. 26-60 (2012).;;Neumann et al., “Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a pho-dependent mechanism,” J. Neurosci. 22(3): 854-62 (2002).;;Paik et al., “Sphingosine 1-Phasphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and rho-dependent activation of avβ- and β1-containing integrins,” J. Biol. Chem. 276(15): 11830-7 (2001).;;Park et al., “Comparison of canine umbilical cord blood-derived mesenchymal stem cell transplantation time: involvement of astrogliosis, inflammation, intracellular actin cytoskeleton pathways, and neurotrophin-3,” Cell transplant. 20:1867-80 (2011).;;Park et al., “Human umbilical cord blood-derived mesenchymal stem cell therapy promotes functional recovery of contused rat spinal cord through enhancement of endogenous cell proliferation and oligogenesis,” J. Biomed. & Biotechnol. 2012: (2012) (8 pages).;;Pearse et al., “cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury,” Nat Med. 10(6): 610-616 (2004).;;Popovich et al., “Hematogenous macrophages express CD8 and distribute to regions of lesion cavitation after spinal cord injury,” Exp. Neurol. 182(2): 275-287 (2003).;;Ramer et al., “Rho-kinase inhibition enhances axonal plasticity and attenuates cold hyperalgesia after dorsal rhizotomy,” J Neurosci. 24(48):10796-10805 (2004).;;Schira et al., “Significant clinical, neuropathological and behavioral recovery from acute spinal cord trauma by transplantation of a well-defined somatic stem cell from human umbilical cord blood,” Brain. 135(2): 431-446 (2012).;;Siddall et al., “Pain report and the relationship of pain to physical factors in the first 6 months following spinal cord injury,” Pain. 81 (1-2): 187-197 (1999).;;Siddall et al., “A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury,” Pain. 103(3): 249-257 (2003).;;Sung et al., “A possible role of RhoA/Rho-kinase in experimental spinal cord injury in rat,” 959(1): 29-38 (2003).;;Tigyi et al., “Lysophosphatidic acid-induced neurite retraction in PC12 cells: neurite-protective effects of cyclic AMP signaling,” J Neurochem. 66(2): 549-558 (1996).;;Watanabe et al., “A ROCK inhibitor permits survival of dissociated human embryonic stem cells,” Nat Biotechnol. 25(6): 681-686 (2007).;;Weaver et al., “Central mechanisms for autonomic dysreflexia after spinal cord injury,” Prog Brain Res. 137: 83-95 (2002).;;Wong et al., “A three-month, open-label, single-arm trial evaluating the safety and pharmacokinetics of oral lithium in patients with chronic spinal cord injury,” Spinal Cord. 49(1): 94-98 (2011).;;Woodcock et al., “Development of novel combination therapies,” N Engl J Med. 364(11): 985-987 (2011).;;Yang et al., “Efficacy and safety of lithium carbonate treatment of chronic spinal cord injuries: a double-blind, randomized, placebo-controlled clinical trial,” Spinal Cord. 50(2): 141-146 (2012).;;Yick et al., “Lithium chloride reinforces the regeneration-promoting effect of chondroitinase ABC on rubrospinal neurons after spinal cord injury,” J Neurotrauma, 21 (7): 932-943 (2004).;;Young, “Review of lithium effects on brain and blood,” Cell Trans. 18(9): 951-975 (2009).",ACTIVE
726,TW,A,TW 202333323 A,194-902-479-483-380,2023-08-16,2023,TW 111146397 A,2022-12-02,US 202217589876 A,2022-01-31,Micro-OLED display module thermal management,"A device includes a micro-organic light emitting diode ([mu]-OLED) display panel and an electronic component. An electrical connector electrically couples the [mu]-OLED display panel and the electronic component. A standoff is disposed between the electronic component and the [mu]-OLED display panel. The standoff physically couples the electronic component and the [mu]-OLED display panel with a gap therebetween. The gap thermally decouples the electronic component from the [mu]-OLED display panel. A fan that is integrated with the [mu]-OLED display panel is placed in the standoff and actively cools the display panel. When the fan provides air flow over the [mu]-OLED display panel, heat generated by the [mu]-OLED display is mitigated by cooling air.",META PLATFORMS TECHNOLOGIES LLC,ANDO MARK SHINTARO;;MOGHADDAM GITI KARIMI;;PARK KYUNG WON;;KLEMENT ALEXANDER;;FLEMING RYAN;;NAM DONG-HEE;;KUO YI-CHEN;;MOSKOWITZ DOUGLAS,,https://lens.org/194-902-479-483-380,Patent of Addition,no,0,0,3,3,0,G06F1/163;;G06F1/1637;;G06F1/203;;G02B27/0176;;G06F3/011;;G02B27/0172;;H10K50/87;;G02B27/0176;;H05K7/20972;;G06F1/163,H01L23/467;;F04D29/58;;G02B27/01,,0,0,,,,PENDING
727,US,A1,US 2022/0265765 A1,098-150-162-805-928,2022-08-25,2022,US 202217738362 A,2022-05-06,US 202217738362 A;;US 201916618021 A;;US 2018/0035144 W;;US 201862675659 P;;US 201862675680 P;;US 201862675714 P;;US 201762512661 P;;US 201762512673 P;;US 201762512695 P,2017-05-30,C3 FUSION PROTEIN AND METHODS OF MAKING AND USING THEREOF,"The present invention provides, among other things, improved therapeutic compositions comprising a C3 fusion protein and methods of making and using the same. In particular, the present invention provides improved methods for the treatment of spinal cord injury and other CNS trauma and/or facilitate axon growth or other tissue repair.",BIOAXONE BIOSCIENCES INC,BORJAS RICARDO;;FLEMING MARK;;HUANG MEI;;JAIN MAYUR;;SANGHVI TAPAN;;SAXENA KUMKUM;;TORRES-DELGADO AMARIS;;YIN PING;;MCKERRACHER LISA;;RYU ELIZABETH,,https://lens.org/098-150-162-805-928,Patent Application,yes,0,0,6,6,28,A61K38/363;;A61K38/45;;C12Y204/02036;;C12N9/1077;;C07K2319/10;;A61P25/02;;A61P25/28;;Y02A50/30;;A61K38/1725;;A61K38/363;;A61K38/38;;A61K38/57;;C07K14/472;;C07K2319/70;;C12N9/1077;;C12Y204/02036,A61K38/17;;A61K38/36;;A61K38/38;;A61K38/57;;C07K14/47;;C12N9/10,,0,0,,,,PENDING
728,DE,A1,DE 102011120044 A1,095-048-290-316-838,2012-06-06,2012,DE 102011120044 A,2011-12-02,US 95848710 A,2010-12-02,Härtbare Amin-Flussmittelzusammensetzung und Lötverfahren,"Es wird eine härtbare Amin-Flussmittelzusammensetzung bereitgestellt, die als ursprüngliche Komponenten eine Harzkomponente mit mindestens zwei Oxirangruppen pro Molekül, ein Amin-Flussmittel, das durch die Formel I dargestellt ist,worin R1, R2, R3 und R4 unabhängig aus Wasserstoff, einer substituierten C1-80-Alkylgruppe, einer unsubstituierten C1-80-Alkylgruppe, einer substituierten C7-80-Arylalkylgruppe und einer unsubstituierten C7-80-Arylalkylgruppe ausgewählt sind, worin R7 und R8 unabhängig aus einer C1-20-Alkylgruppe, einer substituierten C1-20-Alkylgruppe, einer C6-20-Arylgruppe und einer substituierten C6-20-Arylgruppe ausgewählt sind oder worin R7 und R8 zusammen mit dem Kohlenstoffatom, an das sie gebunden sind, einen C3-20-Cycloalkylring bilden, der gegebenenfalls mit einer C1-6-Alkylgruppe substituiert ist, worin R10 und R11 unabhängig aus einer C1-20-Alkylgruppe, einer substituierten C1-20-Alkylgruppe, einer C6-20-Arylgruppe und einer substituierten C6-20-Arylgruppe ausgewählt sind oder worin R10 und R11 zusammen mit dem Kohlenstoffatom, an das sie gebunden sind, einen C3-20-Cycloalkylring bilden, der gegebenenfalls mit einer C1-6-Alkylgruppe substituiert ist, und worin R9 aus Wasserstoff, einer C1-30-Alkylgruppe, einer substituierten C1-30-Alkylgruppe, einer C6-30-Arylgruppe und einer substituierten C6-30-Arylgruppe ausgewählt ist, und gegebenenfalls ein Härtungsmittel umfasst. Es wird auch ein Verfahren zum Löten eines elektrischen Kontakts unter Verwendung der härtbaren Amin-Flussmittelzusammensetzung bereitgestellt.",ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS ELECT MAT,GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;PEERA ASGHAR AKBER;;TOMLINSON IAN;;FLEMING DAVID D;;ROBINSON GLEN;;WINKLE MARK R,"ROHM AND HAAS ELECTRONIC MATERIALS, L.L.C., MA, US (2015-01-14);;DOW GLOBAL TECHNOLOGIES LLC, MIDLAND, US (2015-01-14)",https://lens.org/095-048-290-316-838,Patent Application,no,2,0,12,12,0,B23K35/3615;;B23K35/3615;;B23K1/0016;;B23K1/0016;;B23K1/203;;B23K1/203;;B23K1/203;;B23K35/3615;;B23K35/362;;B23K35/362;;B23K35/365;;B23K2101/38;;B23K2101/38;;B23K2101/42;;B23K2101/42;;C07C211/09,B23K35/363;;H01L23/488,,0,0,,,,DISCONTINUED
729,CN,A,CN 102554517 A,175-631-292-137-25X,2012-07-11,2012,CN 201110463045 A,2011-12-02,US 95848710 A,2010-12-02,Curable amine flux composition and method of soldering,"The invention relates to a curable amine flux composition and a method of soldering. The curable amine flux composition comprises, as initial components: a resin component having at least two oxirane groups per molecule; an amine fluxing agent represented by formula I: wherein R<1>, R<2>, R<3> and R<4> are independently selected from a hydrogen, a substituted C1-80 alkyl group, an unsubstituted C1-80 alkyl group, a substituted C7-80 arylalkyl group and an unsubstituted C7-80 arylalkyl group; wherein R<7> and R<8> are independently selected from a C1-20 alkyl group, a substituted C1-20 alkyl group, a C6-20 aryl group and a substituted C6-20 aryl group or wherein R<7> and R<8>, together with the carbon to which they are attached, form a C3-20 cycloalkyl ring optionally substituted with a C1-6 alkyl group; wherein R<10> and R<11> are independently selected from a C1-20 alkyl group, a substituted C1-20 alkyl group, a C6-20 aryl group and a substituted C6-20 aryl group or wherein R<10> and R<11>, together with the carbon to which they are attached, form a C3-20 cycloalkyl ring optionally substituted with a C1-6 alkyl group; and, wherein R<9> is selected from a hydrogen, a C1-30 alkyl group, a substituted C1-30 alkyl group, a C6-30 aryl group and a substituted C6-30 aryl group; and, optionally, a curing agent. Also provided is a method of soldering an electrical contact using the curable amine flux composition.",ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,FLEMING DAVID D;;GALLAGHER MIKE K;;SANG HO KIM;;XIANG-QIAN LIU;;AKBER PEERA ASGHAR;;GLEN ROBINSON;;IAN TOMLINSON;;WINKLE MARK R,,https://lens.org/175-631-292-137-25X,Patent Application,no,4,3,12,12,0,B23K35/3615;;B23K35/3615;;B23K1/0016;;B23K1/0016;;B23K1/203;;B23K1/203;;B23K1/203;;B23K35/3615;;B23K35/362;;B23K35/362;;B23K35/365;;B23K2101/38;;B23K2101/38;;B23K2101/42;;B23K2101/42;;C07C211/09,B23K35/363;;B23K1/00;;C07C213/02;;C07C213/04;;C07C215/18;;C07C215/28;;C07C217/28,,0,0,,,,INACTIVE
730,TW,A,TW 201229008 A,109-899-310-089-33X,2012-07-16,2012,TW 100144127 A,2011-12-01,US 95849310 A,2010-12-02,An amine flux composition and method of soldering,"An amine flux composition is provided, comprising, as an initial component: an amine fluxing agent represented by formula I: wherein R1, R2, R3 and R4 are independently selected from a hydrogen, a substituted C1-80 alkyl group, an unsubstituted C1-80 alkyl group, a substituted C7-80 arylalkyl group and an unsubstituted C7-80 arylalkyl group; wherein R7 and R8 are independently selected from a C1-20 alkyl group, a substituted C1-20 alkyl group, a C6-20 aryl group and a substituted C6-20 aryl group or wherein R7 and R8, together with the carbon to which they are attached, form a C3-20 cycloalkyl ring optionally substituted with a C1-6 alkyl group; wherein R10 and R11 are independently selected from a C1-20 alkyl group, a substituted C1-20 alkyl group, a C6-20 aryl group and a substituted C6-20 aryl group or wherein R10and R11, together with the carbon to which they are attached, form a C3-20 cycloalkyl ring optionally substituted with a C1-6 alkyl group; and, wherein R9 is selected from a hydrogen, a C1-30 alkyl group, a substituted C1-30 alkyl group, C6-30 aryl group and a substituted C6-30 aryl group. Also provided is a method of soldering an electrical contact using the amine flux composition.",ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;PEERA ASGHAR AKBER;;ROBINSON GLENN;;TOMLINSON IAN;;WINKLE MARK R,,https://lens.org/109-899-310-089-33X,Patent of Addition,no,0,0,12,12,0,B23K1/0016;;B23K1/203;;B23K35/3615;;B23K35/362;;C07C215/18;;C07C215/28;;C07C217/28;;B23K2101/38;;B23K2101/42;;C07C211/09;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/3615;;B23K35/362;;B23K1/0016;;B23K1/203;;C07C215/18;;C07C217/28;;C07C215/28;;B23K2101/38;;B23K2101/42,B23K35/362;;C07C211/00;;C07C211/09;;H05K3/34,,0,0,,,,INACTIVE
731,JP,A,JP 2012135814 A,066-993-514-022-439,2012-07-19,2012,JP 2011260167 A,2011-11-29,US 95848710 A,2010-12-02,CURABLE AMINE FLUX COMPOSITION AND METHOD OF SOLDERING,"PROBLEM TO BE SOLVED: To provide a curable amine flux composition which facilitates manufacturing of interconnection in which reliable soldering and sealing are performed in an electric machine part.SOLUTION: The curable amine flux composition comprising, as initial components: a resin component having at least two oxirane groups per molecule; an amine fluxing agent represented by formula I; and, optionally, a curing agent. In the formula, R, R, Rand Rare each independently selected from a hydrogen or the like, Rand Rare independently selected from a 1-20C alkyl group or the like, Rand Rare independently selected from a 1-20C alkyl group or the like, and Ris selected from a hydrogen or the like.",ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;ASGHAR AKBER PEERA;;GLENN ROBINSON;;IAN TOMLINSON;;MARK R WINKLE,,https://lens.org/066-993-514-022-439,Patent Application,no,6,3,12,12,0,B23K35/3615;;B23K35/3615;;B23K1/0016;;B23K1/0016;;B23K1/203;;B23K1/203;;B23K1/203;;B23K35/3615;;B23K35/362;;B23K35/362;;B23K35/365;;B23K2101/38;;B23K2101/38;;B23K2101/42;;B23K2101/42;;C07C211/09,B23K35/363;;B23K1/00;;B23K3/00;;B23K35/26;;B23K101/42;;C22C12/00;;C22C13/00;;C22C13/02;;H01L21/60;;H05K3/34,,0,0,,,,INACTIVE
732,FR,B1,FR 2968227 B1,035-816-213-853-704,2014-05-09,2014,FR 1161085 A,2011-12-02,US 95848710 A,2010-12-02,COMPOSITION DE FONDANT D'AMINE DURCISSABLE ET PROCEDE DE BRASAGE,,ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;PEERA ASGHAR AKBER;;ROBINSON GLEN;;TOMLINSON IAN;;WINKLE MARK R,"DOW GLOBAL TECHNOLOGIES LLC, US (2015-02-10);;ROHM AND HAAS ELECTRONIC MATERIALS LLC, US (2015-02-10)",https://lens.org/035-816-213-853-704,Granted Patent,no,0,0,12,12,0,B23K35/3615;;B23K35/3615;;B23K1/0016;;B23K1/0016;;B23K1/203;;B23K1/203;;B23K1/203;;B23K35/3615;;B23K35/362;;B23K35/362;;B23K35/365;;B23K2101/38;;B23K2101/38;;B23K2101/42;;B23K2101/42;;C07C211/09,B23K35/363;;C08K5/17;;C08L63/00;;H01L21/56;;H05K3/32,,0,0,,,,INACTIVE
733,JP,A,JP 2012148337 A,144-542-013-651-506,2012-08-09,2012,JP 2011260174 A,2011-11-29,US 95849310 A,2010-12-02,AMINE FLUX COMPOSITION AND METHOD OF SOLDERING,"PROBLEM TO BE SOLVED: To provide a flux composition that is non-curable, facilitates reliable soldering and is customizable so as to promote the compatibility with a conventional epoxy-based underfill material.SOLUTION: This amine flux composition contains an amine fluxing agent that is a non-curable composition and represented by (I). The amine flux composition is designed to facilitate the compatibility thereof with variable underfill compositions, accordingly a soldered surface preferably does not need cleaning before application of the underfill compositions for forming finishing electrical joining.",ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;ASGHAR AKBER PEERA;;GLENN ROBINSON;;IAN TOMLINSON;;MARK R WINKLE,,https://lens.org/144-542-013-651-506,Patent Application,no,6,3,12,12,0,B23K1/0016;;B23K1/203;;B23K35/3615;;B23K35/362;;C07C215/18;;C07C215/28;;C07C217/28;;B23K2101/38;;B23K2101/42;;C07C211/09;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/3615;;B23K35/362;;B23K1/0016;;B23K1/203;;C07C215/18;;C07C217/28;;C07C215/28;;B23K2101/38;;B23K2101/42,B23K35/363;;B23K1/00;;B23K3/00;;B23K35/26;;B23K101/42;;C22C12/00;;C22C13/00;;H05K3/34,,0,0,,,,INACTIVE
734,TW,A,TW 201231439 A,122-016-627-545-62X,2012-08-01,2012,TW 100144124 A,2011-12-01,US 95848710 A,2010-12-02,A curable amine flux composition and method of soldering,"A curable amine flux composition is provided, comprising, as initial components: a resin component having at least two oxirane groups per molecule; an amine fluxing agent represented by formula I: wherein R1, R2, R3 and R4 are independently selected from a hydrogen, a substituted C1-80 alkyl group, an unsubstituted C1-80 alkyl group, a substituted C7-80 arylalkyl group and an unsubstituted C7-80 arylalkyl group; wherein R7 and R8 are independently selected from a C1-20 alkyl group, a substituted C1-20 alkyl group, a C6-20 aryl group and a substituted C6-20 aryl group or wherein R7 and R8, together with the carbon to which they are attached, form a C3-20 cycloalkyl ring optionally substituted with a C1-6 alkyl group; wherein R10 and R11 are independently selected from a C1-20 alkyl group, a substituted C1-20 alkyl group, a C6-20 aryl group and a substituted C6-20 aryl group or wherein R10 and R11, together with the carbon to which they are attached, form a C3-20 cycloalkyl ring optionally substituted with a C1-6 alkyl group; and, wherein R9 is selected from a hydrogen, a C1-30 alkyl group, a substituted C1-30 alkyl group, a C6-30 aryl group and a substituted C6-30 aryl group; and, optionally, a curing agent. Also provided is a method of soldering an electrical contact using the curable amine flux composition.",ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;PEERA ASGHAR AKBER;;ROBINSON GLENN;;TOMLINSON IAN;;WINKLE MARK R,,https://lens.org/122-016-627-545-62X,Patent of Addition,no,0,0,12,12,0,B23K35/3615;;B23K35/3615;;B23K1/0016;;B23K1/0016;;B23K1/203;;B23K1/203;;B23K1/203;;B23K35/3615;;B23K35/362;;B23K35/362;;B23K35/365;;B23K2101/38;;B23K2101/38;;B23K2101/42;;B23K2101/42;;C07C211/09,C07C209/34;;B23K35/362;;C07C211/09;;H01L21/56;;H05K3/34,,0,0,,,,INACTIVE
735,FR,A1,FR 2968229 A1,075-204-811-077-921,2012-06-08,2012,FR 1161088 A,2011-12-02,US 95849310 A,2010-12-02,COMPOSITION DE FONDANT ET PROCEDE DE BRASAGE,"Il est fourni une composition de fondant d'amine, comprenant, comme constituant initial : un agent de couverture de fondant d'amine représenté par la formule I : dans laquelle R , R , R et R sont indépendamment choisis parmi un hydrogène, un groupe alkyle en C substitué, un groupe alkyle en C non substitué, un groupe arylalkyle en C substitué et un groupe arylalkyle en C non substitué ; dans laquelle R et R sont indépendamment choisis parmi un groupe alkyle en C , un groupe alkyle en C substitué, un groupe aryle en C et un groupe aryle en C substitué ou dans laquelle R et R , avec l'atome de carbone auquel ils sont fixés, forment un cycle cycloalkyle en C éventuellement substitué avec un groupe alkyle en C ; dans laquelle R et R sont indépendamment choisis parmi des groupes alkyle et des groupes aryle ; et, dans laquelle R est choisi parmi un hydrogène, des groupes alkyle et des groupes aryle.",ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;PEERA ASGHAR AKBER;;ROBINSON GLEN;;TOMLINSON IAN;;WINKLE MARK R,"DOW GLOBAL TECHNOLOGIES LLC, US (2015-02-10);;ROHM AND HAAS ELECTRONIC MATERIALS LLC, US (2015-02-10)",https://lens.org/075-204-811-077-921,Patent Application,no,4,0,12,12,0,B23K1/0016;;B23K1/203;;B23K35/3615;;B23K35/362;;C07C215/18;;C07C215/28;;C07C217/28;;B23K2101/38;;B23K2101/42;;C07C211/09;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/3615;;B23K35/362;;B23K1/0016;;B23K1/203;;C07C215/18;;C07C217/28;;C07C215/28;;B23K2101/38;;B23K2101/42,B23K35/363;;C07C211/09;;H05K3/32,,0,0,,,,INACTIVE
736,TW,B,TW I419860 B,133-007-883-648-251,2013-12-21,2013,TW 100144124 A,2011-12-01,US 95848710 A,2010-12-02,A curable amine flux composition and method of soldering,,ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;PEERA ASGHAR AKBER;;ROBINSON GLENN;;TOMLINSON IAN;;WINKLE MARK R,,https://lens.org/133-007-883-648-251,Granted Patent,no,3,0,12,12,0,B23K35/3615;;B23K35/3615;;B23K1/0016;;B23K1/0016;;B23K1/203;;B23K1/203;;B23K1/203;;B23K35/3615;;B23K35/362;;B23K35/362;;B23K35/365;;B23K2101/38;;B23K2101/38;;B23K2101/42;;B23K2101/42;;C07C211/09,,,0,0,,,,INACTIVE
737,CN,A,CN 102642101 A,186-788-477-660-236,2012-08-22,2012,CN 201110463356 A,2011-12-02,US 95849310 A,2010-12-02,Amine flux composition and method of soldering,The invention provides an amine flux composition and a soldering method. The amine flux composition comprises an amine fluxing agent represented by formula I as an initial component. The invention also provides a method of soldering an electrical contact using the amine flux composition.,ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,FLEMING DAVID D;;GALLAGHER MIKE K;;SANG HO KIM;;XIANG-QIAN LIU;;AKBER PEERA ASGHAR;;GLEN ROBINSON;;IAN TOMLINSON;;WINKLE MARK R,,https://lens.org/186-788-477-660-236,Patent Application,no,6,0,12,12,0,B23K1/0016;;B23K1/203;;B23K35/3615;;B23K35/362;;C07C215/18;;C07C215/28;;C07C217/28;;B23K2101/38;;B23K2101/42;;C07C211/09;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/3615;;B23K35/362;;B23K1/0016;;B23K1/203;;C07C215/18;;C07C217/28;;C07C215/28;;B23K2101/38;;B23K2101/42,B23K35/363;;B23K1/00,,0,0,,,,INACTIVE
738,US,B1,US 6253722 B1,060-229-636-311-261,2001-07-03,2001,US 43076499 A,1999-10-29,US 43076499 A;;US 10735598 P,1998-11-06,Starting apparatus for internal combustion engines,"A starting device has a rotary drive member that is operable by hand or power devices. The device has a detented or geared strip arranged to engage with a similarly detented or geared starting wheel. The teeth of these parts are designed to grab and lock with each other in the starting direction and to slip past each other in the opposite direction. Crimping, sticking and other failure modes of conventional wind up rope units are virtually eliminated. A more consistent pull is afforded owing to a constant radius interface with the starter wheel rather than a diminishing radius of the type delivered by a wound rope.",ALLIED SIGNAL INC,ROBINSON BRIAN W;;MCMASTER WILLIAM J;;MARSH WALTER H W;;MINNICHELLI MARK;;AADAHL FRANK P;;FLEMING JOHN T;;OPPEDISANO ROY;;MANNING EARL,BASF AKTIENGESELLSCHAFT (2003-05-12);;ALLIEDSIGNAL INC (1999-10-29),https://lens.org/060-229-636-311-261,Granted Patent,yes,32,11,1,1,0,F02N11/12;;F02N11/12;;F02N3/02;;F02N3/02;;Y10T74/1548;;Y10T74/1548,F02N3/02;;F02N11/12,123/179.24;;123/185.2;;123/185.5;;74/139,1,0,,,Statutory Invention Registration No. H517 Sato et al. 9/98.,EXPIRED
739,CN,B,CN 102554517 B,084-825-745-107-544,2015-05-06,2015,CN 201110463045 A,2011-12-02,US 95848710 A,2010-12-02,Curable amine flux composition and method of soldering,,ROHM & HAAS ELECT MAT;;DOW GLOBAL TECHNOLOGIES INC,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;PEERA ASGHAR AKBER;;ROBINSON GLEN;;TOMLINSON IAN;;WINKLE MARK R,,https://lens.org/084-825-745-107-544,Granted Patent,no,0,0,12,12,0,B23K35/3615;;B23K35/3615;;B23K1/0016;;B23K1/0016;;B23K1/203;;B23K1/203;;B23K1/203;;B23K35/3615;;B23K35/362;;B23K35/362;;B23K35/365;;B23K2101/38;;B23K2101/38;;B23K2101/42;;B23K2101/42;;C07C211/09,B23K35/363;;B23K1/00;;C07C213/02;;C07C213/04;;C07C215/18;;C07C215/28;;C07C217/28,,0,0,,,,INACTIVE
740,FR,B1,FR 2968229 B1,039-209-369-466-98X,2014-05-02,2014,FR 1161088 A,2011-12-02,US 95849310 A,2010-12-02,COMPOSITION DE FONDANT ET PROCEDE DE BRASAGE,,ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;PEERA ASGHAR AKBER;;ROBINSON GLEN;;TOMLINSON IAN;;WINKLE MARK R,"DOW GLOBAL TECHNOLOGIES LLC, US (2015-02-10);;ROHM AND HAAS ELECTRONIC MATERIALS LLC, US (2015-02-10)",https://lens.org/039-209-369-466-98X,Granted Patent,no,0,0,12,12,0,B23K1/0016;;B23K1/203;;B23K35/3615;;B23K35/362;;C07C215/18;;C07C215/28;;C07C217/28;;B23K2101/38;;B23K2101/42;;C07C211/09;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/3615;;B23K35/362;;B23K1/0016;;B23K1/203;;C07C215/18;;C07C217/28;;C07C215/28;;B23K2101/38;;B23K2101/42,B23K35/363;;C07C211/09;;H05K3/32,,0,0,,,,INACTIVE
741,FR,A1,FR 2968227 A1,096-021-221-812-092,2012-06-08,2012,FR 1161085 A,2011-12-02,US 95848710 A,2010-12-02,COMPOSITION DE FONDANT D'AMINE DURCISSABLE ET PROCEDE DE BRASAGE,"Il est fourni une composition de fondant d'amine durcissable, comprenant, comme constituants initiaux : un constituant de résine présentant au moins deux groupes oxirane par molécule ; un agent de couverture de fondant d'amine représenté par la formule I : dans laquelle R , R , R et R sont indépendamment choisis parmi un hydrogène, un groupe alkyle en C substitué, un groupe alkyle en C non substitué, un groupe arylalkyle en C substitué et un groupe arylalkyle en C non substitué ; dans laquelle R et R sont indépendamment choisis parmi des groupes alkyle substitués ou non substitués, des groupes aryle substitués ou non substitués, ou dans laquelle R et R , avec l'atome de carbone auquel ils sont fixés, forment un cycle cycloalkyle en C ; dans laquelle R et R sont indépendamment choisis parmi des groupes alkyle et des groupes aryle ; et, dans laquelle R est choisi parmi un hydrogène, des groupes alkyle et des groupes aryle ; et, éventuellement, un agent durcissant.",ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;PEERA ASGHAR AKBER;;ROBINSON GLEN;;TOMLINSON IAN;;WINKLE MARK R,"DOW GLOBAL TECHNOLOGIES LLC, US (2015-02-10);;ROHM AND HAAS ELECTRONIC MATERIALS LLC, US (2015-02-10)",https://lens.org/096-021-221-812-092,Patent Application,no,4,0,12,12,0,B23K35/3615;;B23K35/3615;;B23K1/0016;;B23K1/0016;;B23K1/203;;B23K1/203;;B23K1/203;;B23K35/3615;;B23K35/362;;B23K35/362;;B23K35/365;;B23K2101/38;;B23K2101/38;;B23K2101/42;;B23K2101/42;;C07C211/09,B23K35/363;;C08K5/17;;C08L63/00;;H01L21/56;;H05K3/32,,0,0,,,,INACTIVE
742,TW,B,TW I444355 B,016-978-591-709-817,2014-07-11,2014,TW 100144127 A,2011-12-01,US 95849310 A,2010-12-02,An amine flux composition and method of soldering,,ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;PEERA ASGHAR AKBER;;ROBINSON GLENN;;TOMLINSON IAN;;WINKLE MARK R,,https://lens.org/016-978-591-709-817,Granted Patent,no,0,0,12,12,0,B23K1/0016;;B23K1/203;;B23K35/3615;;B23K35/362;;C07C215/18;;C07C215/28;;C07C217/28;;B23K2101/38;;B23K2101/42;;C07C211/09;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/3615;;B23K35/362;;B23K1/0016;;B23K1/203;;C07C215/18;;C07C217/28;;C07C215/28;;B23K2101/38;;B23K2101/42,,,0,0,,,,INACTIVE
743,KR,A,KR 20120060775 A,050-487-717-976-395,2012-06-12,2012,KR 20110128555 A,2011-12-02,US 95848710 A,2010-12-02,A curable amine flux composition and method of soldering,"PURPOSE: A curable amine flux composition is provided to facilitate the production of electric components with curable properties and sealed electrical internal connection, and to use as a no flow underfill composition in production of a semiconductor device. CONSTITUTION: A curable amine flux composition comprises a resin component having at least two oxirane groups per molecule, an amine flux agent in chemical formula 1, and randomly comprises curing agent. In chemical formula 1, R^1, R^2, R^3 and R^4 is respectively and independently selected from hydrogen, a substituted or unsubstituted C1-80 alkyl group, and a substituted or unsubstituted C7-80 arylalkyl group, and R^7and R^8 is selected from a substituted or unsubstituted a substituted C1-20 alkyl group, a C6-20 aryl group, and a substituted C6-20 aryl group, or forms a C3-20 cyclo alkyl ring capable of substituted by C1-6 alkyl group together with carbon combining with the same.",ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,FLEMING DAVID D;;GALLAGHER MIKE K;;KIM SANG HO;;LIU XIANG QIAN;;ASGHAR AKBER PEERA;;GLEN ROBINSON;;TOMLINSON IAN;;WINKLE MARK R,,https://lens.org/050-487-717-976-395,Patent Application,no,6,1,12,12,0,B23K35/3615;;B23K35/3615;;B23K1/0016;;B23K1/0016;;B23K1/203;;B23K1/203;;B23K1/203;;B23K35/3615;;B23K35/362;;B23K35/362;;B23K35/365;;B23K2101/38;;B23K2101/38;;B23K2101/42;;B23K2101/42;;C07C211/09,C07C211/09;;B23K1/00;;B23K35/363,,0,0,,,,ACTIVE
744,CN,B,CN 102642101 B,130-838-054-983-384,2015-05-13,2015,CN 201110463356 A,2011-12-02,US 95849310 A,2010-12-02,Amine flux composition and method of soldering,,ROHM & HAAS ELECT MAT;;DOW GLOBAL TECHNOLOGIES INC,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;PEERA ASGHAR AKBER;;ROBINSON GLEN;;TOMLINSON IAN;;WINKLE MARK R,,https://lens.org/130-838-054-983-384,Granted Patent,no,0,0,12,12,0,B23K1/0016;;B23K1/203;;B23K35/3615;;B23K35/362;;C07C215/18;;C07C215/28;;C07C217/28;;B23K2101/38;;B23K2101/42;;C07C211/09;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/3615;;B23K35/362;;B23K1/0016;;B23K1/203;;C07C215/18;;C07C217/28;;C07C215/28;;B23K2101/38;;B23K2101/42,B23K35/363;;B23K1/00,,0,0,,,,INACTIVE
745,DE,A1,DE 102011120521 A1,083-696-101-780-94X,2012-06-06,2012,DE 102011120521 A,2011-12-02,US 95849310 A,2010-12-02,Amin-Flussmittelzusammensetzung und Lötverfarhen,"Es wird eine Amin-Flussmittelzusammensetzung bereitgestellt, die als eine ursprüngliche Komponente ein Amin-Flussmittel umfasst, das durch die Formel I dargestellt ist,worin R1, R2, R3 und R4 unabhängig aus Wasserstoff, einer substituierten C1-80-Alkylgruppe, einer unsubstituierten C1-80-Alkylgruppe, einer substituierten C7-80-Arylalkylgruppe und einer unsubstituierten C7-80-Arylalkylgruppe ausgewählt sind, worin R7 und R8 unabhängig aus einer C1-20-Alkylgruppe, einer substituierten C1-20-Alkylgruppe, einer C6-20-Arylgruppe und einer substituierten C6-20-Arylgruppe ausgewählt sind oder worin R7 und R8 zusammen mit dem Kohlenstoffatom, an das sie gebunden sind, einen C3-20-Cycloalkylring bilden, der gegebenenfalls mit einer C1-6-Alkylgruppe substituiert ist, worin R10 und R11 unabhängig aus einer C1-20-Alkylgruppe, einer substituierten C1-20-Alkylgruppe, einer C6-20-Arylgruppe und einer substituierten C6-20-Arylgruppe ausgewählt sind oder worin R10 und R11 zusammen mit dem Kohlenstoffatom, an das sie gebunden sind, einen C3-20-Cycloalkylring bilden, der gegebenenfalls mit einer C1-6-Alkylgruppe substituiert ist, und worin R9 aus Wasserstoff, einer C1-30-Alkylgruppe, einer substituierten C1-30-Alkylgruppe, einer C6-30-Arylgruppe und einer substituierten C6-30-Arylgruppe ausgewählt ist. Es wird auch ein Verfahren zum Löten eines elektrischen Kontakts unter Verwendung der Amin-Flussmittelzusammensetzung bereitgestellt.",ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;PEERA ASGHAR AKBER;;ROBINSON GLEN;;TOMLINSON IAN;;WINKLE MARK R,"ROHM AND HAAS ELECTRONIC MATERIALS, L.L.C., MA, US (2015-01-14);;DOW GLOBAL TECHNOLOGIES LLC, MIDLAND, US (2015-01-14)",https://lens.org/083-696-101-780-94X,Patent Application,no,0,0,12,12,0,B23K1/0016;;B23K1/203;;B23K35/3615;;B23K35/362;;C07C215/18;;C07C215/28;;C07C217/28;;B23K2101/38;;B23K2101/42;;C07C211/09;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/3615;;B23K35/362;;B23K1/0016;;B23K1/203;;C07C215/18;;C07C217/28;;C07C215/28;;B23K2101/38;;B23K2101/42,B23K35/363,,0,0,,,,DISCONTINUED
746,KR,A,KR 20120060773 A,186-809-596-313-413,2012-06-12,2012,KR 20110128394 A,2011-12-02,US 95849310 A,2010-12-02,AMINE FLUX COMPOSITION AND METHOD OF SOLDERING,"PURPOSE: An amine flux composition is provided to be compatible with various epoxy base underfill material, and not to require cleansing soldering surface for forming final electrical joint before introducing underfill composition for forming final electric conjugation part. CONSTITUTION: An amine flux composition comprises a fluxing agent in chemical formula 1 as an initial component. An applying method of a solder into an electrical contact comprises: a step of providing electrical contact; a step of providing amine flux composition; a step of applying the amine flux composition into the electrical contact; a step of providing the amine flux composition to the electrical contact; a step of providing a solder; a step of melting the solder; and a step of displacing the amine flux composition applied to the electrical contact.",ROHM & HAAS ELECT MAT;;DOW GLOBAL TECHNOLOGIES LLC;;ANGUS CHEMICAL,FLEMING DAVID D;;GALLAGHER MIKE K;;KIM SANG HO;;LIU XIANG QIAN;;PEERA ASGHAR AKBER;;ROBINSON GLEN;;TOMLINSON IAN;;WINKLE MARK R,,https://lens.org/186-809-596-313-413,Patent Application,no,4,0,12,12,0,B23K1/0016;;B23K1/203;;B23K35/3615;;B23K35/362;;C07C215/18;;C07C215/28;;C07C217/28;;B23K2101/38;;B23K2101/42;;C07C211/09;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/3615;;B23K35/362;;B23K1/0016;;B23K1/203;;C07C215/18;;C07C217/28;;C07C215/28;;B23K2101/38;;B23K2101/42,C07C211/09;;B23K1/00;;B23K35/363,,0,0,,,,ACTIVE
747,TW,A,TW 201910511 A,040-086-121-961-918,2019-03-16,2019,TW 107118575 A,2018-05-30,US 201762512661 P;;US 201762512673 P;;US 201762512695 P;;US 201862675659 P;;US 201862675680 P;;US 201862675714 P,2017-05-30,C3 fusion protein and methods of making and using thereof,"The present invention provides, among other things, improved therapeutic compositions comprising a C3 fusion protein and methods of making and using the same. In particular, the present invention provides improved methods for the treatment of spinal cord injury and other CNS trauma and/or facilitate axon growth or other tissue repair.",VERTEX PHARMA;;BIOAXONE BIOSCIENCES INCORPORATED,BORJAS RICARDO;;FLEMING MARK;;HUANG MEI;;JAIN MAYUR;;SANGHVI TAPAN;;SAXENA KUMKUM;;TORRES-DELGADO AMARIS;;YIN PING;;MCKERRACHER LISA;;RYU ELIZABETH JIN-SUN,,https://lens.org/040-086-121-961-918,Patent of Addition,no,0,0,6,6,0,A61K38/363;;A61K38/45;;C12Y204/02036;;C12N9/1077;;C07K2319/10;;A61P25/02;;A61P25/28;;Y02A50/30;;A61K38/1725;;A61K38/363;;A61K38/38;;A61K38/57;;C07K14/472;;C07K2319/70;;C12N9/1077;;C12Y204/02036,C12N9/10;;A61K38/45;;A61P25/02;;A61P25/28;;C07K1/18,,0,0,,,,PENDING
748,US,B1,US 8717028 B1,160-917-580-600-172,2014-05-06,2014,US 201113220594 A,2011-08-29,US 201113220594 A;;US 96185807 A;;US 87126806 P,2006-12-21,Spring clips for use with locating transmitters,"A high-Q human-portable, battery-powered self-correcting tunable resonator in a transmitter apparatus for inducing alternating currents of high quality in buried conductors to facilitate their location is disclosed. The transmitter apparatus may employ an FET-driven capacitive tuning circuit and a coil design that achieves high precision, high-quality transmission signals, and which may be equipped with a high-voltage booster for facilitating fault-localization applications.",MEREWETHER RAY;;OLSSON MARK S;;PRSHA JEFFREY A;;SOUKUP JAN;;COX DAVID A;;FLEMING MARK F;;LATIMER LISA E;;LEVIN RYAN B;;TURGEON MICHAEL E;;BENCH STEPHEN M;;DENACI EDWARD N;;SEESCAN INC,MEREWETHER RAY;;OLSSON MARK S;;PRSHA JEFFREY A;;SOUKUP JAN;;COX DAVID A;;FLEMING MARK F;;LATIMER LISA E;;LEVIN RYAN B;;TURGEON MICHAEL E;;BENCH STEPHEN M;;DENACI EDWARD N,EMERSON ELECTRIC CO (2008-02-05);;SEESCAN INC (2008-01-18),https://lens.org/160-917-580-600-172,Granted Patent,yes,2,39,7,7,0,G01V3/101;;G01V3/15;;Y10T24/44376;;Y10T24/44376;;G01V3/165;;G01V3/10;;G01V3/101;;G01V3/15,F16L3/00;;G01V3/08,324/329;;24/499,0,0,,,,ACTIVE
749,US,B1,US 8013610 B1,194-741-649-204-766,2011-09-06,2011,US 96185807 A,2007-12-20,US 96185807 A;;US 87126806 P,2006-12-21,High-Q self tuning locating transmitter,"A high-Q human-portable, battery-powered self-correcting tunable resonator in a transmitter apparatus for inducing alternating currents of high quality in buried conductors to facilitate their location. The transmitter apparatus employs an FET-driven capacitive tuning circuit and a coil design that achieves high precision, high-quality transmission signals, and which is equipped with a high-voltage booster for facilitating fault-localization applications.",SEEKTECH INC,MEREWETHER RAY;;OLSSON MARK S;;PRAHA JEFFREY A;;SOUKUP JAN;;COX DAVID A;;FLEMING MARK F;;LATIMER LISA E;;LEVIN RYAN B;;TURGEON MICHAEL E;;BENCH STEPHEN M;;DENACI EDWARD N,SEEKTECH INC (2008-01-18);;EMERSON ELECTRIC. CO (2008-02-05),https://lens.org/194-741-649-204-766,Granted Patent,yes,16,98,7,7,0,G01V3/101;;G01V3/15;;Y10T24/44376;;Y10T24/44376;;G01V3/165;;G01V3/10;;G01V3/101;;G01V3/15,G01V3/08,324/329;;324/228,0,0,,,,ACTIVE
750,US,B2,US 10233186 B2,112-115-583-117-885,2019-03-19,2019,US 201715488257 A,2017-04-14,US 201715488257 A;;US 201662322948 P;;US 201662411172 P,2016-04-15,Inhibitors of activin receptor-like kinase,"Described herein are compounds, such as compounds of formula (I) and pharmaceutically acceptable salts thereof, that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions",BLUEPRINT MEDICINES CORP,BROOIJMANS NATASJA;;BRUBAKER JASON D;;CRONIN MARK;;FLEMING PAUL E;;HODOUS BRIAN L;;KIM JOSEPH L;;WILLIAMS BRETT;;WILSON DOUGLAS;;WILSON KEVIN J,BLUEPRINT MEDICINES CORPORATION (2017-06-08),https://lens.org/112-115-583-117-885,Granted Patent,yes,47,8,33,34,0,C07D487/04;;C07D519/00;;A61P19/00;;A61P25/00;;A61P35/00;;A61P43/00;;C07D487/04;;A61K31/5025;;C07D519/00;;A61P19/00;;A61K31/5025;;C07D487/04;;C07D519/00;;A61P35/00;;A61K31/5025;;A61K31/5377;;A61K31/5383;;C07D487/04;;C07D519/00,C07D487/04;;C07D519/00,,40,16,088-370-144-352-621;;008-942-401-930-226;;032-731-534-802-99X;;084-355-145-743-009;;002-991-350-666-500;;005-753-148-365-857;;045-982-641-446-458;;000-280-598-328-165;;020-133-096-140-934;;030-718-452-891-192;;054-241-151-537-523;;039-985-594-433-094;;021-156-914-619-84X;;052-176-800-840-741;;141-984-169-041-148;;054-207-309-797-175,pmc5697787;;29177121;;10.1080/21678707.2017.1304211;;10.1038/ejhg.2008.178;;pmc2986177;;18830232;;22508565;;pmc3556640;;10.1002/jbmr.1637;;10.1002/dvg.20201;;16604518;;pmc3160462;;10.1016/j.bone.2010.10.164;;21044902;;25230881;;pmc4747023;;10.1038/nrc3811;;18450872;;pmc3502043;;10.1542/peds.2007-1980;;10.1002/humu.20868;;19085907;;pmc2921861;;pmc4567450;;26097044;;10.1002/ajmg.a.37205;;pmc3901569;;10.1021/cb300655w;;23547776;;26776312;;10.1016/j.cytogfr.2015.12.007;;pmc4753137;;pmc2658887;;10.1371/journal.pone.0005005;;19330033;;10.3410/f.13815.471313;;10.1038/ng1783;;10.3410/f.13815.374845;;10.3410/f.13815.372796;;16642017;;10.1038/nm.1888;;pmc2846458;;19029982;;2299462;;10.1016/s0278-2391(10)80212-5;;pmc6124206;;10.1002/jbm4.10008;;30283890,"Kaplan et al. Expert Opinion on Orphan Drugs, vol. 5, No. 4, 291-294 2017.;;Bocciardi, R. et al. (2009) “Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements” Eur J Hum Genetics, 17:311-318.;;Chakkalakal, S.A. et al. (Aug. 2012) “An Acvr1 R206H knock-in mouse has fibrodysplasia ossificans progressiva” J Bone Miner Res, 27(8):1746-1756.;;Fukuda, T. et al. (Apr. 2006) “Generation of a mouse with conditionally activated signaling through the BMP receptor, ALK2” Genesis, 44:159-167.;;Gregson, C.L. et al. (2011) “A novel ACVR1 mutation in the glycine/serine-rich domain found in the most benign case of a fibrodysplasia ossificans progressiva variant reported to date” Bone, 48:654-658.;;International Search Report and Written Opinion dated Jul. 21, 2017, in International Patent Application No. PCT/US2017/027775, filed Apr. 14, 2017, by Blueprint Medicines Corp. (9 pages).;;Jones, C. and S.J. Baker (2014) “Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma” Nat Rev Cancer, 14:651-661.;;Kaplan, F.S. et al. (May 2008) “Early Diagnosis of Fibrodysplasia Ossificans Progressiva” Pediatrics, 121(5):e1295-e1300. NIH Public Access Author Manuscript; available in PMC Nov. 20, 2012 (12 pages).;;Kaplan, F.S. et al. (2009) “Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1” Hum Mutat, 30(3):379-390.;;Kaplan, F.S. et al.. (2015) “Multi-system involvement in a severe variant of fibrodysplasia ossificans progressiva (ACVR1C.772G>A; R258G): A report of two patients” Am J Med Genet, 167:2265-2271.;;Mohedas, A.H. et al. (Jun. 2013) “Development of an ALK2-biased BMP type I receptor kinase inhibitor” ACS Chem Biol, 8(6):1291-1302. NIH Public Access Author Manuscript; available in PMC Jun. 21, 2014 (20 pages).;;Notice of Allowance dated Jan. 17, 2018, in U.S. Appl. No. 14/887,614, filed Oct. 20, 2015, by Blueprint Medicines Corp.;;Notice of Allowance dated Jan. 16, 2018, in U.S. Appl. No. 15/217,503, filed Jul. 22, 2016, by Blueprint Medicines Corp.;;Notice of Allowance dated Mar. 9, 2018, in U.S. Appl. No. 15/248,207, filed Aug. 26, 2016, by Blueprint Medicines Corp.;;Notice of Allowance dated Feb. 14, 2018, in U.S. Appl. No. 15/295,450, filed Oct. 17, 2016, by Blueprint Medicines Corp.;;Notice of Allowance dated Feb. 20, 2018, in U.S. Appl. No. 15/340,428, filed Nov. 1, 2016, by Blueprint Medicines Corp.;;Notice of Allowance dated Dec. 15, 2017, in U.S. Appl. No. 15/462,255, filed Mar. 17, 2017, by Blueprint Medicines Corp.;;Notice of Allowance dated Nov. 30, 2017, in U.S. Appl. No. 15/479,145, filed Apr. 4, 2017, by Blueprint Medicines Corp.;;Notice of Allowance dated Feb. 22, 2018, in U.S. Appl. No. 15/599,006, filed May 18, 2017, by Blueprint Medicines Corp.;;Notice of Allowance dated Jan. 17, 2018, in U.S. Appl. No. 15/660,840, filed Jul. 26, 2017, by Blueprint Medicines Corp.;;Pacifici, M. and E.M. Shore (Feb. 2016) “Common mutations in ALK2/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disorders” Cytokine & Growth Factor Rev, 27:93-104. HHS Public Access Author Manuscript; available in PMC Feb. 1, 2017 (27 pages).;;Petrie, K.A. et al. (Mar. 30, 2009) “Novel Mutations in ACVR1 Result in Atypical Features in Two Fibrodysplasia Ossificans Progressive Patients” PLoS One, 4(3):e5005 (5 pages).;;Shore, E.M. et al. (2006) “A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva” Nature Genetics, 38(5):525-527.;;U.S. Appl. No. 15/548,925, filed Aug. 4, 2017, by Blueprint Medicines Corp.;;U.S. Appl. No. 15/657,057, filed Jul. 21, 2017, by Blueprint Medicines Corp.;;U.S. Appl. No. 15/660,840, filed Jul. 26, 2017, by Blueprint Medicines Corp.;;U.S. Appl. No. 15/867,637, filed Jan. 10, 2018, by Blueprint Medicines Corp.;;Yu, P.B. et al. (Dec. 2008) “BMP type I receptor inhibition reduces heterotopic ossification” Nat Med, ;14(12):1363-1369, including Erratum (1 page).;;Crofford, L.J. et al. (1990) “Failure of Surgery and Isotrentinoin to Relieve Jaw Immobilization in Fibrodysplasia Ossificans Progressiva: Report of Two Cases” J Oral Maxillofac Surg, 48:204-208.;;Eekhoff, E. et al. (2018) “Flare-Up After Maxillofacial Surgery in a Patient with Fibrodysplasia Ossificans Progressiva: An [18F]-NaF PET/CT Study and a Systematic Review” JBMR Plus, 2(1):55-58.;;Garner. A. (Apr. 16, 2016) “Generation of Highly Selective ALK2 Inhibitors for the Treatment of FOP” Slides presented at the 2016 Annual F.O.P. Italia Meeting (17 pages).;;Garner, A. (Oct. 24, 2016) “Characterization of Highly Selective ALK2 Inhibitors for the Treatment of FOP” Slides presented at the 2016 FOP Drug Development Forum in Boston, MA (9 pages).;;Notice of Allowance dated Aug. 6, 2018, in U.S. Appl. No. 15/462,255, filed Mar. 17, 2017, by Blueprint Medicines Corp.;;Notice of Allowance dated Sep. 21, 2018, in U.S. Appl. No. 15/548,925, filed Aug. 4, 2017, by Blueprint Medicines Corp.;;Notice of Allowance dated Oct. 11, 2018, in U.S. Appl. No. 15/222,523, filed Jul. 28, 2016, by Blueprint Medicines Corp.;;Notice of Allowance dated Oct. 19, 2018, in U.S. Appl. No. 15/657,057, filed Jul. 21, 2017, by Blueprint Medicines Corp.;;U.S. Appl. No. 15/973,340, filed May 7, 2018, by Blueprint Medicines Corp.;;U.S. Appl. No. 15/973,378, filed May 7, 2018, by Blueprint Medicines Corp.;;U.S. Appl. No. 16/002,587, filed Jun. 7, 2018, by Blueprint Medicines Corp.;;U.S. Appl. No. 16/027,166, filed Jul. 3, 2018, by Blueprint Medicines Corp.",ACTIVE
751,US,B1,US 8070046 B1,187-791-590-632-548,2011-12-06,2011,US 95849310 A,2010-12-02,US 95849310 A,2010-12-02,Amine flux composition and method of soldering,"An amine flux composition is provided, comprising, as an initial component: an amine fluxing agent represented by formula I: wherein R 1 , R 2 , R 3 and R 4 are independently selected from a hydrogen, a substituted C 1-80 alkyl group, an unsubstituted C 1-80 alkyl group, a substituted C 7-80 arylalkyl group and an unsubstituted C 7-80 arylalkyl group; wherein R 7 and R 8 are independently selected from a C 1-20 alkyl group, a substituted C 1-20 alkyl group, a C 6-20 aryl group and a substituted C 6-20 aryl group or wherein R 7 and R 8 , together with the carbon to which they are attached, form a C 3-20 cycloalkyl ring optionally substituted with a C 1-6 alkyl group; wherein R 10 and R 11 are independently selected from a C 1-20 alkyl group, a substituted C 1-20 alkyl group, a C 6-20 aryl group and a substituted C 6-20 aryl group or wherein R 10 and R 11 , together with the carbon to which they are attached, form a C 3-20 cycloalkyl ring optionally substituted with a C 1-6 alkyl group; and, wherein R 9 is selected from a hydrogen, a C 1-30 alkyl group, a substituted C 1-30 alkyl group, a C 6-30 aryl group and a substituted C 6-30 aryl group. Also provided is a method of soldering an electrical contact using the amine flux composition.",FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;WINKLE MARK R;;PEERA ASGHAR AKBER;;ROBINSON GLENN N;;TOMLINSON IAN;;ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;WINKLE MARK R;;PEERA ASGHAR AKBER;;ROBINSON GLENN N;;TOMLINSON IAN,ANGUS CHEMICAL COMPANY (2011-09-06);;ROHM AND HAAS ELECTRONIC MATERIALS LLC (2011-02-11);;DOW GLOBAL TECHNOLOGIES LLC (2011-02-11),https://lens.org/187-791-590-632-548,Granted Patent,yes,87,2,12,12,0,B23K1/0016;;B23K1/203;;B23K35/3615;;B23K35/362;;C07C215/18;;C07C215/28;;C07C217/28;;B23K2101/38;;B23K2101/42;;C07C211/09;;B23K1/203;;B23K35/3615;;B23K35/365;;B23K35/3615;;B23K35/362;;B23K1/0016;;B23K1/203;;C07C215/18;;C07C217/28;;C07C215/28;;B23K2101/38;;B23K2101/42,B23K35/34;;B23K31/02,228/180.21;;228/207;;228/223;;228/224;;228/248.1;;148/23;;148/24,5,0,,,"STIC search, no date available.;;Copending U.S. Appl. No. 12/958,495.;;Copending U.S. Appl. No. 12/958,487.;;Copending U.S. Appl. No. 12/958,480.;;Copending U.S. Appl. No. 12/958,473.",INACTIVE
752,US,B1,US 8070045 B1,111-644-226-191-216,2011-12-06,2011,US 95848710 A,2010-12-02,US 95848710 A,2010-12-02,Curable amine flux composition and method of soldering,"A curable amine flux composition is provided, comprising, as initial components: a resin component having at least two oxirane groups per molecule; an amine fluxing agent represented by formula I: wherein R 1 , R 2 , R 3 and R 4 are independently selected from a hydrogen, a substituted C 1-80 alkyl group, an unsubstituted C 1-80 alkyl group, a substituted C 7-80 arylalkyl group and an unsubstituted C 7-80 arylalkyl group; wherein R 7 and R 8 are independently selected from a C 1-20 alkyl group, a substituted C 1-20 alkyl group, a C 6-20 aryl group and a substituted C 6-20 aryl group or wherein R 7 and R 8 , together with the carbon to which they are attached, form a C 3-20 cycloalkyl ring optionally substituted with a C 1-6 alkyl group; wherein R 10 and R 11 are independently selected from a C 1-20 alkyl group, a substituted C 1-20 alkyl group, a C 6-20 aryl group and a substituted C 6-20 aryl group or wherein R 10 and R 11 , together with the carbon to which they are attached, form a C 3-20 cycloalkyl ring optionally substituted with a C 1-6 alkyl group; and, wherein R 9 is selected from a hydrogen, a C 1-30 alkyl group, a substituted C 1-30 alkyl group, a C 6-30 aryl group and a substituted C 6-30 aryl group; and, optionally, a curing agent. Also provided is a method of soldering an electrical contact using the curable amine flux composition.",FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;WINKLE MARK R;;PEERA ASGHAR AKBER;;ROBINSON GLENN N;;TOMLINSON IAN;;ROHM & HAAS ELECT MAT,FLEMING DAVID D;;GALLAGHER MIKE K;;HO KIM SANG;;LIU XIANG-QIAN;;WINKLE MARK R;;PEERA ASGHAR AKBER;;ROBINSON GLENN N;;TOMLINSON IAN,ANGUS CHEMICAL COMPANY (2011-09-06);;ROHM AND HAAS ELECTRONIC MATERIALS LLC (2011-02-11);;DOW GLOBAL TECHNOLOGIES LLC (2011-02-11),https://lens.org/111-644-226-191-216,Granted Patent,yes,87,9,12,12,0,B23K35/3615;;B23K35/3615;;B23K1/0016;;B23K1/0016;;B23K1/203;;B23K1/203;;B23K1/203;;B23K35/3615;;B23K35/362;;B23K35/362;;B23K35/365;;B23K2101/38;;B23K2101/38;;B23K2101/42;;B23K2101/42;;C07C211/09,B23K31/02;;B23K35/34,228/180.21;;228/207;;228/223;;228/224;;228/248.1;;148/23;;148/24,5,0,,,"STIC search (no date available).;;Copending U.S. Appl. No. 12/958,495.;;Copending U.S. Appl. No. 12/958,480.;;Copending U.S. Appl. No. 12/958,493.;;Copending U.S. Appl. No. 12/958,473.",INACTIVE
753,AU,B2,AU 2017/240494 B2,123-087-201-740-182,2020-01-23,2020,AU 2017/240494 A,2017-03-20,EP 17160791 A;;EP 16163187 A;;US 2017/0023143 W,2016-03-31,Razor cartridge with fluid management system,A razor cartridge comprising a housing (20) having an elongated skin contacting element (60) having a plurality of tunnels (62) extending there through to facilitate fluid flow to the blades.,GILLETTE CO LLC,HAINES RODERICK ANDREW;;OLIVER JAMES SIMON;;PETERSON MARK;;SPOONER-FLEMING JOIA KIRIN;;STEPHENS ALISON FIONA;;TANDY JAMES;;WARRICK PAUL LESLIE;;WILLIAMSON FINBARR CHARLES RONALD,,https://lens.org/123-087-201-740-182,Granted Patent,no,3,0,18,18,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,ACTIVE
754,CA,A1,CA 2521850 A1,199-334-692-766-282,2004-10-28,2004,CA 2521850 A,2004-04-08,US 41000603 A;;US 2004/0010704 W,2003-04-09,REDUCTION OF ERRORS IN NON-INVASIVE TISSUE SAMPLING,"The present invention provides methods and devices for using feedback to improve non-invasive tissue measurements by making measurements faster, easi er to perform, and less error prone. In some embodiments, a set of metrics is identified as measurable potential sources of measurement error that can be controlled by a user. In some embodiments, the set of metrics can be analyze d to determine which metrics are related to one another, and some possible err or metrics can be discarded, and others used as surrogate metrics for measuring and monitoring measurement errors.",INLIGHT SOLUTIONS INC,ROBINSON MARK RIES;;RIDDER TRENT D;;HENDEE SHONN P;;HULL EDWARD L;;FLEMING CLIONA M;;VANSLYKE STEPHEN J;;BROWN CHRISTOPHER D;;MAYNARD JOHN D,,https://lens.org/199-334-692-766-282,Patent Application,no,0,0,5,5,0,A61B5/14532;;A61B5/1455;;A61B5/1495;;A61B2560/0223;;A61B2562/146;;G01N21/49;;A61B5/1455;;A61B5/1495;;A61B2560/0223;;G01N21/49;;A61B2562/146;;A61B5/14532,A61B/;;A61B5/00;;A61B5/145;;G01N21/25;;G01N21/49;;G01N37/00;;G06F19/00,,0,0,,,,DISCONTINUED
755,WO,A1,WO 2016/025886 A1,186-242-655-406-421,2016-02-18,2016,US 2015/0045361 W,2015-08-14,US 201562175773 P;;US 201462038041 P;;US 201462083659 P,2014-08-15,BLENDING VOLUME REDUCING DEVICE,"A blending system is disclosed herein. The blending system may comprise a blender base, a container and a blending volume reduction device. The blending volume reduction device may be removably inserted into the container of the blender system at various positions. The positions may alter the working volume of the container when the blending volume reduction device is inserted in the container.",VITA MIX MAN CORP,KOZLOWSKI EUGENE J;;FLEMING MARK F;;KOLAR DAVID J;;HOSEY STEPHEN;;MEHLMAN FRED H;;EMERSON JONATHAN;;HARVANEC BRIAN;;BOOZER RICHARD D;;RUKAVINA STEPHEN P,,https://lens.org/186-242-655-406-421,Patent Application,yes,8,3,11,13,0,A47J43/0727;;A47J43/046;;A47J43/046;;A47J43/0727,A47J43/046;;A47J43/07,,1,0,,,See also references of EP 3179891A4,PENDING
756,CA,A1,CA 3015379 A1,047-118-812-168-239,2017-10-05,2017,CA 3015379 A,2017-03-20,EP 16163187 A;;EP 17160791 A;;US 2017/0023143 W,2016-03-31,RAZOR CARTRIDGE WITH FLUID MANAGEMENT SYSTEM,A razor cartridge comprising a housing (20) having an elongated skin contacting element (60) having a plurality of tunnels (62) extending there through to facilitate fluid flow to the blades.,GILLETTE CO LLC,HAINES RODERICK ANDREW;;OLIVER JAMES SIMON;;PETERSON MARK;;SPOONER-FLEMING JOIA KIRIN;;STEPHENS ALISON FIONA;;TANDY JAMES;;WARRICK PAUL LESLIE;;WILLIAMSON FINBARR CHARLES RONALD,,https://lens.org/047-118-812-168-239,Patent Application,no,0,0,18,18,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,ACTIVE
757,WO,A1,WO 2017/172395 A1,081-382-593-924-828,2017-10-05,2017,US 2017/0023143 W,2017-03-20,EP 16163187 A;;EP 17160791 A,2016-03-31,RAZOR CARTRIDGE WITH FLUID MANAGEMENT SYSTEM,A razor cartridge comprising a housing (20) having an elongated skin contacting element (60) having a plurality of tunnels (62) extending there through to facilitate fluid flow to the blades.,GILLETTE CO LLC,HAINES RODERICK ANDREW;;OLIVER JAMES SIMON;;PETERSON MARK;;SPOONER-FLEMING JOIA KIRIN;;STEPHENS ALISON FIONA;;TANDY JAMES;;WARRICK PAUL LESLIE;;WILLIAMSON FINBARR CHARLES RONALD,,https://lens.org/081-382-593-924-828,Patent Application,yes,11,0,18,18,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,PENDING
758,US,A1,US 2019/0298109 A1,066-665-570-610-902,2019-10-03,2019,US 201916442766 A,2019-06-17,US 201916442766 A;;US 201514826975 A;;US 201462038041 P;;US 201462083659 P;;US 201562175773 P,2014-08-15,BLENDING VOLUME REDUCING DEVICE,"A blending system is disclosed herein. The blending system may comprise a blender base, a container and a blending volume reduction device. The blending volume reduction device may be removably inserted into the container of the blender system at various positions. The positions may alter the working volume of the container when the blending volume reduction device is inserted in the container.",VITA MIX MAN CORP,KOZLOWSKI EUGENE J;;FLEMING MARK F;;KOLAR DAVID J;;HOSEY STEPHEN;;MEHLMAN FRED H;;EMERSON JONATHAN;;HARVANEC BRIAN;;BOOZER RICHARD D;;RUKAVINA STEPHEN P,VITA-MIX MANAGEMENT CORPORATION (2017-11-01),https://lens.org/066-665-570-610-902,Patent Application,yes,0,1,11,13,0,A47J43/0727;;A47J43/046;;A47J43/046;;A47J43/0727,A47J43/046;;A47J43/07,,0,0,,,,ACTIVE
759,BR,A2,BR 112018070019 A2,015-348-208-421-165,2019-02-05,2019,BR 112018070019 A,2017-03-20,US 2017/0023143 W;;EP 16163187 A;;EP 17160791 A,2016-03-31,cartucho de aparelho de barbear ou depilar com sistema de gerenciamento de fluidos,trata-se de um cartucho de aparelho de barbear ou depilar que compreende um invólucro (20) que tem um elemento alongado de contato com a pele (60) que tem uma pluralidade de túneis (62) que se estendem através do mesmo para facilitar o fluxo de fluidos para as lâminas.,GILLETTE CO LLC,ALISON FIONA STEPHENS;;FINBARR CHARLES RONALD WILLIAMSON;;JAMES SIMON OLIVER;;JAMES TANDY;;JOIA KIRIN SPOONER-FLEMING;;MARK PETERSON;;PAUL LESLIE WARRICK;;RODERICK ANDREW HAINES,,https://lens.org/015-348-208-421-165,Patent Application,no,0,0,18,18,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,ACTIVE
760,US,A1,US 2022/0192426 A1,088-091-461-615-243,2022-06-23,2022,US 202117473056 A,2021-09-13,US 202117473056 A;;US 201916442766 A;;US 201514826975 A;;US 201562175773 P;;US 201462083659 P;;US 201462038041 P,2014-08-15,BLENDING VOLUME REDUCING DEVICE,"A blending system is disclosed herein. The blending system may comprise a blender base, a container and a blending volume reduction device. The blending volume reduction device may be removably inserted into the container of the blender system at various positions. The positions may alter the working volume of the container when the blending volume reduction device is inserted in the container.",VITA MIX MAN CORP,KOZLOWSKI EUGENE J;;FLEMING MARK F;;KOLAR DAVID J>;;HOSEY STEPHEN;;MEHLMAN FRED H;;EMERSON JONATHAN;;HARVANEC BRIAN;;BOOZER RICHARD D;;RUKAVINA STEPHEN P,,https://lens.org/088-091-461-615-243,Patent Application,yes,1,1,11,13,0,A47J43/0727;;A47J43/046;;A47J43/046;;A47J43/0727,A47J43/046;;A47J43/07,,0,0,,,,PENDING
761,EP,A2,EP 1617753 A2,191-537-940-809-050,2006-01-25,2006,EP 04759222 A,2004-04-08,US 2004/0010704 W;;US 41000603 A,2003-04-09,REDUCTION OF ERRORS IN NON-INVASIVE TISSUE SAMPLING,,INLIGHT SOLUTIONS INC,MAYNARD JOHN D;;ROBINSON MARK RIES;;RIDDER TRENT D;;HENDEE SHONN P;;BROWN CHRISTOPHER D;;VANSLYKE STEPHEN J;;FLEMING CLIONA M;;HULL EDWARD L,,https://lens.org/191-537-940-809-050,Patent Application,yes,0,0,5,5,0,A61B5/14532;;A61B5/1455;;A61B5/1495;;A61B2560/0223;;A61B2562/146;;G01N21/49;;A61B5/1455;;A61B5/1495;;A61B2560/0223;;G01N21/49;;A61B2562/146;;A61B5/14532,A61B5/00;;A61B/;;A61B5/145;;G01N21/25;;G01N21/49;;G01N37/00;;G06F19/00,,0,0,,,,DISCONTINUED
762,WO,A3,WO 2004/091364 A3,013-307-385-446-335,2007-04-19,2007,US 2004/0010704 W,2004-04-08,US 41000603 A,2003-04-09,REDUCTION OF ERRORS IN NON-INVASIVE TISSUE SAMPLING,"The present invention provides methods and devices for using feedback to improve non-invasive tissue measurements by enhancing speed, improving ease of operation, and reducing errors. In some embodiments, a set of metrics is identified as measurable potential sources of measurement error that can be controlled by a user. In some embodiments, the set of metrics can be analyzed to determine which metrics are related to one another, and some possible error metrics can be discarded, and others used as surrogate metrics for measure and monitoring measurement errors.",INLIGHT SOLUTIONS INC;;MAYNARD JOHN D;;ROBINSON MARK RIES;;RIDDER TRENT D;;HENDEE SHONN P;;BROWN CHRISTOPHER D;;VANSLYKE STEPHEN J;;FLEMING CLIONA M;;HULL EDWARD L,MAYNARD JOHN D;;ROBINSON MARK RIES;;RIDDER TRENT D;;HENDEE SHONN P;;BROWN CHRISTOPHER D;;VANSLYKE STEPHEN J;;FLEMING CLIONA M;;HULL EDWARD L,,https://lens.org/013-307-385-446-335,Search Report,yes,2,0,5,5,0,A61B5/14532;;A61B5/1455;;A61B5/1495;;A61B2560/0223;;A61B2562/146;;G01N21/49;;A61B5/1455;;A61B5/1495;;A61B2560/0223;;G01N21/49;;A61B2562/146;;A61B5/14532,A61B5/00;;A61B/;;A61B5/145;;A61B6/00;;G01N21/25;;G01N21/49;;G01N37/00;;G06F19/00,,0,0,,,,PENDING
763,US,B2,US 10321785 B2,062-986-431-042-695,2019-06-18,2019,US 201514826975 A,2015-08-14,US 201514826975 A;;US 201462038041 P;;US 201462083659 P;;US 201562175773 P,2014-08-15,Blending volume reducing device,"A blending system is disclosed herein. The blending system may comprise a blender base, a container and a blending volume reduction device. The blending volume reduction device may be removably inserted into the container of the blender system at various positions. The positions may alter the working volume of the container when the blending volume reduction device is inserted in the container.",VITA MIX MAN CORP,KOZLOWSKI EUGENE J;;FLEMING MARK F;;KOLAR DAVID J;;HOSEY STEPHEN;;MEHLMAN FRED H;;EMERSON JONATHAN;;HARVANEC BRIAN;;BOOZER RICHARD D;;RUKAVINA STEPHEN P,VITA-MIX MANAGEMENT CORPORATION (2017-11-01),https://lens.org/062-986-431-042-695,Granted Patent,yes,69,0,11,13,0,A47J43/0727;;A47J43/046;;A47J43/046;;A47J43/0727,A47J43/00;;A47J43/046;;A47J43/07,,7,0,,,"Copenheaver, Blaine, International Search Report and Written Opinion, PCT/US2014/029134, dated Aug. 1, 2014, International Search Authority/USA.;;Young, Lee W., International Search Report and Written Opinion, PCT/US2014/029384, dated Aug. 11, 2014, International Search Authority/USA.;;Gaggia Espanola, S.A., ipanerma, brochure, undated.;;Gaggia Espanola, S.A., Copacabana, brochure, undated.;;Gaggia Espanola, S.A., ipanema Space-Saving High Technology, brochure, undated.;;Thomas, Shane, International Search Report and Written Opinion, ISA/US, PCT/US15/45361, dated Nov. 19, 2015, Alexandria, Virginia USA.;;Supplementary Partial European Search Report for Application No. 15831925.1 related to PCT/US2015045361 dated Nov. 14, 2018.",ACTIVE
764,US,B2,US 11116362 B2,083-435-366-353-358,2021-09-14,2021,US 201916442766 A,2019-06-17,US 201916442766 A;;US 201514826975 A;;US 201462038041 P;;US 201462083659 P;;US 201562175773 P,2014-08-15,Blending volume reducing device,"A blending system is disclosed herein. The blending system may comprise a blender base, a container and a blending volume reduction device. The blending volume reduction device may be removably inserted into the container of the blender system at various positions. The positions may alter the working volume of the container when the blending volume reduction device is inserted in the container.",VITA MIX MAN CORP,KOZLOWSKI EUGENE J;;FLEMING MARK F;;KOLAR DAVID J;;HOSEY STEPHEN;;MEHLMAN FRED H;;EMERSON JONATHAN;;HARVANEC BRIAN;;BOOZER RICHARD D;;RUKAVINA STEPHEN P,VITA-MIX MANAGEMENT CORPORATION (2017-11-01),https://lens.org/083-435-366-353-358,Granted Patent,yes,71,0,11,13,0,A47J43/0727;;A47J43/046;;A47J43/046;;A47J43/0727,A47J43/00;;A47J43/046;;A47J43/07,,10,0,,,"Copenheaver, Blaine, International Search Report and Written Opinion, PCT/US2014/029134, dated Aug. 1, 2014, International Search Authority/USA.;;Young, Lee W., International Search Report and Written Opinion, PCT/US2014/029384, dated Aug. 11, 2014, International Search Authority/USA.;;Gaggia Espanola, S.A., ipanerma, brochure, undated.;;Gaggia Espanola, S.A., Copacabana, brochure, undated.;;Gaggia Espanola, S.A., ipanema Space-Saving High Technology, brochure, undated.;;Thomas, Shane, International Search Report and Written Opinion, ISA/US, PCT/US15/45361, dated Nov. 19, 2015, Alexandria, Virginia USA.;;Supplementary Partial European Search Report for Application No. 15831925.1 related to PCT/US2015045361 dated Nov. 14, 2018.;;European Search Report for EP 10178076 dated May 31, 2011 (3 pages).;;International Search Report for PCT/EP01/08503 dated Feb. 13, 2002.;;Office Action and Search Report issued by the State Intellectual Property Office of Peoples Republic of China in connection with Application No. 201580055430.6, dated May 31, 2019, 14 pages.",ACTIVE
765,EP,A4,EP 3179891 A4,115-794-832-581-117,2018-12-12,2018,EP 15831925 A,2015-08-14,US 201462038041 P;;US 201462083659 P;;US 201562175773 P;;US 2015/0045361 W,2014-08-15,BLENDING VOLUME REDUCING DEVICE,,VITA MIX MAN CORP,KOZLOWSKI EUGENE J;;FLEMING MARK F;;KOLAR DAVID J;;HOSEY STEPHEN;;MEHLMAN FRED H;;EMERSON JONATHAN;;HARVANEC BRIAN;;BOOZER RICHARD D;;RUKAVINA STEPHEN P,,https://lens.org/115-794-832-581-117,Search Report,no,5,0,11,13,0,A47J43/0727;;A47J43/046;;A47J43/046;;A47J43/0727,A47J43/07;;A47J43/046,,1,0,,,See also references of WO 2016025886A1,DISCONTINUED
766,EP,A1,EP 3179891 A1,173-629-667-182-132,2017-06-21,2017,EP 15831925 A,2015-08-14,US 201462038041 P;;US 201462083659 P;;US 201562175773 P;;US 2015/0045361 W,2014-08-15,BLENDING VOLUME REDUCING DEVICE,,VITA-MIX MAN CORP,KOZLOWSKI EUGENE J;;FLEMING MARK F;;KOLAR DAVID J;;HOSEY STEPHEN;;MEHLMAN FRED H;;EMERSON JONATHAN;;HARVANEC BRIAN;;BOOZER RICHARD D;;RUKAVINA STEPHEN P,,https://lens.org/173-629-667-182-132,Patent Application,yes,0,0,11,13,0,A47J43/0727;;A47J43/046;;A47J43/046;;A47J43/0727,A47J43/07;;A47J43/046,,0,0,,,,DISCONTINUED
767,KR,A,KR 20180117114 A,049-734-135-710-925,2018-10-26,2018,KR 20187024901 A,2017-03-20,EP 16163187 A;;EP 17160791 A;;US 2017/0023143 W,2016-03-31,유체 관리 시스템을 갖는 면도기 카트리지,블레이드로의 유체 유동을 용이하게 하기 위해 관통 연장되는 복수의 터널(62)을 갖는 긴 피부 접촉 요소(60)를 갖는 하우징(20)을 포함하는 면도기 카트리지.,GILLETTE CO LLC,HAINES RODERICK ANDREW;;OLIVER JAMES SIMON;;PETERSON MARK;;SPOONER FLEMING JOIA KIRIN;;STEPHENS ALISON FIONA;;TANDY JAMES;;WARRICK PAUL LESLIE;;WILLIAMSON FINBARR CHARLES RONALD,,https://lens.org/049-734-135-710-925,Patent Application,no,3,0,18,18,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40;;B26B21/44,,0,0,,,,ACTIVE
768,US,A1,US 2016/0045073 A1,075-479-887-102-401,2016-02-18,2016,US 201514826975 A,2015-08-14,US 201514826975 A;;US 201462038041 P;;US 201462083659 P;;US 201562175773 P,2014-08-15,BLENDING VOLUME REDUCING DEVICE,"A blending system is disclosed herein. The blending system may comprise a blender base, a container and a blending volume reduction device. The blending volume reduction device may be removably inserted into the container of the blender system at various positions. The positions may alter the working volume of the container when the blending volume reduction device is inserted in the container.",VITA MIX MAN CORP,KOZLOWSKI EUGENE J;;FLEMING MARK F;;KOLAR DAVID J;;HOSEY STEPHEN;;MEHLMAN FRED H;;EMERSON JONATHAN;;HARVANEC BRIAN;;BOOZER RICHARD D;;RUKAVINA STEPHEN P,VITA-MIX MANAGEMENT CORPORATION (2017-11-01),https://lens.org/075-479-887-102-401,Patent Application,yes,14,29,11,13,0,A47J43/0727;;A47J43/046;;A47J43/046;;A47J43/0727,A47J43/046,,0,0,,,,ACTIVE
769,CN,A,CN 108778645 A,155-497-362-435-392,2018-11-09,2018,CN 201780018408 A,2017-03-20,EP 16163187 A;;EP 17160791 A;;US 2017/0023143 W,2016-03-31,RAZOR CARTRIDGE WITH FLUID MANAGEMENT SYSTEM,A razor cartridge comprising a housing (20) having an elongated skin contacting element (60) having a plurality of tunnels (62) extending there through to facilitate fluid flow to the blades.,GILLETTE CO LLC,HAINES RODERICK ANDREW;;OLIVER JAMES SIMON;;PETERSON MARK;;SPOONER-FLEMING JOIA KIRIN;;STEPHENS ALISON FIONA;;TANDY JAMES;;WARRICK PAUL LESLIE;;WILLIAMSON FINBARR CHARLES RONALD,,https://lens.org/155-497-362-435-392,Patent Application,no,8,1,18,18,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,ACTIVE
770,US,B2,US 11634422 B2,181-851-100-993-281,2023-04-25,2023,US 202016887262 A,2020-05-29,US 202016887262 A;;US 201916293317 A;;US 201715488257 A;;US 201662411172 P;;US 201662322948 P,2016-04-15,Inhibitors of activin receptor-like kinase,"Described herein are compounds that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.",BLUEPRINT MEDICINES CORP,BROOIJMANS NATASJA;;BRUBAKER JASON D;;FLEMING PAUL E;;HODOUS BRIAN LEWIS;;KIM JOSEPH L;;WILLIAMS BRETT D;;WILSON DOUGLAS;;WILSON KEVIN J;;CRONIN MARK,BLUEPRINT MEDICINES CORPORATION (2017-06-08),https://lens.org/181-851-100-993-281,Granted Patent,yes,53,0,33,34,0,C07D487/04;;C07D519/00;;A61P19/00;;A61P25/00;;A61P35/00;;A61P43/00;;C07D487/04;;A61K31/5025;;C07D519/00;;A61P19/00;;A61K31/5025;;C07D487/04;;C07D519/00;;A61P35/00;;A61K31/5025;;A61K31/5377;;A61K31/5383;;C07D487/04;;C07D519/00,A61P35/00;;A61K31/5025;;A61K31/5377;;A61K31/5383;;C07D487/04;;C07D519/00,,28,17,008-942-401-930-226;;032-731-534-802-99X;;141-984-169-041-148;;054-207-309-797-175;;084-355-145-743-009;;002-991-350-666-500;;005-753-148-365-857;;000-280-598-328-165;;045-982-641-446-458;;088-370-144-352-621;;020-133-096-140-934;;030-718-452-891-192;;054-241-151-537-523;;039-985-594-433-094;;072-573-473-438-011;;052-176-800-840-741;;001-949-984-543-62X,10.1038/ejhg.2008.178;;pmc2986177;;18830232;;22508565;;pmc3556640;;10.1002/jbmr.1637;;2299462;;10.1016/s0278-2391(10)80212-5;;pmc6124206;;10.1002/jbm4.10008;;30283890;;10.1002/dvg.20201;;16604518;;pmc3160462;;10.1016/j.bone.2010.10.164;;21044902;;25230881;;pmc4747023;;10.1038/nrc3811;;10.1002/humu.20868;;19085907;;pmc2921861;;18450872;;pmc3502043;;10.1542/peds.2007-1980;;pmc5697787;;29177121;;10.1080/21678707.2017.1304211;;pmc4567450;;26097044;;10.1002/ajmg.a.37205;;pmc3901569;;10.1021/cb300655w;;23547776;;26776312;;10.1016/j.cytogfr.2015.12.007;;pmc4753137;;pmc2658887;;10.1371/journal.pone.0005005;;19330033;;10.1038/ng0207-276b;;10.1038/nm.1888;;pmc2846458;;19029982;;10.1242/dmm.010280;;pmc3484858;;23115204,"Bocciardi et al., Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements. Eur J Hum Genet. 2009;17(3)1311-318.;;Chakkalakal et al., An Acvrl R206H knock-in mouse has fibrodysplasia ossificans progressiva. J Bone Miner Res. 2012;27(8):1746-1756.;;Crofford et al., Failure of surgery and isotretinoin to relieve jaw immobilization in fibrodysplasia ossificans progressiva: report of two cases. J Oral Maxillofac Surg. 1990;48(2):204-208.;;Eekhoff et al., Flare-Up After Maxillofacial Surgery in a Patient With Fibrodysplasia Ossificans Progressiva: An [18F]-NaF PET/CT Study and a Systematic Review. JBMR Plus. 2017;2(1):55-58.;;Fukuda et al., Generation of a mouse with conditionally activated signaling through the BMP receptor, ALK2. Genesis. 2006;44(4):159-167.;;Garner, Characterization of Highly Selective ALK2 Inhibitors for the Treatment of FOP. Slides presented at the 2016 FOP Drug Development Forum in Boston, MA. 9 pages, Oct. 24, 2016.;;Garner, Generation of Highly Selective ALK2 Inhibitors for the Treatment of FOP. Slides presented at the 2016 Annual FOP Italia Meeting, 17 pages, Apr. 16, 2016.;;Gregson et al., A novel ACVR1 mutation in the glycine/serine-rich domain found in the most benign case of a fibrodysplasia ossificans progressiva variant reported to date. Bone. 2011;48(3):654-658.;;Jones et al., Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma. Nat Rev Cancer. Sep. 18, 2014;14:651-661.;;Kaplan et al., Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat. 2009;30(3):379-390.;;Kaplan et al., Eady diagnosis of fibrodysplasia ossificans progressiva. Pediatrics. 2008;121(5):e1295-e1300.;;Kaplan et al., Hard targets for a second skeleton: therapeutic horizons for fibrodysplasia ossificans progressiva (FOP). Expert Opin Orphan Drugs 2017;5(4):291-294.;;Kaplan et al., Multi-system involvement in a severe variant of fibrodysplasia ossificans progressiva (ACVR1 c.772G>A; R258G): A report of two patients. Am J Med Genet A 2015;167A(10):2265-2271.;;Mohedas et al., Development of an ALK2-biased BMP type I receptor kinase inhibitor. ACS Chem Biol. 2013;8(6):1291-1302.;;Pacifici et al., Common mutations in ALK2/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disorders Cytokine Growth Factor Rev 2016;27:93-104.;;Petrie et al., Novel mutations in ACVR1 result in atypical features in two fibrodysplasia ossificans progressiva patients. PLoS One. 2009;4(3):e5005, 4 pages.;;Shore et al., A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 2006;38(5):525-527. [published correction appears in Nat Genet. Feb. 2007;39(2):276.;;Yu et al., BMP type I receptor inhibition reduces heterotopic [corrected] ossification [published correction appears in Nat Med. Jan. 2009;15(1):117]. Nat Med. 2008;14(12):1363-1369, including Erratum (1 page).;;International Search Report and Written Opinion for Application No. PCT/US2017/027775, dated Jul. 21, 2017, 9 pages.;;U.S. Notice of Allowance U.S. Appl. No. 15/462,255, dated Aug. 6, 2018.;;U.S. Notice of Allowance U.S. Appl. No. 15/222,523, dated Oct. 11, 2018.;;U.S. Notice of Allowance U.S. Appl. No. 15/657,057, dated Oct. 19, 2018.;;U.S. Notice of Allowance U.S. Appl. No. 15/548,925, dated Sep. 21, 2018.;;U.S. Notice of Allowance U.S. Appl. No. 15/867,637, dated Sep. 26, 2018.;;U.S. Appl. No. 16/002,587, filed Jun. 7, 2018, by Blueprint Medicines Corp.—Abandoned.;;Kaplan et al., Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis. Dis Model Mech. Nov. 2012;5(6):756-62.;;U.S. Appl. No. 15/488,257, filed Apr. 14, 2017, U.S. Pat. No. 10,233,186, Issued.;;U.S. Appl. No. 16/293,317, filed Mar. 5, 2019, U.S. Pat. No. 10,669,277, Issued.",ACTIVE
771,US,A1,US 2017/0282388 A1,197-018-426-327-378,2017-10-05,2017,US 201715464730 A,2017-03-21,EP 16163187 A;;EP 17160791 A,2016-03-31,RAZOR CARTRIDGE WITH FLUID MANAGEMENT SYSTEM,A razor cartridge comprising a housing having an elongated skin contacting element having a plurality of tunnels extending there through to facilitate fluid flow to the blades.,GILLETTE CO LLC,HAINES RODERICK ANDREW;;OLIVER JAMES SIMON;;PETERSON MARK;;SPOONER-FLEMING JOIA KIRIN;;STEPHENS ALISON FIONA;;TANDY JAMES;;WARRICK PAUL LESLIE;;WILLIAMSON FINBARR CHARLES RONALD,THE GILLETTE COMPANY LLC (2017-03-14),https://lens.org/197-018-426-327-378,Patent Application,yes,7,4,18,18,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/44,,0,0,,,,DISCONTINUED
772,CN,A,CN 106793893 A,044-992-919-221-441,2017-05-31,2017,CN 201580055430 A,2015-08-14,US 201462038041 P;;US 201462083659 P;;US 201562175773 P;;US 2015/0045361 W,2014-08-15,Blending volume reducing device,"A blending system is disclosed herein. The blending system may comprise a blender base, a container and a blending volume reduction device. The blending volume reduction device may be removably inserted into the container of the blender system at various positions. The positions may alter the working volume of the container when the blending volume reduction device is inserted in the container.",VITA MIX MAN CORP,KOZLOWSKI EUGENE J;;FLEMING MARK F;;KOLAR DAVID J;;HOSEY STEPHEN;;MEHLMAN FRED H;;EMERSON JONATHAN;;HARVANEC BRIAN;;BOOZER RICHARD D;;RUKAVINA STEPHEN P,,https://lens.org/044-992-919-221-441,Patent Application,no,16,6,11,13,0,A47J43/0727;;A47J43/046;;A47J43/046;;A47J43/0727,A47J43/046;;A47J43/07,,2,0,,,"孙诚: ""《包装结构设计》"", 31 March 2009, 北京：中国轻工业出版社;;张瑞菊，王林山: ""《软饮料加工技术》"", 31 March 2007",ACTIVE
773,CN,A,CN 112674622 A,172-997-794-627-408,2021-04-20,2021,CN 202011550671 A,2015-08-14,US 201462038041 P;;US 201462083659 P;;US 201562175773 P;;CN 201580055430 A,2014-08-15,Blending volume reducing device,"A blending system is disclosed herein. The blending system may comprise a blender base, a container and a blending volume reduction device. The blending volume reduction device may be removably inserted into the container of the blender system at various positions. The positions may alter the working volume of the container when the blending volume reduction device is inserted in the container.",VITA MIX CORP,KOZLOWSKI EUGENE J;;FLEMING MARK F;;KOLAR DAVID J;;HOSEY STEPHEN;;MEHLMAN FRED H;;EMERSON JONATHAN;;HARVANEC BRIAN;;BOOZER RICHARD D;;RUKAVINA STEPHEN P,,https://lens.org/172-997-794-627-408,Patent Application,no,8,0,11,13,0,A47J43/0727;;A47J43/046;;A47J43/046;;A47J43/0727,A47J43/046;;A47J43/07,,0,0,,,,PENDING
774,EP,B1,EP 3231564 B1,055-058-560-705-381,2020-07-01,2020,EP 17160791 A,2017-03-14,EP 16163187 A,2016-03-31,RAZOR CARTRIDGE WITH FLUID MANAGEMENT SYSTEM,,GILLETTE CO LLC,HAINES RODERICK ANDREW;;OLIVER JAMES SIMON;;PETERSON MARK;;SPOONER-FLEMING JOIA KIRIN;;STEPHENS ALISON FIONA;;TANDY JAMES;;WARRICK PAUL LESLIE;;WILLIAMSON FINBARR CHARLES RONALD,,https://lens.org/055-058-560-705-381,Granted Patent,yes,5,0,18,18,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,ACTIVE
775,US,S,US D0595084 S,163-427-099-784-97X,2009-06-30,2009,US 31288008 F,2008-11-19,US 31288008 F,2008-11-19,Base of a blender,,VITA MIX CORP,METAXATOS PAUL K;;KOURY STEFFEN F;;MACLAURIN KURTIS R;;ULANSKI ROBERT M;;KOLAR DAVID J;;RUKAVINA STEPHEN P;;FLEMING MARK F;;CIEPIEL ANTHONY M,VITA-MIX MANAGEMENT CORPORATION (2015-04-30);;VITA-MIX HOLDINGS COMPANY (2014-12-29),https://lens.org/163-427-099-784-97X,Design Right,no,0,11,3,3,0,,,3100;;D 7386;;D7/378,0,0,,,,EXPIRED
776,MX,A,MX 2018011814 A,102-881-258-211-464,2019-02-13,2019,MX 2018011814 A,2017-03-20,EP 16163187 A;;EP 17160791 A;;US 2017/0023143 W,2016-03-31,RAZOR CARTRIDGE WITH FLUID MANAGEMENT SYSTEM.,A razor cartridge comprising a housing (20) having an elongated skin contacting element (60) having a plurality of tunnels (62) extending there through to facilitate fluid flow to the blades.,GILLETTE CO LLC,MARK PETERSON;;ALISON FIONA STEPHENS;;PAUL LESLIE WARRICK;;FINBARR CHARLES RONALD WILLIAMSON;;RODERICK ANDREW HAINES;;JAMES SIMON OLIVER;;JOIA KIRIN SPOONER-FLEMING;;JAMES TANDY,,https://lens.org/102-881-258-211-464,Patent Application,no,0,0,18,18,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,PENDING
777,WO,A2,WO 2004/091364 A2,110-975-247-574-371,2004-10-28,2004,US 2004/0010704 W,2004-04-08,US 41000603 A,2003-04-09,REDUCTION OF ERRORS IN NON-INVASIVE TISSUE SAMPLING,"The present invention provides methods and devices for using feedback to improve non-invasive tissue measurements by enhancing speed, improving ease of operation, and reducing errors. In some embodiments, a set of metrics is identified as measurable potential sources of measurement error that can be controlled by a user. In some embodiments, the set of metrics can be analyzed to determine which metrics are related to one another, and some possible error metrics can be discarded, and others used as surrogate metrics for measure and monitoring measurement errors.",INLIGHT SOLUTIONS INC;;MAYNARD JOHN D;;ROBINSON MARK RIES;;RIDDER TRENT D;;HENDEE SHONN P;;BROWN CHRISTOPHER D;;VANSLYKE STEPHEN J;;FLEMING CLIONA M;;HULL EDWARD L,MAYNARD JOHN D;;ROBINSON MARK RIES;;RIDDER TRENT D;;HENDEE SHONN P;;BROWN CHRISTOPHER D;;VANSLYKE STEPHEN J;;FLEMING CLIONA M;;HULL EDWARD L,,https://lens.org/110-975-247-574-371,Patent Application,yes,0,0,5,5,0,A61B5/14532;;A61B5/1455;;A61B5/1495;;A61B2560/0223;;A61B2562/146;;G01N21/49;;A61B5/1455;;A61B5/1495;;A61B2560/0223;;G01N21/49;;A61B2562/146;;A61B5/14532,A61B/;;A61B5/00;;A61B5/145;;G01N21/25;;G01N21/49;;G01N37/00;;G06F19/00,,0,0,,,,PENDING
778,CA,C,CA 3015379 C,192-621-416-716-876,2020-09-29,2020,CA 3015379 A,2017-03-20,EP 16163187 A;;EP 17160791 A;;US 2017/0023143 W,2016-03-31,RAZOR CARTRIDGE WITH FLUID MANAGEMENT SYSTEM,A razor cartridge comprising a housing (20) having an elongated skin contacting element (60) having a plurality of tunnels (62) extending there through to facilitate fluid flow to the blades.,GILLETTE CO LLC,HAINES RODERICK ANDREW;;OLIVER JAMES SIMON;;PETERSON MARK;;SPOONER-FLEMING JOIA KIRIN;;STEPHENS ALISON FIONA;;TANDY JAMES;;WARRICK PAUL LESLIE;;WILLIAMSON FINBARR CHARLES RONALD,,https://lens.org/192-621-416-716-876,Granted Patent,no,0,0,18,18,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,ACTIVE
779,EP,A1,EP 3231564 A1,015-558-434-304-763,2017-10-18,2017,EP 17160791 A,2017-03-14,EP 16163187 A,2016-03-31,RAZOR CARTRIDGE WITH FLUID MANAGEMENT SYSTEM,"A razor cartridge comprising a housing (20) having an elongated skin contacting element (60) having a plurality of tunnels (62) extending there through to facilitate fluid flow to the blades.
 
",GILLETTE CO LLC,HAINES RODERICK ANDREW;;OLIVER JAMES SIMON;;PETERSON MARK;;SPOONER-FLEMING JOIA KIRIN;;STEPHENS ALISON FIONA;;TANDY JAMES;;WARRICK PAUL LESLIE;;WILLIAMSON FINBARR CHARLES RONALD,,https://lens.org/015-558-434-304-763,Patent Application,yes,11,0,18,18,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,ACTIVE
780,AU,A1,AU 2017/240494 A1,105-663-300-486-570,2018-08-30,2018,AU 2017/240494 A,2017-03-20,EP 17160791 A;;EP 16163187 A;;US 2017/0023143 W,2016-03-31,Razor cartridge with fluid management system,A razor cartridge comprising a housing (20) having an elongated skin contacting element (60) having a plurality of tunnels (62) extending there through to facilitate fluid flow to the blades.,GILLETTE CO LLC,HAINES RODERICK ANDREW;;OLIVER JAMES SIMON;;PETERSON MARK;;SPOONER-FLEMING JOIA KIRIN;;STEPHENS ALISON FIONA;;TANDY JAMES;;WARRICK PAUL LESLIE;;WILLIAMSON FINBARR CHARLES RONALD,,https://lens.org/105-663-300-486-570,Patent Application,no,0,0,18,18,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,ACTIVE
781,BR,B1,BR 112018070019 B1,131-195-299-987-156,2022-03-08,2022,BR 112018070019 A,2017-03-20,US 2017/0023143 W;;EP 16163187 A;;EP 17160791 A,2016-03-31,Cartucho de aparelho de barbear ou depilar com sistema de gerenciamento de fluidos,trata-se de um cartucho de aparelho de barbear ou depilar que compreende um invólucro (20) que tem um elemento alongado de contato com a pele (60) que tem uma pluralidade de túneis (62) que se estendem através do mesmo para facilitar o fluxo de fluidos para as lâminas.,GILLETTE CO LLC,ALISON FIONA STEPHENS;;FINBARR CHARLES RONALD WILLIAMSON;;JAMES SIMON OLIVER;;TANDY JAMES;;JOIA KIRIN SPOONER-FLEMING;;PETERSON MARK;;PAUL LESLIE WARRICK;;RODERICK ANDREW HAINES,,https://lens.org/131-195-299-987-156,Granted Patent,no,0,0,18,18,0,B26B21/4018;;B26B21/446;;B26B21/4012;;B26B21/44;;B26B21/4018;;B26B21/446,B26B21/40,,0,0,,,,ACTIVE
782,US,A1,US 2004/0204868 A1,098-140-525-066-599,2004-10-14,2004,US 41000603 A,2003-04-09,US 41000603 A,2003-04-09,Reduction of errors in non-invasive tissue sampling,"
   The present invention provides methods and devices for using feedback to improve non-invasive tissue measurements by making measurements faster, easier to perform, and less error prone. In some embodiments, a set of metrics is identified as measurable potential sources of measurement error that can be controlled by a user. In some embodiments, the set of metrics can be analyzed to determine which metrics are related to one another, and some possible error metrics can be discarded, and others used as surrogate metrics for measuring and monitoring measurement errors. 
",MAYNARD JOHN D.;;ROBINSON MARK RIES;;RIDDER TRENT D.;;HENDEE SHONN P.;;BROWN CHRISTOPHER D.;;VANSLYKE STEPHEN J.;;FLEMING CLIONA M.;;HULL EDWARD L.,MAYNARD JOHN D;;ROBINSON MARK RIES;;RIDDER TRENT D;;HENDEE SHONN P;;BROWN CHRISTOPHER D;;VANSLYKE STEPHEN J;;FLEMING CLIONA M;;HULL EDWARD L,INLIGHT SOLUTIONS INC (2003-04-08),https://lens.org/098-140-525-066-599,Patent Application,yes,4,221,5,5,0,A61B5/14532;;A61B5/1455;;A61B5/1495;;A61B2560/0223;;A61B2562/146;;G01N21/49;;A61B5/1455;;A61B5/1495;;A61B2560/0223;;G01N21/49;;A61B2562/146;;A61B5/14532,A61B/;;A61B5/00;;A61B5/145;;G01N21/25;;G01N21/49;;G01N37/00;;G06F19/00,702 3,0,0,,,,DISCONTINUED
783,EP,A1,EP 3442977 A1,128-602-385-926-285,2019-02-20,2019,EP 17733108 A,2017-04-14,US 201662322948 P;;US 201662411172 P;;US 2017/0027775 W,2016-04-15,INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE,,BLUEPRINT MEDICINES CORP,BROOIJMANS NATASJA;;BRUBAKER JASON D;;FLEMING PAUL E;;HODOUS BRIAN L;;KIM JOSEPH L;;WAETZIG JOSH;;WILLIAMS BRETT;;WILSON DOUGLAS;;WILSON KEVIN J;;CRONIN MARK,,https://lens.org/128-602-385-926-285,Patent Application,yes,0,0,33,34,0,C07D487/04;;C07D519/00;;A61P19/00;;A61P25/00;;A61P35/00;;A61P43/00;;C07D487/04;;A61K31/5025;;C07D519/00;;A61P19/00;;A61K31/5025;;C07D487/04;;C07D519/00;;A61P35/00;;A61K31/5025;;A61K31/5377;;A61K31/5383;;C07D487/04;;C07D519/00,C07D487/04;;A61K31/5025;;A61P19/00;;C07D519/00,,0,0,,,,ACTIVE
784,WO,A1,WO 2017/181117 A1,191-815-391-915-383,2017-10-19,2017,US 2017/0027775 W,2017-04-14,US 201662322948 P;;US 201662411172 P,2016-04-15,INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE,"Described herein are compounds that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.",BLUEPRINT MEDICINES CORP,BROOIJMANS NATASJA;;BRUBAKER JASON D;;FLEMING PAUL E;;HODOUS BRIAN L;;KIM JOSEPH L;;WAETZIG JOSH;;WILLIAMS BRETT;;WILSON DOUGLAS;;WILSON KEVIN J;;CRONIN MARK,,https://lens.org/191-815-391-915-383,Patent Application,yes,1,14,33,34,0,C07D487/04;;C07D519/00;;A61P19/00;;A61P25/00;;A61P35/00;;A61P43/00;;C07D487/04;;A61K31/5025;;C07D519/00;;A61P19/00;;A61K31/5025;;C07D487/04;;C07D519/00;;A61P35/00;;A61K31/5025;;A61K31/5377;;A61K31/5383;;C07D487/04;;C07D519/00,C07D487/04;;A61K31/5025;;A61P19/00;;C07D519/00,,13,10,032-731-534-802-99X;;084-355-145-743-009;;000-280-598-328-165;;002-991-350-666-500;;020-133-096-140-934;;039-985-594-433-094;;008-942-401-930-226;;054-241-151-537-523;;005-753-148-365-857;;045-982-641-446-458,22508565;;pmc3556640;;10.1002/jbmr.1637;;10.1002/dvg.20201;;16604518;;10.1002/humu.20868;;19085907;;pmc2921861;;pmc3160462;;10.1016/j.bone.2010.10.164;;21044902;;pmc4567450;;26097044;;10.1002/ajmg.a.37205;;pmc2658887;;10.1371/journal.pone.0005005;;19330033;;10.1038/ejhg.2008.178;;pmc2986177;;18830232;;26776312;;10.1016/j.cytogfr.2015.12.007;;pmc4753137;;25230881;;pmc4747023;;10.1038/nrc3811;;18450872;;pmc3502043;;10.1542/peds.2007-1980,"SHORE ET AL., NATURE GENETICS, vol. 38, 2006, pages 525 - 27;;CHAKKALAKAL ET AL., J BONE MINER RES., vol. 27, no. 8, 2012, pages 1746 - 1756;;FUKUDA ET AL., GENESIS, vol. 44, 2006, pages 159 - 167;;KAPLAN ET AL., HUM MUTAT., vol. 30, no. 3, 2009, pages 379 - 390;;GREGSON ET AL., BONE, vol. 48, 2011, pages 654 - 658;;KAPLAN ET AL., AM J MED GENET, vol. 167, 2015, pages 2265 - 2271;;PETRIE ET AL., PLOS ONE, vol. 4, no. 3, 2009, pages e5005;;BOCCIARDI ET AL., EUR J HUM GENETICS, vol. 17, 2009, pages 311 - 318;;PACIFICI; SHORE, CYTOKINE & GROWTH FACTOR REVIEWS, vol. 27, 2016, pages 93 - 104;;JONES; BAKER, NATURE REV CANCER, vol. 14, 2014, pages 651 - 661;;BERGE ET AL.: ""Pharmaceutical Salts"", J. PHARM. SCI., vol. 66, 1977, pages 1 - 19, XP002675560, DOI: doi:10.1002/jps.2600660104;;KAPLAN, PEDIATRICS, vol. 121, no. 5, 2008, pages e1295 - e1300;;WUTS; GREENE: ""Protective Groups in Organic Synthesis, 4th ed.,"", 2006, JOHN WILEY & SONS",PENDING
785,US,A1,US 2022/0315585 A1,168-185-460-001-327,2022-10-06,2022,US 202016887262 A,2020-05-29,US 202016887262 A;;US 201916293317 A;;US 201715488257 A;;US 201662411172 P;;US 201662322948 P,2016-04-15,INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE,"Described herein are compounds that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.",BLUEPRINT MEDICINES CORP,BROOIJMANS NATASJA;;BRUBAKER JASON D;;FLEMING PAUL E;;HODOUS BRIAN L;;KIM JOSEPH L;;WAETZIG JOSH;;WILLIAMS BRETT;;WILSON DOUGLAS;;WILSON KEVIN J;;CRONIN MARK,BLUEPRINT MEDICINES CORPORATION (2017-06-08),https://lens.org/168-185-460-001-327,Patent Application,yes,1,0,33,34,0,C07D487/04;;C07D519/00;;A61P19/00;;A61P25/00;;A61P35/00;;A61P43/00;;C07D487/04;;A61K31/5025;;C07D519/00;;A61P19/00;;A61K31/5025;;C07D487/04;;C07D519/00;;A61P35/00;;A61K31/5025;;A61K31/5377;;A61K31/5383;;C07D487/04;;C07D519/00,C07D487/04;;C07D519/00,,0,0,,,,ACTIVE
786,US,A1,US 2021/0016040 A1,012-922-838-187-97X,2021-01-21,2021,US 202016925080 A,2020-07-09,US 202016925080 A;;US 201962875827 P,2019-07-18,SYSTEM AND METHOD FOR HIGH FLOW OXYGEN THERAPY,"A method of method of high flow oxygen therapy (HFOT) and carbon dioxide (CO 2 ) monitoring includes delivering high flow oxygen therapy (HFOT) via a central lumen of a nasal cannula, the nasal cannula comprising a proximal end, a distal end positioned within a pharynx region of a patient's airway, and the central lumen and a sampling lumen formed within a wall of the nasal cannula. The method also includes receiving sampled exhaled breath of the patient via the sampling lumen at a CO 2 monitor, wherein the sampling lumen is configured to sample the exhaled breath at the pharynx region through the CO2-permeable membrane and direct the sampled exhaled breath to a CO 2 monitor fluidly coupled to the sampling lumen and determining a level of CO 2 in the exhaled breath using the CO 2 monitor.",COVIDIEN LP,MCGANN MARK A;;CURLEY JAMES P;;GALLOGLY PAUL J;;DONLON KIERAN M;;MAGUIRE SEAMUS P;;THIESSEN RONALD;;MCLAUGHLIN ERIN F;;KAUC RICHARD;;FLEMING GRAHAM B,COVIDIEN LP (2019-08-23),https://lens.org/012-922-838-187-97X,Patent Application,yes,0,2,2,2,0,A61B5/0836;;A61M16/0096;;A61M16/0434;;A61M16/0461;;A61M16/0672;;A61M16/085;;A61M2202/0208;;A61M2210/065;;A61M2230/432;;A61B5/4839;;A61B5/4821;;A61B5/082;;A61M16/0672;;A61M16/085;;A61M16/0434;;A61M16/0096;;A61B5/0836;;A61M2202/0208;;A61M2230/432;;A61M2210/065;;A61M16/0461,A61M16/06;;A61M16/00;;A61M16/04;;A61M16/08,,0,0,,,,ACTIVE
787,MX,A,MX 2018012664 A,133-572-180-599-635,2019-03-07,2019,MX 2018012664 A,2017-04-14,US 201662322948 P;;US 201662411172 P;;US 2017/0027775 W,2016-04-15,INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE.,"Described herein are compounds that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.",BLUEPRINT MEDICINES CORP,DOUGLAS WILSON;;JOSEPH L KIM;;PAUL E FLEMING;;JASON D BRUBAKER;;NATASJA BROOIJMANS;;JOSH WAETZIG;;BRETT WILLIAMS;;MARK CRONIN;;BRIAN L HODOUS;;KEVIN J WILSON,,https://lens.org/133-572-180-599-635,Patent Application,no,0,0,33,34,0,C07D487/04;;C07D519/00;;A61P19/00;;A61P25/00;;A61P35/00;;A61P43/00;;C07D487/04;;A61K31/5025;;C07D519/00;;A61P19/00;;A61K31/5025;;C07D487/04;;C07D519/00;;A61P35/00;;A61K31/5025;;A61K31/5377;;A61K31/5383;;C07D487/04;;C07D519/00,A61K31/5025;;A61P19/00;;C07D487/04;;C07D519/00,,0,0,,,,PENDING
788,EP,A3,EP 4285996 A3,174-246-160-052-732,2024-01-10,2024,EP 23181727 A,2017-04-14,US 201662322948 P;;US 2017/0027775 W;;US 201662411172 P;;EP 17733108 A,2016-04-15,INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE,"Described herein are compounds that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.",BLUEPRINT MEDICINES CORP,BROOIJMANS NATASJA;;BRUBAKER JASON D;;FLEMING PAUL E;;HODOUS BRIAN L;;KIM JOSEPH L;;WAETZIG JOSH;;WILLIAMS BRETT;;WILSON DOUGLAS;;WILSON KEVIN J;;CRONIN MARK,,https://lens.org/174-246-160-052-732,Search Report,yes,1,0,33,34,0,C07D487/04;;C07D519/00;;A61P19/00;;A61P25/00;;A61P35/00;;A61P43/00;;C07D487/04;;A61K31/5025;;C07D519/00;;A61P19/00;;A61K31/5025;;C07D487/04;;C07D519/00;;A61P35/00;;A61K31/5025;;A61K31/5377;;A61K31/5383;;C07D487/04;;C07D519/00,C07D487/04;;A61K31/5025;;A61P19/00;;C07D519/00,,0,0,,,,PENDING
789,CL,A1,CL 2018002945 A1,157-366-704-684-157,2019-03-15,2019,CL 2018002945 A,2018-10-16,US 201662322948 P;;US 201662411172 P,2016-04-15,Inhibidores de quinasa tipo receptor de activina.,"EN LA PRESENTE SE DESCRIBEN COMPUESTOS QUE INHIBEN ALK2 Y SUS MUTANTES, COMPOSICIONES FARMACÉUTICAS QUE INCLUYEN TALES COMPUESTOS, Y MÉTODOS DE USO DE TALES COMPUESTOS Y COMPOSICIONES.",BLUEPRINT MEDICINES CORP,BRUBAKER JASON D;;KIM JOSEPH L;;WILSON KEVIN J;;WILSON DOUGLAS;;BROOIJMANS NATASJA;;FLEMING PAUL E;;HODOUS BRIAN L;;WAETZIG JOSH;;WILLIAMS BRETT;;CRONIN MARK,,https://lens.org/157-366-704-684-157,Patent Application,no,0,0,33,34,0,C07D487/04;;C07D519/00;;A61P19/00;;A61P25/00;;A61P35/00;;A61P43/00;;C07D487/04;;A61K31/5025;;C07D519/00;;A61P19/00;;A61K31/5025;;C07D487/04;;C07D519/00;;A61P35/00;;A61K31/5025;;A61K31/5377;;A61K31/5383;;C07D487/04;;C07D519/00,A61K31/5025;;A61P19/00;;C07D487/04;;C07D519/00,,0,0,,,,PENDING
790,BR,A2,BR 112018071184 A2,039-409-556-024-374,2019-02-12,2019,BR 112018071184 A,2017-04-14,US 2017/0027775 W;;US 201662322948 P;;US 201662411172 P,2016-04-15,inibidores do receptor de activina tipo quinase,"são descritos neste documento compostos que inibem o alk2 e seus mutantes, composições farmacêuticas incluindo esses compostos, e métodos de utilização desses compostos e composições.",BLUEPRINT MEDICINES CORP,BRETT WILLIAMS;;BRIAN L HODOUS;;DOUGLAS WILSON;;JASON D BRUBAKER;;JOSEPH L KIM;;JOSH WAETZIG;;KEVIN J WILSON;;MARK CRONIN;;NATASJA BROOIJMANS;;PAUL E FLEMING,,https://lens.org/039-409-556-024-374,Patent Application,no,0,0,33,34,0,C07D487/04;;C07D519/00;;A61P19/00;;A61P25/00;;A61P35/00;;A61P43/00;;C07D487/04;;A61K31/5025;;C07D519/00;;A61P19/00;;A61K31/5025;;C07D487/04;;C07D519/00;;A61P35/00;;A61K31/5025;;A61K31/5377;;A61K31/5383;;C07D487/04;;C07D519/00,C07D487/04;;A61K31/5025;;A61P19/00;;C07D519/00,,0,0,,,,PENDING
791,FR,A1,FR 2980726 A1,083-593-460-223-49X,2013-04-05,2013,FR 1259146 A,2012-09-28,US 201113250125 A,2011-09-30,"COMPOSITION DE FONDANT AMINE, ACIDE CARBOXYLIQUE DURCISSABLE ET PROCEDE DE SOUDAGE","Une composition de fondant durcissable est fournie, comprenant, comme composants initiaux: un composant résine ayant au moins deux groupes oxirane par molécule; un acide carboxylique; et un agent fondant amine représenté par la formule I: et, éventuellement, un agent durcisseur. Est également fourni un procédé de soudage d'un contact électrique utilisant la composition de fondant durcissable.",ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,DHOBLE AVIN V;;WINKLE MARK R;;GALLAGHER MICHAEL K;;HO KIM SANG;;LIU XIANG-QIAN;;PEERA ASGHAR A;;ROBINSON GLENN;;TOMLINSON IAN;;FLEMING DAVID D,"DOW GLOBAL TECHNOLOGIES LLC, US (2015-02-10);;ROHM AND HAAS ELECTRONIC MATERIALS LLC, US (2015-02-10)",https://lens.org/083-593-460-223-49X,Patent Application,no,4,0,13,13,0,C08K5/09;;C08K5/17;;B23K35/3618;;B23K35/362;;H05K3/3436;;H05K3/3489;;H05K2201/10674;;H05K2201/10977;;H01L2224/81011;;H01L2224/27422;;H01L2224/2939;;B23K1/0016;;B23K1/203;;H01L24/11;;H01L24/13;;H01L24/16;;H01L24/27;;H01L24/29;;H01L24/32;;H01L24/81;;H01L24/83;;H01L24/92;;H01L2224/11334;;H01L2224/131;;H01L2224/13111;;H01L2224/16227;;H01L2224/2732;;H01L2224/2741;;H01L2224/27418;;H01L2224/2929;;H01L2224/29311;;H01L2224/29387;;H01L2224/32225;;H01L2224/73204;;H01L2224/81024;;H01L2224/81143;;H01L2224/81191;;H01L2224/81192;;H01L2224/81815;;H01L2224/83192;;H01L2224/83862;;H01L2224/9211;;H01L2224/29294;;H01L21/563;;H01L2224/16225;;B23K2101/42;;B23K35/362;;C07C215/02;;C07C211/09;;B23K35/3618;;C08K5/09;;H05K2201/10977;;H05K3/3436;;C08K5/17;;B23K35/362;;H05K2201/10674;;H05K3/3489;;H01L24/16;;H01L2224/131;;H01L2224/32225;;H01L21/563;;H01L2224/2732;;H01L2224/81191;;H01L24/27;;H01L2224/11334;;H01L2224/2939;;H01L2224/81143;;H01L24/81;;H01L2224/29294;;H01L2224/27422;;H01L2224/83192;;H01L2224/81011;;H01L2224/29387;;H01L24/13;;H01L24/29;;H01L24/83;;H01L2224/2929;;H01L2224/81815;;B23K1/0016;;H01L2224/13111;;H01L2224/2741;;H01L2224/73204;;H01L2224/81024;;H01L2224/9211;;H01L2224/83862;;H01L2224/16227;;H01L2224/27418;;H01L24/32;;H01L24/11;;B23K1/203;;H01L24/92;;H01L2224/29311;;H01L2224/81192;;H01L2224/16225;;B23K2101/42,B23K35/363;;C08K5/09;;C08K5/17;;C08L63/00;;H01L21/56;;H05K3/34,,0,0,,,,INACTIVE
792,FR,B1,FR 2980726 B1,004-384-957-652-963,2014-06-13,2014,FR 1259146 A,2012-09-28,US 201113250125 A,2011-09-30,"COMPOSITION DE FONDANT AMINE, ACIDE CARBOXYLIQUE DURCISSABLE ET PROCEDE DE SOUDAGE",,ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,DHOBLE AVIN V;;WINKLE MARK R;;GALLAGHER MICHAEL K;;HO KIM SANG;;LIU XIANG-QIAN;;PEERA ASGHAR A;;ROBINSON GLENN;;TOMLINSON IAN;;FLEMING DAVID D,"DOW GLOBAL TECHNOLOGIES LLC, US (2015-02-10);;ROHM AND HAAS ELECTRONIC MATERIALS LLC, US (2015-02-10)",https://lens.org/004-384-957-652-963,Granted Patent,no,0,0,13,13,0,C08K5/09;;C08K5/17;;B23K35/3618;;B23K35/362;;H05K3/3436;;H05K3/3489;;H05K2201/10674;;H05K2201/10977;;H01L2224/81011;;H01L2224/27422;;H01L2224/2939;;B23K1/0016;;B23K1/203;;H01L24/11;;H01L24/13;;H01L24/16;;H01L24/27;;H01L24/29;;H01L24/32;;H01L24/81;;H01L24/83;;H01L24/92;;H01L2224/11334;;H01L2224/131;;H01L2224/13111;;H01L2224/16227;;H01L2224/2732;;H01L2224/2741;;H01L2224/27418;;H01L2224/2929;;H01L2224/29311;;H01L2224/29387;;H01L2224/32225;;H01L2224/73204;;H01L2224/81024;;H01L2224/81143;;H01L2224/81191;;H01L2224/81192;;H01L2224/81815;;H01L2224/83192;;H01L2224/83862;;H01L2224/9211;;H01L2224/29294;;H01L21/563;;H01L2224/16225;;B23K2101/42;;B23K35/362;;C07C215/02;;C07C211/09;;B23K35/3618;;C08K5/09;;H05K2201/10977;;H05K3/3436;;C08K5/17;;B23K35/362;;H05K2201/10674;;H05K3/3489;;H01L24/16;;H01L2224/131;;H01L2224/32225;;H01L21/563;;H01L2224/2732;;H01L2224/81191;;H01L24/27;;H01L2224/11334;;H01L2224/2939;;H01L2224/81143;;H01L24/81;;H01L2224/29294;;H01L2224/27422;;H01L2224/83192;;H01L2224/81011;;H01L2224/29387;;H01L24/13;;H01L24/29;;H01L24/83;;H01L2224/2929;;H01L2224/81815;;B23K1/0016;;H01L2224/13111;;H01L2224/2741;;H01L2224/73204;;H01L2224/81024;;H01L2224/9211;;H01L2224/83862;;H01L2224/16227;;H01L2224/27418;;H01L24/32;;H01L24/11;;B23K1/203;;H01L24/92;;H01L2224/29311;;H01L2224/81192;;H01L2224/16225;;B23K2101/42,B23K35/363;;C08K5/09;;C08K5/17;;C08L63/00;;H01L21/56;;H05K3/34,,0,0,,,,INACTIVE
793,US,A1,US 2017/0298069 A1,050-479-285-359-122,2017-10-19,2017,US 201715488257 A,2017-04-14,US 201715488257 A;;US 201662322948 P;;US 201662411172 P,2016-04-15,INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE,"Described herein are compounds that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.",BLUEPRINT MEDICINES CORP,BROOIJMANS NATASJA;;BRUBAKER JASON D;;CRONIN MARK;;FLEMING PAUL E;;HODOUS BRIAN L;;KIM JOSEPH L;;WAETZIG JOSH;;WILLIAMS BRETT;;WILSON DOUGLAS;;WILSON KEVIN J,BLUEPRINT MEDICINES CORPORATION (2017-06-08),https://lens.org/050-479-285-359-122,Patent Application,yes,0,28,33,34,0,C07D487/04;;C07D519/00;;A61P19/00;;A61P25/00;;A61P35/00;;A61P43/00;;C07D487/04;;A61K31/5025;;C07D519/00;;A61P19/00;;A61K31/5025;;C07D487/04;;C07D519/00;;A61P35/00;;A61K31/5025;;A61K31/5377;;A61K31/5383;;C07D487/04;;C07D519/00,C07D487/04;;C07D519/00,,1,1,088-370-144-352-621,pmc5697787;;29177121;;10.1080/21678707.2017.1304211,"KAPLAN et al. EXPERT OPINION ON ORPHAN DRUGS, VOL. 5, NO. 4, 291–294 2017.",ACTIVE
794,EP,A2,EP 4285996 A2,174-424-490-083-514,2023-12-06,2023,EP 23181727 A,2017-04-14,US 201662322948 P;;US 2017/0027775 W;;US 201662411172 P;;EP 17733108 A,2016-04-15,INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE,"Described herein are compounds that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.",BLUEPRINT MEDICINES CORP,BROOIJMANS NATASJA;;BRUBAKER JASON D;;FLEMING PAUL E;;HODOUS BRIAN L;;KIM JOSEPH L;;WAETZIG JOSH;;WILLIAMS BRETT;;WILSON DOUGLAS;;WILSON KEVIN J;;CRONIN MARK,,https://lens.org/174-424-490-083-514,Patent Application,yes,2,0,33,34,0,C07D487/04;;C07D519/00;;A61P19/00;;A61P25/00;;A61P35/00;;A61P43/00;;C07D487/04;;A61K31/5025;;C07D519/00;;A61P19/00;;A61K31/5025;;C07D487/04;;C07D519/00;;A61P35/00;;A61K31/5025;;A61K31/5377;;A61K31/5383;;C07D487/04;;C07D519/00,A61P19/00,,13,11,032-731-534-802-99X;;084-355-145-743-009;;000-280-598-328-165;;002-991-350-666-500;;039-985-594-433-094;;008-942-401-930-226;;054-241-151-537-523;;005-753-148-365-857;;007-364-858-655-289;;045-982-641-446-458;;050-247-819-044-289,22508565;;pmc3556640;;10.1002/jbmr.1637;;10.1002/dvg.20201;;16604518;;10.1002/humu.20868;;19085907;;pmc2921861;;pmc3160462;;10.1016/j.bone.2010.10.164;;21044902;;pmc2658887;;10.1371/journal.pone.0005005;;19330033;;10.1038/ejhg.2008.178;;pmc2986177;;18830232;;26776312;;10.1016/j.cytogfr.2015.12.007;;pmc4753137;;25230881;;pmc4747023;;10.1038/nrc3811;;10.1002/jps.2600660104;;833720;;18450872;;pmc3502043;;10.1542/peds.2007-1980;;10.1002/0470053488,"SHORE ET AL., NATURE GENETICS, vol. 38, 2006, pages 525 - 27;;CHAKKALAKAL ET AL., J BONE MINER RES., vol. 27, no. 8, 2012, pages 1746 - 1756;;FUKUDA ET AL., GENESIS, vol. 44, 2006, pages 159 - 167;;KAPLAN ET AL., HUM MUTAT, vol. 30, no. 3, 2009, pages 379 - 390;;GREGSON ET AL., BONE, vol. 48, 2011, pages 654 - 658;;KAPLAN ET AL., AM 7 MED GENET, vol. 167, 2015, pages 2265 - 2271;;PETRIE ET AL., PLOS ONE, vol. 4, no. 3, 2009, pages e5005;;BOCCIARDI ET AL., EUR J HUM GENETICS, vol. 17, 2009, pages 311 - 318;;PACIFIC!SHORE, CYTOKINE & GROWTH FACTOR REVIEWS, vol. 27, 2016, pages 93 - 104;;JONESBAKER, NATURE REV CANCER, vol. 14, 2014, pages 651 - 661;;BERGE ET AL.: ""Pharmaceutical Salts"", J. PHARM. SCI., vol. 66, 1977, pages 1 - 19, XP002675560, DOI: 10.1002/jps.2600660104;;KAPLAN, PEDIATRICS, vol. 121, no. 5, 2008, pages e1295 - e1300;;WUTSGREENE: ""Protective Groups in Organic Synthesis"", 2006, JOHN WILEY & SONS",PENDING
795,EP,B1,EP 3442977 B1,145-903-080-900-362,2023-06-28,2023,EP 17733108 A,2017-04-14,US 201662322948 P;;US 201662411172 P;;US 2017/0027775 W,2016-04-15,INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE,,BLUEPRINT MEDICINES CORP,BROOIJMANS NATASJA;;BRUBAKER JASON D;;FLEMING PAUL E;;HODOUS BRIAN L;;KIM JOSEPH L;;WAETZIG JOSH;;WILLIAMS BRETT;;WILSON DOUGLAS;;WILSON KEVIN J;;CRONIN MARK,,https://lens.org/145-903-080-900-362,Granted Patent,yes,1,0,33,34,0,C07D487/04;;C07D519/00;;A61P19/00;;A61P25/00;;A61P35/00;;A61P43/00;;C07D487/04;;A61K31/5025;;C07D519/00;;A61P19/00;;A61K31/5025;;C07D487/04;;C07D519/00;;A61P35/00;;A61K31/5025;;A61K31/5377;;A61K31/5383;;C07D487/04;;C07D519/00,C07D487/04;;A61K31/5025;;A61P19/00;;C07D519/00,,0,0,,,,ACTIVE
796,PH,A1,PH 12018502205 A1,054-130-831-161-417,2019-10-28,2019,PH 12018502205 A,2018-10-15,US 201662411172 P;;US 201662322948 P;;US 2017/0027775 W,2016-04-15,INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE,"Described herein are compounds that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.",BLUEPRINT MEDICINES CORP,BROOIJMANS NATASJA;;BRUBAKER JASON D;;CRONIN MARK;;FLEMING PAUL E;;HODOUS BRIAN L;;KIM JOSEPH L;;WAETZIG JOSH;;WILLIAMS BRETT;;WILSON DOUGLAS;;WILSON KEVIN J,,https://lens.org/054-130-831-161-417,Patent Application,no,0,0,33,34,0,C07D487/04;;C07D519/00;;A61P19/00;;A61P25/00;;A61P35/00;;A61P43/00;;C07D487/04;;A61K31/5025;;C07D519/00;;A61P19/00;;A61K31/5025;;C07D487/04;;C07D519/00;;A61P35/00;;A61K31/5025;;A61K31/5377;;A61K31/5383;;C07D487/04;;C07D519/00,A61K31/5025;;A61P19/00;;C07D487/04;;C07D519/00,,0,0,,,,PENDING
797,US,B2,US 11478596 B2,135-240-362-109-870,2022-10-25,2022,US 202016925080 A,2020-07-09,US 202016925080 A;;US 201962875827 P,2019-07-18,System and method for high flow oxygen therapy,"A method of method of high flow oxygen therapy (HFOT) and carbon dioxide (CO 2 ) monitoring includes delivering high flow oxygen therapy (HFOT) via a central lumen of a nasal cannula, the nasal cannula comprising a proximal end, a distal end positioned within a pharynx region of a patient's airway, and the central lumen and a sampling lumen formed within a wall of the nasal cannula. The method also includes receiving sampled exhaled breath of the patient via the sampling lumen at a CO 2 monitor, wherein the sampling lumen is configured to sample the exhaled breath at the pharynx region through the CO2-permeable membrane and direct the sampled exhaled breath to a CO 2 monitor fluidly coupled to the sampling lumen and determining a level of CO 2 in the exhaled breath using the CO 2 monitor.",COVIDIEN LP,MCGANN MARK A;;CURLEY JAMES P;;GALLOGLY PAUL J;;DONLON KIERAN M;;MAGUIRE SEAMUS P;;THIESSEN RONALD;;MCLAUGHLIN ERIN F;;KAUC RICHARD;;FLEMING GRAHAM B,COVIDIEN LP (2019-08-23),https://lens.org/135-240-362-109-870,Granted Patent,yes,17,0,2,2,0,A61B5/0836;;A61M16/0096;;A61M16/0434;;A61M16/0461;;A61M16/0672;;A61M16/085;;A61M2202/0208;;A61M2210/065;;A61M2230/432;;A61B5/4839;;A61B5/4821;;A61B5/082;;A61M16/0672;;A61M16/085;;A61M16/0434;;A61M16/0096;;A61B5/0836;;A61M2202/0208;;A61M2230/432;;A61M2210/065;;A61M16/0461,A61M16/06;;A61B5/083;;A61M16/00;;A61M16/04;;A61M16/08,,3,1,001-339-785-458-993,28003556;;10.4187/respcare.05111,"“High flow oxygen therapy,” Hamilton Medical AG, 2018, 4 pgs.;;“Nomoline: Trouble-free sidestream gas analysis,” Phasein AB, Sweden, 2009, 8 pgs.;;Phillips, Justin S. et al.; “A Comparison of Different Techniques for Interfacing Capnography with Adults and Pediatric Supplemental Oxygen Masks,” Respiratory Care, vol. 62, No. 1, Jan. 2017, pp. 78-85.",ACTIVE
798,DK,T3,DK 3442977 T3,183-560-402-614-374,2023-10-09,2023,DK 17733108 T,2017-04-14,US 201662322948 P;;US 201662411172 P;;US 2017/0027775 W,2016-04-15,INHIBITORER AF ACTIVINRECEPTORLIGNENDE KINASE,,BLUEPRINT MEDICINES CORP,BROOIJMANS NATASJA;;BRUBAKER JASON D;;FLEMING PAUL E;;HODOUS BRIAN L;;KIM JOSEPH L;;WAETZIG JOSH;;WILLIAMS BRETT;;WILSON KEVIN J;;CRONIN MARK;;WILSON DOUGLAS,,https://lens.org/183-560-402-614-374,Granted Patent,no,0,0,33,34,0,C07D487/04;;C07D519/00;;A61P19/00;;A61P25/00;;A61P35/00;;A61P43/00;;C07D487/04;;A61K31/5025;;C07D519/00;;A61P19/00;;A61K31/5025;;C07D487/04;;C07D519/00;;A61P35/00;;A61K31/5025;;A61K31/5377;;A61K31/5383;;C07D487/04;;C07D519/00,C07D487/04;;A61K31/5025;;A61P19/00;;C07D519/00,,0,0,,,,ACTIVE
799,KR,A,KR 20190005876 A,143-444-370-269-318,2019-01-16,2019,KR 20187032927 A,2017-04-14,US 201662322948 P;;US 201662411172 P;;US 2017/0027775 W,2016-04-15,액티빈 수용체 유사 키나아제의 저해제,"본 명세서에는 ALK2 및 이의 돌연변이체를 저해하는 화합물, 이러한 화합물을 포함하는 약제학적 조성물 및 이러한 화합물 및 조성물의 사용 방법이 기술된다.",BLUEPRINT MEDICINES CORP,BROOIJMANS NATASJA;;BRUBAKER JASON D;;CRONIN MARK;;FLEMING PAUL E;;HODOUS BRIAN L;;KIM JOSEPH L;;WAETZIG JOSH;;WILLIAMS BRETT;;WILSON DOUGLAS;;WILSON KEVIN J,,https://lens.org/143-444-370-269-318,Patent Application,no,4,0,33,34,0,C07D487/04;;C07D519/00;;A61P19/00;;A61P25/00;;A61P35/00;;A61P43/00;;C07D487/04;;A61K31/5025;;C07D519/00;;A61P19/00;;A61K31/5025;;C07D487/04;;C07D519/00;;A61P35/00;;A61K31/5025;;A61K31/5377;;A61K31/5383;;C07D487/04;;C07D519/00,C07D487/04;;A61K31/5025;;A61P19/00;;C07D519/00,,0,0,,,,ACTIVE
800,CA,A1,CA 3020870 A1,195-905-300-243-775,2017-10-19,2017,CA 3020870 A,2017-04-14,US 201662322948 P;;US 201662411172 P;;US 2017/0027775 W,2016-04-15,INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE,"Described herein are compounds that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.",BLUEPRINT MEDICINES CORP,BROOIJMANS NATASJA;;BRUBAKER JASON D;;HODOUS BRIAN L;;KIM JOSEPH L;;WAETZIG JOSH;;WILLIAMS BRETT;;WILSON DOUGLAS;;WILSON KEVIN J;;FLEMING PAUL E;;CRONIN MARK,,https://lens.org/195-905-300-243-775,Patent Application,no,0,0,33,34,0,C07D487/04;;C07D519/00;;A61P19/00;;A61P25/00;;A61P35/00;;A61P43/00;;C07D487/04;;A61K31/5025;;C07D519/00;;A61P19/00;;A61K31/5025;;C07D487/04;;C07D519/00;;A61P35/00;;A61K31/5025;;A61K31/5377;;A61K31/5383;;C07D487/04;;C07D519/00,C07D487/04;;A61K31/5025;;A61P19/00;;C07D519/00,,0,0,,,,PENDING
801,FR,A1,FR 2980727 A1,060-876-135-640-551,2013-04-05,2013,FR 1259147 A,2012-09-28,US 201113250184 A,2011-09-30,"COMPOSITION DE FONDANT AMINE, ACIDE CARBOXYLIQUE ET PROCEDE DE SOUDAGE","Il est fourni une composition de fondant comprenant, comme composants initiaux: un acide carboxylique; et un agent fondant amine représenté par la formule I: Il est fourni aussi un procédé de soudage d'un contact électrique utilisant la composition de fondant.",ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,HO KIM SANG;;WINKLE MARK R;;DHOBLE AVIN V;;GALLAGHER MICHAEL K;;LIU XIANG-QIAN;;PEERA ASGHAR A;;ROBINSON GLENN;;TOMLINSON IAN;;FLEMING DAVID D,"DOW GLOBAL TECHNOLOGIES LLC, US (2015-02-10);;ROHM AND HAAS ELECTRONIC MATERIALS LLC, US (2015-02-10)",https://lens.org/060-876-135-640-551,Patent Application,no,4,0,13,13,0,C07C215/10;;C07C215/28;;B23K35/3618;;B23K35/362;;H05K3/3489;;H05K2201/10674;;B23K35/362;;C07C215/02;;C07C211/09;;H05K3/3489;;C07C215/28;;C07C215/10;;B23K35/3618;;B23K35/362;;H05K2201/10674,B23K35/363;;C07C215/06;;H05K3/34,,0,0,,,,INACTIVE
802,FR,B1,FR 2980727 B1,058-295-268-795-437,2014-05-09,2014,FR 1259147 A,2012-09-28,US 201113250184 A,2011-09-30,"COMPOSITION DE FONDANT AMINE, ACIDE CARBOXYLIQUE ET PROCEDE DE SOUDAGE",,ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,HO KIM SANG;;WINKLE MARK R;;DHOBLE AVIN V;;GALLAGHER MICHAEL K;;LIU XIANG-QIAN;;PEERA ASGHAR A;;ROBINSON GLENN;;TOMLINSON IAN;;FLEMING DAVID D,"DOW GLOBAL TECHNOLOGIES LLC, US (2015-02-10);;ROHM AND HAAS ELECTRONIC MATERIALS LLC, US (2015-02-10)",https://lens.org/058-295-268-795-437,Granted Patent,no,0,0,13,13,0,C07C215/10;;C07C215/28;;B23K35/3618;;B23K35/362;;H05K3/3489;;H05K2201/10674;;B23K35/362;;C07C215/02;;C07C211/09;;H05K3/3489;;C07C215/28;;C07C215/10;;B23K35/3618;;B23K35/362;;H05K2201/10674,B23K35/363;;C07C215/06;;H05K3/34,,0,0,,,,INACTIVE
803,CN,A,CN 109311889 A,070-566-193-792-413,2019-02-05,2019,CN 201780035906 A,2017-04-14,US 201662322948 P;;US 201662411172 P;;US 2017/0027775 W,2016-04-15,Inhibitors of activin receptor-like kinase,"Described herein are compounds that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.",BLUEPRINT MEDICINES CORP,BROOIJMANS NATASJA;;BRUBAKER JASON D;;CRONIN MARK;;FLEMING PAUL E;;HODOUS BRIAN L;;KIM JOSEPH L;;WAETZIG JOSH;;WILLIAMS BRETT;;WILSON DOUGLAS;;WILSON KEVIN J,,https://lens.org/070-566-193-792-413,Patent Application,no,1,2,33,34,0,C07D487/04;;C07D519/00;;A61P19/00;;A61P25/00;;A61P35/00;;A61P43/00;;C07D487/04;;A61K31/5025;;C07D519/00;;A61P19/00;;A61K31/5025;;C07D487/04;;C07D519/00;;A61P35/00;;A61K31/5025;;A61K31/5377;;A61K31/5383;;C07D487/04;;C07D519/00,C07D487/04;;A61K31/5025;;A61P19/00;;C07D519/00,,0,0,,,,ACTIVE
804,US,A1,US 2013/0082093 A1,082-162-927-652-335,2013-04-04,2013,US 201113250184 A,2011-09-30,US 201113250184 A,2011-09-30,"Amine, Carboxylic Acid Flux Composition And Method Of Soldering","A flux composition is provided, comprising, as initial components: a carboxylic acid; and, an amine fluxing agent represented by formula I: Also provided is a method of soldering an electrical contact using the flux composition.",HO KIM S;;WINKLE MARK R;;DHOBLE AVIN V;;GALLAGHER MICHAEL K;;LIU XIANG-QIAN;;PEERA ASGHAR A;;ROBINSON GLENN N;;TOMLINSON IAN A;;FLEMING DAVID;;ROHM & HAAS ELECT MAT,HO KIM S;;WINKLE MARK R;;DHOBLE AVIN V;;GALLAGHER MICHAEL K;;LIU XIANG-QIAN;;PEERA ASGHAR A;;ROBINSON GLENN N;;TOMLINSON IAN A;;FLEMING DAVID,ANGUS CHEMICAL COMPANY (2011-12-12);;ROHM AND HAAS ELECTRONIC MATERIALS LLC (2011-11-16);;DOW GLOBAL TECHNOLOGIES LLC (2011-11-16),https://lens.org/082-162-927-652-335,Patent Application,yes,0,2,13,13,0,C07C215/10;;C07C215/28;;B23K35/3618;;B23K35/362;;H05K3/3489;;H05K2201/10674;;B23K35/362;;C07C215/02;;C07C211/09;;H05K3/3489;;C07C215/28;;C07C215/10;;B23K35/3618;;B23K35/362;;H05K2201/10674,B23K35/363;;B23K1/20,228/223;;148/23;;148/24,0,0,,,,INACTIVE
805,JP,A,JP 2013079376 A,076-027-247-561-967,2013-05-02,2013,JP 2012210449 A,2012-09-25,US 201113250125 A,2011-09-30,"CURABLE AMINE, CARBOXYLIC ACID FLUX COMPOSITION AND METHOD OF SOLDERING","PROBLEM TO BE SOLVED: To provide a curable fluxing material that facilitates manufacturing reliable soldered and encapsulated inter connects in electrical components (e.g., inter connects between a semiconductor chip and a printed circuit board).SOLUTION: There is provided the curable flux composition which comprises: a resin component having at least two oxirane groups per molecule; a carboxylic acid; an amine fluxing agent represented by formula I; and optionally, a curing agent.",ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,DHOBLE AVIN V;;MARK R WINKLE;;GALLAGHER MICHAEL K;;KIM S HO;;LIU XIANG-QIAN;;ASGHAR A PEERA;;ROBINSON GLENN N;;IAN TOMLINSON;;FLEMING DAVID D,,https://lens.org/076-027-247-561-967,Patent Application,no,24,1,13,13,0,C08K5/09;;C08K5/17;;B23K35/3618;;B23K35/362;;H05K3/3436;;H05K3/3489;;H05K2201/10674;;H05K2201/10977;;H01L2224/81011;;H01L2224/27422;;H01L2224/2939;;B23K1/0016;;B23K1/203;;H01L24/11;;H01L24/13;;H01L24/16;;H01L24/27;;H01L24/29;;H01L24/32;;H01L24/81;;H01L24/83;;H01L24/92;;H01L2224/11334;;H01L2224/131;;H01L2224/13111;;H01L2224/16227;;H01L2224/2732;;H01L2224/2741;;H01L2224/27418;;H01L2224/2929;;H01L2224/29311;;H01L2224/29387;;H01L2224/32225;;H01L2224/73204;;H01L2224/81024;;H01L2224/81143;;H01L2224/81191;;H01L2224/81192;;H01L2224/81815;;H01L2224/83192;;H01L2224/83862;;H01L2224/9211;;H01L2224/29294;;H01L21/563;;H01L2224/16225;;B23K2101/42;;B23K35/362;;C07C215/02;;C07C211/09;;B23K35/3618;;C08K5/09;;H05K2201/10977;;H05K3/3436;;C08K5/17;;B23K35/362;;H05K2201/10674;;H05K3/3489;;H01L24/16;;H01L2224/131;;H01L2224/32225;;H01L21/563;;H01L2224/2732;;H01L2224/81191;;H01L24/27;;H01L2224/11334;;H01L2224/2939;;H01L2224/81143;;H01L24/81;;H01L2224/29294;;H01L2224/27422;;H01L2224/83192;;H01L2224/81011;;H01L2224/29387;;H01L24/13;;H01L24/29;;H01L24/83;;H01L2224/2929;;H01L2224/81815;;B23K1/0016;;H01L2224/13111;;H01L2224/2741;;H01L2224/73204;;H01L2224/81024;;H01L2224/9211;;H01L2224/83862;;H01L2224/16227;;H01L2224/27418;;H01L24/32;;H01L24/11;;B23K1/203;;H01L24/92;;H01L2224/29311;;H01L2224/81192;;H01L2224/16225;;B23K2101/42,C08G59/56;;C08K5/09;;C08K5/17;;C08L63/00,,0,0,,,,INACTIVE
806,KR,A,KR 20130035954 A,090-633-840-088-602,2013-04-09,2013,KR 20120108917 A,2012-09-28,US 201113250125 A,2011-09-30,"CURABLE AMINE, CARBOXYLIC ACID FLUX COMPOSITION AND METHOD OF SOLDERING","PURPOSE: An amine-carboxylic acid flux composite and a soldering method are provided to easily manufacture electric parts with soldered and encapsulated electric inner connections. CONSTITUTION: An amine-carboxylic acid flux composite comprises a resin component with at least two oxirane groups per molecule, a carboxylic acid, an amine flux agent, and an auxiliary curing agent as initial components. A soldering method comprises; providing a curable flux composite, a plurality of primary electric contact points, a plurality of secondary electric contact points, and solder; a step for applying the curable flux composite to a plurality of primary electric contact points and secondary electric contact points; and a step for positioning the primary electric contact points to the secondary electric contact points to be close; a step for positioning the primary electric contact points to the secondary electric contact points to be closed; a step for forming molten solder by heating the solder over reflow temperature; a step for exposing the molten solder to the primary electric contact points and the secondary electric contact points; a step for displacing the curable flux composite with the molten solder; a step for forming a plurality of electric inner connections between the primary electric contact points and the secondary electric contact points; and a step for curing the resin component and encapsulating the electric inner connections.",ROHM & HAAS ELECT MAT;;DOW GLOBAL TECHNOLOGIES LLC;;ANGUS CHEMICAL,AVIN V DHOBLE;;MARK R WINKLE;;MICHAEL K GALLAGHER;;KIM SANG HO;;XIANG QIAN LIU;;ASGHAR A PEERA;;GLENN N ROBINSON;;IAN TOMLINSON;;DAVID D FLEMING,,https://lens.org/090-633-840-088-602,Patent Application,no,5,1,13,13,0,C08K5/09;;C08K5/17;;B23K35/3618;;B23K35/362;;H05K3/3436;;H05K3/3489;;H05K2201/10674;;H05K2201/10977;;H01L2224/81011;;H01L2224/27422;;H01L2224/2939;;B23K1/0016;;B23K1/203;;H01L24/11;;H01L24/13;;H01L24/16;;H01L24/27;;H01L24/29;;H01L24/32;;H01L24/81;;H01L24/83;;H01L24/92;;H01L2224/11334;;H01L2224/131;;H01L2224/13111;;H01L2224/16227;;H01L2224/2732;;H01L2224/2741;;H01L2224/27418;;H01L2224/2929;;H01L2224/29311;;H01L2224/29387;;H01L2224/32225;;H01L2224/73204;;H01L2224/81024;;H01L2224/81143;;H01L2224/81191;;H01L2224/81192;;H01L2224/81815;;H01L2224/83192;;H01L2224/83862;;H01L2224/9211;;H01L2224/29294;;H01L21/563;;H01L2224/16225;;B23K2101/42;;B23K35/362;;C07C215/02;;C07C211/09;;B23K35/3618;;C08K5/09;;H05K2201/10977;;H05K3/3436;;C08K5/17;;B23K35/362;;H05K2201/10674;;H05K3/3489;;H01L24/16;;H01L2224/131;;H01L2224/32225;;H01L21/563;;H01L2224/2732;;H01L2224/81191;;H01L24/27;;H01L2224/11334;;H01L2224/2939;;H01L2224/81143;;H01L24/81;;H01L2224/29294;;H01L2224/27422;;H01L2224/83192;;H01L2224/81011;;H01L2224/29387;;H01L24/13;;H01L24/29;;H01L24/83;;H01L2224/2929;;H01L2224/81815;;B23K1/0016;;H01L2224/13111;;H01L2224/2741;;H01L2224/73204;;H01L2224/81024;;H01L2224/9211;;H01L2224/83862;;H01L2224/16227;;H01L2224/27418;;H01L24/32;;H01L24/11;;B23K1/203;;H01L24/92;;H01L2224/29311;;H01L2224/81192;;H01L2224/16225;;B23K2101/42,B23K35/362;;C07C211/09;;C07C215/02,,0,0,,,,ACTIVE
807,JP,A,JP 2013078798 A,126-672-407-558-42X,2013-05-02,2013,JP 2012210450 A,2012-09-25,US 201113250184 A,2011-09-30,"AMINE, CARBOXYLIC ACID FLUX COMPOSITION, AND SOLDERING METHOD","PROBLEM TO BE SOLVED: To provide a flux composition, along with its method, which is non-hardenable and capable of facilitating reliable soldering connection, and promoting adaptivity to conventional epoxy-based underfill material.SOLUTION: The flux composition includes, as initial components, carboxylic acid and amine fluxing agent represented by formula I. The composition does not contain a compound which has two or more reactive functional groups per molecule, capable of forming an intermolecular covalent bonding by reaction under a soldering condition. Further, the amine fluxing agent does not contain two or more reactive functional groups per molecule, capable of forming an intermolecular covalent bond by reaction under a soldering condition.",ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,KIM S HO;;MARK R WINKLE;;DHOBLE AVIN V;;GALLAGHER MICHAEL K;;LIU XIANG-QIAN;;ASGHAR A PEERA;;ROBINSON GLENN N;;IAN TOMLINSON;;FLEMING DAVID D,,https://lens.org/126-672-407-558-42X,Patent Application,no,8,1,13,13,0,C07C215/10;;C07C215/28;;B23K35/3618;;B23K35/362;;H05K3/3489;;H05K2201/10674;;B23K35/362;;C07C215/02;;C07C211/09;;H05K3/3489;;C07C215/28;;C07C215/10;;B23K35/3618;;B23K35/362;;H05K2201/10674,B23K1/00;;B23K35/363;;B23K3/00;;B23K35/22;;B23K35/26;;B23K101/42;;C22C12/00;;C22C13/00;;H05K3/34,,0,0,,,,INACTIVE
808,US,B2,US 8430293 B2,019-545-268-466-38X,2013-04-30,2013,US 201113250125 A,2011-09-30,US 201113250125 A,2011-09-30,"Curable amine, carboxylic acid flux composition and method of soldering","A curable flux composition is provided, comprising, as initial components: a resin component having at least two oxirane groups per molecule; a carboxylic acid; and, an amine fluxing agent represented by formula I: and, optionally, a curing agent. Also provided is a method of soldering an electrical contact using the curable flux composition.",DHOBLE AVIN V;;WINKLE MARK R;;GALLAGHER MICHAEL K;;HO KIM S;;LIU XIANG-QIAN;;PEERA ASGHAR A;;ROBINSON GLENN N;;TOMLINSON IAN A;;FLEMING DAVID;;ROHM & HAAS ELECT MAT,DHOBLE AVIN V;;WINKLE MARK R;;GALLAGHER MICHAEL K;;HO KIM S;;LIU XIANG-QIAN;;PEERA ASGHAR A;;ROBINSON GLENN N;;TOMLINSON IAN A;;FLEMING DAVID,ANGUS CHEMICAL COMPANY (2011-12-12);;ROHM AND HAAS ELECTRONIC MATERIALS LLC (2011-09-30);;DOW GLOBAL TECHNOLOGIES LLC (2011-09-30),https://lens.org/019-545-268-466-38X,Granted Patent,yes,57,1,13,13,0,C08K5/09;;C08K5/17;;B23K35/3618;;B23K35/362;;H05K3/3436;;H05K3/3489;;H05K2201/10674;;H05K2201/10977;;H01L2224/81011;;H01L2224/27422;;H01L2224/2939;;B23K1/0016;;B23K1/203;;H01L24/11;;H01L24/13;;H01L24/16;;H01L24/27;;H01L24/29;;H01L24/32;;H01L24/81;;H01L24/83;;H01L24/92;;H01L2224/11334;;H01L2224/131;;H01L2224/13111;;H01L2224/16227;;H01L2224/2732;;H01L2224/2741;;H01L2224/27418;;H01L2224/2929;;H01L2224/29311;;H01L2224/29387;;H01L2224/32225;;H01L2224/73204;;H01L2224/81024;;H01L2224/81143;;H01L2224/81191;;H01L2224/81192;;H01L2224/81815;;H01L2224/83192;;H01L2224/83862;;H01L2224/9211;;H01L2224/29294;;H01L21/563;;H01L2224/16225;;B23K2101/42;;B23K35/362;;C07C215/02;;C07C211/09;;B23K35/3618;;C08K5/09;;H05K2201/10977;;H05K3/3436;;C08K5/17;;B23K35/362;;H05K2201/10674;;H05K3/3489;;H01L24/16;;H01L2224/131;;H01L2224/32225;;H01L21/563;;H01L2224/2732;;H01L2224/81191;;H01L24/27;;H01L2224/11334;;H01L2224/2939;;H01L2224/81143;;H01L24/81;;H01L2224/29294;;H01L2224/27422;;H01L2224/83192;;H01L2224/81011;;H01L2224/29387;;H01L24/13;;H01L24/29;;H01L24/83;;H01L2224/2929;;H01L2224/81815;;B23K1/0016;;H01L2224/13111;;H01L2224/2741;;H01L2224/73204;;H01L2224/81024;;H01L2224/9211;;H01L2224/83862;;H01L2224/16227;;H01L2224/27418;;H01L24/32;;H01L24/11;;B23K1/203;;H01L24/92;;H01L2224/29311;;H01L2224/81192;;H01L2224/16225;;B23K2101/42,B23K35/34;;B23K31/02,228/180.21;;228/207;;228/223;;228/224;;228/248.1;;148/23;;148/24,9,0,,,"Copending U.S. Appl. No. 12/958,495.;;Copending U.S. Appl. No. 12/958,487.;;Copending U.S. Appl. No. 12/958,480.;;Copending U.S. Appl. No. 12/958,493.;;Copending U.S. Appl. No. 12/958,473.;;Copending U.S. Appl. No. 13/250,226.;;Copending U.S. Appl. No. 13/250,007.;;Copending U.S. Appl. No. 13/250,184.;;Copending U.S. Appl. No. 13/250,297.",INACTIVE
809,CN,A,CN 103071950 A,050-695-046-371-569,2013-05-01,2013,CN 201210566313 A,2012-09-29,US 201113250125 A,2011-09-30,"Curable amine, carboxylic acid flux composition and method of soldering","Curable amine, a carboxylic acid flux composition and a method of soldering. A curable flux composition is provided, comprising, as initial components: a resin component having at least two oxirane groups per molecule; a carboxylic acid; and, an amine fluxing agent represented by formula I: and, optionally, a curing agent. Also provided is a method of soldering an electrical contact using the curable flux composition.",ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,AVIN V DHOBLE;;MARK R WINKLE;;MICHAEL K GALLAGHER;;KIM SANG HO;;XIANG QIAN LIU;;ASGHAR A PEERA;;GLENN N ROBINSON;;IAN TOMLINSON;;DAVID D FLEMING,,https://lens.org/050-695-046-371-569,Patent Application,no,4,0,13,13,0,C08K5/09;;C08K5/17;;B23K35/3618;;B23K35/362;;H05K3/3436;;H05K3/3489;;H05K2201/10674;;H05K2201/10977;;H01L2224/81011;;H01L2224/27422;;H01L2224/2939;;B23K1/0016;;B23K1/203;;H01L24/11;;H01L24/13;;H01L24/16;;H01L24/27;;H01L24/29;;H01L24/32;;H01L24/81;;H01L24/83;;H01L24/92;;H01L2224/11334;;H01L2224/131;;H01L2224/13111;;H01L2224/16227;;H01L2224/2732;;H01L2224/2741;;H01L2224/27418;;H01L2224/2929;;H01L2224/29311;;H01L2224/29387;;H01L2224/32225;;H01L2224/73204;;H01L2224/81024;;H01L2224/81143;;H01L2224/81191;;H01L2224/81192;;H01L2224/81815;;H01L2224/83192;;H01L2224/83862;;H01L2224/9211;;H01L2224/29294;;H01L21/563;;H01L2224/16225;;B23K2101/42;;B23K35/362;;C07C215/02;;C07C211/09;;B23K35/3618;;C08K5/09;;H05K2201/10977;;H05K3/3436;;C08K5/17;;B23K35/362;;H05K2201/10674;;H05K3/3489;;H01L24/16;;H01L2224/131;;H01L2224/32225;;H01L21/563;;H01L2224/2732;;H01L2224/81191;;H01L24/27;;H01L2224/11334;;H01L2224/2939;;H01L2224/81143;;H01L24/81;;H01L2224/29294;;H01L2224/27422;;H01L2224/83192;;H01L2224/81011;;H01L2224/29387;;H01L24/13;;H01L24/29;;H01L24/83;;H01L2224/2929;;H01L2224/81815;;B23K1/0016;;H01L2224/13111;;H01L2224/2741;;H01L2224/73204;;H01L2224/81024;;H01L2224/9211;;H01L2224/83862;;H01L2224/16227;;H01L2224/27418;;H01L24/32;;H01L24/11;;B23K1/203;;H01L24/92;;H01L2224/29311;;H01L2224/81192;;H01L2224/16225;;B23K2101/42,B23K35/363;;B23K1/008,,0,0,,,,INACTIVE
810,TW,A,TW 201319019 A,152-576-974-239-76X,2013-05-16,2013,TW 101135051 A,2012-09-25,US 201113250184 A,2011-09-30,"Amine, carboxylic acid flux composition and method of soldering","A flux composition is provided, comprising, as initial components: a carboxylic acid; and, an amine fluxing agent represented by formula I: Also provided is a method of soldering an electrical contact using the flux composition.",ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,HO KIM S;;WINKLE MARK R;;DHOBLE AVIN V;;GALLAGHER MICHAEL K;;LIU XIANG-QIAN;;PEERA ASGHAR A;;ROBINSON GLENN;;TOMLINSON LAN A;;FLEMING DAVID D,,https://lens.org/152-576-974-239-76X,Patent of Addition,no,0,0,13,13,0,C07C215/10;;C07C215/28;;B23K35/3618;;B23K35/362;;H05K3/3489;;H05K2201/10674;;B23K35/362;;C07C215/02;;C07C211/09;;H05K3/3489;;C07C215/28;;C07C215/10;;B23K35/3618;;B23K35/362;;H05K2201/10674,C07C211/09;;B23K35/362;;C07C211/49,,0,0,,,,INACTIVE
811,ZA,B,ZA 202005341 B,178-390-275-296-501,2022-01-26,2022,ZA 202005341 A,2020-08-27,US 201662322948 P;;US 201662411172 P,2016-04-15,INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE,,BLUEPRINT MEDICINES CORP,NATASJA BROOIJMANS;;JASON D BRUBAKER;;MARK CRONIN (DECEASED);;PAUL E FLEMING;;BRIAN L HODOUS;;JOSEPH L KIM;;JOSH WAETZIG;;BRETT WILLIAMS;;DOUGLAS WILSON;;KEVIN J WILSON,,https://lens.org/178-390-275-296-501,Granted Patent,no,0,0,33,34,0,C07D487/04;;C07D519/00;;A61P19/00;;A61P25/00;;A61P35/00;;A61P43/00;;C07D487/04;;A61K31/5025;;C07D519/00;;A61P19/00;;A61K31/5025;;C07D487/04;;C07D519/00;;A61P35/00;;A61K31/5025;;A61K31/5377;;A61K31/5383;;C07D487/04;;C07D519/00,,,0,0,,,,ACTIVE
812,TW,B,TW I438177 B,061-195-217-451-01X,2014-05-21,2014,TW 101135052 A,2012-09-25,US 201113250125 A,2011-09-30,"Curable amine, carboxylic acid flux composition and method of soldering",,ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,DHOBLE AVIN V;;WINKLE MARK R;;GALLAGHER MICHAEL K;;HO KIM SANG;;LIU XIANG-QIAN;;PEERA ASGHAR AKBER;;ROBINSON GLENN;;TOMLINSON LAN A;;FLEMING DAVID A,,https://lens.org/061-195-217-451-01X,Granted Patent,no,0,0,13,13,0,C08K5/09;;C08K5/17;;B23K35/3618;;B23K35/362;;H05K3/3436;;H05K3/3489;;H05K2201/10674;;H05K2201/10977;;H01L2224/81011;;H01L2224/27422;;H01L2224/2939;;B23K1/0016;;B23K1/203;;H01L24/11;;H01L24/13;;H01L24/16;;H01L24/27;;H01L24/29;;H01L24/32;;H01L24/81;;H01L24/83;;H01L24/92;;H01L2224/11334;;H01L2224/131;;H01L2224/13111;;H01L2224/16227;;H01L2224/2732;;H01L2224/2741;;H01L2224/27418;;H01L2224/2929;;H01L2224/29311;;H01L2224/29387;;H01L2224/32225;;H01L2224/73204;;H01L2224/81024;;H01L2224/81143;;H01L2224/81191;;H01L2224/81192;;H01L2224/81815;;H01L2224/83192;;H01L2224/83862;;H01L2224/9211;;H01L2224/29294;;H01L21/563;;H01L2224/16225;;B23K2101/42;;B23K35/362;;C07C215/02;;C07C211/09;;B23K35/3618;;C08K5/09;;H05K2201/10977;;H05K3/3436;;C08K5/17;;B23K35/362;;H05K2201/10674;;H05K3/3489;;H01L24/16;;H01L2224/131;;H01L2224/32225;;H01L21/563;;H01L2224/2732;;H01L2224/81191;;H01L24/27;;H01L2224/11334;;H01L2224/2939;;H01L2224/81143;;H01L24/81;;H01L2224/29294;;H01L2224/27422;;H01L2224/83192;;H01L2224/81011;;H01L2224/29387;;H01L24/13;;H01L24/29;;H01L24/83;;H01L2224/2929;;H01L2224/81815;;B23K1/0016;;H01L2224/13111;;H01L2224/2741;;H01L2224/73204;;H01L2224/81024;;H01L2224/9211;;H01L2224/83862;;H01L2224/16227;;H01L2224/27418;;H01L24/32;;H01L24/11;;B23K1/203;;H01L24/92;;H01L2224/29311;;H01L2224/81192;;H01L2224/16225;;B23K2101/42,,,0,0,,,,INACTIVE
813,CN,A,CN 103056559 A,134-037-876-556-408,2013-04-24,2013,CN 201210566312 A,2012-09-29,US 201113250184 A,2011-09-30,"Amine, carboxylic acid flux composition and method of soldering","A flux composition is provided, comprising, as initial components: a carboxylic acid; and, an amine fluxing agent represented by formula I: Also provided is a method of soldering an electrical contact using the flux composition.",ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,HO KIM S;;WINKLE MARK R;;DHOBLE AVIN V;;GALLAGHER MICHAEL K;;LIU XIANG-QIAN;;PEERA ASGHAR A;;ROBINSON GLENN N;;TOMLINSON IAN A;;FLEMING DAVID,,https://lens.org/134-037-876-556-408,Patent Application,no,5,1,13,13,0,C07C215/10;;C07C215/28;;B23K35/3618;;B23K35/362;;H05K3/3489;;H05K2201/10674;;B23K35/362;;C07C215/02;;C07C211/09;;H05K3/3489;;C07C215/28;;C07C215/10;;B23K35/3618;;B23K35/362;;H05K2201/10674,B23K35/363;;B23K1/008,,0,0,,,,INACTIVE
814,KR,A,KR 20130035946 A,151-846-992-148-694,2013-04-09,2013,KR 20120108718 A,2012-09-28,US 201113250184 A,2011-09-30,"AMINE, CARBOXYLIC ACID FLUX COMPOSITION AND METHOD OF SOLDERING","PURPOSE: An amine-carboxylic acid flux composite and a soldering method are provided to enable an unhardened soldering connection with reliability and to obtain compatibility with a normal epoxy based under fill material. CONSTITUTION: A flux composite comprises a carboxylic acid and an amine fluxing agent as initial components. A soldering method is as follows; supplying the flux composite with an electric contact, applying the flux composition to the electric contact, supplying solder, and displacing the flux composite supplied to the electric contact with molten solder. The molten solder is in physical contact with the electric contact and joined to the electric contact.",ROHM & HAAS ELECT MAT;;DOW GLOBAL TECHNOLOGIES LLC;;ANGUS CHEMICAL,KIM SANG HO;;MARK R WINKLE;;AVIN V DHOBLE;;MICHAEL K GALLAGHER;;XIANG QIAN LIU;;ASGHAR A PEERA;;GLENN N ROBINSON;;IAN TOMLINSON;;DAVID D FLEMING,,https://lens.org/151-846-992-148-694,Patent Application,no,5,0,13,13,0,C07C215/10;;C07C215/28;;B23K35/3618;;B23K35/362;;H05K3/3489;;H05K2201/10674;;B23K35/362;;C07C215/02;;C07C211/09;;H05K3/3489;;C07C215/28;;C07C215/10;;B23K35/3618;;B23K35/362;;H05K2201/10674,B23K35/362;;C07C211/09;;C07C215/02,,0,0,,,,ACTIVE
815,DE,A1,DE 102012019259 A1,171-410-723-796-683,2013-04-04,2013,DE 102012019259 A,2012-09-28,US 201113250125 A,2011-09-30,"Härtbare Amin-, Carbonsäure-Flussmittelzusammensetzung und Lötverfahren","Es wird eine härtbare Flussmittelzusammensetzung bereitgestellt, die als Ausgangskomponenten: eine Harzkomponente mit mindestens zwei Oxiran-Gruppen pro Molekül; eine Carbonsäure und ein Aminflussmittel, dargestellt durch Formel I:und gegebenenfalls ein Härtungsmittel umfasst. Ebenso wird ein Verfahren zum Löten eines elektrischen Kontakts unter Verwendung der härtbaren Flussmittelzusammensetzung bereitgestellt.",ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS ELECT MAT,DHOBLE AVIN V;;WINKLE MARK R;;GALLAGHER MICHAEL K;;HO KIM S;;ROBINSON GLENN N;;TOMLINSON IAN;;FLEMING DAVID D;;LIU XIANG-QIAN;;PEERA ASGHAR A,"ROHM AND HAAS ELECTRONIC MATERIALS, L.L.C., MA, US (2015-01-14);;DOW GLOBAL TECHNOLOGIES LLC, MIDLAND, US (2015-01-14)",https://lens.org/171-410-723-796-683,Patent Application,no,2,0,13,13,0,C08K5/09;;C08K5/17;;B23K35/3618;;B23K35/362;;H05K3/3436;;H05K3/3489;;H05K2201/10674;;H05K2201/10977;;H01L2224/81011;;H01L2224/27422;;H01L2224/2939;;B23K1/0016;;B23K1/203;;H01L24/11;;H01L24/13;;H01L24/16;;H01L24/27;;H01L24/29;;H01L24/32;;H01L24/81;;H01L24/83;;H01L24/92;;H01L2224/11334;;H01L2224/131;;H01L2224/13111;;H01L2224/16227;;H01L2224/2732;;H01L2224/2741;;H01L2224/27418;;H01L2224/2929;;H01L2224/29311;;H01L2224/29387;;H01L2224/32225;;H01L2224/73204;;H01L2224/81024;;H01L2224/81143;;H01L2224/81191;;H01L2224/81192;;H01L2224/81815;;H01L2224/83192;;H01L2224/83862;;H01L2224/9211;;H01L2224/29294;;H01L21/563;;H01L2224/16225;;B23K2101/42;;B23K35/362;;C07C215/02;;C07C211/09;;B23K35/3618;;C08K5/09;;H05K2201/10977;;H05K3/3436;;C08K5/17;;B23K35/362;;H05K2201/10674;;H05K3/3489;;H01L24/16;;H01L2224/131;;H01L2224/32225;;H01L21/563;;H01L2224/2732;;H01L2224/81191;;H01L24/27;;H01L2224/11334;;H01L2224/2939;;H01L2224/81143;;H01L24/81;;H01L2224/29294;;H01L2224/27422;;H01L2224/83192;;H01L2224/81011;;H01L2224/29387;;H01L24/13;;H01L24/29;;H01L24/83;;H01L2224/2929;;H01L2224/81815;;B23K1/0016;;H01L2224/13111;;H01L2224/2741;;H01L2224/73204;;H01L2224/81024;;H01L2224/9211;;H01L2224/83862;;H01L2224/16227;;H01L2224/27418;;H01L24/32;;H01L24/11;;B23K1/203;;H01L24/92;;H01L2224/29311;;H01L2224/81192;;H01L2224/16225;;B23K2101/42,C08L63/00;;B23K35/00;;C08K3/08;;C08K5/09;;C08K5/17,,0,0,,,,DISCONTINUED
816,US,A1,US 2013/0082092 A1,128-836-501-790-082,2013-04-04,2013,US 201113250125 A,2011-09-30,US 201113250125 A,2011-09-30,"Curable Amine, Carboxylic Acid Flux Composition And Method Of Soldering","A curable flux composition is provided, comprising, as initial components: a resin component having at least two oxirane groups per molecule; a carboxylic acid; and, an amine fluxing agent represented by formula I: and, optionally, a curing agent. Also provided is a method of soldering an electrical contact using the curable flux composition.",DHOBLE AVIN V;;WINKLE MARK R;;GALLAGHER MICHAEL K;;HO KIM S;;LIU XIANG-QIAN;;PEERA ASGHAR A;;ROBINSON GLENN N;;TOMLINSON IAN A;;FLEMING DAVID;;ROHM & HAAS ELECT MAT,DHOBLE AVIN V;;WINKLE MARK R;;GALLAGHER MICHAEL K;;HO KIM S;;LIU XIANG-QIAN;;PEERA ASGHAR A;;ROBINSON GLENN N;;TOMLINSON IAN A;;FLEMING DAVID,ANGUS CHEMICAL COMPANY (2011-12-12);;ROHM AND HAAS ELECTRONIC MATERIALS LLC (2011-09-30);;DOW GLOBAL TECHNOLOGIES LLC (2011-09-30),https://lens.org/128-836-501-790-082,Patent Application,yes,0,1,13,13,0,C08K5/09;;C08K5/17;;B23K35/3618;;B23K35/362;;H05K3/3436;;H05K3/3489;;H05K2201/10674;;H05K2201/10977;;H01L2224/81011;;H01L2224/27422;;H01L2224/2939;;B23K1/0016;;B23K1/203;;H01L24/11;;H01L24/13;;H01L24/16;;H01L24/27;;H01L24/29;;H01L24/32;;H01L24/81;;H01L24/83;;H01L24/92;;H01L2224/11334;;H01L2224/131;;H01L2224/13111;;H01L2224/16227;;H01L2224/2732;;H01L2224/2741;;H01L2224/27418;;H01L2224/2929;;H01L2224/29311;;H01L2224/29387;;H01L2224/32225;;H01L2224/73204;;H01L2224/81024;;H01L2224/81143;;H01L2224/81191;;H01L2224/81192;;H01L2224/81815;;H01L2224/83192;;H01L2224/83862;;H01L2224/9211;;H01L2224/29294;;H01L21/563;;H01L2224/16225;;B23K2101/42;;B23K35/362;;C07C215/02;;C07C211/09;;B23K35/3618;;C08K5/09;;H05K2201/10977;;H05K3/3436;;C08K5/17;;B23K35/362;;H05K2201/10674;;H05K3/3489;;H01L24/16;;H01L2224/131;;H01L2224/32225;;H01L21/563;;H01L2224/2732;;H01L2224/81191;;H01L24/27;;H01L2224/11334;;H01L2224/2939;;H01L2224/81143;;H01L24/81;;H01L2224/29294;;H01L2224/27422;;H01L2224/83192;;H01L2224/81011;;H01L2224/29387;;H01L24/13;;H01L24/29;;H01L24/83;;H01L2224/2929;;H01L2224/81815;;B23K1/0016;;H01L2224/13111;;H01L2224/2741;;H01L2224/73204;;H01L2224/81024;;H01L2224/9211;;H01L2224/83862;;H01L2224/16227;;H01L2224/27418;;H01L24/32;;H01L24/11;;B23K1/203;;H01L24/92;;H01L2224/29311;;H01L2224/81192;;H01L2224/16225;;B23K2101/42,B23K31/02;;B23K35/363,228/180.1;;148/23,0,0,,,,INACTIVE
817,TW,A,TW 201323376 A,059-133-474-605-029,2013-06-16,2013,TW 101135052 A,2012-09-25,US 201113250125 A,2011-09-30,"Curable amine, carboxylic acid flux composition and method of soldering","A curable flux composition is provided, comprising, as initial components: a resin component having at least two oxirane groups per molecule; a carboxylic acid; and, an amine fluxing agent represented by formula I: and, optionally, a curing agent. Also provided is a method of soldering an electrical contact using the curable flux composition.",ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,DHOBLE AVIN V;;WINKLE MARK R;;GALLAGHER MICHAEL K;;HO KIM SANG;;LIU XIANG-QIAN;;PEERA ASGHAR AKBER;;ROBINSON GLENN;;TOMLINSON LAN A;;FLEMING DAVID A,,https://lens.org/059-133-474-605-029,Patent of Addition,no,0,0,13,13,0,C08K5/09;;C08K5/17;;B23K35/3618;;B23K35/362;;H05K3/3436;;H05K3/3489;;H05K2201/10674;;H05K2201/10977;;H01L2224/81011;;H01L2224/27422;;H01L2224/2939;;B23K1/0016;;B23K1/203;;H01L24/11;;H01L24/13;;H01L24/16;;H01L24/27;;H01L24/29;;H01L24/32;;H01L24/81;;H01L24/83;;H01L24/92;;H01L2224/11334;;H01L2224/131;;H01L2224/13111;;H01L2224/16227;;H01L2224/2732;;H01L2224/2741;;H01L2224/27418;;H01L2224/2929;;H01L2224/29311;;H01L2224/29387;;H01L2224/32225;;H01L2224/73204;;H01L2224/81024;;H01L2224/81143;;H01L2224/81191;;H01L2224/81192;;H01L2224/81815;;H01L2224/83192;;H01L2224/83862;;H01L2224/9211;;H01L2224/29294;;H01L21/563;;H01L2224/16225;;B23K2101/42;;B23K35/362;;C07C215/02;;C07C211/09;;B23K35/3618;;C08K5/09;;H05K2201/10977;;H05K3/3436;;C08K5/17;;B23K35/362;;H05K2201/10674;;H05K3/3489;;H01L24/16;;H01L2224/131;;H01L2224/32225;;H01L21/563;;H01L2224/2732;;H01L2224/81191;;H01L24/27;;H01L2224/11334;;H01L2224/2939;;H01L2224/81143;;H01L24/81;;H01L2224/29294;;H01L2224/27422;;H01L2224/83192;;H01L2224/81011;;H01L2224/29387;;H01L24/13;;H01L24/29;;H01L24/83;;H01L2224/2929;;H01L2224/81815;;B23K1/0016;;H01L2224/13111;;H01L2224/2741;;H01L2224/73204;;H01L2224/81024;;H01L2224/9211;;H01L2224/83862;;H01L2224/16227;;H01L2224/27418;;H01L24/32;;H01L24/11;;B23K1/203;;H01L24/92;;H01L2224/29311;;H01L2224/81192;;H01L2224/16225;;B23K2101/42,C07C211/09;;B23K35/363;;H05K3/34,,0,0,,,,INACTIVE
818,TW,B,TW I450879 B,195-258-772-619-509,2014-09-01,2014,TW 101135051 A,2012-09-25,US 201113250184 A,2011-09-30,"Amine, carboxylic acid flux composition and method of soldering",,ROHM & HAAS ELECT MAT;;ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC,HO KIM S;;WINKLE MARK R;;DHOBLE AVIN V;;GALLAGHER MICHAEL K;;LIU XIANG-QIAN;;PEERA ASGHAR A;;ROBINSON GLENN;;TOMLINSON LAN A;;FLEMING DAVID D,,https://lens.org/195-258-772-619-509,Granted Patent,no,3,0,13,13,0,C07C215/10;;C07C215/28;;B23K35/3618;;B23K35/362;;H05K3/3489;;H05K2201/10674;;B23K35/362;;C07C215/02;;C07C211/09;;H05K3/3489;;C07C215/28;;C07C215/10;;B23K35/3618;;B23K35/362;;H05K2201/10674,,,0,0,,,,INACTIVE
819,DE,A1,DE 102012019260 A1,005-314-449-821-313,2013-04-04,2013,DE 102012019260 A,2012-09-28,US 201113250184 A,2011-09-30,"Amin-, Carbonsäure-Flussmittelzusammensetzung und Lötverfahren","Es wird eine Flussmittelzusammensetzung bereitgestellt, die als Ausgangskomponenten: eine Carbonsäure und ein Aminflussmittel, dargestellt durch die Formel I:umfasst. Ebenso wird ein Verfahren zum Löten eines elektrischen Kontaktes unter Verwendung der Flussmittelzusammensetzung bereitgestellt.",ANGUS CHEMICAL;;DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS ELECT MAT,DHOBLE AVIN V;;WINKLE MARK R;;GALLAGHER MICHAEL K;;HO KIM S;;PEERA ASGHAR A;;TOMLINSON IAN;;LIU XIANG-QIAN;;ROBINSON GLENN N;;FLEMING DAVID D,"ROHM AND HAAS ELECTRONIC MATERIALS, L.L.C., MA, US (2015-01-14);;DOW GLOBAL TECHNOLOGIES LLC, MIDLAND, US (2015-01-14)",https://lens.org/005-314-449-821-313,Patent Application,no,0,0,13,13,0,C07C215/10;;C07C215/28;;B23K35/3618;;B23K35/362;;H05K3/3489;;H05K2201/10674;;B23K35/362;;C07C215/02;;C07C211/09;;H05K3/3489;;C07C215/28;;C07C215/10;;B23K35/3618;;B23K35/362;;H05K2201/10674,B23K35/36;;B23K35/363,,0,0,,,,DISCONTINUED
820,US,B2,US 8430294 B2,174-566-764-606-268,2013-04-30,2013,US 201113250184 A,2011-09-30,US 201113250184 A,2011-09-30,"Amine, carboxylic acid flux composition and method of soldering","A flux composition is provided, comprising, as initial components: a carboxylic acid; and, an amine fluxing agent represented by formula I: Also provided is a method of soldering an electrical contact using the flux composition.",HO KIM S;;WINKLE MARK R;;DHOBLE AVIN V;;GALLAGHER MICHAEL K;;LIU XIANG-QIAN;;PEERA ASGHAR A;;ROBINSON GLENN N;;TOMLINSON IAN A;;FLEMING DAVID;;ROHM & HAAS ELECT MAT,HO KIM S;;WINKLE MARK R;;DHOBLE AVIN V;;GALLAGHER MICHAEL K;;LIU XIANG-QIAN;;PEERA ASGHAR A;;ROBINSON GLENN N;;TOMLINSON IAN A;;FLEMING DAVID,ANGUS CHEMICAL COMPANY (2011-12-12);;ROHM AND HAAS ELECTRONIC MATERIALS LLC (2011-11-16);;DOW GLOBAL TECHNOLOGIES LLC (2011-11-16),https://lens.org/174-566-764-606-268,Granted Patent,yes,57,1,13,13,0,C07C215/10;;C07C215/28;;B23K35/3618;;B23K35/362;;H05K3/3489;;H05K2201/10674;;B23K35/362;;C07C215/02;;C07C211/09;;H05K3/3489;;C07C215/28;;C07C215/10;;B23K35/3618;;B23K35/362;;H05K2201/10674,B23K35/34;;B23K31/02,228/180.21;;228/207;;228/223;;228/224;;228/248.1;;148/23;;148/24,9,0,,,"Copending U.S. Appl. No. 12/958,495.;;Copending U.S. Appl. No. 12/958,487.;;Copending U.S. Appl. No. 12/958,480.;;Copending U.S. Appl. No. 12/958,493.;;Copending U.S. Appl. No. 12/958,473.;;Copending U.S. Appl. No. 13/250,226.;;Copending U.S. Appl. No. 13/250,007.;;Copending U.S. Appl. No. 13/250,297.;;Copending U.S. Appl. No. 13/250,125.",INACTIVE
821,US,B1,US 7065452 B1,086-725-567-318-481,2006-06-20,2006,US 43146999 A,1999-11-01,US 43146999 A;;US 51281595 A,1995-08-09,Molecules comprising a calcineurin-like binding pocket and encoded data storage medium capable of graphically displaying them,"The present invention relates to crystallized molecules and molecular complexes which comprise the active site binding pocket or the FKBP12/FK506 binding pocket of calcineurin or close structural homologues to either binding pocket. This invention also relates to a data storage material encoded with the corresponding structure coordinates of those crystallized molecules or molecular complexes. Such data storage material is capable of displaying such molecules and molecular complexes as a graphical three-dimensional representation on a computer screen. In addition, this invention relates to methods of using the structure coordinates of those molecules or molecular complexes to solve the structure of homologous proteins. This invention also relates to methods of using the structure coordinates to screen and design compounds that bind to calcineurin or homologues thereof.",VERTEX PHARMA,ARMISTEAD DAVID M;;FITZGIBBON MATTHEW JAMES;;FLEMING MARK ANDREW;;GRIFFITH JAMES P;;KIM EUNICE E;;KIM JOSEPH L;;SINTCHAK MICHAEL D;;THOMSON JOHN ALLAN;;WILSON KEITH P,,https://lens.org/086-725-567-318-481,Granted Patent,yes,6,2,8,8,0,C07K14/705;;C12N9/16;;C07K14/705;;C12N9/16,C12N9/16;;G06G7/48;;G06F17/50;;G06N7/06,702/27;;703/2,39,35,008-847-207-001-866;;023-774-609-430-283;;066-824-819-004-349;;006-914-403-314-178;;090-961-440-562-419;;025-286-886-144-752;;144-433-300-416-581;;066-824-819-004-349;;121-312-857-082-253;;008-847-207-001-866;;087-317-650-837-833;;008-782-290-622-57X;;019-899-924-340-24X;;050-930-610-164-868;;023-774-609-430-283;;034-389-368-463-129;;080-243-480-377-884;;162-375-470-495-884;;057-355-233-717-557;;124-128-285-358-11X;;045-470-558-777-812;;102-345-845-395-203;;119-687-205-724-766;;062-672-417-308-555;;005-407-101-849-051;;030-042-017-746-591;;131-046-096-401-339;;025-802-799-712-238;;069-450-943-413-364;;141-777-356-359-483;;038-505-398-849-808;;064-406-626-054-484;;184-644-637-972-373;;151-919-600-413-52X;;129-297-815-048-32X,7543369;;007543369;;10.1016/0092-8674(95)90439-5;;10.1038/378641a0;;8524402;;8289294;;10.1006/jmbi.1994.1027;;7512379;;10.1021/bi00180a001;;8142351;;10.1021/bi00178a010;;7525078;;10.1016/0092-8674(94)90253-4;;10.1021/ja00075a092;;8289294;;10.1006/jmbi.1994.1027;;7694595;;10.1016/0952-7915(93)90135-f;;7543369;;007543369;;10.1016/0092-8674(95)90439-5;;2556704;;10.1073/pnas.86.23.9183;;pmc298458;;10.1021/ja00075a008;;10.1021/bi00430a066;;2541767;;10.1093/protein/6.6.615;;8234231;;10.1038/378641a0;;8524402;;7694398;;10.1016/0968-0004(93)90069-y;;10.1016/s0021-9258(17)36094-5;;3944089;;7770774;;10.1126/science.7770774;;10.1016/0014-5793(93)81629-e;;8262199;;8768897;;10.1016/s0958-1669(96)80114-5;;10.1107/s0907444994014514;;15299838;;1583540;;10.1007/bf00124387;;10.1021/jm00165a001;;2407844;;10.1002/prot.340190305;;7937734;;10.1007/bf00126441;;8320553;;10.1021/jm00145a002;;3892003;;10.1002/prot.340080302;;2281083;;10.1016/s0959-440x(94)90179-1;;7154081;;10.1016/0022-2836(82)90153-x;;10.1007/bf00124349;;8035213;;10.1021/jm00090a001;;1613742;;10.1002/prot.340110104;;1961699;;10.1002/jcc.540130412;;10.1016/0959-440x(92)90147-y;;10.1016/s0040-4020(01)86503-0,"Griffith et al., ""X-ray Structure of Calcineurin Inhibited by the Immunophilin-Immunosuppressant FKBP12-FK506 Comples"", Cell Press vol. 82 Aug. 11, 1995 pp. 507-522.;;Kissinger et al., ""Crystal structure of human calcineurin and the human FKBP12-FK506-calcineurin complex"", NATURE vol. 378, Dec. 7, 1995, pp. 641-644.;;Barford et al., ""Co-crystallization of the Catalytic Subunit of the Serin/Threonine Specific Protein Phosphatase 1 from Human in Complex eit Microcystin LR"", J. Mol. Biol. (1994) vol. 235, pp. 763-766.;;Cheng et al., ""Biochemistry"", vol. 33 No. 14, Apr. 12, 1994, pp. 4093-4100.;;Anglister et al., ""1H, 13C, 15N Nuclear Magnetic Resonance Backbone Assignments and Secondary Structure of Human Calcineurin B"", Biochemistry 1994, vol. 33 pp. 3540-3547.;;Milan et al., ""The Latch Region of Calcineurin B Is Involved in Both Immunosuppressant-Immunophilin Complex docking and Phosphatase Activation"", Cell Press Nov. 4, 1994, pp. 437-447.;;Andrus, M.B. and Schreiber, S.L., ""Structure-Based Design of an Acyclic Ligand That Bridges FKBP12 and Calcineurin"" J. Am. Chem. Soc., 115, pp. 10420-10421 (1993).;;Barford, D. and Keller, J.C., ""Co-crystallization of the Catalytic Subunit of the Serine/Threonine Specific Protein Phosphatase 1 from Human in Complex with Microcystin LR"", J. Mol. Biol., 235, pp. 763-766 (1994).;;Bierer, B.E. et al., ""Cyclosporin A and FK506: Molecular Mechanisms of Immunosuppression and Probes for Transplantation Biology"" Curr. Opinion in Immunology, 5, pp. 763-773 (1993).;;Caffrey, M.V. et al. ""Synthesis And Evaluation Of Dual Domain Macrocyclic FKBP12 Ligands"" Bioorg. Med. Chem. Lett., 4, pp. 2507-2510 (Nov., 1994).;;Campbell, I.D. and Dwek, R.A., ""Diffraction"" in Biological Spectroscopy, The Benjamin/Cummings Publishing Company, Menlo Park, CA, pp. 299-326 (1984).;;Griffith, J.P. et al., ""X-Ray Structure of Calcineurin Inhibited by the Immunophilin-Immunosuppressant FKBP12-FK506 Complex"", Cell, 82, pp. 507-522 (1995).;;Guerini, D. and Klee, C.B., ""Cloning of Human Calcineurin A: Evidence for Two Isozymes and Identification of a Polyproline Structural Domain"", Proc. Natl. Acad. Sci. USA, 86, pp. 9183-9187 (1989).;;Holt, D.A. et al., ""Design, Synthesis, and Kinetic Evaluation of High-Affinity FKBP Ligands and the X-ray Crystal Structures of Their Complexes with FKBP12"" J. Am. Chem. Soc., 115, pp. 9925-9938 (1993).;;Hubbard, M.J. and Klee, C.B., ""Functional Domain Structure of Calcineurin A: Mapping by Limited Proteolysis"", Biochemistry, 28, pp. 1868-1874 (1989).;;Kajihara, A. et al., ""Protein Modelling Using a Chimera Reference Protein Derived From Exons"" Protein Eng., 6, pp. 615-620 (1993).;;Kissinger, C.R. et al., ""Crystal Structures of Human Calcineurin and the Human FKBP12-FK506-Calcineurin Complex"", Nature, 378, pp. 641-644 (1995).;;Kunz, J. and Hall, M.N. ""Cyclosporin A, FK506 and Rapamycin: More Than Just Immunosuppression"" TIBS, 18, pp. 334-338 (1993).;;Sharma, R.K. and Wang, J.H., ""Calmodulin and Ca<SUP>2+</SUP>-Dependent Phosphorylation and Dephosphorylation of 63-kDa Subunit-Containing Bovine Brain Calmodulin-Stimulated Cyclic Nucleotide Phosphodiesterase Isozyme"" J. Biol. Chem., 261, pp. 1322-1328 (1986).;;Sträter, N. et al., ""Crystal Structure of a Purple Acid Phosphatase Containing a Dinuclear Fe(III)-Zn(II) Active Site"", Science, 268, pp. 1489-1492 (1995).;;Uhlin, U. et al., ""Crystallization and Crystallographic Investigations of Ribonucleotide Reductase Protein R1 from Escherichia coli"" FEBS Lett., 336, pp. 148-152 (1993).;;Villafranca, J.E. et al., ""Protein Serine/Threonine Phosphatases"", Current Opinion in Biotech., 7, pp. 387-402 (1996).;;Wilson, K.P. et al., ""Comparative X-ray Strucutres of the Major Binding Protein for the Immunosuppressant FK506 (Tacrolimus) in Unliganded Form and in Complex with FK506 and Rapamycin"" Acta Cryst., D51, pp. 511-521 (Ju., 1995).;;Balbes, L.M., et al., ""A Perspective of Modern Methods in Computer-Aided Drug Design,"" in ""Reviews in Computational Chemistry,"" K.B. Lipkowitz and D.B. Boyd, Eds., VCH Publishers, New York, 5: 337-379 (1994).;;Bartlett, P.A., et al., ""CAVEAT: A Program to Facilitate the Structure-Derived Design of Biologically Active Molecules,"" in ""Molecular Recognition in Chemical and Biological Problems,"" S.M. Roberts, Ed., Royal Society of Chemistry, Special Publication No. 78: 182-196 (1989).;;Böhm, H.-J., ""The Computer Program LUDI: A New Method for the De Novo Design of Enzyme Inhibitors,"" J. Comp. Aid. Molec. Design, 6: 61-78 (1992).;;Cohen, N.C., et al., ""Molecular Modeling Software and Methods for Medicinal Chemistry,"" J. Med. Chem., 33: 883-894 (1990).;;Eisen, M.B., et al., ""HOOK: A Program for Finding Novel Molecular Architectures that Satisfy the Chemical and Steric Requirements of a Macromolecule Binding Site,"" Proteins Struct. Funct. Genet., 19: 199-221 (1994).;;Gillet, V., et al., ""SPROUT: A Program for Structure Generation,"" J. Comp. Aid. Molec. Design, 7: 127-153 (1993).;;Goodford, P.J., ""A Computational Procedure for Determining Energetically Favorable Binding Sites on Biologically Important Macromolecules,"" J. Med. Chem., 28: 849-857 (1985).;;Goodsell, D.S., and Olson, A.J., ""Automated Docking of Substrates to Proteins by Simulated Annealing,"" Proteins Struct. Funct. Genet., 8: 195-202 (1990).;;Guida, W.C., ""Software for Structure-Based Drug Design,"" Curr. Opin. Struct. Biology, 4: 777-781 (1994).;;Kuntz, I.D., et al., ""A Geometric Approach to Macromolecule-Ligand Interactions,"" J. Mol. Biol., 161: 269-288 (1982).;;Lauri, G. and Bartlett, P.A., ""CAVEAT: A Program to Facilitate the Design of Organic Molecules,"" J. Comp. Aid. Molec. Design, 8: 51-66 (1994).;;Martin, Y.C., ""3D Database Searching in Drug Design,"" J. Med. Chem., 35: 2145-2154 (1992).;;Miranker, A., and Karplus, M., ""Functionality Maps of Binding Sites: A Multiple Copy Simultaneous Search Method,"" Proteins Struct. Funct. Genet., 11: 29-34 (1991).;;Meng, E.C., et al., ""Automated Docking with Grid-Based Energy Evaluation,"" Journal of Computational Chemistry, 13: 505-524 (1992).;;Navia, M.A. and Murcho, M.A., ""Use of Structural Information in Drug Design,"" Current Opinion in Structural Biology, 2: 202-210 (1992).;;Nishibata, Y., and Itai, A., ""Automatic Creation of Drug Candidate Structures Based on Receptor Structure. Starting Point for Artificial Lead Generation."" Tetrahedron, 47: 8985-8990 (1991).",EXPIRED
822,AU,A,AU 1996/067668 A,188-755-264-683-807,1997-03-05,1997,AU 1996/067668 A,1996-08-01,US 51281595 A;;US 9612818 W,1995-08-09,Molecules comprising a calcineurin-like binding pocket and encoded data storage medium capable of graphically displayingthem,,VERTEX PHARMA,ARMISTEAD DAVID M;;FITZGIBBON MATTHEW JAMES;;FLEMING MARK ANDREW;;GRIFFITH JAMES P;;KIM EUNICE E;;KIM JOSEPH L;;SINTCHAK MICHAEL D;;THOMSON JOHN ALLAN;;WILSON KEITH P,,https://lens.org/188-755-264-683-807,Patent Application,no,0,0,8,8,0,C07K14/705;;C12N9/16;;C07K14/705;;C12N9/16,C12N9/16;;G06F17/50,,0,0,,,,PENDING
823,US,B2,US 8915286 B2,123-798-404-329-394,2014-12-23,2014,US 201113314730 A,2011-12-08,US 201113314730 A;;US 201061424116 P,2010-12-17,Roller shade filler panel,"Certain embodiments of the present invention provide an apparatus for closing off an opening above, below, or between electronic equipment in a rack. The rack includes a pair of equipment rails. The electronic equipment is mounted to the equipment rails. The apparatus includes a base, a roller shade, and a handle. The roller shade is rotatably connected to the base and includes a free end extending from the base when the roller shade is rotated. The handle is connected to the free end of the roller shade. The base is removably connected to the equipment rails at a first position. The handle is removably connected to the equipment rails at a second position spaced apart from the first position such that the free end of the roller shade is extended to close off the opening in the rack.",ZERNACH GARY L;;PASCARELLA NATHAN W;;WRIGHT DARRON J;;SAMPLES TRAVIS M;;DUKES JOSEPH ALLEN;;ACKLIN MARK A;;FLEMING JAMES N;;RAMEY SAMUEL C;;GRACZYK FRANK J;;PANDUIT CORP,ZERNACH GARY L;;PASCARELLA NATHAN W;;WRIGHT DARRON J;;SAMPLES TRAVIS M;;DUKES JOSEPH ALLEN;;ACKLIN MARK A;;FLEMING JAMES N;;RAMEY SAMUEL C;;GRACZYK FRANK J,PANDUIT CORP (2011-12-20),https://lens.org/123-798-404-329-394,Granted Patent,yes,69,1,12,12,0,H05K7/1488;;H05K7/1489;;H05K7/1488;;E06B9/78,H05K7/14;;A47H1/00;;H05K7/20,160/31;;361/690,3,0,,,"42U Hot/Cold Aisle Containment Curtains, webpages, http://www.42u.com/colling/hot-aisle-containment/aisle-containment-curtains.htm; undated, (3 pages).;;SharkRack, Inc. Tool-less Filler Panel Pack, 1U x 5, webpage, 2009, (1 pg.).;;Plenafill® 27U Scalable Blanking Panel, webpages, http://www.plenaform.com/PlenaFill.htm, Sep. 9, 2008 (2 pages).",ACTIVE
824,WO,A3,WO 2012/082541 A3,068-350-841-903-974,2012-08-16,2012,US 2011/0064099 W,2011-12-09,US 201061424116 P;;US 201113314730 A,2010-12-17,ROLLER SHADE FILLER PANEL,"Certain embodiments of the present invention provide an apparatus for closing off an opening above, below, or between electronic equipment in a rack. The rack includes a pair of equipment rails. The electronic equipment is mounted to the equipment rails. The apparatus includes a base, a roller shade, and a handle. The roller shade is rotatably connected to the base and includes a free end extending from the base when the roller shade is rotated. The handle is connected to the free end of the roller shade. The base is removably connected to the equipment rails at a first position. The handle is removably connected to the equipment rails at a second position spaced apart from the first position such that the free end of the roller shade is extended to close off the opening in the rack.",PANDUIT CORP;;ZERNACH GARY L;;PASCARELLA NATHAN W;;WRIGHT DARRON J;;SAMPLES TRAVIS M;;DUKES JOSEPH A;;ACKLIN MARK A;;FLEMING JAMES N;;RAMEY SAMUEL C;;GRACZYK FRANK J,ZERNACH GARY L;;PASCARELLA NATHAN W;;WRIGHT DARRON J;;SAMPLES TRAVIS M;;DUKES JOSEPH A;;ACKLIN MARK A;;FLEMING JAMES N;;RAMEY SAMUEL C;;GRACZYK FRANK J,,https://lens.org/068-350-841-903-974,Search Report,yes,4,0,12,12,0,H05K7/1488;;H05K7/1489;;H05K7/1488;;E06B9/78,H05K7/14,,0,0,,,,PENDING
825,EP,A2,EP 0846163 A2,186-680-644-153-764,1998-06-10,1998,EP 96928071 A,1996-08-01,US 9612818 W;;US 51281595 A,1995-08-09,MOLECULES COMPRISING A CALCINEURIN-LIKE BINDING POCKET AND ENCODED DATA STORAGE MEDIUM CAPABLE OF GRAPHICALLY DISPLAYING THEM,,VERTEX PHARMA,ARMISTEAD DAVID M;;FITZGIBBON MATTHEW JAMES;;FLEMING MARK ANDREW;;GRIFFITH JAMES P;;KIM EUNICE E;;KIM JOSEPH L;;SINTCHAK MICHAEL D;;THOMSON JOHN ALLAN;;WILSON KEITH P,,https://lens.org/186-680-644-153-764,Patent Application,yes,0,0,8,8,0,C07K14/705;;C12N9/16;;C07K14/705;;C12N9/16,C12N9/16;;G06F17/50,,0,0,,,,DISCONTINUED
826,WO,A3,WO 1997/006246 A3,029-264-766-174-779,1997-02-20,1997,US US9612818,1996-08-01,"US 8/512,815",1995-08-09,MOLECULES COMPRISING A CALCINEURIN-LIKE BINDING POCKET AND ENCODED DATA STORAGE MEDIUM CAPABLE OF GRAPHICALLY DISPLAYING THEM,"The present invention relates to crystallized molecules and molecular complexes which comprise the active site binding pocket or the FKBP12/FK506 binding pocket of calcineurin or close structural homologues to either binding pocket. This invention also relates to a data storage material encoded with the corresponding structure coordinates of those crystallized molecules or molecular complexes. Such data storage material is capable of displaying such molecules and molecular complexes as a graphical three-dimensional representation on a computer screen. In addition, this invention relates to methods of using the structure coordinates of those molecules or molecular complexes to solve the structure of homologous proteins. This invention also relates to methods of using the structure coordinates to screen and design compounds that bind to calcineurin or homologues thereof.",VERTEX PHARMACEUTICALS INCORPORATED,"ARMISTEAD, David, M.;;FITZGIBBON, Matthew, James;;FLEMING, Mark, Andrew;;GRIFFITH, James, P.;;KIM, Eunice, E.;;KIM, Joseph, L.;;SINTCHAK, Michael, D.;;THOMSON, John, Allan;;WILSON, Keith, P.",,https://lens.org/029-264-766-174-779,Search Report,yes,0,0,1,1,0,,C12N9/16,,0,0,,,,UNKNOWN
827,US,A1,US 2012/0152471 A1,113-475-418-172-43X,2012-06-21,2012,US 201113314730 A,2011-12-08,US 201113314730 A;;US 201061424116 P,2010-12-17,Roller Shade Filler Panel,"Certain embodiments of the present invention provide an apparatus for closing off an opening above, below, or between electronic equipment in a rack. The rack includes a pair of equipment rails. The electronic equipment is mounted to the equipment rails. The apparatus includes a base, a roller shade, and a handle. The roller shade is rotatably connected to the base and includes a free end extending from the base when the roller shade is rotated. The handle is connected to the free end of the roller shade. The base is removably connected to the equipment rails at a first position. The handle is removably connected to the equipment rails at a second position spaced apart from the first position such that the free end of the roller shade is extended to close off the opening in the rack.",ZERNACH GARY L;;PASCARELLA NATHAN W;;WRIGHT DARRON J;;SAMPLES TRAVIS M;;DUKES JOSEPH ALLEN;;ACKLIN MARK A;;FLEMING JAMES N;;RAMEY SAMUEL C;;GRACZYK FRANK J;;PANDUIT CORP,ZERNACH GARY L;;PASCARELLA NATHAN W;;WRIGHT DARRON J;;SAMPLES TRAVIS M;;DUKES JOSEPH ALLEN;;ACKLIN MARK A;;FLEMING JAMES N;;RAMEY SAMUEL C;;GRACZYK FRANK J,PANDUIT CORP (2011-12-20),https://lens.org/113-475-418-172-43X,Patent Application,yes,12,6,12,12,0,H05K7/1488;;H05K7/1489;;H05K7/1488;;E06B9/78,E06B9/78,160/323.1,0,0,,,,ACTIVE
828,WO,A3,WO 1997/006246 A3,163-312-520-975-068,1997-03-13,1997,US 9612818 W,1996-08-01,US 51281595 A,1995-08-09,MOLECULES COMPRISING A CALCINEURIN-LIKE BINDING POCKET AND ENCODED DATA STORAGE MEDIUM CAPABLE OF GRAPHICALLY DISPLAYING THEM,"The present invention relates to crystallized molecules and molecular complexes which comprise the active site binding pocket or the FKBP12/FK506 binding pocket of calcineurin or close structural homologues to either binding pocket. This invention also relates to a data storage material encoded with the corresponding structure coordinates of those crystallized molecules or molecular complexes. Such data storage material is capable of displaying such molecules and molecular complexes as a graphical three-dimensional representation on a computer screen. In addition, this invention relates to methods of using the structure coordinates of those molecules or molecular complexes to solve the structure of homologous proteins. This invention also relates to methods of using the structure coordinates to screen and design compounds that bind to calcineurin or homologues thereof.",VERTEX PHARMA,ARMISTEAD DAVID M;;FITZGIBBON MATTHEW JAMES;;FLEMING MARK ANDREW;;GRIFFITH JAMES P;;KIM EUNICE E;;KIM JOSEPH L;;SINTCHAK MICHAEL D;;THOMSON JOHN ALLAN;;WILSON KEITH P,,https://lens.org/163-312-520-975-068,Search Report,yes,2,0,8,8,0,C07K14/705;;C12N9/16;;C07K14/705;;C12N9/16,C12N9/16;;G06F17/50,,7,6,066-824-819-004-349;;008-847-207-001-866;;023-774-609-430-283;;019-899-924-340-24X;;087-317-650-837-833;;162-375-470-495-884,8289294;;10.1006/jmbi.1994.1027;;7543369;;007543369;;10.1016/0092-8674(95)90439-5;;10.1038/378641a0;;8524402;;10.1021/bi00430a066;;2541767;;2556704;;10.1073/pnas.86.23.9183;;pmc298458;;7770774;;10.1126/science.7770774,"D.BARFORD E.A.: ""Cocrystallization of the catalytic subunit of the serine/threonine specific PP1 from human in complex with microcystin LR"", J.MOL.BIOL., vol. 235, no. 2, 1994, pages 763 - 768, XP000616128;;J.M.GRIFFITH E.A.: ""X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex"", CELL, vol. 82, no. 3, 11 August 1995 (1995-08-11), NA US, pages 507 - 522, XP002023480;;C.R.KISSINGER E.A.: ""Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex"", NATURE, vol. 378, 7 December 1995 (1995-12-07), LONDON GB, pages 641 - 644, XP002023481;;M.J.HUBBARD E.A.: ""Functional domain structure of calcineurin A: mapping by limited proteolysis"", BIOCHEMISTRY, vol. 28, no. 4, 1989, EASTON, PA US, pages 1868 - 1874, XP002023482;;D.GUERINI E.A.: ""Cloning of human calcineurin A..."", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 86, December 1989 (1989-12-01), WASHINGTON US, pages 9183 - 9187, XP002023483;;N.STRÄTER E.A.: ""Crystal structure of a purple acid phosphatase containing a dinuclear Fe(III)-Zn(II) active site"", SCIENCE, vol. 268, - 9 June 1995 (1995-06-09), LANCASTER, PA US, pages 1489 - 1492, XP002023505;;J.E.VILLAFRANCA E.A.: ""protein serine/threonine phosphatase"", CURRENT OPINION IN BIOTECHN., vol. 7, August 1996 (1996-08-01), pages 387 - 402, XP000616057",PENDING
829,WO,A2,WO 2012/082541 A2,030-145-957-149-406,2012-06-21,2012,US 2011/0064099 W,2011-12-09,US 201061424116 P;;US 201113314730 A,2010-12-17,ROLLER SHADE FILLER PANEL,"Certain embodiments of the present invention provide an apparatus for closing off an opening above, below, or between electronic equipment in a rack. The rack includes a pair of equipment rails. The electronic equipment is mounted to the equipment rails. The apparatus includes a base, a roller shade, and a handle. The roller shade is rotatably connected to the base and includes a free end extending from the base when the roller shade is rotated. The handle is connected to the free end of the roller shade. The base is removably connected to the equipment rails at a first position. The handle is removably connected to the equipment rails at a second position spaced apart from the first position such that the free end of the roller shade is extended to close off the opening in the rack.",PANDUIT CORP;;ZERNACH GARY L;;PASCARELLA NATHAN W;;WRIGHT DARRON J;;SAMPLES TRAVIS M;;DUKES JOSEPH A;;ACKLIN MARK A;;FLEMING JAMES N;;RAMEY SAMUEL C;;GRACZYK FRANK J,ZERNACH GARY L;;PASCARELLA NATHAN W;;WRIGHT DARRON J;;SAMPLES TRAVIS M;;DUKES JOSEPH A;;ACKLIN MARK A;;FLEMING JAMES N;;RAMEY SAMUEL C;;GRACZYK FRANK J,,https://lens.org/030-145-957-149-406,Patent Application,yes,0,0,12,12,0,H05K7/1488;;H05K7/1489;;H05K7/1488;;E06B9/78,H05K7/20,,0,0,,,,PENDING
830,WO,A2,WO 1997/006246 A2,103-864-234-312-959,1997-02-20,1997,US 9612818 W,1996-08-01,US 51281595 A,1995-08-09,MOLECULES COMPRISING A CALCINEURIN-LIKE BINDING POCKET AND ENCODED DATA STORAGE MEDIUM CAPABLE OF GRAPHICALLY DISPLAYING THEM,"The present invention relates to crystallized molecules and molecular complexes which comprise the active site binding pocket or the FKBP12/FK506 binding pocket of calcineurin or close structural homologues to either binding pocket. This invention also relates to a data storage material encoded with the corresponding structure coordinates of those crystallized molecules or molecular complexes. Such data storage material is capable of displaying such molecules and molecular complexes as a graphical three-dimensional representation on a computer screen. In addition, this invention relates to methods of using the structure coordinates of those molecules or molecular complexes to solve the structure of homologous proteins. This invention also relates to methods of using the structure coordinates to screen and design compounds that bind to calcineurin or homologues thereof.",VERTEX PHARMA,ARMISTEAD DAVID M;;FITZGIBBON MATTHEW JAMES;;FLEMING MARK ANDREW;;GRIFFITH JAMES P;;KIM EUNICE E;;KIM JOSEPH L;;SINTCHAK MICHAEL D;;THOMSON JOHN ALLAN;;WILSON KEITH P,,https://lens.org/103-864-234-312-959,Patent Application,no,0,9,8,8,0,C07K14/705;;C12N9/16;;C07K14/705;;C12N9/16,C12N9/16;;G06F17/50,,0,0,,,,PENDING
831,US,A,US 5978740 A,097-509-518-573-163,1999-11-02,1999,US 51281595 A,1995-08-09,US 51281595 A,1995-08-09,Molecules comprising a calcineurin-like binding pocket and encoded data storage medium capable of graphically displaying them,"The present invention relates to crystallized molecules and molecular complexes which comprise the active site binding pocket or the FKBP12/FK506 binding pocket of calcineurin or close structural homologues to either binding pocket. This invention also relates to a data storage material encoded with the corresponding structure coordinates of those crystallized molecules or molecular complexes. Such data storage material is capable of displaying such molecules and molecular complexes as a graphical three-dimensional representation on a computer screen. In addition, this invention relates to methods of using the structure coordinates of those molecules or molecular complexes to solve the structure of homologous proteins. This invention also relates to methods of using the structure coordinates to screen and design compounds that bind to calcineurin or homologues thereof.",VERTEX PHARMA,ARMISTEAD DAVID M;;FITZGIBBON MATTHEW JAMES;;FLEMING MARK ANDREW;;GRIFFITH JAMES P;;KIM EUNICE E;;KIM JOSEPH L;;SINTCHAK MICHAEL D;;THOMSON JOHN ALLAN;;WILSON KEITH P,VERTEX PHARMACEUTICALS INCORPORATED (1996-01-19),https://lens.org/097-509-518-573-163,Granted Patent,yes,5,44,8,8,0,C07K14/705;;C12N9/16;;C07K14/705;;C12N9/16,C12N9/16;;G06F17/50,702/19;;702/27,17,15,066-824-819-004-349;;008-847-207-001-866;;087-317-650-837-833;;019-899-924-340-24X;;023-774-609-430-283;;162-375-470-495-884;;124-128-285-358-11X;;144-433-300-416-581;;121-312-857-082-253;;008-782-290-622-57X;;050-930-610-164-868;;034-389-368-463-129;;080-243-480-377-884;;057-355-233-717-557;;045-470-558-777-812,8289294;;10.1006/jmbi.1994.1027;;7543369;;007543369;;10.1016/0092-8674(95)90439-5;;2556704;;10.1073/pnas.86.23.9183;;pmc298458;;10.1021/bi00430a066;;2541767;;10.1038/378641a0;;8524402;;7770774;;10.1126/science.7770774;;8768897;;10.1016/s0958-1669(96)80114-5;;10.1021/ja00075a092;;7694595;;10.1016/0952-7915(93)90135-f;;10.1021/ja00075a008;;10.1093/protein/6.6.615;;8234231;;7694398;;10.1016/0968-0004(93)90069-y;;10.1016/s0021-9258(17)36094-5;;3944089;;10.1016/0014-5793(93)81629-e;;8262199;;10.1107/s0907444994014514;;15299838,"Barford, D. and Keller, J.C., Co crystallization of the Catalytic Subunit of the Serine/Threonine Specific Protien Phosphatase 1 from Human in Complex with Microcystin LR , J. Mol. Biol., 235, pp. 763 766 (1994).;;Griffith, J.P. et al., X Ray Structure of Calcineurin Inhibited by the Immunophilin Immunosuppressant FKBP12 FK506 Complex , Cell, 82, pp. 507 522 Aug. 1995.;;Guerini, D. and Klee, C.B., Cloning of Human Calcineurin A: Evidence for Two Isozymes and Identification of a Polyproline Structural Domain , Proc. Natl. Acad. Sci. USA, 86, pp. 9183 9187 (1989).;;Hubbard, M.J. and Klee, C.B., Functional Domain Structure of Calcineurin A: Mapping by Limited Proteolysis , Biochemistry, 28, pp. 1868 1874 (1989).;;Kissinger, C.R. et al., Crystal Structures of Human Calcineurin and the Human FKBP12 FK506 Calcineurin Complex , Nature, 378, pp. 641 644 Dec. 1995.;;Str a ter, N. et al., Crystal Structure of a Purple Acid Phosphatase Containing a Dinuclear Fe(III) Zn(II) Active Site , Science, 268, pp. 1489 1492 Jun. 1995.;;Villafranca, J.E. et al., Protein Serine/Threonine Phosphatases , Current Opinion in Biotech., 7, pp. 387 402 (1996) No month.;;Andrus, M.B. and Schreiber, S.L., Structure Based Design of an Acyclic Ligand That Bridges FKBP12 and Calcineurin J. Am. Chem. Soc., 115, pp. 10420 10421 (1993).;;Bierer, B.E. et al., Cyclosporin A and FK506: Molecular Mechanisms of Immunosuppression and Probes for Transplantation Biology Curr. Opinion in Immunology, 5, pp. 763 773 (1993).;;Caffrey, M.V. et al. Synthesis And Evaluation Of Dual Domain Macrocyclic FKBP12 Ligands Bioorg. Med. Chem. Lett., 4, pp. 2507 2510 (Nov., 1994).;;Campbell, I.D. and Dwek, R.A., Diffraction in Biological Spectroscopy, The Benjamin/Cummings Publishing Company, Menlo Park, CA, pp. 299 326 (1984).;;Holt, D.A. et al., Design, Synthesis, and Kinetic Evaluation of High Affinity FKBP Ligands and the X ray Crystal Structures of Their Complexes with FKBP12 J. Am. Chem. Soc., 115, pp. 9925 9938 (1993).;;Kajihara, A. et al., Protein Modelling Using a Chimera Reference Protein Derived From Exons Protein Engng, 6, pp. 615 620 (1993).;;Kunz, J. and Hall, M.N. Cyclosporin A, FK506 and Rapamycin: More Than Just Immunosuppression TIBS, 18, pp. 334 338.;;Sharma, R.K. and Wang, J.H., Calmodulin and Ca 2 Dependent Phosphorylation and Dephosphorylation of 63 kDa Subunit Containing Bovine Brain Calmodulin Stimulated Cyclic Nucleotide Phosphodiesterase Isozyme J. Biol. Chem., 261, pp. 1322 1328 (1986).;;Uhlin, U. et al., Crystallization and Crystallographic Investigations of Ribonucleotide Reductase Protein R1 from Escherichia coli FEBS, 336, pp. 148 152 (1993).;;Wilson, K.P. et al. Comparative X ray Structures of the Major Binding Protein for the Immunosuppressant FK506 (Tacrolimus) in Unliganded Form and in Complex with FK506 and Rapamycin Acta Cryst., D51, pp. 511 521 (Jul., 1995).",EXPIRED
832,US,S,US D0595087 S,118-494-905-391-969,2009-06-30,2009,US 31288108 F,2008-11-19,US 31288108 F,2008-11-19,Enclosure for a blender,,VITA MIX CORP,METAXATOS PAUL K;;KOURY STEFFEN F;;MACLAURIN KURTIS R;;KOLAR DAVID J;;KOZLOWSKI EUGENE J;;ULANSKI ROBERT M;;FLEMING MARK F;;RUKAVINA STEPHEN P;;CIEPIEL ANTHONY M,VITA-MIX MANAGEMENT CORPORATION (2015-04-30);;VITA-MIX HOLDINGS COMPANY (2014-12-29),https://lens.org/118-494-905-391-969,Design Right,no,0,16,3,3,0,,,0702;;D 7413;;D7/412,0,0,,,,EXPIRED
833,US,A1,US 2015/0090410 A1,181-567-346-351-715,2015-04-02,2015,US 201414567171 A,2014-12-11,US 201414567171 A;;US 201113314730 A;;US 201061424116 P,2010-12-17,Roller Shade Filler Panel,"Certain embodiments of the present invention provide an apparatus for closing off an opening above, below, or between electronic equipment in a rack. The rack includes a pair of equipment rails. The electronic equipment is mounted to the equipment rails. The apparatus includes a base, a roller shade, and a handle. The roller shade is rotatably connected to the base and includes a free end extending from the base when the roller shade is rotated. The handle is connected to the free end of the roller shade. The base is removably connected to the equipment rails at a first position. The handle is removably connected to the equipment rails at a second position spaced apart from the first position such that the free end of the roller shade is extended to close off the opening in the rack.",PANDUIT CORP,ZERNACH GARY L;;PASCARELLA NATHAN W;;WRIGHT DARRON J;;SAMPLES TRAVIS M;;DUKES JOSEPH ALLEN;;ACKLIN MARK A;;FLEMING JAMES N;;RAMEY SAMUEL C;;GRACZYK FRANK J,,https://lens.org/181-567-346-351-715,Patent Application,yes,6,2,12,12,0,H05K7/1488;;H05K7/1489;;H05K7/1488;;E06B9/78,E06B9/78;;H05K7/14,160/323.1,0,0,,,,ACTIVE
834,US,A1,US 2007/0010952 A1,129-299-229-530-147,2007-01-11,2007,US 47129006 A,2006-06-19,US 47129006 A;;US 43146999 A;;US 51281595 A,1995-08-09,Molecules comprising a calcineurin-like binding pocket and encoded data storage medium capable of graphically displaying them,"The present invention relates to crystallized molecules and molecular complexes which comprise the active site binding pocket or the FKBP12/FK506 binding pocket of calcineurin or close structural homologues to either binding pocket. This invention also relates to a data storage material encoded with the corresponding structure coordinates of those crystallized molecules or molecular complexes. Such data storage material is capable of displaying such molecules and molecular complexes as a graphical three-dimensional representation on a computer screen. In addition, this invention relates to methods of using the structure coordinates of those molecules or molecular complexes to solve the structure of homologous proteins. This invention also relates to methods of using the structure coordinates to screen and design compounds that bind to calcineurin or homologues thereof.",ARMISTEAD DAVID M;;FITZGIBBON MATTHEW J;;FLEMING MARK A;;GRIFFITH JAMES P;;KIM EUNICE E;;KIM JOSEPH L;;SINTCHAK MICHAEL D;;THOMSON JOHN A;;WILSON KEITH P,ARMISTEAD DAVID M;;FITZGIBBON MATTHEW J;;FLEMING MARK A;;GRIFFITH JAMES P;;KIM EUNICE E;;KIM JOSEPH L;;SINTCHAK MICHAEL D;;THOMSON JOHN A;;WILSON KEITH P,,https://lens.org/129-299-229-530-147,Patent Application,yes,5,0,8,8,0,C07K14/705;;C12N9/16;;C07K14/705;;C12N9/16,C07K14/705;;G06F19/00;;C12N9/16;;G06F17/50,702/19;;530/350,0,0,,,,DISCONTINUED
835,CN,A,CN 103262672 A,182-279-004-756-755,2013-08-21,2013,CN 201180059959 A,2011-12-09,US 2011/0064099 W;;US 201061424116 P;;US 201113314730 A,2010-12-17,Roller shade filler panel,"Certain embodiments of the present invention provide an apparatus for closing off an opening above, below, or between electronic equipment in a rack. The rack includes a pair of equipment rails. The electronic equipment is mounted to the equipment rails. The apparatus includes a base, a roller shade, and a handle. The roller shade is rotatably connected to the base and includes a free end extending from the base when the roller shade is rotated. The handle is connected to the free end of the roller shade. The base is removably connected to the equipment rails at a first position. The handle is removably connected to the equipment rails at a second position spaced apart from the first position such that the free end of the roller shade is extended to close off the opening in the rack.",PANDUIT CORP,ZERNACH GARY L;;PASCARELLA NATHAN W;;WRIGHT DARRON J;;SAMPLES TRAVIS M;;DUKES JOSEPH A;;ACKLIN MARK A;;FLEMING JAMES N;;RAMEY SAMUEL C;;GRACZYK FRANK J,,https://lens.org/182-279-004-756-755,Patent Application,no,9,0,12,12,0,H05K7/1488;;H05K7/1489;;H05K7/1488;;E06B9/78,H05K7/14,,0,0,,,,ACTIVE
836,CA,C,CA 2397232 C,157-378-870-192-236,2007-01-23,2007,CA 2397232 A,2001-01-26,EP 0100866 W;;US 18056000 P,2000-02-04,"SYNTHESIS OF 3,6-DIALKYL-5,6-DIHYDRO-4-HYDROXY-PYRAN-2-ONE","The present invention relates to a novel process for producing a .delta.-lactone of the formula (I) using an acyl halide of the formula (1) wherein R1, R2, R3 and X are described herein, as well as novel intermediates. In particular, the present invention relates to a process for enantioselectively producing the (R)-.delta.-lactone.",HOFFMANN LA ROCHE,FLEMING MICHAEL PAUL;;PUENTENER KURT;;MICHELI ROGER P;;HODGES LEWIS M;;HAN YEUN-KWEI;;JOHNSTON DAVID A;;ROBERTS CHRISTOPHER R;;TOPPING ROBERT J;;SCALONE MICHELANGELO;;SCHWINDT MARK A,,https://lens.org/157-378-870-192-236,Granted Patent,no,0,0,29,29,0,C07B2200/07;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02;;C07D309/32;;C07F3/02;;C07D309/32;;C07D305/12;;C07C67/30;;C07C67/31;;C07B2200/07,C07D309/32;;C07B61/00;;C07C67/30;;C07C67/31;;C07D305/12;;C07F3/02,,0,0,,,,EXPIRED
837,US,B2,US 6818789 B2,068-774-371-346-681,2004-11-16,2004,US 36469203 A,2003-02-10,US 36469203 A;;US 66883400 A;;US 18056000 P,2000-02-04,"Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one","
    The present invention relates to a novel process for producing a -lactone of the formula: 

    using an acyl halide of the formula: 

    wherein R ^{ 1 } , R ^{ 2 } R ^{ 3 } and X are described herein, as well as novel intermediates. In particular, the present invention relates to a process for enantioselectively producing the (R)--lactone. 
",ROCHE COLORADO CORP,FLEMING MICHAEL P;;HAN YEUN-KWEI;;HODGES LEWIS M;;JOHNSTON DAVID A;;MICHELI ROGER P;;PUENTENER KURT;;ROBERTS CHRIS R;;SCALONE MICHELANGELO;;SCHWINDT MARK A;;TOPPING ROBERT J,F. HOFFMANN-LA ROCHE AG (2003-07-08);;CHEPLAPHARM ARZNEIMITTEL GMBH (2018-05-31);;ROCHE COLORADO CORPORATION (2008-08-21);;ROCHE PALO ALTO LLC (2011-05-13),https://lens.org/068-774-371-346-681,Granted Patent,yes,10,6,29,29,0,C07B2200/07;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02;;C07D309/32;;C07F3/02;;C07D309/32;;C07D305/12;;C07C67/30;;C07C67/31;;C07B2200/07,C07B61/00;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02,560/179;;568/881;;568/885,14,13,109-258-766-265-100;;014-754-019-673-600;;051-717-246-238-739;;061-756-549-203-554;;131-790-529-867-480;;124-294-479-097-820;;088-643-901-208-24X;;021-321-526-049-415;;032-937-212-445-399;;092-918-571-165-543;;053-745-108-727-375;;098-709-496-517-832;;157-968-049-972-600,10.1016/s0040-4039(00)60566-x;;10.1246/bcsj.64.1542;;10.1246/bcsj.60.3823;;10.1246/cl.1991.1319;;10.1246/bcsj.65.1513;;10.1021/jo00180a020;;10.1021/jo00297a090;;10.1055/s-1993-25849;;10.1002/chin.198552160;;10.1055/s-1994-25684;;10.1055/s-1991-20872;;10.1016/s0040-4020(99)00443-3;;10.1016/s0040-4039(98)00842-9,"Landl, John J. et al., ""A New Route to beta-Keto-delta-lactones: Practical Preparation of (R)-3-Hexyl-5, 6,-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one, a Key Intermediate in Asymmetric Synthesis of Tetrahydrolipstatin,"" Tetrahedron Letters, vol. 34, No. 2, pp. 277-280 (1993).;;Miura, Katsukiyo et al., ""Triethylborane Induced Perfluoroalkylation of Silyl Enol Ethers and Ketene Silyl Acetals with Perfluoroalkyl Iodides,"" Bull. Chem. Soc. Jpn., vol. 64, No. 5, pp. 1542-1553 (1991).;;Umemoto, Teruo et al., ""1H,1H-Perfluoroalkylation of Enol Silyl Ethers with (1H,1H-Perfluoroalkyl)-phenyliodonium Triflates. A New Method for the Preparation of beta- and delta- Trifluoromethyl Carbonyl Compounds and Their Higher Perfluoroalkyl Homologues),"" Bull. Chem. Soc. Jpn., vol. 60, pp. 3823-3825 (1987).;;Sugimoto, Jiro et al., ""Triethylborane Induced Radical Reaction of Ketene Silyl Acetals with Polyhalomethanes. Synthesis of 3,3-Dihalo- and 3-Haloacrylates,"" The Chemical Society of Japan, Chemistry Letters, pp. 1319-1322 (1991).;;Miura, Katsukiyo et al., ""Triethylborane Induced Radical Reaction of Keten Silyl Acetals with Polyhalomethanes,"" Bull. Chem. Soc. Jpn. vol. 65, pp. 1513-1521 (1992).;;Shono, Tatsuya et al., ""Electroorganic Chemistry. 82. beta-Amino Acid Esters from alpha-Methoxycarbamates and Ketene Silyl Acetals; Cyclization to beta-Lactams,"" J. Org. Chem. vol. 49, pp. 1056-1059 (1984).;;Purrington, Suzanne T. et al., ""Preparation of alpha-Fluoro Carboxylic Acids and Derivatives,"" J. Org. Chem., vol. 55, pp. 3423-3424 (1990).;;Clay, Ronald J. et al., ""A Safe, Economical Method for the Preparation of beta-Oxo Esters,"" Synthesis, pp. 290-292 (1993).;;Rathke, Michael W. et al. ""Procedures for the Acylation of Diethyl Malonate and Ethyl Acetoacetate with Acid Chlorides Using Tertiary Amine Bases and Magnesium Chloride,"" J. Org. Chem, vol. 50, pp. 2622-2624 (1985).;;Pommier, Agnes et al., ""An Asymmetric Synthesis of (-)- Tetrahydrolipstatin,"" Synthesis, pp. 1294-1295 (1994).;;Schmid, R. et al., ""Asymmetric hydrogenation in process research of pharmaceuticals, vitamins and fine chemicals,"" Chiral Europe (1994).;;Case-Green, Stephen C. et al., ""Asymmetric Synthesis of (-)-Tetrahydrolipstatin,"" Synlett, pp. 781-782, Nov. 1991.;;Kitamura, Masato et al., ""Asymmetric Synthesis of beta-Hydroxy Sulfonic Acids by BINAP/Ru-Catalyzed Hydrogenation,"" Tetrahedron, vol. 55, pp. 8769-8785 (1999).;;Pye, Phillip J. et al., ""[2.2]Phanephos-Ruthenium(II) Complexes: Highly Active Asymmetric Catalysts for the Hydrogenation of beta-Ketoesters,"" Tetrahedron Letters, vol. 39, pp. 4441-4444 (1998).",EXPIRED
838,CN,A,CN 1680347 A,069-495-311-162-527,2005-10-12,2005,CN 200510070933 A,2001-01-26,US 18056000 P,2000-02-04,"Synthesis of 3, 6-dialkyl-5, 6-dihydro-4-hydroxy-pyran-2-ketone","The present invention relates to a novel process for producing a delta-lactone of the formula:using an acyl halide of the formula:wherein R<1>, R<2 >R<3 >and X are described herein, as well as novel intermediates. In particular, the present invention relates to a process for enantioselectively producing the (R)-delta-lactone.",ROCHE COLORADO CORP,FLEMING MICHAEL P;;YEUN-KWEI HAN;;HODGES LEWIS M;;JOHNSTON DAVID A;;MICHELI ROGER P;;KURT PUENTENER;;ROBERTS CHRIS R;;MICHELANGELO SCALONE;;SCHWINDT MARK A;;TOPPING ROBER J,,https://lens.org/069-495-311-162-527,Patent Application,no,0,2,29,29,0,C07B2200/07;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02;;C07D309/32;;C07F3/02;;C07D309/32;;C07D305/12;;C07C67/30;;C07C67/31;;C07B2200/07,C07B61/00;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02,,0,0,,,,EXPIRED
839,WO,A3,WO 2001/057014 A3,112-263-816-318-069,2002-04-18,2002,EP 0100866 W,2001-01-26,US 18056000 P,2000-02-04,"SYNTHESIS OF 3,6-DIALKYL-5,6-DIHYDRO-4-HYDROXY-PYRAN-2-ONE","The present invention relates to a novel process for producing a δ-lactone of the formula (I) using an acyl halide of the formula (1) wherein R?1, R2, R3¿ and X are described herein, as well as novel intermediates. In particular, the present invention relates to a process for enantioselectively producing the (R)-δ-lactone.",HOFFMANN LA ROCHE,FLEMING MICHAEL PAUL;;HAN YEUN-KWEI;;HODGES LEWIS M;;JOHNSTON DAVID A;;MICHELI ROGER P;;PUENTENER KURT;;ROBERTS CHRISTOPHER R;;SCALONE MICHELANGELO;;SCHWINDT MARK A;;TOPPING ROBERT J,,https://lens.org/112-263-816-318-069,Search Report,yes,1,0,29,29,0,C07B2200/07;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02;;C07D309/32;;C07F3/02;;C07D309/32;;C07D305/12;;C07C67/30;;C07C67/31;;C07B2200/07,C07B61/00;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02,,1,1,092-918-571-165-543,10.1055/s-1994-25684,"POMMIER A ET AL: ""AN SYMMETRIC SYNTHESIS OF(-)-TETRAHYDROLIPSTATIN"", SYNTHESIS,DE,GEORG THIEME VERLAG. STUTTGART, 1 December 1994 (1994-12-01), pages 1294 - 1300, XP002064051, ISSN: 0039-7881",PATENTED
840,EP,A2,EP 1255747 A2,097-097-701-016-463,2002-11-13,2002,EP 01909697 A,2001-01-26,EP 0100866 W;;US 18056000 P,2000-02-04,"SYNTHESIS OF 3,6-DIALKYL-5,6-DIHYDRO-4-HYDROXY-PYRAN-2-ONE","The present invention relates to a novel process for producing a delta-lactone of the formula:using an acyl halide of the formula:wherein R<1>, R<2 >R<3 >and X are described herein, as well as novel intermediates. In particular, the present invention relates to a process for enantioselectively producing the (R)-delta-lactone.",HOFFMANN LA ROCHE,FLEMING MICHAEL PAUL;;HAN YEUN-KWEI;;HODGES LEWIS M;;JOHNSTON DAVID A;;MICHELI ROGER P;;PUENTENER KURT;;ROBERTS CHRISTOPHER R;;SCALONE MICHELANGELO;;SCHWINDT MARK A;;TOPPING ROBERT J,"CHEPLAFARM ARZNEIMITTEL GMBH, DE (2018-07-13);;CHEPLAPHARM ARZNEIMITTEL GMBH (2018-07-25);;CHEPLAPHARM ARZNEIMITTEL GMBH, DE (2019-02-22);;CHEPLAPHARM ARZNEIMITTEL GMBH; DE (2018-06-26)",https://lens.org/097-097-701-016-463,Patent Application,yes,0,0,29,29,0,C07B2200/07;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02;;C07D309/32;;C07F3/02;;C07D309/32;;C07D305/12;;C07C67/30;;C07C67/31;;C07B2200/07,C07B61/00;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02,,0,0,,,,EXPIRED
841,US,A1,US 2003/0158422 A1,134-556-762-176-604,2003-08-21,2003,US 36453603 A,2003-02-10,US 36453603 A;;US 66883400 A;;US 18056000 P,2000-02-04,"Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one","
    The present invention relates to a novel process for producing a -lactone of the formula: 

    wherein R ¹ , R ² R ³ and X are described herein, as well as novel intermediates. In particular, the present invention relates to a process for enantioselectively producing the (R)--lactone. 
",ROCHE COLORADO CORP,FLEMING MICHAEL P;;HAN YEUN-KWEI;;HODGES LEWIS M;;JOHNSTON DAVID A;;MITCHELI ROGER P;;PUENTENER KURT;;ROBERTS CHRIS R;;SCALONE MICHELANGELO;;SCHWINDT MARK A;;TOPPING ROBERT J,F. HOFFMANN-LA ROCHE AG (2003-07-08);;CHEPLAPHARM ARZNEIMITTEL GMBH (2018-05-31);;ROCHE COLORADO CORPORATION (2008-08-21);;ROCHE PALO ALTO LLC (2011-05-13),https://lens.org/134-556-762-176-604,Patent Application,yes,10,3,29,29,0,C07B2200/07;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02;;C07D309/32;;C07F3/02;;C07D309/32;;C07D305/12;;C07C67/30;;C07C67/31;;C07B2200/07,C07B61/00;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02,549/292;;554/231;;260/665,0,0,,,,EXPIRED
842,AU,A,AU 2001/037347 A,084-751-140-321-135,2001-08-14,2001,AU 2001/037347 A,2001-01-26,EP 0100866 W;;US 18056000 P,2000-02-04,"Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one","The present invention relates to a novel process for producing a delta-lactone of the formula:using an acyl halide of the formula:wherein R<1>, R<2 >R<3 >and X are described herein, as well as novel intermediates. In particular, the present invention relates to a process for enantioselectively producing the (R)-delta-lactone.",HOFFMANN LA ROCHE,FLEMING MICHAEL PAUL;;HAN YEUN-KWEI;;HODGES LEWIS M;;JOHNSTON DAVID A;;MICHELI ROGER P;;PUENTENER KURT;;ROBERTS CHRISTOPHER R;;SCALONE MICHELANGELO;;SCHWINDT MARK A;;TOPPING ROBERT J,,https://lens.org/084-751-140-321-135,Patent Application,no,0,0,29,29,0,C07B2200/07;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02;;C07D309/32;;C07F3/02;;C07D309/32;;C07D305/12;;C07C67/30;;C07C67/31;;C07B2200/07,C07B61/00;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02,,0,0,,,,PENDING
843,EP,B1,EP 1255747 B1,143-461-435-922-432,2006-10-04,2006,EP 01909697 A,2001-01-26,EP 0100866 W;;US 18056000 P,2000-02-04,"SYNTHESIS OF 3,6-DIALKYL-5,6-DIHYDRO-4-HYDROXY-PYRAN-2-ONE","The present invention relates to a novel process for producing a delta-lactone of the formula:using an acyl halide of the formula:wherein R<1>, R<2 >R<3 >and X are described herein, as well as novel intermediates. In particular, the present invention relates to a process for enantioselectively producing the (R)-delta-lactone.",HOFFMANN LA ROCHE,FLEMING MICHAEL PAUL;;HAN YEUN-KWEI;;HODGES LEWIS M;;JOHNSTON DAVID A;;MICHELI ROGER P;;PUENTENER KURT;;ROBERTS CHRISTOPHER R;;SCALONE MICHELANGELO;;SCHWINDT MARK A;;TOPPING ROBERT J,"CHEPLAFARM ARZNEIMITTEL GMBH, DE (2018-07-13);;CHEPLAPHARM ARZNEIMITTEL GMBH (2018-07-25);;CHEPLAPHARM ARZNEIMITTEL GMBH, DE (2019-02-22);;CHEPLAPHARM ARZNEIMITTEL GMBH; DE (2018-06-26)",https://lens.org/143-461-435-922-432,Granted Patent,yes,1,0,29,29,0,C07B2200/07;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02;;C07D309/32;;C07F3/02;;C07D309/32;;C07D305/12;;C07C67/30;;C07C67/31;;C07B2200/07,C07D309/32;;C07B61/00;;C07C67/30;;C07C67/31;;C07D305/12;;C07F3/02,,1,0,,,"POMMIER A ET AL: ""AN SYMMETRIC SYNTHESIS OF(-)-TETRAHYDROLIPSTATIN"" SYNTHESIS,DE,GEORG THIEME VERLAG. STUTTGART, 1 December 1994 (1994-12-01), pages 1294-1300, XP002064051 ISSN: 0039-7881 cited in the application",EXPIRED
844,US,A1,US 2003/0171602 A1,176-836-370-775-560,2003-09-11,2003,US 36469203 A,2003-02-10,US 36469203 A;;US 66883400 A;;US 18056000 P,2000-02-04,"Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one","
    The present invention relates to a novel process for producing a -lactone of the formula: 

    using an acyl halide of the formula: 

    wherein R ¹ , R ² R ³ and X are described herein, as well as novel intermediates. In particular, the present invention relates to a process for enantioselectively producing the (R)--lactone. 
",ROCHE COLORADO CORP,FLEMING MICHAEL P;;HAN YEUN-KWEI;;HODGES LEWIS M;;JOHNSTON DAVID A;;MICHELI ROGER P;;PUENTENER KURT;;ROBERTS CHRIS R;;SCALONE MICHELANGELO;;SCHWINDT MARK A;;TOPPING ROBER J,F. HOFFMANN-LA ROCHE AG (2003-07-08);;CHEPLAPHARM ARZNEIMITTEL GMBH (2018-05-31);;ROCHE COLORADO CORPORATION (2008-08-21);;ROCHE PALO ALTO LLC (2011-05-13),https://lens.org/176-836-370-775-560,Patent Application,yes,10,3,29,29,0,C07B2200/07;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02;;C07D309/32;;C07F3/02;;C07D309/32;;C07D305/12;;C07C67/30;;C07C67/31;;C07B2200/07,C07B61/00;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02,549/292,0,0,,,,EXPIRED
845,DK,T3,DK 1255747 T3,060-773-438-593-391,2007-02-12,2007,DK 01909697 T,2001-01-26,US 18056000 P;;EP 0100866 W,2000-02-04,"Syntese af 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-on","The present invention relates to a novel process for producing a delta-lactone of the formula:using an acyl halide of the formula:wherein R<1>, R<2 >R<3 >and X are described herein, as well as novel intermediates. In particular, the present invention relates to a process for enantioselectively producing the (R)-delta-lactone.",HOFFMANN LA ROCHE,HAN YEUN-KWEI;;HODGES LEWIS M;;JOHNSTON DAVID A;;ROBERTS CHRISTOPHER R;;SCALONE MICHELANGELO;;SCHWINDT MARK A;;TOPPING ROBERT J;;FLEMING MICHAEL PAUL;;MICHELI ROGER P;;PUENTENER KURT,,https://lens.org/060-773-438-593-391,Granted Patent,no,0,0,29,29,0,C07B2200/07;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02;;C07D309/32;;C07F3/02;;C07D309/32;;C07D305/12;;C07C67/30;;C07C67/31;;C07B2200/07,C07D309/32;;C07B61/00;;C07C67/30;;C07C67/31;;C07D305/12;;C07F3/02,,0,0,,,,EXPIRED
846,US,A1,US 2003/0158423 A1,171-250-204-334-452,2003-08-21,2003,US 36454703 A,2003-02-10,US 36454703 A;;US 66883400 A;;US 18056000 P,2000-02-04,"Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one","
    The present invention relates to a novel process for producing a -lactone of the formula: 

    using an acyl halide of the formula: 

    wherein R ¹ , R ² R ³ and X are described herein, as well as novel intermediates. In particular, the present invention relates to a process for enantioselectively producing the (R)--lactone. 
",ROCHE COLORADO CORP,FLEMING MICHAEL P;;HAN YEUN-KWEI;;HODGES LEWIS M;;JOHNSTON DAVID A;;MICHELI ROGER P;;PUENTENER KURT;;ROBERTS CHRIS R;;SCALONE MICHELANGELO;;SCHWINDT MARK A;;TOPPING ROBERT J,F. HOFFMANN-LA ROCHE AG (2003-07-08);;CHEPLAPHARM ARZNEIMITTEL GMBH (2018-05-31);;ROCHE COLORADO CORPORATION (2008-08-21);;ROCHE PALO ALTO LLC (2011-05-13),https://lens.org/171-250-204-334-452,Patent Application,yes,0,3,29,29,0,C07B2200/07;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02;;C07D309/32;;C07F3/02;;C07D309/32;;C07D305/12;;C07C67/30;;C07C67/31;;C07B2200/07,C07B61/00;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02,549/292;;260/665;;554/227,0,0,,,,EXPIRED
847,JO,B1,JO 2243 B1,062-667-390-084-849,2004-10-07,2004,JO P20010004 A,2001-01-04,US 18056000 P,2000-02-04,"SYNTHESIS OF 3,6-DIALKYL-5.6-DIHYDRO-4-HYDROXY-PYRAN-2 ONE","The present invention relates to a novel process for producing a delta -lactone of the formula (I) using an acyl halide of the formula (1) wherein R<1>, R<2>, R<3> and X are described herein, as well as novel intermediates. In particular, the present invention relates to a process for enantioselectively producing the (R)- delta -lactone.",HOFFMANN LA ROCHE,MICHELANGELO SCALONE;;KURT PUENTENER;;LEWIS M MODGES;;CHRISTOPHER R ROBERTS;;DAVID A JOHNSTON;;MARK A SCHWINDT;;MICHAEL PAUL FLEMING;;ROBERT J TOPPING;;ROGER P MICHELI;;YEUN-KWEI HAN,,https://lens.org/062-667-390-084-849,Granted Patent,no,0,0,29,29,0,C07B2200/07;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02;;C07D309/32;;C07F3/02;;C07D309/32;;C07D305/12;;C07C67/30;;C07C67/31;;C07B2200/07,C07B61/00;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02,,0,0,,,,EXPIRED
848,AT,T1,AT E341541 T1,133-045-953-241-906,2006-10-15,2006,AT 01909697 T,2001-01-26,US 18056000 P,2000-02-04,"SYNTHESE VON 3,6-DIALKYL-5,6-DIHYDRO-4-HYDROXY- PYRAN-2-ONE","The present invention relates to a novel process for producing a delta-lactone of the formula:using an acyl halide of the formula:wherein R<1>, R<2 >R<3 >and X are described herein, as well as novel intermediates. In particular, the present invention relates to a process for enantioselectively producing the (R)-delta-lactone.",HOFFMANN LA ROCHE,FLEMING MICHAEL PAUL;;HAN YEUN-KWEI;;HODGES LEWIS M;;JOHNSTON DAVID A;;MICHELI ROGER P;;PUENTENER KURT;;ROBERTS CHRISTOPHER R;;SCALONE MICHELANGELO;;SCHWINDT MARK A;;TOPPING ROBERT J,,https://lens.org/133-045-953-241-906,Granted Patent,no,0,0,29,29,0,C07B2200/07;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02;;C07D309/32;;C07F3/02;;C07D309/32;;C07D305/12;;C07C67/30;;C07C67/31;;C07B2200/07,C07B61/00;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02,,0,0,,,,EXPIRED
849,US,B2,US 6743927 B2,153-643-082-199-305,2004-06-01,2004,US 36454703 A,2003-02-10,US 36454703 A;;US 66883400 A;;US 18056000 P,2000-02-04,"Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one","
    The present invention relates to a novel process for producing a -lactone of the formula: 

    using an acyl halide of the formula: 

    wherein R ^{ 1 } , R ^{ 2 } R ^{ 3 } and X are described herein, as well as novel intermediates. In particular, the present invention relates to a process for enantioselectively producing the (R)--lactone. 
",ROCHE COLORADO CORP,FLEMING MICHAEL P;;HAN YEUN-KWEI;;HODGES LEWIS M;;JOHNSTON DAVID A;;MICHELI ROGER P;;PUENTENER KURT;;ROBERTS CHRIS R;;SCALONE MICHELANGELO;;SCHWINDT MARK A;;TOPPING ROBERT J,F. HOFFMANN-LA ROCHE AG (2003-07-08);;CHEPLAPHARM ARZNEIMITTEL GMBH (2018-05-31);;ROCHE COLORADO CORPORATION (2008-08-21);;ROCHE PALO ALTO LLC (2011-05-13),https://lens.org/153-643-082-199-305,Granted Patent,yes,10,0,29,29,0,C07B2200/07;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02;;C07D309/32;;C07F3/02;;C07D309/32;;C07D305/12;;C07C67/30;;C07C67/31;;C07B2200/07,C07B61/00;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02,549/292;;549/294,14,13,109-258-766-265-100;;014-754-019-673-600;;051-717-246-238-739;;061-756-549-203-554;;131-790-529-867-480;;124-294-479-097-820;;088-643-901-208-24X;;021-321-526-049-415;;032-937-212-445-399;;092-918-571-165-543;;053-745-108-727-375;;098-709-496-517-832;;157-968-049-972-600,10.1016/s0040-4039(00)60566-x;;10.1246/bcsj.64.1542;;10.1246/bcsj.60.3823;;10.1246/cl.1991.1319;;10.1246/bcsj.65.1513;;10.1021/jo00180a020;;10.1021/jo00297a090;;10.1055/s-1993-25849;;10.1002/chin.198552160;;10.1055/s-1994-25684;;10.1055/s-1991-20872;;10.1016/s0040-4020(99)00443-3;;10.1016/s0040-4039(98)00842-9,"Landl, John J. et al., ""A New Route to beta-Keto-delta-lactones: Practical Preparation of (R)-3-Hexyl-5, 6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one, a Key Intermediate in Asymmetric Synthesis of Tetrahydrolipstatin,"" Tetrahedron Letters, vol. 34, No. 2, pp. 277-280 (1993).;;Miura, Katsukiyo et al., ""Triethylborane Induced Perfluoroalkylation of Silyl Enol Ethers and Ketene Silyl Acetals with Perfluoroalkyl lodides,"" Bull. Chem. Soc. Jpn., vol. 64, No. 5, pp. 1542-1553 (1991).;;Umemoto, Teruo et al., ""1H,1H-Perfluoroalkylation of Enol Silyl Ethers with (1H,1H-Perfluoroalkyl)-phenyliodonium Triflates. A New Method for the Preparation of beta- and delta-Trifluoromethyl Carbonyl Compounds and Their Higher Perfluoroalkyl Homologues),"" Bull. Chem. Soc. Jpn., vol. 60, pp. 3823-3825 (1987).;;Sugimoto, Jiro et al., ""Triethylborane Induced Radical Reaction of Ketene Silyl Acetals with Polyhalomethanes. Synthesis of 3,3-Dihalo- and 3-Haloacrylates,"" The Chemical Society of Japan, Chemistry Letters, pp. 1319-1322 (1991).;;Miura, Katsukiyo et al., ""Triethylborane Induced Radical Reaction of Keten Silyl Acetals with Polyhalomethanes,"" Bull. Chem. Soc. Jpn. vol. 65, pp. 1513-1521 (1992).;;Shono, Tatsuya et al., ""Electroorganic Chemistry. 82. beta-Amino Acid Esters from alpha-Methoxycarbamates and Ketene Silyl Acetals; Cyclization to beta-Lactams,"" J. Org. Chem. vol. 49, pp. 1056-1059 (1984).;;Purrington, Suzanne T. et al., ""Preparation of alpha-Fluoro Carboxylic Acids and Derivatives,"" J. Org. Chem., vol. 55, pp. 3423-3424 (1990).;;Clay, Ronald J. et al., ""A Safe, Economical Method for the Preparation of beta-Oxo Esters,"" Synthesis, pp. 290-292 (1993).;;Rathke, Michael W. et al., ""Procedures for the Acylation of Diethyl Malonate and Ethyl Acetoacetate with Acid Chlorides Using Tertiary Amine Bases and Magnesium Chloride,"" J. Org. Chem, vol. 50, pp. 2622-2624 (1985).;;Pommier, Agnes et al., ""An Asymmetric Synthesis of (-)-Tetrahydrolipstatin,"" Synthesis, pp. 1294-1295 (1994).;;Schmid, R. et al., ""Asymmetric hydrogenation in process research of pharmaceuticals, vitamins and fine chemicals,"" Chiral Europe (1994).;;Case-Green, Stephen C. et al., ""Asymmetric Synthesis of (-)-Tetrahydrolipstatin,"" Synlett, pp. 781-782, Nov. 1991.;;Kitamura, Masato et al., ""Asymmetric Synthesis of beta-Hydroxy Sulfonic Acids by BINAP/Ru-Catalyzed Hydrogenation,"" Tetrahedron, vol. 55, pp. 8769-8785 (1999).;;Pye, Philip J. et al., ""[2.2]PHANEPHOS-Ruthenium(II) Complexes: Highly Active Asymmetric Catalysts for the Hydrogenation of beta-Ketoesters,"" Tetrahedron Letters, vol. 39, pp. 4441-4444 (1998).",EXPIRED
850,CA,A1,CA 2397232 A1,032-586-776-083-977,2001-08-09,2001,CA 2397232 A,2001-01-26,EP 0100866 W;;US 18056000 P,2000-02-04,"SYNTHESIS OF 3,6-DIALKYL-5,6-DIHYDRO-4-HYDROXY-PYRAN-2-ONE","The present invention relates to a novel process for producing a .delta.- lactone of the formula (I) using an acyl halide of the formula (1) wherein R 1, R2, R3 and X are described herein, as well as novel intermediates. In particular, the present invention relates to a process for enantioselectivel y producing the (R)-.delta.-lactone.",HOFFMANN LA ROCHE,MICHELI ROGER P;;TOPPING ROBERT J;;PUENTENER KURT;;ROBERTS CHRISTOPHER R;;SCALONE MICHELANGELO;;SCHWINDT MARK A;;JOHNSTON DAVID A;;FLEMING MICHAEL PAUL;;HAN YEUN-KWEI;;HODGES LEWIS M,,https://lens.org/032-586-776-083-977,Patent Application,no,0,0,29,29,0,C07B2200/07;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02;;C07D309/32;;C07F3/02;;C07D309/32;;C07D305/12;;C07C67/30;;C07C67/31;;C07B2200/07,C07B61/00;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02,,0,0,,,,EXPIRED
851,US,B2,US 6858749 B2,095-341-268-061-958,2005-02-22,2005,US 36453603 A,2003-02-10,US 36453603 A;;US 66883400 A;;US 18056000 P,2000-02-04,"Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one","The present invention relates to a novel process for producing a δ-lactone of the formula: using an acyl halide of the formula: wherein R 1 , R 2 R 3 and X are described herein, as well as novel intermediates. In particular, the present invention relates to a process for enantioselectively producing the (R)-δ-lactone.",ROCHE COLORADO CORP,FLEMING MICHAEL P;;HAN YEUN-KWEI;;HODGES LEWIS M;;JOHNSTON DAVID A;;MICHELI ROGER P;;PUENTENER KURT;;ROBERTS CHRIS R;;SCALONE MICHELANGELO;;SCHWINDT MARK A;;TOPPING ROBERT J,F. HOFFMANN-LA ROCHE AG (2003-07-08);;CHEPLAPHARM ARZNEIMITTEL GMBH (2018-05-31);;ROCHE COLORADO CORPORATION (2008-08-21);;ROCHE PALO ALTO LLC (2011-05-13),https://lens.org/095-341-268-061-958,Granted Patent,yes,0,0,29,29,0,C07B2200/07;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02;;C07D309/32;;C07F3/02;;C07D309/32;;C07D305/12;;C07C67/30;;C07C67/31;;C07B2200/07,C07B61/00;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02,560/179;;560/188,15,13,109-258-766-265-100;;014-754-019-673-600;;051-717-246-238-739;;061-756-549-203-554;;131-790-529-867-480;;124-294-479-097-820;;088-643-901-208-24X;;021-321-526-049-415;;032-937-212-445-399;;092-918-571-165-543;;053-745-108-727-375;;098-709-496-517-832;;157-968-049-972-600,10.1016/s0040-4039(00)60566-x;;10.1246/bcsj.64.1542;;10.1246/bcsj.60.3823;;10.1246/cl.1991.1319;;10.1246/bcsj.65.1513;;10.1021/jo00180a020;;10.1021/jo00297a090;;10.1055/s-1993-25849;;10.1002/chin.198552160;;10.1055/s-1994-25684;;10.1055/s-1991-20872;;10.1016/s0040-4020(99)00443-3;;10.1016/s0040-4039(98)00842-9,"Landl, John J. et al., ""A New Route to beta-Keto-delta-lactones: Practical Preparation of (R)-3-Hexyl-5, 6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one, a Key Intermediate in Asymmetric Synthesis of Tetrahydrolipstatin,"" Tetrahedron Letters, vol. 34, No. 2, pp. 277-280 (1993).;;Miura, Katsukiyo et al., ""Triethylborane Induced Perfluoroalkylation of Silyl Enol Ethers and Ketene Silyl Acetals with Perfluoroalkyl Iodides,"" Bull. Chem. Soc. Jpn., vol. 64, No. 5, pp. 1542-1553 (1991).;;Umemoto, Teruo et al., ""1H,1H-Perfluoroalkylation of Enol Silyl Ethers with (1H,1H-Perfluoroalkyl)-phenyliodonium Triflates. A New Method for the Preparation of beta- and delta-Trifluoromethyl Carbonyl Compounds and Their Higher Perfluoroalkyl Homologues),"" Bull. Chem. Soc. Jpn., vol. 60, pp. 3823-3825 (1987).;;Sugimoto, Jiro et al., ""Triethylborane Induced Radical Reaction of Ketene Silyl Acetals with Polyhalomethanes. Synthesis of 3,3-Dihalo- and 3-Haloacrylates,"" The Chemical Society of Japan, Chemistry Letters, pp. 1319-1322 (1991).;;Miura, Katsukiyo et al., ""Triethylborane Induced Radical Reaction of Keten Silyl Acetals with Polyhalomethanes,"" Bull. Chem. Soc. Jpn. vol. 65, pp. 1513-1521 (1992).;;Shono, Tatsuya et al., ""Electroorganic Chemistry. 82. betaAmino Acid Esters for alpha-Methoxycarbamates and Ketene Silyl Acetals; Cyclization to beta-Lactams,"" J. Org. Chem. vol. 49, pp. 1056-1059 (1984).;;Purrington, Suzanne T. et al., ""Preparation of alpha-Fluoro Carboxylic Acids and Derivatives,"" J. Org. Chem., vol. 55, pp. 3423-3424 (1990).;;Clay, Ronald J. et al., ""A Safe, Economical Method for the Preparation of beta-Oxo Esters,"" Synthesis, pp. 290-292 (1993).;;Rathke, Michael W. et al., ""Procedures for the Acylation of Diethyl Malonate and Ethyl Acetoacetate with Acid Chlorides Using Tertiary Amine Bases and Magnesium Chloride,"" J. Org. Chem, vol. 50, pp. 2622-2624 (1985).;;Trost, Barry M. et al., ""Comprehensive Organic Synthesis: Selectivity, Strategy & Efficiency in Modern Organic Chemistry,"" vol. 6, Pergamon Press, pp. 301-319.;;Pommier, Agnes et al., ""An Asymmetric Synthesis of (-)-Tetrahydrolipstatin,"" Synthesis, pp. 1294-1295 (1994).;;Schmid, R. et al., ""Asymmetric hydrogenation in process research of pharmaceuticals, vitamins and fine chemicals,"" Chiral Europe (1994).;;Case-Green, Stephen C. et al., ""Asymmetric Synthesis of (-)-Tetrahydrolipstatin,"" Synlett, pp. 781-782, Nov. 1991.;;Kitamura, Masato et al., ""Asymmetric Synthesis of beta-Hydroxy Sulfonic Acids by BINAP/Ru-Catalyzed Hydrogenation,"" Tetrahedron, vol. 55, pp. 8769-8785 (1999).;;Pye, Philip J. et al., ""[2.2]PHANEPHOS-Ruthenium(II) Complexes: Highly Active Asymmetric Catalysts for the Hydrogenation of beta-Ketoesters,"" Tetrahedron Letters, vol. 39, pp. 4441-4444 (1998).",EXPIRED
852,US,B1,US 6545165 B1,129-198-297-256-28X,2003-04-08,2003,US 66883400 A,2000-09-22,US 66883400 A;;US 18056000 P,2000-02-04,"Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one","
    The present invention relates to a novel process for producing a -lactone of the formula: 

    using an acyl halide of the formula: 

    wherein R ^{ 1 } , R ^{ 2 } R ^{ 3 } and X are described herein, as well as novel intermediates. In particular, the present invention relates to a process for enantioselectively producing the (R)--lactone. 
",ROCHE COLORADO CORP,FLEMING MICHAEL P;;HAN YEUN-KWEI;;HODGES LEWIS M;;JOHNSTON DAVID A;;MICHELI ROGER P;;PUENTENER KURT;;ROBERTS CHRIS R;;SCALONE MICHELANGELO;;SCHWINDT MARK A;;TOPPING ROBERT J,CHEPLAPHARM ARZNEIMITTEL GMBH (2018-05-31);;ROCHE COLORADO CORPORATION (2008-08-21);;ROCHE PALO ALTO LLC (2011-05-13);;F. HOFFMAN-LAROCHE AG (2000-12-18),https://lens.org/129-198-297-256-28X,Granted Patent,yes,9,21,29,29,0,C07B2200/07;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02;;C07D309/32;;C07F3/02;;C07D309/32;;C07D305/12;;C07C67/30;;C07C67/31;;C07B2200/07,C07B61/00;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02,549/292;;549/294,14,13,109-258-766-265-100;;014-754-019-673-600;;051-717-246-238-739;;061-756-549-203-554;;131-790-529-867-480;;124-294-479-097-820;;088-643-901-208-24X;;021-321-526-049-415;;032-937-212-445-399;;092-918-571-165-543;;053-745-108-727-375;;098-709-496-517-832;;157-968-049-972-600,10.1016/s0040-4039(00)60566-x;;10.1246/bcsj.64.1542;;10.1246/bcsj.60.3823;;10.1246/cl.1991.1319;;10.1246/bcsj.65.1513;;10.1021/jo00180a020;;10.1021/jo00297a090;;10.1055/s-1993-25849;;10.1002/chin.198552160;;10.1055/s-1994-25684;;10.1055/s-1991-20872;;10.1016/s0040-4020(99)00443-3;;10.1016/s0040-4039(98)00842-9,"Landl, John J. et al., ""A New Route to beta-Keto-delta-lactones: Practical Preparation of (R)-3-Hexyl-5, 6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one, a Key Intermediate in Asymmetric Synthesis of Tetrahydrolipstatin,"" Tetrahedron Letters, vol. 34, No. 2, pp. 277-280 (1993).;;Miura, Katsukiyo et al., ""Triethylborane Induced Perfluoroalkylation of Silyl Enol Ethers and Ketene Silyl Acetals with Perfluoroalkyl Iodides,"" Bull. Chem. Soc. Jpn., vol. 64, No. 5, pp. 1542-1553 (1991).;;Umemoto, Teruo et al., ""1H,1H-Perfluoroalkylation of Enol Silyl Ethers with (1H,1H-Perfluoroalkyl)-phenyliodonium Triflates. A New Method for the Preparation of beta- and delta-Trifluoromethyl Carbonyl Compounds and Their Higher Perfluoroalkyl Homologues),"" Bull. Chem. Soc. Jpn., vol. 60, pp. 3823-3825 (1987).;;Sugimoto, Jiro et al., ""Triethylborane Induced Radical Reaction of Ketene Silyl Acetals with Polyhalomethanes. Synthesis of 3,3-Dihalo- and 3-Haloacrylates,"" The Chemical Society of Japan, Chemistry Letters, pp. 1319-1322 (1991).;;Miura, Katsukiyo et al., ""Triethylborane Induced Radical Reaction of Keten Silyl Acetals with Polyhalomethanes,"" Bull. Chem. Soc. Jpn. vol. 65, pp. 1513-1521 (1992).;;Shono, Tatsuya et al., ""Electroorganic Chemistry. 82. beta-Amino Acid Esters from alpha-Methoxycarbamates and Ketene Silyl Acetals; Cyclization to beta-Lactams,"" J. Org. Chem. vol. 49, pp. 1056-1059 (1984).;;Purrington, Suzanne T. et al., ""Preparation of alpha-Fluoro Carboxylic Acids and Derivatives,"" J. Org. Chem., vol. 55, pp. 3423-3424 (1990).;;Clay, Ronald J. et al., ""A Safe, Economical Method for the Preparation of beta-Oxo Esters,"" Synthesis, pp. 290-292 (1993).;;Rathke, Michael W. et al., ""Procedures for the Acylation of Diethyl Malonate and Ethyl Acetoacetate with Acid Chlorides Using Tertiary Amine Bases and Magnesium Chloride,"" J. Org. Chem, vol. 50, pp. 2622-2624 (1985).;;Pommier, Agnes et al., ""An Asymmetric Synthesis of (-)-Tetrahydrolipstatin,"" Synthesis, pp. 1294-1295 (1994).;;Schmid, R. et al., ""Asymmetric hydrogenation in process research of pharmaceuticals, vitamins and fine chemicals,"" Chiral Europe (1994).;;Case-Green, Stephen C. et al., ""Asymmetric Synthesis of (-)-Tetrahydrolipstatin,"" Synlett, pp. 781-782, Nov. 1991.;;Kitamura, Masato et al., ""Asymmetric Synthesis of beta-Hydroxy Sulfonic Acids by BINAP/Ru-Catalyzed Hydrogenation,"" Tetrahedron, vol. 55, pp. 8769-8785 (1999).;;Pye, Philip J. et al., ""[2.2]PHANEPHOS-Ruthenium(II) Complexes: Highly Active Asymmetric Catalysts for the Hydrogenation of beta-Ketoesters,"" Tetrahedron Letters, vol. 39, pp. 4441-4444 (1998).",EXPIRED
853,WO,A2,WO 2001/057014 A2,142-722-197-191-633,2001-08-09,2001,EP 0100866 W,2001-01-26,US 18056000 P,2000-02-04,"SYNTHESIS OF 3,6-DIALKYL-5,6-DIHYDRO-4-HYDROXY-PYRAN-2-ONE","The present invention relates to a novel process for producing a δ-lactone of the formula (I) using an acyl halide of the formula (1) wherein R?1, R2, R3¿ and X are described herein, as well as novel intermediates. In particular, the present invention relates to a process for enantioselectively producing the (R)-δ-lactone.",HOFFMANN LA ROCHE,FLEMING MICHAEL PAUL;;HAN YEUN-KWEI;;HODGES LEWIS M;;JOHNSTON DAVID A;;MICHELI ROGER P;;PUENTENER KURT;;ROBERTS CHRISTOPHER R;;SCALONE MICHELANGELO;;SCHWINDT MARK A;;TOPPING ROBERT J,,https://lens.org/142-722-197-191-633,Patent Application,yes,0,1,29,29,0,C07B2200/07;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02;;C07D309/32;;C07F3/02;;C07D309/32;;C07D305/12;;C07C67/30;;C07C67/31;;C07B2200/07,C07B61/00;;C07C67/30;;C07C67/31;;C07D305/12;;C07D309/32;;C07F3/02,,0,0,,,,PATENTED
854,US,A1,US 2005/0261939 A1,066-860-187-064-703,2005-11-24,2005,US 12785705 A,2005-05-12,US 12785705 A;;US 11912505 A;;US 57258604 P;;US 60191804 P,2004-05-19,Pharmacy benefits calculator,"A Pharmacy Benefits Calculator reads in an insured's prior pharmacy claims history and then calculates said insured's anticipated out-of-pocket costs for one or more pharmacy benefits plans that said insured is eligible to enroll in. Provision is made for an insured to modify their anticipated future pharmacy needs. Provision is also made for an insured to compare their out-of-pocket costs for different alternative drugs, said alternative drugs providing comparable therapeutic benefits. Provision also is made for an insured to substitute a lower cost generic equivalent for a brand drug, when available. Another provision is made for an insured to choose to price drugs at a retail pharmacy store or a mail order pharmacy and determine cost differences. The pricing available from said retail pharmacy store may be based on a price negotiated by an insurance company offering said pharmacy benefits plans.",HUMANA INC,AUGSPURGER KRISTEN R;;STEPHENS SARAH A;;KARRER MICHAEL A;;VINSON KENNON L;;FLINCHUM MARK A;;KALLIK INESSA;;ELIZABETH MEGAN K;;WARREN ELIZABETH M;;FLEMING WILLIAM K;;LORD JONATHAN T,HUMANA INC (2005-05-10),https://lens.org/066-860-187-064-703,Patent Application,yes,20,67,1,22,0,G06Q10/10;;G06Q40/02;;G06Q40/08;;G16H20/10;;G06Q10/10;;G06Q40/02;;G06Q40/08;;G16H20/10,G06Q10/00;;G06Q40/00,705/2;;705/4,0,0,,,,DISCONTINUED
855,WO,A2,WO 2005/116894 A2,033-924-156-635-051,2005-12-08,2005,US 2005/0016913 W,2005-05-13,US 11912505 A;;US 57258604 P;;US 60191804 P,2004-05-19,PHARMACY BENEFITS CALCULATOR,"A Pharmacy Benefits Calculator reads in an insured&apos;s prior pharmacy claims history and then calculates said insured&apos;s anticipated out-of-pocket costs for one or more pharmacy benefits plans that said insured is eligible to enroll in. Provision is made for an insured to modify their anticipated future pharmacy needs. Provision is also made for an insured to compare their out-of-pocket costs for different alternative drugs, said alternative drugs providing comparable therapeutic benefits. Provision also is made for an insured to substitute a lower cost generic equivalent for a brand drug, when available. Another provision is made for an insured to choose to price drugs at a retail pharmacy store or a mail order pharmacy and determine cost differences. The pricing available from said retail pharmacy store may be based on a price negotiated by an insurance company offering said pharmacy benefits plans.",HUMANA INC;;AUGSPURGER KRISTEN R;;STEPHENS SARAH A;;KARRER MICHAEL A;;VINSON KENNON L;;FLINCHUM MARK A;;KALLIK INESSA;;ELIZABETH MEGAN K;;WARREN ELIZABETH M;;FLEMING WILLIAM K;;LORD JONATHAN T,AUGSPURGER KRISTEN R;;STEPHENS SARAH A;;KARRER MICHAEL A;;VINSON KENNON L;;FLINCHUM MARK A;;KALLIK INESSA;;ELIZABETH MEGAN K;;WARREN ELIZABETH M;;FLEMING WILLIAM K;;LORD JONATHAN T,,https://lens.org/033-924-156-635-051,Patent Application,yes,0,1,4,22,0,G06Q10/087;;G06Q30/08;;G06Q10/10;;G16H10/60;;G06Q10/087;;G06Q30/08;;G16H10/60;;G06Q10/10,G06F19/00;;G06Q30/00,,0,0,,,,PENDING
856,WO,A3,WO 2005/116894 A3,055-002-052-668-139,2007-02-01,2007,US 2005/0016913 W,2005-05-13,US 11912505 A;;US 57258604 P;;US 60191804 P,2004-05-19,PHARMACY BENEFITS CALCULATOR,"A Pharmacy Benefits Calculator reads in an insured's prior pharmacy claims history and then calculates said insured's anticipated out-of-pocket costs for one or more pharmacy benefits plans that said insured is eligible to enroll in. Provision is made for an insured to modify their anticipated future pharmacy needs. Provision is also made for an insured to compare their out-of-pocket costs for different alternative drugs, said alternative drugs providing comparable therapeutic benefits. Provision also is made for an insured to substitute a lower cost generic equivalent for a brand drug, when available. Another provision is made for an insured to choose to price drugs at a retail pharmacy store or a mail order pharmacy and determine cost differences. The pricing available from said retail pharmacy store may be based on a price negotiated by an insurance company offering said pharmacy benefits plans.",HUMANA INC;;AUGSPURGER KRISTEN R;;STEPHENS SARAH A;;KARRER MICHAEL A;;VINSON KENNON L;;FLINCHUM MARK A;;KALLIK INESSA;;ELIZABETH MEGAN K;;WARREN ELIZABETH M;;FLEMING WILLIAM K;;LORD JONATHAN T,AUGSPURGER KRISTEN R;;STEPHENS SARAH A;;KARRER MICHAEL A;;VINSON KENNON L;;FLINCHUM MARK A;;KALLIK INESSA;;ELIZABETH MEGAN K;;WARREN ELIZABETH M;;FLEMING WILLIAM K;;LORD JONATHAN T,,https://lens.org/055-002-052-668-139,Search Report,yes,4,0,4,22,0,G06Q10/087;;G06Q30/08;;G06Q10/10;;G16H10/60;;G06Q10/087;;G06Q30/08;;G16H10/60;;G06Q10/10,G06F19/00;;G06Q30/00,,0,0,,,,PENDING
857,EP,A2,EP 1759346 A2,052-661-782-513-446,2007-03-07,2007,EP 05749662 A,2005-05-13,US 2005/0016913 W;;US 57258604 P;;US 60191804 P;;US 11912505 A,2004-05-19,PHARMACY BENEFITS CALCULATOR,,HUMANA INC,AUGSPURGER KRISTEN R;;STEPHENS SARAH A;;KARRER MICHAEL A;;VINSON KENNON L;;FLINCHUM MARK A;;KALLIK INESSA;;ELIZABETH MEGAN K;;WARREN ELIZABETH M;;FLEMING WILLIAM K;;LORD JONATHAN T,,https://lens.org/052-661-782-513-446,Patent Application,yes,0,0,4,22,0,G06Q10/087;;G06Q30/08;;G06Q10/10;;G16H10/60;;G06Q10/087;;G06Q30/08;;G16H10/60;;G06Q10/10,G06F19/00;;G06Q30/00,,0,0,,,,DISCONTINUED
858,US,A1,US 2007/0286994 A1,001-767-527-670-319,2007-12-13,2007,US 42705506 A,2006-06-28,US 42705506 A;;US 42378106 A,2006-06-13,DURABLE ANTIREFLECTIVE FILM,"Antireflective films are described having a surface layer comprising a the reaction product of a polymerizable low refractive index composition comprising at least one fluorinated free-radically polymerizable material and surface modified inorganic nanoparticles. A high refractive index layer is coupled to the low refractive index layer. In one emboidiment, the high refractive index layer comprises surface modified inorganic nanoparticles dispersed in a crosslinked organic material. The antireflective film is preferably durable, exhibiting a haze of less than 1.0% after 25 wipes with steel wool using a 3.2 cm mandrel and a mass of 1000 grams.",WALKER CHRISTOPHER B;;RADCLIFFE MARC D;;KLUN THOMAS P;;LIU LAN H;;POKORNY RICHARD J;;COGGIO WILLIAM D;;CAO CHUNTAO;;PELLERITE MARK J;;KELLEY PAUL C;;FLEMING ROBERT J,WALKER CHRISTOPHER B;;RADCLIFFE MARC D;;KLUN THOMAS P;;LIU LAN H;;POKORNY RICHARD J;;COGGIO WILLIAM D;;CAO CHUNTAO;;PELLERITE MARK J;;KELLEY PAUL C;;FLEMING ROBERT J,3M INNOVATIVE PROPERTIES COMPANY (2006-06-29),https://lens.org/001-767-527-670-319,Patent Application,yes,10,46,15,15,0,B32B27/00;;B82Y30/00;;C08L27/00;;G02B1/11;;G02B1/111;;G02B1/111;;Y10T428/24942;;Y10T428/24942;;Y10T428/25;;Y10T428/25;;Y10T428/254;;Y10T428/254;;Y10T428/256;;Y10T428/256;;Y10T428/265;;Y10T428/265;;Y10T428/269;;Y10T428/269;;Y10T428/3154;;Y10T428/3154;;Y10T428/31935;;Y10T428/31935,B32B27/30;;B32B5/16;;B32B27/20,428/212;;428/421;;428/323;;428/339;;428/522;;428/328,0,0,,,,DISCONTINUED
859,US,B2,US 8137801 B2,147-910-073-496-013,2012-03-20,2012,US 30450507 A,2007-06-06,US 42378106 A;;US 42705506 A;;US 2007/0070465 W;;US 30450507 A,2006-06-13,Durable antireflective film,"Antireflective films are described having a surface layer comprising a the reaction product of a polymerizable low refractive index composition comprising at least one fluorinated free-radically polymerizable material and surface modified inorganic nanoparticles. A high refractive index layer is coupled to the low refractive index layer. In one embodiment, the high refractive index layer comprises surface modified inorganic nanoparticles dispersed in a crosslinked organic material. The antireflective film is preferably durable, exhibiting a haze of less than 1.0% after 25 wipes with steel wool using a 3.2 cm mandrel and a mass of 1000 grams.",WALKER JR CHRISTOPHER B;;RADCLIFFE MARC D;;KLUN THOMAS P;;LIU LAN H;;POKORNY RICHARD J;;COGGIO WILLIAM D;;CAO CHUNTAO;;PELLERITE MARK J;;KELLEY PAUL C;;FLEMING ROBERT J;;3M INNOVATIVE PROPERTIES CO,WALKER JR CHRISTOPHER B;;RADCLIFFE MARC D;;KLUN THOMAS P;;LIU LAN H;;POKORNY RICHARD J;;COGGIO WILLIAM D;;CAO CHUNTAO;;PELLERITE MARK J;;KELLEY PAUL C;;FLEMING ROBERT J,3M INNOVATIVE PROPERTIES COMPANY (2008-11-24),https://lens.org/147-910-073-496-013,Granted Patent,yes,28,4,15,15,0,B32B27/00;;B82Y30/00;;C08L27/00;;G02B1/11;;G02B1/111;;G02B1/111;;Y10T428/24942;;Y10T428/24942;;Y10T428/25;;Y10T428/25;;Y10T428/254;;Y10T428/254;;Y10T428/256;;Y10T428/256;;Y10T428/265;;Y10T428/265;;Y10T428/269;;Y10T428/269;;Y10T428/3154;;Y10T428/3154;;Y10T428/31935;;Y10T428/31935,B32B27/36;;B32B5/16,428/323;;359/586;;428/327,2,1,006-978-951-592-550,10.1021/ma00011a061,"Macromolecules 1991, 24, 3434-3442; Properties of Fractal Divinylbenzene Microgels, Antonietti et al.;;Solvay Solexis, Fomblin Z Drivatives Product Data Sheet, (2002) 1 page.",ACTIVE
860,US,A1,US 2013/0088782 A1,037-654-158-321-134,2013-04-11,2013,US 201213690064 A,2012-11-30,US 201213690064 A;;US 201213365313 A;;US 30450508 A;;US 2007/0070465 W;;US 42705506 A;;US 42378106 A,2006-06-13,DURABLE ANTIREFLECTIVE FILM,"Antireflective films are described having a surface layer comprising a the reaction product of a polymerizable low refractive index composition comprising at least one free-radically polymerizable fluoropolymer and surface modified inorganic nanoparticles. A high refractive index layer is coupled to the low refractive index layer. In one embodiment, the high refractive index layer comprises surface modified inorganic nanoparticles dispersed in a crosslinked organic material. The antireflective film is preferably durable, exhibiting a haze of less than 1.0% after 25 wipes with steel wool using a 3.2 cm mandrel and a mass of 1000 grams.",3M INNOVATIVE PROPERTIES CO;;3M INNOVATIVE PROPERTIES CO,WALKER JR CHRISTOPHER B;;RADCLIFFE MARC D;;KLUN THOMAS P;;LIU LAN H;;POKORNY RICHARD J;;COGGIO WILLIAM D;;CAO CHUNTAO;;PELLERITE MARK J;;KELLEY PAUL C;;FLEMING ROBERT J,3M INNOVATIVE PROPERTIES COMPANY (2012-11-08),https://lens.org/037-654-158-321-134,Patent Application,yes,0,1,15,15,0,B32B27/00;;B82Y30/00;;C08L27/00;;G02B1/11;;G02B1/111;;G02B1/111;;Y10T428/24942;;Y10T428/24942;;Y10T428/25;;Y10T428/25;;Y10T428/254;;Y10T428/254;;Y10T428/256;;Y10T428/256;;Y10T428/265;;Y10T428/265;;Y10T428/269;;Y10T428/269;;Y10T428/3154;;Y10T428/3154;;Y10T428/31935;;Y10T428/31935,G02B1/11,359/580,0,0,,,,ACTIVE
861,CN,A,CN 101809465 A,133-346-347-046-296,2010-08-18,2010,CN 200780021922 A,2007-06-06,US 2007/0070465 W;;US 42378106 A;;US 42705506 A,2006-06-13,Durable antireflective film,"Antireflective films are described having a surface layer comprising a the reaction product of a polymerizable low refractive index composition comprising at least one fluorinated free-radically polymerizable material and surface modified inorganic nanoparticles. A high refractive index layer is coupled to the low refractive index layer. In one emboidiment, the high refractive index layer comprises surface modified inorganic nanoparticles dispersed in a crosslinked organic material. The antireflective film is preferably durable, exhibiting a haze of less than 1.0% after 25 wipes with steel wool using a 3.2 cm mandrel and a mass of 1000 grams.",3M INNOVATIVE PROPERTIES CO,WALKER CHRISTOPHER B JR;;RADCLIFFE MARC D;;KLUN THOMAS P;;LIU LAN H;;POKORNY RICHARD J;;COGGIO WILLIAM D;;CHUNTAO CAO;;PELLERITE MARK J;;KELLEY PAUL C;;FLEMING ROBERT J,,https://lens.org/133-346-347-046-296,Patent Application,no,0,14,15,15,0,B32B27/00;;B82Y30/00;;C08L27/00;;G02B1/11;;G02B1/111;;G02B1/111;;Y10T428/24942;;Y10T428/24942;;Y10T428/25;;Y10T428/25;;Y10T428/254;;Y10T428/254;;Y10T428/256;;Y10T428/256;;Y10T428/265;;Y10T428/265;;Y10T428/269;;Y10T428/269;;Y10T428/3154;;Y10T428/3154;;Y10T428/31935;;Y10T428/31935,G02B1/11,,0,0,,,,ACTIVE
862,CN,B,CN 101809465 B,130-216-567-754-265,2013-04-10,2013,CN 200780021922 A,2007-06-06,US 2007/0070465 W;;US 42378106 A;;US 42705506 A,2006-06-13,Durable antireflective film,,3M INNOVATIVE PROPERTIES CO,WALKER CHRISTOPHER B JR;;RADCLIFFE MARC D;;KLUN THOMAS P;;LIU LAN H;;POKORNY RICHARD J;;COGGIO WILLIAM D;;CAO CHUNTAO;;PELLERITE MARK J;;KELLEY PAUL C;;FLEMING ROBERT J,,https://lens.org/130-216-567-754-265,Granted Patent,no,0,0,15,15,0,B32B27/00;;B82Y30/00;;C08L27/00;;G02B1/11;;G02B1/111;;G02B1/111;;Y10T428/24942;;Y10T428/24942;;Y10T428/25;;Y10T428/25;;Y10T428/254;;Y10T428/254;;Y10T428/256;;Y10T428/256;;Y10T428/265;;Y10T428/265;;Y10T428/269;;Y10T428/269;;Y10T428/3154;;Y10T428/3154;;Y10T428/31935;;Y10T428/31935,G02B1/11,,0,0,,,,ACTIVE
863,WO,A3,WO 2007/146686 A3,086-214-180-736-000,2010-05-27,2010,US 2007/0070465 W,2007-06-06,US 42378106 A;;US 42705506 A,2006-06-13,DURABLE ANTIREFLECTIVE FILM WITH SURFACE MODIFIED INORGANIC NANOPARTICLES,"Antireflective films are described having a surface layer (20) comprising the reaction product of a polymerizable low refractive index composition comprising at least one fluorinated free -radically polymerizable material and surface modified inorganic nanoparticles. A high refractive index layer (22) is coupled to the low refractive index layer. The high refractive index (22) layer comprises surface modified inorganic nanoparticles dispersed in a crosslinked organic material. The antireflective film is preferably durable, exhibiting a haze of less than 1.0% after 25 wipes with steel wool using a 3.2 cm mandrel and a mass of 1000 grams.",3M INNOVATIVE PROPERTIES CO;;WALKER CHRISTOPHER B JR;;RADCLIFFE MARC D;;KLUN THOMAS P;;LIU LAN H;;POKORNY RICHARD J;;COGGIO WILLIAM D;;CAO CHUNTAO;;PELLERITE MARK J;;KELLEY PAUL C;;FLEMING ROBERT J,WALKER CHRISTOPHER B JR;;RADCLIFFE MARC D;;KLUN THOMAS P;;LIU LAN H;;POKORNY RICHARD J;;COGGIO WILLIAM D;;CAO CHUNTAO;;PELLERITE MARK J;;KELLEY PAUL C;;FLEMING ROBERT J,,https://lens.org/086-214-180-736-000,Search Report,yes,6,0,15,15,0,B32B27/00;;B82Y30/00;;C08L27/00;;G02B1/11;;G02B1/111;;G02B1/111;;Y10T428/24942;;Y10T428/24942;;Y10T428/25;;Y10T428/25;;Y10T428/254;;Y10T428/254;;Y10T428/256;;Y10T428/256;;Y10T428/265;;Y10T428/265;;Y10T428/269;;Y10T428/269;;Y10T428/3154;;Y10T428/3154;;Y10T428/31935;;Y10T428/31935,G02B1/11,,0,0,,,,PENDING
864,US,A1,US 2010/0232021 A1,106-764-865-366-460,2010-09-16,2010,US 30450507 A,2007-06-06,US 42378106 A;;US 42705506 A;;US 2007/0070465 W;;US 30450507 A,2006-06-13,DURABLE ANTIREFLECTIVE FILM,"Antireflective films are described having a surface layer comprising a the reaction product of a polymerizable low refractive index composition comprising at least one fluorinated free-radically polymerizable material and surface modified inorganic nanoparticles. A high refractive index layer is coupled to the low refractive index layer. In one embodiment, the high refractive index layer comprises surface modified inorganic nanoparticles dispersed in a crosslinked organic material. The antireflective film is preferably durable, exhibiting a haze of less than 1.0% after 25 wipes with steel wool using a 3.2 cm mandrel and a mass of 1000 grams.",WALKER CHRISTOPHER BLAND JR;;RADCLIFFE MARC D;;KLUN THOMAS P;;LIU LAN H;;POKORNY RICHARD J;;COGGIO WILLIAM D;;CAO CHUNTAO;;PELLERITE MARK J;;KELLEY PAUL C;;FLEMING ROBERT J,WALKER CHRISTOPHER BLAND JR;;RADCLIFFE MARC D;;KLUN THOMAS P;;LIU LAN H;;POKORNY RICHARD J;;COGGIO WILLIAM D;;CAO CHUNTAO;;PELLERITE MARK J;;KELLEY PAUL C;;FLEMING ROBERT J,3M INNOVATIVE PROPERTIES COMPANY (2008-11-24),https://lens.org/106-764-865-366-460,Patent Application,yes,3,13,15,15,0,B32B27/00;;B82Y30/00;;C08L27/00;;G02B1/11;;G02B1/111;;G02B1/111;;Y10T428/24942;;Y10T428/24942;;Y10T428/25;;Y10T428/25;;Y10T428/254;;Y10T428/254;;Y10T428/256;;Y10T428/256;;Y10T428/265;;Y10T428/265;;Y10T428/269;;Y10T428/269;;Y10T428/3154;;Y10T428/3154;;Y10T428/31935;;Y10T428/31935,G02B1/11;;B32B5/16;;B32B27/18,359/586;;428/421;;428/336;;428/323;;428/327,0,0,,,,ACTIVE
865,EP,A2,EP 2653020 A2,157-582-144-760-436,2013-10-23,2013,EP 11811212 A,2011-12-09,US 201113314730 A;;US 201061424116 P;;US 2011/0064099 W,2010-12-17,ROLLER SHADE FILLER PANEL,,PANDUIT CORP,ZERNACH GARY L;;PASCARELLA NATHAN W;;WRIGHT DARRON J;;SAMPLES TRAVIS M;;DUKES JOSEPH A;;ACKLIN MARK A;;FLEMING JAMES N;;RAMEY SAMUEL C;;GRACZYK FRANK J;;EATON ALVA B,,https://lens.org/157-582-144-760-436,Patent Application,yes,0,0,12,12,0,H05K7/1488;;H05K7/1489;;H05K7/1488;;E06B9/78,H05K7/14,,0,0,,,,ACTIVE
866,US,B2,US 8343624 B2,074-849-284-412-346,2013-01-01,2013,US 201213365313 A,2012-02-03,US 201213365313 A;;US 30450508 A;;US 2007/0070465 W;;US 42378106 A;;US 42705506 A,2006-06-13,Durable antireflective film,"Antireflective films are described having a surface layer comprising a the reaction product of a polymerizable low refractive index composition comprising at least one free-radically polymerizable fluoropolymer and surface modified inorganic nanoparticles. A high refractive index layer is coupled to the low refractive index layer. In one embodiment, the high refractive index layer comprises surface modified inorganic nanoparticles dispersed in a crosslinked organic material. The antireflective film is preferably durable, exhibiting a haze of less than 1.0% after 25 wipes with steel wool using a 3.2 cm mandrel and a mass of 1000 grams.",3M INNOVATIVE PROPERTIES CO;;WALKER JR CHRISTOPHER B;;RADCLIFFE MARC D;;KLUN THOMAS P;;LIU LAN H;;POKORNY RICHARD J;;COGGIO WILLIAM D;;CAO CHUNTAO;;PELLERITE MARK J;;KELLEY PAUL C;;FLEMING ROBERT J,WALKER JR CHRISTOPHER B;;RADCLIFFE MARC D;;KLUN THOMAS P;;LIU LAN H;;POKORNY RICHARD J;;COGGIO WILLIAM D;;CAO CHUNTAO;;PELLERITE MARK J;;KELLEY PAUL C;;FLEMING ROBERT J,,https://lens.org/074-849-284-412-346,Granted Patent,yes,31,4,2,2,0,G02B1/111;;G02B1/111;;Y10T428/24942;;Y10T428/24942;;Y10T428/25;;Y10T428/25;;Y10T428/254;;Y10T428/254,B32B27/36;;B32B5/16,428/323;;428/212;;428/327;;359/586;;977/773;;977/902,2,1,006-978-951-592-550,10.1021/ma00011a061,"Macromolecules 1991, 24, 3434-3442; Properties of Fractal Divinylbenzene Microgels, Antonietti et al.;;Solvay Solexis, Fomblin Z Drivatives Product Data Sheet, (2002) 1 page.",ACTIVE
867,TW,B,TW I393632 B,096-838-145-506-822,2013-04-21,2013,TW 96121171 A,2007-06-12,US 42378106 A;;US 42705506 A,2006-06-13,Durable antireflective film,,3M INNOVATIVE PROPERTIES CO,WALKER CHRISTOPHER BLAND JR;;COGGIO WILLIAM DOMENIC;;RADCLIFFE MARC DUDLEY;;CAO CHUNTAO;;KLUN THOMAS PAUL;;PELLERITE MARK JAMES;;LIU LAN HONG;;KELLEY PAUL CLAIRE;;POKORNY RICHARD JOHN;;FLEMING ROBERT JAMES,,https://lens.org/096-838-145-506-822,Granted Patent,no,2,0,15,15,0,B32B27/00;;B82Y30/00;;C08L27/00;;G02B1/11;;G02B1/111;;G02B1/111;;Y10T428/24942;;Y10T428/24942;;Y10T428/25;;Y10T428/25;;Y10T428/254;;Y10T428/254;;Y10T428/256;;Y10T428/256;;Y10T428/265;;Y10T428/265;;Y10T428/269;;Y10T428/269;;Y10T428/3154;;Y10T428/3154;;Y10T428/31935;;Y10T428/31935,,,0,0,,,,INACTIVE
868,EP,A2,EP 2033020 A2,196-729-654-911-60X,2009-03-11,2009,EP 07798145 A,2007-06-06,US 2007/0070465 W;;US 42378106 A;;US 42705506 A,2006-06-13,DURABLE ANTIREFLECTIVE FILM WITH SURFACE MODIFIED INORGANIC NANOPARTICLES,,3M INNOVATIVE PROPERTIES CO,WALKER CHRISTOPHER B JR;;RADCLIFFE MARC D;;KLUN THOMAS P;;LIU LAN H;;POKORNY RICHARD J;;COGGIO WILLIAM D;;CAO CHUNTAO;;PELLERITE MARK J;;KELLEY PAUL C;;FLEMING ROBERT J,,https://lens.org/196-729-654-911-60X,Patent Application,yes,0,0,15,15,0,B32B27/00;;B82Y30/00;;C08L27/00;;G02B1/11;;G02B1/111;;G02B1/111;;Y10T428/24942;;Y10T428/24942;;Y10T428/25;;Y10T428/25;;Y10T428/254;;Y10T428/254;;Y10T428/256;;Y10T428/256;;Y10T428/265;;Y10T428/265;;Y10T428/269;;Y10T428/269;;Y10T428/3154;;Y10T428/3154;;Y10T428/31935;;Y10T428/31935,G02B1/11,,1,0,,,See references of WO 2007146686A3,DISCONTINUED
869,US,B2,US 9574398 B2,006-987-483-200-02X,2017-02-21,2017,US 201414567171 A,2014-12-11,US 201414567171 A;;US 201113314730 A;;US 201061424116 P,2010-12-17,Roller shade filler panel,"Certain embodiments of the present invention provide an apparatus for closing off an opening above, below, or between electronic equipment in a rack. The rack includes a pair of equipment rails. The electronic equipment is mounted to the equipment rails. The apparatus includes a base, a roller shade, and a handle. The roller shade is rotatably connected to the base and includes a free end extending from the base when the roller shade is rotated. The handle is connected to the free end of the roller shade. The base is removably connected to the equipment rails at a first position. The handle is removably connected to the equipment rails at a second position spaced apart from the first position such that the free end of the roller shade is extended to close off the opening in the rack.",PANDUIT CORP,ZERNACH GARY L;;PASCARELLA NATHAN W;;WRIGHT DARRON J;;SAMPLES TRAVIS M;;DUKES JOSEPH ALLEN;;ACKLIN MARK A;;FLEMING JAMES N;;RAMEY SAMUEL C;;GRACZYK FRANK J;;EATON ALVA B,,https://lens.org/006-987-483-200-02X,Granted Patent,yes,81,2,12,12,0,H05K7/1488;;H05K7/1489;;H05K7/1488;;E06B9/78,E06B9/00;;E06B9/78;;H05K7/14,,3,0,,,"42U Hot/Cold Aisle Containment Curtains, webpages, http://www.42u.com/colling/hot-aisle-containment/aisle-containment-curtains.htm; undated, 3 pages.;;SharkRack, Inc. Tool-less Filler Panel Pack, 1U X 5, webpage, 2009, 1 page.;;Plenafill® 27U Scalable Blanking Panel, webpages, http://www.plenaform.com/PlenaFill.htm, Sep. 9, 2008, 2 pages.",ACTIVE
870,WO,A2,WO 2007/146686 A2,053-713-180-772-107,2007-12-21,2007,US 2007/0070465 W,2007-06-06,US 42378106 A;;US 42705506 A,2006-06-13,DURABLE ANTIREFLECTIVE FILM,"Antireflective films are described having a surface layer comprising a the reaction product of a polymerizable low refractive index composition comprising at least one fluorinated free-radically polymerizable material and surface modified inorganic nanoparticles. A high refractive index layer is coupled to the low refractive index layer. In one emboidiment, the high refractive index layer comprises surface modified inorganic nanoparticles dispersed in a crosslinked organic material. The antireflective film is preferably durable, exhibiting a haze of less than 1.0% after 25 wipes with steel wool using a 3.2 cm mandrel and a mass of 1000 grams.",3M INNOVATIVE PROPERTIES CO;;WALKER CHRISTOPHER B JR;;RADCLIFFE MARC D;;KLUN THOMAS P;;LIU LAN H;;POKORNY RICHARD J;;COGGIO WILLIAM D;;CAO CHUNTAO;;PELLERITE MARK J;;KELLEY PAUL C;;FLEMING ROBERT J,WALKER CHRISTOPHER B JR;;RADCLIFFE MARC D;;KLUN THOMAS P;;LIU LAN H;;POKORNY RICHARD J;;COGGIO WILLIAM D;;CAO CHUNTAO;;PELLERITE MARK J;;KELLEY PAUL C;;FLEMING ROBERT J,,https://lens.org/053-713-180-772-107,Patent Application,yes,0,3,15,15,0,B32B27/00;;B82Y30/00;;C08L27/00;;G02B1/11;;G02B1/111;;G02B1/111;;Y10T428/24942;;Y10T428/24942;;Y10T428/25;;Y10T428/25;;Y10T428/254;;Y10T428/254;;Y10T428/256;;Y10T428/256;;Y10T428/265;;Y10T428/265;;Y10T428/269;;Y10T428/269;;Y10T428/3154;;Y10T428/3154;;Y10T428/31935;;Y10T428/31935,G02B1/11,,0,0,,,,PENDING
871,EP,B1,EP 2653020 B1,140-368-516-376-490,2018-07-11,2018,EP 11811212 A,2011-12-09,US 201113314730 A;;US 201061424116 P;;US 2011/0064099 W,2010-12-17,ROLLER SHADE FILLER PANEL,,PANDUIT CORP,ZERNACH GARY L;;PASCARELLA NATHAN W;;WRIGHT DARRON J;;SAMPLES TRAVIS M;;DUKES JOSEPH A;;ACKLIN MARK A;;FLEMING JAMES N;;RAMEY SAMUEL C;;GRACZYK FRANK J;;EATON ALVA B,,https://lens.org/140-368-516-376-490,Granted Patent,yes,4,0,12,12,0,H05K7/1488;;H05K7/1489;;H05K7/1488;;E06B9/78,H05K7/14,,0,0,,,,ACTIVE
872,KR,A,KR 20090018951 A,023-803-307-531-759,2009-02-24,2009,KR 20087030336 A,2007-06-06,US 42378106 A;;US 42705506 A;;US 2007/0070465 W,2006-06-13,DURABLE ANTIREFLECTIVE FILM,"Antireflective films are described having a surface layer comprising the reaction product of a polymerizable low refractive index composition comprising at least one fluorinated free-radically polymerizable material and surface modified inorganic nanoparticles. A high refractive index layer is coupled to the low refractive index layer. In one emboidiment, the high refractive index layer comprises surface modified inorganic nanoparticles dispersed in a crosslinked organic material. The antireflective film is preferably durable, exhibiting a haze of less than 1.0% after 25 wipes with steel wool using a 3.2 cm mandrel and a mass of 1000 grams.",3M INNOVATIVE PROPERTIES CO,WALKER CHRISTOPHER B JR;;RADCLIFFE MARC D;;KLUN THOMAS P;;LIU LAN H;;POKORNY RICHARD J;;COGGIO WILLIAM D;;CAO CHUNTAO;;PELLERITE MARK J;;KELLEY PAUL C;;FLEMING ROBERT J,,https://lens.org/023-803-307-531-759,Patent Application,no,0,1,15,15,0,B32B27/00;;B82Y30/00;;C08L27/00;;G02B1/11;;G02B1/111;;G02B1/111;;Y10T428/24942;;Y10T428/24942;;Y10T428/25;;Y10T428/25;;Y10T428/254;;Y10T428/254;;Y10T428/256;;Y10T428/256;;Y10T428/265;;Y10T428/265;;Y10T428/269;;Y10T428/269;;Y10T428/3154;;Y10T428/3154;;Y10T428/31935;;Y10T428/31935,G02B1/11;;B32B27/00;;C08K3/00;;C08L27/00,,0,0,,,,ACTIVE
873,US,A1,US 2012/0135210 A1,035-094-107-352-373,2012-05-31,2012,US 201213365313 A,2012-02-03,US 201213365313 A;;US 30450508 A;;US 2007/0070465 W;;US 42378106 A;;US 42705506 A,2006-06-13,DURABLE ANTIREFLECTIVE FILM,"Antireflective films are described having a surface layer comprising a the reaction product of a polymerizable low refractive index composition comprising at least one free-radically polymerizable fluoropolymer and surface modified inorganic nanoparticles. A high refractive index layer is coupled to the low refractive index layer. In one embodiment, the high refractive index layer comprises surface modified inorganic nanoparticles dispersed in a crosslinked organic material. The antireflective film is preferably durable, exhibiting a haze of less than 1.0% after 25 wipes with steel wool using a 3.2 cm mandrel and a mass of 1000 grams.",WALKER JR CHRISTOPHER B;;RADCLIFFE MARC D;;KLUN THOMAS P;;LIU LAN H;;POKORNY RICHARD J;;COGGIO WILLIAM D;;CAO CHUNTAO;;PELLERITE MARK J;;KELLEY PAUL C;;FLEMING ROBERT J;;3M INNOVATIVE PROPERTIES CO,WALKER JR CHRISTOPHER B;;RADCLIFFE MARC D;;KLUN THOMAS P;;LIU LAN H;;POKORNY RICHARD J;;COGGIO WILLIAM D;;CAO CHUNTAO;;PELLERITE MARK J;;KELLEY PAUL C;;FLEMING ROBERT J,,https://lens.org/035-094-107-352-373,Patent Application,yes,0,14,2,2,0,G02B1/111;;G02B1/111;;Y10T428/24942;;Y10T428/24942;;Y10T428/25;;Y10T428/25;;Y10T428/254;;Y10T428/254,B32B27/18;;B32B7/02;;B82Y20/00;;B82Y30/00,428/212;;977/773;;977/902,0,0,,,,ACTIVE
874,US,B2,US 8470439 B2,143-893-750-918-651,2013-06-25,2013,US 201213690064 A,2012-11-30,US 201213690064 A;;US 201213365313 A;;US 30450508 A;;US 2007/0070465 W;;US 42705506 A;;US 42378106 A,2006-06-13,Durable antireflective film,"Antireflective films are described having a surface layer comprising a the reaction product of a polymerizable low refractive index composition comprising at least one free-radically polymerizable fluoropolymer and surface modified inorganic nanoparticles. A high refractive index layer is coupled to the low refractive index layer. In one embodiment, the high refractive index layer comprises surface modified inorganic nanoparticles dispersed in a crosslinked organic material. The antireflective film is preferably durable, exhibiting a haze of less than 1.0% after 25 wipes with steel wool using a 3.2 cm mandrel and a mass of 1000 grams.",3M INNOVATIVE PROPERTIES CO,WALKER JR CHRISTOPHER B;;RADCLIFFE MARC D;;KLUN THOMAS P;;LIU LAN H;;POKORNY RICHARD J;;COGGIO WILLIAM D;;CAO CHUNTAO;;PELLERITE MARK J;;KELLEY PAUL C;;FLEMING ROBERT J,3M INNOVATIVE PROPERTIES COMPANY (2012-11-08),https://lens.org/143-893-750-918-651,Granted Patent,yes,35,4,15,15,0,B32B27/00;;B82Y30/00;;C08L27/00;;G02B1/11;;G02B1/111;;G02B1/111;;Y10T428/24942;;Y10T428/24942;;Y10T428/25;;Y10T428/25;;Y10T428/254;;Y10T428/254;;Y10T428/256;;Y10T428/256;;Y10T428/265;;Y10T428/265;;Y10T428/269;;Y10T428/269;;Y10T428/3154;;Y10T428/3154;;Y10T428/31935;;Y10T428/31935,B32B27/36;;B32B27/06,428/323;;359/586;;428/212;;977/773;;977/902,3,1,006-978-951-592-550,10.1021/ma00011a061,"Macromolecules 1991, 24, 3434-3442; Properties of Fractal Divinylbenzene Microgels, Antonietti et al.;;Solvay Solexis, Fomblin Z Drivatives Product Data Sheet, (2002) 1 page.;;Search Report for Patnt Application, ROC (Taiwan) Patent Application No. 096121171, Dec. 4, 2012, 1 page.",ACTIVE
875,TW,A,TW 200808541 A,113-047-473-762-132,2008-02-16,2008,TW 96121171 A,2007-06-12,US 42378106 A;;US 42705506 A,2006-06-13,Durable antireflective film,"Antireflective films are described having a surface layer comprising the reaction product of a polymerizable low refractive index composition comprising at least one fluorinated free-radically polymerizable material and surface modified inorganic nanoparticles. A high refractive index layer is coupled to the low refractive index layer. In one emboidiment, the high refractive index layer comprises surface modified inorganic nanoparticles dispersed in a crosslinked organic material. The antirefiective film is preferably durable, exhibiting a haze of less than 1.0% after 25 wipes with steel wool using a 3.2 cm mandrel and a mass of 1000 grams.",3M INNOVATIVE PROPERTIES CO,WALKER CHRISTOPHER BLAND JR;;COGGIO WILLIAM DOMENIC;;RADCLIFFE MARC DUDLEY;;CAO CHUN-TAO;;KLUN THOMAS PAUL;;PELLERITE MARK JAMES;;LIU LAN HONG;;KELLEY PAUL CLAIRE;;POKORNY RICHARD JOHN;;FLEMING ROBERT JAMES,,https://lens.org/113-047-473-762-132,Patent of Addition,no,0,3,15,15,0,B32B27/00;;B82Y30/00;;C08L27/00;;G02B1/11;;G02B1/111;;G02B1/111;;Y10T428/24942;;Y10T428/24942;;Y10T428/25;;Y10T428/25;;Y10T428/254;;Y10T428/254;;Y10T428/256;;Y10T428/256;;Y10T428/265;;Y10T428/265;;Y10T428/269;;Y10T428/269;;Y10T428/3154;;Y10T428/3154;;Y10T428/31935;;Y10T428/31935,B32B27/08;;C08K3/22;;C08L27/12;;C08L33/16;;G02B1/11,,0,0,,,,INACTIVE
876,US,A1,US 2023/0157836 A1,154-269-529-715-812,2023-05-25,2023,US 202318158533 A,2023-01-24,US 202318158533 A;;US 201916660174 A;;US 201615264677 A;;US 201313941095 A;;US 201213483852 A,2012-05-30,EXPANDABLE INTERBODY SPACER,"Devices and methods for treating one or more damaged, diseased, or traumatized portions of the spine, including intervertebral discs, to reduce or eliminate associated back pain. In one or more embodiments, the present invention relates to an expandable interbody spacer. The expandable interbody spacer may comprise a first jointed arm comprising a plurality of links pivotally coupled end to end. The expandable interbody spacer further may comprise a second jointed arm comprising a plurality of links pivotally coupled end to end. The first jointed arm and the second jointed arm may be interconnected at a proximal end of the expandable interbody spacer. The first jointed arm and the second jointed arm may be interconnected at a distal end of the expandable interbody spacer.",GLOBUS MEDICAL INC,PERLOFF JONATHAN;;RHODA WILLIAM;;WEIMAN MARK;;GLERUM CHAD;;DWYER EDWARD;;ALEXANDER VICTORIA;;GARVEY BRIAN;;WAITE DANIEL;;FLEMING CONOR;;PETERSHEIM SAMUEL;;HOWELL BRIA;;NIEMIEC MARCIN;;KUNJACHAN VIPIN;;GRAY JASON;;SAVILLE CHRISTOPHER;;HIMMELBERGER JAMES;;GAHMAN KEVIN,GLOBUS MEDICAL INC (2010-06-21),https://lens.org/154-269-529-715-812,Patent Application,yes,0,0,17,17,0,A61F2/447;;A61F2/4611;;A61F2002/30405;;A61F2002/30471;;A61F2002/30492;;A61F2002/30545;;A61F2002/3055;;A61F2002/30772;;A61F2002/30904;;A61F2002/4627;;A61F2310/00017;;A61F2310/00023;;A61F2310/00179;;A61F2002/30484;;A61F2002/4415;;A61B17/7097;;A61F2/44;;A61F2002/2835;;A61F2002/30143;;A61F2002/30156;;A61F2002/30159;;A61F2002/30166;;A61F2002/30176;;A61F2002/30189;;A61F2002/30266;;A61F2002/30364;;A61F2002/30365;;A61F2002/3037;;A61F2002/30462;;A61F2002/305;;A61F2002/30515;;A61F2002/30518;;A61F2002/30525;;A61F2002/30579;;A61F2002/30581;;A61F2002/30588;;A61F2002/30836;;A61F2002/30892;;A61F2002/4677;;A61F2/4455;;A61F2002/30433;;A61F2002/30507;;A61F2002/3054;;A61F2002/30624;;A61F2002/30593;;A61F2/447;;A61F2/4611;;A61F2002/30405;;A61F2002/30471;;A61F2002/30492;;A61F2002/30545;;A61F2002/3055;;A61F2002/30772;;A61F2002/30904;;A61F2002/4627;;A61F2310/00017;;A61F2310/00023;;A61F2310/00179;;A61F2002/30484;;A61F2002/4415;;A61B17/7097;;A61F2/44;;A61F2002/2835;;A61F2002/30143;;A61F2002/30156;;A61F2002/30159;;A61F2002/30166;;A61F2002/30176;;A61F2002/30189;;A61F2002/30266;;A61F2002/30364;;A61F2002/30365;;A61F2002/3037;;A61F2002/30462;;A61F2002/305;;A61F2002/30515;;A61F2002/30518;;A61F2002/30525;;A61F2002/30579;;A61F2002/30581;;A61F2002/30588;;A61F2002/30836;;A61F2002/30892;;A61F2002/4677;;A61F2002/3054;;A61F2002/30433;;A61F2002/30507;;A61F2002/30593;;A61F2002/30624;;A61F2/4455;;A61F2/442;;A61F2/4425;;A61F2002/30108,A61F2/44;;A61B17/70;;A61F2/46,,0,0,,,,PENDING
877,US,A1,US 2014/0052253 A1,090-930-688-643-878,2014-02-20,2014,US 201313941095 A,2013-07-12,US 201313941095 A;;US 201213483852 A,2012-05-30,Expandable Interbody Spacer,"The present invention relates to devices and methods for treating one or more damaged, diseased, or traumatized portions of the spine, including intervertebral discs, to reduce or eliminate associated back pain. In one or more embodiments, the present invention relates to an expandable interbody spacer. The expandable interbody spacer may comprise a first jointed arm comprising a plurality of links pivotally coupled end to end. The expandable interbody spacer further may comprise a second jointed arm comprising a plurality of links pivotally coupled end to end. The first jointed arm and the second jointed arm may be interconnected at a proximal end of the expandable interbody spacer. The first jointed arm and the second jointed arm may be interconnected at a distal end of the expandable interbody spacer.",PERLOFF JONATHAN;;RHODA WILLIAM;;WEIMAN MARK;;GLERUM CHAD;;DWYER EDWARD;;ALEXANDER VICTORIA;;GARVEY BRIAN;;WAITE DAN;;FLEMING CONOR;;PETERSHEIM SAM;;HOWELL BRIA;;NIEMIEC MARCIN;;KUNJACHAN VIPIN;;GRAY JASON;;SAVILLE CHRISTOPHER;;HIMMELBERGER JAMES;;GAHMAN KEVIN,PERLOFF JONATHAN;;RHODA WILLIAM;;WEIMAN MARK;;GLERUM CHAD;;DWYER EDWARD;;ALEXANDER VICTORIA;;GARVEY BRIAN;;WAITE DAN;;FLEMING CONOR;;PETERSHEIM SAM;;HOWELL BRIA;;NIEMIEC MARCIN;;KUNJACHAN VIPIN;;GRAY JASON;;SAVILLE CHRISTOPHER;;HIMMELBERGER JAMES;;GAHMAN KEVIN,GLOBUS MEDICAL INC (2010-06-21),https://lens.org/090-930-688-643-878,Patent Application,yes,8,33,17,17,0,A61F2/447;;A61F2/4611;;A61F2002/30405;;A61F2002/30471;;A61F2002/30492;;A61F2002/30545;;A61F2002/3055;;A61F2002/30772;;A61F2002/30904;;A61F2002/4627;;A61F2310/00017;;A61F2310/00023;;A61F2310/00179;;A61F2002/30484;;A61F2002/4415;;A61B17/7097;;A61F2/44;;A61F2002/2835;;A61F2002/30143;;A61F2002/30156;;A61F2002/30159;;A61F2002/30166;;A61F2002/30176;;A61F2002/30189;;A61F2002/30266;;A61F2002/30364;;A61F2002/30365;;A61F2002/3037;;A61F2002/30462;;A61F2002/305;;A61F2002/30515;;A61F2002/30518;;A61F2002/30525;;A61F2002/30579;;A61F2002/30581;;A61F2002/30588;;A61F2002/30836;;A61F2002/30892;;A61F2002/4677;;A61F2/4455;;A61F2002/30433;;A61F2002/30507;;A61F2002/3054;;A61F2002/30624;;A61F2002/30593;;A61F2/447;;A61F2/4611;;A61F2002/30405;;A61F2002/30471;;A61F2002/30492;;A61F2002/30545;;A61F2002/3055;;A61F2002/30772;;A61F2002/30904;;A61F2002/4627;;A61F2310/00017;;A61F2310/00023;;A61F2310/00179;;A61F2002/30484;;A61F2002/4415;;A61B17/7097;;A61F2/44;;A61F2002/2835;;A61F2002/30143;;A61F2002/30156;;A61F2002/30159;;A61F2002/30166;;A61F2002/30176;;A61F2002/30189;;A61F2002/30266;;A61F2002/30364;;A61F2002/30365;;A61F2002/3037;;A61F2002/30462;;A61F2002/305;;A61F2002/30515;;A61F2002/30518;;A61F2002/30525;;A61F2002/30579;;A61F2002/30581;;A61F2002/30588;;A61F2002/30836;;A61F2002/30892;;A61F2002/4677;;A61F2002/3054;;A61F2002/30433;;A61F2002/30507;;A61F2002/30593;;A61F2002/30624;;A61F2/4455;;A61F2/442;;A61F2/4425;;A61F2002/30108,A61F2/44,623/17.15,0,0,,,,ACTIVE
878,US,B2,US 11583409 B2,085-392-791-569-913,2023-02-21,2023,US 201916660174 A,2019-10-22,US 201916660174 A;;US 201615264677 A;;US 201313941095 A;;US 201213483852 A,2012-05-30,Expandable interbody spacer,"Devices and methods for treating one or more damaged, diseased, or traumatized portions of the spine, including intervertebral discs, to reduce or eliminate associated back pain. In one or more embodiments, the present invention relates to an expandable interbody spacer. The expandable interbody spacer may comprise a first jointed arm comprising a plurality of links pivotally coupled end to end. The expandable interbody spacer further may comprise a second jointed arm comprising a plurality of links pivotally coupled end to end. The first jointed arm and the second jointed arm may be interconnected at a proximal end of the expandable interbody spacer. The first jointed arm and the second jointed arm may be interconnected at a distal end of the expandable interbody spacer.",GLOBUS MEDICAL INC,PERLOFF JONATHAN;;RHODA WILLIAM;;WEIMAN MARK;;GLERUM CHAD;;DWYER EDWARD;;ALEXANDER VICTORIA;;GARVEY BRIAN;;WAITE DANIEL;;FLEMING CONOR;;PETERSHEIM SAMUEL;;HOWELL BRIA;;NIEMIEC MARCIN;;KUNJACHAN VIPIN;;GRAY JASON;;SAVILLE CHRISTOPHER;;HIMMELBERGER JAMES;;GAHMAN KEVIN,GLOBUS MEDICAL INC (2010-06-21),https://lens.org/085-392-791-569-913,Granted Patent,yes,10,0,17,17,0,A61F2/447;;A61F2/4611;;A61F2002/30405;;A61F2002/30471;;A61F2002/30492;;A61F2002/30545;;A61F2002/3055;;A61F2002/30772;;A61F2002/30904;;A61F2002/4627;;A61F2310/00017;;A61F2310/00023;;A61F2310/00179;;A61F2002/30484;;A61F2002/4415;;A61B17/7097;;A61F2/44;;A61F2002/2835;;A61F2002/30143;;A61F2002/30156;;A61F2002/30159;;A61F2002/30166;;A61F2002/30176;;A61F2002/30189;;A61F2002/30266;;A61F2002/30364;;A61F2002/30365;;A61F2002/3037;;A61F2002/30462;;A61F2002/305;;A61F2002/30515;;A61F2002/30518;;A61F2002/30525;;A61F2002/30579;;A61F2002/30581;;A61F2002/30588;;A61F2002/30836;;A61F2002/30892;;A61F2002/4677;;A61F2/4455;;A61F2002/30433;;A61F2002/30507;;A61F2002/3054;;A61F2002/30624;;A61F2002/30593;;A61F2/447;;A61F2/4611;;A61F2002/30405;;A61F2002/30471;;A61F2002/30492;;A61F2002/30545;;A61F2002/3055;;A61F2002/30772;;A61F2002/30904;;A61F2002/4627;;A61F2310/00017;;A61F2310/00023;;A61F2310/00179;;A61F2002/30484;;A61F2002/4415;;A61B17/7097;;A61F2/44;;A61F2002/2835;;A61F2002/30143;;A61F2002/30156;;A61F2002/30159;;A61F2002/30166;;A61F2002/30176;;A61F2002/30189;;A61F2002/30266;;A61F2002/30364;;A61F2002/30365;;A61F2002/3037;;A61F2002/30462;;A61F2002/305;;A61F2002/30515;;A61F2002/30518;;A61F2002/30525;;A61F2002/30579;;A61F2002/30581;;A61F2002/30588;;A61F2002/30836;;A61F2002/30892;;A61F2002/4677;;A61F2002/3054;;A61F2002/30433;;A61F2002/30507;;A61F2002/30593;;A61F2002/30624;;A61F2/4455;;A61F2/442;;A61F2/4425;;A61F2002/30108,A61F2/44;;A61B17/70;;A61F2/28;;A61F2/30;;A61F2/46,,0,0,,,,ACTIVE
879,US,B2,US 9480573 B2,159-818-814-193-874,2016-11-01,2016,US 201313941095 A,2013-07-12,US 201313941095 A;;US 201213483852 A,2012-05-30,Expandable interbody spacer,"The present invention relates to devices and methods for treating one or more damaged, diseased, or traumatized portions of the spine, including intervertebral discs, to reduce or eliminate associated back pain. In one or more embodiments, the present invention relates to an expandable interbody spacer. The expandable interbody spacer may comprise a first jointed arm comprising a plurality of links pivotally coupled end to end. The expandable interbody spacer further may comprise a second jointed arm comprising a plurality of links pivotally coupled end to end. The first jointed arm and the second jointed arm may be interconnected at a proximal end of the expandable interbody spacer. The first jointed arm and the second jointed arm may be interconnected at a distal end of the expandable interbody spacer.",GLOBUS MEDICAL INC,PERLOFF JONATHAN;;RHODA WILLIAM;;WEIMAN MARK;;GLERUM CHAD;;DWYER EDWARD;;ALEXANDER VICTORIA;;GARVEY BRIAN;;WAITE DANIEL;;FLEMING CONOR;;PETERSHEIM SAMUEL;;HOWELL BRIA;;NIEMIEC MARCIN;;KUNJACHAN VIPIN;;GRAY JASON;;SAVILLE CHRISTOPHER;;HIMMELBERGER JAMES;;GAHMAN KEVIN,GLOBUS MEDICAL INC (2010-06-21),https://lens.org/159-818-814-193-874,Granted Patent,yes,65,24,17,17,0,A61F2/447;;A61F2/4611;;A61F2002/30405;;A61F2002/30471;;A61F2002/30492;;A61F2002/30545;;A61F2002/3055;;A61F2002/30772;;A61F2002/30904;;A61F2002/4627;;A61F2310/00017;;A61F2310/00023;;A61F2310/00179;;A61F2002/30484;;A61F2002/4415;;A61B17/7097;;A61F2/44;;A61F2002/2835;;A61F2002/30143;;A61F2002/30156;;A61F2002/30159;;A61F2002/30166;;A61F2002/30176;;A61F2002/30189;;A61F2002/30266;;A61F2002/30364;;A61F2002/30365;;A61F2002/3037;;A61F2002/30462;;A61F2002/305;;A61F2002/30515;;A61F2002/30518;;A61F2002/30525;;A61F2002/30579;;A61F2002/30581;;A61F2002/30588;;A61F2002/30836;;A61F2002/30892;;A61F2002/4677;;A61F2/4455;;A61F2002/30433;;A61F2002/30507;;A61F2002/3054;;A61F2002/30624;;A61F2002/30593;;A61F2/447;;A61F2/4611;;A61F2002/30405;;A61F2002/30471;;A61F2002/30492;;A61F2002/30545;;A61F2002/3055;;A61F2002/30772;;A61F2002/30904;;A61F2002/4627;;A61F2310/00017;;A61F2310/00023;;A61F2310/00179;;A61F2002/30484;;A61F2002/4415;;A61B17/7097;;A61F2/44;;A61F2002/2835;;A61F2002/30143;;A61F2002/30156;;A61F2002/30159;;A61F2002/30166;;A61F2002/30176;;A61F2002/30189;;A61F2002/30266;;A61F2002/30364;;A61F2002/30365;;A61F2002/3037;;A61F2002/30462;;A61F2002/305;;A61F2002/30515;;A61F2002/30518;;A61F2002/30525;;A61F2002/30579;;A61F2002/30581;;A61F2002/30588;;A61F2002/30836;;A61F2002/30892;;A61F2002/4677;;A61F2002/3054;;A61F2002/30433;;A61F2002/30507;;A61F2002/30593;;A61F2002/30624;;A61F2/4455;;A61F2/442;;A61F2/4425;;A61F2002/30108,A61F2/44;;A61B17/70;;A61F2/28;;A61F2/30;;A61F2/46,,1,0,,,"International Search Report and Written Opinion of the International Searching Authority for PCT/US2013/043466 dated Aug. 23, 2013.",ACTIVE
880,US,B2,US 10485674 B2,199-163-713-877-085,2019-11-26,2019,US 201615264677 A,2016-09-14,US 201615264677 A;;US 201313941095 A;;US 201213483852 A,2012-05-30,Expandable interbody spacer,"Devices and methods for treating one or more damaged, diseased, or traumatized portions of the spine, including intervertebral discs, to reduce or eliminate associated back pain. In one or more embodiments, the present invention relates to an expandable interbody spacer. The expandable interbody spacer may comprise a first jointed arm comprising a plurality of links pivotally coupled end to end. The expandable interbody spacer further may comprise a second jointed arm comprising a plurality of links pivotally coupled end to end. The first jointed arm and the second jointed arm may be interconnected at a proximal end of the expandable interbody spacer. The first jointed arm and the second jointed arm may be interconnected at a distal end of the expandable interbody spacer.",GLOBUS MEDICAL INC,PERLOFF JONATHAN;;RHODA WILLIAM;;WEIMAN MARK;;GLERUM CHAD;;DWYER EDWARD;;ALEXANDER VICTORIA;;GARVEY BRIAN;;WAITE DANIEL;;FLEMING CONOR;;PETERSHEIM SAMUEL;;HOWELL BRIA;;NIEMIEC MARCIN;;KUNJACHAN VIPIN;;GRAY JASON;;SAVILLE CHRISTOPHER;;HIMMELBERGER JAMES;;GAHMAN KEVIN,GLOBUS MEDICAL INC (2010-06-21),https://lens.org/199-163-713-877-085,Granted Patent,yes,10,1,17,17,0,A61F2/447;;A61F2/4611;;A61F2002/30405;;A61F2002/30471;;A61F2002/30492;;A61F2002/30545;;A61F2002/3055;;A61F2002/30772;;A61F2002/30904;;A61F2002/4627;;A61F2310/00017;;A61F2310/00023;;A61F2310/00179;;A61F2002/30484;;A61F2002/4415;;A61B17/7097;;A61F2/44;;A61F2002/2835;;A61F2002/30143;;A61F2002/30156;;A61F2002/30159;;A61F2002/30166;;A61F2002/30176;;A61F2002/30189;;A61F2002/30266;;A61F2002/30364;;A61F2002/30365;;A61F2002/3037;;A61F2002/30462;;A61F2002/305;;A61F2002/30515;;A61F2002/30518;;A61F2002/30525;;A61F2002/30579;;A61F2002/30581;;A61F2002/30588;;A61F2002/30836;;A61F2002/30892;;A61F2002/4677;;A61F2/4455;;A61F2002/30433;;A61F2002/30507;;A61F2002/3054;;A61F2002/30624;;A61F2002/30593;;A61F2/447;;A61F2/4611;;A61F2002/30405;;A61F2002/30471;;A61F2002/30492;;A61F2002/30545;;A61F2002/3055;;A61F2002/30772;;A61F2002/30904;;A61F2002/4627;;A61F2310/00017;;A61F2310/00023;;A61F2310/00179;;A61F2002/30484;;A61F2002/4415;;A61B17/7097;;A61F2/44;;A61F2002/2835;;A61F2002/30143;;A61F2002/30156;;A61F2002/30159;;A61F2002/30166;;A61F2002/30176;;A61F2002/30189;;A61F2002/30266;;A61F2002/30364;;A61F2002/30365;;A61F2002/3037;;A61F2002/30462;;A61F2002/305;;A61F2002/30515;;A61F2002/30518;;A61F2002/30525;;A61F2002/30579;;A61F2002/30581;;A61F2002/30588;;A61F2002/30836;;A61F2002/30892;;A61F2002/4677;;A61F2002/3054;;A61F2002/30433;;A61F2002/30507;;A61F2002/30593;;A61F2002/30624;;A61F2/4455;;A61F2/442;;A61F2/4425;;A61F2002/30108,A61F2/44;;A61B17/70;;A61F2/28;;A61F2/30;;A61F2/46,,0,0,,,,ACTIVE
881,US,A1,US 2020/0046517 A1,191-728-768-732-494,2020-02-13,2020,US 201916660174 A,2019-10-22,US 201916660174 A;;US 201615264677 A;;US 201313941095 A;;US 201213483852 A,2012-05-30,EXPANDABLE INTERBODY SPACER,"Devices and methods for treating one or more damaged, diseased, or traumatized portions of the spine, including intervertebral discs, to reduce or eliminate associated back pain. In one or more embodiments, the present invention relates to an expandable interbody spacer. The expandable interbody spacer may comprise a first jointed arm comprising a plurality of links pivotally coupled end to end. The expandable interbody spacer further may comprise a second jointed arm comprising a plurality of links pivotally coupled end to end. The first jointed arm and the second jointed arm may be interconnected at a proximal end of the expandable interbody spacer. The first jointed arm and the second jointed arm may be interconnected at a distal end of the expandable interbody spacer.",GLOBUS MEDICAL INC,PERLOFF JONATHAN;;RHODA WILLIAM;;WEIMAN MARK;;GLERUM CHAD;;DWYER EDWARD;;ALEXANDER VICTORIA;;GARVEY BRIAN;;WAITE DANIEL;;FLEMING CONOR;;PETERSHEIM SAMUEL;;HOWELL BRIA;;NIEMIEC MARCIN;;KUNJACHAN VIPIN;;GRAY JASON;;SAVILLE CHRISTOPHER;;HIMMELBERGER JAMES;;GAHMAN KEVIN,GLOBUS MEDICAL INC (2010-06-21),https://lens.org/191-728-768-732-494,Patent Application,yes,4,0,17,17,0,A61F2/447;;A61F2/4611;;A61F2002/30405;;A61F2002/30471;;A61F2002/30492;;A61F2002/30545;;A61F2002/3055;;A61F2002/30772;;A61F2002/30904;;A61F2002/4627;;A61F2310/00017;;A61F2310/00023;;A61F2310/00179;;A61F2002/30484;;A61F2002/4415;;A61B17/7097;;A61F2/44;;A61F2002/2835;;A61F2002/30143;;A61F2002/30156;;A61F2002/30159;;A61F2002/30166;;A61F2002/30176;;A61F2002/30189;;A61F2002/30266;;A61F2002/30364;;A61F2002/30365;;A61F2002/3037;;A61F2002/30462;;A61F2002/305;;A61F2002/30515;;A61F2002/30518;;A61F2002/30525;;A61F2002/30579;;A61F2002/30581;;A61F2002/30588;;A61F2002/30836;;A61F2002/30892;;A61F2002/4677;;A61F2/4455;;A61F2002/30433;;A61F2002/30507;;A61F2002/3054;;A61F2002/30624;;A61F2002/30593;;A61F2/447;;A61F2/4611;;A61F2002/30405;;A61F2002/30471;;A61F2002/30492;;A61F2002/30545;;A61F2002/3055;;A61F2002/30772;;A61F2002/30904;;A61F2002/4627;;A61F2310/00017;;A61F2310/00023;;A61F2310/00179;;A61F2002/30484;;A61F2002/4415;;A61B17/7097;;A61F2/44;;A61F2002/2835;;A61F2002/30143;;A61F2002/30156;;A61F2002/30159;;A61F2002/30166;;A61F2002/30176;;A61F2002/30189;;A61F2002/30266;;A61F2002/30364;;A61F2002/30365;;A61F2002/3037;;A61F2002/30462;;A61F2002/305;;A61F2002/30515;;A61F2002/30518;;A61F2002/30525;;A61F2002/30579;;A61F2002/30581;;A61F2002/30588;;A61F2002/30836;;A61F2002/30892;;A61F2002/4677;;A61F2002/3054;;A61F2002/30433;;A61F2002/30507;;A61F2002/30593;;A61F2002/30624;;A61F2/4455;;A61F2/442;;A61F2/4425;;A61F2002/30108,A61F2/44;;A61B17/70;;A61F2/46,,0,0,,,,ACTIVE
882,US,A1,US 2021/0121155 A1,027-840-285-683-935,2021-04-29,2021,US 202017071558 A,2020-10-15,US 202017071558 A;;US 201962926932 P,2019-10-28,TUBE POSITION MONITORING SYSTEM,"A position monitoring system is provided that includes a tracheal tube having a distal portion with a radiopaque indicator. The tracheal tube is configured to be positioned within an airway of a patient. The position monitoring system also includes an external sensor configured to be positioned on an external surface of the patient. The external sensor includes an emitter configured to transmit energy into the patient and toward the distal portion and a detector configured to receive a reflected portion of the energy to permit identification of a position of the distal portion. The position monitoring system, in certain embodiments, further includes a video laryngoscope communicatively coupled to the external sensor. The video laryngoscope includes a display and a processor, and the processor is configured to instruct the display to present an indication of the position of the distal portion based on feedback from the detector.",COVIDIEN LP,MAGUIRE SEAMUS P;;MCGANN MARK A;;DONLON KIERAN M;;CURLEY JAMES P;;WATERS DANIEL P;;FLEMING GRAHAM B;;MORRIS SEAN;;HANAMY RONAN J;;MORGAN NOEL;;CAHILL ROSEMARY;;HAND CONOR;;SAVAGE ANNE M;;KSIENZYK IZABELA A,COVIDIEN LP (2019-11-13),https://lens.org/027-840-285-683-935,Patent Application,yes,11,2,1,1,0,A61M2205/32;;A61M16/0488;;A61M2205/3317;;A61M2205/3375;;A61M2205/587;;A61M2205/584;;A61M2205/6054;;A61M16/0434;;A61M2205/581;;A61M2205/582;;A61M2205/505;;A61M2205/8206;;A61M2205/3553;;A61M2205/3561;;A61M2205/3592;;A61M16/0688;;A61M16/0683;;A61M16/0411;;A61B1/267;;A61B1/00045;;A61B6/12;;A61B8/0841;;A61B8/0841;;A61M16/04;;A61M2205/32;;A61B1/00045;;A61B6/12;;A61B1/267,A61B8/08;;A61B1/00;;A61B1/267;;A61B6/12;;A61M16/04,,0,0,,,,PENDING
883,DE,A1,DE 102022129923 A1,137-095-680-672-700,2023-06-22,2023,DE 102022129923 A,2022-11-11,US 202117558172 A,2021-12-21,"VERFAHREN, SYSTEME UND EINRICHTUNGEN ZUM REKONFIGURIEREN EINES COMPUTERS","Es sind Verfahren, Systeme und Einrichtungen zum Rekonfigurieren eines Computers offenbart. Eine beispielhafte elektronische Vorrichtung beinhaltet mindestens einen Speicher, Anweisungen in der elektronischen Vorrichtung und eine Prozessorschaltungsanordnung zum Ausführen von Anweisungen zum Analysieren von Daten, die einer ersten Konfiguration der elektronischen Vorrichtung entsprechen, um eine mit der elektronischen Vorrichtung assoziierte Änderung zu erkennen, wobei die erste Konfiguration einem jeweiligen ersten Benutzerprofil entspricht, Ermitteln einer zweiten Konfiguration der elektronischen Vorrichtung basierend auf der erkannten Änderung und Anpassen einer Konfiguration der elektronischen Vorrichtung von der ersten Konfiguration auf die zweite Konfiguration.",INTEL CORP,ZHU JIANFANG;;CHEN IVAN;;COOPER BARNES;;DAI JIANWEI;;DIXON MARTIN;;FLEMING KRISTOFFER;;GALLINA MARK;;GLENDINNING DUNCAN;;KIRUBAKARAN DEEPAK SAMUEL;;KUO CHIA-HUNG S;;LI YIFAN;;NORMAN ADAM;;ROSENZWEIG MICHAEL;;WANG KAI P;;YAN JIN;;ADSURE VIRENDRA VIKRAMSINH,,https://lens.org/137-095-680-672-700,Patent Application,no,0,0,3,3,0,G06F9/5027;;G06F9/4893;;G06F1/206;;G06F9/4451;;G06F11/3438;;G06F9/44505;;G06F11/3051;;G06F11/3058;;G06F11/3089;;G06F2201/81;;G06F9/4451;;G06F15/7882,G06F9/44;;G06F11/34,,0,0,,,,PENDING
884,US,A1,US 2022/0114136 A1,136-851-892-704-115,2022-04-14,2022,US 202117558172 A,2021-12-21,US 202117558172 A,2021-12-21,"METHODS, SYSTEMS, AND APPARATUS TO RECONFIGURE A COMPUTER","Methods, systems, and apparatus to reconfigure a computer are disclosed. An example electronic device includes at least one memory, instructions in the electronic device, and processor circuitry to execute instructions to analyze data corresponding to a first configuration of the electronic device to detect a change associated with the electronic device, the first configuration corresponding to a respective first user profile, determine a second configuration of the electronic device based on the detected change, and adjust a configuration of the electronic device from the first configuration to the second configuration.",INTEL CORP,ZHU JIANFANG;;CHEN IVAN;;COOPER BARNES;;DAI JIANWEI;;DIXON MARTIN;;FLEMING KRISTOFFER;;GALLINA MARK;;GLENDINNING DUNCAN;;KIRUBAKARAN DEEPAK SAMUEL;;KUO CHIA-HUNG S;;LI YIFAN;;NORMAN ADAM;;ROSENZWEIG MICHAEL;;WANG KAI P;;YAN JIN;;ADSURE VIRENDRA VIKRAMSINH,INTEL CORPORATION (2021-10-26),https://lens.org/136-851-892-704-115,Patent Application,yes,0,0,3,3,0,G06F9/5027;;G06F9/4893;;G06F1/206;;G06F9/4451;;G06F11/3438;;G06F9/44505;;G06F11/3051;;G06F11/3058;;G06F11/3089;;G06F2201/81;;G06F9/4451;;G06F15/7882,G06F15/78;;G06F9/445,,0,0,,,,PENDING
885,CN,A,CN 116302470 A,154-177-773-096-795,2023-06-23,2023,CN 202211640419 A,2022-12-20,US 202117558172 A,2021-12-21,"Method, system and apparatus for reconfiguring computer","Methods, systems, and apparatus for reconfiguring a computer are disclosed. An example electronic device includes at least one memory, instructions in the electronic device, and processor circuitry to execute the instructions to analyze data corresponding to a first configuration of the electronic device to detect a change associated with the electronic device, the first configuration corresponding to a respective first user profile; determining a second configuration of the electronic device based on the detected change; and adjusting the configuration of the electronic equipment from the first configuration to the second configuration.",INTEL CORP,JOO JAKE;;CHEN IRWIN;;COOPER BETH;;DAI JUNHONG;;DICKSON MICHAEL;;FLEMING KERMIN;;GALLINA MARK;;GLENDINNING DUNCAN;;KIRUBAKARAN DEEPAK SAMUEL;;KUO CHI-HUNG STEVEN;;LI YUZHUO;;NORMAN ALEXANDER;;ROSENZWEIG MARCEL;;WONG KIM P;;YAN JOHN;;ADESUR VISHNU V,,https://lens.org/154-177-773-096-795,Patent Application,no,0,0,3,3,0,G06F9/5027;;G06F9/4893;;G06F1/206;;G06F9/4451;;G06F11/3438;;G06F9/44505;;G06F11/3051;;G06F11/3058;;G06F11/3089;;G06F2201/81;;G06F9/4451;;G06F15/7882,G06F9/50;;G06F1/20;;G06F9/48,,0,0,,,,PENDING
886,US,S,US D0676889 S,078-648-455-929-126,2013-02-26,2013,US 37914510 F,2010-11-15,US 37914510 F;;US 35867710 F,2010-03-30,Electronic device,,CISCO TECH INC;;DINGER MAARTEN;;SHEPPARD NASAHN ADAM;;KAPLAN JONATHAN;;FURLAN JOHN;;BRAUNSTEIN ARIEL;;FLEMING-WOOD SIMON;;INMAN RICHARD TOBIAS;;CLEARY ELIZABETH A;;DE LATTRE MONTFORD;;MARTINEZ MARK MANUEL;;CUMMINGS GREG ALLEN;;MICHAELIAN PETER;;FARAHANI HOUTAN RAHIMI;;JETTER ROBERT;;TAYLOR MATTHEW MORRIS;;LAU TIM OONTHIM;;ORNER WILLIAM,DINGER MAARTEN;;SHEPPARD NASAHN ADAM;;KAPLAN JONATHAN;;FURLAN JOHN;;BRAUNSTEIN ARIEL;;FLEMING-WOOD SIMON;;INMAN RICHARD TOBIAS;;CLEARY ELIZABETH A;;DE LATTRE MONTFORD;;MARTINEZ MARK MANUEL;;CUMMINGS GREG ALLEN;;MICHAELIAN PETER;;FARAHANI HOUTAN RAHIMI;;JETTER ROBERT;;TAYLOR MATTHEW MORRIS;;LAU TIM OONTHIM;;ORNER WILLIAM,,https://lens.org/078-648-455-929-126,Design Right,no,0,2,2,2,0,,,1605;;D16/219,0,0,,,,ACTIVE
887,US,S,US D0631902 S,124-898-324-216-546,2011-02-01,2011,US 35867710 F,2010-03-30,US 35867710 F,2010-03-30,Digital video camera,,CISCO TECH INC,DINGER MAARTEN;;SHEPPARD NASAHN ADAM;;KAPLAN JONATHAN;;FURLAN JOHN;;BRAUNSTEIN ARIEL;;FLEMING-WOOD SIMON;;INMAN RICHARD TOBIAS;;CLEARY ELIZABETH A;;DE LATTRE MONTFORD;;MARTINEZ MARK MANUEL;;CUMMINGS GREG ALLEN;;MICHAELIAN PETER;;FARAHANI HOUTAN RAHIMI;;JETTER ROBERT;;TAYLOR MATTHEW MORRIS;;LAU TIM OONTHIM;;ORNER WILLIAM,CISCO TECHNOLOGY INC (2010-03-31),https://lens.org/124-898-324-216-546,Design Right,no,0,0,2,2,0,,,1601;;D16/202,0,0,,,,ACTIVE
888,WO,A1,WO 2019/143607 A1,188-517-304-076-46X,2019-07-25,2019,US 2019/0013638 W,2019-01-15,US 201862617828 P;;US 201862618561 P;;US 201862633477 P,2018-01-16,METHODS OF TREATING CANCER WITH ANTIBODIES AGAINST TIM3,"This disclosure provides a method for treating a subject afflicted with a tumor or a cancer, wherein the method comprises administering to the subject therapeutically effective amounts of an anti- TIM3 antibody, alone or in combination with an inhibitor of the PD-1 signaling pathway ( e.g. , anti-PD-1 antibody). In some embodiments, the antibody is administered as a flat dose or a weight-based dose.",BRISTOL MYERS SQUIBB CO,SCHEBYE XIAO MIN;;SELBY MARK J;;HAN MICHELLE MINHUA;;BEE CHRISTINE;;DENG ANDY X;;CHUNTHARAPAI ANAN;;DEVAUX BRIGITTE;;LI HUIMING;;SHEPPARD PAUL O;;KORMAN ALAN J;;ARDOUREL DANIEL F;;DEYANOVA EKATERINA;;HUANG RICHARD;;CHEN GUODONG;;KUHNE MICHELLE;;TRUONG HONG-AN;;PATAH POLIANA;;JACKSON JEFFREY R;;FLEMING RONALD A,,https://lens.org/188-517-304-076-46X,Patent Application,yes,83,4,6,6,448,C07K16/2803;;C07K16/2818;;A61K2039/507;;A61P35/00;;C07K16/2803;;C07K16/2818;;C07K16/2878;;C07K16/2827;;A61P35/00;;A61K2039/507;;A61P35/00;;A61K39/3955;;A61K2039/505;;A61K2039/507;;A61K2039/545;;C07K16/2803;;C07K16/2818;;C07K2317/21;;C07K2317/52;;C07K2317/565,C07K16/28;;A61K39/395;;A61P35/00,,58,21,014-766-704-525-495;;077-322-394-487-953;;019-709-193-272-051;;013-097-935-371-671;;095-501-820-764-762;;074-817-300-512-106;;017-150-654-990-340;;002-264-966-090-625;;010-953-281-569-514;;014-277-808-472-992;;061-754-151-573-898;;113-327-994-370-771;;006-553-734-546-212;;068-238-957-669-243;;105-316-874-895-908;;032-728-154-591-070;;056-201-471-905-934;;028-862-168-091-90X;;052-660-996-132-29X;;051-218-620-433-15X;;142-369-222-567-694,10.2147/ott.s170385;;pmc6198883;;30410357;;10.1158/1538-7445.am2017-2628;;10.1158/1535-7163.mct-16-0665;;28265006;;28520840;;10.1093/annonc/mdx235;;pmc5834087;;10.1158/1538-7445.am2017-ct101;;10.1038/341544a0;;2677748;;3140379;;10.1126/science.3140379;;10.1073/pnas.85.16.5879;;3045807;;pmc281868;;10.1038/nbt1135;;16151405;;10.4049/jimmunol.137.11.3614;;2431039;;10.1016/0042-6822(90)90025-m;;1693247;;1697100;;10.1111/j.1365-3083.1990.tb02896.x;;8424945;;10.1021/bi00055a024;;10556249;;10.1093/protein/12.10.879;;pmc19525;;9012796;;10.1073/pnas.94.2.412;;10.1016/0022-2836(70)90057-4;;5420325;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;28679395;;pmc5499002;;10.1186/s13045-017-0506-z;;24872026;;10.1158/2326-6066.cir-14-0040;;10.1158/1078-0432.ccr-13-0855;;23674495;;pmc4102335,"HE YAYI ET AL: ""TIM-3, a promising target for cancer immunotherapy."", ONCOTARGETS AND THERAPY 2018, vol. 11, 2018, pages 7005 - 7009, XP002789761, ISSN: 1178-6930;;LEI ZHENG ET AL.: ""Abstract A203: Generation of human TIM3 knock-in mice for preclinical efficacy assessment of therapeutic antibodies"", 30 October 2017 (2017-10-30), XP002789762, Retrieved from the Internet <URL:http://mct.aacrjournals.org/content/17/1_Supplement/A203> [retrieved on 20190315];;WEISS G J: ""A phase 1 study of TSR-022, an anti-TIM-3 monoclonal antibody, in patients (pts) with advanced solid tumors"", JOURNAL FOR IMMUNOTHERAPY OF CANCER 20171101 BIOMED CENTRAL LTD. NLD, vol. 5, no. Supplement 2, 1 November 2017 (2017-11-01), XP002789763, ISSN: 2051-1426;;DEANGELIS N ET AL: ""Development of JNJ-64158120, an anti-TIM-3 antibody to overcome innate and acquired mechanisms of resistance to PD-1 therapy"", JOURNAL FOR IMMUNOTHERAPY OF CANCER 20171101 BIOMED CENTRAL LTD. NLD, vol. 5, no. Supplement 2, 1 November 2017 (2017-11-01), XP002789764, ISSN: 2051-1426;;TONG ZHANG ET AL.: ""Abstract 2628: BGB-A425: a humanized anti-human Tim-3 antibody that exhibits strong immune cell activation"", 5 April 2017 (2017-04-05), XP002789765, Retrieved from the Internet <URL:http://cancerres.aacrjournals.org/content/77/13_Supplement/2628> [retrieved on 20190315];;BUROVA E ET AL: ""Characterization of the Anti PD-1 Antibody REGN2810 and Its Antitumor Activity in Human PD-1 Knock-In Mice"", MOL CANCER THER. 2017 MAY,, vol. 16, no. 5, 6 March 2017 (2017-03-06), pages 861 - 870, XP002788765;;NOVARTIS PHARMACEUTICALS: ""Study NCT02608268 on Date: December 14, 2017 (v15)"", 14 December 2017 (2017-12-14), XP002789766, Retrieved from the Internet <URL:https://clinicaltrials.gov/ct2/history/NCT02608268?V_15> [retrieved on 20190315];;ZHAO X ET AL: ""Assessment of nivolumab benefit-risk profile of a 240-mg flat dose relative to a 3-mg/kg dosing regimen in patients with advanced tumors."", ANNALS OF ONCOLOGY : OFFICIAL JOURNAL OF THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY 01 AUG 2017, vol. 28, no. 8, 1 August 2017 (2017-08-01), pages 2002 - 2008, XP002789767, ISSN: 1569-8041;;ZHAO ET AL: ""Abstract CT101: A model-based exposure-response (E-R) assessment of a nivolumab (NIVO) 4-weekly (Q4W) dosing schedule across multiple tumor types"", July 2017 (2017-07-01), XP002789768, Retrieved from the Internet <URL:http://cancerres.aacrjournals.org/content/77/13_Supplement/CT101> [retrieved on 20190315];;JUO, PEI-SHOW: ""Concise Dictionary of Biomedicine and Molecular Biology"", CRC PRESS;;""The Dictionary of Cell and Molecular Biology"", 1999, ACADEMIC PRESS;;""Oxford Dictionary Of Biochemistry And Molecular Biology"", 2000, OXFORD UNIVERSITY PRESS;;WARD ET AL., NATURE, vol. 341, 1989, pages 544 - 546;;BIRD ET AL., SCIENCE, vol. 242, 1988, pages 423 - 426;;HUSTON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 5879 - 5883;;LONBERG, NATURE BIOTECH., vol. 23, no. 9, 2005, pages 1117 - 1125;;JEFFERIS ET AL., MABS, vol. 1, 2009, pages 1;;""Epitope Mapping Protocols in Methods in Molecular Biology"", vol. 66, 1996;;ED HARLOW; DAVID LANE, COLD SPRING HARB PROTOC, 2006;;ED HARLOW; DAVID LANE: ""Using Antibodies"", 1999, COLD SPRING HARBOR LABORATORY PRESS;;STAHLI ET AL., METHODS IN ENZYMOLOGY, vol. 9, 1983, pages 242;;KIRKLAND ET AL., J. IMMUNOL., vol. 137, 1986, pages 3614;;HARLOW; LANE: ""Antibodies: A Laboratory Manual"", 1988, COLD SPRING HARBOR PRESS;;MOREL ET AL., MOL. IMMUNOL., vol. 25, no. 1, 1988, pages 7;;CHEUNG ET AL., VIROLOGY, vol. 176, 1990, pages 546;;MOLDENHAUER ET AL., SCAND. J. IMMUNOL., vol. 32, 1990, pages 77;;BRUMMELL ET AL., BIOCHEM., vol. 32, 1993, pages 1180 - 1187;;KOBAYASHI ET AL., PROTEIN ENG., vol. 12, no. 10, 1999, pages 879 - 884;;BURKS ET AL., PROC. NATL. ACAD. SCI. USA, vol. 94, 1997, pages 412 - 417;;E. MEYERS; W. MILLER, CABIOS, vol. 4, 1989, pages 11 - 17;;NEEDLEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 444 - 453;;ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 10;;ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, no. 17, 1997, pages 3389 - 3402;;""Current Protocols in Molecular Biology"", 1987, GREENE PUBLISHING AND WILEY INTERSCIENCE;;SI-YANG LIU ET AL., J. HEMATOL. ONCOL., vol. 10, 2017, pages 136;;WANG ET AL., CANCER IMMUNOL RES., vol. 2, no. 9, 2014, pages 846 - 56;;HERBST ET AL., J CLIN ONCOL, vol. 31, 2013, pages 3000;;ZHANG ET AL., CELL DISCOV., vol. 7, March 2017 (2017-03-01), pages 3;;GORELIK ET AL., AACR, vol. 4606, April 2016 (2016-04-01);;NCCN GUIDELINES, 2014, Retrieved from the Internet <URL:worldwideweb.nccn.org/professionals/physician_gls/f_guidelines.asp>;;CHEN ET AL., CLIN CANCER RES, vol. 19, no. 13, 2013, pages 3462 - 3473;;""Molecular Cloning A Laboratory Manual"", 1989, COLD SPRING HARBOR LABORATORY PRESS;;""Molecular Cloning: A Laboratory Manual"", 1992, COLD SPRINGS HARBOR LABORATORY;;""DNA Cloning"", vol. I;II, 1985;;""Oligonucleotide Synthesis"", 1984;;""Nucleic Acid Hybridization"", 1984;;""Transcription And Translation"", 1984;;FRESHNEY: ""Culture Of Animal Cells"", 1987, ALAN R. LISS, INC.;;""Immobilized Cells And Enzymes"", 1986, IRL PRESS;;PERBAL: ""A Practical Guide To Molecular Cloning"", 1984;;""Methods In Enzymology"", ACADEMIC PRESS, INC.;;""Gene Transfer Vectors For Mammalian Cells"", 1987, COLD SPRING HARBOR LABORATORY;;""Methods In Enzymology"", vol. 154;155;;""Immunochemical Methods In Cell And Molecular Biology"", 1987, ACADEMIC PRESS;;""Handbook Of Experimental Immunology"", vol. I-IV, 1986;;""Manipulating the Mouse Embryo"", 1986, COLD SPRING HARBOR LABORATORY PRESS;;CROOKS: ""Antisense drug Technology: Principles, strategies and applications"", 2007, CRC PRESS;;AUSUBEL ET AL.: ""Current Protocols in Molecular Biology"", 1989, JOHN WILEY AND SONS",PENDING
889,KR,A,KR 20200109339 A,163-155-615-858-271,2020-09-22,2020,KR 20207023142 A,2019-01-15,US 201862617828 P;;US 201862618561 P;;US 201862633477 P;;US 2019/0013638 W,2018-01-16,TIM3에 대한 항체를 사용하여 암을 치료하는 방법,"본 개시내용은 종양 또는 암을 앓고 있는 대상체에게 치료 유효량의 항-TIM3 항체를 단독으로 또는 PD-1 신호전달 경로의 억제제 (예를 들어, 항-PD-1 항체)와 조합하여 투여하는 것을 포함하는, 종양 또는 암을 앓고 있는 대상체를 치료하는 방법을 제공한다. 일부 실시양태에서, 항체는 균일 용량 또는 체중-기준 용량으로 투여된다.",BRISTOL MYERS SQUIBB CO,SCHEBYE XIAO MIN;;SELBY MARK J;;HAN MICHELLE MINHUA;;BEE CHRISTINE;;DENG ANDY X;;CHUNTHARAPAI ANAN;;DEVAUX BRIGITTE;;LI HUIMING;;SHEPPARD PAUL O;;KORMAN ALAN J;;ARDOUREL DANIEL F;;DEYANOVA EKATERINA;;HUANG RICHARD;;CHEN GUODONG;;KUHNE MICHELLE;;TRUONG HONG AN;;PATAH POLIANA;;JACKSON JEFFREY R;;FLEMING RONALD A,,https://lens.org/163-155-615-858-271,Patent Application,no,0,0,6,6,894,C07K16/2803;;C07K16/2818;;A61K2039/507;;A61P35/00;;C07K16/2803;;C07K16/2818;;C07K16/2878;;C07K16/2827;;A61P35/00;;A61K2039/507;;A61P35/00;;A61K39/3955;;A61K2039/505;;A61K2039/507;;A61K2039/545;;C07K16/2803;;C07K16/2818;;C07K2317/21;;C07K2317/52;;C07K2317/565,C07K16/28;;A61K39/00;;A61P35/00,,0,0,,,,PENDING
890,CN,A,CN 111868091 A,173-815-437-906-376,2020-10-30,2020,CN 201980019319 A,2019-01-15,US 201862617828 P;;US 201862618561 P;;US 201862633477 P;;US 2019/0013638 W,2018-01-16,METHODS OF TREATING CANCER WITH ANTIBODIES AGAINST TIM3,"This disclosure provides a method for treating a subject afflicted with a tumor or a cancer, wherein the method comprises administering to the subject therapeutically effective amounts of an anti- TIM3 antibody, alone or in combination with an inhibitor of the PD-1 signaling pathway (e.g., anti-PD-1 antibody). In some embodiments, the antibody is administered as a flat dose or a weight-based dose.",SQUIBB BRISTOL MYERS COMPANY,SCHEBYE XIAO MIN;;SELBY MARK J;;HAN MICHELLE MINHUA;;BEE CHRISTINE;;DENG ANDY X;;CHUNTHARAPAI ANAN;;DEVAUX BRIGITTE;;LI HUIMING;;SHEPPARD PAUL O;;KORMAN ALAN J;;ARDOUREL DANIEL F;;DEYANOVA EKATERINA;;HUANG RICHARD;;CHEN GUODONG;;KUHNE MICHELLE;;TRUONG HONG-AN;;PATAH POLIANA;;JACKSON JEFFREY R;;FLEMING RONALD A,,https://lens.org/173-815-437-906-376,Patent Application,no,2,2,6,6,0,C07K16/2803;;C07K16/2818;;A61K2039/507;;A61P35/00;;C07K16/2803;;C07K16/2818;;C07K16/2878;;C07K16/2827;;A61P35/00;;A61K2039/507;;A61P35/00;;A61K39/3955;;A61K2039/505;;A61K2039/507;;A61K2039/545;;C07K16/2803;;C07K16/2818;;C07K2317/21;;C07K2317/52;;C07K2317/565,C07K16/28;;A61K39/395;;A61P35/00,,0,0,,,,PENDING
891,EP,A1,EP 3740506 A1,126-344-326-310-235,2020-11-25,2020,EP 19706784 A,2019-01-15,US 201862617828 P;;US 201862618561 P;;US 201862633477 P;;US 2019/0013638 W,2018-01-16,METHODS OF TREATING CANCER WITH ANTIBODIES AGAINST TIM3,,BRISTOL MYERS SQUIBB CO,SCHEBYE XIAO MIN;;SELBY MARK J;;HAN MICHELLE MINHUA;;BEE CHRISTINE;;DENG ANDY X;;CHUNTHARAPAI ANAN;;DEVAUX BRIGITTE;;LI HUIMING;;SHEPPARD PAUL O;;KORMAN ALAN J;;ARDOUREL DANIEL F;;DEYANOVA EKATERINA;;HUANG RICHARD;;CHEN GUODONG;;KUHNE MICHELLE;;TRUONG HONG-AN;;PATAH POLIANA;;JACKSON JEFFREY R;;FLEMING RONALD A,,https://lens.org/126-344-326-310-235,Patent Application,yes,0,0,6,6,0,C07K16/2803;;C07K16/2818;;A61K2039/507;;A61P35/00;;C07K16/2803;;C07K16/2818;;C07K16/2878;;C07K16/2827;;A61P35/00;;A61K2039/507;;A61P35/00;;A61K39/3955;;A61K2039/505;;A61K2039/507;;A61K2039/545;;C07K16/2803;;C07K16/2818;;C07K2317/21;;C07K2317/52;;C07K2317/565,C07K16/28;;A61K39/395;;A61P35/00,,0,0,,,,PENDING
892,US,A1,US 2021/0363242 A1,037-820-876-460-316,2021-11-25,2021,US 201916962805 A,2019-01-15,US 201916962805 A;;US 201862617828 P;;US 201862618561 P;;US 201862633477 P;;US 2019/0013638 W,2018-01-16,METHODS OF TREATING CANCER WITH ANTIBODIES AGAINST TIM3,"This disclosure provides a method for treating a subject afflicted with a tumor or a cancer, wherein the method comprises administering to the subject therapeutically effective amounts of an anti-TIM3 antibody, alone or in combination with an inhibitor of the PD-1 signaling pathway (e.g., anti-PD-1 antibody). In some embodiments, the antibody is administered as a flat dose or a weight-based dose.",BRISTOL MYERS SQUIBB CO,SCHEBYE XIAO MIN;;SELBY MARK J;;HAN MICHELLE MINHUA;;BEE CHRISTINE;;DENG ANDY X;;CHUNTHARAPAI ANAN;;DEVAUX BRIGITTE;;LI HUIMING;;SHEPPARD PAUL O;;KORMAN ALAN J;;ARDOUREL DANIEL F;;DEYANOVA EKATERINA;;HUANG RICHARD YU-CHENG;;CHEN GUODONG;;KUHNE MICHELLE RENNE;;TRUONG HONG-AN;;PATAH POLIANA;;JACKSON JEFFREY R;;FLEMING RONALD A,BRISTOL-MYERS SQUIBB COMPANY (2018-04-24),https://lens.org/037-820-876-460-316,Patent Application,yes,2,1,6,6,448,C07K16/2803;;C07K16/2818;;A61K2039/507;;A61P35/00;;C07K16/2803;;C07K16/2818;;C07K16/2878;;C07K16/2827;;A61P35/00;;A61K2039/507;;A61P35/00;;A61K39/3955;;A61K2039/505;;A61K2039/507;;A61K2039/545;;C07K16/2803;;C07K16/2818;;C07K2317/21;;C07K2317/52;;C07K2317/565,C07K16/28;;A61K39/395;;A61P35/00,,7,6,018-069-206-369-372;;091-637-220-567-447;;034-863-257-615-287;;077-322-394-487-953;;030-454-062-264-322;;004-040-568-027-145,10.1158/2326-6066.cir-14-0039;;24795351;;24115948;;pmc3792396;;10.3389/fimmu.2013.00302;;pmc8726659;;10.1080/19420862.2021.1999195;;34780320;;10.1158/1538-7445.am2017-2628;;10.3389/fimmu.2021.625667;;pmc7994325;;33777008;;10.3390/antib8040055;;pmc6963682;;31816964,"Anderson, A., Tim-3: An Emerging Target in the Cancer Immunotherapy Landscape, Cancer Immunol Res (2014) 2 (5): 393–398. (Year: 2014);;Sela-Culang, I. et al, The Structural basis of Antibody-Antigen Recognition, Frontiers in Immunology, Vol 4, Article 302, October 2013 (Year: 2013);;Cunningham, O. et al, Polyreactivity and polyspecificity in therapeutic antibody development: risk factors for failure in preclinical and clinical development campaigns, MABS, Vol 13, NO. 1 2021 (Year: 2021);;Zhang, T. et al. ""BGB-A425: a humanized anti-human Tim-3 antibody that exhibits strong immune cell activation."" Cancer Research 77.13_Supplement (2017): 2628-2628. (Year: 2017);;Jorgovanovic D. et al, ROles of IFN-γ in tumor progression and regression: a review. Biomarker Research 8, 49, 2020 (Year: 2020);;Lee, J. et al, The Multifaceted Tole of TH1, Th9, and Th17 cells in Immune Checkpoint Inhibition Therapy. Frontiers in Immunology, 12:625667, 2021 (Year: 2021);;Chiu M. et al, Antibody Structure and Function: The Basis for Engineering Therapeutics. Antibodies 8(4), 55, 2019 (Year: 2019)",DISCONTINUED
893,WO,A1,WO 2015/038014 A1,073-888-280-084-467,2015-03-19,2015,NZ 2014000202 W,2014-09-15,US 201361877566 P;;US 201361877622 P;;US 201361877736 P;;US 201461971474 P;;US 201462032462 P,2013-09-13,HUMIDIFICATION SYSTEM,"A humidification system can include a heater base, a chamber, and a breathing circuit. The heater base includes a heater plate positioned in a recessed region, and a heat conductive portion of the chamber is configured to contact the heater plate. The heater base includes a guard configured to control movement of the chamber into and out of the recessed region. The guard includes an anti-racking mechanism. The system can detect when breathing circuits are connected in reverse. Methods of controlling the respiratory humidification system are described, including determining whether an outlet port temperature has increased by more than a predetermined amount in a predetermined time, or setting a target dew point. The system may comprise an inspiratory conduit comprising an identification component that outputs a signal to a controller configured to control power to a heater plate.",FISHER & PAYKEL HEALTHCARE LTD,JACKSON JOHN JAMES;;MANON BARRY SHACK;;CORRALES VICTOR ROSALES;;VAN WORKUM STEFAN LEO;;ANDRESEN MICHAEL JOHN;;EVANS STEPHEN DAVID;;HAMILTON MARK SAMUEL;;BUCKLEY PAUL FLEMING;;KLENNER JASON ALLAN;;OSBORNE HAMISH;;BOGGS SAMUEL GRAHAM;;STANTON JAMES WILLIAM;;GRIFFITHS JOSEPH NATHANIEL;;LAMBERT JONATHAN ANDREW GEORGE;;VAUGHAN NICHOLAS EDWARD;;KEHOE JAMES OWEN;;DE LA FUENTE FRANCISCO ERNESTO DE LA PENA;;MCKENNA NICHOLAS JAMES MICHAEL;;PORTER RACHAEL;;STAM SIMON MORDECHAI;;KEMPS DAVID ROBERT;;LYONS EDWIN JOSEPH;;MARTIN MADELEINE BESS,,https://lens.org/073-888-280-084-467,Patent Application,yes,20,31,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/16,,1,0,,,See also references of EP 3043854A4,PENDING
894,GB,A,GB 2584026 A,165-833-055-606-940,2020-11-18,2020,GB 202010752 A,2014-09-15,US 201361877566 P;;US 201361877622 P;;US 201361877736 P;;US 201461971474 P;;US 201462032462 P;;GB 201917384 A,2013-09-13,Humidification system,"The heater base comprises a base portion having a heater plate 108, a spine portion 210 extending from the base portion which defines a cavity 168 in which one or more boards 170A, 170B that control the heater plate are located.",FISHER & PAYKEL HEALTHCARE LTD,JOHN JAMES JACKSON;;BARRY SHACK MANON;;VICTOR ROSALES CORRALES;;STEFAN LEO VAN WORKUM;;MICHAEL JOHN ANDRESEN;;STEPHEN DAVID EVANS;;MARK SAMUEL HAMILTON;;PAUL FLEMING BUCKLEY;;JASON ALLAN KLENNER;;HAMISH ADRIAN OSBORNE;;SAMUEL GRAHAM BOGGS;;JAMES WILLIAM STANTON;;JOSEPH NATHANIEL GRIFFITHS;;JONATHAN ANDREW GEORGE LAMBERT;;NICHOLAS EDWARD VAUGHAN;;JAMES OWEN KEHOE;;FRANCISCO ERNESTO DE LA PENA DE LA FUENTE;;NICHOLAS JAMES MICHAEL MCKENNA;;RACHAEL PORTER;;SIMON MORDECHAI STAM;;DAVID ROBERT KEMPS;;EDWIN JOSEPH LYONS;;MADELEINE BESS MARTIN;;HUANG-KU LIU;;ADA YIWEN SHOU,,https://lens.org/165-833-055-606-940,Patent Application,no,3,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/16,,0,0,,,,ACTIVE
895,AU,B2,AU 2014/319043 B2,174-816-331-589-14X,2020-01-30,2020,AU 2014/319043 A,2014-09-15,US 201462032462 P;;US 201361877622 P;;US 201361877566 P;;US 201461971474 P;;US 201361877736 P;;NZ 2014000202 W,2013-09-13,Humidification system,,FISHER AND PAYKEL HEALTHCARE LTD,JACKSON JOHN JAMES;;MANON BARRY SHACK;;CORRALES VICTOR ROSALES;;VAN WORKUM STEFAN LEO;;ANDRESEN MICHAEL JOHN;;EVANS STEPHEN DAVID;;HAMILTON MARK SAMUEL;;BUCKLEY PAUL FLEMING;;KLENNER JASON ALLAN;;OSBORNE HAMISH;;BOGGS SAMUEL GRAHAM;;STANTON JAMES WILLIAM;;GRIFFITHS JOSEPH NATHANIEL;;LAMBERT JONATHAN ANDREW GEORGE;;VAUGHAN NICHOLAS EDWARD;;KEHOE JAMES OWEN;;DE LA FUENTE FRANCISCO ERNESTO DE LA PENA;;MCKENNA NICHOLAS JAMES MICHAEL;;PORTER RACHAEL;;STAM SIMON MORDECHAI;;KEMPS DAVID ROBERT;;LYONS EDWIN JOSEPH;;MARTIN MADELEINE BESS;;SHOU ADA YIWEN;;LIU HUANG-KU,,https://lens.org/174-816-331-589-14X,Granted Patent,no,3,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/16,,0,0,,,,ACTIVE
896,WO,A1,WO 2021/203007 A1,063-583-058-495-695,2021-10-07,2021,US 2021/0025591 W,2021-04-02,US 202063004713 P,2020-04-03,SUBSTITUTED 5-HYDROXYINDOLE COMPOUNDS AS MODULATORS OF ALPHA-1 ANTITRYPSIN,"Novel compounds, compositions, and methods of using and preparing the same, which may be useful for treating alpha-1 antitrypsin deficiency (AATD).",VERTEX PHARMA,GIROUX SIMON;;CLARK MICHAEL PHILIP;;TANG QING;;NUHANT PHILIPPE MARCEL;;JONES PETER;;MESSERSMITH DAVID;;BANDARAGE UPUL KEERTHI;;COTTRELL KEVIN MICHAEL;;BRODNEY MICHAEL AARON;;FLEMING GABRIELLE SIMONE;;WANG JIAN;;XU JINWANG;;DANIEL KEVIN BRETT;;BOYD MICHAEL JOHN;;MORRIS MARK A;;WAAL NATHAN D;;COLLIER PHILIP NOEL;;KESAVAN SARATHY;;RONKIN STEVEN M;;DENG HONGBO;;BOUCHER DIANE MARIE;;FANNING LEV T D;;HALL AMY B;;HURLEY DENNIS JAMES;;JOHNSON JR;;MAXWELL JOHN PATRICK;;SWETT REBECCA JANE;;TAPLEY TIMOTHY LEWIS;;THOMSON STEPHEN A;;DAMAGNEZ VERONIQUE,,https://lens.org/063-583-058-495-695,Patent Application,yes,5,2,7,7,0,C07D209/10;;C07D209/14;;C07D209/12;;C07D209/22;;C07D209/24;;C07D209/42;;C07D401/04;;C07D405/04;;C07D403/04;;C07D405/14;;C07D409/04;;A61P11/00;;A61P29/00;;A61P43/00;;C07D209/22;;C07D209/24;;C07D401/04;;C07D403/04;;C07D405/04;;C07D405/14;;C07D409/04;;C07D413/06;;C07D413/14,C07D209/10;;A61K31/404;;A61P11/00;;A61P29/00;;A61P43/00;;C07D209/12;;C07D209/14;;C07D209/22;;C07D209/24;;C07D209/42;;C07D401/04;;C07D403/04;;C07D405/04;;C07D405/14;;C07D409/04,,10,5,042-774-002-956-325;;097-364-203-604-725;;018-263-920-996-794;;035-897-673-514-583;;007-364-858-655-289,10.1007/bf00471301;;10.1164/rccm.168.7.818;;14522813;;pmc442392;;10.1172/jci113214;;3500183;;pmc4968684;;10.2147/copd.s109173;;27555756;;10.1002/jps.2600660104;;833720,"A. N. GRINEV, V. I. SHVEDOV, A. K. CHIZHOV, T. F. VLASOVA: ""Synthesis of aldehydes and nitriles in the 5-hydroxyindole series"", CHEMISTRY OF HETEROCYCLIC COMPOUNDS, vol. 11, 1975, pages 1087 - 1090, XP002803923;;AM J RESPIR CRIT CARE MED, vol. 168, no. 7, 2003, pages 818 - 900;;OGUSHI ET AL., J CLIN INVEST, vol. 80, no. 5, 1987, pages 1366 - 74;;TANASH ET AL., INT J CHRON OBSTRUCT PULM DIS, vol. 11, 2016, pages 1663 - 9;;PIITULAINENTANASH, COPD, vol. 12, no. 1, 2015, pages 36 - 41;;P. J. KOCIENSKI: ""Protecting Groups"", 1994, THIEME;;LLOYD, THE ART, SCIENCE AND TECHNOLOGY OF PHARMACEUTICAL COMPOUNDING, 1999;;S. M. BERGE ET AL., J. PHARMACEUTICAL SCIENCES, vol. 66, 1977, pages 1 - 19;;""Remington: The Science and Practice of Pharmacy"", 2005, LIPPINCOTT WILLIAMS & WILKINS;;""Encyclopedia of Pharmaceutical Technology"", 1988, MARCEL DEKKER",PENDING
897,GB,B,GB 2584026 B,153-816-384-702-749,2021-03-17,2021,GB 202010752 A,2014-09-15,US 201361877566 P;;US 201361877622 P;;US 201361877736 P;;US 201461971474 P;;US 201462032462 P;;GB 201917384 A,2013-09-13,A heater base for supplying humidified gases to a patient,,FISHER & PAYKEL HEALTHCARE LTD,JOHN JAMES JACKSON;;BARRY SHACK MANON;;VICTOR ROSALES CORRALES;;STEFAN LEO VAN WORKUM;;MICHAEL JOHN ANDRESEN;;STEPHEN DAVID EVANS;;MARK SAMUEL HAMILTON;;PAUL FLEMING BUCKLEY;;JASON ALLAN KLENNER;;HAMISH ADRIAN OSBORNE;;SAMUEL GRAHAM BOGGS;;JAMES WILLIAM STANTON;;JOSEPH NATHANIEL GRIFFITHS;;JONATHAN ANDREW GEORGE LAMBERT;;NICHOLAS EDWARD VAUGHAN;;JAMES OWEN KEHOE;;FRANCISCO ERNESTO DE LA PENA DE LA FUENTE;;NICHOLAS JAMES MICHAEL MCKENNA;;RACHAEL PORTER;;SIMON MORDECHAI STAM;;DAVID ROBERT KEMPS;;EDWIN JOSEPH LYONS;;MADELEINE BESS MARTIN;;HUANG-KU LIU;;ADA YIWEN SHOU,,https://lens.org/153-816-384-702-749,Granted Patent,no,3,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/16,,0,0,,,,ACTIVE
898,GB,B,GB 2583008 B,031-792-899-305-606,2020-12-30,2020,GB 201917384 A,2014-09-15,US 201361877566 P;;US 201361877622 P;;US 201361877736 P;;US 201461971474 P;;US 201462032462 P;;GB 201604541 A,2013-09-13,Humidification system,,FISHER & PAYKEL HEALTHCARE LTD,JOHN JAMES JACKSON;;BARRY SHACK MANON;;VICTOR ROSALES CORRALES;;STEFAN LEO VAN WORKUM;;MICHAEL JOHN ANDRESEN;;STEPHEN DAVID EVANS;;MARK SAMUEL HAMILTON;;PAUL FLEMING BUCKLEY;;JASON ALLAN KLENNER;;HAMISH ADRIAN OSBORNE;;SAMUEL GRAHAM BOGGS;;JAMES WILLIAM STANTON;;JOSEPH NATHANIEL GRIFFITHS;;JONATHAN ANDREW GEORGE LAMBERT;;NICHOLAS EDWARD VAUGHAN;;JAMES OWEN KEHOE;;FRANCISCO ERNESTO DE LA PENA DE LA FUENTE;;NICHOLAS JAMES MICHAEL MCKENNA;;RACHAEL PORTER;;SIMON MORDECHAI STAM;;DAVID ROBERT KEMPS;;EDWIN JOSEPH LYONS;;MADELEINE BESS MARTIN;;HUANG-KU LIU;;ADA YIWEN SHOU,,https://lens.org/031-792-899-305-606,Granted Patent,no,3,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/16,,0,0,,,,ACTIVE
899,US,A1,US 2016/0228671 A1,014-034-774-615-863,2016-08-11,2016,US 201415021616 A,2014-09-15,US 201415021616 A;;US 201361877566 P;;US 201361877622 P;;US 201361877736 P;;US 201461971474 P;;US 201462032462 P;;NZ 2014000202 W,2013-09-13,HUMIDIFICATION SYSTEM,"A humidification system can include a heater base, a chamber, and a breathing circuit. The heater base includes a heater plate positioned in a recessed region, and a heat conductive portion of the chamber is configured to contact the heater plate. The heater base includes a guard configured to control movement of the chamber into and out of the recessed region. The guard includes an anti-racking mechanism. The chamber includes an inlet port, an outlet port. A downward extension extends into the chamber from the inlet port, and a baffle is disposed at a lower end of the downward extension. A component of the breathing circuit can include a conduit hanging end cap for shipping and storage. The end cap can include a hanging component to allow the breathing circuit component to be hung from a medical stand. The system can detect when breathing circuits are connected in reverse.",FISHER & PAYKEL HEALTHCARE LTD,JACKSON JOHN JAMES;;MANON BARRY SHACK;;CORRALES VICTOR ROSALES;;VAN WORKUM STEFAN LEO;;ANDRESEN MICHAEL JOHN;;EVANS STEPHEN DAVID;;HAMILTON MARK SAMUEL;;BUCKLEY PAUL FLEMING;;KLENNER JASON ALLAN;;OSBORNE HAMISH;;BOGGS SAMUEL GRAHAM;;STANTON JAMES WILLIAM;;GRIFFITHS JOSEPH NATHANIEL;;LAMBERT JONATHAN ANDREW GEORGE;;VAUGHAN NICHOLAS EDWARD;;KEHOE JAMES OWEN;;DE LA FUENTE FRANCISCO ERNESTO DE LA PENA;;MCKENNA NICHOLAS JAMES MICHAEL;;PORTER RACHAEL;;STAM SIMON MORDECHAI;;KEMPS DAVID ROBERT;;LYONS EDWIN JOSEPH;;MARTIN MADELEINE BESS;;SHOU ADA YIWEN;;LIU HUANG-KU,FISHER & PAYKEL HEALTHCARE LIMITED (2016-05-10),https://lens.org/014-034-774-615-863,Patent Application,yes,18,23,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/16;;A61M16/08;;A61M16/10,,1,1,094-336-926-853-533,19467849;;10.1016/j.rmed.2009.04.007,Dysart K et al. Research in high flow therapy: mechanisms of action. Respir Med. 2009 Oct;103(10):1400-5.,ACTIVE
900,GB,A,GB 2533515 A,048-370-267-402-413,2016-06-22,2016,GB 201604541 A,2014-09-15,US 201361877566 P;;US 201361877736 P;;US 201361877622 P;;US 201462032462 P;;US 201461971474 P;;NZ 2014000202 W,2013-09-13,Humidification system,"A humidification system can include a heater base, a chamber, and a breathing circuit. The heater base includes a heater plate positioned in a recessed region, and a heat conductive portion of the chamber is configured to contact the heater plate. The heater base includes a guard configured to control movement of the chamber into and out of the recessed region. The guard includes an anti-racking mechanism. The system can detect when breathing circuits are connected in reverse. Methods of controlling the respiratory humidification system are described, including determining whether an outlet port temperature has increased by more than a predetermined amount in a predetermined time, or setting a target dew point. The system may comprise an inspiratory conduit comprising an identification component that outputs a signal to a controller configured to control power to a heater plate.",FISHER & PAYKEL HEALTHCARE LTD,HUANG-KU LIU;;ADA YIWEN SHOU;;JOHN JAMES JACKSON;;BARRY SHACK MASON;;VICTOR ROSALES CORRALES;;STEFAN LEO VAN WORKUM;;MICHAEL JOHN ANDRESEN;;STEPHEN DAVID EVANS;;MARK SAMUEL HAMILTON;;PAUL FLEMING BUCKLEY;;JASON ALLAN KLENNER;;HAMISH OSBORNE;;SAMUEL GRAHAM BOGGS;;JAMES WILLIAM STANTON;;JOSEPH NATHANIEL GRIFFITHS;;JONATHAN ANDREW GREORGE LAMBERT;;NICHOLAS EDWARD VAUGHAN;;JAMES OWEN KEHOE;;FRANCISCO ERNESTO DE LA PENA DE LA FUENTE;;NICHOLAS JAMES MICHAEL MCKENNA;;RACHAEL PORTER;;SIMON MORDECHAI STAM;;DAVID ROBERT KEMPS;;EDWIN JOSEPH LYONS;;MADELEINE BESS MARTIN,,https://lens.org/048-370-267-402-413,Patent Application,no,18,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/16;;A61M16/08,,0,0,,,,ACTIVE
901,AU,A1,AU 2022/201383 A1,008-893-414-215-493,2022-03-24,2022,AU 2022/201383 A,2022-02-28,AU 2022/201383 A;;AU 2019/283948 A;;AU 2014/319043 A;;US 201462032462 P;;US 201361877622 P;;US 201361877566 P;;US 201461971474 P;;US 201361877736 P;;NZ 2014000202 W,2013-09-13,HUMIDIFICATION SYSTEM,"HUMIDIFICATION SYSTEM A humidification system can include a heater base, a chamber, and a breathing circuit. The heater base includes a heater plate positioned in a recessed region, and a heat conductive portion of the chamber is configured to contact the heater plate. The heater base includes a guard configured to control movement of the chamber into and out of the recessed region. The guard includes an anti-racking mechanism. The chamber includes an inlet port, an outlet port. A downward extension extends into the chamber from the inlet port, and a baffle is disposed at a lower end of the downward extension. A component of the breathing circuit can include a conduit hanging end cap for shipping and storage. The end cap can include a hanging component to allow the breathing circuit component to be hung from a medical stand. The system can detect when breathing circuits are connected in reverse.",FISHER & PAYKEL HEALTHCARE LTD,JACKSON JOHN JAMES;;MANON BARRY SHACK;;CORRALES VICTOR ROSALES;;VAN WORKUM STEFAN LEO;;EVANS STEPHEN DAVID;;HAMILTON MARK SAMUEL;;BUCKLEY PAUL FLEMING;;KLENNER JASON ALLAN;;OSBORNE HAMISH;;BOGGS SAMUEL GRAHAM;;STANTON JAMES WILLIAM;;GRIFFITHS JOSEPH NATHANIEL;;LAMBERT JONATHAN ANDREW GEORGE;;VAUGHAN NICHOLAS EDWARD;;KEHOE JAMES OWEN;;DE LA FUENT FRANCISCO ERNESTO DE LA PENA;;MCKENNA NICHOLAS JAMES MICHAEL;;PORTER RACHAEL;;STAM SIMON MORDECHAI;;KEMPS DAVID ROBERT;;LYONS EDWIN JOSEPH;;MARTIN MADELEINE BESS;;SHOU ADA YIWEN;;LIU HUANG-KU;;ANDRESEN MICHAEL JOHN,,https://lens.org/008-893-414-215-493,Patent Application,no,0,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/16,,0,0,,,,PENDING
902,US,A1,US 2023/0181866 A1,038-261-895-944-242,2023-06-15,2023,US 202218046081 A,2022-10-12,US 202218046081 A;;US 201615021616 A;;NZ 2014000202 W;;US 201361877566 P;;US 201361877622 P;;US 201361877736 P;;US 201461971474 P;;US 201462032462 P,2013-09-13,HUMIDIFICATION SYSTEM,"A humidification system can include a heater base, a chamber, and a breathing circuit. The heater base includes a heater plate positioned in a recessed region, and a heat conductive portion of the chamber is configured to contact the heater plate. The heater base includes a guard configured to control movement of the chamber into and out of the recessed region. The guard includes an anti-racking mechanism. The chamber includes an inlet port, an outlet port. A downward extension extends into the chamber from the inlet port, and a baffle is disposed at a lower end of the downward extension. A component of the breathing circuit can include a conduit hanging end cap for shipping and storage. The end cap can include a hanging component to allow the breathing circuit component to be hung from a medical stand. The system can detect when breathing circuits are connected in reverse.",FISHER & PAYKEL HEALTHCARE LTD,JACKSON JOHN JAMES;;MANON BARRY SHACK;;CORRALES VICTOR ROSALES;;VAN WORKUM STEFAN LEO;;ANDRESEN MICHAEL JOHN;;EVANS STEPHEN DAVID;;HAMILTON MARK SAMUEL;;BUCKLEY PAUL FLEMING;;KLENNER JASON ALLAN;;OSBORNE HAMISH;;BOGGS SAMUEL GRAHAM;;STANTON JAMES WILLIAM;;GRIFFITHS JOSEPH NATHANIEL;;LAMBERT JONATHAN ANDREW GEORGE;;VAUGHAN NICHOLAS EDWARD;;KEHOE JAMES OWEN;;DE LA PEÑA DE LA FUENTE FRANCISCO ERNESTO;;MCKENNA NICHOLAS JAMES MICHAEL;;PORTER RACHAEL;;STAM SIMON MORDECHAI;;KEMPS DAVID ROBERT;;LYONS EDWIN JOSEPH;;MARTIN MADELEINE BESS;;SHOU ADA YIWEN;;LIU HUANG-KU,FISHER & PAYKEL HEALTHCARE LIMITED (2016-05-10),https://lens.org/038-261-895-944-242,Patent Application,yes,0,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/16;;A61M16/08;;A61M16/10,,0,0,,,,PENDING
903,CN,A,CN 115916749 A,065-542-149-493-750,2023-04-04,2023,CN 202180039825 A,2021-04-02,US 202063004713 P;;US 2021/0025591 W,2020-04-03,Substituted 5-hydroxyindole compounds as alpha-1 antitrypsin modulators,"Novel compounds, compositions, and methods of use and preparation thereof, which are useful for the treatment of alpha-1 antitrypsin deficiency (AATD).",VERTEX PHARMA,GIROUX SIMON;;CLARK MICHAEL P;;TANG QIWEI;;NUHANT PAUL M;;JONES PAUL;;MERCESMITH DANIEL;;BANDARAGE UPUL K;;COTTRELL KEVIN MICHAEL;;BRODNEY MICHAEL AARON;;FLEMING GARY S;;WANG JUN;;SUH JUNGWON;;DANIEL KEVIN B;;BOYD MICHAEL J;;MORRIS MARK A;;WAHL NATHAN D;;COLLIER PHILIP N;;KESAVAN SHIVKUMAR;;RONKIN STEVEN M;;DENG HONGLI;;BOUCHER DAVID M;;FANNING LEV T D;;HALL ANDREW B;;HURLEY DENNIS J;;JOHNSON MICHAEL A JR;;MAXWELL JOHN P;;SWEET RAYMOND J;;TAPLEY TIMOTHY L;;THOMSON STEPHEN A;;DAMARNIEZ VICTORIA,,https://lens.org/065-542-149-493-750,Patent Application,no,0,0,7,7,0,C07D209/10;;C07D209/14;;C07D209/12;;C07D209/22;;C07D209/24;;C07D209/42;;C07D401/04;;C07D405/04;;C07D403/04;;C07D405/14;;C07D409/04;;A61P11/00;;A61P29/00;;A61P43/00;;C07D209/22;;C07D209/24;;C07D401/04;;C07D403/04;;C07D405/04;;C07D405/14;;C07D409/04;;C07D413/06;;C07D413/14,C07D209/10;;A61K31/404;;A61P11/00;;A61P29/00;;A61P43/00;;C07D209/12;;C07D209/14;;C07D209/22;;C07D209/24;;C07D209/42;;C07D401/04;;C07D403/04;;C07D405/04;;C07D405/14;;C07D409/04,,0,0,,,,PENDING
904,GB,B,GB 2533515 B,111-036-634-578-285,2020-01-15,2020,GB 201604541 A,2014-09-15,US 201361877566 P;;US 201361877736 P;;US 201361877622 P;;US 201462032462 P;;US 201461971474 P;;NZ 2014000202 W,2013-09-13,Heater base with a front guard and an anti-racking mechanism,,FISHER & PAYKEL HEALTHCARE LTD,HUANG-KU LIU;;ADA YIWEN SHOU;;JOHN JAMES JACKSON;;BARRY SHACK MANON;;VICTOR ROSALES CORRALES;;STEFAN LEO VAN WORKUM;;MICHAEL JOHN ANDRESEN;;STEPHEN DAVID EVANS;;MARK SAMUEL HAMILTON;;PAUL FLEMING BUCKLEY;;JASON ALLAN KLENNER;;HAMISH ADRIAN OSBORNE;;SAMUEL GRAHAM BOGGS;;JAMES WILLIAM STANTON;;JOSEPH NATHANIEL GRIFFITHS;;JONATHAN ANDREW GEORGE LAMBERT;;NICHOLAS EDWARD VAUGHAN;;JAMES OWEN KEHOE;;FRANCISCO ERNESTO DE LA PENA DE LA FUENTE;;NICHOLAS JAMES MICHAEL MCKENNA;;RACHAEL PORTER;;SIMON MORDECHAI STAM;;DAVID ROBERT KEMPS;;EDWIN JOSEPH LYONS;;MADELEINE BESS MARTIN,,https://lens.org/111-036-634-578-285,Granted Patent,no,18,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/16;;A61M16/08,,0,0,,,,ACTIVE
905,US,A1,US 2023/0339915 A1,110-237-703-825-345,2023-10-26,2023,US 202117916388 A,2021-04-02,US 202117916388 A;;US 202063004713 P;;US 2021/0025591 W,2020-04-03,MODULATORS OF ALPHA-1 ANTITRYPSIN,"Novel compounds, compositions, and methods of using and preparing the same, which maybe useful for treating alpha-1 antitrypsin deficiency (AATD).",VERTEX PHARMA,GIROUX SIMON;;CLARK MICHAEL PHILIP;;TANG QING;;NUHANT PHILIPPE MARCEL;;JONES PETER;;MESSERSMITH DAVID;;BANDARAGE UPUL KEERTHI;;COTTRELL KEVIN MICHAEL;;BRODNEY MICHAEL AARON;;FLEMING GABRIELLE SIMONE;;WANG JIAN;;XU JINWANG;;DANIEL KEVIN BRETT;;BOYD MICHAEL JOHN;;MORRIS MARK A;;WAAL NATHAN D;;COLLIER PHILIP NOEL;;KESAVAN SARATHY;;RONKIN STEVEN M;;DENG HONGBO;;BOUCHER DIANE MARIE;;FANNING LEV T D;;HALL AMY B;;HURLEY DENNIS JAMES;;JOHNSON JR MAC ARTHUR;;MAXWELL JOHN PATRICK;;SWETT REBECCA JANE;;TAPLEY TIMOTHY LEWIS;;THOMSON STEPHEN A;;DAMAGNEZ VERONIQUE,VERTEX PHARMACEUTICALS (SAN DIEGO) LLC (2021-03-10);;VERTEX PHARMACEUTICALS INCORPORATED (2021-01-19),https://lens.org/110-237-703-825-345,Patent Application,yes,0,0,7,7,0,C07D209/10;;C07D209/14;;C07D209/12;;C07D209/22;;C07D209/24;;C07D209/42;;C07D401/04;;C07D405/04;;C07D403/04;;C07D405/14;;C07D409/04;;A61P11/00;;A61P29/00;;A61P43/00;;C07D209/22;;C07D209/24;;C07D401/04;;C07D403/04;;C07D405/04;;C07D405/14;;C07D409/04;;C07D413/06;;C07D413/14,C07D209/22;;C07D405/04;;C07D209/24;;C07D401/04;;C07D403/04;;C07D405/14;;C07D409/04;;C07D413/06;;C07D413/14,,0,0,,,,PENDING
906,EP,A1,EP 4126817 A1,184-874-029-037-131,2023-02-08,2023,EP 21732608 A,2021-04-02,US 202063004713 P;;US 2021/0025591 W,2020-04-03,SUBSTITUTED 5-HYDROXYINDOLE COMPOUNDS AS MODULATORS OF ALPHA-1 ANTITRYPSIN,,VERTEX PHARMA,GIROUX SIMON;;CLARK MICHAEL PHILIP;;TANG QING;;NUHANT PHILIPPE MARCEL;;JONES PETER;;MESSERSMITH DAVID;;BANDARAGE UPUL KEERTHI;;COTTRELL KEVIN MICHAEL;;BRODNEY MICHAEL AARON;;FLEMING GABRIELLE SIMONE;;WANG JIAN;;XU JINWANG;;DANIEL KEVIN BRETT;;BOYD MICHAEL JOHN;;MORRIS MARK A;;WAAL NATHAN D;;COLLIER PHILIP NOEL;;KESAVAN SARATHY;;RONKIN STEVEN M;;DENG HONGBO;;BOUCHER DIANE MARIE;;FANNING LEV T D;;HALL AMY B;;HURLEY DENNIS JAMES;;JOHNSON JR MAC ARTHUR;;MAXWELL JOHN PATRICK;;SWETT REBECCA JANE;;TAPLEY TIMOTHY LEWIS;;THOMSON STEPHEN A;;DAMAGNEZ VERONIQUE,,https://lens.org/184-874-029-037-131,Patent Application,yes,0,0,7,7,0,C07D209/10;;C07D209/14;;C07D209/12;;C07D209/22;;C07D209/24;;C07D209/42;;C07D401/04;;C07D405/04;;C07D403/04;;C07D405/14;;C07D409/04;;A61P11/00;;A61P29/00;;A61P43/00;;C07D209/22;;C07D209/24;;C07D401/04;;C07D403/04;;C07D405/04;;C07D405/14;;C07D409/04;;C07D413/06;;C07D413/14,C07D209/10;;A61K31/404;;A61P11/00;;A61P29/00;;A61P43/00;;C07D209/12;;C07D209/14;;C07D209/22;;C07D209/24;;C07D209/42;;C07D401/04;;C07D403/04;;C07D405/04;;C07D405/14;;C07D409/04,,0,0,,,,PENDING
907,EP,B1,EP 3622993 B1,183-376-847-417-55X,2021-07-21,2021,EP 19206758 A,2014-09-15,US 201361877566 P;;US 201361877622 P;;US 201361877736 P;;US 201461971474 P;;US 201462032462 P;;EP 14843707 A;;NZ 2014000202 W,2013-09-13,HEATER BASE HAVING A GUARD TO CONTROL THE MOVEMENT OF A HUMIDIFICATION CHAMBER,,FISHER & PAYKEL HEALTHCARE LTD,JACKSON JOHN JAMES;;MANON BARRY SHACK;;CORRALES VICTOR ROSALES;;VAN WORKUM STEFAN LEO;;ANDRESEN MICHAEL JOHN;;EVANS STEPHEN DAVID;;HAMILTON MARK SAMUEL;;BUCKLEY PAUL FLEMING;;KLENNER JASON ALLAN;;OSBORNE HAMISH;;BOGGS SAMUEL GRAHAM;;STANTON JAMES WILLIAM;;GRIFFITHS JOSEPH NATHANIEL;;LAMBERT JONATHAN ANDREW GEORGE;;VAUGHAN NICHOLAS EDWARD;;KEHOE JAMES OWEN;;DE LA FUENTE FRANCISCO ERNESTO DE LA PENA;;MCKENNA NICHOLAS JAMES MICHAEL;;PORTER RACHAEL;;STAM SIMON MORDECHAI;;KEMPS DAVID ROBERT;;LYONS EDWIN JOSEPH;;MARTIN MADELEINE BESS;;LIU HUANG-KU;;SHOU ADA YIWEN,,https://lens.org/183-376-847-417-55X,Granted Patent,yes,3,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/00;;A61M16/08;;A61M16/10;;A61M16/16,,0,0,,,,ACTIVE
908,AU,B2,AU 2019/283948 B2,170-884-894-086-166,2021-12-09,2021,AU 2019/283948 A,2019-12-19,AU 2019/283948 A;;AU 2014/319043 A;;US 201462032462 P;;US 201361877622 P;;US 201361877566 P;;US 201461971474 P;;US 201361877736 P;;NZ 2014000202 W,2013-09-13,HUMIDIFICATION SYSTEM,"HUMIDIFICATION SYSTEM A humidification system can include a heater base, a chamber, and a breathing circuit. The heater base includes a heater plate positioned in a recessed region, and a heat conductive portion of the chamber is configured to contact the heater plate. The heater base includes a guard configured to control movement of the chamber into and out of the recessed region. The guard includes an anti-racking mechanism. The chamber includes an inlet port, an outlet port. A downward extension extends into the chamber from the inlet port, and a baffle is disposed at a lower end of the downward extension. A component of the breathing circuit can include a conduit hanging end cap for shipping and storage. The end cap can include a hanging component to allow the breathing circuit component to be hung from a medical stand. The system can detect when breathing circuits are connected in reverse.",FISHER & PAYKEL HEALTHCARE LTD,JACKSON JOHN JAMES;;MANON BARRY SHACK;;CORRALES VICTOR ROSALES;;VAN WORKUM STEFAN LEO;;EVANS STEPHEN DAVID;;HAMILTON MARK SAMUEL;;BUCKLEY PAUL FLEMING;;KLENNER JASON ALLAN;;OSBORNE HAMISH;;BOGGS SAMUEL GRAHAM;;STANTON JAMES WILLIAM;;GRIFFITHS JOSEPH NATHANIEL;;LAMBERT JONATHAN ANDREW GEORGE;;VAUGHAN NICHOLAS EDWARD;;KEHOE JAMES OWEN;;DE LA FUENTE FRANCISCO ERNESTO DE LA PENA;;MCKENNA NICHOLAS JAMES MICHAEL;;PORTER RACHAEL;;STAM SIMON MORDECHAI;;KEMPS DAVID ROBERT;;LYONS EDWIN JOSEPH;;MARTIN MADELEINE BESS;;SHOU ADA YIWEN;;LIU HUANG-KU;;ANDRESEN MICHAEL JOHN,,https://lens.org/170-884-894-086-166,Granted Patent,no,3,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/16,,0,0,,,,ACTIVE
909,EP,B8,EP 3622993 B8,059-093-743-335-765,2021-08-25,2021,EP 19206758 A,2014-09-15,US 201361877566 P;;US 201361877622 P;;US 201361877736 P;;US 201461971474 P;;US 201462032462 P;;EP 14843707 A;;NZ 2014000202 W,2013-09-13,HEATER BASE HAVING A GUARD TO CONTROL THE MOVEMENT OF A HUMIDIFICATION CHAMBER,,FISHER & PAYKEL HEALTHCARE LTD,JACKSON JOHN JAMES;;MANON BARRY SHACK;;CORRALES VICTOR ROSALES;;VAN WORKUM STEFAN LEO;;ANDRESEN MICHAEL JOHN;;EVANS STEPHEN DAVID;;HAMILTON MARK SAMUEL;;BUCKLEY PAUL FLEMING;;KLENNER JASON ALLAN;;OSBORNE HAMISH;;BOGGS SAMUEL GRAHAM;;STANTON JAMES WILLIAM;;GRIFFITHS JOSEPH NATHANIEL;;LAMBERT JONATHAN ANDREW GEORGE;;VAUGHAN NICHOLAS EDWARD;;KEHOE JAMES OWEN;;DE LA FUENTE FRANCISCO ERNESTO DE LA PENA;;MCKENNA NICHOLAS JAMES MICHAEL;;PORTER RACHAEL;;STAM SIMON MORDECHAI;;KEMPS DAVID ROBERT;;LYONS EDWIN JOSEPH;;MARTIN MADELEINE BESS;;LIU HUANG-KU;;SHOU ADA YIWEN,,https://lens.org/059-093-743-335-765,Amended Patent,yes,3,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/00;;A61M16/08;;A61M16/10;;A61M16/16,,0,0,,,,ACTIVE
910,GB,A,GB 2584025 A,095-835-330-037-087,2020-11-18,2020,GB 202010750 A,2014-09-15,US 201361877566 P;;US 201361877622 P;;US 201361877736 P;;US 201461971474 P;;US 201462032462 P;;GB 201917384 A,2013-09-13,Humidification system,"The assembly 2900 comprises a heater plate (2903, fig 29C) a heating element (2930) and a heater plate set 2925 having one or more insulation layers located between the plate and element. The heater plate may be mounted on springs allowing the assembly to be depressed during installation of a humidification chamber. The assembly may comprise a back plate and a back plate set 2920 comprising at least one insulation layer located between the back plate and the opposite side of the heating element. The assembly may comprise two wires and insulation pieces 2915 to insulate the wires from the back plate. The heating element may comprise a flat filament wound around a non-conductive core.",FISHER & PAYKEL HEALTHCARE LTD,JOHN JAMES JACKSON;;BARRY SHACK MANON;;VICTOR ROSALES CORRALES;;STEFAN LEO VAN WORKUM;;MICHAEL JOHN ANDRESEN;;STEPHEN DAVID EVANS;;MARK SAMUEL HAMILTON;;PAUL FLEMING BUCKLEY;;JASON ALLAN KLENNER;;HAMISH ADRIAN OSBORNE;;SAMUEL GRAHAM BOGGS;;JAMES WILLIAM STANTON;;JOSEPH NATHANIEL GRIFFITHS;;JONATHAN ANDREW GEORGE LAMBERT;;NICHOLAS EDWARD VAUGHAN;;JAMES OWEN KEHOE;;FRANCISCO ERNESTO DE LA PENA DE LA FUENTE;;NICHOLAS JAMES MICHAEL MCKENNA;;RACHAEL PORTER;;SIMON MORDECHAI STAM;;DAVID ROBERT KEMPS;;EDWIN JOSEPH LYONS;;MADELEINE BESS MARTIN;;HUANG-KU LIU;;ADA YIWEN SHOU,,https://lens.org/095-835-330-037-087,Patent Application,no,2,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/16;;A61M16/10,,0,0,,,,ACTIVE
911,CA,A1,CA 3176048 A1,105-019-368-061-977,2015-03-19,2015,CA 3176048 A,2014-09-15,US 201361877566 P;;US 201361877622 P;;US 201361877736 P;;US 201461971474 P;;US 201462032462 P;;CA 2924039 A,2013-09-13,HUMIDIFICATION SYSTEM,"A humidification system can include a heater base, a chamber, and a breathing circuit. The heater base includes a heater plate positioned in a recessed region, and a heat conductive portion of the chamber is configured to contact the heater plate. The heater base includes a guard configured to control movement of the chamber into and out of the recessed region. The guard includes an anti-racking mechanism. The system can detect when breathing circuits are connected in reverse. Methods of controlling the respiratory humidification system are described, including determining whether an outlet port temperature has increased by more than a predetermined amount in a predetemined time, or setting a target dew point. The system may comprise an inspiratory conduit comprising an identification component that outputs a signal to a controller configured to control power to a heater plate.",FISHER AND PAYKEL HEALTHCARE LTD,JACKSON JOHN JAMES;;MANON BARRY SHACK;;CORRALES VICTOR ROSALES;;VAN WORKUM STEFAN LEO;;ANDRESEN MICHAEL JOHN;;EVANS STEPHEN DAVID;;HAMILTON MARK SAMUEL;;BUCKLEY PAUL FLEMING;;KLENNER JASON ALLAN;;OSBORNE HAMISH;;BOGGS SAMUEL GRAHAM;;STANTON JAMES WILLIAM;;GRIFFITHS JOSEPH NATHANIEL;;LAMBERT JONATHAN ANDREW GEORGE;;VAUGHAN NICHOLAS EDWARD;;KEHOE JAMES OWEN;;DE LA FUENTE FRANCISCO ERNESTO DE LA PENA;;MCKENNA NICHOLAS JAMES MICHAEL;;PORTER RACHAEL;;STAM SIMON MORDECHAI;;KEMPS DAVID ROBERT;;LYONS EDWIN JOSEPH;;MARTIN MADELEINE BESS;;SHOU ADA YIWEN;;LIU HUANG-KU,,https://lens.org/105-019-368-061-977,Patent Application,no,0,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/16,,0,0,,,,PENDING
912,GB,B,GB 2584025 B,061-121-487-692-647,2021-03-10,2021,GB 202010750 A,2014-09-15,US 201361877566 P;;US 201361877622 P;;US 201361877736 P;;US 201461971474 P;;US 201462032462 P;;GB 201917384 A,2013-09-13,Heater plate for a humidification system,,FISHER & PAYKEL HEALTHCARE LTD,JOHN JAMES JACKSON;;BARRY SHACK MANON;;VICTOR ROSALES CORRALES;;STEFAN LEO VAN WORKUM;;MICHAEL JOHN ANDRESEN;;STEPHEN DAVID EVANS;;MARK SAMUEL HAMILTON;;PAUL FLEMING BUCKLEY;;JASON ALLAN KLENNER;;HAMISH ADRIAN OSBORNE;;SAMUEL GRAHAM BOGGS;;JAMES WILLIAM STANTON;;JOSEPH NATHANIEL GRIFFITHS;;JONATHAN ANDREW GEORGE LAMBERT;;NICHOLAS EDWARD VAUGHAN;;JAMES OWEN KEHOE;;FRANCISCO ERNESTO DE LA PENA DE LA FUENTE;;NICHOLAS JAMES MICHAEL MCKENNA;;RACHAEL PORTER;;SIMON MORDECHAI STAM;;DAVID ROBERT KEMPS;;EDWIN JOSEPH LYONS;;MADELEINE BESS MARTIN;;HUANG-KU LIU;;ADA YIWEN SHOU,,https://lens.org/061-121-487-692-647,Granted Patent,no,2,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/16;;A61M16/10,,0,0,,,,ACTIVE
913,EP,A1,EP 3622993 A1,083-380-548-236-528,2020-03-18,2020,EP 19206758 A,2014-09-15,US 201361877566 P;;US 201361877622 P;;US 201361877736 P;;US 201461971474 P;;US 201462032462 P;;EP 14843707 A;;NZ 2014000202 W,2013-09-13,HEATER BASE HAVING A GUARD TO CONTROL THE MOVEMENT OF AN HUMIFIER CHAMBER,"A humidification system can include a heater base (202), a chamber, and a breathing circuit. The heater base (108) includes a heater plate positioned in a recessed region, and a heat conductive portion of the chamber is configured to contact the heater plate. The heater base includes a guard (107) configured to control movement of the chamber into and out of the recessed region. The guard includes an anti-racking mechanism. The chamber includes an inlet port, an outlet port. A downward extension extends into the chamber from the inlet port, and a baffle is disposed at a lower end of the downward extension. A component of the breathing circuit can include a conduit hanging end cap for shipping and storage. The end cap can include a hanging component to allow the breathing circuit component to be hung from a medical stand. The system can detect when breathing circuits are connected in reverse.
",FISHER & PAYKEL HEALTHCARE LTD,JACKSON JOHN JAMES;;MANON BARRY SHACK;;CORRALES VICTOR ROSALES;;VAN WORKUM STEFAN LEO;;ANDRESEN MICHAEL JOHN;;EVANS STEPHEN DAVID;;HAMILTON MARK SAMUEL;;BUCKLEY PAUL FLEMING;;KLENNER JASON ALLAN;;OSBORNE HAMISH;;BOGGS SAMUEL GRAHAM;;STANTON JAMES WILLIAM;;GRIFFITHS JOSEPH NATHANIEL;;LAMBERT JONATHAN ANDREW GEORGE;;VAUGHAN NICHOLAS EDWARD;;KEHOE JAMES OWEN;;DE LA FUENTE FRANCISCO ERNESTO DE LA PENA;;MCKENNA NICHOLAS JAMES MICHAEL;;PORTER RACHAEL;;STAM SIMON MORDECHAI;;KEMPS DAVID ROBERT;;LYONS EDWIN JOSEPH;;MARTIN MADELEINE BESS;;LIU HUANG-KU;;SHOU ADA YIWEN,,https://lens.org/083-380-548-236-528,Patent Application,yes,3,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/00;;A61M16/08;;A61M16/10;;A61M16/16,,2,0,,,"CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 123-94-4;;""Standard Practice for Surface Wettability of Coatings, Substrates and Pigments by Advancing Contact Angle Measurement"", ASTM STANDARD D7334, 2008",ACTIVE
914,CA,A1,CA 2924039 A1,104-836-576-469-137,2015-03-19,2015,CA 2924039 A,2014-09-15,US 201361877566 P;;US 201361877622 P;;US 201361877736 P;;US 201461971474 P;;US 201462032462 P;;NZ 2014000202 W,2013-09-13,HUMIDIFICATION SYSTEM,"A humidification system can include a heater base, a chamber, and a breathing circuit. The heater base includes a heater plate positioned in a recessed region, and a heat conductive portion of the chamber is configured to contact the heater plate. The heater base includes a guard configured to control movement of the chamber into and out of the recessed region. The guard includes an anti-racking mechanism. The system can detect when breathing circuits are connected in reverse. Methods of controlling the respiratory humidification system are described, including determining whether an outlet port temperature has increased by more than a predetermined amount in a predetermined time, or setting a target dew point. The system may comprise an inspiratory conduit comprising an identification component that outputs a signal to a controller configured to control power to a heater plate.",FISHER & PAYKEL HEALTHCARE LTD,JACKSON JOHN JAMES;;MANON BARRY SHACK;;CORRALES VICTOR ROSALES;;VAN WORKUM STEFAN LEO;;ANDRESEN MICHAEL JOHN;;EVANS STEPHEN DAVID;;HAMILTON MARK SAMUEL;;BUCKLEY PAUL FLEMING;;KLENNER JASON ALLAN;;OSBORNE HAMISH;;BOGGS SAMUEL GRAHAM;;STANTON JAMES WILLIAM;;GRIFFITHS JOSEPH NATHANIEL;;LAMBERT JONATHAN ANDREW GEORGE;;VAUGHAN NICHOLAS EDWARD;;KEHOE JAMES OWEN;;DE LA FUENTE FRANCISCO ERNESTO DE LA PENA;;MCKENNA NICHOLAS JAMES MICHAEL;;PORTER RACHAEL;;STAM SIMON MORDECHAI;;KEMPS DAVID ROBERT;;LYONS EDWIN JOSEPH;;MARTIN MADELEINE BESS;;SHOU ADA YIWEN;;LIU HUANG-KU,,https://lens.org/104-836-576-469-137,Patent Application,no,0,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/16,,0,0,,,,PENDING
915,CA,A1,CA 3177524 A1,138-872-970-896-470,2021-10-07,2021,CA 3177524 A,2021-04-02,US 202063004713 P;;US 2021/0025591 W,2020-04-03,MODULATORS OF ALPHA-1 ANTITRYPSIN,"Novel compounds, compositions, and methods of using and preparing the same, which may be useful for treating alpha-1 antitrypsin deficiency (AATD).",VERTEX PHARMA,GIROUX SIMON;;CLARK MICHAEL PHILIP;;TANG QING;;NUHANT PHILIPPE MARCEL;;JONES PETER;;MESSERSMITH DAVID;;BANDARAGE UPUL KEERTHI;;COTTRELL KEVIN MICHAEL;;BRODNEY MICHAEL AARON;;FLEMING GABRIELLE SIMONE;;WANG JIAN;;XU JINWANG;;DANIEL KEVIN BRETT;;BOYD MICHAEL JOHN;;MORRIS MARK A;;WAAL NATHAN D;;COLLIER PHILIP NOEL;;KESAVAN SARATHY;;RONKIN STEVEN M;;DENG HONGBO;;BOUCHER DIANE MARIE;;FANNING LEV T D;;HALL AMY B;;HURLEY DENNIS JAMES;;JOHNSON JR;;MAXWELL JOHN PATRICK;;SWETT REBECCA JANE;;TAPLEY TIMOTHY LEWIS;;THOMSON STEPHEN A;;DAMAGNEZ VERONIQUE,,https://lens.org/138-872-970-896-470,Patent Application,no,0,0,7,7,0,C07D209/10;;C07D209/14;;C07D209/12;;C07D209/22;;C07D209/24;;C07D209/42;;C07D401/04;;C07D405/04;;C07D403/04;;C07D405/14;;C07D409/04;;A61P11/00;;A61P29/00;;A61P43/00;;C07D209/22;;C07D209/24;;C07D401/04;;C07D403/04;;C07D405/04;;C07D405/14;;C07D409/04;;C07D413/06;;C07D413/14,A61K31/404;;A61P11/00;;A61P29/00;;A61P43/00;;C07D209/10;;C07D209/12;;C07D209/14;;C07D209/22;;C07D209/24;;C07D209/42;;C07D401/04;;C07D403/04;;C07D405/04;;C07D405/14;;C07D409/04,,0,0,,,,PENDING
916,EP,A4,EP 3043854 A4,178-947-190-775-410,2017-04-26,2017,EP 14843707 A,2014-09-15,US 201361877566 P;;US 201361877622 P;;US 201361877736 P;;US 201461971474 P;;US 201462032462 P;;NZ 2014000202 W,2013-09-13,HUMIDIFICATION SYSTEM,,FISHER & PAYKEL HEALTHCARE LTD,JACKSON JOHN JAMES;;MANON BARRY SHACK;;CORRALES VICTOR ROSALES;;VAN WORKUM STEFAN LEO;;ANDRESEN MICHAEL JOHN;;EVANS STEPHEN DAVID;;HAMILTON MARK SAMUEL;;BUCKLEY PAUL FLEMING;;KLENNER JASON ALLAN;;OSBORNE HAMISH;;BOGGS SAMUEL GRAHAM;;STANTON JAMES WILLIAM;;GRIFFITHS JOSEPH NATHANIEL;;LAMBERT JONATHAN ANDREW GEORGE;;VAUGHAN NICHOLAS EDWARD;;KEHOE JAMES OWEN;;DE LA FUENTE FRANCISCO ERNESTO DE LA PENA;;MCKENNA NICHOLAS JAMES MICHAEL;;PORTER RACHAEL;;STAM SIMON MORDECHAI;;KEMPS DAVID ROBERT;;LYONS EDWIN JOSEPH;;MARTIN MADELEINE BESS;;LIU HUANG-KU;;SHOU ADA YIWEN,,https://lens.org/178-947-190-775-410,Search Report,no,3,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/16;;A61M16/00;;A61M16/08;;A61M16/10;;A61M39/08;;B29C53/78;;F16L11/16,,1,0,,,See also references of WO 2015038014A1,ACTIVE
917,EP,B1,EP 3043854 B1,014-941-299-492-786,2019-11-06,2019,EP 14843707 A,2014-09-15,US 201361877566 P;;US 201361877622 P;;US 201361877736 P;;US 201461971474 P;;US 201462032462 P;;NZ 2014000202 W,2013-09-13,HUMIDIFICATION SYSTEM,,FISHER & PAYKEL HEALTHCARE LTD,JACKSON JOHN JAMES;;MANON BARRY SHACK;;CORRALES VICTOR ROSALES;;VAN WORKUM STEFAN LEO;;ANDRESEN MICHAEL JOHN;;EVANS STEPHEN DAVID;;HAMILTON MARK SAMUEL;;BUCKLEY PAUL FLEMING;;KLENNER JASON ALLAN;;OSBORNE HAMISH;;BOGGS SAMUEL GRAHAM;;STANTON JAMES WILLIAM;;GRIFFITHS JOSEPH NATHANIEL;;LAMBERT JONATHAN ANDREW GEORGE;;VAUGHAN NICHOLAS EDWARD;;KEHOE JAMES OWEN;;DE LA FUENTE FRANCISCO ERNESTO DE LA PENA;;MCKENNA NICHOLAS JAMES MICHAEL;;PORTER RACHAEL;;STAM SIMON MORDECHAI;;KEMPS DAVID ROBERT;;LYONS EDWIN JOSEPH;;MARTIN MADELEINE BESS;;LIU HUANG-KU;;SHOU ADA YIWEN,,https://lens.org/014-941-299-492-786,Granted Patent,yes,21,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/16;;A61M16/00;;A61M16/08;;A61M16/10;;A61M39/08;;B29C53/78;;F16L11/16,,0,0,,,,ACTIVE
918,CA,C,CA 2924039 C,050-197-259-671-002,2023-01-17,2023,CA 2924039 A,2014-09-15,US 201361877566 P;;US 201361877622 P;;US 201361877736 P;;US 201461971474 P;;US 201462032462 P;;NZ 2014000202 W,2013-09-13,HUMIDIFICATION SYSTEM,"A humidification system can include a heater base, a chamber, and a breathing circuit. The heater base includes a heater plate positioned in a recessed region, and a heat conductive portion of the chamber is configured to contact the heater plate. The heater base includes a guard configured to control movement of the chamber into and out of the recessed region. The guard includes an anti-racking mechanism. The system can detect when breathing circuits are connected in reverse. Methods of controlling the respiratory humidification system are described, including determining whether an outlet port temperature has increased by more than a predetermined amount in a predetermined time, or setting a target dew point. The system may comprise an inspiratory conduit comprising an identification component that outputs a signal to a controller configured to control power to a heater plate.",FISHER AND PAYKEL HEALTHCARE LTD,JACKSON JOHN JAMES;;MANON BARRY SHACK;;CORRALES VICTOR ROSALES;;VAN WORKUM STEFAN LEO;;ANDRESEN MICHAEL JOHN;;EVANS STEPHEN DAVID;;HAMILTON MARK SAMUEL;;BUCKLEY PAUL FLEMING;;KLENNER JASON ALLAN;;OSBORNE HAMISH;;BOGGS SAMUEL GRAHAM;;STANTON JAMES WILLIAM;;GRIFFITHS JOSEPH NATHANIEL;;LAMBERT JONATHAN ANDREW GEORGE;;VAUGHAN NICHOLAS EDWARD;;KEHOE JAMES OWEN;;DE LA FUENTE FRANCISCO ERNESTO DE LA PENA;;MCKENNA NICHOLAS JAMES MICHAEL;;PORTER RACHAEL;;STAM SIMON MORDECHAI;;KEMPS DAVID ROBERT;;LYONS EDWIN JOSEPH;;MARTIN MADELEINE BESS;;SHOU ADA YIWEN;;LIU HUANG-KU,,https://lens.org/050-197-259-671-002,Granted Patent,no,0,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/16,,0,0,,,,PENDING
919,AU,A1,AU 2019/283948 A1,069-098-530-274-044,2020-01-23,2020,AU 2019/283948 A,2019-12-19,AU 2019/283948 A;;AU 2014/319043 A;;US 201462032462 P;;US 201361877622 P;;US 201361877566 P;;US 201461971474 P;;US 201361877736 P;;NZ 2014000202 W,2013-09-13,HUMIDIFICATION SYSTEM,"HUMIDIFICATION SYSTEM A humidification system can include a heater base, a chamber, and a breathing circuit. The heater base includes a heater plate positioned in a recessed region, and a heat conductive portion of the chamber is configured to contact the heater plate. The heater base includes a guard configured to control movement of the chamber into and out of the recessed region. The guard includes an anti-racking mechanism. The chamber includes an inlet port, an outlet port. A downward extension extends into the chamber from the inlet port, and a baffle is disposed at a lower end of the downward extension. A component of the breathing circuit can include a conduit hanging end cap for shipping and storage. The end cap can include a hanging component to allow the breathing circuit component to be hung from a medical stand. The system can detect when breathing circuits are connected in reverse.",FISHER & PAYKEL HEALTHCARE LTD,JACKSON JOHN JAMES;;MANON BARRY SHACK;;CORRALES VICTOR ROSALES;;VAN WORKUM STEFAN LEO;;EVANS STEPHEN DAVID;;HAMILTON MARK SAMUEL;;BUCKLEY PAUL FLEMING;;KLENNER JASON ALLAN;;OSBORNE HAMISH;;BOGGS SAMUEL GRAHAM;;STANTON JAMES WILLIAM;;GRIFFITHS JOSEPH NATHANIEL;;LAMBERT JONATHAN ANDREW GEORGE;;VAUGHAN NICHOLAS EDWARD;;KEHOE JAMES OWEN;;DE LA FUENTE FRANCISCO ERNESTO DE LA PENA;;MCKENNA NICHOLAS JAMES MICHAEL;;PORTER RACHAEL;;STAM SIMON MORDECHAI;;KEMPS DAVID ROBERT;;LYONS EDWIN JOSEPH;;MARTIN MADELEINE BESS;;SHOU ADA YIWEN;;LIU HUANG-KU;;ANDRESEN MICHAEL JOHN,,https://lens.org/069-098-530-274-044,Patent Application,no,0,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/16,,0,0,,,,ACTIVE
920,EP,A1,EP 3043854 A1,109-052-044-631-718,2016-07-20,2016,EP 14843707 A,2014-09-15,US 201361877566 P;;US 201361877622 P;;US 201361877736 P;;US 201461971474 P;;US 201462032462 P;;NZ 2014000202 W,2013-09-13,HUMIDIFICATION SYSTEM,,FISHER & PAYKEL HEALTHCARE LTD,JACKSON JOHN JAMES;;MANON BARRY SHACK;;CORRALES VICTOR ROSALES;;VAN WORKUM STEFAN LEO;;ANDRESEN MICHAEL JOHN;;EVANS STEPHEN DAVID;;HAMILTON MARK SAMUEL;;BUCKLEY PAUL FLEMING;;KLENNER JASON ALLAN;;OSBORNE HAMISH;;BOGGS SAMUEL GRAHAM;;STANTON JAMES WILLIAM;;GRIFFITHS JOSEPH NATHANIEL;;LAMBERT JONATHAN ANDREW GEORGE;;VAUGHAN NICHOLAS EDWARD;;KEHOE JAMES OWEN;;DE LA FUENTE FRANCISCO ERNESTO DE LA PENA;;MCKENNA NICHOLAS JAMES MICHAEL;;PORTER RACHAEL;;STAM SIMON MORDECHAI;;KEMPS DAVID ROBERT;;LYONS EDWIN JOSEPH;;MARTIN MADELEINE BESS;;LIU HUANG-KU;;SHOU ADA YIWEN,,https://lens.org/109-052-044-631-718,Patent Application,yes,0,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/16;;A61M16/00;;A61M16/08;;A61M16/10;;A61M39/08;;B29C53/78;;F16L11/16,,0,0,,,,ACTIVE
921,AU,A1,AU 2021/246104 A1,172-647-223-526-62X,2022-10-20,2022,AU 2021/246104 A,2021-04-02,US 202063004713 P;;US 2021/0025591 W,2020-04-03,Substituted 5-hydroxyindole compounds as modulators of alpha-1 antitrypsin,"Novel compounds, compositions, and methods of using and preparing the same, which may be useful for treating alpha-1 antitrypsin deficiency (AATD).",VERTEX PHARMA,GIROUX SIMON;;CLARK MICHAEL PHILIP;;TANG QING;;NUHANT PHILIPPE MARCEL;;JONES PETER;;MESSERSMITH DAVID;;BANDARAGE UPUL KEERTHI;;COTTRELL KEVIN MICHAEL;;BRODNEY MICHAEL AARON;;FLEMING GABRIELLE SIMONE;;WANG JIAN;;XU JINWANG;;DANIEL KEVIN BRETT;;BOYD MICHAEL JOHN;;MORRIS MARK A;;WAAL NATHAN D;;COLLIER PHILIP NOEL;;KESAVAN SARATHY;;RONKIN STEVEN M;;DENG HONGBO;;BOUCHER DIANE MARIE;;FANNING LEV T D;;HALL AMY B;;HURLEY DENNIS JAMES;;JOHNSON JR MAC ARTHUR;;MAXWELL JOHN PATRICK;;SWETT REBECCA JANE;;TAPLEY TIMOTHY LEWIS;;THOMSON STEPHEN A;;DAMAGNEZ VERONIQUE,,https://lens.org/172-647-223-526-62X,Patent Application,no,0,0,7,7,0,C07D209/10;;C07D209/14;;C07D209/12;;C07D209/22;;C07D209/24;;C07D209/42;;C07D401/04;;C07D405/04;;C07D403/04;;C07D405/14;;C07D409/04;;A61P11/00;;A61P29/00;;A61P43/00;;C07D209/22;;C07D209/24;;C07D401/04;;C07D403/04;;C07D405/04;;C07D405/14;;C07D409/04;;C07D413/06;;C07D413/14,C07D209/10;;A61K31/404;;A61P11/00;;A61P29/00;;A61P43/00;;C07D209/12;;C07D209/14;;C07D209/22;;C07D209/24;;C07D209/42;;C07D401/04;;C07D403/04;;C07D405/04;;C07D405/14;;C07D409/04,,0,0,,,,PENDING
922,GB,A,GB 2583008 A,008-625-074-117-545,2020-10-14,2020,GB 201917384 A,2014-09-15,US 201361877566 P;;US 201361877622 P;;US 201361877736 P;;US 201461971474 P;;US 201462032462 P;;GB 201604541 A,2013-09-13,Humidification system,The method comprises monitoring the parameters of flow gases performing one or more tests on the parameters to detect one or more flow anomalies.,FISHER & PAYKEL HEALTHCARE LTD,JOHN JAMES JACKSON;;BARRY SHACK MANON;;VICTOR ROSALES CORRALES;;STEFAN LEO VAN WORKUM;;MICHAEL JOHN ANDRESEN;;STEPHEN DAVID EVANS;;MARK SAMUEL HAMILTON;;PAUL FLEMING BUCKLEY;;JASON ALLAN KLENNER;;HAMISH ADRIAN OSBORNE;;SAMUEL GRAHAM BOGGS;;JAMES WILLIAM STANTON;;JOSEPH NATHANIEL GRIFFITHS;;JONATHAN ANDREW GEORGE LAMBERT;;NICHOLAS EDWARD VAUGHAN;;JAMES OWEN KEHOE;;FRANCISCO ERNESTO DE LA PENA DE LA FUENTE;;NICHOLAS JAMES MICHAEL MCKENNA;;RACHAEL PORTER;;SIMON MORDECHAI STAM;;DAVID ROBERT KEMPS;;EDWIN JOSEPH LYONS;;MADELEINE BESS MARTIN;;HUANG-KU LIU;;ADA YIWEN SHOU,,https://lens.org/008-625-074-117-545,Patent Application,no,3,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/16,,0,0,,,,ACTIVE
923,EP,A1,EP 3895750 A1,057-861-171-044-749,2021-10-20,2021,EP 21178872 A,2014-09-15,US 201361877566 P;;US 201361877622 P;;US 201361877736 P;;US 201461971474 P;;US 201462032462 P;;EP 19206758 A;;EP 14843707 A;;NZ 2014000202 W,2013-09-13,HUMIDIFICATION SYSTEM,"A respiratory humidification system comprising: a heater base comprising at least a chamber and a heat source, the chamber including an inlet and an outlet, the heat source configured to heat a liquid to humidify a flow of gases provided by the gases source and flowing from the inlet to the outlet of the chamber; one or more sensors positioned at or near the chamber inlet and/or outlet and configured to monitor parameters of the flow of gases when the respiratory humidification system is in a first operating mode; a hardware and/or software controller in electrical communication with the one or more sensors, the hardware and/or software controller configured to: detect one or more flow anomaly conditions (3012, 3014, 3016) using the monitored parameters when the humidification system is in the first operating mode; upon detection of the one or more flow anomaly conditions (3012, 3014, 3016), change the operating mode of the humidification system from the first operating mode (3010) to at least one second operating mode (3020) to determine a cause of the one or more flow anomaly conditions; and determine whether the flow of gases is reverse to a normal flow of gases under normal operating circumstances of the first operating mode using the monitored parameters when the humidification system operates in the at least second operating mode (3020).
 
 
",FISHER & PAYKEL HEALTHCARE LTD,JACKSON JOHN JAMES;;MANON BARRY SHACK;;CORRALES VICTOR ROSALES;;VAN WORKUM STEFAN LEO;;ANDRESEN MICHAEL JOHN;;EVANS STEPHEN DAVID;;HAMILTON MARK SAMUEL;;BUCKLEY PAUL FLEMING;;KLENNER JASON ALLAN;;OSBORNE HAMISH;;BOGGS SAMUEL GRAHAM;;STANTON JAMES WILLIAM;;GRIFFITHS JOSEPH NATHANIEL;;LAMBERT JONATHAN ANDREW GEORGE;;VAUGHAN NICHOLAS EDWARD;;KEHOE JAMES OWEN;;DE LA FUENTE FRANCISCO ERNESTO DE LA PENA;;MCKENNA NICHOLAS JAMES MICHAEL;;PORTER RACHAEL;;STAM SIMON MORDECHAI;;KEMPS DAVID ROBERT;;LYONS EDWIN JOSEPH;;MARTIN MADELEINE BESS;;LIU HUANG-KU;;SHOU ADA YIWEN,,https://lens.org/057-861-171-044-749,Patent Application,yes,9,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/00;;A61G11/00;;A61M16/08;;A61M16/10;;A61M16/16,,0,0,,,,PENDING
924,AU,A1,AU 2014/319043 A1,160-123-896-381-864,2016-03-31,2016,AU 2014/319043 A,2014-09-15,US 201462032462 P;;US 201361877622 P;;US 201361877566 P;;US 201461971474 P;;US 201361877736 P;;NZ 2014000202 W,2013-09-13,Humidification system,"A humidification system can include a heater base, a chamber, and a breathing circuit. The heater base includes a heater plate positioned in a recessed region, and a heat conductive portion of the chamber is configured to contact the heater plate. The heater base includes a guard configured to control movement of the chamber into and out of the recessed region. The guard includes an anti-racking mechanism. The system can detect when breathing circuits are connected in reverse. Methods of controlling the respiratory humidification system are described, including determining whether an outlet port temperature has increased by more than a predetermined amount in a predetermined time, or setting a target dew point. The system may comprise an inspiratory conduit comprising an identification component that outputs a signal to a controller configured to control power to a heater plate.",FISHER AND PAYKEL HEALTHCARE LTD,JACKSON JOHN JAMES;;MANON BARRY SHACK;;CORRALES VICTOR ROSALES;;VAN WORKUM STEFAN LEO;;ANDRESEN MICHAEL JOHN;;EVANS STEPHEN DAVID;;HAMILTON MARK SAMUEL;;BUCKLEY PAUL FLEMING;;KLENNER JASON ALLAN;;OSBORNE HAMISH;;BOGGS SAMUEL GRAHAM;;STANTON JAMES WILLIAM;;GRIFFITHS JOSEPH NATHANIEL;;LAMBERT JONATHAN ANDREW GEORGE;;VAUGHAN NICHOLAS EDWARD;;KEHOE JAMES OWEN;;DE LA FUENTE FRANCISCO ERNESTO DE LA PENA;;MCKENNA NICHOLAS JAMES MICHAEL;;PORTER RACHAEL;;STAM SIMON MORDECHAI;;KEMPS DAVID ROBERT;;LYONS EDWIN JOSEPH;;MARTIN MADELEINE BESS;;SHOU ADA YIWEN;;LIU HUANG-KU,,https://lens.org/160-123-896-381-864,Patent Application,no,0,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/16,,0,0,,,,ACTIVE
925,US,B2,US 11511069 B2,045-028-997-764-245,2022-11-29,2022,US 201415021616 A,2014-09-15,US 201415021616 A;;US 201361877566 P;;US 201361877622 P;;US 201361877736 P;;US 201461971474 P;;US 201462032462 P;;NZ 2014000202 W,2013-09-13,Humidification system,"A humidification system can include a heater base, a chamber, and a breathing circuit. The heater base includes a heater plate positioned in a recessed region, and a heat conductive portion of the chamber is configured to contact the heater plate. The heater base includes a guard configured to control movement of the chamber into and out of the recessed region. The guard includes an anti-racking mechanism. The chamber includes an inlet port, an outlet port. A downward extension extends into the chamber from the inlet port, and a baffle is disposed at a lower end of the downward extension. A component of the breathing circuit can include a conduit hanging end cap for shipping and storage. The end cap can include a hanging component to allow the breathing circuit component to be hung from a medical stand. The system can detect when breathing circuits are connected in reverse.",FISHER & PAYKEL HEALTHCARE LTD,JACKSON JOHN JAMES;;MANON BARRY SHACK;;CORRALES VICTOR ROSALES;;VAN WORKUM STEFAN LEO;;ANDRESEN MICHAEL JOHN;;EVANS STEPHEN DAVID;;HAMILTON MARK SAMUEL;;BUCKLEY PAUL FLEMING;;KLENNER JASON ALLAN;;OSBORNE HAMISH;;BOGGS SAMUEL GRAHAM;;STANTON JAMES WILLIAM;;GRIFFITHS JOSEPH NATHANIEL;;LAMBERT JONATHAN ANDREW GEORGE;;VAUGHAN NICHOLAS EDWARD;;KEHOE JAMES OWEN;;DE LA PE{HACEK OVER (N)}A DE LA FUENTE FRANCISCO ERNESTO;;MCKENNA NICHOLAS JAMES MICHAEL;;PORTER RACHAEL;;STAM SIMON MORDECHAI;;KEMPS DAVID ROBERT;;LYONS EDWIN JOSEPH;;MARTIN MADELEINE BESS;;SHOU ADA YIWEN;;LIU HUANG-KU,FISHER & PAYKEL HEALTHCARE LIMITED (2016-05-10),https://lens.org/045-028-997-764-245,Granted Patent,yes,511,0,31,337,0,A61M16/16;;A61M16/0875;;A61M2016/0033;;A61M2205/02;;A61M2205/14;;A61M2205/17;;A61M2205/18;;A61M2205/21;;A61M2205/3334;;A61M2205/3368;;A61M2205/6018;;A61M2205/6045;;A61M2209/06;;A61M2209/08;;A61M16/0833;;A61M16/108;;A61M16/1085;;A61M16/109;;A61M16/1095;;A61M16/168;;A61M16/024;;A61M16/16;;A61M16/022;;A61M16/1075;;A61M16/109;;A61M2205/3334;;A61M2205/3368;;A61M16/109;;A61M16/0875;;A61M2016/0033;;A61M16/108;;A61M16/1085;;A61M16/16;;A61M16/168;;A61M2205/17;;A61M2205/14;;A61M16/1095;;A61M16/0833;;A61M2205/02;;A61M2205/18;;A61M2205/6045;;A61M2209/08;;A61M2205/6018;;A61M2205/21;;A61M2209/06;;A61M16/161;;A61M16/0816;;A61M2205/0216;;A61M2205/123;;A61M2205/502;;A61M2205/6027,A61M16/16;;A61M16/00;;A61M16/08;;A61M16/10,,2,1,094-336-926-853-533,19467849;;10.1016/j.rmed.2009.04.007,"Dysart K et al. Research in high flow therapy: mechanisms of action. Respir Med. Oct. 2009;103(10):1400-5.;;International Search Report; PCT/NZ2014/000202; dated Jan. 13, 2015; 15 pages.",ACTIVE
